Citrus Sinensis ID: 043900
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 953 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.962 | 0.907 | 0.448 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.971 | 0.898 | 0.440 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.966 | 0.898 | 0.449 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.933 | 0.758 | 0.351 | 1e-132 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.874 | 0.85 | 0.353 | 1e-131 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.935 | 0.810 | 0.338 | 1e-121 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.926 | 0.785 | 0.328 | 1e-121 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.911 | 0.788 | 0.329 | 1e-120 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.935 | 0.817 | 0.333 | 1e-118 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.932 | 0.779 | 0.326 | 1e-117 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/956 (44%), Positives = 588/956 (61%), Gaps = 39/956 (4%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R+++RV L L L+L G ISP +GNLSFL L LY N F IP E +L RL+ L +
Sbjct: 63 RKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMG 122
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
N + G IP + +CS L+ +RL N L G +PSELGSL+ + L++ NN+ G +P+SL
Sbjct: 123 INYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL 182
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNL+ + L L+ NNL+G IP L + +L + N SG P +++N+SS+ G
Sbjct: 183 GNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIG 242
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N G + D G L NL F++ N TG+IP +SN S LE + N LTG +P
Sbjct: 243 YNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTF 302
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
L + + NSLGS +L FL SLTN T+L L I N GG LP I+NLS
Sbjct: 303 GNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAK 362
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L L L I G+IP IG +NLQ+L + N LSG +P ++G+L NLR L L N+
Sbjct: 363 LVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLS 422
Query: 361 GNIPPSIGNLKVF-NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G IP IGN+ + LDLS N +G +P+SLG L + + DN L GTIP + + +
Sbjct: 423 GGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQ 482
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
LL LD+S N L GS+P ++G L+NL L + +NKL G++P TLG+C +E L ++GN
Sbjct: 483 LL-RLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLF 541
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
G IP L L G+ +DLS N+LSG IPE+ F LE LNLS NNLEG VP++G+F+N
Sbjct: 542 YGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFEN 600
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISK--------ESKHKKLTLALKLALAIISGLTGLS 591
AT S++GN LCGGI FQL C+S+ S+ KK+ + + + + ++ L
Sbjct: 601 ATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLL-----LL 655
Query: 592 LALSFLILCLVRKRKEKKNPSSPINS-----FPNISYQNLYNATDGFASANEIGVGSFGS 646
L ++ + L +RKRK+ K ++P S ISY +L NAT+GF+S+N +G GSFG+
Sbjct: 656 LFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGT 715
Query: 647 VYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706
VYK +L K VAVKV N+ GA KSF+AEC +LK+IRHRNLVK+LTACS +D+QGN+
Sbjct: 716 VYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNE 775
Query: 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP 766
F+AL++EFM N SL+ WLHP E+ R+L LL+RLNI IDVA L YLH C P
Sbjct: 776 FRALIYEFMPNGSLDMWLHPEEVEE-IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 834
Query: 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGL 821
I HCDLKPSNVLLD+++ AHVSDFGLAR L Q SS +G+IGY APEYG+
Sbjct: 835 IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGV 894
Query: 822 GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSD 881
G + SINGDVYS+GILLLE+ T K+P + +F G+ L+++ + ALP+ ++DIVD ++L
Sbjct: 895 GGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHI 954
Query: 882 DEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937
+ +ECL + +G+ C ESP +R+ + VV++L SI+
Sbjct: 955 GLRVGF------------PVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/970 (44%), Positives = 564/970 (58%), Gaps = 44/970 (4%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RR +RV LNL KL G ISP +GNLSFL++L L +NSF IP + RL RLQ L ++
Sbjct: 70 RRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMS 129
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
N + G IP+++S+CS L + L N L +PSELGSLSK+ L +S NNLTG+ P+SL
Sbjct: 130 YNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASL 189
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNL+S+ L N + G IPD L + +A N SG P +++NISS+ +
Sbjct: 190 GNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLA 249
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY- 239
N G + DFG+ L NL+ + NQ TGAIP ++N S+LE F N L+G +P
Sbjct: 250 DNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLS 309
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
K + L I NSLG+ S L F+ ++ N T+L L + N GG LPA I+NLST
Sbjct: 310 FGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLST 369
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF 359
TL L L N I G IP IG V+LQ L + N LSG +P + G+L NL+ + L N
Sbjct: 370 TLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAI 429
Query: 360 LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
G IP GN+ ++ L L+ N G IP SLG+ + L + + N L GTIP + L +
Sbjct: 430 SGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIP 489
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
L +DLS N LTG P EVG L+ L L NKL G++P +G C +E L MQGN
Sbjct: 490 SLAY-IDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNS 548
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFK 538
G IP +S L L +D S NNLSG+IP +L L NLNLS N EG VP GVF+
Sbjct: 549 FDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFR 607
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKES--KHKKLTLALKLALAIISGLTGLSLALSF 596
NAT SV GN +CGG+ E QL CI + S K K L++ K+ I G+ L L +
Sbjct: 608 NATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIV 667
Query: 597 LILCLVRKRKEKKNPS--SPINS------FPNISYQNLYNATDGFASANEIGVGSFGSVY 648
LC KRK+K N S +P +S +SY+ L++AT F+S N IG G+FG+V+
Sbjct: 668 ASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVF 727
Query: 649 KGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708
KG+L VAVKV NLL HGA KSF+AEC T K IRHRNLVK++T CS +D +GNDF+
Sbjct: 728 KGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFR 787
Query: 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768
ALV+EFM SL+ WL + ++ + RSL ++LNI IDVA AL YLH C P+
Sbjct: 788 ALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVA 846
Query: 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLGS 823
HCD+KPSN+LLD+++ AHVSDFGLA+ L Q SS +G+IGY APEYG+G
Sbjct: 847 HCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGG 906
Query: 824 EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDE 883
+ SI GDVYS+GILLLE+ + KKP D F GD NLH++ + L S S
Sbjct: 907 QPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL---------SGCTSSGG 957
Query: 884 DLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943
A+ E L ++++G+ CS E P DRM VR+L SI++
Sbjct: 958 SNAID--------------EGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003
Query: 944 R-IVSNMQRD 952
+ ++ RD
Sbjct: 1004 KTTITESPRD 1013
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/953 (44%), Positives = 568/953 (59%), Gaps = 32/953 (3%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNN 61
+H+RV ++L LKL G +SP VGNLSFL+ L L +N F+ IPSE L RLQ L ++N
Sbjct: 79 KHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSN 138
Query: 62 NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121
N GG IP +S+CS+L + L N L +P E GSLSK+ LS+ NNLTG P+SLG
Sbjct: 139 NLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLG 198
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181
NL+S+ L N ++G IP LK + +A N +G P I+N+SS+
Sbjct: 199 NLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITG 258
Query: 182 NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-L 240
N G + DFG L NLQ + N TG IP +SN S+L N LTG++P
Sbjct: 259 NSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSF 318
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
+ Q L + + NSLG+ +L+FL +LTN ++L L + N GG LP I+NLST
Sbjct: 319 GRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQ 378
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L L L N I G+IP IG V+LQ L++ N L+G +PP++GEL LR++ L N
Sbjct: 379 LTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLS 438
Query: 361 GNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G IP S+GN+ L L N +GSIPSSLG L ++L N L G+IP + + L
Sbjct: 439 GEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPS 498
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L++ L++S N L G + ++G LK L LDV NKL G+IP TL +C LE L +QGN
Sbjct: 499 LVV-LNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSF 557
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
GPIP + L GL LDLS+NNLSG IPE++ F L+NLNLS NN +G VP EGVF+N
Sbjct: 558 VGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRN 616
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISK-----ESKHKKLTLALKLALAIISGLTGLSLAL 594
+ SV GN+ LCGGIP QL C + S K +T+ + +A + L + L
Sbjct: 617 TSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYL 676
Query: 595 SFLILCLVRKRK---EKKNPSSPINSF-PNISYQNLYNATDGFASANEIGVGSFGSVYKG 650
+ L + R E SP+ SF ISY LY T GF+S+N IG G+FG+V+KG
Sbjct: 677 CWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG 736
Query: 651 ILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710
L VA+KV NL GA KSFIAEC L IRHRNLVK++T CS D++GNDF+AL
Sbjct: 737 FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRAL 796
Query: 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHC 770
V+EFM N +L+ WLHP E+ T R+L L RLNI IDVA AL YLH C PI HC
Sbjct: 797 VYEFMPNGNLDMWLHPDEIEE-TGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHC 855
Query: 771 DLKPSNVLLDEEMMAHVSDFGLARFL-----PLSPAQTSSIDAKGSIGYIAPEYGLGSEV 825
D+KPSN+LLD+++ AHVSDFGLA+ L Q SS +G+IGY APEYG+G
Sbjct: 856 DIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHP 915
Query: 826 SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD-HVVDIVDSTLLSDDED 884
SI GDVYS+GI+LLE+ T K+P + +F + LH+F + AL +DI D T+L
Sbjct: 916 SIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL----- 970
Query: 885 LAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937
R A+ + +ECL + R+GV+CS ESP +R++M + +L SI+
Sbjct: 971 -------RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 347/986 (35%), Positives = 506/986 (51%), Gaps = 96/986 (9%)
Query: 16 LAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSC 75
L GSI +G L+ L L L N IP +F L LQ L L N + G+IPA I +C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 76 SNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN 135
S+L+Q+ L+ N+L GKIP+ELG+L +++ L + N LT SIPSSL L+ + L L++N+
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 136 LDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFT 195
L G I + G+L++L L + N +G P SI N+ ++T G N + G +P D G
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382
Query: 196 LQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENS 255
L NL+ S +N LTG IP +ISN + L+L N++TGE+P L+ SI N
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNH 442
Query: 256 LGSR------GHSNLNFLCSLTNS------------TRLNRLLINANNFGGLLPACISNL 297
SNL L N+ +L L ++ N+ G +P I NL
Sbjct: 443 FTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNL 502
Query: 298 STTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRN 357
L +L L +N G IP + LQ L M++N L G IP + +++ L L L N
Sbjct: 503 KD-LNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNN 561
Query: 358 KFLGNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLG 416
KF G IP L+ L L N GSIP+SL L D+SDN LTGTIP + L
Sbjct: 562 KFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLA 621
Query: 417 -LSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEM- 474
L + + L+ S N LTG+IP E+G L+ ++ +D+ N G IP +L +CK + L+
Sbjct: 622 SLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFS 681
Query: 475 -------------QG-----------NFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEF 510
QG N G IP S ++ L LDLS NNL+G+IPE
Sbjct: 682 QNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPES 741
Query: 511 LVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCISKESKH 570
L L++L L++NNL+G VP GVFKN + ++GN LCG + T K S
Sbjct: 742 LANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHF 801
Query: 571 KKLTLALKLALAIISGLTGLSLALSFLILCLVRKRKEKKNPSSPINSFPNISY------- 623
K T + + L + L + L + L C +++K + + S S P++
Sbjct: 802 SKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSES---SLPDLDSALKLKRF 858
Query: 624 --QNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAEC 679
+ L ATD F SAN IG S +VYKG L+ G T +AVKV NL A K F E
Sbjct: 859 EPKELEQATDSFNSANIIGSSSLSTVYKGQLEDG-TVIAVKVLNLKEFSAESDKWFYTEA 917
Query: 680 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS 739
TL ++HRNLVKIL G ++ KALV FM+N +LE+ +H AP
Sbjct: 918 KTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIH-------GSAAPIG 966
Query: 740 LNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS 799
+LL+++++ + +A + YLH PI HCDLKP+N+LLD + +AHVSDFG AR L
Sbjct: 967 -SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFR 1025
Query: 800 P--AQTSSIDA-KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG-- 854
+ T+S A +G+IGY+APE+ +V+ DV+S+GI+++EL+T+++P E
Sbjct: 1026 EDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQ 1085
Query: 855 DMNLHNFARMALPD---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRI 911
DM L ++ + +V ++D L D V Q E + +++
Sbjct: 1086 DMTLRQLVEKSIGNGRKGMVRVLDMEL----GDSIVSLKQE----------EAIEDFLKL 1131
Query: 912 GVACSMESPGDRMNMTNVVRQLQSIK 937
+ C+ P DR +M ++ L ++
Sbjct: 1132 CLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1208), Expect = e-131, Method: Compositional matrix adjust.
Identities = 334/945 (35%), Positives = 495/945 (52%), Gaps = 112/945 (11%)
Query: 57 LALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSI 116
L ++ +GGEI +I++ + L + L N VGKIP E+GSL +
Sbjct: 71 LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHE--------------- 115
Query: 117 PSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF---NISS 173
++ L L++N L G IP G L L L + N L+G+IP +F + SS
Sbjct: 116 --------TLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSS 167
Query: 174 ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKL 233
+ D N L G IPL++ L+ L+F ++ N+LTG +P ++SN++NL+ + N L
Sbjct: 168 LQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNML 227
Query: 234 TGEVP--YLEKPQRLSVFSITENSLGSRGH-SNLN-FLCSLTNSTRLNRLLINANNFGGL 289
+GE+P + K +L ++ N S + +NL F SL NS+ L L + N+ GG
Sbjct: 228 SGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGE 287
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPAAIG------------------------KFVNL 325
+ + + +LS L + LD N+I G+IP I K L
Sbjct: 288 ITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKL 347
Query: 326 QRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQG 384
+R+ + NN L+G IP +G++ L L + RN G+IP S GNL ++ L L N L G
Sbjct: 348 ERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSG 407
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLG-LSWLLIGLDLSRNQLTGSIPSEVGNLK 443
++P SLG+ L I+DLS NNLTGTIP + + L L + L+LS N L+G IP E+ +
Sbjct: 408 TVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMD 467
Query: 444 NLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
+ +D+ N+L G+IP LGSC LE L + N +PSSL L L LD+S N L
Sbjct: 468 MVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRL 527
Query: 504 SGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTC 563
+G IP L++LN S N L G V +G F TI S LG+ LCG I Q C
Sbjct: 528 TGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--AC 585
Query: 564 ISKESKHKKLTLALKLALAIISGLTGLSLALSFLILCLVR-------------KRKEKKN 610
+ KHK ++ L + L++I+ T + + ++ R + +EK+N
Sbjct: 586 ---KKKHKYPSVLLPVLLSLIA--TPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQN 640
Query: 611 PSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG 670
+ P +P ISYQ L AT GF +++ IG G FG VYKG+L + T VAVKV +
Sbjct: 641 QNDP--KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTAL 697
Query: 671 AFK-SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITR 729
F SF EC LK RHRNL++I+T CS F ALV M N SLE L+P
Sbjct: 698 EFSGSFKRECQILKRTRHRNLIRIITTCSKP-----GFNALVLPLMPNGSLERHLYP--- 749
Query: 730 EDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789
E + ++L+L+Q +NI DVA ++YLHH + HCDLKPSN+LLD+EM A V+D
Sbjct: 750 ---GEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTD 806
Query: 790 FGLARFLPLSPAQTSSIDAK----------GSIGYIAPEYGLGSEVSINGDVYSYGILLL 839
FG++R + S+ D+ GS+GYIAPEYG+G S +GDVYS+G+LLL
Sbjct: 807 FGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLL 866
Query: 840 ELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN 899
E+V+ ++P D + +LH F + PD + I++ A+ + Q +
Sbjct: 867 EIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQ---------ALSRWKPQGKPEKC 917
Query: 900 SKI--ECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942
K+ E ++ M+ +G+ C+ +P R +M +V ++ +K L
Sbjct: 918 EKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFA 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 437 bits (1125), Expect = e-121, Method: Compositional matrix adjust.
Identities = 330/976 (33%), Positives = 489/976 (50%), Gaps = 84/976 (8%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
+K L L L GSI +GNLS L+ L++Y+N+ IP +L++L+++ N
Sbjct: 141 LKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFS 200
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
G IP+ IS C +L + L N L G +P +L L + L + N L+G IP S+GN+S
Sbjct: 201 GVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISR 260
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
+ L L +N G IP G L + L + N L+G IP I N+ D NQL
Sbjct: 261 LEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLT 320
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-LEKPQ 244
G IP +FG L NL+ +FEN L G IP + + LE +N+L G +P L+
Sbjct: 321 GFIPKEFGHIL-NLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLP 379
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
L + +N L + + F + + L ++AN+ G +PA TL +L
Sbjct: 380 YLVDLQLFDNQLEGKIPPLIGFY------SNFSVLDMSANSLSGPIPAHFCRFQ-TLILL 432
Query: 305 LLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP 364
L +NK+ GNIP + +L +L + +N+L+G++P + LQNL L L +N GNI
Sbjct: 433 SLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNIS 492
Query: 365 PSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIG 423
+G LK + L L+ N G IP +G + ++S N LTG IP + LG +
Sbjct: 493 ADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKE-LGSCVTIQR 551
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LDLS N+ +G I E+G L LE+L + +N+L GEIP + G +L +L++ GN L I
Sbjct: 552 LDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENI 611
Query: 484 PSSLSSLKGLNV-LDLSQNNLSGKIPEFLVGFQLLENL---------------------- 520
P L L L + L++S NNLSG IP+ L Q+LE L
Sbjct: 612 PVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLL 671
Query: 521 --NLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLT--LA 576
N+SNNNL G VP VF+ ++ GN LC P +SK L
Sbjct: 672 ICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQ 731
Query: 577 LKLALAIISGLTGLSLALSFLILCLVRKRKEKKNPSSPINSFPNI-----------SYQN 625
+ L I + G ++FL LC KR+E + + P++ +YQ
Sbjct: 732 RQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQG 791
Query: 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK--SFIAECNTLK 683
L +AT F+ +G G+ G+VYK + G+ +AVK N GA SF AE +TL
Sbjct: 792 LVDATRNFSEDVVLGRGACGTVYKAEMSGGE-VIAVKKLNSRGEGASSDNSFRAEISTLG 850
Query: 684 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
IRHRN+VK+ C Y N L++E+M SL E L + E L+
Sbjct: 851 KIRHRNIVKLYGFC----YHQNS-NLLLYEYMSKGSLGEQL-------QRGEKNCLLDWN 898
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
R I + A L YLHHDC+P I H D+K +N+LLDE AHV DFGLA+ + LS +++
Sbjct: 899 ARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKS 958
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863
S A GS GYIAPEY +V+ D+YS+G++LLEL+T K PV + +G +L N+ R
Sbjct: 959 MSAVA-GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVR 1016
Query: 864 MALPDHV--VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921
++ + + +++ D+ L ++D+ VH + +++I + C+ SP
Sbjct: 1017 RSIRNMIPTIEMFDARLDTNDKR-TVHE---------------MSLVLKIALFCTSNSPA 1060
Query: 922 DRMNMTNVVRQLQSIK 937
R M VV + +
Sbjct: 1061 SRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 325/988 (32%), Positives = 494/988 (50%), Gaps = 105/988 (10%)
Query: 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+++ N+ + KL+G + +G+L L+ L+ Y N+ +P L +L N
Sbjct: 158 QLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDF 217
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLS 124
G IP I C NL + L N + G++P E+G L K++ + + N +G IP +GNL+
Sbjct: 218 SGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLT 277
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184
S+ TL L N+L G IP G +K+L L + +N L+GTIP + +S + D N L
Sbjct: 278 SLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLL 337
Query: 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP----YL 240
G IP++ + L+ +F+N+LTG IP +S NL +N LTG +P L
Sbjct: 338 SGEIPVELS-KISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNL 396
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
++L +F NSL L L + + N G +P I S
Sbjct: 397 TSMRQLQLF---HNSLSGVIPQGLGLYSPLW------VVDFSENQLSGKIPPFICQQS-N 446
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L +L L +N+IFGNIP + + +L +L + NRL+G P + +L NL + L +N+F
Sbjct: 447 LILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFS 506
Query: 361 GNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G +PP IG K+ L L+ N ++P+ + + L ++S N+LTG IP +
Sbjct: 507 GPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCK- 565
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
+L LDLSRN GS+P E+G+L LE+L + EN+ G IP T+G+ L +L+M GN
Sbjct: 566 MLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLF 625
Query: 480 QGPIPSSLSSLKGLNV-LDLSQNNLSGKIPEFLVGFQLL------------------ENL 520
G IP L L L + ++LS N+ SG+IP + LL ENL
Sbjct: 626 SGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENL 685
Query: 521 ------NLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLT 574
N S NNL G +P +F+N T+TS LGN LCGG L +C S ++
Sbjct: 686 SSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHIS 741
Query: 575 LALKLALA--------IISGLTGLSLALSFLILCLVRKRKEKKNP----------SSPIN 616
+LK A + S + G+SL L +++ +R E P S I
Sbjct: 742 -SLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIY 800
Query: 617 SFPN--ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN-------LL 667
P + +++ AT GF + +G G+ G+VYK ++ GK T+AVK
Sbjct: 801 FVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGK-TIAVKKLESNREGNNNN 859
Query: 668 HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPI 727
+ SF AE TL IRHRN+V++ + C +QG++ L++E+M SL E LH
Sbjct: 860 SNNTDNSFRAEILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMSRGSLGELLH-- 914
Query: 728 TREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
S++ R I + A L+YLHHDC+P I H D+K +N+L+DE AHV
Sbjct: 915 ------GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHV 968
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
DFGLA+ + + P S GS GYIAPEY +V+ D+YS+G++LLEL+T K P
Sbjct: 969 GDFGLAKVIDM-PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
Query: 848 VDSMFEGDMNLHNFARMALPDHVV--DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 905
V + +G +L + R + DH + +I+D L ++D+ ++ +
Sbjct: 1028 VQPLEQGG-DLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNH---------------M 1071
Query: 906 VAMVRIGVACSMESPGDRMNMTNVVRQL 933
+ + +I V C+ SP DR M VV L
Sbjct: 1072 ITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1116), Expect = e-120, Method: Compositional matrix adjust.
Identities = 321/973 (32%), Positives = 493/973 (50%), Gaps = 104/973 (10%)
Query: 15 KLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISS 74
+++GS+ +GNL L L+ Y+N+ + +P L+RL N I G +P+ I
Sbjct: 156 RISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGG 215
Query: 75 CSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDN 134
C +L+ + L N+L G++P E+G L K+ + + N +G IP + N +S+ TL L N
Sbjct: 216 CESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKN 275
Query: 135 NLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGF 194
L G IP G L++L L + N L+GTIP I N+S D N L G IPL+ G
Sbjct: 276 QLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELG- 334
Query: 195 TLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-LEKPQRLSVFSITE 253
++ L+ +FENQLTG IP +S NL +N LTG +P + + L + + +
Sbjct: 335 NIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQ 394
Query: 254 NSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG 313
NSL L + L L ++ N+ G +P+ + L + + +L L N + G
Sbjct: 395 NSLSGTIPPKLGWYSDLW------VLDMSDNHLSGRIPSYLC-LHSNMIILNLGTNNLSG 447
Query: 314 NIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVF 373
NIP I L +L + N L G P + + N+ + L +N+F G+IP +GN
Sbjct: 448 NIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSAL 507
Query: 374 N-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT 432
L L+ N G +P +G L +++S N LTG +P + +L LD+ N +
Sbjct: 508 QRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCK-MLQRLDMCCNNFS 566
Query: 433 GSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKG 492
G++PSEVG+L LE+L + N L G IP LG+ +L +L+M GN G IP L SL G
Sbjct: 567 GTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTG 626
Query: 493 LNV-LDLSQNNLSGKIPEFLVGFQLLE------------------------NLNLSNNNL 527
L + L+LS N L+G+IP L +LE N S N+L
Sbjct: 627 LQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSL 686
Query: 528 EGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCIS------KESKHKKLTLALKLAL 581
G +P+ +N +++S +GN LCG L CI +S K + +
Sbjct: 687 TGPIPL---LRNISMSSFIGNEGLCGP----PLNQCIQTQPFAPSQSTGKPGGMRSSKII 739
Query: 582 AIISGLTG-LSLALSFLILCLVRKRKEKKNPSSPINSFPN-------------ISYQNLY 627
AI + + G +SL L LI+ L+R R + SS + P+ ++Q+L
Sbjct: 740 AITAAVIGGVSLMLIALIVYLMR-RPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798
Query: 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-----FKSFIAECNTL 682
ATD F + +G G+ G+VYK +L G T+AVK H G SF AE TL
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAG-YTLAVKKLASNHEGGNNNNVDNSFRAEILTL 857
Query: 683 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
NIRHRN+VK+ C ++QG++ L++E+M SL E LH + +L+
Sbjct: 858 GNIRHRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEILH---------DPSCNLDW 903
Query: 743 LQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
+R I + A L+YLHHDC+P I H D+K +N+LLD++ AHV DFGLA+ + + ++
Sbjct: 904 SKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSK 963
Query: 803 TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862
+ S A GS GYIAPEY +V+ D+YSYG++LLEL+T K PV + +G ++ N+
Sbjct: 964 SMSAIA-GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWV 1021
Query: 863 RMALPDHVVD--IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920
R + + ++D+ L +DE + H ++ +++I + C+ SP
Sbjct: 1022 RSYIRRDALSSGVLDARLTLEDERIVSH----------------MLTVLKIALLCTSVSP 1065
Query: 921 GDRMNMTNVVRQL 933
R +M VV L
Sbjct: 1066 VARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 320/960 (33%), Positives = 491/960 (51%), Gaps = 68/960 (7%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVL-ALN 60
R +++K L+L + L G I +GNLS L L+L++N + IP L+ LQVL A
Sbjct: 139 RLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGG 198
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
N ++ GE+P I +C NL+ + L L GK+P+ +G+L +++ +++ + L+G IP +
Sbjct: 199 NKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEI 258
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
G + + L+L N++ G IP T G LK L +L + +N L G IP+ + N + D
Sbjct: 259 GYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFS 318
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N L G IP FG L+NLQ + NQ++G IP ++N + L + D N +TGE+P L
Sbjct: 319 ENLLTGTIPRSFG-KLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSL 377
Query: 241 EKPQR-LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
R L++F +N L N SL+ L + ++ N+ G +P I L
Sbjct: 378 MSNLRSLTMFFAWQNKLTG------NIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRN 431
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF 359
++LLL N+ + G IP IG NL RL + NRL+G+IP IG L+NL + + N+
Sbjct: 432 LTKLLLLSND-LSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRL 490
Query: 360 LGNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQY--KTLTIIDLSDNNLTGTIPPQFLG 416
+G+IPP+I + LDL N L GS+ LG K+L ID SDN L+ T+PP +G
Sbjct: 491 VGSIPPAISGCESLEFLDLHTNSLSGSL---LGTTLPKSLKFIDFSDNALSSTLPPG-IG 546
Query: 417 LSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLE-QLEMQ 475
L L L+L++N+L+G IP E+ ++L++L++ EN GEIP LG L L +
Sbjct: 547 LLTELTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLS 606
Query: 476 GNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535
N G IPS S LK L VLD+S N L+G + L Q L +LN+S N+ G +P
Sbjct: 607 CNRFVGEIPSRFSDLKNLGVLDVSHNQLTGNL-NVLTDLQNLVSLNISYNDFSGDLPNTP 665
Query: 536 VFKNATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALS 595
F+ ++ + N L P ++ S +LT I+ + ++ +
Sbjct: 666 FFRRLPLSDLASNRGLYISNAISTRPDPTTRNSSVVRLT--------ILILVVVTAVLVL 717
Query: 596 FLILCLVRKRKEKKN-PSSPINSFPNISYQNLYNATD----GFASANEIGVGSFGSVYKG 650
+ LVR R K I+S+ YQ L + D SAN IG GS G VY+
Sbjct: 718 MAVYTLVRARAAGKQLLGEEIDSWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRI 777
Query: 651 ILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710
+ G++ K+++ GAF S E TL +IRHRN+V++L CS + K L
Sbjct: 778 TIPSGESLAVKKMWSKEESGAFNS---EIKTLGSIRHRNIVRLLGWCS-----NRNLKLL 829
Query: 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHC 770
++++ N SL LH + ++ R ++ + VA AL+YLHHDC P I H
Sbjct: 830 FYDYLPNGSLSSRLHGAGKGG-------CVDWEARYDVVLGVAHALAYLHHDCLPTIIHG 882
Query: 771 DLKPSNVLLDEEMMAHVSDFGLARFLPLSP-------AQTSSIDAKGSIGYIAPEYGLGS 823
D+K NVLL +++DFGLAR + P T+ GS GY+APE+
Sbjct: 883 DVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQ 942
Query: 824 EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDE 883
++ DVYSYG++LLE++T K P+D G +L + R DH+ + D + L D
Sbjct: 943 RITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVR----DHLAEKKDPSRLLDP- 997
Query: 884 DLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943
+ R +S + ++ + + C +R M +VV L I++I +G
Sbjct: 998 ---------RLDGRTDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTEIRHIDVGR 1048
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1090), Expect = e-117, Method: Compositional matrix adjust.
Identities = 313/960 (32%), Positives = 485/960 (50%), Gaps = 71/960 (7%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN-NN 62
+ ++ L L S +L G I P + S LK L+L++N IP+E +L L+V+ + N
Sbjct: 153 RNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNK 212
Query: 63 SIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGN 122
I G+IP+ I CSNL + L + G +PS LG L K+E LS+ ++G IPS LGN
Sbjct: 213 EISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGN 272
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
S + LFL +N+L G IP G L L L + +N L G IP I N S++ D +N
Sbjct: 273 CSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-YLE 241
L G IP G L L+ F + +N+ +G+IP ISN S+L Q D N+++G +P L
Sbjct: 333 LLSGSIPSSIG-RLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELG 391
Query: 242 KPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTL 301
+L++F N L + L + T L L ++ N+ G +P+ + L L
Sbjct: 392 TLTKLTLFFAWSNQLEG------SIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLR-NL 444
Query: 302 EMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLG 361
LLL +N + G IP IG +L RL + NR++G IP IG L+ + L N+ G
Sbjct: 445 TKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHG 504
Query: 362 NIPPSIGNLKVFNL-DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420
+P IG+ + DLS N L+GS+P+ + L ++D+S N +G IP LG
Sbjct: 505 KVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPAS-LGRLVS 563
Query: 421 LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLE-QLEMQGNFL 479
L L LS+N +GSIP+ +G L++LD+ N+L GEIPS LG + LE L + N L
Sbjct: 564 LNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRL 623
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
G IPS ++SL L++LDLS N L G + L + L +LN+S N+ G +P +F+
Sbjct: 624 TGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQ 682
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISKESKHKKL------TLALKLALAIISGLTGLSLA 593
+ + GN KLC + +C K L + KL L + +T +
Sbjct: 683 LSPQDLEGNKKLCSSTQD----SCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVL 738
Query: 594 LSFLILCLVRKRK----EKKNPSSPINSFPNISYQNLYNATDG----FASANEIGVGSFG 645
+ + ++R R+ E+ + + +Q L + D N IG G G
Sbjct: 739 MILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSG 798
Query: 646 SVYKGILDQGKTTVAVKVFNLLHHGAF--------KSFIAECNTLKNIRHRNLVKILTAC 697
VY+ +D G+ K++ + +G SF AE TL IRH+N+V+ L C
Sbjct: 799 VVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCC 858
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ + L++++M N SL LH E SL+ R I + A L+
Sbjct: 859 -----WNRNTRLLMYDYMPNGSLGSLLH--------ERRGSSLDWDLRYRILLGAAQGLA 905
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAP 817
YLHHDC PPI H D+K +N+L+ + +++DFGLA+ + S GS GYIAP
Sbjct: 906 YLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAP 965
Query: 818 EYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDST 877
EYG +++ DVYSYG+++LE++T K+P+D ++L ++ R ++++DST
Sbjct: 966 EYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDST 1023
Query: 878 LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937
L ++R ++ + ++ ++ + C SP +R M +V L+ IK
Sbjct: 1024 L----------------RSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 953 | ||||||
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.972 | 0.577 | 0.0 | |
| 255581223 | 1015 | receptor-kinase, putative [Ricinus commu | 0.976 | 0.917 | 0.560 | 0.0 | |
| 255586722 | 936 | serine-threonine protein kinase, plant-t | 0.975 | 0.993 | 0.562 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.976 | 0.911 | 0.543 | 0.0 | |
| 224119102 | 1007 | predicted protein [Populus trichocarpa] | 0.973 | 0.921 | 0.527 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.980 | 0.923 | 0.525 | 0.0 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.985 | 0.917 | 0.521 | 0.0 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.895 | 0.885 | 0.552 | 0.0 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.989 | 0.906 | 0.517 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.990 | 0.923 | 0.508 | 0.0 |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/950 (57%), Positives = 684/950 (72%), Gaps = 12/950 (1%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RRHQRV +L+L S KL GSISPH+GNLSFL+VL L N FNH IP E L+RLQ+L L+
Sbjct: 6 RRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQMLFLS 65
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NNS+ GEIPAN+SSCS L+ I + +N LVGKIP+ELGSLSK+++L + N+L+G IP S
Sbjct: 66 NNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGGIPRSF 125
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNLSS+ L T NN+ G IP + L L +A+ N LSGTIP S+ N+SS+ F
Sbjct: 126 GNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLIFFAVS 185
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N L G +P + G TL NLQ S+ N+ TG+IP ++SNASNLE F + N LTG+VP L
Sbjct: 186 FNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTGKVPSL 245
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
EK QRL FS+T N+LG+ +L FL SLTN + L L +N NNFGG+LP I N ST
Sbjct: 246 EKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESIGNWSTK 305
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L LLLD NKI G+IPA IG V+L+RLEMW N+LSG+IP IG+LQNLR L L +NK
Sbjct: 306 LATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLMLIKNKLS 365
Query: 361 GNIPPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G +P S+GNL+ + L L N+ QG IPSSLG+ + L +DLS NNL+GTIPPQ + LS
Sbjct: 366 GILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQVVSLSS 425
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L I LD+S N+LTG++P EVGNLKNL VLDV N L G IPS++GSC LE L M+GNF
Sbjct: 426 LSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSMKGNFF 485
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFL--VGFQLLENLNLSNNNLEGMVPIEGVF 537
QG IPSS SSL+G+ +LDLS NNLSGKIPEFL + FQL +NLS N+ EG++P EGVF
Sbjct: 486 QGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQL---VNLSYNDFEGILPTEGVF 542
Query: 538 KNATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFL 597
KN + TS++GN KLCGGIPEFQLP C +E K + L+LALK+ +A +SGL ++ LSFL
Sbjct: 543 KNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVLSFL 602
Query: 598 ILCLVRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKT 657
I +RK+K + SS S +SYQ+L ATDGF+S+N IGVGSFGSVYKGILD T
Sbjct: 603 IFLWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGT 662
Query: 658 TVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQN 717
+AVKV NLL GA KSFIAEC L+NIRHRNLVK+LTACSGVDYQGNDFKA+V+EFM N
Sbjct: 663 AIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVN 722
Query: 718 RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNV 777
SLE+WLHP + PR LN LQRLNI IDVACAL YLHH CQ PI HCDLKPSNV
Sbjct: 723 GSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNV 782
Query: 778 LLDEEMMAHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLGSEVSINGDVY 832
LLD EM HV DFG+A+FLP + Q+SSI +G+IGY APEYG+GSEVS +GDVY
Sbjct: 783 LLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVY 842
Query: 833 SYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQR 892
S+GILLLE+ T K+P + MF+ +N+HNF + A+P+ V +I D LL + ++ +QR
Sbjct: 843 SFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQR 902
Query: 893 QRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942
R A + ECL+++ IG+ACS E P +R N+T+ +L S+++I LG
Sbjct: 903 -RMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFLG 951
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2518), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/955 (56%), Positives = 661/955 (69%), Gaps = 24/955 (2%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RRHQRV ILNL SL+LAGSISPH+GNLSFL+ L L NNSF+HGIP E RL+RLQ L L+
Sbjct: 72 RRHQRVAILNLRSLQLAGSISPHIGNLSFLRDLYLQNNSFSHGIPPEVGRLRRLQRLRLS 131
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NNS+ G IP+NIS+CS L +I YN+L G+IP EL L+K++ +S+ N +GSIP S+
Sbjct: 132 NNSLTGNIPSNISACSKLSEIYFAYNQLEGEIPEELSLLAKLQVISIQKNYFSGSIPPSI 191
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNLSS+ L +N L G IPD G L NL ++++ N LSGTIP SI+N+SSI +
Sbjct: 192 GNLSSLQVLSAPENYLSGNIPDAIGQLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNIV 251
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
NQ+QG +P + G TL NLQ F++ N G+IP + SNASNL NKLTG VP L
Sbjct: 252 YNQIQGRLPSNLGITLPNLQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTGRVPSL 311
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
E+ L + + N LG + +L+F+ SL N T L RL I+ N F G+LP ISN STT
Sbjct: 312 EQLHNLQILGLGYNYLGLEAN-DLDFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFSTT 370
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L++ N I G IP++I VNL+RLEM NN+LSG IP G L L+ L L NK
Sbjct: 371 FSQLVIAENNIAGRIPSSISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNKLS 430
Query: 361 GNIPPSIGNLKV-FNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G IP S+GNL + L N LQG IPSSL + + L ++DL+ NNL+G+IP Q GLS
Sbjct: 431 GTIPSSLGNLTMLLTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGLSS 490
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L I LDLS N TG IP EVGNLK+LE L + +N L G IP +LGSC KLE L +QGNF
Sbjct: 491 LSIALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGNFF 550
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
G +PSSLSSL+GL VLD S NNLSG+IPEFL F LLE+LNLS NN EG VP+EG+F+N
Sbjct: 551 DGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRN 610
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLIL 599
A+ T V+GN KLCGGIPEF L C +K KKLTL LK+ ++ I L GLS L F +
Sbjct: 611 ASTTLVMGNDKLCGGIPEFHLAKCNAKSP--KKLTLLLKIVISTICSLLGLSFILIFALT 668
Query: 600 CLVRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTV 659
+RK+KE+ + N+S+Q+L ATDGF+SAN IG GSFG VYKG LD+G T+
Sbjct: 669 FWLRKKKEEPTSDPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEGNVTI 728
Query: 660 AVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRS 719
AVKV NLLHHGA SFIAEC L+NIRHRNLVK+LTACSG+DYQGNDFKALV+E+M N S
Sbjct: 729 AVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYMVNGS 788
Query: 720 LEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779
LEEWLHPI R ++ E PRSLNLLQRLNI IDVA AL YLH+ C PI HCDLKPSNVLL
Sbjct: 789 LEEWLHPIPRTEEV-EPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSNVLL 847
Query: 780 DEEMMAHVSDFGLARFLPLSP-----AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834
D EM HVSDFGLA+ L S +Q+SSI +G++G+ PEYG+GS VS GDVYSY
Sbjct: 848 DSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGDVYSY 907
Query: 835 GILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQR 894
GILLLEL T K+P D MF+ D+NLHNFA +A D + ++ D LL ++ AV R
Sbjct: 908 GILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILL---QETAV------R 958
Query: 895 QARINSKI-----ECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHR 944
+ R+NS+ ECL +M+RIGVACS E P +RM + +VV L +I++ L+ R
Sbjct: 959 ETRLNSRKCQRLEECLFSMLRIGVACSTEMPQERMKINDVVTGLHAIRDKLVRIR 1013
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2492), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/941 (56%), Positives = 664/941 (70%), Gaps = 11/941 (1%)
Query: 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
RV L+L SLKLAGSISP VGNLSFL+ L L NNSF+H P E + L RL++L L+NNSI
Sbjct: 1 RVTKLDLRSLKLAGSISPSVGNLSFLRELNLRNNSFSHEFPQEINHLGRLEILDLSNNSI 60
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLS 124
G +PANISSCSNLI +RL N++ G IP++ G L ++ L V NNLTGSIP SLGNLS
Sbjct: 61 SGHMPANISSCSNLISVRLGRNQIEGNIPAQFGHLFNLQILYVHNNNLTGSIPHSLGNLS 120
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184
+ L L DNNL G IP T G L NL L+ N LSG IPSS+FN+SSI D N
Sbjct: 121 YLLALSLCDNNLVGTIPYTIGQLMNLTFLSCCSNRLSGVIPSSVFNLSSIGTLDISGNYF 180
Query: 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQ 244
G +P D G L ++Q F+ F N TG IP +ISNASNLE+ D+NK G+VP LE+
Sbjct: 181 HGSLPSDLGIFLSSIQRFNAFSNLFTGRIPSSISNASNLEILALDINKFIGDVPSLERLP 240
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
RL +T N LG+ +L+FL SLTNS+ L L IN N FGG +P+ I N ST+L L
Sbjct: 241 RLQWLLLTSNYLGNGKVDDLSFLYSLTNSSELEILGINGNYFGGSIPSVICNFSTSLIYL 300
Query: 305 LLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP 364
+DNN + G+IP+ IG V+LQ E+WNN+LSG IPP IG+LQNLR L NKF G +P
Sbjct: 301 FMDNNHLTGSIPSGIGNLVSLQDFEVWNNQLSGFIPPTIGKLQNLRVLDFSSNKFSGQLP 360
Query: 365 PSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIG 423
S+GNL + L S N L G++PS+LG + L +++LS N+L+ IPPQ L L+ L +
Sbjct: 361 TSLGNLTNLIQLIASENNLGGNMPSNLGTCENLLLLNLSHNHLSDAIPPQLLNLTSLSLY 420
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LDLS NQLTG++P EVGNLK+L LDV NKL G IPSTLGSCK LE L M+GN QG I
Sbjct: 421 LDLSDNQLTGTVPVEVGNLKSLGQLDVSNNKLSGWIPSTLGSCKSLESLHMKGNNFQGLI 480
Query: 484 PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATIT 543
PSSL SLK L VLDLS NNLSG+IPEFL LL+ LNLS+NN EG VP +GVF+N + T
Sbjct: 481 PSSLGSLKALQVLDLSHNNLSGQIPEFLSQIVLLQ-LNLSHNNFEGPVPAKGVFRNVSAT 539
Query: 544 SVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLILCLVR 603
S+ GN KLCGGIPEF L CIS K LT L++ +A + L G++L L +++ ++
Sbjct: 540 SLEGNNKLCGGIPEFHLAPCISTRHKKSGLTHNLRIVVATVCVLVGVTLLLWVIVVFFLK 599
Query: 604 KRKEKKNPSSPINSFP-NISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK 662
K++ K++ SS +SY LY ATDGF+SAN +G GSFG+V+KG L G+T++AVK
Sbjct: 600 KKRRKESSSSFSEKKALELSYHTLYKATDGFSSANTLGAGSFGTVFKGELGGGETSIAVK 659
Query: 663 VFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEE 722
VFNL+ HGAFKSFIAEC L+NIRHRNLVK+LTACS VDYQGN+FKALV+EFM N SLEE
Sbjct: 660 VFNLMRHGAFKSFIAECEALRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEE 719
Query: 723 WLHPITREDKTEEAPR-SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781
WLHP D+ + PR +LN+LQRLNI +DVACAL YLH+ C+ PI HCDLKPSN+LLD
Sbjct: 720 WLHP---PDEAKAIPRNNLNILQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDN 776
Query: 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 841
EM HV DFGLA+F Q+SSI +GS+GY EYG G+EVS +GDVYSYGILLLE+
Sbjct: 777 EMTGHVGDFGLAKFYRERSHQSSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEI 836
Query: 842 VTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDE-DLAVHGNQRQRQARINS 900
T K+P+D F D++LHN+ + ALP+ VV+I+D TL + E +++ R+ A IN
Sbjct: 837 FTGKRPMDDWFNEDVSLHNYVKNALPEQVVEILDPTLFQEGEGGISL---IRRSNASINR 893
Query: 901 KIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941
+ECL+++ IGVACS E+PG+RMN+ +V QL SI+N LL
Sbjct: 894 TMECLISICEIGVACSAETPGERMNICDVAGQLVSIRNKLL 934
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2471), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/949 (54%), Positives = 651/949 (68%), Gaps = 18/949 (1%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RRHQRV++L L SLKL+G+ISPH+GNLSFL+ L L NNSF H IP + RL+ LQ+ +L+
Sbjct: 68 RRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQIFSLH 127
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NNSI G+IP +IS CSNLI I++ +N L G+IP ELGSL K+++L++ VN LTG+IP SL
Sbjct: 128 NNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLTLEVNGLTGTIPPSL 187
Query: 121 GNLSSINTLFLTDNN-LDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDA 179
GNLSS+ L L N L G +P T G LKNL L + +N LSG IP SIFN+SS+TA D
Sbjct: 188 GNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSLTALDI 247
Query: 180 GMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239
G N G +P D G +L NL+FFS+ NQ TG+IP +ISNASN+EL Q +N LTGEVP
Sbjct: 248 GFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLTGEVPT 307
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
LEK RL+ F++ N LGS ++L+FL SLTN+T L L I NNFGG LP ISNLST
Sbjct: 308 LEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQISNLST 367
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF 359
L ++ L N I G+IPA I K VNL+ ++ NN++SG IP +IGELQNL L L N
Sbjct: 368 MLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLVLDYNNL 427
Query: 360 LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
G IP S+GNL K+ L L N L+GSIPSSLG K L ++ L NNL+G IPP G+
Sbjct: 428 SGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPPGLFGIF 487
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
LL + S+N +GS+P E+G L NLE LDV N L GEIPS+LG C LE L M NF
Sbjct: 488 SLLY-ICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDLYMNSNF 546
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFK 538
G IPS+LSSL+G+ + S NNLSGKIPEF GF LE L+LS NN EGM+P EG+FK
Sbjct: 547 FHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIPDEGIFK 606
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLI 598
N+T SV+GN +LCGG E LP C K + K+L L LK+A+ I+ L L+L ++ L
Sbjct: 607 NSTAVSVIGNSQLCGGNTELGLPRC--KVHQPKRLKLKLKIAIFAITVLLALALVVTCLF 664
Query: 599 LCLVRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTT 658
LC R+++ + SS N +SYQ L AT+GF+S+N +G+GSFGSVYKG+LDQ
Sbjct: 665 LCSSRRKRREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQNGMV 724
Query: 659 VAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNR 718
+AVKV NL+ GA +SFIAEC L+NIRHRNLVK+LTACS +DY GNDFKA+V+EFM N
Sbjct: 725 IAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEFMANG 784
Query: 719 SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778
SLE+WLHP T LQRLNI IDVACAL YLHH C+ PI HCDLKPSNVL
Sbjct: 785 SLEDWLHPTGTGGGTTLTLNL---LQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSNVL 841
Query: 779 LDEEMMAHVSDFGLARFLP-----LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYS 833
LD+E+ HV DFGLA+FL +++SI +G+IGY PEYG+G EVS GD YS
Sbjct: 842 LDDELTGHVGDFGLAKFLSGASLDYPTNESTSIGVRGTIGYAPPEYGVGGEVSAYGDTYS 901
Query: 834 YGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDE--DLAVHGNQ 891
YGILLLE+ T K+P D MF NLHNF + A+P+ V I D TLL ++ D H
Sbjct: 902 YGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQEEPTGDDDKHEIS 961
Query: 892 RQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940
R +R +ECL +++RIG++CS+E P +RM +++ V QL S++N L
Sbjct: 962 SMRNSR---PLECLNSILRIGISCSVEFPRERMKISDAVAQLHSVRNEL 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119102|ref|XP_002331325.1| predicted protein [Populus trichocarpa] gi|222873908|gb|EEF11039.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2409), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/948 (52%), Positives = 652/948 (68%), Gaps = 20/948 (2%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
++HQRV +L+L SLKL+GS+SP++GNLSFL+ L L +NSF+H IP++ L RLQ+LAL+
Sbjct: 73 QKHQRVAVLDLQSLKLSGSVSPYIGNLSFLRNLYLQHNSFSHEIPAQIGHLHRLQILALH 132
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NNS GEIPA++SS NL+ + L N+L G+IP E GS K+ L + NNL G+IP SL
Sbjct: 133 NNSFTGEIPASMSSSYNLVSLILDNNKLTGEIPKEFGSFLKLTDLYIDDNNLVGTIPPSL 192
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GN+SS+ L+L DNNL G +P T L NL L++ N SGTIP S+ N+SS+ F G
Sbjct: 193 GNISSLQELWLDDNNLFGNLPATLSKLVNLRVLSLFNNRFSGTIPPSMLNLSSLRTFQVG 252
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
+N QG +P D G +L NL+FFS++ NQ TG++P +ISN SNLE+ + ++NKL G++P L
Sbjct: 253 LNHFQGNLPPDLGISLPNLEFFSIYSNQFTGSVPVSISNLSNLEMLELNLNKLRGKMPSL 312
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
EK QRL +I N+LGS ++L+FL SLTN+T L L+I NNF G LP ISNLSTT
Sbjct: 313 EKLQRLLSITIASNNLGSGEANDLSFLSSLTNATNLEELIITQNNFQGQLPPQISNLSTT 372
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
LE++ LD+N +FG+IP I ++L E+ NN LSG IP IG+LQNL L L N F
Sbjct: 373 LEIMGLDSNLLFGSIPDGIENLISLNDFEVQNNHLSGIIPSTIGKLQNLEILGLALNNFS 432
Query: 361 GNIPPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G+IP S+GNL + L L+ +QGSIPSSL L +DLS N +TG+IPP GLS
Sbjct: 433 GDIPSSLGNLTNLIGLYLNDINVQGSIPSSLANCNKLLELDLSGNYITGSIPPGIFGLSS 492
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L I LDLSRN L+GS+P EVGNL+NLE+ + N + G+IPS+L C L+ L + NF
Sbjct: 493 LSINLDLSRNHLSGSLPKEVGNLENLEIFAISGNMISGKIPSSLAQCISLQFLYLDANFF 552
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
+G +PSSLS+L+G+ + S NNLSGKI EF F+ LE L+LS NN EGMVP G+FKN
Sbjct: 553 EGSVPSSLSTLRGIQEFNFSHNNLSGKIHEFFQDFRSLEILDLSYNNFEGMVPFRGIFKN 612
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLIL 599
AT TSV+GN KLCGG P+F+LP C K K+L+L +K+ + +IS L +++ ++ L L
Sbjct: 613 ATATSVIGNSKLCGGTPDFELPPCNFKHP--KRLSLKMKITIFVISLLLAVAVLITGLFL 670
Query: 600 CLVRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTV 659
RK++ + PSS N +SYQ+L AT+GF+S N IG GSFGSVYKGILD T V
Sbjct: 671 FWSRKKRREFTPSSDGNVLLKVSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAV 730
Query: 660 AVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRS 719
AVKV NL GA KSF+AEC L N+RHRNLVK++TACSGVDY GNDFKALV+EFM N S
Sbjct: 731 AVKVLNLRRQGASKSFMAECEALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGS 790
Query: 720 LEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779
LE WLHP T+E L+L QRL+I IDVA AL Y HH C+ I HCDLKP NVLL
Sbjct: 791 LETWLHP---SRATDEVRGILDLTQRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLL 847
Query: 780 DEEMMAHVSDFGLARF-----LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834
D+EM+ HV DFGLA+F L S +SSI +G+IGY PEYG G+EVS GDVYSY
Sbjct: 848 DDEMVGHVGDFGLAKFLLEDTLHHSTNPSSSIGIRGTIGYTPPEYGAGNEVSAYGDVYSY 907
Query: 835 GILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQR 894
GILLLE+ T K+P D +F G +NLH++ + LP+ V+ I D TL + GN ++
Sbjct: 908 GILLLEMFTGKRPTDDLFNG-LNLHSYVKTFLPEKVLQIADPTL----PQINFEGNSIEQ 962
Query: 895 QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942
N ++CLV++ G++CS+ESP +RM + +V+ QL S +N LLG
Sbjct: 963 ----NRVLQCLVSVFTTGISCSVESPQERMGIADVIAQLFSARNELLG 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2382), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/950 (52%), Positives = 634/950 (66%), Gaps = 16/950 (1%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RHQR+ LNL S +L G++SPH+GNLSFL+VL L N F+ IP E RL RLQ L L
Sbjct: 71 HRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVLG 130
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NN+ GEIP NISSCSNL+ + L N L GKIP++LGSLSK+ + NNL G IPSS
Sbjct: 131 NNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLGSLSKLGAFVLQGNNLVGDIPSSF 190
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNLSS+ F T N L GGIP++ G LK L A+AEN LSGTIPSSI NISS+ G
Sbjct: 191 GNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLG 250
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
NQL G +P D G L NL + + N L G IP +SNAS + L N LTG++P L
Sbjct: 251 QNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIPDL 310
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
L + N LG+ +L+FL +L NST L L IN NNFGG+LP +SN ST
Sbjct: 311 ASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTN 370
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L+ + N+I G+IP IG ++L L + N+L G IP +IG+LQNL L L NK
Sbjct: 371 LKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKIS 430
Query: 361 GNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G+IP S+GN+ + + + N LQG+IP+SLG + L I+DLS NNL+G IP + LG+S
Sbjct: 431 GSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISS 490
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L + L L NQLTGS+PSEVG L NL L V +N+L GEIP +L SCK LE L++ GNF
Sbjct: 491 LSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFF 550
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
+GP+P LSSL+ L +L LS NNLSG+IP+FL F+LLE L+LS N+ EG VP +GVF+N
Sbjct: 551 EGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFEN 609
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLIL 599
+ SV GN KLCGGIP+ LP C S E K L L +AI G G+ L SFL+
Sbjct: 610 TSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFLLF 669
Query: 600 CLVRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTV 659
+ + E + S +SF ++YQ+L ATDGF+S+N +G G+FGSVY+G L V
Sbjct: 670 YSRKTKDEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVV 729
Query: 660 AVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRS 719
AVKV NLL GA KSF+AEC L NIRHRNLVK++TACS D+QGNDFKALV+EFM N S
Sbjct: 730 AVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGS 789
Query: 720 LEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779
LEEWLHP+ D T E R+L+L+QRLNI IDVA AL YLH+ CQ P+ HCDLKPSNVLL
Sbjct: 790 LEEWLHPVHISDVTPET-RNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLL 848
Query: 780 DEEMMAHVSDFGLARFLP-----LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834
++M A V DFGLARFLP L ++SS+ KG+IGY APEYG+GSEVS GDVYSY
Sbjct: 849 GDDMTACVGDFGLARFLPEASNQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSY 908
Query: 835 GILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQR 894
GILLLE+ T ++P D MF+ NLHN+A+M LPD+V++ VD TL +E N
Sbjct: 909 GILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTLREHEE-----MNHNDD 963
Query: 895 QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHR 944
++ +EC+V+++++G+ACS E PG+RM + NVV +L I+ +L G +
Sbjct: 964 SHKV---MECMVSIIKVGLACSAELPGERMGIANVVVELHRIREMLDGRK 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2377), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/949 (52%), Positives = 647/949 (68%), Gaps = 10/949 (1%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R+H+RV L+L S +LAGS+SPH+GNLSFL++L L NSF++ IP E RL R+Q L+L
Sbjct: 71 RKHRRVVELDLHSSQLAGSLSPHIGNLSFLRILNLEKNSFSYLIPQELGRLFRIQELSLG 130
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NN+ GEIP NIS C+NL+ I L N L GK+P+E GSLSK++ L+ N+L G IP S
Sbjct: 131 NNTFSGEIPVNISRCTNLLSIGLASNNLTGKLPAEFGSLSKLQVLNFQRNHLFGEIPPSY 190
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNLS + + NNL GGIPD+ G LK LA N LSGTIPSSI+N+SS+ F A
Sbjct: 191 GNLSELQIIRGVRNNLQGGIPDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSAP 250
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
+NQL G++P + G TL NL F++ NQ G IP +SNAS + Q N TG+VP L
Sbjct: 251 LNQLYGILPPELGLTLPNLDTFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVPSL 310
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
L + N+LG+ +L FL L N+T L L IN NNFGG+LP + N ST
Sbjct: 311 AGLHNLQRLVLNFNNLGNNEDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFSTK 370
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L ++++ N + G+IP IGK + L L + N+L+G IP +IG+LQ L + NK
Sbjct: 371 LRIMIIGENNLRGSIPTEIGKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKIS 430
Query: 361 GNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
GNIP S+GN+ + + N LQG IPSSLG + L ++ L NNL+G+IP + LG+S
Sbjct: 431 GNIPSSLGNITSLLEVYFFANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGISS 490
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L + LDL+ NQL G +PSEVG L +L L+V++N+L GEIP L SC LE L + NF
Sbjct: 491 LSMYLDLAENQLIGPLPSEVGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNFF 550
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
QG IP SLSSL+ L +L+LS NNLSGKIP+FL F+LL +L+LS NNLEG VP++GVF
Sbjct: 551 QGSIPESLSSLRALQILNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFAR 610
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLIL 599
A+ S+LGN KLCGG P+ L C SK+S+ K + +KL +AI G G+ L +S+++
Sbjct: 611 ASGFSMLGNKKLCGGRPQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLF 670
Query: 600 CLVRKRKEKKNPSSPINS-FPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTT 658
L++++K + SP S F ++Y++L AT GF+ AN IG GSFGSVYKGIL
Sbjct: 671 FLLKEKKSRPASGSPWESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAA 730
Query: 659 VAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNR 718
VAVKVFNLL GA KSF+AEC L NIRHRNLVK+LTACSG+D+QGNDFKALV+EFM N
Sbjct: 731 VAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNG 790
Query: 719 SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778
SLEEWLHP+ D+ R L+LLQRLNI IDVA AL YLH+ CQ + HCDLKPSNVL
Sbjct: 791 SLEEWLHPVQISDEA-HVRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVL 849
Query: 779 LDEEMMAHVSDFGLARFLP-----LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYS 833
LD +M AHV DFGLAR LP L QTSSI KG+IGY APEYGLGSEVS GDVYS
Sbjct: 850 LDGDMTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYS 909
Query: 834 YGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQ 893
YGILLLE+ T ++P + +F+ +NLHNFA+ ALP V +++D L+++ E+ + G+ +
Sbjct: 910 YGILLLEVFTGRRPTNGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETS--GDASR 967
Query: 894 RQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942
R + I + +ECL A+V++GVACS E P +RM +++V +L+ I++ILLG
Sbjct: 968 RMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLG 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2365), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/890 (55%), Positives = 616/890 (69%), Gaps = 37/890 (4%)
Query: 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN 62
H+RV +L+L SLK++GSISP++GNLSFL+ L + NNSF H IP + L+RL+ L LNNN
Sbjct: 80 HRRVTVLDLHSLKISGSISPYIGNLSFLRALNIQNNSFGHEIPQQIGYLRRLEELRLNNN 139
Query: 63 SIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGN 122
S+GG+IP NIS CSNL+ I L N+L G +P ELG LS ++ LS+ N LTGSIP SLGN
Sbjct: 140 SVGGKIPTNISRCSNLVFISLGKNKLEGNVPEELGVLSNLQVLSIFGNKLTGSIPHSLGN 199
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
LS + L L +N + G +P++ GWL+NL L++ N LSGTIPSS+FN+SSI D G N
Sbjct: 200 LSQLQRLSLAENRMVGEVPNSLGWLRNLTFLSLRSNRLSGTIPSSLFNLSSIRNLDIGEN 259
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
G +P D GF L N+++F++ N+ TG IP ++SNA+NLE N LTGEVP L K
Sbjct: 260 NFHGNLPSDIGFLLPNIRWFAISSNEFTGKIPVSLSNATNLESLLLLQNNLTGEVPSLAK 319
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
RL VFS+T N+LG+ +L+FL SLTN+T L L +N NNFGG+LP I+NLSTTL
Sbjct: 320 LDRLRVFSLTSNNLGTGKADDLSFLHSLTNTTALEELGVNGNNFGGMLPDSIANLSTTLR 379
Query: 303 MLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGN 362
+LLLDNN+I G+IP+ I V+L+ E+WNN+LSG IP +IG+LQNL L L N G+
Sbjct: 380 ILLLDNNRIIGSIPSGIENLVSLEDFEVWNNQLSGFIPDSIGKLQNLVVLALNSNMLSGH 439
Query: 363 IPPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLL 421
IP S+GNL + L + N L G IPS LG+ + + + LS NN +G+IPP+ + +S L
Sbjct: 440 IPSSLGNLTNLIQLLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGSIPPEVISISSLS 499
Query: 422 IGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG 481
I LDLS+N LTG++P EVGNLK+L DV NKL GEIP TLGSC LE L M GN QG
Sbjct: 500 IYLDLSQNNLTGTLPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISLEILNMAGNNFQG 559
Query: 482 PIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNAT 541
IPSSLSSL+ L +LDLS NN+L GMVP +G+FKNA+
Sbjct: 560 LIPSSLSSLRALQILDLS------------------------NNHLSGMVPSKGIFKNAS 595
Query: 542 ITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLILCL 601
TSV GN LCGGIPEFQLP C S K +LT LK ++ ISG +A L+L L
Sbjct: 596 ATSVEGNNMLCGGIPEFQLPVCNSARHKKNRLTPVLKTVISAISG-----MAFLILMLYL 650
Query: 602 VRKRKEKKNPSSPINSFPNI---SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTT 658
R++K N ++ S I SYQNL+ ATDGF+SAN IG+GSFGSVYKG LD+ T
Sbjct: 651 FWFRQKKVNETTADFSEKKIMELSYQNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTL 710
Query: 659 VAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNR 718
+AVKVFNL+ G FKSF+AEC L+NIRHRNL+K+LTACS +DY GNDFKALV+EFM N
Sbjct: 711 IAVKVFNLMRRGGFKSFLAECEALRNIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNG 770
Query: 719 SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778
SLEEWLHP ++ E R LN LQRLNI IDVA AL YLHH C+P I HCDLKPSN+L
Sbjct: 771 SLEEWLHPPVATNEAELETRKLNFLQRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNIL 830
Query: 779 LDEEMMAHVSDFGLARFLPLSP----AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834
LDEE+ HV DFGLARFL + Q+SSI +G++GY PEYG+ SEVS GDVYSY
Sbjct: 831 LDEELTGHVGDFGLARFLLDATQNHYTQSSSIGVRGTVGYAPPEYGMSSEVSTYGDVYSY 890
Query: 835 GILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDED 884
GILLLE+ T K+P+D MF+ NLHNF + ALP+ VV+IVD LL + E+
Sbjct: 891 GILLLEMFTGKRPMDDMFKDGFNLHNFVKAALPNQVVEIVDPNLLPEIEE 940
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2361), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/958 (51%), Positives = 632/958 (65%), Gaps = 15/958 (1%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RHQRV LNL SL L GS+SP +GNL+FL L L N+F+ IP E RL RL+ L L
Sbjct: 78 HRHQRVNTLNLNSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLT 137
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NNS GEIPAN+S CSNL+ RL +N L+G+IPS LGS K+ + + NNLTG +P SL
Sbjct: 138 NNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSL 197
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNL+SI +L N+L+G IP G L+ L + + N SG IPSS++N+SS+ F
Sbjct: 198 GNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLP 257
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-- 238
N+L G +P D FTL NLQ ++ N TG++P ++SNASNL F ++ TG+V
Sbjct: 258 YNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSID 317
Query: 239 YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS 298
+ P +F + N LG +L+FL SL L L ++ + FGG+LP I+NLS
Sbjct: 318 FGGMPNLWGLF-LASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLS 376
Query: 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK 358
T L L LDNN++ G IP IG VNL L + NN +G+IP IG LQ L + L RN+
Sbjct: 377 TQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQ 436
Query: 359 FLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGL 417
G+IP S+GN+ ++++L L N L G IPSS G L +DLS N+L GTIP + + L
Sbjct: 437 LSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDL 496
Query: 418 SWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGN 477
L I L+L+RNQLTG +PSEV LKNL LDV ENKL GEIP LGSC LE L M+GN
Sbjct: 497 VSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGN 556
Query: 478 FLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVF 537
F +G IP S SL+GL LDLS+NNLSG+IPEFL L NLNLS NN EG +P +GVF
Sbjct: 557 FFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSL-SNLNLSFNNFEGQLPTKGVF 615
Query: 538 KNATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFL 597
NAT TSV GN KLCGGIPE LP C + K + LKL + +++G GL L +S L
Sbjct: 616 NNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLL 675
Query: 598 ILCLVR--KRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQG 655
++ +R KR+ + +S + N+SY L+ AT GF+SAN IG G FGSVYKGIL Q
Sbjct: 676 VINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQD 735
Query: 656 KTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715
+T VAVKV L GA KSF AEC L+NIRHRNLVK+LT CS VDYQGNDFKALV+EFM
Sbjct: 736 ETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFM 795
Query: 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775
N SLE WLHP+ D+ + R L+L QRLNI IDVA AL YLHH C PI HCDLKPS
Sbjct: 796 PNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPS 855
Query: 776 NVLLDEEMMAHVSDFGLARFLPLS-----PAQTSSIDAKGSIGYIAPEYGLGSEVSINGD 830
N+LLD +M AHV DFGLARF+P + P+Q+SSI KG+IGY APEYG+G++VS GD
Sbjct: 856 NILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGD 915
Query: 831 VYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSD---DEDLAV 887
YSYGILLLE+ T K+P +SMF +NLHNF +MALP+ + DI+D LS +E+
Sbjct: 916 TYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTA 975
Query: 888 HGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHRI 945
+ + ECL++++RIGV+CS+ESP +RM +T +++LQ I+ ILLG+ +
Sbjct: 976 ADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLGNGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 913 bits (2360), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/949 (50%), Positives = 638/949 (67%), Gaps = 5/949 (0%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RRHQRV L+L S +L GS+SPH+GNLSFL++L L NNS + IP E RL RL+ L L
Sbjct: 73 RRHQRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLR 132
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NN+ G IPANIS C+NL + L GK+P+ELG LSK++ L++ +NN G IP S
Sbjct: 133 NNTFDGGIPANISRCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSF 192
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNLS+IN ++ + NNL+G IP+ FG LK L L++ N LSG IP SIFN+SS+T
Sbjct: 193 GNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFP 252
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
+NQL G +P G TL NLQ F++ NQ G IP SNASNL FQ N G+VP L
Sbjct: 253 VNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVPPL 312
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNS-TRLNRLLINANNFGGLLPACISNLST 299
L V + +N+LG +++LNF+ L N+ T L L + NNFGG+LP +SN ST
Sbjct: 313 SSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFST 372
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF 359
L + N+I G+IP IG +NL+ L + N+L+G IP ++G+LQ L +L L NK
Sbjct: 373 KLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKI 432
Query: 360 LGNIPPSIGNLKVF-NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
G IP S+GN+ +++ N L+GSIP SLG ++ L + LS NNL+G IP + + +
Sbjct: 433 SGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIP 492
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
L + L LS N+LTGS+P E+ L NL LDV +N+ GEIP +LGSC LE L ++ NF
Sbjct: 493 SLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENF 552
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFK 538
LQGPIP +LSSL+ + L+LS NNL+G+IPEFL F+LLE+LNLS N+ EG VP++G F+
Sbjct: 553 LQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQ 612
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLI 598
N + S+ GN KLCGGIP+ L C S E + K L + + G G+ L +SFL+
Sbjct: 613 NTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLL 672
Query: 599 LCLVRKRKEKKNPSSPI--NSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGK 656
RK+K+K S P SFP ++Y++L ATDGF+SAN IG GSFGSV+KGIL K
Sbjct: 673 FYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDK 732
Query: 657 TTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQ 716
VAVKV NLL GA KSF+AEC LK+IRHRNLVK+LT CS +D+QGNDFKALV+EFM
Sbjct: 733 IVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMV 792
Query: 717 NRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSN 776
N +LEEWLHP+ D+ P++L+L+ RLNI I +A AL+YLHHDCQ PI HCDLKPSN
Sbjct: 793 NGNLEEWLHPVQTSDEA-NGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSN 851
Query: 777 VLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGI 836
+LLD M AHV DFGLARF + QTSS+ KG+IGY APEYG+G +VS GDVYSYGI
Sbjct: 852 ILLDTNMTAHVGDFGLARFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGI 911
Query: 837 LLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQA 896
LLLE+ T K+PVD MF+ +NLH++A+MALPD +V++VD L+ + +
Sbjct: 912 LLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHI 971
Query: 897 RINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHRI 945
+ CL+ ++++GVACS+E P +RM++ +VV +L IK+ LLG R+
Sbjct: 972 GPHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTRM 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 953 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.967 | 0.912 | 0.420 | 6.4e-186 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.587 | 0.546 | 0.418 | 2.1e-182 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.974 | 0.906 | 0.419 | 4.8e-181 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.965 | 0.911 | 0.407 | 7e-180 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.967 | 0.911 | 0.404 | 1.9e-179 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.971 | 0.898 | 0.406 | 1.1e-172 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.748 | 0.876 | 0.4 | 2.2e-128 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.950 | 0.772 | 0.331 | 3e-117 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.567 | 0.433 | 0.348 | 9.4e-116 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.565 | 0.472 | 0.341 | 1.8e-113 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1803 (639.7 bits), Expect = 6.4e-186, P = 6.4e-186
Identities = 400/951 (42%), Positives = 541/951 (56%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R+++RV L L L+L G ISP +GNLSFL L LY N F IP E +L RL+ L +
Sbjct: 63 RKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMG 122
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
N + G IP + +CS L+ +RL N L G +PSELGSL+ + L++ NN+ G +P+SL
Sbjct: 123 INYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL 182
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNL+ + L L+ NNL+G IP L + +L + N SG P +++N+SS+ G
Sbjct: 183 GNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIG 242
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N G + D G L NL F++ N TG+IP +SN S LE + N LTG +P
Sbjct: 243 YNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTF 302
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
L + + NSLGS +L FL SLTN T+L L I N GG LP I+NLS
Sbjct: 303 GNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAK 362
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKFL 360
L L L I G+IP IG +NLQ+L + N LSG +P ++G +
Sbjct: 363 LVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLS 422
Query: 361 GNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXXX 419
G IP IGN+ + LDLS N +G +P+SLG L + + DN L GTIP +
Sbjct: 423 GGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQ 482
Query: 420 XXXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
N L GS+P ++G L+NL L + +NKL G++P TLG+C +E L ++GN
Sbjct: 483 LLRLDMSG-NSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLF 541
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFKN 539
G IP L L G+ +DLS N+LSG IPE+ F G VP++G+F+N
Sbjct: 542 YGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFEN 600
Query: 540 ATITSVLGNLKLCGGIPEFQLPTCISKES---KHXXXXXXXXXXXXXXXXXXXXXXXXXX 596
AT S++GN LCGGI FQL C+S+ K
Sbjct: 601 ATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMAS 660
Query: 597 XXXXXVRKRKEKKXX-----XXXXXXXXXXXYQNLYNATDGFASANEIGVGSFGSVYKGI 651
+RKRK+ K Y +L NAT+GF+S+N +G GSFG+VYK +
Sbjct: 661 VTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKAL 720
Query: 652 LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711
L K VAVKV N+ GA KSF+AEC +LK+IRHRNLVK+LTACS +D+QGN+F+AL+
Sbjct: 721 LLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALI 780
Query: 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCD 771
+EFM N SL+ WLHP E+ R+L LL+RLNI IDVA L YLH C PI HCD
Sbjct: 781 YEFMPNGSLDMWLHPEEVEE-IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCD 839
Query: 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLGSEVS 826
LKPSNVLLD+++ AHVSDFGLAR L Q SS +G+IGY APEYG+G + S
Sbjct: 840 LKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPS 899
Query: 827 INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLA 886
INGDVYS+GILLLE+ T K+P + +F G+ L+++ + ALP+ ++DIVD ++L
Sbjct: 900 INGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL------- 952
Query: 887 VHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937
H R +ECL + +G+ C ESP +R+ + VV++L SI+
Sbjct: 953 -HIGLRVGFP----VVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 2.1e-182, Sum P(2) = 2.1e-182
Identities = 236/564 (41%), Positives = 309/564 (54%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNN 61
+H+RV ++L LKL G +SP VGNLSFL+ L L +N F+ IPSE L RLQ L ++N
Sbjct: 79 KHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSN 138
Query: 62 NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121
N GG IP +S+CS+L + L N L +P E GSLSK+ LS+ NNLTG P+SLG
Sbjct: 139 NLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLG 198
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181
NL+S+ L N ++G IP LK + +A N +G P I+N+SS+
Sbjct: 199 NLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITG 258
Query: 182 NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-L 240
N G + DFG L NLQ + N TG IP +SN S+L N LTG++P
Sbjct: 259 NSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSF 318
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
+ Q L + + NSLG+ +L+FL +LTN ++L L + N GG LP I+NLST
Sbjct: 319 GRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQ 378
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKFL 360
L L L N I G+IP IG V+LQ L++ N L+G +PP++G
Sbjct: 379 LTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLS 438
Query: 361 GNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXXX 419
G IP S+GN+ L L N +GSIPSSLG L ++L N L G+IP +
Sbjct: 439 GEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPS 498
Query: 420 XXXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
N L G + ++G LK L LDV NKL G+IP TL +C LE L +QGN
Sbjct: 499 LVVLNVSF-NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSF 557
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFKN 539
GPIP + L GL LDLS+NNLSG IPE++ F G VP EGVF+N
Sbjct: 558 VGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRN 616
Query: 540 ATITSVLGNLKLCGGIPEFQLPTC 563
+ SV GN+ LCGGIP QL C
Sbjct: 617 TSAMSVFGNINLCGGIPSLQLQPC 640
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1757 (623.6 bits), Expect = 4.8e-181, P = 4.8e-181
Identities = 399/952 (41%), Positives = 539/952 (56%)
Query: 1 RRH-QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLAL 59
RRH RV L L S L+G ISP +GNLSFL+ L L +N + IP E RL RLQ+L L
Sbjct: 75 RRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLEL 134
Query: 60 NNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELG-SLSKIEHLSVSVNNLTGSIPS 118
++NSI G IPA I +C+ L + L +N+L G IP E+G SL + +L + N L+G IPS
Sbjct: 135 SDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPS 194
Query: 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFD 178
+LGNL+S+ L+ N L G IP + G L +L T+ + +N LSG IP+SI+N+SS+ AF
Sbjct: 195 ALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFS 254
Query: 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238
N+L G+IP + TL L+ + N+ G IP +++NAS+L + Q N +G +
Sbjct: 255 VRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIIT 314
Query: 239 Y-LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNL 297
+ + L+ + N +R + F+ LTN ++L L + NN GG+LP SNL
Sbjct: 315 SGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNL 374
Query: 298 STTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXX 357
ST+L L L+ NKI G+IP IG + LQ L + NN G++P ++G
Sbjct: 375 STSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYEN 434
Query: 358 KFLGNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXX 416
G+IP +IGNL N L L N G IP +L L + LS NNL+G IP +
Sbjct: 435 NLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFN 494
Query: 417 XXXXXXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQG 476
+N L GSIP E+G+LKNL N+L G+IP+TLG C+ L L +Q
Sbjct: 495 IQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQN 554
Query: 477 NFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGV 536
N L G IPS+L LKGL LDLS NNLSG+IP L G VP G
Sbjct: 555 NLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGA 614
Query: 537 FKNATITSVLGNLKLCGGIPEFQLPTC--ISKESKHXXXXXXXXXXXXXXXXXXXXXXXX 594
F A+ S+ GN KLCGGIP+ LP C + + KH
Sbjct: 615 FAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLI 674
Query: 595 XXXXXXXVRKRKEKKXXXXXXXXXXXXXYQNLYNATDGFASANEIGVGSFGSVYKGILDQ 654
++ K+ Y L ATDGFA N +G GSFGSVYKG L+
Sbjct: 675 TWH-----KRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNI 729
Query: 655 GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 714
+ VAVKV L + A KSF AEC L+N+RHRNLVKI+T CS +D +GNDFKA+V++F
Sbjct: 730 -QDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDF 788
Query: 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774
M N SLE+W+HP T D+ ++ R LNL +R+ I +DVACAL YLH P+ HCD+K
Sbjct: 789 MPNGSLEDWIHPETN-DQADQ--RHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKS 845
Query: 775 SNVLLDEEMMAHVSDFGLARFL----PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGD 830
SNVLLD +M+AHV DFGLAR L L TSS+ G+IGY APEYG+G S +GD
Sbjct: 846 SNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGD 905
Query: 831 VYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGN 890
+YSYGIL+LE+VT K+P DS F D+ L + + L V D+VD+ L+ D E+ ++
Sbjct: 906 IYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENW-LNST 964
Query: 891 QRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942
RI EC+V ++R+G++CS E P R +++ +L +IK L G
Sbjct: 965 NNSPCRRIT---ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1746 (619.7 bits), Expect = 7.0e-180, P = 7.0e-180
Identities = 388/952 (40%), Positives = 541/952 (56%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R+H+RV L+L L+L G ISP +GNLSFL L L NNSF IP E L RL+ LA+
Sbjct: 63 RKHKRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVG 122
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
N + GEIPA++S+CS L+ + LF N L +PSELGSL K+ +L + +N+L G P +
Sbjct: 123 FNYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFI 182
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
NL+S+ L L N+L+G IPD L + +L + N SG P + +N+SS+
Sbjct: 183 RNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLL 242
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV-PY 239
N G + DFG L N+ S+ N LTGAIP ++N S LE+F N++TG + P
Sbjct: 243 GNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPN 302
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
K + L + NSLGS +L FL +LTN + L+ L ++ N GG LP I N+ST
Sbjct: 303 FGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMST 362
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKF 359
L +L L N I+G+IP IG + LQ L + +N L+G +P ++G +F
Sbjct: 363 ELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRF 422
Query: 360 LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXX 418
G IP IGNL ++ L LS N +G +P SLG + + + N L GTIP +
Sbjct: 423 SGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIP 482
Query: 419 XXXXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
N L+GS+P+++G L+NL L + N L G +P TLG C +E + +Q N
Sbjct: 483 TLVHLNMES-NSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENH 541
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFK 538
G IP + L G+ +DLS NNLSG I E+ F G VP EG+F+
Sbjct: 542 FDGTIPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQ 600
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISK----ESKHXXXXXXXXXXXXXXXXXXXXXXXX 594
NAT+ SV GN LCG I E +L CI++ E++H
Sbjct: 601 NATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIV 660
Query: 595 XXXXXXXVRKRKEK---KXXXXXXXXXXXXXYQNLYNATDGFASANEIGVGSFGSVYKGI 651
RK +K Y +L NATDGF+S+N +G GSFG+V+K +
Sbjct: 661 SLSWFKK-RKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKAL 719
Query: 652 LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711
L VAVKV N+ GA KSF+AEC +LK+IRHRNLVK+LTAC+ +D+QGN+F+AL+
Sbjct: 720 LQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALI 779
Query: 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCD 771
+EFM N SL++WLHP E+ R+L LL+RLNI IDVA L YLH C PI HCD
Sbjct: 780 YEFMPNGSLDKWLHPEEVEE-IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCD 838
Query: 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLGSEVS 826
LKPSN+LLD+++ AHVSDFGLAR L Q SS +G+IGY APEYG+G + S
Sbjct: 839 LKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPS 898
Query: 827 INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLA 886
I+GDVYS+G+L+LE+ T K+P + +F G+ L+++ + ALP+ V+DI D ++L
Sbjct: 899 IHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL------- 951
Query: 887 VHGNQRQRQARINSKI-ECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937
H R+ + ECL ++ +G+ C ESP +R+ + ++L SI+
Sbjct: 952 -HSG-----LRVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKELISIR 997
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1742 (618.3 bits), Expect = 1.9e-179, P = 1.9e-179
Identities = 385/952 (40%), Positives = 544/952 (57%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R+H+RV LNL L+L G +SP +GN+SFL L L +N+F IP E L RL+ L +
Sbjct: 63 RKHKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMA 122
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
NS+ G IPA +S+CS L+ + L+ N L +PSELGSL+K+ L + NNL G +P SL
Sbjct: 123 FNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSL 182
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNL+S+ +L TDNN++G +PD L + L ++ N G P +I+N+S++
Sbjct: 183 GNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLF 242
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV-PY 239
+ G + DFG L N++ ++ EN L GAIP +SN S L+ F + N +TG + P
Sbjct: 243 GSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPN 302
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
K L ++EN LGS +L F+ SLTN T L L + GG LP I+N+ST
Sbjct: 303 FGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMST 362
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKF 359
L L L N FG+IP IG + LQRL++ N L+G +P ++G +
Sbjct: 363 ELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRM 422
Query: 360 LGNIPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXX 418
G IP IGNL L LS N +G +P SLG+ + + + N L GTIP +
Sbjct: 423 SGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIP 482
Query: 419 XXXXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
N L+GS+P+++G+L+NL L + NK G +P TLG+C +EQL +QGN
Sbjct: 483 TLVNLSMEG-NSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNS 541
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFK 538
G IP+ + L G+ +DLS N+LSG IPE+ F G VP +G F+
Sbjct: 542 FDGAIPN-IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQ 600
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKE----SKHXXXXXXXXXXXXXXXXXXXXXXXX 594
N+TI V GN LCGGI + +L C+++E +KH
Sbjct: 601 NSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIA 660
Query: 595 XXXXXXXVRKRKEKKXX----XXXXXXXXXXXYQNLYNATDGFASANEIGVGSFGSVYKG 650
++RK ++ Y +L NAT+GF+S+N +G GSFG+V+K
Sbjct: 661 SMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKA 720
Query: 651 ILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710
+L VAVKV N+ GA KSF+AEC +LK+ RHRNLVK+LTAC+ D+QGN+F+AL
Sbjct: 721 LLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRAL 780
Query: 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHC 770
++E++ N S++ WLHP E+ PR+L LL+RLNI IDVA L YLH C PI HC
Sbjct: 781 IYEYLPNGSVDMWLHPEEVEE-IRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHC 839
Query: 771 DLKPSNVLLDEEMMAHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLGSEV 825
DLKPSNVLL++++ AHVSDFGLAR L Q SS +G+IGY APEYG+G +
Sbjct: 840 DLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQP 899
Query: 826 SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDL 885
SI+GDVYS+G+LLLE+ T K+P D +F G++ LH++ ++ALP+ V +I D +L L
Sbjct: 900 SIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIG--L 957
Query: 886 AVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937
V G R A ECL ++ +G+ C E P +R+ + V ++L SI+
Sbjct: 958 RV-GF---RTA------ECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIR 999
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1678 (595.7 bits), Expect = 1.1e-172, P = 1.1e-172
Identities = 394/970 (40%), Positives = 520/970 (53%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
RR +RV LNL KL G ISP +GNLSFL++L L +NSF IP + RL RLQ L ++
Sbjct: 70 RRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMS 129
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
N + G IP+++S+CS L + L N L +PSELGSLSK+ L +S NNLTG+ P+SL
Sbjct: 130 YNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASL 189
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
GNL+S+ L N + G IPD L + +A N SG P +++NISS+ +
Sbjct: 190 GNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLA 249
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY- 239
N G + DFG+ L NL+ + NQ TGAIP ++N S+LE F N L+G +P
Sbjct: 250 DNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLS 309
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
K + L I NSLG+ S L F+ ++ N T+L L + N GG LPA I+NLST
Sbjct: 310 FGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLST 369
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKF 359
TL L L N I G IP IG V+LQ L + N LSG +P + G
Sbjct: 370 TLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAI 429
Query: 360 LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXX 418
G IP GN+ ++ L L+ N G IP SLG+ + L + + N L GTIP +
Sbjct: 430 SGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIP 489
Query: 419 XXXXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
N LTG P EVG L+ L L NKL G++P +G C +E L MQGN
Sbjct: 490 SLAYIDLS-NNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNS 548
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFK 538
G IP +S L L +D S NNLSG+IP +L G VP GVF+
Sbjct: 549 FDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFR 607
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKES--KHXXXXXXXXXXXXXXXXXXXXXXXXXX 596
NAT SV GN +CGG+ E QL CI + S K
Sbjct: 608 NATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIV 667
Query: 597 XXXXXVRKRKEKKXXXXXXXXXXXX--------XYQNLYNATDGFASANEIGVGSFGSVY 648
KRK+K Y+ L++AT F+S N IG G+FG+V+
Sbjct: 668 ASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVF 727
Query: 649 KGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708
KG+L VAVKV NLL HGA KSF+AEC T K IRHRNLVK++T CS +D +GNDF+
Sbjct: 728 KGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFR 787
Query: 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768
ALV+EFM SL+ WL + ++ + RSL ++LNI IDVA AL YLH C P+
Sbjct: 788 ALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVA 846
Query: 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT-----SSIDAKGSIGYIAPEYGLGS 823
HCD+KPSN+LLD+++ AHVSDFGLA+ L ++ SS +G+IGY APEYG+G
Sbjct: 847 HCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGG 906
Query: 824 EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDE 883
+ SI GDVYS+GILLLE+ + KKP D F GD NLH++ + L S S
Sbjct: 907 QPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL---------SGCTSSGG 957
Query: 884 DLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943
A+ E L ++++G+ CS E P DRM VR+L SI++
Sbjct: 958 SNAID--------------EGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003
Query: 944 RI-VSNMQRD 952
+ ++ RD
Sbjct: 1004 KTTITESPRD 1013
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
Identities = 290/725 (40%), Positives = 403/725 (55%)
Query: 31 KVLLLYNNSFN-HGIPS-EFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNEL 88
+V+ L S N GI S L L+ L L++N + G+IP +S S L Q+ L +N L
Sbjct: 79 RVVKLRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSL 138
Query: 89 VGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLK 148
G+IP+ LG+L+ + L ++ N L+G+IPSSLG L+ + L L +N L G IP +FG L+
Sbjct: 139 SGEIPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLR 198
Query: 149 NLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQ 208
L+ L++A N LSG IP I+NISS+T F+ N+L G +P + L +LQ ++ NQ
Sbjct: 199 RLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQ 258
Query: 209 LTGAIPPAISNASNLELFQADVNKLTGEVP-YLEKPQRLSVFSITENSLGSRGHSNLNFL 267
G IP +I NASN+ +F +N +G VP + + + L + E + ++ F+
Sbjct: 259 FHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFM 318
Query: 268 CSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQR 327
+LTN + L + + FGG+LP +SNLS++L L + +NKI G++P IG VNLQ
Sbjct: 319 TALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQY 378
Query: 328 LEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKFLGNIPPSIGNL-KVFNLDLSCNFLQGSI 386
L + NN L+G++P + K +G++P +IGNL ++ N+++ N G+I
Sbjct: 379 LSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTI 438
Query: 387 PSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXXXXXXXXXXXRNQLTGSIPSEVGNLKNLE 446
PS+LG L I+L NN G IP + N L GSIP E+G LKN+
Sbjct: 439 PSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIV 498
Query: 447 VLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGK 506
NKL GE PST+G C+ L+ L +Q NFL G IP +L+ LKGL+ LDLS NNLSG+
Sbjct: 499 EFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQ 558
Query: 507 IPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCISK 566
IP L G VP GVF NA+ + GN +CGGIPE LPTC K
Sbjct: 559 IPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLK 618
Query: 567 ESKHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXVRKRKEKKXXXXXXXXXXXXXYQNL 626
K R++KE Y+ L
Sbjct: 619 SRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGHPMIT-YKQL 677
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQ--GKTT--VAVKVFNLLHHGAFKSFIAECNTL 682
ATDGF+S++ +G GSFGSVYKG D G+ T VAV+V L A KSF AEC TL
Sbjct: 678 VKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETL 737
Query: 683 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
+N RHRNLVKI+T CS +D +GNDFKA+V++FM N SLE+WLHP T D+ E+ R L L
Sbjct: 738 RNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETN-DQAEQ--RHLTL 794
Query: 743 LQRLN 747
QR++
Sbjct: 795 HQRVS 799
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1155 (411.6 bits), Expect = 3.0e-117, P = 3.0e-117
Identities = 320/966 (33%), Positives = 464/966 (48%)
Query: 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI 68
L LT L G I +GN S L L LY+N IP+E L +LQ L + N + I
Sbjct: 245 LVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSI 304
Query: 69 PANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128
P+++ + L + L N LVG I E+G L +E L++ NN TG P S+ NL ++
Sbjct: 305 PSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTV 364
Query: 129 LFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188
L + NN+ G +P G L NL L+ +N L+G IPSSI N + + D NQ+ G I
Sbjct: 365 LTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEI 424
Query: 189 PLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV-PYLEKPQRLS 247
P FG NL F S+ N TG IP I N SNLE N LTG + P + K Q+L
Sbjct: 425 PRGFG--RMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLR 482
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
+ ++ NSL + N LN L +++N F G +P +SNL T L+ L +
Sbjct: 483 ILQVSYNSLTGPIPREIG------NLKDLNILYLHSNGFTGRIPREMSNL-TLLQGLRMY 535
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKFLGNIPPSI 367
+N + G IP + L L++ NN+ SG IP KF G+IP S+
Sbjct: 536 SNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASL 595
Query: 368 GNLKVFN-LDLSCNFLQGSIPSSL-GQYKTLTI-IDLSDNNLTGTIPPQFXXXXXXXXXX 424
+L + N D+S N L G+IP L K + + ++ S+N LTGTIP +
Sbjct: 596 KSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEID 655
Query: 425 XXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTL-GSCKKLEQLEMQGNFLQGPI 483
N +GSIP + KN+ LD +N L G IP + + L + N G I
Sbjct: 656 LS-NNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714
Query: 484 PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFKNATIT 543
P S ++ L LDLS NNL+G+IPE L G VP GVFKN +
Sbjct: 715 PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774
Query: 544 SVLGNLKLCGGIPEFQLPTCISKESKHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXVR 603
++GN LCG + P I ++S H +
Sbjct: 775 DLMGNTDLCGSKKPLK-PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKK 833
Query: 604 KRKEKKXXXXXXXXXXXXXYQ-------NLYNATDGFASANEIGVGSFGSVYKGILDQGK 656
K K+ + + L ATD F SAN IG S +VYKG L+ G
Sbjct: 834 KEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDG- 892
Query: 657 TTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 714
T +AVKV NL A K F E TL ++HRNLVKIL G ++ KALV F
Sbjct: 893 TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPF 948
Query: 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774
M+N +LE+ +H AP +LL+++++ + +A + YLH PI HCDLKP
Sbjct: 949 MENGNLEDTIHG-------SAAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKP 1000
Query: 775 SNVLLDEEMMAHVSDFGLARFLPLSP--AQTSSIDA-KGSIGYIAPEYGLGSEVSINGDV 831
+N+LLD + +AHVSDFG AR L + T+S A +G+IGY+APE+ +V+ DV
Sbjct: 1001 ANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADV 1060
Query: 832 YSYGILLLELVTRKKPVDSMFEG--DMNLHNFARMALPDH---VVDIVDSTLLSDDEDLA 886
+S+GI+++EL+T+++P E DM L ++ + +V ++D L D ++
Sbjct: 1061 FSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVS 1118
Query: 887 VHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHRIV 946
+ +Q +A IE +++ + C+ P DR +M ++ L ++ R
Sbjct: 1119 L----KQEEA-----IE---DFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGKANSFRED 1166
Query: 947 SNMQRD 952
N R+
Sbjct: 1167 RNEDRE 1172
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 9.4e-116, Sum P(2) = 9.4e-116
Identities = 194/556 (34%), Positives = 278/556 (50%)
Query: 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
RV LNLT L L GSISP G L L L +N+ IP+ L L+ L L +N +
Sbjct: 72 RVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQL 131
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLS 124
GEIP+ + S N+ +R+ NELVG IP LG+L ++ L+++ LTG IPS LG L
Sbjct: 132 TGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLV 191
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184
+ +L L DN L+G IP G +L AEN L+GTIP+ + + ++ + N L
Sbjct: 192 RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251
Query: 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP--YLEK 242
G IP G + LQ+ S+ NQL G IP ++++ NL+ N LTGE+P +
Sbjct: 252 TGEIPSQLG-EMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNM 310
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
Q L + + GS S +CS N+T L +L+++ G +P +S + L+
Sbjct: 311 SQLLDLVLANNHLSGSLPKS----ICS--NNTNLEQLVLSGTQLSGEIPVELSKCQS-LK 363
Query: 303 MLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKFLGN 362
L L NN + G+IP A+ + V L L + NN L GT+ P+I G
Sbjct: 364 QLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423
Query: 363 IPPSIGNLKVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXXXXX 421
+P I L+ L L N G IP +G +L +ID+ N+ G IPP
Sbjct: 424 LPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELN 483
Query: 422 XXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG 481
+N+L G +P+ +GN L +LD+ +N+L G IPS+ G K LEQL + N LQG
Sbjct: 484 LLHLR-QNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQG 542
Query: 482 PIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIE-GVFKNA 540
+P SL SL+ L ++LS N L+G I L G +P+E G +N
Sbjct: 543 NLPDSLISLRNLTRINLSHNRLNGTIHP-LCGSSSYLSFDVTNNGFEDEIPLELGNSQNL 601
Query: 541 TITSVLGNLKLCGGIP 556
LG +L G IP
Sbjct: 602 DRLR-LGKNQLTGKIP 616
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 1.8e-113, Sum P(3) = 1.8e-113
Identities = 189/553 (34%), Positives = 283/553 (51%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ ++ L L S +L G I P + S LK L+L++N IP+E +L L+V+ + N
Sbjct: 153 RNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNK 212
Query: 64 -IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGN 122
I G+IP+ I CSNL + L + G +PS LG L K+E LS+ ++G IPS LGN
Sbjct: 213 EISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGN 272
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
S + LFL +N+L G IP G L L L + +N L G IP I N S++ D +N
Sbjct: 273 CSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-LE 241
L G IP G L L+ F + +N+ +G+IP ISN S+L Q D N+++G +P L
Sbjct: 333 LLSGSIPSSIG-RLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELG 391
Query: 242 KPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTL 301
+L++F N L G + L + T L L ++ N+ G +P+ + L
Sbjct: 392 TLTKLTLFFAWSNQL--EG----SIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLT 445
Query: 302 EMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGXXXXXXXXXXXXXKFLG 361
++LL+ N+ + G IP IG +L RL + NR++G IP IG + G
Sbjct: 446 KLLLISNS-LSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHG 504
Query: 362 NIPPSIGNLKVFNL-DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFXXXXXX 420
+P IG+ + DLS N L+GS+P+ + L ++D+S N +G IP
Sbjct: 505 KVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSL 564
Query: 421 XXXXXXXRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLE-QLEMQGNFL 479
+N +GSIP+ +G L++LD+ N+L GEIPS LG + LE L + N L
Sbjct: 565 NKLILS-KNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRL 623
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQXXXXXXXXXXXXXGMVPIEGVFKN 539
G IPS ++SL L++LDLS N L G + L + G +P +F+
Sbjct: 624 TGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQ 682
Query: 540 ATITSVLGNLKLC 552
+ + GN KLC
Sbjct: 683 LSPQDLEGNKKLC 695
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4487 | 0.9622 | 0.9079 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01680029 | hypothetical protein (1021 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 953 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-112 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-24 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 367 bits (944), Expect = e-112
Identities = 291/938 (31%), Positives = 458/938 (48%), Gaps = 115/938 (12%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
++ LNL++ GSI G++ L+ L L NN + IP++ L+VL L N +
Sbjct: 120 LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
G+IP ++++ ++L + L N+LVG+IP ELG + ++ + + NNL+G IP +G L+S
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
+N L L NNL G IP + G LKNL L + +N LSG IP SIF++ + + D N L
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245
G IP + LQNL+ +F N TG IP A+++ L++ Q NK +GE+P
Sbjct: 298 GEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP------- 349
Query: 246 LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLL 305
+LG H+NL L +LST
Sbjct: 350 --------KNLGK--HNNLTVL----------------------------DLST------ 365
Query: 306 LDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPP 365
N + G IP + NL +L +++N L G IP ++G ++LR +RLQ N F G +P
Sbjct: 366 ---NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 366 SIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGL 424
L V+ LD+S N LQG I S +L ++ L+ N G +P F S L L
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG--SKRLENL 480
Query: 425 DLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIP 484
DLSRNQ +G++P ++G+L L L + ENKL GEIP L SCKKL L++ N L G IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 485 SSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITS 544
+S S + L+ LDLSQN LSG+IP+ L + L +N+S+N+L G +P G F ++
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600
Query: 545 VLGNLKLCGGIPEFQLPTC-ISKESKHKKLTLALKLALAIISGLTGLSLALSFLILCLVR 603
V GN+ LCGG LP C +++ + L ++ L L
Sbjct: 601 VAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL 660
Query: 604 KRKEKKNPSSPINSFPNISYQNLYNATDGFASANE---IGVGSFGSVYKGILDQGKTTVA 660
KR E ++ + + F + D +S E I G G+ YKG +
Sbjct: 661 KRVENEDGTWELQFF-DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 661 VKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSL 720
VK N ++ S IA+ + ++H N+VK++ C + L+ E+++ ++L
Sbjct: 720 VKEINDVNSIP-SSEIAD---MGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNL 770
Query: 721 EEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780
E L R+L+ +R I I +A AL +LH C P + +L P +++D
Sbjct: 771 SEVL-------------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
Query: 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI--GYIAPEYGLGSEVSINGDVYSYGILL 838
+ H L LS D K I Y+APE +++ D+Y +G++L
Sbjct: 818 GKDEPH---------LRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLIL 868
Query: 839 LELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI-VDSTLLSDDEDLAVHGNQRQRQAR 897
+EL+T K P D+ F ++ +AR D +D+ +D ++ D++V+ N+
Sbjct: 869 IELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI---RGDVSVNQNE------ 919
Query: 898 INSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935
+V ++ + + C+ P R +V++ L+S
Sbjct: 920 -------IVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 8e-56
Identities = 141/410 (34%), Positives = 204/410 (49%), Gaps = 36/410 (8%)
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNIS-SITAFDAG 180
N S + ++ L+ N+ G I L + T+ ++ N LSG IP IF S S+ +
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N G IP + NL+ + N L+G IP I + S+L++ N L G++P
Sbjct: 127 NNNFTGSIPRGS---IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP-- 181
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
SLTN T L L + +N G +P + + +
Sbjct: 182 ---------------------------NSLTNLTSLEFLTLASNQLVGQIPRELGQMK-S 213
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L+ + L N + G IP IG +L L++ N L+G IP ++G L+NL+ L L +NK
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273
Query: 361 GNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G IPPSI +L K+ +LDLS N L G IP + Q + L I+ L NN TG IP L
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L + L L N+ +G IP +G NL VLD+ N L GEIP L S L +L + N L
Sbjct: 334 LQV-LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
+G IP SL + + L + L N+ SG++P L+ L++SNNNL+G
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 69/247 (27%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILT 695
++G GSFG VY + VA+KV + + E LK ++H N+V++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
++ D LV E+ + L + L L+ + + A
Sbjct: 65 V-----FEDEDKLYLVMEYCEGGDLFDLLK----------KRGRLSEDEARFYLRQILSA 109
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L YLH I H DLKP N+LLDE+ ++DFGLAR L T+ + G+ Y+
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYM 163
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875
APE LG D++S G++L EL+T K P F GD L +
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPP 219
Query: 876 STLLSDD 882
+S +
Sbjct: 220 EWDISPE 226
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-37
Identities = 107/265 (40%), Positives = 145/265 (54%), Gaps = 7/265 (2%)
Query: 296 NLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGEL-QNLRELRL 354
N S+ + + L I G I +AI + +Q + + NN+LSG IP I +LR L L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 355 QRNKFLGNIPP-SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ 413
N F G+IP SI NL LDLS N L G IP+ +G + +L ++DL N L G IP
Sbjct: 126 SNNNFTGSIPRGSIPNL--ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 414 FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLE 473
L+ L L L+ NQL G IP E+G +K+L+ + + N L GEIP +G L L+
Sbjct: 184 LTNLTSLEF-LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 474 MQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP- 532
+ N L GPIPSSL +LK L L L QN LSG IP + Q L +L+LS+N+L G +P
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 533 IEGVFKNATITSVLGNLKLCGGIPE 557
+ +N I + N G IP
Sbjct: 303 LVIQLQNLEILHLFSN-NFTGKIPV 326
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 638 EIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK 692
++G G+FG VYKG L + +T VAVK + F+ E + +K + H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+L C+ QG +V E+M L ++L + L L L + + +
Sbjct: 66 LLGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQI 111
Query: 753 ACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
A + YL + H DL N L+ E ++ +SDFGL+R + K
Sbjct: 112 AKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 844
I ++APE + + DV+S+G+LL E+ T
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+G G FG+VY + VA+K+ + + E LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
GV ++ + LV E+ + SL++ L +E L+ + L I + + L
Sbjct: 58 -GV-FEDENHLYLVMEYCEGGSLKDLL---------KENEGKLSEDEILRILLQILEGLE 106
Query: 758 YLHHDCQPPITHCDLKPSNVLLDE-EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YLH I H DLKP N+LLD ++DFGL++ L + +I G+ Y+A
Sbjct: 107 YLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMA 161
Query: 817 PEYGLG-SEVSINGDVYSYGILLLEL 841
PE LG S D++S G++L EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 69/246 (28%), Positives = 111/246 (45%), Gaps = 26/246 (10%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 689
++G G+FG VYKG L D T VAVK L A + F+ E +K + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 690 LVKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
+V++L C+ + Y LV E+M+ L ++L +R +L+L L+
Sbjct: 58 VVRLLGVCTEEEPLY-------LVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLS 109
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
I +A + YL H DL N L+ E+++ +SDFGL+R +
Sbjct: 110 FAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSMFEGDM--NLHNFARM 864
K I ++APE + DV+S+G+LL E+ T P + ++ L R+
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 865 ALPDHV 870
P++
Sbjct: 227 PKPEYC 232
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 68/247 (27%), Positives = 108/247 (43%), Gaps = 24/247 (9%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G GSFG+VYK VAVK+ ++ E L+ + H N+V+++
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
+ LV E+ + L ++L L+ + I + + L
Sbjct: 65 --DAFEDKDHL-YLVMEYCEGGDLFDYL----------SRGGPLSEDEAKKIALQILRGL 111
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YLH + I H DLKP N+LLDE + ++DFGLA+ L S + ++ G+ Y+A
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMA 166
Query: 817 PE-YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875
PE G+ DV+S G++L EL+T K P D L R+ P D
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPK 225
Query: 876 STLLSDD 882
+ S++
Sbjct: 226 WSSGSEE 232
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 638 EIGVGSFGSVYKGILDQG----KTTVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRN 689
++G G+FG VYKG L + VAVK L A + F+ E ++ + H N
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK+L C+ + +V E+M L ++L + P+ L+L L+
Sbjct: 63 IVKLLGVCTEEEPL-----MIVMEYMPGGDLLDYLR--------KNRPKELSLSDLLSFA 109
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+ +A + YL H DL N L+ E ++ +SDFGL+R L K
Sbjct: 110 LQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGK 165
Query: 810 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR 844
I ++APE G + S DV+S+G+LL E+ T
Sbjct: 166 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 77/313 (24%), Positives = 119/313 (38%), Gaps = 78/313 (24%)
Query: 638 EIGVGSFGSVYKGILDQG----KTTVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRN 689
++G G+FG VYKG L K VAVK L A + F+ E ++ + H N
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK+L C+ + +V E+M+ L +L K L+L L+
Sbjct: 63 VVKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLR------KNRPK---LSLSDLLSFA 108
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+ +A + YL H DL N L+ E ++ +SDFGL+R L K
Sbjct: 109 LQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGK 164
Query: 810 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR------KKPVDSMFEGDMNLHN 860
I ++APE G + S DV+S+G+LL E+ T + + E L N
Sbjct: 165 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQPYPGMSNEEVLE---YLKN 218
Query: 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920
R+ P + C + + + C E P
Sbjct: 219 GYRLPQPPN----------------------------------CPPELYDLMLQCWAEDP 244
Query: 921 GDRMNMTNVVRQL 933
DR + +V L
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-31
Identities = 92/291 (31%), Positives = 148/291 (50%), Gaps = 13/291 (4%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
Q ++IL+L S G I + +L L+VL L++N F+ IP + L VL L+ N+
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ GEIP + S NL ++ LF N L G+IP LG+ + + + N+ +G +PS L
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 124 SSINTLFLTDNNLDGGIPDTFGW-LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
+ L +++NNL G I ++ W + +L L++A N G +P S F + D N
Sbjct: 428 PLVYFLDISNNNLQGRI-NSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRN 485
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP--YL 240
Q G +P G +L L + EN+L+G IP +S+ L N+L+G++P +
Sbjct: 486 QFSGAVPRKLG-SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLP 291
E P LS +++N L NL + SL ++ I+ N+ G LP
Sbjct: 545 EMPV-LSQLDLSQNQLSGEIPKNLGNVESLV------QVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK--SFIAECNTLKNIRHRNLVKILTA 696
+G G FG V+ G + G T VAVK L G +F+ E +K +RH LV++
Sbjct: 14 LGAGQFGEVWMGTWN-GTTKVAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 697 CSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
CS + Y +V E+M SL ++L K+ E + L L Q +++ +A
Sbjct: 70 CSEEEPIY-------IVTEYMSKGSLLDFL-------KSGEG-KKLRLPQLVDMAAQIAE 114
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
++YL H DL N+L+ E ++ ++DFGLAR + T+ AK I +
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKW 170
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVT 843
APE +I DV+S+GILL E+VT
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 28/205 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
IG G FG V G +G+ VAVK A ++F+AE + + +RH NLV++L
Sbjct: 14 IGKGEFGDVMLGDY-RGQK-VAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLL---- 66
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS-LNLLQRLNIGIDVACALS 757
GV QGN +V E+M SL ++L +R R+ + L Q+L +DV +
Sbjct: 67 GVVLQGNPL-YIVTEYMAKGSLVDYLR--SRG-------RAVITLAQQLGFALDVCEGME 116
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID-AKGSIGYIA 816
YL + H DL NVL+ E+++A VSDFGLA+ + D K + + A
Sbjct: 117 YLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTA 167
Query: 817 PEYGLGSEVSINGDVYSYGILLLEL 841
PE + S DV+S+GILL E+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/209 (35%), Positives = 107/209 (51%), Gaps = 27/209 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILTA 696
+G G FG V++G+ + T VAVK L G K F+AE +K +RH L+++
Sbjct: 14 LGAGQFGEVWEGLWN-NTTPVAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 697 CSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
C+ + Y +V E M+ SL E+L A R+L L Q +++ VA
Sbjct: 70 CTLEEPIY-------IVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQVAS 114
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
++YL + Q I H DL NVL+ E + V+DFGLAR + + AK I +
Sbjct: 115 GMAYL--EAQNYI-HRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKW 170
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVT 843
APE L + SI DV+S+GILL E+VT
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRN 689
F ++G G FG V++G L + + VA+K+ +LL F+ E LK +RH++
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRHKH 63
Query: 690 LVKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
L+ + CS + Y ++ E M+ SL +L ++ E + L + ++
Sbjct: 64 LISLFAVCSVGEPVY-------IITELMEKGSLLAFL-------RSPEG-QVLPVASLID 108
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ VA ++YL + H DL N+L+ E+++ V+DFGLAR + SS D
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSS-D 163
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 844
K + APE S DV+S+GILL E+ T
Sbjct: 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG G FG VYK + VA+KV L + I E LK +H N+VK +
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS- 65
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITRE-DKTEEAPRSLNLLQRLNIGIDVACAL 756
Y D +V EF SL++ L + +++ A LL+ L
Sbjct: 66 ----YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK----------GL 111
Query: 757 SYLH--HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
YLH I H D+K +N+LL + + DFGL+ L + A+ + + G+ +
Sbjct: 112 EYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYW 163
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+APE G D++S GI +EL K P
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G GSFGSVY + +AVK L ++ E L +++H N+V+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY-- 65
Query: 697 CSGVDYQGNDFKALVF-EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
G + +F E++ SL + + K E ++++ +
Sbjct: 66 --GSERDEEKNTLNIFLEYVSGGSLS---SLLKKFGKLPE-----PVIRKYTR--QILEG 113
Query: 756 LSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
L+YLH + I H D+K +N+L+D + + ++DFG A+ L + +G+ +
Sbjct: 114 LAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+APE G E D++S G ++E+ T K P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 33/235 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
E+G G FG V+ G +GK VA+K ++ GA FI E + + H NLV++
Sbjct: 11 ELGSGQFGVVHLGKW-RGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C+ Q F +V E+M N L +L E L L++ DV A
Sbjct: 67 VCT---KQRPIF--IVTEYMANGCLLNYL---------RERKGKLGTEWLLDMCSDVCEA 112
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
+ YL + H DL N L+ E+ + VSDFGLAR++ L TSS K + +
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWA 168
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870
PE S S DV+S+G+L+ E+ + EG M F+ + + V
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFS---------EGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 637 NEIGVGSFGSVYKGI-LDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKI 693
+ IG G+FG VYKG+ L+ G VA+K +L + A KS + E + LKN++H N+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+ + + +D ++ E+ +N SL + + ++ A +LQ
Sbjct: 65 IGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ--------- 110
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
L+YLH + + H D+K +N+L ++ + ++DFG+A L+ G+
Sbjct: 111 -GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPY 164
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
++APE S S D++S G ++EL+T P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+++G G +G VY+G+ + TVAVK + F+ E +K I+H NLV++L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
C+ + F ++ EFM +L ++L R+ +N + L + ++ A+
Sbjct: 71 CT----REPPF-YIITEFMTYGNLLDYLRECNRQ--------EVNAVVLLYMATQISSAM 117
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YL + H DL N L+ E + V+DFGL+R + T+ AK I + A
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 173
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVT 843
PE ++ SI DV+++G+LL E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-21
Identities = 69/237 (29%), Positives = 114/237 (48%), Gaps = 2/237 (0%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNN 61
+H + +L+L++ L G I + + L L+L++NS IP + L+ + L +
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413
Query: 62 NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121
NS GE+P+ + + + + N L G+I S + ++ LS++ N G +P S G
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181
+ + L L+ N G +P G L L L ++EN LSG IP + + + + D
Sbjct: 474 S-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 182 NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238
NQL G IP F + L + +NQL+G IP + N +L N L G +P
Sbjct: 533 NQLSGQIPASFS-EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.3 bits (238), Expect = 4e-21
Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 36/282 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRH-RNLVKI 693
++G GSFG VY + VA+KV + F+ E L ++ H N+VK+
Sbjct: 7 KLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+Q LV E++ SLE+ L I R+ L+ + L I +
Sbjct: 64 YDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQIL 111
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFLPL----SPAQTSSIDA 808
AL YLH I H D+KP N+LLD + + + DFGLA+ LP S +
Sbjct: 112 SALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 809 KGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDS------MFEGDMNLH 859
G+ GY+APE LG S + D++S GI L EL+T P + + +
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSK 901
+L + + DL + + R++S
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 68/247 (27%), Positives = 98/247 (39%), Gaps = 33/247 (13%)
Query: 637 NEIGVGSFGSVYKGILD--QGKTT--VAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLV 691
++G G FG V D T VAVK N +S F E L+ + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
K C G L+ E++ + SL ++L + +NL + L
Sbjct: 70 KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQ--------RHRDQ-INLKRLLLFSSQ 117
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ + YL H DL N+L++ E + +SDFGLA+ LP + S
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 812 -IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH---NFARMALP 867
I + APE S+ S DV+S+G+ L EL T GD + F RM
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY---------GDPSQSPPAEFLRMIGI 225
Query: 868 DHVVDIV 874
IV
Sbjct: 226 AQGQMIV 232
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
EIG G FG V+ G K VA+K + GA + FI E + + H LV++
Sbjct: 11 EIGSGQFGLVWLGYW-LEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C+ LVFEFM++ L ++L R + + + +L L + +DV
Sbjct: 67 VCTE-----RSPICLVFEFMEHGCLSDYL----RAQRGKFSQETL-----LGMCLDVCEG 112
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++YL + H DL N L+ E + VSDFG+ RF+ L TSS K + +
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWS 168
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKK 846
+PE S+ S DV+S+G+L+ E+ + K
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 72/239 (30%), Positives = 123/239 (51%), Gaps = 33/239 (13%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
++G G FG V+ G G T VA+K L G+ ++F+AE N +K ++H LV++
Sbjct: 13 KLGAGQFGEVWMGYY-NGHTKVAIKS---LKQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ + ++ E+M+N SL ++L KT E + L + + +++ +A
Sbjct: 69 VVT------QEPIYIITEYMENGSLVDFL-------KTPEGIK-LTINKLIDMAAQIAEG 114
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++++ + H DL+ +N+L+ E + ++DFGLAR + + T+ AK I +
Sbjct: 115 MAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EYTAREGAKFPIKWT 170
Query: 816 APE---YGLGSEVSINGDVYSYGILLLELVTRKK-PVDSMFEGDM--NLHNFARMALPD 868
APE YG +I DV+S+GILL E+VT + P M ++ NL RM PD
Sbjct: 171 APEAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
++G G FG V+ G + G T VA+K L G ++F+ E +K +RH LV++
Sbjct: 13 KLGQGCFGEVWMGTWN-GTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
S + +V E+M SL ++L E + L L Q +++ +A
Sbjct: 69 VVS------EEPIYIVTEYMSKGSLLDFL--------KGEMGKYLRLPQLVDMAAQIASG 114
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++Y+ + H DL+ +N+L+ E ++ V+DFGLAR + T+ AK I +
Sbjct: 115 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWT 170
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKK 846
APE L +I DV+S+GILL EL T+ +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTA 696
+G GS G VYK A+K ++ F+ + E TL++ +VK
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---- 63
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT-EEAPRSLNLLQRLNIGIDVACA 755
C G Y+ + ++V E+M SL + + ++ E + I +
Sbjct: 64 CYGAFYKEGEI-SIVLEYMDGGSLAD----LLKKVGKIPEPVLAY-------IARQILKG 111
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L YLH I H D+KPSN+L++ + ++DFG+++ L + Q ++ G++ Y+
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+PE G S D++S G+ LLE K P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 24/211 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
++G G FG V+ G + G T VAVK L G +SF+ E +K +RH LV++
Sbjct: 13 KLGNGQFGEVWMGTWN-GNTKVAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
S + +V E+M SL ++L K E R+L L +++ VA
Sbjct: 69 VVS------EEPIYIVTEYMSKGSLLDFL-------KDGEG-RALKLPNLVDMAAQVAAG 114
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++Y+ + H DL+ +N+L+ + ++ ++DFGLAR + T+ AK I +
Sbjct: 115 MAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWT 170
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKK 846
APE L +I DV+S+GILL ELVT+ +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
IG G FG V G D VAVK + ++F+AE + + +RH NLV++L
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL---- 65
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY 758
GV + +V E+M SL ++L R + L +DV A+ Y
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC--------LLKFSLDVCEAMEY 117
Query: 759 LHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPE 818
L + H DL NVL+ E+ +A VSDFGL + A ++ K + + APE
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPE 169
Query: 819 YGLGSEVSINGDVYSYGILLLEL 841
+ S DV+S+GILL E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS--FIAECNTLKNIRHRNLVKILT 695
E+G G FG V G +G+ VA+K ++ G+ FI E + + H LV++
Sbjct: 11 ELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C+ Q + +V E+M N L +L E + Q L + DV
Sbjct: 67 VCTK---QRPIY--IVTEYMSNGCLLNYL---------REHGKRFQPSQLLEMCKDVCEG 112
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++YL H DL N L+D++ VSDFGL+R++ L TSS+ +K + +
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 168
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKK 846
PE L S+ S DV+++G+L+ E+ + K
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 36/242 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V A+KV ++ + + E N L I H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGIDVAC 754
+ +Q + LV E+ L + H +++E + +EE R ++
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGEL--FSH-LSKEGRFSEERARF--------YAAEIVL 104
Query: 755 ALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
AL YLH I + DLKP N+LLD + ++DFGLA+ L ++T++ G+
Sbjct: 105 ALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CGTPE 158
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-----MNLHNFARMALPD 868
Y+APE LG D +S G+LL E++T K P F + + P+
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP----FYAEDRKEIYEKILKDPLRFPE 214
Query: 869 HV 870
+
Sbjct: 215 FL 216
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
++G G FG V+ G + G T VA+K L G ++F+ E +K +RH LV +
Sbjct: 13 KLGQGCFGEVWMGTWN-GTTKVAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
S + +V EFM SL ++L E + L L Q +++ +A
Sbjct: 69 VVS------EEPIYIVTEFMGKGSLLDFL--------KEGDGKYLKLPQLVDMAAQIADG 114
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++Y+ + H DL+ +N+L+ + ++ ++DFGLAR + T+ AK I +
Sbjct: 115 MAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWT 170
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKK 846
APE L +I DV+S+GILL ELVT+ +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 637 NEIGVGSFGSVYKGI-LDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKI 693
N+IG G+FG VY + LD G +AVK + K E L+ ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 694 LTACSGVDYQGNDFKALVF-EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
GV+ K +F E+ +LEE L D+ +L LL+
Sbjct: 64 ---YYGVEVHRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE-------- 110
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL--PLSPAQTSSIDAKG 810
L+YLH I H D+KP+N+ LD + + DFG A L + G
Sbjct: 111 --GLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 811 SIGYIAPEYGLGSEVSING---DVYSYGILLLELVTRKKP 847
+ Y+APE G + +G D++S G ++LE+ T K+P
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 639 IGVGSFGSVYKGI----LDQGKTTVAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G+FG+VYKG+ ++ K VA+KV A K + E + ++ H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
L C Q L+ + M L +++ R K + L LN + +A
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYV----RNHKDNIGSQYL-----LNWCVQIA 119
Query: 754 CALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+SYL + H DL NVL+ ++DFGLA+ L + + + K
Sbjct: 120 KGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDS 850
I ++A E L + DV+SYG+ + EL+T KP +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-17
Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 36/192 (18%)
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
W + GL L L G IP+++ L++L+ +++ N ++G IP +LGS LE L++ N
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFK 538
G IP SL L L +L+L+ N+LSG++P L G +
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASF 520
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLI 598
N T N LC GIP L C L++ K+ +A G+S+A FL+
Sbjct: 521 NFT-----DNAGLC-GIP--GLRACGP------HLSVGAKIGIAF-----GVSVAFLFLV 561
Query: 599 LCLVRKRKEKKN 610
+C + K ++N
Sbjct: 562 ICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 638 EIGVGSFGSVYKG-----ILDQGKTTVAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G+FG V+ G + K VAVK + A K F E L N +H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS----LNLLQRLN 747
K C+ +G D +VFE+M++ L ++L + ++P S L L Q L
Sbjct: 72 KFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
I + +A + YL H H DL N L+ +++ + DFG++R + T
Sbjct: 127 IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDV----YTTDY 177
Query: 806 IDAKGS----IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 846
G I ++ PE + + + DV+S+G++L E+ T K
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 74/248 (29%), Positives = 121/248 (48%), Gaps = 34/248 (13%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
++G G FG V+ G + T VAVK L G ++F+ E N +K ++H LV++
Sbjct: 13 KLGAGQFGEVWMGYYNN-STKVAVKT---LKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 696 ACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+ + Y ++ E+M SL ++L K++E + + L + ++ +A
Sbjct: 69 VVTKEEPIY-------IITEYMAKGSLLDFL-------KSDEGGK-VLLPKLIDFSAQIA 113
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
++Y+ + H DL+ +NVL+ E +M ++DFGLAR + T+ AK I
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIK 169
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKK-PVDSMFEGDM--NLHNFARMA----L 866
+ APE +I DV+S+GILL E+VT K P M D+ L RM
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC 229
Query: 867 PDHVVDIV 874
PD + DI+
Sbjct: 230 PDELYDIM 237
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
IG G+FG V K A+K N + G+ ++ + E L+ + H LV +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ +Q + LV + + L H + +EE + ++ A
Sbjct: 68 S-----FQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKF--------WICEIVLA 112
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L YLH I H D+KP N+LLDE+ H++DF +A + T + G+ GY+
Sbjct: 113 LEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYM 166
Query: 816 APE----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
APE G V D +S G+ E + K+P
Sbjct: 167 APEVLCRQGYSVAV----DWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 44/304 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G FGSV +G L Q + VAVK L + + F++E +K+ H N++K+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 694 LTAC-SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ C Q ++ FM++ L +L + P L L L +D+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTLLKFMVDI 122
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
A + YL + H DL N +L E+M V+DFGL++ + AK +
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872
+IA E + DV+++G+ + E+ TR + + + G N
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ---TPYPGVEN--------------- 221
Query: 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932
+ D HGN R+ +CL + + +C P DR T +
Sbjct: 222 -------HEIYDYLRHGN------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
Query: 933 LQSI 936
L++I
Sbjct: 269 LENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 7e-17
Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 33/223 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G++G VYK + VA+K L + G + + E + LK ++H N+VK+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL-- 64
Query: 697 CSGVDYQGNDFK-ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
D + K LVFE+ L+++L P S NL++ I +
Sbjct: 65 ----DVIHTERKLYLVFEYCD-MDLKKYL-------DKRPGPLSPNLIKS--IMYQLLRG 110
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF--LPLSPAQTSSIDAKGSIG 813
L+Y H I H DLKP N+L++ + + ++DFGLAR +PL T + ++
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTHEVV---TLW 163
Query: 814 YIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
Y APE LGS+ S D++S G + E++T K +F GD
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK----PLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 689
IG G FG V +G L + + VA+K L G+ F+ E + + H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++++ GV + ++ E+M+N SL+++L RE+ + + Q + +
Sbjct: 67 IIRLE----GVVTKSRPV-MIITEYMENGSLDKFL----RENDGK-----FTVGQLVGML 112
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+A + YL H DL N+L++ ++ VSDFGL+R L S A ++ K
Sbjct: 113 RGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169
Query: 810 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
I + APE Y + S DV+S+GI++ E+++
Sbjct: 170 IPIRWTAPEAIAYRKFTSAS---DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
IG G FG+V +G + VAVK N+ ++F+ E + + H+NLV++L
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-- 67
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY 758
+ + G +V E M +L +L R ++++Q L +DVA + Y
Sbjct: 68 -ILHNG---LYIVMELMSKGNLVNFLRTRGRA--------LVSVIQLLQFSLDVAEGMEY 115
Query: 759 LHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPE 818
L + H DL N+L+ E+ +A VSDFGLAR + S + K + APE
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVK----WTAPE 167
Query: 819 YGLGSEVSINGDVYSYGILLLELVTRKK---PVDSMFEGDMNLHNFARMALPD 868
+ S DV+SYG+LL E+ + + P S+ E + RM P+
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 39/274 (14%)
Query: 632 GFASANEIGVGSFGSVYK-GILDQGKTTVAVKVFNLLHHGAF--------KSF---IAEC 679
+A +G G+FG VYK + G+ +A+K N+ H+ AF KS ++E
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINV-HNPAFGKDKRERDKSIGDIVSEV 59
Query: 680 NTLK-NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR 738
+K +RH N+V+ + ND +V + ++ L E H + ++K +
Sbjct: 60 TIIKEQLRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTE 112
Query: 739 SLNLLQRL-NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797
+R+ NI + + AL YLH + + I H DL P+N++L E+ ++DFGLA+
Sbjct: 113 -----ERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ 165
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS--MFEGD 855
TS + G+I Y PE DV+++G +L ++ T + P S M
Sbjct: 166 PESKLTSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222
Query: 856 MNLHNFARMALPD-----HVVDIVDSTLLSDDED 884
+ LP+ V D++ S L D E
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEA 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 638 EIGVGSFGSVYKGIL-----DQGKTTVAVK-VFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G GSFG VY+G+ + +T VA+K V F+ E + +K ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 692 KILTACSGVDYQGNDFKALV-FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
++L GV G LV E M L+ +L E + L + + +
Sbjct: 73 RLL----GVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++A ++YL H DL N ++ E++ + DFG+ R + + KG
Sbjct: 127 EIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET--DYYRKGGKG 181
Query: 811 --SIGYIAPEYGLGSEV-SINGDVYSYGILLLELVT 843
+ ++APE L V + DV+S+G++L E+ T
Sbjct: 182 LLPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 60/268 (22%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 694
+IG GSFG VY +K +L + + + E LK + H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--TEEAPRSLNLLQRLNIGIDV 752
++ +V E+ L + + +E K EE Q L+ + +
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE--------QILDWFVQL 112
Query: 753 ACALSYLH--HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
AL YLH I H D+KP N+ L + + DFG+++ L ++ AK
Sbjct: 113 CLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKT 162
Query: 811 SIG---YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
+G Y++PE Y S D++S G +L EL T K P FEG+ NL
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKS------DIWSLGCVLYELCTLKHP----FEGE-NLLEL 211
Query: 862 ARM-------ALPDHV----VDIVDSTL 878
A +P ++V S L
Sbjct: 212 ALKILKGQYPPIPSQYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 78/249 (31%), Positives = 119/249 (47%), Gaps = 36/249 (14%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL 690
F +IG G++G VYK VA+K L G + I E + LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 691 VKILTACSGVDYQGNDFKA-LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL----LQR 745
VK+L D + K LVFEF+ ++ L++++ D + + L L L +
Sbjct: 62 VKLL------DVIHTENKLYLVFEFL-HQDLKKFM------DASPLSGIPLPLIKSYLFQ 108
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
L G+ A + H + H DLKP N+L++ E ++DFGLAR + P +T +
Sbjct: 109 LLQGL----AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYT 158
Query: 806 IDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKK--PVDSMFEGDMNLHNFA 862
+ ++ Y APE LG + S D++S G + E+VTR+ P DS E D F
Sbjct: 159 HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFR 215
Query: 863 RMALPDHVV 871
+ PD VV
Sbjct: 216 TLGTPDEVV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 638 EIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLV 691
E+G G+FG VYKG L T+VA+K + F E + +++H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWL---HPI---TREDKTEEAPRSLNLLQR 745
+L C+ ++FE++ + L E+L P E E SL+
Sbjct: 72 CLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 746 LNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
L+I I +A + YL HH H DL N L+ E + +SDFGL+R + +
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 841
+ + ++ PE L + + D++S+G++L E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 68/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTAC 697
IG G+FG VYKG+L +G T VAVK K F+ E LK H N+VK++ C
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
V Q +V E + SL +L R+ K L + + L + +D A +
Sbjct: 62 --VQKQP---IYIVMELVPGGSLLTFL----RKKKNR-----LTVKKLLQMSLDAAAGME 107
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAP 817
YL H DL N L+ E + +SDFG++R S + I + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 818 E---YGLGSEVSINGDVYSYGILLLELVT 843
E YG + DV+SYGILL E +
Sbjct: 165 EALNYG---RYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
E+G G FG V+ G + + VA+K N GA + FI E + + H LV++
Sbjct: 11 ELGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C+ Q +V EFM+N L +L R+ + + + L L++ DV
Sbjct: 67 VCT----QQKPL-YIVTEFMENGCLLNYL----RQRQGKLSKDML-----LSMCQDVCEG 112
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
+ YL + H DL N L+ + VSDFG+ R++ L TSS AK + +
Sbjct: 113 MEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWS 168
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKK 846
PE S+ S DV+S+G+L+ E+ T K
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 639 IGVGSFGSVYKGILDQ-GK--TTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK-- 692
IG G FG V +G L GK VA+K + + F++E + + H N++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 693 -ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSL-NLLQRLNIGI 750
++T V ++ EFM+N +L+ +L R++ + L +L+ + G+
Sbjct: 72 GVVTKSRPV--------MIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGM 119
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL---PLSPAQTSSID 807
++Y+H D L N+L++ ++ VSDFGL+RFL P TSS+
Sbjct: 120 KYLSEMNYVHRD---------LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
K I + APE + + DV+SYGI++ E+++
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 639 IGVGSFGSVYKGILD-QGKTTVAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNLVKIL 694
IG G FG V++GIL G+ VAV + L K F++E + + H N++++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL- 71
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSL-NLLQRLNIGIDVA 753
GV + ++ E+M+N +L+++L R+ E + L +L+ + G+
Sbjct: 72 ---EGVVTKFKPA-MIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT-SSIDAKGSI 812
++Y+H D L N+L++ + VSDFGL+R L P T ++ K I
Sbjct: 124 SDMNYVHRD---------LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ APE + + DV+S+GI++ E+++
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRN 689
D E+G G+ G V K + +AVK L + A K + E + L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V A Y D ++ E+M SL++ L +E + I
Sbjct: 61 IVGFYGAF----YNNGDI-SICMEYMDGGSLDKIL---------KEVQGRIPERILGKIA 106
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+ V L+YLH + I H D+KPSN+L++ + DFG++ L S A+T
Sbjct: 107 VAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---- 160
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
G+ Y+APE G++ S+ D++S G+ L+EL T + P
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 638 EIGVGSFGSVYK----GIL-DQGKTTVAVKVFNLLHHGAF----KSFIAECNTLKNIRHR 688
+IG G+FG V++ G+L + T VAVK +L A F E + H
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDHP 68
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------------HPITREDKTEEA 736
N+VK+L C+ G L+FE+M L E+L H + K
Sbjct: 69 NIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 737 PRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
P L+ ++L I VA ++YL + H DL N L+ E M+ ++DFGL+R +
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 797 PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 841
+ +S + I ++ PE + + DV++YG++L E+
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVK--VFNLLHHGAFKSFIAECNTLKNIR---HRNLV 691
EIG G++G+VYK VA+K L G S + E LK + H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWL--HPITREDKTEEAPRSLNLLQRLNIG 749
++L C G LVFE + ++ L +L P +L+++L G
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCP----KPGLPPETIKDLMRQLLRG 119
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+D +LH I H DLKP N+L+ + ++DFGLAR A TS +
Sbjct: 120 VD------FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV--- 167
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 845
++ Y APE L S + D++S G + EL R+
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKILT 695
++G G FG V+ ++ T VAVK + G+ ++F+AE N +K ++H LVK+
Sbjct: 13 KLGAGQFGEVWMATYNK-HTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ + ++ EFM SL ++L K++E + L + ++ +A
Sbjct: 69 VVT------KEPIYIITEFMAKGSLLDFL-------KSDEGSK-QPLPKLIDFSAQIAEG 114
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++++ Q H DL+ +N+L+ ++ ++DFGLAR + T+ AK I +
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 170
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVT 843
APE +I DV+S+GILL+E+VT
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 32/216 (14%)
Query: 638 EIGVGSFGSVYKGILDQ--GKT-TVAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLV 691
++G GSFG V +G GK VAVK L F+ E + ++ H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++ GV +V E SL + L ++A + + +
Sbjct: 60 RLY----GVVLT--HPLMMVTELAPLGSLLDRLR--------KDALGHFLISTLCDYAVQ 105
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDAKG 810
+A + YL H DL N+LL + + DFGL R LP + K
Sbjct: 106 IANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 811 SIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
+ APE S S DV+ +G+ L E+ T
Sbjct: 163 PFAWCAPESLRTRTFSHAS---DVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 18/219 (8%)
Query: 638 EIGVGSFGSVYKG-----ILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
E+G G+FG V+ + +Q K VAVK A + F E L ++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH---PITR--EDKTEEAPRSLNLLQRLN 747
C+ +VFE+M++ L +L P + + AP L L Q L
Sbjct: 72 FYGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
I +A + YL H DL N L+ + ++ + DFG++R + +
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 846
I ++ PE L + + D++S+G++L E+ T K
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
+G GS+GSVYK I + VA+KV + + I E + LK +VK
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62
Query: 699 GVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
Y G+ FK +V E+ S+ + + IT + TEE + L Q L
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEI-AAILYQTLK------- 110
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG- 813
L YLH H D+K N+LL+EE A ++DFG++ L + A+ +++ IG
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-----IGT 162
Query: 814 --YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
++APE + D++S GI +E+ K P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 639 IGVGSFGSVYKGIL------DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 688
+G G+FG VY+G G VAVK L GA K F+ E + + N H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT---LRKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+VK+L C + N+ + ++ E M+ L L + P L L + L+I
Sbjct: 60 NIVKLLGVC--LL---NEPQYIIMELMEGGDL---LSYLRDARVERFGPPLLTLKELLDI 111
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-----MMAHVSDFGLARFLPLSPAQT 803
+DVA YL Q H DL N L+ E+ + + DFGLAR + S
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + ++APE L + + DV+S+G+L+ E++T
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G++G VYK VA+K L G K+ + E LK + H N++K+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
V D LVFEFM + I + + L +L L
Sbjct: 66 ---VFRHKGDL-YLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQL------LQGL 111
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
++ H I H DLKP N+L++ E + ++DFGLAR + Y A
Sbjct: 112 AFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRA 166
Query: 817 PEYGLGSEV-SINGDVYSYGILLLELVTRK 845
PE LG + S D++S G + EL++R+
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 639 IGVGSFGSVYKGIL----DQGKTTVAVKVF-NLLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G FG+V+KGI D K VA+K + F+ + ++ H +V++
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
L C G Q LV + SL + + R+ + P+ L LN + +A
Sbjct: 75 LGICPGASLQ------LVTQLSPLGSLLDHV----RQHRDSLDPQRL-----LNWCVQIA 119
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+ YL + H +L N+LL + + ++DFG+A L + + K I
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVT 843
++A E L + DV+SYG+ + E+++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 41/229 (17%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRN 689
E+G G+FGSV KG+ + VAVK L + F+ E + + + H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKT---LKQEHIAAGKKEFLREASVMAQLDHPC 57
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL--HPITREDKTEEAPRSLNLLQRLN 747
+V+++ C +G LV E L ++L +E Q
Sbjct: 58 IVRLIGVC-----KGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL-----AHQ--- 103
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-PLSPAQTSSI 806
VA ++YL H DL NVLL A +SDFG++R L S ++
Sbjct: 104 ----VAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156
Query: 807 DAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ + + APE YG S S DV+SYG+ L E + KP M
Sbjct: 157 AGRWPLKWYAPECINYGKFSSKS---DVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 26/235 (11%)
Query: 630 TDGFASANEIGVGSFGSVYKGI-LDQGKTTVA---VKVFNLLHHGAFKSFIAECNTLKNI 685
F +IG G F VYK I L G+ VA V++F ++ A + + E + LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRV-VALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
H N++K L + + N+ +V E L + ++ +
Sbjct: 60 DHPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-- 112
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
+ + AL ++H I H D+KP+NV + + + D GL RF S T++
Sbjct: 113 ----VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAA 163
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-MNLH 859
G+ Y++PE + + D++S G LL E+ + P F GD MNL+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 17/218 (7%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF-KSFIAECNTLKNIRHRN 689
+ + +G G+ GSV K L A+K + K + E K+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK A +D + + E+ + SL+ I ++ K +L ++
Sbjct: 61 IVKYYGAF--LDESSSSIG-IAMEYCEGGSLDS----IYKKVKKRGGRIGEKVLGKIAES 113
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
V LSYLH I H D+KPSN+LL + + DFG++ L S A T +
Sbjct: 114 --VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---- 164
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ Y+APE G SI DV+S G+ LLE+ + P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 20/235 (8%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIR---HRNLVK 692
EIGVG++G+VYK VA+K + G S + E LK + H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
++ C+ LVFE + ++ L +L + E + +L+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQF------ 117
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
L +LH +C I H DLKP N+L+ ++DFGLAR A T + ++
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVV---VTL 171
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867
Y APE L S + D++S G + E+ RK E D F + LP
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 41/114 (35%), Positives = 63/114 (55%), Gaps = 1/114 (0%)
Query: 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNEL 88
F+ L L N IP++ +L+ LQ + L+ NSI G IP ++ S ++L + L YN
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 89 VGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLF-LTDNNLDGGIP 141
G IP LG L+ + L+++ N+L+G +P++LG F TDN GIP
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 67/220 (30%), Positives = 93/220 (42%), Gaps = 25/220 (11%)
Query: 638 EIGVGSFGSV----YKGILDQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVK 692
+G G FG V Y D VAVK S + E N LK + H N+VK
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR-SLNLLQRLNIGID 751
CS QG L+ E++ SL ++L P+ LNL Q L
Sbjct: 71 YKGCCSE---QGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFAQQ 115
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS-SIDAKG 810
+ ++YLH Q I H DL NVLLD + + + DFGLA+ +P D
Sbjct: 116 ICEGMAYLH--SQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
+ + A E ++ S DV+S+G+ L EL+T S
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 55/225 (24%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVF-NLLHHGAFKS----FIAECN 680
+ + D ++ + G+FG ++ GIL K +VF + A + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSL 740
L + H+N++ IL C + + +++ +M +L+ +L + P++L
Sbjct: 61 LLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN--NPQAL 114
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
+ Q +++ I +AC +SYLH + + H D+ N ++DEE+ ++D L+R L P
Sbjct: 115 STQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFP 169
Query: 801 AQTSSI--DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + + ++A E + E S DV+S+G+LL EL+T
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 48/226 (21%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVK-- 692
+IG G++G VYK + VA+K + + G + I E L+ +RH N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 693 -ILTACSGVDYQGNDFKALVFEFMQN--RSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
I+T+ +G+ + +VFE+M + L + P + TE + + Q L
Sbjct: 65 EIVTSKG----KGSIY--MVFEYMDHDLTGLLD--SPEVK--FTESQIKCY-MKQLLE-- 111
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
L YLH + I H D+K SN+L++ + + ++DFGLAR T A
Sbjct: 112 -----GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY------TKRNSAD 157
Query: 810 GS-----IGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRK 845
+ + Y PE LG+ EV D++S G +L EL K
Sbjct: 158 YTNRVITLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 638 EIGVGSFGSV-----YKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
E+G G+FG V Y +Q K VAVK A K F E L N++H ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH---PITREDKTEEAPRSLNLLQRLNIG 749
C +G+ +VFE+M++ L ++L P P L Q L+I
Sbjct: 72 FYGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+A + YL H DL N L+ E ++ + DFG++R + +
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 846
I ++ PE + + + DV+S G++L E+ T K
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 639 IGVGSFGSVYKGI-LDQGKTT---VAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G+FG+VYKGI + +G+T VA+K+ N A F+ E + ++ H +LV++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
L C Q LV + M + L +++H E K + L LN + +A
Sbjct: 75 LGVCLSPTIQ------LVTQLMPHGCLLDYVH----EHKDNIGSQLL-----LNWCVQIA 119
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+ YL + + H DL NVL+ ++DFGLAR L + ++ K I
Sbjct: 120 KGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSM 851
++A E + + DV+SYG+ + EL+T KP D +
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 57/236 (24%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS-----FIAECNTLKNIRHRNLV 691
IG GSFG+V K + K+ + V+ + +G ++E N L+ ++H N+V
Sbjct: 6 ETIGKGSFGTVRKV---RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 692 K---------------ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEA 736
+ ++ C G D K + + +EE I
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC----KKERKYIEE--EFI--------- 107
Query: 737 PRSLNLLQRLNIGIDVACALSYLHH--DCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR 794
I + AL H+ D + H DLKP+N+ LD + DFGLA+
Sbjct: 108 ---------WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
Query: 795 FLPLSPAQTSSIDAKGSIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
L S AK +G Y++PE D++S G L+ EL P
Sbjct: 159 ILG-----HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G++G VYK VA+K L G + I E + LK + H N+V++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD- 65
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
V + N LVFEF+ + L++++ +S L Q L +
Sbjct: 66 ---VVHSENKL-YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY-LYQLLQ-------GI 112
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR-F-LPLSPAQTSSIDAKGSIGY 814
+Y H + H DLKP N+L+D E ++DFGLAR F +P+ T + ++ Y
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVV---TLWY 165
Query: 815 IAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
APE LGS + S D++S G + E+V R+ +F GD
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR----PLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 38/226 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G+ G V+K + TVA+K L L G + E L+ +H +VK+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
V G+ F LV E+M L E L R + +S + L +
Sbjct: 67 ---VFPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQV-KSY-MRMLLK-------GV 112
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL--PLSPAQTSSIDAKGSIGY 814
+Y+H I H DLKP+N+L+ + + ++DFGLAR + + + Y
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWY 166
Query: 815 IAPE--YG---LGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
APE YG V D+++ G + EL+ P +F G+
Sbjct: 167 RAPELLYGARKYDPGV----DLWAVGCIFAELL-NGSP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 638 EIGVGSFGSV-----YKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
E+G G+FG V Y + K VAVK A K F E L N++H ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHP------ITREDKTEEAPRSLNLLQRL 746
C D D +VFE+M++ L ++L I + + +A L L Q L
Sbjct: 72 FYGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSI 806
+I +A + YL H DL N L+ ++ + DFG++R + +
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 807 DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 846
I ++ PE + + + DV+S+G++L E+ T K
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILT 695
N IG G+ G+VYK I A+KV H + I E L+++ H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C + + + L+ EFM SLE I E + R Q L+
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQFLADVAR-----QILS-------G 180
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT-----SSIDAKG 810
++YLH + I H D+KPSN+L++ ++DFG++R L AQT SS+ G
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDPCNSSV---G 230
Query: 811 SIGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+I Y++PE G+ GD++S G+ +LE + P +GD
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 639 IGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 689
+G G FG V K + G TTVAVK +L A + ++E N LK + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH------------PITREDKTEEAP 737
++K+ ACS + L+ E+ + SL +L R + P
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 738 --RSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795
R+L + ++ ++ + YL + + H DL NVL+ E +SDFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + + + ++A E + DV+S+G+LL E+VT
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 41/106 (38%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 43 GIPSEFDRLQRLQV---LALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSL 99
G +FD + L L+N + G IP +IS +L I L N + G IP LGS+
Sbjct: 406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465
Query: 100 SKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFG 145
+ +E L +S N+ GSIP SLG L+S+ L L N+L G +P G
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 29/220 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILT 695
IGVG+ VY I VA+K +L E + H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--Y 64
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
S V D LV ++ SL + + +EA + L + L
Sbjct: 65 YTSFVV---GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK-------G 114
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG-- 813
L YLH + Q H D+K N+LL E+ ++DFG++ L + K +G
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTP 170
Query: 814 -YIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
++APE +G + D++S+GI +EL T P
Sbjct: 171 CWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 25/235 (10%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNL 690
+ +IG G++G VYKG + VA+K L G + I E + LK ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
V + V Q + L+FEF+ L+++L + + + +A + L ++ GI
Sbjct: 62 VCLQD----VLMQESRL-YLIFEFLS-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGI 114
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+ H + H DLKP N+L+D + + ++DFGLAR + P + + +
Sbjct: 115 ------LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV- 163
Query: 811 SIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
++ Y APE LGS S D++S G + E+ T KKP +F GD + R+
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGDSEIDQLFRI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 639 IGVGSFGSVYKGILD-QGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVK-- 692
IG G FG V G L GK + V + L + F++E + + H N++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 693 -ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++T V +V E+M+N SL+ +L + D + + +L+ + G+
Sbjct: 72 GVVTKSKPV--------MIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMK 120
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTSSIDAKG 810
+ Y+H D L N+L++ ++ VSDFGL+R L P A ++ K
Sbjct: 121 YLSDMGYVHRD---------LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
I + APE + + DV+SYGI++ E+++
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-13
Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 1/99 (1%)
Query: 366 SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLD 425
+ G + L L L+G IP+ + + + L I+LS N++ G IPP ++ L + LD
Sbjct: 414 TKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-LD 472
Query: 426 LSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464
LS N GSIP +G L +L +L++ N L G +P+ LG
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 6e-13
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVK----VFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL 694
IG G++G V + + VA+K VF+ L K + E L+++RH N++ +L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHLRHENIIGLL 65
Query: 695 TACSGVDYQGNDFKAL--VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
DF + V E M+ L + + + + T++ + L Q L
Sbjct: 66 DIL--RPPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDHIQYF-LYQIL------ 113
Query: 753 ACALSYLH--HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
L YLH + + H DLKPSN+L++ + DFGLAR D KG
Sbjct: 114 -RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLAR------GVDPDEDEKG 161
Query: 811 SIG-------YIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 845
+ Y APE L S +I D++S G + EL+TRK
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 53/278 (19%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKI 693
IG GSF +V + A+K+ + L+ K E L + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+Q + V E+ N L +++ SL+ ++
Sbjct: 68 YYT-----FQDEENLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFYAAEIL 112
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-PLSPAQTSSIDAK--- 809
AL YLH I H DLKP N+LLD++M ++DFG A+ L P S +++ DA
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 810 --------------GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ Y++PE + D+++ G ++ +++T K P F G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGS 225
Query: 856 MNLHNFAR-MAL--------PDHVVDIVDSTLLSDDED 884
F + + L P D+++ L+ D +D
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQD 263
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 639 IGVGSFGSV----YKGILDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVK 692
+G G+FGSV Y + D VAVK L H A + F E LK+++H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 693 ILTACSGVDYQ-GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
GV Y G LV E++ SL ++L + + + + L ++ G++
Sbjct: 70 Y----KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ---KHRERLDHRKLLLYASQICKGME 122
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS--------PAQT 803
+ Y+H D L N+L++ E + DFGL + LP P ++
Sbjct: 123 YLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
I + APE S+ S+ DV+S+G++L EL T
Sbjct: 174 -------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 8e-13
Identities = 75/243 (30%), Positives = 109/243 (44%), Gaps = 69/243 (28%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAFK------------SFIAECNTLKNI 685
+G G++G V+K I + K VA+K +F AF+ F+ E L +
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF-----DAFRNATDAQRTFREIMFLQE---LGD- 65
Query: 686 RHRNLVKILTACSGVDYQGNDFKA-------LVFEFMQNRSLEEWLHPITREDKTEEAPR 738
H N+VK+L N KA LVFE+M E LH + R + E+ +
Sbjct: 66 -HPNIVKLL----------NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHK 109
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-- 796
+ Q L AL Y+H + H DLKPSN+LL+ + ++DFGLAR L
Sbjct: 110 RYIMYQLLK-------ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 797 ----PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRKKPVDSM 851
P +P T + + Y APE LGS G D++S G +L E++ K +
Sbjct: 160 LEENPENPVLTDYVATR---WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----PL 212
Query: 852 FEG 854
F G
Sbjct: 213 FPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 37/168 (22%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-------HRNL 690
++G G+FGSVY + VA+K F S+ EC L+ ++ H N+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHPNI 60
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK----TEEAPRSLNLLQRL 746
VK+ ++ ND VFE+M E L+ + ++ K +E RS+ + Q
Sbjct: 61 VKLKEV-----FRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSI-IYQ-- 107
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR 794
+ L+++H H DLKP N+L+ + ++DFGLAR
Sbjct: 108 -----ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTAC 697
+G G+FG V+KG L + KT VAVK K F++E LK H N+VK++ C
Sbjct: 3 LGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ + ++ M+ ++L R+ K E L Q + +D A ++
Sbjct: 62 TQ--------RQPIYIVMELVPGGDFL-SFLRKKKDE-----LKTKQLVKFALDAAAGMA 107
Query: 758 YLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YL +C H DL N L+ E + +SDFG++R +SS + I + A
Sbjct: 108 YLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTA 162
Query: 817 PE---YGLGSEVSINGDVYSYGILLLE 840
PE YG S S DV+SYGILL E
Sbjct: 163 PEALNYGRYSSES---DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 639 IGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKIL 694
IG G FG VY G L D K AVK N + + F+ E +K+ H N++ +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
C + +G+ +V +M++ L ++ T P +L+ G+ VA
Sbjct: 63 GIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHN------PTVKDLI---GFGLQVAK 109
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL----PLSPAQTSSIDAKG 810
+ YL H DL N +LDE V+DFGLAR + S + AK
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG--AKL 164
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ ++A E + + DV+S+G+LL EL+TR P
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 52/224 (23%)
Query: 638 EIGVGSFGSVYKGILDQGKTT---VAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLVK 692
+G G++G V K + K T VA+K F K+ + E L+ +RH N+V
Sbjct: 8 VVGEGAYGVVLKC---RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 693 ILTAC--SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLN-------LL 743
+ A G Y LVFE+++ LE E +P L +
Sbjct: 65 LKEAFRRKGRLY-------LVFEYVERTLLEL----------LEASPGGLPPDAVRSYIW 107
Query: 744 QRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
Q L A++Y H H+ I H D+KP N+L+ E + + DFG AR L PA
Sbjct: 108 QLLQ-------AIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 803 --TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVT 843
T + + Y APE +G DV++ G ++ EL+
Sbjct: 157 PLTDYVATR---WYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 41/108 (37%), Positives = 57/108 (52%), Gaps = 23/108 (21%)
Query: 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNI 363
L LDN + G IP I K +LQ + + N + G IPP++G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG------------------- 463
Query: 364 PPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIP 411
SI +L+V LDLS N GSIP SLGQ +L I++L+ N+L+G +P
Sbjct: 464 --SITSLEV--LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 43/303 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTT--VAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+G G FGSV +G L+Q + VAVK + + F++E +K H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 695 TAC-SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
C V+ +G ++ FM++ L H + + P+ L + D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+ YL H DL N +L+E M V+DFGL++ + AK +
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873
+IA E + DV+S+G+ + E+ TR + + + G N
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ---TPYPGVEN---------------- 220
Query: 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933
S+ D GN R+ +CL + + +C + +P DR + + +L
Sbjct: 221 ------SEIYDYLRQGN------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
Query: 934 QSI 936
+
Sbjct: 269 EKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 638 EIGVGSFGSV----YKGILDQGKTTVAVKVFNLLHHGAFKSFIA----ECNTLKNIRHRN 689
++G G FG V Y D VAVK L + + IA E L+N+ H N
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS---LNLLQRL 746
+VK C+ + GN K L+ EF+ + SL+E+L PR+ +NL Q+L
Sbjct: 68 IVKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL------------PRNKNKINLKQQL 112
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSS 805
+ + + YL H DL NVL++ E + DFGL + + T
Sbjct: 113 KYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
D + + APE + S+ I DV+S+G+ L EL+T
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 639 IGVGSFGSVYKGIL-----DQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLV 691
+G G+FG V K +TVAVK+ ++E +K I +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 692 KILTACSG-------VDY--QGNDFKALVFEFMQ-NRSLEEWLHPITREDKTEEAPRSLN 741
+L C+ V+Y GN + +F++ R E+ P E L
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGN-----LRDFLRARRPPGEYASPDDPRPPEET----LT 130
Query: 742 LLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
++ VA + +L H DL NVL+ E+ + ++DFGLAR +
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVT 843
+ + + + ++APE L V + DV+S+G+LL E+ T
Sbjct: 188 YRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 45/234 (19%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G++G VYK VA+KV L F+ E + LK RH N+V +
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
Y D +V E+ SL++ +TR L+ LQ + + L
Sbjct: 69 -----YLRRDKLWIVMEYCGGGSLQDIYQ-VTR--------GPLSELQIAYVCRETLKGL 114
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDAKGS-IG- 813
+YLH I H D+K +N+LL E+ ++DFG++ AQ T++I + S IG
Sbjct: 115 AYLHE--TGKI-HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGT 164
Query: 814 --YIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
++APE + V G D+++ GI +EL + P MF +LH
Sbjct: 165 PYWMAPEV---AAVERKGGYDGKCDIWALGITAIELAELQPP---MF----DLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-12
Identities = 44/135 (32%), Positives = 77/135 (57%), Gaps = 1/135 (0%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNN 61
+R++ L+L+ + +G++ +G+LS L L L N + IP E ++L L L++
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 62 NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121
N + G+IPA+ S L Q+ L N+L G+IP LG++ + +++S N+L GS+PS+ G
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-G 591
Query: 122 NLSSINTLFLTDNNL 136
+IN + N
Sbjct: 592 AFLAINASAVAGNID 606
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 75/252 (29%), Positives = 109/252 (43%), Gaps = 48/252 (19%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKVFNLLHHG-----AFKSFIAECNTLKNIRHRNLVK 692
+G GSFGSVY+G+ LD G AVK +L G A K E L ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDG-DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 693 IL-TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
L T D + E + SL + L + E L Q L
Sbjct: 67 YLGTEREE------DNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL---- 113
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
L YLH H D+K +N+L+D + ++DFG+A+ + + + S KGS
Sbjct: 114 ---GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSF--KGS 164
Query: 812 IGYIAPE-------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
++APE YGL + D++S G +LE+ T K P S EG + R
Sbjct: 165 PYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPPW-SQLEGVAAVFKIGRS 217
Query: 865 ----ALPDHVVD 872
+PDH+ D
Sbjct: 218 KELPPIPDHLSD 229
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 639 IGVGSFGSVYKGIL----DQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G+FG+VYKGI + K VA+KV A K + E + + + ++
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
L C Q LV + M L +++ RE+K + L LN + +A
Sbjct: 75 LGICLTSTVQ------LVTQLMPYGCLLDYV----RENKDRIGSQDL-----LNWCVQIA 119
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+SYL + + H DL NVL+ ++DFGLAR L + + + K I
Sbjct: 120 KGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSM 851
++A E L + DV+SYG+ + EL+T KP D +
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 34/228 (14%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLV 691
+ +++G G++ +V+KG + VA+K L H GA + I E + LKN++H N+V
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 692 KILTACSGVDYQGNDFK-ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
+ D + LVFE++ + L+++L NL+ N+ I
Sbjct: 67 TLH------DIIHTERCLTLVFEYLDS-DLKQYLDNCG------------NLMSMHNVKI 107
Query: 751 ---DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ LSY H I H DLKP N+L++E+ ++DFGLAR + P +T S +
Sbjct: 108 FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNE 163
Query: 808 AKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEG 854
++ Y P+ LGS E S D++ G +L E+ T + MF G
Sbjct: 164 VV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR----PMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 69/239 (28%), Positives = 112/239 (46%), Gaps = 55/239 (23%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFI------AECNTLKNIR 686
+ S ++G G++GSV I + VA+K F+S I E LK+++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 687 HRNLVKIL----TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
H N++ +L +A SG ++Q DF LV +MQ + HP++ EDK + +
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQTDLQKIMGHPLS-EDKVQYL-----V 123
Query: 743 LQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
Q L C L Y+H I H DLKP N+ ++E+ + DFGLAR
Sbjct: 124 YQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------- 165
Query: 803 TSSIDAKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPVDSMFEG 854
DA+ + GY+ + EV +N D++S G ++ E++T K ++F+G
Sbjct: 166 --HADAEMT-GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
F IG GSFG VYKGI ++ K VA+K+ +L AE + +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 693 ILTACSG---VDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
+L+ C Y G+ K ++ E++ S + L P EE + +L+
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP----GPLEETYIA-TILRE 109
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
+ G+D YLH + + H D+K +NVLL E+ ++DFG+A L+ Q
Sbjct: 110 ILKGLD------YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKR 158
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ ++APE S D++S GI +EL + P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 46/237 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVK----VFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL 694
IG G++G V I + VA+K F++ K + E L++ +H N++ I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA--KRTLRELKILRHFKHDNIIAIR 70
Query: 695 TACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPI--TREDKTEEAPRSLNLLQRLNIGI 750
+ G DFK +V + M++ LH I + + TEE R L Q L
Sbjct: 71 DI---LRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYF-LYQLL---- 117
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
L Y+H + H DLKPSN+L++E+ + DFG+AR L +S + K
Sbjct: 118 ---RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL-----SSSPTEHKY 166
Query: 811 -------SIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
+ Y APE L E + D++S G + E++ R++ +F G +H
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPGKNYVH 219
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKV--FNLLHHGAFKSFIAECNTLKNIRHRNL 690
F N IG G++G VY+ VA+K + G S + E L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQN---RSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
V++ G + D LV E+ + L+ P + E + L +LQ L
Sbjct: 69 VELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFS-----ESQVKCL-MLQLLR 119
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
L YLH + I H DLK SN+LL ++ ++DFGLAR
Sbjct: 120 -------GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTP 167
Query: 808 AKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRK 845
++ Y APE LG D+++ G +L EL+ K
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHR 688
D + +IG G++G VYK T+A+K L G + I E + LK ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 689 NLVKILTACSGVDYQGNDFKA-LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
N+V++ D ++ + LVFE++ + L++ + D + + ++ L++
Sbjct: 62 NIVRLQ------DVVHSEKRLYLVFEYL-DLDLKKHM------DSSPDFAKNPRLIKTYL 108
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA-HVSDFGLARFLPLSPAQTSSI 806
I A + H + H DLKP N+L+D A ++DFGLAR + P +T +
Sbjct: 109 YQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTH 162
Query: 807 DAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ ++ Y APE LGS S D++S G + E+V +K +F GD
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK----PLFPGD 207
|
Length = 294 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 71/250 (28%), Positives = 107/250 (42%), Gaps = 51/250 (20%)
Query: 620 NISYQNLYNATDG---FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA----- 671
+ L++ D F EIG GSFG+VY + VA+K + + G
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEK 58
Query: 672 FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA----LVFEFMQNRS---LEEWL 724
++ I E L+ +RH N + +Y+G + LV E+ + LE
Sbjct: 59 WQDIIKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYCLGSASDILEVHK 109
Query: 725 HPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784
P+ +E E A LQ L+YLH + H D+K N+LL E
Sbjct: 110 KPL-QEV--EIAAICHGALQ----------GLAYLHSHER---IHRDIKAGNILLTEPGT 153
Query: 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLEL 841
++DFG A + SPA + G+ ++APE L E +G DV+S GI +EL
Sbjct: 154 VKLADFGSASLV--SPANSFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 842 VTRKKPVDSM 851
RK P+ +M
Sbjct: 208 AERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 29/81 (35%), Positives = 55/81 (67%)
Query: 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWL 147
L G IP+++ L ++ +++S N++ G+IP SLG+++S+ L L+ N+ +G IP++ G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 148 KNLATLAMAENWLSGTIPSSI 168
+L L + N LSG +P+++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 24/235 (10%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVK---VFNLLHHGAFKSFIAECNTLKNIRHRN 689
F +IG G F VY+ VA+K +F+L+ A I E + LK + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++K + + N+ +V E L + ++ +
Sbjct: 64 VIKYYASF----IEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF------ 112
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+ + AL ++H + H D+KP+NV + + + D GL RF S T++
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 167
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-MNLHNFAR 863
G+ Y++PE + + D++S G LL E+ + P F GD MNL++ +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKILTA 696
IG G+FG V+ G L T VAVK K+ F+ E LK H N+V+++
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 697 CSGVD--------YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
C+ QG DF F++ E PR L + + + +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLT----FLRT-----------------EGPR-LKVKELIQM 99
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ A + YL H DL N L+ E+ + +SDFG++R ++
Sbjct: 100 VENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156
Query: 809 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLE 840
+ + + APE YG S S DV+S+GILL E
Sbjct: 157 QIPVKWTAPEALNYGRYSSES---DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 697
IG G++G+VY+G VA+K+ NL S I E L +R I
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI---- 64
Query: 698 SGVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
Y G+ K ++ E+ + S+ + + E + ++++ R +V
Sbjct: 65 --TKYYGSYLKGPRLWIIMEYAEGGSVRT----LMKAGPIAE--KYISVIIR-----EVL 111
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS--IDAKGS 811
AL Y+H + H D+K +N+L+ + DFG+A L Q SS G+
Sbjct: 112 VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRSTFVGT 164
Query: 812 IGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKP 847
++APE G D++S GI + E+ T P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 659 VAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715
VA+K+ F E + H N+V +L SG VFE++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGE--APPGLLFAVFEYV 61
Query: 716 QNRSLEEWLHPITREDKTEEAPRSLNL-LQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774
R+L E L D A + L LQ L+ +ACA H+ I H DLKP
Sbjct: 62 PGRTLREVL----AADGALPAGETGRLMLQVLD---ALACA-----HN--QGIVHRDLKP 107
Query: 775 SNVLL---DEEMMAHVSDFGLARFLP-----LSPAQTSSIDAKGSIGYIAPEYGLGSEVS 826
N+++ A V DFG+ LP T + + G+ Y APE G V+
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 827 INGDVYSYGILLLELVTRKKPV 848
N D+Y++G++ LE +T ++ V
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
IG G+ G VYK VA+K L + I E +K+ +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDS-- 83
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY 758
Y D +V E+M SL + + + +N Q + +V L Y
Sbjct: 84 ---YLVGDELWVVMEYMDGGSLTDII---------TQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 759 LHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK-----GSIG 813
LH + H D+K N+LL ++ ++DFG A AQ + +K G+
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPY 181
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELV 842
++APE + D++S GI+ +E+
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 638 EIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGAFK---SFIAECNTLKNIRHRN 689
E+G GSFG VY+GI D+ +T VA+K N + + F+ E + +K +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHH 70
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V++L GV QG ++ E M L+ +L + E + +L + + +
Sbjct: 71 VVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
++A ++YL+ + H DL N ++ E+ + DFG+ R + +
Sbjct: 126 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ +++PE + DV+S+G++L E+ T
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 26/216 (12%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTT---VAVKVFNL-LHHGAFKSFIAECNTLKNIRHR 688
F ++G G++ +VYKG + +TT VA+K +L G + I E + +K ++H
Sbjct: 2 FKQLEKLGEGTYATVYKG---RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+V++ V + N LVFE+M L++++ T +L+ +
Sbjct: 59 NIVRL----HDVIHTENKL-MLVFEYMDK-DLKKYM-------DTHGVRGALDPNTVKSF 105
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ +++ H + + H DLKP N+L+++ ++DFGLAR + P T S +
Sbjct: 106 TYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-PVNTFSNEV 161
Query: 809 KGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVT 843
++ Y AP+ LGS S + D++S G ++ E++T
Sbjct: 162 V-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
I G++G V+ A+KV ++ + E + L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ +QG LV E++ L L + D E+ R ++ A
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLD--EDVAR--------IYIAEIVLA 105
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF------LPLSPAQTSSIDAK 809
L YLH I H DLKP N+L+D ++DFGL++ + L+ +
Sbjct: 106 LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
G+ YIAPE LG S D +S G +L E +
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 74/266 (27%), Positives = 114/266 (42%), Gaps = 38/266 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTA 696
EIG G+FG+V K + T +AVK K + + + + R + I
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--RSSDCPYI--- 65
Query: 697 CSGVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
V + G F+ + E M + SL++ + E P +L + I +
Sbjct: 66 ---VKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPE--EILGK--IAVAT 116
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL+YL + + I H D+KPSN+LLD + DFG++ L S A+T DA G
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR--DA-GCR 171
Query: 813 GYIAPEYGLGSEVS---INGDVYSYGILLLELVTRKKPV---DSMFE-------GDM-NL 858
Y+APE S + DV+S GI L E+ T K P +S+F+ GD L
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231
Query: 859 HNFARMALPDHVVDIVDSTLLSDDED 884
N V+ ++ L+ D+
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESK 257
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNL 690
F N+IG GSFG V+K + K A+K +L + I E L + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
++ S +D +V E+ +N L + L P + + R I I
Sbjct: 62 IRYYE--SFLDKG---KLNIVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQI 110
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+ L++LH I H D+K N+ LD + D G+A+ L ++ A
Sbjct: 111 LLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFANT 160
Query: 811 SIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854
+G Y++PE + DV++ G++L E T K P D+ +G
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G FGSV + L + VAVK+ ++ + F+ E +K H N++K+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 694 LTACSGVDYQGN-DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ +G ++ FM++ L H + E P +L L + ID+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
A + YL H DL N +L+E M V+DFGL++ + +K +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTR 844
++A E + + + DV+++G+ + E++TR
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 19/212 (8%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G FG V + A K N L ++ + E L + R +V +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
A +Q LV M L ++ + E+ PR+ + +
Sbjct: 61 A-----FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISG 109
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L +LH Q I + DLKP NVLLD + +SD GLA + L Q+ + G+ G++
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFM 164
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
APE G E + D ++ G+ L E++ + P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 41/113 (36%), Positives = 60/113 (53%), Gaps = 12/113 (10%)
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
I + + AL YLH + + H D+KPSNVL++ + DFG++ +L S A+T ID
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT--ID 163
Query: 808 AKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKPVDS---MFE 853
A G Y+APE + DV+S GI ++EL T + P DS F+
Sbjct: 164 A-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA---FKSFIAECNTLKNI-RHRNLVKIL 694
IG G+FG V K + + + + + + + + F E L + H N++ +L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEA-------PRSLNLLQRLN 747
AC +++G + L E+ + +L ++L +R +T+ A +L+ Q L+
Sbjct: 75 GAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
DVA + YL Q H DL N+L+ E +A ++DFGL+R + +T
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--- 182
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + ++A E S + N DV+SYG+LL E+V+
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 54/223 (24%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLV------ 691
+G GS+ +VYKG VA+K L H GA + I E + LK+++H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 692 ---KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLN------- 741
K LT LVFE++ L++++ ++ L+
Sbjct: 73 HTKKTLT--------------LVFEYLD-TDLKQYM---------DDCGGGLSMHNVRLF 108
Query: 742 LLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
L Q L L+Y H + H DLKP N+L+ E ++DFGLAR + P+
Sbjct: 109 LFQLLR-------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV-PS 157
Query: 802 QTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVT 843
+T S + ++ Y P+ LGS E S + D++ G + E+ T
Sbjct: 158 KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 61/245 (24%)
Query: 618 FPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKV----FNLLHHGAFK 673
P+ YQNL + +G G++G V + VA+K F H K
Sbjct: 13 VPDR-YQNL----------SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA--K 59
Query: 674 SFIAECNTLKNIRHRN---LVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPIT 728
E LK++ H N L+ + T S + DF+ LV M L+ I
Sbjct: 60 RTYRELRLLKHMDHENVIGLLDVFTPASSL----EDFQDVYLVTHLMGAD-----LNNIV 110
Query: 729 REDK-TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
+ K +++ + L + Q L L Y+H I H DLKPSN+ ++E+ +
Sbjct: 111 KCQKLSDDHIQFL-VYQILR-------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKI 159
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLE 840
DFGLAR T GY+A + E+ +N D++S G ++ E
Sbjct: 160 LDFGLAR-------HTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 841 LVTRK 845
L+T K
Sbjct: 209 LLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 39/244 (15%)
Query: 638 EIGVGSFGSVYKGILDQGKT--TVAVKVF-NLLHHGAFK-SFIAECNTLKNIRHRNLVKI 693
E+G G+FG+V KG+ K+ TVAVK+ N + A K + E N ++ + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHP---ITREDKTEEAPRSLNLLQRLNIGI 750
+ C + LV E + L ++L +T ++ TE L+ ++++G
Sbjct: 62 IGICEAESWM------LVMELAELGPLNKFLQKNKHVTEKNITE-------LVHQVSMG- 107
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS----PAQTSSI 806
+ YL + H DL NVLL + A +SDFGL++ L A+T
Sbjct: 108 -----MKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH-- 157
Query: 807 DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSMFEGDMN--LHNFAR 863
K + + APE + S DV+S+G+L+ E + +KP M ++ + + R
Sbjct: 158 -GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
Query: 864 MALP 867
M P
Sbjct: 217 MECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKI 693
+G G++ VYK + VA+K L G + + E L+ ++H N++ +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK----TEEAPRSLNLLQRLNIG 749
L + LVFEFM+ LE+ + DK T +S +L L
Sbjct: 68 LDV-----FGHKSNINLVFEFMET-DLEKVIK-----DKSIVLTPADIKSY-MLMTLR-- 113
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ--TSSID 807
L YLH + I H DLKP+N+L+ + + ++DFGLAR SP + T +
Sbjct: 114 -----GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV 164
Query: 808 AKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 845
Y APE G+ V + D++S G + EL+ R
Sbjct: 165 T---RWYRAPELLFGARHYGVGV--DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+ C L +LH Q I + DLKP NVLLD+ +SD GLA L G
Sbjct: 103 QIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAG 156
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ GY+APE G + D ++ G L E++ + P
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 30/233 (12%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVK---VFNLLHHGAFKSFIAECNTLKNIRHRN 689
F +IG G F VY+ + VA+K +F ++ A + + E + LK + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++K L + + ++ +V E L + + ++ + L+ +
Sbjct: 64 VIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQKR---------LIPERTVW 109
Query: 750 ---IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSI 806
+ + A+ ++H + H D+KP+NV + + + D GL RF S T++
Sbjct: 110 KYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH 164
Query: 807 DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-MNL 858
G+ Y++PE + + D++S G LL E+ + P F GD MNL
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILT 695
+GVG FG V + T A+K H G + +E L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC- 754
++ + ++ E+ L L D E R +AC
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFY-----------IACV 102
Query: 755 --ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
A YLH+ I + DLKP N+LLD + DFG A+ L S +T + G+
Sbjct: 103 VLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTF--CGTP 156
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
Y+APE L + D +S GILL EL+T + P
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNI 685
+ A + + ++G GS+ +VYKGI VA+KV ++ G + I E + LK +
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL--HPITREDKTEEAPRSLNLL 743
+H N+V + + VFE+M L +++ HP L +
Sbjct: 61 KHANIVLLHDII-----HTKETLTFVFEYMHT-DLAQYMIQHP----GGLHPYNVRLFMF 110
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
Q L L+Y+H I H DLKP N+L+ ++DFGLAR + P+QT
Sbjct: 111 QLLR-------GLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQT 159
Query: 804 SSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELV 842
S + ++ Y P+ LG+ + S D++ G + +E++
Sbjct: 160 YSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
F +IG GSFG V+KGI ++ + VA+K+ +L AE + +++I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 693 ILTACSG---VDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
+L+ C Y G+ K ++ E++ S + L P D+T+ A +L+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIA----TILRE 109
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
+ G+D YLH + + H D+K +NVLL E ++DFG+A L+ Q
Sbjct: 110 ILKGLD------YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKR 158
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ ++APE S D++S GI +EL + P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 638 EIGVGSFGSVYKGI-LDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIR---HRNLV 691
EIG G++G V+K L G VA+K + G S I E L+++ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++ C+ LVFE + ++ L +L + E + + + Q L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM-MFQLLR---- 121
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
L +LH + H DLKP N+L+ ++DFGLAR A TS + +
Sbjct: 122 ---GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VT 172
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
+ Y APE L S + D++S G + E+ R+KP +F G ++ ++
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGKI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNL----------LHHGAFKSFIAECNTLKNIRHR 688
IG G++G VY + +AVK L K+ +E TLK++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+V G + ++ ++ E++ S+ L + EE Q L
Sbjct: 69 NIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLR---TYGRFEEQLVRFFTEQVLE- 119
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
L+YLH I H DLK N+L+D + + +SDFG+++ ++
Sbjct: 120 ------GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 809 KGSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKP------VDSMFE 853
+GS+ ++APE Y G + D++S G ++LE+ ++P + +MF+
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 32/90 (35%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 281 INANNFG--GLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGT 338
+ +N G G +P IS L L+ + L N I GNIP ++G +L+ L++ N +G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 339 IPPAIGELQNLRELRLQRNKFLGNIPPSIG 368
IP ++G+L +LR L L N G +P ++G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 46/217 (21%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V A+K+ + ++ + + E L++IRH LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI----- 750
+ +Q + LV E++ L L R +
Sbjct: 69 S-----FQDDSNLYLVMEYVPGGELFSHLRKS----------------GRFPEPVARFYA 107
Query: 751 -DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
V AL YLH I + DLKP N+LLD + ++DFG A+ + +T ++
Sbjct: 108 AQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTL--C 159
Query: 810 GSIGYIAPEY----GLGSEVSINGDVYSYGILLLELV 842
G+ Y+APE G G V D ++ GIL+ E++
Sbjct: 160 GTPEYLAPEIILSKGYGKAV----DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 639 IGVGSFGSVYKGIL--DQGKTTVAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRNLVKIL 694
IG G+FG V + ++ D K A+K+ + F E L + H N++ +L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 695 TACSGVDY---------QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
AC Y GN + +F++ + E +E T S LLQ
Sbjct: 70 GACENRGYLYIAIEYAPYGN-----LLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ- 123
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
DVA + YL + H DL NVL+ E + + ++DFGL+R + +T
Sbjct: 124 --FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM- 177
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + ++A E S + DV+S+G+LL E+V+
Sbjct: 178 --GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 58/268 (21%), Positives = 99/268 (36%), Gaps = 59/268 (22%)
Query: 638 EIGVGSFGSVYKGILDQGKTT---VAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLV 691
I G+FGSVY L + ++T A+KV +++ + AE + V
Sbjct: 3 PISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL----- 746
L +Q D+ LV E++ +L++ L
Sbjct: 60 AKLYYS----FQSKDYLYLVMEYLNGGDCA-------------------SLIKTLGGLPE 96
Query: 747 ----NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
+V + LH I H D+KP N+L+D+ ++DFGL+R +
Sbjct: 97 DWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-- 151
Query: 803 TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE---- 853
G+ Y+APE LG D +S G ++ E + P D++F+
Sbjct: 152 ----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
Query: 854 GDMNLHNFARMALPDHVVDIVDSTLLSD 881
+N + VD+++ L D
Sbjct: 208 RRINWPEEVKEFCSPEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 37/97 (38%), Positives = 49/97 (50%), Gaps = 9/97 (9%)
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
AL YL + H D+KPSN+LLD + DFG++ L S A+T S G Y
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAY 180
Query: 815 IAPEY----GLGSEVSINGDVYSYGILLLELVTRKKP 847
+APE + I DV+S GI L+EL T + P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILT 695
+++G G++ +VYKG VA+K L H GA + I E + LK+++H N+V +
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
LVFE++ ++ L+++L N + N+ + +
Sbjct: 72 II-----HTEKSLTLVFEYL-DKDLKQYLDDCG------------NSINMHNVKLFLFQL 113
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L L++ + + H DLKP N+L++E ++DFGLAR + P +T S + ++ Y
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYR 171
Query: 816 APEYGLGS-EVSINGDVYSYGILLLELVT 843
P+ LGS + S D++ G + E+ T
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 40/244 (16%)
Query: 639 IGVGSFGSVYKGI---LDQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKIL 694
IG G FG VY+G+ + K VAVK + + F+ E ++ H ++VK++
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + +V E L +L + + A L Q ++
Sbjct: 74 GVIT------ENPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQ-------LST 118
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
AL+YL H D+ NVL+ + DFGL+R+L +S K I +
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPIKW 174
Query: 815 IAPEYGLGSEVSIN-------GDVYSYGILLLELVTR-KKPVDSMFEGD--MNLHNFARM 864
+APE SIN DV+ +G+ + E++ KP + D + N R+
Sbjct: 175 MAPE-------SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL 227
Query: 865 ALPD 868
+P
Sbjct: 228 PMPP 231
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 45/219 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVF------NLLHHGAFKSFIAECNTLKNIRHRNLVK 692
IG GS+G V+K + VA+K F ++ A + E LK ++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
++ ++ LVFE+ + L E E+ PR + I
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVLNE----------LEKNPRGVPEHLIKKIIWQT 109
Query: 753 ACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
A+++ H H+C H D+KP N+L+ ++ + DFG AR L+ D +
Sbjct: 110 LQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVAT 163
Query: 812 IGYIAPE-------YGLGSEVSINGDVYSYGILLLELVT 843
Y APE Y G V DV++ G + EL+T
Sbjct: 164 RWYRAPELLVGDTQY--GPPV----DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 633 FASANEIGVGSFGSVYKGI-LDQG---KTTVAVKVF-NLLHHGAFKSFIAECNTLKNIRH 687
F +G G+FG+VYKG+ + +G K VA+K A K + E + ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++ ++L C Q L+ + M L +++ RE K + L LN
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV----REHKDNIGSQYL-----LN 113
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ +A ++YL + + H DL NVL+ ++DFGLA+ L + +
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSM 851
K I ++A E L + DV+SYG+ + EL+T KP D +
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 73/308 (23%), Positives = 121/308 (39%), Gaps = 57/308 (18%)
Query: 639 IGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVK 692
+G G+FG VY+G+ D + VAVK +S F+ E + H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGID 751
GV ++ + ++ E M L+ +L RE++ E P SL + L D
Sbjct: 74 ----LIGVSFERLP-RFILLELMAGGDLKSFL----RENRPRPERPSSLTMKDLLFCARD 124
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLD---EEMMAHVSDFGLARFLPLSPAQTSSIDA 808
VA YL + H D+ N LL +A ++DFG+AR + + A
Sbjct: 125 VAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868
I ++ PE L + DV+S+G+LL E+ + M P
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS-----------------LGYMPYPG 224
Query: 869 HVVDIVDSTLLSDDE--DLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926
++ E + G R++ C + RI C +P DR N
Sbjct: 225 ----------RTNQEVMEFVTGG------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF 268
Query: 927 TNVVRQLQ 934
++ ++Q
Sbjct: 269 ATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 638 EIGVGSFGSVYKGIL-----DQGKTTVAVKVF----NLLHHGAFKSFIAECNTLKNIRHR 688
E+G +FG +YKG L D + VA+K N G F+ E + + + H
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQL-VAIKTLKDINNPQQWGEFQQ---EASLMAELHHP 67
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITRE---------DKTEEAPRS 739
N+V +L GV Q ++FE++ L E+L I R D+ S
Sbjct: 68 NIVCLL----GVVTQEQPV-CMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDGTVKSS 120
Query: 740 LNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS 799
L+ L+I I +A + YL H DL N+L+ E++ +SD GL+R + +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 800 PAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ I ++ PE + + S + D++S+G++L E+ +
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSF----IAECNTLKNIRHRNLVK 692
+IG G+FG V+K + K VA+K +L + F + E L+ ++H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 693 ILTACSGVDYQGNDFKA---LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++ C N +K LVFEF ++ L L + E + + +L LN
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML--LN-- 130
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR--FLPLSPAQTSSID 807
L Y+H + I H D+K +N+L+ ++ + ++DFGLAR L + +
Sbjct: 131 -----GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 808 AKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTR 844
++ Y PE LG I D++ G ++ E+ TR
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPI--DMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRN 689
F +EIG GSFG+VY VAVK + + ++ I E L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 690 LVKILTACSGVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
++Y+G K LV E+ + D E + L ++
Sbjct: 83 T---------IEYKGCYLKEHTAWLVMEYCLGSA----------SDLLEVHKKPLQEVEI 123
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
I L+YLH + H D+K N+LL E ++DFG A SPA +
Sbjct: 124 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK--SSPANSFV 178
Query: 806 IDAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLELVTRKKPVDSM 851
G+ ++APE L E +G DV+S GI +EL RK P+ +M
Sbjct: 179 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 678 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAP 737
E L+ + R +V + A Y+ D LV M L+ H + E
Sbjct: 50 EKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEG 102
Query: 738 RSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797
R++ ++ C L LH Q I + DLKP N+LLD+ +SD GLA +P
Sbjct: 103 RAVFY------AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153
Query: 798 LSPAQTSSIDAK-GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ +I + G++GY+APE + + D ++ G LL E++ + P
Sbjct: 154 ----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 34/226 (15%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
F IG GSFG V+KGI ++ + VA+K+ +L AE + +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 693 ILTACSG---VDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
+L+ C Y G+ K ++ E++ S + L R +E + +L+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEF-QIATMLKE 109
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
+ G+D YLH + + H D+K +NVLL E+ ++DFG+A L+ Q
Sbjct: 110 ILKGLD------YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKR 158
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851
G+ ++APE S D++S GI +EL + P M
Sbjct: 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA--ECNTLKNIRHRNLVKILTA 696
+G GS+G V K + VA+K F IA E LK +RH NLV ++
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
+ LVFEF+ + L D E+ P L+ + + +
Sbjct: 69 FR----RKKRLY-LVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQILRGI 113
Query: 757 SYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
+ H H+ I H D+KP N+L+ + + + DFG AR L +P + + D + Y
Sbjct: 114 EFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYT-DYVATRWYR 167
Query: 816 APEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858
APE +G ++ D+++ G L+ E++T + +F GD ++
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 46/223 (20%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTA 696
IG GSFG VYK I + VA+KV +L I E L R + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---- 63
Query: 697 CSGVDYQG---NDFK-ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI-- 750
Y G K ++ E+ S + L P ++ I
Sbjct: 64 -----YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY--------------IAFIL 104
Query: 751 -DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+V L YLH + I H D+K +N+LL EE ++DFG++ Q +S +K
Sbjct: 105 REVLLGLEYLH--EEGKI-HRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSK 154
Query: 810 -----GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ ++APE S D++S GI +EL + P
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI 685
+ D + ++G GS+ +VYKG VA+KV L G + I E + LK +
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW------LHPITREDKTEEAPRS 739
+H N+V + + LVFE++ + LHP + +
Sbjct: 61 KHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHP----ENVK----- 106
Query: 740 LNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS 799
L L Q L LSY+H Q I H DLKP N+L+ + ++DFGLAR +
Sbjct: 107 LFLFQLLR-------GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV- 155
Query: 800 PAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELV 842
P+ T S + ++ Y P+ LGS E S D++ G + +E++
Sbjct: 156 PSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 37/247 (14%)
Query: 639 IGVGSFGSVYKG-----ILDQGKTTVAVKVFNLLHHGAFK-SFIAECNTLKNI-RHRNLV 691
+G G+FG V + VAVK+ H + + + ++E + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 692 KILTAC--SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+L AC G ++ E+ L +L + E+ +L L L+
Sbjct: 103 NLLGACTIGGPIL-------VITEYCCYGDLLNFLR------RKRESFLTLEDL--LSFS 147
Query: 750 IDVACALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
VA +++L +C H DL NVLL + + DFGLAR + +A
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK------PVDSMFEGDMNLHNFA 862
+ + ++APE + DV+SYGILL E+ + PVDS F +
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK--LIKEGY 261
Query: 863 RMALPDH 869
RMA P+H
Sbjct: 262 RMAQPEH 268
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 32/81 (39%), Positives = 51/81 (62%), Gaps = 2/81 (2%)
Query: 361 GNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
G IP I L + +++LS N ++G+IP SLG +L ++DLS N+ G+IP L+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 420 LLIGLDLSRNQLTGSIPSEVG 440
L I L+L+ N L+G +P+ +G
Sbjct: 492 LRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 37/249 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNL---------LHHGAFKSFIAECNTLKNIRHRN 689
IG GSFGSVY G+ +AVK L + E LK ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSL--NLLQRLN 747
+V+ L + D+ N F E++ S+ L + +L N ++++
Sbjct: 68 IVQYLGSSLDADHL-NIF----LEYVPGGSVAALL------NNYGAFEETLVRNFVRQIL 116
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
G L+YLH+ I H D+K +N+L+D + +SDFG+++ L + T +
Sbjct: 117 KG------LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 808 AK----GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM--FEGDMNLHNF 861
A+ GS+ ++APE + + D++S G L++E++T K P + +
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227
Query: 862 ARMALPDHV 870
A +P ++
Sbjct: 228 ASPEIPSNI 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNI 685
+ + + ++G G++ +V+KG + VA+K L H GA + I E + LK++
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
+H N+V + + LVFE++ ++ L++++ N++
Sbjct: 62 KHANIVTLHDIV-----HTDKSLTLVFEYL-DKDLKQYMDDCG------------NIMSM 103
Query: 746 LNIGI---DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
N+ I + L+Y H + + H DLKP N+L++E ++DFGLAR + P +
Sbjct: 104 HNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTK 159
Query: 803 TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVT 843
T S + ++ Y P+ LG SE S D++ G + E+ +
Sbjct: 160 TYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 73/245 (29%), Positives = 107/245 (43%), Gaps = 44/245 (17%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHR 688
D F +IG G++G VYK VA+K L + G + I E L+ + HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 689 NLVK---ILTACSGVDYQGNDFKA------LVFEFMQNR---SLEEWLHPITREDKTEEA 736
N+V I+T DFK LVFE+M + LE L +E+
Sbjct: 67 NIVNLKEIVTD----KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDH 117
Query: 737 PRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
+S + Q L L+Y H + H D+K SN+LL+ + ++DFGLAR
Sbjct: 118 IKSF-MKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 797 PLSPAQTSSIDAKGSIGYIAPEYGLGSEV---SINGDVYSYGILLLELVTRKKPVDSMFE 853
S + ++ Y PE LG E +I DV+S G +L EL T+K +F+
Sbjct: 167 -NSEESRPYTNKVITLWYRPPELLLGEERYGPAI--DVWSCGCILGELFTKK----PIFQ 219
Query: 854 GDMNL 858
+ L
Sbjct: 220 ANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 46/236 (19%)
Query: 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH 687
N + + E+G G+FG VYK + A KV + + ++ E + L + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
N+VK+L A Y N+ L+ EF +++ + E R L Q
Sbjct: 62 PNIVKLLDAF----YYENNLWILI-EFCAGGAVDAVML---------ELERPLTEPQ--- 104
Query: 748 IGIDVAC-----ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
I V C AL+YLH + I H DLK N+L + ++DFG +S
Sbjct: 105 --IRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG------VSAKN 153
Query: 803 TSSIDAKGSIGYIAPEYGLGSEVSI-----------NGDVYSYGILLLELVTRKKP 847
T +I + S +I Y + EV + DV+S GI L+E+ + P
Sbjct: 154 TRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 61/240 (25%), Positives = 91/240 (37%), Gaps = 50/240 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKV-------FNLLHHGAFKSFIAECNTLKNIRHRNLV 691
IG G G VY VA+K LL K F+ E ++ H +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHPGIV 65
Query: 692 KILTACSGVD--------YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
+ + CS D +G K+L+ Q SL + L T S+
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT----------SVGAF 115
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
L+I + + Y+H + H DLKP N+LL + D+G A F L
Sbjct: 116 --LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 804 SSIDAK----------------GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
ID G+ Y+APE LG S + D+Y+ G++L +++T P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 41/217 (18%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+G G+ G+VYK + +AVKV L + K ++E ++IL C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKC 56
Query: 698 SG---VDYQGNDFK----ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
+ + G F ++ EFM SL D + P ++L R I +
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSL----------DVYRKIPE--HVLGR--IAV 102
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
V L+YL I H D+KPSN+L++ + DFG++ L S A+T G
Sbjct: 103 AVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----G 155
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ Y+APE G + I+ DV+S GI +EL + P
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 53/238 (22%)
Query: 632 GFASANEIGVGSFGSVYKGILDQGKTT--VAVKVF---NLLHHGAFKSFIAECNTLKNIR 686
+ IG G++G VYK GK A+K F + G +S E L+ ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 687 HRNLVK----ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPIT--REDKTEEAPRSL 740
H N+V L Y L+F++ ++ + I R+ K P S+
Sbjct: 61 HENVVSLVEVFLEHADKSVY-------LLFDYAEH----DLWQIIKFHRQAKRVSIPPSM 109
Query: 741 --NLL-QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLA 793
+LL Q LN + YLH + + H DLKP+N+L+ E + + D GLA
Sbjct: 110 VKSLLWQILN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 794 RFL--PLSPAQTSSIDAKG---SIGYIAPEYGLGSE---VSINGDVYSYGILLLELVT 843
R PL P D +I Y APE LG+ +I D+++ G + EL+T
Sbjct: 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAI--DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 71/272 (26%), Positives = 112/272 (41%), Gaps = 52/272 (19%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNLVKI 693
++G G+ GSV K T +A KV +H GA K + E + R +V
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKV---VHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
A + + + EFM SL+ I ++ P + +L + I + V
Sbjct: 69 YGA-----FLNENNICMCMEFMDCGSLDR----IYKK----GGPIPVEILGK--IAVAVV 113
Query: 754 CALSYL---HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
L+YL H I H D+KPSN+L++ + DFG++ L S A T G
Sbjct: 114 EGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----G 164
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-VDSMFEGDMNLHNFARMAL--- 866
+ Y++PE G + ++ DV+S GI ++EL K P S + D + L
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224
Query: 867 --------------PDHVVDIVDSTLLSDDED 884
P+ + D VD+ LL D +
Sbjct: 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNLVKIL 694
EIG G FG V G ++ G T V V L + + F+ E ++++H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
C+ V LV EF L+ +L + + P +L QR+ ++A
Sbjct: 62 GQCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL---QRM--ACEIAL 111
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
L +LH + H DL N LL ++ + D+GL+ + + +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 815 IAPEYGLGSEVSIN---------GDVYSYGILLLEL 841
IAPE L EV N +V+S G+ + EL
Sbjct: 169 IAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 639 IGVGSFGSVYKGI---LDQGK----TTVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 686
+G G FG V LD+ K T VAVK +L A I+E +K I +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH---PITRE---DKTEEAPRSL 740
H+N++ +L AC+ Q +V E+ +L E+L P E + T+ L
Sbjct: 83 HKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
+ ++ VA + YL H DL NVL+ E+ + ++DFGLAR +
Sbjct: 138 SFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 194
Query: 801 AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + + + ++APE + DV+S+G+LL E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 65/264 (24%), Positives = 104/264 (39%), Gaps = 39/264 (14%)
Query: 611 PSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYK----GI-LDQGKTTVAVKVFN 665
P P F D +G G FG V GI D+ K V V V
Sbjct: 5 PEDPRWEFSR----------DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM 54
Query: 666 LLHHGAFKSF---IAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE 721
L K ++E +K I +H+N++ +L AC+ Q +V E+ +L
Sbjct: 55 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLR 109
Query: 722 EWLH---PITRE---DKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775
E+L P E D + ++ VA + YL H DL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 776 NVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYG 835
NVL+ E + ++DFGLAR + + + + + ++APE + DV+S+G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 836 ILLLELVTRKK------PVDSMFE 853
+L+ E+ T PV+ +F+
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 5/97 (5%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++ C L +LH I + DLK N+LLD + ++DFG+ + L A+T + G
Sbjct: 104 EIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF--CG 158
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ YIAPE LG + + + D +S+G+LL E++ + P
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 37/249 (14%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKVFNLLHHGA-----FKSFIAECNTLKNIRHRNLVK 692
+G G+FG VY +D G+ +AVK + E LKN++H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 693 ILTACSGVDYQGNDFKALVF-EFMQNRSLEEWL--HPITREDKTEEAPRSLNLLQRLNIG 749
+D +F E+M S+++ L + E T + R +L+
Sbjct: 69 YYGC------LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----- 115
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA-RFLPLSPAQTSSIDA 808
+ YLH + I H D+K +N+L D + DFG + R + + T
Sbjct: 116 -----GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM---- 864
G+ +++PE G DV+S G ++E++T K P FE + A
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNP 226
Query: 865 ALPDHVVDI 873
LP HV
Sbjct: 227 QLPSHVSPD 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 35/239 (14%)
Query: 639 IGVGSFGSVYKGI---LDQGK----TTVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 686
+G G FG V +D+ K TVAVK +L A ++E +K I +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK---MLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH---PITRE---DKTEEAPRSL 740
H+N++ +L AC+ Q LV E+ +L E+L P + D + L
Sbjct: 77 HKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
++ VA + YL H DL NVL+ E+ + ++DFGLAR +
Sbjct: 132 TFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 801 AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK------PVDSMFE 853
+ + + + ++APE + DV+S+G+LL E+ T PV+ +F+
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 38/223 (17%)
Query: 639 IGVGSFGSVY--KGILDQGKTTVAVKVFNLLHHGAFK----SFIAECNTLKNIRHRNLVK 692
+G G+FG V+ + DQ V +K + K + EC LK + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKL--VIIKQIPV--EQMTKDERLAAQNECQVLKLLSHPNII- 62
Query: 693 ILTACSGVDYQGN--DFKAL--VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
+Y N + KAL V E+ +L E++ E+ L+
Sbjct: 63 --------EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI--------LHF 106
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAHVSDFGLARFLPLSPAQTSSID 807
+ + AL ++H I H DLK N+LLD+ +M+ + DFG+++ L + +
Sbjct: 107 FVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV- 162
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
G+ YI+PE G + D+++ G +L EL + K+ ++
Sbjct: 163 --GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 40/230 (17%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRN 689
F+ EIG GSFG+VY + VA+K + + ++ I E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 690 LVKILTACSGVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
+ Y+G + LV E+ + D E + L ++
Sbjct: 77 TI---------QYRGCYLREHTAWLVMEYCLGSA----------SDLLEVHKKPLQEVEI 117
Query: 746 LNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
+ L+YLH H+ + H D+K N+LL E + + DFG A ++PA
Sbjct: 118 AAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASI--MAPANXF 171
Query: 805 SIDAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLELVTRKKPVDSM 851
G+ ++APE L E +G DV+S GI +EL RK P+ +M
Sbjct: 172 V----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 62/263 (23%), Positives = 96/263 (36%), Gaps = 79/263 (30%)
Query: 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI 685
L + T F IG G++G VYK + VA+K+ +++ + E N L+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 686 -RHRNLVKILTACSGVDYQGNDFKA----------LVFEF--------------MQNRSL 720
H N+ + G K LV E + + L
Sbjct: 60 SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 721 -EEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779
EEW+ I RE L+YLH + + H D+K N+LL
Sbjct: 111 KEEWIAYILRE---------------------TLRGLAYLH---ENKVIHRDIKGQNILL 146
Query: 780 DEEMMAHVS--DFGLARFLPLSPAQTSSIDAKGS-IG---YIAPE-----YGLGSEVSIN 828
+ A V DFG++ L S++ + + IG ++APE +
Sbjct: 147 TKN--AEVKLVDFGVSAQL------DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR 198
Query: 829 GDVYSYGILLLELVTRKKPVDSM 851
DV+S GI +EL K P+ M
Sbjct: 199 SDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK- 809
++ C L LH + + DLKP N+LLD+ +SD GLA +P + SI +
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP----EGESIRGRV 162
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G++GY+APE +++ D + G L+ E++ + P
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 639 IGVGSFGSVYKGIL--DQGKTTVAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRNLVKIL 694
IG G+FG V K + D + A+K + F E L + H N++ +L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 695 TACS--GVDYQGNDFKAL--VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
AC G Y ++ + +F++ + E + T +L+ Q L+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS---TLSSQQLLHFAA 119
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
DVA + YL Q H DL N+L+ E +A ++DFGL+R + +T +
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ ++A E S + N DV+SYG+LL E+V+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL------LHHGAFKSFIAECNTLKNIRHRNL 690
+G G++G+VY G+ +QG+ +AVK L ++ E + LK+++H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
V+ L C N ++ EF+ S+ L+ + + +L
Sbjct: 65 VQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------ 113
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID--- 807
++YLH++C + H D+K +NV+L + + DFG AR L + +
Sbjct: 114 ----GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 808 -AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851
G+ ++APE S D++S G + E+ T K P+ SM
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 74/265 (27%), Positives = 110/265 (41%), Gaps = 38/265 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 694
IG GSFG V + AVKV +L +AE N L KN++H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV--- 59
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
G+ Y + L F E + H + RE E PR+ R +VA
Sbjct: 60 ----GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLE-PRA-----RF-YAAEVAS 107
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
A+ YLH I + DLKP N+LLD + ++DFGL + + P +T+S G+ Y
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFC-GTPEY 162
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFEGDMNLHNFARMALPDH 869
+APE D + G +L E++ P V M++ ++ + LP
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH----KPLQLPGG 218
Query: 870 VVDIVDSTLLSDDEDLAVHGNQRQR 894
L+ +H +QR+R
Sbjct: 219 KTVAACDLLVG-----LLHKDQRRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 639 IGVGSFGSVYK----GILDQGK---TTVAVKVFNLLHHGAFKSF---IAECNTLKNI-RH 687
+G G FG V + GI TVAVK+ L + K I+E +K I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH---PITRE---DKTEEAPRSLN 741
+N++ +L C+ Q +V E+ +L E+L P + D T+ L+
Sbjct: 78 KNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 742 LLQRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
++ VA + YL C H DL NVL+ E+ + ++DFGLAR +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 801 AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + + + ++APE + DV+S+GIL+ E+ T
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 24/184 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 694
IG GSFG V AVKV +L K +AE N L KN++H LV +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ +Q D V +++ L + H + RE E PR+ R ++A
Sbjct: 63 YS-----FQTADKLYFVLDYVNGGEL--FFH-LQRERSFPE-PRA-----RF-YAAEIAS 107
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
AL YLH I + DLKP N+LLD + ++DFGL + + ++T+S G+ Y
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC-GTPEY 162
Query: 815 IAPE 818
+APE
Sbjct: 163 LAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 9/130 (6%)
Query: 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSIN 828
H DL N+LL E + + DFGLAR + P DA+ + ++APE +
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ 255
Query: 829 GDVYSYGILLLELVT---RKKPVDSMFEGDMN-LHNFARMALPDHVVDIVDSTLLSDDED 884
DV+S+G+LL E+ + P + E L RM P++ + S +L
Sbjct: 256 SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD---- 311
Query: 885 LAVHGNQRQR 894
H N R
Sbjct: 312 -CWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 638 EIGVGSFGSVYKGI--LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHR----NLV 691
E+G G+FG V KG+ + + + VA+KV L + KS E I H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKV---LKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+++ C LV E L ++L K +E S N+++ ++
Sbjct: 59 RMIGVCEAEALM------LVMEMASGGPLNKFL-----SGKKDEITVS-NVVELMH---Q 103
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA-QTSSIDAKG 810
V+ + YL H DL NVLL + A +SDFGL++ L + + K
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ + APE + S DV+SYGI + E + +KP M
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 42/220 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS---FIAECNTLKNIRHRNLVKILT 695
+G G+FG V+ + A+KV + K E LK + H ++++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
F ++ E++ L +L + L ++ CA
Sbjct: 69 T-----EHDQRFLYMLMEYVPGGELFSYL----------RNSGRFSNSTGLFYASEIVCA 113
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK----GS 811
L YLH I + DLKP N+LLD+E ++DFG A+ L D G+
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---------RDRTWTLCGT 161
Query: 812 IGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKP 847
Y+APE G V D ++ GIL+ E++ P
Sbjct: 162 PEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 639 IGVGSFGSVY----KGILDQGK-TTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVK 692
+G G FG V+ KGI ++G T V VK F E + + + H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 693 ILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
+L C + Y ++ E+ L+++L T+ + P L+ Q++ +
Sbjct: 73 LLGLCREAEPHY-------MILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALCT 124
Query: 751 DVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+A + +L H DL N L+ + VS L++ + +A
Sbjct: 125 QIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNA 178
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ ++APE + S DV+S+G+L+ E+ T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 73/272 (26%), Positives = 112/272 (41%), Gaps = 51/272 (18%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-----FKSFIAECNTLKNIRH 687
F EIG GSFG+VY +T V + + + G ++ I E L+ I+H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 688 RNLVKILTACSGVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
N ++Y+G + LV E+ + D E + L +
Sbjct: 85 PN---------SIEYKGCYLREHTAWLVMEYCLGSA----------SDLLEVHKKPLQEV 125
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
+ I L+YLH + H D+K N+LL E ++DFG A SPA +
Sbjct: 126 EIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI--ASPANS 180
Query: 804 SSIDAKGSIGYIAPEYGLG-SEVSING--DVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860
G+ ++APE L E +G DV+S GI +EL RK P+ +M L++
Sbjct: 181 FV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH 235
Query: 861 FARMALP--------DHVVDIVDSTLLSDDED 884
A+ P D+ + VDS L +D
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQD 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
E+G G+FG VYK + A K+ + + F+ E + L +H N+V + A
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA- 70
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y + ++ EF +L+ E R L Q + + AL+
Sbjct: 71 ----YFYENKLWILIEFCDGGALD---------SIMLELERGLTEPQIRYVCRQMLEALN 117
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK-----GSI 812
+LH + H DLK N+LL + ++DFG++ A+ S K G+
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-------AKNKSTLQKRDTFIGTP 167
Query: 813 GYIAPEYGLGSEVSIN-----GDVYSYGILLLELVTRKKP 847
++APE N D++S GI L+EL + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 638 EIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLV 691
E+G FG VYKG L + VA+K G + F E ++H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWL-----HP---ITREDKTEEAPRSLNLL 743
+L GV + +++F + + L E+L H T +DKT ++ +L
Sbjct: 72 CLL----GVVTKEQPL-SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS--TLEPA 124
Query: 744 QRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
++I +A + +L HH H DL NVL+ +++ +SD GL R + +
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
++ I +++PE + + SI+ D++SYG++L E+ +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 36/112 (32%), Positives = 62/112 (55%), Gaps = 6/112 (5%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++ AL++LH + I + DLK NVLLD + ++D+G+ + L P T+S G
Sbjct: 104 EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFC-G 158
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG-DMNLHNF 861
+ YIAPE G E + D ++ G+L+ E++ + P D + + DMN ++
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+++ AL+YLH + I + DLK NVLLD E ++D+G+ + L P T+S G
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC-G 158
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ YIAPE G + + D ++ G+L+ E++ + P D + D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
++ C L +LH I + DLK NVLLD++ ++DFG+ + + S+
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-- 156
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ YIAPE G + + + D +S+G+LL E++ + P F G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 85/324 (26%), Positives = 128/324 (39%), Gaps = 80/324 (24%)
Query: 639 IGVGSFGSVYK----GILDQGKT--TVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNL 690
+G G+FG V + GI D+ T TVAVK+ H ++ ++E L +I H N+
Sbjct: 15 LGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 73
Query: 691 VKILTACSG--------VDY------------QGNDF---KALVFEFMQNRS-------- 719
V +L AC+ V++ + +F K F Q +S
Sbjct: 74 VNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133
Query: 720 LEEWLHPITR----------EDKT------EEAPRS------LNLLQRLNIGIDVACALS 757
L+ L IT E+K+ EEA + L L + VA +
Sbjct: 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193
Query: 758 YL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
+L C H DL N+LL E + + DFGLAR + P DA+ + ++A
Sbjct: 194 FLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 249
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKP------VDSMFEGDMNLHNFARMALPDHV 870
PE +I DV+S+G+LL E+ + +D F L RM PD+
Sbjct: 250 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYT 307
Query: 871 VDIVDSTLLSDDEDLAVHGNQRQR 894
+ T+L HG QR
Sbjct: 308 TPEMYQTMLD-----CWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 26/67 (38%), Positives = 43/67 (64%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ ++ +NL+ + G+I P +G+++ L+VL L NSFN IP +L L++L LN NS
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 64 IGGEIPA 70
+ G +PA
Sbjct: 502 LSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 28/129 (21%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK- 809
++A AL +LH I + DLKP N+LLDEE ++DFGL++ SID +
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---------ESIDHEK 153
Query: 810 ------GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-----MNL 858
G++ Y+APE + + D +S+G+L+ E++T P F+G M +
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTM 209
Query: 859 HNFARMALP 867
A++ +P
Sbjct: 210 ILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
++ C L +LH I + DLK NV+LD + ++DFG+ + + S+
Sbjct: 102 AAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-- 156
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ YIAPE G + + + D +S+G+LL E++ + P F GD
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 52/237 (21%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFI------AECNTLKNIRHRN-- 689
++G G++G+V + + VA+K + F+S + E LK+++H N
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKL----YRPFQSELFAKRAYRELRLLKHMKHENVI 77
Query: 690 -LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
L+ + T +D + +DF LV FM L + + +K E + Q L
Sbjct: 78 GLLDVFTPDLSLD-RFHDF-YLVMPFMGTD-----LGKLMKHEKLSEDRIQFLVYQMLK- 129
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
L Y+H I H DLKP N+ ++E+ + DFGLAR QT S
Sbjct: 130 ------GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDS--- 170
Query: 809 KGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPVDSMFEGDMNL 858
GY+ + EV +N D++S G ++ E++T K +F+G +L
Sbjct: 171 -EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG G+ G+VY I VA+K NL + I E ++ +H N+V L +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS- 84
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y D +V E++ SL + + E +E Q + + AL
Sbjct: 85 ----YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALE 129
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAP 817
+LH + + H D+K N+LL + ++DFG ++P Q+ G+ ++AP
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 184
Query: 818 EYGLGSEVSINGDVYSYGILLLELVTRKKP 847
E D++S GI+ +E+V + P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 49/214 (22%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 638 EIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLHHGAFK---SFIAECNTLKNIRHRN 689
E+G GSFG VY+G + +T VAVK N + + F+ E + +K +
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHH 70
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V++L GV +G +V E M + L+ +L + E + L + + +
Sbjct: 71 VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
++A ++YL+ H DL N ++ + + DFG+ R + +
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ ++APE + + D++S+G++L E+ +
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK- 809
++ C L LH + I + DLKP N+LLD+ +SD GLA +P + +I +
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP----EGETIRGRV 162
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G++GY+APE + + D + G L+ E++ K P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 34/251 (13%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTT---VAVKVFNLL--HHGAFKSFIAECNTLKNI 685
D + +IG G++G VYK + K T VA+K L G + + E + L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKA---RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML 57
Query: 686 RHRN-LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
+V++L + G LVFE++ + L+++ + + P ++
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKF---MDSNGRGPGRPLPAKTIK 113
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLAR--FLPLSPA 801
+ A + H + H DLKP N+L+D++ + ++D GL R +P+ +
Sbjct: 114 SFMYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-S 167
Query: 802 QTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN--- 857
T I ++ Y APE LGS S D++S G + E+ RK+P +F GD
Sbjct: 168 YTHEI---VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQP---LFPGDSELQQ 220
Query: 858 -LHNFARMALP 867
LH F + P
Sbjct: 221 LLHIFKLLGTP 231
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTT---VAVKVFNLLHHGAFKSF----IAECNTLK 683
D + N I G++G VY+ + K T VA+K L + F + E N L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRA---RDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59
Query: 684 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQN--RSLEEWLHP--ITREDKTEEAPRS 739
++H N+V + G + D +V E++++ +SL E + + E K
Sbjct: 60 KLQHPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC------ 110
Query: 740 LNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL--P 797
L+ +L G+ +LH + I H DLK SN+LL+ + + DFGLAR P
Sbjct: 111 --LMLQLLSGVA------HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRK 845
L P T + ++ Y APE LG E S D++S G + EL+T+K
Sbjct: 160 LKP-YTQLV---VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
+G G++G VY + +A+K + E ++HRN+V+ L + S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY 758
N F + E + SL L +++ P N + + L Y
Sbjct: 76 -----ENGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 759 LHHDCQPPITHCDLKPSNVLLDE-EMMAHVSDFGLARFLP-LSPAQTSSIDAKGSIGYIA 816
LH + I H D+K NVL++ + +SDFG ++ L ++P T + G++ Y+A
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TETF--TGTLQYMA 177
Query: 817 PEY------GLGSEVSINGDVYSYGILLLELVTRKKP 847
PE G G+ D++S G ++E+ T K P
Sbjct: 178 PEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 694
IG GSFG V AVKV +L+ K +AE N L KN++H LV +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ +Q + V +F+ L + H + +++ PR+ R ++A
Sbjct: 63 YS-----FQTTEKLYFVLDFVNGGEL--FFH--LQRERSFPEPRA-----RFYAA-EIAS 107
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
AL YLH I + DLKP N+LLD + ++DFGL + ++ + T++ G+ Y
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC-GTPEY 162
Query: 815 IAPE 818
+APE
Sbjct: 163 LAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 34/242 (14%)
Query: 607 EKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL 666
E+K + IN PN SY+ N IG GSFG VY+ I VA+K +
Sbjct: 52 EEKMIDNDINRSPNKSYK----------LGNIIGNGSFGVVYEAICIDTSEKVAIK--KV 99
Query: 667 LHHGAFKSFIAECNTLKNIRHRNLVKI----LTACSGVDYQGNDFKALVFEFMQNRSLEE 722
L +K+ E +KN+ H N++ + T C + + N F +V EF+ +++ +
Sbjct: 100 LQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKN-EKNIFLNVVMEFIP-QTVHK 155
Query: 723 WLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782
++ R + +L L + AL+Y+H I H DLKP N+L+D
Sbjct: 156 YMKHYARNNH------ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPN 206
Query: 783 MMA-HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLE 840
+ DFG A+ L S I ++ Y APE LG+ + + D++S G ++ E
Sbjct: 207 THTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 841 LV 842
++
Sbjct: 264 MI 265
|
Length = 440 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++ L +LH + I + DLK NVLLD E ++DFG+ + L TS+ G
Sbjct: 104 EIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF--CG 158
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ YIAPE D ++ G+LL E++ + P FEGD
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 690
+ S +IG GS G V VAVK +L + E +++ H N+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
V + + Y D +V EF++ +L + + TR ++ + A L++L+
Sbjct: 82 VDMYNS-----YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLR------ 129
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSSIDAK 809
ALSYLH+ + H D+K ++LL + +SDFG A+ P + S +
Sbjct: 130 ----ALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV--- 179
Query: 810 GSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ ++APE G+EV D++S GI+++E++ + P
Sbjct: 180 GTPYWMAPEVISRLPYGTEV----DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+ +IG G+ G+V+ I VA+K NL + I E +K +++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
L + + D +V E++ SL + + T D+ + A LQ
Sbjct: 81 FLDS-----FLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQ-------- 126
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL +LH + + H D+K NVLL + ++DFG ++P Q+ G+
Sbjct: 127 --ALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
++APE D++S GI+ +E+V + P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 59/232 (25%), Positives = 88/232 (37%), Gaps = 52/232 (22%)
Query: 638 EIGVGSFGSVYKGILDQGKTT---VAVKVFN--LLHH-GAFKSFIAECNTLKNIRHRNLV 691
++G G +G V+ L + K T VA+K LL + + E + L + LV
Sbjct: 8 QVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 692 KILTACSGVDY--------QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
K+L A +Y G DF+ L+ L E + A
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSE-----------DHA------- 103
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
R + ++ A+ LH + H DLKP N L+D ++DFGL+ T
Sbjct: 104 -RFYM-AEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVT 153
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ GS Y+APE G D +S G +L E + P F G
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 22/221 (9%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAE--CNTLKNIRHRNLVKILTA 696
+G GS+G V +K NL + + AE L ++H N+V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
G D +V F + L L +E K + P + Q + + +A AL
Sbjct: 68 WEGEDGL----LYIVMGFCEGGDLYHKL----KEQKGKLLPEN----QVVEWFVQIAMAL 115
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YLH + I H DLK NV L + V D G+AR L S++ G+ Y++
Sbjct: 116 QYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGTPYYMS 170
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857
PE + DV++ G + E+ T K ++ DMN
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
++G G++G VYK GK + + G S E L+ ++H N++ A
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI----AL 63
Query: 698 SGVDYQGNDFKA-LVFEFMQNRSLEEW----LHPITREDKTE-EAPRSL--NLLQRLNIG 749
V +D K L+F++ ++ + W H ++ +K + PRS+ +LL ++ G
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFL--PLSPAQT 803
I YLH + + H DLKP+N+L+ E ++D G AR PL P
Sbjct: 121 I------HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--L 169
Query: 804 SSID-AKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860
+ +D + Y APE LG+ D+++ G + EL+T +P+ + D+ N
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
E+G G+FG VYK + A KV + ++ E L H +VK+L A
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA- 77
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC--- 754
+ + ++ EF +++ + + R + I V C
Sbjct: 78 ----FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--------------IQVICRQM 119
Query: 755 --ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL YLH I H DLK NVLL + ++DFG +S ++ + S
Sbjct: 120 LEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFG------VSAKNVKTLQRRDS- 169
Query: 813 GYIAPEYGLGSEVSI-----------NGDVYSYGILLLELVTRKKP 847
+I Y + EV + D++S GI L+E+ + P
Sbjct: 170 -FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 44/134 (32%), Positives = 62/134 (46%), Gaps = 24/134 (17%)
Query: 721 EEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780
E + H RE TE R+ I ++ AL +LH Q I + D+K N+LLD
Sbjct: 91 ELFTHLYQREHFTESE-------VRVYIA-EIVLALDHLH---QLGIIYRDIKLENILLD 139
Query: 781 EEMMAHVSDFGLAR-FLPLSPAQTSSIDAKGSIGYIAPEY------GLGSEVSINGDVYS 833
E ++DFGL++ FL + S G+I Y+APE G V D +S
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSF--CGTIEYMAPEVIRGGSGGHDKAV----DWWS 193
Query: 834 YGILLLELVTRKKP 847
G+L EL+T P
Sbjct: 194 LGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRN 689
D F +E+G G+ G V K +A K+ +L A ++ I E L H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HEC 60
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR-SLNLLQRLNI 748
+ G Y + ++ E M SL++ L +EA R +L +++I
Sbjct: 61 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVL---------KEAKRIPEEILGKVSI 110
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
V L+YL Q I H D+KPSN+L++ + DFG++ L S A +
Sbjct: 111 A--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 163
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848
G+ Y++PE G+ S+ D++S G+ L+EL + P+
Sbjct: 164 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK- 809
++ C L L + I + DLKP N+LLD+ +SD GLA +P + ++ +
Sbjct: 110 ELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP----EGETVRGRV 162
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G++GY+APE + + + D + G L+ E++ + P
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 41/232 (17%)
Query: 638 EIGVGSFGSV----YKGILDQGKTTVAVK----VFN--LLHHGAFKSFIAECNTLKNIR- 686
E+G G++G V ++ TVA+K VF+ +L K + E L++ R
Sbjct: 7 ELGQGAYGIVCSARNAETSEE--ETVAIKKITNVFSKKIL----AKRALRELKLLRHFRG 60
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT-EEAPRSLNLLQR 745
H+N+ L V + L E M E LH I R + +A + Q
Sbjct: 61 HKNITC-LYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
L C L Y+H + H DLKP N+L++ + + DFGLAR +P + +
Sbjct: 115 L-------CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 806 --IDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854
+ + Y APE L + DV+S G +L EL+ RK +F+G
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAFKSFI-AECNTLKNIRHRNLVKILTA 696
IG GS+G V I VA+K + ++ H + + I E L+ +RH ++V+I
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 697 CSGVDYQGNDFKAL--VFEFMQNRSLEEWLHPITR--EDKTEEAPRSLNLLQRLNIGIDV 752
+ +FK + VFE M E LH + + +D T E + L Q L
Sbjct: 68 M--LPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFF-LYQLLR----- 114
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL-SPAQTSSIDAKGS 811
AL Y+H + H DLKP N+L + + + DFGLAR +P D +
Sbjct: 115 --ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 812 IGYIAPEY--GLGSEVSINGDVYSYGILLLELVTRK 845
Y APE S+ + D++S G + E++T K
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-07
Identities = 31/113 (27%), Positives = 57/113 (50%)
Query: 102 IEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161
I+ L + L G IP+ + L + ++ L+ N++ G IP + G + +L L ++ N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 162 GTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIP 214
G+IP S+ ++S+ + N L G +P G L + F+ +N IP
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 74/272 (27%), Positives = 109/272 (40%), Gaps = 56/272 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI------RHRNLVK 692
IG G++G V + VA+K AF + I TL+ I H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 693 ILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
I F +V+E M LH I R +T L +L G
Sbjct: 69 IKDIMPPP--HREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRG- 120
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
L Y+H + H DLKPSN+LL+ + DFGLAR T+S
Sbjct: 121 -----LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDF 164
Query: 811 SIGYI------APEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863
Y+ APE L SE + DV+S G + EL+ RK +F G +H +
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK----PLFPGKDYVH---Q 217
Query: 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQ 895
+ L + +++ S +EDL N++ R+
Sbjct: 218 LKL---ITELLGS---PSEEDLGFIRNEKARR 243
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+++ AL++LH + I + DLK NVLLD E ++D+G+ + + P T+S G
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFC-G 158
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
+ YIAPE G + + D ++ G+L+ E++ + P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 59/237 (24%), Positives = 94/237 (39%), Gaps = 48/237 (20%)
Query: 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRN 689
F ++G GS+GSVYK A+K +L + + + E L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 690 LVKILTA-------CSGVDYQ--GNDFKALVFEFMQNRSLEE---WLHPITREDKTEEAP 737
++ A C ++Y G+ KA+ + + + E W
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW-------------- 106
Query: 738 RSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797
I I + L LH + I H DLK +N+LL + + D G+++ L
Sbjct: 107 ---------RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854
+ A+T G+ Y+APE G S D++S G LL E+ T P FE
Sbjct: 155 KNMAKTQI----GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 9e-07
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG G+ G+VY I VA+K NL + I E ++ ++ N+V L +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS- 84
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y D +V E++ SL + + T D+ + A LQ AL
Sbjct: 85 ----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ----------ALD 129
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAP 817
+LH + + H D+K N+LL + ++DFG ++P Q+ G+ ++AP
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 184
Query: 818 EYGLGSEVSINGDVYSYGILLLELVTRKKP 847
E D++S GI+ +E+V + P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 11/260 (4%)
Query: 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGE 67
L+L +L +IS + L+ L L L NN+ P L+ L L++N I
Sbjct: 97 SLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ES 154
Query: 68 IPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
+P+ + + NL + L +N+L +P L +LS + +L +S N +P + LS++
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS-GNKISDLPPEIELLSALE 212
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
L L++N++ + + LKNL+ L ++ N +P SI N+S++ D NQ+ +
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQISSI 270
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
L +L NL+ + N L+ A+P LE LT + L+ L
Sbjct: 271 SSL---GSLTNLRELDLSGNSLSNALPLIALLLLLLE--LLLNLLLTLKALELKLNSILL 325
Query: 248 VFSITENSLGSRGHSNLNFL 267
+I N S +
Sbjct: 326 NNNILSNGETSSPEALSILE 345
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 8/213 (3%)
Query: 338 TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQ-GSIPSSLGQYKTL 396
P + E + L L + + PS + + LS + + +L L
Sbjct: 36 NFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPL 95
Query: 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLK-NLEVLDVFENKL 455
+DL+ N L I L+ L LDL N +T IP +G LK NL+ LD+ +NK+
Sbjct: 96 PSLDLNLNRLRSNISELL-ELT-NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI 152
Query: 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515
+ +PS L + L+ L++ N L +P LS+L LN LDLS N +S +P +
Sbjct: 153 E-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLS 209
Query: 516 LLENLNLSNNNLEGMVPIEGVFKNATITSVLGN 548
LE L+LSNN++ ++ KN + + N
Sbjct: 210 ALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 43/226 (19%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+ +IG GS G V VAVK +L + E +++ +H N+V+
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ ++ Y D +V EF++ +L + +T EE Q + + V
Sbjct: 81 MYSS-----YLVGDELWVVMEFLEGGALTDI---VTHTRMNEE--------QIATVCLAV 124
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK--- 809
ALS+LH + H D+K ++LL + +SDFG AQ S +
Sbjct: 125 LKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-------AQVSKEVPRRKS 174
Query: 810 --GSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ ++APE Y G+EV D++S GI+++E+V + P
Sbjct: 175 LVGTPYWMAPEVISRLPY--GTEV----DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 11/130 (8%)
Query: 730 EDKTEEAPRSLNLLQRLNIGIDVACALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVS 788
+++ E L+L L VA + +L +C H D+ NVLL + +A +
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKIC 254
Query: 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 847
DFGLAR + +A+ + ++APE ++ DV+SYGILL E+ + K P
Sbjct: 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
Query: 848 -----VDSMF 852
V+S F
Sbjct: 315 YPGILVNSKF 324
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG G+ G+VY + VA++ NL + I E ++ ++ N+V L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS- 85
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y D +V E++ SL + + T D+ + A LQ AL
Sbjct: 86 ----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ----------ALE 130
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAP 817
+LH + + H D+K N+LL + ++DFG ++P Q+ G+ ++AP
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 185
Query: 818 EYGLGSEVSINGDVYSYGILLLELVTRKKP 847
E D++S GI+ +E++ + P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA------FKSFIAECNTLKNIRHRNLVK 692
+G G+F S Y+ + T +AVK + + + ++ E + + H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
G + + F V E+M S+ L + +EA Q L
Sbjct: 68 ----MLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLR----- 114
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFLPLSPAQTSSIDAK-- 809
LSYLH + I H D+K +N+L+D ++DFG A L +
Sbjct: 115 --GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+I ++APE G + + DV+S G +++E+ T K P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 17/113 (15%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR-FLPLSPAQTSSIDAK 809
++ AL +LH + I + D+K N+LLD E ++DFGL++ FL +T S
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF--C 167
Query: 810 GSIGYIAPEY-----GLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857
G+I Y+APE G G V D +S GIL+ EL+T P EG+ N
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASPF--TLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS-FIAECNTLKNIRHRN 689
D F +E+G G+ G V+K +A K+ +L A ++ I E L H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HEC 60
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+ G Y + ++ E M SL++ L K P +L +++I
Sbjct: 61 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVL------KKAGRIPE--QILGKVSIA 111
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
V L+YL + I H D+KPSN+L++ + DFG++ L S A +
Sbjct: 112 --VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 163
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848
G+ Y++PE G+ S+ D++S G+ L+E+ + P+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 66/240 (27%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSV---YKGILDQGKTTVAVKV----FNLLHHG--AFK 673
YQNL IG G+ G V Y + Q VA+K F + H A++
Sbjct: 18 YQNL----------KPIGSGAQGIVCAAYDTVTGQ---NVAIKKLSRPFQNVTHAKRAYR 64
Query: 674 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHP-ITREDK 732
+ +K + H+N++ +L F +SLEE+ + E
Sbjct: 65 ELV----LMKLVNHKNIIGLLNV-----------------FTPQKSLEEFQDVYLVMELM 103
Query: 733 TEEAPRSLNLLQRLNIGID----------VACALSYLHHDCQPPITHCDLKPSNVLLDEE 782
NL Q + + +D + C + +LH I H DLKPSN+++ +
Sbjct: 104 DA------NLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSD 154
Query: 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELV 842
+ DFGLAR S T + + Y APE LG N D++S G ++ E++
Sbjct: 155 CTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 56/238 (23%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSV---YKGILDQGKTTVAVKVFN--LLHHGAFKSFIA 677
YQNL IG G+ G V Y +LD+ VA+K + + K
Sbjct: 19 YQNL----------KPIGSGAQGIVCAAYDAVLDR---NVAIKKLSRPFQNQTHAKRAYR 65
Query: 678 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAP 737
E +K + H+N++ +L F +SLEE+ + +
Sbjct: 66 ELVLMKCVNHKNIISLLNV-----------------FTPQKSLEEFQDVYLVMELMDA-- 106
Query: 738 RSLNLLQRLNIGID----------VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
NL Q + + +D + C + +LH I H DLKPSN+++ + +
Sbjct: 107 ---NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 845
DFGLAR S T + + Y APE LG N D++S G ++ E+V K
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 734 EEAPRSLNLLQRLNIGIDVACALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792
EE +L+ L+ VA +S+L +C H DL N+LL + + DFGL
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK------ 846
AR + +A+ + ++APE + DV+SYGILL E+ +
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
Query: 847 PVDSMF 852
PVDS F
Sbjct: 321 PVDSKF 326
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 759 LHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK----GSIGY 814
+HH + H D+K +N+LL + + DFG ++ A T S D G+ Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY----AATVSDDVGRTFCGTPYY 211
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
+APE S D++S G+LL EL+T K+P D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/246 (23%), Positives = 97/246 (39%), Gaps = 68/246 (27%)
Query: 624 QNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFI------A 677
+ ++ + + + + +G G++GSV + VAVK + F+S I
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR----PFQSIIHAKRTYR 65
Query: 678 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW-------------L 724
E LK+++H N++ +L F RSLEE+ L
Sbjct: 66 ELRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVTHLMGADL 108
Query: 725 HPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784
+ I + K + + Q L L Y+H I H DLKPSN+ ++E+
Sbjct: 109 NNIVKCQKLTDDHVQFLIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCE 158
Query: 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING-------DVYSYGIL 837
+ DFGLAR GY+A + E+ +N D++S G +
Sbjct: 159 LKILDFGLARH-----------TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207
Query: 838 LLELVT 843
+ EL+T
Sbjct: 208 MAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 35/264 (13%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
++G G++G VYK GK + + G S E L+ ++H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL---- 63
Query: 698 SGVDYQGNDFKA-LVFEFMQNRSLEEW----LHPITREDKTE-EAPRSL--NLLQRLNIG 749
V D K L+F++ ++ + W H ++ +K + PR + +LL ++ G
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFL--PLSPAQT 803
I YLH + + H DLKP+N+L+ E ++D G AR PL P
Sbjct: 121 I------HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--L 169
Query: 804 SSID-AKGSIGYIAPEYGLGSEVSING-DVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
+ +D + Y APE LG+ D+++ G + EL+T +P+ + D+ N
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNP 228
Query: 862 ARMALPDHVVDIVDSTLLSDDEDL 885
D + +++ D ED+
Sbjct: 229 YHHDQLDRIFNVMGFPADKDWEDI 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 46/236 (19%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS----FIAEC----------NTL 682
+G G++G V K VA+K ++ + + C +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 683 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
I+H N++ ++ Y DF LV + M + + + R+ + E+ L
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMAS----DLKKVVDRKIRLTESQVKCIL 125
Query: 743 LQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR---FLPLS 799
LQ LN L+ LH + H DL P+N+ ++ + + ++DFGLAR + P S
Sbjct: 126 LQILN-------GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 800 PAQTSSIDAKG---------SIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRK 845
+ + ++ Y APE +G+E D++S G + EL+T K
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 42/129 (32%), Positives = 61/129 (47%), Gaps = 30/129 (23%)
Query: 751 DVAC--------ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
D AC AL +LH I + DLKP N+LLD + ++DFGL +
Sbjct: 100 DTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156
Query: 803 TSSIDAKGSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVT---------RKKPVD 849
T + G+I Y+APE G G V D +S G L+ +++T RKK +D
Sbjct: 157 THTF--CGTIEYMAPEILMRSGHGKAV----DWWSLGALMYDMLTGAPPFTAENRKKTID 210
Query: 850 SMFEGDMNL 858
+ +G +NL
Sbjct: 211 KILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 35/223 (15%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK---SFIAECNTLKNIRHRNLVKI 693
+EIG G FG V G +G + V V L F+ E + + H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 694 LTAC-SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS-LNLLQRLNIGID 751
L C + Y LV EF L+ +L R ++ A + ++LQR+ +
Sbjct: 61 LGQCIESIPY------LLVLEFCPLGDLKNYL----RSNRGMVAQMAQKDVLQRM--ACE 108
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
VA L +LH Q H DL N L ++ + D+GLA L K
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDC 161
Query: 812 ----IGYIAPEYG-------LGSEVSINGDVYSYGILLLELVT 843
+ ++APE L + + +++S G+ + EL T
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVKI 693
+G G+FG VY +D G+ A +V F+ K A EC LKN++H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
C + + + E+M S+++ L ++ + +L+
Sbjct: 70 Y-GC--LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE--------- 117
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA-RFLPLSPAQTSSIDAKGSI 812
+SYLH + I H D+K +N+L D + DFG + R + + T G+
Sbjct: 118 -GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+++PE G DV+S G ++E++T K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 639 IGVGSFGSVYKGILD-QGKTTVAVKVFNLLHHGAF----KSFIAECNTLKNIRHRNLVKI 693
+G G FG + +G L K + V + + L G + F+AE TL H N+V++
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
GV +GN +V E+M N +L+ +L + + A + + +L L G+
Sbjct: 72 ----EGVITRGNTM-MIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT--SSIDAKGS 811
+ Y+H L VL++ +++ +S F R L ++ +++ K
Sbjct: 124 SEMGYVHK---------GLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSP 171
Query: 812 IGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
+ + APE Y S S DV+S+GI++ E+++
Sbjct: 172 VLWAAPEAIQYHHFSSAS---DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG GS G V + VAVK +L + E +++ +H N+V++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS- 85
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y D +V EF++ +L + + TR ++ + A L +L+ ALS
Sbjct: 86 ----YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLK----------ALS 130
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSSIDAKGSIGYIA 816
LH + H D+K ++LL + +SDFG A+ P + S + G+ ++A
Sbjct: 131 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV---GTPYWMA 184
Query: 817 PE----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
PE G EV D++S GI+++E+V + P
Sbjct: 185 PELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 39/232 (16%)
Query: 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH 687
N + F IG G++G VYK A+KV L F E +K+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
N+V + Y D + EF SL++ H +++ A S LQ
Sbjct: 66 SNIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ--- 117
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
L YLH + H D+K +N+LL + ++DFG++ AQ ++
Sbjct: 118 -------GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATI 160
Query: 808 AK-----GSIGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPV 848
AK G+ ++APE + V G D+++ GI +EL + P+
Sbjct: 161 AKRKSFIGTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
I I V L+YL + I H D+KPSN+L++ + DFG++ L S A +
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-- 159
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848
G+ Y++PE G+ ++ D++S G+ L+E+ + P+
Sbjct: 160 --GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 38/171 (22%)
Query: 682 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLN 741
LK + H+N++ +L F +SLEE+ + + N
Sbjct: 74 LKCVNHKNIISLLNV-----------------FTPQKSLEEFQDVYLVMELMDA-----N 111
Query: 742 LLQRLNIGID----------VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791
L Q +++ +D + C + +LH I H DLKPSN+++ + + DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 168
Query: 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELV 842
LAR + T + + Y APE LG N D++S G ++ ELV
Sbjct: 169 LARTACTNFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 21/148 (14%)
Query: 733 TEEAPRSLNLLQRLNIGIDVACALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791
+++ L L L+ VA + +L +C H DL NVLL + + + DFG
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFG 282
Query: 792 LARFLPLSPAQTSSIDAKGS----IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
LAR + S+ +KGS + ++APE + + DV+SYGILL E+ +
Sbjct: 283 LARDI----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGT 338
Query: 848 ------VDSMFEGDMNLHNFARMALPDH 869
VDS F + + RMA PDH
Sbjct: 339 PYPGMIVDSTFYN--KIKSGYRMAKPDH 364
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 22/208 (10%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK-----SFIAECNTLKNIRHRNLVKI 693
+G GSFG+VY + +KV + G E L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+ + D ++ E+ + R L+ L + KT + +L +G+
Sbjct: 68 HAS-----FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH-- 120
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
Y+H Q I H DLK N+ L ++ + DFG++R L S ++ G+
Sbjct: 121 ----YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF--TGTPY 170
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLEL 841
Y++PE D++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL--PLSPAQTSSID 807
+ A+SY+H + I H D+K N+ L + + + DFG+++ L S A+T
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---- 160
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
G+ Y++PE G + + D+++ G +L EL+T K+ D+
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 31/258 (12%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRH 687
D F IG G+FG V + + A+K+ N +L F E N L N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
+ + + A +Q ++ LV ++ L L ED+ E + R
Sbjct: 61 QWITTLHYA-----FQDENYLYLVMDYYVGGDLLTLLSKF--EDRLPED------MARFY 107
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
I ++ A+ +H Q H D+KP NVLLD ++DFG + SS+
Sbjct: 108 IA-EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV- 162
Query: 808 AKGSIGYIAPEY------GLGSEVSINGDVYSYGILLLELVTRKKP--VDSMFEGDMNLH 859
A G+ YI+PE G+G + D +S G+ + E++ + P +S+ E +
Sbjct: 163 AVGTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
Query: 860 NF-ARMALPDHVVDIVDS 876
N R P H+ D+ +
Sbjct: 222 NHEERFQFPSHITDVSEE 239
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 59/245 (24%), Positives = 93/245 (37%), Gaps = 58/245 (23%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKN 684
D F IG G+FG V+ L + K T A+KV ++ AE + L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 685 IRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
+VK+ + +Q + LV E+M L L I ++ EE R
Sbjct: 58 ADSPWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY---- 106
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLA--------R 794
++ AL +H + H D+KP N+L+D + H+ +DFGL R
Sbjct: 107 ----IAELVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDR 157
Query: 795 FLPLSPAQTSSIDAK-------------------GSIGYIAPEYGLGSEVSINGDVYSYG 835
L+ + G+ YIAPE G+ + D +S G
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG 217
Query: 836 ILLLE 840
++L E
Sbjct: 218 VILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 48/231 (20%), Positives = 97/231 (41%), Gaps = 43/231 (18%)
Query: 639 IGVGSFGSVYKGIL----DQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRN 689
+G G+F ++YKG+L D +V +L H +F + + + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
LVK+ C + +V E+++ L+ +LH +++L +L++
Sbjct: 63 LVKLYGVCVRDENI------MVEEYVKFGPLDVFLH---------REKNNVSLHWKLDVA 107
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-------MMAHVSDFGLARFLPLSPAQ 802
+A AL YL + H ++ N+L+ +SD G+ + +
Sbjct: 108 KQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSRE 162
Query: 803 TSSIDAKGSIGYIAPEY--GLGSEVSINGDVYSYGILLLELVTR-KKPVDS 850
I +IAPE + ++I D +S+G LLE+ + ++P+ +
Sbjct: 163 ERVER----IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSF----IAECNTLKNIRHRNLVKIL 694
+G G+FG VYK + VA+K +L H F + E LK ++H N+V ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 695 -TACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
A D + +V +M + L L K E+ +LQ L
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE--NPSVKLTESQIKCYMLQLLE---- 126
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR 794
++YLH + I H D+K +N+L+D + + ++DFGLAR
Sbjct: 127 ---GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 40/124 (32%), Positives = 50/124 (40%), Gaps = 42/124 (33%)
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
V AL YLH I + DLKP N+LL E H+ SDF L++ + P S K
Sbjct: 112 VLLALEYLH--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 810 GSIG---------------------------YIAPE----YGLGSEVSINGDVYSYGILL 838
GS YIAPE G GS V D ++ GILL
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILL 222
Query: 839 LELV 842
E++
Sbjct: 223 YEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 46/239 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFI------AECNTLKNIRHRNLVK 692
+G G++GSV + + VAVK + F+S I E LK+++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSR----PFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+L + +F + ++ + L+ I + K + + Q L
Sbjct: 79 LLDVFTPAT-SIENFNEV---YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR----- 129
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
L Y+H I H DLKPSNV ++E+ + DFGLAR Q
Sbjct: 130 --GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-------QADD----EMT 173
Query: 813 GYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
GY+A + E+ +N D++S G ++ EL+ K ++F G+ + R+
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 18/228 (7%)
Query: 620 NISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAEC 679
I + + + +D + IG G++G V+K + + + AVK+ + +H + AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEY 65
Query: 680 NTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR 738
N LK + H N+VK D + D LV E S+ + + + + E P
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
+L +G L +LH + H D+K +N+LL E + DFG++ L
Sbjct: 126 IAYILHEALMG------LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QL 174
Query: 799 SPAQTSSIDAKGSIGYIAPEY-----GLGSEVSINGDVYSYGILLLEL 841
+ + + G+ ++APE L S DV+S GI +EL
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+E+G G++GSVYK + T+A+K L L F I E + L H+ + +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI- 61
Query: 696 ACSGVDYQGNDF-KALVF---EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
VD+ G F + V+ E+M SL++ + E ++L+R I
Sbjct: 62 ----VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-----DVLRR--ITYA 110
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
V L +L + I H D+KP+NVL++ + DFG++ L S A+T+ G
Sbjct: 111 VVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GC 164
Query: 812 IGYIAPEY--GLGSE----VSINGDVYSYGILLLELVTRKKP 847
Y+APE G ++ DV+S G+ +LE+ + P
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 59/260 (22%), Positives = 103/260 (39%), Gaps = 42/260 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
+G GS G V+ + VAVK L + K + E ++ + H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEW----LHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + E ++E+ L + + E L + Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
L Y+H + H DLKP+NV ++ E+++ + DFGLAR + KG +
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV------DPHYSHKGYLS 176
Query: 814 -------YIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865
Y +P L + + D+++ G + E++T K +F G H +M
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGA---HELEQMQ 229
Query: 866 LPDHVVDIVDSTLLSDDEDL 885
L I++S + +ED
Sbjct: 230 L------ILESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVKIL 694
IG GSFG V + AVKV +L K ++E N L KN++H LV +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+Q D V +++ L + + RE E PR+ R ++A
Sbjct: 62 ----HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLE-PRA-----RF-YAAEIAS 107
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
AL YLH I + DLKP N+LLD + ++DFGL + + T+S G+ Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC-GTPEY 162
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
+APE D + G +L E++ P S +M
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V L A+KV +L + E L + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C +Q D V E++ L + I R K +E PRS R +V A
Sbjct: 63 CC----FQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDE-PRS-----RF-YAAEVTLA 108
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L +LH + + + DLK N+LLD E ++DFG+ + L+ T++ G+ YI
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF--CGTPDYI 163
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
APE E + D ++ G+L+ E++ + P ++ E D+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 29/91 (31%), Positives = 44/91 (48%)
Query: 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI 68
L L + L G I + L L+ + L NS IP + L+VL L+ NS G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 69 PANISSCSNLIQIRLFYNELVGKIPSELGSL 99
P ++ ++L + L N L G++P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 37/122 (30%), Positives = 57/122 (46%), Gaps = 12/122 (9%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA-RFLPLSPAQTSSIDAK 809
++ L ++H+ + + DLKP+N+LLDE +SD GLA F P +
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----- 156
Query: 810 GSIGYIAPE-YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868
G+ GY+APE G+ + D +S G +L +L+ P D H RM L
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTV 214
Query: 869 HV 870
+V
Sbjct: 215 NV 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 33/110 (30%), Positives = 52/110 (47%), Gaps = 6/110 (5%)
Query: 738 RSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797
R L + + ++ + C + +LH I + D+KP NVLLD++ +SD GLA L
Sbjct: 90 RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
T G+ GY+APE S D ++ G + E+V + P
Sbjct: 147 DGKTITQR---AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 16/114 (14%)
Query: 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS----IGYIAPEYGLGSE 824
H DL NVL+ E + + DFGLAR + + S+ +KGS + ++APE +
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDI----MRDSNYISKGSTFLPLKWMAPESIFNNL 317
Query: 825 VSINGDVYSYGILLLELVT------RKKPVDSMFEGDMNLHNFARMALPDHVVD 872
+ DV+S+GILL E+ T + P++ F + RMA P H D
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA--IKRGYRMAKPAHASD 369
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG GS G V VAVK+ +L + E +++ +H+N+V++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS- 86
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y + ++ EF+Q +L + + LN Q + V AL
Sbjct: 87 ----YLVGEELWVLMEFLQGGALTDIVSQT-----------RLNEEQIATVCESVLQALC 131
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSSIDAKGSIGYIA 816
YLH + H D+K ++LL + +SDFG A+ P + S + G+ ++A
Sbjct: 132 YLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMA 185
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
PE + D++S GI+++E+V + P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 32/232 (13%)
Query: 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH 687
N + +G G++G VYK AVK+ L F E +K +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
N+V + Y + + E+ SL++ H L+ LQ
Sbjct: 66 CNIVAYFGS-----YLSREKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAY 110
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ + L+YLH + H D+K +N+LL + ++DFG+A + + A+ S
Sbjct: 111 VCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF- 166
Query: 808 AKGSIGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPVDSMFE 853
G+ ++APE + V NG D+++ GI +EL + P MF+
Sbjct: 167 -IGTPYWMAPEV---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 56/238 (23%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSV---YKGILDQGKTTVAVKVFN--LLHHGAFKSFIA 677
YQNL IG G+ G V Y IL++ VA+K + + K
Sbjct: 26 YQNL----------KPIGSGAQGIVCAAYDAILER---NVAIKKLSRPFQNQTHAKRAYR 72
Query: 678 ECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAP 737
E +K + H+N++ +L F +SLEE+ + +
Sbjct: 73 ELVLMKCVNHKNIIGLLNV-----------------FTPQKSLEEFQDVYIVMELMDA-- 113
Query: 738 RSLNLLQRLNIGID----------VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
NL Q + + +D + C + +LH I H DLKPSN+++ + +
Sbjct: 114 ---NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 845
DFGLAR S T + + Y APE LG N D++S G ++ E++
Sbjct: 168 LDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++A L +LH I + DLK NV+LD E ++DFG+ + T + G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF--CG 163
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
+ YIAPE + D +++G+LL E++ + P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 26/241 (10%)
Query: 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECN 680
+ ++L + TD + IG G++G VYK + + AVK+ + + + AE N
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYN 70
Query: 681 TLKNI-RHRNLVKILTACSGVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKTEE 735
L+++ H N+VK G+ Y+ + LV E S+ E + + + +
Sbjct: 71 ILQSLPNHPNVVKFY----GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 736 APRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795
+L +G L +LH++ I H D+K +N+LL E + DFG++
Sbjct: 127 EAMISYILYGALLG------LQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA- 176
Query: 796 LPLSPAQTSSIDAKGSIGYIAPEY-----GLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
L+ + + G+ ++APE DV+S GI +EL P+
Sbjct: 177 -QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
Query: 851 M 851
M
Sbjct: 236 M 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 8/174 (4%)
Query: 275 RLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNR 334
L L ++ N LP+ + NL L+ L L N + ++P + NL L++ N+
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNL-PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197
Query: 335 LSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYK 394
+S +PP I L L EL L N + + S+ NLK + N +P S+G
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLS 255
Query: 395 TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVL 448
L +DLS+N ++ +I + LDLS N L+ ++P L LE+L
Sbjct: 256 NLETLDLSNNQIS-SISSLGSLTNLRE--LDLSGNSLSNALPLIALLLLLLELL 306
|
Length = 394 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+++ L +LH + I + DLK NV+LD E ++DFG+ + + T + G
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF--CG 163
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
+ YIAPE + D ++YG+LL E++ + P D E ++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 33/247 (13%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKV-FNLLHHGAFKSFIA-ECNT--LKNIRHRNLVKI 693
+G G+FG VY D G+ +V F+ K A EC LKN+RH +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 694 LTACSGVDYQGNDFKALVF-EFMQNRSLEEWL--HPITREDKTEEAPRSLNLLQRLNIGI 750
G + K +F E+M S+++ L + E+ T R +LQ
Sbjct: 70 Y----GCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR--QILQ------ 117
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA-RFLPLSPAQTSSIDAK 809
+SYLH + I H D+K +N+L D + DFG + R + + T
Sbjct: 118 ----GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA----RMA 865
G+ +++PE G DV+S ++E++T K P + +E + A +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW-AEYEAMAAIFKIATQPTKPM 229
Query: 866 LPDHVVD 872
LPD V D
Sbjct: 230 LPDGVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 24/60 (40%), Positives = 31/60 (51%)
Query: 468 KLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L+ L++ N L + L L VLDLS NNL+ PE G L +L+LS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 34/230 (14%)
Query: 639 IGVGSFGSVY--KGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG GSFG +Y K D + + ++ E L ++H N+V +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT--EEAPRSLNLLQRLNIGIDVAC 754
+Q N +V E+ L + I R+ E Q L+ + ++
Sbjct: 68 -----FQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED-------QILSWFVQISL 112
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFL--PLSPAQTSSIDAKGS 811
L ++H I H D+K N+ L + M+A + DFG+AR L + A T G+
Sbjct: 113 GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV----GT 165
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
Y++PE + D++S G +L EL T K P FEG+ NLH
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 638 EIGVGSFGSVY----KGIL----------DQGKTTVAVKVFNL-LHHGAFKSFIAECNTL 682
++G G FG V+ +G+ D VAVK+ + A F+ E +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 683 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR--SL 740
+++ N++++L C +D ++ E+M+N L ++L E A S+
Sbjct: 72 SRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
++ L + + +A + YL H DL N L+ ++DFG++R L
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 801 AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
A I ++A E L + + DV+++G+ L E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 25/75 (33%), Positives = 39/75 (52%)
Query: 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSIN 828
H DL N+LL E + + DFGLAR + P A+ + ++APE +
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256
Query: 829 GDVYSYGILLLELVT 843
DV+S+G+LL E+ +
Sbjct: 257 SDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V L + AVKV +L + + E L R+ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
C +Q D V EF+ L + I + + +EA ++ A
Sbjct: 63 CC----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-------YAAEITSA 108
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L +LH I + DLK NVLLD E ++DFG+ + + TS+ G+ YI
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF--CGTPDYI 163
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKPV-----DSMFEGDMN 857
APE + D ++ G+LL E++ P D +FE +N
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 45/218 (20%), Positives = 88/218 (40%), Gaps = 41/218 (18%)
Query: 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
G+ + GS G V+ V +K+ G + + E L+N+ H +++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVI 120
Query: 692 KIL-------TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
++ C + + + + ++ ++ RS R L + Q
Sbjct: 121 RMKDTLVSGAITCMVLPH----YSSDLYTYLTKRS------------------RPLPIDQ 158
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
L I + L YLH I H D+K N+ +++ + D G A+F ++PA
Sbjct: 159 ALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--- 212
Query: 805 SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELV 842
+ G++ APE + + D++S GI+L E++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 8/111 (7%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++ AL +LH + I + D+K N+LLD ++DFGL++ + G
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCG 168
Query: 811 SIGYIAPEYGLGSEVSING--DVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
+I Y+AP+ G + + D +S G+L+ EL+T P +G+ N
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--TVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 659 VAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQN 717
VAVK+ + A F+ E L ++ N++++L C VD D ++ E+M+N
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC--VD---EDPLCMITEYMEN 103
Query: 718 RSLEEWLHPITREDKTEEA----PRSLNLL-----QRLNIGIDVACALSYLHHDCQPPIT 768
L ++L +DK E P + L L++ + +A + YL
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSIN 828
H DL N L+ E + ++DFG++R L A I ++A E L + +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 829 GDVYSYGILLLEL--VTRKKPVDSMFEGDM 856
DV+++G+ L E+ + +++P + + +
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 37/120 (30%), Positives = 54/120 (45%), Gaps = 7/120 (5%)
Query: 736 APRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795
A R++ + L I V A+ YLH + I H D+K N+ ++ + DFG A F
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF 231
Query: 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
P+ G+I APE D++S GI+L E+ T DS+FE D
Sbjct: 232 -PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 14/127 (11%)
Query: 722 EWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781
E H + RE + + + + L CAL LH + + + DLKP N+LLD
Sbjct: 79 ELFHHLQREGRFDLSRARFYTAELL-------CALENLH---KFNVIYRDLKPENILLDY 128
Query: 782 EMMAHVSDFGLARFLPLSPAQTSSIDA-KGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 840
+ + DFGL + L+ + G+ Y+APE LG + D ++ G+LL E
Sbjct: 129 QGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYE 185
Query: 841 LVTRKKP 847
++T P
Sbjct: 186 MLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 39/242 (16%)
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAF-KSFIAECNTLKN 684
+ T+ + +G+G+FG V VA+K + K E LK+
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 685 IRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
+RH N++ + S + + V E + LH + E+ L Q
Sbjct: 66 LRHENIISL----SDIFISPLEDIYFVTELLGTD-----LHRLLTSRPLEKQFIQYFLYQ 116
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
L L Y+H + H DLKPSN+L++E + DFGLAR P T
Sbjct: 117 ILR-------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTG 164
Query: 805 SIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
+ + Y APE L EV D++S G + E++ K +F G +++
Sbjct: 165 YVSTR---YYRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGK----PLFPGKDHVN 213
Query: 860 NF 861
F
Sbjct: 214 QF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 60/233 (25%), Positives = 92/233 (39%), Gaps = 47/233 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTAC 697
+G G++G VYKG + A+KV ++ + E N LK HRN+ A
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 698 SGVDYQGNDFKA-LVFEFMQNRSL-------------EEWLHPITREDKTEEAPRSLNLL 743
+ G D + LV EF S+ EEW+ I RE
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE------------- 119
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
+ LS+LH Q + H D+K NVLL E + DFG++ L + +
Sbjct: 120 --------ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168
Query: 804 SSIDAKGSIGYIAPEYGLGSE-----VSINGDVYSYGILLLELVTRKKPVDSM 851
++ G+ ++APE E D++S GI +E+ P+ M
Sbjct: 169 NTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-05
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 34/230 (14%)
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF-KSFIAECNTLKNI 685
++ + + + IG G++G V VA+K + H F + + E L+
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 686 RHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
+H N++ IL ++ F +V E M E L+ + + L
Sbjct: 61 KHENIIGILDIIRPPSFE--SFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLY 113
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
Q L L Y+H + H DLKPSN+LL+ + DFGLAR
Sbjct: 114 QILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IADPE 159
Query: 804 SSIDAKGSIG-------YIAPEYGLGS-EVSINGDVYSYGILLLELVTRK 845
D G + Y APE L S + D++S G +L E+++ +
Sbjct: 160 H--DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 34/222 (15%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRN 689
F +G GSFG V A+K +L + E + L + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V ++ CS +Q + + EF+ L L +A R N + +
Sbjct: 80 IVNMM--CS---FQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKF-YH 124
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
++ A YLH I + DLKP N+LLD + V+DFG A+ +P +
Sbjct: 125 AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----DRTFTLC 176
Query: 810 GSIGYIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ Y+APE G G V D ++ G+LL E + P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+IG G++G+V+K + VA+K L G S + E LK ++H+N+V++
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL-- 64
Query: 696 ACSGVDYQGNDFK-ALVFEFMQNRSLEEWLHPITRE-DKTEEAPRSLNLLQRLNIGIDVA 753
D +D K LVFE+ ++ L+++ + D LL+ L
Sbjct: 65 ----YDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL------- 112
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
A + H+ + H DLKP N+L+++ ++DFGLAR + P + S + ++
Sbjct: 113 -AFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLW 164
Query: 814 YIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPV 848
Y P+ G+++ S + D++S G + EL +P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 55/254 (21%), Positives = 104/254 (40%), Gaps = 44/254 (17%)
Query: 639 IGVGSFGSVY-------KGILDQ---------GKTTVAVKVFNLLHHGAFKS----FIAE 678
+G G FG V+ + ++ VAVKV L A + F+ E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV---LRPDASDNAREDFLKE 69
Query: 679 CNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR 738
L + N+ ++L C+ + ++ E+M+N L ++L +T
Sbjct: 70 VKILSRLSDPNIARLLGVCT-----VDPPLCMIMEYMENGDLNQFLQ--KHVAETSGLAC 122
Query: 739 SLNLLQR---LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795
+ L L + +A + YL H DL N L+ + ++DFG++R
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178
Query: 796 LPLSPAQTSSID--AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPVDSM 851
L + + A I ++A E L + + DV+++G+ L E++T R++P + +
Sbjct: 179 -NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
Query: 852 FEGDM--NLHNFAR 863
+ + N +F R
Sbjct: 238 TDQQVIENAGHFFR 251
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 60/255 (23%), Positives = 97/255 (38%), Gaps = 47/255 (18%)
Query: 617 SFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFI 676
S +I L + F +G G++G VYKG + A+KV ++ +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60
Query: 677 AECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA-LVFEFMQNRSL-------------E 721
E N LK HRN+ A G+D + LV EF S+ E
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 722 EWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781
+W+ I RE + L++LH + H D+K NVLL E
Sbjct: 121 DWIAYICRE---------------------ILRGLAHLHAH---KVIHRDIKGQNVLLTE 156
Query: 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEY-----GLGSEVSINGDVYSYGI 836
+ DFG++ L + + ++ G+ ++APE + D++S GI
Sbjct: 157 NAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214
Query: 837 LLLELVTRKKPVDSM 851
+E+ P+ M
Sbjct: 215 TAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 9/98 (9%)
Query: 771 DLKPSNVLLDEEMMAHVSDFGLA-RFLPLSPAQTSSIDAKGSIGYIAPE-YGLGSEVSIN 828
DLKP+N+LLDE +SD GLA F P + G+ GY+APE G +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSS 176
Query: 829 GDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866
D +S G +L +L+ P D H RM L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 9e-05
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G+FG V IL + K + A+K+ ++ + E LKN RH L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ + +Q D V E++ L + H ++RE E G ++
Sbjct: 60 LKYS-----FQTKDRLCFVMEYVNGGEL--FFH-LSRERVFSEDRTRF-------YGAEI 104
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL YLH I + DLK N++LD++ ++DFGL + A + G+
Sbjct: 105 VSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--CGTP 159
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
Y+APE ++ D + G+++ E++ + P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 29/249 (11%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
IG G+FG V L A+K+ N +L F E + L N ++ + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
A +Q + LV ++ L L ED+ E L + + I ID
Sbjct: 69 A-----FQDENNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMV-IAIDSVHQ 120
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L Y+H D +KP N+L+D ++DFG L SS+ A G+ YI
Sbjct: 121 LHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYI 170
Query: 816 APEYGLGSE-----VSINGDVYSYGILLLELVTRKKP--VDSMFEGDMNLHNFA-RMALP 867
+PE E D +S G+ + E++ + P +S+ E + N R P
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
Query: 868 DHVVDIVDS 876
V D+ +
Sbjct: 231 AQVTDVSED 239
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 10/299 (3%)
Query: 19 SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNL 78
S ++ NL L L L N I + L L L L+NN+I +IP I +
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 79 IQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG 138
++ + + +PS L +L +++L +S N+L+ +P L NLS++N L L+ N +
Sbjct: 142 LKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-S 199
Query: 139 GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQN 198
+P L L L ++ N + + SS+ N+ +++ + N+L+ + + L N
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP--ESIGNLSN 256
Query: 199 LQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGS 258
L+ + NQ++ ++ + +NL N L+ +P + L +
Sbjct: 257 LETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314
Query: 259 RGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA 317
LN + N N I N A
Sbjct: 315 ALELKLNSILLNNNILSNGETSSPEALSILESL-NNLWTLDNALDESNLNRYIVKNPNA 372
|
Length = 394 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++A L +LH I + DLK NV+LD E ++DFG+ + T + G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF--CG 163
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV-----DSMFEGDMNLHNFA 862
+ YIAPE + D +++G+LL E++ + P D +F+ M HN A
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVA 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G+FG V IL + K T A+K+ ++ + E L+N RH L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGID 751
+ A +Q +D V E+ L + H ++RE TEE R G +
Sbjct: 60 LKYA-----FQTHDRLCFVMEYANGGEL--FFH-LSRERVFTEERARFY--------GAE 103
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ AL YLH + + D+K N++LD++ ++DFGL + A + G+
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGT 158
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
Y+APE ++ D + G+++ E++ + P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 9/123 (7%)
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-PLSPAQTSSIDAKGSIG 813
+SYLH + I H D+K +N+L D + DFG ++ L + + T G+
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM----ALPDH 869
+++PE G D++S G ++E++T K P + FE + A LP H
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW-AEFEAMAAIFKIATQPTNPVLPPH 233
Query: 870 VVD 872
V D
Sbjct: 234 VSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 639 IGVGSFGSVYKGIL-DQG------KTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
+G G+F ++KGI + G KT V +KV + H +SF + + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
C D +V E+++ SL+ +L +++K +N+ +L +
Sbjct: 63 LNYGVCVCGDES-----IMVQEYVKFGSLDTYL----KKNKN-----LINISWKLEVAKQ 108
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEE 782
+A AL +L +TH ++ NVLL E
Sbjct: 109 LAWALHFLE---DKGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-04
Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 15/124 (12%)
Query: 182 NQ-LQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-Y 239
NQ L+G IP D L++LQ ++ N + G IPP++ + ++LE+ N G +P
Sbjct: 427 NQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL-----LPACI 294
L + L + ++ NSL R + L L+R N + GL L AC
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRL-------LHRASFNFTDNAGLCGIPGLRACG 538
Query: 295 SNLS 298
+LS
Sbjct: 539 PHLS 542
|
Length = 623 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-----A 801
NI D+ L Y+H + I+H D+KP N+++D ++ D+G+A + +
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ +G++ Y + G+ V+ GD+ S G +L+ K P
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L YLH I H D+KP N+L++ + + DFGLAR ++ + + Y
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 816 APEYGLGSEVSING-DVYSYGILLLELVTRK 845
APE +GS + D++S G + EL+ R+
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 35/212 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G++G V K + K VA+K F + + ++ + E L+ ++ N+V++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
++ LVFE+++ LE LL+ + G+
Sbjct: 69 -----FRRRGKLYLVFEYVEKNMLE--------------------LLEEMPNGVPPEKVR 103
Query: 757 SYLH------HDCQP-PITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
SY++ H C I H D+KP N+L+ + + DFG AR L + + +
Sbjct: 104 SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYV 162
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 841
+ Y +PE LG+ D++S G +L EL
Sbjct: 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS 826
I + DLKP N+LLD++ ++DFG A+ + T + G+ YIAPE L
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 827 INGDVYSYGILLLELVTRKKP 847
D ++ GI + E++ P
Sbjct: 207 KAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 755 ALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
AL +LH +D I + DLKP N+LLD + DFGL++ T++ G+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTE 161
Query: 814 YIAPEY-----GLGSEVSINGDVYSYGILLLEL 841
Y+APE G V D +S G+L+ E+
Sbjct: 162 YLAPEVLLDEKGYTKHV----DFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 31/187 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G+FG V IL + K T A+K+ ++ + E L+N RH L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGID 751
+ + +Q +D V E+ L + H ++RE +E+ R G +
Sbjct: 60 LKYS-----FQTHDRLCFVMEYANGGEL--FFH-LSRERVFSEDRARFY--------GAE 103
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ AL YLH C + + DLK N++LD++ ++DFGL + +S T G+
Sbjct: 104 IVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GT 158
Query: 812 IGYIAPE 818
Y+APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G+FG V IL + K T A+K+ ++ + E L+N RH
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH----P 55
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGID 751
LTA +Q +D V E+ L + H ++RE +E+ R G +
Sbjct: 56 FLTALK-YSFQTHDRLCFVMEYANGGEL--FFH-LSRERVFSEDRARFY--------GAE 103
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ AL YLH + + + DLK N++LD++ ++DFGL + A + G+
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGT 159
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
Y+APE ++ D + G+++ E++ + P
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 61/242 (25%), Positives = 95/242 (39%), Gaps = 39/242 (16%)
Query: 324 NLQRLEMWNNRLSGTIPPAIGEL----QNLRELRLQRNKFLGNIPPSIGNL--------K 371
LQ L + N L A+ +L+EL L G IP + +L
Sbjct: 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCL-SLNETGRIPRGLQSLLQGLTKGCG 82
Query: 372 VFNLDLSCNFLQGSIP---SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL-----LIG 423
+ LDLS N L SL + +L + L++N L L L
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR-LLAKGLKDLPPALEK 141
Query: 424 LDLSRNQLTG----SIPSEVGNLKNLEVLDVFENKLKGE-IPST---LGSCKKLEQLEMQ 475
L L RN+L G ++ + ++L+ L++ N + I + L + LE L++
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 476 GNFLQ----GPIPSSLSSLKGLNVLDLSQNNLSGKI-----PEFLVGFQLLENLNLSNNN 526
N L + +L+SLK L VL+L NNL+ L L L+LS N+
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261
Query: 527 LE 528
+
Sbjct: 262 IT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 22/170 (12%)
Query: 688 RNLVKILTACS--GVDYQGNDFKA-----LVFEFMQNRSLEEWLHPITREDKTEEAPRSL 740
R+ + L AC G+ +DFK+ L+ E+ L + + ++ E P
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLP--- 165
Query: 741 NLLQRLNIGI---DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797
Q +G+ + AL +H + H DLK +N+ L + + DFG ++
Sbjct: 166 --FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
S + + G+ Y+APE S D++S G++L EL+T +P
Sbjct: 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 265 NFLCSLTNSTRLN--RLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG---NIPAAI 319
N L SL + + N L N+N + PA L T++ + L N+I +P+A
Sbjct: 209 NELKSLPENLQGNIKTLYANSNQLTSI-PA---TLPDTIQEMELSINRITELPERLPSA- 263
Query: 320 GKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSC 379
LQ L++++N++S EL+ L ++P I +L V + L+
Sbjct: 264 -----LQSLDLFHNKISCLPENLPEELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLT- 317
Query: 380 NFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV 439
L ++P L KTL + + +L ++PP+ L LD+S+NQ+T +P +
Sbjct: 318 -ALPETLPPGL---KTLEAGENALTSLPASLPPE-------LQVLDVSKNQIT-VLPETL 365
Query: 440 GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKG 492
+ LDV N L +P L + L+ ++ N L +P SL +G
Sbjct: 366 P--PTITTLDVSRNALT-NLPENLPAA--LQIMQASRNNL-VRLPESLPHFRG 412
|
Length = 754 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 11/116 (9%)
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
AL LH + I DL P+N+LLD+ H+ L F S + S Y
Sbjct: 97 ALDALH---REGIVCRDLNPNNILLDDR--GHIQ---LTYFSRWSEVEDSCDGEAVENMY 148
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870
APE G SE + D +S G +L EL+T K V+ G +N H + +P+ V
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-INTH--TTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFL--PLSPAQTSSIDAKGSIGYIAPEYGLGSE 824
+ H D+K N+ L + + DFG AR L P + A T G+ Y+ PE
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV----GTPYYVPPEIWENMP 176
Query: 825 VSINGDVYSYGILLLELVTRKKP 847
+ D++S G +L EL T K P
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 31/214 (14%)
Query: 646 SVYKGILDQGKTTVAVKVFNLLHHGAFK---SFIAECNTLKNIRHRNLVKILTACSGVDY 702
S+YKGI + V ++ F H G E L+ I N++KI G
Sbjct: 35 SIYKGIFNN--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY----GFII 88
Query: 703 QGND---FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYL 759
D +L+ E+ L E L DK + L+ +L++ ID L L
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVL------DKE----KDLSFKTKLDMAIDCCKGLYNL 138
Query: 760 HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEY 819
+ P + L + L+ E + GL + L P + + Y + +
Sbjct: 139 YKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKM 191
Query: 820 GLG--SEVSINGDVYSYGILLLELVTRKKPVDSM 851
SE +I D+YS G++L E+ T K P +++
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 20/44 (45%), Positives = 28/44 (63%), Gaps = 3/44 (6%)
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR 794
+VA AL YLH + I H DLKP N+L+ E ++DFGL++
Sbjct: 112 EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 953 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.86 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.62 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-107 Score=1022.20 Aligned_cols=874 Identities=32% Similarity=0.511 Sum_probs=739.0
Q ss_pred cCcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccC-CCCCCCcEEeCCCCccccccCcCccCCCCCcEE
Q 043900 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEF-DRLQRLQVLALNNNSIGGEIPANISSCSNLIQI 81 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L 81 (953)
..+|+.|||+++++.+.++..+..+++|++|+|++|++++.+|..+ ..+++|++|+|++|.+++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 4689999999999999999999999999999999999998788765 4999999999999999988886 568999999
Q ss_pred eccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 82 RLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 82 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
+|++|.+++.+|..|+++++|++|+|++|.+.+.+|.+|+++++|++|+|++|++.+.+|..|+.+++|++|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC-C
Q 043900 162 GTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-L 240 (953)
Q Consensus 162 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-l 240 (953)
+.+|..+.++++|++|++++|++++.+|..+. .+++|++|++++|++.+..|..+.++++|+.|++++|.+++.+|. +
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 304 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence 99999999999999999999999999998876 799999999999999999999999999999999999999987664 7
Q ss_pred CCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCcccc
Q 043900 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIG 320 (953)
Q Consensus 241 ~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~ 320 (953)
..+++|+.+++++|.+.... ...+..+++|+.|++++|.+.+.+|..+..+ ++|+.|++++|++.+..|..+.
T Consensus 305 ~~l~~L~~L~l~~n~~~~~~------~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 305 IQLQNLEILHLFSNNFTGKI------PVALTSLPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred cCCCCCcEEECCCCccCCcC------ChhHhcCCCCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHh
Confidence 88899999999999886532 2345678899999999999999999999888 6899999999999999999999
Q ss_pred CCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEE
Q 043900 321 KFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTII 399 (953)
Q Consensus 321 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L 399 (953)
.+++|+.|++++|.+.+..|..+..+++|+.|++++|++++.+|..+..+ .+..|++++|.+++.+|..+..+++|+.|
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 457 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEE
Confidence 99999999999999999999999999999999999999999999999888 47899999999999999999999999999
Q ss_pred EcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccc
Q 043900 400 DLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479 (953)
Q Consensus 400 ~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 479 (953)
+|++|++.+.+|..+. . ..++.|++++|++++..|..|.++++|+.|+|++|++.+.+|..+.++++|+.|+|++|.+
T Consensus 458 ~L~~n~~~~~~p~~~~-~-~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 458 SLARNKFFGGLPDSFG-S-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred ECcCceeeeecCcccc-c-ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 9999999988887653 2 4677999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccccccCCcCCCCCCCCCC
Q 043900 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQ 559 (953)
Q Consensus 480 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~ 559 (953)
++.+|..|..+++|+.|||++|++++.+|..+..+++|+.|++++|+++|.+|..+.+..+...++.||+.+||..+...
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~ 615 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC
Confidence 99999999999999999999999999999999999999999999999999999999999988899999999999877666
Q ss_pred CCccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhccc--cCCCCC-CCCCC--------CCcCHHHHHH
Q 043900 560 LPTCISKESKHKKLTLALKLALAIISGLTGLSLALSFLILCLVRKRKE--KKNPSS-PINSF--------PNISYQNLYN 628 (953)
Q Consensus 560 ~~~c~~~~~~~~~~~~~~~~~~~ii~~~~~~~~~~~~~~~~~~~~r~~--~~~~~~-~~~~~--------~~~~~~~~~~ 628 (953)
.++|........ +.++++++++++++++++++++++++++++. ++.... ..... ..++++ .
T Consensus 616 ~~~c~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 687 (968)
T PLN00113 616 LPPCKRVRKTPS-----WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN---D 687 (968)
T ss_pred CCCCccccccce-----eeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHH---H
Confidence 778854321111 1111111222222222222222222222211 111100 00000 112222 3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
....|...+.||+|+||.||+|++..+++.||||+++.... ....|++.+++++||||++++++|.. ++..
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~ 758 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS-----EKGA 758 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-----CCCC
Confidence 34567788899999999999999988888999999864332 12346888999999999999999753 3678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.++++ .++|.++.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++.
T Consensus 759 ~lv~Ey~~~g~L~~~l~-------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR-------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred EEEEeCCCCCcHHHHHh-------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 99999999999999994 37899999999999999999997666799999999999999999988876
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.+..... .....+++.|+|||++.+..++.++|||||||++|||+||+.||+..........+|++.....
T Consensus 826 -~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 826 -LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898 (968)
T ss_pred -ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence 665543211 1123578999999999999999999999999999999999999976555555666666554433
Q ss_pred h-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 869 H-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 869 ~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
. ...++|+.+.... ....+...++.+++.+||+.||++||||+||+++|+++.+...
T Consensus 899 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 899 CHLDMWIDPSIRGDV----------------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cchhheeCccccCCC----------------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 2 3334443332211 1112445678899999999999999999999999999876443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-59 Score=589.43 Aligned_cols=570 Identities=33% Similarity=0.485 Sum_probs=497.1
Q ss_pred CccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCcc-CCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 27 LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANIS-SCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 27 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
..+++.|+|++|++++.+|.+|..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 35799999999999999999999999999999999999988998765 999999999999999988875 568999999
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+.+++|++|+|++|++++.+|..+.++.+|+.|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC-CCCCCCccceeeecccccCCCCCCcc
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-YLEKPQRLSVFSITENSLGSRGHSNL 264 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~l~~~~~L~~l~l~~n~l~~~~~~~~ 264 (953)
+.+|..+. .+++|++|++++|++++.+|..++++++|+.|++++|++++..| .+..+++|+++++++|.+....
T Consensus 226 ~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~---- 300 (968)
T PLN00113 226 GEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI---- 300 (968)
T ss_pred CcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC----
Confidence 99998886 89999999999999999999999999999999999999998655 5788899999999999886432
Q ss_pred cccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCcc
Q 043900 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIG 344 (953)
Q Consensus 265 ~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 344 (953)
...+.++++|+.|++++|.+.+.+|..+..+ ++|+.|++++|.+.+..|..++.+++|+.|++++|.+++..|.+++
T Consensus 301 --p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 301 --PELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred --ChhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence 2235678899999999999999999999888 5899999999999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCcccccee
Q 043900 345 ELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIG 423 (953)
Q Consensus 345 ~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~ 423 (953)
.+++|+.|++++|++.+.+|..++.+ .++.|++++|.+++.+|..|..+++|+.|++++|++++.+|..+..+. .++.
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~ 456 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP-SLQM 456 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCC-CCcE
Confidence 99999999999999999999999887 579999999999999999999999999999999999998888776655 4669
Q ss_pred eeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcc
Q 043900 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503 (953)
Q Consensus 424 L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 503 (953)
|++++|++.+.+|..+ ..++|+.|++++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+
T Consensus 457 L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 457 LSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred EECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 9999999999888876 468999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccccccccCceEeccCCcCcccCCCC-CcccccccccccCCcCCCCCCCCCCC-------------Cccccccch
Q 043900 504 SGKIPEFLVGFQLLENLNLSNNNLEGMVPIE-GVFKNATITSVLGNLKLCGGIPEFQL-------------PTCISKESK 569 (953)
Q Consensus 504 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lcg~~~~~~~-------------~~c~~~~~~ 569 (953)
++.+|..+..+++|+.|+|++|+++|.+|.. ..+..+....+.+|. +.|..|.... .-|......
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~-l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~ 614 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH-LHGSLPSTGAFLAINASAVAGNIDLCGGDTTS 614 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc-ceeeCCCcchhcccChhhhcCCccccCCcccc
Confidence 9999999999999999999999999999864 334455566666665 4443442210 123221110
Q ss_pred --hhhH-HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhccccC
Q 043900 570 --HKKL-TLALKLALAIISGLTGLSLALSFLILCLVRKRKEKK 609 (953)
Q Consensus 570 --~~~~-~~~~~~~~~ii~~~~~~~~~~~~~~~~~~~~r~~~~ 609 (953)
.... .......+.+++++++++++++++++.++++|+++.
T Consensus 615 ~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (968)
T PLN00113 615 GLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN 657 (968)
T ss_pred CCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 0000 011222334566666666666666777777776544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=421.56 Aligned_cols=290 Identities=39% Similarity=0.672 Sum_probs=244.4
Q ss_pred CCCCcCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEee
Q 043900 617 SFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696 (953)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 696 (953)
....|++.++..+|++|...+.||+|+||.||+|...++ +.||||++........++|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567799999999999999999999999999999999987 5899998875443214569999999999999999999999
Q ss_pred ecccccCCCC-ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 697 CSGVDYQGND-FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 697 ~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
|.+. + +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.+.|+||||||+
T Consensus 140 C~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~--------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 140 CLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGE--------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred EecC-----CceEEEEEEccCCCCHHHHhCCCCCC--------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 9754 3 589999999999999999743321 6899999999999999999999998889999999999
Q ss_pred CeEecCCCcEEEeccccceecCCCCCccccccc-ccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcc-c
Q 043900 776 NVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA-KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF-E 853 (953)
Q Consensus 776 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~-~ 853 (953)
|||+|+++++||+|||+|+..+.. ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... .
T Consensus 207 NILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 207 NILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred HeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 999999999999999999765431 1111112 79999999999999999999999999999999999999988644 3
Q ss_pred CCccHHHHHHhhCCc-hhhhhccccccC-CchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 854 GDMNLHNFARMALPD-HVVDIVDSTLLS-DDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....+..|+...+.+ .+.+++|+.+.. .+.. .+...++..++.+|++.+|.+||+|.||++
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~-----------------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD-----------------EKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCCh-----------------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 345588888777666 588999988762 2211 034566999999999999999999999999
Q ss_pred HHHHHHHH
Q 043900 932 QLQSIKNI 939 (953)
Q Consensus 932 ~L~~i~~~ 939 (953)
+|+.+...
T Consensus 348 ~L~~~~~~ 355 (361)
T KOG1187|consen 348 ELEGILSL 355 (361)
T ss_pred HHHhhccc
Confidence 99665543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=381.84 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=207.8
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC-ceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND-FKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~l 710 (953)
.+..+.||+|..|+||++.++.+++.+|+|++.. ..+...+++.+|++++++.+||+||.++|.|.. +. ...|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~isI 155 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEISI 155 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEEe
Confidence 4557889999999999999999999999999963 345567889999999999999999999999643 34 6999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++|+|+++++. .+.+++...-+|+.+|++||.|||+ + +||||||||+|||++..|+|||||
T Consensus 156 ~mEYMDgGSLd~~~k~----------~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR----------VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred ehhhcCCCCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecc
Confidence 9999999999999963 2468999999999999999999996 5 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.++.+... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||........+..........+.
T Consensus 223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 223 FGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred ccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 9999877543 445567999999999999999999999999999999999999999864222222222221111111
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.. +.+.. .+++++.+++..|+++||.+|||++|+++.
T Consensus 299 ------------pP-------------~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 ------------PP-------------RLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ------------CC-------------CCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00000 467889999999999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=398.08 Aligned_cols=261 Identities=32% Similarity=0.463 Sum_probs=211.8
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
...+.||+|+||+||+|.+++.. .||||++..... ...+.|.+|+.+|.+++|||||+++|+|... ....++|
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~iV 118 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLCIV 118 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceEEE
Confidence 44566999999999999998864 599999974332 2256999999999999999999999998643 1268999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC-eEeecCCCCCeEecCCC-cEEEec
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP-ITHCDLKPSNVLLDEEM-MAHVSD 789 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~D 789 (953)
||||++|+|.++++.. ....+++..+++||.|||+||.|||++ + ||||||||+|||++.++ ++||+|
T Consensus 119 tEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECC
Confidence 9999999999999753 134799999999999999999999999 7 99999999999999997 999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC--CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL--GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+...... ....+...
T Consensus 188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-~~~v~~~~-- 262 (362)
T KOG0192|consen 188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-ASAVVVGG-- 262 (362)
T ss_pred Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcC--
Confidence 99998764322 2333467999999999999 56999999999999999999999999986433111 11100000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 943 (953)
.|...+..+++.+..++.+||..||+.||++.|++..|+.+.......
T Consensus 263 ----------------------------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 263 ----------------------------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred ----------------------------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 011111136778999999999999999999999999999998876654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.30 Aligned_cols=257 Identities=30% Similarity=0.449 Sum_probs=216.1
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+...+.||+|-||+||.|.+.... .||+|.++... ...+.|.+|+++|++++|++||+++++|... +..+|||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCC-cccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence 456788999999999999998874 79999998643 2447888999999999999999999998643 4789999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
|||+.|+|.+|++... ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+
T Consensus 281 E~m~~GsLl~yLr~~~--------~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE--------GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EecccCcHHHHhhhcC--------CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence 9999999999997522 34688999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
|+.... +.........-+..|.|||.+..+.++.|||||||||+|||++| |+.||..+...+ +.
T Consensus 350 Ar~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~ 414 (468)
T KOG0197|consen 350 ARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VL 414 (468)
T ss_pred ccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HH
Confidence 995433 23333344446789999999999999999999999999999999 999987643321 11
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
+. ..++.|.+.+..||++++++|..||..+|++|||++.+...++++....
T Consensus 415 ~~------------------le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 415 EL------------------LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HH------------------HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 11 1233455666689999999999999999999999999999999887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=357.55 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=211.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEee--ccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.+|.+.++||+|+||+||++....+++.||.|.++ ..+....+....|+.++++++|||||+++++-. .+++...
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence 45888999999999999999999999999999986 345566788999999999999999999988421 2333448
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCC-CCeEeecCCCCCeEecCCCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQ-PPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
+||||||..|||.+.++..+.+ .+.+++..+|+++.|++.||.++|.... .-|+||||||.||+++.+|.|||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~q------kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQ------KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhc------cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 9999999999999999765544 5679999999999999999999999422 23999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++.+.. ........+|||.||+||.+.+..|+++|||||+||++|||+.-++||.+. ++.......-.
T Consensus 170 GDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~q 242 (375)
T KOG0591|consen 170 GDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQ 242 (375)
T ss_pred ccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHc
Confidence 99999998853 344555678999999999999999999999999999999999999999752 22222221111
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.+. .+-+ ..-.+..+.+++..|+..||+.||+...+++.+..
T Consensus 243 gd~--------~~~p------------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDY--------PPLP------------------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCC--------CCCc------------------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 100 0000 01456679999999999999999997666555544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=370.23 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=203.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-------hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
.+.|.+.+.+|+|+||.|-+|..+.+++.||||+++... ........+|+++|++++||+||++++++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----- 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----- 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence 356888999999999999999999999999999996321 11223467999999999999999999995
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+.++..||||||++||+|.+++-. .+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~----------nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVA----------NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSND 312 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHh----------ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccC
Confidence 455788999999999999999953 33566777789999999999999999 99999999999999765
Q ss_pred ---CcEEEeccccceecCCCCCcccccccccccccccccccCCCC--CC-cccchHHHHHHHHHHHhCCCCCCCcccCCc
Q 043900 783 ---MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE--VS-INGDVYSYGILLLELVTRKKPVDSMFEGDM 856 (953)
Q Consensus 783 ---~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~sDv~slG~vl~elltg~~pf~~~~~~~~ 856 (953)
..+||+|||+|+..+ ....+...+||+.|.|||++.+.. ++ .+.||||+|||+|-+++|.+||.+......
T Consensus 313 ~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred CcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 689999999999875 344556678999999999987653 33 478999999999999999999986433221
Q ss_pred cHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 857 NLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+.....+.. ....+.+..++..+++.+|+..||++|||++|+++
T Consensus 390 l~eQI~~G~y~f----------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYAF----------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCcccc----------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222221111110 11223366778999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=368.17 Aligned_cols=201 Identities=31% Similarity=0.517 Sum_probs=180.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
...+|...+.||+|+||+||+|+++.++..||||.+... ..+..+-+..|+++++.++|||||++++++. .++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCC
Confidence 456789999999999999999999999999999999654 5566778899999999999999999999954 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC----
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE---- 782 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 782 (953)
..|+|||||.||||.+|++.. +.+++..++.++.|+|.||++||++ +||||||||+|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~----------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR----------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARND 149 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCC
Confidence 999999999999999999743 3689999999999999999999999 99999999999999764
Q ss_pred --CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 783 --MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 783 --~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
-.+||+|||+|+.+.+. ......+|++.|||||++...+|+.|+|+||+|+++||+++|+.||+.
T Consensus 150 ~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 46899999999988633 333456799999999999999999999999999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=403.59 Aligned_cols=272 Identities=26% Similarity=0.418 Sum_probs=225.9
Q ss_pred CCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+.+..+.||+|+||.||+|+.. .....||||.++..... ...+|++|++++..++|||||+++|+|...
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~----- 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG----- 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----
Confidence 4456788999999999999974 33457999999865555 788999999999999999999999998644
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCC----ccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEA----PRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
+..++|+|||..|||.+|+..+......... +.+++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 7899999999999999999866554333322 44599999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHH
Q 043900 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~ 860 (953)
+..|||+|||+++.+-..+.........-+.+|||||.+..+++|.+|||||||||+||+++ |+.||.+....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999998765555544444556889999999999999999999999999999999 999998754332
Q ss_pred HHHhhCCchhhhhc-cccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 861 FARMALPDHVVDIV-DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 861 ~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+.+.+ +..+ .+.++.||.++++||..||+..|++||+++||-.+|++..+.
T Consensus 714 ---------VIe~i~~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 ---------VIECIRAGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ---------HHHHHHcCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 11111 1111 234457899999999999999999999999999999998776
Q ss_pred hcccc
Q 043900 940 LLGHR 944 (953)
Q Consensus 940 ~~~~~ 944 (953)
.+.+.
T Consensus 766 s~~~~ 770 (774)
T KOG1026|consen 766 SPKYS 770 (774)
T ss_pred Ccccc
Confidence 65543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=381.72 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=210.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+|...+.||+|||+.||.+++.++++.||+|++.. ......+.+.+|+++.++++|||||+++++ |++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 579999999999999999999988888999999963 345567889999999999999999999999 566799
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
+|||.|+|+.++|.++++ ..+.+++.+++.+++||+.||.|||+. +|+|||||..|++++++.+|||
T Consensus 93 VYivLELC~~~sL~el~K----------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHH----------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEe
Confidence 999999999999999996 234799999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|..+..+ .......+|||.|.|||++.....+..+||||+|||+|.|+.|++||+...
T Consensus 160 gDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------------- 222 (592)
T KOG0575|consen 160 GDFGLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------------- 222 (592)
T ss_pred cccceeeeecCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---------------
Confidence 999999988533 234456789999999999999999999999999999999999999997521
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.+.++..-..+ ...+...+.+..+++..+|+.||.+|||+++|+.
T Consensus 223 --vkety~~Ik~~~----------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 223 --VKETYNKIKLNE----------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --HHHHHHHHHhcC----------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111100000 1111134556789999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=348.63 Aligned_cols=272 Identities=23% Similarity=0.306 Sum_probs=208.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
+.|+...++|+|+||.||+++++++++.||||++.... +...+..++|++++++++|||+|.++++| ......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 45788899999999999999999999999999996433 33456788999999999999999999995 455889
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++|+|||+..-|.+ +.. .+..++...+.++++|+++|+.|+|++ +++||||||+|||++.+|.+|||
T Consensus 77 hLVFE~~dhTvL~e-Le~---------~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHE-LER---------YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecchHHHHH-HHh---------ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEec
Confidence 99999997744443 322 234688899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh--
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA-- 865 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-- 865 (953)
|||+|+.+.. .....+..+.|.+|+|||.+.| .+|+...||||+||++.||++|.+.|++..+-|. ....+..
T Consensus 144 DFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly~I~ktLG 219 (396)
T KOG0593|consen 144 DFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LYLIRKTLG 219 (396)
T ss_pred cchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HHHHHHHHc
Confidence 9999998753 3334556779999999999887 6899999999999999999999999987443332 2222222
Q ss_pred -CCchhhhhccccccCCchhhhhcccch----hhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 -LPDHVVDIVDSTLLSDDEDLAVHGNQR----QRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 -~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+..+...++...- .+++..- .+..-..........+.+++..|++.||++|++.+|++.
T Consensus 220 ~L~prhq~iF~~N~-------~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNP-------FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCHHHHHHhccCC-------ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2222233322111 0111110 011111122244457899999999999999999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=382.72 Aligned_cols=458 Identities=28% Similarity=0.422 Sum_probs=325.3
Q ss_pred CCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCC
Q 043900 44 IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123 (953)
Q Consensus 44 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L 123 (953)
-.+.++.-..|+.|+|++|.++ .+...+.++..|..|++.+|+++ ..|.+++.+..++.|+.++|+++ .+|..++.+
T Consensus 37 e~e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~ 113 (565)
T KOG0472|consen 37 EGENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSL 113 (565)
T ss_pred chhhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhh
Confidence 3445566667778888888877 66666777788888888888887 77778888888888888888887 777788888
Q ss_pred CcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEE
Q 043900 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFS 203 (953)
Q Consensus 124 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 203 (953)
.+|+.|+.++|++. ..|+.++.+-.|+.|+..+|+++ ..|+.++++.++..|++.+|.++ ..|.+.. .|+.|+.|+
T Consensus 114 ~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld 189 (565)
T KOG0472|consen 114 ISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLD 189 (565)
T ss_pred hhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcc
Confidence 88888888888887 67777888888888888888887 77888888888888888888887 4444444 378888888
Q ss_pred eeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccC
Q 043900 204 VFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINA 283 (953)
Q Consensus 204 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~ 283 (953)
...|-++ .+|..++.|.+|+.|++.+|++...| .+..+..|.++++..|.++.
T Consensus 190 ~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~------------------------- 242 (565)
T KOG0472|consen 190 CNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEM------------------------- 242 (565)
T ss_pred cchhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHh-------------------------
Confidence 8888887 67888888888888888888887554 66666666666666666553
Q ss_pred CcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccC--
Q 043900 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLG-- 361 (953)
Q Consensus 284 n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-- 361 (953)
+|.....-.+++..|||+.|+++ ..|+.++.+.+|.+||+|+|.|+ ..|..++++ .|+.|-+.+|.+..
T Consensus 243 ------lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiR 313 (565)
T KOG0472|consen 243 ------LPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIR 313 (565)
T ss_pred ------hHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHH
Confidence 33333322245666666666665 45556666666666666666665 455566666 56666666665421
Q ss_pred -----------------------------------C-CCCCCCCc----eeeEEEccCCcCCCCCCccCCCCCC---CcE
Q 043900 362 -----------------------------------N-IPPSIGNL----KVFNLDLSCNFLQGSIPSSLGQYKT---LTI 398 (953)
Q Consensus 362 -----------------------------------~-~p~~~~~l----~l~~L~L~~N~l~~~~p~~~~~l~~---L~~ 398 (953)
. .+..|... ..+.|++++=+++ .+|+....-.+ .+.
T Consensus 314 r~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~ 392 (565)
T KOG0472|consen 314 REIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTS 392 (565)
T ss_pred HHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEE
Confidence 0 11111111 2356777777777 45555444443 677
Q ss_pred EEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCcc
Q 043900 399 IDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478 (953)
Q Consensus 399 L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 478 (953)
.+++.|++. ++|..+..+..+++.+.+++|.++ -+|..++.+++|..|+|++|.+. .+|..++.+..|+.||++.|+
T Consensus 393 VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~Nr 469 (565)
T KOG0472|consen 393 VNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNR 469 (565)
T ss_pred EecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccc
Confidence 888888887 788877777777777777777776 57777788888888888888887 778888888888888888888
Q ss_pred ccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccccccCCc
Q 043900 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNL 549 (953)
Q Consensus 479 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 549 (953)
|. .+|..+..+..|+.+-.++|++....|+.+.+|.+|.+|||.+|.+...+|..+.+.+.+.....|||
T Consensus 470 Fr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 470 FR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred cc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCc
Confidence 87 67777777777777777777777555555777777777777777777777777777777777777775
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=385.22 Aligned_cols=468 Identities=25% Similarity=0.369 Sum_probs=327.6
Q ss_pred cCcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEe
Q 043900 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIR 82 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ 82 (953)
.+.+++|++++++++ ++|++++.+..++.|+.++|+++. +|.++..+..|+.|+.++|.+. .+|+.++.+..|+.|+
T Consensus 67 L~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~ 143 (565)
T KOG0472|consen 67 LACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLD 143 (565)
T ss_pred ccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhh
Confidence 456788888888887 888889999899999999999886 8888888889999999999988 8888888899999999
Q ss_pred ccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC
Q 043900 83 LFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (953)
..+|+++ ..|+.++++.+|..|++.+|+++. .|...-+++.|+.||...|-++ .+|..++++.+|..|+|.+|+|.
T Consensus 144 ~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~- 219 (565)
T KOG0472|consen 144 ATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR- 219 (565)
T ss_pred ccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-
Confidence 9999988 788888888999999999999884 4444444889999999999887 77778999999999999999998
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCC
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~ 242 (953)
.+| .|.+++.|++|+++.|+|+ .+|.+...+++++..|||.+|+++ ..|+.++-+++|+.||+++|.+++.++.+++
T Consensus 220 ~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgn 296 (565)
T KOG0472|consen 220 FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGN 296 (565)
T ss_pred cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccccc
Confidence 778 7888999999999999998 788888878999999999999998 7888999999999999999999998888888
Q ss_pred CCccceeeecccccCCCCCCcccccccccccccccEEe--ccCCcccccCChhhhhccccCcEEEcccCcccccCCcccc
Q 043900 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLL--INANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIG 320 (953)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~--l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~ 320 (953)
+ +|+.+.+-+|.+......-+ +-..-.-|++|. +...+++..-- .+-..-++ ..+ ......
T Consensus 297 l-hL~~L~leGNPlrTiRr~ii----~~gT~~vLKyLrs~~~~dglS~se~-------~~e~~~t~----~~~-~~~~~~ 359 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTIRREII----SKGTQEVLKYLRSKIKDDGLSQSEG-------GTETAMTL----PSE-SFPDIY 359 (565)
T ss_pred c-eeeehhhcCCchHHHHHHHH----cccHHHHHHHHHHhhccCCCCCCcc-------cccccCCC----CCC-cccchh
Confidence 8 88888888887654321110 000000111110 00000000000 00000000 000 001122
Q ss_pred CCCCCCEEEeecCcccccCCcCccCCCC---CCeEEeccccccCCCCCCCCCce--eeEEEccCCcCCCCCCccCCCCCC
Q 043900 321 KFVNLQRLEMWNNRLSGTIPPAIGELQN---LRELRLQRNKFLGNIPPSIGNLK--VFNLDLSCNFLQGSIPSSLGQYKT 395 (953)
Q Consensus 321 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~--l~~L~L~~N~l~~~~p~~~~~l~~ 395 (953)
.+.+.+.|+++.=+++ .+|+....-.. .+..+++.|++. .+|..+..++ ...+.+++|.++ .+|..++.+++
T Consensus 360 ~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~k 436 (565)
T KOG0472|consen 360 AIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQK 436 (565)
T ss_pred hhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhc
Confidence 2334455555555554 33333222222 444455555544 3333333332 122333333333 33444444444
Q ss_pred CcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEcc
Q 043900 396 LTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQ 475 (953)
Q Consensus 396 L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 475 (953)
|. .|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+-.+..|+.+-.+
T Consensus 437 Lt-------------------------~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas 489 (565)
T KOG0472|consen 437 LT-------------------------FLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLAS 489 (565)
T ss_pred ce-------------------------eeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhc
Confidence 44 4555555554 57777778888888888888887 788877777777877777
Q ss_pred CccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCc
Q 043900 476 GNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528 (953)
Q Consensus 476 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 528 (953)
+|++....|..+.+|.+|.+|||.+|.+. .+|..+++|++|++|++++|+|.
T Consensus 490 ~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 490 NNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 88888666666888888888888888887 77888888888888888888887
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=332.39 Aligned_cols=277 Identities=23% Similarity=0.299 Sum_probs=211.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|...+++|+|.||.||+|++..+++.||||+++... ++......+|++.++.++|+||+.++++ +...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 46888999999999999999999999999999997443 3345678899999999999999999999 4556889
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
.+|+|||+. +|...++. ....++..++..++.++++|++|||++ .|+||||||.|+|++.+|.+||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd---------~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKD---------KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEeccc-cHHHHhcc---------cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEee
Confidence 999999954 99999963 345799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+|+.+..... ...+.+-|.+|+|||.+.|. .|+...||||.|||+.||+-|.+-|.+..+-++ +....+..-.
T Consensus 144 DFGLAr~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-L~~If~~LGT 220 (318)
T KOG0659|consen 144 DFGLARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-LSKIFRALGT 220 (318)
T ss_pred cccchhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-HHHHHHHcCC
Confidence 9999998864433 33344789999999998886 699999999999999999999887765332221 1222222111
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.....+-+-.-.+++.++.. .+.+... ..-..++....+++..|+..||.+|+|++|++++
T Consensus 221 P~~~~WP~~~~lpdY~~~~~---~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 221 PTPDQWPEMTSLPDYVKIQQ---FPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCcccCccccccccHHHHhc---CCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11222222222233333221 0111111 0112344567999999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=372.50 Aligned_cols=267 Identities=27% Similarity=0.413 Sum_probs=211.7
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+.+...+...+.+.||+|.||+||+|.|.+ .||||+++... ++..+.|.+|+.++++-+|.||+-+.|||...
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-- 460 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-- 460 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--
Confidence 333445556788999999999999999987 49999997543 44678999999999999999999999997543
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
. ..||+.+|+|-+|+.+++... ..+...+.+.||+|||+||.|||.+ +|||||||..||++.++
T Consensus 461 ---~-~AIiTqwCeGsSLY~hlHv~e---------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~ 524 (678)
T KOG0193|consen 461 ---P-LAIITQWCEGSSLYTHLHVQE---------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHED 524 (678)
T ss_pred ---c-eeeeehhccCchhhhhccchh---------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccC
Confidence 3 499999999999999998433 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
++|||+|||++..-..-..........|...|||||++..+ +|++.+||||||+|+|||+||..||... ..+..+-
T Consensus 525 ~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIif 603 (678)
T KOG0193|consen 525 LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIF 603 (678)
T ss_pred CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEE
Confidence 99999999999764332222233344588999999998654 7999999999999999999999999732 1111100
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
..-+.....+ .......|+.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 604 mVGrG~l~pd---------------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 MVGRGYLMPD---------------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EecccccCcc---------------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0000000000 0112236778999999999999999999999999999988765
Q ss_pred h
Q 043900 940 L 940 (953)
Q Consensus 940 ~ 940 (953)
.
T Consensus 657 ~ 657 (678)
T KOG0193|consen 657 L 657 (678)
T ss_pred c
Confidence 4
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=383.15 Aligned_cols=271 Identities=24% Similarity=0.420 Sum_probs=224.1
Q ss_pred CCcCHHHHHHhhcC---------CcccCcccccceeeEEEEEEcCCC---eEEEEEEeecc-chhhHHHHHHHHHHHhhc
Q 043900 619 PNISYQNLYNATDG---------FASANEIGVGSFGSVYKGILDQGK---TTVAVKVFNLL-HHGAFKSFIAECNTLKNI 685 (953)
Q Consensus 619 ~~~~~~~~~~~~~~---------~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l 685 (953)
..++|+|--.+... ..+.++||.|.||+||+|+.+..+ ..||||.++.. .++...+|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 34566665444433 357789999999999999996543 46999999854 455678999999999999
Q ss_pred CCCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCC
Q 043900 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQP 765 (953)
Q Consensus 686 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 765 (953)
+||||+++.|+. .....++||+|||++|+|+.|++.+.+ .+++.+...+.++||.||+||.++
T Consensus 688 dHPNIIrLEGVV-----Tks~PvMIiTEyMENGsLDsFLR~~DG---------qftviQLVgMLrGIAsGMkYLsdm--- 750 (996)
T KOG0196|consen 688 DHPNIIRLEGVV-----TKSKPVMIITEYMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIASGMKYLSDM--- 750 (996)
T ss_pred CCCcEEEEEEEE-----ecCceeEEEhhhhhCCcHHHHHhhcCC---------ceEeehHHHHHHHHHHHhHHHhhc---
Confidence 999999999994 455889999999999999999975543 589999999999999999999999
Q ss_pred CeEeecCCCCCeEecCCCcEEEeccccceecCCCC-CcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-
Q 043900 766 PITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT- 843 (953)
Q Consensus 766 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt- 843 (953)
++|||||.++||||+.+..+|++|||+++.+.++. .........-+.+|.|||.+..++++.+|||||||+||||.++
T Consensus 751 ~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSy 830 (996)
T KOG0196|consen 751 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 830 (996)
T ss_pred CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEeccc
Confidence 99999999999999999999999999999886544 2223333445689999999999999999999999999999998
Q ss_pred CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCC
Q 043900 844 RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDR 923 (953)
Q Consensus 844 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 923 (953)
|..||.++...+.. ..+ ....|.+.+++|+.++.+||..||++|-.+|
T Consensus 831 GERPYWdmSNQdVI--------------kaI------------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~R 878 (996)
T KOG0196|consen 831 GERPYWDMSNQDVI--------------KAI------------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRR 878 (996)
T ss_pred CCCcccccchHHHH--------------HHH------------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcC
Confidence 99999876543211 111 1123445566899999999999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 043900 924 MNMTNVVRQLQSIKN 938 (953)
Q Consensus 924 Pt~~evl~~L~~i~~ 938 (953)
|++.||+..|+++..
T Consensus 879 P~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 879 PKFAQIVSTLDKLIR 893 (996)
T ss_pred CCHHHHHHHHHHHhc
Confidence 999999999998754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=364.27 Aligned_cols=276 Identities=22% Similarity=0.255 Sum_probs=209.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|.+.++||.|.||+||+|+...++..||||.++..-.. +.-.-.+|++.+++++ ||||+++.+++. +++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~-----d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR-----DND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh-----ccC
Confidence 346799999999999999999999999999999999743322 1223468999999998 999999999853 334
Q ss_pred -ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 707 -FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 707 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
..++|||||+ .+|.+.++.+ .+.+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+
T Consensus 83 ~~L~fVfE~Md-~NLYqLmK~R---------~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~i 149 (538)
T KOG0661|consen 83 RILYFVFEFMD-CNLYQLMKDR---------NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVI 149 (538)
T ss_pred ceEeeeHHhhh-hhHHHHHhhc---------CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEeccccee
Confidence 8999999994 5999999743 34799999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+|+.+... ...+.++.|.+|+|||++. .+-|+.+.||||+|||++|+++-++.|.+..+-|..+.-..-.
T Consensus 150 KiaDFGLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL 226 (538)
T KOG0661|consen 150 KIADFGLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL 226 (538)
T ss_pred EecccccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence 99999999987543 3445677999999999865 4678999999999999999999999998865554332222111
Q ss_pred hCCch--hhh--hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDH--VVD--IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~--~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..|.. +.+ -+...+ .....+..+.....-...++.+..+++.+|++|||++||||+|.++.
T Consensus 227 GtP~~~~~~eg~~La~~m-------nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 227 GTPDKDSWPEGYNLASAM-------NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCccccchhHHHHHHHh-------ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111 000 000000 00000000001111112366788999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=358.13 Aligned_cols=278 Identities=23% Similarity=0.261 Sum_probs=211.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+.|+.+++||+|.||.||+|++..+++.||+|+++... ++......+|+.+|++++||||+++.+...+. ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 345777899999999999999999999999999997543 55567778999999999999999999986533 3468
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+|+|||+. ||..++... ...+++.++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||
T Consensus 193 iYlVFeYMdh-DL~GLl~~p---------~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSP---------GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEEEEecccc-hhhhhhcCC---------CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEe
Confidence 9999999976 888888532 33699999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+|+++...... ..+..+.|.+|+|||.+.|. .|+.+.|+||.|||+.||++|++.|.+..+-+ ..+.+....
T Consensus 260 aDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklc 336 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLC 336 (560)
T ss_pred ccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHh
Confidence 999999988654332 35667799999999998886 69999999999999999999999998643322 222222211
Q ss_pred --Cch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 --PDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 --~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
|.+ .+... .+. .... ++..........+.....+....+++..+|..||.+|.||.++++
T Consensus 337 GSP~e~~W~~~--kLP-~~~~--~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVS--KLP-HATI--FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccc--cCC-cccc--cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 11111 111 0000 000000001111112345667889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=355.61 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=204.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
..+|...+.||+|+||+||++...+++...|||.+........+.+.+|+.+|.+++|||||+++|..... ....++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeE
Confidence 34578889999999999999999988889999999755433367789999999999999999999963221 113689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-CCcEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 788 (953)
+.|||+++|+|.+++.... . .+++..+..+++||++||+|||++ |||||||||+|||++. ++.+||+
T Consensus 93 i~mEy~~~GsL~~~~~~~g--------~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG--------G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeeccCCCcHHHHHHHcC--------C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence 9999999999999996332 1 589999999999999999999999 9999999999999999 7999999
Q ss_pred ccccceecCC-CCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 789 DFGLARFLPL-SPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 789 DfG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|||.++.... ...........||+.|||||++.++ ...+++||||+||++.||+||+.||....... ........
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~~ig~ 237 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALLLIGR 237 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHHHHhc
Confidence 9999987653 1122333456799999999999853 34469999999999999999999998631110 11111110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
..... ..+...+.+..+++.+|++.||++||||+|+++.--
T Consensus 238 ~~~~P---------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 238 EDSLP---------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred cCCCC---------------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 00000 011134567889999999999999999999998643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=347.95 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=208.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.+.|+..++||.|..++||+|+....++.||||++..... ...+.+.+|+..|+.++||||++++..|. .+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----eccee
Confidence 4579999999999999999999998889999999974332 23688999999999999999999998754 44889
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
|+||+||.+|++.+.++.... ..+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~--------~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYP--------DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEeehhhcCCcHHHHHHHHcc--------ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence 999999999999999975443 3699999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCC-cccc-cccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 789 DFGLARFLPLSPA-QTSS-IDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 789 DfG~a~~~~~~~~-~~~~-~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
|||.+..+..... .... ...+||++|||||++... .|+.|+||||||++..|+.+|..||..+....+.+......
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999876644331 1111 445799999999995543 69999999999999999999999998654433222221111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. +...... ...++.......+.+++..|+++||.+||||+++++
T Consensus 249 p-p~~~t~~----------------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 P-PTLLTSG----------------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred C-CCccccc----------------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0000000 011122234457999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.47 Aligned_cols=202 Identities=30% Similarity=0.396 Sum_probs=180.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|++.++||+|+||.||.++.+++++.+|+|+++.. .....+...+|..++.+++||.||+++.. |++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 456799999999999999999999999999999999632 33456778899999999999999999876 7788
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..|+|+||+.||.|..++++ .+.+++..+.-++.+|+.||.|||+. |||||||||+|||+|.+|.+
T Consensus 98 ~kLylVld~~~GGeLf~hL~~----------eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQR----------EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred CeEEEEEeccCCccHHHHHHh----------cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence 999999999999999999952 34789999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
+|+|||+++..-.. .......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||..
T Consensus 165 ~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred EEeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 99999999854322 2233346899999999999999999999999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.87 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=208.2
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.....+|..++.||+|+|++||+|+.+.+++.||||++.. ..+...+.+..|-++|.++ .||.|++++-. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 3445679999999999999999999999999999999853 2233345677888999999 89999999977 6
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
++....|+|+||+++|+|.+++++. +.+++...+-+|.+|+.|++|||++ |||||||||+|||+|+|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~----------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d 210 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKY----------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD 210 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHh----------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC
Confidence 7778999999999999999999743 3689999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCc---------ccc--cccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 783 MMAHVSDFGLARFLPLSPAQ---------TSS--IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
+++||+|||.|+.+++.... ... ...+||..|.+||++.+...++++|+|||||++|+|+.|.+||...
T Consensus 211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 99999999999988643221 111 4477999999999999999999999999999999999999999753
Q ss_pred ccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 852 FEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+- ..+ +.+++- .++.+...++...+|+.+.+..||.+|+|++||.+
T Consensus 291 Ney----liF---------qkI~~l--------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 291 NEY----LIF---------QKIQAL--------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred cHH----HHH---------HHHHHh--------------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 221 111 111110 01111133456889999999999999999988876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.78 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=209.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
..|...++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||.+++.|. ..++.|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEE
Confidence 34677789999999999999999999999999998777767778899999999999999999998853 3488999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
|||||+||+|.+.+. ...+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+||
T Consensus 348 VMEym~ggsLTDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVT-----------KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEeecCCCchhhhhh-----------cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeee
Confidence 999999999999994 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|++..+.... ......+||++|||||+.....|+++.||||||++++||+.|.+||-. + ..+.........
T Consensus 414 GFcaqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E-~PlrAlyLIa~n--- 484 (550)
T KOG0578|consen 414 GFCAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---E-NPLRALYLIATN--- 484 (550)
T ss_pred eeeecccccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---C-ChHHHHHHHhhc---
Confidence 9998875433 344567899999999999999999999999999999999999999853 1 111111110000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......+...+.++.+++.+|++.||++||+|.|+++
T Consensus 485 -----------------------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 485 -----------------------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -----------------------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 00111223356778999999999999999999999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=389.38 Aligned_cols=271 Identities=25% Similarity=0.395 Sum_probs=223.0
Q ss_pred CcccCcccccceeeEEEEEEcCCC-----eEEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 633 FASANEIGVGSFGSVYKGILDQGK-----TTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
....+.||+|+||.||.|+..+.. ..||+|.++. .+.+...+|.+|..+|++++|||||+++|+|.. ..
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~~ 768 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----SG 768 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----CC
Confidence 345678999999999999986543 2499999864 456677899999999999999999999999864 37
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..+|++|||++|||..|++..+.... ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~---~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPF---QPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccC---CCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 78999999999999999986654322 256799999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+|+.+...+.........-+..|||||.+.++.++.|+|||||||++||++| |..||......+. ..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~----- 915 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LL----- 915 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HH-----
Confidence 999999996644444433333345679999999999999999999999999999999 9999976322211 00
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccccc
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHRI 945 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 945 (953)
.+ ..+.|.+.+..|++.++++|..||+.+|++||++..+++.+..+.....+...
T Consensus 916 ------~~-------------------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 916 ------DV-------------------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred ------HH-------------------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 00 01123445557899999999999999999999999999999999988877654
Q ss_pred c
Q 043900 946 V 946 (953)
Q Consensus 946 ~ 946 (953)
.
T Consensus 971 ~ 971 (1025)
T KOG1095|consen 971 G 971 (1025)
T ss_pred c
Confidence 3
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=363.73 Aligned_cols=388 Identities=21% Similarity=0.218 Sum_probs=222.7
Q ss_pred ceeecCCCccCcCCCccCCCC--CCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRL--QRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
..||++++.+..+....+.++ ..-++|||++|.+....+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 556666666665433334333 23344666666666555555666666666666666666 555544444556666666
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
+|.|+..-.++++.++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+......|.++.+|..|.|+.|+|+
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit--- 210 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT--- 210 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc---
Confidence 66666554555666666666666666666444455555556666666666666444555555555555555555555
Q ss_pred ccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccc
Q 043900 189 PLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLC 268 (953)
Q Consensus 189 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~ 268 (953)
...+..|.+|++|+.|+|..|++.... .
T Consensus 211 ----------------------tLp~r~Fk~L~~L~~LdLnrN~irive-~----------------------------- 238 (873)
T KOG4194|consen 211 ----------------------TLPQRSFKRLPKLESLDLNRNRIRIVE-G----------------------------- 238 (873)
T ss_pred ----------------------ccCHHHhhhcchhhhhhccccceeeeh-h-----------------------------
Confidence 334444555555555555555544110 0
Q ss_pred cccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCC
Q 043900 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQN 348 (953)
Q Consensus 269 ~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 348 (953)
-.|..+ ++|+.|.|..|.|+.....+|..+.++++|+|+.|+++..-.+++-+++.
T Consensus 239 -----------------------ltFqgL-~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~ 294 (873)
T KOG4194|consen 239 -----------------------LTFQGL-PSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTS 294 (873)
T ss_pred -----------------------hhhcCc-hhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccch
Confidence 001111 35666666666666666677777888888888888887777777788888
Q ss_pred CCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccC
Q 043900 349 LRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSR 428 (953)
Q Consensus 349 L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~ 428 (953)
|+.|+||+|.|..+. ++++...++|++|+|++|+|+ .++++-+.....+++|+|+.
T Consensus 295 L~~L~lS~NaI~rih-----------------------~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~ 350 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIH-----------------------IDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSH 350 (873)
T ss_pred hhhhccchhhhheee-----------------------cchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccc
Confidence 888888777776533 344444445555555555554 33333333333444555555
Q ss_pred CcccCCCCccccCCCccceeeecCCcccccCCC---CccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccc
Q 043900 429 NQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPS---TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505 (953)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (953)
|.|+..-..+|.++++|+.|||++|.|+..+.+ .|.+|++|+.|+|.+|+|..+.-.+|.++..|+.|||.+|.|..
T Consensus 351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee
Confidence 555544455555666666666666666544432 34556666666666666664444556666666666666666665
Q ss_pred cCCccccccccCceEecc
Q 043900 506 KIPEFLVGFQLLENLNLS 523 (953)
Q Consensus 506 ~~p~~~~~l~~L~~l~l~ 523 (953)
.-|++|..| .|+.|-++
T Consensus 431 Iq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 431 IQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecccccccc-hhhhhhhc
Confidence 556666655 55555443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=338.21 Aligned_cols=291 Identities=21% Similarity=0.236 Sum_probs=218.7
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEee--ccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+.+.....|...+.||+|+||.|+.|.+..+++.||+|++. ....-..++..+|+++++.++|+||+.+.+++.....
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 34455667777899999999999999999999999999996 4455567888999999999999999999999766445
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
..-..+|+|+|+| +.+|...++. ...++...+.-+.+|+++||+|+|+. +|+|||+||+|++++.+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~----------~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKS----------QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD 161 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHc----------CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC
Confidence 5567899999999 6699999962 23489999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
...||+|||+|+...........+..+.|.+|+|||++. ...|+.+.||||.||++.||++|++.|.+...-+ ....
T Consensus 162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~--Ql~l 239 (359)
T KOG0660|consen 162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH--QLQL 239 (359)
T ss_pred CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH--HHHH
Confidence 999999999999886544455667788999999999854 4589999999999999999999999998632221 1111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccc-hhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQ-RQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.....+..-.+.+. .+............. .++...........+...+++.+|+..||.+|+|++|.++.
T Consensus 240 I~~~lGtP~~e~l~-~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 240 ILELLGTPSEEDLQ-KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhcCCCCHHHHH-HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 22222111111110 000000000111111 11111111122445678899999999999999999999873
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.23 Aligned_cols=281 Identities=22% Similarity=0.282 Sum_probs=210.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+.|+..++|++|.||.||+|+++.+++.||+|+++...+ +-.-...+|+.++.+.+|||||.+-.+.++. +-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence 4568889999999999999999999999999999975432 2234568999999999999999999997754 3356
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+|||||+. ||...+.... .++...++..++.|+++|++|||.+ .|+|||||++|+|++..|.+||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~---------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMK---------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhcc---------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEe
Confidence 9999999966 8988886443 3689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+|+.++.. ....+..+.|.+|+|||.+.|. .|+.+.|+||+|||+.|++++++.|.+..+-++...-+.....
T Consensus 219 aDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 219 ADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred cccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 999999988543 3445667789999999998876 6999999999999999999999999875544432222222222
Q ss_pred Cch--hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
|.+ +..+..-..... ..+..+. ...-..++... ...+.-++++...+..||++|.||+|.++
T Consensus 297 Pte~iwpg~~~lp~~k~-~~f~~~p-yn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKK-MTFSEHP-YNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccCCCccccchhhc-cccCCCC-chhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence 221 111110000000 0000000 00000111111 13456778999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=362.68 Aligned_cols=271 Identities=24% Similarity=0.353 Sum_probs=207.3
Q ss_pred hcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.++||+|+||.||+|.+. ..++.||+|+++... ....+.+.+|+.+++++ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 457999999999999999999852 234579999997432 33456789999999999 89999999998742
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCc--------------------------------------------------
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDK-------------------------------------------------- 732 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 732 (953)
.+...++||||+++|+|.+++........
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 33568999999999999999864321100
Q ss_pred --ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCccccccccc
Q 043900 733 --TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810 (953)
Q Consensus 733 --~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~g 810 (953)
.......+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 001124588999999999999999999999 999999999999999999999999999986543322222233446
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcc
Q 043900 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHG 889 (953)
Q Consensus 811 t~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 889 (953)
+..|+|||++.+..++.++|||||||++|||++ |..||......+ ...... .+....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~-----------~~~~~~---------- 296 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRL-----------KDGTRM---------- 296 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHH-----------hcCCCC----------
Confidence 788999999999999999999999999999997 999997532211 010000 000000
Q ss_pred cchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 890 NQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..+..+++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 297 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 297 ---------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0001234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=347.31 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=206.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
...|+..+.||+|+||.||+|.+..+++.||+|++... .....++.++|+.++..++++||.++++.+ -.+...
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccH
Confidence 34577789999999999999999999999999999843 345578899999999999999999999984 445789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
+++||||.||++.+.++. ...+.+.++.-|++++..|+.|||.+ +.+|||||+.||++..+|.||++
T Consensus 87 wiiMey~~gGsv~~lL~~----------~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS----------GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred HHHHHHhcCcchhhhhcc----------CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEE
Confidence 999999999999999963 22347777888999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+..+... .......+||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+......
T Consensus 154 DfgVa~ql~~~--~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------------- 217 (467)
T KOG0201|consen 154 DFGVAGQLTNT--VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------------- 217 (467)
T ss_pred ecceeeeeech--hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------------
Confidence 99999877533 23335678999999999999989999999999999999999999999764331
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.-.+.+.-.+ ..+. .+.+.+.+++..|+.+||+.||+|.++++
T Consensus 218 rvlflIpk~~PP----------------~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 218 RVLFLIPKSAPP----------------RLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred eEEEeccCCCCC----------------cccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111111111111 1111 45677999999999999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.43 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=207.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+. .+++.+.+.+|++++++++||||+.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 4688899999999999999999999999999999643 34456789999999999999999999998 5566899
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
|+|+||+.| +|..++. ....+++..+..|+.|++.||.|||+. +|.|||+||.|||++.++.+|++
T Consensus 77 ~vVte~a~g-~L~~il~----------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE----------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeec
Confidence 999999976 9999995 345799999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||+|+.+.. .....+...|||.|||||...+++|+..+|+||+||++||+++|++||... .+.+.++....+
T Consensus 143 dFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d 215 (808)
T KOG0597|consen 143 DFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD 215 (808)
T ss_pred hhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC
Confidence 9999997643 333445567999999999999999999999999999999999999999631 112222222111
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+. .+......+..++...+.+||..|.|..+++.
T Consensus 216 ~v~----------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 PVK----------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCC----------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 100 01134566889999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.39 Aligned_cols=283 Identities=26% Similarity=0.330 Sum_probs=210.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc--CCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
......+.||+|.||.||+|...+ +.||||++.. ...+.|.+|-++.+.. +|+||++++++-...+.. ..++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC--ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 344567889999999999999977 5899999964 3456777777776654 899999999884333222 4578
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC------CCCCeEeecCCCCCeEecCC
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD------CQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~ 782 (953)
++|+||.+.|+|.+|++ ...++|....+|+.-+++||+|||+. .+++|+|||||++||||..|
T Consensus 284 wLVt~fh~kGsL~dyL~-----------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK-----------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred eEEeeeccCCcHHHHHH-----------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 99999999999999996 34689999999999999999999976 46889999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCC--cccC
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE------VSINGDVYSYGILLLELVTRKKPVDS--MFEG 854 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slG~vl~elltg~~pf~~--~~~~ 854 (953)
+++.|+|||+|..+............+||.+|||||++.+.. .-.+.||||+|.|+||++++..-++. ..+-
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999999987766666666688999999999988753 22468999999999999997655431 1111
Q ss_pred CccHHHHHHhh-CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 855 DMNLHNFARMA-LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 855 ~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
...+..-+... .-+++++. .++...++.-............+.+.+..||..||+.|.|+.=|.+++
T Consensus 433 qlpfe~evG~hPt~e~mq~~------------VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQEL------------VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred cCchhHHhcCCCCHHHHHHH------------HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 22222111111 00111111 111111111111222224456789999999999999999999999999
Q ss_pred HHHHHHhcc
Q 043900 934 QSIKNILLG 942 (953)
Q Consensus 934 ~~i~~~~~~ 942 (953)
.++...-+.
T Consensus 501 ~~l~~~~~~ 509 (534)
T KOG3653|consen 501 AELMMLWED 509 (534)
T ss_pred HHHhccCCc
Confidence 998776543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.94 Aligned_cols=271 Identities=18% Similarity=0.255 Sum_probs=217.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.+|+|||+-||.++.-.+++.||+|++.....+..+..++|++..++++|||++++++++.....+.....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46899999999999999999999888889999999877777888999999999999999999999998665455567799
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
++++|+..|+|.+.+.....+ +..+++.++++|+.+|++||++||+. .++++||||||.||++.+++.+++.|
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k------g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK------GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred EEeehhccccHHHHHHHHhhc------CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 999999999999999755433 34799999999999999999999998 44599999999999999999999999
Q ss_pred cccceecCCCCCc-------ccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 790 FGLARFLPLSPAQ-------TSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 790 fG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
||.++..+..-.. ........|..|+|||.+. +...++++|||||||++|+|+.|..||+........+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9999765321111 1112234789999999764 55678999999999999999999999986433221111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
- .+... +..++.....++.+.+++.+|++.||.+||++.|++..++.+
T Consensus 253 L-----------Av~n~------------------q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 L-----------AVQNA------------------QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred E-----------eeecc------------------ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0 00000 001111112567799999999999999999999999988765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.76 Aligned_cols=244 Identities=23% Similarity=0.382 Sum_probs=201.1
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
...+.+|.|+.|.||+|+.++. .||||+++... ..+++-|++++||||+.+.|+|... ..+|||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~ne--tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHNE--TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhhhccCcccceeeeeccCc--eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 3467899999999999999874 69999875322 3478889999999999999998654 77999999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
||+.|-|.++++ ..+.++......|..+||.||.|||.+ .|||||||+-||||+.+..|||+|||-+
T Consensus 193 fCa~GqL~~VLk----------a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 193 FCAQGQLYEVLK----------AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ccccccHHHHHh----------ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence 999999999996 344688888999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (953)
+..... .......||..|||||++...+.++|+||||||||||||+||..||.+...... ++..-...
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGVGsNs---- 327 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGVGSNS---- 327 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEeccCCc----
Confidence 876432 334456799999999999999999999999999999999999999976422211 00000000
Q ss_pred ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 874 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
....-+..|++.+.-+++.||+..|..||++.+++..|+-...
T Consensus 328 ----------------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 328 ----------------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ----------------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 0111233788889999999999999999999999998876543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.22 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=211.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
...+.++||+|-||+|..++... ...||||+++..... ...+|.+|+++|.+++||||++++|+|... +..++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePicm 612 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLCM 612 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchHH
Confidence 45677899999999999999877 458999999865444 458999999999999999999999999643 77999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
|+|||++|+|.+|+..+... ...-....+|+.||+.||+||.+. ++||||+.++|+|++.++++||+||
T Consensus 613 I~EYmEnGDLnqFl~aheap--------t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELP--------TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred HHHHHhcCcHHHHHHhccCc--------ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCc
Confidence 99999999999999755332 134445567999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|+++-+-.++........+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....+++. .+
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ve-------- 751 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VE-------- 751 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HH--------
Confidence 99997766666666666677899999999999999999999999999999987 7788876433321 11
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
...++.+..- +..-...+.-|+.+++++|.+||..|-++||+++++...|.+.
T Consensus 752 n~~~~~~~~~---------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 752 NAGEFFRDQG---------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhhcCCCC---------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111100 0011122335788899999999999999999999999988764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.59 Aligned_cols=287 Identities=23% Similarity=0.292 Sum_probs=208.1
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
.|...+++|.|+||.||+|....+.+.||||+.-.... .-.+|+++|++++|||||++.-+|......+.-...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46778999999999999999999988999999853322 23479999999999999999988765533323456799
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-CcEEEecc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDF 790 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Df 790 (953)
||||+. +|.++++.... ....++...+.-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+|||||
T Consensus 101 leymP~-tL~~~~r~~~~------~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR------ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHhchH-HHHHHHHHHhh------cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence 999976 99999864322 245688888999999999999999998 99999999999999965 89999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.|+....+... .....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.+....+ .+...+.. +...
T Consensus 171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~eIik~-lG~P 245 (364)
T KOG0658|consen 171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVEIIKV-LGTP 245 (364)
T ss_pred CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHHHHHH-hCCC
Confidence 999988654433 445689999999998886 69999999999999999999999998732222 22222222 2222
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSIKNI 939 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~ 939 (953)
..+.+..+-.. ..+.....-......+ -.....+++..+++.++++++|.+|.++.|++.. +.++++.
T Consensus 246 t~e~I~~mn~~-y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 246 TREDIKSMNPN-YTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CHHHHhhcCcc-cccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 12212111111 0000000000000000 0122456788999999999999999999999863 5555443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.75 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=206.6
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc----ch-hhHHHHHHHHHHHhhcC-CCCeeEEEeeecccc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL----HH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVD 701 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 701 (953)
.....|.+.+.||+|+||.|+.|.+..+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 3456899999999999999999999998899999977542 11 33456778999999998 999999999954
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
.....++||||+.+|+|.+++.. ...+.+.++..++.|++.|++|+|++ ||+||||||+|||++.
T Consensus 91 --t~~~~~ivmEy~~gGdL~~~i~~----------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 91 --TPTKIYIVMEYCSGGDLFDYIVN----------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG 155 (370)
T ss_pred --cCCeEEEEEEecCCccHHHHHHH----------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence 34669999999999999999963 34688899999999999999999999 9999999999999999
Q ss_pred C-CcEEEeccccceecCCCCCcccccccccccccccccccCCCC-CC-cccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 782 E-MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VS-INGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 782 ~-~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+ +.+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++. ..
T Consensus 156 ~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~ 228 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NV 228 (370)
T ss_pred CCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cH
Confidence 9 999999999999764 2233445567999999999999987 86 7899999999999999999999861 11
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHH-HHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIEC-LVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
....+..... .+..+..+ ++++..++.+|+..||.+|+|+.|++ .-.-++
T Consensus 229 ~~l~~ki~~~----------------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 229 PNLYRKIRKG----------------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred HHHHHHHhcC----------------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 1111110000 00011122 55688999999999999999999999 444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.91 Aligned_cols=390 Identities=24% Similarity=0.241 Sum_probs=283.4
Q ss_pred EEEEEeCCCeeeeecCc-cccCC--ccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEe
Q 043900 6 VKILNLTSLKLAGSISP-HVGNL--SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIR 82 (953)
Q Consensus 6 ~~~l~l~~~~~~~~~~~-~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ 82 (953)
...||.+..++. .+.. .+..+ ..-+.|++++|+++.+.+..|.++++|++++|.+|.++ .+|.......+|+.|+
T Consensus 54 ~~lldcs~~~le-a~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 54 TRLLDCSDRELE-AIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred ceeeecCccccc-cccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 456788887775 3211 22222 24577999999999999999999999999999999999 9999888888999999
Q ss_pred ccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC
Q 043900 83 LFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (953)
|.+|.|+.+-.+++.-++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+....+.|.++.+|.+|.|++|+|+.
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 99999998888899999999999999999996555688888899999999999999999999999999999999999995
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCC
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~ 242 (953)
..+..|.++++|+.|||..|+|.-+....| .+|++|+.|.|..|.|.......|-.|.++++|+|+.|+++..-..+
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltF-qgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~-- 288 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTF-QGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW-- 288 (873)
T ss_pred cCHHHhhhcchhhhhhccccceeeehhhhh-cCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc--
Confidence 445567779999999999999984334444 48999999999999999888889999999999999999998654321
Q ss_pred CCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCC
Q 043900 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKF 322 (953)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l 322 (953)
++++ ++|+.|+|++|.|..+.++++...
T Consensus 289 ---------------------------------------------------lfgL-t~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 289 ---------------------------------------------------LFGL-TSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred ---------------------------------------------------cccc-chhhhhccchhhhheeecchhhhc
Confidence 2222 345555555555555555555555
Q ss_pred CCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcC
Q 043900 323 VNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLS 402 (953)
Q Consensus 323 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 402 (953)
++|+.|+|++|+|+...+++|..+..|++|+|++|+|... ...+|..+++|+.|||+
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l-----------------------~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHL-----------------------AEGAFVGLSSLHKLDLR 373 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHH-----------------------HhhHHHHhhhhhhhcCc
Confidence 5555666666665555555555555555555555555421 12233333444444444
Q ss_pred CCccCCCCCcc--ccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccC
Q 043900 403 DNNLTGTIPPQ--FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQG 476 (953)
Q Consensus 403 ~N~l~~~~p~~--~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 476 (953)
+|.|+..+.+. .+.....++.|+|.+|+|..+...+|.++.+|+.|||.+|.|..+-|.+|..+ .|++|.+..
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 44443333221 11112233344444444444444577777888888888888877777778777 777776543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.80 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=209.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC---eE-EEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK---TT-VAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
.++....++||+|+||.||+|+.+..+ .. ||||..+. .......++++|+++|++++|||||+++|++..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--- 232 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--- 232 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC---
Confidence 334455689999999999999987542 23 89999974 446678899999999999999999999999654
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
....++|||+|+||+|.++++.... .++..++..++.++|.||+|||++ +++||||.++|+|++.+
T Consensus 233 --~~Pl~ivmEl~~gGsL~~~L~k~~~---------~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 233 --EEPLMLVMELCNGGSLDDYLKKNKK---------SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK 298 (474)
T ss_pred --CCccEEEEEecCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC
Confidence 3789999999999999999974432 489999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+++.-. ..........-+..|+|||.+....|++++|||||||++||+++ |..||.+....+ ...+
T Consensus 299 ~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~k 374 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAK 374 (474)
T ss_pred CeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHH
Confidence 999999999997542 11111112246789999999999999999999999999999999 889998643321 1111
Q ss_pred H-HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 862 A-RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 862 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
+ .... +...+...+.++..++.+||..||++||||.++.+.++.+....
T Consensus 375 I~~~~~------------------------------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 375 IVKNGY------------------------------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHhcCc------------------------------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1 1000 11111134667889999999999999999999999999998765
Q ss_pred c
Q 043900 941 L 941 (953)
Q Consensus 941 ~ 941 (953)
.
T Consensus 425 ~ 425 (474)
T KOG0194|consen 425 E 425 (474)
T ss_pred c
Confidence 5
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.65 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=214.6
Q ss_pred cccCcccccceeeEEEEEEcCC----CeEEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 634 ASANEIGVGSFGSVYKGILDQG----KTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
...+.||+|.||.||+|.+.+- .-.||||..+. ...+..+.|..|+.+|+.++||||++++|+|.+ ...
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cce
Confidence 3457899999999999998433 34599999875 445567889999999999999999999999864 568
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
|||||.++.|.|..|++... ..++......++.||+.||+|||+. .+|||||..+||||.....|||+
T Consensus 466 WivmEL~~~GELr~yLq~nk---------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK---------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eEEEecccchhHHHHHHhcc---------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 99999999999999997544 3588899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++.+..+..... ....-++.|||||.+.-++++.+||||-|||++||+++ |..||.+....|...
T Consensus 534 DFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------- 603 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------- 603 (974)
T ss_pred ccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE---------
Confidence 9999998865544333 34456789999999999999999999999999999999 999998765543211
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
....+.|.+.+..|++.++.+|.+||++||.+||++.|+...|+++..
T Consensus 604 -----------------------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 -----------------------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----------------------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 011123444556899999999999999999999999999999999876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.32 Aligned_cols=259 Identities=23% Similarity=0.310 Sum_probs=201.2
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------------hhhHHHHHHHHHHHhhcCCCCeeEE
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------------HGAFKSFIAECNTLKNIRHRNLVKI 693 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~~ 693 (953)
...+.|++.+.||+|.||.|-+|.+..+++.||+|++.... ....+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45678999999999999999999999999999999995211 1123588999999999999999999
Q ss_pred EeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 694 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
+.+..+ ...+..|||+|||..|.+...-. ....+++.++++++++++.||+|||.+ ||||||||
T Consensus 174 iEvLDD---P~s~~~YlVley~s~G~v~w~p~----------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIK 237 (576)
T KOG0585|consen 174 IEVLDD---PESDKLYLVLEYCSKGEVKWCPP----------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIK 237 (576)
T ss_pred EEeecC---cccCceEEEEEeccCCccccCCC----------CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccc
Confidence 998543 45578999999998877654331 122389999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeccccceecCCCCCc---ccccccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCC
Q 043900 774 PSNVLLDEEMMAHVSDFGLARFLPLSPAQ---TSSIDAKGSIGYIAPEYGLGSE----VSINGDVYSYGILLLELVTRKK 846 (953)
Q Consensus 774 p~NIll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slG~vl~elltg~~ 846 (953)
|+|+|++++|+|||+|||.+.....+... ......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99999999999999999999876332111 1122356999999999987742 3577899999999999999999
Q ss_pred CCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 847 PVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 847 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
||-+.+.- . . ...++...+ .++...+..+++.+++.++|++||+.|.+.
T Consensus 318 PF~~~~~~----~-l--------~~KIvn~pL------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l 366 (576)
T KOG0585|consen 318 PFFDDFEL----E-L--------FDKIVNDPL------------------EFPENPEINEDLKDLIKRLLEKDPEQRITL 366 (576)
T ss_pred CcccchHH----H-H--------HHHHhcCcc------------------cCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence 99652211 0 0 111111111 111122455678999999999999999999
Q ss_pred HHHHHHH
Q 043900 927 TNVVRQL 933 (953)
Q Consensus 927 ~evl~~L 933 (953)
.+|....
T Consensus 367 ~~ik~Hp 373 (576)
T KOG0585|consen 367 PDIKLHP 373 (576)
T ss_pred hhheecc
Confidence 9987643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.03 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=208.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..-|+.++.||.|+-|.|-.|++..+++.+|||++... .......+.+|+-+|+-+.||||++++++ |++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 34688999999999999999999999999999999533 22334667899999999999999999999 67779
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
++|+|.||+++|-|.+++. ..+.+++.+..++++||+.|+.|+|+. +|+|||+||+|+|+|..+++|
T Consensus 86 ~lylvlEyv~gGELFdylv----------~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV----------RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eEEEEEEecCCchhHHHHH----------hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence 9999999999999999995 345799999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+|..-.++ ..-...+|+++|.|||++.|.+|. .++||||+|||+|.|+||+.||++ .++.......
T Consensus 153 IADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV 224 (786)
T KOG0588|consen 153 IADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKV 224 (786)
T ss_pred eeccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHH
Confidence 9999999864332 233345799999999999999985 889999999999999999999983 2333332222
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... .++-+..++.+..+++.+|+..||++|.|++||.+.
T Consensus 225 ~~G----------------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 QRG----------------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HcC----------------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 111 111122456778999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=337.77 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=201.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|..+..||+|+||+||+|+-++++..+|+|+++.. ..+..+.+..|-.+|...++|.||+++-. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 457899999999999999999999999999999999743 34556778899999999999999999977 6788
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..|+||||++|||+..++.. ...+++..+..++.+++-|++.+|+. |+|||||||+|+|||..|++
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~----------~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMR----------KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CeeEEEEEecCCccHHHHHHh----------cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCE
Confidence 999999999999999999952 34789999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCC---------------------CCcc-----cc-------------------ccccccccccccccc
Q 043900 786 HVSDFGLARFLPLS---------------------PAQT-----SS-------------------IDAKGSIGYIAPEYG 820 (953)
Q Consensus 786 kL~DfG~a~~~~~~---------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~ 820 (953)
||+|||++.-+... .... .. ...+|||.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 99999999543210 0000 00 123499999999999
Q ss_pred CCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhh
Q 043900 821 LGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINS 900 (953)
Q Consensus 821 ~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 900 (953)
.+..|+..+|.||+|||+|||+.|.+||......+ .+....... .. ..++.
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr--~~--------------------------l~fP~ 411 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQE-TYRKIVNWR--ET--------------------------LKFPE 411 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh--hh--------------------------ccCCC
Confidence 99999999999999999999999999997632221 111111100 00 00111
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCC---HHHHH
Q 043900 901 KIECLVAMVRIGVACSMESPGDRMN---MTNVV 930 (953)
Q Consensus 901 ~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl 930 (953)
...+.++..++|.+|+. ||+.|-. ++||.
T Consensus 412 ~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 412 EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 11344678899999998 9999975 55543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=360.19 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=213.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccc-cCC-CCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD-YQG-NDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~-~~~ 707 (953)
.++++.+.|.+|||+.||.|++..++..||+|++-..++...+...+|+++|+.|+ |+|||.++|...... ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45678899999999999999999887799999998778888899999999999996 999999999432221 222 257
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
+++.||||+||.|-+++..+... .+++.++++|+.|+++|+++||.. +++|||||||-+|||++.++..||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~--------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT--------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc--------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 88999999999999999644432 599999999999999999999986 788999999999999999999999
Q ss_pred eccccceecCCCCCcccc-------cccccccccccccc---cCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 788 SDFGLARFLPLSPAQTSS-------IDAKGSIGYIAPEY---GLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~---~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
||||.|+-.-........ ....-|+.|+|||+ ..+...++|+||||+||+||.|+....||+....-
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 999999754332211111 12237899999997 45778999999999999999999999999752111
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.+++... .++.....+..+.+||..||+.||.+||++.||++.+.++.
T Consensus 265 --------------aIlng~Y------------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 --------------AILNGNY------------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred --------------eEEeccc------------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 1111110 11111245678999999999999999999999999999887
Q ss_pred HHh
Q 043900 938 NIL 940 (953)
Q Consensus 938 ~~~ 940 (953)
..-
T Consensus 313 ~~~ 315 (738)
T KOG1989|consen 313 NKP 315 (738)
T ss_pred cCC
Confidence 543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.07 Aligned_cols=271 Identities=21% Similarity=0.341 Sum_probs=203.2
Q ss_pred cCCcccCcccccceeeEEEEEEcC----------------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ----------------GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKI 693 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~ 693 (953)
++|++.++||+|+||.||+|.+.+ ++..||+|+++... ......+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999998643 33469999987542 3345678999999999999999999
Q ss_pred EeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcc---------cCCccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 043900 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT---------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQ 764 (953)
Q Consensus 694 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 764 (953)
++++.. .+..++||||+++|+|.+++......... ......+++..+++++.||+.||+|||+.
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 999643 36789999999999999998643221111 11224578999999999999999999999
Q ss_pred CCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-
Q 043900 765 PPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT- 843 (953)
Q Consensus 765 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt- 843 (953)
+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999999986643332222233446789999999988899999999999999999997
Q ss_pred -CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCC
Q 043900 844 -RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD 922 (953)
Q Consensus 844 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 922 (953)
|..||...... .................. ...+..++..+.+++.+||+.||++
T Consensus 237 ~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 237 CKEQPYGELTDE--QVIENAGEFFRDQGRQVY-----------------------LFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred cCCCCCCcCCHH--HHHHHHHHHhhhcccccc-----------------------ccCCCCCCHHHHHHHHHHccCCchh
Confidence 55677643211 111111110000000000 0001134567899999999999999
Q ss_pred CCCHHHHHHHHH
Q 043900 923 RMNMTNVVRQLQ 934 (953)
Q Consensus 923 RPt~~evl~~L~ 934 (953)
|||++||.+.|+
T Consensus 292 RPs~~~i~~~l~ 303 (304)
T cd05096 292 RPSFSDIHAFLT 303 (304)
T ss_pred CcCHHHHHHHHh
Confidence 999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=352.56 Aligned_cols=269 Identities=23% Similarity=0.358 Sum_probs=205.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|++.. +...||+|+++.. .......+.+|+++++.+ +|+||++++++|..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence 4578999999999999999998643 3347999999743 333456788999999999 89999999999643
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcC----------------------------------------------------
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITRE---------------------------------------------------- 730 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 730 (953)
....++||||+++|+|.++++.....
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 46789999999999999998542210
Q ss_pred --------CcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCc
Q 043900 731 --------DKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802 (953)
Q Consensus 731 --------~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 802 (953)
.........+++.++++++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 00001223588999999999999999999999 9999999999999999999999999999866433222
Q ss_pred ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCC
Q 043900 803 TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSD 881 (953)
Q Consensus 803 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 881 (953)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .......... ...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~------------~~~ 335 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY------------QMS 335 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc------------Ccc
Confidence 22223345678999999999999999999999999999997 999997532211 1111111000 000
Q ss_pred chhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 882 DEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.+...++++.+++.+||+.||++|||+.||++.|+++.
T Consensus 336 ------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 ------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00012456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.82 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=198.3
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchh---hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG---AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
...||+|++|.||+|.+. ++.||||+++..... ..+.+.+|+.++++++||||+++++++.+. .......++||
T Consensus 25 ~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence 367999999999999984 468999999744322 246788999999999999999999997542 12345689999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++.....++.|++.|++|||+. .+++||||||+||++++++.+||+|||+
T Consensus 102 Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 102 EYCTRGYLREVLDK----------EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred EeCCCCcHHHHHhh----------CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccch
Confidence 99999999999963 23578999999999999999999973 1788999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~i~~~~- 238 (283)
T PHA02988 170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDLIINKN- 238 (283)
T ss_pred Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcC-
Confidence 98653221 23458899999999876 68999999999999999999999999753211 1111100000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
. +...+..+++++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 239 -------~------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 -------N------------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -------C------------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0 000011345679999999999999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=321.92 Aligned_cols=273 Identities=23% Similarity=0.376 Sum_probs=210.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc--CCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~ 706 (953)
........+.||+|.||+||+|.|++. .||||++...++ +.+.+|.++.+.+ +|+||+.+++.-... -..-.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCC--ceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceE
Confidence 445677889999999999999999876 599999965443 5667788877765 999999998772211 11124
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeecCCCCCeEecC
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD-----CQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~ 781 (953)
..++|++|.+.|||.||+.. ..++....++++.-+|.||+|||.. .+|.|+|||||+.||||..
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-----------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-----------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-----------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 68999999999999999963 3688899999999999999999965 5789999999999999999
Q ss_pred CCcEEEeccccceecCCCCC--cccccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhC---------
Q 043900 782 EMMAHVSDFGLARFLPLSPA--QTSSIDAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTR--------- 844 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slG~vl~elltg--------- 844 (953)
++.+.|+|+|+|........ .......+||.+|||||++... ..-..+||||||.|+||+..+
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999987754422 2334556799999999997653 122458999999999999874
Q ss_pred -CCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCC
Q 043900 845 -KKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDR 923 (953)
Q Consensus 845 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 923 (953)
+.||.+....|..+.++.....-+.....+ +.++ ...++...+.++|+.||..+|+.|
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i--------------------pnrW-~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI--------------------PNRW-KSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCCC--------------------Cccc-ccCHHHHHHHHHHHHhhcCCchhh
Confidence 357777666666555443332222222111 1222 223567789999999999999999
Q ss_pred CCHHHHHHHHHHHHHH
Q 043900 924 MNMTNVVRQLQSIKNI 939 (953)
Q Consensus 924 Pt~~evl~~L~~i~~~ 939 (953)
-||-.+.+.|.++.+.
T Consensus 491 ltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 491 LTALRIKKTLAKLSNS 506 (513)
T ss_pred hHHHHHHHHHHHHhcC
Confidence 9999999999998753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=341.78 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=215.9
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+....++||.|.||.||.|.|+.-.-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|... ..+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYIi 341 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYII 341 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEEE
Confidence 456678999999999999999998889999999753 34578999999999999999999999998543 678999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
+|||.+|+|.+|++++.++ .++....+.+|.||+.||+||..+ .+|||||.++|+||.++..||++|||
T Consensus 342 TEfM~yGNLLdYLRecnr~--------ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRS--------EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EecccCccHHHHHHHhchh--------hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 9999999999999877655 577778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
+++++..+. ........-++.|.|||-+.-..++.|+|||+|||++||+.| |..||.+..- .+ +
T Consensus 411 LsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----Sq---------V 475 (1157)
T KOG4278|consen 411 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ---------V 475 (1157)
T ss_pred hhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HH---------H
Confidence 999886432 223333445788999999999999999999999999999999 9999876311 11 1
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.+++. ...|++.+..|++.++++|+.||+|.|.+||++.|+.+.++.+
T Consensus 476 Y~LLE------------------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 476 YGLLE------------------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHh------------------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 12221 2234556668999999999999999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.23 Aligned_cols=287 Identities=23% Similarity=0.329 Sum_probs=211.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCC-eeEEEeeecccc-cCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRN-LVKILTACSGVD-YQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-~~~~ 705 (953)
...|...++||+|+||+||+|+.+.+++.||+|+++.... +......+|+.++++++|+| |+++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777889999999999999999999999999975433 45567789999999999999 999999976432 1223
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||++ -+|..++....... ..++...+..++.||+.||+|||++ +|+||||||.||+|+++|.+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcE
Confidence 47889999995 59999996544321 3566689999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+|+.+... ....+..++|..|+|||++.|. .|+...||||+||++.||++++..|.+..+.+....-+-..
T Consensus 160 KlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 160 KLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred eeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 99999999966422 2234566799999999999887 78999999999999999999999998755533222222111
Q ss_pred hCCch--hhhhccccccCCchhhhhcccchhhh-hh--hhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHH
Q 043900 865 ALPDH--VVDIVDSTLLSDDEDLAVHGNQRQRQ-AR--INSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSI 936 (953)
Q Consensus 865 ~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 936 (953)
..|.. +..+. ..+++. ...+.+. .+ ........+...+++.+|++.+|++|.|++.+++. +..+
T Consensus 238 GtP~e~~Wp~v~---~~~~~k-----~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 238 GTPNEKDWPGVS---SLPDYK-----APFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccCCCCcc---cccccc-----ccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 22211 11111 000110 0011111 00 00011112467899999999999999999999875 5444
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=350.75 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=204.4
Q ss_pred hcCCcccCcccccceeeEEEEEE-----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|++ .+++..||||+++... ....+.+.+|+.+++.+ +||||++++++|..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 34688999999999999999975 3445689999996432 33456788999999999 89999999999643
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcc-------------------------------------------------
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKT------------------------------------------------- 733 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------- 733 (953)
++..++||||+++|+|.++++........
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 46789999999999999998643211000
Q ss_pred ----------------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 734 ----------------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 734 ----------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
......+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 01123588999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccc
Q 043900 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876 (953)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (953)
............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+......
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~---------- 334 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGY---------- 334 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCc----------
Confidence 3322222222345678999999999999999999999999999998 888986532211 1111111000
Q ss_pred cccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 877 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
... .+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 335 --~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 --RML------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --cCC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000 0001245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=338.32 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=198.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++|++|+++.+++. .++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 3778899999999999999999888899999986432 223346788999999999999999998853 44689
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMG--------NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999988875322 22588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ..... ......
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~-~~~~~~ 219 (285)
T cd05631 145 DLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEV-DRRVKE 219 (285)
T ss_pred eCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHH-HHHhhc
Confidence 999998754322 1223468999999999999999999999999999999999999997532211 00000 000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
.. .......+.++.+++.+||+.||++||+ ++|+++
T Consensus 220 ~~---------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 DQ---------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cc---------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 0001123456889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.20 Aligned_cols=284 Identities=21% Similarity=0.214 Sum_probs=201.5
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999988889999998632 223345688999999999999999999987544333335689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELME-SDLHQVIKA----------NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecCC-CCHHHHHHh----------cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEcc
Confidence 9999995 689888842 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC-cccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~ 224 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLL 224 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHh
Confidence 999986532211 112234568999999999866 67899999999999999999999999753211 1111111111
Q ss_pred CchhhhhccccccCCchhhhhcccch-hhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQR-QRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.....+............. ...... .+..........++++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRY-LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHH-HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1000000000000000000 000000 0000000011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.53 Aligned_cols=197 Identities=25% Similarity=0.340 Sum_probs=177.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|+..+.+|.|+||.|.+++.+.++..+|+|+++.. .....+...+|..+++.+.||.++++++.| .+...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence 4678889999999999999999999999999999643 334456678899999999999999999884 55689
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++||-|..++++. +++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||
T Consensus 119 lymvmeyv~GGElFS~Lrk~----------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS----------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred EEEEEeccCCccHHHHHHhc----------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEE
Confidence 99999999999999999743 3689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
+|||+|+.... .....+|||.|+|||++....+..++|-|||||++|||+.|.+||..
T Consensus 186 tDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 186 TDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred EeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 99999997642 24456799999999999999999999999999999999999999975
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.57 Aligned_cols=283 Identities=22% Similarity=0.288 Sum_probs=199.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..++|.+.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++.++||||+++++++. .+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~ 77 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCe
Confidence 35789999999999999999999998888999999864332 23346778999999999999999999854 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 144 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKH---------PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKL 144 (303)
T ss_pred EEEEEECCC-cCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999995 6787777432 23578889999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+++...... .......+++.|+|||++.+ ..++.++||||+||++|||++|..||.+................
T Consensus 145 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 222 (303)
T cd07869 145 ADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222 (303)
T ss_pred CCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhC
Confidence 9999997543221 12233458999999998765 45788999999999999999999999764322111111111110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+...............................+..+.+++.+|++.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000000000000000000000000112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=310.54 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=203.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEee--ccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++.|++.+.||+|+|+.||++....+++.+|+|++. .......+++.+|+.+.+.++||||+++.+. +.....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 456888899999999999999999999999999985 2333467889999999999999999999987 455588
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---CCCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD---EEMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 784 (953)
.|+|+|+|.|++|..-+-. ....++..+-..++||+++|.|+|.+ +|||||+||+|+++- ..-.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~----------R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eEEEEecccchHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCc
Confidence 9999999999999776631 23578889999999999999999999 999999999999994 3347
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+|..+. ........+|||+|||||++...+|+..+||||.||++|-++.|++||.+.... ..+.+....
T Consensus 152 vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g 227 (355)
T KOG0033|consen 152 VKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAG 227 (355)
T ss_pred eeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhcc
Confidence 9999999999886 333445677999999999999999999999999999999999999999862111 111111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ++- ..+.....++..+++.+|+..||++|.|+.|.+.
T Consensus 228 ~y-----d~~-----------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 AY-----DYP-----------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cc-----CCC-----------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 00 000 0111244567889999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=338.74 Aligned_cols=279 Identities=21% Similarity=0.263 Sum_probs=202.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++. .++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 36899999999999999999999988899999997432 233567889999999999999999998853 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++++.+..+.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEE----------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence 99999999887765542 123588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh--hC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM--AL 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~ 866 (953)
|||+++....... .......|++.|+|||++.+..++.++||||+||++|||++|+.||......+. ....... ..
T Consensus 143 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~ 220 (287)
T cd07848 143 DFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPL 220 (287)
T ss_pred eccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCC
Confidence 9999987643221 122334689999999999998999999999999999999999999975322111 1111110 11
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.......... .........................+.++.+++.+|++.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 221 PAEQMKLFYSN--PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHhhhcc--chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111100000 0000000000000000000111134567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.79 Aligned_cols=277 Identities=23% Similarity=0.329 Sum_probs=200.0
Q ss_pred cCCcccCcccccceeeEEEEEEc-CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhc---CCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD-QGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~ 704 (953)
++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999985 456789999986432 22234566777777665 6999999999986544445
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||++ ++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 567899999996 68988885322 22588999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+ .+......
T Consensus 149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~ 224 (290)
T cd07862 149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 224 (290)
T ss_pred EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence 999999999876432 22234458999999999988899999999999999999999999997633221 11111111
Q ss_pred h-C--CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 A-L--PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~-~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. . +........ .. ..........+ ........+..+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~--~~----~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRDVA--LP----RQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhhhc--cc----chhccCCCCCC--HHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1 0 000000000 00 00000000000 00011134567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.51 Aligned_cols=265 Identities=25% Similarity=0.431 Sum_probs=207.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCC-----eEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGK-----TTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
++|++.+.||+|+||.||+|...... ..||+|.++... ......+.+|+..+++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 46888999999999999999986554 679999986433 334567899999999999999999999854 3
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcc------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKT------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
....+++|||+++++|.+++......... ......+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 46789999999999999999654321110 11124689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCcc
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMN 857 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~ 857 (953)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-- 234 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-- 234 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986543332223334457889999999998899999999999999999998 999987532211
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
....... ... ...+..++.++.+++.+||+.||++||+++||++.|++
T Consensus 235 ~~~~i~~-----------~~~-------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRS-----------RQL-------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc-----------CCc-------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111000 000 00112456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=333.73 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=193.7
Q ss_pred ccCcccccceeeEEEEEEc----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 635 SANEIGVGSFGSVYKGILD----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+.+.||.|+||.||+|++. ..+..|+||+++... ....+.+.+|++.+++++||||++++|+|.. .+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 4578999999999999998 445689999996533 3347889999999999999999999999862 35689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.++++... ...+++.+++.|+.||++||+|||+. +++||||+++||+++.++.+||+|
T Consensus 78 lv~e~~~~g~L~~~L~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKN--------KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEE--TTEBHHHHHHHTC--------TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccccccccc--------cccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 9999999999999997541 23689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||++....................|+|||.+.+..++.++||||||+++||+++ |+.||...... .........
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~~~~~~~~~ 221 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----EIIEKLKQG 221 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----HHHHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc
Confidence 999987733333333344557889999999999999999999999999999999 78888653111 111111000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
.. ...+..++..+.+++.+||+.||++|||++|++++|
T Consensus 222 ~~---------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QR---------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EE---------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc---------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 000112455688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.90 Aligned_cols=270 Identities=24% Similarity=0.353 Sum_probs=206.6
Q ss_pred cCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
++|++.+.||+|+||.||+|...+ +++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~---- 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK---- 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence 479999999999999999997543 23689999987432 33456778899999999 89999999998743
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCc---------------------------------------------------
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDK--------------------------------------------------- 732 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------- 732 (953)
.+...+++|||+++++|.+++........
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 34678899999999999999854321100
Q ss_pred ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCccccccccccc
Q 043900 733 TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812 (953)
Q Consensus 733 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~ 812 (953)
.......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.............++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 000123689999999999999999999999 99999999999999999999999999998764333222233344677
Q ss_pred ccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccc
Q 043900 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQ 891 (953)
Q Consensus 813 ~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 891 (953)
.|+|||++.+..++.++|||||||++|||++ |..||......+ ....... ... ..
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~~--------~~----------- 295 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLK----EGT--------RM----------- 295 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHh----ccC--------CC-----------
Confidence 8999999999999999999999999999998 999987532211 1111000 000 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 892 RQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 892 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..+...++++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 296 -------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 -------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0001234568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.97 Aligned_cols=253 Identities=20% Similarity=0.266 Sum_probs=209.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc-
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF- 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~- 707 (953)
+.|..++.+|+|+||.++.++++.+.+.||+|.+... .....+...+|+.++++++|||||.+.+.+ ..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCce
Confidence 5788999999999999999999999999999999643 233455788999999999999999999984 33455
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.+|||+|++||++.+.+.+.+ ...+++..+..|+.|++.|+.|||+. .|+|||||+.||+++.++.|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k--------~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkL 147 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK--------GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKL 147 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh--------hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceee
Confidence 999999999999999997544 24689999999999999999999998 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+...... ......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|.... ....+...
T Consensus 148 gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki-- 218 (426)
T KOG0589|consen 148 GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKI-- 218 (426)
T ss_pred cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHH--
Confidence 9999999886443 24445779999999999999999999999999999999999999987521 11111111
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
......+ .+.....++..++..|++.+|+.||++.+++.+-
T Consensus 219 ------~~~~~~P-------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 219 ------NRGLYSP-------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ------hhccCCC-------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1111100 1113456789999999999999999999999873
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.72 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=201.1
Q ss_pred cCCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.+|++.+.||+|+||.||+|.+. .....||+|+++... ......+.+|+..+++++||||+++++++. .++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence 46889999999999999999875 345689999987542 334567889999999999999999999864 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH---------EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence 899999999999999998532 13588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
++|||.+....... ........++..|+|||++.+..++.++|||||||++||+++ |..||......+ ......
T Consensus 148 l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~-- 222 (266)
T cd05064 148 ISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVE-- 222 (266)
T ss_pred ECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHH--
Confidence 99999876532211 111112335678999999999999999999999999999875 999997532211 111000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
+... ...+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 223 ---------~~~~-------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 ---------DGFR-------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---------CCCC-------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0000 000113456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=339.11 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=198.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 46889999999999999999999888899999996432 23446688999999999999999999874 44578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN----------SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEE
Confidence 9999999999999999852 23588899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 143 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i-- 210 (291)
T cd05612 143 TDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKI-- 210 (291)
T ss_pred EecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH--
Confidence 999999865321 12345899999999999999999999999999999999999999753211 111100
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVRQ 932 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 932 (953)
..... ..+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 211 ------~~~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 211 ------LAGKL--------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------HhCCc--------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00000 000012446889999999999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.66 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=174.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|++..++..||+|+++.. .......+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 46799999999999999999999998889999999754 2334567899999999999999999999864 34678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----------AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEc
Confidence 999999999999999853 23578999999999999999999985 169999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|||++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999765322 12234589999999999999999999999999999999999999965
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.51 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=213.9
Q ss_pred CcccCcccccceeeEEEEEEcCC----CeEEEEEEee-ccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 633 FASANEIGVGSFGSVYKGILDQG----KTTVAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+..++||+|+||+||+|.+--. +-+||+|++. ....+...++..|+-+|.+++|||+++++++|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 34568899999999999998433 3469999985 34455678899999999999999999999998643 3
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
..||++||+.|+|.+|++..+. .+.....+.|..|||+||.|||.+ ++|||||.++||||..-..+||
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~---------~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD---------NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc---------cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEE
Confidence 7899999999999999986443 578889999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
.|||+|+....+..........-.+.|||=|.+....|+.++|||||||++||++| |..|+++....+
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------- 908 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------- 908 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------
Confidence 99999999877666655555566789999999999999999999999999999999 999998643221
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
+.+.+. .+.|..++.-|+..++.+|.+||..|++.||+++++..++.+..+
T Consensus 909 ---I~dlle------------------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 909 ---IPDLLE------------------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---hhHHHh------------------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 111111 112334445678889999999999999999999999999988753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.87 Aligned_cols=278 Identities=23% Similarity=0.324 Sum_probs=199.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|.+.+.||+|+||.||+|....+++.||+|+++... ......+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence 357999999999999999999999888899999986432 223456789999999999999999999853 34678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNC---------GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred EEEEeCCCc-CHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence 999999974 898888532 12478899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++...... .......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ....... ...
T Consensus 146 DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~ 221 (288)
T cd07871 146 DFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFR-LLG 221 (288)
T ss_pred cCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhC
Confidence 999997653221 12233458999999998865 568999999999999999999999997532211 1111111 111
Q ss_pred chhhhhcccccc-CCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLL-SDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....+....... ..............+ ..........+..+++.+|+++||.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQP--LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCc--hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110000000000 000000000000000 00001123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.60 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=204.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe----EEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT----TVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|+..+.||+|+||.||+|++..+++ .||+|+++.. .....+++.+|+.+++.++||||++++++|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 468999999999999999999865443 3899998643 33455778899999999999999999999753
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence 34679999999999999986322 2578899999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... ........
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~ 226 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK 226 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhC
Confidence 9999999987654332222222335678999999999999999999999999999998 99998652111 11111100
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
. . +......++.++.+++.+||+.+|++||++.+++..+..+.+.
T Consensus 227 ~------------~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 G------------E------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C------------C------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 0 0000012344688999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=344.50 Aligned_cols=269 Identities=24% Similarity=0.345 Sum_probs=206.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhhcC-CCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG-----KTTVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 702 (953)
.++|.+.+.||+|+||.||+|++... ...||||+++... ....+.+.+|+++++++. ||||++++++|.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence 56788999999999999999997432 2469999996433 334567899999999995 999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCc--------------------------------------------------
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDK-------------------------------------------------- 732 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 732 (953)
.....++||||+++|+|.++++.......
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 34678999999999999999864321000
Q ss_pred ------------------------------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCC
Q 043900 733 ------------------------------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSN 776 (953)
Q Consensus 733 ------------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 776 (953)
.......+++.++..++.|+++||+|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 000123588999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCC
Q 043900 777 VLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGD 855 (953)
Q Consensus 777 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~ 855 (953)
|+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999987643332222333446788999999999999999999999999999997 999987532211
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.... ..... . +......++.++.+++.+||+.||++|||+.+|.++|++
T Consensus 348 ~~~~-~~~~~------------~------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 TFYN-KIKSG------------Y------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHHH-HHhcC------------C------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1100 00000 0 000111345678999999999999999999999999987
Q ss_pred HH
Q 043900 936 IK 937 (953)
Q Consensus 936 i~ 937 (953)
+.
T Consensus 397 l~ 398 (400)
T cd05105 397 LL 398 (400)
T ss_pred Hc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=342.87 Aligned_cols=242 Identities=19% Similarity=0.246 Sum_probs=194.0
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|+...+++.||+|+++.. .......+.+|+.++++++||||+++++++. .++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence 4699999999999999988899999999743 2334456788999999999999999998853 4478999999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 9999999998852 23588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (953)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~---- 211 (323)
T cd05571 143 KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE---- 211 (323)
T ss_pred cccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC----
Confidence 753211 1122345699999999999999999999999999999999999999964211 11111100000
Q ss_pred ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 874 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.. .+...++++.+++.+||+.||++|| ++.|+++
T Consensus 212 --~~----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 --IR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CC----------------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00 0012345688999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=342.46 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=193.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|+..+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|+||+++++++ ..++..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 34667789999999999999999888899999996433 33456788999999999999999999985 3457889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence 999999999986543 345677889999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+++.+.... .......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+......
T Consensus 212 fG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCA 287 (353)
T ss_pred cccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHH
Confidence 99998764221 11233468999999998743 23456899999999999999999999732211 11111110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..... .......++.++.+++.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMSQ---------------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhccC---------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000011334578999999999999999999999873
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=330.69 Aligned_cols=269 Identities=25% Similarity=0.401 Sum_probs=209.9
Q ss_pred cCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|.+.+.||+|+||.||+|... .++..||+|.++.........+.+|++++++++||||++++++|. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 46888999999999999999862 344579999987666566678999999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCc---ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDK---TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+..++||||+++++|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 778999999999999999864332111 111234589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+ .
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~ 231 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----V 231 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----H
Confidence 9999999999986543322222233446788999999998999999999999999999999 899986432111 0
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
........ ... ....++.++.+++.+||+.||.+|||+.|+.+.|+++.+.
T Consensus 232 ~~~i~~~~--------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGR--------VLQ-------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCC--------cCC-------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000000 000 0002345689999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.68 Aligned_cols=266 Identities=22% Similarity=0.385 Sum_probs=203.6
Q ss_pred hhcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
..++|++.+.||+|+||.||+|.+.. .++.||+|+++... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 45679999999999999999998753 34579999986432 234567889999999999999999999864
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.+...++||||+++|+|.++++..............+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 34678999999999999999865332211111233578899999999999999999998 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~ 230 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QV 230 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HH
Confidence 9999999999976543322222222345788999999999999999999999999999999 78888643211 11
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
........ ... ....++.++.+++.+||+.||++|||+.|+++.|+
T Consensus 231 ~~~~~~~~--------~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGG--------LLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCC--------cCC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11000000 000 00123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=328.99 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=202.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT----TVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|++.+.||+|+||.||+|.+..+++ .|++|.+.... .....++..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 468889999999999999999876554 47777775332 2344677888889999999999999998632
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++++||+++|+|.+++... ...+++..+..++.||+.||+|||+. +++||||||+||++++++.+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQH---------RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence 3467999999999999999632 23589999999999999999999998 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||.++...............++..|+|||++.+..++.++|||||||++||+++ |..||.+.... ...+....
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~ 226 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEK 226 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC
Confidence 9999999987644333223334457789999999998899999999999999999998 99998753211 11111110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
. .... ....++..+.+++.+||..||++|||+.|+++.|..+.+.
T Consensus 227 ~------------~~~~------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 G------------ERLA------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C------------CcCC------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0 0000 0001234578899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.72 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=202.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
..++|...++||+|+||.|++|..+.+++.+|||++++. ..++.+..+.|.+++... +||.++.++.+ |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 446799999999999999999999999999999999743 345677888898888877 59999999988 677
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.++.|.||||+.||++..+.+ ...+++..+.-+|..|+.||+|||++ |||+||||.+|||+|.+|.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence 799999999999999655553 34699999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++.--. ........+||+.|||||++.+..|+.++|.|||||+||||+.|..||.+..++
T Consensus 507 ~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------- 574 (694)
T KOG0694|consen 507 VKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------- 574 (694)
T ss_pred EEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------
Confidence 99999999985421 223455678999999999999999999999999999999999999999863222
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
++.|..+..+. ..+..++.+...++++++..+|++|-.+
T Consensus 575 -------e~FdsI~~d~~----------------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -------EVFDSIVNDEV----------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------HHHHHHhcCCC----------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111111111 0112456678899999999999999866
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.63 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=202.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++..++||||+++++++. .++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 36899999999999999999999888899999997432 234567889999999999999999999854 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN----------LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence 9999999999999999952 23578999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ ....... ..
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~--~~ 214 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKY--WK 214 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHh--cc
Confidence 99999986532 2234568999999999999999999999999999999999999997532111 0000000 00
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..... +... ......++++.+++.+||+.+|++||+++|+++.
T Consensus 215 ----~~~~~---~~~~---------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 ----ETLQR---PVYD---------------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccC---CCCC---------------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000 0000 0001345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=298.18 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=208.0
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+.++|.+++.||+|.||.||.|+.+.+.-.||+|++... ..+...++.+|+++-..++||||++++++ +.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 456799999999999999999999999989999998532 22345788999999999999999999999 4556
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...|+++||.++|.+...++.... ..+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~--------~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM--------KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc--------ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence 899999999999999999974332 3578888899999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||.+..-+ .......+||..|.|||+..+..++...|+|++|+..||++.|.+||.... .+..+.+.....
T Consensus 164 kiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~ 238 (281)
T KOG0580|consen 164 KIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD 238 (281)
T ss_pred eccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc
Confidence 999999998643 233345679999999999999999999999999999999999999998643 111222211111
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+ ..+...+.+..+++.+|+..+|.+|.+..|+++.
T Consensus 239 ~--------------------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 L--------------------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred c--------------------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 0112345568899999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=355.66 Aligned_cols=254 Identities=18% Similarity=0.196 Sum_probs=203.2
Q ss_pred CCcccCcccccceeeEEEEEEcCC-CeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQG-KTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++||||++++++|. .++..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 488999999999999999998776 6789999876555555667888999999999999999999964 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.++++.... ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLK------EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence 9999999999998853221 123588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~- 287 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGK- 287 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC-
Confidence 999876543322233345699999999999999999999999999999999999999964211 11111100000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .+..++.++.+++.+||+.||++||++++++.
T Consensus 288 -------~~~-------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 -------YDP-------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -------CCC-------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 00123456889999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=326.84 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=203.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.+|.+.+.||+|+||.||+|.+...++.||+|+++... .....+.+|++++++++||||++++++|.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence 35788899999999999999999888899999987433 345678899999999999999999998643 367899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLRECN--------RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCC
Confidence 999999999999985432 23588999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~---- 218 (263)
T cd05052 149 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELL---- 218 (263)
T ss_pred cccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH----
Confidence 99986643211 11112234668999999999999999999999999999998 9999864211 1111110
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
...... ..+..++.++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 219 -----~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 -----EKGYRM------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HCCCCC------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000000 00112356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=353.81 Aligned_cols=265 Identities=21% Similarity=0.247 Sum_probs=207.6
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC-
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ- 703 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~- 703 (953)
....++|.+.+.||+|+||+||+|++..+++.||||+++.. .......+.+|+..+..++|++++++.+.+......
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999999988889999998643 344456788999999999999999998775432111
Q ss_pred --CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 704 --GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 704 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
.....++||||+++|+|.++++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~------~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAK------TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS 178 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC
Confidence 11246899999999999999864322 134689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~ 253 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEV 253 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHH
Confidence 99999999999987643322223334569999999999999999999999999999999999999996421 1111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
........ ... .+..+++++.+++.+||+.||++||++.++++.
T Consensus 254 ~~~~~~~~--------~~~-------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 MHKTLAGR--------YDP-------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHhcCC--------CCC-------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111000 000 001235678899999999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.26 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=209.0
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
|.+++++|+|+||+||+|.++.++..||+|.+.... +.+++.+|+.+|++++.|++|++||.+ -.+...||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEeeh
Confidence 667889999999999999999999999999987543 467889999999999999999999984 3457899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
|||..|+..+.++. ..+.+++.++..+.+..++||+|||.. .-+|||||+.|||++.+|.+||+|||.
T Consensus 108 EYCGAGSiSDI~R~---------R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA---------RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhcCCCcHHHHHHH---------hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence 99999999999963 345799999999999999999999999 899999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
|..+. +.......+.||+.|||||++..-.|+.++||||+|++..||..|++||.+....... -
T Consensus 176 AGQLT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------F 239 (502)
T KOG0574|consen 176 AGQLT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------F 239 (502)
T ss_pred cchhh--hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------E
Confidence 97653 2333445577999999999999999999999999999999999999999763222110 0
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
++ ...++.-+..++..+.++.++++.|+-+.|++|-||.++++.
T Consensus 240 MI----------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 240 MI----------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ec----------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 00 011222333455667889999999999999999999998873
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.10 Aligned_cols=262 Identities=20% Similarity=0.319 Sum_probs=207.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|+...+++.||+|.++. ........+.+|+++++.++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 578999999999999999999998888999998753 22344567889999999999999999999854 3467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+. +++||||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKK------QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 8999999999999988853221 123578899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+......
T Consensus 148 ~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~ 222 (267)
T cd08228 148 GDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKIEQ 222 (267)
T ss_pred Cccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHHhc
Confidence 9999998764322 1122345888999999998888999999999999999999999998642211 1111111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.. ..+ ......+..+.+++.+||+.+|++||++.||++.++.++
T Consensus 223 ~~--------~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CD--------YPP------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC--------CCC------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 000 001133466899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.48 Aligned_cols=246 Identities=21% Similarity=0.237 Sum_probs=198.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++. .++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 357899999999999999999999988899999996432 234467889999999999999999999854 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----------AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEE
Confidence 89999999999999999853 23578889999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ........
T Consensus 159 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~ 228 (329)
T PTZ00263 159 VTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKIL 228 (329)
T ss_pred EeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHh
Confidence 99999998764321 234689999999999999999999999999999999999999964211 11111100
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
.. ... .+...+.++.+++.+||+.||.+||+ +++++.
T Consensus 229 ~~--------~~~--------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 229 AG--------RLK--------------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred cC--------CcC--------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 000 00012345789999999999999997 577664
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=330.40 Aligned_cols=271 Identities=24% Similarity=0.404 Sum_probs=210.7
Q ss_pred cCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|.+.+.||+|+||.||+|.+.. +...|++|.++.......+.+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 357888999999999999998643 34569999987666555678899999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCC------cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITRED------KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
+..++||||+++++|.+++....... ........+++..++.++.|++.|++|||++ +++||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 67899999999999999996543210 0011223589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccH
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNL 858 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~ 858 (953)
+.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||....... .
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 234 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V 234 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999976543322222333456789999999999999999999999999999999 999986422111 1
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..... ... .. .....++..+.+++.+||+.||++|||+++|+++|+++.+
T Consensus 235 ~~~~~---~~~--------~~-------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECIT---QGR--------VL-------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHh---CCC--------CC-------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 00000 000 00 0001234568899999999999999999999999999977
Q ss_pred Hhc
Q 043900 939 ILL 941 (953)
Q Consensus 939 ~~~ 941 (953)
..+
T Consensus 285 ~~~ 287 (291)
T cd05094 285 ATP 287 (291)
T ss_pred hcC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.47 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=204.0
Q ss_pred CcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCCC
Q 043900 633 FASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 706 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 706 (953)
|.+.+.||+|+||.||+|....+ ...||+|+++.. .......+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999998653 367999998743 23345678999999999999999999998754322 2234
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|..++...... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence 579999999999999998543221 1233689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .......
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~-- 229 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLR-- 229 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH--
Confidence 999999987644332222222335678999999988899999999999999999999 88888642211 1111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
+.... ..+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 230 ---------~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 ---------HGNRL-------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------cCCCC-------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 00112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.09 Aligned_cols=265 Identities=24% Similarity=0.418 Sum_probs=202.3
Q ss_pred CcccCcccccceeeEEEEEEcCCCe--EEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCCCc
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKT--TVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDF 707 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 707 (953)
|.+.+.||+|+||.||+|++...+. .||+|.++.. .....+.+.+|+++++.++||||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999877654 5899988643 34456788999999999999999999998754311 12245
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 78999999999999987432211 1234589999999999999999999998 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+++.+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||...... .......
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~--- 228 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLR--- 228 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---
Confidence 99999987643322111222346778999999999999999999999999999999 88888642111 1111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.... . .....++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ~~~~--------~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNR--------L-------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCC--------C-------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0 00012345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=329.70 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=205.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCC-----CeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG-----KTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
++|.+.+.||+|+||.||+|+..+. ++.||+|+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 4688889999999999999987543 468999999754433 45789999999999999999999999643
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCc----ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDK----TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
....++||||+++++|.+++........ .......+++.++..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc
Confidence 3779999999999999999975432110 012234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
.++.+||+|||.++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~ 234 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VI 234 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH
Confidence 999999999999986533322222233346788999999999999999999999999999999 999986432111 11
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
..... ..... ....++.++.+++.+||+.||++||++.||++.|+
T Consensus 235 ~~~~~-----------~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQ-----------GRLLQ-------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHc-----------CCcCC-------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11000 00000 00123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=337.84 Aligned_cols=242 Identities=20% Similarity=0.261 Sum_probs=193.0
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|....+++.||+|+++.. .......+.+|+++++.++||||+++++++. .++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 4699999999999999988889999999743 2334456778999999999999999998853 4478999999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|..++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 9999999988852 23588999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (953)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~--- 212 (323)
T cd05595 143 KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEI--- 212 (323)
T ss_pred ccccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC---
Confidence 753221 11222346899999999999999999999999999999999999999642111 11110000000
Q ss_pred ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 874 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.. +...++++.+++.+||+.||++|| ++.++++
T Consensus 213 ---~~----------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 ---RF----------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ---CC----------------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00 012345688999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.62 Aligned_cols=200 Identities=26% Similarity=0.367 Sum_probs=173.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.++||+|+||.||+|.+..++..||+|+++.. .......+.+|++++++++||||++++++|.. ++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 46899999999999999999999988889999998753 33345678999999999999999999999643 4789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEe
Confidence 999999999999999852 23578889999999999999999974 179999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|||++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999765322 11234589999999999998999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.34 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=191.3
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 79999999999999988889999999642 2334567788999999999999999998853 447899999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQR----------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 99999999853 23588999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............
T Consensus 143 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~------ 209 (312)
T cd05585 143 NMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEP------ 209 (312)
T ss_pred CccC--CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCC------
Confidence 4221 122234568999999999999999999999999999999999999997421 111111111000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC---HHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN---MTNVVR 931 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 931 (953)
. ..+...++++.+++.+||+.||++||+ +.|++.
T Consensus 210 --~--------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 210 --L--------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --C--------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0 000123456889999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.75 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=204.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|.+... ...||+|+++... ......+.+|+.++++++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 35689999999999999999998643 4579999987433 334567889999999999999999999853 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++.... ..+++.++++++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND---------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCE
Confidence 67899999999999999986322 2588999999999999999999998 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..||...... ........
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~ 223 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVED 223 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHc
Confidence 9999999987752222222223345678999999999999999999999999999998 99998643211 01111100
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.. .. +....++..+.+++.+||+.+|++||++.||++.|+++
T Consensus 224 ~~-----------~~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GY-----------RL-------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----------CC-------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00 00012345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.42 Aligned_cols=201 Identities=29% Similarity=0.343 Sum_probs=173.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-C-----CCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-H-----RNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 704 (953)
.+|.+.+.||+|+||.|.+|.+..+++.||||+++.... ...+...|+.+|..++ | -|+|+++++| ..
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~f 259 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YF 259 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cc
Confidence 378999999999999999999999999999999985443 4566778999999996 3 4899999995 44
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM- 783 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 783 (953)
..+.|||+|.+ ..+|.++++.+... .++...++.|+.||+.||.+||+. +|||+||||+|||+.+-+
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~--------Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFR--------GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKR 327 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCc
Confidence 58999999999 56999999866543 699999999999999999999999 999999999999996433
Q ss_pred -cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 784 -MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 784 -~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
.+||+|||.|++..... .....+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+..+.
T Consensus 328 ~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 79999999999753221 2456889999999999999999999999999999999998888764443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.34 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=204.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..+|++.+.+|+|.||.|-+|.....++.||||.++.. +..+.-.+.+|+++|..++||||+.++.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 45788899999999999999999888899999999643 34445567899999999999999999998 56678
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
...|||||..+|.|++|+.. .+.+++.+...+++||+.|+.|+|.+ +++|||||.+|||+|.++++|
T Consensus 127 KIvivMEYaS~GeLYDYiSe----------r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISE----------RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eEEEEEEecCCccHHHHHHH----------hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence 99999999999999999963 34799999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||++-.+.. .......+|++-|.+||+..|.+|. +..|.||+||++|.++.|..||++. +....++..
T Consensus 194 IADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQI 265 (668)
T KOG0611|consen 194 IADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQI 265 (668)
T ss_pred eeccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHh
Confidence 999999987743 3344567899999999999999885 8899999999999999999999863 111222211
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
......+ .+.+....-++++|+..+|++|.|..+|...
T Consensus 266 s~GaYrE-----------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 266 SRGAYRE-----------------------------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hcccccC-----------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1111100 0112234568899999999999999998754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=357.79 Aligned_cols=272 Identities=21% Similarity=0.297 Sum_probs=208.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.++||+|+||.||+|++..+++.||+|+++.. .....+++.+|++++++++||||+++++++. +++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 5799999999999999999999988889999998642 2233567899999999999999999999864 3477
Q ss_pred eeEEEeeccCCchhhccccCCcCC-cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITRED-KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
.++||||+++|+|.+++....... .........++..+++++.||++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 899999999999999986432111 1112234577888999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC----------------cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 787 VSDFGLARFLPLSPA----------------QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 787 L~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987621110 0111234699999999999999999999999999999999999999965
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-NMTNV 929 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev 929 (953)
........ ..... + .. ......+.++.+.+++.+|++.||++|| +++++
T Consensus 234 ~~~~ki~~----~~~i~-------~------P~-------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRKISY----RDVIL-------S------PI-------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhhhhh----hhhcc-------C------hh-------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 21111000 00000 0 00 0000113456788999999999999995 67788
Q ss_pred HHHHHHHHHHh
Q 043900 930 VRQLQSIKNIL 940 (953)
Q Consensus 930 l~~L~~i~~~~ 940 (953)
.+.|+...+..
T Consensus 284 l~~Le~~lq~~ 294 (932)
T PRK13184 284 KQDLEPHLQGS 294 (932)
T ss_pred HHHHHHHHhcC
Confidence 88888876543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=365.97 Aligned_cols=482 Identities=29% Similarity=0.358 Sum_probs=367.3
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.+|.+.+++. -||..+..-..++.|++++|.+...+-+...+..+|+.|||++|++. ..|..+..+..|+.|+++.|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 3678888886 88888888778999999999998743344456667999999999998 999999999999999999999
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCc
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSS 167 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 167 (953)
|. ..|.+..++.+|++|.|.+|.+. ..|.+++.+.+|++|+++.|++. .+|..+..+..+..+..++|.....++..
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~ 156 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQT 156 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccc
Confidence 99 88999999999999999999998 89999999999999999999998 89999999999999999999322233332
Q ss_pred ccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccc
Q 043900 168 IFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247 (953)
Q Consensus 168 l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~ 247 (953)
.++.+++..|.+.+.++.+.. .+.. .|+|++|.+. .-.+.++.+|+.|.++.|++....- ..++++
T Consensus 157 -----~ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~---~g~~l~ 222 (1081)
T KOG0618|consen 157 -----SIKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI---SGPSLT 222 (1081)
T ss_pred -----cchhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe---cCcchh
Confidence 288999999999988888765 3444 5999999987 3357788899999999999875421 235677
Q ss_pred eeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCE
Q 043900 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQR 327 (953)
Q Consensus 248 ~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 327 (953)
.++.+.|.+.. +....-..++++++++.|++++ +|+++..+ .+|+.+...+|+++ .+|..+...++|+.
T Consensus 223 ~L~a~~n~l~~--------~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~-~nle~l~~n~N~l~-~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 223 ALYADHNPLTT--------LDVHPVPLNLQYLDISHNNLSN-LPEWIGAC-ANLEALNANHNRLV-ALPLRISRITSLVS 291 (1081)
T ss_pred eeeeccCccee--------eccccccccceeeecchhhhhc-chHHHHhc-ccceEecccchhHH-hhHHHHhhhhhHHH
Confidence 77777777652 2223345678888999998886 45888887 58999999999996 67888888888999
Q ss_pred EEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCC-CCc--eeeEEEccCCcCCCCCCc-cCCCCCCCcEEEcCC
Q 043900 328 LEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI-GNL--KVFNLDLSCNFLQGSIPS-SLGQYKTLTIIDLSD 403 (953)
Q Consensus 328 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l--~l~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~ 403 (953)
|.+.+|.+. -+|....+++.|++|+|..|+|. ..|..+ .-+ .+..|+.+.|.+.. .|. .=..++.|+.|++.+
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLST-LPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccc-cccccchhhHHHHHHHHhc
Confidence 999999998 67888888899999999999987 455433 222 34556666676663 331 112345677777888
Q ss_pred CccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCC
Q 043900 404 NNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483 (953)
Q Consensus 404 N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 483 (953)
|.++...-+-+- ....|+.|+|++|++.......+.++..|++|+||+|+++ .+|.++.++..|++|...+|+|. ..
T Consensus 369 N~Ltd~c~p~l~-~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~f 445 (1081)
T KOG0618|consen 369 NHLTDSCFPVLV-NFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SF 445 (1081)
T ss_pred Ccccccchhhhc-cccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ec
Confidence 877743332222 2334567788888777444455677777888888888887 67777777888888888888877 56
Q ss_pred CccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCc
Q 043900 484 PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNN 526 (953)
Q Consensus 484 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~ 526 (953)
| .+..+++|+++|+|.|+|+...-......++|++|||++|.
T Consensus 446 P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 446 P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 6 67777888888888887774322222223677888888876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.51 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=206.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
...+|++.+.||+|+||.||+|.+.+ ++.||+|+++.........+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 34578999999999999999999988 5689999998666555678899999999999999999999864 34678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.++++... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.+||+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~ 146 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE--------GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVA 146 (261)
T ss_pred EEEEeecccCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEc
Confidence 99999999999999996432 23589999999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.+........ ......++..|+|||+..+..++.++||||||+++|+|++ |+.||......+ .......
T Consensus 147 d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~--- 219 (261)
T cd05148 147 DFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITA--- 219 (261)
T ss_pred cccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHh---
Confidence 9999986643211 1123346778999999988899999999999999999998 899986532110 0000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
... ......+++++.+++.+||+.||++|||++++++.|+.+
T Consensus 220 ---------~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 ---------GYR------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------CCc------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 000113456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.77 Aligned_cols=271 Identities=25% Similarity=0.349 Sum_probs=203.1
Q ss_pred CC-cccCcccccceeeEEEEEE----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GF-ASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~-~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+| .+.+.||+|+||+||++.. ..+++.||+|+++... ......+.+|++++++++||||++++++|.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 44 8889999999999988764 3456689999997543 2345678899999999999999999998743 233
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcE
Confidence 568999999999999999842 2489999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||+||..||................
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 226 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence 999999998764322211 1122235677999999998899999999999999999999999986432111000000000
Q ss_pred hC-CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 865 AL-PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 865 ~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.. .....+..+... ....+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 QMTVVRLIELLERGM------------------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccchhhhhhhhhcCC------------------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 000111111000 00011234567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.32 Aligned_cols=267 Identities=24% Similarity=0.398 Sum_probs=204.9
Q ss_pred CCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+|++.+.||+|+||.||+|+... +...||+|.+.... ......+.+|+.+++.++||||+++++.|. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47788999999999999999753 23568999886433 334567889999999999999999999864 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCc--------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDK--------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCD 771 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 771 (953)
+..++||||+++|+|.+++........ .......+++..++.++.|++.||+|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 678999999999999999864322110 011234689999999999999999999998 999999
Q ss_pred CCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 043900 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDS 850 (953)
Q Consensus 772 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~ 850 (953)
|||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322222223346778999999988899999999999999999999 9999864
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
.... ... +........ .....++.++.+++.+||+.+|++||+++|++
T Consensus 233 ~~~~--~~~------------~~~~~~~~~------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 233 IAPE--RLF------------NLLKTGYRM------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CCHH--HHH------------HHHhCCCCC------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 2211 111 111110000 00012345688999999999999999999999
Q ss_pred HHHHHHHH
Q 043900 931 RQLQSIKN 938 (953)
Q Consensus 931 ~~L~~i~~ 938 (953)
+.|+++..
T Consensus 281 ~~l~~~~~ 288 (290)
T cd05045 281 KELEKMMV 288 (290)
T ss_pred HHHHHHHh
Confidence 99998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.12 Aligned_cols=270 Identities=25% Similarity=0.378 Sum_probs=204.6
Q ss_pred cCCcccCcccccceeeEEEEEE----cCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.+|++.+.||+|+||.||+|.. ..+++.||+|+++.......+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4688899999999999999985 34567899999986666667788999999999999999999998643 2335
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH---------RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 689999999999999998532 12488999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTS-SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... ........
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~ 225 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGND 225 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccc
Confidence 999999987643322111 11122455699999999889999999999999999999988775432110 00000000
Q ss_pred CC--c---hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 866 LP--D---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 866 ~~--~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.. . ...+.+... .+......++.++.+++.+||+.+|++||||.||++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 226 KQGQMIVYHLIELLKNN------------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccchHHHHHHHhcC------------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 0 000000000 00011123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=337.48 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=194.2
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4699999999999999988899999999743 233456788899999999999999999885 34578999999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCC
Confidence 9999999988852 23588999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (953)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~---- 211 (328)
T cd05593 143 KEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMED---- 211 (328)
T ss_pred ccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCC----
Confidence 753221 1122335689999999999999999999999999999999999999964211 11111110000
Q ss_pred ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 043900 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVRQ 932 (953)
Q Consensus 874 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 932 (953)
..+ +...+.++.+++.+||+.||++|| ++.|+++.
T Consensus 212 --~~~----------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 --IKF----------------------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --ccC----------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000 012345688999999999999997 88998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=341.81 Aligned_cols=270 Identities=20% Similarity=0.238 Sum_probs=198.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++||||+++++++. .+...++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEE
Confidence 57999999999999999999999999999999753 235678999999999999999999853 3467899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
|||++. ++|..++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 161 v~e~~~-~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA----------KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEecCC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence 999995 688888742 23578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC------ccHHHHHHh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD------MNLHNFARM 864 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~------~~~~~~~~~ 864 (953)
|+|+..... .........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..+......
T Consensus 227 G~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 227 GAACFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred Ccccccccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 999754221 1122234569999999999999999999999999999999999998875422111 111111111
Q ss_pred hC--Cch----hhhhccccccCCchhhhhcccchhhh--hhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 AL--PDH----VVDIVDSTLLSDDEDLAVHGNQRQRQ--ARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~--~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. +.. .....+... .... ......+. ..+......+.++.+++.+||+.||++|||++|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIY----IGLA-KKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHH----HHHH-hccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 10 000 000000000 0000 00000000 111222345678999999999999999999999985
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.56 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=201.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.++||+|+||.||+|...++ ..||+|.+.... ...+.+.+|+.++++++|+||+++++++. .....+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCC-ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcE
Confidence 35789999999999999999998665 479999886433 23568899999999999999999998853 346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDE--------GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEecCCCCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence 9999999999999986432 23578889999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ..........
T Consensus 147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~- 222 (261)
T cd05072 147 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYR- 222 (261)
T ss_pred CccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCC-
Confidence 9999876432211 1222346778999999988899999999999999999998 999986422111 1111100000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.+....++.++.+++.+||..+|++||+++++.+.|++
T Consensus 223 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 -----------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00001234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=339.00 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=197.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC-eEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK-TTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+++++.++||||+++++++. +.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence 456999999999999999999976554 68999998632 2334567889999999999999999999964 44
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR----------NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 789999999999999999852 23588999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 171 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~- 239 (340)
T PTZ00426 171 KMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQK- 239 (340)
T ss_pred EEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHHH-
Confidence 99999999875321 12346899999999999989999999999999999999999999752111 00000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 932 (953)
+...... .+...+..+.+++.+|++.||++|+ +++|+++.
T Consensus 240 -------i~~~~~~--------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 -------ILEGIIY--------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------HhcCCCC--------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0000000 0001234577999999999999995 88888763
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.52 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=204.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCe----EEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKT----TVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
.++|++.+.||+|+||+||+|++..+++ .||+|+++.. .......+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 3568889999999999999999865554 4899998643 33445678899999999999999999998742
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
...+++|||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVREN---------KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence 3467999999999999998632 23588999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||...... ....+..
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~ 225 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLE 225 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987754333222223345678999999999999999999999999999998 89998642211 1111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... ......++.++.+++.+||+.||++||++.|+++.|+.+...
T Consensus 226 ~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 226 KGER------------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCc------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0000 000012345688999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.60 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=195.1
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
+.||+|+||.||+|++..+++.||+|.+... ..+....+.+|++++++++||||++++++|.. ....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 4699999999999999888889999988643 23445678999999999999999999999643 36789999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRTE---------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 999999998522 22578999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIV 874 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 874 (953)
...............+..|+|||.+.+..++.++|||||||++|||++ |..||....... ... .+
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~------------~~ 209 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TRE------------AI 209 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHH------------HH
Confidence 532211111111223567999999999999999999999999999998 888886422110 000 00
Q ss_pred cccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 875 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 875 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
...... .....++.++.+++.+||+.+|++|||+.||.++|+
T Consensus 210 ~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRL------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCC------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000000 001123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.41 Aligned_cols=269 Identities=23% Similarity=0.394 Sum_probs=210.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcC----CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ----GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
.++|.+.+.||+|+||.||+|.+.. +...||+|+++.. .......+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 4678899999999999999999876 2468999988643 33446778899999999999999999998643 3
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
+...++++||+++++|.+++....... ......+++.+++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence 467899999999999999986543221 11234689999999999999999999998 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||..... .....+..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~ 233 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLK 233 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHH
Confidence 99999999986643332222223346778999999998899999999999999999999 9999864211 11111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... ......+++++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 234 ~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYR------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0000 000112345789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.35 Aligned_cols=265 Identities=23% Similarity=0.388 Sum_probs=202.8
Q ss_pred cCCcccCcccccceeeEEEEEEc----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|++.+.||+|+||.||+|... ..+..||+|.++... ......+.+|++++++++||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 46788899999999999999852 345689999997432 334467889999999999999999999853 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCC-------cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITRED-------KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
...++||||+++++|.+++....... ........+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 67899999999999999985332110 0011123588999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCcc
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMN 857 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~ 857 (953)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+... ..
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QE 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 99999999999999986643322222233446778999999988899999999999999999999 9999864211 11
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.......... .. ....+++++.+++.+||+.||++||++.+|.++|.+
T Consensus 235 ~~~~~~~~~~-----------~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL-----------LP-------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc-----------CC-------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111110000 00 001234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.89 Aligned_cols=279 Identities=24% Similarity=0.303 Sum_probs=198.9
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhc---CCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 706 (953)
+|++.+.||+|+||+||+|++..+++.||+|.++... ........+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999999988999999986432 22234456677776665 799999999997654444456
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||++ ++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 7899999997 48888885322 12589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++...... ......|+..|+|||++.+..++.++||||+||++|||++|++||......+ ..........
T Consensus 149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhC
Confidence 99999998664221 1223458899999999999999999999999999999999999986532211 1111111100
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+. ......... .. ..............+.++.+++.+|++.||++|||+.|++.
T Consensus 225 ~~~~~~~~-~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWP-RDVTLPRGA--FS--PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCc-ccccccccc--cC--CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 000000000 00 00000000011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.50 Aligned_cols=265 Identities=22% Similarity=0.369 Sum_probs=205.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC-----eEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK-----TTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|.+.+.||+|+||.||+|.+.... ..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 357889999999999999999986433 689999986432 334567889999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....++||||+++|+|.+++...............+++..++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 34778999999999999999965433211112234588999999999999999999998 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~ 862 (953)
.+||+|||.++...............++..|+|||.+.+..++.++|||||||++||+++ |..||...... ......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~ 234 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFV 234 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHH
Confidence 999999999986643332222333446789999999988899999999999999999998 99998642111 111111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
. +.... ..+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 235 ~-----------~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 I-----------DGGHL-------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred h-----------cCCCC-------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 00000 000123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.83 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=202.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|.+.+.||+|+||.||+|.+.. ....||+|.+.... ......+.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 4578999999999999999999977 66789999886433 3345678999999999999999999998643
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
....++||||+++++|.+++....... .....+++.++++++.||+.|++|||+. +++||||||+||+++.++
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG 153 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC
Confidence 356799999999999999996543221 1223689999999999999999999999 999999999999998654
Q ss_pred ---cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 784 ---MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 784 ---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
.+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence 699999999987633222222222234578999999999999999999999999999997 999987532111 11
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
... ..... ...+..++.++.+++.+||+.+|++||++.+|++.|.
T Consensus 232 ~~~------------~~~~~------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFV------------TGGGR------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHH------------HcCCc------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 00000 0001123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.47 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=197.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|.++.+. .||+|.++... .....+.+|+.++++++||||++++++|. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~-~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQI-KVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCc-eEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 45888999999999999999987654 79999886432 23467889999999999999999999864 3467899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.++++... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ---------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhCc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence 999999999999985321 2478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ........ ..
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~---~~ 218 (256)
T cd05114 145 GMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISR---GF 218 (256)
T ss_pred CCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC---CC
Confidence 99986532221 11222335678999999988899999999999999999999 89998642111 11111100 00
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
... .+...+.++.+++.+||+.+|++||+++|+++.|
T Consensus 219 --------~~~-------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 --------RLY-------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCC-------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 000 0001234689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.75 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=198.7
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
+|++.++||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||+|+++++++. .++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4788899999999999999998888899999986432 222345778999999999999999998853 34689
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMG--------NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEe
Confidence 99999999999998885321 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||++........ .....|+..|+|||++.+..++.++||||+||++||+++|+.||.+.... ....... ..+..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~-~~~~~ 219 (285)
T cd05605 145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVE-RRVKE 219 (285)
T ss_pred eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHH-HHhhh
Confidence 9999987542221 12346899999999999999999999999999999999999999752211 0001100 00000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVRQ 932 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 932 (953)
. . .......+..+.+++.+||+.||++|| +++++++.
T Consensus 220 ~--------~-------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 D--------Q-------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred c--------c-------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 0 000112455688999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.09 Aligned_cols=255 Identities=31% Similarity=0.479 Sum_probs=201.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|++|.||+|.+..+ +.||+|.++.... ..+.+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCee
Confidence 35688999999999999999998665 5899999875432 3567889999999999999999999854 346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA--------GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeecccCCcHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence 9999999999999996322 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||+++........ .......+..|+|||+..+..++.++||||||+++|||++ |+.||.+..... ....
T Consensus 147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~------- 216 (261)
T cd05068 147 FGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQ------- 216 (261)
T ss_pred cceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH-------
Confidence 9999876522111 1112223468999999999999999999999999999999 999986532110 0000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
++..... .....++.++.+++.+|++.+|++||+++++.+.|++
T Consensus 217 -----~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 -----VDQGYRM------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----HHcCCCC------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000000 0001234568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.11 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=193.4
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||+|+||+||+|.+..+++.||+|++.... ....+.+..|+++++.++||+|+++.+++. .....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 699999999999999888899999986432 223456778999999999999999998853 446799999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++|+|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~g~L~~~~~~~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVDE------ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 99999988753221 134689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 147 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~------ 217 (280)
T cd05608 147 LKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS------ 217 (280)
T ss_pred cCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC------
Confidence 643222 2223468999999999999999999999999999999999999997532211 0011111000000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
...+...+.++.+++.+||+.||++|| +++|+++
T Consensus 218 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 218 ----------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ----------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 000113456788999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.25 Aligned_cols=268 Identities=22% Similarity=0.380 Sum_probs=206.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC-----CeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG-----KTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|..... ...||+|.++.. .......+.+|+++++++ +|+||++++++|.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---- 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence 45688999999999999999998643 368999998743 233456788999999999 8999999999864
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSN 776 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 776 (953)
.+...++||||+++|+|.++++....... .......+++..++.++.|++.|++|||+. +|+||||||+|
T Consensus 87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 34678999999999999999964321100 002234689999999999999999999998 99999999999
Q ss_pred eEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCC
Q 043900 777 VLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGD 855 (953)
Q Consensus 777 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~ 855 (953)
|+++.++.+||+|||.++.+.............++..|+|||++.+..++.++|||||||++||+++ |..||......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 241 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 241 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence 9999999999999999987643322222223345678999999988899999999999999999998 99998642211
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.... ....... ...+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus 242 ----~~~~---------~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 242 ----ELFK---------LLKEGYR------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred ----HHHH---------HHHcCCc------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 1000 0000000 00011234568899999999999999999999999998
Q ss_pred HH
Q 043900 936 IK 937 (953)
Q Consensus 936 i~ 937 (953)
+.
T Consensus 291 ~~ 292 (293)
T cd05053 291 ML 292 (293)
T ss_pred hh
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.35 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=192.1
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||+|+||.||+++.+.+++.||+|.+.... .........|++++++++||||+++.+++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999999999888899999986321 12234556799999999999999999885 3457899999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~g~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYNVG--------ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHhcc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 9999998885322 22588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
..... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..............
T Consensus 145 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~------ 214 (277)
T cd05607 145 LKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE------ 214 (277)
T ss_pred cCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc------
Confidence 64322 222345899999999999989999999999999999999999999753221 11111111111000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... .....+.++.+++.+||+.||++||++.|+++.
T Consensus 215 --~~~-------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 215 --VKF-------------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred --ccc-------------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 000 000234568899999999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.25 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=191.1
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHH---hhcCCCCeeEEEeeecccccCCCC
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTL---KNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|.+++ +.++||||+++++++. ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 677899999999999999999888899999997432 22345566666554 5668999999999853 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|..+++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEE
Confidence 8999999999999998874 13589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 142 L~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i- 213 (324)
T cd05589 142 IADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSI- 213 (324)
T ss_pred eCcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-
Confidence 9999998753221 12223456899999999999999999999999999999999999999753211 111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
..... ..+...+..+.+++.+||+.||++||+ +.++++
T Consensus 214 -------~~~~~--------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 214 -------VNDEV--------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------HhCCC--------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00000 000123456789999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.30 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=200.9
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeecc
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQ 716 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 716 (953)
-++|+|.||+||-|++..++..+|||.+........+-+..|+..-++++|.|||+++|.|. .+++.-|.||.++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCC
Confidence 36999999999999999999999999998777777788899999999999999999999954 4478899999999
Q ss_pred CCchhhccccCCcCCcccCCcccc--CHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-CCCcEEEeccccc
Q 043900 717 NRSLEEWLHPITREDKTEEAPRSL--NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSDFGLA 793 (953)
Q Consensus 717 ~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a 793 (953)
||+|.+.++. ..+++ .+.++--+.+||++||.|||+. .|||||||-+||||+ -.|.+||+|||-+
T Consensus 656 GGSLSsLLrs---------kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 656 GGSLSSLLRS---------KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCcHHHHHHh---------ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccc
Confidence 9999999952 23445 6778888999999999999999 999999999999996 6889999999999
Q ss_pred eecCCCCCcccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
+.+.. -........||..|||||++..+ .|+.++|||||||++.||.||++||.........+ .+-.
T Consensus 724 KRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVG------ 792 (1226)
T KOG4279|consen 724 KRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVG------ 792 (1226)
T ss_pred hhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhc------
Confidence 87642 22333345699999999998776 48899999999999999999999997543221111 0000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+ .+. .++.+.+.+.+...++.+|+.+||.+||+|+++++
T Consensus 793 ------m------------yKv---HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 ------M------------YKV---HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ------c------------eec---CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 0 000 01123366778899999999999999999999986
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.97 Aligned_cols=268 Identities=21% Similarity=0.363 Sum_probs=204.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
..++|++.+.||+|+||.||+|..++ ....||+|.++... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 45689999999999999999997653 24579999886332 233456788999999999999999999854
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.+...++||||+++|+|.+++................++..+..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 34678999999999999999975432211222234567888999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~ 230 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QV 230 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH
Confidence 9999999999986543322222222345778999999998899999999999999999999 78888642211 11
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.... .+..... ....+++.+.+++.+||+.||++|||+.|+++.+++.
T Consensus 231 ~~~~--------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFV--------MDGGYLD-------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHH--------HcCCCCC-------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1100 0000000 0012345799999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=295.51 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=204.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------HGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
--..|...+.+|+|..++|-++..+.++..+|+|++.... ....+.-.+|+.+++++ .||+|+.+.++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~--- 91 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV--- 91 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee---
Confidence 3456777889999999999999999999999999996322 11234556899999999 69999999999
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
++.+...++|+|.|+.|.|.+++. ....+++.+..+|++|+.+|++|||.. .||||||||+|||+
T Consensus 92 --yes~sF~FlVFdl~prGELFDyLt----------s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl 156 (411)
T KOG0599|consen 92 --YESDAFVFLVFDLMPRGELFDYLT----------SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL 156 (411)
T ss_pred --ccCcchhhhhhhhcccchHHHHhh----------hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence 556688999999999999999994 234689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCCCCCccc
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG------SEVSINGDVYSYGILLLELVTRKKPVDSMFE 853 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slG~vl~elltg~~pf~~~~~ 853 (953)
+++.++||+|||+|+.++++. .....+|||+|.|||.+.- ..|+...|+||+||++|.++.|.+||..-
T Consensus 157 ddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-- 231 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-- 231 (411)
T ss_pred ccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--
Confidence 999999999999999876443 3456789999999998643 25788899999999999999999999631
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... +.+. +.+. . .+.+.+++.+.+....+++.+|++.||.+|.|++|+++.
T Consensus 232 kQml---MLR~-ImeG-----------k------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 KQML---MLRM-IMEG-----------K------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHH---HHHH-HHhc-----------c------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1100 0111 0010 0 012233444667788999999999999999999999873
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.81 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=207.1
Q ss_pred CcccCcccccceeeEEEEEEcCC---CeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 633 FASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
....+.||+|.||.|++|.|... ...||||.++..... ...+|.+|+.+|.+++|||++++||++.+ ...
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence 34568899999999999999642 345999999865544 67899999999999999999999999642 567
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
.+|||.++.|+|.+.+++.. ...+-......++.|||.||.||.++ ++||||+..+|+++-....|||+
T Consensus 186 mMV~ELaplGSLldrLrka~--------~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAK--------KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred hHHhhhcccchHHHHHhhcc--------ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeee
Confidence 89999999999999997522 23688888999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccc-cccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhC
Q 043900 789 DFGLARFLPLSPAQTSS-IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|||+.+-++..+..... ....-.+.|+|||.+....++.++|||+|||++|||+| |..||.+....
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------ 322 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------ 322 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------
Confidence 99999988765544333 33446789999999999999999999999999999999 88998763221
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
.+.+.+| ...+...+..|++.++++|+.||..+|++|||+..+.+.+
T Consensus 323 --qIL~~iD------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 323 --QILKNID------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --HHHHhcc------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1111111 1123344457889999999999999999999999998554
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.26 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=206.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|+...+++.||||.+... ......++.+|+.+++.++||||+++++++. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 4688899999999999999999888889999988642 2334567889999999999999999999854 3467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.+++..... ....+++..++.++.|+++|++|||+. +++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK------QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 8999999999999998853221 123689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||.+........ ......++..|+|||++.+..++.++||||||+++|||++|..||...... ........
T Consensus 148 ~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-- 220 (267)
T cd08229 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-- 220 (267)
T ss_pred CcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh--
Confidence 99999986643221 122345889999999998889999999999999999999999998642211 11111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.....+.. .....++++.+++.+||+.||++||||.+|++.++++.
T Consensus 221 ---~~~~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 ---EQCDYPPL---------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---hcCCCCCC---------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00000000 00134567999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=331.38 Aligned_cols=271 Identities=24% Similarity=0.353 Sum_probs=204.7
Q ss_pred hcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 357999999999999999999853 345689999997432 33456788999999999 68999999998743
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcc-------------------------------------------------
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKT------------------------------------------------- 733 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------- 733 (953)
.+...++||||+++|+|.++++........
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 235678999999999999998643210000
Q ss_pred --------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccc
Q 043900 734 --------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805 (953)
Q Consensus 734 --------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 805 (953)
......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 00113478899999999999999999999 9999999999999999999999999999865433222222
Q ss_pred cccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchh
Q 043900 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDED 884 (953)
Q Consensus 806 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 884 (953)
....++..|+|||++.+..++.++||||||+++||+++ |..||....... ........... .
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-----------~----- 301 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR-----------M----- 301 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC-----------C-----
Confidence 23346678999999988899999999999999999997 999986532111 01000000000 0
Q ss_pred hhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 885 LAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..+...++++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 302 --------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 --------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000123468899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=335.34 Aligned_cols=270 Identities=21% Similarity=0.316 Sum_probs=205.3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD 701 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 701 (953)
..++|.+.+.||+|+||.||+|++.+ .++.||+|+++... ....+.+.+|++++.++. ||||++++++|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 34567888999999999999999643 34679999997432 333457889999999997 9999999999643
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCc-------------------------------------------------
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDK------------------------------------------------- 732 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------- 732 (953)
....++||||+++|+|.++++.......
T Consensus 113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 3678999999999999999975432100
Q ss_pred ---------------------------------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 733 ---------------------------------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 733 ---------------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
.......+++..++.++.|++.||+|||+. +++|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence 001123578889999999999999999998 99999999
Q ss_pred CCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcc
Q 043900 774 PSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMF 852 (953)
Q Consensus 774 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~ 852 (953)
|+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999986543222222223346788999999998899999999999999999998 889986432
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..+. ... .+..... ...+..++.++.+++.+||..+|++||+++||++.
T Consensus 347 ~~~~-~~~------------~~~~~~~------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQ-FYN------------AIKRGYR------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHH-HHH------------HHHcCCC------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1110 000 0000000 00001234578999999999999999999999999
Q ss_pred HHHHH
Q 043900 933 LQSIK 937 (953)
Q Consensus 933 L~~i~ 937 (953)
|+.+.
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=336.12 Aligned_cols=243 Identities=19% Similarity=0.258 Sum_probs=193.0
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+++++.++||||+++.+++. .++..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence 4699999999999999988899999999743 2234456788999999999999999998853 4478999999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
|+++|+|..++.. ...+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 76 YANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred CCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCC
Confidence 9999999988842 2358999999999999999999997 6 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~~-- 213 (325)
T cd05594 143 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEI-- 213 (325)
T ss_pred CeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCCC--
Confidence 97542211 1222346999999999999999999999999999999999999999642111 11111000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVRQ 932 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 932 (953)
.. +...++++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ----~~----------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 ----RF----------------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----CC----------------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00 002345688999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=319.15 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=207.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|....+++.||+|.++. ......+.+.+|++++++++|++++++++++. .++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 578999999999999999999998888999998863 22334567889999999999999999999864 3467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.+++..... ....+++.+++.++.|++.|++|||+. |++||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK------QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc------cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence 8999999999999998854321 123588999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||.+........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ............
T Consensus 148 ~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~ 222 (267)
T cd08224 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEK 222 (267)
T ss_pred eccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhc
Confidence 99999986543211 1223458889999999998899999999999999999999999986421 111111110000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
. ..... .....+..+.+++.+||..+|++|||+.+|+++++++.
T Consensus 223 ~--------~~~~~------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 C--------DYPPL------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C--------CCCCC------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 00000 00134457889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.01 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=204.0
Q ss_pred cCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|+..++||+|+||.||+|... ..+..||+|.++.........+.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence 35778899999999999999753 3455799999876666667789999999999999999999998643 4
Q ss_pred CceeEEEeeccCCchhhccccCCcCC-----cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITRED-----KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
...++||||+++++|.+++....... ........+++..++.++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 67899999999999999996443210 0011223589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 234 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AI 234 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HH
Confidence 999999999999986543222222223335788999999999999999999999999999998 899986422211 00
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
.......+ ...+..+++.+.+++.+||+.||++||++.||.+.|+
T Consensus 235 ~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRE------------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCcc------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000000 0000133456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.44 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=202.2
Q ss_pred cCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
++|.+.+.||+|+||.||+|.+. .....||+|+++... ....+.+.+|+++++++ +||||++++++|..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 110 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI---- 110 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec----
Confidence 46899999999999999999862 334579999987443 33456788999999999 79999999998643
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.+..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 178 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRE--------SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGK 178 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCC
Confidence 3678999999999999999863221 2389999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~ 862 (953)
.+|++|||.++...............++..|+|||++.+..++.++||||+||++|||++ |..||......+ ......
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~ 257 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLI 257 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHH
Confidence 999999999986643322212222346788999999999999999999999999999998 999986532211 111110
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
+...... .....++++.+++.+||+.+|++|||+.|+++.|++.
T Consensus 258 ------------~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 ------------KEGYRMA------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------------HcCCcCC------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000000 0001235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.54 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=199.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.++++++||||+++++++. ..+..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 347999999999999999999998888899999997555455567889999999999999999999864 336789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.++++. ...+++.++..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|
T Consensus 83 iv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred EEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECc
Confidence 99999999999998852 23578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||......+..
T Consensus 150 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------- 218 (267)
T cd06646 150 FGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------- 218 (267)
T ss_pred Cccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---------
Confidence 99998663221 1122345889999999874 345788999999999999999999998642211100
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..+....... .........+.++.+++.+||+.+|++|||++++++.
T Consensus 219 ----~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 219 ----FLMSKSNFQP---------------PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ----eeeecCCCCC---------------CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0000000000 0000011234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.87 Aligned_cols=201 Identities=21% Similarity=0.295 Sum_probs=171.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.|+..+.||+|+||+||+|++..+++.||+|+++.. .......+.+|++++++++||||+++++++. +.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 588899999999999999999999999999999643 2334567889999999999999999999854 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----------MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEe
Confidence 999999999999999852 23578889999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCC---------------------------------------------cccccccccccccccccccCCC
Q 043900 789 DFGLARFLPLSPA---------------------------------------------QTSSIDAKGSIGYIAPEYGLGS 823 (953)
Q Consensus 789 DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 823 (953)
|||+++.+..... ........||+.|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999864321000 0001234699999999999999
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 824 EVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 824 ~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcC
Confidence 999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.65 Aligned_cols=242 Identities=21% Similarity=0.290 Sum_probs=188.6
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++.. .....+....|..++... +||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 4699999999999999998889999999743 223344556677777654 8999999998853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQS----------SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 99999999998852 23588899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~~--- 212 (316)
T cd05592 143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILNDR--- 212 (316)
T ss_pred CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCC---
Confidence 98643222 2223456899999999999999999999999999999999999999753211 1111100000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT-NVVR 931 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 931 (953)
... +..++.++.+++.+||+.||++||++. ++++
T Consensus 213 ---~~~----------------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 ---PHF----------------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CCC----------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 000 012344678999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=344.27 Aligned_cols=286 Identities=22% Similarity=0.277 Sum_probs=199.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC---CCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ---GND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~~ 706 (953)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++....+. ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 357999999999999999999999888899999885322 2345799999999999999999886433221 223
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MA 785 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~ 785 (953)
..++||||+++ ++.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYAR------NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence 56799999975 77776643211 134689999999999999999999999 999999999999998665 79
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||.+....+ .+......
T Consensus 211 kL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~ 286 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQV 286 (440)
T ss_pred eeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 999999998664322 22234689999999998764 68999999999999999999999997532211 11111111
Q ss_pred hCCch--hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHHHH
Q 043900 865 ALPDH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR--QLQSIKN 938 (953)
Q Consensus 865 ~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i~~ 938 (953)
..... ......+ ...+..... ......+...+...++++.+++.+||+.||.+|||+.|+++ .++.+++
T Consensus 287 ~~~p~~~~~~~~~~----~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 287 LGTPTEDQLKEMNP----NYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hCCCCHHHHHHhch----hhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 10000 0000000 000000000 00000001111123567899999999999999999999985 3555543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.71 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=197.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.. .......+.+|+++++.++||||+++++++. .++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 4789999999999999999999988889999999743 2334456788999999999999999999854 4578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK----------KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEE
Confidence 9999999999999999852 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcc------------------------------------cccccccccccccccccCCCCCCcccch
Q 043900 788 SDFGLARFLPLSPAQT------------------------------------SSIDAKGSIGYIAPEYGLGSEVSINGDV 831 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 831 (953)
+|||+++.+....... ......||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999997653211000 0112358999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHH
Q 043900 832 YSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRI 911 (953)
Q Consensus 832 ~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 911 (953)
|||||++|||++|..||...... ......... . .... .......++++.++
T Consensus 223 wSlG~il~el~~G~~Pf~~~~~~-----~~~~~i~~~-----~-~~~~------------------~~~~~~~s~~~~~l 273 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCSDNPQ-----ETYRKIINW-----K-ETLQ------------------FPDEVPLSPEAKDL 273 (364)
T ss_pred ecchhHHHHhhcCCCCCCCCCHH-----HHHHHHHcC-----C-CccC------------------CCCCCCCCHHHHHH
Confidence 99999999999999999753211 111000000 0 0000 00000124467789
Q ss_pred hhccccCCCCCCCC---HHHHHH
Q 043900 912 GVACSMESPGDRMN---MTNVVR 931 (953)
Q Consensus 912 ~~~cl~~dP~~RPt---~~evl~ 931 (953)
+.+|+. +|.+|++ ++|+++
T Consensus 274 i~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 274 IKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHcc-CHhhcCCCCCHHHHhc
Confidence 999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.11 Aligned_cols=202 Identities=24% Similarity=0.298 Sum_probs=173.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||+||+|....+++.||+|+++... ......+.+|+.++.+++||+|+++++++ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47899999999999999999999888899999996432 23345678899999999999999999985 34578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK----------KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEE
Confidence 9999999999999999852 23588999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc---------------------------------ccccccccccccccccccCCCCCCcccchHHH
Q 043900 788 SDFGLARFLPLSPAQ---------------------------------TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~sl 834 (953)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999999765321100 00123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 043900 835 GILLLELVTRKKPVDS 850 (953)
Q Consensus 835 G~vl~elltg~~pf~~ 850 (953)
||++|||++|+.||.+
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.55 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=191.8
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++.. .......+..|.+++..+ +||+|+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 4699999999999999988889999999743 233445677888888876 7999999999853 447799999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQR----------SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccc
Confidence 99999999988852 23578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~--- 212 (321)
T cd05591 143 CKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDD--- 212 (321)
T ss_pred ceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC---
Confidence 97543221 1223346899999999999999999999999999999999999999753211 1111100000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-------CHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-------NMTNVVRQ 932 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~ 932 (953)
.. .+..++.++.+++.+|++.||++|| +++++++.
T Consensus 213 -----~~--------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -----VL--------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -----CC--------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00 0001235688999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.66 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=201.8
Q ss_pred CCcccCcccccceeeEEEEEEcCC-----CeEEEEEEeeccch-hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQG-----KTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+|++.+.||+|+||.||+|.+..+ +..||+|+++.... .....+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----E 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence 477889999999999999997543 46899999974432 234668899999999999999999999643 3
Q ss_pred CceeEEEeeccCCchhhccccCCcC------CcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITRE------DKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
...++++||+++++|.+++...... .........+++..++.++.|++.||+|+|+. +++||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence 6789999999999999998532111 00111234588999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccH
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNL 858 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~ 858 (953)
++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---- 233 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---- 233 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999886543322222233446789999999988899999999999999999998 88888642111
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.+........ ... ....++..+.+++.+||+.+|++||+++||++.|+.
T Consensus 234 -~~~~~i~~~~--------~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 -DVIEMIRNRQ--------VLP-------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHcCC--------cCC-------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111110000 000 011345668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=324.38 Aligned_cols=268 Identities=22% Similarity=0.352 Sum_probs=204.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe--EEEEEEeec-cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT--TVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|++.+.||+|+||.||+|....++. .+++|.++. ......+.+.+|++++.++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 478899999999999999999876553 478888864 3334456789999999999 7999999999864 336
Q ss_pred ceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
..++||||+++++|.++++....... .......+++..++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 78999999999999999965332111 011223589999999999999999999998 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
+++.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 154 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----- 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----- 225 (297)
T ss_pred CCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 9999999999998643211 11111223567999999988899999999999999999998 99998643211
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
...... ..... ...+..++.++.+++.+||+.+|.+|||++++++.|+.+.+.
T Consensus 226 ~~~~~~---------~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 226 ELYEKL---------PQGYR------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHHH---------hcCCC------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 00000 000012345688999999999999999999999999998775
Q ss_pred hc
Q 043900 940 LL 941 (953)
Q Consensus 940 ~~ 941 (953)
..
T Consensus 279 ~~ 280 (297)
T cd05089 279 RK 280 (297)
T ss_pred hc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.84 Aligned_cols=238 Identities=24% Similarity=0.284 Sum_probs=188.8
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|+++.+++.||+|+++.. .......+..|..++... +||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence 4699999999999999988889999999642 233456677888888877 6999999999853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~~----------~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQK----------SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 99999999998852 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~--- 212 (320)
T cd05590 143 CKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE--- 212 (320)
T ss_pred CeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC---
Confidence 87542211 1223346899999999999999999999999999999999999999753211 1111110000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
. . .+...+.++.+++.+|++.||++||++.
T Consensus 213 -----~-~-------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 213 -----V-V-------------------YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred -----C-C-------------------CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 0 0 0001245688999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.01 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=190.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCC-CeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHR-NLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 707 (953)
+|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|.+++..+.|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 488899999999999999999998889999999742 233456778899999999765 577887774 34478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEE
Confidence 9999999999999998852 23578899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ......
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i-- 213 (324)
T cd05587 143 ADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSI-- 213 (324)
T ss_pred eecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHH--
Confidence 9999987532111 1223346899999999999999999999999999999999999999753211 111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
..... . .+...+.++.+++.+||..||++||++
T Consensus 214 ------~~~~~--~------------------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 214 ------MEHNV--S------------------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------HcCCC--C------------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00000 0 000223467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.78 Aligned_cols=283 Identities=20% Similarity=0.241 Sum_probs=200.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+++++.++||||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999888889999998632 233456788999999999999999999997544222223789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----------PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 9999996 578777742 23689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||+++....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||......+ ...........
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~ 223 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGT 223 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence 999986543221 222334578999999998774 47899999999999999999999997532211 11111111110
Q ss_pred hhhhhccccccCCchhhhhcccc--hhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQ--RQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...+.+...... .......... +............++++.+++.+|++.||++|||++|+++.
T Consensus 224 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRSACEG-ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHHhhHH-HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 0000000000 00000000111235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.74 Aligned_cols=277 Identities=22% Similarity=0.322 Sum_probs=199.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 57999999999999999999999888899999987433 223456778999999999999999999964 346799
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC---------GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCCC-CHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 99999975 888877422 22478899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++...... .......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ......+ ....
T Consensus 148 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~-~~~~ 223 (309)
T cd07872 148 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFR-LLGT 223 (309)
T ss_pred cccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCC
Confidence 99997643221 12223457899999998765 468899999999999999999999997532221 1111111 1111
Q ss_pred hhhhhcccccc-CCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLL-SDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+....... ............ +..........+.++.+++.+|++.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 224 PTEETWPGISSNDEFKNYNFPKYK--PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCHHHHhhhcchhhhhhhhcCccC--CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 10000000000 000000000000 00000111234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=340.23 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=201.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|.+.+.||+|+||+||+|++..+++.||+|+++... ......+.+|++++..++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 46899999999999999999999888899999997432 23456788999999999999999999884 44578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK----------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEe
Confidence 99999999999999999532 3588999999999999999999998 9999999999999999999999
Q ss_pred eccccceecCCCC---------------------------CcccccccccccccccccccCCCCCCcccchHHHHHHHHH
Q 043900 788 SDFGLARFLPLSP---------------------------AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 840 (953)
Q Consensus 788 ~DfG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~e 840 (953)
+|||++....... .........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998664332 0112234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 043900 841 LVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920 (953)
Q Consensus 841 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 920 (953)
|++|+.||...... ........ .. .... .......++++.+++.+|++ ||
T Consensus 223 ll~g~~Pf~~~~~~-----~~~~~i~~-----~~-~~~~------------------~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 223 MLYGFPPFYSDTLQ-----ETYNKIIN-----WK-ESLR------------------FPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred hccCCCCCCCCCHH-----HHHHHHhc-----cC-Cccc------------------CCCCCCCCHHHHHHHHHHcc-Ch
Confidence 99999999753211 00000000 00 0000 00000134568899999997 99
Q ss_pred CCCCC-HHHHHHH
Q 043900 921 GDRMN-MTNVVRQ 932 (953)
Q Consensus 921 ~~RPt-~~evl~~ 932 (953)
.+||+ ++|+++.
T Consensus 273 ~~R~~s~~~ll~h 285 (350)
T cd05573 273 EDRLGSFEEIKSH 285 (350)
T ss_pred hhcCCCHHHHhcC
Confidence 99999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=333.25 Aligned_cols=205 Identities=26% Similarity=0.294 Sum_probs=171.5
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 704 (953)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++.... ...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3467899999999999999999999988889999998632 3344567889999999999999999999875321 122
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCC
Confidence 2457999999965 5666552 2477888999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 162 ~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 162 LKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred EEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999754321 1223346899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.79 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=201.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.++||+|+||.||+|++.++. .||+|+++.... ..+.+.+|++++++++||||+++++++. ....++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI 77 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEE
Confidence 56899999999999999999987765 699999874332 3457889999999999999999998742 245789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEM--------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred EEEcCCCCcHHHHHhhcc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccC
Confidence 999999999999996321 23578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++.+...... ......++..|+|||+..+..++.++||||||+++||++| |..||......+ ....
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~----- 215 (262)
T cd05071 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQ----- 215 (262)
T ss_pred Cceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHH-----
Confidence 999876433221 1223346778999999988899999999999999999999 888886432111 0000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
...... ......++..+.+++.+|++.||++||+++++++.|++.
T Consensus 216 ----~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 216 ----VERGYR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----HhcCCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000000 000113456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.72 Aligned_cols=271 Identities=20% Similarity=0.325 Sum_probs=201.1
Q ss_pred cCCcccCcccccceeeEEEEEEcCC--------------CeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEe
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG--------------KTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILT 695 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~ 695 (953)
++|++.+.||+|+||.||+|...+. ...||+|+++.. .......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5789999999999999999987543 235899998643 3334567899999999999999999999
Q ss_pred eecccccCCCCceeEEEeeccCCchhhccccCCcCCc--ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 696 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
++. .....++||||+++++|.+++........ .......+++..++.++.|++.||+|||+. +++|||||
T Consensus 85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 964 34678999999999999999864321100 011123478999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCCc
Q 043900 774 PSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPVDSM 851 (953)
Q Consensus 774 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt--g~~pf~~~ 851 (953)
|+||++++++.+||+|||++................++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999976543322222223345778999999988899999999999999999998 56677642
Q ss_pred ccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 852 FEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... ................ . ......+++.+.+++.+||+.||++||++++|++
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~----~-------------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQ--VIENTGEFFRNQGRQI----Y-------------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHH--HHHHHHHhhhhccccc----c-------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2111 1000000000000000 0 0000123457999999999999999999999999
Q ss_pred HHH
Q 043900 932 QLQ 934 (953)
Q Consensus 932 ~L~ 934 (953)
.|+
T Consensus 292 ~l~ 294 (295)
T cd05097 292 FLR 294 (295)
T ss_pred HHh
Confidence 886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=325.04 Aligned_cols=272 Identities=22% Similarity=0.367 Sum_probs=208.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEc-------CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILD-------QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
..++|.+.+.||+|+||.||+|+.. .....||+|.++.. .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 3457889999999999999999852 22347999998643 234457789999999999 8999999999864
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcc------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
.....++||||+++|+|.+++......... ......+++.+++.++.||++||+|||+. |++|||||
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 346789999999999999999754321100 01234689999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcc
Q 043900 774 PSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMF 852 (953)
Q Consensus 774 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~ 852 (953)
|+||++++++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++||+++ |..||....
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654333222333346778999999999899999999999999999998 788875421
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. ........... . ......++.++.+++.+||+.+|++|||+.|+++.
T Consensus 245 ~-----~~~~~~~~~~~---------~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 V-----EELFKLLKEGH---------R------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred H-----HHHHHHHHcCC---------c------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1 11111100000 0 00011345678899999999999999999999999
Q ss_pred HHHHHHHh
Q 043900 933 LQSIKNIL 940 (953)
Q Consensus 933 L~~i~~~~ 940 (953)
|+++....
T Consensus 293 l~~~~~~~ 300 (304)
T cd05101 293 LDRILTLT 300 (304)
T ss_pred HHHHHHhh
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.50 Aligned_cols=254 Identities=20% Similarity=0.232 Sum_probs=198.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|+...+++.||+|+++.. .......+.+|+.+++.++||||+++++++ .++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 45799999999999999999999998889999999632 223345578899999999999999999885 3457
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~k 182 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEE
Confidence 89999999999999999852 2477888899999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
|+|||.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 183 L~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~ 256 (370)
T cd05596 183 LADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTY 256 (370)
T ss_pred EEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHH
Confidence 999999986643221 122345699999999987653 4789999999999999999999999752211 011
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD--RMNMTNVVRQ 932 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 932 (953)
.. +.+.... ...+.....+.++.+++.+|++.+|++ |||++|+++.
T Consensus 257 ~~--------i~~~~~~----------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 SK--------IMDHKNS----------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HH--------HHcCCCc----------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10 1000000 000000123456889999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.61 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=193.9
Q ss_pred cccccceeeEEEEEEc--CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEee
Q 043900 638 EIGVGSFGSVYKGILD--QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
.||+|+||.||+|.+. +++..||+|++.... ....+.+.+|+.++++++||||++++++|. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 4899999999999875 444579999987543 233467889999999999999999999863 2467999999
Q ss_pred ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccce
Q 043900 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR 794 (953)
Q Consensus 715 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 794 (953)
+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 76 ~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSGK---------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence 9999999998532 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 795 FLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 795 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
......... ......++..|+|||++.+..++.++|||||||++||+++ |..||......+ ......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~--------- 212 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIE--------- 212 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHH---------
Confidence 654322211 1112224578999999988889999999999999999996 999987532211 111110
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
..... ..+..+++++.+++.+||+.||++||++.+|.+.|+.+
T Consensus 213 ---~~~~~------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 ---QGKRL------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00000 00113456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.92 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=201.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++|||++++++++.. +...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence 578899999999999999999988888999999976555556778899999999999999999998643 468999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred eecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999842 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|.+....... .......+++.|+|||.+.+..++.++|||||||++|||++|+.||....... .+.... ....
T Consensus 161 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~-~~~~ 233 (296)
T cd06654 161 GFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA-TNGT 233 (296)
T ss_pred ccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHh-cCCC
Confidence 9987653221 11223458899999999998889999999999999999999999996432111 000000 0000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.. ......+..+.+++.+||..||++|||+.|+++
T Consensus 234 -----~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 -----PEL--------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -----CCC--------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 001123456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.82 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=192.2
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|..++.++ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 4699999999999999998899999999743 233445678899999988 7999999999854 447889999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcc
Confidence 99999999988842 23689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC---ccHHHHHHhhCCch
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD---MNLHNFARMALPDH 869 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~ 869 (953)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....+.....
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--- 217 (329)
T cd05588 143 CKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--- 217 (329)
T ss_pred ccccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---
Confidence 9743211 112233568999999999999999999999999999999999999996421111 11111111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC------HHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN------MTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~ 931 (953)
..... ..+..++.++.+++.+|++.||++||+ ++|+++
T Consensus 218 ----~~~~~--------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 218 ----LEKQI--------------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----HcCCC--------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 00000 000123456889999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.22 Aligned_cols=366 Identities=29% Similarity=0.473 Sum_probs=251.1
Q ss_pred CCCcEEeCCCCccc-cccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEe
Q 043900 52 QRLQVLALNNNSIG-GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLF 130 (953)
Q Consensus 52 ~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 130 (953)
+-.+-.|+++|.++ +..|.....++.++.|.|...++. .+|++++.|.+|++|.+++|++. .+-+.++.|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 34445555666555 456666666666666666666666 77888888888888888888877 6667778888888888
Q ss_pred ccccccc-ccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccc
Q 043900 131 LTDNNLD-GGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209 (953)
Q Consensus 131 L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 209 (953)
+.+|+++ .-+|..+-.|..|+.|+|++|+++ ..|..+.+-.++-.|+||+|+|. .+|..++.++..|-+|+|++|++
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchh
Confidence 8888874 345666777888888888888887 77888888888888888888888 78888888888899999999998
Q ss_pred cCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCccc-c
Q 043900 210 TGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFG-G 288 (953)
Q Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~-~ 288 (953)
. .+|.-+..+.+|++|+|++|.+.-- -+..++.++.|..|.+++.+-+ .
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hf-----------------------------QLrQLPsmtsL~vLhms~TqRTl~ 212 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNHF-----------------------------QLRQLPSMTSLSVLHMSNTQRTLD 212 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhHH-----------------------------HHhcCccchhhhhhhcccccchhh
Confidence 8 6777788888999999999887621 1222333333333333332221 2
Q ss_pred cCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCC
Q 043900 289 LLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIG 368 (953)
Q Consensus 289 ~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 368 (953)
-+|.++..+ .+|..+||+.|.+. ..|+++.++.+|+.|+||+|+|+ .+....+...+|++|+||+|+++
T Consensus 213 N~Ptsld~l-~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-------- 281 (1255)
T KOG0444|consen 213 NIPTSLDDL-HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-------- 281 (1255)
T ss_pred cCCCchhhh-hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc--------
Confidence 234444443 34444445554444 44444444444555555555444 23333344444444444444444
Q ss_pred CceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCcccee
Q 043900 369 NLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVL 448 (953)
Q Consensus 369 ~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L 448 (953)
.+|++++.+++|+.|++.+|+++ +. -+|+.++.|.+|+.+
T Consensus 282 ----------------~LP~avcKL~kL~kLy~n~NkL~-----------------------Fe-GiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 282 ----------------VLPDAVCKLTKLTKLYANNNKLT-----------------------FE-GIPSGIGKLIQLEVF 321 (1255)
T ss_pred ----------------cchHHHhhhHHHHHHHhccCccc-----------------------cc-CCccchhhhhhhHHH
Confidence 57777777777777777777765 11 367788888888888
Q ss_pred eecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCccc
Q 043900 449 DVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS 504 (953)
Q Consensus 449 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (953)
..++|.+. .+|+.++.|..|+.|.|++|++- .+|+++.-|+.|++|||..|.=-
T Consensus 322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred Hhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 88888887 78888888888888888888887 68888888888888888888644
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=325.90 Aligned_cols=272 Identities=23% Similarity=0.379 Sum_probs=207.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC-------CeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG-------KTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++|.+.+.||+|+||.||+|.+... ...||+|.++.. .......+.+|+++++++ +||||++++++|.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 35799999999999999999987432 246999999743 233456788899999999 7999999999964
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
..+..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 33678999999999999999975432110 001223589999999999999999999998 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~- 247 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 999999999999999999976543221111222234578999999999899999999999999999998 888885421
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
....... +.... +...+..++.++.+++.+||..+|++|||+.||++.|
T Consensus 248 ----~~~~~~~---------~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 248 ----VEELFKL---------LKEGH------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred ----HHHHHHH---------HHcCC------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 1111110 00000 0001113345788999999999999999999999999
Q ss_pred HHHHHHhc
Q 043900 934 QSIKNILL 941 (953)
Q Consensus 934 ~~i~~~~~ 941 (953)
+++.....
T Consensus 297 ~~~~~~~~ 304 (307)
T cd05098 297 DRILALTS 304 (307)
T ss_pred HHHHHHhh
Confidence 99887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.67 Aligned_cols=243 Identities=22% Similarity=0.286 Sum_probs=188.7
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++.++ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 4699999999999999999889999999743 233445677888888777 7999999999854 347899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 99999999988742 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC---ccHHHHHHhhCCch
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD---MNLHNFARMALPDH 869 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~ 869 (953)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 220 (329)
T cd05618 143 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220 (329)
T ss_pred cccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC
Confidence 97532211 12233568999999999999999999999999999999999999996422111 11111111100000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
.. ..+...+.++.+++.+||+.||++||++
T Consensus 221 -------~~--------------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 -------QI--------------------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -------CC--------------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 00 0001234568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.18 Aligned_cols=253 Identities=19% Similarity=0.197 Sum_probs=198.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|.+.+.||+|+||+||+|.+..+++.||+|+++... ....+.+.+|+.+++.++||+|+++++++. +.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 46889999999999999999999888999999997432 234567889999999999999999998853 4477
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE---------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEe
Confidence 999999999999999996321 3588999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL------GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+|||++......... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ..
T Consensus 144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~ 217 (330)
T cd05601 144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KT 217 (330)
T ss_pred ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HH
Confidence 999999876433221 223346899999999986 456789999999999999999999999642211 11
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........ . .. . .......+.++.+++..|++ +|++|||++++++
T Consensus 218 ~~~i~~~~--~----~~-~-----------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 218 YNNIMNFQ--R----FL-K-----------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHcCC--C----cc-C-----------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11000000 0 00 0 00001234568899999997 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=334.58 Aligned_cols=283 Identities=20% Similarity=0.195 Sum_probs=202.3
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 704 (953)
...++|++.+.||+|+||.||+|.+...++.||+|++... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4567899999999999999999999888889999998642 2334567889999999999999999999875321 223
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+++ ++.+++. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~ 157 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence 3467999999965 6666663 2478889999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus 158 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~ 233 (355)
T cd07874 158 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ 233 (355)
T ss_pred EEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 999999999865322 12233468999999999999999999999999999999999999997532111 11111110
Q ss_pred hC----------CchhhhhccccccCCchhhhhcccch--hhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 AL----------PDHVVDIVDSTLLSDDEDLAVHGNQR--QRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~----------~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.. ........+.... ........... ..............++.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 234 LGTPCPEFMKKLQPTVRNYVENRPK--YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hCCCCHHHHHhhcHHHHHHHhcCCc--cccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0000111100000 00000000000 0000000111234568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.56 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=202.1
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|.+.+.||+|++|.||+|+...+++.||+|.+... .......+.+|++++++++|||++++++++. .++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 477889999999999999999988889999998632 3445678889999999999999999999854 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQR--------GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcc
Confidence 9999999999999996432 23688999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.++....... ......|++.|+|||+..+..++.++|||||||++|||++|+.||...... .........
T Consensus 145 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~- 216 (256)
T cd08529 145 LGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILKIIRG- 216 (256)
T ss_pred cccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcC-
Confidence 999987643221 122345888999999999999999999999999999999999999743211 111100000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... ......+.++.+++.+||+.+|++||++.|+++.
T Consensus 217 -------~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 -------VFP-------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -------CCC-------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 0001234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=318.99 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=201.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe---EEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT---TVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.+|++.+.||+|+||.||+|+...+++ .||+|+++.. .......+..|+.++++++||||+++++++. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence 357889999999999999999876543 5999998754 3445678999999999999999999999853 446
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence 789999999999999998532 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCccccccc---ccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDA---KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~ 862 (953)
|+|||.+............... ..+..|+|||++.+..++.++|||||||++||+++ |..||...... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i 224 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI 224 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH
Confidence 9999999866433221111111 12457999999999999999999999999999887 99998653211 111111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.... +.....+++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 225 ~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDY------------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCC------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0000113456688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.13 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=189.4
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++... .........|..++... +||||+++++++. ..+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999988899999997431 23345567788888764 8999999999854 347799999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQS----------CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999852 23578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.....
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~------- 211 (316)
T cd05619 143 CKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD------- 211 (316)
T ss_pred ceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-------
Confidence 97542211 1223346899999999999999999999999999999999999999752111 010000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT-NVVR 931 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 931 (953)
.... +.....++.+++.+||+.||++||++. ++.+
T Consensus 212 --~~~~----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 --NPCY----------------------PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCC----------------------CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0000 001234578999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.48 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=197.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|.+.+.. .||+|.++... .....+.+|+.++++++||||++++++|.. ....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~-~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCC-cEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 46888999999999999999887654 69999887432 234678999999999999999999999643 356899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLREH---------GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence 99999999999998532 12588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||......+ ...... ...
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~---~~~ 218 (256)
T cd05113 145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVS---QGL 218 (256)
T ss_pred ccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHh---cCC
Confidence 99986543221 12222335678999999988889999999999999999999 999986422110 000000 000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
... .....+..+.+++.+||+.+|++|||+.++++.++
T Consensus 219 --------~~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 --------RLY-------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --------CCC-------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000 00012456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.80 Aligned_cols=271 Identities=18% Similarity=0.309 Sum_probs=202.6
Q ss_pred cCCcccCcccccceeeEEEEEEcC----------------CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ----------------GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKI 693 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~ 693 (953)
++|++.+.||+|+||.||+|.+.. +...||+|+++.. .......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468999999999999999986532 3346999999743 33445688999999999999999999
Q ss_pred EeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcc-cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC
Q 043900 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT-EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDL 772 (953)
Q Consensus 694 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 772 (953)
++++.. ++..++||||+++++|.+++......... ......+++.+++.++.|++.|++|||+. +++||||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 998643 36789999999999999999754322111 12234588999999999999999999999 9999999
Q ss_pred CCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCC
Q 043900 773 KPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPVDS 850 (953)
Q Consensus 773 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt--g~~pf~~ 850 (953)
||+||+++.++.++|+|||.++.+.............++..|+|||+..++.++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986543322222222335678999999888899999999999999999998 7788764
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
....+ .... ............ .......++..+.+++.+||+.||++||++.||+
T Consensus 237 ~~~~~-----~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 237 LSDEQ-----VIEN-----TGEFFRDQGRQV---------------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cChHH-----HHHH-----HHHHHhhccccc---------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 32211 1000 000000000000 0000112446789999999999999999999999
Q ss_pred HHHH
Q 043900 931 RQLQ 934 (953)
Q Consensus 931 ~~L~ 934 (953)
+.|+
T Consensus 292 ~~l~ 295 (296)
T cd05095 292 ATLL 295 (296)
T ss_pred HHHh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=329.76 Aligned_cols=242 Identities=21% Similarity=0.255 Sum_probs=191.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+..|..++..+ +|++|+++++++. ..+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 4788999999999999999999988899999997432 22344567788888777 5899999988853 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEE
Confidence 9999999999999988852 23578899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......
T Consensus 143 ~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~~~i-- 213 (323)
T cd05616 143 ADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSI-- 213 (323)
T ss_pred ccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHHHHH--
Confidence 9999997543211 1223456899999999999999999999999999999999999999753211 111100
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
...... .+...+.++.+++.+|++.||++|+++
T Consensus 214 ------~~~~~~--------------------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 214 ------MEHNVA--------------------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------HhCCCC--------------------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 000000 000234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.11 Aligned_cols=254 Identities=21% Similarity=0.290 Sum_probs=199.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++. ..+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEE
Confidence 347888899999999999999999888899999998665555667889999999999999999999853 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.. ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|
T Consensus 83 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV----------TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred EEEeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 99999999999999852 23588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||.+...... ........|+..|+|||++. ...++.++||||+||++|||++|..||......... ........
T Consensus 150 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~ 226 (267)
T cd06645 150 FGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKSNF 226 (267)
T ss_pred ceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-HhhhccCC
Confidence 9999765422 11223346899999999874 456889999999999999999999998643211100 00000000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. +.. .....++..+.+++.+|++.+|++||+++++++
T Consensus 227 ~~-------~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QP-------PKL--------------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CC-------Ccc--------------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 000 000012345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.66 Aligned_cols=255 Identities=19% Similarity=0.231 Sum_probs=196.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+.+++.++||||+++++++ ..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 346799999999999999999999998889999998632 223345678899999999999999999985 345
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence 789999999999999999852 2478888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
||+|||+|........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..
T Consensus 182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~ 255 (370)
T cd05621 182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GT 255 (370)
T ss_pred EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HH
Confidence 9999999987643221 122345699999999998654 3788999999999999999999999742111 01
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD--RMNMTNVVRQ 932 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 932 (953)
.. .+.+..... ..+.....+..+.+++..|++.+|.+ ||+++|+++.
T Consensus 256 ~~--------~i~~~~~~~----------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 YS--------KIMDHKNSL----------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HH--------HHHhCCccc----------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 011000000 00001123456778888999755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.29 Aligned_cols=258 Identities=23% Similarity=0.410 Sum_probs=202.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC---eEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK---TTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|+..+.||+|+||.||+|+...++ ..||+|.++.. .....+.+.+|++++++++|||++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 346788899999999999999986543 36999998644 3344567889999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.++++.. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDH---------DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence 6789999999999999998532 23588999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccc-cccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSS-IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
||+|||++............ .....+..|+|||++.+..++.++|||||||++||+++ |+.||...... ....
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~ 221 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMK 221 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHH
Confidence 99999999876433221111 11223567999999988889999999999999999998 99998642211 1111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
... .... .+....++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 222 ~i~--------~~~~-------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 AIN--------DGFR-------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHh--------cCCC-------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 0000 000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.21 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=203.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++... ......+.+|+.++++++|||+++++++|..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 4578999999999999999999753 45689999987433 3345678899999999999999999998643
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCc------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDK------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCD 771 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 771 (953)
+...++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++|||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 3678999999999999999964322111 111224588999999999999999999998 999999
Q ss_pred CCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 043900 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDS 850 (953)
Q Consensus 772 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~ 850 (953)
|||+||++++++.++|+|||.+..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976543222222222335678999999998899999999999999999998 8888864
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
.... +........ .... ....++.++.+++.+||+.||++|||+.|++
T Consensus 236 ~~~~-----~~~~~~~~~--------~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 236 MAHE-----EVIYYVRDG--------NVLS-------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CCHH-----HHHHHHhcC--------CCCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 2211 111110000 0000 0012345789999999999999999999999
Q ss_pred HHHH
Q 043900 931 RQLQ 934 (953)
Q Consensus 931 ~~L~ 934 (953)
+.|+
T Consensus 284 ~~l~ 287 (288)
T cd05050 284 RILQ 287 (288)
T ss_pred HHhh
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.26 Aligned_cols=242 Identities=23% Similarity=0.250 Sum_probs=190.4
Q ss_pred CcccccceeeEEEEEEc---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 637 NEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+.||+|+||.||+|+.. ..++.||+|+++... ......+.+|+++++.++||||+++++++. .++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 67999999999999874 456789999997422 223456778999999999999999998853 346799
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 77 LILEYLSGGELFMHLER----------EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EEEeCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEee
Confidence 99999999999999852 23577888899999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 144 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~--- 213 (323)
T cd05584 144 FGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKIL--- 213 (323)
T ss_pred CcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---
Confidence 99997543221 1222346899999999999989999999999999999999999999752111 1111110
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.... ..+...++++.+++.+||+.||++|| +++++++
T Consensus 214 -----~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 214 -----KGKL--------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----cCCC--------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0000 00012245688999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=328.92 Aligned_cols=242 Identities=22% Similarity=0.266 Sum_probs=192.2
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|.+..+++.||+|+++.. .......+..|.++++.+ +||||+++++++. ..+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 4699999999999999988889999999743 233456677888888888 7999999999854 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCC
Confidence 99999999988852 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 143 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~~~~--- 212 (318)
T cd05570 143 CKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDE--- 212 (318)
T ss_pred CeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHHcCC---
Confidence 97532211 1222345899999999999999999999999999999999999999743211 1111000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH-----HHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM-----TNVVR 931 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 931 (953)
. ..+...+.++.+++.+||+.||++||++ .++++
T Consensus 213 -----~--------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 -----V--------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----C--------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0 0001234568899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.95 Aligned_cols=273 Identities=22% Similarity=0.364 Sum_probs=207.0
Q ss_pred hcCCcccCcccccceeeEEEEEEc-------CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-------QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++|.+.+.||+|+||.||+|+.. .....||+|.++.. .......+.+|+.+++++ +||||++++++|..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 357889999999999999999863 23456999998743 234456788999999999 69999999998643
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
....++||||+++|+|.+++........ .......+++.++..++.|++.||+|||++ |++||||||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 3678999999999999999965332100 011234689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986643222211222234568999999999899999999999999999999 8888864211
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. ........... ......++.++.+++.+||+.+|++|||+.|+++.|
T Consensus 243 ~-----~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 243 E-----ELFKLLREGHR---------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred H-----HHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 11110000000 000112345688999999999999999999999999
Q ss_pred HHHHHHhcc
Q 043900 934 QSIKNILLG 942 (953)
Q Consensus 934 ~~i~~~~~~ 942 (953)
+++......
T Consensus 291 ~~~~~~~~~ 299 (314)
T cd05099 291 DKVLAAVSE 299 (314)
T ss_pred HHHHHHhcC
Confidence 998765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.58 Aligned_cols=272 Identities=23% Similarity=0.342 Sum_probs=204.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC----------------eEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeE
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK----------------TTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVK 692 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 692 (953)
.++|++.+.||+|+||.||+|++...+ ..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999999876532 468999987433 345678899999999999999999
Q ss_pred EEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcc-cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 043900 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT-EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCD 771 (953)
Q Consensus 693 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 771 (953)
++++|. .++..++||||+++++|.+++......... ......+++..++.++.|++.||+|||+. +++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999964 337889999999999999999654321111 11233689999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCC
Q 043900 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPVD 849 (953)
Q Consensus 772 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt--g~~pf~ 849 (953)
|||+||+++.++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543332222334456789999999988899999999999999999998 677775
Q ss_pred CcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 043900 850 SMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV 929 (953)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 929 (953)
.....+ ................ .......++.++.+++.+||+.||++|||+.||
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 236 HLTDQQ--VIENAGHFFRDDGRQI-----------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CcChHH--HHHHHHhccccccccc-----------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 422111 1011100000000000 000011234579999999999999999999999
Q ss_pred HHHHH
Q 043900 930 VRQLQ 934 (953)
Q Consensus 930 l~~L~ 934 (953)
++.|+
T Consensus 291 ~~~L~ 295 (296)
T cd05051 291 HLFLQ 295 (296)
T ss_pred HHHhc
Confidence 99885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=328.57 Aligned_cols=241 Identities=22% Similarity=0.304 Sum_probs=188.9
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++... .........|..++... +||+|+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 46999999999999999988899999997432 23345567788887765 8999999999853 457899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQD----------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCC
Confidence 99999999998852 23578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~------- 211 (316)
T cd05620 143 CKENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVD------- 211 (316)
T ss_pred CeecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-------
Confidence 8753211 11223456899999999999999999999999999999999999999742211 010000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT-NVV 930 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 930 (953)
.... +...+.++.+++.+||+.||++||++. ++.
T Consensus 212 --~~~~----------------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 --TPHY----------------------PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCC----------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000 001234678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.46 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=203.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+.|+..+.||.|.-|+||+|+.+++...+|+|++.... .....+...|-+||+.++||.++.+|+. ++.+..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 35677889999999999999999998999999996432 3345677889999999999999999998 556688
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+|||||+||+|....++... +.+++..++-+|.+++-||+|||-. |||.|||||+||||.++|.+.|
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~--------~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG--------KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC--------CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEe
Confidence 9999999999999999975443 4799999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCC------------------------------------------------------Ccccccccccccc
Q 043900 788 SDFGLARFLPLSP------------------------------------------------------AQTSSIDAKGSIG 813 (953)
Q Consensus 788 ~DfG~a~~~~~~~------------------------------------------------------~~~~~~~~~gt~~ 813 (953)
+||.++......+ ....+...+||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 9999985432100 0011123459999
Q ss_pred cccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchh
Q 043900 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQ 893 (953)
Q Consensus 814 y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 893 (953)
|.|||++.|...+.++|.|+|||++|||+.|..||.+....+ .+... +.+.+
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NI------------v~~~l--------------- 352 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNI------------VGQPL--------------- 352 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHH------------hcCCC---------------
Confidence 999999999999999999999999999999999998643322 11111 11100
Q ss_pred hhhhhhhHHHHHHHHHHHhhccccCCCCCCCC----HHHHHH
Q 043900 894 RQARINSKIECLVAMVRIGVACSMESPGDRMN----MTNVVR 931 (953)
Q Consensus 894 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 931 (953)
.+....+.+.+..++|++.|.+||.+|.. |.||.+
T Consensus 353 ---~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 353 ---KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ---cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 11111244567889999999999999988 777654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.65 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=197.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|++++++++||||++++++|.. .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 3678889999999999999999888889999998643 23345678899999999999999999999643 36789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999997653 367888999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH--HHHHHhhCC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL--HNFARMALP 867 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~--~~~~~~~~~ 867 (953)
||++...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .........
T Consensus 139 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 214 (279)
T cd06619 139 FGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214 (279)
T ss_pred CCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc
Confidence 9999865322 1223468999999999999999999999999999999999999997533221110 000000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.. .... .....++++.+++.+||+.+|++||+++|+++.
T Consensus 215 ~~-----~~~~---------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 215 ED-----PPVL---------------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cC-----CCCC---------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 0000 000223568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.16 Aligned_cols=203 Identities=22% Similarity=0.298 Sum_probs=172.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|+...+++.||+|++.... ......+.+|++++++++||||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999999988999999986322 22346688999999999999999999985 34578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999853 23578888999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCC-----------------------------------------cccccccccccccccccccCCCCCC
Q 043900 788 SDFGLARFLPLSPA-----------------------------------------QTSSIDAKGSIGYIAPEYGLGSEVS 826 (953)
Q Consensus 788 ~DfG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 826 (953)
+|||+|..+..... ........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999853311000 0001134699999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCCCCc
Q 043900 827 INGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 827 ~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
.++|||||||++|||++|+.||...
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=338.46 Aligned_cols=202 Identities=22% Similarity=0.269 Sum_probs=171.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++++++||||+++++++. ++..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 4689999999999999999999999999999998642 2234567888999999999999999999854 4578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 9999999999999999852 23578889999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc------------c---------------------------------cccccccccccccccccCC
Q 043900 788 SDFGLARFLPLSPAQ------------T---------------------------------SSIDAKGSIGYIAPEYGLG 822 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~ 822 (953)
+|||+++.+...... . ......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 999999643211000 0 0012459999999999999
Q ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 823 SEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 823 ~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
..++.++|||||||++|||++|..||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 9999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.44 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=199.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|....+. .||+|.++.... ..+.+.+|+.++++++|++++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNT-KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCc-eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence 46889999999999999999887654 799999875333 3467899999999999999999998852 245789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.++++... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGE--------GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred EEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCc
Confidence 999999999999986322 23588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.+......... ......++..|+|||+..+..++.++||||||+++|||++ |..||......+ .......
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~----- 218 (260)
T cd05070 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVER----- 218 (260)
T ss_pred eeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHc-----
Confidence 999876432211 1122335678999999988899999999999999999999 889986422110 1111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
... .+.+...+.++.+++.+||+.+|++|||+.++.+.|++
T Consensus 219 -------~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 -------GYR------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------CCC------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 00011234568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.04 Aligned_cols=284 Identities=19% Similarity=0.228 Sum_probs=201.7
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-c
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-Y 702 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~ 702 (953)
.....++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.++++++||||+++++++.... .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3456688999999999999999999998888899999986432 223456778999999999999999998864321 1
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
......++++|++ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~ 154 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNED 154 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCC
Confidence 2234578999998 789988874 23589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....+
T Consensus 155 ~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~ 228 (343)
T cd07878 155 CELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRI 228 (343)
T ss_pred CCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 99999999999865322 223468999999999877 568899999999999999999999996532111 11111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN-SKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... .....+...... ..............+..... ......+.+.+++.+|++.||++|||++|+++.
T Consensus 229 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 229 MEVV-GTPSPEVLKKIS-SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHh-CCCCHHHHHhcc-hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 000000000000 00000000000000000000 001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.30 Aligned_cols=266 Identities=24% Similarity=0.394 Sum_probs=202.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT--TVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|++.+.||+|+||.||+|.+..++. .+|+|.++.. .......+.+|++++.++ +||||+++++++. .++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence 468888999999999999999876553 4677776532 334456788999999999 8999999999964 346
Q ss_pred ceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
..++||||+++++|.++++....... .......+++.+++.++.|++.|++|||+. |++||||||+||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence 78999999999999999965432110 011234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
+++.+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 159 ~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----- 230 (303)
T cd05088 159 ENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 230 (303)
T ss_pred CCCcEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----
Confidence 999999999999864321 111111234678999999988889999999999999999998 99998642211
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
...... +.. . +.......+.++.+++.+||+.+|++||+++++++.++.+...
T Consensus 231 ~~~~~~-~~~--------~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 231 ELYEKL-PQG--------Y------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHHH-hcC--------C------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 000 0 0000012345688999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=333.25 Aligned_cols=205 Identities=23% Similarity=0.279 Sum_probs=172.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 704 (953)
...++|++.+.||+|+||.||+|.+...++.||||++... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3467899999999999999999999988889999998642 2334567889999999999999999999864321 223
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+++ ++.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCc
Confidence 3568999999965 6766663 2477888999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 165 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred EEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999865322 1223346899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.75 Aligned_cols=272 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred CCcccCcccccceeeEEEEEE----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.|++.+.||+|+||.||+|.+ ..++..||+|.++... ......+.+|++++++++|||++++.+++.. .+..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence 478889999999999999985 3456789999987443 3345678999999999999999999998743 2235
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ...+++.++..++.|++.||+|||+. |++||||||+||+++.++.+|
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN---------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence 689999999999999998522 12589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.++........ .......++..|+|||++.+..++.++|||||||++|||+|++.|+....... .......
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~~ 226 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGPT 226 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhcccc
Confidence 9999999876432221 11123446778999999988899999999999999999999887654321100 0000000
Q ss_pred CCch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 866 LPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 866 ~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
..+. ........ . ...+.+....++.++.+++.+||+.+|++|||++++++.++++
T Consensus 227 ~~~~~~~~~~~~~---------~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 227 HGQMTVTRLVRVL---------E------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccHHHHHHHH---------H------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 00000000 0 0000011113456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=329.47 Aligned_cols=252 Identities=22% Similarity=0.238 Sum_probs=194.2
Q ss_pred CCcccCcccccceeeEEEEEEc---CCCeEEEEEEeecc----chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 632 GFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLL----HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
+|++.+.||+|+||.||+|+.. .+++.||+|+++.. .....+.+.+|+.+++++ +||+|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4888999999999999999874 45678999999632 223345678899999999 599999999884 3
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.++..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----------RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence 45778999999999999999852 23588999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
.+||+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ......
T Consensus 143 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~ 220 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVS 220 (332)
T ss_pred CEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHH
Confidence 999999999986532222 122235699999999998875 47889999999999999999999996432211 111111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
...... +... +...+..+.+++.+||+.||++|| +++++++
T Consensus 221 ~~~~~~------~~~~----------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 RRILKC------DPPF----------------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHhcC------CCCC----------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 110000 0000 012345688999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.95 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=189.7
Q ss_pred CcccccceeeEEEEEEcC--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQ--GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|.+.+ +...+|+|.++... ......+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 368999999999998754 34579999886443 2334578889999999999999999998643 366899999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-----ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhhhc-----ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence 99999999999643221 123467788889999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcccccccccccccccccccCCC-------CCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-------EVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
+...............++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~---~ 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY---T 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH---H
Confidence 754332222222334578889999987642 35789999999999999996 9999965322111 000 0
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
.........++... ...++++.+++.+|| .+|++|||++||++.|+
T Consensus 223 ~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VREQQLKLPKPRLK----------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hhcccCCCCCCccC----------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000010000 012345788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.81 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=203.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|.+.+.||+|+||.||+|.+.+. ...||+|...... ....+.+.+|+.++++++||||++++++|.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4578889999999999999997543 4469999987544 4456688999999999999999999998642 4
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---------KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence 568999999999999999532 12489999999999999999999998 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||......+. .......
T Consensus 148 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~~ 224 (270)
T cd05056 148 LGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIENG 224 (270)
T ss_pred EccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcC
Confidence 9999999876433211 1122335568999999988889999999999999999996 9999975322110 0000000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
. +......++.++.+++.+|+..+|++|||+.++++.|+++++.
T Consensus 225 --~----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 --E----------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --C----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0000113456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.51 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=193.7
Q ss_pred cccccceeeEEEEEE--cCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 638 EIGVGSFGSVYKGIL--DQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999976 3456789999986432 334567899999999999999999999863 245789999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQK----------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccc
Confidence 9999999999852 23588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 794 RFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 794 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
+......... ......++..|+|||.+....++.++|||||||++|||++ |..||...... ...+....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~------- 213 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIES------- 213 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHC-------
Confidence 8764332211 1122234678999999988889999999999999999998 99999753211 11111110
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.... ..+..+++++.+++.+||+.||++||++++|.+.|++
T Consensus 214 -----~~~~------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 214 -----GERM------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----CCCC------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0000 0001245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.21 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=200.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC-CCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ-GND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~ 706 (953)
+++.|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +|||+++++++|...... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5667889999999999999999999988999999997543 3346788899999998 799999999997643221 134
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEE
Confidence 6899999999999999986422 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
|+|||++...... ........|+..|+|||++. +..++.++|||||||++|||++|+.||....... ..
T Consensus 152 l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~ 225 (272)
T cd06637 152 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL 225 (272)
T ss_pred EccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HH
Confidence 9999999865322 12223456899999999976 3468889999999999999999999986422110 00
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ..... .... ....++.++.+++.+||..||.+|||+.|+++
T Consensus 226 ~~-~~~~~-----~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FL-IPRNP-----APRL---------------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH-HhcCC-----CCCC---------------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00000 0000 00023456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.89 Aligned_cols=251 Identities=19% Similarity=0.229 Sum_probs=200.6
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++|||++++.+++. ..+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 478889999999999999999988889999998642 3345567889999999999999999999853 4478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++++||
T Consensus 76 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQR--------GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence 999999999999885322 23578899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|.+....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ............
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~ 217 (255)
T cd08219 145 GSARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSY 217 (255)
T ss_pred Ccceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCC
Confidence 9998664321 122234588999999999998999999999999999999999999974211 111111000000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. . .+...+..+.+++.+||+.||++|||+.|++.+
T Consensus 218 ~--------~-------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 K--------P-------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C--------C-------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 0 001234468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.27 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=196.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.+|++.+.||+|+||.||+|.++.+ ..+|+|++.... .....+.+|++++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCC-ccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence 3578899999999999999998754 479999986432 23456888999999999999999999854 3467899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df 144 (256)
T cd05059 77 VTEYMANGCLLNYLRERK---------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF 144 (256)
T ss_pred EEecCCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence 999999999999985321 2588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ .........
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~--- 218 (256)
T cd05059 145 GLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGY--- 218 (256)
T ss_pred ccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCC---
Confidence 999865422111 1112224568999999999999999999999999999999 899986422111 100000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. ...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 219 -----~----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 -----R----------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----c----------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 000012355799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.74 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=196.3
Q ss_pred CcccccceeeEEEEEEcCCC---eEEEEEEeeccch-hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGK---TTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
++||+|+||.||+|.+.... ..||+|.++.... ...+.+.+|+.+++++.|||++++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999876544 6899999874433 34567889999999999999999999853 24579999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKKR----------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence 999999999999532 2578999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 793 ARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 793 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
++......... ......++..|+|||...+..++.++|||||||++||+++ |..||..... ...........+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~--- 216 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER--- 216 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc---
Confidence 98764332211 1112224568999999999999999999999999999998 9999865321 111111111000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
...+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 217 ---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 ---------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 000112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=352.16 Aligned_cols=262 Identities=18% Similarity=0.254 Sum_probs=201.4
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.....++|.+.+.||+|+||+||+|.+..++..||+|++... .......+..|+.++++++||||++++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---K 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---c
Confidence 334557899999999999999999999999999999998643 33445678999999999999999999998643 2
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC----CCCeEeecCCCCCeEe
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC----QPPITHCDLKPSNVLL 779 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~Dlkp~NIll 779 (953)
.....++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.. ..+||||||||+|||+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYK------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 34578999999999999999964321 1236899999999999999999999852 1259999999999999
Q ss_pred cC-----------------CCcEEEeccccceecCCCCCcccccccccccccccccccCC--CCCCcccchHHHHHHHHH
Q 043900 780 DE-----------------EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLE 840 (953)
Q Consensus 780 ~~-----------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~vl~e 840 (953)
+. .+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 64 2359999999998653221 2233468999999999854 458899999999999999
Q ss_pred HHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 043900 841 LVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920 (953)
Q Consensus 841 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 920 (953)
|+||..||..... ............ .+. ....+.++.+++..||+.+|
T Consensus 236 LLTGk~PF~~~~~----~~qli~~lk~~p-------~lp---------------------i~~~S~eL~dLI~~~L~~dP 283 (1021)
T PTZ00266 236 LCSGKTPFHKANN----FSQLISELKRGP-------DLP---------------------IKGKSKELNILIKNLLNLSA 283 (1021)
T ss_pred HHHCCCCCCcCCc----HHHHHHHHhcCC-------CCC---------------------cCCCCHHHHHHHHHHhcCCh
Confidence 9999999964211 111111100000 000 00123568899999999999
Q ss_pred CCCCCHHHHHH
Q 043900 921 GDRMNMTNVVR 931 (953)
Q Consensus 921 ~~RPt~~evl~ 931 (953)
.+||++.|++.
T Consensus 284 eeRPSa~QlL~ 294 (1021)
T PTZ00266 284 KERPSALQCLG 294 (1021)
T ss_pred hHCcCHHHHhc
Confidence 99999999984
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.26 Aligned_cols=250 Identities=28% Similarity=0.378 Sum_probs=197.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|.+.+.||+|+||.||+|...+ +.||+|.++... ..+.+.+|+.++++++|++++++++++. ..+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcC--CcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 468889999999999999998764 469999986432 3467889999999999999999998753 33466899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence 999999999999986432 12578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|++....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ........
T Consensus 147 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~---- 212 (256)
T cd05082 147 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRV---- 212 (256)
T ss_pred ccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----
Confidence 9998643221 12235678999999998899999999999999999998 999986421 11111110
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
....... ....+++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 213 -----~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 213 -----EKGYKMD------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----hcCCCCC------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0000000 0013356788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.54 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=199.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|.+.+.||+|++|.||+|....+++.||+|.++... ....+.+.+|++++++++||||+++++++. .+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 56899999999999999999998888899999986432 123456888999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----------YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 689999999999999998852 23578889999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCccc-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTS-SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|+|||.++.......... .....++..|+|||++.+..++.++||||+|+++||+++|+.||...... ......
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~ 219 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKI 219 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHH
Confidence 9999999986543211111 12345788999999999999999999999999999999999998642111 100000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...... ...+..++..+.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQPTN---------------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccCCC---------------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000 00011234568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=356.15 Aligned_cols=484 Identities=27% Similarity=0.348 Sum_probs=405.2
Q ss_pred eeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccc
Q 043900 32 VLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNN 111 (953)
Q Consensus 32 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 111 (953)
.+|++.++++- +|..+..-..++.|++++|.+-...-+...+...|+.|++++|++. ..|..+..+.+|+.|+++.|-
T Consensus 2 ~vd~s~~~l~~-ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLEL-IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCcc-cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 47889999996 8877777777999999999987332344456667999999999998 899999999999999999999
Q ss_pred cccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccc
Q 043900 112 LTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLD 191 (953)
Q Consensus 112 l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 191 (953)
|. ..|.+.+++.+|++|.|.+|++. ..|..+..+++|++|+++.|++. .+|..+..++.+..++.++|.-...++.
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~- 155 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ- 155 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc-
Confidence 99 88999999999999999999998 89999999999999999999998 8999999999999999999933323332
Q ss_pred cccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCccccccccc
Q 043900 192 FGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLT 271 (953)
Q Consensus 192 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~ 271 (953)
..++.++|..|.+.+.++..+..+.+ .|+|++|.+. .-.+..+..|+.+....|.+...-.
T Consensus 156 -----~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--~~dls~~~~l~~l~c~rn~ls~l~~---------- 216 (1081)
T KOG0618|consen 156 -----TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--VLDLSNLANLEVLHCERNQLSELEI---------- 216 (1081)
T ss_pred -----ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh--hhhhhhccchhhhhhhhcccceEEe----------
Confidence 23889999999999999999998888 8999999998 4456677888888888888765322
Q ss_pred ccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCe
Q 043900 272 NSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRE 351 (953)
Q Consensus 272 ~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 351 (953)
..++++.|+.+.|.+....+. ..+.+|+++++++|+++ .+|.+++.+.+|+.|+..+|+++ .+|..+...++|+.
T Consensus 217 ~g~~l~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 217 SGPSLTALYADHNPLTTLDVH---PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVS 291 (1081)
T ss_pred cCcchheeeeccCcceeeccc---cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHH
Confidence 357889999999999854332 23468999999999998 46699999999999999999996 78999999999999
Q ss_pred EEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCcc-CCCCC-CCcEEEcCCCccCCCCCccccCccccceeeeccC
Q 043900 352 LRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSS-LGQYK-TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSR 428 (953)
Q Consensus 352 L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~-~~~l~-~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~ 428 (953)
|.+.+|.++ .+|.....+ .+++|+|..|.|. .+|+. |.-+. +|..|..+.|++. ..|..-......++.|.+.+
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhc
Confidence 999999998 677777766 5799999999998 45553 33333 3788999999998 66643334455677999999
Q ss_pred CcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCC
Q 043900 429 NQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIP 508 (953)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 508 (953)
|.++...-..+.+...|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..++.|++|....|++. ..|
T Consensus 369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 9999877778899999999999999999444456788999999999999999 78999999999999999999998 778
Q ss_pred ccccccccCceEeccCCcCcccC-CCCCcccccccccccCCcCC
Q 043900 509 EFLVGFQLLENLNLSNNNLEGMV-PIEGVFKNATITSVLGNLKL 551 (953)
Q Consensus 509 ~~~~~l~~L~~l~l~~N~l~~~~-p~~~~~~~~~~~~~~~n~~l 551 (953)
.+..++.|+.+|+|-|+|+-.. |.....+++....+.||.++
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 7889999999999999997443 22222255666777788754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.26 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=203.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT----TVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|++.+.||+|+||.||+|.+..+++ .||+|..+... ......+.+|+.++++++|||+++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 568889999999999999999865443 58999886443 3345678899999999999999999999753
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNH---------KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeE
Confidence 5689999999999999998532 22488999999999999999999998 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||.++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ .......
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~ 226 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEK 226 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhC
Confidence 9999999987653322222222334678999999988899999999999999999999 999987532111 1111110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
. . ... .+..++..+.+++.+||..||++||++.++++.|+++.+.
T Consensus 227 ~---~--------~~~-------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 G---E--------RLP-------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C---C--------CCC-------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 0 000 0001234578999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=322.27 Aligned_cols=270 Identities=22% Similarity=0.294 Sum_probs=207.6
Q ss_pred cCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
+.++.+..+.++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566667889999999999999999999999888899999986432 2235678899999999 69999999998765
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
.....+...++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+. +++||||||+||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili 157 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK------RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILL 157 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc------cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEE
Confidence 444556789999999999999998753211 123578999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
+.++.+||+|||.++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 999999999999998664321 12233458999999998753 45788999999999999999999998643211
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..... . ... ..... ..+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 236 ----~~~~~-~-~~~----~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 ----RALFK-I-PRN----PPPTL--------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----HHHhh-c-ccc----CCCcc--------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 0 000 00000 0000123468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=337.40 Aligned_cols=201 Identities=21% Similarity=0.314 Sum_probs=171.2
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.|++.+.||+|+||+||+|+...+++.||+|++.... ......+.+|++++++++||||+++++++. +++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5888999999999999999999999999999996432 234567889999999999999999999854 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM----------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999998532 2578888999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCC---------------------------------------------cccccccccccccccccccCCC
Q 043900 789 DFGLARFLPLSPA---------------------------------------------QTSSIDAKGSIGYIAPEYGLGS 823 (953)
Q Consensus 789 DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 823 (953)
|||+++.+..... ........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999753311000 0001124689999999999999
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 824 EVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 824 ~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
.++.++||||+||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=324.23 Aligned_cols=272 Identities=22% Similarity=0.356 Sum_probs=207.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCC-------CeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG-------KTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 701 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 701 (953)
.+|.+.+.||+|+||.||+|++... ...||+|.++.. .....+.+.+|+++++++ +||||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 4689999999999999999986432 236899988643 234457889999999999 79999999999643
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
....++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 3678999999999999999965322100 011234689999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccC
Q 043900 776 NVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEG 854 (953)
Q Consensus 776 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~ 854 (953)
||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999987643322222223335678999999999999999999999999999998 8888864211
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
............. .....++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 243 ----~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 243 ----EELFKLLKEGHRM---------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred ----HHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1111111000000 000123456889999999999999999999999999
Q ss_pred HHHHHhcc
Q 043900 935 SIKNILLG 942 (953)
Q Consensus 935 ~i~~~~~~ 942 (953)
.+......
T Consensus 292 ~~~~~~~~ 299 (334)
T cd05100 292 RVLTVTST 299 (334)
T ss_pred HHhhhcCC
Confidence 99855433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.27 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=197.1
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEee----ccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVFN----LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
...+||+|+|-+||+|.+..++..||--.++ ...+...++|..|+++|+.++||||+++++++.+. .+....+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeee
Confidence 3467999999999999999888777644332 23345568999999999999999999999986543 2356789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-CCCcEEEec
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSD 789 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~D 789 (953)
|+|.|..|+|+.|.++.+ .++...+..|++||++||.|||++ .|+|+|||||-+||+|+ ..|.|||+|
T Consensus 121 iTEL~TSGtLr~Y~kk~~----------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR----------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeecccCCcHHHHHHHhc----------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 999999999999997544 577889999999999999999997 78999999999999997 557999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
+|+|+..... ......|||.|||||+.. ..|++.+||||||++++||+|+..||.........+.+......|..
T Consensus 190 LGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 190 LGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 9999977433 333467999999999976 78999999999999999999999999754332222222222122222
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+- .+++.++|.+|+.. ..+|||+.|+++
T Consensus 265 l~kV~------------------------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVK------------------------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccC------------------------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22211 24688999999999 999999999986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.30 Aligned_cols=273 Identities=25% Similarity=0.373 Sum_probs=206.2
Q ss_pred cCCcccCcccccceeeEEEEEEcC----CCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ----GKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+.|...+.||+|+||.||+|++.. .++.||+|+++..... ..+.+.+|++.++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 357778999999999999999753 3678999999755443 56789999999999999999999998643 234
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR---------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc---------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence 67899999999999999996322 2589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|+|||.+.......... ......++..|+|||...+..++.++||||||+++|||++|+.|+................
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 228 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence 999999998765322211 1112335667999999988899999999999999999999999986532221110000000
Q ss_pred -hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 865 -ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 865 -~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.......+.+... .+......++.++.+++.+||+.+|++||||.||+++|+.+
T Consensus 229 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 QMIVTRLLELLKEG------------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccHHHHHHHHHcC------------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000000100000 00111123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=336.42 Aligned_cols=196 Identities=24% Similarity=0.313 Sum_probs=167.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
..+|.+.+.||+|+||.||+|.+...++.||||... ...+.+|++++++++|+||+++++++.. ++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 346999999999999999999999988899999643 2345689999999999999999998643 36789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+|||++. ++|.+++... ...+++.+++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 237 lv~e~~~-~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR---------LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEccC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence 9999994 6888887422 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~ 849 (953)
||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 999987643322222234569999999999999999999999999999999999887654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=341.15 Aligned_cols=202 Identities=23% Similarity=0.302 Sum_probs=165.1
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCC------CCeeEEEeeec
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH------RNLVKILTACS 698 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~ 698 (953)
++....++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999999888899999996432 223445667777776654 45888888864
Q ss_pred ccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCe
Q 043900 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNV 777 (953)
Q Consensus 699 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NI 777 (953)
. ...+.|+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ . +|+||||||+||
T Consensus 202 ~----~~~~~~iv~~~~-g~~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NI 263 (467)
T PTZ00284 202 N----ETGHMCIVMPKY-GPCLLDWIMK----------HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENI 263 (467)
T ss_pred c----CCceEEEEEecc-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence 2 335789999998 7788888752 2358999999999999999999997 5 999999999999
Q ss_pred EecCCC----------------cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHH
Q 043900 778 LLDEEM----------------MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLEL 841 (953)
Q Consensus 778 ll~~~~----------------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~el 841 (953)
|++.++ .+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 998765 49999999886432 122345699999999999999999999999999999999
Q ss_pred HhCCCCCCC
Q 043900 842 VTRKKPVDS 850 (953)
Q Consensus 842 ltg~~pf~~ 850 (953)
++|+.||+.
T Consensus 339 ltG~~pf~~ 347 (467)
T PTZ00284 339 YTGKLLYDT 347 (467)
T ss_pred HhCCCCCCC
Confidence 999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.95 Aligned_cols=252 Identities=24% Similarity=0.271 Sum_probs=207.0
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch---hhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 704 (953)
....|.+.+.||+|.||.||+++.+.+++.+|+|++..... .....+.+|+.+|+++. ||||+.+.+++ +.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 44578899999999999999999999999999999964333 24568999999999998 99999999995 44
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE--- 781 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 781 (953)
...+++|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+|+..
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC
Confidence 57899999999999999999522 289999999999999999999998 9999999999999953
Q ss_pred -CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHH
Q 043900 782 -EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 782 -~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~ 860 (953)
++.+|++|||+|..... .......+||+.|+|||++.+..|+..+||||+||++|.|++|..||....+..... .
T Consensus 174 ~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~ 249 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A 249 (382)
T ss_pred CCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H
Confidence 35799999999998754 334556789999999999999999999999999999999999999998643322111 1
Q ss_pred HHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 861 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.....+ ++- .+.....+....+++..|+..||.+|+|+.++++
T Consensus 250 i~~~~~-----~f~-----------------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 ILRGDF-----DFT-----------------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHcCCC-----CCC-----------------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111100 000 0111234567889999999999999999999998
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.18 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=189.9
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|....+++.||+|+++.. .....+.+.+|+.++.++ +||+|+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 4699999999999999999889999999743 233456688899999888 6999999999853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQR----------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccc
Confidence 99999999988842 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccC-CccHHHHHHhhCCchhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG-DMNLHNFARMALPDHVV 871 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 871 (953)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 217 (327)
T cd05617 143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--- 217 (327)
T ss_pred ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---
Confidence 97532111 1223356899999999999999999999999999999999999999643221 11111111110000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
... ..+...+..+.+++.+||+.||++||++.
T Consensus 218 ----~~~--------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 ----KPI--------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ----CCC--------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 000 00012235578999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.97 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=192.6
Q ss_pred CcccccceeeEEEEEEcC---CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQ---GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|.+.+ ....||+|.+... .....+.+.+|+.+++.++|||+++++++|.. .+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999999753 3457999998533 33446788899999999999999999998642 235678999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.... ...++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRSET---------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccc
Confidence 9999999999985322 2367788899999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCCcccCCccHHHHHHhhCCch
Q 043900 793 ARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 793 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
++........ .......++..|+|||.+.+..++.++|||||||++|||++| .+||..... ...........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~ 219 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITVYLLQGR 219 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHhcCC
Confidence 9765322111 111223467789999999888999999999999999999995 555543211 11111000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
. ......++..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 220 --------~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 --------R-------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --------C-------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 0000123456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.04 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=188.0
Q ss_pred CcccccceeeEEEEEEcC--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQ--GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|.... ....||+|.+.... ......+.+|+..++.++||||++++++|.. ....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence 369999999999997643 33468888876432 3344678899999999999999999998643 467899999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.+++...... .....++.....++.||+.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-----VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhcccc-----ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence 99999999999644321 122356788899999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCcccccccccccccccccccC-------CCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGL-------GSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
................++..|+|||+.. +..++.++|||||||++|||++ |..||......+ .......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~-- 224 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR-- 224 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh--
Confidence 7543222222223334677899999864 3457889999999999999999 788886432111 0111000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
.......++. .....+.++.+++..|| .||++|||++||++.|.
T Consensus 225 --~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 --EQDIKLPKPQ----------------------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --ccCccCCCCc----------------------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000000000 01123456778899999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.37 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=197.9
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++|++++++++.+. ..+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 3677889999999999999999999999999986432 222345778999999999999999998853 34689
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMG--------EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999885322 12588999999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||++....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..... .... .
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~-~ 218 (285)
T cd05630 145 DLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLV-K 218 (285)
T ss_pred eccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhh-h
Confidence 999997653222 1123468999999999999999999999999999999999999997532110 00000 0000 0
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
.... . ....+++++.+++.+||+.||++||| ++|+++
T Consensus 219 ~~~~----~----------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 219 EVQE----E----------------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhh----h----------------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0000 0 00123456889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.89 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=199.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|.+.+.||+|++|.||+|.+..+. .||+|.+.... ...+.+.+|+.++++++||+++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 46888999999999999999987765 69999886433 23467889999999999999999998853 245789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGD--------GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence 999999999999996322 22578999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++....... .......++..|+|||...+..++.++||||||+++|||++ |..||.+....+ ...........
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~- 222 (260)
T cd05069 147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM- 222 (260)
T ss_pred ccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC-
Confidence 99987643221 11222346778999999988899999999999999999999 899987532111 11110000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
......+..+.+++.+||+.||++||++++|.+.|++
T Consensus 223 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -----------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.84 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=197.9
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||+++++++|.. +...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence 6778899999999999999999888999999976666667788999999999999999999998643 46789999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++++|..++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 82 EFCAGGAVDAVMLEL---------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccc
Confidence 999999999887521 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+...... ........++..|+|||++. +..++.++|||||||++|||++|+.||......+ ......... +
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~-~ 225 (282)
T cd06643 150 SAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE-P 225 (282)
T ss_pred ccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC-C
Confidence 9764321 11223345889999999874 4467889999999999999999999986532111 000000000 0
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. . ...+..++.++.+++.+||+.||.+||+++++++
T Consensus 226 ~---~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 P---T-------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C---C-------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0000123456889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.50 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=201.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|++..+ ...||+|.++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 35688899999999999999998533 3379999986432 334568899999999999999999999853 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD---------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVC 145 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeE
Confidence 67899999999999999995321 2578999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+|+|||.+..+....... ......++..|+|||++.+..++.++||||||+++||+++ |..||......+ ......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~ 223 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIE 223 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHh
Confidence 999999998764332211 1112224568999999998899999999999999999887 999986532111 111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.... ......+++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 ~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 EGYR------------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCc------------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0000 000012345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.85 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=196.9
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
|+..+.||+|+||+||+|.+..+++.||+|.++... ......+.+|++++++++|++++++.+++. .++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence 677789999999999999999888899999986432 223355778999999999999999988853 447899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMG--------NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCccHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEec
Confidence 9999999999998885322 22589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||++....... ......|+..|+|||++.+..++.++||||+||++|||++|..||........ .... .......
T Consensus 146 fg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~-~~~~~~~ 220 (285)
T cd05632 146 LGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEV-DRRVLET 220 (285)
T ss_pred CCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHhhhcc
Confidence 99997653221 12234689999999999999999999999999999999999999975321110 0111 0000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVRQ 932 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 932 (953)
... .....+.++.+++.+||+.||++||+ +.++++.
T Consensus 221 ~~~---------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 EEV---------------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccc---------------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000 00123456789999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=328.82 Aligned_cols=238 Identities=26% Similarity=0.262 Sum_probs=185.7
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 46999999999999999888899999996432 222344555554 567789999999998853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQR----------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 99999999998852 23578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~---- 211 (323)
T cd05575 143 CKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNK---- 211 (323)
T ss_pred CcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC----
Confidence 8753211 1222345689999999999999999999999999999999999999975211 1111111000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
... .....+.++.+++.+|++.||++||++.
T Consensus 212 ----~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 ----PLR--------------------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCC--------------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000 0001245688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.50 Aligned_cols=251 Identities=29% Similarity=0.426 Sum_probs=201.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence 356888999999999999999986 35799999975543 56788999999999999999999999643 47789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR--------AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence 99999999999999863321 2589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++....... ....+..|+|||++.+..++.++||||||+++||+++ |+.||......+ ........
T Consensus 146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~--- 215 (256)
T cd05039 146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKG--- 215 (256)
T ss_pred cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcC---
Confidence 999986632211 2235678999999988899999999999999999997 999986431110 10000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.. ......+++++.+++.+||..+|++|||++|++++|+.+
T Consensus 216 ---------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 ---------YR------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---------CC------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00 000112356788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=332.20 Aligned_cols=205 Identities=21% Similarity=0.283 Sum_probs=174.1
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+....++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~---- 113 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ---- 113 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE----
Confidence 344557899999999999999999999999999999998632 2233456788999999999999999998853
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.+...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 114 -~~~~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~ 178 (371)
T cd05622 114 -DDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 178 (371)
T ss_pred -cCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCC
Confidence 45789999999999999999852 2477888999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
+.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 179 ~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 179 GHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 9999999999987643221 122345699999999998654 378999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.62 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=202.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|||+++++++|. .++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 367999999999999999999998888899999997655555677889999999999999999999864 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred EeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence 99999999999999842 2478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+....... .......+++.|+|||...+..++.++|||||||++|++++|..||........... ... ..
T Consensus 159 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~----~~ 231 (297)
T cd06656 159 FGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT----NG 231 (297)
T ss_pred CccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ecc----CC
Confidence 99998654322 112234588899999999998899999999999999999999999964221110000 000 00
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+ ....+...+..+.+++.+||+.+|++||+++++++
T Consensus 232 -----~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 -----TP--------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -----CC--------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00001123456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.97 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=199.8
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHH--HHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK--SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|++.+.||+|+||+||+|....+++.||+|++......... ...+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 67789999999999999999999999999999865443322 34569999999999999999999543 578899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++. ....+++.+++.++.|+++||+|||+. +++||||||+||++++++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 999999999999995 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.+.... ..........++..|+|||++. +..++.++||||+|+++|+|++|..||...... .............
T Consensus 143 g~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 143 GSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKRP 218 (260)
T ss_dssp TTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHTH
T ss_pred ccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccccc
Confidence 9998651 2223334556899999999998 888999999999999999999999999854110 0111110000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ...........++.+++.+||+.||++||++.|+++
T Consensus 219 ~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LP------------------------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HH------------------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc------------------------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000011267999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.87 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=203.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++. .....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence 57899999999999999999998888899999998665556788999999999999999999999853 3477999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
+|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+||
T Consensus 78 ~~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT---------RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEeCCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcc
Confidence 99999999999988532 13588999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|.+....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......... .......
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~- 221 (262)
T cd06613 146 GVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNF- 221 (262)
T ss_pred ccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccC-
Confidence 9997653221 122234578899999998877 88999999999999999999999987532111000 0000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. .........+.++.+++.+||+.+|++|||+++|+.
T Consensus 222 -------~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 -------PP-------------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------CC-------------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000111234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.68 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=201.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKT----TVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... ......+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3567888999999999999999866554 47888886433 2334578899999999999999999998743
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK---------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence 23579999999999999985321 2478899999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||.++...............++..|+|||++.+..++.++|||||||++||+++ |..||.+.... ....+..
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~ 225 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLE 225 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987643322222223446778999999999999999999999999999998 89998653211 1111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
... .. .....++..+.+++.+||..+|++||+++++++.++++.+.
T Consensus 226 ~~~----------~~--------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 226 KGE----------RL--------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCC----------CC--------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000 00 00001234578999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.96 Aligned_cols=268 Identities=23% Similarity=0.275 Sum_probs=205.7
Q ss_pred CHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 622 SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
+.+++..+.++|.+.+.||+|+||.||+|....+++.||+|++..... ....+.+|+.+++++ +|||+++++++|...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 345555668899999999999999999999998888999999864322 345677899999999 899999999998654
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
+.......++||||+++++|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~ 162 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLI------CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLT 162 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc
Confidence 33344678999999999999998853221 123588999999999999999999998 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCCcccCC
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slG~vl~elltg~~pf~~~~~~~ 855 (953)
.++.+||+|||.+........ ......|+..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 999999999999986542211 12234588999999987543 36899999999999999999999986532110
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....+.. .....+ .........+.+++.+||+.+|++||++.|+++
T Consensus 241 -~~~~~~~----~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 -TLFKIPR----NPPPTL-------------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHHHHhc----CCCCCC-------------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000000 000000 000123346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.83 Aligned_cols=257 Identities=22% Similarity=0.263 Sum_probs=198.2
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+++.+.....||+|+||.||+|++..+++.||+|.+........+.+.+|++++++++|+||+++++++. .++.
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~ 79 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGF 79 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCE
Confidence 34555666678999999999999999888899999987666666778999999999999999999999864 3477
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-CCcEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAH 786 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 786 (953)
.++||||+++++|.++++.... ....++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~ 149 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWG-------PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVK 149 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcc-------cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEE
Confidence 8999999999999999863211 11127788899999999999999998 9999999999999976 67999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
|+|||.+........ ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+...
T Consensus 150 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~ 225 (268)
T cd06624 150 ISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVG 225 (268)
T ss_pred EecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhh
Confidence 999999976532211 122234789999999986643 78899999999999999999999864221110 000000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... . ...+..+.+++.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~~------~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 MFKI------H----------------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhcc------C----------------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000 0 0001123456889999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.63 Aligned_cols=239 Identities=24% Similarity=0.250 Sum_probs=188.8
Q ss_pred CcccccceeeEEEEEE---cCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+.||+|+||.||++.. ..+++.||+|+++... ......+.+|++++++++||||+++++++. .+...++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 5799999999999986 3456789999997432 223456778999999999999999999854 44789999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence 999999999998842 23589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
+++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 144 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~--- 213 (318)
T cd05582 144 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKA--- 213 (318)
T ss_pred CCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcC---
Confidence 998653221 1223456899999999999888999999999999999999999999752111 111100000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
.. . .+...++.+.+++.+||+.||++||++.+
T Consensus 214 -----~~-~-------------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 -----KL-G-------------------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----CC-C-------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 0 00123456889999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.85 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=201.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+++++.++|||++++++++. ..+..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 46889999999999999999998888899999997655555677889999999999999999999864 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVT-----------ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 999999999999884 12478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|++........ ......++..|+|||.+.+..++.++|||||||++|++++|+.||........ .. .........
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~-~~~~~~~~~- 234 (296)
T cd06655 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY-LIATNGTPE- 234 (296)
T ss_pred ccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHhcCCcc-
Confidence 99876533221 12234588899999999988899999999999999999999999965322110 00 000000000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+..+++.+.+++.+||+.||++|||+.++++
T Consensus 235 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 ---------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0001133456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.29 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=200.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.++||+|+||.||+|...++ +.||+|.+..... ....+.+|+.++++++|+|++++++++. .+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~-~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCC-ceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence 35688999999999999999998765 4799999874332 3467889999999999999999998742 25689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 77 IITEYMENGSLVDFLKTPE--------GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEcc
Confidence 9999999999999985322 23688999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.+........ .......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ............
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~ 222 (260)
T cd05067 146 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRM 222 (260)
T ss_pred CcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCC
Confidence 999987642221 11223346778999999998899999999999999999999 99999753211 111100000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
......+.++.+++.+||+.+|++|||++++.+.|+.
T Consensus 223 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001234569999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=328.01 Aligned_cols=242 Identities=24% Similarity=0.252 Sum_probs=186.8
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 46999999999999999888899999996422 122234444443 567789999999998853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCC
Confidence 99999999998852 23577888899999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 143 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~------ 209 (325)
T cd05602 143 CKENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNIL------ 209 (325)
T ss_pred CcccccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHH------
Confidence 9754221 11223456999999999999999999999999999999999999999742211 1111000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... .....+..+.+++.+|++.||.+||++.+.+.
T Consensus 210 --~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 210 --NKPLQ--------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --hCCcC--------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 00000 00123456889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.24 Aligned_cols=243 Identities=22% Similarity=0.267 Sum_probs=190.4
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 707 (953)
+|...+.||+|+||+||+|.+..+++.||+|+++.. .....+.+..|..+++.+. |++|+++.+++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 467789999999999999999988889999999742 2234456778888888885 57777888774 34467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ----------VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 9999999999999998852 23588999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i-- 213 (323)
T cd05615 143 ADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSI-- 213 (323)
T ss_pred eccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHH--
Confidence 9999997542221 1222345899999999999999999999999999999999999999753211 111100
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
..... . .+...+.++.+++.+|++.+|++|++..
T Consensus 214 ------~~~~~-~-------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 214 ------MEHNV-S-------------------YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------HhCCC-C-------------------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 00000 0 0002234678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.40 Aligned_cols=277 Identities=20% Similarity=0.275 Sum_probs=201.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||+|+||.||+|.+..++..||+|.++.. .......+.+|++++++++||||++++++|. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 3689999999999999999999988889999998643 2334566889999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
+||||+++++|.++++.. ..+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+
T Consensus 76 lv~ey~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLC 142 (308)
T ss_pred EEeeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEc
Confidence 999999999999999532 357889999999999999999997 5 89999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+...... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .....+.......
T Consensus 143 dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~ 216 (308)
T cd06615 143 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSE 216 (308)
T ss_pred cCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCcccc
Confidence 99998755322 12234588999999999888899999999999999999999999864321 1111111110000
Q ss_pred h-hhhhcccc-cc--CCchhhhhc----ccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 869 H-VVDIVDST-LL--SDDEDLAVH----GNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 869 ~-~~~~~~~~-l~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. ........ .. ......... ........... ....+.++.+++.+||+.||++|||+.||++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000000 00 000000000 00000000000 00245679999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=311.20 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=202.6
Q ss_pred CcccccceeeEEEEEEcCC---CeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQG---KTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|.+... +..||+|+++..... ..+.+.+|++.++.++|+|++++++++.. ....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4699999999999999865 778999999754433 36788999999999999999999998643 57899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++++|.+++....... .......+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999996432110 001124689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
+................++..|+|||.+.+..++.++||||+|+++|||++ |..||...... .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~----- 221 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLR----- 221 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH-----
Confidence 987754432233344557889999999988899999999999999999999 69998753111 1111000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
+.. +......++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 222 ---~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 ---KGY-------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---cCC-------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 00011133567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.85 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=201.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|.+.+.||+|+||.||+|...++ +.||+|.++.... ..+++.+|+.++++++|+|++++++++. .....+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 46789999999999999999998765 5799999874332 3467889999999999999999999853 346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+|
T Consensus 78 ~v~e~~~~~~L~~~i~~~~--------~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGE--------GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEeccCCCCHHHHHhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence 9999999999999996432 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++...... ........++..|+|||.+.+..++.++||||+|+++||+++ |+.||....... ...... ....
T Consensus 147 ~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~-~~~~- 222 (261)
T cd05034 147 FGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVE-RGYR- 222 (261)
T ss_pred cccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH-cCCC-
Confidence 99998764321 111112234568999999998899999999999999999999 999986432110 011000 0000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
.......+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 -----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -----------------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00001224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=320.63 Aligned_cols=206 Identities=21% Similarity=0.306 Sum_probs=163.4
Q ss_pred cCcccccceeeEEEEEEcC--CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 636 ANEIGVGSFGSVYKGILDQ--GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
.++||+|+||+||+|++.+ +++.||+|.++... ......+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 4689999999999999764 45789999986432 23457789999999999999999998643 23456899999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe----cCCCcEEEec
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSD 789 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 789 (953)
|++ ++|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred ccC-CCHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 995 58888775332211 111233589999999999999999999999 99999999999999 4567899999
Q ss_pred cccceecCCCCCc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 790 FGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 790 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
||+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999876432211 122345689999999998774 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.28 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=199.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++|||++++++++. .+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 56889999999999999999999888899999998766666788899999999999999999999864 3367999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|..++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL---------DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence 99999999998887422 23588999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|.+...... ........++..|+|||++. ...++.++|||||||++|||++|..||...... ......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~ 227 (292)
T cd06644 155 GVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKI 227 (292)
T ss_pred ccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHH
Confidence 998754321 11222345788999999874 345788999999999999999999998642211 000000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... +. .......+.++.+++.+||+.||++||+++|+++
T Consensus 228 ~~~~~-----~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 228 AKSEP-----PT--------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred hcCCC-----cc--------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00 0001123456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.57 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=200.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|++|.||+|.+..+++.||+|.+... .....+.+.+|++++++++|+|++++++.+.. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 488899999999999999999988889999998643 23345678899999999999999999887432 234678
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~~~--------~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQK--------GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence 9999999999999996322 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||++....... .......+++.|+|||+..+..++.++||||+|+++||+++|+.||..... ...........
T Consensus 146 f~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~ 218 (257)
T cd08223 146 LGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGK 218 (257)
T ss_pred ccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcC
Confidence 99998764321 122334588999999999999999999999999999999999999864211 11111110000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .....++++.+++.+||+.||++|||+.|+++
T Consensus 219 --------~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 219 --------LPP-------------------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --------CCC-------------------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.71 Aligned_cols=370 Identities=24% Similarity=0.374 Sum_probs=303.4
Q ss_pred cEEEEEeCCCeee-eecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 5 RVKILNLTSLKLA-GSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 5 ~~~~l~l~~~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
=|+.+|+++++.+ +..|.++..++.++-|-|...++.. +|++++.+++|++|.++||++. .+-+.++.++.|+.+.+
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~-vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQ-VPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhh-ChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3788899999987 6788899999999999999999997 8999999999999999999998 78888899999999999
Q ss_pred cCcccc-ccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC
Q 043900 84 FYNELV-GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 84 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (953)
.+|.+. .-+|..+..|..|..||||+|+++ ..|..+..-.++-.|+||+|+|.++....|.+|+.|-.|+|++|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 999986 456888889999999999999998 88888888889999999999998666667889999999999999998
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCcccc-CCCCCCCcCCCCCcEEEcccccccCcCCCCC
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT-GAIPPAISNASNLELFQADVNKLTGEVPYLE 241 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~ 241 (953)
.+|..+..+..|+.|+|++|.+....-..+. .|.+|+.|.+++.+=+ ..+|..+..+.+|..+|++.|.+.
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP-smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp------- 235 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLP-SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP------- 235 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhhHHHHhcCc-cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-------
Confidence 7888888889999999999877532111111 4666667777665543 345666666666666666666654
Q ss_pred CCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccC
Q 043900 242 KPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGK 321 (953)
Q Consensus 242 ~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~ 321 (953)
.+|+++..+ .+|+.|+|++|+|+ .+....+.
T Consensus 236 -----------------------------------------------~vPecly~l-~~LrrLNLS~N~it-eL~~~~~~ 266 (1255)
T KOG0444|consen 236 -----------------------------------------------IVPECLYKL-RNLRRLNLSGNKIT-ELNMTEGE 266 (1255)
T ss_pred -----------------------------------------------cchHHHhhh-hhhheeccCcCcee-eeeccHHH
Confidence 467888888 58999999999998 56667788
Q ss_pred CCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEc
Q 043900 322 FVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDL 401 (953)
Q Consensus 322 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (953)
+.+|++|+||.|+++ .+|++++.+++|+.|.+.+|+++ +. -+|+.++.+.+|+.+..
T Consensus 267 W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~---------------------Fe-GiPSGIGKL~~Levf~a 323 (1255)
T KOG0444|consen 267 WENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT---------------------FE-GIPSGIGKLIQLEVFHA 323 (1255)
T ss_pred Hhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc---------------------cc-CCccchhhhhhhHHHHh
Confidence 899999999999998 89999999999999999999986 22 37888888888888888
Q ss_pred CCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccC
Q 043900 402 SDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG 481 (953)
Q Consensus 402 ~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 481 (953)
++|++. .+|+.++.+..|+.|.|++|++- .+|+++.-++.|+.|||..|.=--
T Consensus 324 anN~LE--------------------------lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 324 ANNKLE--------------------------LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred hccccc--------------------------cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCcc
Confidence 888776 56677778888888888888887 788888888889999998887442
Q ss_pred CCCc
Q 043900 482 PIPS 485 (953)
Q Consensus 482 ~~p~ 485 (953)
..|.
T Consensus 377 MPPK 380 (1255)
T KOG0444|consen 377 MPPK 380 (1255)
T ss_pred CCCC
Confidence 4443
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.26 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=202.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|+..+.||+|+||.||+|....+++.||+|.++.... .+.+.+|++++++++||||+++++++. .+...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 3578999999999999999999998778999999875432 678999999999999999999999854 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+++||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 75 l~~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 75 IVMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred EEEecCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence 999999999999998532 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+........ ......++..|+|||++.+..++.++||||||+++|||++|+.||.......... .
T Consensus 143 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~----- 210 (256)
T cd06612 143 FGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M----- 210 (256)
T ss_pred cccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h-----
Confidence 999986643221 2223447889999999999899999999999999999999999987532211000 0
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .........+.++.+++.+||+.||++|||+.|+++
T Consensus 211 ----~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 ----IPNKPP----------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----hccCCC----------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000000 000111133456889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.71 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=195.9
Q ss_pred CcccccceeeEEEEEEcCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKT--TVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++.+++. .+|+|.++.. .....+.+.+|+++++++ +||||++++++|.. ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 468999999999999977654 4688888643 334556788999999999 79999999999643 36689999
Q ss_pred eeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 713 EFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
||+++|+|.+++........ .......+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 99999999999864332100 011223588999999999999999999998 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 153 l~dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~ 224 (270)
T cd05047 153 IADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL 224 (270)
T ss_pred ECCCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHH
Confidence 999999863221 111111224567999999988899999999999999999997 99998642211 111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
... .. ......++.++.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 225 ~~~---------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQG---------YR------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCC---------CC------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 00 0000123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=322.44 Aligned_cols=285 Identities=18% Similarity=0.165 Sum_probs=198.7
Q ss_pred ccCccccc--ceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 635 SANEIGVG--SFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 635 ~~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+.++||+| +|++||++....+++.||+|+++.. .....+.+.+|+++++.++||||++++++|. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45789999 7899999999999999999999743 2334466788999999999999999999964 3477899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFM--------DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence 9999999999999853321 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCC-----cccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 791 GLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 791 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|.+........ ........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~ 224 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLN 224 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhc
Confidence 87643321110 011122346788999999876 468899999999999999999999997532221111 1110
Q ss_pred hhCCchh-------hhh--------ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 864 MALPDHV-------VDI--------VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 864 ~~~~~~~-------~~~--------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
...+... .+. .+........ .....................+++.+++.+||+.||++|||++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 303 (327)
T cd08227 225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTT-VSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST 303 (327)
T ss_pred CCccccccccchhhhhcccCCcccCCcCCCCcccc-cCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence 0000000 000 0000000000 00000000000001112234568999999999999999999999
Q ss_pred HHH--HHHHHH
Q 043900 929 VVR--QLQSIK 937 (953)
Q Consensus 929 vl~--~L~~i~ 937 (953)
+++ .++.++
T Consensus 304 ll~~p~f~~~~ 314 (327)
T cd08227 304 LLNHSFFKQIK 314 (327)
T ss_pred HhcChhhhhcc
Confidence 987 355544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=327.75 Aligned_cols=242 Identities=25% Similarity=0.254 Sum_probs=187.2
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHH-HHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|+++.. .......+..|.. +++.++||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 4699999999999999988889999999643 2223345555554 467789999999998853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQR----------ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCC
Confidence 99999999988842 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~---- 211 (325)
T cd05604 143 CKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHK---- 211 (325)
T ss_pred cccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcC----
Confidence 8753211 1122345689999999999999999999999999999999999999964211 1111111000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... ....+.++.+++.+|++.||.+||++.+.++
T Consensus 212 ----~~~~--------------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 212 ----PLVL--------------------RPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ----CccC--------------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 0000 0012345779999999999999999864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.69 Aligned_cols=281 Identities=21% Similarity=0.304 Sum_probs=201.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 357899999999999999999999888899999987432 233456778999999999999999999954 34779
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC---------GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred EEEEeccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence 99999996 5888887532 22478899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.+....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||......+ ..........
T Consensus 147 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~ 222 (301)
T cd07873 147 DFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILG 222 (301)
T ss_pred cCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcC
Confidence 999997543221 112234578899999987654 57889999999999999999999997532211 1111111111
Q ss_pred ch----hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHHH
Q 043900 868 DH----VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR--QLQSIK 937 (953)
Q Consensus 868 ~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i~ 937 (953)
.. +....+........ .. ..............+..+.+++.+|++.||.+|||++|+++ .++.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYN---YP--KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred CCChhhchhhhccccccccc---cC--ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11 11111100000000 00 00000000011134557889999999999999999999987 344443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.05 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||.|+||.||+|.+..+++.||+|+++.......+.+.+|++++++++||||+++++++. .+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 457899999999999999999998888899999998766666778999999999999999999999964 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL---------ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence 999999999999998532 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||.+...... ........+++.|+|||++. +..++.++||||||+++|||++|+.||....... ....+..
T Consensus 147 ~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~- 222 (280)
T cd06611 147 FGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK- 222 (280)
T ss_pred Cccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc-
Confidence 9998754322 11222345889999999864 3457889999999999999999999987531110 0100000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... +. ...+..++.++.+++.+||+.+|++||++.++++.
T Consensus 223 ---~~~-----~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 ---SEP-----PT--------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCC-----CC--------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 00 00011234568899999999999999999999774
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.86 Aligned_cols=276 Identities=20% Similarity=0.206 Sum_probs=198.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcC--CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ--GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..+|.+.+.||+|+||.||+|...+ .++.||+|.+... ....+|++++++++||||+++++++. ....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence 3579999999999999999998653 3467999987532 23467999999999999999998853 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+. ++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR----------SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEehhcC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence 899999995 688888731 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC--ccHHHHHHhh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD--MNLHNFARMA 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~--~~~~~~~~~~ 865 (953)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+.......
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 99999987654433333345679999999999999999999999999999999999999997533221 1111111111
Q ss_pred CCchhhhhccc---cccCCchhhhhcccchhh--hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDS---TLLSDDEDLAVHGNQRQR--QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~---~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... .+.... .+........ ...++. ....-.....+.++.+++.+|+..||++|||+.|++..
T Consensus 307 ~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 307 QVHP-LEFPQNGSTNLCKHFKQYA--IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCc-cccCCccchhHHHHHHhhc--ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 000000 0000000000 000000 00000011234568899999999999999999999875
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=315.23 Aligned_cols=276 Identities=24% Similarity=0.317 Sum_probs=198.1
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|++|.||+|+...+++.||+|+++... ......+.+|+.++++++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4788899999999999999999888899999986432 223467889999999999999999999954 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++ ++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK-------GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC-------CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECc
Confidence 9999997 688888853221 23689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC-
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP- 867 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~- 867 (953)
||++....... .......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+.... .......
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~ 221 (285)
T cd07861 145 FGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTP 221 (285)
T ss_pred ccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCC
Confidence 99997653221 122233578899999987654 578999999999999999999999975322111111 1000000
Q ss_pred -chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 -DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 -~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+........ ..+... .................++++.+++.+||+.||++|||+.||++
T Consensus 222 ~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 222 TEDVWPGVTS--LPDYKN---TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred Chhhhhcchh--hHHHHh---hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000000 00000000000001124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.26 Aligned_cols=240 Identities=22% Similarity=0.335 Sum_probs=184.5
Q ss_pred cccccceeeEEEEEEcC------------------------CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEE
Q 043900 638 EIGVGSFGSVYKGILDQ------------------------GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKI 693 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 693 (953)
.||+|+||.||+|.... ....||+|+++.........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998532 123589999875555555678889999999999999999
Q ss_pred EeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 694 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
+++|.. +...++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+|||||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk 144 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKE---------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence 999753 36789999999999999988532 23578899999999999999999998 99999999
Q ss_pred CCCeEecCCC-------cEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHH-hC
Q 043900 774 PSNVLLDEEM-------MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELV-TR 844 (953)
Q Consensus 774 p~NIll~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~ell-tg 844 (953)
|+||+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997643 4899999988643211 12347788999998865 56899999999999999995 69
Q ss_pred CCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 043900 845 KKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924 (953)
Q Consensus 845 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 924 (953)
+.||......+ ......... ... .....++.+++.+||+.+|++||
T Consensus 219 ~~p~~~~~~~~--~~~~~~~~~----------~~~----------------------~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 219 EVPLKERTPSE--KERFYEKKH----------RLP----------------------EPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CCCccccChHH--HHHHHHhcc----------CCC----------------------CCCChHHHHHHHHHcccChhhCc
Confidence 99986432111 011100000 000 01123588999999999999999
Q ss_pred CHHHHHHHHH
Q 043900 925 NMTNVVRQLQ 934 (953)
Q Consensus 925 t~~evl~~L~ 934 (953)
|+.++++.|+
T Consensus 265 s~~~il~~L~ 274 (274)
T cd05076 265 SFRTILRDLT 274 (274)
T ss_pred CHHHHHHhhC
Confidence 9999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.20 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=196.7
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.|.-.+.||.|+||.||-|++..+.+.||||++.. ...+.+.++.+|+..+++++|||++.+.|+|. .....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence 35566889999999999999999999999999963 33445678999999999999999999999853 33667
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
|+||||| -|+-.+.+.-. .+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+
T Consensus 102 WLVMEYC-lGSAsDlleVh---------kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred HHHHHHH-hccHHHHHHHH---------hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence 9999999 55777776422 34688999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|||.|....+ ....+|||.|||||++. .+.|+-++||||+|++..|+..+++|+..+..... +.+.+...
T Consensus 169 DFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIAQNe 241 (948)
T KOG0577|consen 169 DFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE 241 (948)
T ss_pred cccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHHhcC
Confidence 9999987642 23457999999999864 46899999999999999999999999765322111 01111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. +.+. ..+.++.+.+++..|+++-|.+|||.+++++
T Consensus 242 s---------PtLq---------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 S---------PTLQ---------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C---------CCCC---------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 0 0010 1144667999999999999999999999875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.99 Aligned_cols=202 Identities=25% Similarity=0.302 Sum_probs=173.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|+..+.||+|+||.||+|+...+++.||+|+++.. .......+.+|+.++..++||+|+++++++ .+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4688999999999999999999998899999999642 233456788899999999999999999985 44578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK----------KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEE
Confidence 9999999999999999852 23588999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc---------------------------------ccccccccccccccccccCCCCCCcccchHHH
Q 043900 788 SDFGLARFLPLSPAQ---------------------------------TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~sl 834 (953)
+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754321100 00123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 043900 835 GILLLELVTRKKPVDS 850 (953)
Q Consensus 835 G~vl~elltg~~pf~~ 850 (953)
||++|||++|+.||..
T Consensus 223 Gvilyel~tG~~Pf~~ 238 (360)
T cd05627 223 GVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeeecccCCCCCCC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=307.68 Aligned_cols=248 Identities=28% Similarity=0.403 Sum_probs=194.9
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
++||+|+||.||+|.+.+ ++.||+|+++..... ....+.+|++++++++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 469999999999999987 679999998754333 5568899999999999999999999864 336789999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++... ...+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.+..
T Consensus 75 ~~~~l~~~l~~~---------~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRKK---------KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 999999998532 12478899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIV 874 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 874 (953)
..............++..|+|||.+.+..++.++|||||||++|||+| |..||...... ..........
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~-------- 212 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY-------- 212 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC--------
Confidence 532211111112234667999999998899999999999999999999 88888643211 1111110000
Q ss_pred cccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 875 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 875 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
. ...+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 213 ----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 ----R------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ----C------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0 0000123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.78 Aligned_cols=277 Identities=22% Similarity=0.286 Sum_probs=200.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++|||++++++++. .+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 46889999999999999999999888899999986432 223456789999999999999999999854 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++++++..+... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN----------PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEEC
Confidence 999999999988887642 23589999999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh--h
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM--A 865 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~ 865 (953)
|||.+........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+.. ...... .
T Consensus 143 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~ 219 (286)
T cd07847 143 DFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YLIRKTLGD 219 (286)
T ss_pred ccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCC
Confidence 9999987643321 1223347889999999876 45789999999999999999999999754322111 111100 0
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+..+...... ........ ............+..+.+++.+||+.||++|||+.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 220 LIPRHQQIFSTNQFFK--GLSIPEPE-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CChHHhhhcccccccc--cccCCCcc-cccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0001111111000000 00000000 000000011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=312.48 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=196.9
Q ss_pred CcccccceeeEEEEEEcCCC------eEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 637 NEIGVGSFGSVYKGILDQGK------TTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+.||+|+||.||+|+..+.. +.||+|.+.... ......+.+|+.+++.++||||++++++|. ..+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36899999999999986533 679999885432 344667889999999999999999999864 346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-----c
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-----M 784 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~ 784 (953)
+||||+++++|.+++....... .....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence 9999999999999996432210 0233578999999999999999999998 999999999999999877 8
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
++++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~ 227 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVT 227 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHh
Confidence 99999999976543322222223346788999999999999999999999999999998 99998642111 1111000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
. .. +.......+..+.+++.+||+.+|++||+++++++.|+
T Consensus 228 ~---~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 A---GG---------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c---CC---------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 00 00011134567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.27 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=197.1
Q ss_pred CcccccceeeEEEEEEcC-CC--eEEEEEEeeccch-hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQ-GK--TTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|++|.||+|.+.. ++ ..||+|.++.... ...+.+.+|+..+++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999865 22 3699999976554 566789999999999999999999998532 6789999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--------GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhccc--------ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence 99999999999964221 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 793 ARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 793 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ........ ..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~--~~- 218 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKE--GE- 218 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc--CC-
Confidence 9876442221 11123447789999999998899999999999999999999 999986432111 10000000 00
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
. .......+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ------~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 ------R--------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------c--------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0000123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.62 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=200.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|+++++.++|+|++++++++. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 36888899999999999999999888899999987443 344567889999999999999999999854 337889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+|+||+++++|.+++.. ..+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999852 2588999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.++...... .......++..|+|||++.+..++.++||||||+++|||+||+.||....... .........+..
T Consensus 142 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~ 217 (274)
T cd06609 142 FGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPPS 217 (274)
T ss_pred cccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCCC
Confidence 99998775321 22233458889999999999889999999999999999999999996432110 000000000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. . ..++.++.+++.+||..||++|||++++++
T Consensus 218 --------~~--------------------~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 --------LE--------------------G-NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --------Cc--------------------c-cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 0 013456889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.81 Aligned_cols=251 Identities=19% Similarity=0.268 Sum_probs=202.6
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|+..+.||+|+||.||.++...+++.||+|.+... .....+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 488899999999999999999988889999998643 3445677889999999999999999999964 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK--------GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHhcc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECc
Confidence 9999999999999986322 23588999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+........ ......+++.|+|||+..+..++.++||||||+++|||++|..||..... ..........
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~- 216 (256)
T cd08221 145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQG- 216 (256)
T ss_pred CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcC-
Confidence 999987643321 22334589999999999888899999999999999999999999864211 1111110000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... ....++.++.+++.+||+.+|++||++.|+++.
T Consensus 217 -------~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 217 -------NYTP-------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -------CCCC-------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0000 001334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.63 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=201.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
..|+..+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++++.||||+++++++. ++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 35778899999999999999998888899999987433 345678889999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.+++.. ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|
T Consensus 79 lv~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence 99999999999998852 2478889999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+....... .......++..|+|||++.+..++.++|||||||++|||++|..||........ .
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~------- 210 (277)
T cd06640 145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L------- 210 (277)
T ss_pred cccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h-------
Confidence 99997664322 122234578899999999888999999999999999999999999875321110 0
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
........ ......++..+.+++.+||+.+|++||+++++++.
T Consensus 211 --~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 --FLIPKNNP------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --hhhhcCCC------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000000 00112356678899999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.41 Aligned_cols=266 Identities=22% Similarity=0.258 Sum_probs=205.2
Q ss_pred cCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
.+..++....+.|++.+.||+|+||.||+|.+...++.||+|++.... .....+..|+.+++++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 345566667788999999999999999999999888899999986543 3345678899999998 69999999999753
Q ss_pred ccc-CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 700 VDY-QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 700 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
... ......++||||+++|+|.+++..... ..+++..++.++.|++.|++|||+. +++||||+|+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--------NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL 153 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 311 234678999999999999999864322 2477888999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCccc
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFE 853 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~ 853 (953)
+++++.++|+|||.+....... .......|+..|+|||++. +..++.++|||||||++|||++|..||.....
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 9999999999999987553211 1222345889999999875 35688899999999999999999999964321
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .. .... ..... .....++.++.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~----~~---------~~~~-~~~~~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 MRA----LF---------LIPR-NPPPK-----------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhh----hh---------hHhh-CCCCC-----------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 100 00 0000 00000 000124557899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=309.43 Aligned_cols=240 Identities=22% Similarity=0.370 Sum_probs=185.3
Q ss_pred CcccccceeeEEEEEEcCC------------CeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 637 NEIGVGSFGSVYKGILDQG------------KTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
+.||+|+||.||+|+.... ...||+|++..........+.+|+.+++.++||||++++++|..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 4689999999999986422 23589998876555556678889999999999999999999643
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
+...++||||+++|+|..++... ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK---------SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCc
Confidence 36679999999999999887522 23588999999999999999999999 9999999999999987664
Q ss_pred -------EEEeccccceecCCCCCcccccccccccccccccccC-CCCCCcccchHHHHHHHHHHH-hCCCCCCCcccCC
Q 043900 785 -------AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELV-TRKKPVDSMFEGD 855 (953)
Q Consensus 785 -------~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slG~vl~ell-tg~~pf~~~~~~~ 855 (953)
++++|||.+..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||......+
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred cCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 89999999875421 12234788999999886 467899999999999999998 5888876421110
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
...... ..... .....+++.+++.+||+.||++||++.++++.+
T Consensus 218 --~~~~~~------------~~~~~--------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 --KERFYE------------GQCML--------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --HHHHHh------------cCccC--------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000 00000 001134688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.23 Aligned_cols=265 Identities=23% Similarity=0.379 Sum_probs=200.7
Q ss_pred CcccCcccccceeeEEEEEEcC---CCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC-CCC
Q 043900 633 FASANEIGVGSFGSVYKGILDQ---GKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ-GND 706 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 706 (953)
|.+.+.||+|+||.||+|.+.. +++.||+|+++.. .....+++.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999998753 4578999998643 334466788999999999999999999987543111 112
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++++||+++|+|.+++...... .....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence 357899999999999887432211 1123578999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.++...............++..|++||.+.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~-- 229 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI-- 229 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH--
Confidence 999999986643322222223345678999999988889999999999999999999 88888642211 1111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
... .. . ....++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 230 -~~~-------~~-~-------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -KGN-------RL-K-------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -cCC-------cC-C-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00 0 0012345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=315.41 Aligned_cols=281 Identities=22% Similarity=0.323 Sum_probs=196.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++++|.+.+.||+|+||.||+|....+++.||+|+++... ......+.+|+.+++.++|+||+++++++. .++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 4578999999999999999999998888899999986432 233346778999999999999999999854 3467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH---------PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEE
Confidence 899999995 6777666321 12467888999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH-hh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR-MA 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~-~~ 865 (953)
+|||+++....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||+........+..... ..
T Consensus 145 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 222 (291)
T cd07870 145 ADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222 (291)
T ss_pred eccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC
Confidence 99999975432211 12234478899999998764 5788999999999999999999999753322111111110 00
Q ss_pred CCch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.. ...... ........ ...................+.++.+++.+|++.||++|||++|++.
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 223 VPTEDTWPGVS-KLPNYKPE-WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CCChhhhhhhh-hcccccch-hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 1110 000000 00000000 0000000000000001112456889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.53 Aligned_cols=202 Identities=24% Similarity=0.284 Sum_probs=171.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|+...+++.||+|+++.. .....+.+.+|..++..++|++|+++++++. .++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 4789999999999999999999988889999999632 2234456888999999999999999999854 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEE
Confidence 99999999999999998532 23588899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
+|||++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 144 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 144 ADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99999976543222 12223458999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.97 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=192.7
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
++||+|+||.||+|...+ ++.||+|+++... ......+.+|++++++++||||++++++|.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 469999999999999765 5589999986443 3334578899999999999999999999643 36789999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++... ...+++..++.++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++..
T Consensus 75 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRKK---------KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 999999988532 12478999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIV 874 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 874 (953)
...... .......++..|+|||++.+..++.++||||||+++||+++ |..||....... ........
T Consensus 143 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~--------- 210 (250)
T cd05085 143 EDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKG--------- 210 (250)
T ss_pred cccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcC---------
Confidence 432211 11112234678999999998899999999999999999999 999986532111 00000000
Q ss_pred cccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 875 DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 875 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
... .....++.++.+++.+||+.+|++||++.|+++.|.
T Consensus 211 ---~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 ---YRM------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCC------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 000 000123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.07 Aligned_cols=238 Identities=25% Similarity=0.253 Sum_probs=184.5
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999888899999986422 222344555554 578889999999998853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|..++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQR----------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCC
Confidence 99999999888742 23578888999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~---- 211 (321)
T cd05603 143 CKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHK---- 211 (321)
T ss_pred CccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcC----
Confidence 8753221 1122345689999999999999999999999999999999999999965211 1111111000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
... .+.....++.+++.+|++.||++||++.
T Consensus 212 ----~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 ----PLQ--------------------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----CCC--------------------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 000 0001234588999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=322.64 Aligned_cols=282 Identities=19% Similarity=0.212 Sum_probs=204.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 56899999999999999999999988889999998642 23345678889999999999999999998765555555678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++|+||++ +++.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~lv~e~~~-~~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEehhcc-cCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEC
Confidence 99999996 47877764 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 789 DFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|||++......... .......|+..|+|||++.+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~ 226 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVL 226 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHc
Confidence 99999865432211 12223468899999998654 56889999999999999999999999652211 0111111111
Q ss_pred C----chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 P----DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. +....+.+......... ................+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKS----LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhh----cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111111100000000 00000000000011235678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.02 Aligned_cols=275 Identities=20% Similarity=0.282 Sum_probs=196.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4788899999999999999999888899999986432 22335677899999999999999999984 4457899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+|+||++ ++|.+++... ...+++..++.++.||++||+|||+. +++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSC---------NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECc
Confidence 9999996 5787776422 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++...... .......++..|+|||++.+. .++.++|||||||++|||+||..||.........+..........
T Consensus 143 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 143 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99998653221 112234578899999988765 478999999999999999999998653222211111111111000
Q ss_pred hh--hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HV--VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ...+... ...... ..........+.....+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKL--PDYKPY---PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhc--cccccc---CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000000 000000 0000000000011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.16 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=186.1
Q ss_pred CcccccceeeEEEEEEcCCC--eEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGK--TTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.||+|+||.||+|....+. ..+++|.++... ....+.+.+|+..++.++||||++++++|.. ....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence 36999999999999865432 346677665332 3456789999999999999999999999643 367899999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.++++..... ....++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQWH------RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhhcc------cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence 99999999999643211 22467778889999999999999998 9999999999999999999999999998
Q ss_pred eecCCCCCcccccccccccccccccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLG-------SEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
................++..|+|||++.+ ..++.++|||||||++|||++ |..||...... ......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~ 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----EVLNHV 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence 64322211122233457889999998743 245789999999999999997 56677542211 111111
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
.........++.+.. ...+.+.+++..|| .+|++||+++||++.|.
T Consensus 222 ~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 IKDQQVKLFKPQLEL----------------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HhhcccccCCCccCC----------------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111111111111 12345788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.24 Aligned_cols=264 Identities=23% Similarity=0.255 Sum_probs=202.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|++++++++||||++++++|... .....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 36888899999999999999999888899999987432 23456789999999999999999999987432 335689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK------RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence 99999999999988753221 133578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||++........ ....++..|+|||.+.+..++.++||||+||++|||++|+.||...........+.........
T Consensus 149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 999875432211 1334788999999999999999999999999999999999999754221111111111100000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... +.. ........++++.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~~-----~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 NPE-----LKD----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chh-----hcc----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 000 00000123457899999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.51 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=185.8
Q ss_pred CcccccceeeEEEEEEcCCCe-------EEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 637 NEIGVGSFGSVYKGILDQGKT-------TVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+.||+|+||.||+|.....+. .||+|.+........+.+.+|+.+++.++|||++++++++.. ++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 469999999999999865433 488888865555556778899999999999999999999643 36789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc-----
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM----- 784 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~----- 784 (953)
+||||+++|+|.++++... ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK---------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCC
Confidence 9999999999999996322 2578999999999999999999999 9999999999999987765
Q ss_pred ---EEEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCC-CCCCCcccCCccHH
Q 043900 785 ---AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRK-KPVDSMFEGDMNLH 859 (953)
Q Consensus 785 ---~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~-~pf~~~~~~~~~~~ 859 (953)
++++|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||...... ...
T Consensus 144 ~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~ 215 (258)
T cd05078 144 PPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKL 215 (258)
T ss_pred CceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHH
Confidence 69999998875432 1223478899999998874 5789999999999999999985 554421110 000
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
...... ..+ +.....++.+++.+||+.||++|||++++++.|
T Consensus 216 ~~~~~~----------~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 216 QFYEDR----------HQL----------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHcc----------ccC----------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 000 001124588999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.29 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=199.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|.+..+. .||+|.++... ...+.+.+|++++++++|+||+++.+++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~-~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCc-cEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 467899999999999999999876554 79999886432 345678899999999999999999988532 5679
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
++|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDE--------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHhCC--------ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence 9999999999999996422 23578889999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.+........ .......++..|+|||++.+..++.++|||||||++|+++| |+.||...... ............
T Consensus 146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM 222 (260)
T ss_pred CcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC
Confidence 999986643221 11122345678999999998889999999999999999999 99998642111 111111000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.22 Aligned_cols=193 Identities=22% Similarity=0.354 Sum_probs=163.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
...+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++.. ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-----CCee
Confidence 445799999999999999999999988889999985422 23468999999999999999998643 4678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+. ++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 133 ~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKR---------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred EEEEEccC-CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence 99999994 6888887532 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
|||.++..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 200 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999753221 1222345899999999999999999999999999999999965554
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=312.92 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=198.9
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++. .+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence 4667788999999999999998888899999987432 344567889999999999999999999854 4477999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++||
T Consensus 80 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 80 IMEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccc
Confidence 9999999999998841 3578899999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|++....... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ ... ....
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~~~~- 216 (277)
T cd06642 146 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL----IPKN- 216 (277)
T ss_pred cccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh----hhcC-
Confidence 9997654321 122234578899999999998999999999999999999999999864322110 000 0000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... ......+.++.+++.+||+.+|++||++.|+++.
T Consensus 217 -------~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 -------SPP------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -------CCC------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000 0001234568899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=314.35 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=202.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence 46888899999999999999999888899999886432 3445788999999999999999999999643 37889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.. ...+++..+..++.+++.|+.|||+. .+++||||||+||++++++.++|+|
T Consensus 80 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEcc
Confidence 99999999999998852 23588999999999999999999963 2899999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||++....... .....|+..|+|||++.+..++.++|||||||++||+++|+.||.......... ..+..
T Consensus 148 ~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~ 217 (284)
T cd06620 148 FGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMG 217 (284)
T ss_pred CCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhH
Confidence 99987542211 123458999999999988899999999999999999999999997543221100 00000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
..+.......... ... ....++.++.+++.+||+.||++|||+.|+++..
T Consensus 218 ~~~~~~~~~~~~~-------------~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 218 ILDLLQQIVQEPP-------------PRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHhhccC-------------CCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111110000000 000 0012456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.00 Aligned_cols=249 Identities=21% Similarity=0.269 Sum_probs=197.9
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
|.....||+|+||.||+|....++..||+|.++.......+.+.+|+..+++++|||++++++.+. .++..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence 444577999999999999998888899999987655556677899999999999999999998854 347889999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++++|.+++. ...+++.++..++.||+.||+|||+. +++||||||+||++++++.++|+|||+
T Consensus 99 e~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 99 EFLEGGALTDIVT-----------HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred eCCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999884 12478899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
+....... .......|+..|+|||...+..++.++||||||+++||+++|+.||...... ..........
T Consensus 165 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~------ 234 (292)
T cd06658 165 CAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNL------ 234 (292)
T ss_pred hhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC------
Confidence 97553221 1222345889999999998889999999999999999999999998642111 0000000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..... .....+..+.+++.+||..||++|||++|+++.
T Consensus 235 --~~~~~--------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 --PPRVK--------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --CCccc--------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000 001234468899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.39 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=202.5
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||.|+||.||+|.+..+++.||+|+++.. .....+.+..|++++++++|||++++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 478889999999999999999888889999998632 33445678899999999999999999987642 2345689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEeecCCCCCeEecCCCc
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH-----HDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
++|||+++++|.+++..... ....+++..++.++.|++.||+||| +. +++||||+|+||+++.++.
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK------ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN 148 (265)
T ss_pred EEehhccCCCHHHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence 99999999999999964321 1346899999999999999999999 66 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||.+........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||.... .......
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~ 221 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK 221 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH
Confidence 99999999987643221 1223458999999999999899999999999999999999999997532 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. ...... ......+.++.+++.+|++.+|++||++.||++.
T Consensus 222 ~---------~~~~~~------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 I---------KEGKFR------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred H---------hcCCCC------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 000000 0011334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.44 Aligned_cols=278 Identities=22% Similarity=0.335 Sum_probs=196.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|++|.||+|..+.+++.||+|.+.... ......+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 467999999999999999999998888899999986432 222345678999999999999999999953 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~---------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCG---------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred EEEEecCCC-CHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence 999999974 8998885321 2578999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC-
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL- 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~- 866 (953)
|||.++....... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||..................
T Consensus 146 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07844 146 DFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT 223 (291)
T ss_pred ccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence 9999875432111 1122346889999998876 45889999999999999999999999753311111111111000
Q ss_pred --CchhhhhccccccCCchhhhhccc-chhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 --PDHVVDIVDSTLLSDDEDLAVHGN-QRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 --~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
++......+. ........... ......... .......+.+++.+|++.+|++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 224 PTEETWPGVSSN---PEFKPYSFPFYPPRPLINHAP-RLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CChhhhhhhhhc---cccccccccccCChhHHHhCc-CCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 00000000000 000000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.62 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=194.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|...+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 36888999999999999999998888899999986321 2334578899999999999999999998642 223
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA----------YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 567899999999999999852 22478889999999999999999998 99999999999999999999
Q ss_pred EEeccccceecCCCCC-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++....... ........++..|+|||++.+..++.++||||+||++||+++|+.||...... .. ...
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~-~~~ 220 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AA-IFK 220 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HH-HHH
Confidence 9999999976532111 11112345888999999999999999999999999999999999999743111 00 000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... ... ..+....+.+.+++ +||..+|++||+++||++
T Consensus 221 ~~~~~--------~~~------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQP--------TNP------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCC--------CCC------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000 000 00112234566676 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.96 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=197.2
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch---------hhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+|.+...||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 47788999999999999999988888999998863221 123568899999999999999999998643
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++++
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~ 142 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNN----------YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK 142 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC
Confidence 4678999999999999999952 23578889999999999999999998 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCc----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 783 MMAHVSDFGLARFLPLSPAQ----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+.+||+|||.++........ .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||......
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 218 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---- 218 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----
Confidence 99999999999876422111 1112234788999999999889999999999999999999999999753111
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... ......+. .+...+..+.+++.+||+.||++||++.|+++
T Consensus 219 ~~~~~------~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QAIFK------IGENASPE----------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHH------HhccCCCc----------------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 00000000 00123456889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.37 Aligned_cols=206 Identities=21% Similarity=0.311 Sum_probs=163.0
Q ss_pred cCcccccceeeEEEEEEcC--CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 636 ANEIGVGSFGSVYKGILDQ--GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
..+||+|+||.||+|+..+ +.+.||+|.++... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3679999999999999764 44689999986432 23467889999999999999999998743 23467899999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe----cCCCcEEEec
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSD 789 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 789 (953)
|++ ++|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 81 YAE-HDLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeC-CcHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 986 47877775322211 111234589999999999999999999999 99999999999999 5667999999
Q ss_pred cccceecCCCCCc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 790 FGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 790 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999876432211 122334689999999998764 5889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.44 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=202.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
-|.++..||.|+||.||+|..++++...|.|++.....+..++++-|++++..++||+||++++.|+ ..+..+|.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEE
Confidence 4667788999999999999999988778899998888888899999999999999999999998843 34779999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
.|||.||-....+-. -.+.+++.++.-+++|++.||.|||+. .|||||||+.|||++-+|.++|+|||
T Consensus 108 iEFC~GGAVDaimlE---------L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLE---------LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EeecCCchHhHHHHH---------hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence 999999999888853 234799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYG-----LGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
.+.... ..........|||+|||||+. .+.+|+.++||||||+++.||..+.+|....... +-.....-
T Consensus 176 VSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllKiaK 249 (1187)
T KOG0579|consen 176 VSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAK 249 (1187)
T ss_pred ccccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHHHhh
Confidence 986432 122333456799999999984 4668999999999999999999999997642211 00000000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+. +-.-.+......+.+++.+|+..||..||+++++++
T Consensus 250 SeP--------------------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 250 SEP--------------------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCC--------------------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 000 001111233456889999999999999999999976
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.62 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=206.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..-|...+.||+|.|+.|-+|++--+++.||||++....- .....+.+|+.-|+-++|||||++|++ .+....
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence 3458888999999999999999999999999999975443 334678899999999999999999998 556688
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe-cCCCcEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL-DEEMMAH 786 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~k 786 (953)
.|+|+|.-++|+|.+|+-++.. .+.+.-..+++.||+.|+.|+|+. .+|||||||+||.+ ..-|-||
T Consensus 92 lyLiLELGD~GDl~DyImKHe~---------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEE---------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhc---------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceE
Confidence 9999999999999999965443 588999999999999999999999 99999999999977 4668999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|.|||++-.+.++. .....+|+..|-|||++.|..|+ ++.||||+||++|.|++|++||....+.+
T Consensus 160 LTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------- 226 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------- 226 (864)
T ss_pred eeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------
Confidence 99999998775443 23345799999999999999987 67899999999999999999998643322
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.-++|... .-+...+.+..++|..|+..||.+|.+.+||+.
T Consensus 227 ---TLTmImDCKY--------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 ---TLTMIMDCKY--------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---hhhhhhcccc--------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1222222211 112255678899999999999999999999875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.77 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=199.0
Q ss_pred CCcccCcccccceeeEEEEEEcC-CCeEEEEEEeecc----------chhhHHHHHHHHHHHhh-cCCCCeeEEEeeecc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQ-GKTTVAVKVFNLL----------HHGAFKSFIAECNTLKN-IRHRNLVKILTACSG 699 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 699 (953)
+|++.+.||+|+||.||+|.+.. +++.||+|.+... ......++.+|+.++.+ ++||||++++++|.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999987 6678999988532 22334567788888865 69999999999864
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeE
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVL 778 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIl 778 (953)
.++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ . +++||||+|+||+
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil 146 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKE------KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIM 146 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEE
Confidence 34789999999999999998853221 12358899999999999999999996 5 8999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
++.++.+||+|||.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----- 218 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----- 218 (269)
T ss_pred ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----
Confidence 9999999999999998754332 22345588999999999998899999999999999999999999864211
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
....... .+....+.. ....++++.+++.+||+.||++||++.|+.++++
T Consensus 219 ~~~~~~~--------~~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 LSLATKI--------VEAVYEPLP------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHH--------hhccCCcCC------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111100 000000000 0023456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.34 Aligned_cols=250 Identities=19% Similarity=0.268 Sum_probs=200.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||++....+++.||+|.+... .....+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 488899999999999999999988889999998642 234456789999999999999999999985 3457899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQR--------GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEee
Confidence 9999999999999885322 12578899999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+....... .......|++.|+|||+..+..++.++|||||||++|++++|+.||.... ............
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~ 217 (256)
T cd08218 145 FGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGS 217 (256)
T ss_pred ccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCC
Confidence 99998654321 11223457889999999999999999999999999999999999986421 111111110000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ......+.++.+++.+||+.+|++||++.||++
T Consensus 218 --------~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 --------YP-------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --------CC-------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 001123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=321.29 Aligned_cols=202 Identities=24% Similarity=0.293 Sum_probs=172.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|.+.+.||+|+||+||+|++..+++.||+|++... .......+.+|..++..++|++|+++++++. ..+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 4789999999999999999999988889999998642 2233456788999999999999999999853 4578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEE
Confidence 99999999999999999632 12578889999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 144 ADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 99999987643222 12223469999999999875 4678999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.26 Aligned_cols=259 Identities=19% Similarity=0.217 Sum_probs=205.2
Q ss_pred HhhcCCccc-CcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCC
Q 043900 628 NATDGFASA-NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 628 ~~~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 705 (953)
..+++|++. ++||-|-.|.|-.+..+.+++.+|+|++.. .....+|++.--.. .|||||.+++++... +...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENS-YQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCc
Confidence 356677664 679999999999999999999999999852 23456777765444 699999999998665 6777
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---C
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---E 782 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~ 782 (953)
....+|||.|+||.|...++..+. ..+++.++.+|+.||+.|+.|||+. .|+||||||+|+|... +
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~--------~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD--------QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc--------ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence 888999999999999999975543 3799999999999999999999999 9999999999999964 4
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
-.+||+|||+|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.+.....
T Consensus 201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------- 270 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------- 270 (400)
T ss_pred cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------
Confidence 5899999999986532 233345568999999999999999999999999999999999999998643221
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
++.....-+... .+ ..-.+++...+++..++++.+++.+|.+|.|+.|++.
T Consensus 271 ---ispgMk~rI~~g---qy------------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ---ISPGMKRRIRTG---QY------------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ---CChhHHhHhhcc---Cc------------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111111111100 00 0011234567788999999999999999999999875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.69 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=196.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEee--ccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
...|++.+.||+||.+.||++...+.+ .||+|++. ..+......|.+|+..|.++ .|.+|+++++|-. .++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cCc
Confidence 346899999999999999999987765 67777664 44556678899999999999 5999999999943 358
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..||||||= ..||..++++.... ++...++.+..|++.|+.++|.+ ||||.||||.|+|+-. |.+|
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~---------~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LK 499 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSI---------DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLK 499 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCC---------CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEE
Confidence 899999976 56999999754432 33237888999999999999999 9999999999999954 6799
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCC-----------CCCcccchHHHHHHHHHHHhCCCCCCCcccCC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-----------EVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slG~vl~elltg~~pf~~~~~~~ 855 (953)
|+|||.|..+..+.........+||+.||+||.+... +.++++||||+||++|+|+.|+.||.....
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-- 577 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-- 577 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--
Confidence 9999999988776666666677899999999987543 256889999999999999999999975211
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.|++ +..+.++...-.+.+ . ....++.++|+.||++||.+|||..|+++
T Consensus 578 ----~~aK------l~aI~~P~~~Iefp~-------------~----~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 ----QIAK------LHAITDPNHEIEFPD-------------I----PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHH------HHhhcCCCccccccC-------------C----CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1111 111122111000000 0 00123889999999999999999999986
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.26 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=203.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc-CCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY-QGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~ 706 (953)
..++|++.+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +|+||+++++++..... ....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 46789999999999999999999988888999999875443 346788999999999 79999999999865422 3356
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRK------KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEE
Confidence 78999999999999998864321 124688999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
|+|||.+...... ........|+..|+|||++.. ..++.++|||||||++|++++|+.||....... .....
T Consensus 154 l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 230 (275)
T cd06608 154 LVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI 230 (275)
T ss_pred ECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh
Confidence 9999999865322 122233458899999998753 346789999999999999999999996421110 00000
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ... .........+.++.+++.+||..||++|||++|+++
T Consensus 231 ~~----~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PR----NPP-------------------------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hc----cCC-------------------------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 000 000111124567889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.32 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=198.1
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||+|+||.||+|.+...++.||+|.++.. .......+.+|++++++++||||+++++++. .+...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 3688899999999999999999988889999998743 3344567889999999999999999999853 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|..++.... ....+++..+..++.|++.|+.|||+. .+++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGV-------ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999885321 123689999999999999999999963 2899999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE------VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
||.+...... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||...... .......
T Consensus 147 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~ 220 (286)
T cd06622 147 FGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLS 220 (286)
T ss_pred cCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHH
Confidence 9999765322 122335788999999985543 588999999999999999999999642111 0000000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...+... ...+..++.++.+++.+||+.+|++||++++++..
T Consensus 221 --------~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 --------AIVDGDP-------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------HHhhcCC-------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0000000 00011345678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.24 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=201.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence 36788899999999999999999888899999987543 3455678899999999999999999998643 37899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ---------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999986322 368889999999999999999999 7 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+........ ....++..|+|||.+.+..++.++||||||+++|++++|+.||....................
T Consensus 144 d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd06605 144 DFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219 (265)
T ss_pred ecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence 9999875532111 115588899999999999999999999999999999999999975432211111111111100
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ..... ....+.++.+++.+||..||++|||+.|++.
T Consensus 220 ~--------~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 P--------PPRLP------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred C--------CCCCC------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0 00000 0014567899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.03 Aligned_cols=210 Identities=24% Similarity=0.328 Sum_probs=175.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCC----eEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGK----TTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
....|+....||+|.||.||+|...++. +.+|+|.++... .+......+|+..++.++|||++.+..++..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~--- 98 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS--- 98 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc---
Confidence 3456899999999999999999765543 268999997442 2334567899999999999999999988643
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.+..+++++||.+. +|.+.++..+.. ..+.++...+..|+.||+.|+.|||++ -|+||||||.||||..+
T Consensus 99 -~d~~v~l~fdYAEh-DL~~II~fHr~~-----~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 99 -HDKKVWLLFDYAEH-DLWHIIKFHRAS-----KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGD 168 (438)
T ss_pred -cCceEEEEehhhhh-hHHHHHHHhccc-----hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEecc
Confidence 25789999999976 999999765543 235789999999999999999999999 89999999999999877
Q ss_pred ----CcEEEeccccceecCCCCCc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 783 ----MMAHVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 783 ----~~~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
|.|||+|||+|+.+...-.. .....++.|.+|+|||.+.|. .|+.+.||||.||++.||+|-.+.|.+.
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 89999999999988543222 234456789999999998886 5899999999999999999999888753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.73 Aligned_cols=202 Identities=23% Similarity=0.276 Sum_probs=170.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.++||+|+||+||+|+...+++.||+|++... .......+.+|+.++..++|++|+++++++. +.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 4689999999999999999999998889999998632 2223445788999999999999999998853 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999632 12578889999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
+|||++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 144 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred eecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 99999976532221 1222346999999999976 34688999999999999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=314.20 Aligned_cols=277 Identities=22% Similarity=0.295 Sum_probs=199.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46889999999999999999999888899999985322 22346788999999999999999999985 345789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++++++.++... ...+++.+++.++.|+++|++|||+. +++||||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY----------PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEE
Confidence 999999999999887642 22488999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH--hh
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR--MA 865 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~ 865 (953)
|||++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....... ..
T Consensus 143 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~ 219 (286)
T cd07846 143 DFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGN 219 (286)
T ss_pred eeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCC
Confidence 999998654322 22223457899999998875 357889999999999999999999986422111 0011000 00
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.........+......... .................+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 220 LIPRHQEIFQKNPLFAGMR---LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CchhhHHHhccchHhhccc---cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 1111111110000000000 00000000000111234677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.44 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=198.9
Q ss_pred CcccCcccccceeeEEEEEEcCCC----eEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 633 FASANEIGVGSFGSVYKGILDQGK----TTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+++.+.||.|+||.||+|.+...+ ..||+|+++..... ..+.+..|++.++.++|+||+++++++.. .+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence 356789999999999999998755 78999999754433 56788999999999999999999998643 367
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.+++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP--------KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh--------ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEE
Confidence 9999999999999999863221 1289999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||.++........... ...+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ........
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~ 218 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEYLK 218 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHh
Confidence 999999876543222111 2337789999999988889999999999999999999 7888764211 11111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
... . .......+.++.+++.+|+..||++|||+.|+++.|
T Consensus 219 ~~~--------~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGY--------R-------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCC--------C-------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 0 000012455789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.52 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=198.7
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|+..+.||+|+||.||+|....+++.||+|.+... .......+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 478889999999999999999988899999998643 234467888999999999999999999884 3447889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-CcEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~ 788 (953)
+||||+++++|.+++.... ...+++..+..++.|+++|++|||++ +++||||+|+||+++++ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC--------NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 9999999999999996422 23588999999999999999999999 99999999999999855 468999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 145 d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~--- 213 (256)
T cd08220 145 DFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKI--- 213 (256)
T ss_pred cCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHH---
Confidence 999998764322 222345888999999999888999999999999999999999998642111 111100
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....... .....+.++.+++.+||+.+|++|||+.|+++
T Consensus 214 -----~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 214 -----MSGTFAP-------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----HhcCCCC-------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000000 00023456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.57 Aligned_cols=263 Identities=22% Similarity=0.361 Sum_probs=201.9
Q ss_pred cCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
++|++.+.||+|+||.||+|+.+. +.+.||+|.+...... ....+.+|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence 468889999999999999999753 3457999988654433 45778999999999999999999998643
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+++|+|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKD-EKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccc-ccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence 367899999999999999996443211 111223689999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
++++|||++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||...... .......
T Consensus 156 ~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~ 232 (275)
T cd05046 156 VKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQ 232 (275)
T ss_pred EEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHH
Confidence 9999999987543221 112223346788999999988889999999999999999999 78888642211 1111000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
... .. +.....++.++.+++.+||+.+|++|||+.|+++.|.
T Consensus 233 ---~~~--------~~------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ---AGK--------LE------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---cCC--------cC------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00 0000123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.09 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=196.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
.+|++.+.||+|+||.||+|.+..+ +.+|+|.++.... ....+.+|++++++++||+++++++++. .....++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCC-CeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence 4688889999999999999998754 4799998864322 3457889999999999999999999854 3467899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 144 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQ---------RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCC
Confidence 99999999999998532 12478899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....... ..
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~-~~ 217 (256)
T cd05112 145 GMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETIN-AG 217 (256)
T ss_pred cceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHh-CC
Confidence 99986543221 11122335678999999998899999999999999999998 99998642211 1111100 00
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. ....+ ...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 218 ~-~~~~~-------------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 218 F-RLYKP-------------------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C-CCCCC-------------------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0 00000 01235689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.58 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=195.1
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc------hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+|++.+.||+|+||+||+|.... ++.||+|.++... ......+.+|++++++++|+||++++++|. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEcC-CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 47889999999999999998754 4589999886322 223456889999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF----------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeE
Confidence 7899999999999999998521 2478899999999999999999998 99999999999999999999
Q ss_pred EEeccccceecCCCCC----cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 786 HVSDFGLARFLPLSPA----QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+|+|||.+........ ........|+..|+|||++.+..++.++|||||||++||+++|..||....... .....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~ 220 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYI 220 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHh
Confidence 9999999976532111 111223458899999999999899999999999999999999999996432111 00000
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .. . .+.. ....+.++.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~---~~---~-~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GAH---RG---L-MPRL----------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhc---cC---C-CCCC----------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00 0 0000 0123456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=294.91 Aligned_cols=276 Identities=20% Similarity=0.300 Sum_probs=224.1
Q ss_pred HHHHHhhcCCcccCcccccceeeEEEEEEcCCC-----eEEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeee
Q 043900 624 QNLYNATDGFASANEIGVGSFGSVYKGILDQGK-----TTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697 (953)
Q Consensus 624 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 697 (953)
+++.....+++....+-+|.||.||+|.+++.+ +.|-+|.++. .++-....+..|...+....|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 334444566777788999999999999886543 2366676653 3344567788999999999999999999998
Q ss_pred cccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 043900 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNV 777 (953)
Q Consensus 698 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 777 (953)
.+ +.+..++++.++.-|+|..|+..++..+ ....+.++..+...+|.|++.|++|||++ +|||.||.++|.
T Consensus 357 ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~--~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC 427 (563)
T KOG1024|consen 357 IE----DYATPFVLYPATGVGNLKSFLQICRGDD--PSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC 427 (563)
T ss_pred ee----ccCcceEEEeccCcchHHHHHHHhccCC--CccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence 54 4577899999999999999998776432 23455788899999999999999999999 999999999999
Q ss_pred EecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCc
Q 043900 778 LLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDM 856 (953)
Q Consensus 778 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~ 856 (953)
+||+..+|||+|=.+++..-+.+...-....-.+..||+||.+....|+.++|||||||++|||+| |+.||.+....+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999999998877766666666667889999999999999999999999999999999 999987532211
Q ss_pred cHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 857 NLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
+..+ + ..+.|..++..||++++.+|.-||+.+|++||+++|++..|.+.
T Consensus 507 -m~~y------------l------------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 -MEHY------------L------------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHH------------H------------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111 1 11234455568999999999999999999999999999999988
Q ss_pred HHHh
Q 043900 937 KNIL 940 (953)
Q Consensus 937 ~~~~ 940 (953)
...+
T Consensus 556 ~~ql 559 (563)
T KOG1024|consen 556 HTQL 559 (563)
T ss_pred HHHH
Confidence 6543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.08 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=196.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc----------hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH----------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 701 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 701 (953)
+|.+.+.||+|+||.||+|....+++.||+|.++... ....+.+.+|+.++++++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 4778899999999999999998888899999885321 112346788999999999999999999864
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~ 143 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA 143 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence 347789999999999999998532 3588899999999999999999998 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
++.++++|||.++...............++..|+|||.+.... ++.++||||||+++||+++|..||...... .
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~ 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----A 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----H
Confidence 9999999999997653222222223345889999999987654 889999999999999999999998632111 1
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... .........+.. .....++.++.+++.+||..||++|||++||++
T Consensus 220 ~~~~-~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 220 AMFK-LGNKRSAPPIPP----------------------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHH-hhccccCCcCCc----------------------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1110 000000000000 001134567889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.40 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=202.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||.|+||+||+|....++..||+|++.... ....+.+.+|++.++.++|+|++++++.+. .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 46899999999999999999998888899999986332 335678899999999999999999998853 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|
T Consensus 76 iv~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP-------RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 99999999999999963221 13588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcc--cccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQT--SSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||.+..+....... ......|+..|+|||++... .++.++|||||||++|||++|+.||....... .........
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~- 223 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND- 223 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-
Confidence 99997665432221 22334588999999998777 78999999999999999999999997532211 111111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+ ..... .......+.++.+++.+||+.||++|||++|+++
T Consensus 224 ~--------~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 P--------PSLET-----------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C--------CCcCC-----------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000 0001134567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.32 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=201.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++|||+++++++|. ..+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 57899999999999999999988777899999987555555677889999999999999999999864 3467899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
|+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccC
Confidence 9999999999999852 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|.+........ ......+++.|+|||.+.+..++.++||||||+++||+++|+.||......+.... ...
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~~~------- 229 (293)
T cd06647 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT------- 229 (293)
T ss_pred cceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-hhc-------
Confidence 99876543221 22234588899999999888899999999999999999999999975322110000 000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... .........+..+.+++.+||+.+|++||++.+++..
T Consensus 230 ----~~~------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 ----NGT------------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----CCC------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000111234568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.07 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=195.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|... ++.||+|.++... ....+.+|+.++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecccC--CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 46889999999999999999753 4579999986432 34678899999999999999999998632 34689
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRTRG--------RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence 999999999999996432 22578999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.+....... .....+..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 145 g~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~----- 209 (254)
T cd05083 145 GLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKEC----- 209 (254)
T ss_pred ccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHH-----
Confidence 9997643211 12234578999999988899999999999999999998 99998643211 11100
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
+....... ....++.++.+++.+||+.+|++||+++++++.|++
T Consensus 210 ----~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 ----VEKGYRME------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----HhCCCCCC------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00000000 001234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.62 Aligned_cols=257 Identities=20% Similarity=0.243 Sum_probs=198.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|.+...++.||+|.+.... ......+.+|+++++.++||||+++++.+. .++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 36888999999999999999999998899999986432 233457889999999999999999998853 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN----------IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEE
Confidence 8999999999999999952 23578999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCC-------------cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 788 SDFGLARFLPLSPA-------------QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 788 ~DfG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
+|||.++....... ........++..|+|||.+.+..++.++|||||||++||+++|..||.+....
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999864211100 00111234788999999998889999999999999999999999998642111
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
........... ..+ ......+.++.+++.+||+.||++||++.++.+.++
T Consensus 223 -----~~~~~~~~~~~---~~~----------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 223 -----ELFGQVISDDI---EWP----------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -----HHHHHHHhccc---CCC----------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11111000000 000 000023456889999999999999999766666554
Q ss_pred H
Q 043900 935 S 935 (953)
Q Consensus 935 ~ 935 (953)
.
T Consensus 273 ~ 273 (305)
T cd05609 273 H 273 (305)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=317.30 Aligned_cols=288 Identities=23% Similarity=0.267 Sum_probs=208.6
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 710 (953)
|...+.||+||||.||+|+.+.+++.||||.++.. .....+...+|++++++++|||||+++++-.+.. +-......+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567899999999999999999999999999743 3345677889999999999999999998833221 111456789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec--CCC--cEE
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--EEM--MAH 786 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~k 786 (953)
|||||.+|||..++.... ....+++.+.+.+..+++.||.|||++ |||||||||.||++- .+| ..|
T Consensus 95 vmEyC~gGsL~~~L~~PE-------N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-------NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEeecCCCcHHHHhcCcc-------cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEe
Confidence 999999999999996433 345799999999999999999999999 999999999999983 334 689
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.|+..+.+. .....+||..|.|||+... +.|+..+|.|||||++||..||..||-.... .....+..+..
T Consensus 165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~-pk~~~~~~~~~ 240 (732)
T KOG4250|consen 165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG-PKNNKEIMWHI 240 (732)
T ss_pred eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC-ccccchhhhhh
Confidence 99999999875433 5556789999999999984 7889999999999999999999999976322 22111111111
Q ss_pred C---CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC--CHHHHHHHHHHHHHHh
Q 043900 866 L---PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM--NMTNVVRQLQSIKNIL 940 (953)
Q Consensus 866 ~---~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~evl~~L~~i~~~~ 940 (953)
. +..+.-...+...+. .......+. -..........+..++..++.++|++|- ...+....+.+|.+..
T Consensus 241 ~tkkp~~v~i~~~~~eNgp---v~~s~~lP~---p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGP---VEWSSTLPQ---PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hccCCCceeEeeecccCCc---eeeeccCCC---cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 1 111111111111000 000000000 0011112234466777788889999998 8888888888876553
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.94 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=197.1
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
|.....||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.+++.++|||++++++++. .++..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 334557999999999999998888899999997555555677889999999999999999999854 347889999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++++|.+++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 98 e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~ 163 (297)
T cd06659 98 EFLQGGALTDIVS-----------QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGF 163 (297)
T ss_pred ecCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechh
Confidence 9999999998874 13578999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
+....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~--- 236 (297)
T cd06659 164 CAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPK--- 236 (297)
T ss_pred Hhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCC---
Confidence 97553221 1223345889999999999889999999999999999999999998642111 0000000000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. ......+.++.+++.+||+.+|++||+++|+++.
T Consensus 237 -----~--------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 -----L--------------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -----c--------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000223458899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=303.82 Aligned_cols=253 Identities=20% Similarity=0.218 Sum_probs=195.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 46889999999999999999999888899999885321 23346788899999999999999999985322 23
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS----------YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCE
Confidence 467899999999999999852 12478888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~ 221 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKI 221 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHH
Confidence 99999999865322111 1122345888999999998888999999999999999999999998642111 111000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... . ...+......+.+++.+|+. +|++||+++|+++
T Consensus 222 ~~~~~-----~----------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQPT-----N----------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcCCC-----C----------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000 0 00111334567788899984 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.38 Aligned_cols=274 Identities=21% Similarity=0.250 Sum_probs=200.6
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 4888999999999999999998888899999997443 334567899999999999999999999854 357889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE---------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 999999985322 3589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.+........ .......++..|+|||++.+. .++.++||||+|+++|||++|.+||...... ............
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~ 219 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGT 219 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCC
Confidence 999987643321 122334588999999998654 4689999999999999999998887643221 111111111110
Q ss_pred h----hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 H----VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ..+..+. ..............+ ......+.+.++.+++.+|++.+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 220 PNEETWPGLTSL---PDYNKITFPESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CChHHHhhccCc---chhhcccCCCCCcch--HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0000000 000000000000000 00001133478999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=322.24 Aligned_cols=241 Identities=22% Similarity=0.218 Sum_probs=183.3
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhc---CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
||+|+||+||+|++..+++.||+|++.... ......+..|..++... +||+|+++++++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999999988899999986322 22233455666666655 699999999885 3447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQK----------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCc
Confidence 99999999988852 23588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...........
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~-- 213 (330)
T cd05586 143 SKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGK-- 213 (330)
T ss_pred CcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCC--
Confidence 97542211 122345699999999998765 489999999999999999999999965211 11111100000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC----HHHHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN----MTNVVR 931 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 931 (953)
..+.. ...++++.+++.+||+.||++||+ +.|+++
T Consensus 214 ----~~~~~---------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 214 ----VRFPK---------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ----CCCCC---------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00000 012446789999999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.47 Aligned_cols=275 Identities=27% Similarity=0.337 Sum_probs=197.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|+..+.||+|++|.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++. +++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 4788899999999999999999888899999986332 223457889999999999999999999853 457899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASP--------LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEee
Confidence 9999995 68888885322 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh-CC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA-LP 867 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~ 867 (953)
||.+....... .......++..|+|||++.+.. ++.++||||||+++|||+||+.||....+.+ ...+..... .+
T Consensus 144 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~ 220 (284)
T cd07860 144 FGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP 220 (284)
T ss_pred ccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99997653221 1122334688999999887654 5889999999999999999999997532211 111111111 11
Q ss_pred ch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ....... . +.... ...... .............++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~-~-~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 221 DEVVWPGVTS-L-PDYKP-SFPKWA--RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ChhhhhhhhH-H-HHHHh-hccccc--ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 10 0000000 0 00000 000000 00000001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.49 Aligned_cols=239 Identities=24% Similarity=0.418 Sum_probs=187.7
Q ss_pred CcccccceeeEEEEEEcCCC----------eEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 637 NEIGVGSFGSVYKGILDQGK----------TTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
+.||+|+||.||+|.+...+ ..|++|+++..... ...+.+|+.++++++||||++++++|.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46999999999999998765 35888887644333 6788899999999999999999998642 4
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC---
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM--- 783 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 783 (953)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK---------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcccc
Confidence 5689999999999999986322 1588999999999999999999998 999999999999999887
Q ss_pred ----cEEEeccccceecCCCCCcccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHh-CCCCCCCcccCCc
Q 043900 784 ----MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVT-RKKPVDSMFEGDM 856 (953)
Q Consensus 784 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~ 856 (953)
.+||+|||.+..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-- 213 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-- 213 (259)
T ss_pred CCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--
Confidence 799999999986532 1223467789999998876 78999999999999999999 57777543211
Q ss_pred cHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 857 NLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
....+.. .....+. ....++.+++.+||..+|.+|||+.|+++.|+
T Consensus 214 ~~~~~~~-----------~~~~~~~---------------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 EKERFYQ-----------DQHRLPM---------------------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hHHHHHh-----------cCCCCCC---------------------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111100 0000000 00146889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.40 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=199.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch---hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+..|+++++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 368889999999999999999998888999999964332 24567889999999999999999999853 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQP--------GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCC--------CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence 999999999999999986322 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc---------------------------ccccccccccccccccccCCCCCCcccchHHHHHHHHH
Q 043900 788 SDFGLARFLPLSPAQ---------------------------TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLE 840 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~e 840 (953)
+|||++......... .......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 999998755322110 01112357889999999999999999999999999999
Q ss_pred HHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 043900 841 LVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920 (953)
Q Consensus 841 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 920 (953)
|++|+.||....... .+. .+.+.... .......+.++.+++.+||+.||
T Consensus 225 l~~g~~pf~~~~~~~-~~~------------~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 225 MLYGTTPFKGSNRDE-TFS------------NILKKEVT------------------FPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HhhCCCCCCCCchHH-HHH------------HHhcCCcc------------------CCCccccCHHHHHHHHHHccCCH
Confidence 999999997532110 010 00100000 00001145679999999999999
Q ss_pred CCCCC----HHHHHH
Q 043900 921 GDRMN----MTNVVR 931 (953)
Q Consensus 921 ~~RPt----~~evl~ 931 (953)
++||| ++|++.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.13 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=191.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHH-HhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+..|+.. ++..+|||++++++++. .+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 46889999999999999999999888999999987432 2233455566665 56668999999999964 34678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++ |+|.+++..... ....+++..++.++.|++.|++|||++ .+++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYD------KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEe
Confidence 99999996 688887753221 124689999999999999999999974 289999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG----SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
|||.+....... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 147 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~-- 218 (283)
T cd06617 147 DFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLK-- 218 (283)
T ss_pred eccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHH--
Confidence 999998653221 1122457889999998765 45688999999999999999999998642211 11110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........... ...++.++.+++.+||+.+|++||+++++++
T Consensus 219 -------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 -------QVVEEPSPQLP------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------HHHhcCCCCCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000 0023456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=302.87 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=197.4
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
+|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|++++++++|+||+++++++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4778899999999999999998777899999986433 234567899999999999999999999854 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----------YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 78999999999999999852 22478999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.+....... ......++..|+|||.+.... ++.++|+||||+++|++++|+.||....... ......
T Consensus 143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~ 215 (258)
T cd06632 143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFKIG 215 (258)
T ss_pred EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----HHHHHH
Confidence 99999998654322 123345889999999987766 8999999999999999999999997532110 000000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .......+.+.+++.+||+.+|++||++.++++
T Consensus 216 ~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RSKELP---------------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hcccCC---------------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000 000123456789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.13 Aligned_cols=285 Identities=19% Similarity=0.256 Sum_probs=203.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|....+++.||+|++.... ......+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 468999999999999999999999888899999986432 234567788999999999999999998865432 33457
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS----------DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehhh-hhHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEe
Confidence 899999995 689888842 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc--ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||.+......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHH
Confidence 999999765432211 11223468899999998765 468899999999999999999999997532211 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARI-NSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.......+..+.......... ...........+ ......+.++.+++.+||+.||++|||+++++..
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKY-IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhCCChhHhhhhhchhhHHHH-HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111111110000000000 000000000000 0112346779999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=303.43 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=198.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc------hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+|+..+.||+|+||.||+|....+++.||+|+++... ....+.+.+|++++++++|+|++++++++. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 4788899999999999999998888899999986432 223567899999999999999999999954 44
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-c
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-M 784 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~ 784 (953)
+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----------YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 788999999999999999852 12578899999999999999999999 999999999999998776 6
Q ss_pred EEEeccccceecCCCCCc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
+||+|||.+......... .......++..|+|||.+.+..++.++||||+|+++|++++|..||....... .....
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~ 220 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALI 220 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHH
Confidence 999999999876432111 11223457889999999988889999999999999999999999986421111 11110
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ...... ...+...++++.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~--------~~~~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKI--------ASATTA------------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHH--------hccCCC------------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 000000 0011134567889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.64 Aligned_cols=276 Identities=22% Similarity=0.301 Sum_probs=201.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++|+||+++++++.. ++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 3688999999999999999999988889999998643 23345778999999999999999999999643 4779
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++++.+..+... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEAS----------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEE
Confidence 999999998777665531 23478999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh---
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM--- 864 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~--- 864 (953)
|||.+........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ .......
T Consensus 143 d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~ 219 (288)
T cd07833 143 DFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLG 219 (288)
T ss_pred eeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 9999987654322 122334578899999999888 88999999999999999999999997532211 1111100
Q ss_pred hCCchhhhhcc--ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVD--STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..+........ ...... . .................++.++.+++.+||..+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 220 PLPPSHQELFSSNPRFAGV--A--FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCHHHhhhcccCcccccc--c--cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 01111000000 000000 0 000000000000001123678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=316.42 Aligned_cols=288 Identities=21% Similarity=0.226 Sum_probs=206.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|.+.+.||+|+||+||+|++..+++.||+|.++.. .......+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999988889999998642 2333456778999999999999999999875443333356
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----------SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence 899999995 688888842 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh-
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA- 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~- 865 (953)
+|||+++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..........
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 226 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLG 226 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhC
Confidence 9999998664322 22233457889999998765 46889999999999999999999999653111 0011011000
Q ss_pred --CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHHHH
Q 043900 866 --LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSIKN 938 (953)
Q Consensus 866 --~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~ 938 (953)
.++......+.... ....................+++++.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 227 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 227 SPSEEDLGFIRNEKAR----RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CCChHHhhhcCchhhh----HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00001000000000 0000000000000001112456778999999999999999999999986 665533
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=302.92 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=199.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|.+.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|++++++++|+||+++++++. ..+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 58888999999999999999988888999999975443 36678999999999999999999999853 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+|+||+++++|.+++.. ...+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----------GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHhh----------cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999852 22478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccc--ccccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 790 FGLARFLPLSPAQTS--SIDAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 790 fG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||.+........... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||....... ... ...
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~--~~~ 219 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIM--FHV 219 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHH--HHH
Confidence 999987643322211 11345788999999988776 8899999999999999999999997432110 000 000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. .. .... +.....+..+.+++.+||+.+|++|||+.|++.
T Consensus 220 ~~-~~-----~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GA-GH-----KPPI--------------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hc-CC-----CCCC--------------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00 0000 000123456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=305.96 Aligned_cols=249 Identities=20% Similarity=0.256 Sum_probs=198.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
.|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++|||++++++++. ..+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3455679999999999999998888899999987655555667889999999999999999999854 34778999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence 999999999999852 2578899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
.+....... .......|+..|+|||...+..++.++|||||||++|||++|+.||..... ...........
T Consensus 161 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~-- 231 (285)
T cd06648 161 FCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNL-- 231 (285)
T ss_pred cchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcC--
Confidence 887553221 122234588999999999888899999999999999999999999864211 01111000000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.. ......+.++.+++.+||+.+|++|||+.++++
T Consensus 232 ---~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 232 ---PPKL--------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ---CCCC--------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0000 000123457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.48 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=204.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||+|++|.||+|++..+++.||+|++..... .....+.+|++.+.+++|+|++++++++. .+...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368889999999999999999998888999999875443 45678899999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
+||||+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV----------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEc
Confidence 999999999999999532 368999999999999999999999 8 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 143 df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~ 218 (264)
T cd06623 143 DFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDG 218 (264)
T ss_pred cCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcC
Confidence 99999876432221 12345788999999999999999999999999999999999999754321 111111111000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHH-HHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE-CLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... .... ++..+.+++.+||+.+|++||++.|+++.
T Consensus 219 --------~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 --------PPPS-------------------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --------CCCC-------------------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 0001 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=308.44 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=186.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeeccchhh-----------HHHHHHHHHHHhhcCCCCeeEEEe
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLLHHGA-----------FKSFIAECNTLKNIRHRNLVKILT 695 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~ 695 (953)
.++|.+.+.||+|+||.||+|.+.++ ...+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999999877 5567777654222111 011223344556678999999998
Q ss_pred eecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 696 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
++... .......++++|++. .++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKLV-ENTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPE 155 (294)
T ss_pred eeeEe-cCCceEEEEEEehhc-cCHHHHHHh----------hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 75432 111124567888773 355555531 11356778899999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 776 NVLLDEEMMAHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 776 NIll~~~~~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|||++.++.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999876432211 111224599999999999999999999999999999999999999976
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
...... ........+ ...+..... ....++.++.+++..||+.+|++||+++++.
T Consensus 236 ~~~~~~-~~~~~~~~~---~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 236 FGHNGN-LIHAAKCDF---IKRLHEGKI---------------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cccchH-HHHHhHHHH---HHHhhhhhh---------------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 422211 111110000 000000000 0012356789999999999999999999999
Q ss_pred HHH
Q 043900 931 RQL 933 (953)
Q Consensus 931 ~~L 933 (953)
+.+
T Consensus 291 ~~~ 293 (294)
T PHA02882 291 KIF 293 (294)
T ss_pred Hhh
Confidence 876
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.16 Aligned_cols=275 Identities=22% Similarity=0.253 Sum_probs=198.4
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
+|...+.||+|+||.||+|.+..+++.||+|.++.... .....+..|++++++++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 47788999999999999999988888999999974432 234567789999999999999999999643 47
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+ +|+|.+++.... ..+++..++.++.||++||+|||+. +++||||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~---------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS---------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEE
Confidence 889999999 899999995321 2589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.++....... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+ .........
T Consensus 143 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~ 219 (298)
T cd07841 143 LADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEAL 219 (298)
T ss_pred EccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHc
Confidence 999999987643321 1222346788999998765 467899999999999999999987776422111 111111110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.........+......... ................+.++.+++.+||++||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 220 GTPTEENWPGVTSLPDYVE----FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CCCchhhhhhccccccccc----ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000000000 0000000000011234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.04 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=198.4
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
-|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+..+++++||||+++++++. .+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 4778889999999999999998888899999986432 334567889999999999999999999854 3477899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+||
T Consensus 80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence 9999999999999841 2578999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|++....... .......++..|+|||.+.+..++.++|||||||++|+|++|..||...... ...... ...
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~- 216 (277)
T cd06641 146 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLI-PKN- 216 (277)
T ss_pred ccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHH-hcC-
Confidence 9997654321 1122235788999999998888999999999999999999999998642211 000000 000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... .....+.++.+++.+||+.+|++||++.++++.
T Consensus 217 -------~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 -------NPPT------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------CCCC------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 001234568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.75 Aligned_cols=209 Identities=23% Similarity=0.314 Sum_probs=170.4
Q ss_pred CCcccCcccccceeeEEEEEEcC--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQ--GKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
+|++.+.||+|+||.||+|.+.. .++.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47888999999999999999988 77899999997532 34456778899999999999999999997532 236
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC----C
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE----E 782 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~ 782 (953)
..++||||+++ ++.+++...... ....+++..++.++.|++.||+|||+. +++||||||+||+++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQA-----KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccC-----CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence 79999999965 676666432221 123688999999999999999999999 9999999999999999 9
Q ss_pred CcEEEeccccceecCCCCC-cccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 783 MMAHVSDFGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
+.+||+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999999999987643322 1122334578899999987664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=341.38 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=203.1
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..+-+|.....||.|.||.||-|...++++..|+|.++. ......+...+|+.++..++|||+|+++|+ .-+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecH
Confidence 445678888999999999999999999999999998863 334456678899999999999999999998 3345
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..+|.||||++|+|.+.+.. ++..++.....+..|++.|++|||++ |||||||||+||+++.+|.+
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~----------gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEH----------GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHh----------cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcE
Confidence 789999999999999999952 33467777788999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCC--CcccccccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHH
Q 043900 786 HVSDFGLARFLPLSP--AQTSSIDAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 786 kL~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~ 860 (953)
|++|||.|..+.... .........||+.|||||++.+.. ...++||||+|||+.||+||+.||......-..+-+
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~ 1453 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH 1453 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH
Confidence 999999998875432 112234567999999999988754 457899999999999999999999864333211111
Q ss_pred HHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 861 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.... ++.+...+.+=.+++.+|++.||++|.++.|+++
T Consensus 1454 V~~gh~-------------------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 VAAGHK-------------------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhccCC-------------------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111111 1111234556778999999999999999987765
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=307.69 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=197.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++||||+++++++. .+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 4688999999999999999999988889999998642 2334567889999999999999999999853 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS----------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 89999999999999998532 3688999999999999999999998 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .........
T Consensus 143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~ 212 (290)
T cd05580 143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKILE 212 (290)
T ss_pred eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc
Confidence 999999876432 2234588999999999888899999999999999999999999864221 000000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.. ..+ +...+..+.+++.+||+.||.+|| +++|+++
T Consensus 213 ~~------~~~----------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GK------VRF----------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CC------ccC----------------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00 000 001235688999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.97 Aligned_cols=285 Identities=19% Similarity=0.190 Sum_probs=202.8
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 704 (953)
...++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.++++++||||+++++++.... ..+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 456789999999999999999999998888999999853 23334466778999999999999999999865321 223
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||++ ++|.+++. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQ------------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence 356799999995 58888773 1378889999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||.++...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+......
T Consensus 157 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~ 232 (353)
T cd07850 157 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQ 232 (353)
T ss_pred EEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh
Confidence 9999999998754321 122345788999999999999999999999999999999999999643211 011111110
Q ss_pred hC--CchhhhhccccccCCchhhh------hcc---cchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 AL--PDHVVDIVDSTLLSDDEDLA------VHG---NQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~--~~~~~~~~~~~l~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.. +....+..+........... ... ....+..........+.++.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00111111100000000000 000 0000000000011335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=278.69 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=192.6
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
...+..||.|..|.||+++.+.++...|||.+... ..++.+++...+.++.+- .+|+||+.+|||. .+..+++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~I 168 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFI 168 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHH
Confidence 34556799999999999999999999999999743 445567777888877666 4999999999964 3467889
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
.||.|. ..+..+++.. ..++++..+-++...+++||.||-+++ +|+|||+||+|||+|+.|++|+|||
T Consensus 169 cMelMs-~C~ekLlkri---------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 169 CMELMS-TCAEKLLKRI---------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred HHHHHH-HHHHHHHHHh---------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence 999983 3455555422 235888888899999999999998763 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|.+.++..+.+... ..|-+.|||||.+... .|+-++||||||++++||.||+.||.+...+...+..... ..|
T Consensus 237 GIsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP 312 (391)
T KOG0983|consen 237 GISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP 312 (391)
T ss_pred cccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC
Confidence 99987765544433 3588999999987643 6889999999999999999999999864332211111111 111
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .+ ......++.+.+++..|++.|+.+||...++++
T Consensus 313 P--------~L--------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 P--------LL--------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C--------CC--------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 11 111124667999999999999999999998876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.77 Aligned_cols=284 Identities=20% Similarity=0.260 Sum_probs=199.1
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++ ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999999888899999986432 223457888999999994 699999999875443223344
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-CCcEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAH 786 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 786 (953)
.++||||+++ +|.+++...... ....+++..++.++.||+.||+|||+. +++||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 7999999975 888887533211 123589999999999999999999999 9999999999999998 88999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.++.+.... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ........
T Consensus 152 l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~ 228 (295)
T cd07837 152 IADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLL 228 (295)
T ss_pred EeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHh
Confidence 99999998653221 11223346888999998765 4578999999999999999999999975322111 11111100
Q ss_pred -CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 -LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.. ... +........ ...... .+..........+.++.+++.+||+.||++||+++|++.
T Consensus 229 ~~~~~--~~~-~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTE--QVW-PGVSKLRDW-HEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCCh--hhC-cchhhccch-hhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000 000000000 000000 000000111235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=313.92 Aligned_cols=288 Identities=22% Similarity=0.276 Sum_probs=202.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++++ +||||++++++|.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 45678999999999999999999988888999998853 2233345677899999999 99999999998643 233
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 56899999996 589888842 1578889999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc---ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 786 HVSDFGLARFLPLSPAQ---TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
||+|||.+......... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 99999999866433221 12233458899999998765 4578999999999999999999999965322111 1111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSI 936 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 936 (953)
.. .......+................................+.++.+++.+||+.||++|||+.++++. ++..
T Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 226 IE-VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HH-HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 00000000000000000000000000000000001111246779999999999999999999999975 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.58 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=196.8
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcC---CCCeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 707 (953)
.|+..+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.++++++ |||+++++++|. .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 477789999999999999999888889999998643 3344567888999999996 999999999864 3467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.++++. ..+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence 8999999999999998842 2588999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||.+....... .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... ......
T Consensus 143 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~- 214 (277)
T cd06917 143 CDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLI- 214 (277)
T ss_pred ccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhcc-
Confidence 9999998765332 222334588999999987654 5689999999999999999999999642111 000000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... ..+.+.. ...+.++.+++.+||+.||++||++.|+++.
T Consensus 215 ~~~----~~~~~~~---------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 215 PKS----KPPRLED---------------------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccC----CCCCCCc---------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000 0000000 0134568899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.16 Aligned_cols=279 Identities=22% Similarity=0.278 Sum_probs=198.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++... .....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 57889999999999999999999888899999997433 22234567899999999999999999986432 23689
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMK---------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEehhcC-cCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEe
Confidence 99999997 58988885321 2589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC-
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL- 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~- 866 (953)
|||.+....... .......+++.|+|||.+.+. .++.++||||+|+++|||++|..||......+ ..........
T Consensus 149 d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~ 225 (293)
T cd07843 149 DFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGT 225 (293)
T ss_pred ecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Confidence 999998765332 122234578899999988765 46899999999999999999999997532111 1111111000
Q ss_pred --CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 --PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 --~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+..+....+-..... ... .............. ....+.+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 226 PTEKIWPGFSELPGAKK-KTF-TKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CchHHHHHhhccchhcc-ccc-ccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000 000 00000000000000 013566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.87 Aligned_cols=285 Identities=21% Similarity=0.280 Sum_probs=197.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc---CC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 704 (953)
.++|++.+.||+|+||.||+|....+++.||+|.+.... ......+.+|++++++++||||++++++|..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999999888999999986432 2223456789999999999999999999765421 12
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+. +++.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK---------NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGI 157 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCc
Confidence 345699999996 4787777421 22589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCc--ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+||+|||.+......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...... .....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~ 235 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTL 235 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 999999999866432211 112234578899999987665 4788999999999999999999998653211 11111
Q ss_pred HHh---hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARM---ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ..+.......+... ...........................+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLE--LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchh--hhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111 11111100000000 000000000000000000000012345779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=291.66 Aligned_cols=280 Identities=21% Similarity=0.242 Sum_probs=202.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-C-C----CeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-H-R----NLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~ 702 (953)
.+.+|.+...+|+|.||.|-.+.+...+..||||+++... ...+..+-|+++++++. + | -+|.+.+| +
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----F 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----F 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----h
Confidence 3788999999999999999999999999999999997543 24456678999999993 2 2 25666666 4
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE- 781 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 781 (953)
+..++.|||+|.+ |-|+.++++.+.. .+++..++..|++|++++++|||+. +++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y--------~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNY--------IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCc--------cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 5568999999999 6799999975543 3789999999999999999999999 9999999999999821
Q ss_pred -------------------CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHH
Q 043900 782 -------------------EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELV 842 (953)
Q Consensus 782 -------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ell 842 (953)
+..+|++|||.|++..+.. ...+.|..|+|||++.+-.|+.++||||+||||+|++
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3368999999998753322 4456899999999999999999999999999999999
Q ss_pred hCCCCCCCcccC-CccHHHHHHhhCCchhhh------hccccccCCch------hhhhcccchhhhhhhhhHHHHHHHHH
Q 043900 843 TRKKPVDSMFEG-DMNLHNFARMALPDHVVD------IVDSTLLSDDE------DLAVHGNQRQRQARINSKIECLVAMV 909 (953)
Q Consensus 843 tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~------~~~~~l~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~ 909 (953)
||...|..-... +..+.+.+-..+|..+.. .+...-..+++ ...+....++.............++.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 999998753311 111111111122221111 11111000000 00111111111111222334556799
Q ss_pred HHhhccccCCCCCCCCHHHHHH
Q 043900 910 RIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 910 ~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+++++|+..||.+|+|+.|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.49 Aligned_cols=243 Identities=22% Similarity=0.265 Sum_probs=183.7
Q ss_pred cccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHh---hcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLK---NIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
.||+|+||.||+|.+..+++.||+|.+.... ......+.+|..+++ ..+||+++.+++++. ..+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999888899999986422 111223344443333 347999999998853 34678999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLSQ----------HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence 999999999998852 23589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
++....... .....|+..|+|||.+. +..++.++||||+||++|||++|..||........ .........
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~--- 213 (279)
T cd05633 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT--- 213 (279)
T ss_pred cceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc---
Confidence 997553221 12345899999999886 45689999999999999999999999975322111 111000000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVRQ 932 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 932 (953)
... ..+...+.++.+++.+||+.||++|| |++|+++.
T Consensus 214 ---~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 ---VNV----------------------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CCc----------------------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 00112356788999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.67 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=193.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.+.|+..+.||+|+||.||+|+...+++.||+|++... .....+.+.+|+++++.++|||++++.++|.. ++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CC
Confidence 35688899999999999999999888889999998632 22344678899999999999999999999643 36
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||++ |++.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+|
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVH---------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence 7899999996 5676666321 22589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|+|||++...... ....++..|+|||++. ...++.++||||||+++|||+||+.||....... ...
T Consensus 156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~ 224 (307)
T cd06607 156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALY 224 (307)
T ss_pred EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHH
Confidence 9999999765322 1235788999999874 4568899999999999999999999986421110 000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
....... ... ....++.++.+++.+||+.||++||++.+++..
T Consensus 225 ~~~~~~~---------~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 HIAQNDS---------PTL-----------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHhcCCC---------CCC-----------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 000 001245578999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.43 Aligned_cols=275 Identities=21% Similarity=0.286 Sum_probs=199.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+|++.+.||+|++|.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++.. .+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 4888999999999999999999888899999987443 2334667789999999999999999999643 467899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV-------RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHhcCC-------CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence 9999975 88888753221 23589999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC---
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL--- 866 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--- 866 (953)
|.+....... .......++..|+|||++.+. .++.++|||||||++||+++|+.||......+ ..........
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 221 (284)
T cd07836 145 GLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPT 221 (284)
T ss_pred chhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCC
Confidence 9997553221 112234578899999987664 57889999999999999999999997532211 1111111110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+.+. ...... ................+.++.+++.+|++.||.+||+++|+++
T Consensus 222 ~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQL--PEYKPT----FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcC--chhccc----ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001111100 000000 0000000001111234677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.77 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=198.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|.+.+.||+|+||.||+|....++..||+|.+.... ....+.+.+|++++++++|+||+++++.+. .+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 4788899999999999999999888899999986431 234467789999999999999999999853 447899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 788 (953)
+|+||+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQR--------GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEec
Confidence 9999999999999986322 12578999999999999999999999 999999999999999875 57999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+....... .......|++.|+|||+..+..++.++||||||+++||+++|..||.... ..+........
T Consensus 145 d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~ 217 (257)
T cd08225 145 DFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQG 217 (257)
T ss_pred ccccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc
Confidence 999998664322 12223458899999999988899999999999999999999999986421 11111111111
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... . ....+.++.+++.+||+.+|++|||+.|+++
T Consensus 218 ~~~~--------~-------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 218 YFAP--------I-------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cCCC--------C-------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 0 0012346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.07 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+.|+.-++||+|+||.||-++.+.+++.+|.|.+... .........+|-.++.+++.+.||.+--. ++..+.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCCc
Confidence 4577889999999999999999999999999988422 23344567789999999999999988655 566789
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+|+..|.||||.-++.... .+.+++..+.-+|.+|+-||++||.. +||.||+||+|||+|+.|+++|
T Consensus 260 LClVLtlMNGGDLkfHiyn~g--------~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG--------NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eEEEEEeecCCceeEEeeccC--------CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 999999999999999996443 34799999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|.|+|..++.+... ...+||.+|||||++.+..|+...|-||+||++|||+.|+.||....+.
T Consensus 329 SDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------- 392 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------- 392 (591)
T ss_pred eccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------------
Confidence 999999988654332 3447999999999999999999999999999999999999999642211
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
...+.+|++...+... .+...+++..++.+..++.||++|...
T Consensus 393 -vk~eEvdrr~~~~~~e---------------y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 -VKREEVDRRTLEDPEE---------------YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -hhHHHHHHHHhcchhh---------------cccccCHHHHHHHHHHHccCHHHhccC
Confidence 1112223322222211 122456778889999999999998643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.12 Aligned_cols=274 Identities=27% Similarity=0.343 Sum_probs=196.5
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+|++++++++|||++++++++. +++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 677889999999999999998888899999986432 233457888999999999999999999964 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||++ ++|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL--------TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence 999995 689998853221 2589999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh-CCc
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA-LPD 868 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~ 868 (953)
|.+........ ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+ ......... .+.
T Consensus 144 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 220 (283)
T cd07835 144 GLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPD 220 (283)
T ss_pred ccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 99976532211 11223468899999987664 57899999999999999999999996532211 111111111 011
Q ss_pred h-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 H-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ....... + ...... ..... ...........+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~-~-~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 221 EDVWPGVTS-L-PDYKPT-FPKWA--RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hHHhhhhhh-c-hhhhhh-ccccc--ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000 0 000000 00000 00000011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.00 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=195.9
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
..+||+|+||.||+|....+++.||+|++..........+.+|+.+++.++|+|++++++++. .++..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecC
Confidence 367999999999999999888899999987555555677899999999999999999999854 347899999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++. ...+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+..
T Consensus 100 ~~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 100 EGGALTDIVT-----------HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999874 12478899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
..... .......|+..|+|||...+..++.++||||+|+++|||++|..||...... ..........+....
T Consensus 166 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~---- 237 (292)
T cd06657 166 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKLK---- 237 (292)
T ss_pred ccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcccC----
Confidence 54321 1122345889999999998888999999999999999999999998642111 111111111111000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.....+..+.+++.+||+.||.+||++.++++
T Consensus 238 ------------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 ------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ------------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00123456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=306.72 Aligned_cols=258 Identities=24% Similarity=0.282 Sum_probs=192.1
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++. .+...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 4566788999999999999999888899999986432 344567889999999996 999999999854 346788
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
++|||+.. ++.++...... .....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYE-----VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEecccC-CHHHHHHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEee
Confidence 99999854 55443321100 1123689999999999999999999963 2899999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||+++....... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .........
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~ 224 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVV 224 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhc
Confidence 999976532211 1223588899999998776 689999999999999999999999864210 001111100
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... +.+.. .....++.++.+++.+||+.||++|||++||++.
T Consensus 225 ~~~~-----~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 KGDP-----PILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCC-----CcCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000 0001345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=296.89 Aligned_cols=251 Identities=18% Similarity=0.237 Sum_probs=193.0
Q ss_pred HHHHHHhhcCCcccCcc--cccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 623 YQNLYNATDGFASANEI--GVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 623 ~~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
..+.....++|++.+.+ |+|+||.||++..+.+++.+|+|+++....... |+.....+ +|||++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~- 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT- 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe-
Confidence 34455556678887777 999999999999998888999999864322111 22222222 7999999999864
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
.++..++||||+++++|.+++... ..+++.++..++.|+++|++|||+. +++||||||+||++
T Consensus 80 ----~~~~~~iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~ 142 (267)
T PHA03390 80 ----TLKGHVLIMDYIKDGDLFDLLKKE----------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142 (267)
T ss_pred ----cCCeeEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence 346899999999999999999521 2689999999999999999999999 99999999999999
Q ss_pred cCCC-cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 780 DEEM-MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 780 ~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+.++ .++|+|||.++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||......+...
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred eCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 9988 9999999999865322 12348899999999999999999999999999999999999997543333222
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-HHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-MTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 931 (953)
..+.... ... .......++.+.+++.+||+.+|.+||+ ++|+++
T Consensus 217 ~~~~~~~-~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESLLKRQ-QKK----------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhh-ccc----------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2222111 000 0000134556899999999999999996 588764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=255.79 Aligned_cols=276 Identities=21% Similarity=0.288 Sum_probs=198.4
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.|...++||+|.||+||+|+..++.+.||+|.++. .+++......+|+-+++.++|.|||+++++ ...+....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 56778899999999999999999999999999974 334456788999999999999999999998 45568889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+|+|||. .+|..|.... .+.++...+..++.|+++|+.|+|++ .+.|||+||.|.+++.+|+.|++|
T Consensus 78 lvfe~cd-qdlkkyfdsl---------ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSL---------NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred EeHHHhh-HHHHHHHHhc---------CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecc
Confidence 9999994 5888888543 34588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
||+|+-++.. ..-....+.|.+|++|.++.|.+ |+...|+||.||++.|+.. |++.|.+..-.+ .+.+..+..-.
T Consensus 145 fglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~ 221 (292)
T KOG0662|consen 145 FGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGT 221 (292)
T ss_pred cchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCC
Confidence 9999876432 22233456899999999998875 7889999999999999998 666666533322 23333222211
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.....+-.-.-.+++............... .+.....=.++++..+.-+|..|.++++.++
T Consensus 222 p~ed~wps~t~lpdyk~yp~ypattswsqi---vp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 222 PTEDQWPSMTKLPDYKPYPIYPATTSWSQI---VPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccCCccccCCCCcccCCccccchHHHH---hhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 110011000011111110000000000000 0111122346777777789999999998765
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=301.82 Aligned_cols=276 Identities=22% Similarity=0.271 Sum_probs=199.0
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|++.+.||+|+||.||+|+...+++.||+|+++... ......+.+|++++++++|||++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 667889999999999999999888899999997542 33456788999999999999999999996432 1368999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++ +|.+++... ...+++..++.++.|+++|++|||+. +++|+||+|+||++++++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP---------EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eeccccc-cHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence 9999974 888888532 13689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC--
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP-- 867 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~-- 867 (953)
|.+........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~ 222 (287)
T cd07840 145 GLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPT 222 (287)
T ss_pred cceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCc
Confidence 99987654321 11223456888999997765 45789999999999999999999999753221 111111111000
Q ss_pred -chhhhhccccccCCchhhhhcccchhhhhhhhhHHH-HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 -DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE-CLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 -~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......+. ..... ................. ++.++.+++.+||+.+|.+||+++++++
T Consensus 223 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 223 DENWPGVSKL---PWFEN--LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccc---hhhhh--ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 00000 00000000000001111 3678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.91 Aligned_cols=280 Identities=25% Similarity=0.267 Sum_probs=197.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++|+|++++++++.+. ..+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 467999999999999999999999888899999987432 22234567899999999999999999986432 2356
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ ++|.+++.... ..+++.+++.++.|+++|++|||+. +++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP---------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 799999996 47888875321 3589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||.+....... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 150 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~ 225 (309)
T cd07845 150 ADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLL 225 (309)
T ss_pred CccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhc
Confidence 9999998764322 11222345788999999866 45789999999999999999999999753221 1111111111
Q ss_pred Cchhhhhcccc-ccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........... ..+......... . ............++++.+++.+|+++||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 226 GTPNESIWPGFSDLPLVGKFTLPK-Q-PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCChhhchhhhcccccccccccC-C-CCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11000000000 000000000000 0 000000000123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=279.89 Aligned_cols=273 Identities=20% Similarity=0.273 Sum_probs=207.0
Q ss_pred cCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
-.+++....++ +.||+|+|+.|--+....++..||||++.........+..+|++++.+. .|+||++++++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief--- 144 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF--- 144 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH---
Confidence 35788877775 6899999999999999999899999999877777788999999999999 59999999999
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
+++++..|+|||-|.||+|..++++ ...+++.++.++.++|+.||.|||.+ ||+|||+||+|||.
T Consensus 145 --FEdd~~FYLVfEKm~GGplLshI~~----------~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC 209 (463)
T KOG0607|consen 145 --FEDDTRFYLVFEKMRGGPLLSHIQK----------RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILC 209 (463)
T ss_pred --hcccceEEEEEecccCchHHHHHHH----------hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceee
Confidence 5667899999999999999999963 34689999999999999999999999 99999999999999
Q ss_pred cCCC---cEEEeccccceecCCCC-----CcccccccccccccccccccC---C--CCCCcccchHHHHHHHHHHHhCCC
Q 043900 780 DEEM---MAHVSDFGLARFLPLSP-----AQTSSIDAKGSIGYIAPEYGL---G--SEVSINGDVYSYGILLLELVTRKK 846 (953)
Q Consensus 780 ~~~~---~~kL~DfG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDv~slG~vl~elltg~~ 846 (953)
.... -|||+||.++.-+.... ........+|+..|||||+.. + ..|+.++|.||+|||+|-|++|.+
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred cCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 7554 58999998886442211 122334567999999999742 2 358899999999999999999999
Q ss_pred CCCCcccCCccHHHHHHhhCCch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 043900 847 PVDSMFEGDMNLHNFARMALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN 925 (953)
Q Consensus 847 pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 925 (953)
||.+....+-.+. +...-.. -..++.....+.++ .-...+..++.+..+++...+..||.+|-+
T Consensus 290 PFvG~Cg~dCGWd---rGe~Cr~CQ~~LFesIQEGkYe------------FPdkdWahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 290 PFVGHCGADCGWD---RGEVCRVCQNKLFESIQEGKYE------------FPDKDWAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred CccCccCCcCCcc---CCCccHHHHHHHHHHHhccCCc------------CChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence 9987544322111 0000000 00000000001000 001123355667788888888999999999
Q ss_pred HHHHHH
Q 043900 926 MTNVVR 931 (953)
Q Consensus 926 ~~evl~ 931 (953)
+.+++.
T Consensus 355 a~~vln 360 (463)
T KOG0607|consen 355 AAQVLN 360 (463)
T ss_pred hhhccC
Confidence 998876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.69 Aligned_cols=291 Identities=20% Similarity=0.229 Sum_probs=208.5
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|+++++.++||||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999998878899999987533 34457889999999999999999999987544222234789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIKS----------PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999997 588888852 22689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCc-ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 790 FGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 790 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
||.+......... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+. ... ......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~-i~~~~~ 224 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNL-IVEVLG 224 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHhcC
Confidence 9999876543210 122334578899999999888 889999999999999999999999975432110 111 111111
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSIKN 938 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~ 938 (953)
....+................................+..+.+++.+||+++|++|||++++++. ++.++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000000000000000000000011112246778999999999999999999999984 666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.40 Aligned_cols=287 Identities=19% Similarity=0.238 Sum_probs=197.5
Q ss_pred Cccccc--ceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVG--SFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
..||+| +||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||++++++|. .++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 456766 9999999999888889999998643 2344577889999999999999999999964 347789999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||++++++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.
T Consensus 79 e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKTYFP--------EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHH
Confidence 99999999999864322 2588999999999999999999998 999999999999999999999999986
Q ss_pred ceecCCCCCcc-----cccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 793 ARFLPLSPAQT-----SSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 793 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
+.......... ......++..|+|||++.+. .++.++|||||||++|||++|+.||.................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCC
Confidence 54332111110 01112356679999998764 478999999999999999999999975432211111110000
Q ss_pred CCc--------hhhhhcccc------ccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPD--------HVVDIVDST------LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~--------~~~~~~~~~------l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ......+.. ...................+......+.+.+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000000000 000000000000000001112223356778999999999999999999999975
Q ss_pred --HHHHHHHH
Q 043900 932 --QLQSIKNI 939 (953)
Q Consensus 932 --~L~~i~~~ 939 (953)
.++.+++.
T Consensus 308 ~~~~~~~~~~ 317 (328)
T cd08226 308 HAFFKQVKEQ 317 (328)
T ss_pred CHHHHHHHHh
Confidence 45555553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.36 Aligned_cols=275 Identities=18% Similarity=0.203 Sum_probs=193.8
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|++.+.||+|+||.||+|+...+++.||+|+++... ........+|+..+.++. |+|++++++++.+. ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 677889999999999999999888899999986432 222334557888899885 99999999996432 2367899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||++ |++.+++... ...+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKGR---------KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence 999996 5787777421 13589999999999999999999999 9999999999999999 99999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.++....... .....++..|+|||++.+ ..++.++||||+||++|||++|..||...... .............
T Consensus 144 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCC
Confidence 99986643222 122357889999997644 56789999999999999999999999753221 1111111111111
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..++............ .................+.++.+++.+||+.+|++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVLKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHhhcccccccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1100000000000000 00000000000111245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.12 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=201.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..+.|+..+.||+|++|.||+|.+..++..||+|+++.... ..+.+.+|++.++.++|+|++++++++.. ....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEE
Confidence 45668888999999999999999997778999999975544 45778899999999999999999998643 3788
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~ 158 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLA 158 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEEC
Confidence 99999999999999996322 2689999999999999999999998 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+........ ......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ....... .
T Consensus 159 d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~----~ 231 (286)
T cd06614 159 DFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITT----K 231 (286)
T ss_pred ccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----c
Confidence 9999875532211 1123347889999999988889999999999999999999999986421110 0000000 0
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... ......++.++.+++.+||+.+|.+|||+.++++
T Consensus 232 ~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 232 GIPP-------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCC-------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 0001124557889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.68 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=201.5
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+|+..+.||+|++|.||+|.+..+++.|++|+++.......+.+.+|++.+++++|++++++++++. .+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4778899999999999999998888899999997655456678999999999999999999999854 33778999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN---------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence 99999999999985321 3689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 871 (953)
.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ....
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~---~~~~ 215 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFKIAT---NGPP 215 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHh---cCCC
Confidence 9987643321 234458899999999988889999999999999999999999987421110 0000000 0000
Q ss_pred hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 872 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ......+.++.+++.+||+.||++|||+.|+++
T Consensus 216 ~~-------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 216 GL-------------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred Cc-------------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000112456889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.52 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=198.6
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4788999999999999999999888899999996432 23467889999999999999999999884 445789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK----------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEe
Confidence 9999999999999998522 3688999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+....... ......|+..|+|||++.+..++.++||||+|+++|+|++|..||...... ........ ...
T Consensus 143 d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~~ 216 (258)
T cd05578 143 DFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK-QET 216 (258)
T ss_pred ecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH-hcc
Confidence 999998654322 223345888999999998888999999999999999999999999753221 01111100 000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH--HHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM--TNVV 930 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 930 (953)
. ....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 ~---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 A---------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c---------------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 000111234678899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=329.44 Aligned_cols=268 Identities=25% Similarity=0.386 Sum_probs=210.6
Q ss_pred cCCcccCcccccceeeEEEEEEcC-------CCeEEEEEEeec-cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ-------GKTTVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 701 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 701 (953)
++..+.+.+|+|+||.|++|.... ....||||..+. ....+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 344566799999999999998631 245799999974 3335678899999999999 69999999999864
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCC----c--cccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEA----P--RSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
.+..++|+||++.|+|.++++..+........ . ..++..+.+.++.|||.|++||++. ++||||+.++
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 47899999999999999999876611111111 1 2499999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeccccceecCCCCCcccc-cccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 776 NVLLDEEMMAHVSDFGLARFLPLSPAQTSS-IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 776 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
|||+.++..+||+|||+|+........... ....-+..|||||.+....|+.++|||||||++||++| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999976544333211 11113556999999999999999999999999999999 8999875211
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. .++.++. ..+.|.+.+..|.++++++|+.||+.+|++||++.|+.+.+
T Consensus 528 ~-~~l~~~l------------------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 528 T-EELLEFL------------------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred H-HHHHHHH------------------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 1 0111111 11233444556788999999999999999999999999999
Q ss_pred HHHH
Q 043900 934 QSIK 937 (953)
Q Consensus 934 ~~i~ 937 (953)
+...
T Consensus 577 ~~~l 580 (609)
T KOG0200|consen 577 EKHL 580 (609)
T ss_pred HHHH
Confidence 9853
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=299.86 Aligned_cols=278 Identities=23% Similarity=0.274 Sum_probs=198.4
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhc---CCCCeeEEEeeecccccCCCCc
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 707 (953)
|++.+.||+|+||.||+|+++.+++.||+|+++... ......+.+|+.+++++ +|||++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999998878899999997332 22234566788777666 5999999999986553333345
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.+++|||++ ++|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--------~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--------PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEE
Confidence 899999996 488888753221 2589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||.+........ .....++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCC
Confidence 99999987643321 12234788999999999999999999999999999999999998753221 112222111110
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........... .... ... ............+.++.+.+++.+||+.||++||+++|++.
T Consensus 225 ~~~~~~~~~~~--~~~~-~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRNVS--LPRS-SFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCCcc--cchh-hcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 0000 000 00000001111244677889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=294.95 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=203.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|+..+.||+|++|.||+|....+++.|++|+++... ....+.+.+|++++++++||||+++++++... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 4778899999999999999999888899999997544 24567889999999999999999999986432 126789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++... ..+++.+++.++.|+++|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF----------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcc
Confidence 999999999999998521 2689999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+................++..|+|||...+..++.++||||||+++|+|++|..||..... ........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~---- 216 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKI---- 216 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhc----
Confidence 9999877544321123345688999999999888899999999999999999999999975321 11111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... ...+...+.++.+++.+|++.+|++||++.|+++
T Consensus 217 ----~~~~~~------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 217 ----GSSGEP------------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----cccCCC------------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000000 0001123567899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=299.79 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=190.6
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 699999999999999888899999986422 223456678999999999999999998853 447889999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+..
T Consensus 76 ~~~~L~~~l~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYNVGE--------PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHHcCc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 99999999863321 2589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
.... .......++..|+|||++.+..++.++||||+||++|+|++|+.||....... .............
T Consensus 145 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~------ 214 (277)
T cd05577 145 LKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEMA------ 214 (277)
T ss_pred hccC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcccccc------
Confidence 5321 12223457889999999988889999999999999999999999996532211 1111110000000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.......++.+.+++.+||+.||++|| ++.+++.
T Consensus 215 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 215 ----------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----------------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 000012345688999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=309.10 Aligned_cols=285 Identities=21% Similarity=0.266 Sum_probs=200.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 706 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888889999998632 2223456789999999999999999999875432 12224
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++|+||+. .++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred eEEEEecccc-cCHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 5789999995 46666541 2578899999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~ 231 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 231 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 9999999754321 123457889999999876 468899999999999999999999997532111 111111100
Q ss_pred -CC-chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHHHHH
Q 043900 866 -LP-DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSIKNI 939 (953)
Q Consensus 866 -~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~ 939 (953)
.+ ....+..+..... ..........+..........+.++.+++.+||+.||++||+++|+++. ++..++.
T Consensus 232 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 232 GVPGPEFVQKLEDKAAK---SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCCCHHHHHHhcccchH---HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00 0011111000000 0000000000000000011234568899999999999999999999954 7776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.11 Aligned_cols=281 Identities=20% Similarity=0.237 Sum_probs=200.1
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
+...+++|++.+.||+|+||.||+|.+..+++.||+|++.. ......+.+.+|++++++++|||++++.++|..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 80 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---- 80 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----
Confidence 44577899999999999999999999998888999998753 222345677899999999999999999998642
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....++||||+ +++|.++++ ...+++..+..++.|+++||+|||+. +++||||+|+||++++++
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCC
Confidence 235688999999 568988874 12467888889999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
.+||+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 146 ~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~ 218 (328)
T cd07856 146 DLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSII 218 (328)
T ss_pred CEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 9999999999754321 122357889999998766 56899999999999999999999999653211 000001
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.........++.+........+.........+..........++++.+++.+|++.+|++|||+++++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111110111111000000000000000000000000011235678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=301.66 Aligned_cols=284 Identities=23% Similarity=0.275 Sum_probs=200.7
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc----
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---- 701 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 701 (953)
...++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999999888899999997432 233456778999999999999999999875432
Q ss_pred -cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 702 -YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 702 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
..+....++||||+++ ++..++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~ 150 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN 150 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 1123478999999976 666666421 23589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
+++.+||+|||.+........ .......++..|+|||++.+ ..++.++|||||||++|||++|++||..... ...+.
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~ 228 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLE 228 (302)
T ss_pred CCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Confidence 999999999999987643321 11222346788999998765 3578999999999999999999999974221 11111
Q ss_pred HHHHhh---CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMA---LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .+....++.......... ......+.. .......+..+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMK--PKKQYRRRL---REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccc--cccccccch---hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 010011110000000000 000000000 0011124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=296.23 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=201.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|++++++++|+||+++.+++. .....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 478899999999999999999888889999998743 2344567789999999999999999998853 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKK------KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence 99999999999999864221 124689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+...... ......++..|+|||.+.+..++.++|+||+|+++||+++|+.||...... ....... ...
T Consensus 147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~---~~~ 217 (256)
T cd08530 147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQ---RGK 217 (256)
T ss_pred ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh---cCC
Confidence 9999876433 122245788999999999999999999999999999999999999653211 0110000 000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. . ......+.++.+++.+|++.+|++||++.|+++
T Consensus 218 --------~-~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 --------Y-P------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --------C-C------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0 001134566899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=294.25 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=202.5
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++|||++++.+.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 4788899999999999999999888899999997543 245677889999999999999999999853 337889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+|+||+++++|.+++..... ....+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK------EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc------cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence 99999999999999964321 124689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 219 (258)
T cd08215 147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ 219 (258)
T ss_pred ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC
Confidence 99998764332 12233458889999999988899999999999999999999999986421 111111110000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... +...+.++.+++.+||..+|++|||+.|+++
T Consensus 220 --------~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 --------YPPI-------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --------CCCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0023456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=325.51 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=191.3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc------
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD------ 701 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 701 (953)
-..+|+..+.||+||||.||+++.+-+++.||||++... .........+|++.+.+++|||||+++..+.+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 345688889999999999999999999999999999643 4455677889999999999999999985432110
Q ss_pred -------------------------------------------------cC------C----------------------
Q 043900 702 -------------------------------------------------YQ------G---------------------- 704 (953)
Q Consensus 702 -------------------------------------------------~~------~---------------------- 704 (953)
++ .
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00 0
Q ss_pred -------------------------------CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHH
Q 043900 705 -------------------------------NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753 (953)
Q Consensus 705 -------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~ 753 (953)
....||=||||+..+++++++..... -.....++++++|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---------SQRDEAWRLFREIL 707 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---------hhhHHHHHHHHHHH
Confidence 02257788888887888777533221 03567899999999
Q ss_pred HHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC----------------CCCCcccccccccccccccc
Q 043900 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP----------------LSPAQTSSIDAKGSIGYIAP 817 (953)
Q Consensus 754 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~aP 817 (953)
.||+|+|++ |||||||||.||+++++..|||+|||+|+... .+......+..+||.-|+||
T Consensus 708 EGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 999999999 99999999999999999999999999998721 01122344567899999999
Q ss_pred cccCCCC---CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhh
Q 043900 818 EYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQR 894 (953)
Q Consensus 818 E~~~~~~---~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 894 (953)
|++.+.. |+.|+|+||+|||++||+. ||....+....+...-...+|.. .++.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~------------------- 841 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFD------------------- 841 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccc-------------------
Confidence 9987754 9999999999999999995 66642222111111111111111 11111
Q ss_pred hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 895 QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 895 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+.=..++.++++.||++||||.|++.
T Consensus 842 --------~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 842 --------PEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11223457899999999999999999975
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=303.28 Aligned_cols=276 Identities=19% Similarity=0.171 Sum_probs=190.3
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
.+.+|.| |.||.++...+++.||+|+++.. .....+.+.+|+++++.++||||+++++++. ..+..+++||
T Consensus 7 ~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e 79 (314)
T cd08216 7 GKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSP 79 (314)
T ss_pred hHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEe
Confidence 3344444 45555555557779999998743 3445678999999999999999999999853 4477899999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 793 (953)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 80 ~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~ 148 (314)
T cd08216 80 LMAYGSCEDLLKTHFP--------EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYS 148 (314)
T ss_pred ccCCCCHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccc
Confidence 9999999999864321 2578889999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCC-----cccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 794 RFLPLSPA-----QTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 794 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
........ ........++..|+|||++.+. .++.++|||||||++|||++|+.||............ .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~ 227 (314)
T cd08216 149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTV 227 (314)
T ss_pred eeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccC
Confidence 75532211 1112234477889999998763 5889999999999999999999999753222111111 11000
Q ss_pred Cchh----hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHV----VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+... .............. ....................++.+++.+||++||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 228 PCLLDKSTYPLYEDSMSQSRSS--NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccCchhhhcCCcCccccc--ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000000000000 0000000011111222445678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=301.00 Aligned_cols=277 Identities=24% Similarity=0.296 Sum_probs=195.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|++|.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++. .+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 46889999999999999999999888899999986432 233467889999999999999999999954 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-CCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL 787 (953)
++||||++ +++.+++.... ....++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSP--------DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHhCC--------CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEE
Confidence 99999995 57877774221 12357888899999999999999999 9999999999999985 567999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||.+....... .......+++.|+|||++.+. .++.++||||+||++|+|+||+.||......+. ..+.... .
T Consensus 145 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~-~ 220 (294)
T PLN00009 145 ADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRI-L 220 (294)
T ss_pred cccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH-h
Confidence 9999997653221 112234578899999987664 578999999999999999999999975322111 1111100 0
Q ss_pred Cchhhhhcccc-ccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........+.. ...+.... ................++++.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYKSA---FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCCChhhccccccchhhhhh---cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000 00000000 0000000000001123466889999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.97 Aligned_cols=253 Identities=20% Similarity=0.216 Sum_probs=196.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-----chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|++++++++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 4689999999999999999999988889999987532 223456788999999999999999999986432 23
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA----------YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 567899999999999998852 12478889999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCC-cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|+|||.++....... ........++..|+|||++.+..++.++|||||||++||+++|+.||...... ......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~ 221 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFKI 221 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHHHHH
Confidence 9999999986532111 11112345889999999999888999999999999999999999999742111 110000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ..... ...+....+++.+++.+||+ +|..||++.+++.
T Consensus 222 ~-~~~~~--------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 A-TQPTK--------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred H-cCCCC--------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0 00000 00011334668899999998 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=294.73 Aligned_cols=243 Identities=24% Similarity=0.299 Sum_probs=192.2
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||.|++|.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 699999999999999888899999986432 234567899999999999999999999853 447789999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRDR----------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 999999999532 2478899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
..... ......++..|+|||.+.+..++.++|+||+|+++|++++|..||....... ...... ..+
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~--------~~~ 208 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND--------ILK 208 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH--------Hhc
Confidence 64332 2223457889999999988889999999999999999999999997533211 111111 000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
.... ...+...++++.+++.+||+.+|++||+ ++|+++
T Consensus 209 ~~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 209 GNGK------------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCCC------------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0000 0000122457899999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.71 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=192.7
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
|...+.||+|+||.||+|++..++..||+|++... ..+....+.+|++++++++|||+++++++|.. +...+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEE
Confidence 67788999999999999999888889999998632 23344678899999999999999999999643 36789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++ |++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|
T Consensus 102 lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 102 LVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred EEEeCCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEec
Confidence 9999996 4777776421 23588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||++...... ....|++.|+|||++. +..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 169 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~ 241 (317)
T cd06635 169 FGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES 241 (317)
T ss_pred CCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccC
Confidence 9998754321 2235888999999873 4578899999999999999999999986421110 0011100000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
+ . ......+..+.+++.+||+.+|.+||++.++++..
T Consensus 242 ~------------~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 P------------T------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred C------------C------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0 0 00012345688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=305.62 Aligned_cols=284 Identities=20% Similarity=0.226 Sum_probs=196.4
Q ss_pred CCcccCcccccceeeEEEEEEcCC--CeEEEEEEeecc--chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQG--KTTVAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
+|++.+.||+|+||.||+|.+... +..||+|++... .....+.+.+|+++++++ +||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 788999998632 222346778899999999 599999999875432 12335
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++++||+. ++|.+++.. ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS----------GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 6789999985 689888842 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc--ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 787 VSDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|+|||.++........ .......|+..|+|||+..+ ..++.++||||+||++|++++|+.||......+ .......
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~ 224 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQ 224 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHH
Confidence 9999999866432211 11223468999999998765 468999999999999999999999987522111 1111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.......+..................................++.+++.+|++.||++|||+.|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 225 -VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred -HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000000000000000000000000001224578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=309.05 Aligned_cols=284 Identities=19% Similarity=0.235 Sum_probs=198.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc--------
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 701 (953)
..+|.+.+.||+|+||.||+|....+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999999888899999997665566678889999999999999999998754321
Q ss_pred -cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 702 -YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 702 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
.......++||||++ ++|.+++. ...+++..++.++.||+.||+|||+. +++||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 111245789999996 58888773 12578999999999999999999999 999999999999997
Q ss_pred -CCCcEEEeccccceecCCCCCc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 781 -EEMMAHVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 781 -~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+++.+|++|||.++........ .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~- 227 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ- 227 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 4567899999999865322111 11122357889999997654 5688899999999999999999999975322111
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... ..+....+.............. ...................++.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 MQLILE-SVPVVREEDRNELLNVIPSFVR-NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHH-hcCCCChHHhhhhhhhhhhhhh-hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 111110 0000000000000000000000 00000000000001124467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.00 Aligned_cols=272 Identities=24% Similarity=0.267 Sum_probs=200.1
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|++.+.||+|++|.||+|....+++.||+|+++.... .....+.+|++++++++|++|+++++++. .+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 5678899999999999999988888999999864322 34567889999999999999999999853 4478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++ ++.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 76 v~e~~~~-~l~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIKDR---------QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHHhh---------cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence 9999975 888887532 13689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc-
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD- 868 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~- 868 (953)
|.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+ ...... .....
T Consensus 143 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~-~~~~~~ 218 (283)
T cd05118 143 GLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIF-RTLGTP 218 (283)
T ss_pred eeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHcCCC
Confidence 9998765432 122234578899999998776 78999999999999999999999986532211 111111 11110
Q ss_pred ---hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 ---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+ ........ ................+.++.+++.+||++||.+||+++|++.
T Consensus 219 ~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 219 DPEVWPKFTS-LARNYKFS----FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chHhcccchh-hhhhhhhh----hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0001000 00000000 0000000011122345778999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=295.43 Aligned_cols=244 Identities=21% Similarity=0.256 Sum_probs=186.6
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccch---hhHHHHHHHHHHH-hhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---GAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|.+...++.||+|+++.... .....+..|..++ ...+|+|++++++++. .++..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 569999999999999988888999999864322 2223445555544 3448999999999853 447899999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++++|.++++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.
T Consensus 77 e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKTL----------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccc
Confidence 999999999998522 2578899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 793 ARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 793 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
++.... .....++..|+|||.+.+..++.++||||+|+++|||++|..||....... ..........
T Consensus 144 ~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------ 210 (260)
T cd05611 144 SRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRI------ 210 (260)
T ss_pred ceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc------
Confidence 975432 123357889999999988889999999999999999999999996432110 0000000000
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
+ . . ......++..+.+++.+||+.+|++||++.++.+.+
T Consensus 211 --~--~---~---------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 211 --N--W---P---------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --C--C---C---------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0 0 0 000012456789999999999999999887665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.30 Aligned_cols=286 Identities=21% Similarity=0.236 Sum_probs=202.8
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY- 702 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 702 (953)
+....++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344677899999999999999999999988889999998532 22334568899999999999999999998653211
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
......++||||+ +++|.+++. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~ 154 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED 154 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 1123568999999 779988874 12588999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||.+...... .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||....... .....
T Consensus 155 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~ 228 (343)
T cd07880 155 CELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEI 228 (343)
T ss_pred CCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 99999999999865321 123357889999998876 458899999999999999999999997532111 11111
Q ss_pred HHhhC--CchhhhhccccccCCchhhhhcccchhh-hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHH
Q 043900 862 ARMAL--PDHVVDIVDSTLLSDDEDLAVHGNQRQR-QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR--QLQSI 936 (953)
Q Consensus 862 ~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i 936 (953)
..... +......+. ............... .........+++++.+++.+|++.||++|||+.++++ .++..
T Consensus 229 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 229 MKVTGTPSKEFVQKLQ----SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhcCCCCHHHHHhhc----chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 11000 001111110 000000000000000 0000011234557889999999999999999999984 34444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.28 Aligned_cols=242 Identities=21% Similarity=0.242 Sum_probs=183.4
Q ss_pred cccccceeeEEEEEEcCCCeEEEEEEeeccch---hhHHHHHHHH---HHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---GAFKSFIAEC---NTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
.||+|+||.||+|.+..+++.||+|.+..... .....+..|. ..++...||+|+++.+++. ..+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 48999999999999988888999999864321 1112233343 3444457999999998853 44789999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
|||+++|+|.+++.. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLSQ----------HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence 999999999988842 23589999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
.+....... .....|+..|+|||++.++ .++.++||||+||++|||++|+.||........ .........
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~--- 213 (278)
T cd05606 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT--- 213 (278)
T ss_pred CccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc---
Confidence 997653221 1234589999999998754 689999999999999999999999975322111 000000000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.+.. .+...+.++.+++.+|+..+|++|| ++.|+++
T Consensus 214 ---~~~~----------------------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 ---MAVE----------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCC----------------------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0000 0012245688999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=303.01 Aligned_cols=285 Identities=20% Similarity=0.248 Sum_probs=197.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc---CC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 704 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 568999999999999999999999888899999986332 2223467789999999999999999988644311 22
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+.+ ++...+... ...+++.++..++.|+++||+|||+. +++||||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 3467999999965 666666421 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcc---------cccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 785 AHVSDFGLARFLPLSPAQT---------SSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
+||+|||+++......... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999997654322111 11233568889999987654 5789999999999999999999999753221
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchh-hhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDED-LAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ..................+......... ............ ......+.+.+++.+|++.||++|||+.|++.
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 D-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE---RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred H-HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH---HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1 1111111100000000000000000000 000000000000 11123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=321.47 Aligned_cols=278 Identities=17% Similarity=0.187 Sum_probs=188.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCe-EEEEE------------------EeeccchhhHHHHHHHHHHHhhcCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKT-TVAVK------------------VFNLLHHGAFKSFIAECNTLKNIRHRN 689 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n 689 (953)
..++|++.+.||+|+||+||+|..+.... .+++| .++ ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999988653221 11212 111 11223456889999999999999
Q ss_pred eeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 043900 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITH 769 (953)
Q Consensus 690 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 769 (953)
|+++++++. ..+..++|+|++. +++.+++...... ........++..|+.|++.||+|||+. +|+|
T Consensus 225 Iv~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiH 290 (501)
T PHA03210 225 ILKIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFD-----WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIH 290 (501)
T ss_pred cCcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhcccc-----ccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999964 3467899999994 5777776432211 112344667889999999999999999 9999
Q ss_pred ecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC-C
Q 043900 770 CDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-V 848 (953)
Q Consensus 770 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~p-f 848 (953)
|||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ |
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999999999987643222 222345699999999999999999999999999999999998754 4
Q ss_pred CCcccC-CccHHHHHHhh------CCch---hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccC
Q 043900 849 DSMFEG-DMNLHNFARMA------LPDH---VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSME 918 (953)
Q Consensus 849 ~~~~~~-~~~~~~~~~~~------~~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 918 (953)
...... ...+.+..... +++. ..+.++...... ........-.....+..+.+++.+|+++
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDH---------AGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhccc---------CccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 322111 11111111100 1111 011110000000 0000000001112345678889999999
Q ss_pred CCCCCCCHHHHHH
Q 043900 919 SPGDRMNMTNVVR 931 (953)
Q Consensus 919 dP~~RPt~~evl~ 931 (953)
||++|||+.|+++
T Consensus 441 DP~~Rpsa~elL~ 453 (501)
T PHA03210 441 DWHLRPGAAELLA 453 (501)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.18 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=200.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+|++.+.||+|++|.||+|+...+++.||+|.+..... .....+.+|++++++++||+++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 47888999999999999999988888999999975443 45678999999999999999999999854 347789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++... ..+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKKF----------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 999999999999998522 3689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||.+......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ........ ...
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~ 215 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDD 215 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccC
Confidence 9999876543221 2234588899999998888889999999999999999999999864321 11110000 000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .. .+...+.++.+++.+||..+|++|||+.|++.
T Consensus 216 ~-----~~----------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 H-----PP----------------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-----CC----------------------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 00 00122456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.88 Aligned_cols=285 Identities=20% Similarity=0.228 Sum_probs=203.4
Q ss_pred HHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccc
Q 043900 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGV 700 (953)
Q Consensus 623 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 700 (953)
..++...+++|.+.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667889999999999999999999999888889999998643 222346678899999999999999999987533
Q ss_pred c-cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 701 D-YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 701 ~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
. .......+++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll 153 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAV 153 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEE
Confidence 2 22234578888887 789988774 12588999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
++++.+||+|||+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 154 ~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~ 227 (345)
T cd07877 154 NEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQL 227 (345)
T ss_pred cCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 9999999999999975432 1223457889999998766 46889999999999999999999999642211 111
Q ss_pred HHHHHhhC--CchhhhhccccccCCchhhhhcccchhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 859 HNFARMAL--PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN-SKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 859 ~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
........ +......+... ............+..... .....++++.+++.+|++.||.+||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSE----SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccH----hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111110 01111000000 000000000000000000 000134568899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.14 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=203.6
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.....|.+...||+|.|+.|..|++..++..||+|.++... ......+.+|+++|+.++|||||+++.+. ...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eec
Confidence 34567899999999999999999999999999999997543 23345689999999999999999999994 445
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...|+||||+.+|.+.+|+.... ...+..+..++.|+.+|++|+|++ .|||||||++|||++.+..+
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g----------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG----------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc----------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 78999999999999999997544 345578889999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||++.++... ......+|++.|.|||++.|..| ++++|+||+|+++|-|+.|..||++..-.
T Consensus 195 kIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---------- 261 (596)
T KOG0586|consen 195 KIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---------- 261 (596)
T ss_pred eeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------
Confidence 99999999988633 33445679999999999999876 48899999999999999999999863211
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+.-++.+.+.+ +.+ .-...+..+++++++-.+|.+|++++++.+.
T Consensus 262 -------~Lr~rvl~gk~--------------rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 262 -------ELRPRVLRGKY--------------RIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -------cccchheeeee--------------ccc--ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111111100 000 1123356789999999999999999998763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=278.25 Aligned_cols=285 Identities=21% Similarity=0.284 Sum_probs=202.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEee--ccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc---CCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~ 705 (953)
..|....+||+|.||+||+|+.+++++.||+|++- ...++......+|++++..++|+|++.+++.|....- ...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45667789999999999999999999999998763 2334445667899999999999999999999865432 223
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||.+|+. +|...+... ...++..++.+++.++..||.|+|.. .|+|||+||+|+||+.+|.+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---------~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---------KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---------cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence 458999999965 888887422 24689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCC--CcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 786 HVSDFGLARFLPLSP--AQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 786 kL~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
||+|||+|+.+.... .....+..+.|.+|++||.+.|. .|+++.|||+.|||+.||+||.+-+.+..+.. ..+..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq--ql~~I 241 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ--QLHLI 241 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH--HHHHH
Confidence 999999997664322 22334566679999999987775 69999999999999999999999887643321 12222
Q ss_pred Hhh----CCchhhhhccccccCCchhh-hhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 863 RMA----LPDHVVDIVDSTLLSDDEDL-AVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 863 ~~~----~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .++.+..+..-.+....+.. ...+..+....+.. +..-.++..+++..++..||.+||++++++.
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k-p~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK-PYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc-cccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 221 11111111110000000000 00000010001100 0011235678999999999999999999875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.71 Aligned_cols=275 Identities=21% Similarity=0.241 Sum_probs=194.9
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-hhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|.+.+.||+|++|+||+|+...+++.||+|++..... .......+|+..+++++ |||++++++++. .++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6678899999999999999988888999999864322 22334567899999998 999999999854 3578999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+ +|+|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK--------GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 889998885322 23689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|.+........ .....++..|+|||++. +..++.++||||||+++|||++|+.||......+. ..... ......
T Consensus 144 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~-~~~~~~ 218 (283)
T cd07830 144 GLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKIC-SVLGTP 218 (283)
T ss_pred ccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHH-HhcCCC
Confidence 99986643222 22345788999999875 44678999999999999999999999865322111 11110 011000
Q ss_pred hhh-hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVD-IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..+ ..+.................. .........+.++.+++.+||+.||++|||++|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 219 TKQDWPEGYKLASKLGFRFPQFAPT--SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ChhhhhhHhhhhccccccccccccc--cHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 000000000000000000000 000000112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=308.52 Aligned_cols=281 Identities=19% Similarity=0.231 Sum_probs=200.1
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~ 704 (953)
...++|++.+.||+|++|.||+|.+..+++.||+|++... .......+.+|+.++++++|||++++.+++..... ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999999988889999998642 23344667789999999999999999887543211 22
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++|+||+ +++|.+++.. ..+++.++..++.|++.||+|||+. ||+||||||+||++++++.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCC
Confidence 23589999999 6799998852 3589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||......+ .+.....
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~ 230 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMN 230 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 999999999865322 223457889999998765 367899999999999999999999996432110 0111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARIN-SKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........+............ ............. .....+.++.+++.+|++.||++|||+.||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 231 -LVGTPDEELLQKISSESARNY-IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred -hcCCCCHHHHhhccchhHHHH-HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 010000011100000000000 0000000000010 01123567999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.03 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=191.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ......+..|+.++.+. .||||++++++|.. ...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence 356888999999999999999999878899999997432 23445566777777676 49999999999643 467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
.++||||++ +++.++.... ...+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+|
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRI---------QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred EEEEeeccC-cCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEE
Confidence 999999985 4676666321 2268899999999999999999997 5 899999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE----VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
|+|||.+..+..... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.........+...
T Consensus 156 L~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~- 231 (296)
T cd06618 156 LCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI- 231 (296)
T ss_pred ECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-
Confidence 999999976543221 12234788999999987654 7889999999999999999999986421111001100
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
....... . . ....++.++.+++.+||+.||++||+++++++.
T Consensus 232 ---~~~~~~~-----~-~-------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 232 ---LQEEPPS-----L-P-------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---hcCCCCC-----C-C-------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0 0 000234568999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.08 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=192.9
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccch---hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++.+ ..+...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999998888999999864332 4456788999999999999999998874 3457889999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 76 ~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLENV----------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 999999998521 2589999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC------cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 796 LPLSPA------QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 796 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
...... ........++..|+|||...+..++.++||||||+++||+++|..||...... .........
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~- 216 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNG- 216 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcC-
Confidence 433211 11223345788999999998888999999999999999999999999643211 111000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
.. . .......+.++.+++.+||+.+|++|||+.++.+.|+
T Consensus 217 -------~~-~-----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 -------KI-E-----------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -------Cc-C-----------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 0 0000012567889999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=298.87 Aligned_cols=248 Identities=26% Similarity=0.338 Sum_probs=193.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..|...+.||+|+||.||+|++..+++.||+|.+.. .......++.+|+++++.++|+|++++.+++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 347777899999999999999988888999999863 223345678899999999999999999998643 367
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+. |++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~---------~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEE
Confidence 899999996 5777776421 22478999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||++...... ....++..|+|||++. ...++.++|||||||++|||++|..||....... ........
T Consensus 157 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~ 229 (308)
T cd06634 157 GDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 229 (308)
T ss_pred CCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhc
Confidence 999999765322 2235788999999874 3567889999999999999999999986421110 00000000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
..+. . .....+..+.+++.+||+.+|++||+++++++.-
T Consensus 230 ~~~~---------~---------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESPA---------L---------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCC---------c---------------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0000 0 0012345688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.96 Aligned_cols=278 Identities=20% Similarity=0.277 Sum_probs=195.1
Q ss_pred hcCCcc-cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhh--------------HHHHHHHHHHHhhcCCCCeeEEE
Q 043900 630 TDGFAS-ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA--------------FKSFIAECNTLKNIRHRNLVKIL 694 (953)
Q Consensus 630 ~~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~ 694 (953)
.++|.. .+.||+|+||+||+|.+..+++.||+|+++...... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 467999999999999999888899999986432211 12577899999999999999999
Q ss_pred eeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
+++. ..+..++||||++ |+|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|
T Consensus 87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~ 147 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMA-SDLKKVVDR----------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP 147 (335)
T ss_pred EEEe-----cCCcEEEEEeccc-cCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9954 3478899999996 689888842 23588999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCC------------CcccccccccccccccccccCCC-CCCcccchHHHHHHHHHH
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSP------------AQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLEL 841 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~el 841 (953)
+||+++.++.+||+|||.+....... .........++..|+|||++.+. .++.++||||+||++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999998664111 01111223467889999998764 468999999999999999
Q ss_pred HhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCC
Q 043900 842 VTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921 (953)
Q Consensus 842 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 921 (953)
++|+.||......+ .+..............+.+....+..... ....+..........+.++.+++.+||+.+|+
T Consensus 228 ~tg~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 228 LTGKPLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEF----TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhccccccc----CcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 99999997532211 11111110000000000000000000000 00000000001112356788999999999999
Q ss_pred CCCCHHHHHH
Q 043900 922 DRMNMTNVVR 931 (953)
Q Consensus 922 ~RPt~~evl~ 931 (953)
+|||++|++.
T Consensus 303 ~R~s~~~~l~ 312 (335)
T PTZ00024 303 ERISAKEALK 312 (335)
T ss_pred hccCHHHHhc
Confidence 9999999986
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.29 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=199.4
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 706 (953)
++|.+.+.||+|+||.||+|+...+++.||+|++... .....+.+.+|++++++++ ||||+++++++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 3688999999999999999999988889999998642 2334567889999999998 99999999884 4457
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----------YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence 89999999999999999952 22689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc------------------ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 787 VSDFGLARFLPLSPAQ------------------TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
++|||.+......... .......++..|+|||+..+..++.++||||+|+++|++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999876433211 1222345788999999998888999999999999999999999999
Q ss_pred CCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH--
Q 043900 849 DSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM-- 926 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-- 926 (953)
...... ... . ...+.. ...+...++.+.+++.+||+.+|++||++
T Consensus 223 ~~~~~~----~~~-~--------~~~~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 223 RGSNEY----LTF-Q--------KILKLE--------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred CCccHH----HHH-H--------HHHhcC--------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 753210 000 0 000000 00001224568899999999999999999
Q ss_pred --HHHHH
Q 043900 927 --TNVVR 931 (953)
Q Consensus 927 --~evl~ 931 (953)
+|+++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=295.34 Aligned_cols=245 Identities=27% Similarity=0.348 Sum_probs=190.3
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
|...+.||+|+||.||+|++..+++.||+|++... .......+.+|+++++.++|||++++++++.+ ....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 66678899999999999999888889999998632 22344578889999999999999999999643 36789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+. |++.+++... ...+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEee
Confidence 9999995 5777776421 23588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||.+..... .....|+..|+|||++. +..++.++|||||||++|||++|..||........ .........
T Consensus 165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~ 237 (313)
T cd06633 165 FGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDS 237 (313)
T ss_pred cCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCC
Confidence 999864321 12345888999999974 45688999999999999999999999865321110 000000000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+. . .....+..+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~---------~---------------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PT---------L---------------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC---------C---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 000223458899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=274.28 Aligned_cols=201 Identities=24% Similarity=0.323 Sum_probs=174.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|...+++|+|.||.|.+++-+.+++.+|+|+++.. ..++...-..|-++++..+||.+..+.-. ++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 46788899999999999999999999999999999742 23344556678899999999998877644 67779
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..|.||||+.||.|.-++.. .+.+++....-+...|+.||.|||++ +||.||+|.+|.|+|.+|.+|
T Consensus 242 rlCFVMeyanGGeLf~HLsr----------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred eEEEEEEEccCceEeeehhh----------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceE
Confidence 99999999999999999853 34688888888999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|+|||+++.-- .........+|||.|.|||++....|+.+.|.|.+|||+|||++|+.||..
T Consensus 309 itDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 309 ITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred eeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 99999997432 223344567899999999999999999999999999999999999999975
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=288.81 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=193.4
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-----chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
+|.+.+.||+|+||.||+|.+...+..+++|+.+.. .......+.+|+.++++++||||+++++++. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 588889999999999999999877666777776531 1223345678999999999999999998853 346
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++..... ....+++.+++.++.|++.|+.|||+. +++|+||+|+||+++. +.+|
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH------TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh------cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence 78999999999999998853221 234689999999999999999999999 9999999999999975 5699
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||.+........ ......|++.|+|||...+..++.++||||||+++|+|++|..||..... ........
T Consensus 146 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~ 218 (260)
T cd08222 146 IGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIV 218 (260)
T ss_pred ecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHH
Confidence 999999987643221 22234578899999998888899999999999999999999999863211 11111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... . ......++.++.+++.+||+.+|++||++.|+++
T Consensus 219 ~~~--------~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 EGP--------T-------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cCC--------C-------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 000 0 0001134567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=293.16 Aligned_cols=257 Identities=21% Similarity=0.209 Sum_probs=195.9
Q ss_pred CCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 632 GFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+.+|++++.++ +||+|+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4778899999999999999864 345689999986422 22345678999999999 599999999874 4
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.+...++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 45778999999999999999852 23578899999999999999999998 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
.++|+|||+++........ ......|+..|+|||...+.. .+.++||||||+++|||++|..||...... ......
T Consensus 143 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~ 220 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEI 220 (288)
T ss_pred CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHH
Confidence 9999999999765432211 122345889999999987765 788999999999999999999998632111 011111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
....... . ...+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 221 ~~~~~~~--------~--------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 221 SRRILKS--------K--------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHcc--------C--------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1110000 0 000112345688999999999999999998887766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=291.29 Aligned_cols=271 Identities=23% Similarity=0.300 Sum_probs=198.1
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+..|++++++++|++++++++++. ..+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 566788999999999999999888899999997542 334567788999999999999999999854 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+||
T Consensus 76 v~e~~~-~~l~~~i~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP---------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence 999997 58999996321 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC---
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL--- 866 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--- 866 (953)
|.++....... ......++..|+|||.+.+. .++.++|||||||++||+++|+.||......+ ..........
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 219 (282)
T cd07829 143 GLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPT 219 (282)
T ss_pred CcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCc
Confidence 99986643221 22233467789999998776 88999999999999999999999986532111 1111111100
Q ss_pred Cchhhhhcccc-ccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.......+.. ....... ...... .......+..+.+++.+||+.||++||++++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 220 EESWPGVTKLPDYKPTFPK----FPPKDL---EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHhhcccccccccccc----cCccch---HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00011110000 0000000 000000 0001122567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=302.68 Aligned_cols=266 Identities=22% Similarity=0.263 Sum_probs=216.2
Q ss_pred CHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 622 SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++.+...++.|.+.++||.|.+|.||+++...+++.+|+|+.....+ ..++...|.++++.. .|||++.++|++.-.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444567789999999999999999999999999999999875544 345677888999888 699999999998766
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
....++..|+|||||.+|+..++++... ...+.|..+.-|++.++.|+.+||.+ .++|||||-.|||++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT 157 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLT 157 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEe
Confidence 6667789999999999999999997544 34799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCCcccCC
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slG~vl~elltg~~pf~~~~~~~ 855 (953)
.++.|||+|||.+..... +-.......||+.|||||++... .|+.++|+||+|++..||.-|.+|+.++....
T Consensus 158 ~e~~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 158 ENAEVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred ccCcEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 999999999999987642 33344456799999999997543 57788999999999999999999987643321
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .+ .-.+.++.....+..-..++.+++..|+.+|.++||++.++++
T Consensus 236 a--------LF----------------------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 A--------LF----------------------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred h--------hc----------------------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0 00 0011222223334455678999999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-33 Score=284.73 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=200.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-------chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-------HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
.++|-....||+|||+.||+|.+...++.||||+-... .....+...+|..+-+.++||.||++|+++.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---- 537 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---- 537 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----
Confidence 45788889999999999999999999999999987421 1122356778999999999999999999974
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec--
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-- 780 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-- 780 (953)
-+.+.+|-|+|||+|-+|.-|++.. +.+++.++..|+.||+.||.||.+. +++|||-||||.|||+.
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQh----------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQH----------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhh----------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence 3447789999999999999999643 4689999999999999999999986 78999999999999994
Q ss_pred -CCCcEEEeccccceecCCCCCc-----ccccccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 781 -EEMMAHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGS----EVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 781 -~~~~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
..|.+||+|||+++++..+... .......||++|.+||.+.-+ +.+.|+||||.||++|+.+.|+.||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 5678999999999998655433 222345699999999986533 578899999999999999999999975
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
..... ....... ++...- -.++..+....+..+++++|+++--++|....++.
T Consensus 687 nqsQQ----dILqeNT------IlkAtE-----------------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 687 NQSQQ----DILQENT------ILKATE-----------------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhHH----HHHhhhc------hhccee-----------------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 32211 1111000 000000 00111123455678899999999999998888876
Q ss_pred H
Q 043900 931 R 931 (953)
Q Consensus 931 ~ 931 (953)
.
T Consensus 740 ~ 740 (775)
T KOG1151|consen 740 C 740 (775)
T ss_pred c
Confidence 4
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=320.44 Aligned_cols=147 Identities=28% Similarity=0.400 Sum_probs=129.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|.+.++||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 35799999999999999999999988889999999643 2333467889999999999999999998853 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~----------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY----------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence 899999999999999998521 2478889999999999999999998 999999999999999999999
Q ss_pred Eeccccce
Q 043900 787 VSDFGLAR 794 (953)
Q Consensus 787 L~DfG~a~ 794 (953)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.90 Aligned_cols=252 Identities=22% Similarity=0.253 Sum_probs=191.2
Q ss_pred CCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 632 GFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
+|++.+.||+|+||.||+|... .+++.||+|+++... ....+.+.+|+.+++++ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999974 356789999986432 22346678899999999 599999999884 3
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.+...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence 44678999999999999999852 23578889999999999999999998 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
.+||+|||++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ......
T Consensus 143 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~ 220 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEI 220 (290)
T ss_pred CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHH
Confidence 999999999986543221 122234588999999998753 4678999999999999999999998632111 111111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
........ .. .+..+++.+.+++.+||+.||++|| ++++++.
T Consensus 221 ~~~~~~~~---------~~-------------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 SRRILKSE---------PP-------------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHhhccC---------CC-------------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11110000 00 0012345688999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=295.19 Aligned_cols=240 Identities=21% Similarity=0.223 Sum_probs=192.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++.|.....+|.|+|+.|-.+.+..+.+..+||++.... .+..+|+.++... +||||+++.+.| .++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 556788888999999999999999999999999996542 2334567666666 799999999994 456889
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe-cCCCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL-DEEMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL 787 (953)
|+|||++.++-+.+.+... .....++..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|
T Consensus 392 ~~v~e~l~g~ell~ri~~~-----------~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSK-----------PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeehhccccHHHHHHHhc-----------chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEE
Confidence 9999999998887777421 222367788999999999999999 99999999999999 58999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||.++..... ....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....+ ..+.....
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~---- 527 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ---- 527 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc----
Confidence 999999876433 33445788999999999999999999999999999999999999753222 11111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........+++..+++.+|++.||.+||+|.|+..
T Consensus 528 -----------------------------~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 -----------------------------MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----------------------------CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 00111245677889999999999999999999865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=271.80 Aligned_cols=254 Identities=26% Similarity=0.299 Sum_probs=190.2
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEEee
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
..||.|+||+|++-.++..++..|||+++... ..+.+++..|.+...+- ++|+||+++|.+.. .+.-||.||.
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHHH
Confidence 56999999999999999999999999998544 35667888888865544 79999999999643 3668999999
Q ss_pred ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccce
Q 043900 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLAR 794 (953)
Q Consensus 715 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 794 (953)
| ..++..+-+... ......+++..+-+|+...+.||.||-.. ..|+|||+||+|||++..|.+||||||.+.
T Consensus 145 M-d~SlDklYk~vy-----~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 145 M-DISLDKLYKRVY-----SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred H-hhhHHHHHHHHH-----HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchH
Confidence 9 446655543211 12234688888899999999999999876 389999999999999999999999999997
Q ss_pred ecCCCCCcccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh
Q 043900 795 FLPLSPAQTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD 872 (953)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 872 (953)
.+..+ ...+...|-..|||||.+... .|+-+|||||+|+++||+.||..||..... .+.+...-..
T Consensus 217 qLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~------ 284 (361)
T KOG1006|consen 217 QLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVI------ 284 (361)
T ss_pred hHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHc------
Confidence 66432 223345688999999987643 488999999999999999999999864211 1111111111
Q ss_pred hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 873 IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 873 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+++.. -.......+....+.+++..|+.+|-.+||...++.+.
T Consensus 285 -------gdpp~----------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 -------GDPPI----------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -------CCCCe----------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11100 00001112456679999999999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=277.42 Aligned_cols=283 Identities=22% Similarity=0.256 Sum_probs=204.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC--------CCCeeEEEeeeccccc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR--------HRNLVKILTACSGVDY 702 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~~ 702 (953)
.+|.+.++||.|.|++||+|-+..+++.||+|+.+... ...+....|++++++++ ..+||++++.|... .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence 57999999999999999999999999999999997533 33456788999999983 24799999998654 6
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.++.++|||+|++ |.+|..++..... +.++...+.+|++||+.||.|||..| ||||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--------rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--------RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC--------CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 7788999999999 7799998875443 37999999999999999999999987 99999999999998000
Q ss_pred --------------------------------------------------------------------------------
Q 043900 783 -------------------------------------------------------------------------------- 782 (953)
Q Consensus 783 -------------------------------------------------------------------------------- 782 (953)
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 043900 783 -------------------------------------------------------------------------------- 782 (953)
Q Consensus 783 -------------------------------------------------------------------------------- 782 (953)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred ------CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCccc---
Q 043900 783 ------MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFE--- 853 (953)
Q Consensus 783 ------~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~--- 853 (953)
-+|||+|||-|+.+. ...+....|..|+|||++.|..|++.+||||++|++|||+||...|+.-..
T Consensus 385 ~~~~~di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCccceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 024566666665432 122334478899999999999999999999999999999999999975322
Q ss_pred --CCccHHHHHHhh--CCc-------hhhhhccccccC-CchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCC
Q 043900 854 --GDMNLHNFARMA--LPD-------HVVDIVDSTLLS-DDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921 (953)
Q Consensus 854 --~~~~~~~~~~~~--~~~-------~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 921 (953)
++..+..++... +|. ...+++++.-.- .......=.....-...+....+...++.+++.-|++.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 122222222211 111 122222211000 00000000000111122334456778899999999999999
Q ss_pred CCCCHHHHHH
Q 043900 922 DRMNMTNVVR 931 (953)
Q Consensus 922 ~RPt~~evl~ 931 (953)
+||||.+.++
T Consensus 540 KR~tA~~cl~ 549 (590)
T KOG1290|consen 540 KRPTAAQCLK 549 (590)
T ss_pred ccccHHHHhc
Confidence 9999999885
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.40 Aligned_cols=237 Identities=27% Similarity=0.300 Sum_probs=189.6
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
||+|+||.||+|.....++.||+|+++... ......+..|++++++++|||++++++.+ ..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999998878899999986432 22456788999999999999999999884 4557899999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
++++|.+++.. ...+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSK----------EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCccee
Confidence 99999999852 22588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 796 LPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
..... .......++..|+|||...+..++.++|+||||+++||+++|..||..... ..........
T Consensus 143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~------- 208 (250)
T cd05123 143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD------- 208 (250)
T ss_pred cccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC-------
Confidence 64321 122344578899999999888899999999999999999999999964221 1111111000
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
.. ..+...+.++.+++.+||..||++||++.+
T Consensus 209 -~~--------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 -PL--------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CC--------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 00 000012456889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=284.63 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=189.0
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEe
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
.+++|+|.||+||-|.++.+++.||||++.+. .......+.+|+.+++.++||.||.+.-.| +..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 47899999999999999999999999999632 233457889999999999999999998774 44588999999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC---CcEEEecc
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE---MMAHVSDF 790 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Df 790 (953)
-+.| +..+.+-... ..++++..-.-+..||+.||.|||.+ +|||+||||+|||+... -++|||||
T Consensus 644 Kl~G-DMLEMILSsE--------kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSE--------KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhcc-hHHHHHHHhh--------cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccc
Confidence 9955 5555553222 23688888888999999999999999 99999999999999643 38999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+|+++++. ......+||+.|.|||++....|...-|+||.||++|.-++|..||....+-...+...+.+ +|..
T Consensus 712 GfARiIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp~- 786 (888)
T KOG4236|consen 712 GFARIIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPPN- 786 (888)
T ss_pred cceeecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCCC-
Confidence 999998643 33445679999999999999999999999999999999999999997422111111111111 1111
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
.+.++.++..+++...++..-.+|-+.++-+
T Consensus 787 -----------------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 -----------------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -----------------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1124455667777788888778887776543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=310.64 Aligned_cols=206 Identities=26% Similarity=0.328 Sum_probs=178.5
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+.-..++|.+.++||+|+||.|..++.+.+++.||.|++.. .......-|..|-.+|..-+.+=|+.+.-. |
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----F 144 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----F 144 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----h
Confidence 33456789999999999999999999999999999999964 334445678889999988888888888655 7
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+++.+.|+|||||+||||-..+.... .+++..++-++..|+-||.-+|+. |+|||||||+|||+|..
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~----------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~ 211 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD----------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKS 211 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC----------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEeccc
Confidence 88899999999999999999996332 588888899999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccC----C-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL----G-SEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|++||+|||.+-.+..+ ....+...+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||..
T Consensus 212 GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 212 GHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99999999999877543 344555678999999999864 3 5789999999999999999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=303.88 Aligned_cols=277 Identities=19% Similarity=0.155 Sum_probs=173.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCC----CeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecc-cccC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQG----KTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSG-VDYQ 703 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 703 (953)
..++|.+.+.||+|+||.||+|++..+ +..||+|++...... +....| .+....+.+++.++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 789999987643221 111111 1122222222222221111 1113
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCc----------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDK----------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
.+...++||||+++++|.+++........ ............+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 45778999999999999999864321100 000111223445678999999999999998 99999999
Q ss_pred CCCeEecC-CCcEEEeccccceecCCCCCcccccccccccccccccccCCC----------------------CCCcccc
Q 043900 774 PSNVLLDE-EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS----------------------EVSINGD 830 (953)
Q Consensus 774 p~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 830 (953)
|+|||++. ++.+||+|||+|+.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57999999999986543221 222345689999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC--Cch---hhhhccccccCCchhhhhcccchhhhhhhhhHHHHH
Q 043900 831 VYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL--PDH---VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 905 (953)
Q Consensus 831 v~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (953)
||||||++|||+++..|++.. ...+..... ... +.....+....+. ...+.......
T Consensus 362 VwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~d~~~ 423 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDL------------RRGFEVLDLDG 423 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhh------------hhhhhhccccc
Confidence 999999999999977665421 111111000 000 1111111000000 00000000112
Q ss_pred HHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 906 VAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 906 ~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+..+++.+|++.||++|||++|+++
T Consensus 424 ~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 424 GAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred hHHHHHHHHHccCCcccCCCHHHHhC
Confidence 34568999999999999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=275.55 Aligned_cols=223 Identities=21% Similarity=0.143 Sum_probs=174.7
Q ss_pred cceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeeccCCchh
Q 043900 642 GSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE 721 (953)
Q Consensus 642 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 721 (953)
|.+|.||+|.+..+++.||+|+++... .+.+|...+....|||++++++++. ..+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 899999999999999999999996532 2234445555567999999999853 447899999999999999
Q ss_pred hccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCC
Q 043900 722 EWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801 (953)
Q Consensus 722 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 801 (953)
+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-- 138 (237)
T cd05576 74 SHISKF----------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-- 138 (237)
T ss_pred HHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc--
Confidence 998521 2488999999999999999999998 9999999999999999999999999988655322
Q ss_pred cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCC
Q 043900 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSD 881 (953)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 881 (953)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+...... .......
T Consensus 139 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~~----- 195 (237)
T cd05576 139 ---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTTL----- 195 (237)
T ss_pred ---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccccccc-----
Confidence 12233567899999998888999999999999999999999887531110 0000000
Q ss_pred chhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 043900 882 DEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV 929 (953)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 929 (953)
..+...++.+.+++.+|++.||++||++.+.
T Consensus 196 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 196 -----------------NIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred -----------------CCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 0001234568899999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=246.50 Aligned_cols=211 Identities=25% Similarity=0.320 Sum_probs=170.5
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
....+....+..||+|+||.|-+-++..++...|+|.++.. .....++..+|+.+..+. .+|.+|+++|.. ..
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~r 116 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FR 116 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hc
Confidence 33445556677899999999999999999999999999743 344557778888876655 799999999973 34
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....+|.||.|+ .||..+-++.-. ....+++..+-+||..+++||.|||++ ..++|||+||+|||++.+|+
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~~------~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~Gq 187 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVLK------KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQ 187 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHHh------cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCc
Confidence 478999999994 588776643322 345788999999999999999999987 48999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG----SEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
||+||||.+..+..+-.. +...|-..|||||.+.. ..|+-++||||+|+++.||.+++.||+.....
T Consensus 188 VKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 188 VKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred EEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 999999999877543222 22347789999998654 37899999999999999999999999864443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=267.87 Aligned_cols=204 Identities=23% Similarity=0.308 Sum_probs=169.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
....+|....+||+|+||.|.+|..+++.+.+|||+++.. ..+..+--+.|-+++.-- +-|.++++..+ ++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQ 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQ 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hh
Confidence 3445688999999999999999999999999999999732 222333445566666655 56778888776 44
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.-+..|.||||+.||+|--.+++. +.+.+..+.-+|..||-||-+||++ ||+.||||.+|||+|.+|
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~----------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQV----------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHh----------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCC
Confidence 458899999999999999888643 3566777888999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
.+||+|||+++.--.+ .......+||+.|+|||++...+|+.++|.|||||++|||+.|++||++.
T Consensus 488 HiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 488 HIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred ceEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999853222 22334567999999999999999999999999999999999999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=246.41 Aligned_cols=279 Identities=20% Similarity=0.279 Sum_probs=207.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 706 (953)
...++|++.+++|+|.|++||.|....+.+.++||++++.. .+...+|+.+++.+. ||||++++++..+. ...
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---ccc
Confidence 35678999999999999999999998888899999997543 467889999999996 99999999996543 345
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-CcE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMA 785 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 785 (953)
.+.+|+||+.+.+...... .++..++.-.+.++++||.|+|++ ||.|||+||.|+++|.. -..
T Consensus 109 tpaLiFE~v~n~Dfk~ly~-------------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP-------------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred CchhHhhhhccccHHHHhh-------------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence 6789999999988877663 688889999999999999999999 99999999999999954 479
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|+|+|+|.++.++.. ....+.+..|.-||.+-.. .|+..-|+|||||++..|+..+.||-........+.+.+.-
T Consensus 173 rlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 173 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred eeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 9999999988754332 2334577889999987765 57888999999999999999999986544433344444433
Q ss_pred hCCchhhhhcccc---ccCCchhhhhcccchhhhhhhh-hH-HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDST---LLSDDEDLAVHGNQRQRQARIN-SK-IECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~---l~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.-.+++...+++- +.+.+.++--...+..+..... +. .-..++..+++...+..|-.+||||+|.++
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 3333322222211 1222222111111111111111 11 112367889999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=258.37 Aligned_cols=282 Identities=21% Similarity=0.253 Sum_probs=197.5
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+..+.||-|+||.||.+++..+++.||+|++... .-...+.+.+|++++..++|.|++..++.--....+--.+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4457899999999999999999999999998532 23345788999999999999999998877422211112457889
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
+|.|. .+|...+- .+..++...+.-+.+||++||+|||+. +|.||||||.|.|++.+...||||||
T Consensus 136 TELmQ-SDLHKIIV----------SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV----------SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHHH-hhhhheec----------cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence 99994 58888773 456789999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
+|+.-.. +.....+..+.|..|+|||+++|. .|+.+.||||.||++.|++.++..|..... ....+.....+....
T Consensus 202 LARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 202 LARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPS 278 (449)
T ss_pred cccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCc
Confidence 9986543 333455666789999999999886 689999999999999999999988864221 111222222221111
Q ss_pred hhhccccccCCchhhhhcccchhhh----hhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQ----ARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
.+.+...-.+...-. .++..+.+. ...........+-..+...++..||++|.+.++.+..+
T Consensus 279 ~EaMr~ACEGAk~H~-LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHV-LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHhhhhHHHh-hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111110000000000 000000000 00111112223456778889999999999988877643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=285.44 Aligned_cols=279 Identities=18% Similarity=0.199 Sum_probs=183.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEc----------------CCCeEEEEEEeeccchhhHHHH--------------HHH
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILD----------------QGKTTVAVKVFNLLHHGAFKSF--------------IAE 678 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e 678 (953)
..++|++.++||+|+||.||+|.+. ..++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 2345799999875433333333 346
Q ss_pred HHHHhhcCCCCe-----eEEEeeecccc---cCCCCceeEEEeeccCCchhhccccCCcCC--------------cccCC
Q 043900 679 CNTLKNIRHRNL-----VKILTACSGVD---YQGNDFKALVFEFMQNRSLEEWLHPITRED--------------KTEEA 736 (953)
Q Consensus 679 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~ 736 (953)
+.++.+++|.++ ++++++|.... ....+..++||||+++++|.++++...... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 67777765321 112356899999999999999997432110 00011
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCccccccccccccccc
Q 043900 737 PRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816 (953)
Q Consensus 737 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 816 (953)
...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 23467888999999999999999999 999999999999999999999999999976533211 11122335789999
Q ss_pred ccccCCCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCCcccCCccHHHHHHhhCCchhhhh
Q 043900 817 PEYGLGSEV----------------------SINGDVYSYGILLLELVTRKK-PVDSMFEGDMNLHNFARMALPDHVVDI 873 (953)
Q Consensus 817 PE~~~~~~~----------------------~~~sDv~slG~vl~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (953)
||.+..... ..+.||||+||++|||++|.. ||............ .......+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----ccchHHHH
Confidence 998754321 134699999999999999875 66532111100000 00000000
Q ss_pred ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCC---CCCCCHHHHHH
Q 043900 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP---GDRMNMTNVVR 931 (953)
Q Consensus 874 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~ 931 (953)
. ..... ...+.......+...+++.+++..+| .+|+|++|+++
T Consensus 454 r--~~~~~-------------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 R--MYKGQ-------------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred H--hhccc-------------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 00000 00011111335668899999999766 68999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=265.88 Aligned_cols=239 Identities=28% Similarity=0.344 Sum_probs=189.9
Q ss_pred ceeeEEEEEEcCCCeEEEEEEeeccchhh-HHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeeccCCchh
Q 043900 643 SFGSVYKGILDQGKTTVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE 721 (953)
Q Consensus 643 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 721 (953)
+||.||+|+..++++.||+|++....... .+.+.+|++.+++++|++++++++++.. ....+++|||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999999877899999997554433 6789999999999999999999998643 36789999999999999
Q ss_pred hccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCC
Q 043900 722 EWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801 (953)
Q Consensus 722 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 801 (953)
+++... ..+++..++.++.+++.+++|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 76 ~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 76 DLLKKR----------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred HHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 998521 1278899999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCC
Q 043900 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSD 881 (953)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 881 (953)
......++..|+|||...+..++.++||||+|+++|++++|..||....... .............
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~------------ 206 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKPPF------------ 206 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCC------------
Confidence 2234458889999999988889999999999999999999999986421111 0111000000000
Q ss_pred chhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 882 DEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ......+.++.+++.+|+..+|++||++.++++
T Consensus 207 ~----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 P----------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred c----------------cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 000003456889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=251.44 Aligned_cols=201 Identities=24% Similarity=0.320 Sum_probs=173.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|+..++||+|+|+.|..++.+.+.+.+|+|+++. ..++...-.+.|-.+..+. +||.+|-+..+ ++..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 3568899999999999999999999999999999973 3344455566777777766 69999999877 5566
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++|.||++||+|--++++ .+.+++..+.-+...|+-||.|||++ ||+.||+|.+|||+|..|.+
T Consensus 324 srlffvieyv~ggdlmfhmqr----------qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred ceEEEEEEEecCcceeeehhh----------hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCce
Confidence 889999999999999887752 34689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
||+|||+++.--. ........+||+.|.|||++.|..|....|.||+||+++||+.|+.||+-
T Consensus 391 kltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 391 KLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999985322 22233456799999999999999999999999999999999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=274.18 Aligned_cols=200 Identities=25% Similarity=0.350 Sum_probs=174.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++.++..||-|+||.|-++........+|+|+++. .+....+....|-.+|...+.|.||++|.. +.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 345667789999999999999988776689998863 334456678889999999999999999987 667789
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
+|+.||-|-||.++..++. .+.++.....-++..+++|++|||++ +||.|||||+|.+++.+|-+||
T Consensus 495 vYmLmEaClGGElWTiLrd----------Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD----------RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred hhhhHHhhcCchhhhhhhh----------cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEE
Confidence 9999999999999999963 34577778888999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
.|||+|+.+..+ ......+||+.|.|||++.+...+.++|.||+|+++|||++|.+||.+.
T Consensus 562 VDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 562 VDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred eehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999988643 3344567999999999999999999999999999999999999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=283.97 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=185.1
Q ss_pred ccCccccccee-eEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCceeEEE
Q 043900 635 SANEIGVGSFG-SVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 635 ~~~~ig~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
..+++|.|+.| .||+|...+ +.||||++-. +......+|+..++.- +|||||++++. ..+..+.||..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~--R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIal 582 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEG--REVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIAL 582 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCC--ceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEe
Confidence 34568899987 579999965 5899999842 3345677899999888 69999999877 56678999999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---C--CcEEE
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---E--MMAHV 787 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL 787 (953)
|.| ..+|.+++...... .. ...-...+.+..|+++||++||+. +||||||||.||||+. + .+++|
T Consensus 583 ELC-~~sL~dlie~~~~d-~~-----~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLD-VE-----MQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred hHh-hhhHHHHHhccccc-hh-----hcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEe
Confidence 999 55999999754111 00 111145578899999999999998 9999999999999975 3 48999
Q ss_pred eccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCCcccCCccHHHHHHhh
Q 043900 788 SDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~ 865 (953)
+|||+++..+.+... .......||-+|+|||++....-+.++||||+|||+|+.++| .+||.+..+.+.++..-..
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~-- 730 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY-- 730 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc--
Confidence 999999988654332 233456699999999999999889999999999999999995 9999864443322211000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+..+ . ...++ +..++|.+|+.+||..||+|.+|+.
T Consensus 731 ---~L~~L-----~--------------------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 ---TLVHL-----E--------------------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---ceeee-----c--------------------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00000 0 00012 5779999999999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=261.20 Aligned_cols=284 Identities=20% Similarity=0.205 Sum_probs=205.7
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC------CCCeeEEEeeeccc
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR------HRNLVKILTACSGV 700 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~ 700 (953)
+....+|.+....|+|-|++|.+|.+...+..||||+++... ...+.=.+|+++|+++. --|+++++..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~---- 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH---- 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH----
Confidence 345678999999999999999999998888899999997543 23455578999999994 3477777766
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
|....+.|+|||-+ ..+|.++++..+.. ..+....+..++.|+.-||..|-.. +|+|.||||+||||+
T Consensus 503 -F~hknHLClVFE~L-slNLRevLKKyG~n-------vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 503 -FKHKNHLCLVFEPL-SLNLREVLKKYGRN-------VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVN 570 (752)
T ss_pred -hhhcceeEEEehhh-hchHHHHHHHhCcc-------cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEec
Confidence 44558999999988 56999999866543 4688899999999999999999998 999999999999998
Q ss_pred CCC-cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 781 EEM-MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
+.. .+||||||.|........ +.+..+..|+|||++.|-+|+...|+||.||+|||++||+..|++....++.-.
T Consensus 571 E~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred cCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 654 799999999987653322 223467789999999999999999999999999999999999987554433211
Q ss_pred HH-HHhhCCch-------hhhhccccccCCchh------------hhhccc---c----hhhhhhhhhHHHHHHHHHHHh
Q 043900 860 NF-ARMALPDH-------VVDIVDSTLLSDDED------------LAVHGN---Q----RQRQARINSKIECLVAMVRIG 912 (953)
Q Consensus 860 ~~-~~~~~~~~-------~~~~~~~~l~~~~~~------------~~~~~~---~----~~~~~~~~~~~~~~~~l~~l~ 912 (953)
.+ +...+|.. ...-+|..+.-.+.+ +..... . ...+.-.........++.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 11 11111111 001111111000000 000000 0 000011223345667899999
Q ss_pred hccccCCCCCCCCHHHHHH
Q 043900 913 VACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 913 ~~cl~~dP~~RPt~~evl~ 931 (953)
..|+..||++|.|..|.++
T Consensus 727 dkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHhccChhhcCCHHHHhc
Confidence 9999999999999998875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=261.50 Aligned_cols=206 Identities=22% Similarity=0.312 Sum_probs=172.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
-|..++.||-|+||+|.+++-.++...||.|.++..+ .........|-+||..-+.+-||+++-. |++.+..
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCce
Confidence 3778899999999999999999998899999986432 3345567789999999999999999876 6778999
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
|+||+|++||++-.++-+ -+.+.+.-++-++.++..|+++.|.. |+|||||||+|||||.+|.+||+
T Consensus 705 YFVMdYIPGGDmMSLLIr----------mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR----------MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEEEeccCCccHHHHHHH----------hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence 999999999999998842 23677777888899999999999999 99999999999999999999999
Q ss_pred ccccceecCC---------CCCc--------------c-----------------cccccccccccccccccCCCCCCcc
Q 043900 789 DFGLARFLPL---------SPAQ--------------T-----------------SSIDAKGSIGYIAPEYGLGSEVSIN 828 (953)
Q Consensus 789 DfG~a~~~~~---------~~~~--------------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~ 828 (953)
|||+++-+.. ++.. . ..-..+||+.|+|||++....|+..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9999854311 1000 0 0011249999999999999999999
Q ss_pred cchHHHHHHHHHHHhCCCCCCCcccCC
Q 043900 829 GDVYSYGILLLELVTRKKPVDSMFEGD 855 (953)
Q Consensus 829 sDv~slG~vl~elltg~~pf~~~~~~~ 855 (953)
+|.||.|||||||+.|++||......+
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 999999999999999999997654443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=271.52 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=202.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|....++|.|.||.||+|++..+++..|+|+++....+...-.++|+-+++..+||||+.+++. +...+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs-----ylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS-----YLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh-----hhhhcCcE
Confidence 4578899999999999999999999999999999998877788888999999999999999999988 44558899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+.||||.+|+|++.-+ ....+++.++..+++...+|++|||+. |-+|||||-.||++++.|.+|++|
T Consensus 89 icMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecc
Confidence 9999999999999875 345799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
||.+..+. ..........||+.|||||+.. .+.|...+||||.|++..|+-.-++|..+.... ..-+.-.
T Consensus 156 fgvsaqit--ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmT-- 228 (829)
T KOG0576|consen 156 FGVSAQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMT-- 228 (829)
T ss_pred cCchhhhh--hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhh--
Confidence 99997653 2333444567999999999853 456889999999999999998877774321111 1111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..-+++.-..+ ...-.+.+.++++.|+..+|++|||++.+++
T Consensus 229 ----kS~~qpp~lkD-------------------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 ----KSGFQPPTLKD-------------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----ccCCCCCcccC-------------------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00001100000 0122445889999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=262.06 Aligned_cols=207 Identities=23% Similarity=0.373 Sum_probs=173.6
Q ss_pred cCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhhcC---CCC
Q 043900 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------HGAFKSFIAECNTLKNIR---HRN 689 (953)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~n 689 (953)
...+.......+|...+.+|+|+||.|+.|.++.....|+||.+.+.. +...-...-|+.+|..++ |+|
T Consensus 551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 333334445567999999999999999999999998899999985321 111223557999999996 999
Q ss_pred eeEEEeeecccccCCCCceeEEEeec-cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 690 LVKILTACSGVDYQGNDFKALVFEFM-QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 690 iv~~~~~~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
|++++++ |++++.+|++||-. ++.+|.+++. ....+++.++..|++||+.|+++||+. |||
T Consensus 631 IlKlLdf-----FEddd~yyl~te~hg~gIDLFd~IE----------~kp~m~E~eAk~IFkQV~agi~hlh~~---~iv 692 (772)
T KOG1152|consen 631 ILKLLDF-----FEDDDYYYLETEVHGEGIDLFDFIE----------FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIV 692 (772)
T ss_pred hhhhhhe-----eecCCeeEEEecCCCCCcchhhhhh----------ccCccchHHHHHHHHHHHhcccccccc---Cce
Confidence 9999999 56779999999986 4569999994 345789999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCC
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKP 847 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slG~vl~elltg~~p 847 (953)
|||||-+||.++.+|-+||+|||.|.....++ ....+||..|.|||++.|.+|- ..-||||+|+++|.++...-|
T Consensus 693 hrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 693 HRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred ecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 99999999999999999999999998764433 3345799999999999999875 568999999999999999999
Q ss_pred CC
Q 043900 848 VD 849 (953)
Q Consensus 848 f~ 849 (953)
|.
T Consensus 769 yy 770 (772)
T KOG1152|consen 769 YY 770 (772)
T ss_pred Cc
Confidence 86
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=242.91 Aligned_cols=279 Identities=20% Similarity=0.230 Sum_probs=199.0
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~ 705 (953)
...+|.-.+.+|.|+- .|..|-+.-.++.||+|.... ......++..+|...+..+.|+|+++++.++.... ...-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4567888889999998 788888887788999998742 22345677889999999999999999999864321 1112
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
.+.|+||||| ..+|.+.++ ..++-..+..|..|++.|++|||+. ||+||||||+||++..+..+
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL------------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhe
Confidence 4678999999 569998885 2466678899999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||.|||+|+.-+. ....+..+.|..|+|||++.+..+.+.+||||.||++.||++|+..|.+. ..+.+|....
T Consensus 158 Ki~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~ 230 (369)
T KOG0665|consen 158 KILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKII 230 (369)
T ss_pred eeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHH
Confidence 9999999985432 23556677999999999999999999999999999999999999988742 2222332211
Q ss_pred ----CCch-----hhhhccccccCCchh--hhhcccchhh--hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 ----LPDH-----VVDIVDSTLLSDDED--LAVHGNQRQR--QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ----~~~~-----~~~~~~~~l~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.++. +.+...-.....+.. .......+.. ....+...-......+++.+|+..||++|.+++++++
T Consensus 231 ~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 231 EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0100 000000000000000 0000000000 0001111122345788999999999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=250.37 Aligned_cols=282 Identities=23% Similarity=0.296 Sum_probs=203.3
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcC---CCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQ---GKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
....+.|..+++||+|.|++||+|++.. ..+.||+|.+..... ..+..+|++.+..+ .+.||+++.++ +
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~-----~ 104 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC-----F 104 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh-----h
Confidence 3455678999999999999999999977 778999999975443 35688999999999 59999999988 6
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-C
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-E 781 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~ 781 (953)
..++.+++|+||++.....++.. .++..++..+++.+..||+++|+. |||||||||+|++.+ .
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRR 168 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccc
Confidence 67799999999999988888884 578899999999999999999999 999999999999997 4
Q ss_pred CCcEEEeccccceecCCCC------------------------------------------Ccccccccccccccccccc
Q 043900 782 EMMAHVSDFGLARFLPLSP------------------------------------------AQTSSIDAKGSIGYIAPEY 819 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~ 819 (953)
.+.-.|+|||+|...+... .........||++|+|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 5678999999997321100 0000012349999999999
Q ss_pred cCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhh---hccc--ccc-----------CCc
Q 043900 820 GLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVD---IVDS--TLL-----------SDD 882 (953)
Q Consensus 820 ~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~l~-----------~~~ 882 (953)
+... ..++++||||.||+++-+++++.||-....+-..+.+.+...-+..+.. ..+. .+. ..+
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f 328 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF 328 (418)
T ss_pred HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence 8765 5688999999999999999999999765554444444433221111111 0011 000 000
Q ss_pred hhh--hhcccchhh-hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 883 EDL--AVHGNQRQR-QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 883 ~~~--~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ..-...++. -.+.......+..+++++.+|+..||.+|.||+|.++
T Consensus 329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 000000000 0111111223447899999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=233.54 Aligned_cols=256 Identities=18% Similarity=0.228 Sum_probs=191.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..+.|.+.+.+|+|.||.+-+|+++.+++.+|+|.+... ....++|.+|...--.+ .|.||+.-+++. ++..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCce
Confidence 345688999999999999999999999999999998643 33568899998876666 599999888763 566688
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec--CCCcE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--EEMMA 785 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~ 785 (953)
+++++||++.|+|..-+. ...+.+....+++.|+++|+.|+|+. .+||||||.+||||- +..++
T Consensus 97 YvF~qE~aP~gdL~snv~-----------~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rv 162 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVE-----------AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRV 162 (378)
T ss_pred EEEeeccCccchhhhhcC-----------cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEE
Confidence 999999999999998884 23577888899999999999999999 999999999999993 33489
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-----EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~ 860 (953)
||||||.++..+. ......-+..|.|||..... ...+.+|||.||+++|.++||..||......+..+..
T Consensus 163 KlcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~ 237 (378)
T KOG1345|consen 163 KLCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE 237 (378)
T ss_pred EeeecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH
Confidence 9999999985421 11222356679999974322 4568899999999999999999999865555555555
Q ss_pred HHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 861 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
|....-... ..+...+ ....+...++.++-+.++|++|--..++.++-
T Consensus 238 ~~~w~~rk~------~~~P~~F-------------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 238 WEQWLKRKN------PALPKKF-------------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHhcccC------ccCchhh-------------------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 443221110 0111111 02234566788888899999995555555543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-29 Score=256.79 Aligned_cols=424 Identities=23% Similarity=0.257 Sum_probs=244.8
Q ss_pred CCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccC-ccccc
Q 043900 12 TSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFY-NELVG 90 (953)
Q Consensus 12 ~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~-n~l~~ 90 (953)
++-++. .||..+- ..-..++|..|+|+.++|.+|..+++|+.||||+|+|+.+.|++|.++.+|.+|-+.+ |+|+.
T Consensus 54 r~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 54 RGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred cCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 333443 5555432 2458899999999998889999999999999999999989999999999988887766 99996
Q ss_pred cCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccc
Q 043900 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170 (953)
Q Consensus 91 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 170 (953)
...+.|++|..|+.|.+.-|++.-...++|..|++|..|.+.+|.+..+.-.+|..+.+++.+.+..|.+- ...+
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCn 205 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCN 205 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccc
Confidence 66678999999999999999998777889999999999999999998444458999999999999998842 1122
Q ss_pred cccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceee
Q 043900 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFS 250 (953)
Q Consensus 171 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~ 250 (953)
++-+.. ++..|.+. +. +..-..-..+.++++..+.+..|..- ++.+ +..
T Consensus 206 L~wla~-~~a~~~ie------ts-garc~~p~rl~~~Ri~q~~a~kf~c~--~esl----------~s~----------- 254 (498)
T KOG4237|consen 206 LPWLAD-DLAMNPIE------TS-GARCVSPYRLYYKRINQEDARKFLCS--LESL----------PSR----------- 254 (498)
T ss_pred cchhhh-HHhhchhh------cc-cceecchHHHHHHHhcccchhhhhhh--HHhH----------HHh-----------
Confidence 222211 11122111 11 12222333344455543333333211 1111 000
Q ss_pred ecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEe
Q 043900 251 ITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEM 330 (953)
Q Consensus 251 l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 330 (953)
..+.+...+..|..-+.-.++|+.|+|++|+|+++-+.+|.++..++.|+|
T Consensus 255 -----------------------------~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 255 -----------------------------LSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred -----------------------------hccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 000111111222221222234555555555555555555555555555555
Q ss_pred ecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCC------------------CCCCccCC
Q 043900 331 WNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQ------------------GSIPSSLG 391 (953)
Q Consensus 331 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~------------------~~~p~~~~ 391 (953)
..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+ .+.+|+|-.|.+. |..|- +
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C--q 383 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC--Q 383 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCC--C
Confidence 5555554444455555555555555555555555555444 3444444444432 11111 1
Q ss_pred CCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccc-eeeecCCcccccCCCCccCCcccc
Q 043900 392 QYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLE-VLDVFENKLKGEIPSTLGSCKKLE 470 (953)
Q Consensus 392 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~ 470 (953)
.-..++.+.++++.+. .+.. +.... +. ..-++.-| ...+-+. +...|++.++ .+|..+. ..-.
T Consensus 384 ~p~~~~~~~~~dv~~~-~~~c---~~~ee---~~---~~~s~~cP---~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~t 447 (498)
T KOG4237|consen 384 SPGFVRQIPISDVAFG-DFRC---GGPEE---LG---CLTSSPCP---PPCTCLDTVVRCSNKLLK-LLPRGIP--VDVT 447 (498)
T ss_pred CCchhccccchhcccc-cccc---CCccc---cC---CCCCCCCC---CCcchhhhhHhhcccchh-hcCCCCC--chhH
Confidence 1123555555555443 1111 10000 00 00000111 1222232 2334455555 5665444 4567
Q ss_pred EEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCC
Q 043900 471 QLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNN 525 (953)
Q Consensus 471 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N 525 (953)
+|++.+|.++ .+|.+ .+.+| .+|+|+|+++..--..|.+|++|.+|-||+|
T Consensus 448 elyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 448 ELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 7888888888 67776 56677 8888888888666777888888888888876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=236.11 Aligned_cols=211 Identities=28% Similarity=0.455 Sum_probs=180.7
Q ss_pred ccccceeeEEEEEEcCCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeeccC
Q 043900 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQN 717 (953)
Q Consensus 639 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 717 (953)
||+|++|.||++....+++.+++|++...... ..+.+.+|+..++.++|++++++++++. .....+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 68999999999999887789999999754432 3567899999999999999999999954 33778999999999
Q ss_pred CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-CCcEEEeccccceec
Q 043900 718 RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAHVSDFGLARFL 796 (953)
Q Consensus 718 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~ 796 (953)
++|.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKENE---------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 99999985321 2588999999999999999999999 9999999999999999 899999999999876
Q ss_pred CCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcc
Q 043900 797 PLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875 (953)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (953)
..... ......+...|++||..... .++.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 43321 12234478899999998877 888999999999999999
Q ss_pred ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 876 STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 876 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.++.+++.+|++.+|++||++.++++.
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 137789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=234.00 Aligned_cols=200 Identities=31% Similarity=0.422 Sum_probs=171.0
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
|++.+.||+|++|.||+|...++++.||+|.+...... ..+.+.+|++.+++++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56778999999999999999987789999999765544 5678899999999999999999999854 33678999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
+||+++++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g 143 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG---------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG 143 (225)
T ss_pred EeccCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence 999999999999863221 178899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccccccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYG-LGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
.+........ .......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 144 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 144 LARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9987754321 122334578889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-28 Score=249.35 Aligned_cols=229 Identities=21% Similarity=0.201 Sum_probs=172.5
Q ss_pred CcEEEEEeCCCeeeeecCc-cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCC-CccccccCcCccCCCCCcEE
Q 043900 4 QRVKILNLTSLKLAGSISP-HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNN-NSIGGEIPANISSCSNLIQI 81 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~p~~~~~l~~L~~L 81 (953)
...+.++|..|+|. .||+ +|+.++.|++||||+|+|+.+-|.+|.++..|.+|-+-+ |+|+..--+.|.+|..|+.|
T Consensus 67 ~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 67 PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 34688999999998 7776 899999999999999999999999999999988877666 99995555779999999999
Q ss_pred eccCccccccCCcccCCccccceeeccccccccccCC-cccCCCcccEEecccccc------------cccCCccccccc
Q 043900 82 RLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLTDNNL------------DGGIPDTFGWLK 148 (953)
Q Consensus 82 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~L~~L~L~~N~l------------~~~~~~~~~~l~ 148 (953)
.+.-|++.-+..+.|..|++|..|.+.+|.+. .+++ +|..+.+++.+.+..|.+ ....|-.+++..
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar 224 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR 224 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence 99999999888899999999999999999999 5555 999999999999999982 234455666766
Q ss_pred cccceecccccccCCCCCcccc-cccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEE
Q 043900 149 NLATLAMAENWLSGTIPSSIFN-ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQ 227 (953)
Q Consensus 149 ~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 227 (953)
-..-..+.++++...-+..+.- +.++..=-.+.+...+..|..-|.+|++|+.|+|++|+|+.+.+.+|.++..+++|.
T Consensus 225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~ 304 (498)
T KOG4237|consen 225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY 304 (498)
T ss_pred ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence 6666677777776443333321 112221112223334455655555666666666666666666666666666666666
Q ss_pred ccccccc
Q 043900 228 ADVNKLT 234 (953)
Q Consensus 228 L~~N~l~ 234 (953)
|..|+|.
T Consensus 305 L~~N~l~ 311 (498)
T KOG4237|consen 305 LTRNKLE 311 (498)
T ss_pred cCcchHH
Confidence 6666654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-24 Score=266.06 Aligned_cols=320 Identities=21% Similarity=0.308 Sum_probs=192.2
Q ss_pred ccccCCccCceeecCCCc------cCcCCCccCCCCC-CCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCc
Q 043900 22 PHVGNLSFLKVLLLYNNS------FNHGIPSEFDRLQ-RLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPS 94 (953)
Q Consensus 22 ~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (953)
..|.++++|+.|.+.++. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|+.|+|.+|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 357777777777776553 2333566666653 5777777777776 667666 4577777777777776 5666
Q ss_pred ccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccc
Q 043900 95 ELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSI 174 (953)
Q Consensus 95 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 174 (953)
.+..+++|++|+|++|.....+| .++.+++|++|+|++|.....+|..+..+++|+.|++++|.....+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 67777777777777665333555 46677777777777766545667777777777777777654333556544 56666
Q ss_pred eEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeeccc
Q 043900 175 TAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITEN 254 (953)
Q Consensus 175 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n 254 (953)
+.|++++|.....+|.. ..+|+.|++++|.+. .+|..+ .+++|+.|++..+.......
T Consensus 707 ~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~---------------- 764 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWE---------------- 764 (1153)
T ss_pred CEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccc----------------
Confidence 66666666544344421 245555555555554 333332 34444444444322111000
Q ss_pred ccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCc
Q 043900 255 SLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNR 334 (953)
Q Consensus 255 ~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 334 (953)
.+. .++......+++|+.|++++|...+.+|..++++++|+.|++++|.
T Consensus 765 ------------------------------~~~-~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 765 ------------------------------RVQ-PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred ------------------------------ccc-ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 000 0111122233578888888887776788888888888888888875
Q ss_pred ccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCC
Q 043900 335 LSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403 (953)
Q Consensus 335 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 403 (953)
.-+.+|..+ .+++|+.|+|++|.....+|.... .++.|+|++|.++ .+|.++..+++|+.|+|++
T Consensus 814 ~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~--nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 814 NLETLPTGI-NLESLESLDLSGCSRLRTFPDIST--NISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CcCeeCCCC-CccccCEEECCCCCcccccccccc--ccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 444566655 678888888888765444443322 2344555555555 3455555555555555554
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=214.10 Aligned_cols=169 Identities=21% Similarity=0.220 Sum_probs=126.6
Q ss_pred CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 718 RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 718 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
|+|.++++.. ...+++.+++.|+.|++.||+|||+. + ||+||+++.++.+|+ ||.++...
T Consensus 1 GsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVR---------GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 6788888532 23589999999999999999999998 5 999999999999999 99998764
Q ss_pred CCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhcccc
Q 043900 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDST 877 (953)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (953)
... ..||+.|+|||++.+..++.++|||||||++|||+||+.||..................+..
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 125 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------- 125 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC--------
Confidence 321 25889999999999999999999999999999999999998653222111111111110000
Q ss_pred ccCCchhhhhcccchhhhhhhhhHHHHH--HHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 878 LLSDDEDLAVHGNQRQRQARINSKIECL--VAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 878 l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
.. .+ ....... .++.+++.+||+.||++||++.|+++.+..+..
T Consensus 126 ----~~------------~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 126 ----PR------------DR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ----cc------------cc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00 00 0011222 368999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=263.65 Aligned_cols=160 Identities=18% Similarity=0.237 Sum_probs=98.2
Q ss_pred CCccCCCCCCCcEEeCCCCc------cccccCcCccCCC-CCcEEeccCccccccCCcccCCccccceeecccccccccc
Q 043900 44 IPSEFDRLQRLQVLALNNNS------IGGEIPANISSCS-NLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSI 116 (953)
Q Consensus 44 ~~~~~~~l~~L~~L~L~~n~------i~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 116 (953)
.+.+|.++.+|+.|.+..+. +...+|..|..++ +|+.|.+.+|.+. .+|..| ...+|++|++++|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 44567777777777775543 2234566665553 5777777777766 566665 4567777777777776 56
Q ss_pred CCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccccccccccc
Q 043900 117 PSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTL 196 (953)
Q Consensus 117 p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l 196 (953)
+..+..+++|++|+|++|.....+|+ ++.+++|++|+|++|.....+|..+.++.+|+.|++++|.....+|..+ .+
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l 703 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NL 703 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CC
Confidence 66666777777777776553334553 6666777777777665444666666666666666666654333445433 35
Q ss_pred ccccEEEeeCccc
Q 043900 197 QNLQFFSVFENQL 209 (953)
Q Consensus 197 ~~L~~L~L~~N~l 209 (953)
++|+.|++++|..
T Consensus 704 ~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 704 KSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCEEeCCCCCC
Confidence 5555555555543
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=265.54 Aligned_cols=201 Identities=18% Similarity=0.244 Sum_probs=138.6
Q ss_pred hcCC-CCeeEEEeeecccc--cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHh
Q 043900 684 NIRH-RNLVKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH 760 (953)
Q Consensus 684 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 760 (953)
.++| +||++++++|.... ....+..+.+|||+ +++|.+++... ...+++.+++.++.||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---------DRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---------cccccHHHHHHHHHHHHHHHHHHH
Confidence 3445 57888888763321 12234577888988 66999999522 235899999999999999999999
Q ss_pred hCCCCCeEeecCCCCCeEecC-------------------CCcEEEeccccceecCCCCC--------------cccccc
Q 043900 761 HDCQPPITHCDLKPSNVLLDE-------------------EMMAHVSDFGLARFLPLSPA--------------QTSSID 807 (953)
Q Consensus 761 ~~~~~~ivH~Dlkp~NIll~~-------------------~~~~kL~DfG~a~~~~~~~~--------------~~~~~~ 807 (953)
++ ||+||||||+|||++. ++.+|++|||+++....... ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 99 9999999999999954 34566666666653211000 000112
Q ss_pred cccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhh
Q 043900 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAV 887 (953)
Q Consensus 808 ~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 887 (953)
..||+.|||||++.+..++.++|||||||++|||++|..|+.... ...........+..
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~~------------------ 233 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPPQ------------------ 233 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcChh------------------
Confidence 357889999999999999999999999999999999888764210 00000000000000
Q ss_pred cccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 888 HGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.....++..+++.+||+++|.+||+|.|+++
T Consensus 234 -------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 -------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011223457888999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=210.35 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=187.0
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
...+|.+...|+.|+|++.++. +++|+++... ....++|..|.-.++.+.||||.++++.|..+ ....++.
T Consensus 194 l~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~is 266 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIIS 266 (448)
T ss_pred hhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEee
Confidence 3457899999999999998764 7888886432 33346789999999999999999999998654 6789999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe--cc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS--DF 790 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~--Df 790 (953)
.||+.|+|+..++.... ...+..++.++|.++|+|++|||+. .+-|.--.+.+..|++|++.+++|+ |-
T Consensus 267 q~mp~gslynvlhe~t~--------vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTS--------VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred eeccchHHHHHHhcCcc--------EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccc
Confidence 99999999999985443 3567788999999999999999997 3345555789999999999988874 33
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCC---cccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS---INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
-++.. .....-.+.||+||.++..+-+ .++|+|||++++||+.|+..||.+....+..+.-..
T Consensus 338 kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----- 403 (448)
T KOG0195|consen 338 KFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----- 403 (448)
T ss_pred eeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----
Confidence 22221 1122346899999998876543 678999999999999999999986443322111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
+ + .|...++..+..+.++|.-|...||.+||.++.|+-.|+++.
T Consensus 404 ----e----------------g------lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 ----E----------------G------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----c----------------c------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0 0 011111234456889999999999999999999999998763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=224.89 Aligned_cols=168 Identities=23% Similarity=0.133 Sum_probs=131.4
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcC-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhhcCCCCeeE-EEeeecc
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQ-GKTTVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVK-ILTACSG 699 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~ 699 (953)
....++|.+.+.||+|+||+||+|.+.. +++.||||+.... .......+.+|++++++++|+++++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999875 5667899987522 2234567899999999999999985 4432
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC-CCCCeE
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDL-KPSNVL 778 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIl 778 (953)
+..++||||++|++|.... . .. ...++.|+++||+|||+. ||+|||| ||+|||
T Consensus 91 ------~~~~LVmE~~~G~~L~~~~----~----------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NIL 144 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLAR----P----------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWL 144 (365)
T ss_pred ------CCcEEEEEccCCCCHHHhC----c----------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEE
Confidence 3479999999999996321 0 00 146788999999999999 9999999 999999
Q ss_pred ecCCCcEEEeccccceecCCCCCccc------ccccccccccccccccCCC
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTS------SIDAKGSIGYIAPEYGLGS 823 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 823 (953)
++.++.+||+|||+|+.+........ .....+++.|+|||.+...
T Consensus 145 v~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 145 MGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999999998754432221 1345588899999987654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=244.20 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=128.6
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSV 109 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (953)
-..|+|++|+++. +|..+. .+|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 3445555555554 444443 24555555555555 34431 345555555555555 33432 23555556666
Q ss_pred cccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccc
Q 043900 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIP 189 (953)
Q Consensus 110 N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 189 (953)
|+++ .+|..+ ++|+.|++++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+ .+|
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~-~Lp~l---p~~L~~L~Ls~N~L~-~LP 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLA-SLPAL---PSELCKLWAYNNQLT-SLP 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCccc-cCCCC---cccccccccccCccc-ccc
Confidence 6555 334322 34555566666655 3333 2345666666666665 33331 124555566666665 233
Q ss_pred cccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCccccccc
Q 043900 190 LDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCS 269 (953)
Q Consensus 190 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~ 269 (953)
. + ..+|+.|+|++|+|+. +|... .+|+.|++++|+++..+.. +.
T Consensus 339 ~-l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~LP~l---~~------------------------- 382 (788)
T PRK15387 339 T-L---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTSLPAL---PS------------------------- 382 (788)
T ss_pred c-c---ccccceEecCCCccCC-CCCCC---cccceehhhccccccCccc---cc-------------------------
Confidence 2 1 1356666666666663 33322 3455566666666543211 01
Q ss_pred ccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCC
Q 043900 270 LTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNL 349 (953)
Q Consensus 270 l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 349 (953)
.|+.|++++|.+.+ +|.. +++|+.|++++|++++ +|.. ..+|+.|++++|+|+ .+|..|+.+++|
T Consensus 383 -----~L~~LdLs~N~Lt~-LP~l----~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L 447 (788)
T PRK15387 383 -----GLKELIVSGNRLTS-LPVL----PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSE 447 (788)
T ss_pred -----ccceEEecCCcccC-CCCc----ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCC
Confidence 12223333333322 2211 1356666666666663 3432 234566666666666 456666666666
Q ss_pred CeEEeccccccCC
Q 043900 350 RELRLQRNKFLGN 362 (953)
Q Consensus 350 ~~L~L~~N~l~~~ 362 (953)
+.|+|++|+|++.
T Consensus 448 ~~LdLs~N~Ls~~ 460 (788)
T PRK15387 448 TTVNLEGNPLSER 460 (788)
T ss_pred CeEECCCCCCCch
Confidence 6666666666643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=242.83 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=150.5
Q ss_pred CCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEec
Q 043900 52 QRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFL 131 (953)
Q Consensus 52 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 131 (953)
..-..|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 34567888888887 6777665 36788888888877 45542 467777778777777 45543 356777777
Q ss_pred ccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccC
Q 043900 132 TDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG 211 (953)
Q Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 211 (953)
++|.++ .+|..+ ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|+|+.
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l----p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL----PSELCKLWAYNNQLTS 336 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC----cccccccccccCcccc
Confidence 777776 444422 45666777777776 45542 3456666666666663 3321 1245555566666552
Q ss_pred CCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCC
Q 043900 212 AIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLP 291 (953)
Q Consensus 212 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p 291 (953)
+|.. ..+|+.|++++|+|+..++
T Consensus 337 -LP~l---p~~Lq~LdLS~N~Ls~LP~----------------------------------------------------- 359 (788)
T PRK15387 337 -LPTL---PSGLQELSVSDNQLASLPT----------------------------------------------------- 359 (788)
T ss_pred -cccc---ccccceEecCCCccCCCCC-----------------------------------------------------
Confidence 3321 1245555555555543221
Q ss_pred hhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCce
Q 043900 292 ACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLK 371 (953)
Q Consensus 292 ~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 371 (953)
.+.+|+.|++++|+|.. +|.. ..+|+.|+|++|.|++ +|.. .++|+.|++++|+|++ +|..+. .
T Consensus 360 -----lp~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~~--~ 423 (788)
T PRK15387 360 -----LPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLPS--G 423 (788)
T ss_pred -----CCcccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcchh--h
Confidence 11345555666666653 3332 2356666666666663 3432 2456666776666663 443322 2
Q ss_pred eeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCC
Q 043900 372 VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIP 411 (953)
Q Consensus 372 l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 411 (953)
+..|++++|+|+ .+|..++++++|+.|+|++|+|++..|
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence 344555555555 456666666666666666666665433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-22 Score=216.79 Aligned_cols=265 Identities=22% Similarity=0.222 Sum_probs=197.2
Q ss_pred CCcccCcccccceeeEEEEEEcCCC-eEEEEEEeeccchhhHHHHHHHHHHHhhcC----CCCeeEEEeeecccccCCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGK-TTVAVKVFNLLHHGAFKSFIAECNTLKNIR----HRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~~~~~~~~~~ 706 (953)
+|.+.+.||+|+||.||.|.+..++ +.+|+|............+..|..++..+. .+++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999997764 578899886543333336778888888886 368888888732 3456
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC----
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE---- 782 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 782 (953)
..++||+.+ |.+|.++..... .+.++..++..|+.|++.+|+++|+. |++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~--------~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP--------PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC--------CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence 789999988 889999775332 24799999999999999999999999 99999999999999754
Q ss_pred -CcEEEeccccceecC--CCCC----cc-c-ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCccc
Q 043900 783 -MMAHVSDFGLARFLP--LSPA----QT-S-SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFE 853 (953)
Q Consensus 783 -~~~kL~DfG~a~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~ 853 (953)
..+.|.|||+|+.+. .... .. . .....||..|+++.+..+...+.+.|+||++.++.|+..|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 469999999998332 1111 11 1 2235599999999999999999999999999999999999999965332
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
... ............... .....+.++.+++..+-..+..++|....+...+
T Consensus 243 ~~~-~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 243 TDL-KSKFEKDPRKLLTDR---------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cch-HHHHHHHhhhhcccc---------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 211 111111100000000 0001234566666667678999999999999998
Q ss_pred HHHHHHh
Q 043900 934 QSIKNIL 940 (953)
Q Consensus 934 ~~i~~~~ 940 (953)
+......
T Consensus 295 ~~~~~~~ 301 (322)
T KOG1164|consen 295 KDVFDSE 301 (322)
T ss_pred HHHHHhc
Confidence 8876653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=197.44 Aligned_cols=266 Identities=17% Similarity=0.210 Sum_probs=201.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
-.|+++++||+|+||.+|.|+.--++++||||.-...+ ...++..|....+.+ ..+.|..++-| .+.+.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 36999999999999999999998888999999865333 235677788888888 57888888766 44556778
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-----c
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-----M 784 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~ 784 (953)
+|+|.+ |.+|.++..-+. +.++..++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .
T Consensus 101 LVidLL-GPSLEDLFD~Cg---------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCG---------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhh-CcCHHHHHHHhc---------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence 999998 778888885443 3699999999999999999999999 999999999999996443 6
Q ss_pred EEEeccccceecCCCCCcc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 785 AHVSDFGLARFLPLSPAQT-----SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
+.++|||+|+.+....+.. ......||.+||+-....|.+.+.+.|+=|+|-|+...+-|..||.+.... ....
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~ 246 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNKE 246 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chHH
Confidence 8999999999885443221 112344999999999999999999999999999999999999999874322 1111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
++.. +-+..-... ..+-....|.++...+...-..+-.+-|..+-+...+.++.+.
T Consensus 247 kYeK---------IGe~Kr~T~---------------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 247 KYEK---------IGETKRSTP---------------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHH---------hccccccCC---------------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 1111 111000000 0011123456677777777778888999999888888887766
Q ss_pred hc
Q 043900 940 LL 941 (953)
Q Consensus 940 ~~ 941 (953)
..
T Consensus 303 ~g 304 (449)
T KOG1165|consen 303 LG 304 (449)
T ss_pred cC
Confidence 44
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=190.63 Aligned_cols=263 Identities=18% Similarity=0.250 Sum_probs=195.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCC-CCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 707 (953)
....|+++++||.|+||.+|.|.....++.||+|+-+... ....+..|..+.+.+++ ..|..+..+ ..+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 4567999999999999999999999999999999975332 23456778888888864 555555555 344567
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---CCCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD---EEMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 784 (953)
-.+||+.. |.+|.+.+.-+.+ .++..+++-+|-|++.-++|+|.+ +++||||||+|+|+. ....
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R---------~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR---------RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh---------hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence 78999998 8899998865543 589999999999999999999999 999999999999995 3347
Q ss_pred EEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccC--Ccc
Q 043900 785 AHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG--DMN 857 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~--~~~ 857 (953)
+.++|||+|+.+....+. .......||.+|.+-....+...+.+.|+-|+|.++..+--|..||.+.... ...
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 999999999877533221 2223455999999988888888899999999999999999999999875433 222
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
+...........+..+. ...|.++.-.+..|-..--++-|...-+.+.+..+.
T Consensus 233 yEkI~EkK~s~~ie~LC---------------------------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 233 YEKISEKKMSTPIEVLC---------------------------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHHHhhcCCCHHHHh---------------------------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 22222222222111111 023445666777777777777787777777666554
Q ss_pred H
Q 043900 938 N 938 (953)
Q Consensus 938 ~ 938 (953)
.
T Consensus 286 r 286 (341)
T KOG1163|consen 286 R 286 (341)
T ss_pred h
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-23 Score=235.65 Aligned_cols=255 Identities=20% Similarity=0.215 Sum_probs=189.8
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEeec----cc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVFNL----LH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~----~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..+.+|.|++|.|+.+......+.++.|.++. .. ......+..|+.+-..++|||++..+..+... ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence 45789999999999888876665666665531 11 11122366788888888999998887764332 333
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
.-+|||+++ +|..++... ..++..++..++.|+..|++|+|+. |+.|||+|++|++++.+|.+||+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~----------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN----------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred hhhhhcccH-HHHHHHhcc----------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEe
Confidence 334999999 999999522 3578889999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCc--ccccccccccccccccccCCCCCCcc-cchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 789 DFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGSEVSIN-GDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 789 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|||.+..+...... ......+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||......+..+.. ..
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~ 539 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NN 539 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hc
Confidence 99999876544333 55667789999999999999999866 79999999999999999999765444332200 00
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...+ .........-....+.+...++.+|+++||.+|.|+++|++.
T Consensus 540 ~~~~---------------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 540 YSDQ---------------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccc---------------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000 000000111223556778899999999999999999999863
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=230.68 Aligned_cols=118 Identities=26% Similarity=0.505 Sum_probs=60.9
Q ss_pred CCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecc
Q 043900 77 NLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMA 156 (953)
Q Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 156 (953)
+...|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|++++|+++ .+|..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3455555555555 3444433 34555666666655 3444333 35666666666665 3444332 356666666
Q ss_pred cccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCcccc
Q 043900 157 ENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210 (953)
Q Consensus 157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 210 (953)
+|+++ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|+|+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIR 296 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccc
Confidence 66665 4555443 35666666666666 3443322 23444444444443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=229.72 Aligned_cols=180 Identities=24% Similarity=0.460 Sum_probs=88.0
Q ss_pred EEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccC
Q 043900 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFY 85 (953)
Q Consensus 6 ~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~ 85 (953)
.+.|+++++++. .+|..+. ++|+.|+|++|+|+. +|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 445555555554 4555442 345556666665554 343332 35555666666555 4454432 2455555555
Q ss_pred ccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCC
Q 043900 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 86 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
|.+. .+|..+. ++|+.|++++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP 320 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALP 320 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCC
Confidence 5555 4444443 34555555555555 3444433 35555555555555 2333222 24555555555555 334
Q ss_pred CcccccccceEEecCCcccccccccccccccccccEEEeeCcccc
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 210 (953)
..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+|+
T Consensus 321 ~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 321 ETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT 359 (754)
T ss_pred cccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC
Confidence 3322 34555555555554 2333221 34444444444444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-21 Score=190.11 Aligned_cols=183 Identities=13% Similarity=0.146 Sum_probs=136.9
Q ss_pred HHHHHH--hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHH---H------HHHHHHHHhhcCCCCee
Q 043900 623 YQNLYN--ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK---S------FIAECNTLKNIRHRNLV 691 (953)
Q Consensus 623 ~~~~~~--~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~niv 691 (953)
|.++.. ...+|++.+.+|.|+||.||.+... ...+|+|+++........ . +.+|+..+.++.||+|.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~ 98 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA 98 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence 444433 4678999999999999999997663 347999999743322222 2 67999999999999999
Q ss_pred EEEeeeccccc---CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 692 KILTACSGVDY---QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 692 ~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
.+.+++..... ......++||||++|.+|.++.. ++. ....+++.++..+|+. |++
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~---gi~ 157 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQH---GMV 157 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHc---CCc
Confidence 99888543211 12356899999999999988741 222 2456999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt 843 (953)
|||+||+||++++++ ++++|||........... ..+.....+..++|+||||+++..+..
T Consensus 158 H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 158 SGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred cCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999999999988 999999988754321111 013344556789999999999877653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-19 Score=199.90 Aligned_cols=260 Identities=28% Similarity=0.389 Sum_probs=193.6
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh---hHHHHHHHHHHHhhcCCC-CeeEEEeeecccccCCCCce
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG---AFKSFIAECNTLKNIRHR-NLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 708 (953)
|...+.||.|+||.||++.+. ..+|+|.+...... ....+.+|+..++.+.|+ +++++.+++. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 677889999999999999998 57999998643322 467889999999999888 7999999862 23447
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 787 (953)
+++++|+.++++.+++...... ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEE
Confidence 9999999999999776432210 3588899999999999999999999 999999999999999988 7999
Q ss_pred eccccceecCCCCCcc----cccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCcccC--CccH
Q 043900 788 SDFGLARFLPLSPAQT----SSIDAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPVDSMFEG--DMNL 858 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slG~vl~elltg~~pf~~~~~~--~~~~ 858 (953)
+|||.++......... ......|+..|+|||...+ ..++...|+||+|++++++++|..||...... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 9999998664433221 2355679999999999888 57889999999999999999999997643221 0111
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.......... ....... .... ......+.+++..|+..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~--------~~~~~~~------------~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP--------SLASPLS------------PSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc--------ccccccC------------cccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111111000 0000000 0000 1223467789999999999999999887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-21 Score=216.16 Aligned_cols=248 Identities=18% Similarity=0.214 Sum_probs=177.7
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hh---hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HG---AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+|...+.+|++.|=.|.+|+++++. |+||++-... .- ...+...|++ ...++|||++++.-+ ...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence 5777889999999999999999884 9999985333 22 2333344444 455689999998766 334466
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+|-+|... +|.|.+. .++-+...+.+.||.|++.|+..+|.. ||+|||||.+||||+.-.-+.|
T Consensus 96 AylvRqyvkh-nLyDRlS----------TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLS----------TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHHHHHHHhh-hhhhhhc----------cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhh
Confidence 7889999844 9999985 344678889999999999999999999 9999999999999999999999
Q ss_pred eccccceec--CCCCCc---ccccccccccccccccccCCC----------C-CCcccchHHHHHHHHHHHh-CCCCCCC
Q 043900 788 SDFGLARFL--PLSPAQ---TSSIDAKGSIGYIAPEYGLGS----------E-VSINGDVYSYGILLLELVT-RKKPVDS 850 (953)
Q Consensus 788 ~DfG~a~~~--~~~~~~---~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDv~slG~vl~ellt-g~~pf~~ 850 (953)
+||..-+.. +++... ........-.+|.|||.+... . .+++.||||+|||+.|+++ |++||.-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 999876533 221111 111122344579999975431 2 5788999999999999999 7888862
Q ss_pred cccCCccHHHHHHhhCC-ch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 851 MFEGDMNLHNFARMALP-DH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
.+....... .. ....+. ..+ ...+++++..|++.||++|.+|++
T Consensus 242 --------SQL~aYr~~~~~~~e~~Le------------------------~Ie--d~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 242 --------SQLLAYRSGNADDPEQLLE------------------------KIE--DVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred --------HHHHhHhccCccCHHHHHH------------------------hCc--CccHHHHHHHHHccCchhccCHHH
Confidence 111111111 00 000000 000 124788999999999999999999
Q ss_pred HHHHHHH
Q 043900 929 VVRQLQS 935 (953)
Q Consensus 929 vl~~L~~ 935 (953)
.++..+.
T Consensus 288 yL~~yrG 294 (1431)
T KOG1240|consen 288 YLQKYRG 294 (1431)
T ss_pred HHHhhhc
Confidence 9987544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-20 Score=191.48 Aligned_cols=243 Identities=17% Similarity=0.196 Sum_probs=153.1
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCC----------CCeeEEEeeec
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRH----------RNLVKILTACS 698 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~ 698 (953)
.+...+.||.|+++.||.+++.++++.+|+|++.... ....+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456788999999999999999999999999985322 2345666666654444322 12222222211
Q ss_pred cc---c----cCCCC-----ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043900 699 GV---D----YQGND-----FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP 766 (953)
Q Consensus 699 ~~---~----~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 766 (953)
-. . ..+.. ..+++|+-+ .+||.+++........ ....+....++.+..|+++.+++||+. |
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~---~~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ---THSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT---TSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc---ccchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 00 0 00001 236788877 5688888643221111 123456677788899999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCC--------CCCCcccchHHHHHHH
Q 043900 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG--------SEVSINGDVYSYGILL 838 (953)
Q Consensus 767 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slG~vl 838 (953)
++|+||+|+|++++++|.++|+||+.....+.. ... ...+..|.+||.... ..++.+.|.|++|+++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999999999988765321 111 335678999997533 2578899999999999
Q ss_pred HHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccC
Q 043900 839 LELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSME 918 (953)
Q Consensus 839 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 918 (953)
|.|++|+.||+.......... .+. ... +.++.+..++..++++
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~-------------~f~-----------------------~C~-~~Pe~v~~LI~~lL~~ 283 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW-------------DFS-----------------------RCR-DMPEPVQFLIRGLLQR 283 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG-------------GGT-----------------------TSS----HHHHHHHHHHT-S
T ss_pred HHHHHccCCCCCCCccccccc-------------cch-----------------------hcC-CcCHHHHHHHHHHccC
Confidence 999999999985422211000 000 011 5677899999999999
Q ss_pred CCCCC
Q 043900 919 SPGDR 923 (953)
Q Consensus 919 dP~~R 923 (953)
+|++|
T Consensus 284 ~~~~R 288 (288)
T PF14531_consen 284 NPEDR 288 (288)
T ss_dssp SGGGS
T ss_pred CcccC
Confidence 99988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-20 Score=181.23 Aligned_cols=139 Identities=16% Similarity=0.105 Sum_probs=105.9
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchh--h-------H-----------------HHHHHHHHHHhhcCCCC
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG--A-------F-----------------KSFIAECNTLKNIRHRN 689 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~n 689 (953)
...||+|+||.||+|.+. +++.||||+++..... . . .....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 5679999999743211 0 0 12235999999998776
Q ss_pred eeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHH-hhCCCCCeE
Q 043900 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYL-HHDCQPPIT 768 (953)
Q Consensus 690 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iv 768 (953)
+.....+. . ...++||||++++++..... ....++..++..++.|++.+|+|+ |+. ||+
T Consensus 81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred CCCCcEEE----e---cCCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 63322221 1 22389999998877654431 123578899999999999999999 687 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceec
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFL 796 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~ 796 (953)
||||||+||+++ ++.++|+|||+|...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-22 Score=177.99 Aligned_cols=164 Identities=30% Similarity=0.508 Sum_probs=143.4
Q ss_pred cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 23 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
.+.++++++.|-||||+++. .|..+.++.+|++|++++|+|+ .+|.+++.++.|+.|+++-|++. ++|..|+.++-|
T Consensus 28 gLf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 35577888999999999997 6667999999999999999998 89999999999999999999998 899999999999
Q ss_pred ceeecccccccc-ccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCC
Q 043900 103 EHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181 (953)
Q Consensus 103 ~~L~Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 181 (953)
+.|||++|++.. .+|+.|..|+.|+-|+|++|.+. .+|..++.|++|+.|.+..|.+- .+|+.++.++.|++|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 999999998864 57888888999999999999998 78888999999999999999887 7888888888888888888
Q ss_pred ccccccccccc
Q 043900 182 NQLQGVIPLDF 192 (953)
Q Consensus 182 N~l~~~~~~~~ 192 (953)
|+++ .+|.++
T Consensus 183 nrl~-vlppel 192 (264)
T KOG0617|consen 183 NRLT-VLPPEL 192 (264)
T ss_pred ceee-ecChhh
Confidence 8888 555443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=184.66 Aligned_cols=202 Identities=22% Similarity=0.256 Sum_probs=141.7
Q ss_pred CCCCeeEEEeeeccc----------------------ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHH
Q 043900 686 RHRNLVKILTACSGV----------------------DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743 (953)
Q Consensus 686 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~ 743 (953)
+|||||++.++|.+. ....+...|+||..++ .+|.+|+.. ...+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----------~~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----------RHRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----------CCCchH
Confidence 599999999876432 1223456789999985 499999952 345666
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe--cCCC--cEEEeccccceecCCC----CCcccccccccccccc
Q 043900 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL--DEEM--MAHVSDFGLARFLPLS----PAQTSSIDAKGSIGYI 815 (953)
Q Consensus 744 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~DfG~a~~~~~~----~~~~~~~~~~gt~~y~ 815 (953)
...-+..|+++|+.|||.+ ||.|||+|++|||+ |+|+ ...++|||.+--.... +.........|...-|
T Consensus 342 ~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 7788999999999999999 99999999999999 3444 6788999988532211 1112222334777899
Q ss_pred cccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcc
Q 043900 816 APEYGLGSE------VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHG 889 (953)
Q Consensus 816 aPE~~~~~~------~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 889 (953)
|||+....+ -..|+|.|+.|.+.||+++..-||....+...+...+....+
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL----------------------- 475 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL----------------------- 475 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC-----------------------
Confidence 999865432 236799999999999999999999862221111111111100
Q ss_pred cchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 890 NQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
..-+..+++.+.+++...++.||.+||+..-....|
T Consensus 476 --------Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 476 --------PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred --------CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 111225667788999999999999999876555544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-19 Score=171.21 Aligned_cols=190 Identities=18% Similarity=0.081 Sum_probs=139.6
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeeccch----hhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCce
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH----GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.+...|++|+||+||.+... +.+++.+.++.... -....+.+|+++|+++. |+++++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~--~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGG--ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeecC--CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 45678999999999987773 34688777753322 11235789999999995 5889999886 346
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC-CCCCeEecCCCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDL-KPSNVLLDEEMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL 787 (953)
+++|||++|.+|.+... . ....++.|++.+++++|+. ||+|||| ||+||+++.++.++|
T Consensus 74 ~lvmeyI~G~~L~~~~~--------------~---~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPP--------------R---GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred EEEEeeecCccHHhhhh--------------h---hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEE
Confidence 89999999988865431 0 1135778999999999999 9999999 799999999999999
Q ss_pred eccccceecCCCCCc----cc-------ccccccccccccccccCCC-CCC-cccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 788 SDFGLARFLPLSPAQ----TS-------SIDAKGSIGYIAPEYGLGS-EVS-INGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
+|||+|......... .. ......++.|++|+...-- ..+ .+.+.++-|+-+|.++||+.|+.+..++
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 999999865432211 00 0112256777777753221 233 5678899999999999999987654443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=175.18 Aligned_cols=139 Identities=19% Similarity=0.160 Sum_probs=108.5
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchh--------------------------hHHHHHHHHHHHhhcCCCC
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG--------------------------AFKSFIAECNTLKNIRHRN 689 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~n 689 (953)
...||+|++|.||+|++. +++.||||+++..... ....+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 6679999999743211 0122457899999999988
Q ss_pred eeEEEeeecccccCCCCceeEEEeeccCCchhhc-cccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCe
Q 043900 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW-LHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPI 767 (953)
Q Consensus 690 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~i 767 (953)
+.....+.. ...++||||++++++... +. ...++..+...++.|++.++.++|+ . ||
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~---gi 139 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLK-----------DVPLEEEEAEELYEQVVEQMRRLYQEA---GL 139 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhh-----------hccCCHHHHHHHHHHHHHHHHHHHHhC---CE
Confidence 744433311 124899999988755333 21 1246788899999999999999999 8 99
Q ss_pred EeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 768 THCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 768 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
+||||||+||+++ ++.++|+|||+|+...
T Consensus 140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999999998 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-21 Score=171.67 Aligned_cols=161 Identities=27% Similarity=0.499 Sum_probs=151.9
Q ss_pred cEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEecc
Q 043900 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~ 84 (953)
.++.|.|++++++ .+|+.|..|.+|++|++++|+|+. +|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||.
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 4678899999997 999999999999999999999998 8999999999999999999999 999999999999999999
Q ss_pred Ccccc-ccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCC
Q 043900 85 YNELV-GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGT 163 (953)
Q Consensus 85 ~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 163 (953)
+|.+. ..+|..|..++.|+.|+|++|.++ .+|..+++|++|+.|.+.+|.+- ..|..++.|+.|++|++.+|+++ .
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-v 187 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-V 187 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-e
Confidence 99996 578999999999999999999999 89999999999999999999997 79999999999999999999999 7
Q ss_pred CCCccccc
Q 043900 164 IPSSIFNI 171 (953)
Q Consensus 164 ~p~~l~~l 171 (953)
+|..++++
T Consensus 188 lppel~~l 195 (264)
T KOG0617|consen 188 LPPELANL 195 (264)
T ss_pred cChhhhhh
Confidence 77766654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-19 Score=193.98 Aligned_cols=219 Identities=24% Similarity=0.349 Sum_probs=161.7
Q ss_pred HhhcCCCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh
Q 043900 682 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH 761 (953)
Q Consensus 682 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~ 761 (953)
|+.+.|.|+.+++|.|... ...++|.+|+..|+|.+.+.. ....+++.-...+.++|++||+|+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence 4567899999999997643 788999999999999999964 23468999999999999999999998
Q ss_pred CCCCCe-EeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-------CCCcccchHH
Q 043900 762 DCQPPI-THCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-------EVSINGDVYS 833 (953)
Q Consensus 762 ~~~~~i-vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~s 833 (953)
. +| .|+.+++.|.++|....+||+|||+.................-..-|.|||.+.+. ..+.++||||
T Consensus 67 s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 67 S---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred C---cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 7 44 99999999999999999999999999876431111111222245679999998764 1467799999
Q ss_pred HHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhh
Q 043900 834 YGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGV 913 (953)
Q Consensus 834 lG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 913 (953)
||++++|+++.+.||+........ .+.+..... ....... + . .....+..+++..++.
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~r----P---------------~-i~~~~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFR----P---------------S-IELLNELPPELLLLVA 201 (484)
T ss_pred HHHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcC----c---------------c-hhhhhhcchHHHHHHH
Confidence 999999999999999864333221 111111000 0000000 0 0 1111144557999999
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 914 ACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 914 ~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+||..+|++||++++|-..++.+...
T Consensus 202 ~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 202 RCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HhcccChhhCccHHHHHhhhhhhccc
Confidence 99999999999999999998887654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=204.15 Aligned_cols=198 Identities=21% Similarity=0.217 Sum_probs=156.3
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC---CCCeeEEEeeecccccC
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQ 703 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~ 703 (953)
+...+.|.+.+.||+|+||+||+|+..+ ++.||+|+-++... .+|.--.+++.+++ -+.|..+...+ .
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~-----~ 764 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAH-----V 764 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHH-----c
Confidence 3345678899999999999999999988 67999999864332 22222233444444 22333333321 2
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--- 780 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--- 780 (953)
..+.-++|+||.+.|+|.+++. ..+.++|.-++.++.|+++.+++||.. +||||||||+|.|+.
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N----------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN----------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREI 831 (974)
T ss_pred cCCcceeeeeccccccHHHhhc----------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeeccc
Confidence 2355689999999999999996 234689999999999999999999999 999999999999994
Q ss_pred ----CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCC
Q 043900 781 ----EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 846 (953)
Q Consensus 781 ----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~ 846 (953)
+...++|+|||.+..+..-+........++|-.+-.+|+..|++|+.++|-|.++.+++-|+.|+.
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 234799999999987755555556667789999999999999999999999999999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=166.50 Aligned_cols=139 Identities=17% Similarity=0.225 Sum_probs=105.6
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-----CCCCeeEEEeeecccccCCCCc-
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-----RHRNLVKILTACSGVDYQGNDF- 707 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~- 707 (953)
.-.+.||+|+||.||. +..+... +||++........+.+.+|+.+++.+ .||||++++|++.+. ...+.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 3457899999999995 5555534 69988765444567899999999999 579999999997542 11133
Q ss_pred eeEEEee--ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHH-HHHhhCCCCCeEeecCCCCCeEecC---
Q 043900 708 KALVFEF--MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL-SYLHHDCQPPITHCDLKPSNVLLDE--- 781 (953)
Q Consensus 708 ~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~--- 781 (953)
..+|+|| +++|+|.++++.. .+++. ..++.|++.++ +|||++ +|+||||||+||+++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCC
Confidence 3478999 5579999999521 24444 35678888777 999999 9999999999999974
Q ss_pred -CCcEEEeccccc
Q 043900 782 -EMMAHVSDFGLA 793 (953)
Q Consensus 782 -~~~~kL~DfG~a 793 (953)
++.++|+||+.+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 338999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=169.17 Aligned_cols=142 Identities=18% Similarity=0.139 Sum_probs=110.7
Q ss_pred CCcccCcccccceeeEEEEE-EcCCCeEEEEEEeeccchh------------------------hHHHHHHHHHHHhhcC
Q 043900 632 GFASANEIGVGSFGSVYKGI-LDQGKTTVAVKVFNLLHHG------------------------AFKSFIAECNTLKNIR 686 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 686 (953)
.|++.+.||+|+||.||+|. +..+++.||+|+++..... ....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999999 5556779999998743210 1123568999999996
Q ss_pred C--CCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 043900 687 H--RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQ 764 (953)
Q Consensus 687 h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 764 (953)
+ ..+.+++++ ...++||||++++++..+... .......+...++.|++.++++||+.
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~-- 167 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLK----------DVEPEEEEEFELYDDILEEMRKLYKE-- 167 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCcccccccc----------cCCcchHHHHHHHHHHHHHHHHHHhc--
Confidence 5 334455543 234799999999888765421 12345566789999999999999999
Q ss_pred CC-eEeecCCCCCeEecCCCcEEEeccccceec
Q 043900 765 PP-ITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796 (953)
Q Consensus 765 ~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 796 (953)
+ ++||||||+||+++ ++.++|+|||.|...
T Consensus 168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 889999999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=186.45 Aligned_cols=125 Identities=28% Similarity=0.465 Sum_probs=108.7
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
.+.+|.|++|...+|.+|+...... ...++...+.++.|++.|++| + +.+|||+||.||+...+..+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~-------e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG-------EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc-------cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhh
Confidence 4578999999999999999644322 356788899999999999999 5 89999999999999999999
Q ss_pred EEeccccceecCCCC----CcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 043900 786 HVSDFGLARFLPLSP----AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843 (953)
Q Consensus 786 kL~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt 843 (953)
||.|||+........ .....+...||..||+||.+.+..|+.++||||+|++++|+++
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999999998775544 2334456679999999999999999999999999999999997
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.3e-20 Score=200.71 Aligned_cols=59 Identities=19% Similarity=0.312 Sum_probs=31.9
Q ss_pred cCcEEEcccCcccc----cCCccccCCCCCCEEEeecCccccc----CCcCccCC-CCCCeEEecccc
Q 043900 300 TLEMLLLDNNKIFG----NIPAAIGKFVNLQRLEMWNNRLSGT----IPPAIGEL-QNLRELRLQRNK 358 (953)
Q Consensus 300 ~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l-~~L~~L~L~~N~ 358 (953)
.|+.|++++|.++. .....+..+++|+++++++|.++.. ....+... +.|++|++.+|.
T Consensus 251 ~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 251 SLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred CceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 55666666665541 1223344456667777777776633 33333333 566666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-18 Score=186.56 Aligned_cols=187 Identities=27% Similarity=0.265 Sum_probs=150.5
Q ss_pred cccccceeeEEEEEE---cCCCeEEEEEEeeccchh--hHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCceeEE
Q 043900 638 EIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHG--AFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
++|+|+||.|+.+.- .+.+..+|.|+.+..... .......|..++...+ ||.++++... ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 479999999987553 344456888887533221 1124456777888886 9999999766 4556888999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
++|..+|++...+.. ...+++.....+...++-|++++|+. +++|||+|++||+++.+|.+++.|||
T Consensus 76 ld~~rgg~lft~l~~----------~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK----------EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhcccc----------CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCch
Confidence 999999999988853 23567777888888999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
.++..-..... +||..|||||++. ....++|.||||++++||+||..||..
T Consensus 143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99865322211 7999999999987 467889999999999999999999975
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.4e-19 Score=194.97 Aligned_cols=178 Identities=22% Similarity=0.289 Sum_probs=103.0
Q ss_pred EEEeCCCeee-eecCccccCCccCceeecCCCccCcC----CCccCCCCCCCcEEeCCCCccc------cccCcCccCCC
Q 043900 8 ILNLTSLKLA-GSISPHVGNLSFLKVLLLYNNSFNHG----IPSEFDRLQRLQVLALNNNSIG------GEIPANISSCS 76 (953)
Q Consensus 8 ~l~l~~~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~i~------~~~p~~~~~l~ 76 (953)
.|+|..+++. +.....+..+.+|++|++++|.++.. ++..+...+.|++|+++++.+. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3666677665 45555666777788888888877542 4445566677778888777765 12334455666
Q ss_pred CCcEEeccCccccccCCcccCCccc---cceeecccccccc----ccCCcccCC-CcccEEeccccccccc----CCccc
Q 043900 77 NLIQIRLFYNELVGKIPSELGSLSK---IEHLSVSVNNLTG----SIPSSLGNL-SSINTLFLTDNNLDGG----IPDTF 144 (953)
Q Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~L-~~L~~L~L~~N~l~~~----~~~~~ 144 (953)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..|
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 7777777777766444444544444 6777777666652 222334455 6666666666666522 22334
Q ss_pred cccccccceecccccccCC----CCCcccccccceEEecCCcccc
Q 043900 145 GWLKNLATLAMAENWLSGT----IPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 145 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
..+++|++|+|++|.+++. ++..+..+++|++|++++|.++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 4555666666666665521 1222333345555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=160.45 Aligned_cols=134 Identities=19% Similarity=0.236 Sum_probs=107.7
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccch--------hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
+.||+|++|.||+|.+.+ ..|++|+...... .....+.+|++++..+.|+++.....++.. ....
T Consensus 2 ~~l~~G~~~~vy~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF 74 (211)
T ss_pred cccccCceEEEEEEeeCC--CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence 579999999999999843 4688998653221 112457889999999999887666555422 2567
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||++|++|.+++.. ..+ ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++
T Consensus 75 ~lv~e~~~G~~L~~~~~~-------------~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS-------------NGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHh-------------ccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence 899999999999998841 112 7889999999999999999 999999999999999 7889999
Q ss_pred cccccee
Q 043900 789 DFGLARF 795 (953)
Q Consensus 789 DfG~a~~ 795 (953)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=157.22 Aligned_cols=141 Identities=19% Similarity=0.147 Sum_probs=109.5
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh----------------------hHHHHHHHHHHHhhc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG----------------------AFKSFIAECNTLKNI 685 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l 685 (953)
.....|.+.+.||+|+||.||+|... +++.||||+++..... .......|..++.++
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 33334888899999999999999986 4569999987632210 112367788889988
Q ss_pred CCC--CeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC
Q 043900 686 RHR--NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC 763 (953)
Q Consensus 686 ~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 763 (953)
.|+ .+.+.++. ...++||||+++++|...... .....++.+++.++.++|+.
T Consensus 91 ~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~~- 144 (198)
T cd05144 91 YEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYKH- 144 (198)
T ss_pred HHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHHC-
Confidence 777 44444443 345899999999998765420 23467889999999999998
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 764 QPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 764 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
+++||||||+||++++++.++|+|||.+....
T Consensus 145 --gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 --GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.6e-17 Score=183.62 Aligned_cols=212 Identities=23% Similarity=0.264 Sum_probs=145.1
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
....+|..++.|..|+||.||.++++.+.+.+|.|+=+... ++ .||..+. +.
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------------il-----Rnilt~a-----------~n 131 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------------IL-----RNILTFA-----------GN 131 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccccch------------hh-----hcccccc-----------CC
Confidence 34568999999999999999999999998899996532110 11 1122222 12
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++| ||-...++... .++. +++.+++|+|+. ||+|||+||+|.+|+.-|.+|+
T Consensus 132 pfvv------gDc~tllk~~g----------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKl 184 (1205)
T KOG0606|consen 132 PFVV------GDCATLLKNIG----------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKL 184 (1205)
T ss_pred ccee------chhhhhcccCC----------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccc
Confidence 2333 44444443211 2222 227899999999 9999999999999999999999
Q ss_pred eccccceecCCCC-------------CcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 788 SDFGLARFLPLSP-------------AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 788 ~DfG~a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
.|||+++..-... ........+||+.|+|||++....|+..+|.|++|+++||.+.|+.||.+...+
T Consensus 185 TDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 185 TDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred cchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 9999987532111 111223457999999999999999999999999999999999999999763222
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 924 (953)
+ .+.+.+...+ .+ .++.+..+++..+++.+.++.+|..|-
T Consensus 265 e-lfg~visd~i-----~w------------------------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 265 E-LFGQVISDDI-----EW------------------------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred H-HHhhhhhhhc-----cc------------------------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 1111111110 00 001113356788899999999999994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=175.82 Aligned_cols=144 Identities=19% Similarity=0.221 Sum_probs=112.4
Q ss_pred HHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEe--eccc------hhhHHHHHHHHHHHhhcCCCCeeEEE
Q 043900 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVF--NLLH------HGAFKSFIAECNTLKNIRHRNLVKIL 694 (953)
Q Consensus 623 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~--~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~ 694 (953)
+.........|...+.||+|+||+||+|.+.... +++|+. +... ....+.+.+|++++++++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3333344455677899999999999999987654 444432 2111 11235688999999999999988876
Q ss_pred eeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
.++.. ....++||||+++++|.+++. ....++.++++++.|||+. +++|||+||
T Consensus 403 ~~~~~-----~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp 456 (535)
T PRK09605 403 IYDVD-----PEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTT 456 (535)
T ss_pred EEEEe-----CCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhC---CCccCCCCh
Confidence 66432 245689999999999998873 3567999999999999999 999999999
Q ss_pred CCeEecCCCcEEEecccccee
Q 043900 775 SNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~ 795 (953)
+||++ .++.++|+|||+++.
T Consensus 457 ~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 457 SNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHEEE-ECCcEEEEeCccccc
Confidence 99999 677899999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=153.14 Aligned_cols=130 Identities=19% Similarity=0.230 Sum_probs=100.8
Q ss_pred cccccceeeEEEEEEcCCCeEEEEEEeeccc---h-----hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---H-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.||+|+||.||+|.+.+ ..|++|+..... . ....++.+|++++..++|+++.....++. .....+
T Consensus 1 ~ig~G~~~~vy~~~~~~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeecCC--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 48999999999999644 479999864221 1 12356778999999998876543333322 124568
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++|++|.+++... . ..++.+++.+|.++|+. +++|||++|+||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~~-----------~------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG-----------N------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhhc-----------H------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence 999999999999887310 0 07899999999999999 999999999999999 78999999
Q ss_pred ccccee
Q 043900 790 FGLARF 795 (953)
Q Consensus 790 fG~a~~ 795 (953)
||.+..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=145.95 Aligned_cols=135 Identities=21% Similarity=0.224 Sum_probs=97.0
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchh--hHHH----------------------HHHHHHHHhhcCCC--C
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG--AFKS----------------------FIAECNTLKNIRHR--N 689 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--n 689 (953)
.+.||+|+||+||+|.+. +++.||||+++..... .... ...|...+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 5568999998643211 1111 13455666666433 2
Q ss_pred eeEEEeeecccccCCCCceeEEEeeccCCchhhc-cccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCe
Q 043900 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW-LHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPI 767 (953)
Q Consensus 690 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~i 767 (953)
+.+.+++ ...++||||++++++... +... ... .+...++.+++.++.++|. . +|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-----------~~~-~~~~~~~~~~~~~l~~lh~~~---~i 136 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-----------RLL-EDPEELYDQILELMRKLYREA---GL 136 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh-----------hhc-ccHHHHHHHHHHHHHHHhhcc---Cc
Confidence 4444443 345899999998654321 1100 001 5678899999999999999 7 99
Q ss_pred EeecCCCCCeEecCCCcEEEeccccceec
Q 043900 768 THCDLKPSNVLLDEEMMAHVSDFGLARFL 796 (953)
Q Consensus 768 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 796 (953)
+||||||+||+++ ++.++++|||.+...
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-16 Score=180.75 Aligned_cols=257 Identities=24% Similarity=0.235 Sum_probs=190.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-GKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 705 (953)
...|...+.||+|+|+.|-.+.... ....+|+|.+.... .........|..+-+.+. |+|++++++. ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 3457788889999999999888743 33457777765332 223344455777777776 9999999987 5566
Q ss_pred CceeEEEeeccCCchhhccc-cCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeecCCCCCeEecCCC
Q 043900 706 DFKALVFEFMQNRSLEEWLH-PITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
+..++++||..++++.+.+. ... ...+......+..|+..++.|+| .. +++|||+||+|.+++..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~---------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDS---------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESG 161 (601)
T ss_pred cccccccCcccccccccccccCCc---------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCC
Confidence 88999999999999998883 211 13455566788999999999999 77 999999999999999999
Q ss_pred -cEEEeccccceecCC-CCCccccccccc-ccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 784 -MAHVSDFGLARFLPL-SPAQTSSIDAKG-SIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 784 -~~kL~DfG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
..+++|||+|..+.. ...........| ++.|+|||...+. -..+..|+||.|+++.-+++|..||+.....+..+.
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~ 241 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS 241 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce
Confidence 999999999998876 555555566678 9999999998884 456789999999999999999999986555443333
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.|........ . ...........++...++..+|..|.+.+++..
T Consensus 242 ~~~~~~~~~~--------~--------------------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 242 SWKSNKGRFT--------Q--------------------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eecccccccc--------c--------------------CccccCChhhhhcccccccCCchhccccccccc
Confidence 3332210000 0 000012234567788888899999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=138.22 Aligned_cols=135 Identities=20% Similarity=0.244 Sum_probs=110.9
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCC--CCeeEEEeeecccccCCCCceeEEE
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.+.||+|.++.||++...+ ..+++|..+.... ...+.+|+..++.++| ..+++++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 35789999999999999866 4799999865433 4678899999999976 5888888774 2336789999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||++++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988766543 3456678899999999999986445799999999999999989999999999
Q ss_pred cee
Q 043900 793 ARF 795 (953)
Q Consensus 793 a~~ 795 (953)
++.
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.1e-16 Score=165.36 Aligned_cols=176 Identities=34% Similarity=0.478 Sum_probs=124.3
Q ss_pred CEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCc
Q 043900 326 QRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNN 405 (953)
Q Consensus 326 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 405 (953)
...||+.|++. .+|..++.+..|..+.|..|.|. .+|..++++..|++|||+.|+
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r------------------------~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR------------------------TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce------------------------ecchhhhhhhHHHHhhhccch
Confidence 34455555554 45555555555555555555444 567777777777777777777
Q ss_pred cCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCc
Q 043900 406 LTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPS 485 (953)
Q Consensus 406 l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 485 (953)
++ .+|..+|.+. |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.
T Consensus 133 lS-~lp~~lC~lp--Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP--LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred hh-cCChhhhcCc--ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 77 7777776665 446777777777 67777777778888888888887 67777888888888888888887 4666
Q ss_pred cccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCC
Q 043900 486 SLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIE 534 (953)
Q Consensus 486 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 534 (953)
.+..| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|+|..++...
T Consensus 207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqI 253 (722)
T KOG0532|consen 207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQI 253 (722)
T ss_pred HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHH
Confidence 67744 5778888888887 67888888888888888888887655443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-14 Score=170.06 Aligned_cols=119 Identities=34% Similarity=0.520 Sum_probs=96.3
Q ss_pred ccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEecc
Q 043900 444 NLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLS 523 (953)
Q Consensus 444 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~ 523 (953)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|+.+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37788888888888888888888889999999998888888888888889999999999988888888888889999999
Q ss_pred CCcCcccCCCCC--cccccccccccCCcCCCCCCCCCCCCcccc
Q 043900 524 NNNLEGMVPIEG--VFKNATITSVLGNLKLCGGIPEFQLPTCIS 565 (953)
Q Consensus 524 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~lcg~~~~~~~~~c~~ 565 (953)
+|+++|.+|..- .+.......+.+|+.+||.+. .+.|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCcc
Confidence 999888888641 122334567889999998543 356753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=141.96 Aligned_cols=139 Identities=17% Similarity=0.127 Sum_probs=103.5
Q ss_pred cCccc-ccceeeEEEEEEcCCCeEEEEEEeeccc-------------hhhHHHHHHHHHHHhhcCCCCe--eEEEeeecc
Q 043900 636 ANEIG-VGSFGSVYKGILDQGKTTVAVKVFNLLH-------------HGAFKSFIAECNTLKNIRHRNL--VKILTACSG 699 (953)
Q Consensus 636 ~~~ig-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~ 699 (953)
...|| .|+.|+||.+...+ ..+|||.+.... ......+.+|++++.++.|+++ ++.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~--~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPG--VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeCC--ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 88999999988863 468999885211 1223567889999999988774 666666432
Q ss_pred cccCCCCceeEEEeeccC-CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 700 VDYQGNDFKALVFEFMQN-RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
. .......++||||+++ .+|.+++.. ..++.. .+.+++.++.+||+. ||+||||||+|||
T Consensus 114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NIL 174 (239)
T PRK01723 114 R-HGLFYRADILIERIEGARDLVALLQE-----------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNIL 174 (239)
T ss_pred e-cCcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEE
Confidence 1 1111234699999997 689888742 123332 357899999999999 9999999999999
Q ss_pred ecCCCcEEEecccccee
Q 043900 779 LDEEMMAHVSDFGLARF 795 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~ 795 (953)
++.++.++|+|||.++.
T Consensus 175 v~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 175 LDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EcCCCCEEEEECCCccc
Confidence 99989999999999875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-15 Score=162.47 Aligned_cols=198 Identities=22% Similarity=0.365 Sum_probs=164.8
Q ss_pred eeecCCCccCcCCCccC-CCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 32 VLLLYNNSFNHGIPSEF-DRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 32 ~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
+|.|++-++....-.++ ..+..-+..||+.|++. ++|..+..+..|+.+.|++|.+. .+|..++++..|.+|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 47777777776332333 45666778899999988 88988888888999999999988 88888999999999999999
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPL 190 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 190 (953)
+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..|+.+.|.|. .+|..+.++.+|+.|.++.|++. .+|.
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 998 7787777764 889999999998 88888888889999999999998 78888899999999999999988 5666
Q ss_pred ccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC
Q 043900 191 DFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239 (953)
Q Consensus 191 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (953)
++. --.|..||++.|++. .+|-.|.+|++|++|-|++|.|...+..
T Consensus 207 El~--~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 207 ELC--SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred HHh--CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 664 346888999999999 7899999999999999999999865543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=156.07 Aligned_cols=200 Identities=30% Similarity=0.431 Sum_probs=159.7
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCC-CCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQ-RLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
.+++..+.+. .....+..++.++.|++.+|.++. +|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 3566666653 334455666888999999999997 666677774 8999999999998 77788899999999999999
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+..++++..|.+.+|++. ..+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 998 67777668889999999999998 77766667777999999999654 57777888999999999999987 5578
Q ss_pred cccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCC
Q 043900 167 SIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAI 217 (953)
Q Consensus 167 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 217 (953)
.+..+++++.|++++|+++.. +. ...+.+++.|++++|.+....+...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i-~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSI-SS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hhccccccceecccccccccc-cc--ccccCccCEEeccCccccccchhhh
Confidence 888888899999999999843 33 3378899999999998886555443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=154.53 Aligned_cols=198 Identities=29% Similarity=0.465 Sum_probs=150.3
Q ss_pred eeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCC-CCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 32 VLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCS-NLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 32 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 57888888754 4555667788888888888888 7787777775 8888888888887 66677888888888888888
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPL 190 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 190 (953)
+++ .+|...+.+++|+.|++++|++. .+|.....+..|++|.+++|++. ..+..+.++.++..+.+.+|++.. ++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 888 66666667888888888888887 67776666777888888888654 566777888888888888888773 233
Q ss_pred ccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC
Q 043900 191 DFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239 (953)
Q Consensus 191 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (953)
.+. .+++++.|++++|+++.. +. ++.+.+++.|++++|.+...++.
T Consensus 250 ~~~-~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIG-NLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhc-cccccceecccccccccc-cc-ccccCccCEEeccCccccccchh
Confidence 332 667788888888888733 33 77888888888888887766543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.1e-13 Score=135.49 Aligned_cols=162 Identities=22% Similarity=0.359 Sum_probs=123.7
Q ss_pred HHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHH
Q 043900 679 CNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY 758 (953)
Q Consensus 679 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 758 (953)
...+-.+.|.|++++..|+.+..+.+.....+++|||..|++..++++..+. ...+......+|+-||..||.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~------~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN------QKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh------hhhhhHHHHHHHHHHHHhhhhh
Confidence 4445566799999999997766565667788999999999999999865543 4568888899999999999999
Q ss_pred HhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCC--CCCcccccccccccccccccccCCCCCCcccchHHHHH
Q 043900 759 LHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL--SPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGI 836 (953)
Q Consensus 759 LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~ 836 (953)
||+. .|.|+|+++..+-|++..+|-+|++--.-...... ...........+-++|.|||.-.....+.++|||+||+
T Consensus 192 Lhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 192 LHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 9984 88999999999999999999888753211111100 00011111223678999999866667788999999999
Q ss_pred HHHHHHhCCCC
Q 043900 837 LLLELVTRKKP 847 (953)
Q Consensus 837 vl~elltg~~p 847 (953)
...||..+..-
T Consensus 271 cAlemailEiq 281 (458)
T KOG1266|consen 271 CALEMAILEIQ 281 (458)
T ss_pred HHHHHHHheec
Confidence 99999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.1e-12 Score=142.98 Aligned_cols=142 Identities=20% Similarity=0.241 Sum_probs=99.6
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhH----------------------------------------HHH
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF----------------------------------------KSF 675 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 675 (953)
.+.||.|++|.||+|+.+++ +.||||+.++...... -++
T Consensus 122 ~~plasaSigQVh~A~l~~G-~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDG-KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecCC-CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999999865 5999999864321110 124
Q ss_pred HHHHHHHhhc----CCCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHH
Q 043900 676 IAECNTLKNI----RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751 (953)
Q Consensus 676 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ 751 (953)
.+|+..+.++ +|..-+.+-.++. ......++||||++|++|.++...... .. .+.+++.+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~~---------~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDEA---------GL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHhc---------CC---CHHHHHHH
Confidence 5566666555 2333333333332 122457899999999999887642110 11 23456777
Q ss_pred HHH-HHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 752 VAC-ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 752 i~~-~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
++. .+..+|.. |++|+|++|.||++++++.++++|||++..+.
T Consensus 265 ~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 666 46788988 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.5e-12 Score=141.42 Aligned_cols=199 Identities=26% Similarity=0.290 Sum_probs=155.0
Q ss_pred CCcccCcccc--cceeeEEEEEE--cCCCeEEEEEEee--ccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 632 GFASANEIGV--GSFGSVYKGIL--DQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 632 ~~~~~~~ig~--G~~g~Vy~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
.|.+.+.+|. |.+|.||.+.. ..+...+|+|.-+ .........-.+|+..-+++ .|++.++.... +.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4566788999 99999999998 7777889999854 22223334455677777777 59999986555 666
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHH----HHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC----ALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
.+..++-+|++ +.++.++.+... ..++....+.+..+... |+.++|.. +++|-|+||+||+..
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~---------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC---------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTT 256 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc---------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecc
Confidence 78899999988 578888875322 24667777888888888 99999999 999999999999999
Q ss_pred CC-CcEEEeccccceecCCCCCccc---ccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 043900 781 EE-MMAHVSDFGLARFLPLSPAQTS---SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 781 ~~-~~~kL~DfG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~ 849 (953)
.+ ...+++|||+...+........ .....|...|++||... ..++.++||||+|.|+.+..+|..++.
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 98 8999999999988865442211 12225788899999864 467889999999999999999877654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.3e-12 Score=149.68 Aligned_cols=112 Identities=35% Similarity=0.606 Sum_probs=103.9
Q ss_pred ceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCC
Q 043900 421 LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQ 500 (953)
Q Consensus 421 l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 500 (953)
+..|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCcccccc-ccCceEeccCCcCcccCC
Q 043900 501 NNLSGKIPEFLVGF-QLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 501 N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p 532 (953)
|+++|.+|..+..+ .++..+++++|+..+..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999988764 467889999998655444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=137.77 Aligned_cols=149 Identities=17% Similarity=0.149 Sum_probs=96.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhh----------------------------------H----
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA----------------------------------F---- 672 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~---- 672 (953)
..|+. +.||+|++|.||+|+.+++++.||||+.++.-... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 78999999999999999867799999996432110 0
Q ss_pred --HHHHHHHHHHhhcC----CCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHH
Q 043900 673 --KSFIAECNTLKNIR----HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746 (953)
Q Consensus 673 --~~~~~e~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~ 746 (953)
-++.+|+..+.+++ +...+.+-.++ ++-....++||||++|+.+.++-.-.... .....+....+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~~~la~~~v~ 270 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAAG----TDMKLLAERGVE 270 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhcC----CCHHHHHHHHHH
Confidence 12445555555552 33333333332 12235678999999999998743110000 001123333334
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC----cEEEeccccceecCC
Q 043900 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM----MAHVSDFGLARFLPL 798 (953)
Q Consensus 747 ~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a~~~~~ 798 (953)
.++.|+. .. |++|+|+||.||+++.++ .++++|||++..++.
T Consensus 271 ~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4444443 35 999999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-10 Score=114.11 Aligned_cols=138 Identities=20% Similarity=0.146 Sum_probs=99.8
Q ss_pred cCcccccceeeEEEEEEcC------CCeEEEEEEeeccc----------------------hhhHHHHH----HHHHHHh
Q 043900 636 ANEIGVGSFGSVYKGILDQ------GKTTVAVKVFNLLH----------------------HGAFKSFI----AECNTLK 683 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~ 683 (953)
...||.|.-+.||.|...+ .+..+|||+++... ....+.+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998764 24689999985210 01122333 8999999
Q ss_pred hcC--CCCeeEEEeeecccccCCCCceeEEEeeccCCchhh-ccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHH-
Q 043900 684 NIR--HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEE-WLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYL- 759 (953)
Q Consensus 684 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L- 759 (953)
++. .-++.+.+++ ..-++||||+.++.+.. .++ ...++..+...+..+++.+|..+
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHH
Confidence 984 3566666665 45689999997654321 121 11244456677889999999999
Q ss_pred hhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 760 HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 760 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
|+. |+||||+++.||+++ ++.+.++|||.|....
T Consensus 142 H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 787 999999999999997 4679999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.1e-11 Score=131.42 Aligned_cols=170 Identities=22% Similarity=0.193 Sum_probs=128.6
Q ss_pred EEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCC
Q 043900 649 KGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPIT 728 (953)
Q Consensus 649 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 728 (953)
.|..+.++.+|.|..++...........+.++.++.++||+|+++++. +...+..|+|+|.+. .|..+++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk--- 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLK--- 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHH---
Confidence 466666777899999886655555667788999999999999999988 445578999999983 5666664
Q ss_pred cCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCccccccc
Q 043900 729 REDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808 (953)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~ 808 (953)
.++...+.-.+.||+.||.|||+.| +++|++|..+.|+|++.|..||++|.++........ .....
T Consensus 100 ----------~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~ 165 (690)
T KOG1243|consen 100 ----------ELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL 165 (690)
T ss_pred ----------HhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence 3445667778999999999998653 899999999999999999999999998875432111 11111
Q ss_pred ccccccccccccCCCCCCcccchHHHHHHHHHHHhC
Q 043900 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 844 (953)
Q Consensus 809 ~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg 844 (953)
.--..|..|+.+.... -..|.|.|||++||++.|
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1223466676543322 346999999999999999
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.3e-12 Score=120.81 Aligned_cols=56 Identities=27% Similarity=0.390 Sum_probs=7.9
Q ss_pred CceeecCCCccCcCCCccCC-CCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcccc
Q 043900 30 LKVLLLYNNSFNHGIPSEFD-RLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~ 89 (953)
+++|+|++|+|+.+ +.++ .+.+|++|||++|+|+ .++ .+..+++|+.|++++|+|+
T Consensus 21 ~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 21 LRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred cccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 44444444444431 1232 2344444444444444 222 2333344444444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.4e-12 Score=119.94 Aligned_cols=136 Identities=25% Similarity=0.426 Sum_probs=52.7
Q ss_pred cCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCcc-CCCCCcEEeccCccccccCCcccCCccccceeeccccccc
Q 043900 35 LYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANIS-SCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT 113 (953)
Q Consensus 35 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (953)
|..+.|+. . ..+.+..++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+ .++ .+..+++|++|++++|+|+
T Consensus 4 lt~~~i~~-~-~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIEQ-I-AQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred cccccccc-c-cccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 45566664 2 34667778999999999998 554 465 6889999999999998 443 6888999999999999999
Q ss_pred cccCCcc-cCCCcccEEecccccccccC-CccccccccccceecccccccCCCCC----cccccccceEEe
Q 043900 114 GSIPSSL-GNLSSINTLFLTDNNLDGGI-PDTFGWLKNLATLAMAENWLSGTIPS----SIFNISSITAFD 178 (953)
Q Consensus 114 ~~~p~~~-~~L~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~ 178 (953)
.+++.+ ..+++|+.|+|++|+|.... -..+..+++|+.|+|.+|.++ ..+. .+..+++|+.||
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence 454445 46899999999999997422 256788999999999999998 3444 266889999987
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3e-12 Score=126.62 Aligned_cols=210 Identities=20% Similarity=0.200 Sum_probs=128.9
Q ss_pred cCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc-ccccCCcccCC
Q 043900 20 ISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE-LVGKIPSELGS 98 (953)
Q Consensus 20 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~ 98 (953)
+|-.+.-+++|+.+..|+|.-..+ -.-...=+.|+++...+..++ ..| ++-....+..+.-+.-. .+|..-..+..
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~-~~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQ-DVP-SLLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeeccccc-ccc-cccchhhhcCccCCCCCccCCceEEecch
Confidence 333455566677777777655442 111122245666666555554 222 12222233222222111 12222333444
Q ss_pred ccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEe
Q 043900 99 LSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFD 178 (953)
Q Consensus 99 l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 178 (953)
-.-|++||||+|.|+ .+.++..-+++++.|++|+|.|.. +. .+..|++|+.|+|++|.++ .+...-.++.+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 556778888888887 666777777888888888888763 22 3777888888888888877 5555556677788888
Q ss_pred cCCcccccccccccccccccccEEEeeCccccCC-CCCCCcCCCCCcEEEcccccccCcCCC
Q 043900 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGA-IPPAISNASNLELFQADVNKLTGEVPY 239 (953)
Q Consensus 179 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (953)
|+.|.|...-. + ..+-+|.+|++++|+|... ....+++++-|+.+.|.+|.+.+.+.+
T Consensus 359 La~N~iE~LSG--L-~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 359 LAQNKIETLSG--L-RKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hhhhhHhhhhh--h-HhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 88887763221 1 1566777888888887632 245788888899998888888877654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-12 Score=146.25 Aligned_cols=197 Identities=24% Similarity=0.315 Sum_probs=89.0
Q ss_pred CCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEE
Q 043900 50 RLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTL 129 (953)
Q Consensus 50 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L 129 (953)
.+..+..++++.|.|. .+-..+..+.+|+.|++.+|.|. .+...+..+.+|++|++++|+|+.. . .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i-~-~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL-E-GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc-c-chhhccchhhh
Confidence 4444555555555554 33334555555555555555554 2222245555555555555555522 1 34445555555
Q ss_pred ecccccccccCCccccccccccceecccccccCCCCCc-ccccccceEEecCCcccccccccccccccccccEEEeeCcc
Q 043900 130 FLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSS-IFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQ 208 (953)
Q Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 208 (953)
++++|.|+ . ...|..+++|+.+++++|++....+ . +..+.+++.+++++|.+....... .+..+..+++.+|.
T Consensus 146 ~l~~N~i~-~-~~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i~~~~---~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 146 NLSGNLIS-D-ISGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIREIEGLD---LLKKLVLLSLLDNK 219 (414)
T ss_pred eeccCcch-h-ccCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhcccchH---HHHHHHHhhccccc
Confidence 55555554 1 1224445555555555555552222 1 344455555555555554222222 22333333555555
Q ss_pred ccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeeccccc
Q 043900 209 LTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSL 256 (953)
Q Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l 256 (953)
++...+-....+.+|+.+++++|.+...+..+..+..+..+++.+|.+
T Consensus 220 i~~~~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 220 ISKLEGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred ceeccCcccchhHHHHHHhcccCccccccccccccccccccchhhccc
Confidence 542221111111125555555555554333333334444444444433
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-10 Score=115.03 Aligned_cols=131 Identities=18% Similarity=0.123 Sum_probs=95.0
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCe-eEEEeeecccccCCCCceeEEEee
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+..+ .+++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 357899999999999976 34799999754322 22346789999988865444 3454442 1235799999
Q ss_pred ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC--QPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 715 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
++|.++.+.- . ....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.
T Consensus 73 i~G~~l~~~~---------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTED---------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCcccccc---------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9998775431 0 11245678999999999982 22369999999999999 66899999998
Q ss_pred cee
Q 043900 793 ARF 795 (953)
Q Consensus 793 a~~ 795 (953)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.8e-12 Score=141.78 Aligned_cols=221 Identities=24% Similarity=0.284 Sum_probs=169.5
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.+..++.++++.|.|.. +-..+..+++|+.|++.+|+|+ .+...+..+.+|++|+|++|.|+.+. .+..+..|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 56778888899999987 4556889999999999999998 66666889999999999999998443 46777889999
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
++++|.|+ .++ .+..+.+|+.+++++|++..+.++....+.+|+.+++++|.+.. ...+..+..+..+++..|.++
T Consensus 146 ~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 146 NLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eeccCcch-hcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence 99999998 444 67779999999999999985544115889999999999999962 344556667777799999998
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccC
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLG 257 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~ 257 (953)
..-+.... .+.+|+.+++++|++. ..+..+..+.++..|++..|++.... .+.....+..+....|.+.
T Consensus 222 ~~~~l~~~-~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~-~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 222 KLEGLNEL-VMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE-GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred eccCcccc-hhHHHHHHhcccCccc-cccccccccccccccchhhccccccc-cccccchHHHhccCcchhc
Confidence 55443321 1113899999999998 44477888999999999999988543 2333444555555555543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.8e-10 Score=114.90 Aligned_cols=278 Identities=14% Similarity=0.117 Sum_probs=172.5
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc--cccCCCCceeE
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSG--VDYQGNDFKAL 710 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~l 710 (953)
...+.+|+|+.+.+|-.-.-.+ .+.|++.........+ .++.|... .||-+..-+.+=-. ..........+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3467899999999997554333 4568876443332222 22333333 56654432222000 00112223567
Q ss_pred EEeeccCC-chhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 711 VFEFMQNR-SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 711 v~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
.|+.+++. ....+.....+. ..-....|.-.+++++.++.+.+.||.. |.+-+|+.++|+||++++.|.|+|
T Consensus 88 lmP~v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 78877664 233333222211 2334678999999999999999999999 999999999999999999999998
Q ss_pred cccceecCCCCCccccccccccccccccccc-----CCCCCCcccchHHHHHHHHHHHhC-CCCCCCcccCCc---cHH-
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYG-----LGSEVSINGDVYSYGILLLELVTR-KKPVDSMFEGDM---NLH- 859 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slG~vl~elltg-~~pf~~~~~~~~---~~~- 859 (953)
-..-... .........+|...|.+||.- .+...+...|-|.+|+++++++.| ++||.+...... .++
T Consensus 161 sDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 6654443 222233345689999999963 344567889999999999999996 999987432211 111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMES--PGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~evl~~L~~i~ 937 (953)
..+...+.. .. + ......+..+..-..-.++.+..+..+|+... |.-|||++..+..|.+++
T Consensus 238 ~Ia~g~f~y------------a~-~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 238 DIAHGRFAY------------AS-D---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hhhcceeee------------ch-h---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 111111000 00 0 00001111111222344667888888998653 458999999999999998
Q ss_pred HHhccc
Q 043900 938 NILLGH 943 (953)
Q Consensus 938 ~~~~~~ 943 (953)
+.+..+
T Consensus 302 ~~L~~C 307 (637)
T COG4248 302 QQLKKC 307 (637)
T ss_pred Hhhhhh
Confidence 877655
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.7e-12 Score=125.20 Aligned_cols=133 Identities=23% Similarity=0.254 Sum_probs=77.0
Q ss_pred cCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcc
Q 043900 47 EFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126 (953)
Q Consensus 47 ~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L 126 (953)
.....+.|++||||+|.|+ .+..+..-++.++.|++++|.|.. + +.+..|++|+.||||+|.++ .+.++=-.|-+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444556666666666666 555555556666666666666652 2 22566666666666666665 444454555666
Q ss_pred cEEecccccccccCCccccccccccceecccccccCCC-CCcccccccceEEecCCcccc
Q 043900 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTI-PSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 127 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 185 (953)
++|.|++|.|. .-.+++.|-+|.+|++++|+|.... -..+++++.|+++.|.+|.+.
T Consensus 355 KtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 355 KTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred eeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 66666666664 1223555566666666666665211 234566666666666666665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.1e-12 Score=130.82 Aligned_cols=162 Identities=18% Similarity=0.137 Sum_probs=80.8
Q ss_pred ccccCCccCceeecCCCccCcCCC--ccCCCCCCCcEEeCCCCcccccc--CcCccCCCCCcEEeccCccccccCCcc-c
Q 043900 22 PHVGNLSFLKVLLLYNNSFNHGIP--SEFDRLQRLQVLALNNNSIGGEI--PANISSCSNLIQIRLFYNELVGKIPSE-L 96 (953)
Q Consensus 22 ~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~i~~~~--p~~~~~l~~L~~L~L~~n~l~~~~~~~-~ 96 (953)
.-=.+++.|++..|.++.... .+ .....|++++.||||+|-+..-. -.-...+++|+.|+|+.|++..-..+. -
T Consensus 115 akQsn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~ 193 (505)
T KOG3207|consen 115 AKQSNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT 193 (505)
T ss_pred HHhhhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch
Confidence 333456666677777666664 22 24455666666666666655211 122345666666666666664111111 1
Q ss_pred CCccccceeecccccccccc-CCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCC--Cccccccc
Q 043900 97 GSLSKIEHLSVSVNNLTGSI-PSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP--SSIFNISS 173 (953)
Q Consensus 97 ~~l~~L~~L~Ls~N~l~~~~-p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~ 173 (953)
..+++|+.|.|+.|.++... -..+..+++|+.|+|..|..-.+......-+..|++|+|++|.+- ..+ ...+.++.
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPG 272 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccc
Confidence 24455555566555554211 111234455555566555322233334444555555555555554 222 23444555
Q ss_pred ceEEecCCcccc
Q 043900 174 ITAFDAGMNQLQ 185 (953)
Q Consensus 174 L~~L~L~~N~l~ 185 (953)
|+.|+++.+.|.
T Consensus 273 L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 273 LNQLNLSSTGIA 284 (505)
T ss_pred hhhhhccccCcc
Confidence 555555555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.8e-12 Score=130.33 Aligned_cols=243 Identities=18% Similarity=0.239 Sum_probs=121.7
Q ss_pred CcEEEEEeCCCeeee----ecCccccCCccCceeecCCCcc---CcCCCc-------cCCCCCCCcEEeCCCCccccccC
Q 043900 4 QRVKILNLTSLKLAG----SISPHVGNLSFLKVLLLYNNSF---NHGIPS-------EFDRLQRLQVLALNNNSIGGEIP 69 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~----~~~~~~~~l~~L~~L~L~~n~l---~~~~~~-------~~~~l~~L~~L~L~~n~i~~~~p 69 (953)
..+++|+|+++.+.. .|.+.+.+.++|+.-++|+=.. ...+|. ++...++|++||||+|.|....+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 457777777776642 3455566666777777765321 111222 34555677777777777764444
Q ss_pred cC----ccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccccccc----CC
Q 043900 70 AN----ISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGG----IP 141 (953)
Q Consensus 70 ~~----~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~----~~ 141 (953)
.. +.++.+|++|+|.+|.+.-.--..++. -|..|. .|+. .+.-++|+++...+|++... ..
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~A 178 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATALA 178 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHHHH
Confidence 43 345667777777777765111111110 011111 1111 11224555566665555411 12
Q ss_pred ccccccccccceecccccccCC----CCCcccccccceEEecCCccccccccc---ccccccccccEEEeeCccccCCCC
Q 043900 142 DTFGWLKNLATLAMAENWLSGT----IPSSIFNISSITAFDAGMNQLQGVIPL---DFGFTLQNLQFFSVFENQLTGAIP 214 (953)
Q Consensus 142 ~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~ 214 (953)
..|...+.|+.+.+..|.|... +-..+..+++|+.|||+.|-++..-.. ...+.+++|+.|++++|.+.....
T Consensus 179 ~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga 258 (382)
T KOG1909|consen 179 EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGA 258 (382)
T ss_pred HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccH
Confidence 2345555566666666555411 112345556666666666655422111 111244556666666666654333
Q ss_pred CCC-----cCCCCCcEEEcccccccCcC-----CCCCCCCccceeeecccccC
Q 043900 215 PAI-----SNASNLELFQADVNKLTGEV-----PYLEKPQRLSVFSITENSLG 257 (953)
Q Consensus 215 ~~~-----~~l~~L~~L~L~~N~l~~~~-----~~l~~~~~L~~l~l~~n~l~ 257 (953)
.+| ...++|+.|.+.+|.++..- -.....+.|..|++++|.++
T Consensus 259 ~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 259 IAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 322 23556666666666665321 11233466666666666664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.4e-11 Score=125.80 Aligned_cols=214 Identities=17% Similarity=0.124 Sum_probs=135.2
Q ss_pred CccccceeeccccccccccC--CcccCCCcccEEecccccccccC--CccccccccccceecccccccCCCCCc-ccccc
Q 043900 98 SLSKIEHLSVSVNNLTGSIP--SSLGNLSSINTLFLTDNNLDGGI--PDTFGWLKNLATLAMAENWLSGTIPSS-IFNIS 172 (953)
Q Consensus 98 ~l~~L~~L~Ls~N~l~~~~p--~~~~~L~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~ 172 (953)
++++|+...|.+.... .++ +....|++++.||||.|-+.... -.....|++|+.|+|+.|++.....+. -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 5667777777777765 333 25567777888888887765322 233456788888888888876322222 12566
Q ss_pred cceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcC--CCCCCCCccceee
Q 043900 173 SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV--PYLEKPQRLSVFS 250 (953)
Q Consensus 173 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~l~~~~~L~~l~ 250 (953)
.|+.|.|+.|.++...-.++...+|+|..|+|..|............+..|++|||++|.+-... +....++.|..++
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 78888888888874444444457788888888888543345555666778888888888877654 4456666666666
Q ss_pred ecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCccccc-CCccccCCCCCCEEE
Q 043900 251 ITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGN-IPAAIGKFVNLQRLE 329 (953)
Q Consensus 251 l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~ 329 (953)
++.+.+.+........++. ....++|++|++..|+|..- .-..+..+.+|+.|.
T Consensus 278 ls~tgi~si~~~d~~s~~k-------------------------t~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~ 332 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDK-------------------------THTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR 332 (505)
T ss_pred ccccCcchhcCCCccchhh-------------------------hcccccceeeecccCccccccccchhhccchhhhhh
Confidence 6666665543222211111 12225788888888888421 122345566778888
Q ss_pred eecCcccc
Q 043900 330 MWNNRLSG 337 (953)
Q Consensus 330 L~~N~i~~ 337 (953)
...|.+..
T Consensus 333 ~~~n~ln~ 340 (505)
T KOG3207|consen 333 ITLNYLNK 340 (505)
T ss_pred cccccccc
Confidence 88888873
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-10 Score=127.22 Aligned_cols=251 Identities=18% Similarity=0.131 Sum_probs=171.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEc-CCCeEEEEEEeeccchhh--HHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILD-QGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
...+|..+..||.|.|+.||....+ .++..|++|......... ...-..|+.+...+ .|.++++.... |..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc
Confidence 3456888899999999999998866 666789999875332221 12223455555555 58888776655 444
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-C
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-M 783 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 783 (953)
....++--||+++++...... ....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~ 404 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGF 404 (524)
T ss_pred cccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchh
Confidence 567779999999998877662 123567778899999999999999998 99999999999999876 7
Q ss_pred cEEEeccccceecCCCCCccccccccccccc-ccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGY-IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
..+++|||.++.+... .......+..| .+|+......+..++|+||||..+.|..+|...-... . +|
T Consensus 405 ~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~------~~- 472 (524)
T KOG0601|consen 405 FSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-V------QS- 472 (524)
T ss_pred hhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccc-c------cc-
Confidence 8999999999743211 11111133334 3566666778889999999999999999987532210 0 00
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
..+........ ......+..+.+.+...+|..||.+.++....+-.+
T Consensus 473 --------~~i~~~~~p~~--------------------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 --------LTIRSGDTPNL--------------------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --------eeeecccccCC--------------------CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00000000000 011244667777888899999999988876655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.4e-09 Score=108.10 Aligned_cols=145 Identities=19% Similarity=0.203 Sum_probs=107.4
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccch-hhHHHHHHHHHHHhhcCC--CCeeEEEeeecccccCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 713 (953)
+.|+.|.++.||+++..+ ++.+++|+...... .....+.+|+++++.+.+ ..+.+++.++.... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 568999999999999865 34799999754322 134578899999999965 34566777643221 1135689999
Q ss_pred eccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC-------------------------------
Q 043900 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD------------------------------- 762 (953)
Q Consensus 714 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------- 762 (953)
|++|.++.+.+.. ..++..+...++.++++++.+||+.
T Consensus 81 ~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 81 RVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred EeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 9999888876521 1356677778888888888888842
Q ss_pred ----------------------CCCCeEeecCCCCCeEecC--CCcEEEecccccee
Q 043900 763 ----------------------CQPPITHCDLKPSNVLLDE--EMMAHVSDFGLARF 795 (953)
Q Consensus 763 ----------------------~~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~ 795 (953)
....++|+|++|.||+++. ++.+.++||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-08 Score=109.64 Aligned_cols=182 Identities=15% Similarity=0.138 Sum_probs=138.8
Q ss_pred ceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeeccC-Cchh
Q 043900 643 SFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQN-RSLE 721 (953)
Q Consensus 643 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~ 721 (953)
-..+.|++...-++..|++|+++............-+++++++.|+|+|++.+++....+ ++...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 446889999988888999999953333333344566889999999999999998764433 34678999999987 6777
Q ss_pred hccccCCcCC-----cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceec
Q 043900 722 EWLHPITRED-----KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796 (953)
Q Consensus 722 ~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 796 (953)
++-....... .....+...++..+|.++.|+..||.++|+. |+.-+-+.|.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7654333322 2234456788999999999999999999999 9999999999999999999999999888776
Q ss_pred CCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 043900 797 PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847 (953)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~p 847 (953)
..++.. -+.+ -.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 544311 1111 1356899999999999999654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.3e-10 Score=134.46 Aligned_cols=201 Identities=21% Similarity=0.256 Sum_probs=106.1
Q ss_pred ccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCc--cccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS--IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 28 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
...+...+-+|.+.. ++.+... ++|++|-+..|. +....++.|..++.|+.|||++|.=.+.+|+.+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~-~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEH-IAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhh-ccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 455666666666654 3333222 256666666664 442333335556666666666665555666666666666666
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc--CCCCCcccccccceEEecCCcc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS--GTIPSSIFNISSITAFDAGMNQ 183 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~ 183 (953)
+|++..++ .+|..+++|.+|.+|++..+.-...+|.....|.+|++|.+..-... ...-+.+.++.+|+.+......
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s 679 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISS 679 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecch
Confidence 66666666 56666666666666666666544444555556666666666554321 1112223334444444332222
Q ss_pred ccccccccccccccccc----EEEeeCccccCCCCCCCcCCCCCcEEEcccccccC
Q 043900 184 LQGVIPLDFGFTLQNLQ----FFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235 (953)
Q Consensus 184 l~~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (953)
.. +-..+. .+..|. .+.+.++... ..+..+..+.+|+.|.+.+.....
T Consensus 680 ~~--~~e~l~-~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 680 VL--LLEDLL-GMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred hH--hHhhhh-hhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 10 001111 222222 3333333332 456677788888888888777753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=96.46 Aligned_cols=129 Identities=22% Similarity=0.238 Sum_probs=94.2
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEee--ccc-hh-----hHHHHHHHHHHHhhcCC--CCeeEEEeeecccccCCCC
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLH-HG-----AFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGND 706 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~-----~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~ 706 (953)
..+++|+-+.+|.+.+.+. ++++|.=. ... +. ...+-.+|+.++.+++- -++..++++ +.+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 4588999999999988654 36666431 111 11 12456789999988853 333444444 235
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
...|+|||++|..|.+++... ...++..+-.-+.-||.. ||+|+|+.++||++..+. +.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EE
Confidence 678999999999999888421 245667777778889999 999999999999997765 99
Q ss_pred Eecccccee
Q 043900 787 VSDFGLARF 795 (953)
Q Consensus 787 L~DfG~a~~ 795 (953)
++|||++.+
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-08 Score=99.82 Aligned_cols=125 Identities=23% Similarity=0.253 Sum_probs=82.4
Q ss_pred eEEEEEEcCCCeEEEEEEeeccc--------------h------------hhHHHHHHHHHHHhhcCCC--CeeEEEeee
Q 043900 646 SVYKGILDQGKTTVAVKVFNLLH--------------H------------GAFKSFIAECNTLKNIRHR--NLVKILTAC 697 (953)
Q Consensus 646 ~Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--niv~~~~~~ 697 (953)
.||.|...++. .||+|+.+... . .......+|++.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~-~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPDGE-EVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECTTE-EEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECCCCC-EEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 38999987764 89999985210 0 0123467899999999654 56777766
Q ss_pred cccccCCCCceeEEEeecc--CCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHH-HhhCCCCCeEeecCCC
Q 043900 698 SGVDYQGNDFKALVFEFMQ--NRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY-LHHDCQPPITHCDLKP 774 (953)
Q Consensus 698 ~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp 774 (953)
..-++||||++ |..+..+... .++......++.+++..+.. +|.. |++|||+.+
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~~------------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~ 135 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKDV------------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSE 135 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHHC------------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-ST
T ss_pred --------eCCEEEEEecCCCccchhhHHhc------------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCCh
Confidence 34579999998 5555443321 11133456677888886665 4677 999999999
Q ss_pred CCeEecCCCcEEEeccccceec
Q 043900 775 SNVLLDEEMMAHVSDFGLARFL 796 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~ 796 (953)
.||+++++ .+.++|||.+...
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEET
T ss_pred hhEEeecc-eEEEEecCcceec
Confidence 99999888 8999999999764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.3e-10 Score=129.29 Aligned_cols=205 Identities=23% Similarity=0.288 Sum_probs=143.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..+.+.+.+-+-+|+++.++.+.-...+...+.|+..... ....+....+-.+.-..++|-+++.... +...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 4566778888999999999988877666455555543211 1112222222222222344555544322 3345
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++|++|+.+++|...++.... .+..-.......+..+.+|||.. .+.|+|++|.|++...++..
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~----------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC----------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC----------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCc
Confidence 678899999999999999874442 23333344556678899999997 79999999999999999999
Q ss_pred EEeccccceecCCC---------------------C--------CcccccccccccccccccccCCCCCCcccchHHHHH
Q 043900 786 HVSDFGLARFLPLS---------------------P--------AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGI 836 (953)
Q Consensus 786 kL~DfG~a~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~ 836 (953)
+++|||.....+.- . .........||+.|.|||...+......+|.|+.|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 99999844322110 0 001123345899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCc
Q 043900 837 LLLELVTRKKPVDSM 851 (953)
Q Consensus 837 vl~elltg~~pf~~~ 851 (953)
+++|.++|.+||...
T Consensus 1024 ~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hhhhhhcCCCCCCCc
Confidence 999999999999753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-09 Score=86.07 Aligned_cols=59 Identities=36% Similarity=0.493 Sum_probs=27.8
Q ss_pred CCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccc
Q 043900 77 NLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN 135 (953)
Q Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~ 135 (953)
+|++|++++|+|+...++.|.++++|++|++++|+++...|++|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444444444444444444444444444
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.5e-09 Score=84.41 Aligned_cols=60 Identities=42% Similarity=0.542 Sum_probs=38.8
Q ss_pred ccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccc
Q 043900 101 KIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWL 160 (953)
Q Consensus 101 ~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (953)
+|++|++++|+|+...+++|.++++|++|++++|+|+.+.++.|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 566666666666644445666666666666666666666666666666666666666654
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-10 Score=117.20 Aligned_cols=250 Identities=18% Similarity=0.214 Sum_probs=130.9
Q ss_pred ccCCccccceeeccccccccc----cCCcccCCCcccEEecccccc---cccCCc-------cccccccccceecccccc
Q 043900 95 ELGSLSKIEHLSVSVNNLTGS----IPSSLGNLSSINTLFLTDNNL---DGGIPD-------TFGWLKNLATLAMAENWL 160 (953)
Q Consensus 95 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l---~~~~~~-------~~~~l~~L~~L~L~~N~l 160 (953)
.+..+..+++++||+|.+... +...+.+.++|+..++++--- ...+|+ ++.+.++|++|+||.|-+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 345667788888888887532 334566677888888776432 223333 344556777777777776
Q ss_pred cCCCCCc----ccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCc
Q 043900 161 SGTIPSS----IFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGE 236 (953)
Q Consensus 161 ~~~~p~~----l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (953)
....+.. +..+.+|++|.|.+|.+...-...+...|..|. .......-++|+.+...+|++...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~------------~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELA------------VNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHH------------HHhccCCCcceEEEEeeccccccc
Confidence 5333332 234556666666666655222222211111111 111223445677777777777644
Q ss_pred CC-----CCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCCh----hhhhccccCcEEEcc
Q 043900 237 VP-----YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPA----CISNLSTTLEMLLLD 307 (953)
Q Consensus 237 ~~-----~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~----~~~~~~~~L~~L~L~ 307 (953)
.. .+...+.|+.+.+..|.|...+. ......+..++.|+.|++.+|.|+..... .+..+ ++|+.|+++
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~-~~L~El~l~ 249 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSW-PHLRELNLG 249 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhccc-chheeeccc
Confidence 32 13344566777777777665543 12233445556666666666666543222 22233 245566666
Q ss_pred cCcccccCCccc-----cCCCCCCEEEeecCcccc----cCCcCccCCCCCCeEEeccccc
Q 043900 308 NNKIFGNIPAAI-----GKFVNLQRLEMWNNRLSG----TIPPAIGELQNLRELRLQRNKF 359 (953)
Q Consensus 308 ~N~i~~~~~~~~-----~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l 359 (953)
+|.+......+| ...++|+.|.|.+|.|+. .+.......+.|..|+|++|++
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 666544333322 124556666666666651 1222333455666666666665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.5e-08 Score=93.14 Aligned_cols=141 Identities=19% Similarity=0.242 Sum_probs=97.7
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEe-ecc--c-----hhhHHHHHHHHHHHhhcCCCCe--eEEEeeecccccCC
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVF-NLL--H-----HGAFKSFIAECNTLKNIRHRNL--VKILTACSGVDYQG 704 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~-~~~--~-----~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~ 704 (953)
....+-+|+-+.|+++.+.+. .++||.- ... . .-..++..+|++.+.+++--.| .+++.+ +
T Consensus 11 ~l~likQGAEArv~~~~~~Ge--~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE--AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------D 81 (229)
T ss_pred cceeeeccceeeEeeeccCCc--eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------e
Confidence 567899999999999999764 4556542 111 1 1124567789999988853222 222211 2
Q ss_pred CCceeEEEeeccC-CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 705 NDFKALVFEFMQN-RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 705 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
...-.++|||++| .++.+++...... .........++.+|-+.+.-||.. +|+||||..+||++..++
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~--------~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~ 150 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMED--------ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDG 150 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccC--------cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCC
Confidence 2445799999977 4788888543222 122223367889999999999999 999999999999997655
Q ss_pred ---cEEEecccccee
Q 043900 784 ---MAHVSDFGLARF 795 (953)
Q Consensus 784 ---~~kL~DfG~a~~ 795 (953)
.+.++|||++..
T Consensus 151 ~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 151 NQITPILIDFGLSSV 165 (229)
T ss_pred CcCceEEEeecchhc
Confidence 468999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.8e-08 Score=99.37 Aligned_cols=135 Identities=24% Similarity=0.211 Sum_probs=98.9
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc----------------------hhhHHHHHHHHHHHhhcCCC--
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH----------------------HGAFKSFIAECNTLKNIRHR-- 688 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~-- 688 (953)
+.++..||-|.-+.||.|.+..+. ++|||.-+... ........+|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~-~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR-KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCCCC-EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999998765 89999753110 01234567899999999654
Q ss_pred CeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 689 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
.|.+.+++ +.-++||||++|--|...- ++....-.++..|+.-+.-+-.. |||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~---GiV 224 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRR---GIV 224 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence 77777766 5668999999886554432 12223334455555555555556 999
Q ss_pred eecCCCCCeEecCCCcEEEecccccee
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
|+|+++-||+++++|.+.++||--+..
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999977754
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.6e-09 Score=126.51 Aligned_cols=127 Identities=24% Similarity=0.319 Sum_probs=67.9
Q ss_pred CCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc--ccccCCcccCCccccceeeccccccccccCCcccCCCcccEE
Q 043900 52 QRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE--LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTL 129 (953)
Q Consensus 52 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L 129 (953)
...+...+-+|.+. .++.+..+- +|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45555555555555 444433322 45555555554 332222334556666666666554333556666666666666
Q ss_pred ecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCC
Q 043900 130 FLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181 (953)
Q Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 181 (953)
+|++..++ .+|.++..|++|.+|++..+.-...+|..+..+++|++|.+-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence 66666665 5555666666666666665554334444444555666555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.5e-07 Score=98.27 Aligned_cols=146 Identities=13% Similarity=0.032 Sum_probs=98.4
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccchh-----------hHHHHHHHHHHHhhcCCC--CeeEEEeeecccccC
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-----------AFKSFIAECNTLKNIRHR--NLVKILTACSGVDYQ 703 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~ 703 (953)
+.+-+.....|++++.. ++.|.||........ ....+.+|...+.++... .+.+.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44554455557777663 347999977432211 111477888888888422 233444443221111
Q ss_pred CCCceeEEEeeccCC-chhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-
Q 043900 704 GNDFKALVFEFMQNR-SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE- 781 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 781 (953)
....-++|||++++. +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLP 174 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEecc
Confidence 124568999999885 8988874211 11345667789999999999999999 9999999999999975
Q ss_pred ------CCcEEEecccccee
Q 043900 782 ------EMMAHVSDFGLARF 795 (953)
Q Consensus 782 ------~~~~kL~DfG~a~~ 795 (953)
+..+.++||+.+..
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46899999998863
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.2e-10 Score=124.32 Aligned_cols=180 Identities=24% Similarity=0.295 Sum_probs=94.0
Q ss_pred CccccCCccCceeecCCCccCcCCCccCCCCC-CCcEEeCCCCccc---cccCcCccCC------CCCcEEeccCccccc
Q 043900 21 SPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQ-RLQVLALNNNSIG---GEIPANISSC------SNLIQIRLFYNELVG 90 (953)
Q Consensus 21 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~---~~~p~~~~~l------~~L~~L~L~~n~l~~ 90 (953)
|-.|..+++|++|.|.++.|.. ...+..+. +|++| +-+|+++ ..+....+.. ..|...+.++|.++
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKL-ICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhh-hhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4467777788888888887765 22222221 23333 2233332 0111111111 13455556666665
Q ss_pred cCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCc-cccccccccceecccccccCCCCCccc
Q 043900 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPD-TFGWLKNLATLAMAENWLSGTIPSSIF 169 (953)
Q Consensus 91 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~ 169 (953)
.+..++.-++.|+.|+|++|++. ... .+..|++|+.|||+.|.+. .+|. ...++. |..|.|++|.++. + ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~t-L-~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTT-L-RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHh-h-hhHH
Confidence 45555556666666666666665 222 5566666666666666665 3332 222333 6666666666652 1 2345
Q ss_pred ccccceEEecCCcccccccccccccccccccEEEeeCcccc
Q 043900 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210 (953)
Q Consensus 170 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 210 (953)
++.+|+.||+++|-|.+.--..+.+.|..|+.|+|.+|.+-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 56666666666666654333333335566666666666664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.4e-09 Score=95.71 Aligned_cols=102 Identities=25% Similarity=0.401 Sum_probs=45.9
Q ss_pred EEEeCCCeeeeecCcc---ccCCccCceeecCCCccCcCCCccC-CCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 8 ILNLTSLKLAGSISPH---VGNLSFLKVLLLYNNSFNHGIPSEF-DRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+||++|++. -|++. +....+|+..+|++|.+.. .|..| ..++.++.|+|++|.|+ .+|..+..++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 3455555543 33332 2233344444555555554 23233 23334555555555554 44444444444444444
Q ss_pred cCccccccCCcccCCccccceeeccccccc
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLT 113 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (953)
+.|.+. ..|..+..|.+|-+|+..+|.+.
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 444444 34444444444444444444443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-08 Score=112.43 Aligned_cols=150 Identities=17% Similarity=0.263 Sum_probs=101.6
Q ss_pred HHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccc-------cccccccccccccccCCC
Q 043900 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS-------IDAKGSIGYIAPEYGLGS 823 (953)
Q Consensus 751 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 823 (953)
+++.|+.|+|.. +++||++|.|++|.++..+..||+.|+++............ .-......|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 445899999976 69999999999999999999999999998755432111111 111245679999999998
Q ss_pred CCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHH
Q 043900 824 EVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 902 (953)
Q Consensus 824 ~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 902 (953)
..+.++|+||+|+.+|.+.. |+.-+.. . +............ +.. ......
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a-~-~~~~~~~~~~~~~--------~~~-------------------~~~~s~ 235 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAA-N-GGLLSYSFSRNLL--------NAG-------------------AFGYSN 235 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhc-c-CCcchhhhhhccc--------ccc-------------------cccccc
Confidence 89999999999999999995 4443332 1 1111111110000 000 000112
Q ss_pred HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 903 ECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 903 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.+.++.+=+.+++..++..||++.++..
T Consensus 236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 236 NLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 45677888888999999999998777654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.9e-07 Score=87.08 Aligned_cols=144 Identities=17% Similarity=0.075 Sum_probs=104.2
Q ss_pred cccccceeeEEEEEEcCCCeEEEEEEeec------cchhhHHHHHHHHHHHhhcC--CCCeeEEEeeecccccCCCCcee
Q 043900 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL------LHHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
--|+||-+.|++....+. .+-+|.-.. ..+-....|.+|+..+.++. .-.+.+.+ ++..........-+
T Consensus 25 N~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CcCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 357799999999887655 577887641 11335678999999999984 22244554 32211122234567
Q ss_pred EEEeeccC-CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc--EE
Q 043900 710 LVFEFMQN-RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM--AH 786 (953)
Q Consensus 710 lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~k 786 (953)
||+|-+++ .+|.+++..... .+.+...+..+..++++.++-||+. |+.|+|+.+.||+++.++. ++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~--------~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAV--------SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCc--------CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEE
Confidence 99998864 588888743221 2467778889999999999999999 9999999999999986666 99
Q ss_pred Eecccccee
Q 043900 787 VSDFGLARF 795 (953)
Q Consensus 787 L~DfG~a~~ 795 (953)
++||.-++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999987763
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.9e-09 Score=93.74 Aligned_cols=78 Identities=23% Similarity=0.402 Sum_probs=40.5
Q ss_pred eeccCCcccCCCCccccC-CCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCc
Q 043900 424 LDLSRNQLTGSIPSEVGN-LKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNN 502 (953)
Q Consensus 424 L~ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 502 (953)
.+|++|.+. .+|..|.. .+.++.|+|++|+|+ .+|.+++.++.|+.|+++.|.|. ..|..+..|.+|..||..+|.
T Consensus 58 i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na 134 (177)
T KOG4579|consen 58 ISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENA 134 (177)
T ss_pred Eecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCc
Confidence 444444444 23333332 234555555555555 45555555555555555555555 445555555555555555555
Q ss_pred cc
Q 043900 503 LS 504 (953)
Q Consensus 503 l~ 504 (953)
+.
T Consensus 135 ~~ 136 (177)
T KOG4579|consen 135 RA 136 (177)
T ss_pred cc
Confidence 54
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.6e-09 Score=117.15 Aligned_cols=128 Identities=33% Similarity=0.349 Sum_probs=90.0
Q ss_pred CCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCC-CccCCccccEEE
Q 043900 395 TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLE 473 (953)
Q Consensus 395 ~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 473 (953)
.|...+.+.|+++ .. +.-..+.+.++.|||++|+++.. +.+..++.|+.|||+.|.+. .+|. ...++. |..|+
T Consensus 165 ~L~~a~fsyN~L~-~m-D~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LM-DESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hH-HHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 4666677777776 22 22334445566778888887743 26778888899999999888 4543 334454 88999
Q ss_pred ccCccccCCCCccccCCCCCcEEECCCCcccccC-CccccccccCceEeccCCcCccc
Q 043900 474 MQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKI-PEFLVGFQLLENLNLSNNNLEGM 530 (953)
Q Consensus 474 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~ 530 (953)
|++|.++.. ..+.+|++|+.|||++|-|.+.- -..++.+..|..|+|.+|++.+-
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 999998843 45788888999999999887532 12356678888999999988643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.8e-06 Score=83.76 Aligned_cols=142 Identities=14% Similarity=0.127 Sum_probs=92.3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHH---------HHHHHHHHhhcC---CCCeeEEEee
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS---------FIAECNTLKNIR---HRNLVKILTA 696 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~niv~~~~~ 696 (953)
...+|...+++-......|.+....+ ..+++|..+.......+. ..+++..+.+++ ....+.++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~--~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG--KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC--cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34667777888877777777766654 479999886433322222 223444444442 2333333333
Q ss_pred ecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCC
Q 043900 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSN 776 (953)
Q Consensus 697 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 776 (953)
+.-..+.-....++||||++|..|.+... ++. .++..+++++.-+|+. |++|+|..|.|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgN 165 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGN 165 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCc
Confidence 22221222345679999999988877652 222 3556777889999999 99999999999
Q ss_pred eEecCCCcEEEeccccce
Q 043900 777 VLLDEEMMAHVSDFGLAR 794 (953)
Q Consensus 777 Ill~~~~~~kL~DfG~a~ 794 (953)
+++++++ ++++||+..+
T Consensus 166 Flv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEECCc-EEEEECcccc
Confidence 9998655 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.5e-06 Score=84.80 Aligned_cols=153 Identities=20% Similarity=0.160 Sum_probs=101.3
Q ss_pred CcCHHHHHHhhcCCcccC---cccccceeeEEEEEEcCCCeEEEEEEeeccchhh-------------------HH----
Q 043900 620 NISYQNLYNATDGFASAN---EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-------------------FK---- 673 (953)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~---~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~~---- 673 (953)
..+...+....++..+.. .|+.|.-+.||+|...++ ..||||+++...... .+
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~-~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG-RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC-ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 344555555555555444 466777789999998554 589999996322110 00
Q ss_pred -HHHHHHHHHhhc--CCCCeeEEEeeecccccCCCCceeEEEeeccCC-chhhccccCCcCCcccCCccccCHHHHHHHH
Q 043900 674 -SFIAECNTLKNI--RHRNLVKILTACSGVDYQGNDFKALVFEFMQNR-SLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749 (953)
Q Consensus 674 -~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~ 749 (953)
=..+|+..|+++ .+-.+.+.+++ ..-.+||||+... .-.-.|+ ...+...+...+.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~Lk-----------Dv~~e~~e~~~~~ 172 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLK-----------DVPLELEEAEGLY 172 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCcc-----------cCCcCchhHHHHH
Confidence 124677777777 24555555655 3457999999553 1111111 1123333667788
Q ss_pred HHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 750 IDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 750 ~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
.++++.+.-|-. . ++||+||+.=|||+. ++.+.++|||-|....
T Consensus 173 ~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 173 EDVVEYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 888888888876 5 999999999999999 8899999999997653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 953 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-37 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-28 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-37 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-27 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 9e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 9e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-05 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 7e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 5e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 479 bits (1235), Expect = e-156
Identities = 166/574 (28%), Positives = 257/574 (44%), Gaps = 27/574 (4%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
+ L+++S + I P +G+ S L+ L + N + L++L +++N G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
IP +L + L N+ G+IP L G+ + L +S N+ G++P G+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 126 INTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWLSGTIPSSIFNIS-SITAFDAGMNQ 183
+ +L L+ NN G +P DT ++ L L ++ N SG +P S+ N+S S+ D N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 184 LQGVIPLDFG-FTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-YLE 241
G I + LQ + N TG IPP +SN S L N L+G +P L
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 242 KPQRLSVFSITENSL-GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
+L + N L G L L L+++ N+ G +P+ +SN T
Sbjct: 440 SLSKLRDLKLWLNMLEGE-------IPQELMYVKTLETLILDFNDLTGEIPSGLSNC-TN 491
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L + L NN++ G IP IG+ NL L++ NN SG IP +G+ ++L L L N F
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 361 GNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDN--NLTGTIPPQFLGLS 418
G IP ++ ++ NF+ G + + N G Q LS
Sbjct: 552 GTIPAAMFKQS---GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
+++ G N ++ LD+ N L G IP +GS L L + N
Sbjct: 609 TRNP-CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFK 538
+ G IP + L+GLN+LDLS N L G+IP+ + +L ++LSNNNL G +P G F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 539 NATITSVLGNLKLCGGIPEFQLPTCISKESKHKK 572
L N LCG + LP C +
Sbjct: 728 TFPPAKFLNNPGLCG----YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-130
Identities = 159/610 (26%), Positives = 247/610 (40%), Gaps = 59/610 (9%)
Query: 2 RHQRVKILNLTSLKLA---GSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLA 58
R +V ++L+S L ++S + +L+ L+ L L N+ N + F L L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 59 LNNNSIGGEIPA--NISSCSNLIQIRLFYNELVGKIP-SELGSLSKIEHLSVSVNNLTGS 115
L+ NS+ G + ++ SCS L + + N L S L+ +E L +S N+++G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 116 IPSSL---GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNIS 172
+ L ++ N + G + NL L ++ N S IP + + S
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 173 SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNK 232
++ D N+L G T L+ ++ NQ G IPP +L+ NK
Sbjct: 224 ALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENK 280
Query: 233 LTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPA 292
TGE+P + L L L ++ N+F G +P
Sbjct: 281 FTGEIP---------------DFLSG-------------ACDTLTGLDLSGNHFYGAVPP 312
Query: 293 CISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPPAIGEL-QNLR 350
+ S LE L L +N G +P + K L+ L++ N SG +P ++ L +L
Sbjct: 313 FFGSCS-LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371
Query: 351 ELRLQRNKFLGNIPPSIGNLKVFNL---DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT 407
L L N F G I P++ L L N G IP +L L + LS N L+
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 408 GTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCK 467
GTIP LS L L L N L G IP E+ +K LE L + N L GEIPS L +C
Sbjct: 432 GTIPSSLGSLSKLRD-LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 468 KLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L + + N L G IP + L+ L +L LS N+ SG IP L + L L+L+ N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 528 EGMVPIEGVFKNATITSVLGNLKLCGGIPEF----QLPTCISKESKHKKLTLALKLALAI 583
G +P + + + G + + + L
Sbjct: 551 NGTIPAA--MFK--QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 584 ISGLTGLSLA 593
+S ++
Sbjct: 607 LSTRNPCNIT 616
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-103
Identities = 139/501 (27%), Positives = 223/501 (44%), Gaps = 53/501 (10%)
Query: 74 SCSN--LIQIRLFYNEL---VGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128
+C + + I L L + S L SL+ +E L +S +++ GS+ +S+ +
Sbjct: 46 TCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS 104
Query: 129 LFLTDNNLDGGIPD--TFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQ 185
L L+ N+L G + + G L L ++ N L S ++S+ D N +
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 186 GVIPLDFGFT--LQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKP 243
G + + + L+ ++ N+++G + +S NLE N + +P
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP----- 217
Query: 244 QRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEM 303
L + + L L I+ N G IS T L++
Sbjct: 218 -------------------------FLGDCSALQHLDISGNKLSGDFSRAISTC-TELKL 251
Query: 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI-GELQNLRELRLQRNKFLGN 362
L + +N+ G IP +LQ L + N+ +G IP + G L L L N F G
Sbjct: 252 LNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 363 IPPSIGNL-KVFNLDLSCNFLQGSIP-SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420
+PP G+ + +L LS N G +P +L + + L ++DLS N +G +P LS
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369
Query: 421 LIGLDLSRNQLTGSIPSEVGN--LKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
L+ LDLS N +G I + L+ L + N G+IP TL +C +L L + N+
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFK 538
L G IPSSL SL L L L N L G+IP+ L+ + LE L L N+L G +P G+
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP-SGLSN 488
Query: 539 NATITSV-LGNLKLCGGIPEF 558
+ + L N +L G IP++
Sbjct: 489 CTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-20
Identities = 37/129 (28%), Positives = 57/129 (44%), Gaps = 1/129 (0%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
N+TS G SP N + L + N + IP E + L +L L +N I
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
G IP + L + L N+L G+IP + +L+ + + +S NNL+G IP G +
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFET 728
Query: 126 INTLFLTDN 134
+N
Sbjct: 729 FPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-10
Identities = 29/91 (31%), Positives = 50/91 (54%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ L+++ L+G I +G++ +L +L L +N + IP E L+ L +L L++N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPS 94
+ G IP +S+ + L +I L N L G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 5e-90
Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 31/297 (10%)
Query: 269 SLTNSTRLNRLLINANNFGG--LLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQ 326
+ T + R+N L ++ N +P+ ++NL + + N + G IP AI K L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 327 RLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSI 386
L + + +SG IP + +++ L L N G +PPSI +L
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL---------------- 148
Query: 387 PSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLE 446
L I N ++G IP + S L + +SRN+LTG IP NL NL
Sbjct: 149 -------PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLA 200
Query: 447 VLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGK 506
+D+ N L+G+ GS K +++ + N L + + K LN LDL N + G
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259
Query: 507 IPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTC 563
+P+ L + L +LN+S NNL G +P G + +++ N LCG LP C
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-60
Identities = 78/383 (20%), Positives = 128/383 (33%), Gaps = 90/383 (23%)
Query: 91 KIPSELGSLSKI----EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG--GIPDTF 144
+I +LG+ + + G + + +N L L+ NL IP +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 145 GWLKNLATLAMA-ENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFS 203
L L L + N L G IP +I L L +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAK-------------------------LTQLHYLY 107
Query: 204 VFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSN 263
+ ++GAIP +S L N L+G +P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP------------------------ 143
Query: 264 LNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFV 323
S+++ L + + N G +P + S + + N++ G IP
Sbjct: 144 -----SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL- 197
Query: 324 NLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQ 383
NL +++ N L G G +N +++ L +N ++ +G
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLS------------- 243
Query: 384 GSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLK 443
K L +DL +N + GT+P L L L++S N L G IP GNL+
Sbjct: 244 ----------KNLNGLDLRNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQG-GNLQ 291
Query: 444 NLEVLDVFENKLKGEIPSTLGSC 466
+V NK P L +C
Sbjct: 292 RFDVSAYANNKCLCGSP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-57
Identities = 78/307 (25%), Positives = 123/307 (40%), Gaps = 36/307 (11%)
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVG--KIPSELGSLSKIEHLSVS-VNNLTGSIP 117
N + G + + + + L L IPS L +L + L + +NNL G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 118 SSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAF 177
++ L+ ++ L++T N+ G IPD +K L TL + N LSGT+P SI ++ ++
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 178 DAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV 237
N++ G IP +G + ++ N+LTG IPP +N NL N L G+
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 238 PYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNL 297
+ ++ + N+ L +
Sbjct: 214 SV-----------------------------LFGSDKNTQKIHLAKNSLAFDLGK-VGLS 243
Query: 298 STTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRN 357
L L L NN+I+G +P + + L L + N L G I P G LQ N
Sbjct: 244 K-NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
Query: 358 KFLGNIP 364
K L P
Sbjct: 302 KCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 186 bits (476), Expect = 6e-53
Identities = 74/346 (21%), Positives = 120/346 (34%), Gaps = 85/346 (24%)
Query: 1 RRHQRVKILNLTSLKLAGS--ISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLA 58
+ RV L+L+ L L I + NL +L L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI-------------------- 86
Query: 59 LNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS 118
N++ G IP I+ + L + + + + G IP L + + L S N L+G++P
Sbjct: 87 ---NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
Query: 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLAT-LAMAENWLSGTIPSSIFNISSITAF 177
S+ +L ++ + N + G IPD++G L T + ++ N L+G IP + N+
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------ 197
Query: 178 DAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV 237
NL F + N L G + N + N L ++
Sbjct: 198 --------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 238 PYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNL 297
+ S LN L + N G LP ++ L
Sbjct: 238 G------------------------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 298 STTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNR-LSGTIPPA 342
L L + N + G IP G NN+ L G+ PA
Sbjct: 268 -KFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-44
Identities = 58/205 (28%), Positives = 78/205 (38%), Gaps = 13/205 (6%)
Query: 363 IPPSIGNLKVF-----NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT--IPPQFL 415
I +GN D G + + Q + +DLS NL IP
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 416 GLSWLLIGLDLS-RNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEM 474
L L L + N L G IP + L L L + + G IP L K L L+
Sbjct: 74 NLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 475 QGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ-LLENLNLSNNNLEGMVPI 533
N L G +P S+SSL L + N +SG IP+ F L ++ +S N L G +P
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 534 EGVFKNATITSV-LGNLKLCGGIPE 557
F N + V L L G
Sbjct: 193 T--FANLNLAFVDLSRNMLEGDASV 215
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-82
Identities = 116/560 (20%), Positives = 190/560 (33%), Gaps = 32/560 (5%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R+ ++ L++ ++ L LKVL L +N + F L L L
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
+NSI NLI + L +N L L ++ L +S N + L
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 121 G--NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF---NISSIT 175
SS+ L L+ N + P F + L L + L ++ + +SI
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 176 AFDAGMNQLQGVIPLDF-GFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234
+QL F G NL + N L + + LE F + N +
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 235 GEVPY-LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNS-----TRLNRLLINANNFGG 288
+ L + ++ + + +L L + + L L + N+ G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFT--KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 289 LLPACISNLSTTLEMLLLDNNKI-FGNIPAAIGKFV---NLQRLEMWNNRLSGTIPPAIG 344
+ + L L+ L L N+ + + L L + N++S A
Sbjct: 344 IKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 345 ELQNLRELRLQRNKFLGNIPPS-IGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLS 402
L +L L L N+ + L +F + LS N +S +L + L
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462
Query: 403 DNNLTG--TIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL----- 455
L + P F L L I LDLS N + + L+ LE+LD+ N L
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTI-LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521
Query: 456 ---KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLV 512
G L L L ++ N L L ++DL NNL+
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 513 GFQLLENLNLSNNNLEGMVP 532
L++LNL N + +
Sbjct: 582 NQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 4e-79
Identities = 104/563 (18%), Positives = 187/563 (33%), Gaps = 60/563 (10%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
+ +LNLT +L + + S L L + N+ + P +L L+VL L +N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
+ C+NL ++ L N + + + L +S N L+ + + L +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 126 INTLFLTDNNLDGGIPDTFGWLKN--LATLAMAENWLSGTIPSSIFNISSITAFDAGMNQ 183
+ L L++N + + N L L ++ N + P I + Q
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 184 LQGVIPLDFGFTLQN--LQFFSVFENQLTGAIPPAISN--ASNLELFQADVNKLTGEVPY 239
L + L N ++ S+ +QL+ +NL + N L
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISN--- 296
S +L + NN L +
Sbjct: 267 -----------------------------SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 297 -----LSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRE 351
L + + + + L+ L M +N + G L NL+
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 352 LRLQRNKFLGNIPP-----SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNL 406
L L + S+ + + L+L+ N + + L ++DL N +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 407 TGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKG--EIPSTLG 464
+ Q + + LS N+ + + +L+ L + LK PS
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 465 SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS--------GKIPEFLVGFQL 516
+ L L++ N + L L+ L +LDL NNL+ G FL G
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 517 LENLNLSNNNLEGMVPIEGVFKN 539
L LNL +N + + VFK+
Sbjct: 538 LHILNLESNGFDEI--PVEVFKD 558
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 1e-75
Identities = 107/544 (19%), Positives = 199/544 (36%), Gaps = 65/544 (11%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQ--RLQVLALNNNSI 64
L+L+ L+ + L L+ LLL NN E D L+ L L++N I
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELG---SLSKIEHLSVSVNNLTGSIPSSLG 121
P + L + L +L + +L + + I +LS+S + L+ + ++
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 122 NL--SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISS------ 173
L +++ L L+ NNL+ D+F WL L + N + S+ + +
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 174 ---ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADV 230
T + L + F L+ L+ ++ +N + G + NL+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQ-WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 231 NKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLL 290
+ S+ ++T + S HS L+ L +LT N +
Sbjct: 363 S-------------FTSLRTLTNETFVSLAHSPLHIL-NLTK-----------NKISKIE 397
Query: 291 PACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPPAIGELQNL 349
S L LE+L L N+I + N+ + + N+ + + +L
Sbjct: 398 SDAFSWL-GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456
Query: 350 RELRLQRNKF--LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNL 406
+ L L+R + + P L + LDLS N + L + L I+DL NNL
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
Query: 407 TGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSC 466
L ++ G + L +L +L++ N
Sbjct: 517 A-----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 467 KKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPE-FLVGFQLLENLNLSNN 525
+L+ +++ N L S ++ L L+L +N ++ + F F+ L L++ N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 526 NLEG 529
+
Sbjct: 620 PFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-74
Identities = 99/544 (18%), Positives = 187/544 (34%), Gaps = 71/544 (13%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
++ + + LKL + + + + VL L +N + F R +L L + N+I
Sbjct: 7 EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
P L + L +NEL + + L + N++ + ++
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186
TL L+ N L T L+NL L LS N++Q
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQEL-----LLSN-------------------NKIQA 159
Query: 187 VIPLDFG-FTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245
+ + F +L+ + NQ+ P L + +L +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT------- 212
Query: 246 LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS-TTLEML 304
LC +T + L ++ + L T L ML
Sbjct: 213 -------------------EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
Query: 305 LLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNI- 363
L N + + L+ + N + ++ L N+R L L+R+ +I
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313
Query: 364 --------PPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPP-- 412
S LK + +L++ N + G + L + LS++ +
Sbjct: 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE 373
Query: 413 QFLGLS-WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIP-STLGSCKKLE 470
F+ L+ L L+L++N+++ L +LEVLD+ N++ E+ + +
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 471 QLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG--KIPEFLVGFQLLENLNLSNNNLE 528
++ + N +S + + L L L + L P + L L+LSNNN+
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA 493
Query: 529 GMVP 532
+
Sbjct: 494 NIND 497
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-49
Identities = 81/460 (17%), Positives = 164/460 (35%), Gaps = 40/460 (8%)
Query: 4 QRVKILNLTSLKLAGSISPHVG---NLSFLKVLLLYNNSFNHGIPSEFDRLQ--RLQVLA 58
R+ L L +++L S++ + + ++ L L N+ + + F L+ L +L
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 59 LNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL---------SVSV 109
L+ N++ + + L L YN + L L + +L S+S+
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS-GTIPSSI 168
+L S L + L + DN++ G + F L NL L+++ ++ S T+ +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 169 F---NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLE 224
F S + + N++ + F L +L+ + N++ + N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFS-WLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 225 LFQADVNKLTGEVPY-LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINA 283
NK L + +L S+ + L N L L ++
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL-KNVDSSPSPFQPLRN---LTILDLSN 489
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKI--------FGNIPAAIGKFVNLQRLEMWNNRL 335
NN + + L LE+L L +N + G + +L L + +N
Sbjct: 490 NNIANINDDMLEGL-EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 336 SGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLG-QY 393
+L L+ + L N N + +L+L N + G +
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608
Query: 394 KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG 433
+ LT +D+ N T ++W + ++ + +
Sbjct: 609 RNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-28
Identities = 47/242 (19%), Positives = 84/242 (34%), Gaps = 11/242 (4%)
Query: 7 KILNLTSLKLAGSISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
++L+L ++ ++ L + + L N + + F + LQ L L ++
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 66 G--EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT--------GS 115
P+ NL + L N + L L K+E L + NNL G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 116 IPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSIT 175
L LS ++ L L N D + F L L + + N L+ S N S+
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 176 AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235
+ + N + V FG +NL + N + + ++ +L+
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSS 647
Query: 236 EV 237
Sbjct: 648 HY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-23
Identities = 33/138 (23%), Positives = 50/138 (36%), Gaps = 4/138 (2%)
Query: 395 TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENK 454
+ + D S LT +P L + L+L+ NQL + L LDV N
Sbjct: 5 SHEVADCSHLKLT-QVPD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 455 LKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGF 514
+ P L+ L +Q N L + + L L L N++ V
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 515 QLLENLNLSNNNLEGMVP 532
+ L L+LS+N L
Sbjct: 121 KNLITLDLSHNGLSSTKL 138
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 25/126 (19%), Positives = 42/126 (33%), Gaps = 5/126 (3%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ ILNL S +L LK++ L N+ N S F+ L+ L L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 64 IGGEIPANIS-SCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSI----PS 118
I + NL ++ + +N S ++ I ++ L+ P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 119 SLGNLS 124
Sbjct: 656 HYHGFP 661
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-82
Identities = 108/517 (20%), Positives = 182/517 (35%), Gaps = 25/517 (4%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89
K L L N H F LQVL L+ I S S+L + L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGG-IPDTFGWLK 148
LS ++ L NL +G+L ++ L + N + +P+ F L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 149 NLATLAMAENWLSGTIPSSIFNISSITAF----DAGMNQLQGVIPLDFGFTLQNLQFFSV 204
NL L ++ N + + + + + D +N + + P F L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP--GAFKEIRLHKLTL 207
Query: 205 FENQLTGAIPP-AISNASNLELFQADVNKLTGEVPYLEKP----QRLSVFSITENSLGSR 259
N + + I + LE+ + + + E + + L +I E L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 260 GHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAI 319
+ + + T ++ + + + S + L L N K FG P
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF-GWQHLELVNCK-FGQFPT-- 321
Query: 320 GKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK--FLGNIPPSIGNLKVFN-LD 376
K +L+RL G + +L +L L L RN F G S LD
Sbjct: 322 LKLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 377 LSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIP 436
LS N + + S+ + L +D +NL LI LD+S +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 437 SEVGNLKNLEVLDVFENKLKGEI-PSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
L +LEVL + N + P + L L++ L+ P++ +SL L V
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 496 LDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532
L++S NN L+ L+ S N++
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-80
Identities = 101/539 (18%), Positives = 184/539 (34%), Gaps = 26/539 (4%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
K L+L+ L S + L+VL L + L L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLS 124
S S+L ++ L +G L ++ L+V+ N + +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNL----ATLAMAENWLSGTIPSSIFNISSITAFDAG 180
++ L L+ N + L + +L ++ N ++ I F +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLE-LFQADVNKLTGEVPY 239
N + L L+ + + + S LE L + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 240 LEKPQRLSVF----SITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACIS 295
+ +F +++ SL + + + + L + FG +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSL---VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 296 NLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLS--GTIPPAIGELQNLRELR 353
+L L G + +L+ L++ N LS G + +L+ L
Sbjct: 326 SLKR------LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 354 LQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS-LGQYKTLTIIDLSDNNLTGTIPP 412
L N + +G ++ +LD + L+ S + L +D+S +
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 413 QFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
F GLS L + L ++ N + ++ L+NL LD+ + +L+ P+ S L+
Sbjct: 440 IFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 472 LEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVG-FQLLENLNLSNNNLEG 529
L M N L L VLD S N++ + L L LNL+ N+
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-69
Identities = 104/506 (20%), Positives = 171/506 (33%), Gaps = 39/506 (7%)
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
+IP N+ + + L +N L S +++ L +S + + +LS +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186
+TL LT N + F L +L L E L+ I ++ ++ + N +Q
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADV----NKLTGEVPYLEK 242
++ L NL+ + N++ + + L + N + P K
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 243 PQRLSVFSITENSL-GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS--T 299
RL ++ N + + + L L + N N + + L T
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF 359
E L + +I N+ + + + + L L KF
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 360 LGNIPPSIGNLKVFN--------------------LDLSCNFL--QGSIPSSLGQYKTLT 397
+ +LK LDLS N L +G S +L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 398 IIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLK 456
+DLS N + T+ FLGL L LD + L V +L+NL LD+ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 457 GEIPSTLGSCKKLEQLEMQGNFLQGPI-PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515
LE L+M GN Q P + L+ L LDLSQ L P
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 516 LLENLNLSNNNLEGMVPIEGVFKNAT 541
L+ LN+S+NN +K
Sbjct: 495 SLQVLNMSHNNFFS--LDTFPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-36
Identities = 64/384 (16%), Positives = 121/384 (31%), Gaps = 47/384 (12%)
Query: 6 VKILNLTSLKLAGSISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
++ L L + L+ + L + + +F Q L L N
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF 316
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT--GSIPSSLGN 122
G + S L + G L +E L +S N L+ G S
Sbjct: 317 GQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGM 181
+S+ L L+ N + + F L+ L L + L S+F ++ ++ D
Sbjct: 372 TTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 182 NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLTGEVPYL 240
+ F L +L+ + N P + NL +L P
Sbjct: 431 THTRVAFNGIFN-GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT- 488
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
+ + + L L ++ NNF L L +
Sbjct: 489 ----------------------------AFNSLSSLQVLNMSHNNFFSLDTFPYKCL-NS 519
Query: 301 LEMLLLDNNKIFGNIPAAIGKFV-NLQRLEMWNNRLSGTIPPA--IGELQNLRELRLQRN 357
L++L N I + + F +L L + N + T + +++ R+L ++
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 579
Query: 358 KFLGNIPPSIGNLKVFNLDLSCNF 381
+ P + V +L+++C
Sbjct: 580 RMECATPSDKQGMPVLSLNITCQM 603
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 3/124 (2%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ + L+L+ +L +LS L+VL + +N+F + L LQVL + N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 64 IGGEIPANISSC-SNLIQIRLFYNELVGKIPSE--LGSLSKIEHLSVSVNNLTGSIPSSL 120
I + S+L + L N+ + L + L V V + + PS
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 121 GNLS 124
+
Sbjct: 590 QGMP 593
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-81
Identities = 86/536 (16%), Positives = 161/536 (30%), Gaps = 64/536 (11%)
Query: 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG----EIPANISSCSNLIQ 80
+ + L L + +P +L L+VLAL ++ P IS+ + Q
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 81 IRLFYNELVGKIPSELG--SLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG 138
+ S + ++ + SI S + NN+
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-T 196
Query: 139 GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQN 198
+ L L M + + + Q L + L++
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWD-NLKD 250
Query: 199 LQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGS 258
L V+ +P + ++L N+ G
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS---------------------GE 289
Query: 259 RGHSNLNFLCSLTNSTRLNRLLINANNFGGL-LPACISNLSTTLEMLLLDNNKIFGNIPA 317
+ + L ++ + I NN + + + L ML N++ G +PA
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM-KKLGMLECLYNQLEGKLPA 348
Query: 318 AIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNL-- 375
G + L L + N+++ G + + L NK L IP V +
Sbjct: 349 -FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK-LKYIPNIFDAKSVSVMSA 406
Query: 376 -DLSCNFLQG-------SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLS 427
D S N + + + + ++ I+LS+N ++ F S L ++L
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS-PLSSINLM 465
Query: 428 RNQLTG-------SIPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFL 479
N LT N L +D+ NKL + L +++ N
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF 525
Query: 480 QGPIPSSLSSLKGL------NVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
P+ + L N D N + PE + L L + +N++
Sbjct: 526 SK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-76
Identities = 83/535 (15%), Positives = 163/535 (30%), Gaps = 89/535 (16%)
Query: 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI 68
+ S SI + +N+ + RL +L+ + N+ E
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 69 PANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128
N Y + + +L + + V +P+ L L +
Sbjct: 223 ICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 129 LFLTDNNL--------DGGIPDTFGWLKNLATLAMAENWL-SGTIPSSIFNISSITAFDA 179
+ + N D + + + + N L + + +S+ + + +
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 180 GMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239
NQL+G +P FG + L ++ NQ+T +E NKL +P
Sbjct: 338 LYNQLEGKLP-AFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIP- 393
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299
N+ S++ ++ + + N G +
Sbjct: 394 -----------------------NIFDAKSVSV---MSAIDFSYNEIGSV---------- 417
Query: 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF 359
+ K F + K +N+ + + NN++S L + L N
Sbjct: 418 --------DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 360 LGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419
IP + + LT IDL N LT
Sbjct: 470 TE-IPKNSL---------------KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513
Query: 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFE------NKLKGEIPSTLGSCKKLEQLE 473
L+G+DLS N + P++ N L+ + N+ E P + C L QL+
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 474 MQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+ N ++ + + ++VLD+ N ++ + L + +
Sbjct: 573 IGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 1e-70
Identities = 64/499 (12%), Positives = 147/499 (29%), Gaps = 69/499 (13%)
Query: 62 NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTG----SIP 117
+ G + +++S + + L G++P +G L+++E L++ + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 118 SSLGNLSSINTLFLTDNNLDGGIPDTFGWLK--NLATLAMAENWLSGTIPSSIFNISSIT 175
+ S + D +L + + +I S T
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 176 AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235
N + + L L+ F + + N E +
Sbjct: 187 QIGQLSNNITF-VSKAVM-RLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYK 239
Query: 236 EVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACIS 295
N L + + LP +
Sbjct: 240 TEDL-----------------------------KWDNLKDLTDVEVYNCPNLTKLPTFLK 270
Query: 296 NLSTTLEMLLLDNNKI--------FGNIPAAIGKFVNLQRLEMWNNRL-SGTIPPAIGEL 346
L ++++ + N+ A +Q + + N L + + ++ ++
Sbjct: 271 AL-PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 347 QNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNN 405
+ L L N+ G P+ G+ K+ +L+L+ N + + G + + + + N
Sbjct: 330 KKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 406 LTGTIPPQFLGLSWLLIGLDLSRNQLTG-------SIPSEVGNLKNLEVLDVFENKLKGE 458
L ++ +D S N++ + N+ +++ N++
Sbjct: 389 LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448
Query: 459 IPSTLGSCKKLEQLEMQGNFLQG-------PIPSSLSSLKGLNVLDLSQNNLSGKIPEFL 511
+ L + + GN L + + L +DL N L+ +F
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508
Query: 512 VG-FQLLENLNLSNNNLEG 529
L ++LS N+
Sbjct: 509 ATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-60
Identities = 71/486 (14%), Positives = 145/486 (29%), Gaps = 80/486 (16%)
Query: 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTF 144
+ + L S ++ LS+ +G +P ++G L+ + L L +
Sbjct: 66 LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER--- 122
Query: 145 GWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGF-TLQNLQFFS 203
P I S Q +L
Sbjct: 123 -----------------LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC 165
Query: 204 VFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSN 263
+ + +I + N +T V
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK------------------------ 200
Query: 264 LNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFV 323
++ T+L + + + F N+ E + + +
Sbjct: 201 -----AVMRLTKLRQFYMGNSPFVA------ENICEAWENENSEYAQQYKTEDLKWDNLK 249
Query: 324 NLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL--------GNIPPSIGNLK-VFN 374
+L +E++N +P + L ++ + + N+ + + +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 375 LDLSCNFLQ-GSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG 433
+ + N L+ + +SL + K L +++ N L G P F L L+L+ NQ+T
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLAS-LNLAYNQITE 367
Query: 434 SIPSEVGNLKNLEVLDVFENKLKGEIPSTL--GSCKKLEQLEMQGNFLQG-------PIP 484
+ G + +E L NKLK IP+ S + ++ N + P+
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 485 SSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITS 544
+ ++ ++LS N +S E L ++NL N L + +N +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 545 VLGNLK 550
L
Sbjct: 487 -TYLLT 491
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-57
Identities = 73/467 (15%), Positives = 137/467 (29%), Gaps = 89/467 (19%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI-- 64
+ N + + NL L + +YN +P+ L +Q++ + N
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 65 ------GGEIPANISSCSNLIQIRLFYNEL-VGKIPSELGSLSKIEHLSVSVNNLTGSIP 117
+ A+ + I + YN L + + L + K+ L N L G +P
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
Query: 118 SSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF--NISSIT 175
+ G+ + +L L N + + G+ + + L+ A N L IP+ ++S ++
Sbjct: 348 -AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405
Query: 176 AFDAGMNQLQGVIPLDFG------FTLQNLQFFSVFENQLTGAIPPAISNASNLELFQAD 229
A D N++ V +F F N+ ++ NQ++ S S L
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 230 VNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289
N LT N
Sbjct: 466 GNMLTEIPK----------------------------------------------NSLKD 479
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPPAIGELQN 348
N L + L NK+ L +++ N S P
Sbjct: 480 ENENFKNT-YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 349 LRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTG 408
L+ ++ D N P + +LT + + N++
Sbjct: 538 LKGFGIRN-----------------QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR- 579
Query: 409 TIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455
+ + + LD+ N S V + +F +K
Sbjct: 580 KVNEKITP---NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-21
Identities = 25/191 (13%), Positives = 50/191 (26%), Gaps = 11/191 (5%)
Query: 350 RELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT 409
L + G N N + + SL +T + L +G
Sbjct: 40 DALNGKNWSQQGFGTQPGANW---NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGR 96
Query: 410 IPPQFLGLSWLLIGLDLSRNQLTG----SIPSEVGNLKNLEVLDVFENKLKGEIPSTLG- 464
+P L+ L + L L + P + + E +
Sbjct: 97 VPDAIGQLTELEV-LALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155
Query: 465 -SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLS 523
L + + + Q I S + NN++ + + ++ L +
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214
Query: 524 NNNLEGMVPIE 534
N+ E
Sbjct: 215 NSPFVAENICE 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 5e-78
Identities = 101/320 (31%), Positives = 157/320 (49%), Gaps = 38/320 (11%)
Query: 622 SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECN 680
S + L A+D F++ N +G G FG VYKG L G T VAVK G F E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERTQGGELQFQTEVE 79
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSL 740
+ HRNL+++ C + + LV+ +M N S+ L ++ E P L
Sbjct: 80 MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR-----ERPESQPP-L 128
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
+ +R I + A L+YLH C P I H D+K +N+LLDEE A V DFGLA+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--Y 186
Query: 801 AQTS-SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF---EGDM 856
T + +G+IG+IAPEY + S DV+ YG++LLEL+T ++ D + D+
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 857 NLHNFARMALPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVAC 915
L ++ + L + + +VD L + +D E + ++++ + C
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKD------------------EEVEQLIQVALLC 288
Query: 916 SMESPGDRMNMTNVVRQLQS 935
+ SP +R M+ VVR L+
Sbjct: 289 TQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-70
Identities = 93/331 (28%), Positives = 149/331 (45%), Gaps = 37/331 (11%)
Query: 610 NPSSPINSFPN--ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL 667
SS + F + + +L AT+ F IG G FG VYKG+L G VA+K
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPE 74
Query: 668 HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPI 727
+ F E TL RH +LV ++ C + L++++M+N +L+ L+
Sbjct: 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY-- 127
Query: 728 TREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
++ S++ QRL I I A L YLH I H D+K N+LLDE + +
Sbjct: 128 ----GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+DFG+++ S KG++GYI PEY + ++ DVYS+G++L E++ +
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 848 VD-SMFEGDMNLHNFARMALPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 905
+ S+ +NL +A + + + IVD L +I E L
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----------------ADKIRP--ESL 282
Query: 906 VAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
V C S DR +M +V+ +L+
Sbjct: 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 9e-70
Identities = 96/538 (17%), Positives = 179/538 (33%), Gaps = 47/538 (8%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
K N +L L I + + + L N + F RL L L L I
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
S L + L N L+ + L ++HL ++ L N ++
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSIT--AFDAGMNQL 184
+L+L N++ + L L N + + ++ T + + N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQ 244
G+ P F Q + Q I + N++ Q
Sbjct: 192 AGIEPG--AFDSAVFQSLNFGGTQNLLVIFKGLKNST---------------------IQ 228
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
L + + + + LC ++ + + + + F + + L+ L
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMS----VESINLQKHYFFNISSNTFHCF-SGLQEL 283
Query: 305 LLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP 364
L + +P+ + L++L + N+ + +L L ++ N +
Sbjct: 284 DLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 365 PSI----GNLKVFNLDLSCNFLQGS--IPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
NL+ LDLS + ++ S L L ++LS N F
Sbjct: 343 TGCLENLENLRE--LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400
Query: 419 WLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGN 477
L + LDL+ +L NL L+VL++ + L L+ L +QGN
Sbjct: 401 QLEL-LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 478 FLQGPI---PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532
+SL +L L +L LS +LS +++ +++LS+N L
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-65
Identities = 102/537 (18%), Positives = 186/537 (34%), Gaps = 41/537 (7%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
+ L + L + L L L L F RL L L N +
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
+S L + + L + +E L + N+++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLA--TLAMAENWLSGTIPSSIFNISSITAFDAGMNQ 183
+ L +N + + L+ +L + N ++ I F+ + + + G Q
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQ 213
Query: 184 LQGVIPLDFGF-TLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
VI T+Q+L + + P + + ++
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ----------- 262
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
+ F+I+ N+ + L L + A + LP+ + LS TL+
Sbjct: 263 --KHYFFNISSNTFH--------------CFSGLQELDLTATHLSE-LPSGLVGLS-TLK 304
Query: 303 MLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNK--F 359
L+L NK + F +L L + N + + L+NLREL L +
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 360 LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
+ NL + +L+LS N + + L ++DL+ L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEI---PSTLGSCKKLEQLEMQ 475
LL L+LS + L S L L+ L++ N ++L + +LE L +
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 476 GNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532
L + +SLK +N +DLS N L+ E L + + LNL++N++ ++P
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-49
Identities = 86/508 (16%), Positives = 174/508 (34%), Gaps = 46/508 (9%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQV--LALNN 61
+ ++ L L S ++ P LKVL NN+ ++ + LQ+ L LN
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 62 NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELG--SLSKIEHLSVSVNNLTGSIPSS 119
N I I + + + + I L ++ + + + P+
Sbjct: 189 NDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 120 LGNLS--SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAF 177
L S+ ++ L + +TF L L + LS +PS + +S++
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 178 DAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLTGE 236
N+ + + + +L S+ N + + N NL
Sbjct: 307 VLSANKFENLCQISAS-NFPSLTHLSIKGNTKRLELGTGCLENLENLR------------ 353
Query: 237 VPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISN 296
++ + + + NL N + L L ++ N L
Sbjct: 354 -----------ELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 297 LSTTLEMLLLDNNKIFGNIP-AAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQ 355
LE+L L ++ + L+ L + ++ L + L L+ L LQ
Sbjct: 399 C-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 356 RNKFLGNIPPSIGNLK----VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIP 411
N F +L+ + L LS L + K + +DLS N LT +
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 412 PQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
L + L+L+ N ++ +PS + L +++ +N L S + + ++
Sbjct: 518 EALSHLKGIY--LNLASNHISIILPSLLPILSQQRTINLRQNPLDC-TCSNIYFLEWYKE 574
Query: 472 LEMQGNFLQGPIPSSLSSLKGLNVLDLS 499
+ + + + L+G+ + D++
Sbjct: 575 NMQKLEDTEDTLCENPPLLRGVRLSDVT 602
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-43
Identities = 76/463 (16%), Positives = 144/463 (31%), Gaps = 45/463 (9%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSE--FDRLQRLQVLAL 59
+ LNL + I P + + + L I +Q L +
Sbjct: 177 QQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 60 NNNSIGGEIPANISSCS--NLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIP 117
+ PA ++ I L + + S ++ L ++ +L+ +P
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294
Query: 118 SSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITA 176
S L LS++ L L+ N + + +L L++ N + + N+ ++
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 177 FDAGMNQLQGVIPLDFGFT-LQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235
D + ++ + L +LQ ++ N+ A LEL +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 236 EVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACIS 295
+ S F N L L ++ +
Sbjct: 415 KDAQ-------SPFQ---------------------NLHLLKVLNLSHSLLDISSEQLFD 446
Query: 296 NLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLE---MWNNRLSGTIPPAIGELQNLREL 352
L L+ L L N L RLE + LS A L+ + +
Sbjct: 447 GLPA-LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505
Query: 353 RLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPP 412
L N+ + ++ +LK L+L+ N + +PS L I+L N L T
Sbjct: 506 DLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC-- 563
Query: 413 QFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455
+ L + +L + + N L + + + L
Sbjct: 564 ---SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-35
Identities = 64/411 (15%), Positives = 138/411 (33%), Gaps = 42/411 (10%)
Query: 5 RVKILNLTSLKLAGSISPHVGNLSF--LKVLLLYNNSFNHGIPSEFDRLQR--LQVLALN 60
+ LN + I + N + L + + P+ F+ L ++ + L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120
+ S L ++ L L ++PS L LS ++ L +S N S
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 121 GNLSSINTLFLTDNNLDGGI-PDTFGWLKNLATLAMAENWL--SGTIPSSIFNISSITAF 177
N S+ L + N + L+NL L ++ + + S + N+S + +
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 178 DAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLTGE 236
+ N+ + F L+ + +L N L++ + L
Sbjct: 382 NLSYNEPLSLKTEAFKE-CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 237 VPY-LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACIS 295
+ L ++ N N L +L L L+++ + + +
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR---LEILVLSFCDLSSIDQHAFT 497
Query: 296 NLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQ 355
+L + + L +N++ + A+ + L + +N +S +P + L R + L+
Sbjct: 498 SL-KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLR 555
Query: 356 RNKFLGNI--------------------------PPSIGNLKVFNLDLSCN 380
+N PP + +++ ++ LSC+
Sbjct: 556 QNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLSCS 606
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-27
Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 8/193 (4%)
Query: 356 RNKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQF 414
N L IP ++ + + L+ S N L ++ + LT +DL+ + F
Sbjct: 20 ENLGLNEIPGTLPNSTEC--LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 415 LGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEM 474
L L L+ N L + + K L+ L + + L + K LE L +
Sbjct: 78 QSQHRLDT-LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 475 QGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLEN--LNLSNNNLEGMVP 532
N + + L VLD N + E + Q N LNL+ N++ G+ P
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196
Query: 533 IEGVFKNATITSV 545
G F +A S+
Sbjct: 197 --GAFDSAVFQSL 207
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-66
Identities = 101/565 (17%), Positives = 177/565 (31%), Gaps = 85/565 (15%)
Query: 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
RV L+L G + +G L+ LKVL +S D + + I
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 65 GGEIPANISS------CSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS 118
S+L+Q + N + I + K + N +T I
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISK 442
Query: 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFD 178
++ L+ + ++ ++ N S N+ +T +
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNLKDLTDVE 497
Query: 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG---------AIPPAISNASNLELFQAD 229
+P L LQ ++ N+ + +++F
Sbjct: 498 LYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 230 VNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289
N L SL +L L N
Sbjct: 557 YNNLEEFPASA----------------------------SLQKMVKLGLLDCVHNKVRH- 587
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFV-NLQRLEMWNNRLSGTIPPA--IGEL 346
L A L L LD N+I IP F ++ L +N+L IP +
Sbjct: 588 LEA-FGTN-VKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV 643
Query: 347 QNLRELRLQRNKFLG---NIPPSIGNLKVFN---LDLSCNFLQGSIPSSLGQYKTLTIID 400
+ + NK NI S+ + K N + LS N +Q ++ I
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 401 LSDNNLTGTIPPQFLGLSWLLIG-------LDLSRNQLTGSIPSE--VGNLKNLEVLDVF 451
LS+N +T +IP L +DL N+LT S+ + L L +DV
Sbjct: 704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVS 761
Query: 452 ENKLKGEIPSTLGSCKKLEQL------EMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505
N P+ + +L+ + +GN + P+ +++ L L + N++
Sbjct: 762 YNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR- 819
Query: 506 KIPEFLVGFQLLENLNLSNNNLEGM 530
K+ E L L L++++N +
Sbjct: 820 KVDEKL--TPQLYILDIADNPNISI 842
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-60
Identities = 71/539 (13%), Positives = 148/539 (27%), Gaps = 88/539 (16%)
Query: 24 VGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLI---- 79
+ N + L L +P +L L+VL+ +S
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 80 ---QIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNL 136
+IR+ Y ++ L ++ + S +L +T N
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK--DTQIGNLTNR 436
Query: 137 DGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTL 196
I L L + A + + + + ++ + L + L
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWS-NL 490
Query: 197 QNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSL 256
++L ++ +P + + L+ N+
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS--------------------- 529
Query: 257 GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG-NI 315
L +++ + N +
Sbjct: 530 -----------------------AAQLKADWTRLADDEDTG-PKIQIFYMGYNNLEEFPA 565
Query: 316 PAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL--KVF 373
A++ K V L L+ +N++ A G L +L+L N+ + IP +V
Sbjct: 566 SASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQ-IEEIPEDFCAFTDQVE 622
Query: 374 NLDLSCNFLQGSIPS--SLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL----LIGLDLS 427
L S N L+ IP+ + + +D S N + + + LS
Sbjct: 623 GLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
Query: 428 RNQLTGSIPSEVGNLKNLEVLDVFENKLK-------GEIPSTLGSCKKLEQLEMQGNFLQ 480
N++ + + + N + + L ++++ N L
Sbjct: 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741
Query: 481 G-PIPSSLSSLKGLNVLDLSQNNLSGKIPE------FLVGFQLLENLNLSNNNLEGMVP 532
++L L+ +D+S N S P L F + + N + P
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-51
Identities = 76/529 (14%), Positives = 154/529 (29%), Gaps = 66/529 (12%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN-SIGGEIPANISSCSNLIQIRL----F 84
+ Y+ S E ++ ++N + +P + + I+
Sbjct: 218 VVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAI 277
Query: 85 YNELVGKIPSELGSLSKIEHLSVS------VNNLTGSIPSSLGNLSSINTLFLTDNNLDG 138
+ L GK S++ ++ L N + L L G
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 139 GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQN 198
+PD G L L L+ + + + + + ++++ F Q
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 199 LQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGS 258
L + ++ + ++ + + N +
Sbjct: 398 LNLSDLLQDAIN------------------RNPEMKPIKKDSRISLKDTQIGNLTNRITF 439
Query: 259 RGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAA 318
++ T+L + + F + E D K + N +
Sbjct: 440 -------ISKAIQRLTKLQIIYFANSPFTYDNI------AVDWEDANSDYAKQYENEELS 486
Query: 319 IGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF---------LGNIPPSIGN 369
+L +E++N +P + +L L+ L + N+ +
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 370 L-KVFNLDLSCNFLQGSIPS-SLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLS 427
K+ + N L+ S SL + L ++D N + F L L L
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNV-KLTDLKLD 603
Query: 428 RNQLTGSIPSEVG-NLKNLEVLDVFENKLKGEIPST--LGSCKKLEQLEMQGNFLQGPIP 484
NQ+ IP + +E L NKLK IP+ S + ++ N +
Sbjct: 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 485 SSLSSLKGLN-----VLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+ S+ + LS N + E + + LSNN +
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 5e-50
Identities = 52/464 (11%), Positives = 124/464 (26%), Gaps = 86/464 (18%)
Query: 10 NLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIP 69
L + A S + + + L+ L + L N ++P
Sbjct: 449 KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 70 ANISSCSNLIQIRLFYNELVG---------KIPSELGSLSKIEHLSVSVNNLTGSIPS-S 119
+ L + + N + ++ + + KI+ + NNL S S
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 120 LGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFD 178
L + + L N + + FG L L + N + IP +
Sbjct: 569 LQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238
N+L+ + + ++ + N++ + + +
Sbjct: 626 FSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG------------- 672
Query: 239 YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS 298
+ + ++ N +
Sbjct: 673 -----------------------------------INASTVTLSYNEIQKFPTELFATG- 696
Query: 299 TTLEMLLLDNNKI-------FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI--GELQNL 349
+ + ++L NN + L +++ N+L+ ++ L L
Sbjct: 697 SPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL 755
Query: 350 RELRLQRNKFLGNIPPSIGNLK-------VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLS 402
+ + N + P N D N + P+ + +L + +
Sbjct: 756 SNMDVSYNC-FSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 403 DNNLTGTIPPQFLGLSWLLIGLDLSRNQLT-GSIPSEVGNLKNL 445
N++ + + L LD++ N + S ++
Sbjct: 815 SNDIR-KVDEKLTP---QLYILDIADNPNISIDVTSVCPYIEAG 854
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 25/190 (13%), Positives = 61/190 (32%), Gaps = 21/190 (11%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNH-------GIPSEFDRLQRL 54
+ + L+ ++ + S + ++L NN + L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 55 QVLALNNNSIGGEIPANISSC--SNLIQIRLFYNELVGKIPSELGSLSKIEHLS------ 106
+ L N + + + + L + + YN P++ + S+++
Sbjct: 731 TTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRD 788
Query: 107 VSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWL-SGTIP 165
N + P+ + S+ L + N++ + + L L +A+N S +
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVT 845
Query: 166 SSIFNISSIT 175
S I +
Sbjct: 846 SVCPYIEAGM 855
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-64
Identities = 93/344 (27%), Positives = 141/344 (40%), Gaps = 54/344 (15%)
Query: 607 EKKNPSSPINSFPNISYQNLYNATDGF------ASANEIGVGSFGSVYKGILDQGKTTVA 660
E K+ F + S+ L N T+ F N++G G FG VYKG ++ TTVA
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 661 VKVFNLLHHGAFKS------FIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEF 714
VK L + F E + +H NLV++L S G+D LV+ +
Sbjct: 59 VKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVY 111
Query: 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774
M N SL + L P L+ R I A +++LH + H D+K
Sbjct: 112 MPNGSLLDRLS-----CLDGTPP--LSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161
Query: 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSY 834
+N+LLDE A +SDFGLAR + G+ Y+APE G E++ D+YS+
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSF 220
Query: 835 GILLLELVTRKKPVDSMFEGDMNLHNFARMALPD--HVVDIVDSTLLSDDEDLAVHGNQR 892
G++LLE++T VD E L + + + D +D + +
Sbjct: 221 GVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKM----------NDAD 269
Query: 893 QRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
AM + C E R ++ V + LQ +
Sbjct: 270 STSVE---------AMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-63
Identities = 90/519 (17%), Positives = 167/519 (32%), Gaps = 26/519 (5%)
Query: 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87
S K + L N F LQ L L+ I +L + L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG-GIPDTFGW 146
+ P L+ +E+L L +G L ++ L + N + +P F
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 147 LKNLATLAMAENWLSGTIPSSIFNISSITAF----DAGMNQLQGVIPLDFGFTLQNLQFF 202
L NL + ++ N++ + + + D +N + + F L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA--FQGIKLHEL 209
Query: 203 SVFENQLTGAIPP-AISNASNLELFQADVNKLTG----EVPYLEKPQRLSVFSITENSLG 257
++ N + I + N + L + + + + E+ + L +I E L
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL- 268
Query: 258 SRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA 317
+ + + + ++ + + + L + L + ++ P
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP---KHFKWQSLSIIRCQL-KQFPT 324
Query: 318 AIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN--- 374
L+ L + N+ S I L +L L L RN + S +L +
Sbjct: 325 L--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 375 LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGS 434
LDLS N + ++ + L +D + L L+ LD+S
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 435 IPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGL 493
L +L L + N K S + L L++ L+ +L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 494 NVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532
+L++S NNL L L+ S N +E
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-63
Identities = 104/538 (19%), Positives = 190/538 (35%), Gaps = 33/538 (6%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ ++ L+ + + N S L+ L L + L L L L N I
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNL 123
P + S ++L + +L +G L ++ L+V+ N + +P+ NL
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLA----TLAMAENWLSGTIPSSIFNISSITAFDA 179
+++ + L+ N + + +L+ +L M+ N + I F +
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTL 211
Query: 180 GMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239
N I L L + + I S +E +T +
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC----DVTIDEFR 267
Query: 240 LEKPQRLSVFSITENSLGSR-----GHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACI 294
L S + + L + ++ +L + + L I +
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQ--NLREL 352
L + L L NK +I +L L++ N LS + + +L +LR L
Sbjct: 328 PFLKS----LTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 353 RLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIP-SSLGQYKTLTIIDLSDNNLTGTI 410
L N + + L ++ +LD + L+ S+ + L +D+S N
Sbjct: 382 DLSFNG-AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 411 PPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKL 469
FLGL+ L L ++ N + S V N NL LD+ + +L+ + +L
Sbjct: 441 DGIFLGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 470 EQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
+ L M N L S + L L+ LD S N + + L NL+NN++
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-54
Identities = 89/493 (18%), Positives = 165/493 (33%), Gaps = 21/493 (4%)
Query: 56 VLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGS 115
+ + ++P +I S + I L +N L + S+++ L +S +
Sbjct: 15 TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 116 IPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSIT 175
+ L ++ L LT N + P +F L +L L E L+ I + ++
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 176 AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADV----N 231
+ N + + L NL + N + + + N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 232 KLTGEVPYLEKPQRLSVFSITENSL-GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLL 290
+ + +L ++ N + + L L L + + N
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 291 PACISNL-STTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNL 349
P+ + L T++ L F + N+ + + + + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKW 309
Query: 350 RELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT 409
+ L + R + + LK L L+ N +GSI +L+ +DLS N L+ +
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLKS--LTLTMN--KGSISFKKVALPSLSYLDLSRNALSFS 365
Query: 410 IPPQFLGLSWL-LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIP-STLGSCK 467
+ L L LDLS N + + L+ L+ LD + LK S S +
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424
Query: 468 KLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIP-EFLVGFQLLENLNLSNNN 526
KL L++ + L LN L ++ N+ L L+LS
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 527 LEGMVPIEGVFKN 539
LE + GVF
Sbjct: 485 LEQI--SWGVFDT 495
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 38/170 (22%), Positives = 63/170 (37%), Gaps = 5/170 (2%)
Query: 361 GNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420
G++ P I + L +P + + IDLS N L F S L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 421 LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQ 480
LDLSR ++ L +L L + N ++ P + LE L L
Sbjct: 59 QW-LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 481 GPIPSSLSSLKGLNVLDLSQNNLSG-KIPEFLVGFQLLENLNLSNNNLEG 529
+ L L L+++ N + K+P + L +++LS N ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-21
Identities = 33/156 (21%), Positives = 56/156 (35%), Gaps = 6/156 (3%)
Query: 384 GSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLK 443
GS+ + +T D L+ +P + +DLS N L N
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPD---DIPSSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 444 NLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
L+ LD+ +++ L L + GN +Q P S S L L L + L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 504 SGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
+ + L+ LN+++N + + F N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 7e-61
Identities = 72/334 (21%), Positives = 131/334 (39%), Gaps = 39/334 (11%)
Query: 616 NSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSF 675
+S ++ +NLY + G FG V+K L VAVK+F + +++
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQ-N 65
Query: 676 IAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEE 735
E +L ++H N+++ + A D L+ F + SL ++L
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA--------- 115
Query: 736 APRSLNLLQRLNIGIDVACALSYLHHD-------CQPPITHCDLKPSNVLLDEEMMAHVS 788
++ + +I +A L+YLH D +P I+H D+K NVLL + A ++
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING------DVYSYGILLLELV 842
DFGLA + + G+ Y+APE L ++ D+Y+ G++L EL
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 843 TRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 902
+R D + M F ++ D +++ VH +R K
Sbjct: 233 SRCTAADGPVDEYM--LPFEEEIGQHPSLE--------DMQEVVVHKKKRPVLRDYWQKH 282
Query: 903 ECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
+ + C R++ V ++ +
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-52
Identities = 74/342 (21%), Positives = 125/342 (36%), Gaps = 46/342 (13%)
Query: 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECN 680
+ D IG G +G+VYKG LD+ VAVKVF+ + ++FI E N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFAN---RQNFINEKN 57
Query: 681 --TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPR 738
+ + H N+ + + V G LV E+ N SL ++L
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----------H 106
Query: 739 SLNLLQRLNIGIDVACALSYLHHD------CQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792
+ + + + V L+YLH + +P I+H DL NVL+ + +SDFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 793 ARFL------PLSPAQTSSIDAKGSIGYIAPEY-------GLGSEVSINGDVYSYGILLL 839
+ L ++I G+I Y+APE D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 840 ELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQR-QARI 898
E+ R D + + +MA V + D + L QR +
Sbjct: 227 EIFMRCT--DLFPGESVPEY---QMAFQTEVGNHPT---FEDMQVLVSREKQRPKFPEAW 278
Query: 899 NSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940
+ ++ C + R+ ++ + I
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-52
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 601 LVRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANE------IGVGSFGSVYKGILDQ 654
+ I + N+ +Q + D + IG GSFG+V++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 655 GKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712
+ VAVK+ H F+ E +K +RH N+V + A + Q + ++V
Sbjct: 61 --SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVT 113
Query: 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDL 772
E++ SL LH A L+ +RL++ DVA ++YLH+ PPI H +L
Sbjct: 114 EYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNL 165
Query: 773 KPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVY 832
K N+L+D++ V DFGL+R + + S A G+ ++APE + DVY
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 833 SYGILLLELVTRKKPVDSMFEGDMN--------LHNFARMALPDHV 870
S+G++L EL T ++P + +N R+ +P ++
Sbjct: 224 SFGVILWELATLQQP----WGN-LNPAQVVAAVGFKCKRLEIPRNL 264
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-51
Identities = 99/531 (18%), Positives = 176/531 (33%), Gaps = 39/531 (7%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
K L+L+ L S + L+VL L + L L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT-GSIPSSLGNLS 124
S S+L ++ L +G L ++ L+V+ N + +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNL----ATLAMAENWLSGTIPSSIFNISSITAFDAG 180
++ L L+ N + L + +L ++ N ++ I F +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N + L L+ + + N NLE F
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGE--------FRNEGNLEKFDKSA---------- 250
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTT 300
+ L +I E L + + + T ++ + + + +
Sbjct: 251 --LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK-- 358
LE++ + K +L+RL +N+ + +L +L L L RN
Sbjct: 309 LELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLS 360
Query: 359 FLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGL 417
F G S + LDLS N + ++ S+ + L +D +NL
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 418 SWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQG 476
LI LD+S + L +LEVL + N + + L L++
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 477 NFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L+ P++ +SL L VL+++ N L L+ + L N
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-48
Identities = 116/501 (23%), Positives = 183/501 (36%), Gaps = 29/501 (5%)
Query: 54 LQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT 113
+ L L+ N + + S L + L E+ SLS + L ++ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 114 GSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWL-SGTIPSSIFNIS 172
+ LSS+ L + NL G LK L L +A N + S +P N++
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 173 SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVF----ENQLTGAIPPAISNASNLELFQA 228
++ D N++Q + D L + ++ N + I P L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 229 DVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSN------LNFLCSLTNSTRLNRLLIN 282
N + V Q L+ + LG + + L L N T + +
Sbjct: 208 RNNFDSLNVMK-TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT-IEEFRLA 265
Query: 283 ANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPA 342
++ + N T + L + I + Q LE+ N + P
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSY-NFGWQHLELVNCKFGQ-FPT- 321
Query: 343 IGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQ--GSIPSSLGQYKTLTIID 400
+L++L+ L NK GN + + LDLS N L G S +L +D
Sbjct: 322 -LKLKSLKRLTFTSNK-GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 401 LSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEI 459
LS N + T+ FLGL L LD + L V +L+NL LD+ +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 460 PSTLGSCKKLEQLEMQGNFLQGPIPS-SLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLE 518
LE L+M GN Q + L+ L LDLSQ L P L+
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 519 NLNLSNNNLEGMVPIEGVFKN 539
LN+++N L+ VP +G+F
Sbjct: 498 VLNMASNQLK-SVP-DGIFDR 516
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 89/505 (17%), Positives = 156/505 (30%), Gaps = 84/505 (16%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNH-GIPSEFDRLQRLQVLALNNNS 63
+L L S+ G+L LK L + +N +P F L L+ L L++N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
I ++ + + L L +S+N + I
Sbjct: 161 IQSIYCTDLRVLHQMPLLNL--------------------SLDLSLNPMN-FIQPGAFKE 199
Query: 124 SSINTLFLTDNNLDGGIPDT-FGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
++ L L +N + T L L L + N+ +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH-----RLVLGEFRNEGNLEKFDK-----S 249
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
L+G+ L L + + + I + +N+ F + V
Sbjct: 250 ALEGLCNLT--IEEFRLAYLDYYLDD----IIDLFNCLTNVSSFSLVSVTIE-RVKDFSY 302
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
+ G L L LT + + NA + L +LE
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFT---SNKGGNAFSEVDL---------PSLE 350
Query: 303 MLLLDNNKI--FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFL 360
L L N + G + +L+ L++ N + T+ L+ L L Q + L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-L 408
Query: 361 GNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420
+ S + L +D+S + F GLS L
Sbjct: 409 KQMSE---------------------FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 421 LIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
+ L ++ N + ++ L+NL LD+ + +L+ P+ S L+ L M N L
Sbjct: 448 EV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLS 504
+ L L + L N
Sbjct: 507 KSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 33/145 (22%), Positives = 55/145 (37%), Gaps = 5/145 (3%)
Query: 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLK 456
+ N IP L + LDLS N L + L+VLD+ +++
Sbjct: 10 ITYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 457 GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQL 516
S L L + GN +Q + S L L L + NL+ + +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 517 LENLNLSNNNLEGMVPIEGVFKNAT 541
L+ LN+++N ++ + F N T
Sbjct: 126 LKELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-15
Identities = 42/187 (22%), Positives = 75/187 (40%), Gaps = 7/187 (3%)
Query: 4 QRVKILNLT--SLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNN 61
++ L+L+ L G S + LK L L N + S F L++L+ L +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 405
Query: 62 NSIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS-S 119
+++ ++ S NLI + + + LS +E L ++ N+ +
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 120 LGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFD 178
L ++ L L+ L+ P F L +L L MA N L ++P IF ++S+
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIW 524
Query: 179 AGMNQLQ 185
N
Sbjct: 525 LHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-11
Identities = 30/167 (17%), Positives = 62/167 (37%), Gaps = 8/167 (4%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSE--FDRLQRLQVLALNNNS 63
+L L L+ ++S + L L+ L +++ + F L+ L L +++
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTH 432
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPSSLGN 122
+ S+L +++ N + L + L +S L P++ +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF 169
LSS+ L + N L F L +L + + N + P +
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 71/305 (23%), Positives = 124/305 (40%), Gaps = 53/305 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
IG GSFG+VYKG VAVK+ N+ ++F E L+ RH N++ +
Sbjct: 30 QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ A+V ++ + SL LH + + + ++I A
Sbjct: 87 GYSTAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTAR 131
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+ YLH I H DLK +N+ L E+ + DFGLA GSI +
Sbjct: 132 GMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 815 IAPE---YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871
+APE + S DVY++GI+L EL+T + P ++ + D ++
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQII 235
Query: 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931
++V G+ +++ S C M R+ C + +R + ++
Sbjct: 236 EMV------------GRGSLSPDLSKVRS--NCPKRMKRLMAECLKKKRDERPSFPRILA 281
Query: 932 QLQSI 936
+++ +
Sbjct: 282 EIEEL 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-49
Identities = 79/310 (25%), Positives = 118/310 (38%), Gaps = 58/310 (18%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G+FG V K VA+K K+FI E L + H N+VK+ A
Sbjct: 14 EVVGRGAFGVVCKAKWRA--KDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
C N LV E+ + SL LH E ++ + + +
Sbjct: 70 CL------NPV-CLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMM-AHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
+YLH + H DLKP N+LL + DFG A + QT + KGS ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWM 170
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875
APE GS S DV+S+GI+L E++TR+KP F+ + F M
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDE-IGGPAFRIMW---------- 215
Query: 876 STLLSDDEDLAVHGNQRQRQARINSKI--ECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933
AVH R + + + C + P R +M +V+ +
Sbjct: 216 ----------AVHNGTR-------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258
Query: 934 QSIKNILLGH 943
+ G
Sbjct: 259 THLMRYFPGA 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 64/253 (25%), Positives = 105/253 (41%), Gaps = 47/253 (18%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVK 692
IG+G FG VY+ VAVK ++ E ++H N++
Sbjct: 13 EIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ C + + LV EF + L L + + +N + +
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQI 114
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH--------VSDFGLARFLPLSPAQTS 804
A ++YLH + PI H DLK SN+L+ +++ ++DFGLAR +T+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTT 170
Query: 805 SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN------- 857
+ A G+ ++APE S S DV+SYG+LL EL+T + P F G ++
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG-IDGLAVAYG 225
Query: 858 -LHNFARMALPDH 869
N + +P
Sbjct: 226 VAMNKLALPIPST 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 62/313 (19%), Positives = 110/313 (35%), Gaps = 69/313 (22%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
++ G ++KG QG + VKV + + F EC L+ H N++ +L
Sbjct: 16 TKLNENHSGELWKGRW-QG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
AC L+ +M SL LH E ++ Q + +D+A
Sbjct: 74 GACQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMAR 122
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+++LH +P I L +V++DE+M A +S + S + +
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAW 174
Query: 815 IAPE------YGLGSEVSINGDVYSYGILLLELVTRKKP---VDSMFEGDMNLHNFARMA 865
+APE + D++S+ +LL ELVTR+ P + +M G R
Sbjct: 175 VAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231
Query: 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN 925
+P + ++ C E P R
Sbjct: 232 IPPG----------------------------------ISPHVSKLMKICMNEDPAKRPK 257
Query: 926 MTNVVRQLQSIKN 938
+V L+ +++
Sbjct: 258 FDMIVPILEKMQD 270
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-48
Identities = 105/521 (20%), Positives = 191/521 (36%), Gaps = 45/521 (8%)
Query: 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLF 84
L+ + LLL N S F L++LQ+L L + I + NL + L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSI--PSSLGNLSSINTLFLTDNNLDG-GIP 141
+++ P L + L + L+ ++ NL ++ L L+ N + +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 142 DTFGWLKNLATLAMAENWLSGTIPSSIFN---ISSITAFDAGMNQLQGVIPLDFGFTLQN 198
+FG L +L ++ + N + + +++ F N L + +D+G +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 199 LQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG-EVPYLEKPQRLSVFSITENSLG 257
+ + ++G N +++ N ++ + L + +++
Sbjct: 201 FRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 258 SRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA 317
+ L + + L ++ L L L++L L NKI
Sbjct: 254 DPDQNTFAGLARSS----VRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINKIADE 308
Query: 318 AIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI----GNLKVF 373
A NLQ L + N L L + + LQ+N + I L+
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH-IAIIQDQTFKFLEKLQT- 366
Query: 374 NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG 433
LDL N L +++ ++ I LS N L T+P L + + LS N+L
Sbjct: 367 -LDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLI----HLSENRLEN 415
Query: 434 -SIPSEVGNLKNLEVLDVFENKLKG-EIPSTLGSCKKLEQLEMQGNFLQGPIPSSL---- 487
I + + +L++L + +N+ T LEQL + N LQ + L
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 488 -SSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L L VL L+ N L+ P L L+L++N L
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-31
Identities = 77/426 (18%), Positives = 140/426 (32%), Gaps = 67/426 (15%)
Query: 108 SVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSS 167
NLT +P L++ L L+ N + +F +L+ L L + + TI
Sbjct: 12 RFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 168 IF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP--AISNASNLE 224
F N+ ++ D G +++ + P F L +L ++ L+ A+ N L
Sbjct: 68 AFRNLPNLRILDLGSSKIYFLHPDAFQG-LFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 225 LFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINAN 284
N++ +L S L + ++N
Sbjct: 127 RLDLSKNQIR----------------------------SLYLHPSFGKLNSLKSIDFSSN 158
Query: 285 NFGGLLPACISNLS-TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI 343
+ + L TL L N ++ + GK +N R
Sbjct: 159 QIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN--------------- 203
Query: 344 GELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403
L L + N + +I N + S SL +
Sbjct: 204 ---MVLEILDVSGNGWTVDIT-----------GNFSNAISKSQAFSLILAHHIMGAGFGF 249
Query: 404 NNLTGTIPPQFLGLSWL-LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPST 462
+N+ F GL+ + LDLS + LK+L+VL++ NK+
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA 309
Query: 463 LGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNL 522
L+ L + N L S+ L + +DL +N+++ + + L+ L+L
Sbjct: 310 FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369
Query: 523 SNNNLE 528
+N L
Sbjct: 370 RDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 76/454 (16%), Positives = 153/454 (33%), Gaps = 63/454 (13%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
+ + L L ++G N + + ++N+ + + ++I
Sbjct: 202 RNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK- 253
Query: 67 EIPANI---SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ N + S++ + L + + +L ++ L+++ N + + L
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQ 183
++ L L+ N L F L +A + + +N ++ I F
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK------------- 359
Query: 184 LQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKP 243
L+ LQ + +N LT I ++ NKL +
Sbjct: 360 -----------FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT---LPKIN 400
Query: 244 QRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEM 303
++ ++EN L NL+ L L L L++N N F + + +LE
Sbjct: 401 LTANLIHLSENRL-----ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455
Query: 304 LLLDNNKIFGNIPAAI--GKFVNLQRLE---MWNNRLSGTIPPAIGELQNLRELRLQRNK 358
L L N + + F L L+ + +N L+ P L LR L L N+
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 359 FLGNIPPSI--GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLG 416
L + + NL++ LD+S N L P +L+++D++ N
Sbjct: 516 -LTVLSHNDLPANLEI--LDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTF- 568
Query: 417 LSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDV 450
++WL + + + +
Sbjct: 569 INWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSL 602
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-23
Identities = 52/270 (19%), Positives = 99/270 (36%), Gaps = 15/270 (5%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRL 328
S +L L + + + L +L L ++KI+ P A +L L
Sbjct: 43 SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102
Query: 329 EMWNNRLSGTIPP--AIGELQNLRELRLQRNKFLG-NIPPSIGNL-KVFNLDLSCNFLQG 384
++ LS + L+ L L L +N+ + PS G L + ++D S N +
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162
Query: 385 SIPSSLG--QYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNL 442
L Q KTL+ L+ N+L + + + L ++G N
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NG 215
Query: 443 KNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV--LDLSQ 500
+++ F N + +L + + ++ P ++ + L +V LDLS
Sbjct: 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 501 NNLSGKIPEFLVGFQLLENLNLSNNNLEGM 530
+ + L+ LNL+ N + +
Sbjct: 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKI 305
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 5/117 (4%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LT +P L E L + N ++ S+ ++L+ LE+ + I
Sbjct: 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 484 -PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
+ +L L +LDL + + P+ G L L L L V +G F+N
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-48
Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 41/253 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVF-------NLLHHGAFKSFIAECNTLKNIRHRN 689
+IG G FG V+KG L + K+ VA+K F+ F E + N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK+ + +V EF+ L L + + +L +
Sbjct: 85 IVKLYGLMH-------NPPRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLM 128
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDE-----EMMAHVSDFGLARFLPLSPAQTS 804
+D+A + Y+ + PPI H DL+ N+ L + A V+DFGL++ S
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HS 182
Query: 805 SIDAKGSIGYIAPE--YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL---- 858
G+ ++APE + D YS+ ++L ++T + P D G +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 859 -HNFARMALPDHV 870
R +P+
Sbjct: 243 REEGLRPTIPEDC 255
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-47
Identities = 99/507 (19%), Positives = 181/507 (35%), Gaps = 67/507 (13%)
Query: 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFY 85
L+ +L + + L ++ L + I + + +NL QI
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFG 145
N+L P L +L+K+ + ++ N + P L NL+++ L L +N + D
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLK 131
Query: 146 WLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVF 205
L NL L ++ N +S S++ ++S+ G NQ+ + PL L L+ +
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLA---NLTTLERLDIS 185
Query: 206 ENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLN 265
N+++ ++ +NLE A N+++ + L L S+ N L ++
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL-----KDIG 237
Query: 266 FLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNL 325
L SLTN L L L NN+I P + L
Sbjct: 238 TLASLTN----------------------------LTDLDLANNQISNLAP--LSGLTKL 267
Query: 326 QRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGS 385
L++ N++S P + L L L L N+ L +I P + L L N +
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQ-LEDISPISNLKNLTYLTLYFNNISDI 324
Query: 386 IPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445
P + L + +N ++ L+ + L NQ++ P + NL +
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINW-LSAGHNQISDLTP--LANLTRI 377
Query: 446 EVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505
L + + + + ++ L P+++S D++ N S
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS- 434
Query: 506 KIPEFLVGFQLLENLNLSNNNLEGMVP 532
E F + G V
Sbjct: 435 YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-42
Identities = 100/451 (22%), Positives = 174/451 (38%), Gaps = 43/451 (9%)
Query: 94 SELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATL 153
+L++ + N+T ++ +L + TL + D +L NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 154 AMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAI 213
+ N L+ P + N++ + NQ+ + PL L NL ++F NQ+T
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITD-- 126
Query: 214 PPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNS 273
+ N +NL + N ++ + L L S + + L L N
Sbjct: 127 IDPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSF---------GNQVTDLKPLANL 176
Query: 274 TRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNN 333
T L RL I++N + ++ L T LE L+ NN+I P +G NL L + N
Sbjct: 177 TTLERLDISSNKVSDISV--LAKL-TNLESLIATNNQISDITP--LGILTNLDELSLNGN 231
Query: 334 RLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQY 393
+L + L NL +L L N+ + N+ P G K+ L L N + P L
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQ-ISNLAPLSGLTKLTELKLGANQISNISP--LAGL 286
Query: 394 KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFEN 453
LT ++L++N L P + L L L N ++ P V +L L+ L + N
Sbjct: 287 TALTNLELNENQLEDISP---ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 454 KLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVG 513
K+ S+L + + L N + P L++L + L L+ + +
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY--- 394
Query: 514 FQLLENLNLSNNNLEGMVPIEGVFKNATITS 544
+ N N ++ + + T
Sbjct: 395 KANVSIPNTVKNVTGALIAPATISDGGSYTE 425
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-46
Identities = 96/512 (18%), Positives = 182/512 (35%), Gaps = 34/512 (6%)
Query: 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRL 83
G + +K L L N + + LQVL L ++ I I + S +L + L
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDL 81
Query: 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDNNLDGGIP- 141
N L S G LS +++L++ N + S NL+++ TL + + I
Sbjct: 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 142 DTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQF 201
F L +L L + L S+ +I I +++ ++ + L ++++
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI-LSSVRY 200
Query: 202 FSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGH 261
+ + L + + + + L+ S E R
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS----------VLTDESFNELLKLLRYI 250
Query: 262 SNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGK 321
L+ + + LN L + ++ + T+ L + +F ++
Sbjct: 251 LELSEVEFDDCT--LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 322 FVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN----LDL 377
++R+ + N+++ L++L L L N + + + L L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 378 SCNFLQ--GSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435
S N L+ L K LT +D+S N +P + L+LS + +
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF-LNLSSTGIR-VV 425
Query: 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
+ + LEVLDV N L L L++L + N L+ +P + S L V
Sbjct: 426 KT--CIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDA-SLFPVLLV 477
Query: 496 LDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
+ +S+N L L+ + L N
Sbjct: 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-44
Identities = 90/509 (17%), Positives = 174/509 (34%), Gaps = 41/509 (8%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ SL L+ I + L+VL+L ++ N F L L+ L L++N +
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 65 GGEIPANISSCSNLIQIRLFYNELVG-KIPSELGSLSKIEHLSVSVNNLTGSIP-SSLGN 122
+ S+L + L N + S +L+ ++ L + I
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
L+S+N L + +L + ++++ L + + + + +SS+ +
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
L + + L N+L + Y+ +
Sbjct: 207 NLAR-FQFSPLPVDEVSSPMKKLAFR-------------GSVLTDESFNELLKLLRYILE 252
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTN--STRLNRLLINANNFGGLLPACISNLSTT 300
+ T N LG S + + L + + RL I L S L
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL-EK 311
Query: 301 LEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP---AIGELQNLRELRLQRN 357
++ + ++N+K+F + +L+ L++ N + G +L+ L L +N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 358 KF--LGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQF 414
+ + L + +LD+S N +P S + + ++LS + +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429
Query: 415 LGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEM 474
L LD+S N L S L L+ L + NKLK +P L +++
Sbjct: 430 PQ---TLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKI 480
Query: 475 QGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
N L+ L L + L N
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 76/464 (16%), Positives = 149/464 (32%), Gaps = 71/464 (15%)
Query: 74 SCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTD 133
SC IPS L + ++ L +S N +T L +++ L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 134 NNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQGVIPLDF 192
+ ++ D F L +L L +++N LS ++ SS F +SS+ + N Q +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 193 GFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSIT 252
L NLQ + + I
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRI------------------------------------ 142
Query: 253 ENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIF 312
T LN L I A + + ++ + L L ++
Sbjct: 143 ----------------DFAGLTSLNELEIKALSLRNYQSQSLKSI-RDIHHLTLHLSESA 185
Query: 313 GNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-K 371
+ +++ LE+ + L+ + + ++ + S L K
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 372 VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQL 431
+ L + ++ + G + D + + + + L + + L
Sbjct: 246 LLRYILELSEVEFDDCTLNG------LGDFNPSESDVVSELGKVETVTIRR-LHIPQFYL 298
Query: 432 TGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQ---GPIPSSLS 488
+ + L+ ++ + V +K+ S K LE L++ N + +
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 489 SLKGLNVLDLSQNNLS--GKIPEFLVGFQLLENLNLSNNNLEGM 530
+ L L LSQN+L K E L+ + L +L++S N M
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPM 402
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 49/362 (13%), Positives = 113/362 (31%), Gaps = 30/362 (8%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ + L L + A + LS ++ L L + + S + +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ + L++ L +E+ E + + +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVET 285
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMN 182
+I L + L + + L+ + + + + + +P S ++ S+ D N
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344
Query: 183 QLQGVIPLDFGF--TLQNLQFFSVFENQLT--GAIPPAISNASNLELFQADVNKLTGEVP 238
+ + +LQ + +N L + NL N
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPD 404
Query: 239 YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS 298
+ P+++ +++ + L L ++ NN S
Sbjct: 405 SCQWPEKMRFLNLSSTGIRVVKTCIP---------QTLEVLDVSNNNL-----DSFSLFL 450
Query: 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRN 357
L+ L + NK+ +P A F L +++ N+L ++P L +L+++ L N
Sbjct: 451 PRLQELYISRNKL-KTLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
Query: 358 KF 359
+
Sbjct: 508 PW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 32/145 (22%), Positives = 53/145 (36%), Gaps = 6/145 (4%)
Query: 396 LTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455
+ D + T +IP GL+ + LDLS N++T ++ NL+VL + +++
Sbjct: 7 SGVCDGRSRSFT-SIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG-KIPEFLVGF 514
S LE L++ N L S L L L+L N +
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 515 QLLENLNLSNNNLEGMVPIEGVFKN 539
L+ L + N + F
Sbjct: 123 TNLQTLRIGNVETFSEIR-RIDFAG 146
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 34/179 (18%), Positives = 62/179 (34%), Gaps = 16/179 (8%)
Query: 10 NLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNH--GIPSEFDRLQRLQVLALNNNSIGGE 67
+ L S G L+ L+L N L+ L L ++ N+
Sbjct: 345 LMVEEYLKNSAC--KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 68 IPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
+P + + + L + + + + +E L VS NNL S L L
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQ--- 454
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQ 185
L+++ N L + L + ++ N L ++P IF ++S+ N
Sbjct: 455 ELYISRNKLKTLPDASL--FPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-46
Identities = 60/315 (19%), Positives = 108/315 (34%), Gaps = 66/315 (20%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
IG G FG VY G VA+++ ++ + K+F E + RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
AC A++ + R+L + +A L++ + I ++
Sbjct: 96 GACM----SPPHL-AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVK 141
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF---LPLSPAQTSSIDAKGS 811
+ YLH I H DLK NV D ++DFGL L + G
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 812 IGYIAPE---------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862
+ ++APE S + DV++ G + EL R+ P F+
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP----- 247
Query: 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD 922
+ ++ + + ++I + I + C +
Sbjct: 248 ----AEAII-------------WQMGTGMKPNLSQIG----MGKEISDILLFCWAFEQEE 286
Query: 923 RMNMTNVVRQLQSIK 937
R T ++ L+ +
Sbjct: 287 RPTFTKLMDMLEKLP 301
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 61/315 (19%), Positives = 119/315 (37%), Gaps = 43/315 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECN--TLKNIRHRNLVKIL 694
+G G +G V++G VAVK+F+ KS+ E +RH N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQG--ENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + L+ + + SL ++L +L+ + L I + +A
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIAS 116
Query: 755 ALSYLHHD-----CQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP--LSPAQTSSID 807
L++LH + +P I H DLK N+L+ + ++D GLA + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 808 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
G+ Y+APE + D++++G++L E+ R + +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED-------- 228
Query: 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921
P + V D + D + QR L ++ ++ C ++P
Sbjct: 229 --YKPPFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 922 DRMNMTNVVRQLQSI 936
R+ + + L I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 52/249 (20%), Positives = 93/249 (37%), Gaps = 33/249 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G FG K + + +K ++F+ E ++ + H N++K +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
Y+ + E+++ +L + QR++ D+A +
Sbjct: 76 L----YKDKRL-NFITEYIKGGTLRGIIK---------SMDSQYPWSQRVSFAKDIASGM 121
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP------------LSPAQTS 804
+YLH I H DL N L+ E V+DFGLAR + P +
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 805 SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF----EGDMNLHN 860
G+ ++APE G DV+S+GI+L E++ R + +N+
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 861 FARMALPDH 869
F P +
Sbjct: 239 FLDRYCPPN 247
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 66/317 (20%), Positives = 112/317 (35%), Gaps = 43/317 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+IG G +G V+ G VAVKVF ++ E +RH N++ + A
Sbjct: 43 KQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAA 99
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
L+ ++ +N SL ++L +L+ L + L
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGL 147
Query: 757 SYLH-----HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+LH +P I H DLK N+L+ + ++D GLA I
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT-NEVDIPPNTR 206
Query: 812 IG---YIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
+G Y+ PE L ++ N D+YS+G++L E+ R + E + H+
Sbjct: 207 VGTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921
+ ++ R S ECL M ++ C +P
Sbjct: 266 VPSDPSYEDM-----------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 922 DRMNMTNVVRQLQSIKN 938
R+ V + L +
Sbjct: 315 SRLTALRVKKTLAKMSE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 60/317 (18%), Positives = 118/317 (37%), Gaps = 45/317 (14%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECN--TLKNIRHRNLVKIL 694
IG G FG V++G VAVK+F+ +S+ E +RH N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWRG--EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
A + + LV ++ ++ SL ++L+ ++ + + + + A
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTAS 150
Query: 755 ALSYLHHD-----CQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP--LSPAQTSSID 807
L++LH + +P I H DLK N+L+ + ++D GLA +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 808 AKGSIGYIAPEYGLGSEVSING-------DVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860
G+ Y+APE L +++ D+Y+ G++ E+ R + +
Sbjct: 211 RVGTKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL---P 266
Query: 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920
+ + D V+ + + R E L M +I C +
Sbjct: 267 YYDLVPSDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318
Query: 921 GDRMNMTNVVRQLQSIK 937
R+ + + L +
Sbjct: 319 AARLTALRIKKTLSQLS 335
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 100/520 (19%), Positives = 182/520 (35%), Gaps = 82/520 (15%)
Query: 20 ISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLI 79
I+P + +FL+ L ++++ +P E + ++ + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 80 QIRLFYNELVG------------KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
RL +P L E L S N+LT +P +L S+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLL 117
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
L P L L ++ N L +P + N S + D N L+ +
Sbjct: 118 VDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL 168
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
L +L+F + NQL P + N L AD N L ++P + P L
Sbjct: 169 PDL-----PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLP--DLPLSLE 218
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
N L L L +L L + + N L P +L L +
Sbjct: 219 SIVAGNNIL-----EELPELQNLPF---LTTIYADNNLLKTL-PDLPPSLEA----LNVR 265
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI 367
+N + ++P +L L++ N S + NL L N+ + ++
Sbjct: 266 DNYL-TDLPELPQ---SLTFLDVSENIFS-GLSELPP---NLYYLNASSNE-IRSLCDLP 316
Query: 368 GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLS 427
+L+ L++S N L +P+ + L + S N+L +P L L +
Sbjct: 317 PSLEE--LNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLKQL----HVE 365
Query: 428 RNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSL 487
N L P ++++L + + L E+P + L+QL ++ N L+ P
Sbjct: 366 YNPLR-EFPDIPESVEDLRMN----SHLA-EVPELPQN---LKQLHVETNPLRE-FPDIP 415
Query: 488 SSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
S++ L ++ + LE+ +++
Sbjct: 416 ESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 59/243 (24%), Positives = 96/243 (39%), Gaps = 38/243 (15%)
Query: 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGEL------------ 346
T L+ L ++ + +P + + PP GE
Sbjct: 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 347 -QNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNN 405
+ EL L L ++P +L+ +L SCN L +P K+L + + +
Sbjct: 70 DRQAHELELNNLG-LSSLPELPPHLE--SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 406 LTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGS 465
L+ P LL L +S NQL +P E+ N L+++DV N LK ++P S
Sbjct: 126 LSDLPP--------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
Query: 466 CKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNN 525
LE + N L+ L +L L + N+L K+P+ + LE++ NN
Sbjct: 175 ---LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNN 225
Query: 526 NLE 528
LE
Sbjct: 226 ILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 57/291 (19%), Positives = 91/291 (31%), Gaps = 58/291 (19%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLS------------TTLEMLLLDNNKIFGNIP 316
N + + P L L+N + ++P
Sbjct: 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL-SSLP 87
Query: 317 AAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLD 376
+L+ L N L+ +P L++L + L+ L
Sbjct: 88 ELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA----LSDLPPLLEY--LG 137
Query: 377 LSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIP 436
+S N L+ +P L L IID+ +N+L +P L ++ NQL +P
Sbjct: 138 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI----AAGNNQLE-ELP 189
Query: 437 SEVGNLKNLEVLDVFENKLKG------------------EIPSTLGSCKKLEQLEMQGNF 478
E+ NL L + N LK E L + L + N
Sbjct: 190 -ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNL 248
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
L+ +P SL+ LNV D +L L L++S N G
Sbjct: 249 LKT-LPDLPPSLEALNVRDNYLTDLPELPQS-------LTFLDVSENIFSG 291
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 77/365 (21%), Positives = 133/365 (36%), Gaps = 61/365 (16%)
Query: 10 NLTSLKLAG---SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
L L ++ P + N SFLK++ + NNS +P L+ +A NN +
Sbjct: 132 LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE- 186
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
E+P + + L I N L K+P SL E + N L L NL +
Sbjct: 187 ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNILE--ELPELQNLPFL 239
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186
T++ +N L +PD +L L + +N+L+ +P +++ + + + L
Sbjct: 240 TTIYADNNLL-KTLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294
Query: 187 VIP----LDFGF--------TLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234
+ P L+ +L+ +V N+L +P LE A N L
Sbjct: 295 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA 350
Query: 235 GEVPYLEKPQRLSVFSITENSLGSRGHSNL-NFLCSLTNSTRLNRLLINANNFGGLLPAC 293
EVP E PQ L + N L + S+ + + L +P
Sbjct: 351 -EVP--ELPQNLKQLHVEYNPL-----REFPDIPESVEDLRMNSHLAE--------VPEL 394
Query: 294 ISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELR 353
NL L ++ N + P +++ L M + R+ A L +
Sbjct: 395 PQNLKQ----LHVETNPL-REFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDV 446
Query: 354 LQRNK 358
+ +
Sbjct: 447 FEHHH 451
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-39
Identities = 73/364 (20%), Positives = 148/364 (40%), Gaps = 34/364 (9%)
Query: 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLEL 225
+++ + V+ + L+++ V ++ I +NLE
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVAS--IQGIEYLTNLEY 70
Query: 226 FQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANN 285
+ N++T + L +L+ I N + ++++ L +LTN L L +N +N
Sbjct: 71 LNLNGNQITD-ISPLSNLVKLTNLYIGTNKI-----TDISALQNLTN---LRELYLNEDN 121
Query: 286 FGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGE 345
+ P ++NL T + L L N ++ + L L + +++ I
Sbjct: 122 ISDISP--LANL-TKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD--VTPIAN 175
Query: 346 LQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDN 404
L +L L L N+ + +I P + +L + N + P + L + + +N
Sbjct: 176 LTDLYSLSLNYNQ-IEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 405 NLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464
+T P LS L L++ NQ++ + V +L L++L+V N++ S L
Sbjct: 232 KITDLSP--LANLS-QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLN 284
Query: 465 SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524
+ +L L + N L + L L L LSQN+++ P L +++ + +N
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
Query: 525 NNLE 528
++
Sbjct: 343 QVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 77/378 (20%), Positives = 155/378 (41%), Gaps = 36/378 (9%)
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
TL ++ PD L + + ++ + + SIT ++ +
Sbjct: 4 TLATLPAPINQIFPDAD--LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI 59
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
+++ L NL++ ++ NQ+T P +SN L NK+T ++ L+ L
Sbjct: 60 QGIEY---LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLR 113
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
+ E+++ S+++ L +LT + L + AN+ L +SN+ T L L +
Sbjct: 114 ELYLNEDNI-----SDISPLANLTK---MYSLNLGANHNLSDLSP-LSNM-TGLNYLTVT 163
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI 367
+K+ ++ I +L L + N++ + L +L N+ + +I P +
Sbjct: 164 ESKV-KDVTP-IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQ-ITDITP-V 217
Query: 368 GNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDL 426
N+ + +L + N + P L LT +++ N ++ L+ L L++
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLT-KLKMLNV 272
Query: 427 SRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSS 486
NQ++ S + NL L L + N+L E +G L L + N + P
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328
Query: 487 LSSLKGLNVLDLSQNNLS 504
L+SL ++ D + +
Sbjct: 329 LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 69/343 (20%), Positives = 134/343 (39%), Gaps = 35/343 (10%)
Query: 196 LQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENS 255
L + + +T + ++ K+ + +E L ++ N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQ 77
Query: 256 LGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNI 315
+ ++++ L +L L L I N + + NL T L L L+ + I
Sbjct: 78 I-----TDISPLSNLVK---LTNLYIGTNKITDISA--LQNL-TNLRELYLNEDNISDIS 126
Query: 316 PAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLK-VFN 374
P + + L + N + + + L L + +K + ++ P I NL +++
Sbjct: 127 P--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK-VKDVTP-IANLTDLYS 181
Query: 375 LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL--LIGLDLSRNQLT 432
L L+ N ++ P L +L N +T P ++ + L L + N++T
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-----VANMTRLNSLKIGNNKIT 234
Query: 433 GSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKG 492
P + NL L L++ N++ + + KL+ L + N + S L++L
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQ 288
Query: 493 LNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535
LN L L+ N L + E + G L L LS N++ + P+
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 2e-36
Identities = 83/402 (20%), Positives = 157/402 (39%), Gaps = 62/402 (15%)
Query: 11 LTSLKLA----GSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
+L I P +L+ +L S + L+ + L + +
Sbjct: 2 AATLATLPAPINQIFP-DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV-A 57
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
I I +NL + L N++ P L +L K+ +L + N +T S+L NL+++
Sbjct: 58 SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186
L+L ++N+ P L + +L + N + S + N++ + ++++
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRL 246
V P+ L +L S+ NQ+ P +++ ++L F A VN++T
Sbjct: 170 VTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT------------ 212
Query: 247 SVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLL 306
++ + ++T LN L I N L P ++NL + L L +
Sbjct: 213 ----------------DITPVANMTR---LNSLKIGNNKITDLSP--LANL-SQLTWLEI 250
Query: 307 DNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPS 366
N+I +I A+ L+ L + +N++S + L L L L N+
Sbjct: 251 GTNQI-SDIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 367 IGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT 407
IG L + L LS N + P L + D ++ +
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 72/353 (20%), Positives = 144/353 (40%), Gaps = 57/353 (16%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
++T L +AG SI + L+ L+ L L N S L +L L + N I
Sbjct: 45 SITKLVVAGEKVASIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI- 100
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
+ + + +NL ++ L + + S L +L+K+ L++ N+ S S L N++
Sbjct: 101 -TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTG 156
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
+N L +T++ + P L +L +L++ N + P + +++S+ F A +NQ+
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245
+ P+ + L + N++T P ++N S L + N+++
Sbjct: 213 DITPVA---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD---------- 257
Query: 246 LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLL 305
+ ++ + T+L L + +N + ++NL + L L
Sbjct: 258 ---------------------INAVKDLTKLKMLNVGSNQISDISV--LNNL-SQLNSLF 293
Query: 306 LDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK 358
L+NN++ IG NL L + N ++ P + L +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 10 NLTSLKLAG---SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
+L SL L + +L+ L Y N P + RL L + NN I
Sbjct: 178 DLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
P +++ S L + + N++ + + L+K++ L+V N ++ S L NLS +
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
N+LFL +N L + G L NL TL +++N ++ P + ++S + + D ++
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 53/316 (16%), Positives = 113/316 (35%), Gaps = 29/316 (9%)
Query: 207 NQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNF 266
L +S + + + T +L + +
Sbjct: 23 TALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNN---PQIETRTGRAL----KATADL 74
Query: 267 LCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQ 326
L T L + + P L + L+ + +D + +P + +F L+
Sbjct: 75 LEDAT-QPGRVALELRSVPLPQF-PDQAFRL-SHLQHMTIDAAGL-MELPDTMQQFAGLE 130
Query: 327 RLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN----------LD 376
L + N L +P +I L LREL ++ L +P + + L
Sbjct: 131 TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR 189
Query: 377 LSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIP 436
L ++ S+P+S+ + L + + ++ L+ + P L L LDL + P
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE-LDLRGCTALRNYP 246
Query: 437 SEVGNLKNLEVLDVFE-NKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
G L+ L + + + L +P + +LE+L+++G +PS ++ L +
Sbjct: 247 PIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 496 LDLSQNNLSGKIPEFL 511
+ + +L ++ +
Sbjct: 306 ILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 39/268 (14%), Positives = 87/268 (32%), Gaps = 26/268 (9%)
Query: 262 SNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIG- 320
L + + NA+ +N ++ + +
Sbjct: 20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-NNPQIETRTGRAL-KATADLLED 77
Query: 321 -KFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLK-VFNLDLS 378
LE+ + L P L +L+ + + L +P ++ + L L+
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG-LMELPDTMQQFAGLETLTLA 135
Query: 379 CNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSE 438
N L+ ++P+S+ L + + +P E
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD----------------ASGE 178
Query: 439 VGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDL 498
L NL+ L + ++ +P+++ + + L+ L+++ + L + ++ L L LDL
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236
Query: 499 SQNNLSGKIPEFLVGFQLLENLNLSNNN 526
P G L+ L L + +
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 60/388 (15%), Positives = 108/388 (27%), Gaps = 76/388 (19%)
Query: 114 GSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISS 173
GS + S L+ + D + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 174 ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKL 233
L+ L T + L P S+L+
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ--------- 107
Query: 234 TGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPAC 293
+I L LP
Sbjct: 108 --------------HMTIDAAGLME-------------------------------LPDT 122
Query: 294 ISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIG--------- 344
+ LE L L N + +PA+I L+ L + +P +
Sbjct: 123 MQQF-AGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180
Query: 345 ELQNLRELRLQRNKFLGNIPPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403
L NL+ LRL+ + ++P SI NL+ + +L + + L ++ ++ L +DL
Sbjct: 181 GLVNLQSLRLEWTG-IRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238
Query: 404 NNLTGTIPPQFLGLSWLLIGLDLS-RNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPST 462
PP F G + L L L + L ++P ++ L LE LD+ +PS
Sbjct: 239 CTALRNYPPIFGGRAPLKR-LILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 463 LGSCKKLEQLEMQGNFLQGPIPSSLSSL 490
+ + + + +
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 69/388 (17%), Positives = 114/388 (29%), Gaps = 85/388 (21%)
Query: 95 ELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLA 154
S E+L + L N D + N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQR-------HYNADRNRWHSAWRQANSNNPQ 59
Query: 155 MAENWLSG--TIPSSIFNISSI--TAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210
+ + + + A + L P L +LQ ++ L
Sbjct: 60 IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGLM 117
Query: 211 GAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSL 270
+P + + LE N L +P + SL
Sbjct: 118 -ELPDTMQQFAGLETLTLARNPLR-ALP--------------------------ASIASL 149
Query: 271 TNSTRLNRLLINANNFGGLLPACISNLS--------TTLEMLLLDNNKIFGNIPAAIGKF 322
L L I A LP +++ L+ L L+ I ++PA+I
Sbjct: 150 NR---LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANL 205
Query: 323 VNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLK-VFNLDLS-CN 380
NL+ L++ N+ LS + PAI L L EL L+ L N PP G + L L C+
Sbjct: 206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
Query: 381 FLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVG 440
L ++P + + L +DL L+ +PS +
Sbjct: 265 NLL-TLPLDIHRLTQLEKLDLRGC------------------------VNLS-RLPSLIA 298
Query: 441 NLKNLEVLDVFEN---KLKGEIPSTLGS 465
L ++ V + +L P +
Sbjct: 299 QLPANCIILVPPHLQAQLDQHRPVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 59/335 (17%), Positives = 105/335 (31%), Gaps = 78/335 (23%)
Query: 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN 62
+ +++ +LK L L + P + RL LQ + ++
Sbjct: 57 NPQIETRTGRALKATAD-LLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAA 114
Query: 63 SIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGN 122
+ E+P + + L + L N L +P+ + SL+++ LS+ +P L +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182
+ L NL +L + + ++P+SI N
Sbjct: 173 TDA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIAN------------ 204
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLE-LFQADVNKLTGEVPYLE 241
LQNL+ + + L+ A+ PAI + LE L L P
Sbjct: 205 -------------LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR-NYP--- 246
Query: 242 KPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTL 301
RL L + +N LP I L T L
Sbjct: 247 -----------------------PIFGGRAPLKRLI--LKDCSNLLT-LPLDIHRL-TQL 279
Query: 302 EMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLS 336
E L L +P+ I + + + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 18/93 (19%), Positives = 34/93 (36%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
+ L+L + P G + LK L+L + S +P + RL +L+ L L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSL 99
+P+ I+ I + + +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-36
Identities = 95/481 (19%), Positives = 185/481 (38%), Gaps = 34/481 (7%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
ILN++ ++ + + +LS L++L++ +N + S F Q L+ L L++N +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL- 81
Query: 66 GEIPANISSCSNLIQIRLFYNEL-VGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLS 124
+I + NL + L +N I E G++S+++ L +S +L S + +L+
Sbjct: 82 VKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184
L + L++ T ++ + + I ++S T + ++ +
Sbjct: 140 ISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVN-KLTGEVPYLEKP 243
+ V+ + ++ +L SNL L + + L
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKL-----------SNLTLNNIETTWNSFIRILQLVWH 246
Query: 244 QRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEM 303
+ FSI+ L + S + + ++ G + I + + + +
Sbjct: 247 TTVWYFSISNVKLQGQLD--FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNI 363
+ K L+ NN L+ T+ G L L L LQ N+ L +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ-LKEL 363
Query: 364 PPSIG------NLKVFNLDLSCNFLQGSIPSSL-GQYKTLTIIDLSDNNLTGTIPPQFLG 416
+L+ LD+S N + K+L +++S N LT TI F
Sbjct: 364 SKIAEMTTQMKSLQ--QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI---FRC 418
Query: 417 LSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQG 476
L + LDL N++ SIP +V L+ L+ L+V N+LK L+++ +
Sbjct: 419 LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
Query: 477 N 477
N
Sbjct: 478 N 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-29
Identities = 93/470 (19%), Positives = 174/470 (37%), Gaps = 38/470 (8%)
Query: 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNL 150
+P +L K L++S N ++ S + +LS + L ++ N + F + + L
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 151 ATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFT-LQNLQFFSVFENQL 209
L ++ N L I ++ D N +P+ F + L+F + L
Sbjct: 72 EYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 210 TGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFL-- 267
+ I++ + ++ + E P+ L F+ + + +F+
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEK----EDPEGLQDFNTESLHIVFPTNKEFHFILD 183
Query: 268 CSLTNSTRLNRLLINANNFGGLLPACISNLST-----TLEMLLLDNNKIFGNIPAAIGKF 322
S+ L I +S L+ L L L+N + N I +
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
Query: 323 V---NLQRLEMWNNRLSGTIP--PAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN--- 374
V + + N +L G + +L+ L + + P ++F+
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 375 -LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG 433
+ + + + + +D S+N LT T+ L+ L L L NQL
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET-LILQMNQLK- 361
Query: 434 SIPSEVG---NLKNLEVLDVFENKLK-GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSS 489
+ +K+L+ LD+ +N + E K L L M N L I L
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
Query: 490 LKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
+ VLDL N + IP+ +V + L+ LN+++N L+ VP +G+F
Sbjct: 422 R--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 58/385 (15%), Positives = 117/385 (30%), Gaps = 32/385 (8%)
Query: 164 IPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNL 223
+P + T + N + + D +L L+ + N++ L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDIL-SLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 224 ELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINA 283
E NKL ++ L ++ N+ + N ++L L ++
Sbjct: 72 EYLDLSHNKLV-KIS-CHPTVNLKHLDLSFNAFDALPICKE-----FGNMSQLKFLGLST 124
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI 343
+ I++L+ + +L+L P LQ + +
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE------GLQDFNTESLHIVFPTNKEF 178
Query: 344 GELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403
+ ++ + + N+K D C++ SI + L L+ + L++
Sbjct: 179 HFILDVSVKTVANLELS--------NIKCVLEDNKCSYFL-SILAKLQTNPKLSNLTLNN 229
Query: 404 NNLTGTIPPQFLGLSWL--LIGLDLSRNQLTGSIPSEVG-----NLKNLEVLDVFENKLK 456
T + L L W + +S +L G + +LK L + V +
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 457 GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQL 516
+ + + S + LD S N L+ + E
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 517 LENLNLSNNNLEGMVPIEGVFKNAT 541
LE L L N L+ + I +
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 66/377 (17%), Positives = 143/377 (37%), Gaps = 38/377 (10%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
K L L++ L S + +L+ KVLL+ +G + + LQ +L+
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE--TYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 67 EIPANISSCSNLIQIRLFYNELVG-----------KIPSELGSLSKIEHLSVSVNNLTGS 115
+ I S L + + I ++L + K+ +L+++ T +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 116 IPSSLGNL---SSINTLFLTDNNLDG-----GIPDTFGWLKNLATLAMAENWLSGTIPSS 167
+ L +++ +++ L G + LK L+ + + S
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSY 294
Query: 168 IFNI-SSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELF 226
I+ I S++ + ++ + ++ + + N LT + + + LE
Sbjct: 295 IYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 227 QADVNKLT---GEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINA 283
+N+L + + L I++NS+ + + L L +++
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG-----DCSWTKSLLSLNMSS 408
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-A 342
N + C L +++L L +NKI +IP + K LQ L + +N+L ++P
Sbjct: 409 NILTDTIFRC---LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGI 463
Query: 343 IGELQNLRELRLQRNKF 359
L +L+++ L N +
Sbjct: 464 FDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 50/232 (21%), Positives = 85/232 (36%), Gaps = 9/232 (3%)
Query: 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLK 456
++D S N L +P LS L++S+N ++ S++ +L L +L + N+++
Sbjct: 3 FLVDRSKNGLI-HVPK---DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 457 GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL-SGKIPEFLVGFQ 515
S ++LE L++ N L I L LDLS N + I +
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 516 LLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCISKESKHKKLTL 575
L+ L LS +LE + N + ++ L ++ T
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 576 ALKLALAIISGLTGLSLALSFLILCLVRKRKEKKNPSSPINSFPNISYQNLY 627
+ +S T +L LS I C++ K S N NL
Sbjct: 176 KEFHFILDVSVKTVANLELS-NIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 40/184 (21%), Positives = 63/184 (34%), Gaps = 8/184 (4%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
+ I N T +S L NN + L L+ L L N +
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 66 --GEIPANISSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSLGN 122
+I + +L Q+ + N + + L++S N LT +I L
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGM 181
I L L N + IP L+ L L +A N L ++P IF ++S+
Sbjct: 420 PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477
Query: 182 NQLQ 185
N
Sbjct: 478 NPWD 481
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHG--AFKSFIAECNTLKNIRHRNLV 691
+G G FGSV +G L D VAVK L + + F++E +K+ H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++L C + QG ++ FM+ L +L + E P+ + L L +D
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFMVD 155
Query: 752 VACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+A + YL + H DL N +L ++M V+DFGL++ + AK
Sbjct: 156 IALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 810 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR 844
+ +IA E + + S DV+++G+ + E+ TR
Sbjct: 211 MPVKWIAIESLADRVYTSKS---DVWAFGVTMWEIATR 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 694
+++G G +G VY+G+ + TVAVK L + F+ E +K I+H NLV++L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
C+ + F ++ EFM +L ++L E + ++ + L + ++
Sbjct: 283 GVCT----REPPFY-IITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISS 329
Query: 755 ALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
A+ YL + I H +L N L+ E + V+DFGL+R + T+ AK I
Sbjct: 330 AMEYLEKKNF---I-HRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIK 384
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ APE ++ SI DV+++G+LL E+ T P +
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-33
Identities = 83/465 (17%), Positives = 165/465 (35%), Gaps = 28/465 (6%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
K L L NS + + L L+VL L++N I + ++ +L + + +N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 89 VGKIPSELGSLSKIEHLSVSVNNLTGSIPSS--LGNLSSINTLFLTDNNLDGGIPDTFGW 146
I ++ + HL +S N+ +P GNL+ + L L+
Sbjct: 113 Q-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 147 LK-NLATLAMAENWLSGTIPSSIFNI-SSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSV 204
L + L + + G S+ +++ N L V L +LQ ++
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 205 FENQLTGAIPPAI-------SNASNLELFQADVN-KLTGEVPYLEKPQRLSVFSITENSL 256
N N+ L + K + ++ P+ + +I ++
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 257 GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIP 316
+ + + + N + ++ + + +L +
Sbjct: 289 --TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 317 AAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKF--LGNIPPSIGNLKVFN 374
+ L N + ++ L+ L+ L LQRN + N+
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406
Query: 375 L-DLSCNFLQGSIPSSLGQY-KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT 432
D+S N L + +++ +++LS N LTG++ F L + LDL N++
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM 463
Query: 433 GSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGN 477
SIP +V +L+ L+ L+V N+LK L+ + + N
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 42/239 (17%), Positives = 88/239 (36%), Gaps = 16/239 (6%)
Query: 3 HQRVKILNLTSLKLAGSISPHVGN-----LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVL 57
+ V+ LN+ +L + I L L + + N F + + + +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 58 ALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIP 117
L+ + S S+ + N + +L +++ L + N L +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393
Query: 118 SSLGNLSSINTLFLTDNNLD----GGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISS 173
++++L D +L+ T W +++ L ++ N L+G++ +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PK 451
Query: 174 ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVN 231
+ D N++ IP D LQ LQ +V NQL ++P ++L+ N
Sbjct: 452 VKVLDLHNNRIM-SIPKDV-THLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 57/446 (12%), Positives = 126/446 (28%), Gaps = 83/446 (18%)
Query: 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF 169
NLT +P L L+ N++ +L L L ++ N + ++ +F
Sbjct: 41 RNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVF 96
Query: 170 -NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPA--ISNASNLELF 226
+ D N+LQ I + +L+ + N +P N + L
Sbjct: 97 LFNQDLEYLDVSHNRLQN-ISCC---PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFL 151
Query: 227 QADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNF 286
K ++L + + L ++ +
Sbjct: 152 GLSAAKF----------RQLDLLPVAHLHLSCILLDLVS------------------YHI 183
Query: 287 GGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGEL 346
G + +TT+ L+ N +F L L++ N +L+ +
Sbjct: 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQ--VNMSVNALGHLQLSNIKLNDENCQRLMTF 241
Query: 347 QNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNL 406
+ ++ +++ F + + +++ + +
Sbjct: 242 LSELTRGPTLLNV------TLQHIETTWKCSVKLF-------QFFWPRPVEYLNIYNLTI 288
Query: 407 TGTIPPQFLGLSWL----LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPST 462
T I + S L+ + S + + + + +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP------ 342
Query: 463 LGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNL 522
F+ P S SS L+ +QN + + + + L+ L L
Sbjct: 343 ---------------FIHMVCPPSPSSFT---FLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 523 SNNNLEGMVPIEGVFKNATITSVLGN 548
N L+ + + KN + L
Sbjct: 385 QRNGLKNFFKVALMTKNMSSLETLDV 410
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGAF-----KSFIAECNTLKNIRHR 688
+G G FGSV + L D VAVK+ L + F+ E +K H
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKM---LKADIIASSDIEEFLREAACMKEFDHP 85
Query: 689 NLVKILTACSGVDYQGNDFKAL-VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++ K++ +G + + FM++ L +L + E P +L L +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLVR 141
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
+D+AC + YL + H DL N +L E+M V+DFGL+R + +
Sbjct: 142 FMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKI-----YSGD 191
Query: 806 IDAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVTR 844
+G + A E L + S DV+++G+ + E++TR
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHS---DVWAFGVTMWEIMTR 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 694
++G G FG V+ T VAVK + G+ ++F+AE N +K ++H LVK+
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + ++ EFM SL ++L + D+ L + ++ +A
Sbjct: 250 AVVTK------EPIYIITEFMAKGSLLDFL----KSDE----GSKQPLPKLIDFSAQIAE 295
Query: 755 ALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
++++ + H DL+ +N+L+ ++ ++DFGLAR + T+ AK I
Sbjct: 296 GMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIK 350
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ APE +I DV+S+GILL+E+VT
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-32
Identities = 80/381 (20%), Positives = 127/381 (33%), Gaps = 53/381 (13%)
Query: 146 WLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVF 205
A L + E+ L+ T+P + IT N L +P L+ V
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP----ELRTLEVS 89
Query: 206 ENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLN 265
NQLT ++P L +F + L P L I N L S
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPAL------PSGLCKLWIFGNQLTS------- 135
Query: 266 FLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNL 325
L+ ++N LPA S L L NN++ ++P L
Sbjct: 136 LPVLPPGLQELSV----SDNQLASLPALPSELCK----LWAYNNQL-TSLPMLPS---GL 183
Query: 326 QRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGS 385
Q L + +N+L+ ++P EL L + L ++P LK L +S N L S
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNR----LTSLPALPSGLKE--LIVSGNRLT-S 235
Query: 386 IPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445
+P + L + +S N LT ++P GL L + RNQLT +P + +L +
Sbjct: 236 LPVLPSE---LKELMVSGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLSSE 286
Query: 446 EVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505
+++ N L L S+ + L + + L
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL--HLAAADWLVP 344
Query: 506 KIPEFLVGFQLLENLNLSNNN 526
+N
Sbjct: 345 AREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 66/294 (22%)
Query: 268 CSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQR 327
C + LN + + L P C+ + L++ +N + ++PA L+
Sbjct: 37 CLNNGNAVLN---VGESGLTTL-PDCLP---AHITTLVIPDNNL-TSLPALPP---ELRT 85
Query: 328 LEMWNNRLSGTIPPAIGELQNLRELRLQRNKF----------------LGNIPPSIGNLK 371
LE+ N+L+ ++P L L L ++P L+
Sbjct: 86 LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQ 144
Query: 372 VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQL 431
L +S N L S+P+ + L + +N LT ++P GL L +S NQL
Sbjct: 145 --ELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQEL----SVSDNQL 193
Query: 432 TGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLK 491
S+P+ L L + N+L +P+ L++L + GN L +P S LK
Sbjct: 194 A-SLPTLPSELYKLWAYN---NRLT-SLPALPSG---LKELIVSGNRLTS-LPVLPSELK 244
Query: 492 GLNV-----------------LDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
L V L + +N L+ ++PE L+ +NL N L
Sbjct: 245 ELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 76/427 (17%), Positives = 146/427 (34%), Gaps = 92/427 (21%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89
VL + + +P + L + +N++ +PA L + N+L
Sbjct: 42 NAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT 94
Query: 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKN 149
+P L ++ S + +L ++PS L L + N L +P
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLW------IFGNQL-TSLPVLPP---G 142
Query: 150 LATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
L L++++N L+ ++P+ + + A++ NQL +P+ LQ SV +NQL
Sbjct: 143 LQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPS----GLQELSVSDNQL 193
Query: 210 TGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCS 269
++P S L + N+LT +P P L ++ N L S
Sbjct: 194 A-SLPTLPSELYKLWAYN---NRLT-SLP--ALPSGLKELIVSGNRLTS----------- 235
Query: 270 LTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLE 329
LP S L+ L++ N++ ++P L L
Sbjct: 236 --------------------LPVLPSE----LKELMVSGNRL-TSLPMLPS---GLLSLS 267
Query: 330 MWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS 389
++ N+L+ +P ++ L + + L+ N L I S+
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNP-LSERTLQALR---------------EITSA 310
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLD 449
G + D++ + L + L+ G N +
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD-RWHMFGQEDNADAFS 369
Query: 450 VFENKLK 456
+F ++L
Sbjct: 370 LFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 34/133 (25%), Positives = 51/133 (38%), Gaps = 20/133 (15%)
Query: 8 ILNLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
L L ++ S+ L L NN +P+ L+ L ++ N
Sbjct: 180 PSGLQELSVSDNQLASLPTLPSELYKLWAY---NNRLTS-LPAL---PSGLKELIVSGNR 232
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ +P S L ++ + N L +P L LSV N LT +P SL +L
Sbjct: 233 LT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHL 283
Query: 124 SSINTLFLTDNNL 136
SS T+ L N L
Sbjct: 284 SSETTVNLEGNPL 296
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS--FIAECNTLKNIRHRNLVKIL 694
++G G FG V+ G G T VA+K L G F+ E +K +RH LV++
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
S + +V E+M SL ++L E + L L Q +++ +A
Sbjct: 246 AVVSE------EPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIAS 291
Query: 755 ALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
++Y+ + H DL+ +N+L+ E ++ V+DFGLAR + T+ AK I
Sbjct: 292 GMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 346
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ APE L +I DV+S+GILL EL T+ + P M
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF-KSFIAECNTLKNIRHRNLVKILT 695
IG G FG V G VAVK + + A ++F+AE + + +RH NLV++L
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ +V E+M SL ++L L L +DV A
Sbjct: 254 VIV----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEA 301
Query: 756 LSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+ YL ++ H DL NVL+ E+ +A VSDFGL + ++ K + +
Sbjct: 302 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW 352
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVT 843
APE + S DV+S+GILL E+ +
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 694
+++G G +G VY+G+ + TVAVK L + F+ E +K I+H NLV++L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 695 TACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
C+ Y ++ EFM +L ++L RE + ++ + L + +
Sbjct: 76 GVCTREPPFY-------IITEFMTYGNLLDYL----RECN----RQEVSAVVLLYMATQI 120
Query: 753 ACALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ A+ YL + H DL N L+ E + V+DFGL+R + T+ AK
Sbjct: 121 SSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 175
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 844
I + APE ++ SI DV+++G+LL E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 55/224 (24%), Positives = 83/224 (37%), Gaps = 30/224 (13%)
Query: 638 EIGVGSFGSVYKGIL---DQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLV 691
++G GSFG V +G +VAVK L A FI E N + ++ HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++ + +V E SL + L + L +
Sbjct: 85 RLYGVVLTPPMK------MVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQ 129
Query: 752 VACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDA 808
VA + YL H DL N+LL + + DFGL R LP +
Sbjct: 130 VAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
K + APE S D + +G+ L E+ T ++P +
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLV 691
+G G FG+V+KG+ + K V +KV +F++ + ++ H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++L C G Q LV +++ SL + + R+ + +L LN G+
Sbjct: 79 RLLGLCPGSSLQ------LVTQYLPLGSLLDHV----RQHR-----GALGPQLLLNWGVQ 123
Query: 752 VACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
+A + YL H + H +L NVLL V+DFG+A LP Q +AK
Sbjct: 124 IAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
I ++A E + + DV+SYG+ + EL+T +P +
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF--KSFIAECNTLKNIRHRNLVKIL 694
+G G FG V+ G G T VAVK L G+ +F+AE N +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + ++ E+M+N SL ++L + L + + L++ +A
Sbjct: 75 AVVTQ------EPIYIITEYMENGSLVDFL----KTPS----GIKLTINKLLDMAAQIAE 120
Query: 755 ALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
++++ + H DL+ +N+L+ + + ++DFGLAR + T+ AK I
Sbjct: 121 GMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIK 175
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ APE +I DV+S+GILL E+VT
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 688
+G G+FG+VYKG+ ++ K VA+K L K + E + ++ +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNP 77
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
++ ++L C Q L+ + M L +++ RE K ++ LN
Sbjct: 78 HVCRLLGICLTSTVQ------LITQLMPFGCLLDYV----REHK-----DNIGSQYLLNW 122
Query: 749 GIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSI 806
+ +A ++YL + H DL NVL+ ++DFGLA+ L + +
Sbjct: 123 CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 807 DAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
K I ++A E + + + S DV+SYG+ + EL+T KP D +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGI 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 58/217 (26%), Positives = 85/217 (39%), Gaps = 38/217 (17%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLVKI 693
+IG G+FG V+ G L T VAVK F+ E LK H N+V++
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 694 LTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ C+ Y +V E +Q +L R + L + L + D
Sbjct: 178 IGVCTQKQPIY-------IVMELVQGGDFLTFL----RTEG-----ARLRVKTLLQMVGD 221
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
A + YL H DL N L+ E+ + +SDFG++R A G
Sbjct: 222 AAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-----ADGVYAASGG 273
Query: 812 IGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 843
+ + APE S DV+S+GILL E +
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-31
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKS--FIAECNTLKNIRHRNLVKIL 694
++G G FG V+ G G T VA+K L G F+ E +K +RH LV++
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
S + +V E+M SL ++L E + L L Q +++ +A
Sbjct: 329 AVVSE------EPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIAS 374
Query: 755 ALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
++Y+ + H DL+ +N+L+ E ++ V+DFGLAR + T+ AK I
Sbjct: 375 GMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 429
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ APE L +I DV+S+GILL EL T+ + P M
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 44/236 (18%), Positives = 88/236 (37%), Gaps = 14/236 (5%)
Query: 294 ISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELR 353
I ++ + ++ + + + N++ L++ N LS + L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 354 LQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ 413
L N L + LDL+ N++ L ++ + ++NN++ +
Sbjct: 65 LSSNV-LYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSR 118
Query: 414 FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKG-EIPSTLGSCKKLEQL 472
G + L+ N++T + G ++ LD+ N++ S LE L
Sbjct: 119 GQGKKN----IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 473 EMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+Q NF+ + + L LDLS N L+ + + ++L NN L
Sbjct: 175 NLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 47/356 (13%), Positives = 98/356 (27%), Gaps = 71/356 (19%)
Query: 92 IPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA 151
I + ++ + V+ ++L ++ S + ++ L L+ N L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 152 TLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG 211
L ++ N + ++ L L+ + N +
Sbjct: 62 LLNLSSN-----------VLYETLDLES----------------LSTLRTLDLNNNYVQ- 93
Query: 212 AIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLT 271
+ ++E A N ++ ++ +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS---------------RVSCSRG--------------- 119
Query: 272 NSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG-NIPAAIGKFVNLQRLEM 330
+ + N L + ++ L L N+I N L+ L +
Sbjct: 120 --QGKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 331 WNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSS 389
N + + + L+ L L NK L + P + V + L N L I +
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445
L + L DL N F + + + + E + L
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 54/319 (16%), Positives = 104/319 (32%), Gaps = 24/319 (7%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
R KI +T L +++ + +K L L N + ++ +L++L L++N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ E + S S L + L N + EL IE L + NN++ + S
Sbjct: 70 L-YETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RG 119
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG-TIPSSIFNISSITAFDAGMN 182
++L +N + G + L + N + + ++ + N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
+ V L+ + N+L + P +A+ + NKL L
Sbjct: 180 FIYDVKGQVV---FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
Q L F + N + ++ R+ A L + T+
Sbjct: 236 SQNLEHFDLRGN--------GFHCGTLRDFFSKNQRVQTVAKQTVKKLT-GQNEEECTVP 286
Query: 303 MLLLDNNKIFGNIPAAIGK 321
L ++PA
Sbjct: 287 TLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 53/353 (15%), Positives = 111/353 (31%), Gaps = 69/353 (19%)
Query: 19 SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNL 78
+I N + K+ + ++S + S ++ L L+ N + A+++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 79 IQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG 138
+ L N L +L SLS + L ++ N + L SI TL +NN+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 139 GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQN 198
+ + +A N ++ S + D +N++ V + +
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 199 LQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGS 258
L+ ++ N + + +
Sbjct: 171 LEHLNLQYNFIY-DVKGQV----------------------------------------- 188
Query: 259 RGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAA 318
L L +++N + P + + + L NNK+ I A
Sbjct: 189 -------VFAKLK------TLDLSSNKLAFMGPE-FQSA-AGVTWISLRNNKL-VLIEKA 232
Query: 319 IGKFVNLQRLEMWNNRLS-GTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL 370
+ NL+ ++ N GT+ + Q ++ + Q K L +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 31/144 (21%), Positives = 58/144 (40%), Gaps = 11/144 (7%)
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKN 444
+I I ++D++L + + LDLS N L+ +++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKE-LDLSGNPLSQISAADLAPFTK 59
Query: 445 LEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS 504
LE+L++ N L E L S L L++ N++ L + L + NN+S
Sbjct: 60 LELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 505 GKIPEFLVGFQLLENLNLSNNNLE 528
++ Q +N+ L+NN +
Sbjct: 113 -RVSCSR--GQGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 22/77 (28%), Positives = 34/77 (44%)
Query: 459 IPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLE 518
I + + + ++ + L+ + S S + LDLS N LS L F LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 519 NLNLSNNNLEGMVPIEG 535
LNLS+N L + +E
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 694
EIG G FG V+ G K VA+K + GA + FI E + + H LV++
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 695 TACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
C LV EFM++ L ++L R + L + +DV
Sbjct: 70 GVCLEQAPIC-------LVTEFMEHGCLSDYL----RTQR-----GLFAAETLLGMCLDV 113
Query: 753 ACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++YL + H DL N L+ E + VSDFG+ RF+ L TSS K
Sbjct: 114 CEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKF 167
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + +PE S S DV+S+G+L+ E+ +
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-FKSFIAECNTLKNIRHRNLVKILT 695
IG G FG V G VAVK + + A ++F+AE + + +RH NLV++L
Sbjct: 27 QTIGKGEFGDVMLGDYR--GNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ +V E+M SL ++L L L +DV A
Sbjct: 82 VIV----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEA 129
Query: 756 LSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+ YL ++ H DL NVL+ E+ +A VSDFGL + A ++ K + +
Sbjct: 130 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKW 180
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVT 843
APE + S DV+S+GILL E+ +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKILT 695
E+G G FG V G +G+ VAVK+ + G+ F E T+ + H LVK
Sbjct: 15 ELGSGQFGVVKLGKW-KGQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 696 ACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
CS Y +V E++ N L +L R + L Q L + DV
Sbjct: 71 VCSKEYPIY-------IVTEYISNGCLLNYL----RSHG-----KGLEPSQLLEMCYDVC 114
Query: 754 CALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+++L H H DL N L+D ++ VSDFG+ R++ L SS+ K
Sbjct: 115 EGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFP 168
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKP 847
+ + APE + S DV+++GIL+ E+ + K P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRN 689
++G G+FGSV D VAVK L H + F E LK+++H N
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK C G L+ E++ SL ++L ++ K ++ ++ L
Sbjct: 73 IVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYL----QKHKER-----IDHIKLLQYT 120
Query: 750 IDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSID 807
+ + YL H DL N+L++ E + DFGL + LP
Sbjct: 121 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ I + APE S+ S+ DV+S+G++L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 638 EIGVGSFGSVYKGIL--DQGKTTVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLV 691
E+G G+FGSV +G+ + + VA+KV L G K+ + E + + + +V
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+++ C LV E L ++L + + + +
Sbjct: 74 RLIGVCQAEALM------LVMEMAGGGPLHKFL----VGKR-----EEIPVSNVAELLHQ 118
Query: 752 VACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDA 808
V+ + YL + H DL NVLL A +SDFGL++ L + T+
Sbjct: 119 VSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 809 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
K + + APE + S S DV+SYG+ + E ++ +KP M
Sbjct: 174 KWPLKWYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKPYKKM 217
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 694
E+G G FG V G +G+ VA+K+ + G+ FI E + N+ H LV++
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 695 TACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
C+ + ++ E+M N L +L RE + Q L + DV
Sbjct: 86 GVCTKQRPIF-------IITEYMANGCLLNYL----REMR-----HRFQTQQLLEMCKDV 129
Query: 753 ACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
A+ YL H DL N L++++ + VSDFGL+R++ L TSS+ +K
Sbjct: 130 CEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKF 183
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + PE + S+ S D++++G+L+ E+ +
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 638 EIGVGSFGSVYKGIL--DQGKTTVAVKVF--NLLHHGAFKSFIAECNTLKNIRHRNLVKI 693
E+G G+FG+V KG + TVAVK+ +AE N ++ + + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+ C + LV E + L ++L +++ R + + + V+
Sbjct: 84 IGICEAESWM------LVMEMAELGPLNKYL----QQN------RHVKDKNIIELVHQVS 127
Query: 754 CALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDAKG 810
+ YL + H DL NVLL + A +SDFGL++ L + K
Sbjct: 128 MGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 811 SIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ + APE Y + S DV+S+G+L+ E + +KP M
Sbjct: 183 PVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 688
++G G FG V D VAVK L + E L+N+ H
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHE 83
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+VK C+ G + L+ EF+ + SL+E+L ++K +NL Q+L
Sbjct: 84 NIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYL----PKNK-----NKINLKQQLKY 131
Query: 749 GIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSI 806
+ + + YL H DL NVL++ E + DFGL + + T
Sbjct: 132 AVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 807 DAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
D + + APE S DV+S+G+ L EL+T
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIAS---DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRN 689
++G G+FGSV D VAVK L H + F E LK+++H N
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK C + L+ E++ SL ++L ++ K ++ ++ L
Sbjct: 104 IVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYL----QKHK-----ERIDHIKLLQYT 151
Query: 750 IDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSID 807
+ + YL H DL N+L++ E + DFGL + LP
Sbjct: 152 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ I + APE S+ S+ DV+S+G++L EL T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRN 689
+++G G+FGSV D VAVK L H + F E LK +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQ---LQHSGPDQQRDFQREIQILKALHSDF 85
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+VK G G LV E++ + L ++L + + L+ + L
Sbjct: 86 IVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFL----QRHR-----ARLDASRLLLYS 133
Query: 750 IDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTSSID 807
+ + YL C H DL N+L++ E ++DFGLA+ LPL
Sbjct: 134 SQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ I + APE + S DV+S+G++L EL T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 55/447 (12%), Positives = 116/447 (25%), Gaps = 77/447 (17%)
Query: 92 IPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA 151
I + ++ + V+ ++L ++ S + ++ L L+ N L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 152 TLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG 211
L ++ N + + +L L+ + N +
Sbjct: 62 LLNLSSN-----------VLYETLDLE----------------SLSTLRTLDLNNNYVQ- 93
Query: 212 AIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLT 271
+ ++E A N ++ ++ +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS---------------RVSCSRGQG------------- 121
Query: 272 NSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG-NIPAAIGKFVNLQRLEM 330
+ + N L + ++ L L N+I N L+ L +
Sbjct: 122 ----KKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 331 WNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSS 389
N + + + L+ L L NK L + P + V + L N L I +
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLD 449
L + L DL N F +++ + +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSK--NQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 450 VFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG----PIPSSLSSLKGLNVLDLSQNNLSG 505
+ L++ E QG + + +D +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 506 KIPEFLVGFQLLENLNLSNNNLEGMVP 532
I + + Q L L+ V
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 66/510 (12%), Positives = 149/510 (29%), Gaps = 77/510 (15%)
Query: 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84
N + K+ + ++S + S ++ L L+ N + A+++ + L + L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTF 144
N L +L SLS + L ++ N + L SI TL +NN+
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRG 119
Query: 145 GWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSV 204
+ + +A N ++ S + D +N++ V + + L+ ++
Sbjct: 120 ---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 205 FENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNL 264
N + + +
Sbjct: 177 QYNFIY-DVKGQV----------------------------------------------- 188
Query: 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVN 324
L L +++N + + + + L NNK+ I A+ N
Sbjct: 189 -VFAKLK------TLDLSSNKLAFM-GPEFQSA-AGVTWISLRNNKL-VLIEKALRFSQN 238
Query: 325 LQRLEMWNNRLS-GTIPPAIGELQNLRELRLQRNKFL-GNIPPSIGNLKVFNL-DLSCNF 381
L+ ++ N GT+ + Q ++ + Q K L G + + C
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 382 LQGSIPSSLGQYK--TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV 439
L L K ++ + + +D + Q I
Sbjct: 299 LPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR--QREIDALKEQYRTVIDQVT 356
Query: 440 GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLS 499
+ L+ + L ++ + + +L+ Q + + L +L
Sbjct: 357 LRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE-LQHATEEQSPLQLLRAI 415
Query: 500 QNNLSGK-IPEFLVGFQLLENLNLSNNNLE 528
+ + V + + ++ +
Sbjct: 416 VKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 65/459 (14%), Positives = 138/459 (30%), Gaps = 31/459 (6%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
R KI +T L +++ + +K L L N + ++ +L++L L++N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ E + S S L + L N + EL IE L + NN++ S
Sbjct: 70 L-YETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMN 182
+ ++L +N + G + L + N + + + + ++ + N
Sbjct: 123 KN---IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
+ V L+ + N+L + P +A+ + NKL L
Sbjct: 180 FIYDVKGQVV---FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
Q L F + N + ++ R+ A L T
Sbjct: 236 SQNLEHFDLRGN--------GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 303 MLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSG----TIPPAIGELQNLRELRLQRNK 358
+ + + L+R E G + RE+ + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 359 FLGNIPPSIGNLK--VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLG 416
+ + K L+ L + + + L +
Sbjct: 348 -YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEE 405
Query: 417 LSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455
S L + + + + + + D++++K
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 434 SIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGL 493
+I N ++ V ++ LK + S S +++L++ GN L + L+ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 494 NVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+L+LS N L + L L+L+NN ++
Sbjct: 61 ELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 22/77 (28%), Positives = 34/77 (44%)
Query: 459 IPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLE 518
I + + + ++ + L+ + S S + LDLS N LS L F LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 519 NLNLSNNNLEGMVPIEG 535
LNLS+N L + +E
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 61/289 (21%), Positives = 102/289 (35%), Gaps = 32/289 (11%)
Query: 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVN 324
++ + + N N LL C L L L+ + ++P +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKEC---LINQFSELQLNRLNL-SSLPDNLPP--Q 81
Query: 325 LQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQG 384
+ LE+ N L ++P +L L N+ L +P +LK +LD+ N L
Sbjct: 82 ITVLEITQNALI-SLPELPA---SLEYLDACDNR-LSTLPELPASLK--HLDVDNNQLT- 133
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKN 444
+P L I+ +N LT +P L L + NQLT +P ++
Sbjct: 134 MLPELPAL---LEYINADNNQLT-MLPELPTSLEVL----SVRNNQLT-FLPEL---PES 181
Query: 445 LEVLDVFENKLKGEIPSTLGSCKKLEQ----LEMQGNFLQGPIPSSLSSLKGLNVLDLSQ 500
LE LDV N L+ +P+ E+ + N + IP ++ SL + L
Sbjct: 182 LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILED 239
Query: 501 NNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNL 549
N LS +I E L + + + +V
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWF 288
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 3e-17
Identities = 61/375 (16%), Positives = 128/375 (34%), Gaps = 48/375 (12%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+ L L L L+ S+ ++ + VL + N+ +P L+ L +N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALIS-LPELPASLEYLD---ACDNR 111
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ +P +S +L + N+L +P L E+++ N LT +P +L
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSL 162
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISS----ITAFDA 179
L + +N L +P+ ++L L ++ N L ++P+ F
Sbjct: 163 EV---LSVRNNQL-TFLPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 180 GMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239
N++ IP + +L + +N L+ I ++S + + +
Sbjct: 215 RENRIT-HIPENIL-SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 240 LEKPQRLSVFSITE--------------NSLGSRGHSN--LNFLCSLTNSTRLNRLLINA 283
R ++T ++ H+N FL L+++
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFR 332
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI 343
L ++ + + + + NL++ + + G
Sbjct: 333 EQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDT 392
Query: 344 GELQNL-REL-RLQR 356
G L +L RE+ RL+
Sbjct: 393 GALLSLGREMFRLEI 407
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 9e-17
Identities = 56/364 (15%), Positives = 119/364 (32%), Gaps = 52/364 (14%)
Query: 27 LSFLKVLLLYNNSFNH--GIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84
+ L + N + E + + L LN ++ +P N+ + + +
Sbjct: 33 WDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNL-SSLPDNL--PPQITVLEIT 88
Query: 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTF 144
N L+ +P SL E+L N L+ ++P +L L + +N L +P+
Sbjct: 89 QNALI-SLPELPASL---EYLDACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELP 139
Query: 145 GWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSV 204
L + N L+ +P +S+ NQL + L ++L+ V
Sbjct: 140 A---LLEYINADNNQLT-MLPEL---PTSLEVLSVRNNQLTFLPEL-----PESLEALDV 187
Query: 205 FENQLTGAIPPAISNASNLELFQADV----NKLTGEVP-YLEKPQRLSVFSITENSLGSR 259
N L ++P + E + N++T +P + + +N L SR
Sbjct: 188 STNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSR 245
Query: 260 GHSNLNFLCSLTNSTRLNRLLINANNFGG-------------LLPACISNLSTTLEML-L 305
+L+ + + ++ S++S
Sbjct: 246 IRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEH 305
Query: 306 LDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPP 365
++ F + V+ + + +++ + +L ELR Q +
Sbjct: 306 EEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATE 361
Query: 366 SIGN 369
S +
Sbjct: 362 SCED 365
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 23/109 (21%), Positives = 43/109 (39%), Gaps = 10/109 (9%)
Query: 422 IGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSC--KKLEQLEMQGNFL 479
+ + N ++G+ E + + E S L C + +L++ L
Sbjct: 13 LSQNSFYNTISGTYADYFSAWDKWEKQALPGE-NRNEAVSLLKECLINQFSELQLNRLNL 71
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+P +L + VL+++QN L +PE LE L+ +N L
Sbjct: 72 SS-LPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS 113
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 689
IG G G V G L Q VA+K L G + F++E + + H N
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 690 LVKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++++ + +V E+M+N SL+ +L R ++Q +
Sbjct: 112 IIRLEGVVTRGRLAM-------IVTEYMENGSLDTFL----RTHD-----GQFTIMQLVG 155
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTS 804
+ V + YL H DL NVL+D ++ VSDFGL+R L P A +
Sbjct: 156 MLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 805 SIDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ K I + APE + S S DV+S+G+++ E++ ++P +M
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERPYWNM 258
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 688
+G G+FG+VYKG+ ++ K VA+K L K + E + ++ +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNP 77
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
++ ++L C Q L+ + M L +++ RE K ++ LN
Sbjct: 78 HVCRLLGICLTSTVQ------LITQLMPFGCLLDYV----REHK-----DNIGSQYLLNW 122
Query: 749 GIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSI 806
+ +A ++YL + H DL NVL+ ++DFGLA+ L + +
Sbjct: 123 CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 807 DAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
K I ++A E + + + S DV+SYG+ + EL+T KP D +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGI 223
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 38/222 (17%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 689
IG G FG VY G Q + A+K L ++F+ E ++ + H N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS---LSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++ ++ ++ +M + L +++ R + R+ + ++ G
Sbjct: 84 VLALIGIML----PPEGLPHVLLPYMCHGDLLQFI----RSPQ-----RNPTVKDLISFG 130
Query: 750 IDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP--AQTSS 805
+ VA + YL H DL N +LDE V+DFGLAR + +
Sbjct: 131 LQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 806 IDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR 844
A+ + + A E + S DV+S+G+LL EL+TR
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKS---DVWSFGVLLWELLTR 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 639 IGVGSFGSVYKG---ILDQGKTTVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLVK 692
+G G +VY IL+ VA+K F E + + H+N+V
Sbjct: 19 LGGGGMSTVYLAEDTILNI---KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 693 ILTACSGVDY-QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++ D + +D LV E+++ +L E++ P L++ +N
Sbjct: 76 MI------DVDEEDDCYYLVMEYIEGPTLSEYIE--------SHGP--LSVDTAINFTNQ 119
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTSSIDAKG 810
+ + + H I H D+KP N+L+D + DFG+A+ L + QT+ + G
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV--LG 174
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
++ Y +PE G D+YS GI+L E++ + P F G+
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 638 EIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 690
IG G FG V++GI + VA+K + + F+ E T++ H ++
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
VK++ + ++ E L +L + K SL+L +
Sbjct: 79 VKLIGVITENPVW------IIMELCTLGELRSFL----QVRK-----YSLDLASLILYAY 123
Query: 751 DVACALSYL-HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
++ AL+YL H D+ NVL+ + DFGL+R++ + K
Sbjct: 124 QLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGK 178
Query: 810 GSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
I ++APE + + S DV+ +G+ + E++ KP +
Sbjct: 179 LPIKWMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKPFQGV 221
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 71/338 (21%), Positives = 128/338 (37%), Gaps = 51/338 (15%)
Query: 194 FTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITE 253
TL N + + + + + + +EL + ++ I
Sbjct: 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE---------------EIDT 86
Query: 254 NSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG 313
+ + + +L + N L P N+ L +L+L+ N +
Sbjct: 87 YAFA--------------YAHTIQKLYMGFNAIRYLPPHVFQNV-PLLTVLVLERNDL-S 130
Query: 314 NIPAAI-GKFVNLQRLEMWNNRLSGTIPPAI-GELQNLRELRLQRNKFLGNIPPSI-GNL 370
++P I L L M NN L I +L+ L+L N+ L ++ S+ +L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR-LTHVDLSLIPSL 188
Query: 371 KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQ 430
+ ++S N L S+L + +D S N++ P + L+ L L N
Sbjct: 189 F--HANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTIL----KLQHNN 237
Query: 431 LTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSL 490
LT + N L +D+ N+L+ + ++LE+L + N L + +
Sbjct: 238 LT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 294
Query: 491 KGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
L VLDLS N+L + F LENL L +N++
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 72/416 (17%), Positives = 137/416 (32%), Gaps = 77/416 (18%)
Query: 115 SIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSI 174
I S+L + + D L N + + + +P+++ +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLD---- 66
Query: 175 TAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234
+ + ++ ++ + Q+ A + A ++ N +
Sbjct: 67 --------------------SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 235 GEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACI 294
+ + N L L++ N+ L
Sbjct: 107 ---------------YLPPH--------------VFQNVPLLTVLVLERNDLSSLPRGIF 137
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAI-GKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELR 353
N L L + NN + I +LQ L++ +NRL+ + + +L
Sbjct: 138 HNT-PKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHAN 192
Query: 354 LQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ 413
+ N L + I ++ LD S N + + LTI+ L NNLT
Sbjct: 193 VSYNL-LSTLAIPI-AVEE--LDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAW 243
Query: 414 FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQL 472
L L+ +DLS N+L I ++ LE L + N+L + L+ L
Sbjct: 244 LLNYPGLVE-VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 473 EMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
++ N L + + L L L N++ + L L+NL LS+N+ +
Sbjct: 301 DLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 66/377 (17%), Positives = 143/377 (37%), Gaps = 31/377 (8%)
Query: 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI 68
+++ L+ K++ N++ + D +++++L LN+ I EI
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEI 84
Query: 69 PANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
+ + ++ + +N + P ++ + L + N+L+ N +
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
TL +++NNL+ DTF +L L ++ N L+ + S+ S+ + N L +
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLSTL 201
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
++ N + + ++ L + + N LT + +L L
Sbjct: 202 AI------PIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLV 251
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
++ N L + + RL RL I+ N L + TL++L L
Sbjct: 252 EVDLSYNEL-----EKIMY-HPFVKMQRLERLYISNNRLVA-LNLYGQPI-PTLKVLDLS 303
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGN----I 363
+N + ++ +F L+ L + +N + T+ + L+ L L N + N +
Sbjct: 304 HNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL 359
Query: 364 PPSIGNLKVFNLDLSCN 380
++ V + D C
Sbjct: 360 FRNVARPAVDDADQHCK 376
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 70/403 (17%), Positives = 137/403 (33%), Gaps = 37/403 (9%)
Query: 68 IPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
I +N+ + + E +L+ + ++ + + + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQG 186
L L D ++ F + + L M N + +P +F N+ +T N L
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRL 246
+P L S+ N L ++L+ Q N+LT
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------ 178
Query: 247 SVFSITENSLGSRGHSNL--NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
+ + + S H+N+ N L +L + L + N+ + L+ L
Sbjct: 179 ---HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTI----L 231
Query: 305 LLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP 364
L +N + A + + L +++ N L + ++Q L L + N+ L +
Sbjct: 232 KLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-LVALN 288
Query: 365 PSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLI 422
+ + LDLS N L + + Q+ L + L N++ T+ L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKN--- 343
Query: 423 GLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGS 465
L LS N + S +N+ V + +I L
Sbjct: 344 -LTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 69/310 (22%), Positives = 109/310 (35%), Gaps = 59/310 (19%)
Query: 565 SKESKHKKLTLALKLALAIISGLTGLSLALSFLILCLVRKRKEKKNPSSPINSFPNISYQ 624
+ + A L GL G+ + E ++S
Sbjct: 12 HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 625 N--LYNATDGFAS---------ANEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHG 670
N L A IG G FG VY G L D K AVK L+
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRI 128
Query: 671 A----FKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHP 726
F+ E +K+ H N++ +L C +G+ +V +M++ L ++
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-- 182
Query: 727 ITREDKTEEAPRSLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMM 784
R + + + + G+ VA + +L H DL N +LDE+
Sbjct: 183 --RNET-----HNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFT 230
Query: 785 AHVSDFGLARFLPLSPAQTSSIDA--KGSIGYI-----APE---YGLGSEVSINGDVYSY 834
V+DFGLAR + D+ + + A E + S DV+S+
Sbjct: 231 VKVADFGLARDM-----YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSF 282
Query: 835 GILLLELVTR 844
G+LL EL+TR
Sbjct: 283 GVLLWELMTR 292
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRH 687
E+G GSFG VY+G+ D+ +T VA+K ++ A F+ E + +K
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNC 87
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++V++L S QG ++ E M L+ +L + +L + +
Sbjct: 88 HHVVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ ++A ++YL+ H DL N ++ E+ + DFG+ R + +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYY 194
Query: 808 AKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVTR 844
KG G + +PE G+ + S DV+S+G++L E+ T
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIATL 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 638 EIGVGSFGSVYKGIL--DQGKTTVAVKVFNLLHHGAFKS----FIAECNTLKNIRHRNLV 691
E+G G+FGSV +G+ + + VA+KV L G K+ + E + + + +V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+++ C LV E L ++L + + + +
Sbjct: 400 RLIGVCQAEALM------LVMEMAGGGPLHKFL----VGKR-----EEIPVSNVAELLHQ 444
Query: 752 VACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDA 808
V+ + YL + H +L NVLL A +SDFGL++ L + T+
Sbjct: 445 VSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
K + + APE + S DV+SYG+ + E ++ +KP M
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 638 EIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRNL 690
+G G FG VY+G+ K VAVK + F++E +KN+ H ++
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
VK++ + ++ E L +L +K SL +L + +
Sbjct: 76 VKLIGIIEE------EPTWIIMELYPYGELGHYL----ERNK-----NSLKVLTLVLYSL 120
Query: 751 DVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ A++YL + H D+ N+L+ + DFGL+R++ +
Sbjct: 121 QICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVT 174
Query: 809 KGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKP 847
+ I +++PE + + S DV+ + + + E+++ K+P
Sbjct: 175 RLPIKWMSPESINFRRFTTAS---DVWMFAVCMWEILSFGKQP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 689
+G G FG V G L + + +VA+K L G + F+ E + + H N
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 690 LVKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++++ + +V E+M+N SL+ +L R+ ++Q +
Sbjct: 108 IIRLEGVVTKSKPVM-------IVTEYMENGSLDSFL----RKHD-----AQFTVIQLVG 151
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTS 804
+ +A + YL H DL N+L++ ++ VSDFGL R L P A +
Sbjct: 152 MLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 805 SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ K I + +PE + + DV+SYGI+L E+++ ++P M
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-28
Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 37/227 (16%)
Query: 639 IGVGSFGSVYKG---ILDQGKTTVAVKVFNLLHHG---AFKSFIAECNTLKNIRHRNLVK 692
I G G +Y ++ V +K L+H G A +AE L + H ++V+
Sbjct: 88 IAHGGLGWIYLALDRNVN--GRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
I D G+ +V E++ +SL+ + L + + + +++
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEI 191
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
ALSYLH + + DLKP N++L EE + D G + + G+
Sbjct: 192 LPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYL--YGTP 241
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
G+ APE ++ D+Y+ G L L G
Sbjct: 242 GFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 637 NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 689
IG G FG VY G L D K AVK L+ F+ E +K+ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++ +L C +G+ +V +M++ L ++ R + + + + G
Sbjct: 88 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI----RNET-----HNPTVKDLIGFG 134
Query: 750 IDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ VA + YL H DL N +LDE+ V+DFGLAR +
Sbjct: 135 LQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM-----YDKEYY 184
Query: 808 AKGS-------IGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR 844
+ + + ++A E + S DV+S+G+LL EL+TR
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTR 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 34/227 (14%)
Query: 639 IGVGSFGSVYKG---ILDQGKTTVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLVK 692
+G G V+ + VAVKV +L +F F E + H +V
Sbjct: 20 LGFGGMSEVHLARDLRDHR---DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 693 ILTACSGVDYQGNDFKA-LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ +G +V E++ +L + +H E P + + + + D
Sbjct: 77 VYD--TGEAETPAGPLPYIVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIAD 124
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA---QTSSIDA 808
AL++ H Q I H D+KP+N+++ V DFG+AR + S QT+++
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV-- 179
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ Y++PE G V DVYS G +L E++T + P F GD
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 57/252 (22%), Positives = 95/252 (37%), Gaps = 34/252 (13%)
Query: 637 NEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHR 688
++G G FG V D VAVK L A + E + L+ + H
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
+++K C LV E++ SL ++L S+ L Q L
Sbjct: 94 HIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLF 139
Query: 749 GIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSI 806
+ ++YLH H DL NVLLD + + + DFGLA+ +P
Sbjct: 140 AQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 807 DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT--RKKPVDSMFEGDMNLHNFARM 864
D + + APE + DV+S+G+ L EL+T ++ +M
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 865 ALPDHVVDIVDS 876
+ + ++++
Sbjct: 256 TVLR-LTELLER 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 29/223 (13%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G+FG V+ + K VAVK A K F E L N++H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------HPITREDKTEEAPRSLNLLQR 745
K C G+ +VFE+M++ L ++L I + + +A L L Q
Sbjct: 81 KFYGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 746 LNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
L+I +A + YL H H DL N L+ ++ + DFG++R + +
Sbjct: 136 LHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 804 SSIDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
I ++ PE Y + DV+S+G++L E+ T
Sbjct: 191 VGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFT 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 44/231 (19%)
Query: 638 EIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRHRN 689
IG G FG VYKG+L + + VA+K L G F+ E + H N
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 690 LVKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++++ S ++ E+M+N +L+++L RE ++LQ +
Sbjct: 108 IIRLEGVISKYKPMM-------IITEYMENGALDKFL----REKD-----GEFSVLQLVG 151
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP-AQTS 804
+ +A + YL + H DL N+L++ ++ VSDFGL+R L P A +
Sbjct: 152 MLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 805 SIDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ K I + APE Y + + DV+S+GI++ E++T ++P +
Sbjct: 207 TSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFN-LLHHGAFKSFIAECNTLKNI-RHRN 689
+G G+FG V + + VAVK+ H ++ ++E + ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL----HPITREDKTEEAPRSLNLLQR 745
+V +L AC+ G ++ E+ L +L + + A + +
Sbjct: 112 IVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 746 LNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
L+ VA +++L + H D+ NVLL +A + DFGLAR +
Sbjct: 167 LHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+A+ + ++APE ++ DV+SYGILL E+ +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 67/261 (25%), Positives = 105/261 (40%), Gaps = 18/261 (6%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
+S +L L NN I +L L + NN++S I A L+ L++L
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 354 LQRNKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT-IP 411
+ +N L IPP++ +L L + N ++ + + I++ N L +
Sbjct: 109 ISKNH-LVEIPPNLPSSLV--ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 412 PQ-FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKL 469
P F GL L L +S +LT IP + L L + NK++ I L KL
Sbjct: 166 PGAFDGLK--LNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 470 EQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
+L + N ++ SLS L L L L N LS ++P L +LL+ + L NN+
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 530 MVPIEGVFKNATITSVLGNLK 550
V F
Sbjct: 278 KVG-VNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 66/279 (23%), Positives = 107/279 (38%), Gaps = 25/279 (8%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWN 332
S L + N+ L L L L+L NNKI A LQ+L +
Sbjct: 53 SPDTTLLDLQNNDISELRKDDFKGL-QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 333 NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI--GNLKVFNLDLSCNFLQ-GSIPSS 389
N L IPP + +L ELR+ N+ + +P + G + +++ N L+
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNR-IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEV 447
L + +S+ LT IP L+ L L N++ +I E L
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPKDLPETLNEL----HLDHNKIQ-AIELEDLLRYSKLYR 221
Query: 448 LDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKI 507
L + N+++ +L L +L + N L +P+ L LK L V+ L NN++ K+
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KV 279
Query: 508 PE-------FLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
F V ++L NN + F+
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 60/310 (19%), Positives = 101/310 (32%), Gaps = 43/310 (13%)
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNAS 221
+P I T D N + + DF LQ+L + N+++ I A S
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFK-GLQHLYALVLVNNKIS-KIHEKAFSPLR 102
Query: 222 NLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLT----NSTRLN 277
L+ N L E+P P L I +N + + L ++ L
Sbjct: 103 KLQKLYISKNHLV-EIP-PNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 278 RLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSG 337
F GL L L + K+ IP + L L + +N++
Sbjct: 161 NSGFEPGAFDGL----------KLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ- 206
Query: 338 TIPP-AIGELQNLRELRLQRNKFLGNIPP----SIGNLKVFNLDLSCNFLQGSIPSSLGQ 392
I + L L L N+ + I + L+ L L N L +P+ L
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQ-IRMIENGSLSFLPTLRE--LHLDNNKLS-RVPAGLPD 262
Query: 393 YKTLTIIDLSDNNLTGTIPP-QFLGLSWL-----LIGLDLSRNQLT-GSIPSEV-GNLKN 444
K L ++ L NN+T + F + + G+ L N + + + +
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
Query: 445 LEVLDVFENK 454
+ K
Sbjct: 322 RLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 58/311 (18%), Positives = 108/311 (34%), Gaps = 44/311 (14%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ T L L + L L L+L NN + F L++LQ L ++ N +
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLT-GSIPSSLGN 122
EIP N+ S+L+++R+ N + K+P L + + + N L +
Sbjct: 115 -VEIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGM 181
+N L +++ L GIP + L L + N + I S + G
Sbjct: 171 GLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 182 NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLE 241
NQ++ + L L+ + N+L+ +P + + L++ N +T
Sbjct: 227 NQIRMIENGSLS-FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT------- 277
Query: 242 KPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANN--FGGLLPACISNLST 299
+ N + N + + N + + PA + T
Sbjct: 278 --------KVGVNDFCP--------VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV-T 320
Query: 300 TLEMLLLDNNK 310
+ N K
Sbjct: 321 DRLAIQFGNYK 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 15/266 (5%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRL 328
+ N L L + +N + + LS L L + NKI + NL+ L
Sbjct: 75 AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 329 EMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQ 383
E+ +N L I A L +L +L L++ L +IP L V L L +
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCN-LTSIPTEALSHLHGLIV--LRLRHLNIN 189
Query: 384 GSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFL-GLSWLLIGLDLSRNQLTGSIPSEV-GN 441
S + L ++++S T+ P L GL+ L L ++ LT ++P +
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN--LTSLSITHCNLT-AVPYLAVRH 246
Query: 442 LKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQN 501
L L L++ N + S L +L+++++ G L P + L L VL++S N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 502 NLSGKIPEFLVGFQLLENLNLSNNNL 527
L+ LE L L +N L
Sbjct: 307 QLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 61/265 (23%), Positives = 98/265 (36%), Gaps = 19/265 (7%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMW 331
T L + N L ++ LE L L+ N + + A NL+ L +
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASF-PHLEELELNENIV-SAVEPGAFNNLFNLRTLGLR 88
Query: 332 NNRLSGTIPPAI-GELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSI 386
+NRL IP + L NL +L + NK + + + NLK L++ N L I
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENK-IVILLDYMFQDLYNLKS--LEVGDNDLV-YI 143
Query: 387 PS-SLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLK 443
+ +L + L NLT +IP + L L++ L L + +I L
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIV-LRLRHLNIN-AIRDYSFKRLY 200
Query: 444 NLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
L+VL++ + L L + L ++ L L L+LS N +
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260
Query: 504 SGKIPEFLVGFQLLENLNLSNNNLE 528
S L L+ + L L
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 63/269 (23%), Positives = 101/269 (37%), Gaps = 19/269 (7%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAI-GKFVNLQR 327
+ L L +N N + P +NL L L L +N++ IP + NL +
Sbjct: 51 EFASFPHLEELELNENIVSAVEPGAFNNL-FNLRTLGLRSNRL-KLIPLGVFTGLSNLTK 108
Query: 328 LEMWNNRLSGTIPPAI-GELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFL 382
L++ N++ + + +L NL+ L + N L I +L+ L L L
Sbjct: 109 LDISENKIV-ILLDYMFQDLYNLKSLEVGDND-LVYISHRAFSGLNSLEQ--LTLEKCNL 164
Query: 383 QGSIPS-SLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEVG 440
SIP+ +L L ++ L N+ I F L L + L++S ++
Sbjct: 165 T-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKV-LEISHWPYLDTMTPNCL 221
Query: 441 NLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLS 499
NL L + L +P + L L + N + S L L L + L
Sbjct: 222 YGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 500 QNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
L+ P G L LN+S N L
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 55/248 (22%), Positives = 90/248 (36%), Gaps = 32/248 (12%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
+ T +L L N+I F +L+ LE+ N +S + P A L NLR L
Sbjct: 28 EGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLG 86
Query: 354 LQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ 413
L+ N+ L IP + LT +D+S+N + +
Sbjct: 87 LRSNR-LKLIPLGV----------------------FTGLSNLTKLDISENKIV-ILLDY 122
Query: 414 -FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
F L L L++ N L I L +LE L + + L L L
Sbjct: 123 MFQDLYNLKS-LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 472 LEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMV 531
L ++ + S L L VL++S + + L +L++++ NL V
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AV 239
Query: 532 PIEGVFKN 539
P ++
Sbjct: 240 P-YLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 63/338 (18%), Positives = 115/338 (34%), Gaps = 43/338 (12%)
Query: 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYN 86
+ ++L L N EF L+ L LN N + + ++ NL + L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 87 ELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFG 145
L IP LS + L +S N + + +L ++ +L + DN+L F
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149
Query: 146 WLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSV 204
L +L L + + L+ +IP+ ++ + + + F L L+ +
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR-LYRLKVLEI 207
Query: 205 FENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNL 264
+ P NL LT ++ ++ R L
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT---------------AVPYLAV--RHLVYL 250
Query: 265 NFLCSLTNSTRLNRL-LINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKF 322
FL +L+ N + I + L L+ + L ++ + A
Sbjct: 251 RFL-NLSY----NPISTIEGSMLHEL---------LRLQEIQLVGGQL-AVVEPYAFRGL 295
Query: 323 VNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKF 359
L+ L + N+L+ T+ + NL L L N
Sbjct: 296 NYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 72/346 (20%), Positives = 130/346 (37%), Gaps = 44/346 (12%)
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
+P I + + L N + E S +E L ++ N ++ P + NL ++
Sbjct: 25 AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQ 185
TL L N L F L NL L ++EN + + +F ++ ++ + + G N L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLTGEVPYLEKPQ 244
+ F L +L+ ++ + LT +IP A+S+ L + + +
Sbjct: 142 YISHRAF-SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN---------- 189
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
+I + S RL L I+ + + L L
Sbjct: 190 -----AIRD--------------YSFKRLYRLKVLEISHWPYLDTMTPNCLYG-LNLTSL 229
Query: 305 LLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGN 362
+ + + +P A+ V L+ L + N +S TI + EL L+E++L + L
Sbjct: 230 SITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ-LAV 286
Query: 363 IPPSI--GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNL 406
+ P G + L++S N L S L + L N L
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 47/176 (26%), Positives = 71/176 (40%), Gaps = 8/176 (4%)
Query: 356 RNKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ- 413
K +P I ++ LDL N ++ + L ++L++N ++ + P
Sbjct: 19 HRKRFVAVPEGIPTETRL--LDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGA 75
Query: 414 FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQL 472
F L L L L N+L IP V L NL LD+ ENK+ + L+ L
Sbjct: 76 FNNLFNLRT-LGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 473 EMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
E+ N L + S L L L L + NL+ E L L L L + N+
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 16/235 (6%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLALNNNS 63
+L L+L ++ P NL L+ L L +N IP F L L L ++ N
Sbjct: 57 HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENK 115
Query: 64 IGGEIPANI-SSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPS-SL 120
I + + NL + + N+LV I L+ +E L++ NLT SIP+ +L
Sbjct: 116 IV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEAL 172
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180
+L + L L N++ +F L L L ++ T+ + ++T+
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLT 234
L V L L L+F ++ N ++ I + L+ Q +L
Sbjct: 233 HCNLTAVPYLAVR-HLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 44/183 (24%), Positives = 74/183 (40%), Gaps = 9/183 (4%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+L L L SI +L L VL L + + N F RL RL+VL +++
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPSSLGNL 123
+ N NL + + + L +P + L + L++S N ++ S L L
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271
Query: 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMN 182
+ + L L P F L L L ++ N L+ T+ S+F ++ ++ N
Sbjct: 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330
Query: 183 QLQ 185
L
Sbjct: 331 PLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 31/136 (22%), Positives = 58/136 (42%), Gaps = 6/136 (4%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLALNNN 62
R+K+L ++ +++P+ L L + + + +P L L+ L L+ N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYN 258
Query: 63 SIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPSSL 120
I I ++ L +I+L +L + L+ + L+VS N LT S
Sbjct: 259 PI-STIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316
Query: 121 GNLSSINTLFLTDNNL 136
++ ++ TL L N L
Sbjct: 317 HSVGNLETLILDSNPL 332
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 32/223 (14%)
Query: 639 IGVGSFGSVYKG---ILDQGKTTVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLVK 692
+G G G VY+ + ++ VA+K+ L F++ E T ++ ++V
Sbjct: 42 VGRGGMGDVYEAEDTVRER---IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
I G G + + + L L + P L + + I +
Sbjct: 99 IHD--FGEI-DGQLY--VDMRLINGVDLAAMLR--------RQGP--LAPPRAVAIVRQI 143
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL H TH D+KP N+L+ + A++ DFG+A T + G++
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTL 199
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
Y+APE S + D+Y+ +L E +T P ++GD
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 44/235 (18%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRH 687
+G G FG V K G TTVAVK +L A + ++E N LK + H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNH 85
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL--------------HPITREDKT 733
+++K+ ACS Q L+ E+ + SL +L
Sbjct: 86 PHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 734 EEAPRSLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791
R+L + ++ ++ + YL + H DL N+L+ E +SDFG
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFG 195
Query: 792 LARFLPLSPAQTSSIDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
L+R + + + + ++A E + + DV+S+G+LL E+VT
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVT 247
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 90/433 (20%), Positives = 166/433 (38%), Gaps = 68/433 (15%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
+ + L NS + F RLQ LQ L + + G I N S+LI ++L YN+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 89 VGKIPSE-LGSLSKIEHLSVSVNNLTGSI--PSSLGNLSSINTLFLTDNNLDGGIPDT-F 144
+ ++ + L+ +E L+++ NL G++ + L+S+ L L DNN+ P + F
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 145 GWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSV 204
++ L + N + +I + L ++ +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLL-------NFQGKHFT-------LLRLSSITLQDM 195
Query: 205 FENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNL 264
E L +++ N E ++ I L ++
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLIL----SNSY 250
Query: 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAI-GKFV 323
N S ++ + + F GL + ++ L +KIF + ++ F
Sbjct: 251 NMGSSFGHTNFKD---PDNFTFKGLEA-------SGVKTCDLSKSKIF-ALLKSVFSHFT 299
Query: 324 NLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFL 382
+L++L + N ++ I A L +L +L L +N LG+I +F
Sbjct: 300 DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF-LGSIDSR-----MF--------- 343
Query: 383 QGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-G 440
+L + L ++DLS N++ + Q FLGL L L L NQL S+P +
Sbjct: 344 -----ENLDK---LEVLDLSYNHIR-ALGDQSFLGLPNLKE-LALDTNQLK-SVPDGIFD 392
Query: 441 NLKNLEVLDVFEN 453
L +L+ + + N
Sbjct: 393 RLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 67/434 (15%), Positives = 138/434 (31%), Gaps = 66/434 (15%)
Query: 102 IEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWL 160
+ ++ +S+N++ +S L + L + I +TF L +L L + N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 161 SGTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFT-LQNLQFFSVFENQLTGAIP-PAI 217
+ + F ++++ L G + F L +L+ + +N + P
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 218 SNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLN 277
N + NK+ SI E L + + L +
Sbjct: 151 LNMRRFHVLDLTFNKVK---------------SICEEDLLNFQGKHFTLLRLSSI----- 190
Query: 278 RLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSG 337
+ ++ + K ++ L++ N
Sbjct: 191 ------------------------TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 338 TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLD-LSCNFLQGSIPSSLGQYKTL 396
++ + +++ N+ S G+ + D + L+ S +
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS---------GV 277
Query: 397 TIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENK 454
DLS + + + F + L L L++N++ I L +L L++ +N
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQ-LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334
Query: 455 LKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPE-FLVG 513
L + KLE L++ N ++ S L L L L N L +P+
Sbjct: 335 LGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393
Query: 514 FQLLENLNLSNNNL 527
L+ + L N
Sbjct: 394 LTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 51/300 (17%), Positives = 100/300 (33%), Gaps = 38/300 (12%)
Query: 274 TRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWN 332
+N + ++ N+ L S L L+ L ++ I +L L++
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRL-QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 333 NRLSGTIPPAI-GELQNLRELRLQRNKF-LGNIPPSI----GNLKVFNLDLSCNFLQGSI 386
N+ + L NL L L + + + +L+ L L N ++
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE--MLVLRDNNIKKIQ 145
Query: 387 PSSLGQY-KTLTIIDLSDNNLTGTIPPQFLGLSWL-LIGLDLSRNQLTGSIPSEVG---- 440
P+S + ++DL+ N + L L LS L +G
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 441 ----NLKNLEVLDVFENKLKGEIPS---TLGSCKKLEQLEMQGNF----------LQGPI 483
++ LD+ N K + + K++ L + ++ + P
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 484 PSSLSSLK--GLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNAT 541
+ L+ G+ DLS++ + + F LE L L+ N + + + F T
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID-DNAFWGLT 323
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 46/261 (17%), Positives = 86/261 (32%), Gaps = 44/261 (16%)
Query: 296 NLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRL 354
L + + L N I + + +LQ L++ I L +L L+L
Sbjct: 27 ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 355 QRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ- 413
N+ + F + L L ++ L+ NL G +
Sbjct: 87 DYNQ-FLQLETG-----AF--------------NGLAN---LEVLTLTQCNLDGAVLSGN 123
Query: 414 -FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
F L+ L L L N + P+ N++ VLD+ NK+K L + +
Sbjct: 124 FFKPLT-SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182
Query: 472 LEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMV 531
+ L + + D+++ L + + L+LS N + +
Sbjct: 183 TLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228
Query: 532 PIEGVFKNATITSVLGNLKLC 552
F +A + + +L L
Sbjct: 229 A--KRFFDAIAGTKIQSLILS 247
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 68/376 (18%), Positives = 134/376 (35%), Gaps = 74/376 (19%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFN-HGIPSE-FDRLQRLQVLALNNN 62
+L LKL + L+ L+VL L + + + F L L++L L +N
Sbjct: 80 SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 63 SIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSV-NNLTGSIPSSL 120
+I PA+ + + L +N K++ + N G + L
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFN--------------KVKSICEEDLLNFQGKHFTLL 185
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDA- 179
LSSI + + L ++ TL ++ N ++ F+ + T +
Sbjct: 186 -RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244
Query: 180 ------------GMNQLQGVIPLDF-GFTLQNLQFFSVFENQLTGAIPPAI-SNASNLEL 225
G + F G ++ + ++++ A+ ++ S+ ++LE
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQ 303
Query: 226 FQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANN 285
N++ I +N+ LT+ L +L ++ N
Sbjct: 304 LTLAQNEIN---------------KIDDNAFW-----------GLTH---LLKLNLSQNF 334
Query: 286 FGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPP-AI 343
G + NL LE+L L N I + + NL+ L + N+L ++P
Sbjct: 335 LGSIDSRMFENL-DKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIF 391
Query: 344 GELQNLRELRLQRNKF 359
L +L+++ L N +
Sbjct: 392 DRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 30/136 (22%), Positives = 57/136 (41%), Gaps = 11/136 (8%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ + L+ ++ V + + L+ L L N N + F L L L L+ N +
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSS-LG 121
G I + + + L + L YN + + + L ++ L++ N L S+P
Sbjct: 336 G-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 122 NLSSINTLFLTDNNLD 137
L+S+ ++L N D
Sbjct: 393 RLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 38/226 (16%), Positives = 76/226 (33%), Gaps = 22/226 (9%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRL---QRLQVLA 58
R + + ++ L + + + L L N F + F ++Q L
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 59 LNNNSI-GGEIPANISSC-----------SNLIQIRLFYNELVGKIPSEL-GSLSKIEHL 105
L+N+ G S + L +++ + + + +E L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQL 304
Query: 106 SVSVNNLTGSIPS-SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTI 164
+++ N + I + L+ + L L+ N L F L L L ++ N + +
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-AL 362
Query: 165 PSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
F + ++ NQL+ V F L +LQ + N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFD-RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 28/144 (19%), Positives = 43/144 (29%), Gaps = 30/144 (20%)
Query: 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKL 455
+ L +P L + +DLS N + + L++L+ L V +
Sbjct: 13 YNAICINRGLH-QVPE----LPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTP 66
Query: 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515
I ++ L L +L L N G
Sbjct: 67 GLVIR-----------------------NNTFRGLSSLIILKLDYNQFLQLETGAFNGLA 103
Query: 516 LLENLNLSNNNLEGMVPIEGVFKN 539
LE L L+ NL+G V FK
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 17/261 (6%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
+L +L L NNKI NL L + NN++S I P A L L L
Sbjct: 48 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLY 106
Query: 354 LQRNKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT-GTIP 411
L +N+ L +P + L+ L + N + S + +++L N L I
Sbjct: 107 LSKNQ-LKELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 412 PQ-FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKL 469
F G+ L + ++ +T +IP G +L L + NK+ ++ + +L L
Sbjct: 164 NGAFQGMKKLSY-IRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNL 218
Query: 470 EQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
+L + N + SL++ L L L+ N L K+P L + ++ + L NNN+
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276
Query: 530 MVPIEGVFKNATITSVLGNLK 550
+ F + +
Sbjct: 277 AIG-SNDFCPPGYNTKKASYS 296
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 68/269 (25%), Positives = 112/269 (41%), Gaps = 26/269 (9%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWN 332
L + N + NL L L+L NNKI P A V L+RL +
Sbjct: 51 PPDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 333 NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSI-- 386
N+L +P + L+ELR+ N+ + + S+ + V ++L N L+ S
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENE-ITKVRKSVFNGLNQMIV--VELGTNPLKSSGIE 163
Query: 387 PSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNL 445
+ K L+ I ++D N+T TIP GL L L L N++T + + L NL
Sbjct: 164 NGAFQGMKKLSYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKIT-KVDAASLKGLNNL 218
Query: 446 EVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505
L + N + +L + L +L + N L +P L+ K + V+ L NN+S
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 277
Query: 506 ------KIPEFLVGFQLLENLNLSNNNLE 528
P + ++L +N ++
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 52/273 (19%), Positives = 100/273 (36%), Gaps = 30/273 (10%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRL 328
N L+ L++ N + P + L LE L L N++ +P + LQ L
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPL-VKLERLYLSKNQL-KELPEKM--PKTLQEL 126
Query: 329 EMWNNRLSGTIPPAI-GELQNLRELRLQRNKF-LGNIPPSI----GNLKVFNLDLSCNFL 382
+ N ++ + ++ L + + L N I L + ++ +
Sbjct: 127 RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY--IRIADTNI 183
Query: 383 QGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-G 440
+IP L +LT + L N +T + GL+ L L LS N ++ ++ +
Sbjct: 184 T-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAK-LGLSFNSIS-AVDNGSLA 237
Query: 441 NLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG------PIPSSLSSLKGLN 494
N +L L + NKL ++P L K ++ + + N + P + +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 495 VLDLSQNNLS-GKIPEFL-VGFQLLENLNLSNN 525
+ L N + +I + + L N
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 59/308 (19%), Positives = 110/308 (35%), Gaps = 38/308 (12%)
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASN 222
+P + D N++ + DF L+NL + N+++ P A +
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFK-NLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 223 LELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLT----NSTRLNR 278
LE N+L E+P + P+ L + EN + S N L + + L
Sbjct: 102 LERLYLSKNQLK-ELP-EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 279 LLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGT 338
I F G+ L + + + I IP G +L L + N+++
Sbjct: 160 SGIENGAFQGM---------KKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKIT-K 206
Query: 339 IPP-AIGELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIPSSLGQY 393
+ ++ L NL +L L N + + +L+ L L+ N L +P L +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNS-ISAVDNGSLANTPHLRE--LHLNNNKLV-KVPGGLADH 262
Query: 394 KTLTIIDLSDNNLTGTIPPQFLGLSWL-----LIGLDLSRNQLT-GSIPSEV-GNLKNLE 446
K + ++ L +NN++ F + G+ L N + I +
Sbjct: 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 322
Query: 447 VLDVFENK 454
+ + K
Sbjct: 323 AVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 56/334 (16%), Positives = 106/334 (31%), Gaps = 64/334 (19%)
Query: 102 IEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161
L + N +T NL +++TL L +N + P F L L L +++N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 162 GTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT-GAIPP-AISN 219
+P + ++ N++ V F L + + N L I A
Sbjct: 114 -ELPEKMP--KTLQELRVHENEITKVRKSVFN-GLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 220 ASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRL 279
L + +T +I + +L L L N++
Sbjct: 170 MKKLSYIRIADTNIT---------------TIPQGLP-----PSLTEL-HLDG----NKI 204
Query: 280 -LINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSG 337
++A + GL L L L N I + ++ +L+ L + NN+L
Sbjct: 205 TKVDAASLKGL---------NNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 338 TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLT 397
+P + + + ++ + L N + I + F + +
Sbjct: 254 KVPGGLADHKYIQVVYLHNNN-ISAIGSND-------------FCPPGYNTKKAS---YS 296
Query: 398 IIDLSDNNLTGT-IPPQ-FLGLSWLLIGLDLSRN 429
+ L N + I P F + + L
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAA-VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 64/341 (18%), Positives = 115/341 (33%), Gaps = 76/341 (22%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
+L L NN +F L+ L L L NN I +I + L ++ L N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 89 VGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNL-DGGIPD-TFGW 146
++P ++ ++ L V N +T S L+ + + L N L GI + F
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 147 LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFE 206
+K L+ + +A+ ++ TIP + S+T N++ V L NL +
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLK-GLNNLAKLGLSF 225
Query: 207 NQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNF 266
N ++ ++ SL +L
Sbjct: 226 NSIS---------------------------------------AVDNGSL--ANTPHLRE 244
Query: 267 LCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKI-------FGNIPAAI 319
L L N N+L+ ++++ L NN I F P
Sbjct: 245 L-HLNN----NKLVKVPGGLADH---------KYIQVVYLHNNNISAIGSNDFCP-PGYN 289
Query: 320 GKFVNLQRLEMWNNRLSGT-IPP-AIGELQNLRELRLQRNK 358
K + + +++N + I P + ++L K
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 52/312 (16%), Positives = 113/312 (36%), Gaps = 45/312 (14%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ L L I NL L L+L NN + P F L +L+ L L+ N +
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSI--PSSLG 121
E+P + L ++R+ NE+ K+ L+++ + + N L S +
Sbjct: 113 -KELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
+ ++ + + D N+ IP G +L L + N ++ + ++ ++++
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
N + V +L+ + N+L +P +++ +++ N ++
Sbjct: 225 FNSISAVDNGSL-ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS------ 276
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANN--FGGLLPACISNLS 298
+I N G T + + + +N + + P+ +
Sbjct: 277 ---------AIGSNDFCPPG--------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCV- 318
Query: 299 TTLEMLLLDNNK 310
+ L N K
Sbjct: 319 YVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 33/134 (24%)
Query: 396 LTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENK 454
L ++ SD L +P L LDL N++T I NLKNL L + NK
Sbjct: 33 LRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87
Query: 455 LKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGF 514
+ +I P + + L L L LS+N L ++PE +
Sbjct: 88 IS-KIS-----------------------PGAFAPLVKLERLYLSKNQLK-ELPEKM--P 120
Query: 515 QLLENLNLSNNNLE 528
+ L+ L + N +
Sbjct: 121 KTLQELRVHENEIT 134
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 23/222 (10%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA-FKSFIAECNTLKNI-RHRN 689
+G G+FG V + TVAVK+ H ++ ++E L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL--------HPITREDKTEEAPRSLN 741
+V +L AC+ G ++ E+ L +L T E+ +L+
Sbjct: 89 IVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 742 LLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
L L+ VA +++L H DL N+LL + + DFGLAR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+A+ + ++APE + DV+SYGI L EL +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G+FG V+ +Q K VAVK A + F E L ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWL-----HPITREDKTEEAPRSLNLLQRL 746
+ C+ +G +VFE+M++ L +L + AP L L Q L
Sbjct: 107 RFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 747 NIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
+ VA + YL H H DL N L+ + ++ + DFG++R + +
Sbjct: 162 AVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 805 SIDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVT 843
I ++ PE Y + S DV+S+G++L E+ T
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTES---DVWSFGVVLWEIFT 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 686
+G G+FG V + TVAVK +L GA ++ ++E L +I
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGH 89
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------HPITREDKTEEAPRSL 740
H N+V +L AC+ + ++ EF + +L +L + + L
Sbjct: 90 HLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 741 NLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
L + VA + +L H DL N+LL E+ + + DFGLAR +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 799 SPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
P DA+ + ++APE +I DV+S+G+LL E+ +
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 46/232 (19%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRH 687
E+G FG VYKG L + VA+K L A + F E ++H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT---LKDKAEGPLREEFRHEAMLRARLQH 71
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH------PITREDKTEEAPRSLN 741
N+V +L + + +++F + + L E+L + D +L
Sbjct: 72 PNVVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 742 LLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS 799
+++ +A + YL HH + H DL NVL+ +++ +SD GL R +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV--- 178
Query: 800 PAQTSSIDAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 843
+ + APE YG S S D++SYG++L E+ +
Sbjct: 179 --YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/237 (20%), Positives = 99/237 (41%), Gaps = 52/237 (21%)
Query: 638 EIGVGSFGSVYKGIL-------DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL 690
+G G+F ++KG+ +T V +KV + H +SF + + + H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 691 VKILTACSGVD--YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
V C D LV EF++ SL+ +L +++K +N+L +L +
Sbjct: 75 VLNYGVCVCGDENI-------LVQEFVKFGSLDTYL----KKNK-----NCINILWKLEV 118
Query: 749 GIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAH--------VSDFGLARFLPL 798
+A A+ +L + + H ++ N+LL E +SD G++ +
Sbjct: 119 AKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-- 171
Query: 799 SPAQTSSIDAKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTR-KKPVDSM 851
+ I ++ PE +++ D +S+G L E+ + KP+ ++
Sbjct: 172 ----LPKDILQERIPWVPPECIEN--PKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 637 NEIGVGSFGSVYKGIL--DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI-RHRN 689
+ IG G+FG V K + D + A+K + A + F E L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------HPITREDKTEEAPRSLNLL 743
++ +L AC Y L E+ + +L ++L +L+
Sbjct: 88 IINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 744 QRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
Q L+ DVA + YL H DL N+L+ E +A ++DFGL+R
Sbjct: 143 QLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSRG---QEV 194
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + ++A E S + N DV+SYG+LL E+V+
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 46/229 (20%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRH 687
+G G+FG VY+G + D VAVK L F+ E + H
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLMEALIISKFNH 92
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
+N+V+ + Q ++ E M L+ +L P SL +L L+
Sbjct: 93 QNIVRCIGVSL----QSLPR-FILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLH 144
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLD---EEMMAHVSDFGLARFLPLSPAQ 802
+ D+AC YL +H H D+ N LL +A + DFG+AR +
Sbjct: 145 VARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----Y 194
Query: 803 TSSIDAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 843
+S KG + PE G+ + D +S+G+LL E+ +
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFS 240
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 22/214 (10%)
Query: 638 EIGVGSFGSVYKGI-LDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 694
EIG GSF +VYKG+ + VA + F E LK ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTV-EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ LV E M + +L+ +L + + + + + +
Sbjct: 92 DSWESTVKGKKCI-VLVTELMTSGTLKTYL----------KRFKVMKIKVLRSWCRQILK 140
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
L +L H PPI H DLK N+ + + D GLA S A+ G+
Sbjct: 141 GLQFL-HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 195
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
++APE + + DVY++G+ +LE+ T + P
Sbjct: 196 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-26
Identities = 64/338 (18%), Positives = 115/338 (34%), Gaps = 79/338 (23%)
Query: 562 TCISKESKHKKLTLALK-------LALAIISGLTGLSLALSFLILCLV----------RK 604
+ E K +K L LK L + S ++A C + R
Sbjct: 273 QYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRP 332
Query: 605 RKEKKNPSSPINSFPNISYQNLYNATDGFASAN--------------------------- 637
+KE + I N Q + + T + +
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 638 ----EIGVGSFGSVYKGIL---DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIR 686
IG G FG V++GI + VA+K + + F+ E T++
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT---CKNCTSDSVREKFLQEALTMRQFD 449
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746
H ++VK++ + ++ E L +L + K SL+L +
Sbjct: 450 HPHIVKLIGVITENPVW------IIMELCTLGELRSFL----QVRK-----FSLDLASLI 494
Query: 747 NIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
++ AL+YL H D+ NVL+ + DFGL+R++ +
Sbjct: 495 LYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKA 549
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
K I ++APE + DV+ +G+ + E++
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 21/242 (8%)
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI 367
N+K ++P I + RLE+ +N+L +L L +L L N L
Sbjct: 15 NSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG-LSFKGCCS 71
Query: 368 G------NLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ--FLGLSW 419
+LK LDLS N + ++ S+ + L +D +NL + FL L
Sbjct: 72 QSDFGTTSLKY--LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN 127
Query: 420 LLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGN 477
L+ LD+S + + L +LEVL + N + + L L++
Sbjct: 128 LIY-LDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 478 FLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVF 537
L+ P++ +SL L VL++S NN L+ L+ S N++ +
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK-KQEL 243
Query: 538 KN 539
++
Sbjct: 244 QH 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 46/217 (21%), Positives = 83/217 (38%), Gaps = 13/217 (5%)
Query: 6 VKILNLTSLKLAGSISPHV-GNLSFLKVLLLYNN--SFNHGIPSEFDRLQRLQVLALNNN 62
L L S KL S+ V L+ L L L +N SF L+ L L+ N
Sbjct: 30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 63 SIGGEIPANISSCSNLIQIRLFYNELVGKIPSE--LGSLSKIEHLSVSVNNLTGSIPSSL 120
+ + +N L + ++ L ++ SL + +L +S + +
Sbjct: 89 GV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 121 GNLSSINTLFLTDNN-LDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFD 178
LSS+ L + N+ + +PD F L+NL L +++ L + + F ++SS+ +
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP 215
N + + L +LQ N +
Sbjct: 206 MSHNNFFSLDTFPYK-CLNSLQVLDYSLNHIM-TSKK 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 6/209 (2%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG-GEIPANI-SSCSNLIQIRLFYNE 87
L L +N FD+L +L L+L++N + + ++L + L +N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSL-GNLSSINTLFLTDNNLDGGIPDTFGW 146
++ + S L ++EHL +NL S+ +L ++ L ++ + F
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 147 LKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVF 205
L +L L MA N IF + ++T D QL+ + P F +L +LQ ++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF-NSLSSLQVLNMS 207
Query: 206 ENQLTGAIPPAISNASNLELFQADVNKLT 234
N ++L++ +N +
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 12/210 (5%)
Query: 10 NLTSLKL------AGSISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN 62
LT L L + LK L L N + S F L++L+ L ++
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 111
Query: 63 SIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS-SL 120
++ ++ S NLI + + + LS +E L ++ N+ +
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 171
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDA 179
L ++ L L+ L+ P F L +L L M+ N ++ + + ++S+ D
Sbjct: 172 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDY 230
Query: 180 GMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
+N + + +L F ++ +N
Sbjct: 231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 51/305 (16%), Positives = 96/305 (31%), Gaps = 69/305 (22%)
Query: 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF 169
LT S+P+ + SS L L N L F L L L+++ N
Sbjct: 17 KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN----------- 62
Query: 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQAD 229
++ G +L++ + N + + LE
Sbjct: 63 ---GLSFKGCCSQSDFG---------TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 109
Query: 230 VNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289
+ L ++E S+ + L L I+ +
Sbjct: 110 HSNLK---------------QMSEFSV-------------FLSLRNLIYLDISHTHTRVA 141
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPP-AIGELQ 347
+ L ++LE+L + N N + NL L++ +L + P A L
Sbjct: 142 FNGIFNGL-SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199
Query: 348 NLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIPSSL--GQYKTLTIIDL 401
+L+ L + N ++ +L+V LD S N + + +L ++L
Sbjct: 200 SLQVLNMSHNN-FFSLDTFPYKCLNSLQV--LDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 402 SDNNL 406
+ N+
Sbjct: 256 TQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 55/321 (17%), Positives = 109/321 (33%), Gaps = 43/321 (13%)
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT--GSIPSSLGNLS 124
+P I S + ++ L N+L L+++ LS+S N L+ G S +
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 125 SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQ 183
S+ L L+ N + + F L+ L L + L S+F ++ ++ D
Sbjct: 79 SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 184 LQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLTGEVPYLEK 242
+ F L +L+ + N P + NL +L
Sbjct: 138 TRVAFNGIFN-GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-------- 188
Query: 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE 302
++ + + + L L ++ NNF L L +L+
Sbjct: 189 -------QLSPT--------------AFNSLSSLQVLNMSHNNFFSLDTFPYKCL-NSLQ 226
Query: 303 MLLLDNNKIFGNIPAAI--GKFVNLQRLEMWNNRLSGT--IPPAIGELQNLRELRLQRNK 358
+L N I +L L + N + T + +++ R+L ++ +
Sbjct: 227 VLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 285
Query: 359 FLGNIPPSIGNLKVFNLDLSC 379
P + V +L+++C
Sbjct: 286 MECATPSDKQGMPVLSLNITC 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 38/232 (16%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 686
+G G+FG V VAVK +L A ++ ++E + +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGS 107
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL-------------HPITREDKT 733
H N+V +L AC+ L+FE+ L +L + + +
Sbjct: 108 HENIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 734 EEAPRSLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791
EE L L VA + +L H DL NVL+ + + DFG
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
LAR + +A+ + ++APE +I DV+SYGILL E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 15/240 (6%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
+ST +L L N+I + +L+ L++ N + TI A L NL L
Sbjct: 60 DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118
Query: 354 LQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIPSSL-GQYKTLTIIDLSDNNLTG 408
L N+ L IP LK L L N ++ SIPS + +L +DL +
Sbjct: 119 LFDNR-LTTIPNGAFVYLSKLK--ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 409 TIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCK 467
I F GLS L L+L+ L IP+ + L L+ LD+ N L P +
Sbjct: 175 YISEGAFEGLSNLRY-LNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 468 KLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L++L M + +Q ++ +L+ L ++L+ NNL+ + LE ++L +N
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 19/222 (8%)
Query: 315 IPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPP----SIGNL 370
+P I N + L + N++ + L++L L+L RN + I + NL
Sbjct: 58 VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH-IRTIEIGAFNGLANL 114
Query: 371 KVFNLDLSCNFLQGSIPS-SLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSR 428
L+L N L +IP+ + L + L +N + +IP F + L LDL
Sbjct: 115 NT--LELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR-LDLGE 169
Query: 429 -NQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSS 486
+L+ I L NL L++ L+ EIP L KL++L++ GN L P S
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGS 226
Query: 487 LSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
L L L + Q+ + Q L +NL++NNL
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 66/334 (19%), Positives = 115/334 (34%), Gaps = 65/334 (19%)
Query: 27 LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86
LS L + + PS + + ++ E+P IS+ N + L N
Sbjct: 18 LSVLLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHEN 74
Query: 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGW 146
++ + L +E L +S N++ + L+++NTL L DN L F +
Sbjct: 75 QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134
Query: 147 LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFE 206
L L L + N + +IPS FN + +L+ + E
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFN------------------------RIPSLRRLDLGE 169
Query: 207 -NQLTGAIPP-AISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNL 264
+L+ I A SNL + L E+P L +L ++ N L +
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSA------ 221
Query: 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVN 324
I +F GL L+ L + ++I A +
Sbjct: 222 ----------------IRPGSFQGL---------MHLQKLWMIQSQIQVIERNAFDNLQS 256
Query: 325 LQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRN 357
L + + +N L+ +P L +L + L N
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLALNNNS 63
+L L+L+ +I L+ L L L++N IP+ F L +L+ L L NN
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNP 147
Query: 64 IGGEIPANI-SSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPSSLG 121
I IP+ + +L ++ L + + I LS + +L++++ NL IP +L
Sbjct: 148 I-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLT 204
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
L ++ L L+ N+L P +F L +L L M ++ + I + F N+ S+ +
Sbjct: 205 PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLA 263
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
N L ++P D L +L+ + N
Sbjct: 264 HNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 14/185 (7%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLAL-NNN 62
NL +L+L +I LS LK L L NN IPS F+R+ L+ L L
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELK 171
Query: 63 SIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121
+ I SNL + L L +IP+ L L K++ L +S N+L+ P S
Sbjct: 172 RL-SYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQ 228
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
L + L++ + + + F L++L + +A N L+ +P +F + +
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLH 287
Query: 181 MNQLQ 185
N
Sbjct: 288 HNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 55/232 (23%), Positives = 84/232 (36%), Gaps = 17/232 (7%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
N L L I + +L L++L L N F+ L L L L +N +
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPS-SLG 121
IP S L ++ L N + IPS + + L + I +
Sbjct: 125 -TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
LS++ L L NL IP L L L ++ N LS I F + +
Sbjct: 183 GLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMI 239
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVN 231
+Q+Q + F LQ+L ++ N LT +P + +LE N
Sbjct: 240 QSQIQVIERNAFD-NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 13/239 (5%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
+ + L L N I +L+ L++ N + I A L +L L
Sbjct: 71 QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLE 129
Query: 354 LQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT 409
L N L IP L+ L L N ++ + + +L +DL +
Sbjct: 130 LFDNW-LTVIPSGAFEYLSKLR--ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY 186
Query: 410 IPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKK 468
I F GL L L+L + +P+ + L LE L++ N P +
Sbjct: 187 ISEGAFEGLFNLKY-LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 469 LEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L++L + + + ++ L L L+L+ NNLS + + L L+L +N
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 21/230 (9%)
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPP- 365
+ +P I N + L + N + I L +L L+L RN + I
Sbjct: 62 TRRGLSEVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS-IRQIEVG 117
Query: 366 ---SIGNLKVFNLDLSCNFLQGSIPS-SLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWL 420
+ +L L+L N+L IPS + L + L +N + +IP F + L
Sbjct: 118 AFNGLASLNT--LELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSL 173
Query: 421 LIGLDLSR-NQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478
+ LDL +L I L NL+ L++ +K ++P L LE+LEM GN
Sbjct: 174 MR-LDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229
Query: 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
P S L L L + + +S G L LNL++NNL
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 66/307 (21%), Positives = 108/307 (35%), Gaps = 63/307 (20%)
Query: 53 RLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNL 112
+ + + E+P I S N + L N + L +E L + N++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 113 TGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNIS 172
+ L+S+NTL L DN L F +L L L + N + +IPS F
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF--- 167
Query: 173 SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVN 231
+ L LD L L +L I A NL
Sbjct: 168 ------NRVPSLM---RLD----LGEL-------KKLE-YISEGAFEGLFNL-------- 198
Query: 232 KLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLP 291
+ L++ G N+ + +LT L L ++ N+F + P
Sbjct: 199 ------------KYLNL-----------GMCNIKDMPNLTPLVGLEELEMSGNHFPEIRP 235
Query: 292 ACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLR 350
L ++L+ L + N+++ A +L L + +N LS ++P L+ L
Sbjct: 236 GSFHGL-SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293
Query: 351 ELRLQRN 357
EL L N
Sbjct: 294 ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 10/209 (4%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
+ L L N+ F L L+VL L NSI +I + ++L + LF N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWL 135
Query: 89 VGKIPSE-LGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIP-DTFGW 146
IPS LSK+ L + N + + + S+ L L + I F
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 147 LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFE 206
L NL L + + +P ++ + + + N + P F L +L+ V
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFH-GLSSLKKLWVMN 251
Query: 207 NQLTGAIPP-AISNASNLELFQADVNKLT 234
+Q++ I A ++L N L+
Sbjct: 252 SQVS-LIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLAL-NNN 62
+L +L+L I LS L+ L L NN IPS F+R+ L L L
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELK 182
Query: 63 SIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121
+ I NL + L + +P+ L L +E L +S N+ P S
Sbjct: 183 KLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFH 239
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
LSS+ L++ ++ + + F L +L L +A N LS ++P +F + +
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLH 298
Query: 181 MNQLQ 185
N
Sbjct: 299 HNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 51/232 (21%), Positives = 81/232 (34%), Gaps = 17/232 (7%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
N L L I +L L+VL L NS F+ L L L L +N +
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPS-SLG 121
IP+ S L ++ L N + IPS + + L + I +
Sbjct: 136 -TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
L ++ L L N+ +P L L L M+ N I F +SS+
Sbjct: 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVM 250
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVN 231
+Q+ + F L +L ++ N L+ ++P + L N
Sbjct: 251 NSQVSLIERNAFD-GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 637 NEIGVGSFGSVYKGIL-------DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI 685
+G G+FG V + TVAVK+ L A ++E +K I
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMI 97
Query: 686 -RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------HPITREDKTEEAPR 738
+H+N++ +L AC+ Q ++ E+ +L E+L D
Sbjct: 98 GKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 739 SLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
+ ++ +A + YL H DL NVL+ E + ++DFGLAR +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 797 PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + + + ++APE + DV+S+G+L+ E+ T
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 33/227 (14%)
Query: 637 NEIGVGSFGSVYKGIL-------DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI 685
+G G+FG V T VAVK +L A I+E +K I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMI 131
Query: 686 -RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------HPITREDKTEEAPR 738
+H+N++ +L AC+ Q ++ E+ +L E+L + +
Sbjct: 132 GKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 739 SLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
L+ ++ VA + YL H DL NVL+ E+ + ++DFGLAR +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 797 PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843
+ + + + ++APE + DV+S+G+LL E+ T
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 46/229 (20%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRH 687
+G G+FG VY+G + D VAVK L F+ E + H
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLMEALIISKFNH 133
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
+N+V+ + Q ++ E M L+ +L P SL +L L+
Sbjct: 134 QNIVRCIGVSL----QSLPR-FILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLH 185
Query: 748 IGIDVACALSYL--HHDCQPPITHCDLKPSNVLLD---EEMMAHVSDFGLARFLPLSPAQ 802
+ D+AC YL +H H D+ N LL +A + DFG+AR +
Sbjct: 186 VARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----Y 235
Query: 803 TSSIDAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 843
+ KG + PE G+ + + D +S+G+LL E+ +
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS 281
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 29/236 (12%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
+ + + L N+I A+ NL L + +N L+ I A L L +L
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLD 86
Query: 354 LQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ 413
L N L ++ P+ F LG+ L + L L + P
Sbjct: 87 LSDNAQLRSVDPA-----TF--------------HGLGR---LHTLHLDRCGLQ-ELGPG 123
Query: 414 -FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
F GL+ L L L N L ++P + +L NL L + N++ L++
Sbjct: 124 LFRGLAALQY-LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 472 LEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L + N + P + L L L L NNLS E L + L+ L L++N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 56/235 (23%), Positives = 81/235 (34%), Gaps = 33/235 (14%)
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI 367
+ +P I QR+ + NR+S + +NL L L N L I
Sbjct: 19 PQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDA-- 73
Query: 368 GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDL 426
F + L L +DLSDN ++ P F GL L L L
Sbjct: 74 ---AAF--------------TGLAL---LEQLDLSDNAQLRSVDPATFHGLG-RLHTLHL 112
Query: 427 SRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIP 484
R L + + L L+ L + +N L+ +P T L L + GN +
Sbjct: 113 DRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 485 SSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
+ L L+ L L QN ++ P L L L NNL +P
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP-TEALAP 223
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 16/193 (8%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQR 327
S L L +++N + A + L+ ++ L DN ++ ++ L
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL-RSVDPATFHGLGRLHT 109
Query: 328 LEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFL 382
L + L + P L L+ L LQ N L +P GNL L L N +
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTH--LFLHGNRI 165
Query: 383 QGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-G 440
+ +L + L N + + P F L L+ L L N L+ ++P+E
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMT-LYLFANNLS-ALPTEALA 222
Query: 441 NLKNLEVLDVFEN 453
L+ L+ L + +N
Sbjct: 223 PLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 38/209 (18%), Positives = 79/209 (37%), Gaps = 13/209 (6%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ L G + L +L L++N + F L L+ L L++N+
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPS-SLG 121
+ L + L L ++ L+ +++L + N L ++P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
+L ++ LFL N + F L +L L + +N ++ + F ++ +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF 209
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
N L +P + L+ LQ+ + +N
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 50/270 (18%), Positives = 87/270 (32%), Gaps = 62/270 (22%)
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
+P I + +I L N + + + + L + N L ++ L+ +
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 127 NTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
L L+DN + TF L L TL + L + +F
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR--------------- 126
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKLTGEVPYLEKPQ 244
L LQ+ + +N L A+P + NL N+++
Sbjct: 127 ---------GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS---------- 166
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
S+ E + L+RLL++ N + P +L L L
Sbjct: 167 -----SVPER--------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDL-GRLMTL 206
Query: 305 LLDNNKIFGNIPA-AIGKFVNLQRLEMWNN 333
L N + +P A+ LQ L + +N
Sbjct: 207 YLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 26/134 (19%), Positives = 44/134 (32%), Gaps = 31/134 (23%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
L L L ++ +L L L L+ N + F L L L L+ N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 65 GGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSS-LGNL 123
+ + L ++ L + NNL+ ++P+ L L
Sbjct: 190 -AHVHPHA-----------------------FRDLGRLMTLYLFANNLS-ALPTEALAPL 224
Query: 124 SSINTLFLTDNNLD 137
++ L L DN
Sbjct: 225 RALQYLRLNDNPWV 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 43/232 (18%)
Query: 637 NEIGVGSFGSVYKGIL-------DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI 685
+G G FG V + TVAVK+ L A ++E +K I
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMI 143
Query: 686 -RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL------HPITREDKTEEAPR 738
+H+N++ +L AC+ Q ++ E+ +L E+L D
Sbjct: 144 GKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 739 SLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
+ ++ +A + YL H DL NVL+ E + ++DFGLAR +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 797 PLSPAQTSSIDAKGSIGYI-----APEYGLGSEVSINGDVYSYGILLLELVT 843
K + G + APE + DV+S+G+L+ E+ T
Sbjct: 254 -----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 54/240 (22%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNIRH 687
+IG G+FG V++ + T VAVK+ L A F E + +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFDN 109
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWL--------------HPITREDKT 733
N+VK+L C+ G L+FE+M L E+L TR +
Sbjct: 110 PNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 734 EEAPRSLNLLQRLNIGIDVACALSYL--HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791
P L+ ++L I VA ++YL H DL N L+ E M+ ++DFG
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFG 219
Query: 792 LARFLPLSPAQTSSIDAKGSIGYI-----APE---YGLGSEVSINGDVYSYGILLLELVT 843
L+R + ++ I PE Y + S DV++YG++L E+ +
Sbjct: 220 LSRNI-----YSADYYKADGNDAIPIRWMPPESIFYNRYTTES---DVWAYGVVLWEIFS 271
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 76/508 (14%), Positives = 165/508 (32%), Gaps = 62/508 (12%)
Query: 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI 68
+++ L+ K++ N++ + D +++++L LN+ I EI
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEI 90
Query: 69 PANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
+ + ++ + +N + P ++ + L + N+L+ N +
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
TL +++NNL+ DTF +L L ++ N +T D
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSN--------------RLTHVDLS------- 189
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
+ +L +V N L+ ++ +E A N + V L+
Sbjct: 190 -------LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELT 235
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
+ + N+L L N L + ++ N ++ + LE L +
Sbjct: 236 ILKLQHNNLTDTA--------WLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYIS 286
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP--- 364
NN++ + L+ L++ +N L + + L L L N + +
Sbjct: 287 NNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKLST 343
Query: 365 -PSIGNLKVFNLDLSCN-----FLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
++ NL + + D CN F + P+ + I ++ L +
Sbjct: 344 HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDR 403
Query: 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ----LEM 474
L S + + + + + + L ++LE L
Sbjct: 404 LLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRA 463
Query: 475 QGNFLQGPIPSSLSSLKGLNVLDLSQNN 502
+ L L+GL+ +
Sbjct: 464 EVQQLTNEQIQQEQLLQGLHAEIDTNLR 491
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 86/489 (17%), Positives = 163/489 (33%), Gaps = 53/489 (10%)
Query: 61 NNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSEL------GSLSKIEHLSVSVNNLTG 114
++ P SNL +FY+ + ++ +L+ + ++ + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 115 SIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISS 173
+ L + + L L D ++ F + + L M N + +P +F N+
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 124
Query: 174 ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKL 233
+T N L +P L S+ N L ++L+ Q N+L
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183
Query: 234 TGEVPYLEKPQRLSVFSITENSLGSRGHSNL--NFLCSLTNSTRLNRLLINANNFGGLLP 291
T + + + S H+N+ N L +L + L + N+ +
Sbjct: 184 T---------------HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRG 228
Query: 292 ACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRE 351
L+ L L +N + A + + L +++ N L + ++Q L
Sbjct: 229 PVNVELTI----LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282
Query: 352 LRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTI 410
L + N+ L + + + LDLS N L + + Q+ L + L N++ T+
Sbjct: 283 LYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 339
Query: 411 PPQ-FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTL--GSCK 467
L L LS N + S +N+ V + +I L G C
Sbjct: 340 KLSTHHTLKN----LTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 393
Query: 468 KLEQLEMQGNFLQGPIPSSL--------SSLKGLNVLDLSQNNLSGKIPEFLVGFQLLEN 519
K LQ +S+ + ++ Q+ + V Q E
Sbjct: 394 KESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQ 453
Query: 520 LNLSNNNLE 528
L N L
Sbjct: 454 LEAEVNELR 462
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/253 (21%), Positives = 83/253 (32%), Gaps = 50/253 (19%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G FG V+K T +K + E L + H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 697 CSGVDYQGNDFKA-----------LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
G DY + EF +LE+W+ E +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--------LA 124
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
L + + + Y+H + + DLKPSN+ L + + DFGL L +
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL------KND 175
Query: 806 IDAKGSIG---YIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
S G Y++PE YG D+Y+ G++L EL+ FE
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEV------DLYALGLILAELLHVCDT---AFETSK 226
Query: 857 NLHNFARMALPDH 869
+ + D
Sbjct: 227 FFTDLRDGIISDI 239
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/230 (24%), Positives = 89/230 (38%), Gaps = 35/230 (15%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILT 695
IG GS+G K + K + + + ++E N L+ ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--TEEAPRSLNLLQRLNIGIDVA 753
+D +V E+ + L + T+E + EE L + +
Sbjct: 73 --RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEE--------FVLRVMTQLT 121
Query: 754 CALSYLH--HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
AL H D + H DLKP+NV LD + + DFGLAR L + + G+
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGT 179
Query: 812 IGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
Y++PE Y S D++S G LL EL P F
Sbjct: 180 PYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 43/233 (18%), Positives = 87/233 (37%), Gaps = 26/233 (11%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
+G G F V A+K + E + + H N+++++ C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSY 758
++ L+ F + +L + ++ ++ L Q L + + + L
Sbjct: 97 RERGAKHEAW-LLLPFFKRGTLWNEI------ERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 759 LHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA-------KGS 811
+H H DLKP+N+LL +E + D G + + + +
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 812 IGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858
I Y APE + + E + DV+S G +L ++ + P D +F+ ++
Sbjct: 207 ISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/232 (22%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
+G G+FG V K A+K + ++E L ++ H+ +V+ A
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 699 GVDYQGNDFKA--------LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
A + E+ +N +L + I E+ ++ L +
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL---IHSENLNQQRDEYWRLFR------ 123
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL---------PLSPA 801
+ ALSY+H I H DLKP N+ +DE + DFGLA+ +
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 802 QTSSIDAKGSIG---YIAPE-------YGLGSEVSINGDVYSYGILLLELVT 843
SS + +IG Y+A E Y ++ D+YS GI+ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIY 226
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 26/259 (10%), Positives = 60/259 (23%), Gaps = 38/259 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+ VG V+ + A+KVF + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 695 TACS-----------------GVDYQGNDFKA----LVFEFMQNRSLEEWLHPITREDKT 733
+ +D+ L+ LE + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL---FSTLDFV 184
Query: 734 EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA 793
+L + + + L + H P N+ + + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING--DVYSYGILLLELVTRKKPVDSM 851
T + + Y E+ S + + + G+ + + P +
Sbjct: 242 W-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 852 FEGDMNLHNFARMALPDHV 870
G + +P
Sbjct: 297 TPGIKGSWKRPSLRVPGTD 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 59/261 (22%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
S L+ ++ L L NN+I + + + VNLQ L + +N ++ TI + L +L L
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLD 106
Query: 354 LQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIPSSL-GQYKTLTIIDLSDNNLTG 408
L N L N+ S +L L+L N + +SL L I+ + + +
Sbjct: 107 LSYNY-LSNLSSSWFKPLSSLT--FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163
Query: 409 TIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSC 466
I + F GL+ L L++ + L S + +++N+ L + + + +
Sbjct: 164 KIQRKDFAGLT-FLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221
Query: 467 KKLEQLEMQGNFLQGPIPSSLSS--------LKGLNVLDLSQNNLSGKIPEFLVGFQLLE 518
+E LE++ L S LS+ + ++ +L ++ + L L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 519 NLNLSNNNLEGMVPIEGVFKN 539
L S N L+ VP +G+F
Sbjct: 281 ELEFSRNQLK-SVP-DGIFDR 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 46/274 (16%), Positives = 98/274 (35%), Gaps = 30/274 (10%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMW 331
+ + L ++ N + + + L+ L+L +N I I + +L+ L++
Sbjct: 51 TEAVKSLDLSNNRITYISNSDLQRC-VNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLS 108
Query: 332 NNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSI---GNLKVFNLDLSCNFLQGSIP 387
N LS + L +L L L N + + K+ L + I
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNP-YKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 388 ----SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNL 442
+ L L +++ ++L + P+ L + L L Q +
Sbjct: 167 RKDFAGLTF---LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221
Query: 443 KNLEVLDVFENKLKG----EIPS----TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLN 494
++E L++ + L E+ + +L +++ L + L+ + GL
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 495 VLDLSQNNLSGKIPEFLV-GFQLLENLNLSNNNL 527
L+ S+N L +P+ + L+ + L N
Sbjct: 281 ELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 56/252 (22%), Positives = 96/252 (38%), Gaps = 33/252 (13%)
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI 367
++ +IP+ + ++ L++ NNR++ + NL+ L L N + I
Sbjct: 39 SSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIEE-- 93
Query: 368 GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDL 426
F SSLG L +DLS N L+ + F LS L L+L
Sbjct: 94 ---DSF--------------SSLGS---LEHLDLSYNYLS-NLSSSWFKPLS-SLTFLNL 131
Query: 427 SRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIP 484
N + + +L L++L V +I LE+LE+ + LQ P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 485 SSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIE---GVFKNAT 541
SL S++ ++ L L + F+ +E L L + +L+ E G +
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 542 ITSVLGNLKLCG 553
N+K+
Sbjct: 252 KKFTFRNVKITD 263
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 59/336 (17%), Positives = 105/336 (31%), Gaps = 82/336 (24%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89
+K L L NN + S+ R LQ L L +N I I + F +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEED-----------SFSS--- 98
Query: 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSL-GNLSSINTLFLTDNNLDGGIPD--TFGW 146
L +EHL +S N L+ ++ SS LSS+ L L N + + F
Sbjct: 99 ---------LGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
Query: 147 LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFE 206
L L L + I F L L+ +
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFA------------------------GLTFLEELEIDA 183
Query: 207 NQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNF 266
+ L P ++ + N+ + + L +
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHI--------------------LLLEIFVDVTSS 223
Query: 267 LCSLTNSTRLNRLLINANNFGGLLPACISNLS--TTLEMLLLDNNKIFGNIPAAIGKFVN 324
+ L L ++ +F L ++L T + + + +F + + +
Sbjct: 224 VECL----ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 325 LQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKF 359
L LE N+L ++P L +L+++ L N +
Sbjct: 279 LLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 61/326 (18%), Positives = 112/326 (34%), Gaps = 67/326 (20%)
Query: 92 IPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA 151
IPS L ++ L +S N +T S L ++ L LT N ++ D+F L +L
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103
Query: 152 TLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210
L ++ N+LS + SS F +SS+T + N + + L LQ V
Sbjct: 104 HLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 211 GAIPP-AISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCS 269
I + + LE + D + L S SL
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQ---------------SYEPKSL------------- 194
Query: 270 LTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAI--------GK 321
+ ++ L+++ LL + +++E L L + + + + K
Sbjct: 195 -KSIQNVSHLILHMKQHILLLEIFVDVT-SSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 322 FVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNF 381
+ +++ + L + + ++ L EL RN+ L ++P I
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ-LKSVPDGI-------------- 296
Query: 382 LQGSIPSSLGQYKTLTIIDLSDNNLT 407
+ +L I L N
Sbjct: 297 --------FDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 40/242 (16%), Positives = 81/242 (33%), Gaps = 19/242 (7%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
+ SL L+ IS L+ L+L +N N F L L+ L L+ N +
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPS-SLG 121
+ ++ S+L + L N + L L+K++ L V + I
Sbjct: 113 -SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAG 180
L+ + L + ++L P + ++N++ L + + SS+ +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 181 MNQLQGV-------IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKL 233
L + + + + L + ++ S L + N+L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 234 TG 235
Sbjct: 290 KS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 25/150 (16%), Positives = 50/150 (33%), Gaps = 12/150 (8%)
Query: 19 SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCS 76
I L+FL+ L + + P +Q + L L+ + S
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTS 222
Query: 77 NLIQIRLFYNELVGKIPSELGS--------LSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128
++ + L +L SEL + ++ ++ +L + L +S +
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 129 LFLTDNNLDGGIPDTFGWLKNLATLAMAEN 158
L + N L F L +L + + N
Sbjct: 282 LEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 16/142 (11%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
L L++ S P ++ + L+L+ + D ++ L L + +
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234
Query: 65 GGEIPANISS--------CSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSI 116
+ +S+ +++ L ++ L +S + L S N L S+
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SV 292
Query: 117 PSS-LGNLSSINTLFLTDNNLD 137
P L+S+ ++L N D
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPWD 314
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 53/236 (22%), Positives = 85/236 (36%), Gaps = 28/236 (11%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTAC 697
+ G F VY+ A+K ++ I E +K + H N+V+ +A
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 698 SGV--DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
S + + L+ + L E+L + L I A
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD-------TVLKIFYQTCRA 148
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK------ 809
+ ++H +PPI H DLK N+LL + + DFG A + P + S +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 810 ----GSIGYIAPE-YGLGSEVSIN--GDVYSYGILLLELVTRKKPVDSMFEGDMNL 858
+ Y PE L S I D+++ G +L L R+ P FE L
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+G G++G VY G L +A+K + E K+++H+N+V+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQV-RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
G + K + E + SL L K E Q L L
Sbjct: 86 -GSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLK 136
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEM-MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YLH + I H D+K NVL++ + +SDFG ++ L T + G++ Y+A
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 191
Query: 817 PEYGLGSEVSING--DVYSYGILLLELVTRKKP 847
PE D++S G ++E+ T K P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 75/418 (17%), Positives = 133/418 (31%), Gaps = 48/418 (11%)
Query: 148 KNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFEN 207
N A+ A + T S ++++T+ D + + + ++ L L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEK---LTGLTKLICTSN 74
Query: 208 QLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFL 267
+T + +S +NL D NKLT + + +L+ + N L S L
Sbjct: 75 NIT-TLD--LSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKLTKLDVSQNPLL 129
Query: 268 CSL------------TNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNI 315
L +++T+L L + N L ++ T L L NKI +
Sbjct: 130 TYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQ-TQLTTLDCSFNKI-TEL 185
Query: 316 PAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNL 375
+ + L RL N ++ + + + L L NK L I + ++
Sbjct: 186 D--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK-LTEIDVT-PLTQLTYF 238
Query: 376 DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435
D S N L + S LT + +L + L+ +
Sbjct: 239 DCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE------IDLTHNTQLIYFQAEGCRKIK 289
Query: 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
+V + L +LD + E+ L KL L + L + +S L
Sbjct: 290 ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKS 343
Query: 496 LDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCG 553
L ++ + L N + M + TI L G
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 78/454 (17%), Positives = 140/454 (30%), Gaps = 72/454 (15%)
Query: 76 SNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN 135
N E+ L+ + L +++T + + L+ + L T NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 136 LDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFT 195
+ + NL LA N L+ + + ++ +T + N+L LD
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS-Q 125
Query: 196 LQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENS 255
L + + N LT I +S+ + L +NK ++
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD----------------- 165
Query: 256 LGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNI 315
+T T+L L + N L +S L L D N I +
Sbjct: 166 --------------VTPQTQLTTLDCSFNKITEL---DVSQN-KLLNRLNCDTNNIT-KL 206
Query: 316 PAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNL 375
+ + + L L+ +N+L+ I + L L N L + S K+ L
Sbjct: 207 D--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNP-LTELDVS-TLSKLTTL 259
Query: 376 DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435
L I L L + + + L LD +T +
Sbjct: 260 HCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD---VTHNTQLYLLDCQAAGIT-EL 312
Query: 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
+ L L + +L E+ + KL+ L +Q SS+ + LN
Sbjct: 313 D--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNN 365
Query: 496 LDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
++ E L L ++ + G
Sbjct: 366 NFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 74/485 (15%), Positives = 145/485 (29%), Gaps = 79/485 (16%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89
+ ++L L L +N+SI ++ I + L ++ N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTSNNIT 77
Query: 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKN 149
+ L + + +L+ N LT ++ + L+ + L N L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPL 128
Query: 150 LATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
L L A N L+ I S + + +T D +N+ + + L N++
Sbjct: 129 LTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKI 182
Query: 210 TGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCS 269
T + +S L D N +T L+
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNIT----------------------------KLDL--- 208
Query: 270 LTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLE 329
+ +L L ++N + ++ L T L N + + + L L
Sbjct: 209 -NQNIQLTFLDCSSNKLTEI---DVTPL-TQLTYFDCSVNPL-TELD--VSTLSKLTTLH 260
Query: 330 MWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS 389
L I + L + + + + + + N +++ LD + +
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT-HNTQLYLLDCQAAGIT-ELD-- 313
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLD 449
L Q L + L++ LT + L L + VG + L
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELDVSHNT---KLKSLSCVNAHIQ-DFS-SVGKIPALNNNF 367
Query: 450 VFENKLKGEIPSTLGS-----CKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS 504
E + TL + + L+ GN + I + ++ NLS
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLS 425
Query: 505 GKIPE 509
P
Sbjct: 426 TDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 71/438 (16%), Positives = 143/438 (32%), Gaps = 58/438 (13%)
Query: 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
+ ++ + + L+ L L +N+S + ++L L L +N+I
Sbjct: 21 ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-T 77
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
+ +S +NL + N+L + + L+K+ +L+ N LT + +
Sbjct: 78 TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLL 129
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186
L N L L L N + + + +T D N++
Sbjct: 130 TYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184
Query: 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRL 246
LD + L + N +T + ++ L NKLT E+ + +L
Sbjct: 185 ---LDVS-QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID-VTPLTQL 235
Query: 247 SVFSITENSLGS---RGHSNLNFLC---------SLTNSTRLNRLLINANNFGGLLPACI 294
+ F + N L S L L LT++T+L + +
Sbjct: 236 TYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRK--IKELDV 293
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRL 354
++ T L +L I + + + L L + N L+ + + L+ L
Sbjct: 294 THN-TQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346
Query: 355 QRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQF 414
+ + + N + Q T+ L++N+LT + P
Sbjct: 347 VNAH-IQDFSSVGKIPALNNNFEAEG-----------QTITMPKETLTNNSLTIAVSPDL 394
Query: 415 LGLSWLLIGLDLSRNQLT 432
L + ++ +
Sbjct: 395 LDQFGNPMNIEPGDGGVY 412
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 69/409 (16%), Positives = 126/409 (30%), Gaps = 72/409 (17%)
Query: 10 NLTSLKLAGS--ISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGE 67
NLT L + + V L+ L L N + + L L N++ E
Sbjct: 86 NLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTL-TE 141
Query: 68 IPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
I +S + L ++ N+ + ++ +++ L S N +T + +N
Sbjct: 142 ID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLN 194
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
L NN+ + + +T D N+L
Sbjct: 195 RLNCDTNNIT-------------------------KLD--LNQNIQLTFLDCSSNKLTE- 226
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
+D L L +F N LT + +S S L L E+ L +L
Sbjct: 227 --IDVT-PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID-LTHNTQLI 278
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
F + L +T++T+L L A L +S L L L+
Sbjct: 279 YFQAEGC-------RKIKEL-DVTHNTQLYLLDCQAAGITELD---LSQN-PKLVYLYLN 326
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI 367
N ++ + + L+ L N + +G++ L + + +P
Sbjct: 327 NTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKET 380
Query: 368 GNLKVFNLDLSCNFLQGS-----IPSSLGQYKTLTIIDLSDNNLTGTIP 411
+ +S + L I G ++ NL+ P
Sbjct: 381 LTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 50/241 (20%), Positives = 92/241 (38%), Gaps = 31/241 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G+ +V++G + A+KVFN + + E LK + H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
+ K L+ EF SL L + E L +L+ DV +
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR------DVVGGM 125
Query: 757 SYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFL-PLSPAQTSSIDAKGS 811
++L + I H ++KP N++ D + + ++DFG AR L + G+
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGT 178
Query: 812 IGYIAPEYGLGSEVSING--------DVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863
Y+ P+ + + + D++S G+ T P N +
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
Query: 864 M 864
+
Sbjct: 239 I 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 28/254 (11%)
Query: 611 PSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG 670
P + YN F +IG G F VY+ VA+K +
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 671 AFK---SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPI 727
K I E + LK + H N++K + + ++ +V E L +
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGDLSRMIKHF 126
Query: 728 TREDK--TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785
++ + E + + AL ++H + H D+KP+NV + +
Sbjct: 127 KKQKRLIPER--------TVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 175
Query: 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 845
+ D GL RF S+ G+ Y++PE + + D++S G LL E+ +
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
Query: 846 KPVDSMFEGD-MNL 858
P F GD MNL
Sbjct: 234 SP----FYGDKMNL 243
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 49/238 (20%), Positives = 93/238 (39%), Gaps = 35/238 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK-SFIAECNTLKNIRHRNLVKILTAC 697
+G G FG V++ A+K L + + + E L + H +V+ A
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 698 SGVDYQGNDFKA-------LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
+ + + + + +L++W++ ++ E + L+I +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS-------VCLHIFL 125
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-------PLSPAQT 803
+A A+ +LH + H DLKPSN+ + + V DFGL + +
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 804 SSIDAKGSIG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858
+ G +G Y++PE G+ S D++S G++L EL+ F M
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------FSTQMER 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 56/253 (22%), Positives = 92/253 (36%), Gaps = 35/253 (13%)
Query: 603 RKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK 662
R+ + S + S + F + +G GS+G V+K + AVK
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 663 VFNLLHHGAF--KSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRS 719
G +AE + + + +H V++ A ++ L E S
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELCG-PS 142
Query: 720 LEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779
L++ E SL Q D AL++LH + H D+KP+N+ L
Sbjct: 143 LQQHC---------EAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFL 190
Query: 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPE-----YGLGSEVSINGDVYSY 834
+ DFGL L + +G Y+APE YG + DV+S
Sbjct: 191 GPRGRCKLGDFGLLVELG-TAGAGEVQ--EGDPRYMAPELLQGSYGTAA------DVFSL 241
Query: 835 GILLLELVTRKKP 847
G+ +LE+ +
Sbjct: 242 GLTILEVACNMEL 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 49/233 (21%), Positives = 90/233 (38%), Gaps = 48/233 (20%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA----ECNTLKNI-RH 687
F + +G G+ G++ + + VAVK + E L+ H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
N+++ C+ + F+ + E +L+E+ + ++D + LLQ
Sbjct: 78 PNVIRYF--CT---EKDRQFQYIAIELCAA-TLQEY---VEQKDFAHLGLEPITLLQ--- 125
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-----EMMAHVSDFGLARFL-PLSPA 801
L++LH I H DLKP N+L+ ++ A +SDFGL + L +
Sbjct: 126 ---QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 802 QTSSIDAKGSIGYIAPEY-------GLGSEVSINGDVYSYGILLLELVTRKKP 847
+ G+ G+IAPE V D++S G + +++
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTV----DIFSAGCVFYYVISEGSH 228
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 55/285 (19%), Positives = 110/285 (38%), Gaps = 43/285 (15%)
Query: 606 KEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN 665
+ S N+ +Q++ ++ +IG G V++ + ++ + A+K N
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVN 61
Query: 666 L--LHHGAFKSFIAECNTLKNIRHRNL--VKILTACSGVDYQGNDFKALVFEFMQNRSLE 721
L + S+ E L ++ + +++ + +V E N L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY----DYEITDQYIY-MVMECG-NIDLN 115
Query: 722 EWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLD 780
WL +S++ +R + ++ A+ +H H I H DLKP+N L+
Sbjct: 116 SWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 161
Query: 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPE-----------YGLGSEVSING 829
+ M + DFG+A + G++ Y+ PE S++S
Sbjct: 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 830 DVYSYGILLLELVTRKKPVDSMFEGDMN-LHNFARMALPDHVVDI 873
DV+S G +L + K P F+ +N + + P+H ++
Sbjct: 221 DVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPNHEIEF 261
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-22
Identities = 54/277 (19%), Positives = 87/277 (31%), Gaps = 22/277 (7%)
Query: 270 LTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVN---LQ 326
L LL + L S +L+ L + +I I + + LQ
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 327 RLEMWNNRLSGTIPPAIGELQ--NLRELRLQRNKFLGNIP-----PSIGNLKVFNLDLSC 379
L + N ++GT PP + E +L L L+ + + L ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 380 NFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ---FLGLSWLLIGLDLSRNQLT---G 433
+ + L+ +DLSDN G L L L + G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 434 SIPSEVGNLKNLEVLDVFENKLKGEIPSTLGS-CKKLEQLEMQGNFLQGPIPSSLSSLKG 492
+ L+ LD+ N L+ + +L L + L+ + L
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS- 277
Query: 493 LNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
VLDLS N L P + NL+L N
Sbjct: 278 --VLDLSYNRLDR-NPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 40/242 (16%), Positives = 69/242 (28%), Gaps = 30/242 (12%)
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
L ++ + L + + LN ++ L L L++L
Sbjct: 96 GLQELTLENLEVTGTAPPPL-LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 305 LLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIP----PAIGELQNLRELRLQRNKFL 360
+ + F L L++ +N G + L+ L L+
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM- 213
Query: 361 GNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420
G + L +DLS N+L
Sbjct: 214 -------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 421 LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQ 480
L L+LS L +P + L VLD+ N+L PS ++ L ++GN
Sbjct: 255 LNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFL 309
Query: 481 GP 482
Sbjct: 310 DS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 48/279 (17%), Positives = 82/279 (29%), Gaps = 28/279 (10%)
Query: 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANIS---SCSNLIQI 81
G S +L + + G ++ + L+ L + I I S L ++
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 82 RLFYNELVGKIPSELGSL--SKIEHLSVSVNNLTG--SIPSSLGNLS--SINTLFLTDNN 135
L E+ G P L + L++ + + + L + L + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 136 LDGGIPDTFGWLKNLATLAMAENWLSGTI-------PSSIFNISSITAFDAGMNQLQGVI 188
+ L+TL +++N G P + + +AGM GV
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 189 PLDFGFTLQNLQFFSVFENQLTGAIPPAI-SNASNLELFQADVNKLTGEVPYLEKPQRLS 247
LQ + N L A S L L L P +LS
Sbjct: 221 SALAA-ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLS 277
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNF 286
V ++ N L L + L + N F
Sbjct: 278 VLDLSYNRL-----DRNPSPDELPQ---VGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 34/216 (15%), Positives = 68/216 (31%), Gaps = 28/216 (12%)
Query: 2 RHQRVKILNLTSLKLAG--SISPHVGNLSF--LKVLLLYNNSFNHGIPSEFDRLQRLQVL 57
+ ILNL ++ A + + LKVL + + + L L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 58 ALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIP 117
L++N GE + C P + +L + + + +G
Sbjct: 179 DLSDNPELGERGLISALC-----------------PLKFPTLQVLALRNAGMETPSGVCS 221
Query: 118 SSLGNLSSINTLFLTDNNLDGGIPD-TFGWLKNLATLAMAENWLSGTIPSSIFNISSITA 176
+ + L L+ N+L + W L +L ++ L +P + + ++
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSV 278
Query: 177 FDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGA 212
D N+L L + S+ N +
Sbjct: 279 LDLSYNRLDR---NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 25/180 (13%), Positives = 54/180 (30%), Gaps = 21/180 (11%)
Query: 368 GNLKVFNLDLSCN-FLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL--LIGL 424
G + L + + + + +L + + + I L + + L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 425 DLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIP 484
L ++TG+ P + ++ + + + +L
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVS---------------WATRDAWLAELQQ 145
Query: 485 SSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITS 544
LK VL ++Q + E + F L L+LS+N G + +
Sbjct: 146 WLKPGLK---VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKILT 695
+IG GSFG + +K N+ + + E L N++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ ++ N +V ++ + L + ++ E+ Q L+ + + A
Sbjct: 91 S-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED--------QILDWFVQICLA 137
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L ++H I H D+K N+ L ++ + DFG+AR L + + G+ Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTPYYL 192
Query: 816 APE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+PE Y S D+++ G +L EL T K FE
Sbjct: 193 SPEICENKPYNNKS------DIWALGCVLYELCTLKHA----FEAG 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-22
Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 18/218 (8%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKIL-T 695
+G G FG V + I VA+K L + + E +K + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
ND L E+ + L ++L+ +E LL D++ A
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTLLS------DISSA 133
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLD---EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
L YLH + I H DLKP N++L + ++ + D G A+ L T + G++
Sbjct: 134 LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTL 187
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
Y+APE + ++ D +S+G L E +T +P
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 63/305 (20%), Positives = 117/305 (38%), Gaps = 57/305 (18%)
Query: 613 SPINSFPNI--SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG 670
S I + PN S +NL S +G GS G+V QG+ VAVK +
Sbjct: 1 SRIANIPNFEQSLKNLVV------SEKILGYGSSGTVVFQGSFQGRP-VAVKRMLI---D 50
Query: 671 AFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITR 729
+ E L ++ H N+++ CS + F + E +L++ +
Sbjct: 51 FCDIALMEIKLLTESDDHPNVIRYY--CS---ETTDRFLYIALELCNL-NLQDL---VES 101
Query: 730 EDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH--- 786
++ ++E + +++ +A +++LH I H DLKP N+L+
Sbjct: 102 KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQ 158
Query: 787 ----------VSDFGLARFLP--LSPAQTSSIDAKGSIGYIAPEYGLGSEVSING----- 829
+SDFGL + L S +T+ + G+ G+ APE S
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218
Query: 830 --DVYSYGILLLELVTRKKP--------VDSMFEGDMNLHNFARMALPDHVVDIVD--ST 877
D++S G + ++++ K ++ G +L + + + D S
Sbjct: 219 SIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 278
Query: 878 LLSDD 882
++ D
Sbjct: 279 MIDHD 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 2e-21
Identities = 33/281 (11%), Positives = 76/281 (27%), Gaps = 52/281 (18%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLL-------------------------HHGAFK 673
+G + + + + V V + K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 674 SFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE--EWLHPITRED 731
+ ++ K++ + ++ MQ+ E L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 732 KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791
K+ RL + + V L+ LHH + H L+P +++LD+ ++ F
Sbjct: 206 KSLVHHA------RLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-----VSINGDVYSYGILLLELVTRKK 846
+ A + A + ++ D ++ G+ + +
Sbjct: 257 HLVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 847 PVDSMFEGDMNLHNFARM-----ALPDHVVDIVDSTLLSDD 882
P D L + +P V +++ L
Sbjct: 316 P----NTDDAALGGSEWIFRSCKNIPQPVRALLEG-FLRYP 351
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 51/239 (21%), Positives = 92/239 (38%), Gaps = 29/239 (12%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+G G+ +V++G + A+KVFN + + E LK + H+N+VK+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ K L+ EF SL L + E L +L+ DV ++
Sbjct: 76 --EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR------DVVGGMN 126
Query: 758 YLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+L + I H ++KP N++ D + + ++DFG AR L S G+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEE 180
Query: 814 YIAPEYGLGSEVSING--------DVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
Y+ P+ + + + D++S G+ T P N ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRN 689
D F +E+G G+ G V+K +A K+ +L A ++ I E L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V G Y + + E M SL++ L R + +
Sbjct: 93 IVG----FYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGK----------VS 137
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
I V L+YL + I H D+KPSN+L++ + DFG++ L S A +
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 191
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ Y++PE G+ S+ D++S G+ L+E+ + P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 7e-21
Identities = 44/292 (15%), Positives = 83/292 (28%), Gaps = 36/292 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTT-----VAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
+ +G G+F VY+ +KV + F LK +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
K +A + + LV E +L + + + ++ +
Sbjct: 131 KFYSA-----HLFQNGSVLVGELYSYGTLLNAI-----NLYKNTPEKVMPQGLVISFAMR 180
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH-----------VSDFGLARFLPLSP 800
+ + +H I H D+KP N +L + + D G + + L P
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 801 AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH- 859
T + G+ E + D + + ++ G+
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
Query: 860 NFARMALPDHVVDIVDSTLLSDDE------DLAVHGNQRQRQARINSKIECL 905
F R+ D + L D DL ++ Q +KI L
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 49/240 (20%), Positives = 99/240 (41%), Gaps = 36/240 (15%)
Query: 639 IGVGSFGSVY---------------KGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLK 683
+ G F + K +L++ + + + F E +
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 684 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
+I++ + G+ D +++E+M+N S+ ++ DK + ++
Sbjct: 99 DIKNEYCLTCE----GI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
+ I V + SY+H+ + I H D+KPSN+L+D+ +SDFG + ++ +
Sbjct: 154 KC--IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSING---DVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860
S +G+ ++ PE+ +E S NG D++S GI L + P F ++L
Sbjct: 210 S----RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 52/253 (20%), Positives = 98/253 (38%), Gaps = 41/253 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL--VK 692
+IG G V++ + ++ + A+K NL + S+ E L ++ + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ + +V E N L WL +S++ +R + ++
Sbjct: 74 LY----DYEITDQYIY-MVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNM 117
Query: 753 ACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
A+ +H H I H DLKP+N L+ + M + DFG+A + G+
Sbjct: 118 LEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 812 IGYIAPE-----------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860
+ Y+ PE S++S DV+S G +L + K P + LH
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH- 231
Query: 861 FARMALPDHVVDI 873
+ P+H ++
Sbjct: 232 --AIIDPNHEIEF 242
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-20
Identities = 52/253 (20%), Positives = 98/253 (38%), Gaps = 41/253 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNL--VK 692
+IG G V++ + ++ + A+K NL + S+ E L ++ + ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ + +V E N L WL +S++ +R + ++
Sbjct: 121 LY----DYEITDQYIY-MVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNM 164
Query: 753 ACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
A+ +H H I H DLKP+N L+ + M + DFG+A + G+
Sbjct: 165 LEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 812 IGYIAPE-----------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860
+ Y+ PE S++S DV+S G +L + K P + LH
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH- 278
Query: 861 FARMALPDHVVDI 873
+ P+H ++
Sbjct: 279 --AIIDPNHEIEF 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-FKSFIAECN-TLKNIRHRNLVKIL 694
E+G G++G V K +AVK + K + + + +++ + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT-- 70
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT-EEAPRSLNLLQRLNIGIDVA 753
G ++ D + E M + SL+++ + + +T E ++L + I + +
Sbjct: 71 --FYGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPE-----DILGK--IAVSIV 119
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
AL +LH + H D+KPSNVL++ + DFG++ +L A+ G
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKP 174
Query: 814 YIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851
Y+APE S+ D++S GI ++EL + P DS
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 8e-20
Identities = 50/216 (23%), Positives = 80/216 (37%), Gaps = 29/216 (13%)
Query: 637 NEIGVGSFGSVYKGI-LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V++ G AVK L + E + +V +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGF-QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLY- 116
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
G +G + E ++ SL + + + E+ L Q L
Sbjct: 117 ---GAVREGPWVN-IFMELLEGGSLGQLIKQMGCLP--EDRALYY-LGQAL-------EG 162
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFL---PLSPAQTSSIDAKGS 811
L YLH I H D+K NVLL + A + DFG A L L + + G+
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
++APE +G D++S ++L ++ P
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G F ++ K A K+ LL + E + +++ H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
++ NDF +V E + RSL L R E P + L+++
Sbjct: 83 F-----FEDNDFVFVVLELCRRRSL---LELHKRRKALTE-PEARYYLRQI------VLG 127
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL--PLSPAQTSSIDAKGSIG 813
YLH + + H DLK N+ L+E++ + DFGLA + + G+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPN 180
Query: 814 YIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850
YIAPE G EV DV+S G ++ L+ K P ++
Sbjct: 181 YIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFET 217
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNT-LKNIRHRNLVKILT 695
EIG G++GSV K + +AVK + K + + + +++ +V+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ--- 85
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
G ++ D + E M + S +++ + + I + A
Sbjct: 86 -FYGALFREGDCW-ICMELM-STSFDKFYKYVYS-----VLDDVIPEEILGKITLATVKA 137
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
L++L + + I H D+KPSN+LLD + DFG++ L S A+T G Y+
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYM 192
Query: 816 APE----YGLGSEVSINGDVYSYGILLLELVTRKKP---VDSMFE 853
APE + DV+S GI L EL T + P +S+F+
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 59/251 (23%), Positives = 98/251 (39%), Gaps = 39/251 (15%)
Query: 622 SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNT 681
S+ + D + ++G G + V++ I V VK+ + K E
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKI 83
Query: 682 LKNIR-HRNLVKILTACSGVDYQGNDFK-ALVFEFMQNRSLEEWLHPITREDKTEEAPRS 739
L+N+R N++ + + ALVFE + N ++ +T D R
Sbjct: 84 LENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RF 134
Query: 740 LNLLQRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMA-HVSDFGLARFLP 797
+ + L AL Y H I H D+KP NV++D E + D+GLA F
Sbjct: 135 Y-MYEIL-------KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEG 854
+ S + PE + + S+ D++S G +L ++ RK+P F G
Sbjct: 183 PGQEYNVRV---ASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP---FFHG 234
Query: 855 DMNLHNFARMA 865
N R+A
Sbjct: 235 HDNYDQLVRIA 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 57/250 (22%), Positives = 93/250 (37%), Gaps = 51/250 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSF VY+ VA+K+ + + G + E ++H +++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY- 77
Query: 696 ACSGVDYQGNDFKA-LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+Y + LV E N + +L K + + + ++
Sbjct: 78 -----NYFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQI------IT 123
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK----- 809
+ YLH I H DL SN+LL M ++DFGLA Q K
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLC 173
Query: 810 GSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD--MNLHN--- 860
G+ YI+PE G E DV+S G + L+ + P F+ D N N
Sbjct: 174 GTPNYISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP----FDTDTVKNTLNKVV 225
Query: 861 FARMALPDHV 870
A +P +
Sbjct: 226 LADYEMPSFL 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 28/241 (11%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAF-KSFIAECN 680
+ + + + IG G+ G V + VA+K + + K E
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPR 738
+K + H+N++ +L + +F+ +V E M + L + + + E
Sbjct: 77 LMKCVNHKNIIGLLNVFT-PQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMS 130
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
L L Q L C + +LH I H DLKPSN+++ + + DFGLAR
Sbjct: 131 YL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 799 SPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858
S T + + Y APE LG N D++S G ++ E++ +F G ++
Sbjct: 180 SFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHI 232
Query: 859 H 859
Sbjct: 233 D 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 39/289 (13%), Positives = 85/289 (29%), Gaps = 68/289 (23%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVF----------------------------NLLHHG 670
+G + + + + V V N
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 671 AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE--EWLHPIT 728
FI + +K+ + + +++ + + + F ++ MQ+ E L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIR-VRLDERDMWVLSRF--FLYPRMQSNLQTFGEVLLSHS 197
Query: 729 REDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788
+SL RL + + V L+ LHH + H L+P +++LD+ ++
Sbjct: 198 STH------KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLT 248
Query: 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING-----------DVYSYGIL 837
F + + + S G+ PE D ++ G++
Sbjct: 249 GFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 838 LLELVTRKKPVDSMFEGDMNLHNFAR-----MALPDHVVDIVDSTLLSD 881
+ + P D L +P V +++ L
Sbjct: 303 IYWIWCADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 347
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 58/241 (24%), Positives = 93/241 (38%), Gaps = 36/241 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G FG+VY Q K +A+KV L G E ++RH N++++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ L+ E+ ++ + + K +E R+ + L A A
Sbjct: 77 Y-----FHDATRVYLILEYAPLGTV---YRELQKLSKFDE-QRTATYITEL------ANA 121
Query: 756 LSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
LSY H + H D+KP N+LL ++DFG + P S G++ Y
Sbjct: 122 LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDY 173
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD--MNLHN---FARMALPDH 869
+ PE G D++S G+L E + K P FE + + PD
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDF 229
Query: 870 V 870
V
Sbjct: 230 V 230
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G F ++ K A K+ LL + E + +++ H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
++ NDF +V E + RSL L R E P + L+++
Sbjct: 109 F-----FEDNDFVFVVLELCRRRSL---LELHKRRKALTE-PEARYYLRQI------VLG 153
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL--PLSPAQTSSIDAKGSIG 813
YLH + + H DLK N+ L+E++ + DFGLA + + G+
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPN 206
Query: 814 YIAPEY----GLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
YIAPE G EV DV+S G ++ L+ K P FE
Sbjct: 207 YIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 244
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 49/230 (21%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G FG+VY Q K +A+KV L G E ++RH N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM-- 79
Query: 696 ACSGVDYQGNDFKALVFEFMQNRS-----LE-----EWLHPITREDKTEEAPRSLNLLQR 745
+ + +R LE E + + + +E RS ++
Sbjct: 80 ----------------YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSATFMEE 122
Query: 746 LNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSS 805
L A AL Y H + H D+KP N+L+ + ++DFG + P +T
Sbjct: 123 L------ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 806 IDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G++ Y+ PE G D++ G+L E + P F+
Sbjct: 174 ----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 57/228 (25%), Positives = 85/228 (37%), Gaps = 49/228 (21%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTL-KNIRHRNLVKILT 695
E+G G+ G V+K + +AVK + K + + + + K+ +V+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ--- 88
Query: 696 ACSGVDYQGNDFKALVFEFM-----------QNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
C G D + E M Q E L +T
Sbjct: 89 -CFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGKMTVA-------------- 132
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
+ AL YL + H D+KPSN+LLDE + DFG++ L A+
Sbjct: 133 -------IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183
Query: 805 SIDAKGSIGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
S G Y+APE + I DV+S GI L+EL T + P
Sbjct: 184 SA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+ +IG G+ G+VY + VA++ NL + I E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
L + Y D +V E++ SL + + T D+ + A LQ
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ-------- 127
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS- 811
AL +LH + + H D+K N+LL + ++DFG AQ + +K S
Sbjct: 128 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC-------AQITPEQSKRST 175
Query: 812 -IG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+G ++APE D++S GI+ +E++ + P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 39/213 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+G G+F V+ A+K S E LK I+H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Y+ LV + + L + + + R TE+ + + Q L+ A+
Sbjct: 75 ----YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLV-IQQVLS-------AVK 120
Query: 758 YLH-HDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
YLH + I H DLKP N+L +E ++DFGL++ T A G+ G
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPG 172
Query: 814 YIAPE----YGLGSEVSINGDVYSYG----ILL 838
Y+APE V D +S G ILL
Sbjct: 173 YVAPEVLAQKPYSKAV----DCWSIGVITYILL 201
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 50/239 (20%), Positives = 86/239 (35%), Gaps = 36/239 (15%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELR 353
NL + + L L N + + F LQ L++ + TI A L +L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 354 LQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIPSSL-GQYKTLTIIDLSDNNLTG 408
L N + ++ +L+ L L S+ + G KTL ++++ N +
Sbjct: 83 LTGNP-IQSLALGAFSGLSSLQ--KLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138
Query: 409 TIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSC 466
P+ F L+ L LDLS N++ SI L + +L++
Sbjct: 139 FKLPEYFSNLTNLEH-LDLSSNKIQ-SIYCTDLRVLHQMPLLNL---------------- 180
Query: 467 KKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNN 525
L++ N + P + ++ L L L N L L+ + L N
Sbjct: 181 ----SLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 42/234 (17%)
Query: 315 IPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSIGNLKVF 373
IP + + + L++ N L + + L+ L L R + + I +
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCE-IQTIEDG-----AY 72
Query: 374 NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLT 432
SL L+ + L+ N + ++ F GLS L L L
Sbjct: 73 --------------QSLSH---LSTLILTGNPIQ-SLALGAFSGLS-SLQKLVAVETNLA 113
Query: 433 GSIPSEV-GNLKNLEVLDVFENKL-KGEIPSTLGSCKKLEQLEMQGNFLQGPIP----SS 486
S+ + G+LK L+ L+V N + ++P + LE L++ N +Q I
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRV 171
Query: 487 LSSLKGLNV-LDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
L + LN+ LDLS N ++ I L+ L L N L+ VP +G+F
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVP-DGIFDR 222
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPP-QFLGLSWLLIGLDLSRNQLTGSIPSEV-GNL 442
IP +L + +DLS N L + F L + LDLSR ++ +I +L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQV-LDLSRCEIQ-TIEDGAYQSL 75
Query: 443 KNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQN 501
+L L + N ++ + L++L L + LK L L+++ N
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 502 NL-SGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNAT 541
+ S K+PE+ LE+L+LS+N ++ + +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY-CTDLRVLH 173
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 44/211 (20%), Positives = 73/211 (34%), Gaps = 17/211 (8%)
Query: 7 KILNLTSLKLAGSISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLALNNNSI 64
K L+L+ L + + + L+VL L I + L L L L N I
Sbjct: 31 KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSS--L 120
+ S S+L ++ L + + G L ++ L+V+ N + S
Sbjct: 89 -QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145
Query: 121 GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG----TIPSSIFNISSITA 176
NL+++ L L+ N + L + L LS I F +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQM-PLLNLSLDLSLNPMNFIQPGAFKEIRLKE 204
Query: 177 FDAGMNQLQGVIPLDFGFTLQNLQFFSVFEN 207
NQL+ +P L +LQ + N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 47/198 (23%), Positives = 77/198 (38%), Gaps = 18/198 (9%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
K L L N H F LQVL L+ I I S S+L + L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPI 88
Query: 89 VGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSL-GNLSSINTLFLTDNNL-DGGIPDTFG 145
+ LS ++ L NL S+ + G+L ++ L + N + +P+ F
Sbjct: 89 -QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 146 WLKNLATLAMAENWLSGTIPSSIF-NISSITAF----DAGMNQLQGVIPLDF-GFTLQNL 199
L NL L ++ N + +I + + + D +N + + P F L+ L
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKEL 205
Query: 200 QFFSVFENQLTGAIPPAI 217
+ NQL ++P I
Sbjct: 206 ALDT---NQLK-SVPDGI 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 46/259 (17%), Positives = 82/259 (31%), Gaps = 57/259 (22%)
Query: 102 IEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161
++L +S N L S + + L L+ + + L +L+TL + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 162 GTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISN 219
++ F +SS+ A L + G L+ L+ +V N + P SN
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 220 ASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRL 279
+NLE NK+
Sbjct: 148 LTNLEHLDLSSNKIQS-------------------------------------------- 163
Query: 280 LINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTI 339
I + L + L L N + I K + L+ L + N+L ++
Sbjct: 164 -IYCTDLRVL-----HQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SV 215
Query: 340 PP-AIGELQNLRELRLQRN 357
P L +L+++ L N
Sbjct: 216 PDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 7e-07
Identities = 30/141 (21%), Positives = 52/141 (36%), Gaps = 17/141 (12%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE--FDRLQRLQVLALNNN 62
+L L S+ G+L LK L + +N F L L+ L L++N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSN 159
Query: 63 SIGGEIPANI-SSCSNL----IQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIP 117
I I + + + L N + I +++ L++ N L S+P
Sbjct: 160 KIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVP 216
Query: 118 S-SLGNLSSINTLFLTDNNLD 137
L+S+ ++L N D
Sbjct: 217 DGIFDRLTSLQKIWLHTNPWD 237
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 37/221 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
++G G++G V A+K+ + + + E LK + H N++K+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
++ LV E + L + + I R E I V
Sbjct: 103 DF-----FEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAA--------VIIKQVLS 147
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
++YLH I H DLKP N+LL +++ + + DFGL+ + G+
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GT 201
Query: 812 IGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
YIAPE Y + DV+S G++L L+ P
Sbjct: 202 AYYIAPEVLRKKY--DEKC----DVWSIGVILFILLAGYPP 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
S +IG GS G V VAVK+ +L + E +++ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ + Y + ++ EF+Q +L + + R ++ + A +LQ
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQ-------- 152
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK--- 809
AL+YLH + H D+K ++LL + +SDFG AQ S K
Sbjct: 153 --ALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKS 200
Query: 810 --GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ ++APE S + D++S GI+++E+V + P
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 602 VRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAV 661
+RK +E ++ ++ PN ++ + E+G G+FG VYK + A
Sbjct: 2 MRKSREYEHVRRDLD--PNEVWEIV----------GELGDGAFGKVYKAKNKETGALAAA 49
Query: 662 KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE 721
KV + +I E L H +VK+L A Y + ++ EF ++
Sbjct: 50 KVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-----YYHDGKLWIMIEFCPGGAV- 103
Query: 722 EWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781
+ E R L Q + + AL++LH I H DLK NVL+
Sbjct: 104 --------DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTL 152
Query: 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGS--IG---YIAPEYGLGSEVSING-----DV 831
E ++DFG++ A+ K IG ++APE + + D+
Sbjct: 153 EGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205
Query: 832 YSYGILLLELVTRKKP 847
+S GI L+E+ + P
Sbjct: 206 WSLGITLIEMAQIEPP 221
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 54/277 (19%), Positives = 105/277 (37%), Gaps = 26/277 (9%)
Query: 270 LTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLE 329
++ +N + ++L + L + I + NL LE
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADL-DGITTLSAFGTGV-TTIEG-VQYLNNLIGLE 69
Query: 330 MWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS 389
+ +N+++ + P + L + EL L N L N+ G + LDL+ + P
Sbjct: 70 LKDNQIT-DLAP-LKNLTKITELELSGNP-LKNVSAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL--LIGLDLSRNQLTGSIPSEVGNLKNLEV 447
L L ++ L N +T I P L+ L L L + Q++ + + + NL L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISP----LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTT 177
Query: 448 LDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKI 507
L +NK+ +I L S L ++ ++ N + S L++ L ++ L+ ++ +
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQP 233
Query: 508 PEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITS 544
+ L N+ + + N T S
Sbjct: 234 VFY---NNNLVVPNVVKGPSGAPIAPATISDNGTYAS 267
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/278 (19%), Positives = 110/278 (39%), Gaps = 24/278 (8%)
Query: 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQAD 229
+++ AG + + + L + S F +T + +NL +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 230 VNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289
N++T ++ L+ +++ ++ N L N++ + L + + L + + +
Sbjct: 72 DNQIT-DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQS---IKTLDLTSTQITDV 122
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNL 349
P ++ L + L++L LD N+I NI + NLQ L + N ++S + P + L L
Sbjct: 123 TP--LAGL-SNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKL 175
Query: 350 RELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT 409
L+ NK + +I P + + L N + S S L L I+ L++ +T
Sbjct: 176 TTLKADDNK-ISDISPLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQ 232
Query: 410 IPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEV 447
L + S + + S+ G + +
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 48/261 (18%), Positives = 101/261 (38%), Gaps = 24/261 (9%)
Query: 51 LQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110
L +A +++ + + + + F + + L+ + L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDN 73
Query: 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170
+T + L NL+ I L L+ N L L+++ TL + ++ P +
Sbjct: 74 QITD--LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADV 230
+S++ +NQ+ + PL L NLQ+ S+ Q++ + P ++N S L +AD
Sbjct: 128 LSNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADD 182
Query: 231 NKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLL 290
NK++ ++ L L + N + S+++ L + +N L + +
Sbjct: 183 NKIS-DISPLASLPNLIEVHLKNNQI-----SDVSPLANTSN---LFIVTLTNQTITNQP 233
Query: 291 PACISNLSTTLEMLLLDNNKI 311
+NL + I
Sbjct: 234 VFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 17/219 (7%)
Query: 24 VGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83
+L + L + L L L L +N I ++ + + + + ++ L
Sbjct: 37 QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI-TDLA-PLKNLTKITELEL 92
Query: 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDT 143
N L K S + L I+ L ++ +T P L LS++ L+L N + P
Sbjct: 93 SGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP-- 146
Query: 144 FGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFS 203
L NL L++ +S + + N+S +T A N++ + PL +L NL
Sbjct: 147 LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISPLA---SLPNLIEVH 201
Query: 204 VFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242
+ NQ++ P ++N SNL + +T + +
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 22/215 (10%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
NL L+L ++P + NL+ + L L N + S LQ ++ L L + I
Sbjct: 64 NLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQIT 120
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
++ ++ SNL + L N++ S L L+ +++LS+ ++ + + L NLS
Sbjct: 121 -DVT-PLAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVS-DL-TPLANLSK 174
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
+ TL DN + I L NL + + N +S S + N S++ +
Sbjct: 175 LTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPP-AISN 219
NL +V + I P IS+
Sbjct: 231 NQPVFYN----NNLVVPNVVKGPSGAPIAPATISD 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 40/247 (16%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAF-KSFIAECN 680
+ + + + IG G+ G V VA+K + + K E
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPR 738
+K + H+N++ +L + +F+ LV E M + L + + + E
Sbjct: 114 LMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMS 167
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
L L Q L C + +LH I H DLKPSN+++ + + DFGLAR
Sbjct: 168 YL-LYQML-------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
Query: 799 SPAQTSSIDAKGSIGYI------APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF 852
S T Y+ APE LG N D++S G ++ E+V K +F
Sbjct: 217 SFMMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILF 263
Query: 853 EGDMNLH 859
G +
Sbjct: 264 PGRDYID 270
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 43/217 (19%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
E+G G+F V + + A + N L + E + ++H N+V++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ L+F+ + L E + + RE +E + Q L A
Sbjct: 78 S-----ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHC-IQQILE-------A 122
Query: 756 LSYLH-HDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ + H + H +LKP N+LL + ++DFGLA + Q + G+
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGT 176
Query: 812 IGYIAPE------YGLGSEVSINGDVYSYG----ILL 838
GY++PE YG V D+++ G ILL
Sbjct: 177 PGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 63/251 (25%), Positives = 93/251 (37%), Gaps = 37/251 (14%)
Query: 612 SSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA 671
SP S I L + F +G G++G VYKG + A+KV + +
Sbjct: 5 DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDE 63
Query: 672 FKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA-LVFEFMQNRSLEEWLHPITR 729
+ E N LK HRN+ A + G D + LV EF S+ + +
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 730 EDKTEEAPRSLNLLQRLNIGI---DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786
EE I ++ LS+LH + H D+K NVLL E
Sbjct: 124 NTLKEEW-----------IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 787 VSDFGLARFLPLSPAQTSSIDAK--GSIG---YIAPEYGLGSEVSING-----DVYSYGI 836
+ DFG++ AQ + IG ++APE E D++S GI
Sbjct: 170 LVDFGVS-------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 837 LLLELVTRKKP 847
+E+ P
Sbjct: 223 TAIEMAEGAPP 233
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 346 LQNLRELRLQRNKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDN 404
+ + E+ + L +PP + + L LS N L ++L Y LT ++L
Sbjct: 9 VASHLEVNCDKRN-LTALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 405 NLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464
LT + L L LDLS NQL S+P L L VLDV N+L L
Sbjct: 66 ELT-KLQV-DGTLPVLGT-LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 465 SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524
+L++L ++GN L+ P L+ L L L+ NNL+ L G + L+ L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 525 NNLEGMVPIEGVFKNATITSV 545
N+L +P +G F + +
Sbjct: 182 NSLY-TIP-KGFFGSHLLPFA 200
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 18/190 (9%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRL 354
+L +L L N ++ A + + L +L + L T G L L L L
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDL 84
Query: 355 QRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPS----SLGQYKTLTIIDLSDNNLTGT 409
N+ L ++P L + LD+S N L S+P LG+ L + L N L T
Sbjct: 85 SHNQ-LQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE---LQELYLKGNELK-T 138
Query: 410 IPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCK 467
+PP L L L+ N LT +P+ + L+NL+ L + EN L IP
Sbjct: 139 LPPGLLTPTPKLEK-LSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 468 KLEQLEMQGN 477
L + GN
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 9/180 (5%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89
+L L N + RL L L+ + ++ + + L + L +N+L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSL-GNLSSINTLFLTDNNLDGGIPDTFGWLK 148
+P +L + L VS N LT S+P L + L+L N L P
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 149 NLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFEN 207
L L++A N L+ +P+ + + ++ N L IP F F L F + N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGF-FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 36/190 (18%), Positives = 73/190 (38%), Gaps = 11/190 (5%)
Query: 47 EFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLS 106
E ++ + + ++ +P ++ + + L N L + L +++ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 107 VSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166
+ LT + G L + TL L+ N L +P L L L ++ N L+ ++P
Sbjct: 62 LDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 167 SIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAI-SNASNLE 224
+ + N+L+ +P L+ S+ N LT +P + + NL+
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 225 LFQADVNKLT 234
N L
Sbjct: 176 TLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 50/249 (20%), Positives = 71/249 (28%), Gaps = 64/249 (25%)
Query: 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF 169
NLT ++P L L L++N L T L L +
Sbjct: 20 RNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----------- 65
Query: 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQAD 229
++ + TL L + NQL ++P L +
Sbjct: 66 ELTKLQVDG----------------TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108
Query: 230 VNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289
N+LT +P L L L L + N L
Sbjct: 109 FNRLT-SLP-------LGALR------------------GLGE---LQELYLKGNELKTL 139
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPAAI-GKFVNLQRLEMWNNRLSGTIPPAIGELQN 348
P ++ LE L L NN + +PA + NL L + N L TIP
Sbjct: 140 PPGLLTPT-PKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 349 LRELRLQRN 357
L L N
Sbjct: 197 LPFAFLHGN 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
E+G G+F V + + A K+ N L F+ E + ++H N+V++
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ Q F LVF+ + L E + + RE +E + Q L +
Sbjct: 73 S-----IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC-IQQILE-------S 117
Query: 756 LSYLH-HDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
++Y H + I H +LKP N+LL + ++DFGLA ++ ++ G+
Sbjct: 118 IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH-GFAGT 170
Query: 812 IGYIAPE------YGLGSEVSINGDVYSYG----ILL 838
GY++PE Y V D+++ G ILL
Sbjct: 171 PGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---------LLHHGAFKSFIAECNTLKNI-RH 687
+G G V + I AVK+ + ++ + E + L+ + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
N++++ Y+ N F LVF+ M+ L ++L + +E+ R + + L
Sbjct: 84 PNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKI-MRALLE 135
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ LH I H DLKP N+LLD++M ++DFG + L P + +
Sbjct: 136 -------VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR-E 182
Query: 808 AKGSIGYIAPE----------YGLGSEVSINGDVYSYG----ILL 838
G+ Y+APE G G EV D++S G LL
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLL 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 49/265 (18%), Positives = 88/265 (33%), Gaps = 59/265 (22%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+G G FG V++ A+K L + A + + E L + H +V+ A
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAP-------------------- 737
+ + + P + + +
Sbjct: 74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 738 ------------RSL-NLLQR------------LNIGIDVACALSYLHHDCQPPITHCDL 772
+L + + R L+I I +A A+ +LH + H DL
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDL 190
Query: 773 KPSNVLLDEEMMAHVSDFGLARFL-------PLSPAQTSSIDAKGSIG---YIAPEYGLG 822
KPSN+ + + V DFGL + + + G +G Y++PE G
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250
Query: 823 SEVSINGDVYSYGILLLELVTRKKP 847
+ S D++S G++L EL+
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFST 275
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 56/252 (22%), Positives = 102/252 (40%), Gaps = 50/252 (19%)
Query: 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAFKS-FIAECNTLKN 684
D F G G+FG+V G +VA+K V F++ + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAV 75
Query: 685 IRHRNLVKILTA-CSGVDYQGND-FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
+ H N+V++ + + + D + +V E++ + LH R + L
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPIL 130
Query: 743 L-----QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA-HVSDFGLARFL 796
+ Q + ++ LH + H D+KP NVL++E + DFG A+
Sbjct: 131 IKVFLFQLI-------RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAK-- 180
Query: 797 PLSPAQTSSIDAKGSIGYI------APEYGLGSE---VSINGDVYSYGILLLELVTRKKP 847
LSP++ ++ YI APE G++ ++ D++S G + E++ +P
Sbjct: 181 KLSPSEP-------NVAYICSRYYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLG-EP 230
Query: 848 VDSMFEGDMNLH 859
+F GD +
Sbjct: 231 ---IFRGDNSAG 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V K + AVKV N + + + E LK + H N++K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ + +V E L + + I R+ +E + + Q +
Sbjct: 89 I-----LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARI-IKQVFS-------G 133
Query: 756 LSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
++Y+H + I H DLKP N+LL +++ + DFGL+ D G+
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK-DRIGTA 187
Query: 813 GYIAPE-----YGLGSEVSINGDVYSYG----ILL 838
YIAPE Y + DV+S G ILL
Sbjct: 188 YYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA- 696
IG GSFG VY+ L VA+K V FK+ E ++ + H N+V++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIVRLRYFF 116
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
S + + + LV +++ E ++ + R + + ++ + +L
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVK--LYMYQLFRSL 169
Query: 757 SYLH-HDCQPPITHCDLKPSNVLLDEEMMA-HVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+Y+H I H D+KP N+LLD + + DFG A+ L S Y
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---------Y 216
Query: 815 I------APEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
I APE G+ SI DV+S G +L EL+ +P +F GD +
Sbjct: 217 ICSRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLG-QP---IFPGDSGVD 264
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 42/230 (18%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G GSFG V AVKV + + +S + E LK + H N++K+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
++ + LV E L + + I+R+ +E I V
Sbjct: 92 YEF-----FEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA--------RIIRQVL 136
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++Y+H + I H DLKP N+LL ++ + DFGL+ S I G
Sbjct: 137 SGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---G 190
Query: 811 SIGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ YIAPE Y + DV+S G++L L++ P F G
Sbjct: 191 TAYYIAPEVLHGTY--DEKC----DVWSTGVILYILLSGCPP----FNGA 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 3e-17
Identities = 46/249 (18%), Positives = 82/249 (32%), Gaps = 44/249 (17%)
Query: 620 NISYQNLYNATDG---FASANEIGVG--SFGSVYKGILDQGKTTVAVKVFNL--LHHGAF 672
N+ +Q + + + IG G +V V V+ NL +
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 673 KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK 732
E + K H N+V + ++ +V FM S ++ + +
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 733 TEEAPRSLNLLQRLNIGI---DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789
E A I V AL Y+HH + H +K S++L+ + ++S
Sbjct: 126 NELA-----------IAYILQGVLKALDYIHHMGY--V-HRSVKASHILISVDGKVYLSG 171
Query: 790 FGLARFL--PLSPAQTSSIDAKGSIG---YIAPE------YGLGSEVSINGDVYSYGILL 838
+ + K S+ +++PE G ++ D+YS GI
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITA 227
Query: 839 LELVTRKKP 847
EL P
Sbjct: 228 CELANGHVP 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSF----IAECNTLKNIR---HR 688
EIGVG++G+VYK VA+K + + G + E L+ + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+V+++ C+ LVFE + + L +L E + L + Q L
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL-MRQFLR- 131
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
L +LH +C I H DLKP N+L+ ++DFGLAR A T +
Sbjct: 132 ------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ Y APE L S + D++S G + E+ R KP +F G+
Sbjct: 183 ---LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP---LFCGN 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/213 (22%), Positives = 79/213 (37%), Gaps = 39/213 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
IG GS+G V + + A K F E +K++ H N++++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
++ N LV E L E + + + E + + L+ A++
Sbjct: 75 ----FEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARI-MKDVLS-------AVA 120
Query: 758 YLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
Y H + + H DLKP N L + + DFGLA + + G+ Y
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYY 174
Query: 815 IAPE-----YGLGSEVSINGDVYSYG----ILL 838
++P+ YG E D +S G +LL
Sbjct: 175 VSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 55/270 (20%), Positives = 96/270 (35%), Gaps = 70/270 (25%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHHGA----FKSFIAECNTLKNI-R 686
+G G+FG V + TVAVK +L GA ++ ++E L +I
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGH 84
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH--------PITREDKTEEAPR 738
H N+V +L AC+ + ++ EF + +L +L T+ + +
Sbjct: 85 HLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 739 SLNLLQR---------------------LNIGIDVACALSYLHHDCQPPIT--------- 768
+ + + + +T
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 769 ---------------HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
H DL N+LL E+ + + DFGLAR + P DA+ +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVT 843
++APE +I DV+S+G+LL E+ +
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 27/226 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKT--TVAVKVFNLLH--HGAFKSFIAECNTLKNIR---HRN 689
EIG G++G V+K D VA+K + G S I E L+++ H N
Sbjct: 17 AEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V++ C+ LVFE + + L +L + E + + + Q L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDM-MFQLLR-- 131
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
L +LH + H DLKP N+L+ ++DFGLAR A TS +
Sbjct: 132 -----GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT- 182
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ Y APE L S + D++S G + E+ R KP +F G
Sbjct: 183 --LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 32/149 (21%), Positives = 61/149 (40%), Gaps = 10/149 (6%)
Query: 389 SLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL--LIGLDLSRNQLTGSIPSEVGNLKNLE 446
+ Q +LT I L++ N+T G+ + + L ++ T + + L NLE
Sbjct: 39 TEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLE 91
Query: 447 VLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGK 506
L + + + L L L++ + I + +++L +N +DLS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 507 IPEFLVGFQLLENLNLSNNNLEGMVPIEG 535
I L L++LN+ + + IE
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRGIED 179
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 23/183 (12%), Positives = 62/183 (33%), Gaps = 13/183 (7%)
Query: 348 NLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNL 406
+ + + + + L+ + + + + + + +++ +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 407 TGTIPPQFLGLSWL--LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464
T P +S L L L + +T + L +L +LD+ + I + +
Sbjct: 79 TNYNP-----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 465 SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524
+ K+ +++ N I L +L L L++ + + + F L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFS 190
Query: 525 NNL 527
+
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 36/163 (22%), Positives = 63/163 (38%), Gaps = 13/163 (7%)
Query: 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK 358
+L + L N + ++ I N++ L + N + P I L NL LR+
Sbjct: 44 NSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 359 FLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGL 417
+ P++ L + LD+S + SI + + + IDLS N I P L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP----L 155
Query: 418 SWL--LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGE 458
L L L++ + + + + L L F + G+
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 32/183 (17%), Positives = 68/183 (37%), Gaps = 9/183 (4%)
Query: 324 NLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNL-DLSCNFL 382
+ S T ++ +L + L + ++ I N+ DL+ N +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANIN-VTDLTG-IEYAH--NIKDLTINNI 76
Query: 383 QGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNL 442
+ + + L + + ++T P GL+ L LD+S + SI +++ L
Sbjct: 77 HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLT-SLTLLDISHSAHDDSILTKINTL 135
Query: 443 KNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNN 502
+ +D+ N +I L + +L+ L +Q + + + LN L
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQT 192
Query: 503 LSG 505
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 27/159 (16%), Positives = 61/159 (38%), Gaps = 8/159 (5%)
Query: 250 SITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNN 309
S+T +L + ++L + N + L IN + P IS L + LE L +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHN---IKDLTINNIHATNYNP--ISGL-SNLERLRIMGK 98
Query: 310 KIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGN 369
+ + + +L L++ ++ +I I L + + L N + +I P
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL 158
Query: 370 LKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTG 408
++ +L++ + + + + L + + G
Sbjct: 159 PELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 24/182 (13%), Positives = 62/182 (34%), Gaps = 8/182 (4%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89
K L + ++ L + L N ++ ++ I N+ + +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-TDLT-GIEYAHNIKDLTINNIHA- 78
Query: 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKN 149
+ + LS +E L + ++T +L L+S+ L ++ + D I L
Sbjct: 79 -TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
Query: 150 LATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209
+ ++ ++ N I + + + + + + + ++ L F +
Sbjct: 138 VNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIE---DFPKLNQLYAFSQTI 193
Query: 210 TG 211
G
Sbjct: 194 GG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 22/131 (16%), Positives = 52/131 (39%), Gaps = 8/131 (6%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
N+ L + + +P + LS L+ L + L L +L +++++
Sbjct: 67 NIKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
I I++ + I L YN + I L +L +++ L++ + + + +
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPK 182
Query: 126 INTLFLTDNNL 136
+N L+ +
Sbjct: 183 LNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 20/171 (11%), Positives = 53/171 (30%), Gaps = 13/171 (7%)
Query: 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFD 178
+ ++S+ + L + N+ + N+ L + + + I +S++
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238
+ + L +L + + +I I+ + N ++
Sbjct: 95 IMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 239 YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289
L+ L +I + + + + LN+L + GG
Sbjct: 154 PLKTLPELKSLNIQFDGV-----HDYRGIEDFPK---LNQLYAFSQTIGGK 196
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 40/215 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
E+G G+F V + + A K+ N L F+ E + ++H N+V++
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ Q F LVF+ + L E + + RE +E + Q L +
Sbjct: 96 S-----IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC-IQQILE-------S 140
Query: 756 LSYLH-HDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
++Y H + I H +LKP N+LL + ++DFGLA + ++ G+
Sbjct: 141 IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWH-GFAGT 193
Query: 812 IGYIAPE----YGLGSEVSINGDVYSYG----ILL 838
GY++PE V D+++ G ILL
Sbjct: 194 PGYLSPEVLKKDPYSKPV----DIWACGVILYILL 224
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 43/248 (17%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAF-KSFIAECN 680
+ + + S +G G++GSV I + VA+K + F K E
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL 75
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPR 738
LK+++H N++ +L + +F LV FM + L I +EE +
Sbjct: 76 LLKHMQHENVIGLLDVFT-PASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ 129
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
L + Q L L Y+H + H DLKP N+ ++E+ + DFGLAR
Sbjct: 130 YL-VYQML-------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HA 176
Query: 799 SPAQTSSIDAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851
T GY+ APE L + D++S G ++ E++T K ++
Sbjct: 177 DAEMT---------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TL 223
Query: 852 FEGDMNLH 859
F+G L
Sbjct: 224 FKGKDYLD 231
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 29/232 (12%)
Query: 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-FKSFIAECNTLKNIR 686
D + IG G+ V K VA+K NL + E +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746
H N+V T+ + D LV + + S+ + + I + + + L
Sbjct: 72 HPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDES 121
Query: 747 NIGI---DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
I +V L YLH + Q I H D+K N+LL E+ ++DFG++ FL T
Sbjct: 122 TIATILREVLEGLEYLHKNGQ--I-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 804 SSIDAKGSIG---YIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKP 847
+ K +G ++APE G + D++S+GI +EL T P
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKIL 694
+IG G++G+V+K + VA+K L G S + E LK ++H+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
V + LVFEF ++ L+++ D E +S L Q L
Sbjct: 68 ----DVLHSDKKL-TLVFEFC-DQDLKKYFDSC-NGDLDPEIVKSF-LFQLL-------K 112
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS--- 811
L + H + H DLKP N+L++ +++FGLAR A G
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-------------AFGIPVR 156
Query: 812 --------IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ Y P+ G+++ S + D++S G + EL +P +F G+
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 48/221 (21%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--------LLHHGAFKSFIAECNTLKNIRHRN 689
+G G+ G V + VA+K+ + + E LK + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNI 748
++KI + D+ +V E M+ L + + + E + Q
Sbjct: 77 IIKIKNF-----FDAEDY-YIVLELMEGGELFDK---VVGNKRLKEATCKLY-FYQ---- 122
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFL-PLSPAQTS 804
+ A+ YLH + I H DLKP NVLL +E+ + ++DFG ++ L S +T
Sbjct: 123 ---MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 805 SIDAKGSIGYIAPE-------YGLGSEVSINGDVYSYGILL 838
G+ Y+APE G V D +S G++L
Sbjct: 177 C----GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 639 IGVGSFGSVYKGILDQGKT--TVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G++G VYK GK A+K G S E L+ ++H N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 697 CSGVDYQGNDFKALVFEFMQN--RSLEEWLHPITREDKTEEAPRSLN---LLQRLNIGID 751
+ L+F++ ++ + ++ K + PR + L Q L+
Sbjct: 87 FLS---HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD---- 139
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH----VSDFGLARF--LPLSPAQTSS 805
+ YLH + + H DLKP+N+L+ E ++D G AR PL P
Sbjct: 140 ---GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-LADL 192
Query: 806 IDAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ Y APE LG+ +I D+++ G + EL+T +P +F
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTS-EP---IFHCR 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 45/233 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIA-ECNTLKNIRHRNLVKIL 694
+G GS+G V + + + AVK+ L ++ + E L+ +RH+N+++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 695 TACSGVDYQGNDFKA-LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
V Y K +V E+ ++E L + + +L
Sbjct: 73 D----VLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAH--GYFCQL------I 119
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA----QTSSIDAK 809
L YLH I H D+KP N+LL +S G+A L A +TS
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---- 172
Query: 810 GSIGYIAPE-------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
GS + PE + G +V D++S G+ L + T P FEGD
Sbjct: 173 GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 54/263 (20%), Positives = 86/263 (32%), Gaps = 61/263 (23%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN-----LLHHGAFKSFIAECNTLKNIRHRNLVK 692
IG GS+G V I +Q + A+K+ N ++ + E +K + H N+ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 693 ILTACSGVDYQGNDFKALVFEFM---------QNRSLEEWLHPITREDKTEEAPRSLNLL 743
+ Y+ + LV E + KT+ P
Sbjct: 93 LYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 744 QRLNIGIDVAC---------------------ALSYLHHDCQPPITHCDLKPSNVLL--D 780
+ +N I AL YLH I H D+KP N L +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTN 204
Query: 781 EEMMAHVSDFGLARFLPLSPAQTSSI--DAKGSIGYIAPE------YGLGSEVSINGDVY 832
+ + DFGL++ G+ ++APE G + D +
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAW 260
Query: 833 SYGILLLELVTRKKPVDSMFEGD 855
S G+LL L+ P F G
Sbjct: 261 SAGVLLHLLLMGAVP----FPGV 279
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 41/229 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+G GSFG V K + AVKV N + + + E LK + H N++K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + +V E L + + I R+ +E I V
Sbjct: 88 EI-----LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAA--------RIIKQVFS 132
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
++Y+H I H DLKP N+LL +++ + DFGL+ + I G+
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186
Query: 812 IGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
YIAPE Y + DV+S G++L L++ P F G
Sbjct: 187 AYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FYGK 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 44/219 (20%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKV-----FNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
IG G F V + I + AVK+ F + + E + ++H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-----TEEAPRSLNLLQRLN 747
+L Y + +VFEFM + I + +E + Q L
Sbjct: 91 LLET-----YSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHY-MRQILE 141
Query: 748 IGIDVACALSYLH-HDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQT 803
AL Y H ++ I H D+KP VLL + + FG+A L +
Sbjct: 142 -------ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGL 188
Query: 804 SSIDAKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 838
+ G+ ++APE G V DV+ G++L
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 43/250 (17%), Positives = 79/250 (31%), Gaps = 42/250 (16%)
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPS 366
IP+ + N L +L I A +L ++ + +N L I
Sbjct: 17 QESKVTEIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 367 I----GNLK----------------VFN-------LDLSCNFLQGSIPSSLGQYKT-LTI 398
+ L F L +S ++ +P + +
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 399 IDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLK 456
+D+ DN TI F+GLS+ + L L++N + I + + E+ N L+
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
Query: 457 GEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515
E+P+ L++ + L +LK L K+P
Sbjct: 192 -ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL-EKLV 246
Query: 516 LLENLNLSNN 525
L +L+
Sbjct: 247 ALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/304 (17%), Positives = 100/304 (32%), Gaps = 21/304 (6%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
L F L+ + ++ N + I A++ S+ L +IR+
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 89 VGKIPSE-LGSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLTDNNLDGGIPD-TFG 145
+ I E +L +++L +S + +P + L + DN I +F
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 146 WL-KNLATLAMAENWLSGTIPSSIFN-ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFS 203
L L + +N + I +S FN + N L+ + F
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH-GASGPVILD 208
Query: 204 VFENQLTGAIPPAI-SNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENS------L 256
+ ++ ++P N L K ++P LEK L S+T S
Sbjct: 209 ISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPSHCCAFAN 264
Query: 257 GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPAC-ISNLSTTLEMLLLDNNKIFGNI 315
R S L+ +C+ + + + A L S+ S +M + + N
Sbjct: 265 WRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNE 324
Query: 316 PAAI 319
+
Sbjct: 325 VVDV 328
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 49/284 (17%), Positives = 93/284 (32%), Gaps = 43/284 (15%)
Query: 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162
+ +T IPS L + L L F +L + +++N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 163 TIPSSIF-NISSITAFD-AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPA--IS 218
I + +F N+ + N L I + L NLQ+ + + +P I
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 219 NASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNR 278
+ + L D + +I NS L+ + +
Sbjct: 127 SLQKVLLDIQDNINIH---------------TIERNSF-----------VGLSFESVI-- 158
Query: 279 LLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSG 337
L +N N + N + E+ L DNN + +P L++ R+
Sbjct: 159 LWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNL-EELPNDVFHGASGPVILDISRTRIH- 215
Query: 338 TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNF 381
++P L+NL++LR + L +P + + L+
Sbjct: 216 SLPSYG--LENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPS 257
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 38/219 (17%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTA 696
+IG GSFG V+KGI ++ + VA+K+ +L + E L + K +
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI---DVA 753
Y + ++ E++ S + L P L I ++
Sbjct: 89 -----YLKDTKLWIIMEYLGGGSALDLLEP--------------GPLDETQIATILREIL 129
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS-- 811
L YLH + H D+K +NVLL E ++DFG+A Q + K +
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTF 179
Query: 812 IG---YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+G ++APE S D++S GI +EL + P
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 49/244 (20%)
Query: 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIR 686
+++ F ++G G++ +VYKG+ VA+K L G + I E + +K ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQN---RSLEEWLHPITREDKTEEAPRSLNLL 743
H N+V++ + LVFEFM N + ++ T +
Sbjct: 62 HENIVRLYDVIHT---ENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF-QW 115
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT 803
Q L L++ H + I H DLKP N+L+++ + DFGLAR
Sbjct: 116 QLL-------QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR--------- 156
Query: 804 SSIDAKGS-----------IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSM 851
A G + Y AP+ +GS S + D++S G +L E++T KP +
Sbjct: 157 ----AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---L 208
Query: 852 FEGD 855
F G
Sbjct: 209 FPGT 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 46/220 (20%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--------LLHHGAFKSFIAECNTLKNIRHRN 689
+G G+ G V + VA+++ + + E LK + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++KI DY +V E M+ L + + + + E + Q
Sbjct: 202 IIKIKNFFDAEDYY------IVLELMEGGELFDKV--VGNKRLKEATCKLY-FYQ----- 247
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFL-PLSPAQTSS 805
+ A+ YLH + I H DLKP NVLL +E+ + ++DFG ++ L S +T
Sbjct: 248 --MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 806 IDAKGSIGYIAPE-------YGLGSEVSINGDVYSYGILL 838
G+ Y+APE G V D +S G++L
Sbjct: 303 ----GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 54/329 (16%), Positives = 111/329 (33%), Gaps = 16/329 (4%)
Query: 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYL 240
+ ++ + S E L+ ++ S + V++ V +
Sbjct: 229 WFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWR 288
Query: 241 EKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS-- 298
R + L + ++ + + + +
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATD 348
Query: 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK 358
L L K + + + LQ LE N TI + L L + +
Sbjct: 349 EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL-LYEKETLQ 406
Query: 359 FLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418
+ + ++ ++ LD + +Y + ++ L+ +LT + L
Sbjct: 407 YFSTLK-AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC----HLE 460
Query: 419 WL--LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQG 476
L + LDLS N+L ++P + L+ LEVL +N L+ + + + +L++L +
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCN 517
Query: 477 NFLQG-PIPSSLSSLKGLNVLDLSQNNLS 504
N LQ L S L +L+L N+L
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 41/227 (18%), Positives = 76/227 (33%), Gaps = 26/227 (11%)
Query: 322 FVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNF 381
+L + + T + +E L +++ S + ++F +LS
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 382 LQGSIPSSLGQYKTLTIIDLSDNN--LTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV 439
+ S L K L ++ + LT + + L + L P
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 440 GNLKNL------------------EVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG 481
L +L VL + L + L + L++ N L+
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA 477
Query: 482 PIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+P +L++L+ L VL S N L + + L+ L L NN L+
Sbjct: 478 -LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 30/133 (22%), Positives = 58/133 (43%), Gaps = 12/133 (9%)
Query: 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN 62
+ V++L+L L + H+ L + L L +N +P L+ L+VL ++N
Sbjct: 440 YADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN 496
Query: 63 SIGGEIPANISSCSNLIQIRLFYNELVG-KIPSELGSLSKIEHLSVSVNNLT------GS 115
++ E +++ L ++ L N L L S ++ L++ N+L
Sbjct: 497 AL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554
Query: 116 IPSSLGNLSSINT 128
+ L ++SSI T
Sbjct: 555 LAEMLPSVSSILT 567
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 4e-05
Identities = 30/204 (14%), Positives = 66/204 (32%), Gaps = 6/204 (2%)
Query: 8 ILNLTSLKLAGSISPHVGN-LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGG 66
L +L+ S + + L K L + + ++ L L ++
Sbjct: 348 DEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQY 407
Query: 67 EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126
+ ++ + + + + L ++ +LT + L L +
Sbjct: 408 FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLV 465
Query: 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186
L L+ N L +P L+ L L ++N L + + N+ + N+LQ
Sbjct: 466 THLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ 522
Query: 187 VIPLDFGFTLQNLQFFSVFENQLT 210
+ + L ++ N L
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 61/258 (23%), Positives = 98/258 (37%), Gaps = 62/258 (24%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIA----------------- 677
EIG GS+G V + T A+KV + L+ F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 678 ------ECNTLKNIRHRNLVK----ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPI 727
E LK + H N+VK + Y +VFE + + E +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPVME----V 128
Query: 728 TREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
E ++ Q D+ + YLH+ I H D+KPSN+L+ E+ +
Sbjct: 129 PTLKPLSE-DQARFYFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKI 178
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSING---DVYSYGILLLELVTR 844
+DFG++ S A S+ G+ ++APE + +G DV++ G+ L V
Sbjct: 179 ADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 845 KKPVDSMFEGD--MNLHN 860
+ P F + M LH+
Sbjct: 237 QCP----FMDERIMCLHS 250
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 32/210 (15%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN-LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
++G G+FG V+ +K N + AE LK++ H N++KI
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--TEEAPRSLNLLQRLNIGIDVAC 754
++ +V E + L E + K +E + +
Sbjct: 89 -----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA--------ELMKQMMN 135
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
AL+Y H + H DLKP N+L + DFGLA + S+ +A G+
Sbjct: 136 ALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHST-NAAGT 189
Query: 812 IGYIAPE---YGLGSEVSINGDVYSYGILL 838
Y+APE + + D++S G+++
Sbjct: 190 ALYMAPEVFKRDVTFKC----DIWSAGVVM 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 26/205 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
E+G G+FG V++ + K N + + E + + + H L+ + A
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--TEEAPRSLNLLQRLNIGIDVACA 755
++ L+ EF+ L + I ED +E + + Q
Sbjct: 117 ----FEDKYEMVLILEFLSGGELFDR---IAAEDYKMSEAEVINY-MRQACE-------G 161
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIG 813
L ++H + I H D+KP N++ + + + V DFGLA L+P + +
Sbjct: 162 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVK-VTTATAE 215
Query: 814 YIAPEYGLGSEVSINGDVYSYGILL 838
+ APE V D+++ G+L
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 58/234 (24%), Positives = 91/234 (38%), Gaps = 33/234 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF-KSFIAECNTLKNIRHRNLVKILTA 696
+G G++G V VA+K F + E LK+ +H N++ I
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
++ + ++ E M + LH + + + Q L A+
Sbjct: 78 QRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL-------RAV 125
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI--GY 814
LH + H DLKPSN+L++ V DFGLAR + S A S + S +
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 815 I------APEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
+ APE L S ++ DV+S G +L EL R+ +F G H
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAM--DVWSCGCILAELFLRRP----IFPGRDYRH 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 51/284 (17%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAF-KSFIAECN 680
+ + + +G G++G+V + + VA+K ++ F K E
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 76
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPR 738
LK++RH N++ +L + D +DF LV FM L + + +K E
Sbjct: 77 LLKHMRHENVIGLLDVFT-PDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRI 130
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
+ Q L L Y+H I H DLKP N+ ++E+ + DFGLAR
Sbjct: 131 QFLVYQML-------KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QA 178
Query: 799 SPAQTSSIDAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851
T GY+ APE L + D++S G ++ E++T K ++
Sbjct: 179 DSEMT---------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TL 225
Query: 852 FEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQ 895
F+G +L I+ T E + + +
Sbjct: 226 FKGSDHLDQLKE---------IMKVTGTPPAEFVQRLQSDEAKN 260
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 57/234 (24%), Positives = 85/234 (36%), Gaps = 47/234 (20%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIA---ECNTLKNIRHR--N 689
+G G FGSVY GI VA+K + G + E LK +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNI 748
++++L ++ D L+ E + ++ IT EE RS Q
Sbjct: 110 VIRLLDW-----FERPDSFVLILERPEPV--QDLFDFITERGALQEELARSF-FWQ---- 157
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM-AHVSDFGLARFLPLSPAQTSSID 807
V A+ + H+ + H D+K N+L+D + DFG L +
Sbjct: 158 ---VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-- 209
Query: 808 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ Y PE Y G V+S GILL ++V P FE D
Sbjct: 210 --GTRVYSPPEWIRYHRY-HGRSA----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 46/229 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G+F V VA+K+ + L+ + + E +K + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 697 CSGVDYQGNDFKA---LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
++ + + L+ E+ + ++ + + +E + + +++
Sbjct: 80 -----FEVIETEKTLYLIMEYASGGEVFDY---LVAHGRMKE-KEARSKFRQI------V 124
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSSIDAKGSI 812
A+ Y H I H DLK N+LLD +M ++DFG F G+
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAP 177
Query: 813 GYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
Y APE Y G EV DV+S G++L LV+ P F+G
Sbjct: 178 PYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 52/241 (21%), Positives = 90/241 (37%), Gaps = 26/241 (10%)
Query: 602 VRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAV 661
V + +P + D + E+G G+FG V++ A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 662 KVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLE 721
K H ++ E T+ +RH LV + A ++ ++ +++EFM L
Sbjct: 188 KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELF 242
Query: 722 EWLHPITREDK--TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779
E + E +E+ + Q L ++H + H DLKP N++
Sbjct: 243 EK---VADEHNKMSEDEAVEY-MRQVCK-------GLCHMH---ENNYVHLDLKPENIMF 288
Query: 780 DEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGIL 837
+ + DFGL L P Q+ + G+ + APE G V D++S G+L
Sbjct: 289 TTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 838 L 838
Sbjct: 346 S 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-15
Identities = 56/240 (23%), Positives = 93/240 (38%), Gaps = 52/240 (21%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKV-------------FNLLHHGAFKSFIAECNTLK 683
++G G++G V G + A+KV N + E + LK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 684 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
++ H N++K+ ++ + LV EF + L E + I R E ++ +
Sbjct: 102 SLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANI-MK 153
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSP 800
Q + + YLH I H D+KP N+LL + + + DFGL+ F
Sbjct: 154 Q-------ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 801 AQTSSIDAKGSIGYIAPE-----YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ G+ YIAPE Y + DV+S G+++ L+ P F G
Sbjct: 204 KLRDRL---GTAYYIAPEVLKKKY--NEKC----DVWSCGVIMYILLCGYPP----FGGQ 250
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 33/249 (13%)
Query: 604 KRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKV 663
+ + P + S + F ++G GS+GSVYK I + VA+K
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTK--QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 664 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW 723
+ + I E + ++ ++VK + Y N +V E+ S+
Sbjct: 62 VPV--ESDLQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSV--- 111
Query: 724 LHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783
D ++L + I L YLH H D+K N+LL+ E
Sbjct: 112 ------SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEG 162
Query: 784 MAHVSDFGLARFLPLSPAQTSSIDAKGS--IG---YIAPEYGLGSEVSINGDVYSYGILL 838
A ++DFG+A Q + AK + IG ++APE + D++S GI
Sbjct: 163 HAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215
Query: 839 LELVTRKKP 847
+E+ K P
Sbjct: 216 IEMAEGKPP 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 50/225 (22%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNL--------LHHGAFKSFIAECNTLKNIR-HR 688
IG G V + + AVK+ + ++ E + L+ + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLN 747
+++ ++ + Y+ + F LVF+ M+ L +T + +E+ RS+ + L
Sbjct: 161 HIITLIDS-----YESSSFMFLVFDLMRKGEL---FDYLTEKVALSEKETRSI-MRSLLE 211
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
A+S+LH + I H DLKP N+LLD+ M +SDFG + L P + +
Sbjct: 212 -------AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLR-E 258
Query: 808 AKGSIGYIAPE----------YGLGSEVSINGDVYSYG----ILL 838
G+ GY+APE G G EV D+++ G LL
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLL 299
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 48/238 (20%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRN 689
+ + +++G G++ +VYKG VA+K L H GA + I E + LK+++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V + + + LVFE++ ++ L+++L + L Q L
Sbjct: 62 IVTLH----DIIHTEKSL-TLVFEYL-DKDLKQYLDD-CGNIINMHNVKLF-LFQLLR-- 111
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
L+Y H + H DLKP N+L++E ++DFGLAR AK
Sbjct: 112 -----GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR-------------AK 150
Query: 810 GS-----------IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ Y P+ LGS S D++ G + E+ T +P +F G
Sbjct: 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 53/280 (18%), Positives = 116/280 (41%), Gaps = 27/280 (9%)
Query: 251 ITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNK 310
+++L + ++ L + +++++ N ++ + I L + L L+ NK
Sbjct: 23 TIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIKSVQG--IQYL-PNVTKLFLNGNK 76
Query: 311 IFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL 370
+ +I + NL L + N++ + + +L+ L+ L L+ N + +I + +L
Sbjct: 77 L-TDIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNG-ISDING-LVHL 130
Query: 371 KVFN-LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRN 429
L L N + + + L + L + L DN ++ I P GL+ L L LS+N
Sbjct: 131 PQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL-QNLYLSKN 185
Query: 430 QLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSS 489
++ + + LKNL+VL++F + + + + ++ L P S
Sbjct: 186 HIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--- 240
Query: 490 LKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529
+ D + N+ +PEF + ++ +
Sbjct: 241 ----DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 4e-12
Identities = 36/150 (24%), Positives = 58/150 (38%), Gaps = 15/150 (10%)
Query: 388 SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEV 447
+ +L ++T + L + + + + + S+ + L N+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIK-SV-QGIQYLPNVTK 69
Query: 448 LDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIP--SSLSSLKGLNVLDLSQNNLSG 505
L + NKL +I L + K L L + N I SSL LK L L L N +S
Sbjct: 70 LFLNGNKLT-DI-KPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGIS- 122
Query: 506 KIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535
I LV LE+L L NN + + +
Sbjct: 123 DI-NGLVHLPQLESLYLGNNKITDITVLSR 151
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 1e-11
Identities = 46/256 (17%), Positives = 99/256 (38%), Gaps = 24/256 (9%)
Query: 54 LQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLT 113
+ + I +I + + I+ L + + L+ I+ + + +++
Sbjct: 1 MGETITVSTPIK-QIF-PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 114 GSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISS 173
S+ + L ++ LFL N L P LKNL L + EN + + SS+ ++
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 174 ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKL 233
+ + N + + L L L+ + N++T +S + L+ + N++
Sbjct: 111 LKSLSLEHNGISDINGLV---HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165
Query: 234 TGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPAC 293
+ ++ L +L +++N + S+L L L N L+ L + +
Sbjct: 166 S-DIVPLAGLTKLQNLYLSKNHI-----SDLRALAGLKN---LDVLELFSQECLNKPINH 216
Query: 294 ISNLSTTLEMLLLDNN 309
SNL + D +
Sbjct: 217 QSNLVVPNTVKNTDGS 232
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 43/269 (15%), Positives = 91/269 (33%), Gaps = 20/269 (7%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
++ + S+ + L + L L N I L+ L L L+ N I
Sbjct: 44 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKI- 99
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
++ ++ L + L +N + I L L ++E L + N +T + L L+
Sbjct: 100 KDLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTK 154
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
++TL L DN + I L L L +++N + + ++ + ++ + +
Sbjct: 155 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECL 210
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245
P++ L + L P IS+ + E + +
Sbjct: 211 N-KPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQ 267
Query: 246 LSVFSITENSLGSRGHSNLNFLCSLTNST 274
+ R L + +++
Sbjct: 268 PVTIGKAKARFHGRVTQPLKEVYTVSYDV 296
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 51/250 (20%), Positives = 79/250 (31%), Gaps = 77/250 (30%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIA---ECNTLKNIR----H 687
+G G FG+V+ G + VA+KV +L + E L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 688 RNLVKIL--------------TACSGVDYQGNDFKALVFEF-MQNRSLEEWLHPITREDK 732
++++L D +F++ + L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQD---------LFDYITEKGPLGE---------- 138
Query: 733 TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA-HVSDFG 791
+ R Q V A+ + H + H D+K N+L+D + DFG
Sbjct: 139 -GPS-RCF-FGQ-------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG 185
Query: 792 LARFLPLSPAQTSSIDAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRK 845
L P G+ Y PE Y V+S GILL ++V
Sbjct: 186 SGALLHDEPYTDFD----GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMVCGD 236
Query: 846 KPVDSMFEGD 855
P FE D
Sbjct: 237 IP----FERD 242
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 40/256 (15%)
Query: 606 KEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN 665
+ SS + + + ++G G++G VYK D VA+K
Sbjct: 2 HHHHHHSSGRENLYFQGLM------EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIR 54
Query: 666 LLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW 723
L G + I E + LK + H N+V ++ LVFEFM+ L++
Sbjct: 55 LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERCLTLVFEFMEK-DLKKV 108
Query: 724 LHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783
L + + + L Q L +++ H I H DLKP N+L++ +
Sbjct: 109 LD-ENKTGLQDSQIKIY-LYQLL-------RGVAHCHQHR---ILHRDLKPQNLLINSDG 156
Query: 784 MAHVSDFGLARFLPLSPAQTSS---IDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLL 839
++DFGLAR P ++ + + ++ Y AP+ +GS+ S + D++S G +
Sbjct: 157 ALKLADFGLARAFG-IPVRSYTHEVV----TLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211
Query: 840 ELVTRKKPVDSMFEGD 855
E++T KP +F G
Sbjct: 212 EMITG-KP---LFPGV 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 55/245 (22%), Positives = 90/245 (36%), Gaps = 71/245 (28%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIA-----ECNTLKNIRHRNL 690
+G G+FG V+ + + V VK +L + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 691 VKIL--------------TACSGVDYQGNDFKALVFEF-MQNRSLEEWLHPITREDKTEE 735
+K+L SG+D +F F ++ L+E
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLD---------LFAFIDRHPRLDE-----------PL 131
Query: 736 APRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795
A + ++L A+ YL I H D+K N+++ E+ + DFG A +
Sbjct: 132 ASY---IFRQL------VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 796 L-PLSPAQTSSIDAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPV 848
L T G+I Y APE Y G E+ +++S G+ L LV + P
Sbjct: 180 LERGKLFYTFC----GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPF 230
Query: 849 DSMFE 853
+ E
Sbjct: 231 CELEE 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 27/224 (12%), Positives = 56/224 (25%), Gaps = 62/224 (27%)
Query: 638 EIGVGSFGSVYKG---ILDQGKTTVAVKV--FNLLHHGAFKS-FIAECNTLKNIRHRNLV 691
G ++ LD+ VA+ + ++ L I +
Sbjct: 38 FHGGVPPLQFWQALDTALDR---QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++L V + +V E+++ SL+E S + + +
Sbjct: 95 RVLDV---VHTRAGGL--VVAEWIRGGSLQEVAD------------TSPSPVGAIRAMQS 137
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+A A H + PS V + + ++ +P
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP--DANPQD--------- 183
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
D+ G L L+ + P
Sbjct: 184 ------------------DIRGIGASLYALLVNRWP----LPEA 205
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 51/248 (20%), Positives = 91/248 (36%), Gaps = 43/248 (17%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVF-NLLHHGAFKSFIAECNTLKNIR--------HRN 689
+G G F +V+ T VA+K+ + ++ E L+ +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 690 LVKILTACSGVDYQGNDFK--ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
IL +++G + +VFE + +L + K E L +++
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK------KYEHRGIPLIYVKQ-- 135
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH------VSDFGLARFLPL--- 798
I + L Y+H C I H D+KP NVL++ ++D G A +
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 799 SPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK--PVDSMFEGDM 856
+ QT Y +PE LG+ D++S L+ EL+T D
Sbjct: 194 NSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 857 NLHNFARM 864
+ + A++
Sbjct: 246 DDDHIAQI 253
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 52/261 (19%), Positives = 100/261 (38%), Gaps = 20/261 (7%)
Query: 294 ISNLS--TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRE 351
I + L + + + ++ ++ N+ + ++ I L N+ +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTK 72
Query: 352 LRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIP 411
L L NK L +I P + L L N ++ + SSL K L + L N ++ I
Sbjct: 73 LFLNGNK-LTDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 128
Query: 412 PQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
L L L L N++T + + L L+ L + +N++ +I L KL+
Sbjct: 129 G--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 182
Query: 472 LEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMV 531
L + N + +L+ LK L+VL+L K + + ++ +L
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 240
Query: 532 PI--EGVFKNATITSVLGNLK 550
I +G ++ + L
Sbjct: 241 IISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 45/267 (16%), Positives = 99/267 (37%), Gaps = 18/267 (6%)
Query: 46 SEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105
D L S+ + + +++ QI +++ K + L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKL 73
Query: 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165
++ N LT I L NL ++ LFL +N + + LK L +L++ N +S I
Sbjct: 74 FLNGNKLT-DI-KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DI- 127
Query: 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLEL 225
+ + ++ + + G N++ + L L L S+ +NQ++ I P ++ + L+
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLS---RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 182
Query: 226 FQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANN 285
N ++ ++ L + L V + ++ ++ + L + L+
Sbjct: 183 LYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 241
Query: 286 FGGLLPACISNLSTTLEMLLLDNNKIF 312
+ + N F
Sbjct: 242 ISDDGD--YEKPNVKWHLPEFTNEVSF 266
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 42/236 (17%), Positives = 88/236 (37%), Gaps = 22/236 (9%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
++ + S+ + L + L L N L+ L L L+ N +
Sbjct: 47 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKV- 102
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
++ ++ L + L +N + + L L ++E L + N +T + L L+
Sbjct: 103 KDLS-SLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTK 157
Query: 126 INTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185
++TL L DN + +P L L L +++N +S ++ + ++ + +
Sbjct: 158 LDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 213
Query: 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVN--KLTGEVPY 239
P++ L + L P IS+ + E + + T EV +
Sbjct: 214 N-KPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSF 266
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 51/284 (17%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAF-KSFIAECN 680
+ ++ + + + + +G G++GSV + VAVK + K E
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPR 738
LK+++H N++ +L + +F LV M L+ I + K +
Sbjct: 81 LLKHMKHENVIGLLDVFT-PARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHV 134
Query: 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPL 798
+ Q L L Y+H I H DLKPSN+ ++E+ + DFGLAR
Sbjct: 135 QFLIYQIL-------RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HT 182
Query: 799 SPAQTSSIDAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851
+ T GY+ APE L + D++S G ++ EL+T + ++
Sbjct: 183 ADEMT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TL 229
Query: 852 FEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQ 895
F G ++ I+ E L ++ R
Sbjct: 230 FPGTDHIDQLKL---------ILRLVGTPGAELLKKISSESARN 264
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 42/265 (15%), Positives = 89/265 (33%), Gaps = 65/265 (24%)
Query: 612 SSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA 671
+ + S + L +IG G FGSV+K + A+K G+
Sbjct: 2 AMGMKSRYTTEFHEL----------EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS 51
Query: 672 F--KSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPIT 728
++ + E + +H ++V+ +A + +D + E+ SL + +
Sbjct: 52 VDEQNALREVYAHAVLGQHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENY 106
Query: 729 REDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788
R + +LL + V L Y+H + H D+KPSN+ + + + +
Sbjct: 107 RIMSYFKEAELKDLL------LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAA 157
Query: 789 -------------------DFGLARFLPLSPAQTSSIDAKGSIGYIAPE-------YGLG 822
D G +S Q +G ++A E +
Sbjct: 158 SEEGDEDDWASNKVMFKIGDLGHVT--RISSPQVE----EGDSRFLANEVLQENYTHLPK 211
Query: 823 SEVSINGDVYSYGILLLELVTRKKP 847
+ D+++ + ++ +
Sbjct: 212 A------DIFALALTVVCAAGAEPL 230
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 64/239 (26%), Positives = 100/239 (41%), Gaps = 50/239 (20%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHR 688
+ + +IG G++G VYK + T A+K L G + I E + LK ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+VK+ V + LVFE + L++ L + +S LLQ L
Sbjct: 61 NIVKLY----DVIHTKKRL-VLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSF-LLQLL-- 110
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
++Y H + H DLKP N+L++ E ++DFGLAR A
Sbjct: 111 -----NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR-------------A 149
Query: 809 KGS-----------IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G + Y AP+ +GS+ S D++S G + E+V P +F G
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 30/214 (14%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+ +G G FG V+K +A K+ + E + + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--TEEAPRSLNLLQRLNIGI 750
+ A ++ + LV E++ L + I E TE + Q
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELFDR---IIDESYNLTELDTILF-MKQICE--- 198
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDA 808
+ ++H Q I H DLKP N+L + DFGLAR P +
Sbjct: 199 ----GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLK-VN 248
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYG----ILL 838
G+ ++APE VS D++S G +LL
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 39/244 (15%), Positives = 76/244 (31%), Gaps = 60/244 (24%)
Query: 294 ISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRE 351
I +L + + L L + IP+ A N+ R+ + + + + L +
Sbjct: 26 IPSLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 352 LRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIP--SSLGQYKTLTIIDLSDNN 405
+ ++ + L I P LK L + L+ P + + I++++DN
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKF--LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNP 141
Query: 406 LTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464
+IP F GL + L L N T S+ N L+ + + +NK I
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK--- 197
Query: 465 SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524
+ G+ L++S
Sbjct: 198 -----------------------DAFGGVY--------------------SGPSLLDVSQ 214
Query: 525 NNLE 528
++
Sbjct: 215 TSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 37/195 (18%), Positives = 70/195 (35%), Gaps = 10/195 (5%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
+ L L F L + + ++ + ++ ++ + S + I +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 89 VGKIPSE-LGSLSKIEHLSVSVNNLTGSIP--SSLGNLSSINTLFLTDNNLDGGIP-DTF 144
+ I + L L ++ L + L P + + + L +TDN IP + F
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 145 GWLKN-LATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLD-FGFTLQNLQFF 202
L N TL + N + ++ FN + + A N+ VI D FG
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 203 SVFENQLTGAIPPAI 217
V + +T A+P
Sbjct: 211 DVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 16/173 (9%)
Query: 10 NLTSLKLAG-----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLALNNN 62
N++ + ++ + H NLS + + + N I + L L+ L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 63 SIGGEIPAN--ISSCSNLIQIRLFYNELVGKIPSEL--GSLSKIEHLSVSVNNLTGSIPS 118
+ P + S + + N + IP G ++ L + N T S+
Sbjct: 116 GL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG 173
Query: 119 SLGNLSSINTLFLTDNNLDGGIP-DTF-GWLKNLATLAMAENWLSGTIPSSIF 169
N + ++ ++L N I D F G + L +++ ++ +PS
Sbjct: 174 YAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGL 225
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 28/162 (17%), Positives = 58/162 (35%), Gaps = 17/162 (10%)
Query: 10 NLTSLKLAG-----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE--FDRLQRLQVLALNN 61
+T +++ I P L LK L ++N P +L + +
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITD 139
Query: 62 NSIGGEIPANISS--CSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSS 119
N IP N C+ + ++L+ N + + +K++ + ++ N I
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKD 198
Query: 120 L--GNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENW 159
G S + L ++ ++ +P L++L L W
Sbjct: 199 AFGGVYSGPSLLDVSQTSVT-ALPS--KGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 27/154 (17%), Positives = 50/154 (32%), Gaps = 30/154 (19%)
Query: 274 TRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNL----QRLE 329
L L I + +L + +N +IP F L L+
Sbjct: 105 PLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV--NAFQGLCNETLTLK 162
Query: 330 MWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS 389
++NN + ++ L + L +NK+L I F
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK-----DAFG--------------- 201
Query: 390 LGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLI 422
G Y +++D+S ++T +P + L L+
Sbjct: 202 -GVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 51/238 (21%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSF----IAECNTLKNIR 686
+ +IG G+FG V+K + VA+K + + F + E L+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALREIKILQLLK 74
Query: 687 HRNLVKILTACSGVDYQGNDFKA---LVFEFMQN---RSLEEWLHPITREDKTEEAPRSL 740
H N+V ++ C N K LVF+F ++ L L T + + +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI-----KRV 129
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSP 800
+ LN L Y+H + I H D+K +NVL+ + + ++DFGLAR
Sbjct: 130 -MQMLLN-------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF---- 174
Query: 801 AQTSSIDAKGSIG----------YIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 845
S+ Y PE LG I D++ G ++ E+ TR
Sbjct: 175 ----SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI--DLWGAGCIMAEMWTRS 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 66/224 (29%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+GVG+FG V G VAVK+ N + E LK RH +++K+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 696 ACSGVDYQGNDFKA---LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
YQ +V E++ L ++ I + + EE + L Q++
Sbjct: 77 ------YQVISTPTDFFMVMEYVSGGELFDY---ICKHGRVEE-MEARRLFQQI------ 120
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSSIDAKGS 811
A+ Y H + H DLKP NVLLD M A ++DFGL +TS GS
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GS 173
Query: 812 IGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
Y APE Y G EV D++S G++L L+ P D
Sbjct: 174 PNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLPFD 212
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 52/246 (21%), Positives = 86/246 (34%), Gaps = 51/246 (20%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGA----FKSFIA 677
L+ + I GS+G+V G+ D VA+K VFN + G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 678 ------ECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITR 729
E L + H N++ + V ++ LV E M L +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIF--VHFEEPAMHKLYLVTELM-----RTDLAQVIH 125
Query: 730 EDK---TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786
+ + + + + + L L LH + + H DL P N+LL +
Sbjct: 126 DQRIVISPQHIQYF-MYHIL-------LGLHVLH---EAGVVHRDLHPGNILLADNNDIT 174
Query: 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYI------APEYGLGS-EVSINGDVYSYGILLL 839
+ DF LAR +T Y+ APE + + D++S G ++
Sbjct: 175 ICDFNLAREDTADANKT---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 840 ELVTRK 845
E+ RK
Sbjct: 226 EMFNRK 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 55/238 (23%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKIL 694
++G G++G VYK I TVA+K L H G + I E + LK ++HRN++++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ V + + L+FE+ L++++ D + +S L Q +N
Sbjct: 100 S----VIHHNHRL-HLIFEYA-ENDLKKYMD--KNPDVSMRVIKSF-LYQLIN------- 143
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH-----VSDFGLARFLPLSPAQTSSIDAK 809
+++ H H DLKP N+LL + + DFGLAR A
Sbjct: 144 GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-------------AF 187
Query: 810 GS-----------IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G + Y PE LGS S + D++S + E++ + P +F GD
Sbjct: 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 57/240 (23%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA-C 697
IG GSFG V++ L + VA+K +L FK+ E ++ ++H N+V +
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIK--KVLQDKRFKN--RELQIMRIVKHPNVVDLKAFFY 102
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ-------RLNIGI 750
S D + F LV E++ E ++ +R + + L++ R
Sbjct: 103 SNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR----- 152
Query: 751 DVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMA-HVSDFGLARFLPLSPAQTSSIDA 808
+L+Y+H I H D+KP N+LLD + DFG A+ L +
Sbjct: 153 ----SLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEP----- 197
Query: 809 KGSIGYI------APEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
++ YI APE G+ +I D++S G ++ EL+ +P +F G+ +
Sbjct: 198 --NVSYICSRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQG-QP---LFPGESGID 249
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 50/216 (23%), Positives = 78/216 (36%), Gaps = 49/216 (22%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA----ECNTLKNIR-HRNLVK 692
+G GSF K + + AVK+ + K A E LK H N+VK
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVK 70
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGID 751
+ + LV E + L I ++ +E I
Sbjct: 71 LHEV-----FHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS--------YIMRK 114
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ A+S++H + H DLKP N+L ++ + + DFG AR P P
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTP 169
Query: 809 KGSIGYIAPE------YGLGSEVSINGDVYSYGILL 838
++ Y APE Y D++S G++L
Sbjct: 170 CFTLHYAAPELLNQNGYDE--SC----DLWSLGVIL 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 18/182 (9%)
Query: 357 NKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPS--SLGQYKTLTIIDLSDNNLTGTIPPQ 413
+ L N+P S+ + LDLS N L + + + + L + LS N+L I +
Sbjct: 27 KQQLPNVPQSLPSYTAL--LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82
Query: 414 -FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQ 471
F+ + L LDLS N L ++ + +L+ LEVL ++ N + + +L++
Sbjct: 83 AFVPVP-NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQK 140
Query: 472 LEMQGNFLQGPIP----SSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLL--ENLNLSNN 525
L + N + P + L L +LDLS N L L L L NN
Sbjct: 141 LYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
Query: 526 NL 527
L
Sbjct: 200 PL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQ--FLGLSWLLIGLDLSRNQLTGSIPSEV-GN 441
++P SL ++DLS NNL+ + + L+ L L LS N L I SE
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHS-LLLSHNHLN-FISSEAFVP 86
Query: 442 LKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQ 500
+ NL LD+ N L + + LE L + N + ++ + L L LSQ
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145
Query: 501 NNLSGKIPE--FLVGFQL--LENLNLSNNNLE 528
N +S + P G +L L L+LS+N L+
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 37/211 (17%), Positives = 78/211 (36%), Gaps = 17/211 (8%)
Query: 30 LKVLLLYNNSFNHGIPSE--FDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYN 86
+L L +N+ + + +E RL L L L++N + I + NL + L N
Sbjct: 41 TALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 87 ELVGKIPSE-LGSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLTDNNLDGGIPDTF 144
L + L +E L + N++ + + +++ + L+L+ N + +
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156
Query: 145 GW---LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM--NQLQ---GVIPLDFGFTL 196
L L L ++ N L + + + + + N L+ + L +
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQY 216
Query: 197 QNLQFFSVFENQLTGAIPPAISNASNLELFQ 227
+ L F+ L + N +L+ F
Sbjct: 217 RQLSSVMDFQEDLYCMHSKKLHNIFSLDFFN 247
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 41/141 (29%), Positives = 61/141 (43%), Gaps = 16/141 (11%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSE-FDRLQRLQVLALNNNS 63
NL SL L+ IS + L+ L L +N H + F LQ L+VL L NN
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNH 123
Query: 64 IGGEIPANI-SSCSNLIQIRLFYNELVGKIPSE----LGSLSKIEHLSVSVNNLTGSIPS 118
I + N + L ++ L N++ + P E L K+ L +S N L +
Sbjct: 124 I-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 119 SLGNLSSI--NTLFLTDNNLD 137
L L + N L+L +N L+
Sbjct: 182 DLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 32/116 (27%), Positives = 46/116 (39%), Gaps = 13/116 (11%)
Query: 274 TRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWN 332
L L +++N+ L S+L LE+LLL NN I + A LQ+L +
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDL-QALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQ 145
Query: 333 NRLSGTIPP----AIGELQNLRELRLQRNKFLGNIPP----SIGNLKVFNLDLSCN 380
N++S P +L L L L NK L +P + L L N
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNK-LKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 38/203 (18%), Positives = 62/203 (30%), Gaps = 43/203 (21%)
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFT-LQNLQFFSVFENQLTGAIPP-AISNA 220
+P S+ S D N L + ++ T L NL + N L I A
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 221 SNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLL 280
NL N L ++ E ++ L LL
Sbjct: 88 PNLRYLDLSSNHLH---------------TLDEF--------------LFSDLQALEVLL 118
Query: 281 INANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA----AIGKFVNLQRLEMWNNRLS 336
+ N+ + ++ L+ L L N+I P K L L++ +N+L
Sbjct: 119 LYNNHIVVVDRNAFEDM-AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 337 GTIPPAIGELQNLRE--LRLQRN 357
+ +L + L L N
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNN 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 57/237 (24%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKIL 694
+G GS+G V K VA+K F K + E LK +RH NLV +L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLN-------LLQRLN 747
C + LVFEF+ ++ + L E P L+ L Q +N
Sbjct: 91 EVC-----KKKKRWYLVFEFVD-HTILDDL---------ELFPNGLDYQVVQKYLFQIIN 135
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ + H I H D+KP N+L+ + + + DFG AR L +P +
Sbjct: 136 -------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYD-- 182
Query: 808 AKGSIGYI------APEYGLGSEV---SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ APE +G ++ DV++ G L+ E+ +P +F GD
Sbjct: 183 -----DEVATRWYRAPELLVGDVKYGKAV--DVWAIGCLVTEMFMG-EP---LFPGD 228
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 39/215 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN------LLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G F V K A K + E + L+ + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ Y+ L+ E + L ++L +E +EE S + Q L+
Sbjct: 79 TLHDV-----YENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF-IKQILD---- 126
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFLPLSPAQTSSID 807
++YLH I H DLKP N++L + DFGLA + +
Sbjct: 127 ---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFK-N 177
Query: 808 AKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 838
G+ ++APE LG E D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 208
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 56/214 (26%), Positives = 84/214 (39%), Gaps = 32/214 (14%)
Query: 315 IPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN 374
IP+ I + ++L++ +N+LS A L LR L L NK L +P +F
Sbjct: 31 IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQTLPAG-----IFK 82
Query: 375 LDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTG 433
L L + ++DN L +P F L L L L RNQL
Sbjct: 83 --------------ELKN---LETLWVTDNKLQ-ALPIGVFDQLVNLAE-LRLDRNQLK- 122
Query: 434 SIPSEV-GNLKNLEVLDVFENKLKGEIPSTL-GSCKKLEQLEMQGNFLQGPIPSSLSSLK 491
S+P V +L L L + N+L+ +P + L++L + N L+ + L
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 492 GLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNN 525
L L L N L + L+ L L N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 9/182 (4%)
Query: 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
K L L +N + F RL +L++L LN+N + +PA I NL + + N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97
Query: 89 VGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSL-GNLSSINTLFLTDNNLDGGIPDTFGW 146
+P + L + L + N L S+P + +L+ + L L N L F
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155
Query: 147 LKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVF 205
L +L L + N L +P F ++ + NQL+ +P +L+ L+ +
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQ 213
Query: 206 EN 207
EN
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 395 TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
+DL N L+ F L+ L + L L+ N+L ++P+ + LKNLE L V +N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRL-LYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 454 KLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSL-SSLKGLNVLDLSQNNLSGKIPE-- 509
KL+ +P L +L + N L+ +P + SL L L L N L +P+
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 510 F--LVGFQLLENLNLSNNNLEGMVPIEGVFKNAT 541
F L L+ L L NN L+ VP EG F T
Sbjct: 153 FDKLTS---LKELRLYNNQLK-RVP-EGAFDKLT 181
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 9/135 (6%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSI 64
NL +L + ++ V L L L L N P FD L +L L+L N +
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145
Query: 65 GGEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSLGN 122
+P + ++L ++RL+ N+L ++P L++++ L + N L + +
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 123 LSSINTLFLTDNNLD 137
L + L L +N D
Sbjct: 204 LEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 395 TLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
+D S LT IP + LDL N+L+ S+PS+ L L +L + +N
Sbjct: 17 NKNSVDCSSKKLT-AIPS---NIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDN 71
Query: 454 KLKGEIPSTL-GSCKKLEQLEMQGNFLQGPIPSSL-SSLKGLNVLDLSQNNLSGKIPE-- 509
KL+ +P+ + K LE L + N LQ +P + L L L L +N L +P
Sbjct: 72 KLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRV 128
Query: 510 FLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLK 550
F L L+L N L+ +P +GVF L +LK
Sbjct: 129 F-DSLTKLTYLSLGYNELQ-SLP-KGVFDK------LTSLK 160
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 40/222 (18%)
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAI-SNAS 221
IPS+I + D N+L + F L L+ + +N+L +P I
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFH-RLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 222 NLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLI 281
NLE NKL +P + VF L N L L +
Sbjct: 86 NLETLWVTDNKLQ-ALP-------IGVFD------------------QLVN---LAELRL 116
Query: 282 NANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIP 340
+ N L P +L T L L L N++ ++P K +L+ L ++NN+L
Sbjct: 117 DRNQLKSLPPRVFDSL-TKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPE 174
Query: 341 PAIGELQNLRELRLQRNKFLGNIPPSI--GNLKVFNLDLSCN 380
A +L L+ L+L N+ L +P K+ L L N
Sbjct: 175 GAFDKLTELKTLKLDNNQ-LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 64/254 (25%), Positives = 92/254 (36%), Gaps = 70/254 (27%)
Query: 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF 169
LT +IPS++ + L L N L F L L L + +N L T+P+ IF
Sbjct: 26 KKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF 81
Query: 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAI-SNASNLELFQA 228
L+NL+ V +N+L A+P + NL +
Sbjct: 82 K------------------------ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 229 DVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRL----NRLL-INA 283
D N+L L VF SLT T L N L +
Sbjct: 117 DRNQLK----SLPP----RVFD------------------SLTKLTYLSLGYNELQSLPK 150
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI 343
F L T+L+ L L NN++ A K L+ L++ NN+L A
Sbjct: 151 GVFDKL---------TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 344 GELQNLRELRLQRN 357
L+ L+ L+LQ N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 25/204 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
++G G FG V++ + K T K + E + L RHRN++ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGIDVACAL 756
++ + ++FEF+ + E + T + E S + Q AL
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSY-VHQVCE-------AL 115
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIGY 814
+LH I H D++P N++ + + +FG AR L P + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFR-LLFTAPEY 169
Query: 815 IAPEYGLGSEVSINGDVYSYGILL 838
APE VS D++S G L+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 606 KEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFN 665
+ ++ + P + +++ + + + IG G++G V + K VA+K +
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 666 LLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQNRSLEE 722
H + + + E L RH N++ I + K +V + M E
Sbjct: 62 PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE--QMKDVYIVQDLM-----ET 114
Query: 723 WLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782
L+ + + L Q L L Y+H + H DLKPSN+LL+
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQIL-------RGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIG---YIAPEYGLGS-EVSINGDVYSYGILL 838
+ DFGLAR P + + Y APE L S + + D++S G +L
Sbjct: 165 CDLKICDFGLAR--VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222
Query: 839 LELVTRK 845
E+++ +
Sbjct: 223 AEMLSNR 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 40/247 (16%)
Query: 604 KRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKV 663
++ + I N +D F +E+G G+ VY+ + A+KV
Sbjct: 26 VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV 85
Query: 664 FNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEW 723
K E L + H N++K+ ++ +LV E + L +
Sbjct: 86 LK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFDR 138
Query: 724 LHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLL--- 779
+ + + +E + Q L A++YLH + I H DLKP N+L
Sbjct: 139 I--VEKGYYSERDAADA-VKQILE-------AVAYLHENG----IVHRDLKPENLLYATP 184
Query: 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPE----YGLGSEVSINGDVYSYG 835
+ ++DFGL++ + G+ GY APE G EV D++S G
Sbjct: 185 APDAPLKIADFGLSKIVEHQVLMK---TVCGTPGYCAPEILRGCAYGPEV----DMWSVG 237
Query: 836 ----ILL 838
ILL
Sbjct: 238 IITYILL 244
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 50/191 (26%), Positives = 76/191 (39%), Gaps = 31/191 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTAC 697
+G G+ V I AVK+ E L + HRN+++++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TE-EAPRSLNLLQRLNIGIDVACA 755
++ D LVFE M+ S+ L I + E EA ++Q DVA A
Sbjct: 80 ----FEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASV---VVQ------DVASA 123
Query: 756 LSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAK--- 809
L +LH I H DLKP N+L ++ + DF L + L+ + +
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 810 --GSIGYIAPE 818
GS Y+APE
Sbjct: 181 PCGSAEYMAPE 191
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA---FKSFIAECNTLKNIRHRN 689
F+ EIG GSFG+VY + VA+K + + ++ I E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++ Y LV E+ + D E + L ++ +
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCLGSAS----------DLLEVHKKPLQEVEIAAVT 160
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
L+YLH + H D+K N+LL E + + DFG A + + A
Sbjct: 161 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAP--AN 208
Query: 810 GSIG---YIAPEYGLGSEVSING---DVYSYGILLLELVTRKKP 847
+G ++APE L + DV+S GI +EL RK P
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 43/228 (18%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG GS+G V+K VA+K F K + E LK ++H NLV +L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
V + LVFE+ + ++ L + E +S+ Q L A+
Sbjct: 69 --EVFRRKRRL-HLVFEYC-DHTVLHELD-RYQRGVPEHLVKSI-TWQTLQ-------AV 115
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI- 815
++ H H D+KP N+L+ + + + DFG AR L P+ +
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYD-------DEVA 164
Query: 816 -----APEYGLGSEV---SINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+PE +G + DV++ G + EL++ P ++ G
Sbjct: 165 TRWYRSPELLVGDTQYGPPV--DVWAIGCVFAELLSG-VP---LWPGK 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 38/232 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G FG V+ Q K T A K N L ++ + E L + R +V
Sbjct: 193 LGRGGFGEVF---ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
L ++ LV M + ++ + ++ + PR+ +
Sbjct: 250 -LAYA----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-----IFYTA-QI 298
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKG 810
L +LH Q I + DLKP NVLLD++ +V SD GLA L +T G
Sbjct: 299 VSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGY--AG 351
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT---------RKKPVDSMFE 853
+ G++APE LG E + D ++ G+ L E++ K + +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 39/215 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN------LLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G F V K A K + + E + L+ + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ Y+ L+ E + L ++L +E +EE S + Q L+
Sbjct: 79 TLHDV-----YENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF-IKQILD---- 126
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFLPLSPAQTSSID 807
++YLH I H DLKP N++L + DFGLA + +
Sbjct: 127 ---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFK-N 177
Query: 808 AKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 838
G+ ++APE LG E D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 49/242 (20%), Positives = 86/242 (35%), Gaps = 19/242 (7%)
Query: 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNI 363
+ I P N + + ++ + EL ++ + + ++
Sbjct: 2 SIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSN-IQSL 56
Query: 364 PPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIG 423
+ L LS N Q S S L L + ++ N L LS L
Sbjct: 57 AGMQFFTNLKELHLSHN--QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL--- 111
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
L N+L + +LKNLE+L + NKLK I LG KLE L++ GN +
Sbjct: 112 -FLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT- 165
Query: 484 PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIE--GVFKNAT 541
L+ LK +N +DL+ + ++ + + + I G + +
Sbjct: 166 -GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
Query: 542 IT 543
+
Sbjct: 225 VL 226
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 46/230 (20%), Positives = 82/230 (35%), Gaps = 31/230 (13%)
Query: 182 NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLE 241
+ V P L N ++ + +T + S ++ F D + + + ++
Sbjct: 7 TPINQVFPDP---GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQ 60
Query: 242 KPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS--- 298
L ++ N + S+L+ L LT L L +N N + NL+
Sbjct: 61 FFTNLKELHLSHNQI-----SDLSPLKDLTK---LEELSVNRNR--------LKNLNGIP 104
Query: 299 -TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRN 357
L L LDNN++ ++ NL+ L + NN+L +I +G L L L L N
Sbjct: 105 SACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN 160
Query: 358 KFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT 407
+ + N KV +DL+ + + D
Sbjct: 161 E-ITNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 43/192 (22%), Positives = 77/192 (40%), Gaps = 17/192 (8%)
Query: 19 SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNL 78
+ P L+ L S L +Q +N++I + A + +NL
Sbjct: 11 QVFP-DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNL 65
Query: 79 IQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG 138
++ L +N++ + S L L+K+E LSV+ N L L + LFL +N L
Sbjct: 66 KELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACL---SRLFLDNNELRD 120
Query: 139 GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQN 198
D+ LKNL L++ N L +I + +S + D N++ L L+
Sbjct: 121 --TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLT---RLKK 173
Query: 199 LQFFSVFENQLT 210
+ + + +
Sbjct: 174 VNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 24/131 (18%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 10 NLTSLKLAG----SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
L L + +++ + L L L NN L+ L++L++ NN +
Sbjct: 86 KLEELSVNRNRLKNLNG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKL- 140
Query: 66 GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSS 125
+ + S L + L NE+ L L K+ + ++ L
Sbjct: 141 -KSIVMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYI 197
Query: 126 INTLFLTDNNL 136
NT+ D
Sbjct: 198 TNTVKDPDGRW 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 56/230 (24%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G GSFG V + + VA+K + L E + LK +RH +++K+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 696 ACSGVDYQGNDFKALVFEFMQNRS-----LE----EWLHPITREDKTEEAPRSLNLLQRL 746
++ + + +E E I + + E Q++
Sbjct: 75 ----------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-DEGRRFFQQI 117
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSS 805
CA+ Y H I H DLKP N+LLD+ + ++DFGL + +TS
Sbjct: 118 ------ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
Query: 806 IDAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
GS Y APE Y G EV DV+S GI+L ++ + P D
Sbjct: 169 ----GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLPFD 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-14
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 52/228 (22%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFK-----SFIAECNTLKNIRHRNLV 691
+ +G G F +VYK VA+K L H K + + E L+ + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+L ++ +LVF+FM LE + T ++ +L L
Sbjct: 76 GLL----DAFGHKSNI-SLVFDFM-ETDLEVIIKD-NSLVLTPSHIKAY-MLMTL----- 122
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
L YLH I H DLKP+N+LLDE + ++DFGLA+ + GS
Sbjct: 123 --QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-------------SFGS 164
Query: 812 IG-----------YIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 845
Y APE G+ V + D+++ G +L EL+ R
Sbjct: 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRV 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-14
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 62/241 (25%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 697
+G G++G V + + VAVK+ ++ I E K + H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 698 SGVDYQGNDFKALVFEFMQNRS-----LE-----EWLHPITREDKTEEAPRSLNLLQRLN 747
+ + + LE E I + E P + +L
Sbjct: 71 --------------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQL- 114
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA----QT 803
+ YLH ITH D+KP N+LLDE +SDFGLA +
Sbjct: 115 -----MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 804 SSIDAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857
G++ Y+APE + V DV+S GI+L ++ + P ++ +
Sbjct: 167 MC----GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSD 213
Query: 858 L 858
Sbjct: 214 S 214
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 56/266 (21%), Positives = 101/266 (37%), Gaps = 74/266 (27%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL-- 694
+G GSFG V + + A+K V +K E + +K + H N++K++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYK--NRELDIMKVLDHVNIIKLVDY 68
Query: 695 -----------------------------TACSGVDYQGNDFKA--LVFEFMQNRSLEEW 723
V + K ++ E++ +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDT 123
Query: 724 LHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783
LH + + +NL+ + A+ ++H I H D+KP N+L++ +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQL--FRAVGFIH---SLGICHRDIKPQNLLVNSKD 178
Query: 784 MA-HVSDFGLARFLPLSPAQTSSIDAKGSIGYI------APEYGLGSE---VSINGDVYS 833
+ DFG A+ L P++ S+ YI APE LG+ SI D++S
Sbjct: 179 NTLKLCDFGSAK--KLIPSEP-------SVAYICSRFYRAPELMLGATEYTPSI--DLWS 227
Query: 834 YGILLLELVTRKKPVDSMFEGDMNLH 859
G + EL+ KP +F G+ ++
Sbjct: 228 IGCVFGELILG-KP---LFSGETSID 249
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 43/224 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+GVG+FG V G + VAVK+ N + E LK RH +++K+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 696 ACSGVDYQGNDFKA---LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
YQ + +V E++ L ++ I + + +E S L Q++
Sbjct: 82 ------YQVISTPSDIFMVMEYVSGGELFDY---ICKNGRLDE-KESRRLFQQI------ 125
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL-ARFLPLSPAQTSSIDAKGS 811
+ Y H + H DLKP NVLLD M A ++DFGL +TS GS
Sbjct: 126 LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GS 178
Query: 812 IGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
Y APE Y G EV D++S G++L L+ P D
Sbjct: 179 PNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLPFD 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 60/283 (21%), Positives = 98/283 (34%), Gaps = 61/283 (21%)
Query: 606 KEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK-VF 664
+ S N + + D + + IG GS+G VY + VA+K V
Sbjct: 3 HHHHHSSGRENLYF--QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 665 NLLHHGAFKSFIA------ECNTLKNIRHRNLVKILTACSGVDYQGNDFKA--LVFEFMQ 716
F+ I E L ++ ++++ D F +V E
Sbjct: 61 R-----MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL--LKFDELYIVLEIA- 112
Query: 717 NRSLEEWLHPI--TREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774
+ L + T TEE +++ L L +++H + I H DLKP
Sbjct: 113 ----DSDLKKLFKTPIFLTEEHIKTI-LYNLL-------LGENFIH---ESGIIHRDLKP 157
Query: 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG--------------------Y 814
+N LL+++ V DFGLAR + D + + Y
Sbjct: 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 815 IAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEG 854
APE L E SI D++S G + EL+ + +
Sbjct: 218 RAPELILLQENYTKSI--DIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 53/219 (24%), Positives = 81/219 (36%), Gaps = 43/219 (19%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN------LLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G F V K A K + + E N L+ IRH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ ++ L+ E + L ++L +E TE+ L Q L+
Sbjct: 72 TLHDI-----FENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQF-LKQILD---- 119
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ YLH I H DLKP N++L + DFG+A + +
Sbjct: 120 ---GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFK-N 170
Query: 808 AKGSIGYIAPE----YGLGSEVSINGDVYSYG----ILL 838
G+ ++APE LG E D++S G ILL
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILL 205
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 62/285 (21%), Positives = 102/285 (35%), Gaps = 52/285 (18%)
Query: 603 RKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVK 662
++ +++K S + + + D + + IG GS+G V + K VA+K
Sbjct: 25 QEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK 84
Query: 663 -VFNLLHHGAF-KSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSL 720
+ + K + E L + H ++VK+L D + D +V E
Sbjct: 85 KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA----- 139
Query: 721 EEWLHPI--TREDKTEEAPRSLNLLQRLNIGIDVACALSYLH-HDCQPPITHCDLKPSNV 777
+ + T TE ++L L L + Y+H I H DLKP+N
Sbjct: 140 DSDFKKLFRTPVYLTELHIKTL-LYNLL-------VGVKYVHSAG----ILHRDLKPANC 187
Query: 778 LLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG------------------------ 813
L++++ V DFGLAR + S +
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247
Query: 814 -YIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEG 854
Y APE L E +I DV+S G + EL+ K +
Sbjct: 248 WYRAPELILLQENYTEAI--DVWSIGCIFAELLNMIKENVAYHAD 290
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 51/235 (21%), Positives = 95/235 (40%), Gaps = 35/235 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKIL---- 694
+G G G V+ + + VA+K L + K + E ++ + H N+VK+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 695 ---TACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+ + + + +V E+M E L + + E L + Q L
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLL--- 130
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSDFGLARFLPLSPAQTSSIDA 808
L Y+H + H DLKP+N+ ++ E+++ + DFGLAR + P +
Sbjct: 131 ----RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHL 181
Query: 809 KGSIG---YIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
+ Y +P L + D+++ G + E++T K ++F G L
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELE 232
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 54/236 (22%), Positives = 89/236 (37%), Gaps = 41/236 (17%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G FG V Q + T A K + + E L+ + R +V
Sbjct: 192 LGKGGFGEVC---ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
L Y+ D LV M L+ ++ + + E R+ ++
Sbjct: 249 -LAYA----YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE--ARA-----VFYAA-EI 295
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKG 810
C L LH + I + DLKP N+LLD+ H+ SD GLA +P + G
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRV---G 347
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVT---------RKKPVDSMFEGDMN 857
++GY+APE + + D ++ G LL E++ +K + +
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 56/232 (24%), Positives = 86/232 (37%), Gaps = 58/232 (25%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA-ECNTLKNIRHRNLVKILTAC 697
+G G++G V + + VAVK+ ++ I E K + H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 698 SGVDYQGNDFKALVFEFMQNRS-----LE-----EWLHPITREDKTEEAPRSLNLLQRLN 747
+ + + LE E I + E P + +L
Sbjct: 71 --------------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQL- 114
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA----QT 803
+ YLH ITH D+KP N+LLDE +SDFGLA +
Sbjct: 115 -----MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 804 SSIDAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVD 849
G++ Y+APE + V DV+S GI+L ++ + P D
Sbjct: 167 MC----GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 53/215 (24%), Positives = 81/215 (37%), Gaps = 39/215 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN------LLHHGAFKSFIAECNTLKNIRHRNLV 691
E+G G F V K A K + + E + LK I+H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ Y+ L+ E + L ++L +E TEE L Q LN
Sbjct: 78 TLHEV-----YENKTDVILILELVAGGELFDFL--AEKESLTEEEATEF-LKQILN---- 125
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ YLH I H DLKP N++L + + DFGLA + +
Sbjct: 126 ---GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFK-N 176
Query: 808 AKGSIGYIAPE----YGLGSEVSINGDVYSYGILL 838
G+ ++APE LG E D++S G++
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 55/251 (21%), Positives = 94/251 (37%), Gaps = 44/251 (17%)
Query: 607 EKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTT---VAVKV 663
E + + + D F +G GSF +V L + T A+K+
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVV---LARELATSREYAIKI 62
Query: 664 FNLLHHGAFKSFI----------AECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFE 713
K I E + + + H VK+ +Q ++
Sbjct: 63 LE-------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLS 110
Query: 714 FMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH-HDCQPPITHCDL 772
+ +N E L I + +E + R ++ AL YLH I H DL
Sbjct: 111 YAKN---GELLKYIRKIGSFDE-TCT-----RFYTA-EIVSALEYLHGKG----IIHRDL 156
Query: 773 KPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVY 832
KP N+LL+E+M ++DFG A+ L Q + G+ Y++PE + D++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 833 SYGILLLELVT 843
+ G ++ +LV
Sbjct: 217 ALGCIIYQLVA 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 46/211 (21%), Positives = 75/211 (35%), Gaps = 29/211 (13%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHR-NLVKIL 694
E+G G F V + I A K + E L+ + ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
Y+ L+ E+ + P E +E L + Q L
Sbjct: 96 EV-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IKQILE------- 142
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
+ YLH Q I H DLKP N+LL + DFG++R + A + G+
Sbjct: 143 GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELR-EIMGT 196
Query: 812 IGYIAPEYGLGSEVSINGDVYSYG----ILL 838
Y+APE ++ D+++ G +LL
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLL 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 59/239 (24%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVK-VFNLLHHGAFKSFIAECNTLKNIR-------HRNL 690
+G G++G V+K I + VAVK +F+ AF++ T + I H N+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTDAQRTFREIMILTELSGHENI 71
Query: 691 VKILTACSGVDYQGNDFKA--LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
V +L + ++ + LVF++M E LH + R + E + + Q +
Sbjct: 72 VNLLNV-----LRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLI-- 119
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ YLH + H D+KPSN+LL+ E V+DFGL+R T++I
Sbjct: 120 -----KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 809 KGSIG-------------------YIAPEYGLGSE---VSINGDVYSYGILLLELVTRK 845
+ Y APE LGS I D++S G +L E++ K
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI--DMWSLGCILGEILCGK 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 41/222 (18%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
IG GSFG V + K A+K N + ++ E ++ + H LV +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK-TEEAPRSLNLLQRLNIGIDVAC 754
+ +Q + +V + + L H + + EE +L I ++
Sbjct: 83 S-----FQDEEDMFMVVDLLLGGDL--RYH-LQQNVHFKEET-------VKLFIC-ELVM 126
Query: 755 ALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLA-RFLPLSPAQTSSIDAKGSI 812
AL YL I H D+KP N+LLDE H++DF +A + T + G+
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA----GTK 178
Query: 813 GYIAPE-------YGLGSEVSINGDVYSYGILLLELVTRKKP 847
Y+APE G V D +S G+ EL+ ++P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 49/241 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF-KSFIAECNTLKNIRHR------NLV 691
IG GSFG V K + VA+K+ + + F + E L+++R + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKM--VRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+L ++ + + FE + + +L E + K + SL L+++
Sbjct: 163 HMLEN---FTFRNHIC--MTFELL-SMNLYELIK------KNKFQGFSLPLVRK--FAHS 208
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH--VSDFGLARFLPLSPAQTSSIDAK 809
+ L LH + I HCDLKP N+LL ++ + V DFG + + Q
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYT--- 258
Query: 810 GSIGYI------APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863
YI APE LG+ + D++S G +L EL+T + G+ A
Sbjct: 259 ----YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGDQLAC 310
Query: 864 M 864
M
Sbjct: 311 M 311
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/242 (23%), Positives = 84/242 (34%), Gaps = 61/242 (25%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA------ECNTLKNIRHRNLVK 692
IG G+FG K VAVK + E +++RH N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVR 80
Query: 693 ----ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
ILT A++ E+ L E I + E + Q+L
Sbjct: 81 FKEVILT---------PTHLAIIMEYASGGELYER---ICNAGRFSE-DEARFFFQQL-- 125
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH--VSDFGL-ARFLPLSPAQTSS 805
+SY H I H DLK N LLD + DFG + S +++
Sbjct: 126 ----LSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 806 IDAKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859
G+ YIAPE Y G DV+S G+ L ++ P FE
Sbjct: 179 ----GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP----FEDPEEPR 225
Query: 860 NF 861
++
Sbjct: 226 DY 227
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 10/142 (7%)
Query: 362 NIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWL 420
N+P + + + L N ++ P + YK L IDLS+N ++ + P F GL L
Sbjct: 29 NLPET-----ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 421 LIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
L L N++T +P + L +L++L + NK+ L L + N L
Sbjct: 83 NS-LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 480 QGPIPSSLSSLKGLNVLDLSQN 501
Q + S L+ + + L+QN
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 7/143 (4%)
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLTGSIPSEV-GNL 442
IP++L + T+T I L N + IPP F L +DLS NQ++ + + L
Sbjct: 25 EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRR-IDLSNNQIS-ELAPDAFQGL 79
Query: 443 KNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNN 502
++L L ++ NK+ S L+ L + N + + L LN+L L N
Sbjct: 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139
Query: 503 LSGKIPEFLVGFQLLENLNLSNN 525
L + ++ ++L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 31/131 (23%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNELV 89
+ L N+ P F ++L+ + L+NN I E+ + +L + L+ N++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 90 GKIPSEL-GSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLTDNNLDGGIPDTFGWL 147
++P L L ++ L ++ N + + + +L ++N L L DN L TF L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 148 KNLATLAMAEN 158
+ + T+ +A+N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 34/166 (20%), Positives = 66/166 (39%), Gaps = 32/166 (19%)
Query: 315 IPAAIGKFVNLQRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSIGNLKVF 373
IP + + + + N + IPP A + LR + L N+ + + P F
Sbjct: 26 IPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQ-ISELAP-----DAF 76
Query: 374 NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLT 432
++L + L N +T +P F GL L + L L+ N++
Sbjct: 77 Q-----------------GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQL-LLLNANKIN 117
Query: 433 GSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGN 477
+ + +L NL +L +++NKL+ T + ++ + + N
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 25/130 (19%), Positives = 54/130 (41%), Gaps = 3/130 (2%)
Query: 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162
+ + N + P + + + L++N + PD F L++L +L + N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 163 TIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNAS 221
+P S+F + S+ N++ + +D L NL S+++N+L S
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 222 NLELFQADVN 231
++ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 24/113 (21%), Positives = 47/113 (41%), Gaps = 5/113 (4%)
Query: 427 SRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSS 486
LT IP+ + + + + + +N +K P KKL ++++ N + P +
Sbjct: 19 RGKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75
Query: 487 LSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN 539
L+ LN L L N ++ G L+ L L+ N + + F++
Sbjct: 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC-LR-VDAFQD 126
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 46/217 (21%), Positives = 79/217 (36%), Gaps = 49/217 (22%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA---ECNTL-KNIRHRNLVK 692
+IGVGS+ + I AVK+ + KS E L + +H N++
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ Y + +V E M+ L + + + ++ +E + +
Sbjct: 81 LKDV-----YDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREAS--------AVLFTI 125
Query: 753 ACALSYLH-HDCQPPITHCDLKPSNVLL----DEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ YLH + H DLKPSN+L + DFG A+ L +
Sbjct: 126 TKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMT 179
Query: 808 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILL 838
+ ++APE Y D++S G+LL
Sbjct: 180 PCYTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-12
Identities = 90/540 (16%), Positives = 162/540 (30%), Gaps = 127/540 (23%)
Query: 30 LKVLLLYNNSFNH-GIPSEFDRLQRLQVLALNNNSIGGE----IPANISSCSNLIQIRLF 84
++ L + + LQ+ QV+ L++ + I + + L ++ L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 85 YNEL----VGKIPSELGSLS-KIEHLSVSVNNLT----GSIPSSLGNLSSINTLFLTDNN 135
NEL V + L + S KI+ LS+ LT G + S+L L ++ L L+DN
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 136 L-DGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGF 194
L D G L+ L + + L
Sbjct: 125 LGDAG-------LQLLCEGLLDPQ-------------CRLEKLQLEYCSLSAASCEPLAS 164
Query: 195 TL---QNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQ-RLSVFS 250
L + + +V N + A + L+ +L
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQG-------------------LKDSPCQLEALK 205
Query: 251 ITENSLGSRGHSNLNFLCS-LTNSTRLNRLLINANNFGG----LLPACISNLSTTLEMLL 305
+ + S LC + + L L + +N G L + + S+ L L
Sbjct: 206 LESCGVTSDN---CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 306 LDNNKI----FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLG 361
+ I G++ + +L+ L + N L + E +L+
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE------ 316
Query: 362 NIPPSIGNLKVFNLDLSCNFLQG----SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGL 417
+L + S L Q + L + +S+N L G+
Sbjct: 317 ------------SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------GV 358
Query: 418 SWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGE----IPSTLGSCKKLEQLE 473
L GL L VL + + + + +TL + L +L+
Sbjct: 359 RELCQGLGQ--------------PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404
Query: 474 MQGNFLQGPIPSSLS-SLK----GLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+ N L L S++ L L L S + L+ L +L
Sbjct: 405 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE------MEDRLQALEKDKPSLR 458
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 84/480 (17%), Positives = 149/480 (31%), Gaps = 95/480 (19%)
Query: 100 SKIEHLSVSVNNLT-GSIPSSLGNLSSINTLFLTDNNLD----GGIPDTFGWLKNLATLA 154
I+ L + L+ L L + L D L I LA L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 155 MAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIP 214
+ N L D G++ + + +Q L + LTGA
Sbjct: 63 LRSNELG----------------DVGVHCVLQGL-QTPSCKIQKLSLQN---CCLTGAGC 102
Query: 215 PAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCS--LTN 272
+S+ L L +++N LG G L LC L
Sbjct: 103 GVLSST-------------------LRTLPTLQELHLSDNLLGDAG---LQLLCEGLLDP 140
Query: 273 STRLNRLLINANNFGGLLPACISNL---STTLEMLLLDNNKIFGNIPAAIGKF-----VN 324
RL +L + + ++++ + L + NN I + +
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 325 LQRLEMWNNRLS----GTIPPAIGELQNLRELRLQRNKFLGNI-------PPSIGNLKVF 373
L+ L++ + ++ + + +LREL L NK LG++ + ++
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK-LGDVGMAELCPGLLHPSSRLR 259
Query: 374 NLDLSCNFLQ----GSIPSSLGQYKTLTIIDLSDNNLTGT----IPPQFLGLSWLLIGLD 425
L + + G + L ++L + L+ N L + L L L
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 426 LSRNQLTG----SIPSEVGNLKNLEVLDVFENKLKGEIPSTLG-----SCKKLEQLEMQG 476
+ T S + + L L + N+L+ L L L +
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379
Query: 477 NFLQ----GPIPSSLSSLKGLNVLDLSQNNLSGK-IPEFLVGFQ----LLENLNLSNNNL 527
+ + ++L + L LDLS N L I + + + LLE L L +
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-09
Identities = 50/269 (18%), Positives = 89/269 (33%), Gaps = 39/269 (14%)
Query: 297 LSTTLEMLLLDNNKI-FGNIPAAIGKFVNLQRLEMWNNRLSGT----IPPAIGELQNLRE 351
+S ++ L + ++ + Q + + + L+ I A+ L E
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 352 LRLQRNKFLGNI-------PPSIGNLKVFNLDLSCNFLQ----GSIPSSLGQYKTLTIID 400
L L+ N+ LG++ + K+ L L L G + S+L TL +
Sbjct: 61 LNLRSNE-LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 401 LSDNNLTGT----IPPQFLGLSWLLIGLDLSRNQLT----GSIPSEVGNLKNLEVLDVFE 452
LSDN L + L L L L L+ + S + + + L V
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 453 NKLKGE----IPSTLGSCK-KLEQLEMQGNFLQ----GPIPSSLSSLKGLNVLDLSQNNL 503
N + + L +LE L+++ + + ++S L L L N L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 504 SGK-----IPEFLVGFQLLENLNLSNNNL 527
P L L L + +
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 79/456 (17%), Positives = 145/456 (31%), Gaps = 95/456 (20%)
Query: 4 QRVKILNLTSLKL----AGSISPHVGNLSFLKVLLLYNNSFNH-GIPSEFDRLQ----RL 54
Q+ +++ L L IS + L L L +N G+ LQ ++
Sbjct: 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87
Query: 55 QVLALNNNSIGGE----IPANISSCSNLIQIRLFYNELVGKIPSELGSL-----SKIEHL 105
Q L+L N + G + + + + L ++ L N L L ++E L
Sbjct: 88 QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKL 147
Query: 106 SVSVNNLT----GSIPSSLGNLSSINTLFLTDNNL-DGGIPDTFGWLK----NLATLAMA 156
+ +L+ + S L L +++N++ + G+ LK L L +
Sbjct: 148 QLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 207
Query: 157 ENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPA 216
++ L G++ + +L+ ++ N+L
Sbjct: 208 SCGVT----------------SDNCRDLCGIVA-----SKASLRELALGSNKLGDVGMAE 246
Query: 217 ISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRL 276
+ L RL I E + ++G +L L L
Sbjct: 247 LCPG------------------LLHPSSRLRTLWIWECGITAKGCGDLCR--VLRAKESL 286
Query: 277 NRLLINANNFGG----LLPACISNLSTTLEMLLLDNNKI----FGNIPAAIGKFVNLQRL 328
L + N G LL + LE L + + + + + + L L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 329 EMWNNRLSGTIPPAIGEL-----QNLRELRLQRN-------KFLGNIPPSIGNLKVFNLD 376
++ NNRL + + LR L L L + +L+ LD
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR--ELD 404
Query: 377 LSCNFLQGS----IPSSLGQYK-TLTIIDLSDNNLT 407
LS N L + + S+ Q L + L D +
Sbjct: 405 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G+FG V IL + K T A+K+ ++ + E L+N RH L
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
L +Q +D V E+ L ++RE E R+ R ++
Sbjct: 213 -LKYS----FQTHDRLCFVMEYANGGEL---FFHLSRERVFSE-DRA-----RFYGA-EI 257
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL YLH + + + DLK N++LD++ ++DFGL + A + G+
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTP 313
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
Y+APE ++ D + G+++ E++ + P + +FE
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 55/282 (19%), Positives = 95/282 (33%), Gaps = 71/282 (25%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
IG G+F V + + K T A+K+ N +L G F E + L N R + +
Sbjct: 69 IGRGAFSEVA---VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID- 751
+ A +Q ++ LV E+ L L LL + I
Sbjct: 126 LHFA-----FQDENYLYLVMEYYVGGDL-------------------LTLLSKFGERIPA 161
Query: 752 ---------VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLA-RFLPLS 799
+ A+ +H + H D+KP N+LLD H+ +DFG +
Sbjct: 162 EMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG 216
Query: 800 PAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVY-------SYGILLLELVTRKKP----- 847
++ A G+ Y++PE Y + G+ E+ + P
Sbjct: 217 TVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 848 VDSMFEGDMNLHNFARM-----ALPDHVVDIVDSTLLSDDED 884
+ ++ + +P+ D + LL E
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLCPPET 315
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 44/214 (20%), Positives = 80/214 (37%), Gaps = 45/214 (21%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA--ECNTL-KNIRHRNLVKILT 695
+G+G G V + + A+K+ S A E + + ++V IL
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILD 89
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK---TE-EAPRSLNLLQRLNIGID 751
+ + ++ E M+ L I TE EA + D
Sbjct: 90 VYENMHHGKRCL-LIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMR---------D 136
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ A+ +LH I H D+KP N+L +++ + ++DFG A+ + QT
Sbjct: 137 IGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----P 189
Query: 809 KGSIGYIAPE----YGLGSEVSINGDVYSYGILL 838
+ Y+APE D++S G+++
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 639 IGVGSFGSVYKGILDQGKTTV---AVKVFN---LLHHGAFKSFIAECNTL---KNIRHRN 689
IG G FG VY + T A+K + + + E L
Sbjct: 197 IGRGGFGEVY---GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V ++ + D + + + M L + +++ E R
Sbjct: 254 IVC-MSYA----FHTPDKLSFILDLMNGGDL---HYHLSQHGVFSE-ADM-----RFYAA 299
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSID 807
++ L ++H + + DLKP+N+LLDE HV SD GLA S
Sbjct: 300 -EIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV-- 351
Query: 808 AKGSIGYIAPE---YGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ GY+APE G+ + S D +S G +L +L+ P
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 18/168 (10%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI-GELQNLRELR 353
S + E L L + + A L L + N+L T+ + +L L L
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 354 LQRNKFLGNIPPSI--GNLKVFNLDLSCNFLQGSIPS----SLGQYKTLTIIDLSDNNLT 407
L N+ L ++P + ++ L L N L+ S+PS L + L + L+ N L
Sbjct: 90 LANNQ-LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQ 144
Query: 408 GTIPP-QFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
+IP F L+ L L LS NQL S+P L L+ + +F N
Sbjct: 145 -SIPAGAFDKLTNLQT-LSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNELV 89
+ L L + + F L +L L L+ N + + A + + L + L N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 90 GKIPSEL-GSLSKIEHLSVSVNNLTGSIPS----SLGNLSSINTLFLTDNNLDGGIPD-T 143
+P + L++++ L + N L S+PS L L L L N L IP
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKL---KELRLNTNQL-QSIPAGA 150
Query: 144 FGWLKNLATLAMAENWLSGTIPSSIF-NISSIT 175
F L NL TL+++ N L ++P F + +
Sbjct: 151 FDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQ 182
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 10 NLTSLKLAG----SISPHV-GNLSFLKVLLLYNN---SFNHGIPSEFDRLQRLQVLALNN 61
LT L L ++S V +L+ L L L NN S G+ FD L +L L L
Sbjct: 60 KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGV---FDHLTQLDKLYLGG 116
Query: 62 NSIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIP-S 118
N + +P+ + + L ++RL N+L IP+ L+ ++ LS+S N L S+P
Sbjct: 117 NQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173
Query: 119 SLGNLSSINTLFLTDNNLD 137
+ L + T+ L N D
Sbjct: 174 AFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 8/156 (5%)
Query: 7 KILNLTSLKLAGSISPHV-GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
+ L+L S LA ++S L+ L L L N FD L L L L NN +
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96
Query: 66 GEIPANI-SSCSNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSL-GN 122
+P + + L ++ L N+L +PS + L+K++ L ++ N L SIP+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 123 LSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAEN 158
L+++ TL L+ N L F L L T+ + N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAI-GKFVNLQR 327
LT T LN N L A + + T L L L NN++ ++P + L +
Sbjct: 57 GLTKLTWLNL----DYNQLQTLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDK 111
Query: 328 LEMWNNRLSGTIPPAI-GELQNLRELRLQRNKFLGNIPP----SIGNLKVFNLDLSCNFL 382
L + N+L ++P + L L+ELRL N+ L +IP + NL+ L LS N L
Sbjct: 112 LYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ-LQSIPAGAFDKLTNLQT--LSLSTNQL 167
Query: 383 QGSIP-SSLGQYKTLTIIDLSDN 404
Q S+P + + L I L N
Sbjct: 168 Q-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 10/161 (6%)
Query: 115 SIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN-ISS 173
S+PS G + L L L TF L L L + N L T+ + +F+ ++
Sbjct: 28 SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 174 ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAI-SNASNLELFQADVNK 232
+ NQL + F L L + NQL ++P + + L+ + + N+
Sbjct: 85 LGTLGLANNQLASLPLGVFD-HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 233 LTGEVPY--LEKPQRLSVFSITENSLGSRGHSNLNFLCSLT 271
L +P +K L S++ N L S H + L L
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ 182
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 30/118 (25%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LDL L + L L L++ N+L+ +L L + N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 484 PSSLSSLKGLNVLDLSQNNLSGKIPE--F--LVGFQLLENLNLSNNNLEGMVPIEGVF 537
L L+ L L N L +P F L L+ L L+ N L+ +P G F
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQS-IP-AGAF 151
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 54/262 (20%)
Query: 602 VRKRKEKKNPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTT--- 658
+RK K N S N A D + IG G+FG V L + K+T
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAED-YEVVKVIGRGAFGEVQ---LVRHKSTRKV 96
Query: 659 VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715
A+K+ + ++ F E + + +V++ A +Q + + +V E+M
Sbjct: 97 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYM 151
Query: 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA--------CALSYLHHDCQPPI 767
L +NL+ ++ A AL +H
Sbjct: 152 PGGDL-------------------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGF 189
Query: 768 THCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIGYIAPE--YGLGS 823
H D+KP N+LLD+ H+ +DFG + A G+ YI+PE G
Sbjct: 190 IHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGG 246
Query: 824 EVSINGDV--YSYGILLLELVT 843
+ + +S G+ L E++
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLV 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 57/264 (21%), Positives = 96/264 (36%), Gaps = 65/264 (24%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVK 692
IG G+FG V + + K A+K+ N +L F E + L N + +
Sbjct: 82 IGRGAFGEVA---VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID- 751
+ A +Q ++ LV ++ L L LL + +
Sbjct: 139 LHYA-----FQDDNNLYLVMDYYVGGDL-------------------LTLLSKFEDRLPE 174
Query: 752 ---------VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLA-RFLPLS 799
+ A+ +H Q H D+KP N+L+D H+ +DFG + +
Sbjct: 175 EMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG 229
Query: 800 PAQTSSIDAKGSIGYIAPEYGLGSEVSING-----DVYSYGILLLELVTRKKP-----VD 849
Q+S A G+ YI+PE E D +S G+ + E++ + P +
Sbjct: 230 TVQSSV--AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 850 SMFEGDMNLHNFARMALPDHVVDI 873
+ MN R P V D+
Sbjct: 288 ETYGKIMNHKE--RFQFPTQVTDV 309
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 56/264 (21%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR------ 688
+G G+FG V + + +GK+ VA+K+ A E N LK I+ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKENKF 82
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
V + ++ G+ + FE + ++ E+L + P L ++ +
Sbjct: 83 LCVLMSDW---FNFHGHMC--IAFELL-GKNTFEFL------KENNFQPYPLPHVRH--M 128
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT----- 803
+ AL +LH + Q +TH DLKP N+L + + + S T
Sbjct: 129 AYQLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEK-SVKNTSIRVA 184
Query: 804 ---SSIDAKGSIGYI-------APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFE 853
S+ I PE L + DV+S G +L E ++F+
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF----TLFQ 240
Query: 854 GDMNLHNFARM-----ALPDHVVD 872
N + M +P H++
Sbjct: 241 THENREHLVMMEKILGPIPSHMIH 264
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 49/293 (16%), Positives = 92/293 (31%), Gaps = 53/293 (18%)
Query: 300 TLEMLLLDNNKI----FGNIPAAIGKFVNLQRLEMWNNRLSGT----IPPAIGELQNLRE 351
++E L + I ++ A + + +++ + + N + + I ++L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 352 LRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT--GT 409
G +K + + +L + L + LSDN
Sbjct: 65 AEFSDI--------FTGRVKDEIPEAL-----RLLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 410 IP-PQFLGLSWLLIGLDLSRNQLT-------------GSIPSEVGNLKNLEVLDVFENKL 455
P FL L L L N L ++ + N L + N+L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 456 KGE----IPSTLGSCKKLEQLEMQGNFL-----QGPIPSSLSSLKGLNVLDLSQNNLSGK 506
+ T S + L ++M N + + + L+ + L VLDL N +
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 507 ----IPEFLVGFQLLENLNLSNNNL--EGMVPIEGVFKNATITSVLGNLKLCG 553
+ L + L L L++ L G + F L L+L
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQY 283
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 48/348 (13%), Positives = 102/348 (29%), Gaps = 67/348 (19%)
Query: 246 LSVFSITE-----NSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNL--- 297
++ FSI +++ + ++ L + ++++ N G +S
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 298 STTLEMLLLDNNKI----------FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGEL- 346
LE+ + + A+ K L + + +N T + +
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 347 ---QNLRELRLQRNKF--------------LGNIPPSIGNLKVFNLDLSCNFLQG----S 385
L L L N L + + ++ N L+
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 386 IPSSLGQYKTLTIIDLSDNNLT----GTIPPQFLGLSWLLIGLDLSRNQLTG----SIPS 437
+ ++ L + + N + + + L L LDL N T ++
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238
Query: 438 EVGNLKNLEVLDVFENKLKGE----IPSTLGSC--KKLEQLEMQGNFLQGPIPSSLSS-- 489
+ + NL L + + L + L+ L +Q N ++ +L +
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298
Query: 490 ---LKGLNVLDLSQNNLS------GKIPEFLVGFQLLENLNLSNNNLE 528
+ L L+L+ N S +I E E L +
Sbjct: 299 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 41/251 (16%), Positives = 75/251 (29%), Gaps = 60/251 (23%)
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFG--------GLLP 291
L K +L +++N+ G L L+ T L L ++ N G L
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDF--LSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147
Query: 292 ACISNL----STTLEMLLLDNNKIFGNIPA-----AIGKFVNLQRLEMWNNRL-----SG 337
N + L ++ N++ N L ++M N +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 338 TIPPAIGELQNLRELRLQRNKF-------LGNIPPSIGNLKVFNLDLSCNFLQG----SI 386
+ + Q L+ L LQ N F L S NL+ L L+ L ++
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE--LGLNDCLLSARGAAAV 264
Query: 387 PSSLGQY--KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKN 444
+ + L + L N + + L + + +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEIELD------AVRTLKTVI--------------DEKMPD 304
Query: 445 LEVLDVFENKL 455
L L++ N+
Sbjct: 305 LLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 53/328 (16%), Positives = 101/328 (30%), Gaps = 53/328 (16%)
Query: 24 VGNLSFLKVLLLYNNSFNHGIPSEFDRLQR---LQVLALNNNSIGGE----IPANISSCS 76
+ S L + S F L ++ + L+ N+IG E + NI+S
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 77 NLIQIRL---FYNELVGKIPSELGSLSK-------IEHLSVSVNNLTG----SIPSSLGN 122
+L F + +IP L L + + + +S N + L
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 123 LSSINTLFLTDNNL-DGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181
+ + L+L +N L +A + N + + G
Sbjct: 121 HTPLEHLYLHNNGLGPQAG------------AKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 182 NQLQ--GVIPLDFGF-TLQNLQFFSVFENQLT-----GAIPPAISNASNLELFQADVNKL 233
N+L+ + F + + L + +N + + ++ L++ N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 234 TGE-----VPYLEKPQRLSVFSITENSLGSRGHSNL-NFLCSLTNSTRLNRLLINANNFG 287
T L+ L + + L +RG + + + L N L L + N
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIE 287
Query: 288 G----LLPACISNLSTTLEMLLLDNNKI 311
L I L L L+ N+
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 7e-11
Identities = 39/215 (18%), Positives = 70/215 (32%), Gaps = 43/215 (20%)
Query: 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKV--------FNLLHHGAFKSFIAECN 680
T+ +IG G FG V++ I D T VA+K+ N H F+ + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 681 TLKNI---------RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITRED 731
K + R + + + QG+ L+ + S + +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVH---CVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 732 KTEE-----------------APRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774
K ++ + +L +I + +L+ + H DL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 775 SNVLLDEEMMAHVSDFGLAR--FLPLSPAQTSSID 807
NVLL + + + + +P Q S ID
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 60/269 (22%), Positives = 94/269 (34%), Gaps = 62/269 (23%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR-----NL 690
+G G+FG V K AVKV A E + LK I++ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNNI 98
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
VK Y + L+FE + SL E + + + ++ I
Sbjct: 99 VKYHGK---FMYYDHMC--LIFEPL-GPSLYEII------TRNNYNGFHIEDIKL--YCI 144
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK- 809
++ AL+YL +TH DLKP N+LLD+ +
Sbjct: 145 EILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 810 -----GS--------IGYI------APE--YGLGSEVSINGDVYSYGILLLELVTRKKPV 848
G I APE LG +VS D++S+G +L EL T
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS--DMWSFGCVLAELYTG---- 255
Query: 849 DSMFEGDMNLHNFARM-----ALPDHVVD 872
+F ++ + A M +P +++
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 39/237 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR------N 689
IG GSFG V K + VA+K+ + A E L+ +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMKYY 117
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+V + ++ + LVFE + + +L + L T SLNL ++
Sbjct: 118 IVHLKRH---FMFRNHLC--LVFEML-SYNLYDLL------RNTNFRGVSLNLTRK--FA 163
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH--VSDFGLARFLPLSPAQTSSID 807
+ AL +L + I HCDLKP N+LL + + DFG + L I
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQ 220
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
S Y +PE LG + D++S G +L+E+ T + +F G + ++
Sbjct: 221 ---SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGANEVDQMNKI 270
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 98/604 (16%), Positives = 179/604 (29%), Gaps = 155/604 (25%)
Query: 438 EVG--NLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQ-------GNFLQGPIPSSLS 488
E G + ++L VFE+ CK ++ + + + S
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNF-----DCKDVQDMPKSILSKEEIDHIIMSKDAVS-G 63
Query: 489 SLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGN 548
+L+ L Q + + +F+ E L ++ L M PI+ + ++ + +
Sbjct: 64 TLRLFWTLLSKQEEM---VQKFVE-----EVLRINYKFL--MSPIKTEQRQPSMMTRMYI 113
Query: 549 L---KLCGGIPEFQLPTCISKESKHKKLTLAL-KLALA---IISGLTGL---SLALSFLI 598
+L F +S+ + KL AL +L A +I G+ G +AL
Sbjct: 114 EQRDRLYNDNQVFA-KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD--- 169
Query: 599 LCLVRKRKEKKN-------------PSSPINSFPNISYQ---NLYNATDGFAS----ANE 638
+CL K + K + P + + + YQ N + +D ++ +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 639 IGVGS----FGSVYKG---ILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV 691
I Y+ +L + A FNL C L R + +
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL-----------SCKILLTTRFKQVT 278
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSL-EEWLHPITREDKTEEA----PRSLNLLQRL 746
L+A + + + + +SL ++L +D E PR L++
Sbjct: 279 DFLSAATTTHISLDHHS-MTLTPDEVKSLLLKYLD-CRPQDLPREVLTTNPRRLSI---- 332
Query: 747 NIG---IDVACALSYLHHDCQPPITHCDLKPS-NVLLDEEMMAHVSDFGLARFLPLS--- 799
I D H +T ++ S NVL E + P S
Sbjct: 333 -IAESIRDGLATWDNWKHVNCDKLTTI-IESSLNVLEPAEYRKMFDRLSV---FPPSAHI 387
Query: 800 PAQTSSI----DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
P S+ K + + + S V + I + L + K E +
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL-----ENE 442
Query: 856 MNLH-------NFARMALPDHVVDIVDSTLLSDDED------LAVHGNQRQRQAR----- 897
LH N + D L+ D + H + R
Sbjct: 443 YALHRSIVDHYNIPKTFDSDD--------LIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 898 --------INSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN-ILLGHRIVSN 948
+ KI A + + N ++QL+ K I
Sbjct: 495 MVFLDFRFLEQKIR------HDSTAWNASGS-----ILNTLQQLKFYKPYICDNDPKYER 543
Query: 949 MQRD 952
+
Sbjct: 544 LVNA 547
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 95/626 (15%), Positives = 184/626 (29%), Gaps = 176/626 (28%)
Query: 34 LLYNNSFNH--GIPSEFDRLQRL-QVLALNNNSI-----GGEIPANISSCSNLIQ----- 80
+L +H RL L + + N + I+
Sbjct: 45 ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ 104
Query: 81 ---IRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLD 137
+ Y E ++ ++ +K +VS + +L L + + D
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAK---YNVSRLQPYLKLRQALLELRPAKNVLI-----D 156
Query: 138 G--GIPDTFGWLKN-LATLAMAENWLSGTIPSSIF--NISSITAFDAGMNQLQGVIPLDF 192
G G G K +A + + IF N+ + + + + LQ
Sbjct: 157 GVLG----SG--KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ------- 203
Query: 193 GFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY---------LEKP 243
L + T + + + QA++ +L PY ++
Sbjct: 204 -----KL--LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256
Query: 244 QRLSVFS------ITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNL 297
+ + F+ +T +R +FL + +T + L + + L P
Sbjct: 257 KAWNAFNLSCKILLT-----TRFKQVTDFL---SAATTTHISLDHHS--MTLTP------ 300
Query: 298 STTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRN 357
+LL + ++P + N +RL + I E +R+ L
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLT-TNPRRLSI------------IAES--IRD-GLATW 344
Query: 358 KFLGNIPPSIGNLKVFN--LDLSCNFLQGSIPSSLGQ-YKTLTIIDLSDNNLTGTIPPQF 414
++ N ++ S N L+ P+ + + L++ S + IP
Sbjct: 345 DNWKHV-----NCDKLTTIIESSLNVLE---PAEYRKMFDRLSVFPPSAH-----IPTIL 391
Query: 415 LGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL---KGEIPSTLG------- 464
L L W I S+V + V++ K ST+
Sbjct: 392 LSLIW------------FDVIKSDV-----MVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 465 -SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLV----------G 513
K + + + + + K + DL L +
Sbjct: 435 LKVKLENEYALHRSIVD-----HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 514 FQLLENLNLSNNNLEGMVPIEGVFKNAT--ITSVLGNLK-----LCGGIPEFQ------- 559
L + L LE + + NA+ I + L LK +C P+++
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL 549
Query: 560 --LPTCISK--ESKHKKLTLALKLAL 581
LP SK+ L L++AL
Sbjct: 550 DFLPKIEENLICSKYTDL---LRIAL 572
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 8/144 (5%)
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQ--FLGLSWLLIGLDLSRNQLTGSIPSEV-GN 441
IP + Q + L++N T + F L L ++ S N++T I
Sbjct: 25 KIPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLP-QLRKINFSNNKIT-DIEEGAFEG 79
Query: 442 LKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQN 501
+ + + N+L+ + L+ L ++ N + S L + +L L N
Sbjct: 80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139
Query: 502 NLSGKIPEFLVGFQLLENLNLSNN 525
++ P L LNL N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 36/131 (27%), Positives = 56/131 (42%), Gaps = 5/131 (3%)
Query: 31 KVLLLYNNSFNHGIPS-EFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNEL 88
L L NN F + F +L +L+ + +NN I +I S + +I L N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRL 93
Query: 89 VGKIPSELGSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLTDNNLDGGIPDTFGWL 147
L ++ L + N +T + + S LSS+ L L DN + P F L
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152
Query: 148 KNLATLAMAEN 158
+L+TL + N
Sbjct: 153 HSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 22/115 (19%), Positives = 46/115 (40%), Gaps = 6/115 (5%)
Query: 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLF 84
L L+ + NN F+ + + L +N + + + +L + L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113
Query: 85 YNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIP-SSLGNLSSINTLFLTDNNLD 137
N + + ++ LS + LS+ N +T ++ + L S++TL L N +
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 29/139 (20%), Positives = 55/139 (39%), Gaps = 23/139 (16%)
Query: 278 RLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKF---VNLQRLEMWNNR 334
L +N N F L I L + NNKI +I G F + + + +NR
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEE--GAFEGASGVNEILLTSNR 92
Query: 335 LSGTIPPAI-GELQNLRELRLQRNKFLGNIPPSI----GNLKVFNLDLSCNFLQGSIP-- 387
L + + L++L+ L L+ N+ + + +++ L L N + ++
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFIGLSSVR--LLSLYDNQIT-TVAPG 147
Query: 388 --SSLGQYKTLTIIDLSDN 404
+L L+ ++L N
Sbjct: 148 AFDTLHS---LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 18/114 (15%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 105 LSVSVNNLTGSIPSS--LGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162
L ++ N T + ++ L + + ++N + F + + + N L
Sbjct: 37 LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94
Query: 163 TIPSSIF-NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP 215
+ +F + S+ N++ + D L +++ S+++NQ+T + P
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 44/217 (20%), Positives = 75/217 (34%), Gaps = 48/217 (22%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIA--ECNTLKNI-RHRNLVKIL 694
+G+G G V + + + A+K+ A E + ++V+I+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIV 121
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK---TE-EAPRSLNLLQRLNIGI 750
Y G +V E + L I TE EA +
Sbjct: 122 DVYEN-LYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK--------- 168
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ A+ YLH I H D+KP N+L + ++DFG A+ + T
Sbjct: 169 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---T 222
Query: 808 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILL 838
+ Y+APE Y D++S G+++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDK--SC----DMWSLGVIM 253
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-10
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVF---NLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+G G+FG V IL + K T A+K+ ++ + E L+N RH L
Sbjct: 13 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
L +Q +D V E+ L ++RE E R+ R ++
Sbjct: 70 -LKYA----FQTHDRLCFVMEYANGGEL---FFHLSRERVFTE-ERA-----RFYGA-EI 114
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKG 810
AL YLH + + D+K N++LD++ H+ +DFGL + A + G
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTF--CG 167
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
+ Y+APE ++ D + G+++ E++ + P + +FE
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 52/265 (19%), Positives = 100/265 (37%), Gaps = 58/265 (21%)
Query: 639 IGVGSFGSVYKGI-LDQGKTTVAVKVF---NLLHHGAFKSFIAECNTLKNIRHR------ 688
+G G+FG V + I G VAVK+ + A E L+++
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNSTF 77
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
V++L ++ G+ +VFE + S +++ + P L+ +++ +
Sbjct: 78 RCVQMLEW---FEHHGHIC--IVFELL-GLSTYDFI------KENGFLPFRLDHIRK--M 123
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT----- 803
+ ++++LH + +TH DLKP N+L + + + R
Sbjct: 124 AYQICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 804 ---SSIDAKGSIGYI------APE--YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF 852
++ D + + APE LG DV+S G +L+E ++F
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLGF----TVF 234
Query: 853 EGDMNLHNFARM-----ALPDHVVD 872
+ + A M LP H++
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQ 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 53/234 (22%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFNLLHHGAFKSFI----------AECNTLKNI 685
+G GSFG V L + K + A+K+ + K + E L+ +
Sbjct: 49 LGTGSFGRVM---LVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAV 98
Query: 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
LVK+ + ++ N +V E++ + + H + R + E P + R
Sbjct: 99 NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSH-LRRIGRFSE-PHA-----R 144
Query: 746 LNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
+ YLH D + + DLKP N+L+D++ V+DFG A+ + +T
Sbjct: 145 FYAA-QIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTW 196
Query: 805 SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
++ G+ +APE L + D ++ G+L+ E+ P ++E
Sbjct: 197 TL--CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 36/123 (29%), Positives = 55/123 (44%), Gaps = 26/123 (21%)
Query: 752 VACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLA-RFLPLSPAQTSSID 807
+ AL +LH I + D+K N+LLD HV +DFGL+ F+ +
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDF- 220
Query: 808 AKGSIGYIAPE------YGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
G+I Y+AP+ G V D +S G+L+ EL+T P F D ++
Sbjct: 221 -CGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVDGEKNSQ 271
Query: 862 ARM 864
A +
Sbjct: 272 AEI 274
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 29/166 (17%)
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI-GELQN 348
+ + + T ++L L +N+I P +NL+ L + +N+L +P + L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 349 LRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTG 408
L L L N+ L +P VF+ L L + + N LT
Sbjct: 90 LTVLDLGTNQ-LTVLPS-----AVFD--------------RLVH---LKELFMCCNKLT- 125
Query: 409 TIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
+P L+ L L L +NQL SIP L +L +F N
Sbjct: 126 ELPRGIERLT-HLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNELV 89
++L L++N P FD L L+ L L +N + G +P + S + L + L N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 90 GKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLK 148
+PS + L ++ L + N LT +P + L+ + L L N L F L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 149 NLATLAMAEN-W 159
+L + N W
Sbjct: 160 SLTHAYLFGNPW 171
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 42/148 (28%), Positives = 59/148 (39%), Gaps = 7/148 (4%)
Query: 356 RNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-F 414
R+K ++P I L L N + P L + L N L +P F
Sbjct: 27 RSKRHASVPAGIPT-NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVF 84
Query: 415 LGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLE 473
L+ L + LDL NQLT +PS V L +L+ L + NKL E+P + L L
Sbjct: 85 DSLTQLTV-LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 474 MQGNFLQGPIPSSLSSLKGLNVLDLSQN 501
+ N L+ + L L L N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 61/296 (20%), Positives = 100/296 (33%), Gaps = 86/296 (29%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-----HRNLVKI 693
+G G F +V+ QGK VA+KV H ++ + E LK++R N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 694 LTACSGVDYQGNDFK--ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ G + +VFE + L +W+ K+ L +++ I
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLG-HHLLKWII------KSNYQGLPLPCVKK--IIQQ 154
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLL-------------------------------- 779
V L YLH C+ I H D+KP N+LL
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 780 -----------------DEEMMAHVSDFGLARFL---PLSPAQTSSIDAKGSIGYIAPEY 819
E++ ++D G A ++ QT Y + E
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ--------YRSLEV 264
Query: 820 GLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVD 875
+GS + D++S + EL T D +FE DH+ I++
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATG----DYLFEPHSGEEYTRDE---DHIALIIE 313
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVF---NLLHHGAFKSFIAECNTLKNI-RHRNLV 691
+G GSFG V L + K T AVK+ ++ + + E L + L
Sbjct: 349 LGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ L +C +Q D V E++ L + + + +E P + +
Sbjct: 406 Q-LHSC----FQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKE-PHA-----VFYAA-E 450
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
+A L +L I + DLK NV+LD E H+ +DFG+ + T +
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF--C 503
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ YIAPE + D +++G+LL E++ + P FEG+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 51/234 (21%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFNLLHHGAFKSFI-----------AECNTLKN 684
+G G +G V++ G T A+KV K+ I AE N L+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEE 77
Query: 685 IRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
++H +V L +Q L+ E++ L ++ + RE E +
Sbjct: 78 VKHPFIVD-LIYA----FQTGGKLYLILEYLSGGEL--FMQ-LEREGIFME-DTA----- 123
Query: 745 RLNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPA 801
+ +++ AL +LH I + DLKP N++L+ + HV +DFGL +
Sbjct: 124 CFYLA-EISMALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGT 176
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
T + G+I Y+APE + S + D +S G L+ +++T P F G+
Sbjct: 177 VTHTF--CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 5e-09
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 50/235 (21%)
Query: 639 IGVGSFGSVYKGILDQGKTTV---AVKVFNLLHHGAFKSFI---------AECNTLKNIR 686
+G GSFG V+ G A+KV K+ + E + L +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEVN 84
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746
H +VK L +Q L+ +F++ L + +++E E +
Sbjct: 85 HPFIVK-LHYA----FQTEGKLYLILDFLRGGDL--FTR-LSKEVMFTE-EDV-----KF 130
Query: 747 NIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQT 803
+ ++A AL +LH I + DLKP N+LLDEE H+ +DFGL++ +
Sbjct: 131 YLA-ELALALDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKA 183
Query: 804 SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
S G++ Y+APE + + D +S+G+L+ E++T P
Sbjct: 184 YSF--CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 250 SITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNN 309
+ +L + ++ L + ++ N+ + I L + L L N
Sbjct: 20 ETIKANLKKKSVTDAVTQNELNSIDQII----ANNSDIKSVQG-IQYL-PNVRYLALGGN 73
Query: 310 KIFGNIPAAIGKF---VNLQRLEMWNNRLSGTIPPAI-GELQNLRELRLQRNKFLGNIPP 365
K+ I NL L + N+L ++P + +L NL+EL L N+ L ++P
Sbjct: 74 KL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ-LQSLPD 126
Query: 366 SI----GNLKVFNLDLSCNFLQGSIPS----SLGQYKTLTIIDLSDNNLTGTIPP-QFLG 416
+ NL L+L+ N LQ S+P L LT +DLS N L ++P F
Sbjct: 127 GVFDKLTNLT--YLNLAHNQLQ-SLPKGVFDKLTN---LTELDLSYNQLQ-SLPEGVFDK 179
Query: 417 LSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
L+ L L L +NQL S+P V L +L+ + + +N
Sbjct: 180 LT-QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 14/140 (10%)
Query: 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLF 84
L+ L L+L N FD+L L+ L L N + +P + +NL + L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLA 141
Query: 85 YNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPS----SLGNLSSINTLFLTDNNLDGG 139
+N+L +P + L+ + L +S N L S+P L L L L N L
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQL---KDLRLYQNQLK-S 195
Query: 140 IPD-TFGWLKNLATLAMAEN 158
+PD F L +L + + +N
Sbjct: 196 VPDGVFDRLTSLQYIWLHDN 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 31/174 (17%), Positives = 59/174 (33%), Gaps = 32/174 (18%)
Query: 639 IGVGSFGSVYKGILDQG-----KTTVAVKV-----------FNLLHHGAFKSFIAECNTL 682
IG G FG +Y ++ VKV A I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 683 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
+ +++ + K D G ++ ++ + L++ E + +
Sbjct: 103 RKLKYLGVPKYW-GSGLHDKNGKSYRFMIMD-RFGSDLQKIY---------EANAKRFSR 151
Query: 743 LQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--EEMMAHVSDFGLAR 794
L + + + L Y+H H D+K SN+LL+ ++ D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVF---NLLHHGAFKSFIAECNTL-KNIRHRNLV 691
+G GSFG V+ L + K T A+K +L + + E L H L
Sbjct: 25 LGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ +Q + V E++ L + K + R+ +
Sbjct: 82 H-MFCT----FQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDL-SRA-----TFYAA-E 126
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
+ L +LH I + DLK N+LLD++ H+ +DFG+ + L A+T++
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTF--C 179
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
G+ YIAPE LG + + + D +S+G+LL E++ + P + +F
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 31/172 (18%), Positives = 57/172 (33%), Gaps = 31/172 (18%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKV--------------FNLLHHGAFKSFIAECNTLKN 684
IG G FG +Y A V A K I + K
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 685 IRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
+ + + +++G ++ +V E L++ +
Sbjct: 105 LDYLGIPLFY-GSGLTEFKGRSYRFMVME-RLGIDLQKIS----------GQNGTFKKST 152
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--EEMMAHVSDFGLAR 794
L +GI + L Y+H + H D+K +N+LL +++D+GL+
Sbjct: 153 VLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 54/240 (22%), Positives = 97/240 (40%), Gaps = 65/240 (27%)
Query: 639 IGVGSFGSVYKGILDQGKTT---VAVKVFNLLHHGAFKSFI----------AECNTLKNI 685
+G GSFG V+ L + + A+KV K + E L +
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLK-------KEIVVRLKQVEHTNDERLMLSIV 63
Query: 686 RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR 745
H ++++ +Q ++ ++++ L + + + + P + +
Sbjct: 64 THPFIIRMWGT-----FQDAQQIFMIMDYIEGGEL--FSL-LRKSQRFPN-PVA-----K 109
Query: 746 LNIGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQ 802
+V AL YLH D I + DLKP N+LLD+ H+ +DFG A+++ P
Sbjct: 110 FYAA-EVCLALEYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYV---PDV 159
Query: 803 TSSIDAKGSIGYIAPE----YGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
T ++ G+ YIAPE + D +S+GIL+ E++ P +E
Sbjct: 160 TYTL--CGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTPFYDSNTMKTYE 213
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 36/170 (21%)
Query: 290 LPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI-GELQN 348
+ + + L L+ N + + +L +L + N+L ++P + +L +
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 349 LRELRLQRNKFLGNIPP----SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDN 404
L L L N+ L ++P + LK L L+ N LQ S+P G + LT
Sbjct: 78 LTYLNLSTNQ-LQSLPNGVFDKLTQLK--ELALNTNQLQ-SLPD--GVFDKLT------- 124
Query: 405 NLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
L L L +NQL S+P V L +L+ + + +N
Sbjct: 125 QLK---------------DLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNELV 89
L L NS FD L L L L N + +P + + ++L + L N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 90 GKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSL-GNLSSINTLFLTDNNLDGGIPD-TFGW 146
+P+ + L++++ L+++ N L S+P + L+ + L L N L +PD F
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146
Query: 147 LKNLATLAMAEN-W 159
L +L + + +N W
Sbjct: 147 LTSLQYIWLHDNPW 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 25/176 (14%), Positives = 56/176 (31%), Gaps = 36/176 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTT--------VAVKV----------FNLLHHGAFKSFIAECN 680
+ G +Y+ T ++K+ N A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 681 TLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSL 740
L + + + GV + ++ LV RSL+ L + L
Sbjct: 110 KLYSTPLLAIPTCM--GFGV--HQDKYRFLVLP-SLGRSLQSALDVSPK--------HVL 156
Query: 741 NLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL--DEEMMAHVSDFGLAR 794
+ L + + AL +LH + H ++ N+ + +++ ++ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 37/190 (19%), Positives = 60/190 (31%), Gaps = 38/190 (20%)
Query: 366 SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL--LIG 423
+ L ++ + ++L K + LS NN+ + LS + L
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRI 74
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
L L RN + I + LE L + N++ L
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-----------SLS------------- 109
Query: 484 PSSLSSLKGLNVLDLSQNNLSG-KIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKN--A 540
+ L L VL +S N ++ + L LE+L L+ N L
Sbjct: 110 --GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167
Query: 541 TITSVLGNLK 550
+ L NLK
Sbjct: 168 EVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 42/191 (21%), Positives = 68/191 (35%), Gaps = 45/191 (23%)
Query: 321 KFVNLQRLEMWN--NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLS 378
+++E+ + + + L+ + L L N I +L
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSL-------- 66
Query: 379 CNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSE 438
S + + L I+ L N + I ++ L L +S NQ+ S+ S
Sbjct: 67 ---------SGM---ENLRILSLGRNLIK-KIEN-LDAVADTLEELWISYNQIA-SL-SG 110
Query: 439 VGNLKNLEVLDVFENKLK--GEIPSTLGSCKKLEQLEMQGNFLQGPIPSS---------- 486
+ L NL VL + NK+ GEI L + KLE L + GN L +
Sbjct: 111 IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
Query: 487 LSSLKGLNVLD 497
+ L L LD
Sbjct: 170 VKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 31/131 (23%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 30 LKVLLLYNNSFN-HGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNEL 88
+ + L+ + + L+ + LAL+ N+I +I +++S NL + L N +
Sbjct: 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLI 82
Query: 89 VGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNL-DGGIPDTFGWL 147
KI + +E L +S N + S+ S + L ++ L++++N + + G D L
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 148 KNLATLAMAEN 158
L L +A N
Sbjct: 140 DKLEDLLLAGN 150
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 41/170 (24%), Positives = 62/170 (36%), Gaps = 44/170 (25%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV------K 692
IG GSFG +Y G VA+K+ EC +H L K
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--------------EC---VKTKHPQLHIESKIYK 59
Query: 693 ILTACSG---VDYQG--NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
++ G + + G D+ +V E + SL ED R +L L
Sbjct: 60 MMQGGVGIPTIRWCGAEGDYNVMVME-LLGPSL---------EDLFNFCSRKFSLKTVLL 109
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH---VSDFGLAR 794
+ + + Y+H H D+KP N L+ + + DFGLA+
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
+A L +L I + DLK NV+LD E H+ +DFG+ + T +
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF--C 182
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
G+ YIAPE + D +++G+LL E++ + P FEG+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
++ AL+YLH + I + DLK NVLLD E H+ +D+G+ + TS+
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF--C 171
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ YIAPE G + + D ++ G+L+ E++ + P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 16/110 (14%)
Query: 752 VACALSYLH-HDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDA 808
+A AL YLH + I + DLKP N+LLD + H+ +DFGL + + TS+
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTF-- 199
Query: 809 KGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
G+ Y+APE D + G +L E++ P M++
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 7/110 (6%)
Query: 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNELV 89
L L N F +P E + L ++ L+NN I + S+ + L+ + L YN L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL- 90
Query: 90 GKIPSEL-GSLSKIEHLSVSVNNLTGSIP-SSLGNLSSINTLFLTDNNLD 137
IP L + LS+ N+++ +P + +LS+++ L + N L
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 41/125 (32%), Positives = 57/125 (45%), Gaps = 9/125 (7%)
Query: 356 RNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-F 414
NK L +P I V L L N +P L YK LT+IDLS+N ++ T+ Q F
Sbjct: 18 SNKGLKVLPKGIPR-DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSF 74
Query: 415 LGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKLKGEIP-STLGSCKKLEQL 472
++ LL L LS N+L IP LK+L +L + N + +P L L
Sbjct: 75 SNMTQLLT-LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131
Query: 473 EMQGN 477
+ N
Sbjct: 132 AIGAN 136
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
++ AL+YLH + I + DLK NVLLD E H+ +D+G+ + TS+
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF--C 214
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
G+ YIAPE G + + D ++ G+L+ E++ + P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 14/109 (12%)
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAK 809
+ AL +LH I + DLK NVLLD E H +DFG+ + + T++
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATF--C 185
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFE 853
G+ YIAPE D ++ G+LL E++ P D +FE
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 40/166 (24%), Positives = 63/166 (37%), Gaps = 34/166 (20%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACS 698
IG G+FG + G VA+K + + L K L +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK---------LEPMKSRAPQLH--LEYRFYKQLGSGD 65
Query: 699 G---VDYQG--NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
G V Y G + A+V E + SL ED + R+ +L L I I +
Sbjct: 66 GIPQVYYFGPCGKYNAMVLE-LLGPSL---------EDLFDLCDRTFSLKTVLMIAIQLI 115
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLL-----DEEMMAHVSDFGLAR 794
+ Y+H + + D+KP N L+ + + H+ DF LA+
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 45/329 (13%), Positives = 105/329 (31%), Gaps = 62/329 (18%)
Query: 240 LEKPQRLSVFSITENSLGSRGHSNLNFLCS--LTNSTRLNRLLINANNFG----GLLPAC 293
P ++ ++ N+L S L + L ++ N+ G L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSIS---TVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI 74
Query: 294 ISNLSTTLEMLLLDNNKIFGNIPAAIGKFV-----NLQRLEMWNNRLSGTIPPAIGEL-- 346
++ + + L L N + + K + + L++ N S +
Sbjct: 75 LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134
Query: 347 ---QNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403
++ L L+ N +G S + L + + + ++L
Sbjct: 135 NLPASITSLNLRGND--------LG-------IKSSDELIQILAA---IPANVNSLNLRG 176
Query: 404 NNLTGT----IPPQFLGLSWLLIGLDLSRNQLTGSIPSEVG-----NLKNLEVLDVFENK 454
NNL + + + LDLS N L +E+ ++ L++ N
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236
Query: 455 LKGE----IPSTLGSCKKLEQLEMQGNFLQGP-------IPSSLSSLKGLNVLDLSQNNL 503
L G + S K L+ + + + ++ + ++ +++ + ++D + +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 504 SG----KIPEFLVGFQL-LENLNLSNNNL 527
I + + +L N L
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCL 325
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 20/103 (19%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LDL ++ I + L + +D +N+++ ++ ++L+ L + N +
Sbjct: 24 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIG 80
Query: 484 PSSLSSLKGLNVLDLSQNNLSG-KIPEFLVGFQLLENLNLSNN 525
+L L L L+ N+L + L + L L + N
Sbjct: 81 EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 17/105 (16%), Positives = 40/105 (38%), Gaps = 5/105 (4%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
+ L+ + + ++ N LD+ K+ I + + + + ++ N ++ +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 484 PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
L+ L L ++ N + L L L+NN+L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 4/114 (3%)
Query: 46 SEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105
+++ R + L L I I ++ I NE+ K+ L +++ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG-GIPDTFGWLKNLATLAMAEN 158
V+ N + L + L LT+N+L G D LK+L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 28/103 (27%), Positives = 43/103 (41%), Gaps = 4/103 (3%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LD SR+ G + + LE L L I + L KL++LE+ N + G +
Sbjct: 24 LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80
Query: 484 PSSLSSLKGLNVLDLSQNNLSG-KIPEFLVGFQLLENLNLSNN 525
L L+LS N + E L + L++L+L N
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 20/139 (14%)
Query: 369 NLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL--LIGLDL 426
++K LD +G + +++ L + + LT +I L L L L+L
Sbjct: 18 DVKELVLDN-SRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA----NLPKLNKLKKLEL 71
Query: 427 SRNQLTGSIPSEVGNLKNLEVLDVFENKLKG-EIPSTLGSCKKLEQLEMQGNFLQGPI-- 483
S N+++G + NL L++ NK+K L + L+ L++ +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EVTN 127
Query: 484 -----PSSLSSLKGLNVLD 497
+ L L LD
Sbjct: 128 LNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 441 NLKNLEVLDVFENKLK-GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLS 499
+++ L + ++ G++ ++LE L L ++L L L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 500 QNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
N +SG + L +LNLS N ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 26 NLSFLKVLLLYNNSFNHG-IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84
S +K L+L N+ N G + D + L+ L+ N + AN+ + L ++ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72
Query: 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDN 134
N + G + + HL++S N + S L L ++ +L L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 22/111 (19%), Positives = 45/111 (40%), Gaps = 4/111 (3%)
Query: 50 RLQRLQVLALNNNSIG-GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108
++ L L+N+ G++ L + L I + L L+K++ L +S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 109 VNNLTGSIPSSLGNLSSINTLFLTDNNL-DGGIPDTFGWLKNLATLAMAEN 158
N ++G + ++ L L+ N + D + L+NL +L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 33/164 (20%), Positives = 55/164 (33%), Gaps = 29/164 (17%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTA 696
+G+G G V + + + A+K+ E + ++V+I+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK---TEEAPRSLNLLQRLNIGIDVA 753
Y G +V E + L I TE I +
Sbjct: 80 YEN-LYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREAS--------EIMKSIG 127
Query: 754 CALSYLH-HDCQPPITHCDLKPSNVLL---DEEMMAHVSDFGLA 793
A+ YLH + I H D+KP N+L + ++DFG A
Sbjct: 128 EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 9e-07
Identities = 23/104 (22%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 332 NNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPP-SIGNL-KVFNLDLSCNFLQGSIPSS 389
+ + +NL EL ++ + L ++ + L ++ NL + + L+ +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 390 LGQY-KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT 432
+ L+ ++LS N L GLS L L LS N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS--LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 19/119 (15%), Positives = 37/119 (31%), Gaps = 12/119 (10%)
Query: 268 CSLTNSTR-LNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPA-AIGKFVNL 325
++ R ++ + L L ++N + ++ + L
Sbjct: 7 PHGSSGLRCTRDGALD-------SLHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGEL 58
Query: 326 QRLEMWNNRLSGTIPP-AIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQ 383
+ L + + L + P A L L L N ++ L + L LS N L
Sbjct: 59 RNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 20/108 (18%), Positives = 36/108 (33%), Gaps = 4/108 (3%)
Query: 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFENKL 455
+ + + + G L L + Q + L L L + ++ L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
+ P +L +L + N L+ ++ L L L LS N L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 17/107 (15%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 55 QVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSE-LGSLSKIEHLSVSVNNLT 113
+ + ++ + ++ NL ++ + + + + L L ++ +L++ + L
Sbjct: 12 GLRCTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 114 GSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWL 160
P + ++ L L+ N L+ T L +L L ++ N L
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 17/89 (19%), Positives = 32/89 (35%), Gaps = 3/89 (3%)
Query: 458 EIPSTLGSCKKLEQLEMQGNFLQGPIPS-SLSSLKGLNVLDLSQNNLSGKIPEFLVGFQL 516
+ L + L +L ++ + L L L L + ++ L P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 517 LENLNLSNNNLEGMVPIEGVFKNATITSV 545
L LNLS N LE + + ++ +
Sbjct: 82 LSRLNLSFNALESLSW--KTVQGLSLQEL 108
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 36/172 (20%), Positives = 59/172 (34%), Gaps = 46/172 (26%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV------K 692
IG GSFG +++G VA+K E + L K
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--------------EP---RRSDAPQLRDEYRTYK 60
Query: 693 ILTACSG---VDYQG--NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
+L C+G V Y G LV + + SLE+ L + R ++
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVID-LLGPSLEDLL---------DLCGRKFSVKTVAM 110
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA-----HVSDFGLAR 794
+ + +H + + D+KP N L+ +V DFG+ +
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 30/103 (29%), Positives = 44/103 (42%), Gaps = 4/103 (3%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
LD ++ G I NLE L + L + S L KL++LE+ N + G +
Sbjct: 31 LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87
Query: 484 PSSLSSLKGLNVLDLSQNNLSG-KIPEFLVGFQLLENLNLSNN 525
L L L+LS N L E L + L++L+L N
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 35/158 (22%), Positives = 61/158 (38%), Gaps = 24/158 (15%)
Query: 351 ELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTI 410
+++ + + L N P+ ++ LD C G I ++ L + L + L ++
Sbjct: 9 DMKRRIHLELRNRTPA--AVRELVLDN-CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV 64
Query: 411 PPQFLGLSWL--LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLK--GEIPSTLGSC 466
L L L L+LS N++ G + L NL L++ NKLK + L
Sbjct: 65 S----NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKL 119
Query: 467 KKLEQLEMQGNFLQGPI-------PSSLSSLKGLNVLD 497
+ L+ L++ + S L L LD
Sbjct: 120 ECLKSLDLFNC----EVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 10/109 (9%)
Query: 423 GLDLSRN---QLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFL 479
G+D+ R +L P+ V L VLD ++ G+I LE L + L
Sbjct: 7 GMDMKRRIHLELRNRTPAAVREL----VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGL 61
Query: 480 QGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
S+L L L L+LS+N + G + L +LNLS N L+
Sbjct: 62 I--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 4/111 (3%)
Query: 26 NLSFLKVLLLYNNSFNHG-IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84
+ ++ L+L N N G I L+ L+L N + +N+ L ++ L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79
Query: 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDN 134
N + G + L + HL++S N L S L L + +L L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 9/113 (7%)
Query: 300 TLEMLLLDNNKI-FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNK 358
+ L+LDN K G I +FVNL+ L + N L ++ + +L L++L L N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 359 ---FLGNIPPSIGNLKVFNLDLSCNFLQG-SIPSSLGQYKTLTIIDLSDNNLT 407
L + + NL L+LS N L+ S L + + L +DL + +T
Sbjct: 83 IFGGLDMLAEKLPNLTH--LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 25/111 (22%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 50 RLQRLQVLALNNNSIG-GEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108
++ L L+N G+I + NL + L L+ + + L L K++ L +S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 109 VNNLTGSIPSSLGNLSSINTLFLTDNNL-DGGIPDTFGWLKNLATLAMAEN 158
N + G + L ++ L L+ N L D + L+ L +L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 50/315 (15%), Positives = 100/315 (31%), Gaps = 23/315 (7%)
Query: 244 QRLSVFSITENSLGSRGH--SNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS--- 298
+++ + + S + + + L + + +GG + I +S
Sbjct: 46 RKVFIGNCYAVSPATVIRRFPKVRSV-ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSY 104
Query: 299 TTLEMLLLDNNKIFGNIPAAIGK-FVNLQRLEMWN-NRLSGTIPPAIGE-LQNLRELRLQ 355
T LE + L + + I K F N + L + + S AI +NL+EL L+
Sbjct: 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLR 164
Query: 356 RNKF-------LGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQY-KTLTIIDLSDNNLT 407
+ L + P + +L N+ + + S L L + L+
Sbjct: 165 ESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPL 224
Query: 408 GTIPPQFLGLSWLL-IGL----DLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPST 462
+ L +G R + + + K L L F + + +P+
Sbjct: 225 EKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAV 284
Query: 463 LGSCKKLEQLEMQGNFLQGP-IPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLN 521
C +L L + +Q + L L L + + + L L
Sbjct: 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELR 344
Query: 522 LSNNNLEGMVPIEGV 536
+ + M P +
Sbjct: 345 VFPSEPFVMEPNVAL 359
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 44/170 (25%), Positives = 66/170 (38%), Gaps = 44/170 (25%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLV------K 692
IG GSFG +Y G Q VA+K+ E +H L+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--------------EN---VKTKHPQLLYESKIYR 57
Query: 693 ILTACSG---VDYQG--NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
IL +G V + G D+ LV + + SL ED R L+L L
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMD-LLGPSL---------EDLFNFCSRKLSLKTVLM 107
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH---VSDFGLAR 794
+ + + ++H H D+KP N L+ A+ + DFGLA+
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 9/112 (8%)
Query: 31 KVLLLYNNSFNHGIPSE--FDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNE 87
LLL +N I S+ F RL L L L N + I N S++ +++L N+
Sbjct: 32 TELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENK 89
Query: 88 LVGKIPSEL-GSLSKIEHLSVSVNNLTGSIP-SSLGNLSSINTLFLTDNNLD 137
+ +I +++ L +++ L++ N ++ + S +L+S+ +L L N +
Sbjct: 90 I-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 397 TIIDLSDNNLTGTIPPQ--FLGLSWLLIGLDLSRNQLTGSIPSEV-GNLKNLEVLDVFEN 453
T + L+DN L I F L L+ L+L RNQLT I +++ L + EN
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVK-LELKRNQLT-GIEPNAFEGASHIQELQLGEN 88
Query: 454 KLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQN 501
K+K EI + +L+ L + N + +P S L L L+L+ N
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 12/115 (10%)
Query: 278 RLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSG 337
LL+N N G + + L L L N++ G P A ++Q L++ N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 338 TIPPAI-GELQNLRELRLQRNKFLGNIPP----SIGNLKVFNL-----DLSCNFL 382
I + L L+ L L N+ + + P + +L NL + +C+
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQ-ISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 29/116 (25%), Positives = 51/116 (43%), Gaps = 11/116 (9%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI-GELQNLRELR 353
+ + ++ L L++NK+ K L +L + N++ ++P + +L L L
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILY 82
Query: 354 LQRNKFLGNIPP----SIGNLKVFNLDLSCNFLQGSIPS-SLGQYKTLTIIDLSDN 404
L NK L ++P + LK L L N L+ S+P + +L I L N
Sbjct: 83 LHENK-LQSLPNGVFDKLTQLK--ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 374 NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQ-FLGLSWLLIGLDLSRNQLT 432
L+L N LQ + LT + LS N + ++P F L+ L I L L N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTI-LYLHENKLQ 89
Query: 433 GSIPSEV-GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGN 477
S+P+ V L L+ L + N+LK L+++ + N
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 37/366 (10%), Positives = 97/366 (26%), Gaps = 73/366 (19%)
Query: 195 TLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITEN 254
L L+ + +L + + L+ + + E L ++
Sbjct: 24 NLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFH-YEFQNQRFSAEVLSSLRQLNLAGV 82
Query: 255 SLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS---TTLEMLLLDNNKI 311
+ + + + + L+ + + + PA + L L L N +
Sbjct: 83 RMTPVKCTVVAAVL-GSGRHALDEVNLASCQLD---PAGLRTLLPVFLRARKLGLQLNSL 138
Query: 312 FGNIPAAIGKF-----VNLQRLEMWNNRLSGT----IPPAIGELQNLRELRLQRNKFLGN 362
+ + L + NN L+ + + ++ L L
Sbjct: 139 GPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTG---- 194
Query: 363 IPPSIG-------------NLKVFNLDLSCNFLQGS----IPSSLGQYKTLTIIDLSDNN 405
+G N ++ L+++ N + + + ++ +L ++ L N
Sbjct: 195 ----LGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250
Query: 406 LTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGS 465
L+ G L + + V + +
Sbjct: 251 LSSE------GRQVLRDLGGAAE------------GGARVVVSLTEGTAV------SEYW 286
Query: 466 CKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS----GKIPEFLVGFQLLENLN 521
L +++ N + + L + DL + + + + L + L
Sbjct: 287 SVILSEVQRNLNSWD---RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALL 343
Query: 522 LSNNNL 527
+
Sbjct: 344 EQLGSS 349
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 38/240 (15%), Positives = 78/240 (32%), Gaps = 37/240 (15%)
Query: 307 DNNKIFGNIPAAIGKFVNLQRLEMWNNRLS---------GTIPPAIGELQNLRELRLQRN 357
D + I I KF + + L + + P + + L L+++
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 358 KFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLG--QYKTLTIIDLSDNNLTGTIPPQFL 415
L NLK +L++ L S+ + L + L ++
Sbjct: 183 NNLSIGKKPRPNLK--SLEIISGGLPDSVVEDILGSDLPNLEKLVL------------YV 228
Query: 416 GLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLE-- 473
G+ G D N NL+ L + + + + + L QLE
Sbjct: 229 GVED--YGFDGDMNVFRPLFSK--DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 474 -MQGNFLQG----PIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528
+ L + + +K L +++ N LS ++ + L L +++S++
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK-SLPMKIDVSDSQEY 343
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 1e-04
Identities = 20/137 (14%), Positives = 47/137 (34%), Gaps = 18/137 (13%)
Query: 2 RHQRVKILNLTSLKLAGSISPHVG--NLSFLKVLLLYNNSFNHGIPSEFD---------R 50
+K L + S L S+ + +L L+ L+LY ++G + + R
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250
Query: 51 LQRLQVLALNNNSIGGEIPANISSCSNLIQIR---LFYNEL----VGKIPSELGSLSKIE 103
L+ L + + + L Q+ + L + + + ++
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 104 HLSVSVNNLTGSIPSSL 120
+++ N L+ + L
Sbjct: 311 FINMKYNYLSDEMKKEL 327
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 55/268 (20%), Positives = 92/268 (34%), Gaps = 25/268 (9%)
Query: 245 RLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEML 304
RL+ +L G + + S + + L S ++ +
Sbjct: 41 RLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR--VQHM 98
Query: 305 LLDNNKIF-GNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQR-----NK 358
L N+ I + + + LQ L + RLS I + + NL L L
Sbjct: 99 DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 158
Query: 359 FLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQY-KTLTIIDLSD--NNLTGTIPPQFL 415
L + S L NL +F + + ++ +T+T ++LS NL +
Sbjct: 159 ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS------ 212
Query: 416 GLSWL------LIGLDLSR-NQLTGSIPSEVGNLKNLEVLDVFE-NKLKGEIPSTLGSCK 467
LS L L+ LDLS L E L L+ L + + E LG
Sbjct: 213 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 272
Query: 468 KLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
L+ L++ G G + +L L +
Sbjct: 273 TLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 953 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.47 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.8 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.24 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.94 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.66 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.98 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.75 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.56 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.0 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 83.15 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.54 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-70 Score=668.88 Aligned_cols=553 Identities=31% Similarity=0.496 Sum_probs=469.9
Q ss_pred CcEEEEEeCCCeeeeecCc--cccCCccCceeecCCCccCcCCCccC-CCCCCCcEEeCCCCccccccCcC---ccCCCC
Q 043900 4 QRVKILNLTSLKLAGSISP--HVGNLSFLKVLLLYNNSFNHGIPSEF-DRLQRLQVLALNNNSIGGEIPAN---ISSCSN 77 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~p~~---~~~l~~ 77 (953)
.+++.|||++|.+.|.+|. .++++++|++|+|++|.+++..|..+ .++++|++|||++|++++..|.. +.++++
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~ 179 (768)
T 3rgz_A 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179 (768)
T ss_dssp TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence 5789999999999999999 99999999999999999998888766 88999999999999999888877 789999
Q ss_pred CcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccc
Q 043900 78 LIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAE 157 (953)
Q Consensus 78 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (953)
|++|+|++|.+++..| +..+++|++|+|++|++++.+|. |+++++|++|+|++|++++.+|..|+.+++|++|+|++
T Consensus 180 L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~ 256 (768)
T 3rgz_A 180 LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256 (768)
T ss_dssp CCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCS
T ss_pred CCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCC
Confidence 9999999999986655 38889999999999999977776 99999999999999999988899999999999999999
Q ss_pred ccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcC
Q 043900 158 NWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV 237 (953)
Q Consensus 158 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (953)
|++++.+|.. .+++|++|++++|++++.+|..++..+++|++|++++|++++.+|..|+++++|++|++++|.+++..
T Consensus 257 n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~i 334 (768)
T 3rgz_A 257 NQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334 (768)
T ss_dssp SCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred CcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcC
Confidence 9998777765 78889999999999988888888755689999999999998888999999999999999999988665
Q ss_pred CC--CCCCCccceeeecccccCCCCCCccccc-------------------ccccc--cccccEEeccCCcccccCChhh
Q 043900 238 PY--LEKPQRLSVFSITENSLGSRGHSNLNFL-------------------CSLTN--STRLNRLLINANNFGGLLPACI 294 (953)
Q Consensus 238 ~~--l~~~~~L~~l~l~~n~l~~~~~~~~~~l-------------------~~l~~--~~~L~~L~l~~n~~~~~~p~~~ 294 (953)
|. +..+++|+++++++|.+.......+..+ ..+.. ++.|+.|++++|.+.+.+|..+
T Consensus 335 p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l 414 (768)
T 3rgz_A 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414 (768)
T ss_dssp CHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGG
T ss_pred CHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHH
Confidence 53 7788888888888888763211111111 01111 4567888888888888888887
Q ss_pred hhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eee
Q 043900 295 SNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVF 373 (953)
Q Consensus 295 ~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~ 373 (953)
..+ ++|+.|++++|++++..|..|..+++|+.|++++|.+++.+|..|..+++|++|+|++|++++.+|..++++ .++
T Consensus 415 ~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 493 (768)
T 3rgz_A 415 SNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 493 (768)
T ss_dssp GGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred hcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCC
Confidence 777 578888888888888888888888888888888888888888888888888888888888888888877776 467
Q ss_pred EEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCcc---------------
Q 043900 374 NLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSE--------------- 438 (953)
Q Consensus 374 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~--------------- 438 (953)
+|+|++|.+++.+|.+|+.+++|++|+|++|++++.+|..+..+.. ++.|++++|.++|.+|..
T Consensus 494 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~ 572 (768)
T 3rgz_A 494 WISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS-LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT-CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCS
T ss_pred EEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC-CCEEECCCCccCCcCChHHhcccchhhhhcccc
Confidence 8888888888888888888888888888888888788877766544 457888888887666643
Q ss_pred -------------------------------------------------------ccCCCccceeeecCCcccccCCCCc
Q 043900 439 -------------------------------------------------------VGNLKNLEVLDVFENKLKGEIPSTL 463 (953)
Q Consensus 439 -------------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~ 463 (953)
|..+++|+.|||++|+++|.+|..|
T Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l 652 (768)
T 3rgz_A 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652 (768)
T ss_dssp CEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGG
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHH
Confidence 4456789999999999999999999
Q ss_pred cCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccc
Q 043900 464 GSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATIT 543 (953)
Q Consensus 464 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~ 543 (953)
+++++|+.|+|++|+|+|.+|..|+.+++|++|||++|+++|.+|..+..+++|+.|++++|+|+|.||..+++..+...
T Consensus 653 ~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~ 732 (768)
T 3rgz_A 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 732 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGG
T ss_pred hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCcCCCCCCCCCCCCcccccc
Q 043900 544 SVLGNLKLCGGIPEFQLPTCISKE 567 (953)
Q Consensus 544 ~~~~n~~lcg~~~~~~~~~c~~~~ 567 (953)
+|.||+++||.+. ++|....
T Consensus 733 ~~~gN~~Lcg~~l----~~C~~~~ 752 (768)
T 3rgz_A 733 KFLNNPGLCGYPL----PRCDPSN 752 (768)
T ss_dssp GGCSCTEEESTTS----CCCCSCC
T ss_pred HhcCCchhcCCCC----cCCCCCc
Confidence 9999999999765 4676543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-64 Score=620.86 Aligned_cols=540 Identities=32% Similarity=0.474 Sum_probs=399.9
Q ss_pred cCcEEEEEeCCCeeeee---cCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCc--CccCCCC
Q 043900 3 HQRVKILNLTSLKLAGS---ISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPA--NISSCSN 77 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~--~~~~l~~ 77 (953)
.++|+.|||+++.+.|. +|+++.+|++|+.++++.|.+.. .|..|+.+++|++|||++|.+++.+|. .++++++
T Consensus 49 ~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~-l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~ 127 (768)
T 3rgz_A 49 DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHING-SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127 (768)
T ss_dssp TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEE-CCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTT
T ss_pred CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCC-CchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCC
Confidence 46899999999999888 77655555555555555555443 444455555555555555555554554 4555555
Q ss_pred CcEEeccCccccccCCcc----------------------------cCCccccceeeccccccccccCCcccCCCcccEE
Q 043900 78 LIQIRLFYNELVGKIPSE----------------------------LGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTL 129 (953)
Q Consensus 78 L~~L~L~~n~l~~~~~~~----------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L 129 (953)
|++|+|++|.+++..|.. +.++++|++|++++|++++..| ++.+++|++|
T Consensus 128 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L 205 (768)
T 3rgz_A 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFL 205 (768)
T ss_dssp CCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEE
T ss_pred CCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEE
Confidence 555555555554444443 4445555555555555544333 2566777777
Q ss_pred ecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccc
Q 043900 130 FLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL 209 (953)
Q Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 209 (953)
+|++|++++.+|. |+.+++|++|+|++|++++.+|..+.++++|++|++++|++++.+|.. .+++|++|++++|++
T Consensus 206 ~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l 281 (768)
T 3rgz_A 206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKF 281 (768)
T ss_dssp ECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEE
T ss_pred ECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCcc
Confidence 7777777766665 777777777777777777777777777777777777777777666654 577788888888888
Q ss_pred cCCCCCCCcCC-CCCcEEEcccccccCcCC-CCCCCCccceeeecccccC-CCCCCcccccccccccccccEEeccCCcc
Q 043900 210 TGAIPPAISNA-SNLELFQADVNKLTGEVP-YLEKPQRLSVFSITENSLG-SRGHSNLNFLCSLTNSTRLNRLLINANNF 286 (953)
Q Consensus 210 ~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~-~l~~~~~L~~l~l~~n~l~-~~~~~~~~~l~~l~~~~~L~~L~l~~n~~ 286 (953)
++.+|..+..+ ++|++|++++|.+++..| .+..+++|+++++++|.+. ..+. ..+..+++|+.|++++|.+
T Consensus 282 ~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~------~~l~~l~~L~~L~Ls~n~l 355 (768)
T 3rgz_A 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM------DTLLKMRGLKVLDLSFNEF 355 (768)
T ss_dssp EESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH------HHHTTCTTCCEEECCSSEE
T ss_pred CCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH------HHHhcCCCCCEEeCcCCcc
Confidence 77777777665 888888888888886544 4777788888888888775 2221 1144556666677777766
Q ss_pred cccCChhhhhcc--------------------------ccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCC
Q 043900 287 GGLLPACISNLS--------------------------TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIP 340 (953)
Q Consensus 287 ~~~~p~~~~~~~--------------------------~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 340 (953)
.+.+|..+..++ ++|+.|++++|++++..|..|..+++|+.|++++|.+++..|
T Consensus 356 ~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 435 (768)
T 3rgz_A 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435 (768)
T ss_dssp EECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCC
T ss_pred CccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCccc
Confidence 666666665543 346666666666666777778888888888888888888888
Q ss_pred cCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccc
Q 043900 341 PAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419 (953)
Q Consensus 341 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~ 419 (953)
..|+.+++|++|++++|++++.+|..++.+ .+++|++++|.+++.+|..++++++|++|+|++|++++.+|..+..+.
T Consensus 436 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~- 514 (768)
T 3rgz_A 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE- 514 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-
T ss_pred HHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCC-
Confidence 888888888888888888888888888776 578899999999988999999999999999999999988888877665
Q ss_pred cceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCc------------------------------------
Q 043900 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTL------------------------------------ 463 (953)
Q Consensus 420 ~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------------------------ 463 (953)
.++.|++++|++++.+|..++.+++|+.|++++|+++|.+|..+
T Consensus 515 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594 (768)
T ss_dssp TCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEE
T ss_pred CCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccc
Confidence 45689999999999999999999999999999999887776543
Q ss_pred ----------------------------------cCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCc
Q 043900 464 ----------------------------------GSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPE 509 (953)
Q Consensus 464 ----------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 509 (953)
+.+++|+.|+|++|+++|.+|.+|+.+++|+.|+|++|+++|.+|+
T Consensus 595 ~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~ 674 (768)
T 3rgz_A 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674 (768)
T ss_dssp ECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred ccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCCh
Confidence 3457889999999999999999999999999999999999999999
Q ss_pred cccccccCceEeccCCcCcccCCCC-CcccccccccccCCcCCCCCCCC
Q 043900 510 FLVGFQLLENLNLSNNNLEGMVPIE-GVFKNATITSVLGNLKLCGGIPE 557 (953)
Q Consensus 510 ~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lcg~~~~ 557 (953)
.+.++++|+.|||++|+++|.+|.. ..++.+....+.+| .+.|.+|.
T Consensus 675 ~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N-~l~g~iP~ 722 (768)
T 3rgz_A 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN-NLSGPIPE 722 (768)
T ss_dssp GGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS-EEEEECCS
T ss_pred HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC-cccccCCC
Confidence 9999999999999999999999965 34455555555555 67777774
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=558.38 Aligned_cols=550 Identities=21% Similarity=0.211 Sum_probs=464.1
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+++.|||+++++.+..+..|.++++|++|+|++|.++++.|.+|.++++|++|+|++|.+++..+.+|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 56899999999998655567999999999999999999988999999999999999999999555557999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCcccc--ccccccceeccccccc
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFG--WLKNLATLAMAENWLS 161 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~ 161 (953)
++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++..+..|. .+++|++|++++|+++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 99999977778899999999999999999988888999999999999999999977777665 4589999999999999
Q ss_pred CCCCCccccc---------------------------ccceEEecCCccccccccccccccccc--ccEEEeeCccccCC
Q 043900 162 GTIPSSIFNI---------------------------SSITAFDAGMNQLQGVIPLDFGFTLQN--LQFFSVFENQLTGA 212 (953)
Q Consensus 162 ~~~p~~l~~l---------------------------~~L~~L~L~~N~l~~~~~~~~~~~l~~--L~~L~L~~N~l~~~ 212 (953)
+..|..+..+ ++|+.|++++|++++..|..+. .++. |+.|++++|++++.
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~-~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL-GLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG-GGGGSCCCEEECTTSCCCEE
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh-ccCcCCCCEEECCCCCcCcc
Confidence 8778776654 4567777888888877776665 4544 99999999999988
Q ss_pred CCCCCcCCCCCcEEEcccccccCcCC-CCCCCCccceeeecccccCCC-CCCccccc--ccccccccccEEeccCCcccc
Q 043900 213 IPPAISNASNLELFQADVNKLTGEVP-YLEKPQRLSVFSITENSLGSR-GHSNLNFL--CSLTNSTRLNRLLINANNFGG 288 (953)
Q Consensus 213 ~~~~~~~l~~L~~L~L~~N~l~~~~~-~l~~~~~L~~l~l~~n~l~~~-~~~~~~~l--~~l~~~~~L~~L~l~~n~~~~ 288 (953)
.+..|..+++|++|++++|++++.++ .+..+++|+.+++++|..... +...+..+ ..+..+++|++|++++|.+.+
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 88889999999999999999988765 578889999999987654321 00001111 145678899999999999999
Q ss_pred cCChhhhhccccCcEEEcccCccc--ccCCccccCC--CCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCC
Q 043900 289 LLPACISNLSTTLEMLLLDNNKIF--GNIPAAIGKF--VNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP 364 (953)
Q Consensus 289 ~~p~~~~~~~~~L~~L~L~~N~i~--~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 364 (953)
..|..+..+ ++|++|++++|.+. ......|..+ ++|+.|++++|++++..|.+|..+++|++|+|++|++++.+|
T Consensus 344 ~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 422 (680)
T 1ziw_A 344 IKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422 (680)
T ss_dssp CCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred CChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence 888888887 58999999999853 2333344433 589999999999999999999999999999999999988776
Q ss_pred -CCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccC--CCCCccccCccccceeeeccCCcccCCCCcccc
Q 043900 365 -PSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT--GTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVG 440 (953)
Q Consensus 365 -~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~ 440 (953)
..+.++ .+++|++++|.+.+..+..|..+++|+.|++++|.++ +.+|..+..+. .++.|++++|++++..+..|.
T Consensus 423 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~-~L~~L~Ls~N~l~~i~~~~~~ 501 (680)
T 1ziw_A 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR-NLTILDLSNNNIANINDDMLE 501 (680)
T ss_dssp SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT-TCCEEECCSSCCCCCCTTTTT
T ss_pred cccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC-CCCEEECCCCCCCcCChhhhc
Confidence 577777 5799999999999999999999999999999999987 46677666555 466999999999988888899
Q ss_pred CCCccceeeecCCcccccCC--------CCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCcccc
Q 043900 441 NLKNLEVLDVFENKLKGEIP--------STLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLV 512 (953)
Q Consensus 441 ~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 512 (953)
++++|++|+|++|++++..+ ..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++++..+..|.
T Consensus 502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 581 (680)
T 1ziw_A 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581 (680)
T ss_dssp TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhC
Confidence 99999999999999986422 2478999999999999999966666799999999999999999987777789
Q ss_pred ccccCceEeccCCcCcccCCCCC--cccccccccccCCcCCCCCCC
Q 043900 513 GFQLLENLNLSNNNLEGMVPIEG--VFKNATITSVLGNLKLCGGIP 556 (953)
Q Consensus 513 ~l~~L~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~lcg~~~ 556 (953)
.+++|+.|++++|++++.+|... .++++....+.+|++.|.+..
T Consensus 582 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999999999999999877532 467778888999999999764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=541.27 Aligned_cols=522 Identities=21% Similarity=0.219 Sum_probs=454.6
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+++.|||++|.+.+..|..++++++|++|+|++|+++.+.+.+|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 56899999999999888889999999999999999999966678999999999999999999777789999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCccc--CCCcccEEecccccccccCCcccccc--------------
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG--NLSSINTLFLTDNNLDGGIPDTFGWL-------------- 147 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~L~~L~~L~L~~N~l~~~~~~~~~~l-------------- 147 (953)
++|.+++..|..|+++++|++|++++|++++..+..+. .+++|++|++++|++++..|..|..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999988899999999999999999999977776654 56899999999999998888877765
Q ss_pred -------------ccccceecccccccCCCCCccccccc--ceEEecCCcccccccccccccccccccEEEeeCccccCC
Q 043900 148 -------------KNLATLAMAENWLSGTIPSSIFNISS--ITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGA 212 (953)
Q Consensus 148 -------------~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 212 (953)
++|+.|++++|++++..|..+.++.. |+.|+|++|++++..|..+. .+++|++|++++|++++.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCccccc-CcccccEeeCCCCccCcc
Confidence 45678888889998888889988865 99999999999977666665 899999999999999999
Q ss_pred CCCCCcCCCCCcEEEcccccccCc-----CC-----CCCCCCccceeeecccccCCCCCCcccccccccccccccEEecc
Q 043900 213 IPPAISNASNLELFQADVNKLTGE-----VP-----YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLIN 282 (953)
Q Consensus 213 ~~~~~~~l~~L~~L~L~~N~l~~~-----~~-----~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~ 282 (953)
.|..|.++++|+.|++++|...+. .| .+..+++|+.+++++|.+..... ..+.++++|++|+++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS------NMFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCT------TTTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCCh------hHhccccCCcEEECC
Confidence 999999999999999998866532 22 56778999999999999887543 235678899999999
Q ss_pred CCccccc-CC-hhhhhcc-ccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCC-cCccCCCCCCeEEecccc
Q 043900 283 ANNFGGL-LP-ACISNLS-TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIP-PAIGELQNLRELRLQRNK 358 (953)
Q Consensus 283 ~n~~~~~-~p-~~~~~~~-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~ 358 (953)
+|.+... ++ ..+..+. ++|+.|++++|++++..|.+|..+++|+.|++++|.+++.+| ..|.++++|++|++++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 9986432 22 2333322 479999999999999999999999999999999999987665 789999999999999999
Q ss_pred ccCCCCCCCCCc-eeeEEEccCCcCC--CCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCC
Q 043900 359 FLGNIPPSIGNL-KVFNLDLSCNFLQ--GSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435 (953)
Q Consensus 359 l~~~~p~~~~~l-~l~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~ 435 (953)
+++..+..|..+ .+++|++++|.+. +..|..|..+++|+.|+|++|++++ +|+..+.....++.|++++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCc-CChhhhccccccCEEeCCCCCccccc
Confidence 998888899887 5799999999987 5789999999999999999999995 55554444456779999999998642
Q ss_pred C--------ccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccC
Q 043900 436 P--------SEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKI 507 (953)
Q Consensus 436 ~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (953)
+ ..|.++++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 2 24789999999999999999555567999999999999999999887888899999999999999999888
Q ss_pred Ccccc-ccccCceEeccCCcCcccCCC
Q 043900 508 PEFLV-GFQLLENLNLSNNNLEGMVPI 533 (953)
Q Consensus 508 p~~~~-~l~~L~~l~l~~N~l~~~~p~ 533 (953)
|..+. .+++|+.|++++|++.+..+.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 88777 789999999999999987764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=531.88 Aligned_cols=511 Identities=20% Similarity=0.203 Sum_probs=362.7
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.+|.++.++. .+|..+.. ++++|+|++|+|+++.|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 4566666665 66665543 56777777777777667777777777777777777776667777777777777777777
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCc
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSS 167 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 167 (953)
+++..|..|+++++|++|++++|++++..|..|+++++|++|++++|++++.....+..+++|++|+|++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 77666777777777777777777777555666777777777777777776544344444777777777777777555666
Q ss_pred ccccccce--EEecCCcccccccccccccccccccEEEeeCccc--------------------------cCCCCCCCcC
Q 043900 168 IFNISSIT--AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQL--------------------------TGAIPPAISN 219 (953)
Q Consensus 168 l~~l~~L~--~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l--------------------------~~~~~~~~~~ 219 (953)
+..+++|+ .|++++|++++..|..+. ..+|+.|++++|.. ....+..+..
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~--~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFD--SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTT--TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhh--hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 66777776 677777777765555442 35666666666541 0111122222
Q ss_pred CC--CCcEEEcccccccCcCCC-CCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhh
Q 043900 220 AS--NLELFQADVNKLTGEVPY-LEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISN 296 (953)
Q Consensus 220 l~--~L~~L~L~~N~l~~~~~~-l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~ 296 (953)
+. +|+.|++++|.+++.++. +..+++|+.+++++|.+...+. .+..+++|++|++++|.+.+..|..+..
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~-------~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS-------GLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS-------SCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh-------hhcccccCCEEECccCCcCcCchhhhhc
Confidence 22 566777777777766554 5666777777777776664432 2455667777777777777777777776
Q ss_pred ccccCcEEEcccCcccccCCc-cccCCCCCCEEEeecCcccccC--CcCccCCCCCCeEEeccccccCCCCCCCCCc-ee
Q 043900 297 LSTTLEMLLLDNNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTI--PPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KV 372 (953)
Q Consensus 297 ~~~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l 372 (953)
+ ++|++|++++|.+.+..|. .+..+++|+.|++++|.+++.. +..+..+++|++|++++|++++..|..++.+ .+
T Consensus 324 l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 402 (606)
T 3t6q_A 324 F-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402 (606)
T ss_dssp C-TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTC
T ss_pred c-CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccC
Confidence 6 4788888888877754443 4777888888888888887665 6777888888888888888877777777766 46
Q ss_pred eEEEccCCcCCCCCCcc-CCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCC---CCccccCCCcccee
Q 043900 373 FNLDLSCNFLQGSIPSS-LGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGS---IPSEVGNLKNLEVL 448 (953)
Q Consensus 373 ~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~---~~~~~~~l~~L~~L 448 (953)
++|++++|.+.+..|.. |..+++|+.|++++|++++..|..+..+ ..++.|++++|++++. .+..+..+++|+.|
T Consensus 403 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L 481 (606)
T 3t6q_A 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL-PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481 (606)
T ss_dssp SEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTC-TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEE
T ss_pred CeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCC-CCCCEEECCCCCCCccccccchhhccCCCccEE
Confidence 77888888887665543 7788888888888888876555555444 3456788888888752 33567888888888
Q ss_pred eecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCc
Q 043900 449 DVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528 (953)
Q Consensus 449 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 528 (953)
++++|++++..|..|+.+++|+.|+|++|++++..|..+..++.| .|+|++|++++.+|..+..+++|+.|++++|+++
T Consensus 482 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 560 (606)
T 3t6q_A 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred ECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence 888888887778888888888888888888888888888888888 8888888888877888888888888888888888
Q ss_pred ccCCC
Q 043900 529 GMVPI 533 (953)
Q Consensus 529 ~~~p~ 533 (953)
+..+.
T Consensus 561 c~c~~ 565 (606)
T 3t6q_A 561 CTCSN 565 (606)
T ss_dssp CSGGG
T ss_pred ccCCc
Confidence 76553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=541.74 Aligned_cols=508 Identities=19% Similarity=0.184 Sum_probs=273.4
Q ss_pred cEEEEEeCCCeeeeecCccccCCccCceeecCCCccC-cCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFN-HGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
+++.|||++|.+.+..|..|.++++|++|+|++|.+. .+.|.+|.++++|++|+|++|.|++..|..|.++++|++|+|
T Consensus 25 ~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 104 (844)
T 3j0a_A 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRL 104 (844)
T ss_dssp TCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEEC
T ss_pred CcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeC
Confidence 3445555555555444445555555555555555322 222445555555555555555555444555555555555555
Q ss_pred cCccccccCCcc--cCCccccceeeccccccccccC-CcccCCCcccEEecccccccccCCcccccc--ccccceecccc
Q 043900 84 FYNELVGKIPSE--LGSLSKIEHLSVSVNNLTGSIP-SSLGNLSSINTLFLTDNNLDGGIPDTFGWL--KNLATLAMAEN 158 (953)
Q Consensus 84 ~~n~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N 158 (953)
++|.+++..|.. |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..++.|..+ ++|+.|+|++|
T Consensus 105 s~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n 184 (844)
T 3j0a_A 105 YFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184 (844)
T ss_dssp TTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCS
T ss_pred cCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCC
Confidence 555554433332 4555555555555555544332 244555555555555555554455555544 45555555555
Q ss_pred cccCCCCCccccccc------ceEEecCCccccccccccccccc--ccccEEEeeCc---------cccCCCCCCCcCC-
Q 043900 159 WLSGTIPSSIFNISS------ITAFDAGMNQLQGVIPLDFGFTL--QNLQFFSVFEN---------QLTGAIPPAISNA- 220 (953)
Q Consensus 159 ~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~~~~~~~~l--~~L~~L~L~~N---------~l~~~~~~~~~~l- 220 (953)
.+.+..|..+..+.+ |+.|++++|++++..+..+...+ .+++.|.+..+ .+.......|.++
T Consensus 185 ~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~ 264 (844)
T 3j0a_A 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264 (844)
T ss_dssp BSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTT
T ss_pred ccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccc
Confidence 555444444443333 55555555555444444333211 23444444321 2222222233332
Q ss_pred -CCCcEEEcccccccCcCC-CCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhcc
Q 043900 221 -SNLELFQADVNKLTGEVP-YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS 298 (953)
Q Consensus 221 -~~L~~L~L~~N~l~~~~~-~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~ 298 (953)
++|+.|++++|.+++.++ .+..+++|+.+++++|.+..... ..+.++++|++|++++|.+.+..|..+..+
T Consensus 265 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l- 337 (844)
T 3j0a_A 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD------EAFYGLDNLQVLNLSYNLLGELYSSNFYGL- 337 (844)
T ss_dssp TSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT------TTTTTCSSCCEEEEESCCCSCCCSCSCSSC-
T ss_pred cCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh------HHhcCCCCCCEEECCCCCCCccCHHHhcCC-
Confidence 456666666666665533 24555666666666666554321 123445566666666666666556555555
Q ss_pred ccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEcc
Q 043900 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLS 378 (953)
Q Consensus 299 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~ 378 (953)
++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++. ..+++|+.|++++|+++ .+|... ..+..|+++
T Consensus 338 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~~--~~l~~L~ls 409 (844)
T 3j0a_A 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKIN--LTANLIHLS 409 (844)
T ss_dssp TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCCC--TTCCEEECC
T ss_pred CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-cccccc--cccceeecc
Confidence 3566666666666655555666666666666666666532 12556666666666665 334331 234556666
Q ss_pred CCcCCCCCC-ccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCccc-----CCCCccccCCCccceeeecC
Q 043900 379 CNFLQGSIP-SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT-----GSIPSEVGNLKNLEVLDVFE 452 (953)
Q Consensus 379 ~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~ 452 (953)
+|.+++... ..+.++++|+.|+|++|++++..+.........++.|+|++|.++ +..+..|.++++|+.|+|++
T Consensus 410 ~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~ 489 (844)
T 3j0a_A 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489 (844)
T ss_dssp SCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCH
T ss_pred cCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCC
Confidence 666664321 223466666777777776664444333333445556667776665 23344566666677777777
Q ss_pred CcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCC
Q 043900 453 NKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 453 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..+ .+|+.|++++|++.+..+
T Consensus 490 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 490 NYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE 564 (844)
T ss_dssp HHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred CcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence 777666666666667777777777777665555554 566677777777766666554 356666677776666554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=528.75 Aligned_cols=504 Identities=20% Similarity=0.203 Sum_probs=367.2
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.++.++.++. .+|..+. +++++|+|++|+++++.+.+|.++++|++|+|++|++++..|..|.++++|++|+|++|.
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5777787776 7787664 778888888888888777788888888888888888887777888888888888888888
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccc-cCCccccccccccceecccccccCCCCC
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG-GIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
+++..|..|+++++|++|+|++|++++..+..|+++++|++|++++|++++ .+|..|+++++|++|+|++|++++..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 887778888888888888888888886666778888888888888888875 4588888888888888888888877777
Q ss_pred cccccccce----EEecCCcccccccccccccccccccEEEeeCcccc-CCCCCCCcCCCCCcEEEc-------------
Q 043900 167 SIFNISSIT----AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT-GAIPPAISNASNLELFQA------------- 228 (953)
Q Consensus 167 ~l~~l~~L~----~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L------------- 228 (953)
.+..+.+|+ .|++++|.+++. +...+ ...+|+.|++++|.++ +..|..+.++++|+.+++
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~~~-~~~~~-~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPIDFI-QDQAF-QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCCEE-CTTTT-TTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhccccccceeeccCCCccee-Ccccc-cCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 777777665 788888888844 44444 2347888888888775 345556666666666665
Q ss_pred --------------------ccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccc
Q 043900 229 --------------------DVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGG 288 (953)
Q Consensus 229 --------------------~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~ 288 (953)
..|.+.+..+.+..+++|+.+++++|.+...+ .+..+++|+.|++++|.+ +
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~ 320 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-K 320 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-S
T ss_pred cChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-c
Confidence 45555655555666677777777777765433 455666777777777777 5
Q ss_pred cCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCccccc--CCcCccCCCCCCeEEeccccccCCCCCC
Q 043900 289 LLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGT--IPPAIGELQNLRELRLQRNKFLGNIPPS 366 (953)
Q Consensus 289 ~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 366 (953)
.+|. + .+ ++|+.|++++|...+.. .+..+++|++|++++|.+++. .|..+..+++|++|++++|.+++ +|..
T Consensus 321 ~lp~-~-~l-~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~ 394 (606)
T 3vq2_A 321 QFPT-L-DL-PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN 394 (606)
T ss_dssp SCCC-C-CC-SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCC
T ss_pred cccc-C-CC-CccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhh
Confidence 6663 3 44 57777777777544333 566777777777777777755 36677777777777777777764 5566
Q ss_pred CCCc-eeeEEEccCCcCCCCCC-ccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccC-CCCccccCCC
Q 043900 367 IGNL-KVFNLDLSCNFLQGSIP-SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG-SIPSEVGNLK 443 (953)
Q Consensus 367 ~~~l-~l~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~-~~~~~~~~l~ 443 (953)
+..+ .+++|++++|.+.+..| ..|..+++|++|++++|++++..|..+..+. .++.|++++|++++ .+|..|..++
T Consensus 395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~ 473 (606)
T 3vq2_A 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTT 473 (606)
T ss_dssp CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCT-TCCEEECTTCEEGGGEECSCCTTCT
T ss_pred ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCC-CCCEEECCCCcCCCcchHHhhccCC
Confidence 6665 46777777777776666 5677777777777777777766665554443 45577777777776 3677777777
Q ss_pred ccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccc-cCceEec
Q 043900 444 NLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ-LLENLNL 522 (953)
Q Consensus 444 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~l 522 (953)
+|+.|+|++|++++..|..|+.+++|++|+|++|++++..|..|..+++|++|||++|+++ .+|..+..++ +|+.|++
T Consensus 474 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l 552 (606)
T 3vq2_A 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNL 552 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEEC
T ss_pred CCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEc
Confidence 7777777777777777777777777777777777777777777777777777777777777 4566677765 4777777
Q ss_pred cCCcCcccCCC
Q 043900 523 SNNNLEGMVPI 533 (953)
Q Consensus 523 ~~N~l~~~~p~ 533 (953)
++|++.+..+.
T Consensus 553 ~~N~~~c~c~~ 563 (606)
T 3vq2_A 553 TNNSVACICEH 563 (606)
T ss_dssp CSCCCCCSSTT
T ss_pred cCCCcccCCcc
Confidence 77777766554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=518.72 Aligned_cols=496 Identities=19% Similarity=0.130 Sum_probs=438.3
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
..++.|||+++++.+..|..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 46899999999999777889999999999999999999999999999999999999999999888999999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCcccccccccc--ceeccccccc
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA--TLAMAENWLS 161 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l~ 161 (953)
++|.+++..|..|+++++|++|++++|++++..+..+..+++|++|++++|++++..++.|+.+++|+ +|++++|+++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999977788999999999999999999975545666699999999999999988899999999999 8999999999
Q ss_pred CCCCCcccccccceEEecCCccccc-------------------------ccccccccccc--cccEEEeeCccccCCCC
Q 043900 162 GTIPSSIFNISSITAFDAGMNQLQG-------------------------VIPLDFGFTLQ--NLQFFSVFENQLTGAIP 214 (953)
Q Consensus 162 ~~~p~~l~~l~~L~~L~L~~N~l~~-------------------------~~~~~~~~~l~--~L~~L~L~~N~l~~~~~ 214 (953)
+..|.. +...+|+.|++++|.... .++...+..+. +|+.|++++|++++..+
T Consensus 193 ~~~~~~-~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 193 GIEPGA-FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp EECTTT-TTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred ccChhH-hhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 666655 455789999999885110 11112222232 79999999999999888
Q ss_pred CCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChh-
Q 043900 215 PAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPAC- 293 (953)
Q Consensus 215 ~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~- 293 (953)
..|..+++|++|++++|+++..++.+..+++|+++++++|.+..... ..+..+++|++|++++|.+.+.+|..
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQ------ISASNFPSLTHLSIKGNTKRLELGTGC 345 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGG------GCGGGCTTCSEEECCSCSSCCBCCSST
T ss_pred HHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCch------hhhhccCcCCEEECCCCCcccccchhh
Confidence 89999999999999999999888889999999999999999876432 34667889999999999999777765
Q ss_pred hhhccccCcEEEcccCcccccC--CccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCC-CCCc
Q 043900 294 ISNLSTTLEMLLLDNNKIFGNI--PAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPS-IGNL 370 (953)
Q Consensus 294 ~~~~~~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l 370 (953)
+..+ ++|++|++++|.+++.. +..+..+++|+.|++++|.+++..|..|..+++|++|++++|++++..|.. +..+
T Consensus 346 ~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 424 (606)
T 3t6q_A 346 LENL-ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424 (606)
T ss_dssp TTTC-TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTC
T ss_pred hhcc-CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCc
Confidence 5555 79999999999998776 788999999999999999999999999999999999999999999877654 7777
Q ss_pred -eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCC-C-ccccCccccceeeeccCCcccCCCCccccCCCccce
Q 043900 371 -KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTI-P-PQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEV 447 (953)
Q Consensus 371 -~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p-~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~ 447 (953)
.+++|++++|.+++..|..|..+++|++|+|++|++++.. | ...+.....++.|++++|++++..|..|..+++|+.
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 504 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCE
Confidence 5899999999999999999999999999999999998632 2 123344456779999999999988999999999999
Q ss_pred eeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCC
Q 043900 448 LDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIP 508 (953)
Q Consensus 448 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 508 (953)
|+|++|++++..|..|..+++| .|+|++|++++.+|..+..+++|+.|++++|.+.+..+
T Consensus 505 L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9999999999999999999999 99999999999999999999999999999999997544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=527.33 Aligned_cols=526 Identities=21% Similarity=0.183 Sum_probs=445.8
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCcccccc-CcCccCCCCCcEEeccC
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI-PANISSCSNLIQIRLFY 85 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~L~L~~ 85 (953)
...|.+++++. .+|. -.++|++|+|++|.|+++.|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 46788999997 8887 4689999999999999999999999999999999999665555 88999999999999999
Q ss_pred ccccccCCcccCCccccceeeccccccccccCCc--ccCCCcccEEecccccccccCC-ccccccccccceecccccccC
Q 043900 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSS--LGNLSSINTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 86 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 162 (953)
|.+++..|++|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 9999888999999999999999999999866665 9999999999999999987655 689999999999999999998
Q ss_pred CCCCccccc--ccceEEecCCccccccccccccccccc------ccEEEeeCccccCCCCCCCcCC---CCCcEEEcccc
Q 043900 163 TIPSSIFNI--SSITAFDAGMNQLQGVIPLDFGFTLQN------LQFFSVFENQLTGAIPPAISNA---SNLELFQADVN 231 (953)
Q Consensus 163 ~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~~------L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N 231 (953)
..|..+..+ ++|+.|++++|.+.+..|..+. .+++ |+.|++++|++++..+..+... .+++.|.++.+
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~ 241 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred eCHHHcccccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence 889999888 8999999999999988887654 3443 9999999999998888777654 67888888743
Q ss_pred cc---------cCcC-CCCCC--CCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccc
Q 043900 232 KL---------TGEV-PYLEK--PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLST 299 (953)
Q Consensus 232 ~l---------~~~~-~~l~~--~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~ 299 (953)
.+ .... ..+.. ...|+.+++++|.+..... ..+..+++|+.|++++|++.+..|..+..+ +
T Consensus 242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~ 314 (844)
T 3j0a_A 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS------RVFETLKDLKVLNLAYNKINKIADEAFYGL-D 314 (844)
T ss_dssp CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS------CCSSSCCCCCEEEEESCCCCEECTTTTTTC-S
T ss_pred cccccccccccCCCChhhhhccccCCccEEECCCCcccccCh------hhhhcCCCCCEEECCCCcCCCCChHHhcCC-C
Confidence 33 2221 11222 3689999999998876432 345678899999999999999988888887 5
Q ss_pred cCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccC
Q 043900 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSC 379 (953)
Q Consensus 300 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~ 379 (953)
+|++|+|++|++++..|..|..+++|+.|++++|.|++..+.+|..+++|++|+|++|.+++. +. ...++.|++++
T Consensus 315 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~~---~~~L~~L~l~~ 390 (844)
T 3j0a_A 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-HF---IPSIPDIFLSG 390 (844)
T ss_dssp SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-SS---CCSCSEEEEES
T ss_pred CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-cC---CCCcchhccCC
Confidence 899999999999988899999999999999999999988888999999999999999999843 22 22468899999
Q ss_pred CcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCc-cccCCCccceeeecCCccc--
Q 043900 380 NFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPS-EVGNLKNLEVLDVFENKLK-- 456 (953)
Q Consensus 380 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-- 456 (953)
|.++ .+|.. ..+++.|++++|++++.-...+......++.|+|++|++++..+. .+..+++|+.|+|++|.++
T Consensus 391 N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 466 (844)
T 3j0a_A 391 NKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466 (844)
T ss_dssp CCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSS
T ss_pred CCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccc
Confidence 9998 45554 467899999999998543322333345677999999999965443 4677899999999999997
Q ss_pred ---ccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCC
Q 043900 457 ---GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPI 533 (953)
Q Consensus 457 ---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 533 (953)
+..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|.
T Consensus 467 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp CCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC
T ss_pred cccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh
Confidence 44557789999999999999999999999999999999999999999987777665 8999999999999999885
Q ss_pred CCcccccccccccCCcCCCCCCC
Q 043900 534 EGVFKNATITSVLGNLKLCGGIP 556 (953)
Q Consensus 534 ~~~~~~~~~~~~~~n~~lcg~~~ 556 (953)
. +..+....+.+|++.|.+..
T Consensus 545 ~--~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 545 V--FVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp C--CSSCCEEEEEEECCCCSSSC
T ss_pred H--hCCcCEEEecCCCccccccc
Confidence 4 66778888999999997654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=512.87 Aligned_cols=488 Identities=18% Similarity=0.148 Sum_probs=428.6
Q ss_pred cCcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEe
Q 043900 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIR 82 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ 82 (953)
..+++.|||+++++.+..+..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 35789999999999977777999999999999999999998899999999999999999999988899999999999999
Q ss_pred ccCccccccCCcccCCccccceeecccccccc-ccCCcccCCCcccEEecccccccccCCcccccccccc----ceeccc
Q 043900 83 LFYNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA----TLAMAE 157 (953)
Q Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~ 157 (953)
|++|.+++..+..|+++++|++|++++|++++ .+|..|+++++|++|+|++|++++..+..|+.+++|+ +|++++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 99999997777899999999999999999986 5699999999999999999999988899999998887 799999
Q ss_pred ccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEe---------------------------------
Q 043900 158 NWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSV--------------------------------- 204 (953)
Q Consensus 158 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L--------------------------------- 204 (953)
|++++ +|.......+|+.|++++|.+.+.........+++|+.+++
T Consensus 191 n~l~~-~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 269 (606)
T 3vq2_A 191 NPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269 (606)
T ss_dssp CCCCE-ECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred CCcce-eCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence 99994 45554555599999999999874333333346666666665
Q ss_pred eCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCC
Q 043900 205 FENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINAN 284 (953)
Q Consensus 205 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n 284 (953)
..|.+.+..|. +..+++|+.|++++|.+...+ .+...++|+.+++++|.++..+ .+ .++.|+.|++++|
T Consensus 270 ~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-~l~~~~~L~~L~l~~n~l~~lp--------~~-~l~~L~~L~l~~n 338 (606)
T 3vq2_A 270 YTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSIIRCQLKQFP--------TL-DLPFLKSLTLTMN 338 (606)
T ss_dssp CCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-CCCTTCCCSEEEEESCCCSSCC--------CC-CCSSCCEEEEESC
T ss_pred ccccccccccc-cccCCCCCEEEecCccchhhh-hccccccCCEEEcccccCcccc--------cC-CCCccceeeccCC
Confidence 56677766666 899999999999999998765 8888999999999999986544 33 7889999999999
Q ss_pred cccccCChhhhhccccCcEEEcccCccccc--CCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCC
Q 043900 285 NFGGLLPACISNLSTTLEMLLLDNNKIFGN--IPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGN 362 (953)
Q Consensus 285 ~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 362 (953)
...+.+ .+..+ ++|++|++++|++++. .|..+..+++|+.|++++|.+++ .|..|..+++|++|++++|++++.
T Consensus 339 ~~~~~~--~~~~l-~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~ 414 (606)
T 3vq2_A 339 KGSISF--KKVAL-PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV 414 (606)
T ss_dssp SSCEEC--CCCCC-TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEEST
T ss_pred cCccch--hhccC-CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCc
Confidence 766554 34455 6899999999999876 38889999999999999999985 668999999999999999999988
Q ss_pred CC-CCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCC-CCccccCccccceeeeccCCcccCCCCccc
Q 043900 363 IP-PSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT-IPPQFLGLSWLLIGLDLSRNQLTGSIPSEV 439 (953)
Q Consensus 363 ~p-~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~ 439 (953)
.| ..+..+ .+++|++++|.+.+..|..|..+++|++|++++|++++. +|..+..+ ..++.|++++|++++..|..|
T Consensus 415 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~ 493 (606)
T 3vq2_A 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT-TNLTFLDLSKCQLEQISWGVF 493 (606)
T ss_dssp TTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC-TTCCEEECTTSCCCEECTTTT
T ss_pred cChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC-CCCCEEECCCCcCCccChhhh
Confidence 87 678777 589999999999999999999999999999999999974 55555544 566799999999999999999
Q ss_pred cCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCC-CCcEEECCCCcccccCC
Q 043900 440 GNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLK-GLNVLDLSQNNLSGKIP 508 (953)
Q Consensus 440 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p 508 (953)
.++++|+.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..+..++ +|++|++++|.+.+..+
T Consensus 494 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999999999999999888999999999999999999999 6777799997 59999999999997544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=449.73 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=205.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+++.+.++||+|+||+||+|++.+ .||||+++.. .....+.|.+|++++++++|||||+++|+|.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 3567888999999999999998754 5999999743 34456789999999999999999999998742 45
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++|||||++|+|.++++.. ...+++.+++.|+.|||.||+|||++ +||||||||+|||+++++.+||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQ---------ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTS---------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEE
T ss_pred EEEEEEcCCCCCHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEE
Confidence 79999999999999999632 23599999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||+|+...............||+.|||||++.+ .+|+.++|||||||++|||+||+.||.+...... .......
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~ 252 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGR 252 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHT
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhc
Confidence 99999987654433334455679999999999864 4689999999999999999999999975322111 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
... .+... .....+++++.+++.+||+.||++||||+||++.|+.++..++
T Consensus 253 ~~~-------~p~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 253 GYA-------SPDLS-------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TCC-------CCCST-------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCC-------CCCcc-------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 100 00000 0011356679999999999999999999999999999876654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=451.09 Aligned_cols=271 Identities=24% Similarity=0.389 Sum_probs=217.0
Q ss_pred cCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|.+.+.||+|+||+||+|++.. +++.||||+++.......++|.+|++++++++|||||+++|+|.+ +
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 467888999999999999999753 467899999987777777899999999999999999999999753 4
Q ss_pred CceeEEEeeccCCchhhccccCCcCC---cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITRED---KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+..++|||||++|+|.++++...... ........++|.+++.|+.|||+||+|||++ +|+||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 77999999999999999997543110 0112234799999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ ....
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~ 242 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC 242 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence 9999999999987654444334445569999999999999999999999999999999999 899997632211 1111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
+... .. ...+..+++++.+++.+||+.||++||||+||++.|+++.+..+
T Consensus 243 i~~~-----------~~-------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 243 ITQG-----------RV-------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHHT-----------CC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHcC-----------CC-------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 1100 00 00111356679999999999999999999999999999987644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=451.61 Aligned_cols=269 Identities=24% Similarity=0.385 Sum_probs=208.8
Q ss_pred cCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|.+.++||+|+||+||+|++.. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+ +
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 356778899999999999999753 467899999987777777899999999999999999999999753 3
Q ss_pred CceeEEEeeccCCchhhccccCCcCCc-----ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDK-----TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
+..++|||||++|+|.++++....... .......++|.+++.|+.|||+||+|||+. +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 779999999999999999976543211 112345799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
+++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......+ ..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AI 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence 999999999999987754444444455679999999999999999999999999999999999 899997532211 11
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
..+.... +...+..+++++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 271 ~~i~~g~------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGR------------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTC------------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCC------------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1110000 0001113566799999999999999999999999999999765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=482.73 Aligned_cols=486 Identities=20% Similarity=0.203 Sum_probs=327.2
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.++-++.++. ++|..+. +++++|+|++|+++++.+.+|.++++|++|+|++|++++..|..|.++++|++|+|++|.
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 87 (570)
T 2z63_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (570)
T ss_dssp EEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCc
Confidence 3455555554 5666543 457777777777777666677777777777777777776666667777777777777777
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccc-cCCccccccccccceecccccccCCCCC
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG-GIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
+++..|..|+++++|++|++++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred CCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 776666677777777777777777775444467777777777777777765 2467777777777777777777755566
Q ss_pred cccccccc----eEEecCCcccccccccccccccccccEEEeeCcccc-------------------------------C
Q 043900 167 SIFNISSI----TAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT-------------------------------G 211 (953)
Q Consensus 167 ~l~~l~~L----~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------------~ 211 (953)
.+..+.+| +.|++++|.+++..|..+. ..+|+.|++++|... .
T Consensus 168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~ 245 (570)
T 2z63_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK--EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245 (570)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTT--TCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEE
T ss_pred HccchhccchhhhhcccCCCCceecCHHHhc--cCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhh
Confidence 66666666 6777777777755554443 236777777666322 1
Q ss_pred CCCCCCcCCCC--CcEEEcccc-cccCcCC-CCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCccc
Q 043900 212 AIPPAISNASN--LELFQADVN-KLTGEVP-YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFG 287 (953)
Q Consensus 212 ~~~~~~~~l~~--L~~L~L~~N-~l~~~~~-~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~ 287 (953)
.....+..+.+ ++.+++++| .+.+..+ .+..+++|+.+++++|.+...+. .+..+ +|++|++++|.+.
T Consensus 246 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~-------~~~~~-~L~~L~l~~n~~~ 317 (570)
T 2z63_A 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-------FSYNF-GWQHLELVNCKFG 317 (570)
T ss_dssp CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCB-------CCSCC-CCSEEEEESCBCS
T ss_pred cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhh-------hhccC-CccEEeeccCccc
Confidence 11122222222 344444444 4444333 35556777777777776654221 11222 4444444444444
Q ss_pred ccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccC--CcCccCCCCCCeEEeccccccCCCCC
Q 043900 288 GLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTI--PPAIGELQNLRELRLQRNKFLGNIPP 365 (953)
Q Consensus 288 ~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~ 365 (953)
.+|.. .+ ++|+.|++++|.+.+..+. ..+++|+.|++++|.+++.. |..+..+++|++|++++|.+
T Consensus 318 -~l~~~--~l-~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l------ 385 (570)
T 2z63_A 318 -QFPTL--KL-KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV------ 385 (570)
T ss_dssp -SCCBC--BC-SSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSE------
T ss_pred -ccCcc--cc-cccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcc------
Confidence 22221 11 3455555555555433332 44555555555555554332 44455555555555555544
Q ss_pred CCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCcc
Q 043900 366 SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445 (953)
Q Consensus 366 ~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L 445 (953)
.+. |..+..+++|+.|++++|++++..|...+.....++.|++++|.+++..|..|.++++|
T Consensus 386 -----------------~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 447 (570)
T 2z63_A 386 -----------------ITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447 (570)
T ss_dssp -----------------EEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred -----------------ccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcC
Confidence 433 33377888888888888888866664444555567788999999888889999999999
Q ss_pred ceeeecCCccc-ccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccC
Q 043900 446 EVLDVFENKLK-GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524 (953)
Q Consensus 446 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~ 524 (953)
+.|++++|+++ +.+|..|..+++|++|+|++|++++..|.+|..+++|++|+|++|++++..|..+..+++|+.|++++
T Consensus 448 ~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 527 (570)
T 2z63_A 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527 (570)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred cEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecC
Confidence 99999999998 57899999999999999999999998899999999999999999999998888899999999999999
Q ss_pred CcCcccCCCCCc
Q 043900 525 NNLEGMVPIEGV 536 (953)
Q Consensus 525 N~l~~~~p~~~~ 536 (953)
|+++|.+|....
T Consensus 528 N~~~~~~~~~~~ 539 (570)
T 2z63_A 528 NPWDCSCPRIDY 539 (570)
T ss_dssp SCBCCCTTTTHH
T ss_pred CcccCCCcchHH
Confidence 999999886543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=444.63 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=210.7
Q ss_pred CCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 632 GFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++++.+.||+|+||+||+|++. .+++.||||+++.. .....++|.+|+.++++++|||||+++|+|.. +
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence 4567889999999999999974 34578999999743 33445789999999999999999999999753 3
Q ss_pred CceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
+..++|||||++|+|.++++....... .......++|.+++.|+.|||+||+|||+. +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 678999999999999999965432211 112234699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccH
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNL 858 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~ 858 (953)
++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... ..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~ 256 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV 256 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987654444444455679999999999999999999999999999999999 89999764221 11
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
...+.. ... .+.+..+++++.+++.+||+.||++||||+||++.|++.
T Consensus 257 ~~~i~~-----------~~~-------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRN-----------RQV-------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHT-----------TCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHc-----------CCC-------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111110 000 001124567799999999999999999999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=475.04 Aligned_cols=485 Identities=21% Similarity=0.204 Sum_probs=358.6
Q ss_pred EEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccc
Q 043900 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNEL 88 (953)
Q Consensus 9 l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l 88 (953)
.|.+++++. .+|+.+. ++|++|+|++|+++++.|.+|.++++|++|+|++|+|++..|..|+++++|++|+|++|++
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 678888887 8998775 7999999999999998899999999999999999999988889999999999999999999
Q ss_pred cccCCcccCCccccceeeccccccccc-cCCcccCCCcccEEeccccc-ccccCCccccccccccceecccccccCCCCC
Q 043900 89 VGKIPSELGSLSKIEHLSVSVNNLTGS-IPSSLGNLSSINTLFLTDNN-LDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 89 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
++..|..|+++++|++|+|++|++++. .|..|+++++|++|++++|+ ++...+..|.++++|++|++++|++++..|.
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 166 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence 977777899999999999999999863 57789999999999999999 5544457899999999999999999988999
Q ss_pred cccccccceEEecCCcccccccccccccccccccEEEeeCccccCCC---CCCCcCCCCCcEEEcccccccCcCC-----
Q 043900 167 SIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAI---PPAISNASNLELFQADVNKLTGEVP----- 238 (953)
Q Consensus 167 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~----- 238 (953)
.+..+++|++|+++.|.+. .+|..++..+++|++|++++|++++.. ......+++|+.|++++|.+++..+
T Consensus 167 ~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 245 (549)
T 2z81_A 167 SLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245 (549)
T ss_dssp TTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred hhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence 9999999999999999987 667666667999999999999999642 2334568899999999998875422
Q ss_pred CCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCccccc-----CChhhhhccccCcEEEcccCcccc
Q 043900 239 YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL-----LPACISNLSTTLEMLLLDNNKIFG 313 (953)
Q Consensus 239 ~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~-----~p~~~~~~~~~L~~L~L~~N~i~~ 313 (953)
.+.....|+.+++++|.+...+.........+..+.+++.|.+.++.+... ++. +.....+|+.|++++|++.
T Consensus 246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~-~~~~~~~L~~L~l~~n~l~- 323 (549)
T 2z81_A 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST-VYSLLEKVKRITVENSKVF- 323 (549)
T ss_dssp GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCH-HHHHSTTCCEEEEESSCCC-
T ss_pred Hhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchh-hhhhcccceEEEeccCccc-
Confidence 234456677777777776554322211222334455555555555544321 111 1122234555555555554
Q ss_pred cCCccc-cCCCCCCEEEeecCcccccCC---cCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCC--
Q 043900 314 NIPAAI-GKFVNLQRLEMWNNRLSGTIP---PAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIP-- 387 (953)
Q Consensus 314 ~~~~~~-~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p-- 387 (953)
.+|..+ .++++|+.|++++|.+++..| ..++.+++|++|+|++|+++ +..+
T Consensus 324 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-----------------------~~~~~~ 380 (549)
T 2z81_A 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-----------------------SMQKTG 380 (549)
T ss_dssp CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCC-----------------------CHHHHH
T ss_pred cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccc-----------------------ccccch
Confidence 333333 345555555555555554332 23445555555555555554 3221
Q ss_pred ccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCc
Q 043900 388 SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCK 467 (953)
Q Consensus 388 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 467 (953)
..+..+++|++|+|++|+++ .+|..+..+ ..++.|++++|++++ +|..+ .++|++|+|++|+|++.. ..++
T Consensus 381 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~-~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~ 451 (549)
T 2z81_A 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWP-EKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLP 451 (549)
T ss_dssp HHGGGCTTCCEEECTTCCCC-CCCSCCCCC-TTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCT
T ss_pred hhhhcCCCCCEEECCCCCCc-cCChhhccc-ccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCC
Confidence 34566667777777777776 566554443 345567777777763 34333 257888888888888542 5688
Q ss_pred cccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCC
Q 043900 468 KLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPI 533 (953)
Q Consensus 468 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 533 (953)
+|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+..+++|+.|++++|+++|..|.
T Consensus 452 ~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 452 RLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp TCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred hhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 8999999999998 5665 46788999999999999988888888999999999999999887774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=491.50 Aligned_cols=454 Identities=20% Similarity=0.274 Sum_probs=347.1
Q ss_pred cCcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCc------------CCCccCCCCCCCcEEeCCCCccccccCc
Q 043900 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNH------------GIPSEFDRLQRLQVLALNNNSIGGEIPA 70 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~------------~~~~~~~~l~~L~~L~L~~n~i~~~~p~ 70 (953)
.++|+.|+|+++++.|.+|+++++|++|++|+|++|.+.. .+|... +..|+ +++++|.+.+.+|.
T Consensus 80 ~~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~ 156 (636)
T 4eco_A 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRE 156 (636)
T ss_dssp TCCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGG
T ss_pred CCCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchh
Confidence 4689999999999999999999999999999999998732 123222 45566 77777777766666
Q ss_pred CccC-CCCCcEEeccCccccccCCcccCCccccceeecc--ccccccccCCcccCCCcccEEeccccccccc--------
Q 043900 71 NISS-CSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS--VNNLTGSIPSSLGNLSSINTLFLTDNNLDGG-------- 139 (953)
Q Consensus 71 ~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls--~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-------- 139 (953)
.+.. +..+..+++....+. ......++.+++. +|++++ +|.+|+++++|++|+|++|++++.
T Consensus 157 ~~~~~~~~l~~~~l~~~~~~------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 157 DFSDLIKDCINSDPQQKSIK------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp GSCHHHHHHHHHCTTSCCCC------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred hHHHHHHHHhhcCccccccc------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 5552 223333333333222 1112233333333 578887 788888888888888888888864
Q ss_pred ---------CCcccc--ccccccceecccccccCCCCCcccccccceEEecCCcc-ccc-cccccccccc------cccc
Q 043900 140 ---------IPDTFG--WLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQ-LQG-VIPLDFGFTL------QNLQ 200 (953)
Q Consensus 140 ---------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~~l------~~L~ 200 (953)
+|+.++ ++++|++|+|++|++.+.+|..+.++++|++|++++|+ +++ .+|..+. .+ ++|+
T Consensus 230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~L~ 308 (636)
T 4eco_A 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ-ALADAPVGEKIQ 308 (636)
T ss_dssp TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HHHHSGGGGTCC
T ss_pred cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH-hhhccccCCCCC
Confidence 788877 88888888888888888888888888888888888888 887 7887765 44 8899
Q ss_pred EEEeeCccccCCCCC--CCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccE
Q 043900 201 FFSVFENQLTGAIPP--AISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNR 278 (953)
Q Consensus 201 ~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~ 278 (953)
+|++++|+++ .+|. .++++++|+.|++++|++++..|.+
T Consensus 309 ~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~-------------------------------------- 349 (636)
T 4eco_A 309 IIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAF-------------------------------------- 349 (636)
T ss_dssp EEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCC--------------------------------------
T ss_pred EEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhh--------------------------------------
Confidence 9999999998 7887 8889999999998888887544321
Q ss_pred EeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCC-CCEEEeecCcccccCCcCccCCC--CCCeEEec
Q 043900 279 LLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVN-LQRLEMWNNRLSGTIPPAIGELQ--NLRELRLQ 355 (953)
Q Consensus 279 L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~ 355 (953)
..+ ++|+.|++++|+++ .+|..+..+++ |+.|++++|.++ .+|..+..++ +|++|+++
T Consensus 350 ----------------~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls 410 (636)
T 4eco_A 350 ----------------GSE-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS 410 (636)
T ss_dssp ----------------EEE-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECC
T ss_pred ----------------CCC-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECc
Confidence 112 35666777777766 56666777777 777777777777 5666666544 77777777
Q ss_pred cccccCCCCCCCC-------Cc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccc-------c
Q 043900 356 RNKFLGNIPPSIG-------NL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW-------L 420 (953)
Q Consensus 356 ~N~l~~~~p~~~~-------~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-------~ 420 (953)
+|++++.+|..+. .+ .+++|+|++|.+++..+..+..+++|++|+|++|+++ .+|..++.... .
T Consensus 411 ~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~ 489 (636)
T 4eco_A 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYL 489 (636)
T ss_dssp SSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGG
T ss_pred CCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCC
Confidence 7777777776665 33 5677888888888544445667899999999999998 78877665543 6
Q ss_pred ceeeeccCCcccCCCCcccc--CCCccceeeecCCcccccCCCCccCCccccEEEc------cCccccCCCCccccCCCC
Q 043900 421 LIGLDLSRNQLTGSIPSEVG--NLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEM------QGNFLQGPIPSSLSSLKG 492 (953)
Q Consensus 421 l~~L~ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~ 492 (953)
++.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|.++..+++
T Consensus 490 L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~ 567 (636)
T 4eco_A 490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567 (636)
T ss_dssp CCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSS
T ss_pred ccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCC
Confidence 779999999999 6888886 99999999999999996 8999999999999999 568889999999999999
Q ss_pred CcEEECCCCcccccCCccccccccCceEeccCCcCcccC
Q 043900 493 LNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMV 531 (953)
Q Consensus 493 L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 531 (953)
|+.|+|++|++ +.+|..+. ++|+.|++++|++....
T Consensus 568 L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 568 LTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISID 603 (636)
T ss_dssp CCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred CCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcccc
Confidence 99999999999 57888766 79999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=439.24 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=207.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+.|+..++||+|+||+||+|+++.+++.||||+++.......+.+.+|+++|++++|||||++++++. +++..||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 46899999999999999999999999999999998665556677899999999999999999999964 4478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
|||||++|+|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 149 vmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecC
Confidence 9999999999999852 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+|+.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... ..........+..
T Consensus 215 Gla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~- 289 (346)
T 4fih_A 215 GFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPR- 289 (346)
T ss_dssp TTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSCCC-
T ss_pred cCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCC-
Confidence 9999774332 2334567999999999999999999999999999999999999999752211 1111111111000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .....+++++.+++.+||+.||++|||++|+++
T Consensus 290 -------~--------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 -------L--------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -------C--------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------C--------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 001134567889999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=441.31 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=200.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||++++++. +++..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence 6899999999999999999999999999999999643 3445678999999999999999999999954 45789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
|||||||+||+|.+++.... ...+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~--------~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQK--------GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEEC
T ss_pred EEEEeCCCCCcHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEc
Confidence 99999999999999996332 23578999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||+|+.... ........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+........+
T Consensus 168 DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~- 243 (350)
T 4b9d_A 168 DFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP- 243 (350)
T ss_dssp STTEESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC-
T ss_pred ccccceeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC-
Confidence 9999986532 1122334579999999999999999999999999999999999999997532111 11111111000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ...+++++.+++.+||+.||++|||++|+++
T Consensus 244 -----------~~-------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 -----------PV-------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -----------CC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------CC-------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0123456889999999999999999999986
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=465.20 Aligned_cols=509 Identities=22% Similarity=0.211 Sum_probs=426.2
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
..+.++.++.+++. +|..+. .++++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 8 ~~~~~~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 84 (570)
T 2z63_A 8 PNITYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84 (570)
T ss_dssp TTTEEECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEeCCCCccc-cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCc
Confidence 35678999999997 666553 589999999999998888899999999999999999998888899999999999999
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC-CCCCcccccccceEEecCCcccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG-TIPSSIFNISSITAFDAGMNQLQGV 187 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~ 187 (953)
+|++++..|.+|+++++|++|++++|++++..+..|+++++|++|+|++|++++ .+|..+.++++|++|++++|++++.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred CCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 999998888999999999999999999997766689999999999999999986 4699999999999999999999976
Q ss_pred cccccccccccc----cEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCc--CCCCCCCCccceeeecccccCC---
Q 043900 188 IPLDFGFTLQNL----QFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGE--VPYLEKPQRLSVFSITENSLGS--- 258 (953)
Q Consensus 188 ~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~l~~~~~L~~l~l~~n~l~~--- 258 (953)
.+..+. .+++| +.|++++|.+++..+..+..+ +|+.|++++|..... +..+..+..++...+.-..+..
T Consensus 165 ~~~~~~-~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~ 242 (570)
T 2z63_A 165 YCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242 (570)
T ss_dssp CGGGGH-HHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred cHHHcc-chhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchh
Confidence 666655 78888 899999999998888888776 899999999854321 1123334444444443322211
Q ss_pred ---CCCCcccccccccccccccEEeccCC-cccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCc
Q 043900 259 ---RGHSNLNFLCSLTNSTRLNRLLINAN-NFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNR 334 (953)
Q Consensus 259 ---~~~~~~~~l~~l~~~~~L~~L~l~~n-~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 334 (953)
.+...+ ..+..+ .+..+.++.+ .+.+..|..+..+ ++|+.|++++|.+. .+|..+..+ +|+.|++++|.
T Consensus 243 l~~~~~~~~---~~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~ 315 (570)
T 2z63_A 243 LEKFDKSAL---EGLCNL-TIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCK 315 (570)
T ss_dssp CEECCTTTT---GGGGGS-EEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCB
T ss_pred hhhcchhhh---cccccc-chhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeeccCc
Confidence 111111 112222 3667778777 7778888888887 68999999999998 578888888 99999999999
Q ss_pred ccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCC--CccCCCCCCCcEEEcCCCccCCCCC
Q 043900 335 LSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSI--PSSLGQYKTLTIIDLSDNNLTGTIP 411 (953)
Q Consensus 335 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p 411 (953)
+. .+|. ..+++|+.|++++|.+.+..+. ..+ .+++|++++|.+++.. |..+..+++|++|++++|+++ .+|
T Consensus 316 ~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~ 389 (570)
T 2z63_A 316 FG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389 (570)
T ss_dssp CS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE-EEE
T ss_pred cc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc-ccc
Confidence 98 5565 5789999999999999876665 333 5799999999998654 778899999999999999998 455
Q ss_pred ccccCccccceeeeccCCcccCCCC-ccccCCCccceeeecCCcccccCCCCccCCccccEEEccCcccc-CCCCccccC
Q 043900 412 PQFLGLSWLLIGLDLSRNQLTGSIP-SEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQ-GPIPSSLSS 489 (953)
Q Consensus 412 ~~~~~~~~~l~~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~ 489 (953)
..+..+ ..++.|++++|.+++..| ..|..+++|++|++++|.+++..|..|.++++|++|+|++|+++ +.+|..+..
T Consensus 390 ~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~ 468 (570)
T 2z63_A 390 SNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468 (570)
T ss_dssp EEEETC-TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred cccccc-CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence 555544 456799999999998766 57899999999999999999999999999999999999999998 679999999
Q ss_pred CCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCC-CcccccccccccCCcCCCCCCC
Q 043900 490 LKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIE-GVFKNATITSVLGNLKLCGGIP 556 (953)
Q Consensus 490 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lcg~~~ 556 (953)
+++|++|+|++|++++..|..+..+++|+.|++++|++++.+|.. ..++.+....+.+|+..|.++.
T Consensus 469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999999999999988999999999999999999999987753 4567777888899988887543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=440.86 Aligned_cols=276 Identities=24% Similarity=0.330 Sum_probs=219.4
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCC-CCeeEEEeeecc
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQG-----KTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRH-RNLVKILTACSG 699 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~ 699 (953)
+...++|++.+.||+|+||+||+|++... .+.||||+++... ....+.+.+|+++++++.| ||||+++|+|..
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 33457899999999999999999998654 3579999997433 3456789999999999965 999999999743
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
.+...++|||||++|+|.++++....... .......+++.+++.|+.|||+||+|||++ +|||||||
T Consensus 140 ----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 140 ----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp ----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred ----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 34568999999999999999975432110 011234689999999999999999999999 99999999
Q ss_pred CCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcc
Q 043900 774 PSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMF 852 (953)
Q Consensus 774 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~ 852 (953)
|+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998765555445556679999999999999999999999999999999998 999997643
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..+ .+........ +...+..+++++.+++.+||+.||++||||+||++.
T Consensus 293 ~~~-~~~~~i~~g~------------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDE-EFCRRLKEGT------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSH-HHHHHHHHTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-HHHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 221 1111111100 000111345678999999999999999999999999
Q ss_pred HHHHHHHh
Q 043900 933 LQSIKNIL 940 (953)
Q Consensus 933 L~~i~~~~ 940 (953)
|+++.+..
T Consensus 342 L~~llq~~ 349 (353)
T 4ase_A 342 LGNLLQAN 349 (353)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHh
Confidence 99987653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=427.04 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=198.3
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+..++||+|+||+||+|.+..+++.||+|++... .....+.+.+|++++++++|||||+++++|... .......++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 5667899999999999999999999999999633 344567899999999999999999999997543 2334568999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-CCCcEEEecc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSDF 790 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Df 790 (953)
||||++|+|.++++. ...+++..+..|+.||+.||+|||++ .++|+||||||+|||++ .++.+||+||
T Consensus 108 mEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeC
Confidence 999999999999953 23689999999999999999999998 12399999999999998 4789999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ............
T Consensus 177 Gla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~~i~~~~~ 247 (290)
T 3fpq_A 177 GLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVK 247 (290)
T ss_dssp TGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCC
T ss_pred cCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----HHHHHHHHcCCC
Confidence 99985432 22334679999999999865 6999999999999999999999999643221 111111100000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .+..+++++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC--------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00112356889999999999999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=477.03 Aligned_cols=445 Identities=20% Similarity=0.202 Sum_probs=297.7
Q ss_pred cCcEEEEEeCCCeeeeecCccccCCccCceeec-CCCccCcCCCccC---------------------------------
Q 043900 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLL-YNNSFNHGIPSEF--------------------------------- 48 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L-~~n~l~~~~~~~~--------------------------------- 48 (953)
+++|+.|+|+++++.|.+|++|++|++|++|+| ++|.+++..|...
T Consensus 322 ~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s 401 (876)
T 4ecn_A 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401 (876)
T ss_dssp TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred CCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhh
Confidence 578999999999999999999999999999999 9998887533221
Q ss_pred ------------------CCCCCCcEEeCCC--CccccccCcCccCCCCCcEEeccCccccc-----------------c
Q 043900 49 ------------------DRLQRLQVLALNN--NSIGGEIPANISSCSNLIQIRLFYNELVG-----------------K 91 (953)
Q Consensus 49 ------------------~~l~~L~~L~L~~--n~i~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~ 91 (953)
.....++.+.++. |++++ +|..|+++++|+.|+|++|.+++ .
T Consensus 402 ~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence 1222344444444 78886 78888888888888888888886 2
Q ss_pred CCcccC--CccccceeeccccccccccCCcccCCCcccEEeccccc-ccc-cCCccccccc-------cccceecccccc
Q 043900 92 IPSELG--SLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN-LDG-GIPDTFGWLK-------NLATLAMAENWL 160 (953)
Q Consensus 92 ~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l 160 (953)
+|..++ ++++|++|+|++|++.+.+|.+|++|++|++|+|++|+ +++ .+|..|+.++ +|++|+|++|++
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 777766 77788888888877777777777777888888888877 776 6777666665 777777777777
Q ss_pred cCCCCC--cccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCC-CcEEEcccccccCcC
Q 043900 161 SGTIPS--SIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASN-LELFQADVNKLTGEV 237 (953)
Q Consensus 161 ~~~~p~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~ 237 (953)
+ .+|. .+.++++|+.|+|++|+++ .+| .+ ..+++|+.|+|++|+++ .+|..+.++++ |+.|++++|+++..+
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~-~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp 635 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP 635 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC-CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hh-cCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc
Confidence 7 6777 7777777777777777777 666 43 36777777777777777 66777777777 777777777776333
Q ss_pred CCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhcc-ccCcEEEcccCcccccCC
Q 043900 238 PYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLS-TTLEMLLLDNNKIFGNIP 316 (953)
Q Consensus 238 ~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~-~~L~~L~L~~N~i~~~~~ 316 (953)
..+ .... ++|+.|++++|++.+.+|
T Consensus 636 ~~~------------------------------------------------------~~~~~~~L~~L~Ls~N~l~g~ip 661 (876)
T 4ecn_A 636 NIF------------------------------------------------------NAKSVYVMGSVDFSYNKIGSEGR 661 (876)
T ss_dssp SCC------------------------------------------------------CTTCSSCEEEEECCSSCTTTTSS
T ss_pred hhh------------------------------------------------------hccccCCCCEEECcCCcCCCccc
Confidence 221 1110 235666666666655443
Q ss_pred cc---cc--CCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCC
Q 043900 317 AA---IG--KFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLG 391 (953)
Q Consensus 317 ~~---~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~ 391 (953)
.. +. .+++|+.|+|++|.|+...+..+..+++|+.|+|++|+|+ .+|..+... .+..+.
T Consensus 662 ~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~---------------~~~~l~ 725 (876)
T 4ecn_A 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKP---------------KDGNYK 725 (876)
T ss_dssp SCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSC---------------TTSCCT
T ss_pred cchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhcc---------------cccccc
Confidence 22 12 3346788888888887433333457788888888888877 444433211 111233
Q ss_pred CCCCCcEEEcCCCccCCCCCcccc-CccccceeeeccCCcccCCCCccccCCCccceeeecC------CcccccCCCCcc
Q 043900 392 QYKTLTIIDLSDNNLTGTIPPQFL-GLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFE------NKLKGEIPSTLG 464 (953)
Q Consensus 392 ~l~~L~~L~L~~N~l~~~~p~~~~-~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~ 464 (953)
++++|+.|+|++|+|+ .+|..+. .....++.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|.
T Consensus 726 nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~ 803 (876)
T 4ecn_A 726 NTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803 (876)
T ss_dssp TGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGG
T ss_pred ccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHh
Confidence 4456777777777776 5666554 223344566666666665 566677777777777766 556666666666
Q ss_pred CCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCc
Q 043900 465 SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528 (953)
Q Consensus 465 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 528 (953)
.+++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..+.....+..+.|++|++.
T Consensus 804 ~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 804 TCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp GCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred cCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 666666666666666 35665554 46666666666666555555555555555555555543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=432.71 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=207.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.+.|+..++||+|+||+||+|+++.+++.||||+++.... ..+|+.++++++|||||++++++. +++..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 3457888899999999999999999999999999974322 246999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 788 (953)
||||||+||+|.++++. ...+++.++..++.||+.||+|||++ +||||||||+|||++.+| .+||+
T Consensus 127 ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ----------MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence 99999999999999952 23689999999999999999999999 999999999999999988 69999
Q ss_pred ccccceecCCCCCc---ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 789 DFGLARFLPLSPAQ---TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 789 DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|||+|+.+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+...... ........
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~ 272 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP 272 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC
Confidence 99999987543221 122345799999999999999999999999999999999999999976433321 11111110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
.... ..+..+++++.+++.+||+.||++|||+.|+++.|........
T Consensus 273 --~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 273 --PPIR---------------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --CGGG---------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --CCch---------------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0000 0011345678899999999999999999999999988776543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=429.68 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=208.4
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||++++++ .+++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 5699999999999999999999999999999999642 234467899999999999999999999995 45588
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+||||++||+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 107 ~yivmEy~~gG~L~~~i~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence 9999999999999999952 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+........
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~- 251 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEY- 251 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC-
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-
Confidence 99999998765444445556789999999999999999999999999999999999999997522111 1111111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. +...++++.+++.+||+.||++|||++|+..
T Consensus 252 ---------~~----------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 ---------DF----------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---------CC----------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---------CC----------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 00 0023456889999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=425.79 Aligned_cols=281 Identities=21% Similarity=0.275 Sum_probs=202.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|.+.++||+|+||+||+|++. ++.||||+++..... ...+..|+..+.+++|||||+++++|... .......++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEec-CCCceEEEE
Confidence 45788899999999999999984 468999999754322 22334566667788999999999998643 112246799
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeecCCCCCeEecCCCcE
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD-----CQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
|||||++|+|.++++. ..++|..+.+++.|++.||+|||++ ..++|+||||||+|||++.++.+
T Consensus 79 V~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 9999999999999952 3589999999999999999999975 24589999999999999999999
Q ss_pred EEeccccceecCCCCCcc--cccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 786 HVSDFGLARFLPLSPAQT--SSIDAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
||+|||+|+......... ......||+.|||||++.+. .++.++|||||||++|||+||..||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999999998775433221 22345799999999998764 4678999999999999999998887543222111
Q ss_pred HHHHHHhhCC-chhh-hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 858 LHNFARMALP-DHVV-DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 858 ~~~~~~~~~~-~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
+......... +... .+.+....+.. .......+++..+.+++.+||+.||++||||+||++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~-------------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCC-------------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCC-------------CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1100000000 0000 00111111000 0011122566789999999999999999999999999999
Q ss_pred HHHH
Q 043900 936 IKNI 939 (953)
Q Consensus 936 i~~~ 939 (953)
+.+.
T Consensus 295 l~~~ 298 (303)
T 3hmm_A 295 LSQQ 298 (303)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 8753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=440.77 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=207.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+.|++.++||+|+||.||+|+++.+++.||||+++.......+.+.+|+.+|++++|||||+++++|. .++..||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence 56999999999999999999999999999999998666566677899999999999999999999964 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
|||||+||+|.++++ ...+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 226 VmEy~~gG~L~~~i~-----------~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 226 VMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEECCTTEEHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecC
Confidence 999999999999985 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+|+.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... ..........+..
T Consensus 292 Gla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~- 366 (423)
T 4fie_A 292 GFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPR- 366 (423)
T ss_dssp TTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC-
T ss_pred ccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCC-
Confidence 9999774332 2334567999999999999999999999999999999999999999752211 1111111111100
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+ .....+++++.+++.+||+.||++|||++|+++
T Consensus 367 -------~--------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 -------L--------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -------C--------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------C--------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000123457889999999999999999999876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=464.27 Aligned_cols=482 Identities=19% Similarity=0.207 Sum_probs=377.9
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
-+.++++|+++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|+.|+++++|++|+|++|
T Consensus 8 ~~c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 8 GVCDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp SEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred ceEECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 346889999998 666554 79999999999999888899999999999999999999888899999999999999999
Q ss_pred ccccccCCcccCCCcccEEeccccccccc-CCccccccccccceecccccccCCCC-CcccccccceEEecCCccccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGG-IPDTFGWLKNLATLAMAENWLSGTIP-SSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
++++..|.+|+++++|++|+|++|++++. .|..|+.+++|++|++++|++.+.+| ..+.++++|++|++++|++++..
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 164 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred ccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence 99987777799999999999999999863 57789999999999999999444555 68999999999999999999888
Q ss_pred ccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccc
Q 043900 189 PLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLC 268 (953)
Q Consensus 189 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~ 268 (953)
|..+. .+++|+.|++++|.+.......+..+++|+.|++++|++++....- ..
T Consensus 165 ~~~l~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------------------------~~ 217 (549)
T 2z81_A 165 SQSLK-SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP--------------------------LP 217 (549)
T ss_dssp TTTTT-TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCC--------------------------CS
T ss_pred hhhhh-ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccc--------------------------cc
Confidence 88776 7999999999999987433333467899999999999998752100 00
Q ss_pred cccccccccEEeccCCcccccCChhhhh---ccccCcEEEcccCcccccC------CccccCCCCCCEEEeecCccccc-
Q 043900 269 SLTNSTRLNRLLINANNFGGLLPACISN---LSTTLEMLLLDNNKIFGNI------PAAIGKFVNLQRLEMWNNRLSGT- 338 (953)
Q Consensus 269 ~l~~~~~L~~L~l~~n~~~~~~p~~~~~---~~~~L~~L~L~~N~i~~~~------~~~~~~l~~L~~L~L~~N~i~~~- 338 (953)
.....+.|+.|++++|.+.+..+..+.. ..++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+...
T Consensus 218 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~ 297 (549)
T 2z81_A 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY 297 (549)
T ss_dssp SCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG
T ss_pred hhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhh
Confidence 0112344555555555555444433321 1246777777777765431 12346677788888888876532
Q ss_pred ----CCcCccCCCCCCeEEeccccccCCCCCCC-CCc-eeeEEEccCCcCCCCCC---ccCCCCCCCcEEEcCCCccCCC
Q 043900 339 ----IPPAIGELQNLRELRLQRNKFLGNIPPSI-GNL-KVFNLDLSCNFLQGSIP---SSLGQYKTLTIIDLSDNNLTGT 409 (953)
Q Consensus 339 ----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l-~l~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~ 409 (953)
.+..+...++|+.|++++|++. .+|..+ ..+ .+++|++++|.+++.+| ..++.+++|++|+|++|++++
T Consensus 298 ~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~- 375 (549)
T 2z81_A 298 LFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS- 375 (549)
T ss_dssp GSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCC-
T ss_pred hcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccc-
Confidence 1222344567888888888886 566554 334 57888888888887664 347889999999999999984
Q ss_pred CCc--cccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccc
Q 043900 410 IPP--QFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSL 487 (953)
Q Consensus 410 ~p~--~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 487 (953)
++. ..+.....++.|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ++|++|+|++|+|++.+
T Consensus 376 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~---- 447 (549)
T 2z81_A 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS---- 447 (549)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----
T ss_pred cccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----
Confidence 432 23344456779999999999 68889999999999999999998 5565443 68999999999999743
Q ss_pred cCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCC-CCcccccccccccCCcCCCCC
Q 043900 488 SSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPI-EGVFKNATITSVLGNLKLCGG 554 (953)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 554 (953)
..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|. ...++.+....+.+|++.|.+
T Consensus 448 ~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 448 LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 57899999999999999 6776 46799999999999999998886 356677788889999988874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=462.91 Aligned_cols=457 Identities=18% Similarity=0.214 Sum_probs=350.3
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
+.||++++++. .+|..+. ++|++|+|++|+++++.|.+|.++++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46888888887 7888776 78899999999998877788888999999999999988777888888899999999999
Q ss_pred cccccCCcccCCccccceeecccccccc-ccCCcccCCCcccEEecccccccccCCccccccccc--cceecccccc--c
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNL--ATLAMAENWL--S 161 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 161 (953)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..|..+++| ++|+|++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 888 56655 78888999999988886 367888888889999998888874 457777777 8888888888 6
Q ss_pred CCCCCcccccc-cceEEecCCcccccccccccccccccccEEEeeCcc-------ccCCCCCCCcCCCCCcEEEcccccc
Q 043900 162 GTIPSSIFNIS-SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQ-------LTGAIPPAISNASNLELFQADVNKL 233 (953)
Q Consensus 162 ~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~N~l 233 (953)
+..|..+..+. +...+++++|.+.+.++...+..+++|+.|++++|. +.+.++ .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 67777777765 345667777777776666665667777777777776 444333 556666666666666555
Q ss_pred cCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccc
Q 043900 234 TGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG 313 (953)
Q Consensus 234 ~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~ 313 (953)
++.. +.+. +.... .++|++|++++|++++
T Consensus 233 ~~~~------------------------------------------------~~~~-~~~~~--~~~L~~L~l~~n~l~~ 261 (520)
T 2z7x_B 233 TWNS------------------------------------------------FIRI-LQLVW--HTTVWYFSISNVKLQG 261 (520)
T ss_dssp EHHH------------------------------------------------HHHH-HHHHH--TSSCSEEEEEEEEEES
T ss_pred CHHH------------------------------------------------HHHH-HHHhh--hCcccEEEeecccccC
Confidence 4210 0000 01111 1367888888888877
Q ss_pred cCCccc-----cCCCCCCEEEeecCcccccCC-cCccCC---CCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCC
Q 043900 314 NIPAAI-----GKFVNLQRLEMWNNRLSGTIP-PAIGEL---QNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQ 383 (953)
Q Consensus 314 ~~~~~~-----~~l~~L~~L~L~~N~i~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~ 383 (953)
.+|..+ .++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+ .+++|++++|.++
T Consensus 262 ~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~ 337 (520)
T 2z7x_B 262 QLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLT 337 (520)
T ss_dssp CCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCC
T ss_pred ccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccC
Confidence 777777 7788888888888888 344 455544 67888888888876422 11333 4678888888888
Q ss_pred CCCCccCCCCCCCcEEEcCCCccCC--CCCccccCccccceeeeccCCcccCCCCc-cccCCCccceeeecCCcccccCC
Q 043900 384 GSIPSSLGQYKTLTIIDLSDNNLTG--TIPPQFLGLSWLLIGLDLSRNQLTGSIPS-EVGNLKNLEVLDVFENKLKGEIP 460 (953)
Q Consensus 384 ~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~~l~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p 460 (953)
+..|..++.+++|++|+|++|++++ .+|..+..+ ..++.|++++|++++.+|. .|..+++|+.|++++|++++..|
T Consensus 338 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l-~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 416 (520)
T 2z7x_B 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM-KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416 (520)
T ss_dssp TTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTC-TTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGG
T ss_pred hhhhhhhccCCCCCEEEccCCccCccccchHHHhhC-CCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchh
Confidence 8888889999999999999999985 344445444 4566899999999874554 58889999999999999988887
Q ss_pred CCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCcc-ccccccCceEeccCCcCcccCCC
Q 043900 461 STLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEF-LVGFQLLENLNLSNNNLEGMVPI 533 (953)
Q Consensus 461 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~p~ 533 (953)
..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++ +|.. +..+++|+.|++++|++++..+.
T Consensus 417 ~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 417 RCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp GSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred hhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCCc
Confidence 7765 79999999999999 788888899999999999999995 5554 88999999999999999987653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=412.98 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=189.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|++++++++|||||++++++ .+++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 36899999999999999999999999999999999642 233456789999999999999999999995 3457
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..|+||||+ +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQ----------RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHH----------SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred EEEEEEeCC-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence 899999999 6899999853 23689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+... .......
T Consensus 153 l~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~~i 224 (275)
T 3hyh_A 153 IADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFKNI 224 (275)
T ss_dssp ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred EeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH
Confidence 99999998764322 2234579999999999998876 5799999999999999999999975211 1111110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... . .+...++++.+++.+||+.||++|||++|+++
T Consensus 225 --------~~~~~-~-------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 225 --------SNGVY-T-------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --------HHTCC-C-------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------HcCCC-C-------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000 0 00023456889999999999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=454.02 Aligned_cols=528 Identities=21% Similarity=0.183 Sum_probs=364.5
Q ss_pred EeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcccc
Q 043900 10 NLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV 89 (953)
Q Consensus 10 ~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~ 89 (953)
|=++.++. +||+.+- +++++|||++|+|+++.|.+|.++++|++|||++|+|++..|++|.++++|++|+|++|+|+
T Consensus 37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 33444554 7777553 47899999999999988889999999999999999999777788999999999999999999
Q ss_pred ccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccccccc-CCccccccccccceecccccccCCCCCcc
Q 043900 90 GKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGG-IPDTFGWLKNLATLAMAENWLSGTIPSSI 168 (953)
Q Consensus 90 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 168 (953)
+..+..|.++++|++|+|++|++++..+.+|++|++|++|+|++|++++. .|..++.+++|++|+|++|+|++..|..+
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 77777899999999999999999977777899999999999999999753 57888999999999999999987777877
Q ss_pred cccccce----EEecCCcccccccccccccccccccEEEeeCccccC-CCCCCCcCCCCCcEEEcccccccCc-------
Q 043900 169 FNISSIT----AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG-AIPPAISNASNLELFQADVNKLTGE------- 236 (953)
Q Consensus 169 ~~l~~L~----~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~------- 236 (953)
..+.+++ .++++.|.++...+..+ ....+..+++.+|.... ..+..+..+..++...+..+.....
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~i~~~~~--~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~ 271 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 271 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEECTTTT--TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred cchhhhhhhhhhhhcccCcccccCcccc--cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence 7766543 68899999985444333 34567788888886542 2334566777777776654433221
Q ss_pred CCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCC
Q 043900 237 VPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIP 316 (953)
Q Consensus 237 ~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~ 316 (953)
...+.....+....+..+..... .......+.....+..+.+.++.+....+ +... ..++.|++.+|.+....+
T Consensus 272 ~~~~~~~~~l~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~~-~~L~~L~l~~~~~~~~~~ 345 (635)
T 4g8a_A 272 KSALEGLCNLTIEEFRLAYLDYY---LDGIIDLFNCLTNVSSFSLVSVTIERVKD--FSYN-FGWQHLELVNCKFGQFPT 345 (635)
T ss_dssp TTTTGGGGGSEEEEEEEECCCSC---EEECTTTTGGGTTCSEEEEESCEEEECGG--GGSC-CCCSEEEEESCEESSCCC
T ss_pred ccccccccchhhhhhhhhhhccc---ccchhhhhhhhcccccccccccccccccc--cccc-hhhhhhhcccccccCcCc
Confidence 11122233344444433322211 11112233445566667776666654432 2222 467777777777764433
Q ss_pred ccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCC--CCCCC-CCceeeEEEccCCcCCCCCCccCCCC
Q 043900 317 AAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGN--IPPSI-GNLKVFNLDLSCNFLQGSIPSSLGQY 393 (953)
Q Consensus 317 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~-~~l~l~~L~L~~N~l~~~~p~~~~~l 393 (953)
. .+..|+.+++++|.+.. +..+..+++|+.|++++|.+... .+..+ ....++.++++.|.+.. .+..+..+
T Consensus 346 ~---~l~~L~~l~l~~n~~~~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l 419 (635)
T 4g8a_A 346 L---KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGL 419 (635)
T ss_dssp C---BCTTCCEEEEESCCSCC--BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTC
T ss_pred c---cchhhhhcccccccCCC--Ccccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccccc
Confidence 2 34567777777777653 23345677777777777777532 22222 22356677777777663 45566777
Q ss_pred CCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCccc-ccCCCCccCCccccEE
Q 043900 394 KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLK-GEIPSTLGSCKKLEQL 472 (953)
Q Consensus 394 ~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L 472 (953)
++|+.+++++|.+....+...+.....++.++++.|.+++..+..+..++.|+.|+|++|++. +..|..|..+++|++|
T Consensus 420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L 499 (635)
T 4g8a_A 420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 499 (635)
T ss_dssp TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence 777777777777665655555555555667777777777777777777777777777777643 3466777777777777
Q ss_pred EccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCC-cc-cccccccccCCcC
Q 043900 473 EMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG-VF-KNATITSVLGNLK 550 (953)
Q Consensus 473 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-~~-~~~~~~~~~~n~~ 550 (953)
+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..- .+ .++....+.+||+
T Consensus 500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 777777777777777777777777777777777777777777777777777777777766531 22 3455566677777
Q ss_pred CCCC
Q 043900 551 LCGG 554 (953)
Q Consensus 551 lcg~ 554 (953)
.|.|
T Consensus 580 ~C~C 583 (635)
T 4g8a_A 580 ACTC 583 (635)
T ss_dssp CCSG
T ss_pred cccC
Confidence 7764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=464.87 Aligned_cols=432 Identities=18% Similarity=0.256 Sum_probs=351.8
Q ss_pred CCcEEeCCCCccccccCcCccCCCCCcEEeccCcccc------c------cCCcccCCccccceeeccccccccccCCcc
Q 043900 53 RLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELV------G------KIPSELGSLSKIEHLSVSVNNLTGSIPSSL 120 (953)
Q Consensus 53 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~------~------~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 120 (953)
+++.|+|++|.++|.+|.+|+++++|+.|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..+
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~ 158 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDF 158 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGS
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhH
Confidence 4555555555555555555555555555555555441 1 222222 44555 6666666665555544
Q ss_pred cC-------------------CCcccEEecc--cccccccCCccccccccccceecccccccCC----------------
Q 043900 121 GN-------------------LSSINTLFLT--DNNLDGGIPDTFGWLKNLATLAMAENWLSGT---------------- 163 (953)
Q Consensus 121 ~~-------------------L~~L~~L~L~--~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---------------- 163 (953)
+. ...++.+.+. +|++++ +|..|+.+++|++|+|++|++++.
T Consensus 159 ~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~ 237 (636)
T 4eco_A 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237 (636)
T ss_dssp CHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred HHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcc
Confidence 41 1223333333 689997 899999999999999999999975
Q ss_pred -CCCccc--ccccceEEecCCcccccccccccccccccccEEEeeCcc-ccC-CCCCCCcCC------CCCcEEEccccc
Q 043900 164 -IPSSIF--NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQ-LTG-AIPPAISNA------SNLELFQADVNK 232 (953)
Q Consensus 164 -~p~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~ 232 (953)
+|..+. ++++|++|+|++|++.+.+|..+. .+++|++|++++|+ +++ .+|..++.+ ++|+.|++++|+
T Consensus 238 ~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~ 316 (636)
T 4eco_A 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316 (636)
T ss_dssp HTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred cCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence 999999 999999999999999999998876 89999999999999 987 788888876 899999999988
Q ss_pred ccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCCh--hhhhccccCcEEEcccCc
Q 043900 233 LTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPA--CISNLSTTLEMLLLDNNK 310 (953)
Q Consensus 233 l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~--~~~~~~~~L~~L~L~~N~ 310 (953)
++. +|. .+..+ ++|+.|++++|+
T Consensus 317 l~~------------------------------------------------------ip~~~~l~~l-~~L~~L~L~~N~ 341 (636)
T 4eco_A 317 LKT------------------------------------------------------FPVETSLQKM-KKLGMLECLYNQ 341 (636)
T ss_dssp CSS------------------------------------------------------CCCHHHHTTC-TTCCEEECCSCC
T ss_pred CCc------------------------------------------------------cCchhhhccC-CCCCEEeCcCCc
Confidence 873 233 44444 579999999999
Q ss_pred ccccCCccccCCCCCCEEEeecCcccccCCcCccCCCC-CCeEEeccccccCCCCCCCCCc---eeeEEEccCCcCCCCC
Q 043900 311 IFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQN-LRELRLQRNKFLGNIPPSIGNL---KVFNLDLSCNFLQGSI 386 (953)
Q Consensus 311 i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l---~l~~L~L~~N~l~~~~ 386 (953)
++|.+| .|..+++|+.|++++|.++ .+|..|..+++ |++|++++|+++ .+|..++.. .+++|++++|.+++..
T Consensus 342 l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~ 418 (636)
T 4eco_A 342 LEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418 (636)
T ss_dssp CEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT
T ss_pred Cccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc
Confidence 998888 9999999999999999999 88999999999 999999999999 788888776 4899999999999999
Q ss_pred CccCC-------CCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCc-cccCC-------Cccceeeec
Q 043900 387 PSSLG-------QYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPS-EVGNL-------KNLEVLDVF 451 (953)
Q Consensus 387 p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~-~~~~l-------~~L~~L~Ls 451 (953)
|..|. .+++|++|+|++|+++ .+|..++.....++.|+|++|+++ .+|. .+..+ ++|+.|+|+
T Consensus 419 p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 419 GKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp TCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECC
T ss_pred hhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECc
Confidence 99998 8889999999999999 788887766667789999999999 4554 44433 399999999
Q ss_pred CCcccccCCCCcc--CCccccEEEccCccccCCCCccccCCCCCcEEEC------CCCcccccCCccccccccCceEecc
Q 043900 452 ENKLKGEIPSTLG--SCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDL------SQNNLSGKIPEFLVGFQLLENLNLS 523 (953)
Q Consensus 452 ~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~l~l~ 523 (953)
+|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|+|+
T Consensus 497 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls 574 (636)
T 4eco_A 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574 (636)
T ss_dssp SSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECC
Confidence 99999 7888887 99999999999999997 8999999999999999 5688999999999999999999999
Q ss_pred CCcCcccCCCCCcccccccccccCCcCCCC
Q 043900 524 NNNLEGMVPIEGVFKNATITSVLGNLKLCG 553 (953)
Q Consensus 524 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg 553 (953)
+|++ +.+|.. .++.+....+.+|+..|-
T Consensus 575 ~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 575 SNDI-RKVNEK-ITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SSCC-CBCCSC-CCTTCCEEECCSCTTCEE
T ss_pred CCcC-CccCHh-HhCcCCEEECcCCCCccc
Confidence 9999 677765 336777777888877664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=461.36 Aligned_cols=365 Identities=21% Similarity=0.303 Sum_probs=297.3
Q ss_pred cccceeeccc--cccccccCCcccCCCcccEEecccccccc-----------------cCCcccc--ccccccceecccc
Q 043900 100 SKIEHLSVSV--NNLTGSIPSSLGNLSSINTLFLTDNNLDG-----------------GIPDTFG--WLKNLATLAMAEN 158 (953)
Q Consensus 100 ~~L~~L~Ls~--N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~L~~N 158 (953)
..++.+.+.. |++++ +|..|++|++|++|+|++|++++ .+|+.++ .+++|++|+|++|
T Consensus 423 l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred cchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 3455555554 88886 78888889999999999998886 3788876 8999999999999
Q ss_pred cccCCCCCcccccccceEEecCCcc-ccc-ccccccccccc-------cccEEEeeCccccCCCCC--CCcCCCCCcEEE
Q 043900 159 WLSGTIPSSIFNISSITAFDAGMNQ-LQG-VIPLDFGFTLQ-------NLQFFSVFENQLTGAIPP--AISNASNLELFQ 227 (953)
Q Consensus 159 ~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~ 227 (953)
++.+.+|..+.++++|+.|+|++|+ +++ .+|..+. .++ +|+.|+|++|+++ .+|. .++++++|+.|+
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~-~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHH-HHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHH-hhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 8888889889999999999999998 887 7777664 344 8888888888888 6777 788888888888
Q ss_pred cccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcc
Q 043900 228 ADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307 (953)
Q Consensus 228 L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~ 307 (953)
+++|+++ .+|.+ ..+ ++|+.|+|+
T Consensus 580 Ls~N~l~-~lp~~------------------------------------------------------~~L-~~L~~L~Ls 603 (876)
T 4ecn_A 580 CVHNKVR-HLEAF------------------------------------------------------GTN-VKLTDLKLD 603 (876)
T ss_dssp CTTSCCC-BCCCC------------------------------------------------------CTT-SEESEEECC
T ss_pred CCCCCcc-cchhh------------------------------------------------------cCC-CcceEEECc
Confidence 8888877 22222 122 467777777
Q ss_pred cCcccccCCccccCCCC-CCEEEeecCcccccCCcCccCCCC--CCeEEeccccccCCCCCCC---C---CceeeEEEcc
Q 043900 308 NNKIFGNIPAAIGKFVN-LQRLEMWNNRLSGTIPPAIGELQN--LRELRLQRNKFLGNIPPSI---G---NLKVFNLDLS 378 (953)
Q Consensus 308 ~N~i~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~---~l~l~~L~L~ 378 (953)
+|+++ .+|..+..+++ |+.|+|++|.|+ .+|..+..++. |+.|+|++|++++.+|... + ...++.|+|+
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEcc
Confidence 77777 66777777777 888888888887 67777776654 8888888888887666433 2 2257889999
Q ss_pred CCcCCCCCCcc-CCCCCCCcEEEcCCCccCCCCCccccCccc-------cceeeeccCCcccCCCCcccc--CCCcccee
Q 043900 379 CNFLQGSIPSS-LGQYKTLTIIDLSDNNLTGTIPPQFLGLSW-------LLIGLDLSRNQLTGSIPSEVG--NLKNLEVL 448 (953)
Q Consensus 379 ~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-------~l~~L~ls~N~l~~~~~~~~~--~l~~L~~L 448 (953)
+|.++ .+|.. +..+++|+.|+|++|+|+ .+|..++.... .++.|+|++|+|+ .+|..+. .+++|+.|
T Consensus 682 ~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L 758 (876)
T 4ecn_A 682 YNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758 (876)
T ss_dssp SSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEE
T ss_pred CCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEE
Confidence 99998 45554 458999999999999999 88888776553 6789999999999 7888887 99999999
Q ss_pred eecCCcccccCCCCccCCccccEEEccC------ccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEec
Q 043900 449 DVFENKLKGEIPSTLGSCKKLEQLEMQG------NFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNL 522 (953)
Q Consensus 449 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l 522 (953)
+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|+|
T Consensus 759 ~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdL 834 (876)
T 4ecn_A 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDI 834 (876)
T ss_dssp ECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEEC
T ss_pred EeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEEC
Confidence 999999996 899999999999999976 889999999999999999999999999 68898876 69999999
Q ss_pred cCCcCcccCC
Q 043900 523 SNNNLEGMVP 532 (953)
Q Consensus 523 ~~N~l~~~~p 532 (953)
++|++....+
T Consensus 835 s~N~l~~i~~ 844 (876)
T 4ecn_A 835 ADNPNISIDV 844 (876)
T ss_dssp CSCTTCEEEC
T ss_pred CCCCCCccCh
Confidence 9999986554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=417.66 Aligned_cols=243 Identities=23% Similarity=0.250 Sum_probs=190.3
Q ss_pred cCCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|++.+.||+|+||+||+|+.. .+++.||+|+++... ......+.+|++++++++|||||++++++. ++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 57999999999999999999974 456789999996322 223446888999999999999999999954 44
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..|+|||||+||+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence 789999999999999999952 23689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+......
T Consensus 166 Kl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~- 241 (304)
T 3ubd_A 166 KLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKA- 241 (304)
T ss_dssp EEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC-
T ss_pred EecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcC-
Confidence 999999998653222 23334679999999999999999999999999999999999999997532111 01111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
.. . .+..+++++.+++.+||+.||++|||+
T Consensus 242 -----------~~-~-------------------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 -----------KL-G-------------------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -----------CC-C-------------------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -----------CC-C-------------------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 00 0 001234568899999999999999995
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=450.50 Aligned_cols=512 Identities=20% Similarity=0.184 Sum_probs=424.5
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
..++.|||++|++.+-.+.+|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 46899999999998555568999999999999999999988899999999999999999999766778999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccc-cCCcccCCCcccEEecccccccccCCcccccccccc----ceecccc
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGS-IPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA----TLAMAEN 158 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N 158 (953)
++|+|++..+..|+++++|++|+|++|++++. +|..++++++|++|+|++|+|++..+..|..+.+++ .++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 99999977777899999999999999999753 578889999999999999999988999999888766 5788999
Q ss_pred cccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCcc------ccCCCCCCCcCCCCCcEEEccccc
Q 043900 159 WLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQ------LTGAIPPAISNASNLELFQADVNK 232 (953)
Q Consensus 159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~------l~~~~~~~~~~l~~L~~L~L~~N~ 232 (953)
.++ .++........+..+++++|......+...+..+..++...+..+. +.......+..+..+....+..+.
T Consensus 212 ~l~-~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 212 PMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCC-EECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred ccc-ccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 998 4555555666788999999987755555555578888877775543 333445566777778777777654
Q ss_pred cc----CcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEccc
Q 043900 233 LT----GEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDN 308 (953)
Q Consensus 233 l~----~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~ 308 (953)
.. +....+.....++.+.+..+.+.. +..+.....++.|++.+|.+.+..+..+ ..|+.+++..
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~--------~~~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~ 358 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTS 358 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEE--------CGGGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEES
T ss_pred hcccccchhhhhhhhccccccccccccccc--------ccccccchhhhhhhcccccccCcCcccc----hhhhhccccc
Confidence 43 233445556778888888877654 3345566789999999999887655432 5789999999
Q ss_pred CcccccCCccccCCCCCCEEEeecCccc--ccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCC
Q 043900 309 NKIFGNIPAAIGKFVNLQRLEMWNNRLS--GTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGS 385 (953)
Q Consensus 309 N~i~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~ 385 (953)
|.+... ..+..+++|+.|++++|.+. +..+..+..+.+|+.|+++.|.+... +..+..+ .++.+++++|.....
T Consensus 359 n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~-~~~~~~l~~L~~l~l~~~~~~~~ 435 (635)
T 4g8a_A 359 NKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQM 435 (635)
T ss_dssp CCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEE-CSCCTTCTTCCEEECTTSEEEST
T ss_pred ccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccccc-cccccccccccchhhhhcccccc
Confidence 998743 34567899999999999986 34567778899999999999999854 4445444 689999998887755
Q ss_pred CC-ccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcc-cCCCCccccCCCccceeeecCCcccccCCCCc
Q 043900 386 IP-SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQL-TGSIPSEVGNLKNLEVLDVFENKLKGEIPSTL 463 (953)
Q Consensus 386 ~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 463 (953)
.+ ..|..+++++.++++.|.+.+..|.. +.....++.|++++|++ .+..|..|..+++|++|+|++|+|++..|..|
T Consensus 436 ~~~~~~~~l~~l~~l~ls~n~l~~~~~~~-~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 514 (635)
T 4g8a_A 436 SEFSVFLSLRNLIYLDISHTHTRVAFNGI-FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 514 (635)
T ss_dssp TSSCTTTTCTTCCEEECTTSCCEECCTTT-TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ccccccccccccccccccccccccccccc-cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence 44 56889999999999999999655554 44455667999999985 44678999999999999999999999999999
Q ss_pred cCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCcccccc-ccCceEeccCCcCcccCC
Q 043900 464 GSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGF-QLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 464 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p 532 (953)
.++++|++|+|++|+|++..|..|..+++|++|||++|+|++..|..+..+ ++|+.|+|++|+|++...
T Consensus 515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred cCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999999999999999999999999999988 689999999999987544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=412.26 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=191.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-------
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------- 702 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 702 (953)
++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999999999999999997433 3445788999999999999999999999754321
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
......|+|||||++|+|.+++..... ....++..++.|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-------IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-------GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-------CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence 123357999999999999999964322 12356777899999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCc----------ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 783 MMAHVSDFGLARFLPLSPAQ----------TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
+.+||+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 99999999999877543211 12234569999999999999999999999999999999996 775311
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+. ..... .+.+... ........+...+++.+||+.||++|||+.|+++
T Consensus 232 ~~----~~~~~--------~~~~~~~-------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ER----VRTLT--------DVRNLKF-------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH----HHHHH--------HHHTTCC-------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----HHHHH--------HHhcCCC-------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 00000 0000000 0111233455778999999999999999999986
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=440.38 Aligned_cols=458 Identities=22% Similarity=0.218 Sum_probs=355.8
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
++|++++|+++. +|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 579999999997 776665 89999999999999777788999999999999999999888899999999999999999
Q ss_pred ccccccCCcccCCCcccEEecccccccc-cCCccccccccccceecccccccCCCCCcccccccc--eEEecCCccc--c
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDG-GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSI--TAFDAGMNQL--Q 185 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~ 185 (953)
+|+ .+|.. .+++|++|+|++|++++ ..|+.|+.+++|++|+|++|++++ ..+..+++| +.|++++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 998 56655 88999999999999986 467899999999999999999874 356666666 7777777777 5
Q ss_pred cccccccccccc-cccEEEeeCccccCCCC-CCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCc
Q 043900 186 GVIPLDFGFTLQ-NLQFFSVFENQLTGAIP-PAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSN 263 (953)
Q Consensus 186 ~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~ 263 (953)
+..|..+. .+. +...+++++|++.+.++ ..+.++++|+.|++++|......
T Consensus 154 ~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~-------------------------- 206 (520)
T 2z7x_B 154 KEDPEGLQ-DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC-------------------------- 206 (520)
T ss_dssp SCCTTTTT-TCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTT--------------------------
T ss_pred cccccccc-ccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccccc--------------------------
Confidence 55555443 222 23345566666554333 24555666666666555411000
Q ss_pred ccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCcccc---CCCCCCEEEeecCcccccCC
Q 043900 264 LNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIG---KFVNLQRLEMWNNRLSGTIP 340 (953)
Q Consensus 264 ~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~---~l~~L~~L~L~~N~i~~~~~ 340 (953)
..+.+.+| .+..+ ++|+.|++++|.+.+..+..+. ..++|++|++++|.+++.+|
T Consensus 207 --------------------~~~~~~~~-~l~~l-~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p 264 (520)
T 2z7x_B 207 --------------------SYFLSILA-KLQTN-PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264 (520)
T ss_dssp --------------------HHHHHHHH-GGGGC-TTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCC
T ss_pred --------------------ceeecchh-hhccc-cchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccc
Confidence 00222222 33333 4677777777776543222211 24689999999999999999
Q ss_pred cCc-----cCCCCCCeEEeccccccCCCC-CCCC----CceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCC
Q 043900 341 PAI-----GELQNLRELRLQRNKFLGNIP-PSIG----NLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTI 410 (953)
Q Consensus 341 ~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~----~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 410 (953)
..+ +.+++|+.+++++|.+ .+| ..+. +..++.|++++|.+.... .+..+++|++|++++|++++.+
T Consensus 265 ~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~ 340 (520)
T 2z7x_B 265 FRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTV 340 (520)
T ss_dssp CCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTT
T ss_pred cchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhh
Confidence 998 9999999999999999 455 3332 346899999999987432 1368899999999999999888
Q ss_pred CccccCccccceeeeccCCcccC--CCCccccCCCccceeeecCCcccccCCC-CccCCccccEEEccCccccCCCCccc
Q 043900 411 PPQFLGLSWLLIGLDLSRNQLTG--SIPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSL 487 (953)
Q Consensus 411 p~~~~~~~~~l~~L~ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~ 487 (953)
|..+..+. .++.|++++|++++ .+|..|..+++|++|++++|++++.+|. .+..+++|++|+|++|++++..|..+
T Consensus 341 ~~~~~~l~-~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 341 FENCGHLT-ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp TTTCCCCS-SCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred hhhhccCC-CCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence 88876655 56699999999997 5667899999999999999999975665 58899999999999999998888777
Q ss_pred cCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCC-CCcccccccccccCCcCCCCC
Q 043900 488 SSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPI-EGVFKNATITSVLGNLKLCGG 554 (953)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 554 (953)
. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++.++. ...++.+....+.+|+..|.+
T Consensus 420 ~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp C--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred c--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence 5 79999999999999 7888888999999999999999965443 345667777888999887763
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=440.24 Aligned_cols=451 Identities=20% Similarity=0.199 Sum_probs=286.9
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
+++++++|++++ +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|+.|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 566666666665 444332 56666666666666444456666666666666666666555666666666666666666
Q ss_pred ccccccCCcccCCCcccEEeccccccccc-CCccccccccccceecccccccCCCCCcccccccc--eEEecCCccc--c
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGG-IPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSI--TAFDAGMNQL--Q 185 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~ 185 (953)
+|+ .+|.. .+++|++|+|++|++++. .|+.|+++++|++|+|++|++++ ..+..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeeccccccc
Confidence 665 44444 566666666666666542 24566666666666666666653 233344444 6666666666 5
Q ss_pred cccccccccccc-cccEEEeeCccccCCCCC-CCcCCCCCcEEEcccccc-----cCcCCCCCCCCccceeeecccccCC
Q 043900 186 GVIPLDFGFTLQ-NLQFFSVFENQLTGAIPP-AISNASNLELFQADVNKL-----TGEVPYLEKPQRLSVFSITENSLGS 258 (953)
Q Consensus 186 ~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l-----~~~~~~l~~~~~L~~l~l~~n~l~~ 258 (953)
+..|..+. .+. ..-.+++++|.+.+.++. .+..+++|+.|++++|+. .+.++.
T Consensus 185 ~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~------------------- 244 (562)
T 3a79_B 185 GGETESLQ-IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE------------------- 244 (562)
T ss_dssp SSSCCEEE-ECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHH-------------------
T ss_pred ccCccccc-ccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHH-------------------
Confidence 45554443 221 111445566665544332 344566666666666541 111111
Q ss_pred CCCCcccccccccccccccEEeccCCcccccC----ChhhhhccccCcEEEcccCcccccCCccc-----cCCCCCCEEE
Q 043900 259 RGHSNLNFLCSLTNSTRLNRLLINANNFGGLL----PACISNLSTTLEMLLLDNNKIFGNIPAAI-----GKFVNLQRLE 329 (953)
Q Consensus 259 ~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~----p~~~~~~~~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~ 329 (953)
+..++.|+.+++.++.+.+.. +..+. . .+|++|++++|.+++.+|..+ ..++.|+.++
T Consensus 245 -----------l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~-~-~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~ 311 (562)
T 3a79_B 245 -----------LTRGPTLLNVTLQHIETTWKCSVKLFQFFW-P-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEH 311 (562)
T ss_dssp -----------HHSCSSCEEEEEEEEEECHHHHHHHHHHHT-T-SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEE
T ss_pred -----------HhccCcceEEEecCCcCcHHHHHHHHHhhh-c-ccccEEEEeccEeeccccchhhhcccccchheehhh
Confidence 222233333333333332211 11111 1 367888888888877777766 5666666666
Q ss_pred eecCcccccCC-cCccC---CCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCC
Q 043900 330 MWNNRLSGTIP-PAIGE---LQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDN 404 (953)
Q Consensus 330 L~~N~i~~~~~-~~~~~---l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 404 (953)
++.|.+ .+| ..+.. ..+|++|++++|.+..... .+.+ .+++|++++|.+++..|..++++++|++|+|++|
T Consensus 312 ~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 387 (562)
T 3a79_B 312 VKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMVC--PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387 (562)
T ss_dssp EEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCCC--CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSS
T ss_pred ccccee--ecChhhhhhhhccCcceEEEccCCCcccccC--ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCC
Confidence 666666 233 22222 2568888888888753221 1333 4678888888888888888888999999999999
Q ss_pred ccCCCCC---ccccCccccceeeeccCCcccCCCC-ccccCCCccceeeecCCcccccCCCCccCCccccEEEccCcccc
Q 043900 405 NLTGTIP---PQFLGLSWLLIGLDLSRNQLTGSIP-SEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQ 480 (953)
Q Consensus 405 ~l~~~~p---~~~~~~~~~l~~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 480 (953)
++++ ++ ..+..+ ..++.|++++|++++.+| ..|..+++|++|++++|++++..|..+. ++|+.|+|++|+|+
T Consensus 388 ~l~~-~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 388 GLKN-FFKVALMTKNM-SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463 (562)
T ss_dssp CCCB-TTHHHHTTTTC-TTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC
T ss_pred CcCC-cccchhhhcCC-CCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc
Confidence 9884 33 334433 456689999999987444 4588899999999999999887777665 78999999999999
Q ss_pred CCCCccccCCCCCcEEECCCCcccccCCcc-ccccccCceEeccCCcCcccCCC
Q 043900 481 GPIPSSLSSLKGLNVLDLSQNNLSGKIPEF-LVGFQLLENLNLSNNNLEGMVPI 533 (953)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~p~ 533 (953)
.+|..+..+++|++|+|++|+|++ +|.. +..+++|+.|++++|+++|..|.
T Consensus 464 -~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 464 -SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp -CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred -ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 677777799999999999999995 5555 88999999999999999987664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=414.99 Aligned_cols=286 Identities=21% Similarity=0.226 Sum_probs=206.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccc-ccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGV-DYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~~ 706 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|+++|++++|||||++++++... .+.+..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999999999999999999643 234456788999999999999999999987543 244567
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..|+|||||+ |+|.+++.. ...+++.++..++.||+.||+|||++ |||||||||+|||++.++.+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----------~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----------SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----------SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEEEeCCC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEE
Confidence 8999999995 789999853 34699999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCC--CcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 787 VSDFGLARFLPLSP--AQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 787 L~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|+|||+|+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+ .+.....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~ 277 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMM 277 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence 99999998764322 22233456799999999998875 46899999999999999999999997632221 1111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....... ......................+..........++++.+++.+||+.||++|||++|+++
T Consensus 278 ~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSP-AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCG-GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCCh-HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111100 000000000000000000000000000000123457889999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=404.83 Aligned_cols=200 Identities=24% Similarity=0.321 Sum_probs=169.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
..++|++.+.||+|+||+||+|+++ .+++.||+|++.... ...++.+|+++++.+ +||||+++++++. +
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~ 91 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR-----K 91 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----E
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE-----E
Confidence 4678999999999999999999875 356789999986443 345678999999998 6999999999853 4
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-C
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-M 783 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 783 (953)
++..++||||+++|+|.+++. .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred CCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCC
Confidence 578999999999999999984 488999999999999999999999 99999999999999876 7
Q ss_pred cEEEeccccceecCCCCCc--------------------------ccccccccccccccccccCCC-CCCcccchHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQ--------------------------TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGI 836 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~ 836 (953)
.+||+|||+|+........ ......+||+.|||||++.+. .|+.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 9999999999876432211 112234699999999998876 4899999999999
Q ss_pred HHHHHHhCCCCCCCc
Q 043900 837 LLLELVTRKKPVDSM 851 (953)
Q Consensus 837 vl~elltg~~pf~~~ 851 (953)
++|||+||+.||...
T Consensus 236 il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHTCSSSSCC
T ss_pred HHHHHHHCCCCCCCC
Confidence 999999999999653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=421.87 Aligned_cols=456 Identities=17% Similarity=0.158 Sum_probs=361.9
Q ss_pred CCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccE
Q 043900 49 DRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128 (953)
Q Consensus 49 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~ 128 (953)
..+...+++|+++|+++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|++|+++++|++
T Consensus 28 ~~~~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 104 (562)
T 3a79_B 28 FSNELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104 (562)
T ss_dssp -----CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred cccCCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence 33445589999999999 6888765 89999999999999888889999999999999999999888999999999999
Q ss_pred EecccccccccCCccccccccccceecccccccC-CCCCcccccccceEEecCCcccccccccccccccccc--cEEEee
Q 043900 129 LFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG-TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNL--QFFSVF 205 (953)
Q Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L--~~L~L~ 205 (953)
|+|++|+|+ .+|.. .+++|++|+|++|++++ ..|..+.++++|++|++++|++++. .+ ..+++| +.|+++
T Consensus 105 L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~-~~l~~L~L~~L~L~ 177 (562)
T 3a79_B 105 LDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DL-LPVAHLHLSCILLD 177 (562)
T ss_dssp EECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TT-GGGTTSCEEEEEEE
T ss_pred EECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---ch-hhhhhceeeEEEee
Confidence 999999999 56665 89999999999999995 3468999999999999999999853 22 245666 999999
Q ss_pred Cccc--cCCCCCCCcCCC--CCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEec
Q 043900 206 ENQL--TGAIPPAISNAS--NLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLI 281 (953)
Q Consensus 206 ~N~l--~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l 281 (953)
+|++ ++..|..+..+. .+ .++++.|.+.+..+.. .+..+++|+.+++
T Consensus 178 ~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~----------------------------~~~~l~~L~~L~l 228 (562)
T 3a79_B 178 LVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNM----------------------------SVNALGHLQLSNI 228 (562)
T ss_dssp ESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEE----------------------------EESSEEEEEEEEE
T ss_pred cccccccccCcccccccCcceE-EEEecCccchhhhhhh----------------------------cccccceEEEecc
Confidence 9999 888888888776 33 5578888888754431 1122344555555
Q ss_pred cCCc-----ccccCChhhhhccccCcEEEcccCcccccC----CccccCCCCCCEEEeecCcccccCCcCc-----cCCC
Q 043900 282 NANN-----FGGLLPACISNLSTTLEMLLLDNNKIFGNI----PAAIGKFVNLQRLEMWNNRLSGTIPPAI-----GELQ 347 (953)
Q Consensus 282 ~~n~-----~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~ 347 (953)
++|. +.+ .+..+..+ ++|+.|+++++.+.+.. +.. ...++|++|++++|.+++.+|..+ ..++
T Consensus 229 ~~n~~~~~~l~~-~~~~l~~l-~~L~~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~ 305 (562)
T 3a79_B 229 KLNDENCQRLMT-FLSELTRG-PTLLNVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALK 305 (562)
T ss_dssp ECCSTTHHHHHH-HHHHHHSC-SSCEEEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCC
T ss_pred cccccccchHHH-HHHHHhcc-CcceEEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccch
Confidence 5553 111 12334444 57888888887765421 222 234589999999999998899887 7788
Q ss_pred CCCeEEeccccccCCCCC-C----CCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccce
Q 043900 348 NLRELRLQRNKFLGNIPP-S----IGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLI 422 (953)
Q Consensus 348 ~L~~L~L~~N~l~~~~p~-~----~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~ 422 (953)
.|+.++++.|.+ .+|. . +.+..+++|++++|.+.... ....+++|++|++++|++++.+|..+..+. .++
T Consensus 306 ~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~ 380 (562)
T 3a79_B 306 SLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLK-RLQ 380 (562)
T ss_dssp EEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCS-SCC
T ss_pred heehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccC-CCC
Confidence 888888888877 3442 2 23346899999999986432 126889999999999999988888776665 466
Q ss_pred eeeccCCcccCC--CCccccCCCccceeeecCCcccccCCC-CccCCccccEEEccCccccCCCCccccCCCCCcEEECC
Q 043900 423 GLDLSRNQLTGS--IPSEVGNLKNLEVLDVFENKLKGEIPS-TLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLS 499 (953)
Q Consensus 423 ~L~ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 499 (953)
.|++++|++++. +|..|.++++|+.|++++|++++.+|. .+..+++|++|+|++|+|++.+|..+. ++|++|+|+
T Consensus 381 ~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~ 458 (562)
T 3a79_B 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLH 458 (562)
T ss_dssp EEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECC
T ss_pred EEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECC
Confidence 999999999963 357799999999999999999984554 588999999999999999988777665 799999999
Q ss_pred CCcccccCCccccccccCceEeccCCcCcccCCC-CCcccccccccccCCcCCCCC
Q 043900 500 QNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPI-EGVFKNATITSVLGNLKLCGG 554 (953)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 554 (953)
+|+|+ .+|..+..+++|+.|++++|++++.++. ...++.+....+.+|++.|.+
T Consensus 459 ~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 459 NNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp SSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 99999 6888777999999999999999965554 455667777888999988873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=408.43 Aligned_cols=250 Identities=20% Similarity=0.232 Sum_probs=198.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhh---HHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGA---FKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.++||+|+||+||+|+++.+++.||+|+++... ... ......++.+++.++|||||++++++ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 357999999999999999999999999999999996321 111 22334456777888999999999995 4
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
+.+..|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++ |||||||||+|||++.+|
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~----------~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 329 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred ECCEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence 55889999999999999999953 23689999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
.+||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+....+ .....
T Consensus 330 ~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~ 403 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID 403 (689)
T ss_dssp CEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHH
T ss_pred CEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence 99999999999775332 234579999999999864 579999999999999999999999997532221 11111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
....... . ..+...++++.+++.+||+.||++|++ ++||.+
T Consensus 404 ~~i~~~~--------~--------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 404 RMTLTMA--------V--------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHCC--------C--------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HhhcCCC--------C--------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1100000 0 000123456889999999999999998 677654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=382.46 Aligned_cols=285 Identities=31% Similarity=0.471 Sum_probs=227.3
Q ss_pred CHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc
Q 043900 622 SYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD 701 (953)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 701 (953)
++.++...+++|++.+.||+|+||.||+|++.+ ++.||||++........+.+.+|++++++++||||++++++|.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 105 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--- 105 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC---
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECC-CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc---
Confidence 334455577899999999999999999999764 5689999997666666788999999999999999999999954
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
..+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 106 --~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~ 174 (321)
T 2qkw_B 106 --ERNEMILIYKYMENGNLKRHLYGSDL------PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174 (321)
T ss_dssp --CTTCCEEEEECCTTCBTGGGSSSSCC------CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECT
T ss_pred --CCCeEEEEEEcCCCCcHHHHHhccCC------CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECC
Confidence 44778999999999999999964332 123689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC-ccHHH
Q 043900 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-MNLHN 860 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~-~~~~~ 860 (953)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....
T Consensus 175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 99999999999987654333333344568999999999988999999999999999999999999997644332 22333
Q ss_pred HHHhhC-CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 861 FARMAL-PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 861 ~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
|..... .......+++.... ....+++.++.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPNLAD------------------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HTHHHHTTTCCCSSSSSSCTT------------------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhhccccccHHHhcChhhcc------------------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 322111 11122222222111 11235678899999999999999999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=411.63 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=207.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.......+.+.+|+++|+.++|||||++++++ .++...+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 46899999999999999999999999999999999876666677899999999999999999999995 4558899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC--CcEEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE--MMAHV 787 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 787 (953)
+|||||+||+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 231 iv~E~~~gg~L~~~i~~~---------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEECCCCCBHHHHHTCT---------TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEeecCCCcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence 999999999999998532 23589999999999999999999999 99999999999999854 79999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+.+.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ .+.........
T Consensus 299 ~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~~ 374 (573)
T 3uto_A 299 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN 374 (573)
T ss_dssp CCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC
T ss_pred eeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCCC
Confidence 9999999875332 2334579999999999999999999999999999999999999997532211 01111000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .....+++++.+++.+||+.||++|||++|+++
T Consensus 375 ------------~~~----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 ------------MDD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ------------CCS----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------------CCc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000123456889999999999999999999976
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=395.27 Aligned_cols=387 Identities=25% Similarity=0.317 Sum_probs=195.7
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCC-------------cEEeccCccccccC
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNL-------------IQIRLFYNELVGKI 92 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~ 92 (953)
+.++|++|++++|++ +.+|.+|+++++|++|++++|.+++.+|..++++.+| ++|++++|.+++ +
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 346666666666666 3466666666666666666666666666666666654 666666666663 3
Q ss_pred CcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccc
Q 043900 93 PSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNIS 172 (953)
Q Consensus 93 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 172 (953)
|.. .++|++|++++|++++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +| .+.+++
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 331 2466666666666664 4533 2566666666666653 2221 1466666666666663 55 466666
Q ss_pred cceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeec
Q 043900 173 SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSIT 252 (953)
Q Consensus 173 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~ 252 (953)
+|++|++++|++++ +|.. ..+|++|++++|++++ +| .++++++|+.|++++|++++.+..
T Consensus 154 ~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~------------- 213 (454)
T 1jl5_A 154 FLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL------------- 213 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC-------------
T ss_pred CCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC-------------
Confidence 66666666666663 4432 2366666666666664 34 466666666666666666543211
Q ss_pred ccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeec
Q 043900 253 ENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWN 332 (953)
Q Consensus 253 ~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 332 (953)
+++|+.|++++|.++ .+| .++.+++|+.|++++
T Consensus 214 ---------------------------------------------~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~ 246 (454)
T 1jl5_A 214 ---------------------------------------------PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADN 246 (454)
T ss_dssp ---------------------------------------------CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCS
T ss_pred ---------------------------------------------cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCC
Confidence 124666666666665 344 366666666666666
Q ss_pred CcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCc
Q 043900 333 NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPP 412 (953)
Q Consensus 333 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 412 (953)
|++++ +|.. .++|++|++++|++++ +|..+ ..+++|++++|.+++. |.. .++|+.|++++|++++ ++
T Consensus 247 N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~- 313 (454)
T 1jl5_A 247 NLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC- 313 (454)
T ss_dssp SCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC-
T ss_pred CcCCc-cccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc-
Confidence 66663 3332 2566666666666664 34332 2345566666666541 111 1467777777777763 22
Q ss_pred cccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccC--CCCccccCC
Q 043900 413 QFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQG--PIPSSLSSL 490 (953)
Q Consensus 413 ~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l 490 (953)
.....++.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|++|++++|++++ .+|.++..
T Consensus 314 ---~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~- 381 (454)
T 1jl5_A 314 ---DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED- 381 (454)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE-
T ss_pred ---CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh-
Confidence 223345567777777764 4443 466777777777776 4555 35677777777777776 45555443
Q ss_pred CCCcEEECCCCcccccCCccccccccCceEeccCCcCcc
Q 043900 491 KGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529 (953)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 529 (953)
|+.|++.+.+|.. +++|+.|++++|++++
T Consensus 382 -------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 382 -------LRMNSHLAEVPEL---PQNLKQLHVETNPLRE 410 (454)
T ss_dssp -------EECCC---------------------------
T ss_pred -------hhhcccccccccc---cCcCCEEECCCCcCCc
Confidence 2345555555553 3567777777777776
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=395.30 Aligned_cols=393 Identities=18% Similarity=0.179 Sum_probs=258.9
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccC-CcccCCccccceeecc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKI-PSELGSLSKIEHLSVS 108 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls 108 (953)
-+.++.++++++. +|. + .++|++|+|++|.|++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|+
T Consensus 12 ~~~~~c~~~~l~~-lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 12 GYNAICINRGLHQ-VPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TTEEECCSSCCSS-CCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred ccccCcCCCCccc-CCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 3567888888887 554 2 267888888888888777888888888888888888876333 5667788888888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCcc--ccccccccceecccccccCCCCCc-ccccccceEEecCCcccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDT--FGWLKNLATLAMAENWLSGTIPSS-IFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~ 185 (953)
+|++++..|.+|+++++|++|+|++|++++..+.. |..+++|++|+|++|++++..|.. +.++++|++|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 88887777777888888888888888777544333 666666666666666666444444 444444444444444444
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCC--CCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCc
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNA--SNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSN 263 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~ 263 (953)
+..+..+..+ .+|+.|++++|.+.+..+....
T Consensus 168 -------------------------~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~--------------------- 201 (455)
T 3v47_A 168 -------------------------SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG--------------------- 201 (455)
T ss_dssp -------------------------CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT---------------------
T ss_pred -------------------------ccChhhhhccccccccccccccCcccccchhhcc---------------------
Confidence 4444444433 4555566666555543321100
Q ss_pred ccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCC---CCCCEEEeecCcccccCC
Q 043900 264 LNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKF---VNLQRLEMWNNRLSGTIP 340 (953)
Q Consensus 264 ~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~i~~~~~ 340 (953)
......+... ++|++|++++|++++..|..+... ++|+.|++++|.+.+.
T Consensus 202 ------------------------~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~-- 254 (455)
T 3v47_A 202 ------------------------WEKCGNPFKN-TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS-- 254 (455)
T ss_dssp ------------------------HHHHCCTTTT-CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSC--
T ss_pred ------------------------cccccccccc-ceeeeEecCCCcccccchhhhhccccccceeeEeecccccccc--
Confidence 0000001111 345666666666655555444332 4455555555544321
Q ss_pred cCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCC--CCCCcEEEcCCCccCCCCCccccCcc
Q 043900 341 PAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQ--YKTLTIIDLSDNNLTGTIPPQFLGLS 418 (953)
Q Consensus 341 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~~~ 418 (953)
. +..+.+....+..+.. .++|+.|++++|++++.+|..+..+.
T Consensus 255 ----------------------~-------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 299 (455)
T 3v47_A 255 ----------------------S-------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299 (455)
T ss_dssp ----------------------C-------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCT
T ss_pred ----------------------c-------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCC
Confidence 0 0111122122222222 24566666666666655444444333
Q ss_pred ccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEEC
Q 043900 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDL 498 (953)
Q Consensus 419 ~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 498 (953)
.++.|++++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..|.+|..+++|++|+|
T Consensus 300 -~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 300 -DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp -TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred -CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 3446667777776667778888999999999999999888889999999999999999999888999999999999999
Q ss_pred CCCcccccCCccccccccCceEeccCCcCcccCCCCC
Q 043900 499 SQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535 (953)
Q Consensus 499 s~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 535 (953)
++|++++..+..+..+++|+.|++++|++++.+|...
T Consensus 379 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9999998777778899999999999999999988543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.99 Aligned_cols=269 Identities=23% Similarity=0.372 Sum_probs=218.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|.+.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||++++++|.. +...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 4578999999999999999999999889999999977667778889999999999999999999999653 47789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM---------DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEECCTTCBHHHHHHHC---------CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence 999999999999999632 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcc------------cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 790 FGLARFLPLSPAQT------------SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 790 fG~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
||.++......... ......||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764332211 111456999999999999999999999999999999999999998753322111
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.. .......+.. .+..+++++.+++.+||+.||++|||++|+++.|++++
T Consensus 232 ~~--------~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 232 FG--------LNVRGFLDRY----------------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SS--------BCHHHHHHHT----------------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hh--------hhhhcccccc----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0000000000 00123456889999999999999999999999999999
Q ss_pred HHhccccc
Q 043900 938 NILLGHRI 945 (953)
Q Consensus 938 ~~~~~~~~ 945 (953)
....++..
T Consensus 282 ~~~~~~~~ 289 (310)
T 3s95_A 282 MHLAGHLP 289 (310)
T ss_dssp HHHHHCCC
T ss_pred HhccCccc
Confidence 88766543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=378.16 Aligned_cols=290 Identities=33% Similarity=0.542 Sum_probs=231.1
Q ss_pred CCCCCcCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEE
Q 043900 616 NSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKIL 694 (953)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~ 694 (953)
.....+++.++....++|++.+.||+|+||.||+|++.+ ++.||||+++... ......+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 445678999999999999999999999999999998664 5689999996433 22334688999999999999999999
Q ss_pred eeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
++|. .....++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+.++|+||||||
T Consensus 94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 94 GFCM-----TPTERLLVYPYMANGSVASCLRERPES------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp EEEC-----CSSCCEEEEECCTTCBHHHHHHCCSTT------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred EEEe-----cCCceEEEEEeccCCCHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 9964 346789999999999999999754322 34589999999999999999999998777999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc---
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM--- 851 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~--- 851 (953)
+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 999999999999999999987653322 2333455999999999998889999999999999999999999999632
Q ss_pred ccCCccHHHHHHhhCCch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 852 FEGDMNLHNFARMALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
...+.....+........ .....+...... ...+.+.++.+++.+||+.||++|||++||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 303 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGN------------------YKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTS------------------CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhccc------------------cCHHHHHHHHHHHHHHhCcCCccCCCHHHHH
Confidence 122334444444433332 223222222211 1235677899999999999999999999999
Q ss_pred HHHHHH
Q 043900 931 RQLQSI 936 (953)
Q Consensus 931 ~~L~~i 936 (953)
+.|++.
T Consensus 304 ~~L~~~ 309 (326)
T 3uim_A 304 RMLEGD 309 (326)
T ss_dssp HHHHTS
T ss_pred HHhcCc
Confidence 999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=370.31 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=206.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||+||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 4679999999999999999999998889999999986665666788999999999999999999999643 46789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEee
Confidence 99999999999999852 2588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........+.
T Consensus 160 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~- 235 (297)
T 3fxz_A 160 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE- 235 (297)
T ss_dssp CTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC-
T ss_pred CCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC-
Confidence 999987653322 23345699999999999999999999999999999999999999975321110 00000000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+..++..+.+++.+||+.||++|||++|+++
T Consensus 236 ----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 ----------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0001123456889999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=374.53 Aligned_cols=283 Identities=22% Similarity=0.298 Sum_probs=213.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||+||+|++. ++.||||+++.... ......+|+.++++++||||+++++++... .......
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRG-TSVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccC-CCCCceE
Confidence 3568999999999999999999986 46899999975433 334566799999999999999999997643 1223457
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC-------CCCCeEeecCCCCCeEecC
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD-------CQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~Dlkp~NIll~~ 781 (953)
++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. +.++|+||||||+||+++.
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred EEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 999999999999999952 2589999999999999999999975 1348999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc
Q 043900 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~ 856 (953)
++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+......
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 99999999999988765444434445679999999999887 3566789999999999999999999986433321
Q ss_pred c-HHHHHHhhCC-chhhhhc-cccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 857 N-LHNFARMALP-DHVVDIV-DSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 857 ~-~~~~~~~~~~-~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. +......... ....+.. .....+. .........+++++.+++.+||+.||++|||++||++.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPV-------------LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCC-------------CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCC-------------ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 1111000000 0011100 0000000 001111224567799999999999999999999999999
Q ss_pred HHHHHH
Q 043900 934 QSIKNI 939 (953)
Q Consensus 934 ~~i~~~ 939 (953)
+++.+.
T Consensus 314 ~~l~~~ 319 (322)
T 3soc_A 314 TQMQRL 319 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=363.70 Aligned_cols=284 Identities=31% Similarity=0.476 Sum_probs=225.4
Q ss_pred CCCCcCHHHHHHhhcCCccc------CcccccceeeEEEEEEcCCCeEEEEEEeecc----chhhHHHHHHHHHHHhhcC
Q 043900 617 SFPNISYQNLYNATDGFASA------NEIGVGSFGSVYKGILDQGKTTVAVKVFNLL----HHGAFKSFIAECNTLKNIR 686 (953)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~ 686 (953)
+...+++.++..++++|... +.||+|+||.||+|.+. ++.||+|++... .....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 46788999999999998877 89999999999999974 458999998632 2344678999999999999
Q ss_pred CCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043900 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP 766 (953)
Q Consensus 687 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 766 (953)
||||+++++++. ..+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +
T Consensus 89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~---~ 153 (307)
T 2nru_A 89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDG-------TPPLSWHMRCKIAQGAANGINFLHEN---H 153 (307)
T ss_dssp CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGG-------CCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence 999999999964 34678999999999999999864321 23689999999999999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCC
Q 043900 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK 846 (953)
Q Consensus 767 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~ 846 (953)
|+||||||+||+++.++.+||+|||.++...............||+.|+|||++.+ .++.++||||||+++|||++|..
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987654333333344569999999998765 58899999999999999999999
Q ss_pred CCCCcccCCccHHHHHHhh--CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 043900 847 PVDSMFEGDMNLHNFARMA--LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924 (953)
Q Consensus 847 pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 924 (953)
||........ ...+.... ......+.++..... .....+.++.+++.+||+.||++||
T Consensus 233 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 233 AVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMND-------------------ADSTSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp SBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCSC-------------------CCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred CcccCcchHH-HHHHHHHhhhhhhhhhhhccccccc-------------------cchHHHHHHHHHHHHHcCCCcccCc
Confidence 9976433321 11221111 111223333322211 1125567899999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q 043900 925 NMTNVVRQLQSIKN 938 (953)
Q Consensus 925 t~~evl~~L~~i~~ 938 (953)
|++||++.|+++..
T Consensus 293 s~~~l~~~L~~l~~ 306 (307)
T 2nru_A 293 DIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999998854
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=386.59 Aligned_cols=380 Identities=20% Similarity=0.208 Sum_probs=260.7
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCcccccc-CcCccCCCCCcEEeccCc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI-PANISSCSNLIQIRLFYN 86 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~L~L~~n 86 (953)
.++.+++++. .+|. + .++|++|+|++|+|+++.|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4677777775 7777 3 378999999999999988999999999999999999997555 678999999999999999
Q ss_pred cccccCCcccCCccccceeeccccccccccCCc--ccCCCcccEEecccccccccCCcc-ccccccccceecccccccCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSS--LGNLSSINTLFLTDNNLDGGIPDT-FGWLKNLATLAMAENWLSGT 163 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~ 163 (953)
.+++..|..|+++++|++|+|++|++++..|.. |+++++|++|+|++|++++..|.. |..+++|++|+|++|++++.
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 999888999999999999999999999755544 999999999999999999887876 89999999999999999988
Q ss_pred CCCccccc--ccceEEecCCcccccccccccc-------cccccccEEEeeCccccCCCCCCCcCC---CCCcEEEcccc
Q 043900 164 IPSSIFNI--SSITAFDAGMNQLQGVIPLDFG-------FTLQNLQFFSVFENQLTGAIPPAISNA---SNLELFQADVN 231 (953)
Q Consensus 164 ~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~-------~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N 231 (953)
.|..+..+ .+|+.|++++|.+.+..+..+. ..+++|+.|++++|++++..|..+..+ ++|+.|++++|
T Consensus 170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~ 249 (455)
T 3v47_A 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249 (455)
T ss_dssp CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence 88888877 7899999999999865444321 245789999999999887777666544 78888888888
Q ss_pred cccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcc
Q 043900 232 KLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKI 311 (953)
Q Consensus 232 ~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i 311 (953)
.+.+..........+. ... +.. ...+.|+.|++++|.+.+..|..+..+ ++|+.|++++|++
T Consensus 250 ~~~~~~~~~~~~~~~~-------------~~~---~~~-~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l 311 (455)
T 3v47_A 250 YNMGSSFGHTNFKDPD-------------NFT---FKG-LEASGVKTCDLSKSKIFALLKSVFSHF-TDLEQLTLAQNEI 311 (455)
T ss_dssp TTTSCCTTCCSSCCCC-------------TTT---TGG-GTTSCCCEEECCSSCCCEECTTTTTTC-TTCCEEECTTSCC
T ss_pred cccccccchhhhccCc-------------ccc---ccc-ccccCceEEEecCccccccchhhcccC-CCCCEEECCCCcc
Confidence 7765422111110000 000 000 012344555555555555544444444 3455555555555
Q ss_pred cccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccC
Q 043900 312 FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSL 390 (953)
Q Consensus 312 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~ 390 (953)
++..|..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+ .+++|+|++|.+++..+..|
T Consensus 312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 391 (455)
T 3v47_A 312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIF 391 (455)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred cccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHh
Confidence 54444455555555555555555554444555555555555555555554444444443 23444444444444333344
Q ss_pred CCCCCCcEEEcCCCccCCC
Q 043900 391 GQYKTLTIIDLSDNNLTGT 409 (953)
Q Consensus 391 ~~l~~L~~L~L~~N~l~~~ 409 (953)
..+++|++|+|++|.+++.
T Consensus 392 ~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 392 DRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp TTCTTCCEEECCSSCBCCC
T ss_pred ccCCcccEEEccCCCcccC
Confidence 4444444444444444433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=376.27 Aligned_cols=273 Identities=21% Similarity=0.365 Sum_probs=215.1
Q ss_pred hcCCcccCcccccceeeEEEEEEc-------CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-------QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++|++.+.||+|+||.||+|++. .++..||||+++.. .....+.+.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 467899999999999999999974 24457999999754 334567899999999999 8999999999964
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
..+..++||||+++|+|.+++........ .......+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 34678999999999999999975432100 011224589999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999997755443333444567899999999999999999999999999999999 9999975322
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
.+ .......... ...+..++.++.+++.+||+.||++|||+.|+++.|
T Consensus 312 ~~--~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 312 EE--LFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp GG--HHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH--HHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11 1111110000 000113455789999999999999999999999999
Q ss_pred HHHHHHhcc
Q 043900 934 QSIKNILLG 942 (953)
Q Consensus 934 ~~i~~~~~~ 942 (953)
+.+......
T Consensus 360 ~~il~~~~~ 368 (370)
T 2psq_A 360 DRILTLTTN 368 (370)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHhcc
Confidence 999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=364.81 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=206.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhh--cCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||+||+|++. ++.||||++... ....+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 568999999999999999999983 568999998643 33455666666666 7999999999987543 334467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeecCCCCCeEe
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH--------HDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll 779 (953)
.++||||+++|+|.++++ ...+++..++.++.|++.||+||| +. +|+||||||+||++
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEE
T ss_pred eEEehhhccCCCHHHHHh-----------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEE
Confidence 899999999999999994 235899999999999999999999 77 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcc--cccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhC-------
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQT--SSIDAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTR------- 844 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slG~vl~elltg------- 844 (953)
+.++.+||+|||+|+......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999998765433221 12234699999999998877 556799999999999999999
Q ss_pred ---CCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCC
Q 043900 845 ---KKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921 (953)
Q Consensus 845 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 921 (953)
+.||......+................. .. ........++.++.+++.+||+.||+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP----NI-----------------PNRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC----CC-----------------CGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCC----CC-----------------ChhhccCccHHHHHHHHHHHhhcChh
Confidence 7787665444433333322221111000 00 00011124677899999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 043900 922 DRMNMTNVVRQLQSI 936 (953)
Q Consensus 922 ~RPt~~evl~~L~~i 936 (953)
+|||++||++.|+++
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.55 Aligned_cols=279 Identities=23% Similarity=0.362 Sum_probs=210.4
Q ss_pred hcCCcccCcccccceeeEEEEE----EcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGI----LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||+||+|+ ...+++.||||+++.......+.+.+|++++++++||||++++++|... +.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 4678999999999999999999 4567789999999877777778899999999999999999999987432 22
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK---------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHhcc---------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeE
Confidence 45799999999999999996322 2489999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||+||..||...... .......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~ 230 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN 230 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcC
Confidence 99999999876443221 2223344788899999999999999999999999999999999998642111 0000000
Q ss_pred hCCch-h-hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 865 ALPDH-V-VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 865 ~~~~~-~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
..... . ....+. + ....+...+..+++++.+++.+||+.||++|||++|+++.|+++++.+.
T Consensus 231 ~~~~~~~~~~~~~~-~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 231 DKQGQMIVFHLIEL-L--------------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp TCCTHHHHHHHHHH-H--------------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccccchhHHHHHHH-H--------------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00000 0 000000 0 0000111112456779999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=381.71 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=210.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|.+.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||++++++|. ..+..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCCc
Confidence 457889999999999999999999888899999987432 334457889999999999999999999964 33678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 188 ~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~ 255 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE---------GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKIS 255 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEEC
Confidence 9999999999999999632 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++...............+++.|+|||++.+..++.++|||||||++|||+| |..||....... .........
T Consensus 256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~- 332 (377)
T 3cbl_A 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGG- 332 (377)
T ss_dssp CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTC-
T ss_pred cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-
Confidence 9999986543221122222346788999999998899999999999999999999 999997532211 111111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+...+..+++++.+++.+||+.||++|||++|+++.|+++++.
T Consensus 333 -----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 -----------------------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0000112456789999999999999999999999999999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=377.83 Aligned_cols=408 Identities=23% Similarity=0.263 Sum_probs=244.9
Q ss_pred cCcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCC-------------cEEeCCCCccccccC
Q 043900 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRL-------------QVLALNNNSIGGEIP 69 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~L~~n~i~~~~p 69 (953)
..+++.|+++++++ |.+|+++++|++|++|++++|++++.+|.+++++++| ++|++++|+++ .+|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp 87 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCC
Confidence 35788999999999 7999999999999999999999999999999999875 99999999999 566
Q ss_pred cCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCcccccccc
Q 043900 70 ANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKN 149 (953)
Q Consensus 70 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~ 149 (953)
.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+.+++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 53 4799999999999996 7754 3799999999999984 4432 2799999999999995 67 5999999
Q ss_pred ccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcc
Q 043900 150 LATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQAD 229 (953)
Q Consensus 150 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 229 (953)
|++|++++|+++ .+|..+ .+|++|++++|++++ +| .+ ..+++|++|++++|++++ +|... ++|++|+++
T Consensus 155 L~~L~l~~N~l~-~lp~~~---~~L~~L~L~~n~l~~-l~-~~-~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~ 223 (454)
T 1jl5_A 155 LKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE-LP-EL-QNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAG 223 (454)
T ss_dssp CCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSS-CC-CC-TTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECC
T ss_pred CCEEECCCCcCc-ccCCCc---ccccEEECcCCcCCc-Cc-cc-cCCCCCCEEECCCCcCCc-CCCCc---CcccEEECc
Confidence 999999999999 467654 589999999999996 66 44 489999999999999995 45433 589999999
Q ss_pred cccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccC
Q 043900 230 VNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNN 309 (953)
Q Consensus 230 ~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N 309 (953)
+|.++..+ .+..+++|+.+++++|. +.+ +|.. +++|+.|++++|
T Consensus 224 ~n~l~~lp-~~~~l~~L~~L~l~~N~------------------------------l~~-l~~~----~~~L~~L~l~~N 267 (454)
T 1jl5_A 224 NNILEELP-ELQNLPFLTTIYADNNL------------------------------LKT-LPDL----PPSLEALNVRDN 267 (454)
T ss_dssp SSCCSSCC-CCTTCTTCCEEECCSSC------------------------------CSS-CCSC----CTTCCEEECCSS
T ss_pred CCcCCccc-ccCCCCCCCEEECCCCc------------------------------CCc-cccc----ccccCEEECCCC
Confidence 99998443 44444444444443333 332 1211 135666666666
Q ss_pred cccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCcc
Q 043900 310 KIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS 389 (953)
Q Consensus 310 ~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~ 389 (953)
++++ +|.. +++|+.|++++|.+++. |.. .++|++|++++|++++ ++
T Consensus 268 ~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~------------------------i~-- 313 (454)
T 1jl5_A 268 YLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS------------------------LC-- 313 (454)
T ss_dssp CCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE------------------------EC--
T ss_pred cccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc------------------------cc--
Confidence 6654 3322 25566666666666642 111 1455666666555542 11
Q ss_pred CCCC-CCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccc--cCCCCccCC
Q 043900 390 LGQY-KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKG--EIPSTLGSC 466 (953)
Q Consensus 390 ~~~l-~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l 466 (953)
.+ ++|++|++++|++++ +|.. ...++.|++++|+++ .+|. .+++|++|++++|++++ .+|.+++.
T Consensus 314 --~~~~~L~~L~Ls~N~l~~-lp~~----~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~- 381 (454)
T 1jl5_A 314 --DLPPSLEELNVSNNKLIE-LPAL----PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED- 381 (454)
T ss_dssp --CCCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE-
T ss_pred --CCcCcCCEEECCCCcccc-cccc----CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh-
Confidence 12 467788888888874 5554 245667888888887 4555 46888999999999987 56665543
Q ss_pred ccccEEEccCccccCCCCccccCCCCCcEEECCCCcccc--cCCccccccccCceEeccCCcCcccCCCC
Q 043900 467 KKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG--KIPEFLVGFQLLENLNLSNNNLEGMVPIE 534 (953)
Q Consensus 467 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 534 (953)
|+.|.+.+.+|.. +++|+.||+++|++++ .+|.. |+.|.+.+|.+.+.+|..
T Consensus 382 -------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 382 -------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp -------EECCC----------------------------------------------------------
T ss_pred -------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCccccC
Confidence 3457777777764 5789999999999987 56643 566778888888877643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.61 Aligned_cols=262 Identities=22% Similarity=0.255 Sum_probs=212.4
Q ss_pred CCcCHHHHHHhhcC----------CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCC
Q 043900 619 PNISYQNLYNATDG----------FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHR 688 (953)
Q Consensus 619 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 688 (953)
+.++++++..+++. |...+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888777754 67778999999999999999988889999999866666677899999999999999
Q ss_pred CeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 689 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
||+++++++.. .+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+
T Consensus 103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~iv 163 (321)
T 2c30_A 103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHAQ---GVI 163 (321)
T ss_dssp TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 99999999653 3678999999999999999852 2589999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998764322 2223456999999999999999999999999999999999999999
Q ss_pred CCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 849 DSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
...... ..........+. .. ......++++.+++.+||+.||++|||++|
T Consensus 242 ~~~~~~--~~~~~~~~~~~~--------~~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 242 FSDSPV--QAMKRLRDSPPP--------KL--------------------KNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp TTSCHH--HHHHHHHHSSCC--------CC--------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCHH--HHHHHHhcCCCC--------Cc--------------------CccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 753211 111111100000 00 000123456889999999999999999999
Q ss_pred HHH
Q 043900 929 VVR 931 (953)
Q Consensus 929 vl~ 931 (953)
+++
T Consensus 292 ll~ 294 (321)
T 2c30_A 292 LLD 294 (321)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=370.98 Aligned_cols=266 Identities=23% Similarity=0.371 Sum_probs=209.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC---eEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK---TTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|++..++ ..||||+++.. .....+.+.+|++++++++||||++++++|.. +
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----G 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-----G
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 356889999999999999999997443 45999999753 34456789999999999999999999999643 4
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH---------DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CccEEEeeCCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence 6789999999999999999532 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ ......
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~ 268 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVE 268 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHH
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH
Confidence 99999999877543222 22233446788999999998999999999999999999999 999997532211 111010
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 943 (953)
.... ......+++++.+++.+||+.||++|||++||++.|+.+.+...+.
T Consensus 269 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 269 EGYR------------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred cCCC------------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 0000 0001134567899999999999999999999999999998776554
Q ss_pred c
Q 043900 944 R 944 (953)
Q Consensus 944 ~ 944 (953)
+
T Consensus 319 ~ 319 (325)
T 3kul_A 319 R 319 (325)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=366.21 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||+||+|++. ++.||||++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----STT
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 3467899999999999999999874 4589999986432 344567899999999999999999999964 346
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeEecCCCc
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP--ITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 784 (953)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-------REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-------HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 78999999999999999964321 12489999999999999999999998 8 999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......
T Consensus 178 ~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~ 253 (309)
T 3p86_A 178 VKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGF 253 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHH
T ss_pred EEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh
Confidence 999999999865322 122334569999999999999999999999999999999999999997532211 1000000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 942 (953)
.... ...+..+++++.+++.+||+.||++|||++|+++.|+.+.+....
T Consensus 254 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 254 KCKR-----------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp SCCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred cCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 0000 000012345688999999999999999999999999998765433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=368.62 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=204.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++. .++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 468999999999999999999999888999999996433 223466889999999999999999999964 44788
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEE
Confidence 999999999999999952 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++.+.............||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+......
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 227 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence 9999987643333333345679999999999988775 788999999999999999999997643332222222211100
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ....++.++.+++.+||+.||++|||++|+++
T Consensus 228 ~~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 LN------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ST------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 00123456789999999999999999999976
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=374.16 Aligned_cols=282 Identities=23% Similarity=0.317 Sum_probs=219.8
Q ss_pred cCHHHHHHhhcCCcccCcccccceeeEEEEEE-----cCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEE
Q 043900 621 ISYQNLYNATDGFASANEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKI 693 (953)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~ 693 (953)
+.........++|++.+.||+|+||.||+|++ ..+++.||||+++.. .....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455555678899999999999999999994 455689999999753 334457799999999999 79999999
Q ss_pred EeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcc----------------------------------------
Q 043900 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT---------------------------------------- 733 (953)
Q Consensus 694 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------------------------------------- 733 (953)
+++|.. .+...++||||+++|+|.++++........
T Consensus 92 ~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999743 335589999999999999999754321000
Q ss_pred ----------------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 734 ----------------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 734 ----------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 00122389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchhhhhccc
Q 043900 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876 (953)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (953)
............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ............
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~------- 316 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMR------- 316 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCC-------
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCC-------
Confidence 4444444455668999999999999999999999999999999998 9999975332211 111111100000
Q ss_pred cccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 877 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
.+..+++++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 317 -----------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 317 -----------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00023456889999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=367.98 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=203.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+++++.++||||+++++++. ...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 456899999999999999999999888889999999643 3445677889999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEEECCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEE
Confidence 89999999999999999852 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++...... ......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+... .......
T Consensus 155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i 226 (328)
T 3fe3_A 155 IADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERV 226 (328)
T ss_dssp ECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred EeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 99999998664322 23445699999999999888775 789999999999999999999975321 1111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... . .+...++++.+++.+||+.||++|||++|+++
T Consensus 227 --------~~~~~-~-------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 227 --------LRGKY-R-------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --------HHCCC-C-------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --------HhCCC-C-------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0 00012456889999999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.59 Aligned_cols=264 Identities=20% Similarity=0.361 Sum_probs=206.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++. .++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 45799999999999999999999988899999998532 3344578899999999999999999999954 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----------HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++...... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ........
T Consensus 152 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~ 229 (294)
T 4eqm_A 152 IFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-IKHIQDSV 229 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-HHHHSSCC
T ss_pred EEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhhccC
Confidence 99999998654322 12233456999999999999999999999999999999999999999753221100 00000000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHHHHHh
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-NMTNVVRQLQSIKNIL 940 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~ 940 (953)
+.... .....+++.+.+++.+||+.||++|| +++++.+.|+++....
T Consensus 230 ~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNVTT---------------------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCHHH---------------------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCcch---------------------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 00000 00113456789999999999999998 9999999998875443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=374.11 Aligned_cols=267 Identities=23% Similarity=0.368 Sum_probs=209.2
Q ss_pred hcCCcccCcccccceeeEEEEEE-----cCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.. .......+.+|+.++++++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 35789999999999999999995 345678999999643 3445567889999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....++||||+++|+|.+++...... ......+++.+++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCC---SSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccc---cCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence 346779999999999999999754322 12234689999999999999999999999 999999999999999555
Q ss_pred ---cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 784 ---MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 784 ---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~ 296 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL 296 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 599999999986533323333344568999999999999999999999999999999998 99999753211 111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
....... .. .....++.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 297 ~~i~~~~------------~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 EFVTSGG------------RM------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHTTC------------CC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHcCC------------CC------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111000 00 00012345688999999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=364.08 Aligned_cols=253 Identities=19% Similarity=0.260 Sum_probs=204.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh------hHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
..+.|.+.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---- 85 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE---- 85 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE----
Confidence 356799999999999999999999998899999999743321 3467899999999999999999999954
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.....++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. ||+||||||+||+++.+
T Consensus 86 -~~~~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 86 -NRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (361)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHTT----------CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred -eCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCC
Confidence 44789999999999999999952 23689999999999999999999999 99999999999999877
Q ss_pred C----cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 783 M----MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 783 ~----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ .+
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~ 227 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TL 227 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HH
T ss_pred CCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 7 79999999998765432 2234569999999999999999999999999999999999999997532111 00
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .. ... .......++++.+++.+||..||++|||++|+++
T Consensus 228 ~~i~~~------------~~--~~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 228 ANITAV------------SY--DFD--------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHTT------------CC--CCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhc------------CC--CCC--------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 00 000 0001123456889999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.41 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=204.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.++||||+++++++. +.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 468999999999999999999999999999999997543 34567889999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC--CCcEEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE--EMMAHV 787 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL 787 (953)
+||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 78 lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS---------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTSS---------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEE
Confidence 999999999999999532 23589999999999999999999999 9999999999999987 789999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|..||......+ .........
T Consensus 146 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~-- 219 (321)
T 1tki_A 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAE-- 219 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC--
T ss_pred EECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCC--
Confidence 9999998775332 2234568999999999999889999999999999999999999997532111 011111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... .......+.++.+++.+||+.||++|||+.|+++
T Consensus 220 ----------~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 220 ----------YTFD----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----------CCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CCCC----------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 0001133567899999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=372.28 Aligned_cols=262 Identities=23% Similarity=0.413 Sum_probs=198.1
Q ss_pred hcCCcccCcccccceeeEEEEEEc---CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|++. ..+..||||+++.. .....+.+.+|+.++++++||||++++++|. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 357999999999999999999986 45567999999754 3445678999999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.++++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEeCCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCE
Confidence 6789999999999999999632 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .....
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i- 263 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAV- 263 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHH-
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-
Confidence 99999999876533221 11222335788999999999999999999999999999998 999997532111 11100
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
..... ......++.++.+++.+||+.||++||+++||++.|+++.+..
T Consensus 264 -----------~~~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 264 -----------DEGYR------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----------HTTEE------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----------HcCCC------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00000 0001134567899999999999999999999999999997653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=360.19 Aligned_cols=287 Identities=18% Similarity=0.216 Sum_probs=215.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++... .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence 357999999999999999999999988899999997433 33457788999999999999999999987532 33578
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe----cCCCc
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMM 784 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 784 (953)
++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSN-------AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGG-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHHhcc-------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCce
Confidence 999999999999999964322 12489999999999999999999999 99999999999999 78888
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccC--------CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL--------GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~ 856 (953)
+||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 155 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 99999999987754322 23356999999999876 57889999999999999999999999975433222
Q ss_pred cHHHHH--HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 857 NLHNFA--RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 857 ~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
...... ....+......+........ ... .............+..+.+++.+||+.||++|||++|+++...
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGVQKAENGPI---DWS---GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEEECSTTCCE---EEE---SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hHHHHHHHhcCCCcccchhhhcccCCcc---ccC---ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111111 11111111111100000000 000 0000111223466778999999999999999999999999988
Q ss_pred HHHH
Q 043900 935 SIKN 938 (953)
Q Consensus 935 ~i~~ 938 (953)
+...
T Consensus 306 d~~~ 309 (319)
T 4euu_A 306 DILH 309 (319)
T ss_dssp HHTC
T ss_pred HHhh
Confidence 7643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=371.40 Aligned_cols=277 Identities=15% Similarity=0.201 Sum_probs=211.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCC-----CeEEEEEEeeccchhh-----------HHHHHHHHHHHhhcCCCCeeE
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQG-----KTTVAVKVFNLLHHGA-----------FKSFIAECNTLKNIRHRNLVK 692 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 692 (953)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999999765 4679999986543211 123445666777889999999
Q ss_pred EEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC
Q 043900 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDL 772 (953)
Q Consensus 693 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 772 (953)
+++++... .......++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDl 178 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEAN---------AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDI 178 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecC
Confidence 99997643 22335689999999 99999999632 23689999999999999999999999 9999999
Q ss_pred CCCCeEec--CCCcEEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC
Q 043900 773 KPSNVLLD--EEMMAHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 845 (953)
Q Consensus 773 kp~NIll~--~~~~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~ 845 (953)
||+|||++ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 8899999999999876432211 1113345999999999999999999999999999999999999
Q ss_pred CCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 043900 846 KPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN 925 (953)
Q Consensus 846 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 925 (953)
.||...... ................++.+..+.. ..++.++.+++..||+.||++||+
T Consensus 259 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 259 LPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp CTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred CCccccccC-HHHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCC
Confidence 999853222 1222222222222222222222210 123567999999999999999999
Q ss_pred HHHHHHHHHHHHHHhc
Q 043900 926 MTNVVRQLQSIKNILL 941 (953)
Q Consensus 926 ~~evl~~L~~i~~~~~ 941 (953)
+++|++.|+++.+...
T Consensus 317 ~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 317 YENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHcC
Confidence 9999999999887654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.60 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=196.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||+||+|++.. .||+|+++.. .....+.+.+|++++++++||||+++++++. ..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------AP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CC
Confidence 35679999999999999999998754 5999999643 3445678999999999999999999999742 25
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS---------ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred ccEEEEEecCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence 679999999999999999532 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|+|||+++...............||+.|+|||++. +..++.++||||||+++|||++|+.||......+........
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 99999998664333333334456999999999986 667889999999999999999999999764322211111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.......... ...+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 241 ~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 241 GSLSPDLSKV---------------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSCCCCTTSS---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCcchhhc---------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111110000 0134567899999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.41 Aligned_cols=249 Identities=20% Similarity=0.247 Sum_probs=202.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|+...+++.||+|+++.. .......+.+|+.+++.++||||+++++++. ..+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 35799999999999999999999998899999999743 2334567889999999999999999999954 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEE
Confidence 89999999999999999852 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 146 L~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~ 218 (337)
T 1o6l_A 146 ITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELIL 218 (337)
T ss_dssp ECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH
T ss_pred EeeccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HHHHHHH
Confidence 9999999864322 12233456999999999999999999999999999999999999999752111 1111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
..... .+...++++.+++.+||+.||++|| +++|+++
T Consensus 219 --------~~~~~--------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 219 --------MEEIR--------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------HCCCC--------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------cCCCC--------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00000 0002345688999999999999999 8999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=366.86 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=201.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeE----EEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTT----VAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
.++|++.+.||+|+||+||+|++..+++. ||+|.++.. .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35699999999999999999998766544 578877532 33456789999999999999999999999753
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
...++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHS---------TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCeEEEEEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCC
Confidence 3478999999999999999632 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... ......
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~ 233 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILE 233 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHH
Confidence 99999999988765444444445567889999999999999999999999999999999 999997532221 111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..... .....++.++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 234 ~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGERL------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCC------------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCC------------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11000 0001234568899999999999999999999999998864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.36 Aligned_cols=286 Identities=23% Similarity=0.346 Sum_probs=192.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++. .++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 77 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCe
Confidence 3568999999999999999999999888899999997443 334567889999999999999999999954 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ |+|.+++...... .....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVG----NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSS----SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEecC-CCHHHHHHhcccc----ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEE
Confidence 999999997 5999988643221 1224589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh-
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA- 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~- 865 (953)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .........
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~ 226 (317)
T 2pmi_A 150 GDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMG 226 (317)
T ss_dssp CCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred CcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence 9999998764322 122344689999999998764 68999999999999999999999997543221 111111111
Q ss_pred CC-chhhhhccccccCCchhhhhcccc-hhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LP-DHVVDIVDSTLLSDDEDLAVHGNQ-RQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~-~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+ .......... ............. .............+.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 227 TPNESLWPSVTKL-PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp SCCTTTCGGGGGC-TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCChhHhhhhhhh-hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 01 0100000000 0000000000000 0000000011123457899999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=369.70 Aligned_cols=276 Identities=23% Similarity=0.365 Sum_probs=217.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-------CCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-------GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++|.+.+.||+|+||+||+|++.. ....||||+++.. .....+.+.+|+++++++ +||||++++++|.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 4678999999999999999999753 3357999999743 344557889999999999 9999999999964
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
.++..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 34678999999999999999975432110 011234699999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755443344445568899999999999999999999999999999999 9999875321
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. ........... .. .+..+++++.+++.+||+.||++|||++||++.|
T Consensus 300 ~--~~~~~~~~~~~------------~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 300 E--ELFKLLKEGHR------------MD------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp H--HHHHHHHTTCC------------CC------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H--HHHHHHHcCCC------------CC------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 11111110000 00 0012345689999999999999999999999999
Q ss_pred HHHHHHhccccc
Q 043900 934 QSIKNILLGHRI 945 (953)
Q Consensus 934 ~~i~~~~~~~~~ 945 (953)
+++.........
T Consensus 348 ~~~~~~~~~~~~ 359 (382)
T 3tt0_A 348 DRIVALTSNQEM 359 (382)
T ss_dssp HHHHHHSCSCC-
T ss_pred HHHHHHHhcCCC
Confidence 999887665543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=360.24 Aligned_cols=270 Identities=24% Similarity=0.379 Sum_probs=213.6
Q ss_pred hcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|.+.+.||+|+||.||+|++. .+++.||+|+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----- 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-----
Confidence 467899999999999999999983 44578999999743 3445678899999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCC--------------cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITRED--------------KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITH 769 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 769 (953)
..+..++||||+++|+|.+++....... ........+++.+++.++.|++.||+|||+. +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 3467899999999999999997543210 0001224589999999999999999999999 9999
Q ss_pred ecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 043900 770 CDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPV 848 (953)
Q Consensus 770 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf 848 (953)
|||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987755444334444567889999999999899999999999999999999 99999
Q ss_pred CCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 849 DSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
....... ............ ....+++++.+++.+||+.||++|||++|
T Consensus 254 ~~~~~~~--~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 254 PGIPPER--LFNLLKTGHRME------------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp TTCCGGG--HHHHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHHH--HHHHhhcCCcCC------------------------------CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 7532211 111111100000 00123456899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 043900 929 VVRQLQSIKNI 939 (953)
Q Consensus 929 vl~~L~~i~~~ 939 (953)
+++.|+++.+.
T Consensus 302 l~~~l~~~~~~ 312 (314)
T 2ivs_A 302 ISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHhh
Confidence 99999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.05 Aligned_cols=272 Identities=23% Similarity=0.381 Sum_probs=196.3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCe---EEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKT---TVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
..++|++.+.||+|+||.||+|++..++. .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999999877654 7999999743 344567899999999999999999999997543111
Q ss_pred -CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 704 -GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 704 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.....++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIG----ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhcc----ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 112348999999999999999643221 1223589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~ 251 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNY 251 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHH
Confidence 9999999999987654433333344557889999999999999999999999999999999 999997532221 1111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... .... ....+++++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 252 ~~~~-----------~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 252 LIGG-----------NRLK-------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHTT-----------CCCC-------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcC-----------CCCC-------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1000 0000 0012345689999999999999999999999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=358.13 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=203.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh------hHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.+.|.+.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 45699999999999999999999998899999999643321 3577899999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT----------SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred eCCEEEEEEEcCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence 34789999999999999999952 23689999999999999999999999 999999999999999887
Q ss_pred ----cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 784 ----MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 784 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ ...
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~ 227 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 227 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH
T ss_pred CCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHH
Confidence 89999999998774332 2234569999999999999999999999999999999999999996532111 000
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........ .. .......+..+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~-------------~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 228 NVSAVNYE-------------FE---------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHTCCC-------------CC---------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhcCCC-------------cC---------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 00 0001123456889999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=358.55 Aligned_cols=275 Identities=25% Similarity=0.386 Sum_probs=203.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcC---CCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQ---GKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
..++|.+.+.||+|+||.||+|.+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45678899999999999999998865 4458999998743 344557789999999999999999999998654333
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 334579999999999999998533221 1234699999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~ 862 (953)
.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||....... .....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~ 262 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDYL 262 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHH
Confidence 999999999987654333333334557889999999999999999999999999999999 889987532211 11111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 942 (953)
..... .. ....+++++.+++.+||+.||++|||++|+++.|+++.+..++
T Consensus 263 ~~~~~-----------~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 263 LHGHR-----------LK-------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HTTCC-----------CC-------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HcCCC-----------CC-------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 10000 00 0012345689999999999999999999999999999887654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=365.05 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=205.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++. +....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 467999999999999999999999988999999998665556678899999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC--CCcEEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE--EMMAHV 787 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL 787 (953)
+||||+++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 125 lv~E~~~gg~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEECCCCCBHHHHTTCT---------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEE
Confidence 999999999999998532 23589999999999999999999999 9999999999999974 568999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+ ...........
T Consensus 193 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~ 268 (387)
T 1kob_A 193 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE 268 (387)
T ss_dssp CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC
T ss_pred EecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 99999987753322 223469999999999999999999999999999999999999997532110 01111000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. +. .....+++++.+++.+||+.||++|||++|+++
T Consensus 269 ~------~~----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 F------DE----------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp C------CS----------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C------Cc----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 00 000123456889999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.91 Aligned_cols=258 Identities=27% Similarity=0.379 Sum_probs=207.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..+ +.||+|+++.... ..+.+.+|++++++++||||+++++++. +....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEecCC-CeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 35789999999999999999999865 4799999975432 3467899999999999999999999964 346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCcHHHHHHhc---------CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecc
Confidence 999999999999999532 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||+++...... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ...........
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~ 226 (269)
T 4hcu_A 150 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL 226 (269)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCC
T ss_pred ccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCccC
Confidence 99998654321 122233457788999999998999999999999999999999 999997532111 11100000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
. .+...++++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 227 -----------~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 -----------Y-------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -----------C-------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----------C-------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0 0001245688999999999999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=362.18 Aligned_cols=265 Identities=17% Similarity=0.204 Sum_probs=209.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+++++++ +||||+++++++.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence 3679999999999999999999998899999999874432 34678999999999 99999999998643 4778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc----
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM---- 784 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 784 (953)
++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC---------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTT
T ss_pred EEEEEeC-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCc
Confidence 9999999 99999999632 23689999999999999999999999 9999999999999998887
Q ss_pred -EEEeccccceecCCCCCcc-----cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 785 -AHVSDFGLARFLPLSPAQT-----SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 785 -~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~ 225 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--L 225 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--H
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--H
Confidence 9999999999765432211 1234569999999999999999999999999999999999999998643221 1
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
............ . . ........++ ++.+++.+||+.||.+||++++|.+.|+++.+
T Consensus 226 ~~~~~~i~~~~~-~-------~---------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 226 KERYQKIGDTKR-A-------T---------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHHHHHHH-H-------S---------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhhc-c-------C---------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 111100000000 0 0 0000000123 79999999999999999999999999999877
Q ss_pred Hh
Q 043900 939 IL 940 (953)
Q Consensus 939 ~~ 940 (953)
..
T Consensus 282 ~~ 283 (330)
T 2izr_A 282 RK 283 (330)
T ss_dssp HT
T ss_pred Hc
Confidence 64
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=367.36 Aligned_cols=274 Identities=24% Similarity=0.399 Sum_probs=211.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
..++|++.+.||+|+||.||+|++.. +++.||+|+++.. .....+.+.+|+.++++++||||++++++|.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA---- 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence 45789999999999999999999974 4478999999754 3344678999999999999999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCc--------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDK--------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
.++..++||||+++|+|.+++........ .......+++.+++.++.||+.||+|||+. +|+
T Consensus 121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 121 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred -cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 34778999999999999999975432100 001125799999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKP 847 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~p 847 (953)
||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987643333233344568899999999998899999999999999999999 9999
Q ss_pred CCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 848 VDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 848 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
|...... ...... .+...... +..++.++.+++.+||+.||++|||+.
T Consensus 277 ~~~~~~~-----~~~~~~--------~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 277 YYGMAHE-----EVIYYV--------RDGNILAC-------------------PENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp TTTSCHH-----HHHHHH--------HTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCChH-----HHHHHH--------hCCCcCCC-------------------CCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 9753211 111100 00000000 012345689999999999999999999
Q ss_pred HHHHHHHHHHHHhcc
Q 043900 928 NVVRQLQSIKNILLG 942 (953)
Q Consensus 928 evl~~L~~i~~~~~~ 942 (953)
|+++.|+++.+...+
T Consensus 325 ~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 325 SIHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHHTTC----
T ss_pred HHHHHHHHHHhhhhh
Confidence 999999998765543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=354.79 Aligned_cols=275 Identities=20% Similarity=0.286 Sum_probs=201.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++. .+...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 57999999999999999999999988999999997432 334577889999999999999999999964 34789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++ ++.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSC---------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSE-EHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999975 555555321 23689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.++..... ........||+.|+|||++.+.. ++.++||||+||++|||++|..||...................
T Consensus 144 Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 144 NFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999876432 22233456899999999988766 7999999999999999999988864332222222222221111
Q ss_pred c---hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 D---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ....... . ...... ................+.++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~-~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 222 PTEEQWPSMTK-L--PDYKPY---PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGG-S--TTCCCC---CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhhhhhcc-c--cccccc---ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1 0100000 0 000000 0000000000111134567889999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=355.18 Aligned_cols=266 Identities=15% Similarity=0.180 Sum_probs=212.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++++ +|++++++++++. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence 457999999999999999999998888999999986432 234678899999999 7999999999854 34788
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc----
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM---- 784 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 784 (953)
++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence 9999999 99999999632 23589999999999999999999999 9999999999999987776
Q ss_pred -EEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc-
Q 043900 785 -AHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN- 857 (953)
Q Consensus 785 -~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~- 857 (953)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 999999999877543221 1233456999999999999999999999999999999999999999864322110
Q ss_pred -HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 858 -LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 858 -~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
............. ......+++++.+++.+||+.||++|||+++|++.|+++
T Consensus 229 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 229 KYERIGEKKQSTPL---------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhccCccH---------------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0000000000000 000113456799999999999999999999999999999
Q ss_pred HHHhcc
Q 043900 937 KNILLG 942 (953)
Q Consensus 937 ~~~~~~ 942 (953)
.+....
T Consensus 282 ~~~~~~ 287 (298)
T 1csn_A 282 LERLNT 287 (298)
T ss_dssp HHHTTC
T ss_pred HHhcCC
Confidence 877544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.94 Aligned_cols=256 Identities=21% Similarity=0.233 Sum_probs=203.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 356999999999999999999999988999999996322 123577899999999999999999999964 3
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRAD------AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcc------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence 4789999999999999988853221 123589999999999999999999999 9999999999999986654
Q ss_pred ---EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 785 ---AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 785 ---~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i 244 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGI 244 (351)
T ss_dssp TCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHH
T ss_pred CCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHH
Confidence 9999999998775322 223345699999999999999999999999999999999999999975211 001111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ...... .....++.++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~------------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 245 IKG------------KYKMNP----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHT------------CCCCCH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcC------------CCCCCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000000 001123567889999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=352.93 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=202.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh-------hHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-------AFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||+||+|++..+++.||+|++...... ..+.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 36799999999999999999999988899999998643221 12678999999999999999999999642
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeEec
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP--ITHCDLKPSNVLLD 780 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~ 780 (953)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+||+++
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 95 ----PPRMVMEFVPCGDLYHRLLDK---------AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp ----TTEEEEECCTTCBHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEES
T ss_pred ----CCeEEEEecCCCCHHHHHhcc---------cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEe
Confidence 237999999999999988532 23689999999999999999999998 8 99999999999998
Q ss_pred CCCc-----EEEeccccceecCCCCCccccccccccccccccccc--CCCCCCcccchHHHHHHHHHHHhCCCCCCCccc
Q 043900 781 EEMM-----AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYG--LGSEVSINGDVYSYGILLLELVTRKKPVDSMFE 853 (953)
Q Consensus 781 ~~~~-----~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~ 853 (953)
.++. +||+|||+++.... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 8776 99999999985432 22345689999999998 445678999999999999999999999975433
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
............. .... ....+++++.+++.+||+.||++|||++|+++.|
T Consensus 234 ~~~~~~~~~~~~~-----------~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 234 GKIKFINMIREEG-----------LRPT------------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CHHHHHHHHHHSC-----------CCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHhccC-----------CCCC------------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 3221111111100 0000 0012345789999999999999999999999999
Q ss_pred HHH
Q 043900 934 QSI 936 (953)
Q Consensus 934 ~~i 936 (953)
+++
T Consensus 285 ~~l 287 (287)
T 4f0f_A 285 SEL 287 (287)
T ss_dssp HTC
T ss_pred HhC
Confidence 863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=352.30 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=207.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|.+..+ ..||+|+++.... ..+.+.+|++++++++||||+++++++. .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCc-eeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence 46799999999999999999988764 5799999975432 3467899999999999999999999964 447789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---------GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEcc
Confidence 999999999999999532 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++...... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+. .........
T Consensus 148 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~- 223 (268)
T 3sxs_A 148 FGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--VLKVSQGHR- 223 (268)
T ss_dssp TTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHTTCC-
T ss_pred Cccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--HHHHHcCCC-
Confidence 99998765432 222334457788999999999899999999999999999999 9999975322110 000000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
... +...++++.+++.+||+.||++|||++|+++.|+.+++.
T Consensus 224 ----------~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 ----------LYR-------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ----------CCC-------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ----------CCC-------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000 001234688999999999999999999999999988643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.43 Aligned_cols=273 Identities=23% Similarity=0.324 Sum_probs=215.2
Q ss_pred hcCCcccCcccccceeeEEEEEE-----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|++ ..+++.||+|+++... ....+.+.+|+.+++++ +||||++++++|.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---- 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence 46799999999999999999996 4466789999997443 34457889999999999 9999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCc--------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDK--------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
.++..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 34678999999999999999975432100 011223589999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999987765444333444567889999999999999999999999999999999 9999975432
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
.. ............. ....++.++.+++.+||+.||++|||++|+++.|
T Consensus 254 ~~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 254 DS-KFYKMIKEGFRML------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp SH-HHHHHHHHTCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hh-HHHHHhccCCCCC------------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 21 1111111110000 0012345689999999999999999999999999
Q ss_pred HHHHHHhc
Q 043900 934 QSIKNILL 941 (953)
Q Consensus 934 ~~i~~~~~ 941 (953)
+++.....
T Consensus 303 ~~~~~~~~ 310 (313)
T 1t46_A 303 EKQISEST 310 (313)
T ss_dssp HHHHHHTC
T ss_pred HHHHHHhh
Confidence 99876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=374.41 Aligned_cols=254 Identities=27% Similarity=0.366 Sum_probs=205.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++||||++++++|.. .....+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence 356888999999999999999986 3589999997543 45789999999999999999999999743 234789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 264 iv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEee
Confidence 9999999999999996432 12478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||+++...... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||......+ .........
T Consensus 333 fG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~-- 403 (450)
T 1k9a_A 333 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY-- 403 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTC--
T ss_pred CCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC--
Confidence 99998653221 12247889999999999999999999999999999999 999997643221 111111000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+...+..+++++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 404 ----------------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 ----------------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0001113456799999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=370.92 Aligned_cols=254 Identities=17% Similarity=0.196 Sum_probs=202.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++. +.+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence 4567999999999999999999999999999999996433 334567899999999999999999999954 457
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---CCC
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD---EEM 783 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~ 783 (953)
..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++ .++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----------~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----------REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTC
T ss_pred EEEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCC
Confidence 89999999999999999852 23589999999999999999999999 999999999999998 567
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ .......
T Consensus 151 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~ 227 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKA 227 (444)
T ss_dssp CEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred cEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHh
Confidence 89999999998764322 22234569999999999999999999999999999999999999997522110 0111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... . .....+++++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~-----~-----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 228 GAYDFP-----S-----------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TCCCCC-----T-----------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCC-----c-----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 0 000123456889999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=367.20 Aligned_cols=267 Identities=25% Similarity=0.395 Sum_probs=201.5
Q ss_pred CCcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.|.+.+.||+|+||.||+|++..+ ...||+|.++.. .....+.+.+|+.++++++||||++++++|. ..++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence 366778999999999999998543 246899998643 3455678999999999999999999999864 23467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.++++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEE
Confidence 89999999999999999632 23578999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ .......
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~ 311 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ 311 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHc
Confidence 999999866432211 12233457889999999999999999999999999999999 677776532221 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHR 944 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 944 (953)
... .. .+..++.++.+++.+||+.||++|||++|+++.|+++.....+..
T Consensus 312 ~~~-----------~~-------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 GRR-----------LL-------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp TCC-----------CC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CCC-----------CC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 000 00 001234568999999999999999999999999999998877765
Q ss_pred cc
Q 043900 945 IV 946 (953)
Q Consensus 945 ~~ 946 (953)
++
T Consensus 362 ~~ 363 (373)
T 3c1x_A 362 YV 363 (373)
T ss_dssp BC
T ss_pred ee
Confidence 43
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=364.42 Aligned_cols=277 Identities=22% Similarity=0.296 Sum_probs=210.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 701 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 701 (953)
..++|.+.+.||+|+||.||+|++. .+++.||+|+++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--- 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 4567899999999999999999973 35568999999743 234457899999999999 8999999999964
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCc-------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDK-------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
..+..++||||+++|+|.+++........ .......+++..++.++.||+.||+|||+. ||+
T Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 34678999999999999999975432100 001123589999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKP 847 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~p 847 (953)
||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654443334445568889999999999999999999999999999998 9999
Q ss_pred CCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 848 VDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 848 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
|....... ............. .+..+++++.+++.+||+.||++|||+.
T Consensus 275 ~~~~~~~~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 275 YPGIPVDA-NFYKLIQNGFKMD------------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp STTCCCSH-HHHHHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccCCcHH-HHHHHHhcCCCCC------------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 97643221 1111111110000 0012345689999999999999999999
Q ss_pred HHHHHHHHHHHHhcccc
Q 043900 928 NVVRQLQSIKNILLGHR 944 (953)
Q Consensus 928 evl~~L~~i~~~~~~~~ 944 (953)
|+++.|+.+.+......
T Consensus 324 ~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 324 NLTSFLGCQLADAEEAM 340 (344)
T ss_dssp HHHHHHHHHC-------
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 99999999877655443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=356.14 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=201.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|++. ++.||+|+++.. ...+.+.+|++++++++||||+++++++. +..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence 56889999999999999999986 357999998643 34578899999999999999999999864 34789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc-EEEec
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM-AHVSD 789 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~D 789 (953)
||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|
T Consensus 77 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEP-------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp EEECCTTCBHHHHHHCSSS-------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred EEEcCCCCCHHHHHhccCC-------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 9999999999999964321 234788999999999999999999932239999999999999998886 79999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus 150 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 223 (307)
T 2eva_A 150 FGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP- 223 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-
T ss_pred cccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-
Confidence 9999765321 2234589999999999999999999999999999999999999975322211111100000000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 943 (953)
. ....++..+.+++.+||+.||++|||++|+++.|+.+.+...+.
T Consensus 224 -------~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 224 -------P----------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp -------C----------------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred -------C----------------------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 0 00123456889999999999999999999999999998877654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.18 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=197.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--------------------------hhHHHHHHHHHHHh
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--------------------------GAFKSFIAECNTLK 683 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 683 (953)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4679999999999999999999999999999999964321 12356889999999
Q ss_pred hcCCCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC
Q 043900 684 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC 763 (953)
Q Consensus 684 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 763 (953)
+++||||+++++++... .....++||||+++++|.+++. ...+++.+++.++.|++.||+|||+.
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 99999999999997532 3467899999999999988763 23689999999999999999999999
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCC---CCcccchHHHHHHHHH
Q 043900 764 QPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLE 840 (953)
Q Consensus 764 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slG~vl~e 840 (953)
+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++||
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 999999999999999999999999999987653322 223456999999999988765 4788999999999999
Q ss_pred HHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 043900 841 LVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESP 920 (953)
Q Consensus 841 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 920 (953)
|++|+.||..... ....... ...... .. ....+++++.+++.+||+.||
T Consensus 233 l~~g~~pf~~~~~-----~~~~~~~--------~~~~~~-~~-----------------~~~~~~~~l~~li~~~l~~dp 281 (298)
T 2zv2_A 233 FVFGQCPFMDERI-----MCLHSKI--------KSQALE-FP-----------------DQPDIAEDLKDLITRMLDKNP 281 (298)
T ss_dssp HHHSSCSSCCSSH-----HHHHHHH--------HHCCCC-CC-----------------SSSCCCHHHHHHHHHHTCSCT
T ss_pred HHHCCCCCCCccH-----HHHHHHH--------hcccCC-CC-----------------CccccCHHHHHHHHHHhhcCh
Confidence 9999999975211 1111000 000000 00 000234568899999999999
Q ss_pred CCCCCHHHHHH
Q 043900 921 GDRMNMTNVVR 931 (953)
Q Consensus 921 ~~RPt~~evl~ 931 (953)
++|||++|+++
T Consensus 282 ~~R~s~~e~l~ 292 (298)
T 2zv2_A 282 ESRIVVPEIKL 292 (298)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999875
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=370.32 Aligned_cols=359 Identities=19% Similarity=0.189 Sum_probs=231.6
Q ss_pred CccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcc
Q 043900 21 SPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLS 100 (953)
Q Consensus 21 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (953)
+.+++++++|++|+|++|++++ +| .|..+++|++|+|++|+|++ +| ++.+++|++|+|++|.+++. | +++++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence 3455556666666666666665 33 46666666666666666663 23 55566666666666666532 2 55556
Q ss_pred ccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecC
Q 043900 101 KIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAG 180 (953)
Q Consensus 101 ~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 180 (953)
+|++|++++|++++ +| ++.+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+.
T Consensus 107 ~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~----------- 167 (457)
T 3bz5_A 107 KLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVT----------- 167 (457)
T ss_dssp TCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCT-----------
T ss_pred cCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccc-----------
Confidence 66666666666553 33 55555666666666655532 1 455555555555555322222 233
Q ss_pred CcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCC
Q 043900 181 MNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRG 260 (953)
Q Consensus 181 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~ 260 (953)
.+++|+.|++++|++++ +| +..+++|+.|++++|++++.. +
T Consensus 168 --------------~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~--l-------------------- 208 (457)
T 3bz5_A 168 --------------PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLD--L-------------------- 208 (457)
T ss_dssp --------------TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCC--C--------------------
T ss_pred --------------cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeec--c--------------------
Confidence 45555555555555554 22 556666666666666665320 0
Q ss_pred CCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCC
Q 043900 261 HSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIP 340 (953)
Q Consensus 261 ~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 340 (953)
..+ ++|+.|++++|++++ +| ++.+++|+.|++++|.+++..
T Consensus 209 ----------------------------------~~l-~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~- 249 (457)
T 3bz5_A 209 ----------------------------------NQN-IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD- 249 (457)
T ss_dssp ----------------------------------TTC-TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC-
T ss_pred ----------------------------------ccC-CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC-
Confidence 011 356666777777765 34 667777777777777777543
Q ss_pred cCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCcccc
Q 043900 341 PAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420 (953)
Q Consensus 341 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~ 420 (953)
++.+++|+.|++++|++. .|++++|.+.+.+| ++.+++|+.|++++|.+.+.+|... ..
T Consensus 250 --~~~l~~L~~L~l~~n~L~-------------~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~----~~ 308 (457)
T 3bz5_A 250 --VSTLSKLTTLHCIQTDLL-------------EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA----AG 308 (457)
T ss_dssp --CTTCTTCCEEECTTCCCS-------------CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT----CC
T ss_pred --HHHCCCCCEEeccCCCCC-------------EEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC----Cc
Confidence 345667777777777654 46777777776766 5678999999999998877666422 12
Q ss_pred ceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCC
Q 043900 421 LIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQ 500 (953)
Q Consensus 421 l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 500 (953)
++.|+ ++++++|++|++++|+|++. + ++.+++|+.|++++|+|++ ++.|..|++++
T Consensus 309 L~~L~-------------l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~ 364 (457)
T 3bz5_A 309 ITELD-------------LSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALN 364 (457)
T ss_dssp CSCCC-------------CTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGG
T ss_pred ceEec-------------hhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccC
Confidence 23444 44447899999999999974 3 8999999999999999986 24677788999
Q ss_pred CcccccCCccccccccCceEeccCCcCcccCCCC
Q 043900 501 NNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIE 534 (953)
Q Consensus 501 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 534 (953)
|.++|. ..+..|+.+++++|+|+|.+|..
T Consensus 365 n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 365 NNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp TSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred CcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 999986 35677889999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=362.73 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=203.6
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|+.++++++||||+++++++. +..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 356799999999999999999999998899999999743 3345577899999999999999999999964 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC---
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM--- 783 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 783 (953)
..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred EEEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 88999999999999998852 23589999999999999999999999 999999999999998654
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 169 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i~ 243 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIK 243 (362)
T ss_dssp CEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred CEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 59999999998764322 223456999999999999999999999999999999999999999753211 1111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...... . ......+++++.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~------------~---------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 AGAYDY------------P---------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HTCCCC------------C---------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCCC------------C---------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0 00001234568899999999999999999998763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.26 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=203.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeE----EEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTT----VAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|++.+.||+|+||+||+|++..+++. ||+|++... .......+.+|+.++++++||||++++++|. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 5789999999999999999999776654 777777432 2233456778999999999999999999863 2
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQH---------RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSS---------GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCE
T ss_pred CccEEEEEeCCCCCHHHHHHHc---------cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeE
Confidence 5689999999999999999632 23588899999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++...............||..|+|||++.+..++.++|||||||++|||+| |+.||....... .......
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~ 232 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEK 232 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHT
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHc
Confidence 9999999998765444444455668889999999999999999999999999999999 999997532221 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..... .+..++.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 233 ~~~~~------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 233 GERLA------------------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TCBCC------------------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCC------------------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000 000123347789999999999999999999999998854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=360.00 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=200.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 467999999999999999999999888999999996422 223467889999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+ +|+|.+++.. ...+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVE----------KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEE
T ss_pred EEEEEEECC-CCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEE
Confidence 799999999 7899988852 23689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||++....... ......||+.|+|||++.+..+ ++++||||+||++|||++|+.||........
T Consensus 149 l~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------- 216 (336)
T 3h4j_B 149 IADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------- 216 (336)
T ss_dssp ECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------
T ss_pred EEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------
Confidence 99999998664322 2234569999999999988876 6899999999999999999999975322110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+...... .+...++++.+++.+||+.||.+|||++|+++
T Consensus 217 -----~~~i~~~~~~-------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 217 -----FKKVNSCVYV-------------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -----BCCCCSSCCC-------------------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -----HHHHHcCCCC-------------------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000000 00123456889999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=364.25 Aligned_cols=290 Identities=24% Similarity=0.355 Sum_probs=205.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHH--HhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNT--LKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|++ +++.||||+++.... ..+..|.++ +..++||||+++++++..........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46799999999999999999987 456899999975432 333444444 55689999999998766554555667
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeecCCCCCeEecC
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC------QPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~ 781 (953)
.++||||+++|+|.+++.. ...++..++.++.|++.||+|||+.+ .++|+||||||+|||++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred EEEEEecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 8999999999999999952 24588899999999999999999762 338999999999999999
Q ss_pred CCcEEEeccccceecCCCCC------cccccccccccccccccccCC-------CCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 782 EMMAHVSDFGLARFLPLSPA------QTSSIDAKGSIGYIAPEYGLG-------SEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999987653221 122234469999999999887 45678899999999999999998776
Q ss_pred CCcccCCccHHHHHHhh--CCc--hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 043900 849 DSMFEGDMNLHNFARMA--LPD--HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 924 (953)
............+.... .+. ......... ...............+++++.+++.+||+.||++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE-----------KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-----------CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhccc-----------ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc
Confidence 44222111000000000 000 000000000 000000111112234677899999999999999999
Q ss_pred CHHHHHHHHHHHHHHhcccccc
Q 043900 925 NMTNVVRQLQSIKNILLGHRIV 946 (953)
Q Consensus 925 t~~evl~~L~~i~~~~~~~~~~ 946 (953)
|++|+++.|+++........-+
T Consensus 305 s~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 305 TAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp CHHHHHHHHHHHHHCCCC----
T ss_pred chHHHHHHHHHHHHHHHhcccC
Confidence 9999999999998776655443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.80 Aligned_cols=277 Identities=22% Similarity=0.301 Sum_probs=201.1
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
...++|++.+.||+|+||+||+|++.. ++.||+|+++... ......+.+|++++++++||||+++++++. ..
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cC
Confidence 345789999999999999999999976 5699999996432 233567889999999999999999999954 44
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||++ |+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 92 RCLTLVFEFME-KDLKKVLDEN---------KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp SCEEEEEECCS-EEHHHHHHTC---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEEcCCC-CCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCE
Confidence 78999999997 4888877532 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. .......
T Consensus 159 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~ 235 (311)
T 3niz_A 159 KLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSI 235 (311)
T ss_dssp EECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHH
T ss_pred EEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 999999998764322 22334568999999999876 5689999999999999999999999986443322 2222211
Q ss_pred hC---CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 AL---PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~---~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. +.......+...... .................+++++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQ-----RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHS-----CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhhhhccchhhh-----cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 111111000000000 000000000000011123457889999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=365.11 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=197.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
..++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|..+++.+ +||||+++++++. .
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----T 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----e
Confidence 356899999999999999999999998899999999743 233456788999999988 7999999999954 4
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQK----------SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCC
Confidence 4789999999999999999953 23689999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+|+..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......
T Consensus 163 ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~- 238 (353)
T 3txo_A 163 CKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILN- 238 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-
T ss_pred EEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHc-
Confidence 999999999854322 223334569999999999999999999999999999999999999997532211 0111100
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH------HHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM------TNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 931 (953)
.... .+...++++.+++.+||+.||++||++ +|+++
T Consensus 239 -----------~~~~--------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 -----------DEVV--------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----------CCCC--------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----------CCCC--------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0000 000123568899999999999999998 66655
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=361.16 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=201.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||++++++|. ...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 35799999999999999999999999999999999632 2334577889999999999999999999954 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ----------NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 156 L~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~ 230 (384)
T 4fr4_A 156 ITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVH 230 (384)
T ss_dssp ECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHH
T ss_pred EeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHH
Confidence 9999999876433 22344569999999999864 458999999999999999999999997532221 111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-HHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-MTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 931 (953)
.. ...... .+..++.++.+++.+||+.||++||+ ++++.+
T Consensus 231 ~~---------~~~~~~-------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 TF---------ETTVVT-------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HH---------HHCCCC-------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HH---------hhcccC-------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 000000 00123456889999999999999998 666553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=381.10 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=210.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..++..||||+++.... ..+.+.+|+.++++++||||++++++|.. ....+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence 4568889999999999999999998888999999975432 45789999999999999999999999743 36789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 293 lv~E~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT--------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred EEEEccCCCCHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence 99999999999999964322 3589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||+++..... .........+++.|+|||++.+..++.++|||||||++|||+| |..||....... ........
T Consensus 362 FG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~--- 435 (495)
T 1opk_A 362 FGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKD--- 435 (495)
T ss_dssp TTCEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTT---
T ss_pred cccceeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC---
Confidence 9999876432 2222233456789999999998999999999999999999999 999997532211 11111100
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.. ...+..+++++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 436 ---------~~------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 ---------YR------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---------CC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---------CC------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00 0011134567899999999999999999999999998763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.20 Aligned_cols=282 Identities=23% Similarity=0.308 Sum_probs=218.8
Q ss_pred CHHHHHHhhcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEE
Q 043900 622 SYQNLYNATDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKIL 694 (953)
Q Consensus 622 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~ 694 (953)
.........++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 33444455678999999999999999999963 456789999997533 33456789999999999 799999999
Q ss_pred eeecccccCCCCceeEEEeeccCCchhhccccCCcCCcc------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 043900 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKT------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPIT 768 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 768 (953)
++|.. .+...++||||+++|+|.+++......... ......+++..++.++.|++.||+|||+. +|+
T Consensus 98 ~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 99743 235689999999999999999754321000 00122389999999999999999999999 999
Q ss_pred eecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 043900 769 HCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKP 847 (953)
Q Consensus 769 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~p 847 (953)
||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654444444445668899999999999999999999999999999998 9999
Q ss_pred CCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 848 VDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 848 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
|........ ............ . ...+++++.+++.+||+.||++|||++
T Consensus 251 ~~~~~~~~~-~~~~~~~~~~~~--------~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 299 (316)
T 2xir_A 251 YPGVKIDEE-FCRRLKEGTRMR--------A----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFS 299 (316)
T ss_dssp STTCCCSHH-HHHHHHHTCCCC--------C----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcccchhHH-HHHHhccCccCC--------C----------------------CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 975332211 111111100000 0 001245688999999999999999999
Q ss_pred HHHHHHHHHHHHhc
Q 043900 928 NVVRQLQSIKNILL 941 (953)
Q Consensus 928 evl~~L~~i~~~~~ 941 (953)
|+++.|+++.+...
T Consensus 300 ell~~L~~~~~~~~ 313 (316)
T 2xir_A 300 ELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhhhc
Confidence 99999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=353.80 Aligned_cols=279 Identities=23% Similarity=0.344 Sum_probs=206.6
Q ss_pred HHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc--CCCCeeEEEeeecccc
Q 043900 624 QNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI--RHRNLVKILTACSGVD 701 (953)
Q Consensus 624 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~ 701 (953)
..-....++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~- 103 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG- 103 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-
Confidence 333445678999999999999999999986 5689999986432 23445566666554 899999999997543
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeecCCCCC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC-----QPPITHCDLKPSN 776 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~N 776 (953)
.......++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence 1222578999999999999999952 25899999999999999999999751 3489999999999
Q ss_pred eEecCCCcEEEeccccceecCCCCCcc--cccccccccccccccccCCCCCCcc------cchHHHHHHHHHHHhC----
Q 043900 777 VLLDEEMMAHVSDFGLARFLPLSPAQT--SSIDAKGSIGYIAPEYGLGSEVSIN------GDVYSYGILLLELVTR---- 844 (953)
Q Consensus 777 Ill~~~~~~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~slG~vl~elltg---- 844 (953)
|+++.++.+||+|||+++.+....... ......||+.|+|||++.+..++.+ +|||||||++|||+||
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999999999999998764332211 1224569999999999988776665 9999999999999999
Q ss_pred ------CCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccC
Q 043900 845 ------KKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSME 918 (953)
Q Consensus 845 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 918 (953)
..||...................... .... ........+++++.+++.+||+.
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-------------~~~~~~~~~~~~l~~li~~~l~~ 311 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL--------RPSF-------------PNRWSSDECLRQMGKLMTECWAH 311 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC--------CCCC-------------CGGGGGSHHHHHHHHHHHHHSCS
T ss_pred cccccccccHhhhcCCCCchhhhHHHHhhhcc--------Cccc-------------cccchhhHHHHHHHHHHHHhhhh
Confidence 55555433333222222211111000 0000 00111226778899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHh
Q 043900 919 SPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 919 dP~~RPt~~evl~~L~~i~~~~ 940 (953)
||++|||++||++.|+++.+..
T Consensus 312 dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 312 NPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTT
T ss_pred ChhhCCCHHHHHHHHHHHHhhc
Confidence 9999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.03 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=197.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|.+..+ +..||+|+++.. .....+.+.+|+.++++++||||+++++++. .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence 46789999999999999999998653 456999998643 3345677899999999999999999999863 2
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CccEEEEecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCE
Confidence 5678999999999999999532 22589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ .......
T Consensus 156 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~ 232 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIEN 232 (281)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred EECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHc
Confidence 9999999987643221 12233447789999999998899999999999999999997 999997533221 1111110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.. ... ....+++++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 233 ~~-----------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 GE-----------RLP-------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TC-----------CCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-----------CCC-------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 000 0012346788999999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.33 Aligned_cols=276 Identities=21% Similarity=0.353 Sum_probs=213.2
Q ss_pred hcCCcccCcccccceeeEEEEEEc-------CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-------QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++|++.+.||+|+||.||+|++. .+++.||+|+++.. .....+.+.+|+++++++ +||||++++++|.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence 467999999999999999999985 34568999999743 334567889999999999 8999999999964
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcc------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKT------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
..+..++||||+++|+|.+++......... ......+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 346789999999999999999754321000 01123589999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999987754433333444557889999999988899999999999999999999 9999975321
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. ............ .....++.++.+++.+||+.||++|||++|+++.|
T Consensus 266 ~--~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 266 E--ELFKLLKEGHRM------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp H--HHHHHHHHTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H--HHHHHHhcCCCC------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 111111100000 00012345688999999999999999999999999
Q ss_pred HHHHHHhccccc
Q 043900 934 QSIKNILLGHRI 945 (953)
Q Consensus 934 ~~i~~~~~~~~~ 945 (953)
+++.........
T Consensus 314 ~~l~~~~~~~~~ 325 (334)
T 2pvf_A 314 DRILTLTTNEEY 325 (334)
T ss_dssp HHHHHHHC----
T ss_pred HHHHhccccCcc
Confidence 999887665543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=356.19 Aligned_cols=282 Identities=23% Similarity=0.283 Sum_probs=202.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhhc---CCCCeeEEEeeeccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNI---RHRNLVKILTACSGV 700 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 700 (953)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+++++++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999998888999999996322 11234566777777766 499999999998654
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
........++||||++ ++|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--------PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT 154 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence 3333336899999996 599999864322 2489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~ 860 (953)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~ 230 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGK 230 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHH
T ss_pred CCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 99999999999998654322 22345689999999999999999999999999999999999999976332211 111
Q ss_pred HHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 861 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
............+.. ........ .. ...+........+.++++.+++.+||+.||++|||++|+++
T Consensus 231 i~~~~~~~~~~~~~~-~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 231 IFDLIGLPPEDDWPR-DVSLPRGA--FP--PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHCCCCTTTSCS-SCSSCGGG--SC--CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCChhhccc-hhhccccc--cC--CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111000000000 00000000 00 00000000011134567899999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=370.25 Aligned_cols=283 Identities=20% Similarity=0.198 Sum_probs=201.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~ 705 (953)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999743 3445678889999999999999999999975432 2334
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++ ++.+.+. ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CeEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCE
Confidence 678999999975 5666653 2488999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+.......
T Consensus 204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~l 279 (464)
T 3ttj_A 204 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQL 279 (464)
T ss_dssp EECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred EEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 99999999876432 22334569999999999999999999999999999999999999997632211 111111111
Q ss_pred C-C---------chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 L-P---------DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~-~---------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. + ......+..............................++++.+++.+||+.||++|||++|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0 0011111000000000000000000000001112234678999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=360.49 Aligned_cols=266 Identities=21% Similarity=0.317 Sum_probs=199.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++... .....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc-CCCCc
Confidence 46899999999999999999999988999999999743 233456789999999999999999999997543 12223
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.++++. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEE
T ss_pred ccEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEE
Confidence 45999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~ 235 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVRED 235 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHCC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcCC
Confidence 9999999876433221 222345689999999999999999999999999999999999999975322111000 00000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH-HHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV-VRQLQSIKN 938 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev-l~~L~~i~~ 938 (953)
... + ......++.++.+++.+||+.||++||++.++ .+.+..+..
T Consensus 236 ~~~-------------------------~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 236 PIP-------------------------P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CCC-------------------------H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CCC-------------------------c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000 0 00001245678899999999999999965554 455665543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=361.38 Aligned_cols=274 Identities=18% Similarity=0.203 Sum_probs=212.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 46799999999999999999999888889999999776666778899999999999999999999997532 12345789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKD------KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999964321 134689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcc-------cccccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 790 FGLARFLPLSPAQT-------SSIDAKGSIGYIAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 790 fG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
||.+.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 99987653211100 012234799999999987654 68999999999999999999999964322221111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
........ .+ ....++.++.+++.+||+.||++|||++|+++.|+.+...
T Consensus 258 ~~~~~~~~-----------~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 258 LAVQNQLS-----------IP-------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHHCC-------------CC-------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred HHhhccCC-----------CC-------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 11110000 00 0012345689999999999999999999999999988655
Q ss_pred hccc
Q 043900 940 LLGH 943 (953)
Q Consensus 940 ~~~~ 943 (953)
.++.
T Consensus 308 ~~~~ 311 (317)
T 2buj_A 308 APGQ 311 (317)
T ss_dssp CCC-
T ss_pred CCCC
Confidence 4443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.74 Aligned_cols=268 Identities=18% Similarity=0.264 Sum_probs=208.1
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+++++.++|++++..+++|. ...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCCCc
Confidence 345789999999999999999999988899999998754322 245788999999999888887777753 33477
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~ 784 (953)
.++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTC
T ss_pred eEEEEEcc-CCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCe
Confidence 89999999 99999998532 23589999999999999999999999 99999999999999 78899
Q ss_pred EEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc--c
Q 043900 785 AHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM--N 857 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~--~ 857 (953)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 999999999877543321 122345699999999999999999999999999999999999999986433211 1
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
.............. .....+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 227 YERISEKKMSTPIE---------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhcccccchhh---------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 11111110000000 000123567999999999999999999999999999998
Q ss_pred HHhc
Q 043900 938 NILL 941 (953)
Q Consensus 938 ~~~~ 941 (953)
+...
T Consensus 280 ~~~~ 283 (296)
T 4hgt_A 280 HRQG 283 (296)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 7754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=363.57 Aligned_cols=281 Identities=24% Similarity=0.296 Sum_probs=213.1
Q ss_pred hcCCcccCcccccceeeEEEEEE----cCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 35789999999999999999994 56778999999987766677889999999999999999999998652 244
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 166 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRH---------RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHV 166 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEeecCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCE
Confidence 6789999999999999999632 22589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||.++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...+...
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~ 244 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCE 244 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC--
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccc
Confidence 99999999987543322 12233458889999999999999999999999999999999999986421110 0000000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 942 (953)
..........+... ...+......+++++.+++.+||+.||++|||++|+++.|+.+.....+
T Consensus 245 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 245 RDVPALSRLLELLE---------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp --CCHHHHHHHHHH---------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred cccccHHHHHHHhh---------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 00000000000000 0000111123456799999999999999999999999999998655443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=365.50 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=196.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.++||+|+||.||+|+++.+++.||+|+++.. .......+.+|..++.++ +||||+++++++. ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence 45799999999999999999999999999999999743 223345678899999887 8999999999854 45
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|..++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCE
Confidence 789999999999999999852 23689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc---cHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM---NLHNFA 862 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~---~~~~~~ 862 (953)
||+|||+|+..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ......
T Consensus 193 kL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 193 KLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp EECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred EEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 99999999853221 2233446799999999999999999999999999999999999999964322110 000000
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
.. .+..... ..+...+.++.+++.+||+.||++||++
T Consensus 271 ~~-------~i~~~~~--------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 FQ-------VILEKQI--------------------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HH-------HHHHCCC--------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HH-------HHhcccc--------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00 0000000 0001234568899999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.82 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=188.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||++++++|. .....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 4567999999999999999999999988899999997543 3466889999999999999999999964 34779
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---CCcE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---EMMA 785 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 785 (953)
++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 124 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVE----------KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECCCCSCBHHHHHTT----------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCE
Confidence 999999999999999852 23589999999999999999999999 9999999999999975 8899
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 191 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~ 267 (349)
T 2w4o_A 191 KIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred EEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence 999999998664321 22345689999999999999999999999999999999999999965322211111111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ...+ .....+.++.+++.+||+.||++|||+.|+++
T Consensus 268 ~~-----~~~~-----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 YY-----FISP-----------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CC-----CCTT-----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc-----cCCc-----------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 00123456889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.66 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=160.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|++..+++.||||++.. ......+.+.+|++++++++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999998889999999864 23345678899999999999999999999986654555678
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----------PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecc-ccchhhhccc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEee
Confidence 99999998 5799998852 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc-------------------------cccccccccccccccccc-CCCCCCcccchHHHHHHHHHH
Q 043900 788 SDFGLARFLPLSPAQ-------------------------TSSIDAKGSIGYIAPEYG-LGSEVSINGDVYSYGILLLEL 841 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slG~vl~el 841 (953)
+|||+|+........ ......+||+.|+|||++ .+..++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876432211 123345689999999975 566799999999999999999
Q ss_pred HhC
Q 043900 842 VTR 844 (953)
Q Consensus 842 ltg 844 (953)
++|
T Consensus 278 ltg 280 (458)
T 3rp9_A 278 LNM 280 (458)
T ss_dssp HTT
T ss_pred HHh
Confidence 993
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.95 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=200.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc------
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------ 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 702 (953)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||++++++|.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999999888899999997433 3456789999999999999999999998754211
Q ss_pred ----------------------------------------------CCCCceeEEEeeccCCchhhccccCCcCCcccCC
Q 043900 703 ----------------------------------------------QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEA 736 (953)
Q Consensus 703 ----------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 736 (953)
......++||||+++|+|.+++.....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------- 157 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS------- 157 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-------
Confidence 112347999999999999999974332
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCc----------cccc
Q 043900 737 PRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ----------TSSI 806 (953)
Q Consensus 737 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~----------~~~~ 806 (953)
....++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 23457778999999999999999999 9999999999999999999999999999987543211 1223
Q ss_pred ccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhh
Q 043900 807 DAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLA 886 (953)
Q Consensus 807 ~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 886 (953)
...||+.|+|||++.+..++.++||||+||++|||++|..|+... ...... .....
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~--------~~~~~--------- 290 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITD--------VRNLK--------- 290 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHH--------HHTTC---------
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHH--------hhccC---------
Confidence 456999999999999999999999999999999999987764320 000000 00000
Q ss_pred hcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 887 VHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........++++.+++.+||+.||++|||++|+++
T Consensus 291 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 291 ----------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ----------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ----------CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 00111234566789999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.85 Aligned_cols=266 Identities=24% Similarity=0.375 Sum_probs=206.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.+|++.+.||+|+||+||+|++..+ ...||+|.++. ......+.+.+|+.++++++||||++++++|. ..+.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence 4688899999999999999997543 34589999864 33445678899999999999999999999864 3346
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred ceEEEEeCCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEE
Confidence 789999999999999999632 23578999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC--cccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 787 VSDFGLARFLPLSPA--QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 787 L~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
|+|||.++....... ........+|+.|+|||++.+..++.++||||+|+++|||++ |.+||......+ ......
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~ 246 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL 246 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHH
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh
Confidence 999999986643221 122233457889999999999999999999999999999999 555655422211 111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 943 (953)
..... .. +..++.++.+++.+||+.||++|||++|+++.|+++.....+.
T Consensus 247 ~~~~~-----------~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 247 QGRRL-----------LQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TTCCC-----------CC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred cCCCC-----------CC-------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 00000 00 0022456889999999999999999999999999998877665
Q ss_pred c
Q 043900 944 R 944 (953)
Q Consensus 944 ~ 944 (953)
.
T Consensus 297 ~ 297 (298)
T 3f66_A 297 H 297 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.98 Aligned_cols=268 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred CCcccCcccccceeeEEEEEEcCCCe---EEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKT---TVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.|...+.||+|+||+||+|++..+.+ .||+|+++.. .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 45667899999999999999765443 7999998743 33456788999999999999999999999743 2344
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+.+|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSP---------QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEecccCCCHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEe
Confidence 58999999999999999632 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCC--CcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 788 SDFGLARFLPLSP--AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
+|||+++...... .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~ 244 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTT
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcC
Confidence 9999998654322 112223445889999999999999999999999999999999966654332111 1111111111
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccccc
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHRI 945 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 945 (953)
.... ....+++++.+++.+||+.||++|||++|+++.|+++.+...+..+
T Consensus 245 ~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 245 RRLP------------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp CCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred CCCC------------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 0000 0012345688999999999999999999999999999998877665
Q ss_pred c
Q 043900 946 V 946 (953)
Q Consensus 946 ~ 946 (953)
.
T Consensus 295 ~ 295 (298)
T 3pls_A 295 V 295 (298)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.40 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=205.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 467999999999999999999999888899999997433 344578899999999999999999999964 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp EEEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEe
Confidence 999999999999999852 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.+................|++.|+|||++.+..+ +.++||||||+++|||++|+.||............+......
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (276)
T 2yex_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (276)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT
T ss_pred eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc
Confidence 9999987643322223344568999999999988765 788999999999999999999997643332222222111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ......+.++.+++.+||+.||++|||++|+++
T Consensus 228 ~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 L------------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp S------------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------------------------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 000123456889999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=360.17 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=200.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeE----EEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTT----VAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
.++|++.+.||+|+||+||+|++..+++. ||+|.++. ......+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 35799999999999999999999776654 46776643 234456789999999999999999999999753
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
...++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCceEEEEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence 3478999999999999999632 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ......
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~ 233 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILE 233 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
Confidence 99999999987754443334444557889999999999999999999999999999999 999997532221 111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..... .....++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 234 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERL------------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCC------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCC------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 10000 0001234568899999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=353.14 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=213.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ...+.+.+|++++++++||||+++++++. .....
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence 4667999999999999999999999988899999997543 34578899999999999999999999964 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCC--------TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcc--------cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence 99999999999999996432 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.+....... ........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||....... ..........
T Consensus 154 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~~ 230 (288)
T 3kfa_A 154 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR 230 (288)
T ss_dssp CCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCC
T ss_pred cCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccCC
Confidence 999998764332 223334557889999999998999999999999999999999 999987532211 1111111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
. ..+..+++++.+++.+||+.||++|||++|+++.|+++....
T Consensus 231 ------------~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 ------------M------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ------------C------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------C------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000123457899999999999999999999999999886553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=365.46 Aligned_cols=288 Identities=19% Similarity=0.235 Sum_probs=215.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|.+.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++... .....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence 357999999999999999999999988899999997433 33456788999999999999999999987532 33478
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe----cCCCc
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEMM 784 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 784 (953)
++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN-------AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCcee
Confidence 999999999999999964322 12489999999999999999999999 99999999999999 77888
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCC--------CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG--------SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~ 856 (953)
+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 155 ~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 999999999876432 22234569999999999765 5678899999999999999999999975433322
Q ss_pred cHHHHHHh--hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 857 NLHNFARM--ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 857 ~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
........ ..+......+......... ... ............+..+.+++.+||++||++|||++|+++.++
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~---~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGVQKAENGPID---WSG---DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEEECSTTCCEE---EES---SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hHHHHHHHhcCCCcccchhheeccCCCcc---cCc---cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 22221111 1111111111000000000 000 000011122456778999999999999999999999999998
Q ss_pred HHHHH
Q 043900 935 SIKNI 939 (953)
Q Consensus 935 ~i~~~ 939 (953)
++.+.
T Consensus 306 ~il~~ 310 (396)
T 4eut_A 306 DILHR 310 (396)
T ss_dssp HHHTC
T ss_pred HHhhc
Confidence 88654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=372.35 Aligned_cols=260 Identities=18% Similarity=0.190 Sum_probs=204.3
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+....++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|..++..++||||++++++|.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~---- 144 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ---- 144 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE----
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe----
Confidence 3345678999999999999999999999999999999996422 222344889999999999999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 145 -~~~~~~lV~Ey~~gg~L~~~l~~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~ 211 (437)
T 4aw2_A 145 -DDNNLYLVMDYYVGGDLLTLLSKF---------EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN 211 (437)
T ss_dssp -CSSEEEEEECCCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred -eCCEEEEEEecCCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCC
Confidence 447899999999999999999632 23589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+.+||+|||+|+....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||......+ .
T Consensus 212 g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~ 289 (437)
T 4aw2_A 212 GHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-T 289 (437)
T ss_dssp SCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H
T ss_pred CCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-H
Confidence 9999999999987643322 2233457999999999986 5678999999999999999999999997532111 1
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD--RMNMTNVVR 931 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 931 (953)
+..... .. ... ..... ....++++.+++.+|+..+|++ ||+++|+++
T Consensus 290 ~~~i~~----~~-~~~---~~p~~-------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 290 YGKIMN----HK-ERF---QFPTQ-------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHT----HH-HHC---CCCSS-------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHhhhh----cc-ccc---cCCcc-------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111110 00 000 00000 0013456889999999998888 999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=368.42 Aligned_cols=207 Identities=24% Similarity=0.314 Sum_probs=172.6
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|++++++++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 356899999999999999999999999999999999642 334567889999999999999999999997655444446
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||++ |+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----------PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecCC-cCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEE
Confidence 7999999995 699999852 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc--------------------cccccccccccccccccc-CCCCCCcccchHHHHHHHHHHHhCC
Q 043900 787 VSDFGLARFLPLSPAQ--------------------TSSIDAKGSIGYIAPEYG-LGSEVSINGDVYSYGILLLELVTRK 845 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slG~vl~elltg~ 845 (953)
|+|||+|+........ ......+||+.|+|||++ .+..++.++||||+||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999876533211 123456799999999985 5667999999999999999999866
Q ss_pred CCCC
Q 043900 846 KPVD 849 (953)
Q Consensus 846 ~pf~ 849 (953)
.||.
T Consensus 250 ~p~~ 253 (432)
T 3n9x_A 250 QSHI 253 (432)
T ss_dssp TTTC
T ss_pred cccc
Confidence 6554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=361.83 Aligned_cols=270 Identities=18% Similarity=0.236 Sum_probs=203.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcC---CCeEEEEEEeeccchh-----------hHHHHHHHHHHHhhcCCCCeeEEEe
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ---GKTTVAVKVFNLLHHG-----------AFKSFIAECNTLKNIRHRNLVKILT 695 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~ 695 (953)
.++|++.+.||+|+||.||+|++.. ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999986 6678999998644321 1234667888999999999999999
Q ss_pred eecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 696 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
++... +.+....++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQ----------NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBG----------GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 97653 34467899999999 9999999952 22689999999999999999999999 9999999999
Q ss_pred CeEecCCC--cEEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 776 NVLLDEEM--MAHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 776 NIll~~~~--~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999887 9999999999876432211 1123456999999999999999999999999999999999999999
Q ss_pred CCcccCCccHHHHHHh---hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 043900 849 DSMFEGDMNLHNFARM---ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN 925 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 925 (953)
................ ..+....... ....++.++.+++.+||+.||++|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVLKWA-------------------------PSGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHHHHS-------------------------CTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cccccccHHHHHHHHhhcccccHHHHhhc-------------------------cccccHHHHHHHHHHHhhcCcccCCC
Confidence 6432222111111111 0111111000 00023557999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 043900 926 MTNVVRQLQSIKNI 939 (953)
Q Consensus 926 ~~evl~~L~~i~~~ 939 (953)
++||++.|+++...
T Consensus 316 ~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 316 YQALKKILNPHGIP 329 (345)
T ss_dssp HHHHHHHHCTTCCC
T ss_pred HHHHHHHHhccCCc
Confidence 99999999886543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=360.56 Aligned_cols=252 Identities=20% Similarity=0.234 Sum_probs=198.2
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEEeec
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFM 715 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 715 (953)
.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||++++++|. ..+..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence 568999999999999999888899999998766666788999999999999999999999964 347799999999
Q ss_pred cCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe--cCCCcEEEeccccc
Q 043900 716 QNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL--DEEMMAHVSDFGLA 793 (953)
Q Consensus 716 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a 793 (953)
++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 169 ~~~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 169 DGGELFDRIIDE---------SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp TTCEEHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 999999988532 23589999999999999999999999 99999999999999 56789999999999
Q ss_pred eecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhh
Q 043900 794 RFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873 (953)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (953)
+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.........
T Consensus 237 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~------ 306 (373)
T 2x4f_A 237 RRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWD------ 306 (373)
T ss_dssp EECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC------
T ss_pred eecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC------
Confidence 9775332 2223469999999999999999999999999999999999999997532211 11111111000
Q ss_pred ccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHH
Q 043900 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR--QLQSI 936 (953)
Q Consensus 874 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i 936 (953)
... ......++++.+++.+||+.||++|||++|+++ .+++.
T Consensus 307 ------~~~----------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 ------LED----------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ------SCS----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ------CCh----------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 000 000123457899999999999999999999987 44443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.70 Aligned_cols=206 Identities=26% Similarity=0.374 Sum_probs=166.8
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 704 (953)
...++|++.+.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++++. ||||+++++++.. .+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence 346789999999999999999999999999999999853 23445677889999999997 9999999999753 23
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred CCEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCC
Confidence 357899999996 689998852 3588999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCC-------------------CcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhC
Q 043900 785 AHVSDFGLARFLPLSP-------------------AQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTR 844 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg 844 (953)
+||+|||+|+.+.... .........||+.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 9999999998764311 1112234579999999999877 6789999999999999999999
Q ss_pred CCCCCCc
Q 043900 845 KKPVDSM 851 (953)
Q Consensus 845 ~~pf~~~ 851 (953)
+.||.+.
T Consensus 228 ~~pf~~~ 234 (388)
T 3oz6_A 228 KPIFPGS 234 (388)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.19 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=204.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|.+..+ ..||+|+++.... ..+.+.+|++++++++||||+++++++. .....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTT-EEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCC-CeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCe
Confidence 356799999999999999999998854 5899999975432 3467899999999999999999999964 44778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~ 162 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS 162 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEEC
T ss_pred EEEEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEc
Confidence 9999999999999999632 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.++...... ........+|+.|+|||++.+..++.++||||+|+++|||+| |+.||....... .........
T Consensus 163 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~- 238 (283)
T 3gen_A 163 DFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGL- 238 (283)
T ss_dssp STTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTC-
T ss_pred cccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhccc-
Confidence 999998654221 122233447788999999998899999999999999999998 999997532211 111010000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... +...++.+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 239 -------~~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 -------RLYR----------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -------CCCC----------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCC----------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0000 001235688999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=360.69 Aligned_cols=275 Identities=21% Similarity=0.291 Sum_probs=214.2
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCC-----eEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecc
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGK-----TTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSG 699 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 699 (953)
....++|++.+.||+|+||.||+|.+...+ +.||+|+++... ....+.+.+|+.+++++ +||||++++++|.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence 334578999999999999999999987654 379999997543 34567789999999999 8999999999964
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCc----ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDK----TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
..+..++||||+++|+|.+++........ .......+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 121 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 193 (333)
T 2i1m_A 121 ----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 193 (333)
T ss_dssp ----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence 34678999999999999999964321100 001123589999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccC
Q 043900 776 NVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEG 854 (953)
Q Consensus 776 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~ 854 (953)
||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999987654433333444557889999999999999999999999999999999 99999753222
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
. ............. .+..+++++.+++.+||+.||++|||++|+++.|+
T Consensus 274 ~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 274 S-KFYKLVKDGYQMA------------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp H-HHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHHHHhcCCCCC------------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 1 1111111110000 00012456889999999999999999999999999
Q ss_pred HHHHHh
Q 043900 935 SIKNIL 940 (953)
Q Consensus 935 ~i~~~~ 940 (953)
++....
T Consensus 323 ~~~~~~ 328 (333)
T 2i1m_A 323 EQAQED 328 (333)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=360.29 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=201.1
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
...++|.+.+.||+|+||.||+|+++.+++.||+|+++... ......+..|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~----- 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----- 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----
Confidence 34578999999999999999999999999999999997432 33456778899999887 8999999999954
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
..+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCC
Confidence 44789999999999999999952 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 156 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~ 231 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIR 231 (345)
T ss_dssp CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence 99999999998643221 2234457999999999999999999999999999999999999999753211 1110000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT-NVV 930 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 930 (953)
.. ..... ...++++.+++.+||+.||++||++. |++
T Consensus 232 ~~---------~~~~p----------------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 MD---------NPFYP----------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HC---------CCCCC----------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred hC---------CCCCC----------------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 00000 01245688999999999999999997 664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=365.76 Aligned_cols=287 Identities=17% Similarity=0.168 Sum_probs=205.3
Q ss_pred hhcCCcccCccccc--ceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVG--SFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
..++|++.+.||+| +||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----- 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence 35679999999999 99999999999888999999997432 4455778899999999999999999999643
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
++..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFM--------DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGK 166 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 4789999999999999999964322 3589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCC-----CcccccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 785 AHVSDFGLARFLPLSP-----AQTSSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+||+|||.+....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+..
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999987542211 1112223468999999999987 57999999999999999999999999764332211
Q ss_pred HHHHHHhhCCchh-------hhh---ccccccC-Cchh-hhhcccc--hhhhhhhhhHHHHHHHHHHHhhccccCCCCCC
Q 043900 858 LHNFARMALPDHV-------VDI---VDSTLLS-DDED-LAVHGNQ--RQRQARINSKIECLVAMVRIGVACSMESPGDR 923 (953)
Q Consensus 858 ~~~~~~~~~~~~~-------~~~---~~~~l~~-~~~~-~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 923 (953)
... .....+... ... ....... ...+ ....... .............++++.+++.+||+.||++|
T Consensus 247 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 325 (389)
T 3gni_B 247 LEK-LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325 (389)
T ss_dssp HHC---------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred HHH-hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 111 100000000 000 0000000 0000 0000000 00000111223446779999999999999999
Q ss_pred CCHHHHHHH
Q 043900 924 MNMTNVVRQ 932 (953)
Q Consensus 924 Pt~~evl~~ 932 (953)
||++|+++.
T Consensus 326 pta~ell~h 334 (389)
T 3gni_B 326 PSASTLLNH 334 (389)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhcC
Confidence 999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.71 Aligned_cols=269 Identities=20% Similarity=0.291 Sum_probs=202.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|++.+.||+|+||.||+|.+..+++.||+|+++. ........+.+|+.++++++||||+++++++.. .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 34579999999999999999999988888999999974 234456788999999999999999999999653 3
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKK------QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 175 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CcEEEEEecCCCCCHHHHHHHhcc------cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence 678999999999999999863221 134589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||++....... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ........
T Consensus 176 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~ 250 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI 250 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHH
T ss_pred EEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHh
Confidence 999999998664322 1223346899999999999999999999999999999999999999753221 11111110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 942 (953)
.... ..... ...++.++.+++.+||+.||++|||++||++.|++++....+
T Consensus 251 ~~~~--------~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 251 EQCD--------YPPLP------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HTTC--------SCCCC------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred hccc--------CCCCc------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0000 00000 002345688999999999999999999999999999877554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.03 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=201.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC-------eEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK-------TTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
.++|.+.+.||+|+||+||+|++..++ ..||+|+++.......+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 357899999999999999999987655 479999998766667788999999999999999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKN---------KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE 149 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence 346789999999999999999632 22489999999999999999999999 99999999999999988
Q ss_pred Cc--------EEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCccc
Q 043900 783 MM--------AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFE 853 (953)
Q Consensus 783 ~~--------~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~ 853 (953)
+. +||+|||.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 86 99999999975421 123458899999999887 6799999999999999999996555432211
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
... ........ .. ... ..+.++.+++.+||+.||++|||++|+++.|
T Consensus 224 ~~~-~~~~~~~~--~~--------~~~----------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 224 SQR-KLQFYEDR--HQ--------LPA----------------------PKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHH-HHHHHHTT--CC--------CCC----------------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHH-HHHHhhcc--CC--------CCC----------------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 110 00000000 00 000 1123477999999999999999999999999
Q ss_pred HHHHHHh
Q 043900 934 QSIKNIL 940 (953)
Q Consensus 934 ~~i~~~~ 940 (953)
+++....
T Consensus 271 ~~l~~p~ 277 (289)
T 4fvq_A 271 NSLFTPD 277 (289)
T ss_dssp HTCC---
T ss_pred HHhcCCC
Confidence 9885543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.96 Aligned_cols=267 Identities=18% Similarity=0.257 Sum_probs=211.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.++|++++..+.++. ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 5689999999999999999999988889999999865432 346889999999999888777776653 2346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCCcEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAH 786 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 786 (953)
+||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 82 lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEec-CCCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEE
Confidence 999999 99999999532 23589999999999999999999999 99999999999999 4888999
Q ss_pred EeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC--ccHH
Q 043900 787 VSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD--MNLH 859 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~--~~~~ 859 (953)
|+|||.++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 9999999877543321 11234569999999999999999999999999999999999999998643221 1111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
........... ......+++++.+++.+||+.||++|||++|+++.|+++...
T Consensus 229 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 229 RISEKKMSTPI---------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhcccccCCch---------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 11111000000 000012356799999999999999999999999999999876
Q ss_pred hcc
Q 043900 940 LLG 942 (953)
Q Consensus 940 ~~~ 942 (953)
...
T Consensus 282 ~~~ 284 (296)
T 3uzp_A 282 QGF 284 (296)
T ss_dssp TTC
T ss_pred cCC
Confidence 543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=368.48 Aligned_cols=257 Identities=19% Similarity=0.220 Sum_probs=203.3
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
+....++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|+.+++.++||||++++++|.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~---- 139 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ---- 139 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE----
Confidence 3345678999999999999999999999999999999996421 222345788999999999999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+....++||||+++|+|.++++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 140 -~~~~~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 140 -DDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp -CSSEEEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred -ECCEEEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCC
Confidence 45789999999999999999852 2488999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE----VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+.+||+|||+|+...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+ .+
T Consensus 205 g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~ 282 (410)
T 3v8s_A 205 GHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TY 282 (410)
T ss_dssp SCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH
T ss_pred CCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HH
Confidence 999999999998764332 22233567999999999987665 7899999999999999999999997522110 11
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD--RMNMTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 931 (953)
...... . ... . .+.....+.++.+++.+||+.+|.+ ||+++||++
T Consensus 283 ~~i~~~----~-~~~---~--------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 283 SKIMNH----K-NSL---T--------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHTH----H-HHC---C--------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHhc----c-ccc---c--------------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111100 0 000 0 0000023456889999999999998 999999886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.86 Aligned_cols=279 Identities=22% Similarity=0.337 Sum_probs=213.8
Q ss_pred CcCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhh--cCCCCeeEEEeee
Q 043900 620 NISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKN--IRHRNLVKILTAC 697 (953)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~ 697 (953)
..+...-....++|++.+.||+|+||.||+|++. ++.||||+++.. ....+.+|++++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3344444556788999999999999999999984 568999999643 34567788888887 6899999999997
Q ss_pred cccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEe
Q 043900 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH--------HDCQPPITH 769 (953)
Q Consensus 698 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH 769 (953)
... .......++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +. +|+|
T Consensus 106 ~~~-~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH 170 (342)
T 1b6c_B 106 NKD-NGTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAH 170 (342)
T ss_dssp ECC-CSSCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEEC
T ss_pred ccc-CCccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---Ceee
Confidence 543 1112378999999999999999952 25899999999999999999999 67 9999
Q ss_pred ecCCCCCeEecCCCcEEEeccccceecCCCCCcc--cccccccccccccccccCCC------CCCcccchHHHHHHHHHH
Q 043900 770 CDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT--SSIDAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLEL 841 (953)
Q Consensus 770 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slG~vl~el 841 (953)
|||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 9999999999999999999999998765433221 22345699999999998776 344789999999999999
Q ss_pred HhC----------CCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHH
Q 043900 842 VTR----------KKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRI 911 (953)
Q Consensus 842 ltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 911 (953)
+|| ..||......+.....+........ ...... .+ ....+++..+.++
T Consensus 251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~------------~~-~~~~~~~~~l~~l 309 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK--------LRPNIP------------NR-WQSCEALRVMAKI 309 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC--------CCCCCC------------GG-GGTSHHHHHHHHH
T ss_pred HhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH--------hCCCCc------------cc-ccchhHHHHHHHH
Confidence 999 6777654443333333322221111 000000 00 0112567789999
Q ss_pred hhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 912 GVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 912 ~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+.+||+.||++|||++||++.|+++.+.
T Consensus 310 i~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 310 MRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp HHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=359.33 Aligned_cols=272 Identities=23% Similarity=0.370 Sum_probs=210.0
Q ss_pred CcccCcccccceeeEEEEEE----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 633 FASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
|++.+.||+|+||+||+|.+ ..+++.||||+++... ....+.+.+|++++++++||||+++++++... ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 48999999999999988865 3466789999997543 34567789999999999999999999997532 2467
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence 8999999999999999952 2489999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||.++........ .......+|..|+|||++.+..++.++||||||+++|||++|+.||........ .. ...
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~---~~--~~~ 250 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL---EL--IGI 250 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HH--HCS
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh---hh--hcc
Confidence 999999987543322 222344588899999999999999999999999999999999999875221100 00 000
Q ss_pred Cc------hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 867 PD------HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 867 ~~------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
.. ...+.++... .......++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 251 AQGQMTVLRLTELLERGE------------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCHHHHHHHHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHHhccc------------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 00 0111111000 00111234567999999999999999999999999999999887
Q ss_pred cccc
Q 043900 941 LGHR 944 (953)
Q Consensus 941 ~~~~ 944 (953)
.+..
T Consensus 313 ~~~~ 316 (318)
T 3lxp_A 313 QGQA 316 (318)
T ss_dssp HC--
T ss_pred ccCC
Confidence 6553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.49 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=191.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ....+.+.+|+++++.++||||++++++|. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 357899999999999999999986 4689999986432 223567889999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC----
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---- 781 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 781 (953)
+..++||||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 67899999999999999984 235899999999999999999999981112999999999999986
Q ss_pred ----CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 782 ----EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 782 ----~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
++.+||+|||.++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~- 222 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV- 222 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-
T ss_pred ccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 6789999999998654322 2234689999999999999999999999999999999999999975322110
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.... ........ ....+++++.+++.+||+.||++|||++|+++.|+++
T Consensus 223 ----~~~~--------~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ----AYGV--------AMNKLALP------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHH--------HTSCCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHhh--------hcCCCCCC------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0000 00000000 0012345689999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.55 Aligned_cols=246 Identities=21% Similarity=0.252 Sum_probs=201.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|..+++.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 357999999999999999999999888999999997432 234567889999999999999999999954 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence 89999999999999999953 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 147 L~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~-- 214 (318)
T 1fot_A 147 ITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KTYEK-- 214 (318)
T ss_dssp ECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH--
T ss_pred EeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHH--
Confidence 9999999876421 23456999999999999999999999999999999999999999752111 11110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
+...... . +...+.++.+++.+|++.||++|| +++|+++
T Consensus 215 ------i~~~~~~-~-------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 215 ------ILNAELR-F-------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------HHHCCCC-C-------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HHhCCCC-C-------------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0000000 0 001235688999999999999999 8888875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.15 Aligned_cols=271 Identities=26% Similarity=0.399 Sum_probs=207.2
Q ss_pred cCCcccCcccccceeeEEEEE----EcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGI----LDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+.|++.+.||+|+||.||+|+ ...+++.||+|+++.. .....+.+.+|++++++++||||+++++++.. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 458899999999999999999 4567789999999743 23345788999999999999999999999753 223
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN---------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEEeCCCCcHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCE
Confidence 5689999999999999999532 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||.++........ .......||..|+|||++.+..++.++||||+|+++|||++|..|+..... .+...
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~ 239 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLKM 239 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhhc
Confidence 99999999887544322 223345588899999999999999999999999999999999998653211 11111
Q ss_pred hCCch----hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 865 ALPDH----VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 865 ~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
..+.. ......... ...+...+..+++++.+++.+||+.||++|||++|++++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 240 IGPTHGQMTVTRLVNTLK---------------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HCSCCGGGHHHHHHHHHH---------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCcccccCHHHHHHHHh---------------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000 000000000 00001111134567999999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.29 Aligned_cols=273 Identities=23% Similarity=0.316 Sum_probs=196.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++. ..+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 57899999999999999999994 45689999996433 223467889999999999999999999964 34789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++ +|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVC---------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp EEEEECCSE-EHHHHHHTS---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCC-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999975 999888532 23588999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ..........
T Consensus 143 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 219 (288)
T 1ob3_A 143 DFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219 (288)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCC
Confidence 999998664221 122334689999999998764 589999999999999999999999976432211 1111111110
Q ss_pred c---hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 D---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ....... ........ ..... ..........++++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 220 PNSKNWPNVTE--LPKYDPNF--TVYEP--LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTTSTTGGG--STTCCTTC--CCCCC--CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhchhhhc--cccccccc--ccccC--ccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000 00000000 00000 0000001123567889999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=376.14 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=208.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|.+.+.||+|+||.||+|.+..+ ..||||+++... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCc-cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence 356788999999999999999999765 589999997543 34678999999999999999999999863 2568
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.++++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--------HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEEC
T ss_pred EEEEeecCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEe
Confidence 99999999999999996332 12578899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ .........
T Consensus 327 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~- 402 (454)
T 1qcf_A 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGY- 402 (454)
T ss_dssp STTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTC-
T ss_pred eCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-
Confidence 999998764221 111223346789999999998999999999999999999999 999997532211 111111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+...+..+++++.+++.+||+.||++|||+++|++.|+++...
T Consensus 403 -----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 -----------------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0000113456799999999999999999999999999987544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.58 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=198.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|..+++++ +||||+++++++. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence 35789999999999999999999999999999999743 334456788999999988 8999999999954 44
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 789999999999999999852 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc----cHHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM----NLHNF 861 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~----~~~~~ 861 (953)
||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .....
T Consensus 150 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 227 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227 (345)
T ss_dssp EECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred EEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence 999999998643221 223345799999999999999999999999999999999999999975321110 00000
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
.. .+..... ..+...+.++.+++.+||+.||++||++
T Consensus 228 ~~--------~i~~~~~--------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 228 FQ--------VILEKQI--------------------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HH--------HHHHCCC--------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HH--------HHHcCCC--------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 00 0000000 0001234568899999999999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=361.28 Aligned_cols=256 Identities=19% Similarity=0.249 Sum_probs=194.3
Q ss_pred hcCCccc-CcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhh-cCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASA-NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKN-IRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|.+. +.||+|+||+||+|.+..+++.||||+++.. ..+.+|++++.+ .+||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 4567766 6899999999999999999999999999632 456778888754 4899999999987542 334567
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---CCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---EMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 784 (953)
.++||||+++|+|.+++.... ...+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEeCCCCcHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCcc
Confidence 899999999999999996432 23589999999999999999999999 9999999999999987 789
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc--cHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM--NLHNFA 862 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~--~~~~~~ 862 (953)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 203 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 999999999876422 222345689999999999999999999999999999999999999975432211 111111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...... . .. .....++.++.+++.+||+.||++|||++|+++.
T Consensus 280 ~~~~~~---------~-~~-----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 280 RMGQYE---------F-PN-----------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHTCCC---------C-CT-----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HcCccc---------C-CC-----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100000 0 00 0001235678999999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.88 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=202.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|++. ++.||||+++.. .....+.+.+|+.++++++||||++++++|... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 357999999999999999999986 468999999743 344557899999999999999999999997432 2367
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeEecCCCcE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP--ITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~ 785 (953)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. + ++||||||+||+++.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGT--------NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCS--------SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCE
T ss_pred eEeeecccCCCcHHHHHhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcce
Confidence 899999999999999996422 12589999999999999999999998 7 9999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCc---ccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSI---NGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
+|+|||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||......+. .....
T Consensus 153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~ 224 (271)
T 3kmu_A 153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVA 224 (271)
T ss_dssp EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHH
T ss_pred eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHH
Confidence 9999998764321 2345899999999988765554 79999999999999999999975322111 00000
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
..... ... +..+++++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 225 ~~~~~--------~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 LEGLR--------PTI----------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HSCCC--------CCC----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hcCCC--------CCC----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00000 000 01234568999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=359.85 Aligned_cols=211 Identities=28% Similarity=0.331 Sum_probs=181.2
Q ss_pred CCCcCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-----CCCeeE
Q 043900 618 FPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-----HRNLVK 692 (953)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 692 (953)
...+++.+.+...++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++++. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44556666666778999999999999999999999988899999999743 334566788999999986 999999
Q ss_pred EEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC
Q 043900 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDL 772 (953)
Q Consensus 693 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 772 (953)
+++++.. .+..++||||+ +++|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||
T Consensus 101 ~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl 163 (360)
T 3llt_A 101 YHGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNY--------NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDL 163 (360)
T ss_dssp EEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred ccceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCC
Confidence 9999643 36899999999 9999999964322 2589999999999999999999999 9999999
Q ss_pred CCCCeEecC-------------------------CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCc
Q 043900 773 KPSNVLLDE-------------------------EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSI 827 (953)
Q Consensus 773 kp~NIll~~-------------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 827 (953)
||+|||++. ++.+||+|||+|+..... .....||+.|+|||++.+..++.
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 238 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDV 238 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCC
Confidence 999999975 789999999999875422 22346899999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCc
Q 043900 828 NGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 828 ~sDv~slG~vl~elltg~~pf~~~ 851 (953)
++|||||||++|||++|+.||...
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccchHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=361.73 Aligned_cols=287 Identities=18% Similarity=0.220 Sum_probs=208.9
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++.........
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3456899999999999999999999999999999999743 334457889999999999999999999998665455556
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||++ |+|.+++. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~iv~e~~~-~~L~~~l~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLK-----------TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp CEEEEEECCS-EEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEcccC-cCHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEE
Confidence 7899999996 59999884 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 787 VSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
|+|||.++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 247 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGI 247 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHH
Confidence 9999999876433221 11234569999999998654 458999999999999999999999997643222 11111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... ..+................................+.++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LGSP-SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HCSC-CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCC-CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111 00000000000000000000000000000001123567899999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.05 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=204.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|++..++..||+|++........+.+.+|++++++++||||++++++|. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence 3567999999999999999999999999899999998665566788999999999999999999999964 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCCcE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMA 785 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 785 (953)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 82 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----------KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence 999999999999998852 23589999999999999999999999 99999999999999 788899
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||.+....... ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||......+ .........
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~ 223 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGT 223 (277)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred EEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC
Confidence 999999998765332 22334699999999998664 8999999999999999999999997532211 011110000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .. .....+++++.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~-------------~~---------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 FTF-------------PE---------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCC-------------CH---------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCC-------------Cc---------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 000123567899999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=355.01 Aligned_cols=264 Identities=23% Similarity=0.404 Sum_probs=202.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCC----eEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGK----TTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|++.+.||+|+||.||+|.+..++ ..||+|+++.. .......+.+|+.++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence 46778899999999999999986542 45999999743 3344567899999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK---------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CCcEEEEeCCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcE
Confidence 7889999999999999999532 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
||+|||.++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~ 264 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN 264 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH
Confidence 99999999876433221 12223346789999999999999999999999999999999 999996532111 111000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 943 (953)
... ... ....++.++.+++.+||+.||++||++.|+++.|+++.+.....
T Consensus 265 ~~~-----------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 265 DGF-----------RLP-------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp TTC-----------CCC-------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred CCC-----------cCC-------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 000 000 00123456889999999999999999999999999988765544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=361.58 Aligned_cols=273 Identities=20% Similarity=0.361 Sum_probs=212.2
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeec
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACS 698 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 698 (953)
+.....++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999999986 345689999997432 334567899999999999999999999964
Q ss_pred ccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 699 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
.....++||||+++|+|.+++...............+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 99 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 99 -----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred -----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 34678999999999999999964321111111123578999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCcc
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMN 857 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~ 857 (953)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 247 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--- 247 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---
Confidence 99999999999999986643333333334457889999999999999999999999999999999 89998753211
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
....... ....... ...++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 248 --~~~~~~~--------~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 248 --QVLRFVM--------EGGLLDK-------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --HHHHHHH--------TTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --HHHHHHH--------cCCcCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111100 0000000 0123456889999999999999999999999998763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.59 Aligned_cols=275 Identities=21% Similarity=0.267 Sum_probs=199.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 57999999999999999999999988899999985432 2335678899999999999999999999643 4778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 78 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 144 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRY----------QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLC 144 (311)
T ss_dssp EEEEECCSEEHHHHHHHT----------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCchHHHHHhh----------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEe
Confidence 999999999999998742 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC-
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL- 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~- 866 (953)
|||.++...... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+. ........
T Consensus 145 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~ 220 (311)
T 4agu_A 145 DFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLG 220 (311)
T ss_dssp CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred eCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhc
Confidence 999998764322 12234468999999999876 5789999999999999999999999976432211 11111111
Q ss_pred --Cchhhhhccc-cccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 --PDHVVDIVDS-TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 --~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......... ....... ......... ........+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 221 DLIPRHQQVFSTNQYFSGVK-IPDPEDMEP---LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp SCCHHHHHHHHTCGGGTTCC-CCCCSSCCC---HHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccCc-CCCccccch---hhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 0000000 000000000 00001134567899999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.75 Aligned_cols=276 Identities=23% Similarity=0.364 Sum_probs=213.3
Q ss_pred hcCCcccCcccccceeeEEEEEE----cCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|++ ..+++.||+|+++.......+.+.+|++++++++||||+++++++... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence 35689999999999999999994 556789999999876666778899999999999999999999987432 23
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK---------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 184 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST---------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred CceEEEEECCCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcE
Confidence 46899999999999999996322 3589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||+||..||...... .......
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~ 261 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN 261 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCT
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhcc
Confidence 999999998875433221 122345778899999999888999999999999999999999997642110 0000000
Q ss_pred hCCc-----hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 865 ALPD-----HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 865 ~~~~-----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... ...+.+.... +......+++++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNG------------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHhhcCC------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 0000000000 0001123456799999999999999999999999999999887
Q ss_pred hc
Q 043900 940 LL 941 (953)
Q Consensus 940 ~~ 941 (953)
+.
T Consensus 324 l~ 325 (326)
T 2w1i_A 324 MA 325 (326)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.42 Aligned_cols=246 Identities=18% Similarity=0.214 Sum_probs=201.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++. +..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence 357999999999999999999999888999999996432 234567889999999999999999999854 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........
T Consensus 182 L~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~-- 253 (350)
T 1rdq_E 182 VTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSG-- 253 (350)
T ss_dssp ECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC--
T ss_pred EcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcC--
Confidence 9999999876432 234569999999999999999999999999999999999999997531110 01111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
... .+...+.++.+++.+||+.||++||+ ++|+++
T Consensus 254 ----------~~~--------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 ----------KVR--------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------CCC--------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCC--------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 000 00023456889999999999999998 777765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=357.67 Aligned_cols=270 Identities=20% Similarity=0.259 Sum_probs=204.2
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-----chhhHHHHHHHHHHHhhcCCCCeeEEEeeecc
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-----HHGAFKSFIAECNTLKNIRHRNLVKILTACSG 699 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 699 (953)
++....++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++||||++++++|.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 98 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE- 98 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence 3456678899999999999999999999999999999999643 2345678999999999999999999999964
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCc------------------------------ccCCccccCHHHHHHHH
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDK------------------------------TEEAPRSLNLLQRLNIG 749 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~ 749 (953)
+.+..++||||+++|+|.+++........ .......+++..++.++
T Consensus 99 ----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 99 ----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp ----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred ----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 34789999999999999999853211100 00112245778899999
Q ss_pred HHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC--cEEEeccccceecCCCCC--cccccccccccccccccccCC--C
Q 043900 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM--MAHVSDFGLARFLPLSPA--QTSSIDAKGSIGYIAPEYGLG--S 823 (953)
Q Consensus 750 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~ 823 (953)
.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||++.+ .
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 9999999999999 999999999999998776 899999999987643221 112334569999999999875 6
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHH
Q 043900 824 EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIE 903 (953)
Q Consensus 824 ~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (953)
.++.++|||||||++|||++|+.||......+. ...... ....... .....
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~------------~~~~~~~----------------~~~~~ 302 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLN------------KKLCFEN----------------PNYNV 302 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH------------CCCCTTS----------------GGGGG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHh------------cccccCC----------------ccccc
Confidence 789999999999999999999999975322111 111110 0000000 00012
Q ss_pred HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 904 CLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 904 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.++++.+++.+||+.||++|||+.|+++
T Consensus 303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 303 LSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3457889999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.08 Aligned_cols=260 Identities=21% Similarity=0.314 Sum_probs=205.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|.+.+.||+|+||.||+|++... +..||+|+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------ 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence 46799999999999999999997543 346999999754 34456789999999999999999999998632
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERN---------KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEE
T ss_pred CCCEEEEecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcE
Confidence 4568999999999999999532 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||.+........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .......
T Consensus 153 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~ 229 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEK 229 (281)
T ss_dssp EECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHH
T ss_pred EeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhc
Confidence 9999999987643221 12233457889999999988899999999999999999998 999997532221 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
.... . ....+++.+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 230 ~~~~-----------~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 230 GDRL-----------P-------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp TCCC-----------C-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCC-----------C-------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 0000 0 00023456889999999999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.61 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=200.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|..++..+ +||+|+++++++. .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----C
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----c
Confidence 346899999999999999999999998899999999743 223456788999999988 8999999999853 4
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence 4789999999999999999952 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 160 vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~ 232 (353)
T 2i0e_A 160 IKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQS 232 (353)
T ss_dssp EEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred EEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-----HHHHH
Confidence 999999999854322 12233456999999999999999999999999999999999999999753211 11110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
+...... .+...+.++.+++.+||+.||++||+ ++|+++
T Consensus 233 --------i~~~~~~--------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 --------IMEHNVA--------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --------HHHCCCC--------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --------HHhCCCC--------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0000000 00023456889999999999999996 466654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=345.79 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=200.0
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++... .......+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence 477888999999999999999999999999999743 344567889999999999999999999987543 33456789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeEec-CCCcEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP--ITHCDLKPSNVLLD-EEMMAH 786 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~k 786 (953)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+|
T Consensus 106 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEEEecCCCCHHHHHHH----------ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEE
Confidence 99999999999999952 23588999999999999999999998 7 99999999999998 789999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||++...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....... .......
T Consensus 173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~ 243 (290)
T 1t4h_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRVT 243 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHHT
T ss_pred EeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHHHHh
Confidence 9999999754322 2233468999999998764 58999999999999999999999997532211 1111110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....... .....++++.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 244 SGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000000 00012346889999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.28 Aligned_cols=245 Identities=22% Similarity=0.239 Sum_probs=191.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.++||+|+||+||+|++..+++.||||++... ..........|+..+.++ +||||++++++|. .++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 5799999999999999999999988889999998642 233344556666666655 8999999999964 3478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW---------GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH---------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEecc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 99999999 67998888532 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ..........+
T Consensus 199 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~~ 270 (311)
T 3p1a_A 199 GDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYLP 270 (311)
T ss_dssp CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCCC
T ss_pred ccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCCC
Confidence 9999998764322 2234459999999999876 79999999999999999999977664310 01110000000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .....+++++.+++.+||+.||++|||++|+++
T Consensus 271 ~------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 P------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 001123567899999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.62 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=203.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh------hHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG------AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 45799999999999999999999988889999999743221 3577899999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT----------CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCC
Confidence 34789999999999999999952 23589999999999999999999999 999999999999999888
Q ss_pred ----cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 784 ----MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 784 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 225 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---- 225 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----
T ss_pred CCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----
Confidence 79999999998765332 2234469999999999999999999999999999999999999997532111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... ..... .... ......+..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~i--------~~~~~-~~~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 226 -TLANI--------TSVSY-DFDE---------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -HHHHH--------HTTCC-CCCH---------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -HHHHH--------Hhccc-ccCh---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11000 00000 0000 001123456889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.35 Aligned_cols=255 Identities=22% Similarity=0.260 Sum_probs=193.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||+||+|++..+++.||+|+++.... ..+.+.+|+.++++++||||+++++++. .....
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence 35689999999999999999999998899999999975332 3467889999999999999999999964 34789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc--EE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM--AH 786 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~k 786 (953)
++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +|
T Consensus 92 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp EEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred EEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence 999999999999999852 23589999999999999999999999 9999999999999987765 99
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcc-cchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSIN-GDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++..... .......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... .........
T Consensus 159 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~ 234 (361)
T 3uc3_A 159 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRI 234 (361)
T ss_dssp ECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHH
T ss_pred EeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHH
Confidence 9999999754222 22234569999999999988887655 899999999999999999997643322 122211111
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... .. .......++++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~--------~~------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LSVK--------YS------------------IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HTTC--------CC------------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcCC--------CC------------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1000 00 00000124568899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.26 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=208.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|.+.++ +.||+|+++.... ..+.+.+|++++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 83 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY 83 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCC-cEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcE
Confidence 46789999999999999999998754 5899999975432 3577899999999999999999999863 24589
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence 9999999999999996321 12589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .........
T Consensus 153 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~-- 227 (279)
T 1qpc_A 153 FGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGY-- 227 (279)
T ss_dssp CTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC--
T ss_pred CcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhccc--
Confidence 99998765332 122233457889999999988889999999999999999999 999987532111 111110000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGH 943 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 943 (953)
... ....++.++.+++.+||+.||++|||++++++.|+++.....+.
T Consensus 228 ------~~~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 228 ------RMV----------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp ------CCC----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred ------CCC----------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 000 00123457899999999999999999999999999998775544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=358.05 Aligned_cols=280 Identities=21% Similarity=0.247 Sum_probs=198.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~ 705 (953)
..++|++.+.||+|+||.||+|.+..+++.||||++.. ......+.+.+|++++++++||||+++++++.... ....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35689999999999999999999998889999999853 23344577899999999999999999999975431 1223
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCE
Confidence 4579999999 8899999852 3588999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+......
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 241 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKV 241 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 99999999875422 234568999999999877 679999999999999999999999997532211 11111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccch-hhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQR-QRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .....+.... +.............. ............++++.+++.+||+.||++|||++|+++
T Consensus 242 ~-g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 242 T-GTPPAEFVQR-LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp H-CCCCHHHHHT-CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-CCCCHHHHHH-hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1 0000000000 000000000000000 000000001133567899999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.50 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=202.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 46899999999999999999999998899999999643 3345577889999999999999999999964 3477
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc---
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM--- 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 784 (953)
.++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCc
Confidence 8999999999999988852 23589999999999999999999999 9999999999999986655
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ........
T Consensus 147 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~ 222 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAG 222 (284)
T ss_dssp EEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT
T ss_pred EEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhc
Confidence 9999999998764322 2233569999999999999999999999999999999999999997532111 01111000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .....+++++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 223 AYDYPS----------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCCT----------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCc----------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 000123456889999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=366.13 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=202.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|.+.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 357999999999999999999999888899999996432 233567899999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK----------NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS----------SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeE
Confidence 89999999999999999952 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.... .....
T Consensus 157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~- 227 (476)
T 2y94_A 157 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFKK- 227 (476)
T ss_dssp ECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHHH-
T ss_pred EEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHHH-
Confidence 99999998764332 2234569999999999988765 68999999999999999999999753211 11110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.+... .. +...++++.+++.+||+.||++|||++|+++
T Consensus 228 -------i~~~~~-~~-------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 228 -------ICDGIF-YT-------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------HHTTCC-CC-------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HhcCCc-CC-------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 000000 00 0012356889999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.65 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=201.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--------hhHHHHHHHHHHHhhcCCCCeeEEEeeeccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--------GAFKSFIAECNTLKNIRHRNLVKILTACSGV 700 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 700 (953)
..++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 35679999999999999999999999999999999974321 13346778999999999999999999964
Q ss_pred ccCCCCceeEEEeeccCC-chhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 701 DYQGNDFKALVFEFMQNR-SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
..+..++||||+.+| +|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 163 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFIDR----------HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVI 163 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHHT----------CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEE
Confidence 447889999999777 99999852 23589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 780 DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 780 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred cCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 9999999999999987653322 233569999999999988877 78999999999999999999999742110
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
....... +..+++++.+++.+||+.||++|||++|+++.
T Consensus 237 ---------------~~~~~~~--------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---------------VEAAIHP--------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------------TTTCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------------HhhccCC--------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00124568899999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.94 Aligned_cols=267 Identities=19% Similarity=0.204 Sum_probs=199.3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. +
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3578999999999999999999999888999999996432 3335778999999999999999999999643 4
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----------QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA 173 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CeEEEEEEecCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence 788999999999999999952 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||++....... ........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .........
T Consensus 174 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 250 (309)
T 2h34_A 174 YLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA 250 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC
T ss_pred EEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC
Confidence 999999998664322 12223456899999999999999999999999999999999999999753211 111111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHHHHHhcccc
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-NMTNVVRQLQSIKNILLGHR 944 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~~~~~ 944 (953)
.+.. . .....++.++.+++.+||+.||++|| +++++++.|+...+.....+
T Consensus 251 ~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 251 IPRP-S---------------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp CCCG-G---------------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred CCCc-c---------------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 0000 0 00012345688999999999999999 99999999998765544433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=357.21 Aligned_cols=354 Identities=16% Similarity=0.181 Sum_probs=275.9
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+++.|||+++++.+ +| .++.+++|++|+|++|++++ +| |+.+++|++|+|++|+|++ +| ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 568999999999984 56 79999999999999999998 44 9999999999999999995 44 999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCC
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGT 163 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 163 (953)
++|++++ +| ++.+++|++|++++|++++ ++ ++++++|++|++++|+..+.+ .+..+++|++|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 9999995 44 8999999999999999996 43 899999999999999654455 58899999999999999995
Q ss_pred CCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCC
Q 043900 164 IPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKP 243 (953)
Q Consensus 164 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~ 243 (953)
+| +..+++|+.|++++|++++. + + ..+++|++|++++|++++ +| ++.+++|+.|++++|++++.++ ..+
T Consensus 185 l~--l~~l~~L~~L~l~~N~l~~~-~--l-~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~--~~l 253 (457)
T 3bz5_A 185 LD--VSQNKLLNRLNCDTNNITKL-D--L-NQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV--STL 253 (457)
T ss_dssp CC--CTTCTTCCEEECCSSCCSCC-C--C-TTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC--TTC
T ss_pred ec--cccCCCCCEEECcCCcCCee-c--c-ccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH--HHC
Confidence 55 88999999999999999964 2 3 378999999999999997 45 8899999999999999987642 334
Q ss_pred CccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCC
Q 043900 244 QRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFV 323 (953)
Q Consensus 244 ~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~ 323 (953)
++|+.++++.| +|+.|++++|.+.+.+| ++.++
T Consensus 254 ~~L~~L~l~~n---------------------------------------------~L~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 254 SKLTTLHCIQT---------------------------------------------DLLEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp TTCCEEECTTC---------------------------------------------CCSCCCCTTCTTCCEEE--CTTCT
T ss_pred CCCCEEeccCC---------------------------------------------CCCEEECCCCccCCccc--ccccc
Confidence 44444444332 34455566666554444 45667
Q ss_pred CCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCC
Q 043900 324 NLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403 (953)
Q Consensus 324 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 403 (953)
+|+.|++++|...+.+|. ..++|+.|++++|. .+++|++++|++++. + ++++++|+.|++++
T Consensus 287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~~------------~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~ 348 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQNP------------KLVYLYLNNTELTEL-D--VSHNTKLKSLSCVN 348 (457)
T ss_dssp TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTCT------------TCCEEECTTCCCSCC-C--CTTCTTCSEEECCS
T ss_pred cCCEEECCCCcccceecc---CCCcceEechhhcc------------cCCEEECCCCccccc-c--cccCCcCcEEECCC
Confidence 777777777776655553 34556666666552 356677777777763 2 78888888888888
Q ss_pred CccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCcc
Q 043900 404 NNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464 (953)
Q Consensus 404 N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 464 (953)
|+|++ ++ .+..|++++|.++|. ..+..|+.+++++|+++|.+|..+.
T Consensus 349 N~l~~-l~--------~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 349 AHIQD-FS--------SVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp SCCCB-CT--------TGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred CCCCC-cc--------ccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 88884 22 234677788888764 3456677778888888877776543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.15 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=210.3
Q ss_pred cCCcccC-cccccceeeEEEEEEc--CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASAN-EIGVGSFGSVYKGILD--QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~-~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|.+.+ .||+|+||.||+|++. .++..||+|+++.. .....+.+.+|++++++++||||+++++++. .+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 4566666 8999999999999864 45678999999753 3445678999999999999999999999962 24
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC---------CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEE
Confidence 689999999999999999532 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 787 VSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
|+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ........
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~ 228 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ 228 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHT
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhc
Confidence 9999999877543322 12233447899999999988889999999999999999999 99999753221 11111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHR 944 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 944 (953)
... . ..+..+++++.+++.+||+.||++||++.|+++.|+++........
T Consensus 229 ~~~------------~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 229 GKR------------M------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp TCC------------C------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCc------------C------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 000 0 0001335678999999999999999999999999999987766543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=344.34 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=199.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 467999999999999999999999999999999996422 223567889999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~ 149 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 149 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEE
Confidence 78999999999999999852 23589999999999999999999998 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||++...... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||......+ ....... .
T Consensus 150 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~- 222 (279)
T 3fdn_A 150 IADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISR-V- 222 (279)
T ss_dssp ECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH-T-
T ss_pred EEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHh-C-
Confidence 9999998654322 2234468999999999999999999999999999999999999997422110 0000000 0
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... +...++++.+++.+||+.||++|||++|+++.
T Consensus 223 --------~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 --------EFTF----------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --------CCCC----------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --------CCCC----------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00124568899999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=353.22 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=204.2
Q ss_pred hcCCcccCcccccceeeEEEEE-----EcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGI-----LDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||.||+|+ ...+++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence 4679999999999999999999 4455678999999643 3445668899999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC--
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-- 781 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-- 781 (953)
.....++||||+++|+|.+++...... ......+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCC---SSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhccc---ccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC
Confidence 346789999999999999999754322 11234689999999999999999999999 9999999999999984
Q ss_pred -CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 782 -EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 782 -~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
+..+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.||...... ...
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 255 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL 255 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH
Confidence 44699999999986543333333344568899999999988899999999999999999998 99998753211 111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
........ .. ....++.++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 256 ~~~~~~~~------------~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 256 EFVTSGGR------------MD------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHTTCC------------CC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcCCC------------CC------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11110000 00 0012345688999999999999999999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=351.55 Aligned_cols=277 Identities=20% Similarity=0.263 Sum_probs=205.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|++++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 36799999999999999999999988899999999743 3467889999999997 9999999999753 224678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 787 (953)
++||||+++++|.+++. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999884 488899999999999999999999 999999999999999776 8999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+++....... .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||..................
T Consensus 173 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 173 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 99999987653322 233468999999999877 67899999999999999999999999643332222222222111
Q ss_pred CchhhhhccccccCCch---hhhhcccchhh--hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDE---DLAVHGNQRQR--QARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.....+.++........ +.......... ..........++++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111111111100000 00000000000 0000111124567999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=361.98 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=193.8
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhhcCCCCeeEEEeeecc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSG 699 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 699 (953)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999999999999999996432 1122357899999999999999999998632
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 779 (953)
+..++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 212 ------~~~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll 272 (419)
T 3i6u_A 212 ------EDYYIVLELMEGGELFDKVVG----------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272 (419)
T ss_dssp ------SEEEEEEECCTTCBGGGGTSS----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred ------CceEEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence 457999999999999998852 23689999999999999999999999 99999999999999
Q ss_pred cCCC---cEEEeccccceecCCCCCcccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCccc
Q 043900 780 DEEM---MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPVDSMFE 853 (953)
Q Consensus 780 ~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slG~vl~elltg~~pf~~~~~ 853 (953)
+.++ .+||+|||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 7544 5999999999876432 22234569999999999864 5788999999999999999999999975332
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ............. ......+++++.+++.+||+.||++|||++|+++
T Consensus 350 ~~~-~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 350 QVS-LKDQITSGKYNFI---------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCC-HHHHHHTTCCCCC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHH-HHHHHhcCCCCCC---------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 221 1111111100000 0001123567899999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=342.63 Aligned_cols=258 Identities=27% Similarity=0.364 Sum_probs=206.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|.+.++ +.||+|+++.... ..+.+.+|++++++++||||+++++++. ..+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEecCC-CeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence 35788999999999999999999754 5899999975433 3467899999999999999999999964 346789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEeCCCCCcHHHHHhhC---------cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcc
Confidence 999999999999999532 23588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.++..... .........++..|+|||++.+..++.++||||+|+++|||++ |+.||....... ...........
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~~ 224 (267)
T 3t9t_A 148 FGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL 224 (267)
T ss_dssp TTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCC
T ss_pred cccccccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCcC
Confidence 9999865321 1112233457889999999998899999999999999999999 899987522110 11000000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.. +...+.++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 225 --------~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 --------YK----------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CC----------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 001245688999999999999999999999999999763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.38 Aligned_cols=254 Identities=28% Similarity=0.357 Sum_probs=198.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++. ++.||+|+++... ..+.+.+|++++++++||||+++++++.. ..+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence 467999999999999999999885 4689999997433 45778999999999999999999998632 335789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH--------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEee
Confidence 9999999999999995321 12478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.+...... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||......+ ........
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~--- 230 (278)
T 1byg_A 161 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG--- 230 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTT---
T ss_pred cccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcC---
Confidence 9999865322 122347889999999998899999999999999999998 999997532211 11111000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... ....+++++.+++.+||+.||++|||+.|+++.|++++..
T Consensus 231 ---------~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 ---------YKMD------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---------CCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCC------------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0000 0012345789999999999999999999999999999765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=360.47 Aligned_cols=261 Identities=13% Similarity=0.092 Sum_probs=206.0
Q ss_pred hhcCCcccCcccccceeeEEEEE-----EcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC---CCCeeEEEeeeccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGI-----LDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGV 700 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 700 (953)
..++|.+.+.||+|+||+||+|+ ...+++.||+|+++... ...+.+|++++++++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~- 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF- 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence 45679999999999999999994 55667789999997543 345667777777775 9999999999643
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
.+..++||||+++|+|.+++...... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++
T Consensus 139 ----~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 139 ----QNGSVLVGELYSYGTLLNAINLYKNT-----PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG 206 (365)
T ss_dssp ----SSCEEEEECCCCSCBHHHHHHHHHTS-----TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC
T ss_pred ----CCCcEEEEeccCCCcHHHHHHHhhcc-----cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEec
Confidence 47789999999999999999643211 234699999999999999999999999 999999999999999
Q ss_pred C-----------CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 043900 781 E-----------EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 781 ~-----------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~ 849 (953)
. ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999987654344444556679999999999999999999999999999999999999986
Q ss_pred CcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCC-CCHHH
Q 043900 850 SMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDR-MNMTN 928 (953)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~e 928 (953)
........ ........ ...+.+.+++..|++.+|.+| |++++
T Consensus 287 ~~~~~~~~----------------~~~~~~~~---------------------~~~~~~~~~~~~~l~~~p~~r~~~~~~ 329 (365)
T 3e7e_A 287 KNEGGECK----------------PEGLFRRL---------------------PHLDMWNEFFHVMLNIPDCHHLPSLDL 329 (365)
T ss_dssp EEETTEEE----------------ECSCCTTC---------------------SSHHHHHHHHHHHHCCCCTTCCCCHHH
T ss_pred cCCCCcee----------------echhcccc---------------------CcHHHHHHHHHHHcCCCCCCcchHHHH
Confidence 43221100 00000000 013457789999999999998 68899
Q ss_pred HHHHHHHHHHHhcc
Q 043900 929 VVRQLQSIKNILLG 942 (953)
Q Consensus 929 vl~~L~~i~~~~~~ 942 (953)
+.+.|+++......
T Consensus 330 l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 330 LRQKLKKVFQQHYT 343 (365)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhh
Confidence 99999988766443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=372.27 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=203.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|.+..+ ..||||+++.... ..+.+.+|++++++++||||++++++|.. +..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence 345788999999999999999999875 4799999975432 35678999999999999999999999642 567
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.++++... ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 322 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 322 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEehhhcCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEEC
Confidence 99999999999999996321 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ........
T Consensus 323 DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~-- 397 (452)
T 1fmk_A 323 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG-- 397 (452)
T ss_dssp CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT--
T ss_pred CCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC--
Confidence 999998764322 122233447889999999998999999999999999999999 999997532211 11100000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHh
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNIL 940 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~ 940 (953)
. +...+..+++++.+++.+||+.||++|||++++++.|+++....
T Consensus 398 ----------~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 ----------Y------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----------C------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------C------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 0 00001134567899999999999999999999999999875443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=349.74 Aligned_cols=269 Identities=23% Similarity=0.270 Sum_probs=198.3
Q ss_pred hcCCccc-CcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASA-NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+.|.+. +.||+|+||.||+|++..+++.||||+++.........+.+|++++.++ +||||+++++++.. .+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence 3568874 7899999999999999988889999999766555677899999999985 79999999999643 478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc---
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM--- 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 784 (953)
.++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----------RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCS
T ss_pred EEEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCc
Confidence 9999999999999999953 23589999999999999999999999 9999999999999998775
Q ss_pred EEEeccccceecCCCCC-----cccccccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 785 AHVSDFGLARFLPLSPA-----QTSSIDAKGSIGYIAPEYGLG-----SEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999999976532211 111223459999999999875 56889999999999999999999999764433
Q ss_pred CccHHHHHHh-hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 855 DMNLHNFARM-ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 855 ~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+..+...... .......+.+........ . ......+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------------~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGKYEFP------------D---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCCCCCC------------H---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccccccchhHHHHHHHHHhccCcccC------------c---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 2111000000 000000000000000000 0 001124567899999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.05 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=182.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 467999999999999999999998888899999996432 223477899999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTC---------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 889999999999999998632 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||.+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 153 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (278)
T 3cok_A 153 IADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------- 220 (278)
T ss_dssp ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred EEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------
Confidence 999999987643221 22235689999999999999999999999999999999999999975322110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .... .+...+.++.+++.+||+.||++|||++|+++
T Consensus 221 ---~~~~~~----~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 ---LNKVVL----ADYE----------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCS----SCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---HHHHhh----cccC----------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000000 0000 00023456889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=357.14 Aligned_cols=280 Identities=20% Similarity=0.243 Sum_probs=188.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccc-ccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGV-DYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~ 705 (953)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+++++.++||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999999999999999998642 334567788999999999999999999997542 12233
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CCCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CeEEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCE
Confidence 5689999999 7899998852 3589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+......
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 245 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL 245 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 99999999865321 234568999999999877 678999999999999999999999997632211 11111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARI-NSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+............. .......+...+ ......++++.+++.+||+.||++|||++|+++
T Consensus 246 -~g~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 246 -VGTPGAELLKKISSESARNY-IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp -HCSCCHHHHTTCCCHHHHHH-HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -hCCCCHHHHHHhhhHHHHHH-HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11110111100000000000 000000000000 001123467899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=346.62 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=196.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence 357999999999999999999999888899999997433 334578899999999999999999999964 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCCcE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMA 785 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 785 (953)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQA------RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCcHHHHHHhhhh------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence 999999999999999853221 124689999999999999999999999 99999999999999 456789
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+++...... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||......+ ........
T Consensus 167 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~ 240 (285)
T 3is5_A 167 KIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYK 240 (285)
T ss_dssp EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC
T ss_pred EEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccC
Confidence 999999998654322 223456899999999875 568999999999999999999999997532111 11100000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+. .... ....++++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~---------~~~~-------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EPN---------YAVE-------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC---------CCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Ccc---------cccc-------------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000 0012356889999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=346.65 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=206.8
Q ss_pred hhcCCcccC-cccccceeeEEEEEE--cCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 629 ATDGFASAN-EIGVGSFGSVYKGIL--DQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 629 ~~~~~~~~~-~ig~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 88 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE----- 88 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence 345788888 999999999999965 4556789999997432 334578999999999999999999999962
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.+..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 89 -~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 89 -AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred -CCCcEEEEEeCCCCCHHHHHHh----------CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence 2568999999999999999953 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~ 232 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM 232 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 9999999999877543322 12223346789999999988889999999999999999999 99999753221 11111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
...... . ..+..+++++.+++.+||+.||++|||+.|+++.|+++-....
T Consensus 233 ~~~~~~------------~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 233 LEKGER------------M------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp HHTTCC------------C------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHcCCC------------C------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 110000 0 0001234578999999999999999999999999999876554
Q ss_pred c
Q 043900 942 G 942 (953)
Q Consensus 942 ~ 942 (953)
+
T Consensus 283 ~ 283 (291)
T 1xbb_A 283 N 283 (291)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.33 Aligned_cols=266 Identities=17% Similarity=0.227 Sum_probs=207.5
Q ss_pred CCCcCHHHHHHhhcCCccc-CcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhc-CCCCeeEE
Q 043900 618 FPNISYQNLYNATDGFASA-NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNI-RHRNLVKI 693 (953)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~ 693 (953)
-++..++......++|.+. +.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++++ +||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3455666666777788887 89999999999999999988999999997432 33457889999999999 57999999
Q ss_pred EeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 694 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
++++. .....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+|||||
T Consensus 95 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dik 158 (327)
T 3lm5_A 95 HEVYE-----NTSEIILILEYAAGGEIFSLCLPEL--------AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLK 158 (327)
T ss_dssp EEEEE-----CSSEEEEEEECCTTEEGGGGGSSCC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred EEEEE-----eCCeEEEEEEecCCCcHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCC
Confidence 99964 4477999999999999999985322 23689999999999999999999999 99999999
Q ss_pred CCCeEecC---CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 774 PSNVLLDE---EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 774 p~NIll~~---~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999987 7899999999998764322 22335699999999999999999999999999999999999999975
Q ss_pred cccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 851 MFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
....+ ............. ......+++.+.+++.+||+.||++|||++|++
T Consensus 236 ~~~~~-~~~~i~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 236 EDNQE-TYLNISQVNVDYS----------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp SSHHH-HHHHHHHTCCCCC----------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCchH-HHHHHHhcccccC----------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 32211 0111100000000 000012345688999999999999999999997
Q ss_pred H
Q 043900 931 R 931 (953)
Q Consensus 931 ~ 931 (953)
+
T Consensus 287 ~ 287 (327)
T 3lm5_A 287 S 287 (327)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.89 Aligned_cols=257 Identities=19% Similarity=0.218 Sum_probs=201.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
...++|++.+.||+|+||.||+|+.+.+++.||+|+++.. .......+.+|..++..++||||+++++++. +
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----D 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----C
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----e
Confidence 3467899999999999999999999988899999999642 2223455789999999999999999999854 4
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 47899999999999999999632 12589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccC-------CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-------GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+||+|||+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||......+ .
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~ 278 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-T 278 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-H
Confidence 99999999987653322 2223457999999999987 4578999999999999999999999997532111 0
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCC---CCHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDR---MNMTNVVR 931 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~ 931 (953)
+...... . .... . + .....+++++.+++.+||. +|++| |+++|+++
T Consensus 279 ~~~i~~~----~-~~~~---~-p------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHY----K-EHLS---L-P------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTH----H-HHCC---C-C----------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhc----c-cCcC---C-C------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111100 0 0000 0 0 0001235678999999999 99998 58888865
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=353.13 Aligned_cols=267 Identities=21% Similarity=0.225 Sum_probs=196.1
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccc---cCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVD---YQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~---~~~ 704 (953)
...+|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++.... ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999999888899999997666667788999999999996 999999999974221 234
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeEecCC
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP--ITHCDLKPSNVLLDEE 782 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~ 782 (953)
....++||||++ |+|.+++..... ...+++.+++.++.||+.||+|||+. + |+||||||+||+++.+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-------RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-------TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCC
Confidence 456899999995 799998853221 23589999999999999999999998 7 9999999999999999
Q ss_pred CcEEEeccccceecCCCCCcc----------ccccccccccccccccc---CCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 043900 783 MMAHVSDFGLARFLPLSPAQT----------SSIDAKGSIGYIAPEYG---LGSEVSINGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slG~vl~elltg~~pf~ 849 (953)
+.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998765432211 11134589999999998 56778999999999999999999999996
Q ss_pred CcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 043900 850 SMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV 929 (953)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 929 (953)
...... ....... .... ...+..+.+++.+||+.||++|||++|+
T Consensus 255 ~~~~~~-----~~~~~~~------------~~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~ 299 (337)
T 3ll6_A 255 DGAKLR-----IVNGKYS------------IPPH------------------DTQYTVFHSLIRAMLQVNPEERLSIAEV 299 (337)
T ss_dssp ----------------CC------------CCTT------------------CCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred chhHHH-----hhcCccc------------CCcc------------------cccchHHHHHHHHHccCChhhCcCHHHH
Confidence 421110 0000000 0000 0112347789999999999999999999
Q ss_pred HHHHHHHHHHhc
Q 043900 930 VRQLQSIKNILL 941 (953)
Q Consensus 930 l~~L~~i~~~~~ 941 (953)
++.|+.+.....
T Consensus 300 l~~l~~~~~~~~ 311 (337)
T 3ll6_A 300 VHQLQEIAAARN 311 (337)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHhccC
Confidence 999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=351.01 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=178.8
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCceeEEEee
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++. +....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 47899999999999999998899999999643 3466788999999997 999999999964 44788999999
Q ss_pred ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC---cEEEeccc
Q 043900 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM---MAHVSDFG 791 (953)
Q Consensus 715 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfG 791 (953)
+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 88 LNGGELFERIKK----------KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCSCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 999999999953 23689999999999999999999999 999999999999998765 89999999
Q ss_pred cceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCC--ccHHHHHHhhCCch
Q 043900 792 LARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD--MNLHNFARMALPDH 869 (953)
Q Consensus 792 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~ 869 (953)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...........
T Consensus 155 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~--- 229 (325)
T 3kn6_A 155 FARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--- 229 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT---
T ss_pred cceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH---
Confidence 998764322 22334568999999999999999999999999999999999999997532210 11111111110
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... .......+++++.+++.+||+.||++|||++|+++
T Consensus 230 -----~~~~~~----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 230 -----KGDFSF----------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -----TTCCCC----------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -----cCCCCC----------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000000 00111234567899999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=354.33 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=191.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCC--CCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRH--RNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|.+.. ++.||||+++.. .....+.+.+|+.++++++| |||+++++++. .+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 3569999999999999999999865 568999999743 33445788999999999976 99999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||| +.+++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred CEEEEEEe-CCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence 78999999 458899999953 23688999999999999999999999 999999999999997 5789
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----------SEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 9999999987654433333345579999999999864 67899999999999999999999999753221
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..... ..++........ ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~------------~~~~~~~~~~~~------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ISKLH------------AIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHH------------HHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH------------HHhcCCcccCCc------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111 111111000000 0113458899999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=350.69 Aligned_cols=249 Identities=20% Similarity=0.231 Sum_probs=190.1
Q ss_pred hcCCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.++++++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 467999999999999999999985 567799999997432 234456788999999999999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
..+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLER----------EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence 34789999999999999999852 23588999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
+.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~ 234 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKIL 234 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 999999999997543221 22234569999999999999999999999999999999999999997532111 001100
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
.. .. .. +...+.++.+++.+||+.||++|| +++|+++
T Consensus 235 ~~------------~~-~~-------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 235 KC------------KL-NL-------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HT------------CC-CC-------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred hC------------CC-CC-------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00 00 00 002245688999999999999999 6777765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=368.01 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=204.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++. ..+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eCC
Confidence 45789999999999999999999988899999999642 2234567889999999999999999999854 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~--------~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG--------QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS--------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence 8999999999999999986432 22589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~ 402 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVK 402 (576)
T ss_dssp ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHH
T ss_pred EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhh
Confidence 999999987753322 233479999999999999999999999999999999999999997633221 1111111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
. ..... +...++++.+++.+||+.||++|| +++|+++
T Consensus 403 -----~-~~~~~----------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 -----E-VPEEY----------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----H-CCCCC----------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----c-ccccC----------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 00000 012345688999999999999999 7788875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.49 Aligned_cols=275 Identities=21% Similarity=0.316 Sum_probs=195.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchh-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHG-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.+.||+|+||+||+|++..+++.||+|+++..... ....+.+|++++++++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 5799999999999999999999988889999999643321 2224557999999999999999999964 347789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++ |+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC---------GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEECCS-EEHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred EEecccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence 9999996 5898888532 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC--
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL-- 866 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-- 866 (953)
||+++..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ..........
T Consensus 144 fg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 220 (324)
T 3mtl_A 144 FGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTP 220 (324)
T ss_dssp SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred CcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 9999865322 222234468999999999876 568999999999999999999999997643221 1111111111
Q ss_pred -CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 -PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+..+...... .......................++++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 221 TEETWPGILSN-----EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CTTTSTTGGGC-----HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ChHhchhhhcc-----hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1111111000 00000000000000001111234567889999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=352.97 Aligned_cols=246 Identities=26% Similarity=0.332 Sum_probs=197.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+.|+..+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||++++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 45888999999999999999998888999999997432 3345678999999999999999999999643 378
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ |++.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEecCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence 899999996 6888877422 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||+++.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ .......
T Consensus 196 ~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~ 268 (348)
T 1u5q_A 196 GDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN 268 (348)
T ss_dssp CCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS
T ss_pred eeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc
Confidence 99999986532 12346999999999874 56789999999999999999999999975321110 0111100
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. +.... ..+++.+.+++.+||+.||++|||++|+++
T Consensus 269 ~~---------~~~~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 269 ES---------PALQS---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CC---------CCCCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---------CCCCC---------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 00000 022456889999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=346.81 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=206.6
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc------
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY------ 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 702 (953)
...+|++.+.||+|+||.||+|++..+++.||+|+++... ..+.+|++++++++||||+++++++....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999999888899999997543 346789999999999999999998754211
Q ss_pred -----CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 043900 703 -----QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNV 777 (953)
Q Consensus 703 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 777 (953)
......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni 153 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--------GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI 153 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--------GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHE
Confidence 12355799999999999999996332 23689999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 778 LLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 778 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+++.++.+||+|||.+....... ......||+.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 224 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------ 224 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------
T ss_pred EEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------
Confidence 99999999999999998775432 223345899999999999999999999999999999999999886421
Q ss_pred HHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
..... ...+..... ..+.++.+++.+||+.||++|||+.|+++.|+.++
T Consensus 225 -~~~~~--------~~~~~~~~~----------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 225 -SKFFT--------DLRDGIISD----------------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -HHHHH--------HHHTTCCCT----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -HHHHH--------Hhhcccccc----------------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00000 000000000 12345789999999999999999999999999887
Q ss_pred HHh
Q 043900 938 NIL 940 (953)
Q Consensus 938 ~~~ 940 (953)
+..
T Consensus 274 ~~~ 276 (284)
T 2a19_B 274 KSP 276 (284)
T ss_dssp C--
T ss_pred hCC
Confidence 553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=355.71 Aligned_cols=192 Identities=21% Similarity=0.336 Sum_probs=121.1
Q ss_pred cCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccce
Q 043900 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEH 104 (953)
Q Consensus 25 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (953)
..+++|++|++++|.++. +| .+..+++|++|+|++|.+++. |. +.++++|++|++++|.+++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 346677888888888776 44 377777888888888887743 33 7777788888888877774433 777777778
Q ss_pred eeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccc
Q 043900 105 LSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184 (953)
Q Consensus 105 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 184 (953)
|++++|++++. + .++++++|++|++++|++++ ++ .+..+++|++|+++ |.+.+.. .+.++++|+.|++++|++
T Consensus 117 L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDI-D-PLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCC-G-GGTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCC-h-HHcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence 88877777743 3 27777777777777777763 33 37777777777775 4444222 266666666666666666
Q ss_pred ccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccccccc
Q 043900 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234 (953)
Q Consensus 185 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (953)
++. + . +..+++|++|++++|++++..+ ++.+++|+.|++++|+++
T Consensus 190 ~~~-~-~-l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 190 SDI-S-V-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp CCC-G-G-GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CCC-h-h-hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc
Confidence 532 1 1 2245555555555555553322 344444444444444443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.60 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=192.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcC--CCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 706 (953)
++|++.+.||+|+||.||+|.+.. ++.||||++... .....+.+.+|+.++++++ ||||+++++++.. .+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 459999999999999999999876 568999999643 3445678899999999996 5999999999643 36
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||| +.+++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++ ++.+|
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEe-cCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEE
Confidence 7999999 568899999953 23578889999999999999999999 999999999999995 58899
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCcccCC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----------SEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~ 855 (953)
|+|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 999999987654333333345579999999999865 468899999999999999999999997532211
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..+. .+++........ ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~~~------------~~~~~~~~~~~~------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 SKLH------------AIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHH------------HHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH------------HHhCccccCCCC------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111 111111000000 0113458899999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=358.10 Aligned_cols=250 Identities=24% Similarity=0.259 Sum_probs=191.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHH-HhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNT-LKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|+++.+++.||+|+++... ......+.+|..+ ++.++||||+++++++. ..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence 457999999999999999999999999999999997432 2234556677776 56789999999999854 44
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 789999999999999999852 23588999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 179 kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~- 250 (373)
T 2r5t_A 179 VLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDN- 250 (373)
T ss_dssp EECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-----HHHHH-
T ss_pred EEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHH-
Confidence 99999999864322 12233456999999999999999999999999999999999999999752211 11110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+......- +...+.++.+++.+||+.||++||++.+.++.
T Consensus 251 -------i~~~~~~~--------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 251 -------ILNKPLQL--------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp -------HHHSCCCC--------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred -------HHhcccCC--------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 00000000 00223568899999999999999998644433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=350.95 Aligned_cols=282 Identities=19% Similarity=0.181 Sum_probs=197.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 706 (953)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999998999999999742 3345577889999999999999999999975432 22334
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ceEEEEEcCC-CCHHHHHh------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence 7899999996 57888773 2488999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+..... ..
T Consensus 168 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~-~~ 242 (371)
T 2xrw_A 168 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE-QL 242 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC--C
T ss_pred EEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-Hh
Confidence 9999999865422 12234568999999999999999999999999999999999999997532211 1111111 00
Q ss_pred Cchhhh-----------hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVD-----------IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~-----------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.....+ ......................+.........+.++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 000000000000000000000000111223456789999999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.78 Aligned_cols=270 Identities=15% Similarity=0.136 Sum_probs=206.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcC--------CCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeE---------
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ--------GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK--------- 692 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 692 (953)
.++|++.+.||+|+||.||+|++.. .++.||+|+++.. +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3579999999999999999999987 3678999998743 45788999999999999988
Q ss_pred ------EEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043900 693 ------ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP 766 (953)
Q Consensus 693 ------~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 766 (953)
+++++. ..+...++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+. +
T Consensus 116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ 179 (352)
T 2jii_A 116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP--------KHVLSERSVLQVACRLLDALEFLHEN---E 179 (352)
T ss_dssp TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG--------GGCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 344432 2357889999999 999999996432 23689999999999999999999999 9
Q ss_pred eEeecCCCCCeEecCCC--cEEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHH
Q 043900 767 ITHCDLKPSNVLLDEEM--MAHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLL 839 (953)
Q Consensus 767 ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ 839 (953)
|+||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 99999999999999998 9999999999876432211 1123346999999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCC
Q 043900 840 ELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMES 919 (953)
Q Consensus 840 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 919 (953)
||++|+.||................. ........+... .....+.++.+++.+||+.|
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCG---------------------HWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTS---------------------CEECCCHHHHHHHHHHHTCC
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhcc---------------------ccCCCcHHHHHHHHHHHhCC
Confidence 99999999986432221111111110 000000000000 00012456899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHhcc
Q 043900 920 PGDRMNMTNVVRQLQSIKNILLG 942 (953)
Q Consensus 920 P~~RPt~~evl~~L~~i~~~~~~ 942 (953)
|++|||++|+++.|+++.+....
T Consensus 318 p~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 318 YEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhhCCCHHHHHHHHHHHHHhcCC
Confidence 99999999999999999877543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=351.38 Aligned_cols=285 Identities=21% Similarity=0.301 Sum_probs=203.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc---CC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY---QG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 704 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999999888899999985332 2335678899999999999999999999765321 11
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++ ++.+.+... ...+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 162 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCC
Confidence 4578999999975 777776422 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCC--cccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 785 AHVSDFGLARFLPLSPA--QTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i 241 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALI 241 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 99999999987653221 222344568999999999876 4589999999999999999999999976332211 1111
Q ss_pred HHh--hCCchhhhhcc-ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARM--ALPDHVVDIVD-STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~--~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ..+.......+ ........ ..................++++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSC---CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCChhhccccccchhhcccc---cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111 11111111000 00000000 000000000000011112456889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=352.21 Aligned_cols=277 Identities=23% Similarity=0.320 Sum_probs=194.9
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
...++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++. .+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 45678999999999999999999999999999999996433 223456789999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-----
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD----- 780 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~----- 780 (953)
...++||||++ |+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~----------~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDK----------NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC----
T ss_pred CEEEEEEecCC-CCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCC
Confidence 78999999997 599999852 23589999999999999999999999 999999999999994
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
.++.+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 249 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249 (329)
T ss_dssp -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence 5556999999999876422 1223344689999999998875 489999999999999999999999976432221111
Q ss_pred HHHHhhCCch--hhhhcc-ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMALPDH--VVDIVD-STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~~~~~--~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......+.. ...... +........ ..............++++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFPK------FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCC------CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhhh------hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1111111111 000000 000000000 00000000011124567899999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=369.28 Aligned_cols=249 Identities=19% Similarity=0.243 Sum_probs=192.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||++++++|.. .+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 46799999999999999999999999999999999742 33345677889999999999999999999643 36
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred EEEEEEeeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence 79999999999999999852 2368999999999999999999998 7 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 289 kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i 361 (446)
T 4ejn_A 289 KITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI 361 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH
T ss_pred EEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHH
Confidence 99999999854322 22233467999999999999999999999999999999999999999753211 111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
. .... . .+...++++.+++.+||+.||++|| +++|+++
T Consensus 362 ~--------~~~~-~-------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 L--------MEEI-R-------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp H--------HCCC-C-------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred H--------hCCC-C-------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 0000 0 0002345688999999999999999 9999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=361.72 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=206.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC-eeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN-LVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+|+++++.++|++ +..+..++ ...+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~-----~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG-----VEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE-----EETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE-----eeCCEE
Confidence 4689999999999999999999988888999999864432 245788999999997744 44444442 234678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCCcE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMA 785 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 785 (953)
++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+
T Consensus 79 ~lvme~~-g~sL~~ll~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~v 145 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQV 145 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCE
T ss_pred EEEEECC-CCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeE
Confidence 9999999 99999999632 23589999999999999999999999 99999999999999 688899
Q ss_pred EEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCc--cH
Q 043900 786 HVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM--NL 858 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~--~~ 858 (953)
||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence 99999999887543322 122245699999999999999999999999999999999999999986433211 11
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
............. .....++.++.+++.+||+.||++||++++|++.|+++..
T Consensus 226 ~~i~~~~~~~~~~---------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 226 EKISEKKVATSIE---------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHHHHHSCHH---------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhccccccHH---------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111110000000 0011335679999999999999999999999999999876
Q ss_pred Hh
Q 043900 939 IL 940 (953)
Q Consensus 939 ~~ 940 (953)
..
T Consensus 279 ~~ 280 (483)
T 3sv0_A 279 RE 280 (483)
T ss_dssp HT
T ss_pred Hc
Confidence 53
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=344.83 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=203.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|++++++++||||+++++++.. ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 46799999999999999999999988889999999743 34456788999999999999999999998642 23367
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEeecCCCCCeEecCC
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP-----ITHCDLKPSNVLLDEE 782 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~ 782 (953)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTK------ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred EEEEEeCCCCCCHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence 8999999999999999964321 123589999999999999999999998 7 9999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
+.+||+|||.++...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 153 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i 228 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI 228 (279)
T ss_dssp SCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred CCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHH
Confidence 999999999998654321 1222345899999999999999999999999999999999999999753211 111111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
...... .+ +..++.++.+++.+||+.||++|||++|+++.+
T Consensus 229 ~~~~~~--------~~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 229 REGKFR--------RI----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHTCCC--------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hhcccc--------cC----------------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 100000 00 002345688999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.71 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=197.3
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+|.....||+|+||.||+|++..+++.||+|+++.......+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence 34555689999999999999998889999999987666667889999999999999999999999643 3678999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-CCcEEEecc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-EMMAHVSDF 790 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Df 790 (953)
|||+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 98 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWG-------PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EECCSEEEHHHHHHHTTC-------CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCCCCHHHHHHhhcc-------CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999964321 23567889999999999999999999 9999999999999987 899999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|.++...... .......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..................
T Consensus 168 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 243 (295)
T 2clq_A 168 GTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-- 243 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC--
T ss_pred ccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc--
Confidence 9998764321 1223446899999999987653 789999999999999999999999643221111100000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+.. +..+++++.+++.+||+.||++|||++|+++
T Consensus 244 ------~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 ------HPEI----------------------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ------CCCC----------------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ------cccc----------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0123456889999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=375.56 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=202.8
Q ss_pred CcccC-cccccceeeEEEEEEc--CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 633 FASAN-EIGVGSFGSVYKGILD--QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 633 ~~~~~-~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
+.+.+ .||+|+||.||+|.+. .++..||||+++.. .....+.+.+|++++++++||||++++++|.. +..
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~ 410 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL 410 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence 33444 7999999999999886 34567999999754 33456789999999999999999999999742 458
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 411 ~lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~ 478 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKIS 478 (613)
T ss_dssp EEEEECCTTCBHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEeCCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEe
Confidence 9999999999999999532 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhC
Q 043900 789 DFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .........
T Consensus 479 DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~ 556 (613)
T 2ozo_A 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGK 556 (613)
T ss_dssp CCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTC
T ss_pred eccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC
Confidence 99999876432211 11222346789999999998999999999999999999998 999997632211 111111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLG 942 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 942 (953)
+...+..+++++.+++.+||+.||++||++.+|++.|+.+......
T Consensus 557 ------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 ------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ------------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 0001113456799999999999999999999999999998766544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.65 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=198.0
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..++|++.+.||+|+||.||+|.++.+++.||+|+++.... ...+|++++.++ +||||+++++++. ++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCE
Confidence 35679999999999999999999999999999999975432 234688888888 7999999999954 4578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC----C
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE----M 783 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~ 783 (953)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. ||+||||||+||++.++ +
T Consensus 91 ~~lv~E~~~gg~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILR----------QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp EEEEECCCCSCBHHHHHHT----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGG
T ss_pred EEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcC
Confidence 9999999999999999852 23589999999999999999999999 99999999999998533 3
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 158 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~ 233 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILA 233 (342)
T ss_dssp GEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHH
T ss_pred eEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHH
Confidence 59999999998764332 2223456899999999998888999999999999999999999999753221 1111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ........ ......++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~i~--------~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 234 RIG--------SGKFSLSG----------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHH--------HCCCCCCS----------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHc--------cCCcccCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 00000000 000123456889999999999999999999886
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=364.60 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=201.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence 357889999999999999999999888999999996432 234567889999999999999999999854 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~------~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDE------DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSST------TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhc------ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence 89999999999999999864332 134689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 330 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~ 406 (543)
T 3c4z_A 330 ISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL 406 (543)
T ss_dssp ECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH
T ss_pred EeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh
Confidence 999999987653322 2233579999999999999999999999999999999999999997642211 1111111110
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
.... . .+...+.++.+++.+||+.||++||++
T Consensus 407 --------~~~~-~-------------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 407 --------EQAV-T-------------------YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --------HCCC-C-------------------CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --------hccc-C-------------------CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0000 0 001234568899999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.88 Aligned_cols=278 Identities=22% Similarity=0.297 Sum_probs=200.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||++++++|.. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence 467999999999999999999999988899999986433 3335668899999999999999999999643 477
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF----------PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCcchHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEE
Confidence 8999999999999887642 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh-
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA- 865 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~- 865 (953)
+|||.++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ........
T Consensus 166 ~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (331)
T 4aaa_A 166 CDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLG 242 (331)
T ss_dssp CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred EeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhC
Confidence 9999998654322 222345689999999998875 789999999999999999999999976432211 11111110
Q ss_pred -CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 -LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
............-....... ...............+++++.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 243 NLIPRHQELFNKNPVFAGVRL---PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCCHHHHHHHHHCGGGTTCCC---CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCChhhhhHhhhccccccccC---ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01111110000000000000 0000000000111134667999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.13 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=204.3
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch------hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH------GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 568999999999999999999998888999999964321 13578899999999999999999999964 3
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM- 783 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 783 (953)
....++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----------KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSS
T ss_pred CCeEEEEEeecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCC
Confidence 4778999999999999999952 23589999999999999999999999 999999999999998877
Q ss_pred ---cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHH
Q 043900 784 ---MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 784 ---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~ 860 (953)
.+||+|||.+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~ 222 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTN 222 (283)
T ss_dssp SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH
T ss_pred CCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHH
Confidence 89999999998764322 2233458999999999999999999999999999999999999997532111 0000
Q ss_pred HHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHHHH
Q 043900 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR--QLQSIKN 938 (953)
Q Consensus 861 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i~~ 938 (953)
..... . ... .......+..+.+++.+||+.||++|||++|+++ .++.++.
T Consensus 223 ~~~~~------------~-~~~---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 223 ISAVN------------Y-DFD---------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHTTC------------C-CCC---------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred hHhcc------------c-CCc---------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00000 0 000 0001123456889999999999999999999998 4666654
Q ss_pred H
Q 043900 939 I 939 (953)
Q Consensus 939 ~ 939 (953)
.
T Consensus 275 ~ 275 (283)
T 3bhy_A 275 R 275 (283)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.33 Aligned_cols=267 Identities=23% Similarity=0.366 Sum_probs=205.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEE--EEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTV--AVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|++.+.||+|+||.||+|++..++..+ |+|+++.. .....+.+.+|+++++++ +||||+++++++.. .+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----CC
Confidence 57899999999999999999998877655 99988642 333456789999999999 89999999999643 47
Q ss_pred ceeEEEeeccCCchhhccccCCcCCc------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDK------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 79999999999999999964431000 001234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~ 859 (953)
.++.+||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----- 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 248 (327)
T ss_dssp GGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----
T ss_pred CCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----
Confidence 999999999999974321 112223347889999999988889999999999999999998 99999753211
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
...... ...... .....+++++.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 249 ~~~~~~---------~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 249 ELYEKL---------PQGYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHG---------GGTCCC------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHh---------hcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 000000 00012345688999999999999999999999999998765
Q ss_pred h
Q 043900 940 L 940 (953)
Q Consensus 940 ~ 940 (953)
.
T Consensus 302 ~ 302 (327)
T 1fvr_A 302 R 302 (327)
T ss_dssp S
T ss_pred h
Confidence 4
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.93 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=204.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.+.|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 456999999999999999999999888899999997433 3456789999999999999999999999643 3678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence 99999999999999985 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........+
T Consensus 162 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~- 236 (303)
T 3a7i_A 162 DFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNP- 236 (303)
T ss_dssp CCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC-
T ss_pred ecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCC-
Confidence 999998764322 22234568999999999999999999999999999999999999997532111 1111100000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.... ..++.++.+++.+||+.||++|||++|+++.
T Consensus 237 -------~~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 -------PTLE----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -------CCCC----------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -------CCCc----------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0223568899999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.79 Aligned_cols=287 Identities=20% Similarity=0.193 Sum_probs=205.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++....+.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 356899999999999999999999988899999999643 3344567889999999999999999999976655556678
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred EEEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEE
Confidence 999999996 699998852 3589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcc--------cccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 788 SDFGLARFLPLSPAQT--------SSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. .
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~ 232 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-L 232 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-H
Confidence 9999998765322111 1223468999999998654 6789999999999999999999999976322111 1
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.........................+...................+++++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111110000000000000000000000000000000000011134567899999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.93 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=204.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 46799999999999999999999998899999998643 3345677889999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEE
Confidence 78999999999999998852 23689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||.++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ .....
T Consensus 156 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~- 227 (294)
T 2rku_A 156 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI- 227 (294)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH-
T ss_pred EEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-
Confidence 999999987643222 2234568999999999999999999999999999999999999997532111 00000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
..... .. +...+.++.+++.+||+.||++|||++|+++.
T Consensus 228 -------~~~~~-~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 -------KKNEY-SI-------------------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------HTTCC-CC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------hhccC-CC-------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00 00223468899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.51 Aligned_cols=280 Identities=19% Similarity=0.191 Sum_probs=202.3
Q ss_pred HHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhhcCCCCee
Q 043900 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----------HGAFKSFIAECNTLKNIRHRNLV 691 (953)
Q Consensus 623 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv 691 (953)
..++....++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677788999999999999999999999877 5699999985322 12237889999999999999999
Q ss_pred EEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 043900 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCD 771 (953)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 771 (953)
++++++...........++||||++ |+|.+++... ...+++..+..++.||+.||+|||+. +|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D 159 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---------RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRD 159 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecC
Confidence 9999986543344567899999997 6888888522 23589999999999999999999999 999999
Q ss_pred CCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 043900 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDS 850 (953)
Q Consensus 772 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~ 850 (953)
|||+||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999754322 22234568999999999877 6789999999999999999999999975
Q ss_pred cccCCccHHHHHHhhCCch-----------hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCC
Q 043900 851 MFEGDMNLHNFARMALPDH-----------VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMES 919 (953)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 919 (953)
....+ ............. ..+........... ..........++.+.+++.+||+.|
T Consensus 237 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 237 STFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-----------RAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp SSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-----------CCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred CCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh-----------hhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 32211 1111111111111 11111111100000 0000111133567899999999999
Q ss_pred CCCCCCHHHHHH
Q 043900 920 PGDRMNMTNVVR 931 (953)
Q Consensus 920 P~~RPt~~evl~ 931 (953)
|++|||++|+++
T Consensus 305 P~~Rpt~~ell~ 316 (362)
T 3pg1_A 305 PQRRISTEQALR 316 (362)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHHc
Confidence 999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.82 Aligned_cols=251 Identities=21% Similarity=0.233 Sum_probs=199.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 467999999999999999999999888899999998655545567889999999999999999999964 347889
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCCcEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEMMAH 786 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 786 (953)
+||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----------RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEE
T ss_pred EEEEcCCCccHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEE
Confidence 99999999999998852 23588999999999999999999999 99999999999999 7888999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||.++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ..........
T Consensus 150 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~ 223 (304)
T 2jam_A 150 ITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGY 223 (304)
T ss_dssp BCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCC
T ss_pred EccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCC
Confidence 9999999754321 222345899999999999999999999999999999999999999753211 1111110000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ... ......++++.+++.+||+.||++|||++|+++
T Consensus 224 ~~----~~~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 YE----FES-----------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CC----CCT-----------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CC----CCc-----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 000 000123456889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.47 Aligned_cols=280 Identities=23% Similarity=0.273 Sum_probs=197.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDY 702 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 702 (953)
...++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG---- 82 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe----
Confidence 446789999999999999999999998888999999964322 12346789999999999999999999964
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
.....++||||+++ +|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 83 -~~~~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 148 (346)
T 1ua2_A 83 -HKSNISLVFDFMET-DLEVIIKDN---------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 148 (346)
T ss_dssp -CTTCCEEEEECCSE-EHHHHHTTC---------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred -eCCceEEEEEcCCC-CHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCC
Confidence 44778999999975 888888532 23578889999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+ .+...
T Consensus 149 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i 225 (346)
T 1ua2_A 149 GVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRI 225 (346)
T ss_dssp CCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred CCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 999999999998764322 223345689999999998764 58999999999999999999999987532221 11111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...........+.+.....+... .. ..... .........+.++.+++.+||+.||++|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVT--FK-SFPGI-PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCC--CC-CCCCC-CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCChhhhhhhccCccccc--cc-ccCCC-ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11111100000000000000000 00 00000 0000011335679999999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.14 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=204.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
..++|.+.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++. +.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence 346799999999999999999999999999999998643 3345677899999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred CeEEEEEecCCCCCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCE
Confidence 789999999999999998852 23689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 181 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 257 (335)
T 2owb_A 181 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNE 257 (335)
T ss_dssp EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC
T ss_pred EEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCC
Confidence 9999999987643222 2234568999999999999999999999999999999999999997532111 000000000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
. .. +..++.++.+++.+||+.||++|||++|+++.
T Consensus 258 ~----------~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 Y----------SI----------------------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp C----------CC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----------CC----------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 00123468899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.54 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=202.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++. ...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 357999999999999999999999988999999996432 223467899999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK----------HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEE
Confidence 88999999999999999853 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||.+...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ......
T Consensus 155 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~ 225 (284)
T 2vgo_A 155 IADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----THRRIV 225 (284)
T ss_dssp ECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHH
T ss_pred EecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----HHHHHh
Confidence 9999999765422 1233468999999999999999999999999999999999999997532111 000000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. +.... ...+.++.+++.+||+.||++|||++|+++
T Consensus 226 ~~------~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 226 NV------DLKFP----------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TT------CCCCC----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc------ccCCC----------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 00 00000 022456889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.60 Aligned_cols=290 Identities=20% Similarity=0.219 Sum_probs=203.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-----
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY----- 702 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 702 (953)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ...+|+++++.++||||+++++++.....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 456789999999999999999999999889999999864322 22469999999999999999999754321
Q ss_pred ----------------------------CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHH
Q 043900 703 ----------------------------QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754 (953)
Q Consensus 703 ----------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 754 (953)
......++||||++ |+|.+.+..... ....+++..+..++.||+.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR------SGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh------cCCCCCHHHHHHHHHHHHH
Confidence 23455889999997 588777753221 1346899999999999999
Q ss_pred HHHHHhhCCCCCeEeecCCCCCeEec-CCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchH
Q 043900 755 ALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVY 832 (953)
Q Consensus 755 ~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~ 832 (953)
||+|||+. ||+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||
T Consensus 153 aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 153 AVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 99999999 999999999999998 68899999999998764332 22344689999999998775 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHh
Q 043900 833 SYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIG 912 (953)
Q Consensus 833 slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 912 (953)
|+||++|||++|+.||.+....+ .+..............+... ........... ......+...+...+.++.+++
T Consensus 227 slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRM--NPHYTEVRFPT-LKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH--CTTC--CCCCC-CCCCCHHHHSCTTCCHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHh--CcccccccCCc-cCcccHHhhCCCCCCHHHHHHH
Confidence 99999999999999997633221 12222211111110000000 00000000000 0000000001112456789999
Q ss_pred hccccCCCCCCCCHHHHHH--HHHHHHH
Q 043900 913 VACSMESPGDRMNMTNVVR--QLQSIKN 938 (953)
Q Consensus 913 ~~cl~~dP~~RPt~~evl~--~L~~i~~ 938 (953)
.+||+.||++|||+.|+++ .+++++.
T Consensus 303 ~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999999999985 3555544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=341.05 Aligned_cols=255 Identities=19% Similarity=0.289 Sum_probs=200.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 468999999999999999999999888899999996432 2345788999999999999999999998642 334
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||++++ +.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVP--------EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHST--------TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CeEEEEehhccCC-HHHHHHhCc--------ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcE
Confidence 6789999999876 666664322 23689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE--VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
||+|||.+................||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... .....
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~ 223 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFE 223 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHH
Confidence 999999998775433333334556999999999987654 47899999999999999999999975211 11110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
.. ..... . ....+++++.+++.+||+.||++|||++|+++.
T Consensus 224 ~i--------~~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 224 NI--------GKGSY-A-------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HH--------HHCCC-C-------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HH--------hcCCC-C-------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000 0 000234568899999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=348.51 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=203.6
Q ss_pred HHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--------hhHHHHHHHHHHHhhc-CCCCeeEEE
Q 043900 624 QNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--------GAFKSFIAECNTLKNI-RHRNLVKIL 694 (953)
Q Consensus 624 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~ 694 (953)
.......++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3344556789999999999999999999988888999999974331 2245678999999999 799999999
Q ss_pred eeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
+++. .....++||||+++++|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||
T Consensus 167 ~~~~-----~~~~~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp 228 (365)
T 2y7j_A 167 DSYE-----SSSFMFLVFDLMRKGELFDYLTE----------KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKP 228 (365)
T ss_dssp EEEE-----BSSEEEEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred EEEe-----eCCEEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 9964 34789999999999999999852 23689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG------SEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
+||+++.++.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 229 ~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 229 ENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 99999999999999999998775332 2234569999999998753 36889999999999999999999999
Q ss_pred CCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 849 DSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
...... ......... ..... .......+.++.+++.+||+.||++|||++|
T Consensus 306 ~~~~~~--~~~~~i~~~-----------~~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 306 WHRRQI--LMLRMIMEG-----------QYQFS----------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp CCSSHH--HHHHHHHHT-----------CCCCC----------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCHH--HHHHHHHhC-----------CCCCC----------------CcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 652111 010000000 00000 0000123456889999999999999999999
Q ss_pred HHH
Q 043900 929 VVR 931 (953)
Q Consensus 929 vl~ 931 (953)
+++
T Consensus 357 ll~ 359 (365)
T 2y7j_A 357 ALQ 359 (365)
T ss_dssp HHH
T ss_pred Hhc
Confidence 986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=354.27 Aligned_cols=347 Identities=28% Similarity=0.426 Sum_probs=199.4
Q ss_pred CCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccE
Q 043900 49 DRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128 (953)
Q Consensus 49 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~ 128 (953)
..+.+|+.|++++|.++ .+|. +..+++|++|+|++|.+++..| ++++++|++|++++|++++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 44678889999999887 5664 7888899999999998885433 8888889999998888885544 888888888
Q ss_pred EecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCcc
Q 043900 129 LFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQ 208 (953)
Q Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 208 (953)
|++++|.+++..+ |..+++|++|++++|++++ ++ .+..+++|++|+++ |.+.+..+ +..+++|+.|++++|+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~---~~~l~~L~~L~l~~n~ 188 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP---LANLTTLERLDISSNK 188 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG---GTTCTTCCEEECCSSC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh---hccCCCCCEEECcCCc
Confidence 8888888875433 8888888888888888873 33 36666666666664 33332221 2244455555555554
Q ss_pred ccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccc
Q 043900 209 LTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGG 288 (953)
Q Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~ 288 (953)
+++. ..+..+++|+.|++++|.+++.
T Consensus 189 l~~~--~~l~~l~~L~~L~l~~n~l~~~---------------------------------------------------- 214 (466)
T 1o6v_A 189 VSDI--SVLAKLTNLESLIATNNQISDI---------------------------------------------------- 214 (466)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCCC----------------------------------------------------
T ss_pred CCCC--hhhccCCCCCEEEecCCccccc----------------------------------------------------
Confidence 4421 1233444444444444433321
Q ss_pred cCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCC
Q 043900 289 LLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIG 368 (953)
Q Consensus 289 ~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 368 (953)
.| +..+ ++|+.|++++|++++. ..+..+++|+.|++++|.+++..+ +..+++|++|++++|++++
T Consensus 215 -~~--~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~------- 279 (466)
T 1o6v_A 215 -TP--LGIL-TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN------- 279 (466)
T ss_dssp -GG--GGGC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-------
T ss_pred -cc--cccc-CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-------
Confidence 11 1111 3455555555554432 234445555555555555543322 4445555555555444442
Q ss_pred CceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCcccee
Q 043900 369 NLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVL 448 (953)
Q Consensus 369 ~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L 448 (953)
..+ +..+++|+.|+|++|++++. .+ +..+++|+.|
T Consensus 280 ----------------~~~--~~~l~~L~~L~L~~n~l~~~-------------------------~~--~~~l~~L~~L 314 (466)
T 1o6v_A 280 ----------------ISP--LAGLTALTNLELNENQLEDI-------------------------SP--ISNLKNLTYL 314 (466)
T ss_dssp ----------------CGG--GTTCTTCSEEECCSSCCSCC-------------------------GG--GGGCTTCSEE
T ss_pred ----------------ccc--ccCCCccCeEEcCCCcccCc-------------------------hh--hcCCCCCCEE
Confidence 111 44555555555555555421 11 3445555555
Q ss_pred eecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCc
Q 043900 449 DVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528 (953)
Q Consensus 449 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 528 (953)
+|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 555555554333 45555555555555555543 345555555555555555555444 455555555555555555
Q ss_pred c
Q 043900 529 G 529 (953)
Q Consensus 529 ~ 529 (953)
+
T Consensus 389 ~ 389 (466)
T 1o6v_A 389 N 389 (466)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.03 Aligned_cols=270 Identities=23% Similarity=0.285 Sum_probs=201.5
Q ss_pred CCCCcCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEe
Q 043900 617 SFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILT 695 (953)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 695 (953)
....+++.++....++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++++ +||||+++++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence 3444555566667889999999999999999999998888899999997543 2456788999999999 8999999999
Q ss_pred eeccccc-CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 696 ACSGVDY-QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 696 ~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
++..... ......++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp 157 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKG 157 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSG
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcH
Confidence 9754321 11467899999999999999996432 23688999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCC
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~ 849 (953)
+||+++.++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 158 ~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 158 QNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp GGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999998654221 1223346899999999987 5678999999999999999999999996
Q ss_pred CcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 043900 850 SMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV 929 (953)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 929 (953)
....... ......... +... ...++.++.+++.+||+.||++|||++|+
T Consensus 236 ~~~~~~~-~~~~~~~~~---------~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 236 DMHPMRA-LFLIPRNPA---------PRLK---------------------SKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp TSCHHHH-HHHHHHSCC---------CCCS---------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCcHHHH-HHHhhcCcc---------ccCC---------------------ccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 5321110 000000000 0000 00124568899999999999999999999
Q ss_pred HH
Q 043900 930 VR 931 (953)
Q Consensus 930 l~ 931 (953)
++
T Consensus 285 l~ 286 (326)
T 2x7f_A 285 MK 286 (326)
T ss_dssp HT
T ss_pred hh
Confidence 87
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.00 Aligned_cols=260 Identities=13% Similarity=0.134 Sum_probs=195.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec---cchhhHHHHHHHH---HHHhhcCCCCeeEEEeeecccc--
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAEC---NTLKNIRHRNLVKILTACSGVD-- 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~-- 701 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++. ......+.+.+|+ +.+++++||||+++++.+....
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4678889999999999999999988888999999973 3344567889999 4555558999999984332100
Q ss_pred cCCC------------C-----ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 043900 702 YQGN------------D-----FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQ 764 (953)
Q Consensus 702 ~~~~------------~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 764 (953)
+... + ..++||||+ +|+|.+++.....- ......+++..++.|+.||+.||+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY-- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT---TTTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc---ccccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 1111 1 378999999 68999999643211 11123466789999999999999999999
Q ss_pred CCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-----------CCCcccchHH
Q 043900 765 PPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-----------EVSINGDVYS 833 (953)
Q Consensus 765 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~s 833 (953)
+|+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++||||
T Consensus 226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999999999999999999986422 2234457 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhh
Q 043900 834 YGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGV 913 (953)
Q Consensus 834 lG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 913 (953)
|||++|||++|+.||........ ...+.. .. ..+++++.+++.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~-----------------------~~~~~~~~~li~ 341 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG-------------SEWIFR-SC-----------------------KNIPQPVRALLE 341 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC-------------SGGGGS-SC-----------------------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccc-------------hhhhhh-hc-----------------------cCCCHHHHHHHH
Confidence 99999999999999965321110 000000 00 022456889999
Q ss_pred ccccCCCCCCCCHHHHHH--HHHHHHHH
Q 043900 914 ACSMESPGDRMNMTNVVR--QLQSIKNI 939 (953)
Q Consensus 914 ~cl~~dP~~RPt~~evl~--~L~~i~~~ 939 (953)
+||+.||++|||+.|+++ .++++++.
T Consensus 342 ~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 342 GFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 999999999999999997 56666544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=374.34 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=198.4
Q ss_pred CcccccceeeEEEEEEc--CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILD--QGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
+.||+|+||.||+|.+. ..++.||||+++... ....+.+.+|++++++++||||++++++|.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 47999999999999664 455789999997432 3346789999999999999999999999732 4578999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.+++.. ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 449 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 449 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EccCCCCHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 99999999999952 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 793 ARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 793 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ........
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~----- 588 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKG----- 588 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT-----
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----
Confidence 9876543221 22233457889999999999999999999999999999998 999997532211 11111100
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.. ...+..+++++.+++.+||+.||++|||+++|++.|+++-..
T Consensus 589 -------~~------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 589 -------ER------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp -------CC------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CC------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00 000113456799999999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=373.72 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=206.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|++..+ ..||||+++.... ..+.+.+|++++++++||||++++++|.. +..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred chhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence 346788999999999999999999876 4799999975432 35679999999999999999999999642 568
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.++++... ...+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred eEeeehhcCCcHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEc
Confidence 99999999999999996322 12589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+....
T Consensus 406 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~- 481 (535)
T 2h8h_A 406 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY- 481 (535)
T ss_dssp CTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTC-
T ss_pred ccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-
Confidence 999998653211 111223447789999999998999999999999999999999 999997532211 111110000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+......++.++.+++.+||+.||++|||+++|++.|+++...
T Consensus 482 -----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 -----------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0000113456789999999999999999999999999887543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=359.33 Aligned_cols=346 Identities=20% Similarity=0.204 Sum_probs=214.0
Q ss_pred cEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccc
Q 043900 79 IQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAEN 158 (953)
Q Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (953)
+.++.+++.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46677777776 5666554 46777777777777666667777777777777777777666667777777777777777
Q ss_pred cccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC
Q 043900 159 WLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (953)
+++...+..|.++++|++|+|++|++++ ..+..|.++++|+.|++++|.+++..+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~ 145 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVI-------------------------LLDYMFQDLYNLKSLEVGDNDLVYISH 145 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEEECCTTCCEECT
T ss_pred cCCccCcccccCCCCCCEEECCCCcccc-------------------------CChhHccccccCCEEECCCCccceeCh
Confidence 6663333344555555555555555543 333344444444444444444332211
Q ss_pred CCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCcc
Q 043900 239 YLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAA 318 (953)
Q Consensus 239 ~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~ 318 (953)
..+..+ ++|+.|++++|++++..+..
T Consensus 146 -----------------------------------------------------~~~~~l-~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 146 -----------------------------------------------------RAFSGL-NSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp -----------------------------------------------------TSSTTC-TTCCEEEEESCCCSSCCHHH
T ss_pred -----------------------------------------------------hhccCC-CCCCEEECCCCcCcccChhH
Confidence 011111 23444444444444444445
Q ss_pred ccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcE
Q 043900 319 IGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTI 398 (953)
Q Consensus 319 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~ 398 (953)
|.++++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+. +|..+....+|+.
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~-----------------------~~~~~~~~~~L~~ 228 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT-----------------------MTPNCLYGLNLTS 228 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCE-----------------------ECTTTTTTCCCSE
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccc-----------------------cCcccccCccccE
Confidence 55666666666666666665555666666666666665554322 2222222234444
Q ss_pred EEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCcc
Q 043900 399 IDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478 (953)
Q Consensus 399 L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 478 (953)
|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 229 -------------------------L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (477)
T 2id5_A 229 -------------------------LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283 (477)
T ss_dssp -------------------------EEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSC
T ss_pred -------------------------EECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCc
Confidence 4555555553333567778888888888888887777788888888888888888
Q ss_pred ccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccccccCCcCCCCC
Q 043900 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGG 554 (953)
Q Consensus 479 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~ 554 (953)
+++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..+....+.......+.++...|+.
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~ 359 (477)
T 2id5_A 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT 359 (477)
T ss_dssp CSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred cceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCC
Confidence 8888888888888899999999988877777788888899999999988876543322222222344455555543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.96 Aligned_cols=280 Identities=18% Similarity=0.246 Sum_probs=199.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc--------
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 701 (953)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999999988999999998777677788999999999999999999999874321
Q ss_pred -cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 702 -YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 702 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
.......++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN 154 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 234567899999997 699999842 3588999999999999999999999 999999999999997
Q ss_pred -CCCcEEEeccccceecCCCCC-cccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 781 -EEMMAHVSDFGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 781 -~~~~~kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+++.+||+|||.++....... ........+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 567999999999987643211 122233457899999998765 678999999999999999999999997643211 1
Q ss_pred HHHHHHhhCCch----hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 858 LHNFARMALPDH----VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 858 ~~~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..... ...+.. ..+... ... ............ ........++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 234 MQLIL-ESIPVVHEEDRQELLS-VIP-VYIRNDMTEPHK---PLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHH-HHSCCCCHHHHHHHHT-TSC-HHHHHHTTSCCC---CHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHH-HhcCCCchhhhhhhhh-cCc-ccccccccCCCC---ChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111 111110 000000 000 000000000000 000011134567999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.65 Aligned_cols=254 Identities=23% Similarity=0.294 Sum_probs=198.0
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.. .+..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence 35679999999999999999999998888999999976666667889999999999999999999999643 4678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEE
Confidence 9999999999999988532 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCccccccccccccccccccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYG-----LGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
|||++...... ........||+.|+|||++ .+..++.++||||||+++|||++|..||....... .......
T Consensus 160 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 236 (302)
T 2j7t_A 160 DFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK 236 (302)
T ss_dssp CCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred ECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhc
Confidence 99997543110 1112234589999999987 46778999999999999999999999997532111 0011100
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+. . .....++.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~---------~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 SDPPT---------L--------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCCCC---------C--------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCcc---------c--------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 0 000123456889999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.47 Aligned_cols=253 Identities=21% Similarity=0.243 Sum_probs=197.0
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhhcCCCCeeEEEeeeccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSGV 700 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 700 (953)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3467999999999999999999999999999999986322 1223457899999999999999999998632
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 87 -----~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 87 -----EDYYIVLELMEGGELFDKVVG----------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS 148 (322)
T ss_dssp -----SSEEEEEECCTTEETHHHHST----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred -----CceEEEEecCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe
Confidence 348999999999999998852 23689999999999999999999999 999999999999998
Q ss_pred CCCc---EEEeccccceecCCCCCcccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 781 EEMM---AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 781 ~~~~---~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
.++. +||+|||+++..... .......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred cCCCCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 7664 999999999876422 1223345899999999863 567899999999999999999999999753322
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ............ . .......+.++.+++.+||+.||++|||++|+++
T Consensus 226 ~~-~~~~~~~~~~~~------------~---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 VS-LKDQITSGKYNF------------I---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SC-HHHHHHHTCCCC------------C---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH-HHHHHHhCcccc------------C---------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 21 111111100000 0 0001123567899999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.55 Aligned_cols=247 Identities=18% Similarity=0.243 Sum_probs=196.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|+..+.++ +||||+++++++.. .+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 46799999999999999999999988889999999743 334457788999999999 99999999999643 47
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC----
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE---- 782 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 782 (953)
..++||||+++++|.+++..... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYR------IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------
T ss_pred eEEEEEEecCCCcHHHHHHhhcc------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCc
Confidence 88999999999999999964321 123589999999999999999999999 99999999999999844
Q ss_pred ---------------CcEEEeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCC
Q 043900 783 ---------------MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKK 846 (953)
Q Consensus 783 ---------------~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~ 846 (953)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 479999999998764321 23489999999998776 66789999999999999999988
Q ss_pred CCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 847 PVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 847 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
|+... ...........+ ... ..+++++.+++.+||+.||++|||+
T Consensus 230 ~~~~~----~~~~~~~~~~~~---------~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 230 LPRNG----DQWHEIRQGRLP---------RIP----------------------QVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp CCSSS----HHHHHHHTTCCC---------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcch----hHHHHHHcCCCC---------CCC----------------------cccCHHHHHHHHHHhCCCcccCCCH
Confidence 76431 111111110000 000 0234568899999999999999999
Q ss_pred HHHHH
Q 043900 927 TNVVR 931 (953)
Q Consensus 927 ~evl~ 931 (953)
+|+++
T Consensus 275 ~~ll~ 279 (289)
T 1x8b_A 275 MALVK 279 (289)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.66 Aligned_cols=199 Identities=26% Similarity=0.334 Sum_probs=171.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc------CCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI------RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 703 (953)
..+|++.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+++++.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 45799999999999999999999999999999999753 23345677888888777 57799999999643
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
....++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKF--------QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQG 237 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTT
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCC
Confidence 378999999995 699998864332 2589999999999999999999999 999999999999999988
Q ss_pred c--EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 784 M--AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 784 ~--~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
. +||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 999999999865322 22346899999999999999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=363.23 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=200.8
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||+||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 356799999999999999999999988889999999632 2334578899999999999999999999964 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---CCC
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD---EEM 783 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~ 783 (953)
..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++ .++
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred EEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 89999999999999998852 23689999999999999999999999 999999999999995 456
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+ .......
T Consensus 162 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~ 236 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVET 236 (486)
T ss_dssp CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred CEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Confidence 89999999998664322 2234569999999999876 59999999999999999999999997532211 0111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
...... .+....+++++.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFD----------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSC----------------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC----------------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00011235568899999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.79 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=186.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.++...++.++||||+++++++. .++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 467999999999999999999999888999999996432 222334445555688889999999999964 3477
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++ |+|.+++..... ....+++..++.++.|++.||+|||+. .+|+||||||+||+++.++.+||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVID------KGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEB
T ss_pred EEEEEehhc-cchHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence 999999996 588887753211 134689999999999999999999984 28999999999999999999999
Q ss_pred eccccceecCCCCCccccccccccccccccccc----CCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYG----LGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
+|||.++...... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||...............
T Consensus 152 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 152 CDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred eecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence 9999998764322 22234589999999995 5667899999999999999999999999753222111111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+.. . ...+++++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~------------~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 EPSPQL------------P------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCCC------------C------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCc------------c------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 110000 0 0023456889999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=341.10 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=198.4
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 4567999999999999999999999888899999997533 34678999999999999999999999643 3678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLR---------NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEECCTTEEHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEeecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEe
Confidence 9999999999999998521 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||.+...... ........|++.|+|||++.+..++.++||||||+++|||++|+.||....... .........+.
T Consensus 168 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~ 243 (314)
T 3com_A 168 DFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPP 243 (314)
T ss_dssp CCTTCEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCC
T ss_pred ecccchhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCc
Confidence 99999876432 222334568999999999999999999999999999999999999997532111 00000000000
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. . ......+.++.+++.+||+.||++|||+.|+++
T Consensus 244 ~--------~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 T--------F--------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--------C--------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--------c--------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 0 000123456889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.98 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=174.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 35799999999999999999999988899999999754 34456788999999999999999999999643 4779
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||
T Consensus 107 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEECCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEE
Confidence 999999999999999953 2358899999999999999999998 5 8999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
+|||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 174 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred EECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999755321 222346899999999999999999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=349.81 Aligned_cols=278 Identities=21% Similarity=0.234 Sum_probs=199.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGN 705 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 705 (953)
..++|.+.+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|+.+++.++||||+++++++..... ...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 356899999999999999999999999999999999643 33345788899999999999999999999754321 111
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
...++||||++ ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eeEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCE
Confidence 23499999996 68888873 2489999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||.++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ ........
T Consensus 184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 257 (371)
T 4exu_A 184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV 257 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 99999999865322 233468999999999887 689999999999999999999999997532211 11111111
Q ss_pred h-CCc-hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 A-LPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~-~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .+. .....+.... ......................+++++.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKA---AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HCCCCHHHHTTCSCHH---HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCcHHHHHHhhhhh---hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1 111 0111000000 00000000000000000011134567999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=335.81 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=193.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++. ..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 467999999999999999999999888899999996432 234567889999999999999999999964 347
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK----------HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEE
Confidence 89999999999999999952 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||.+....... ......|++.|+|||++.+..+ +.++||||||+++|||++|+.||...... .........
T Consensus 152 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~ 226 (276)
T 2h6d_A 152 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGG 226 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred EeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcC
Confidence 99999998764322 2223458999999999988765 68999999999999999999999752111 000000000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... +...+.++.+++.+||+.||++|||++|+++
T Consensus 227 ------------~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 ------------VFYI-------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ------------CCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------cccC-------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000 0012346889999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=362.09 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=199.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.+++.++||||++++++|. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 456999999999999999999999888999999997432 334577899999999999999999999964 3478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC---Cc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE---MM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~ 784 (953)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.. +.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCc
Confidence 9999999999999998852 23589999999999999999999999 99999999999999764 45
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++.+.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......+ ........
T Consensus 178 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~ 252 (494)
T 3lij_A 178 IKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVEKG 252 (494)
T ss_dssp EEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT
T ss_pred EEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC
Confidence 9999999998765332 233456999999999976 469999999999999999999999997532211 01111100
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSI 936 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 936 (953)
..... . .....+++++.+++.+||+.||++|||+.|+++. +.+.
T Consensus 253 ~~~~~------------~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 253 KYTFD------------S----------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CCCCC------------S----------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCCCC------------c----------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 00000 0 0001234568899999999999999999999863 4443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=363.01 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=199.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-------------hhHHHHHHHHHHHhhcCCCCeeEEEe
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-------------GAFKSFIAECNTLKNIRHRNLVKILT 695 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~ 695 (953)
..++|++.+.||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999964321 23567899999999999999999999
Q ss_pred eecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 696 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
+|. .....++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~ 175 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQIIN----------RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPE 175 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHH
Confidence 964 44789999999999999998852 23589999999999999999999999 9999999999
Q ss_pred CeEecCCC---cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 776 NVLLDEEM---MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 776 NIll~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
||+++.++ .+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998776 69999999998775332 223456999999999987 468999999999999999999999997532
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..+ ....... ...... ......+++++.+++.+||+.||.+|||++|+++
T Consensus 252 ~~~--~~~~i~~-----------~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 252 DQD--IIKKVEK-----------GKYYFD----------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHH--HHHHHHH-----------CCCCCC----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH--HHHHHHc-----------CCCCCC----------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 211 1111100 000000 0011134567899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.64 Aligned_cols=269 Identities=22% Similarity=0.306 Sum_probs=185.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cCC
Confidence 4578999999999999999999998888899999986432 3345678899999999999999999999643 367
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++++|.+++....... ......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKG--EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cEEEehhccCCchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 899999999999999986322110 01234689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCC---cccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 788 SDFGLARFLPLSPA---QTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 788 ~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
+|||.+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~ 240 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTL 240 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHh
Confidence 99999976643221 111233468999999999876 56899999999999999999999999764322111 1010
Q ss_pred hhCCchhh-hhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVV-DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+.... ...+... ...++.++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEM----------------------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CC----------------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchh----------------------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000 0000000 0022456889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=364.44 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=202.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 457999999999999999999999888999999996432 345678999999999999999999999964 447
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---cCCC
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL---DEEM 783 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~ 783 (953)
..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIIS----------RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHT----------CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred EEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCC
Confidence 89999999999999998852 23689999999999999999999999 99999999999999 5678
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||+++.+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ......
T Consensus 167 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~ 240 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKVE 240 (484)
T ss_dssp CEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred cEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence 99999999998764332 2234569999999999876 69999999999999999999999997532211 111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ..... .+....+++++.+++.+||+.||++|||++|+++
T Consensus 241 ~~-----------~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 241 KG-----------KYTFE----------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HC-----------CCCCC----------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC-----------CCCCC----------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00000 0001133567889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.98 Aligned_cols=291 Identities=19% Similarity=0.197 Sum_probs=194.9
Q ss_pred HHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-
Q 043900 624 QNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY- 702 (953)
Q Consensus 624 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 702 (953)
.......++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|++.++.++||||++++++|.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677889999999999999999999999888899999986432 233456778888899999999999999865322
Q ss_pred -CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHh--hCCCCCeEeecCCCCCeEe
Q 043900 703 -QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLH--HDCQPPITHCDLKPSNVLL 779 (953)
Q Consensus 703 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll 779 (953)
......++||||+++ ++.+.+.... .....+++..+..++.|++.||.||| +. +|+||||||+||++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLV 164 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEE
Confidence 222347899999976 4444332111 12346889999999999999999999 77 99999999999999
Q ss_pred cC-CCcEEEeccccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcccCCcc
Q 043900 780 DE-EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857 (953)
Q Consensus 780 ~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~ 857 (953)
+. ++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+ .
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~ 240 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-Q 240 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred eCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-H
Confidence 96 8999999999998764332 223446899999999987654 8999999999999999999999997632221 1
Q ss_pred HHHHHHhhCCc--hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 858 LHNFARMALPD--HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 858 ~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........... ......++..... +....................++++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDV--DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCG--GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhc--cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 22222211111 1111111110000 000000000000001111124667999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.87 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=196.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-C--CeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-G--KTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||+||+|++.. + ...||+|+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4579999999999999999999743 2 236899998643 33456788999999999999999999999643
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
...++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 158 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred --CCceeeEecccCCCHHHHHHhc---------cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence 2378999999999999999632 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~ 861 (953)
.+||+|||++.......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~ 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QI 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HH
Confidence 99999999998775433221 2233457889999999988889999999999999999999 99999753211 11
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
........ .. ......++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 234 ~~~~~~~~--------~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 234 LHKIDKEG--------ER------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHTSC--------CC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHccC--------CC------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11100000 00 000012345789999999999999999999999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.37 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=201.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---------hhhHHHHHHHHHHHhhcC-CCCeeEEEeeec
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---------HGAFKSFIAECNTLKNIR-HRNLVKILTACS 698 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 698 (953)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999999999999999997432 123467889999999995 999999999964
Q ss_pred ccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 699 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
.+...++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 95 -----~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil 156 (298)
T 1phk_A 95 -----TNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL 156 (298)
T ss_dssp -----CSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred -----cCCeEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEE
Confidence 34789999999999999999952 23589999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCcccccccccccccccccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 779 LDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL------GSEVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 779 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
++.++.+||+|||.+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999999999999998765332 223356899999999874 4568899999999999999999999996532
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ......... ..... ......++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~--~~~~~~~~~-----------~~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 QM--LMLRMIMSG-----------NYQFG----------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH--HHHHHHHHT-----------CCCCC----------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH--HHHHHHhcC-----------CcccC----------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 111100000 00000 0000123457899999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.41 Aligned_cols=265 Identities=8% Similarity=0.007 Sum_probs=184.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhc--CCCCeeEEEeee-------
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNI--RHRNLVKILTAC------- 697 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~~~~~~------- 697 (953)
...|.+.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999999888999999997543 23456677885544444 699988865322
Q ss_pred ccccc------------CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHH------HHHHHHHHHHHHHH
Q 043900 698 SGVDY------------QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQR------LNIGIDVACALSYL 759 (953)
Q Consensus 698 ~~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~L 759 (953)
..... ......++||||++ |+|.+++..... .+++..+ ..++.||+.||+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------VYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------ccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 11100 00134799999998 899999964321 2344445 78889999999999
Q ss_pred hhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCC--CCCCcccchHHHHHH
Q 043900 760 HHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGIL 837 (953)
Q Consensus 760 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~v 837 (953)
|++ +|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++|||||||+
T Consensus 211 H~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 QSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 999 9999999999999999999999999999876321 113457799999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCcccCCccHHHHHHhhCCch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccc
Q 043900 838 LLELVTRKKPVDSMFEGDMNLHNFARMALPDH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACS 916 (953)
Q Consensus 838 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 916 (953)
+|||++|+.||......... ..... ........ ........+++++.+++.+||
T Consensus 283 l~elltg~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKG-------SWKRPSLRVPGTDS------------------LAFGSCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTT-------CCCBCCTTSCCCCS------------------CCCTTSSCCCHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCcCccccc-------chhhhhhhhccccc------------------cchhhccCCCHHHHHHHHHHc
Confidence 99999999999864322100 00000 00000000 000001133567899999999
Q ss_pred cCCCCCCCCHHHHHH--HHHHHH
Q 043900 917 MESPGDRMNMTNVVR--QLQSIK 937 (953)
Q Consensus 917 ~~dP~~RPt~~evl~--~L~~i~ 937 (953)
+.||++|||++|+++ .++++.
T Consensus 338 ~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 338 NFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999975 344443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=371.67 Aligned_cols=245 Identities=21% Similarity=0.252 Sum_probs=199.9
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 704 (953)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||+|+++++++ ..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 456799999999999999999999999999999999742 234456788899999988 799999999984 45
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++|+|.++++. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence 5789999999999999999963 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....
T Consensus 481 ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~~~ 553 (674)
T 3pfq_A 481 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQS 553 (674)
T ss_dssp EEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred EEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHHHH
Confidence 9999999998643222 2234567999999999999999999999999999999999999999753211 11111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
. ...... .+...++++.+++.+||+.||++||++
T Consensus 554 i--------~~~~~~--------------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 554 I--------MEHNVA--------------------YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp H--------HSSCCC--------------------CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred H--------HhCCCC--------------------CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1 100000 000234568899999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.00 Aligned_cols=271 Identities=16% Similarity=0.216 Sum_probs=201.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhh-----------------HHHHHHHHHHHhhcCCCCeeE
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA-----------------FKSFIAECNTLKNIRHRNLVK 692 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~ 692 (953)
.++|++.+.||+|+||.||+|++ +++.||+|++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 66799999996432211 178999999999999999999
Q ss_pred EEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeec
Q 043900 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCD 771 (953)
Q Consensus 693 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~D 771 (953)
+++++.. .+..++||||+++|+|.+++.....- .......+++..++.++.|++.||+|||+ . ||+|||
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~d 177 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVL--DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRD 177 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESS--CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCC
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhh--hhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecC
Confidence 9999643 47899999999999999994321100 00113479999999999999999999999 8 999999
Q ss_pred CCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCC-CCCc-ccchHHHHHHHHHHHhCCCCCC
Q 043900 772 LKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSI-NGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 772 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~slG~vl~elltg~~pf~ 849 (953)
|||+||+++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876432 23345689999999999887 6666 9999999999999999999997
Q ss_pred CcccCCccHHHHHHhhC--CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 043900 850 SMFEGDMNLHNFARMAL--PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT 927 (953)
Q Consensus 850 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 927 (953)
................. +........... ...........+.++.+++.+||+.||++|||++
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 318 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLT---------------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTC---------------C--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhcccc---------------ccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence 54332111111111100 000000000000 0000001123456789999999999999999999
Q ss_pred HHHH
Q 043900 928 NVVR 931 (953)
Q Consensus 928 evl~ 931 (953)
|+++
T Consensus 319 e~l~ 322 (348)
T 2pml_X 319 DALK 322 (348)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.70 Aligned_cols=282 Identities=23% Similarity=0.320 Sum_probs=203.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEc-CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhc---CCCCeeEEEeeeccccc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILD-QGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDY 702 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~ 702 (953)
..++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|+.+++.+ +||||++++++|.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 667899999996432 22233556777777666 89999999999764333
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
......++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCC
Confidence 34577899999997 699999864322 2589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
+.+||+|||.++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......
T Consensus 157 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~ 232 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL 232 (326)
T ss_dssp CCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred CCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH
Confidence 99999999999865321 22334568999999999999999999999999999999999999997533221 111111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..........+....... .. ........ ........++.++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALP-RQ--AFHSKSAQ--PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHCCCCGGGSCTTCSSC-GG--GSCCCCCC--CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcCCCCcccCccccccc-hh--hhcccCcc--hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111000000000000000 00 00000000 000011134567889999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=349.84 Aligned_cols=284 Identities=21% Similarity=0.263 Sum_probs=204.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC--------CCCeeEEEeeecccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR--------HRNLVKILTACSGVD 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~ 701 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~- 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS- 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence 46799999999999999999999999999999999743 334567889999999985 78899999987532
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
.......++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+++ ||+||||||+|||++.
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN--------YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 12446789999999 556666654221 235899999999999999999999852 8999999999999997
Q ss_pred CC-------------------------------------------------cEEEeccccceecCCCCCccccccccccc
Q 043900 782 EM-------------------------------------------------MAHVSDFGLARFLPLSPAQTSSIDAKGSI 812 (953)
Q Consensus 782 ~~-------------------------------------------------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~ 812 (953)
++ .+||+|||.++..... .....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence 75 7999999999876432 23346899
Q ss_pred ccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH-----HHHHHhh--CCchhh-------hhccccc
Q 043900 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL-----HNFARMA--LPDHVV-------DIVDSTL 878 (953)
Q Consensus 813 ~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~-----~~~~~~~--~~~~~~-------~~~~~~l 878 (953)
.|+|||++.+..++.++|||||||++|||++|+.||......+... ....... .+.... +......
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 9999999999999999999999999999999999997643322111 1111100 011000 0000000
Q ss_pred -cCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 879 -LSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 879 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..........................+.++.+++.+||+.||++|||++|+++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000000000001112223466788999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.88 Aligned_cols=277 Identities=20% Similarity=0.255 Sum_probs=195.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 708 (953)
..+|++.+.||+|+||.||+|++..+++ ||+|++..... ...+|+++++.++||||++++++|..... .+....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3569999999999999999999988874 88887753222 12369999999999999999999754422 233447
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-CCCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 787 (953)
++||||++++.+..... .. .....+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.+||
T Consensus 114 ~lv~e~~~~~l~~~~~~-~~------~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRH-YA------KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp EEEEECCSEEHHHHHHH-HH------HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEeeccCccHHHHHHH-HH------hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEE
Confidence 89999997754433321 11 1124689999999999999999999999 999999999999999 7999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+........
T Consensus 184 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g 259 (394)
T 4e7w_A 184 IDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLG 259 (394)
T ss_dssp CCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 99999987643322 2345689999999998765 58999999999999999999999997633221 1122221111
Q ss_pred -Cch-hhhhccccccC-CchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 -PDH-VVDIVDSTLLS-DDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 -~~~-~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+.. ......+.... .... ..............++++.+++.+||+.||++|||+.|+++
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQ------IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCC------CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHhhChhhhhhcccc------ccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 110 00000100000 0000 00000000011124567999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.56 Aligned_cols=278 Identities=20% Similarity=0.232 Sum_probs=197.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 708 (953)
..+|++.+.||+|+||.||+|++..+++.||||++..... ...+|++++++++||||++++++|..... .+....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3468999999999999999999998888999999864322 23469999999999999999998754321 222346
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-CcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 787 (953)
++||||+++ ++.+.+..... ....+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred Eeehhcccc-cHHHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEe
Confidence 799999975 66665532111 134689999999999999999999999 99999999999999965 57899
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+.......-
T Consensus 199 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg 274 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLG 274 (420)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred ccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 99999987643322 2335689999999998765 78999999999999999999999997632221 1222222111
Q ss_pred Cc---hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 PD---HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. .+... .+..... ........ ..........++++.+++.+||+.||++|||+.|+++
T Consensus 275 ~p~~~~~~~~-~~~~~~~----~~p~~~~~-~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 275 TPTREQIREM-NPNYTEF----KFPQIKAH-PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCHHHHHHH-CSCCCCC----CCCCCCCC-CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHhh-Chhhhhh----ccCccCCC-CHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11 01111 1100000 00000000 0000001123567899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.11 Aligned_cols=277 Identities=21% Similarity=0.235 Sum_probs=198.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 706 (953)
.++|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999999998999999999643 33345778899999999999999999999754311 1113
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||++ ++|.+++. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 4599999996 68888873 2489999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+.......
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 240 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 240 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHH
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999999865321 223468999999999877 678999999999999999999999997532211 111111110
Q ss_pred -CCc-hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 -LPD-HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 -~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+. .....+.... .......................++++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKA---AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHH---HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHH---HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 010 0000000000 00000000000000000011134567999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.09 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=198.3
Q ss_pred hcCCcccCcccccceeeEEEEEEc---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD---QGKTTVAVKVFNLLH----HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVD 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 701 (953)
.++|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 357999999999999999999984 466799999986321 23345677899999999 69999999998643
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
....++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 131 ---~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 131 ---ETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 194 (355)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred ---CceEEEEeecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 4678999999999999999952 23589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCcccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 782 EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
++.+||+|||+++.+.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...
T Consensus 195 ~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~ 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQA 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHH
T ss_pred CCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHH
Confidence 9999999999998764221 2223345699999999998863 57899999999999999999999997532221 111
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVRQ 932 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 932 (953)
......... ... .+..++..+.+++.+||+.||++|| |++|+++.
T Consensus 273 ~~~~~~~~~------~~~----------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 273 EISRRILKS------EPP----------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHC------CCC----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHhcc------CCC----------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 111110000 000 0012345688999999999999999 99999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=339.16 Aligned_cols=278 Identities=20% Similarity=0.256 Sum_probs=201.8
Q ss_pred hcCCcccCcccccceeeEEEEEE-cCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCC------CeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGIL-DQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHR------NLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 45899999999999999999998 557789999999743 23456788999999988665 4999999864
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE- 781 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 781 (953)
..+..++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENG--------FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS 154 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence 347899999999 889999986432 12588999999999999999999999 9999999999999987
Q ss_pred ------------------CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 043900 782 ------------------EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843 (953)
Q Consensus 782 ------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt 843 (953)
++.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 668999999999875422 223468999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCccHHHHHH--hhCCchhhhhcccc---------ccCCchh-hhhcccchhhhhhhhhHHHHHHHHHHH
Q 043900 844 RKKPVDSMFEGDMNLHNFAR--MALPDHVVDIVDST---------LLSDDED-LAVHGNQRQRQARINSKIECLVAMVRI 911 (953)
Q Consensus 844 g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~---------l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l 911 (953)
|+.||......+ ....... ...+.......... +...... ....................++++.++
T Consensus 230 g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 230 GFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp SSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence 999997532221 1111111 11111111100000 0000000 000000000000111122456789999
Q ss_pred hhccccCCCCCCCCHHHHHH
Q 043900 912 GVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 912 ~~~cl~~dP~~RPt~~evl~ 931 (953)
+.+||+.||++|||++|+++
T Consensus 309 i~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhCcCcccccCHHHHhc
Confidence 99999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=368.21 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=204.5
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
..++|++.+.||+|+||.||+|.+..+ ...||+|+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence 346788999999999999999998643 457999998743 3344578999999999999999999999863
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
++..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~ 529 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR---------KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 529 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred cCceEEEEEcCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCC
Confidence 24579999999999999999632 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ......
T Consensus 530 vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~ 606 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE 606 (656)
T ss_dssp EEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH
T ss_pred EEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH
Confidence 99999999987643321 22233457889999999998899999999999999999997 999997532211 111110
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.... . ..+..+++++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 607 ~~~~-----------~-------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 NGER-----------L-------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HTCC-----------C-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCC-----------C-------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 0 00013356788999999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=348.17 Aligned_cols=211 Identities=22% Similarity=0.307 Sum_probs=156.5
Q ss_pred cCCcc-cCcccccceeeEEEEEEc--CCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFAS-ANEIGVGSFGSVYKGILD--QGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~-~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+.|.+ .++||+|+||+||+|++. .+++.||+|+++... ....+.+|++++++++||||+++++++.. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 34665 568999999999999976 356789999996432 23568899999999999999999999742 33567
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe----cCCC
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL----DEEM 783 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 783 (953)
.++||||++ |+|.+++....... .......+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred EEEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 899999996 58888775322110 011223589999999999999999999999 99999999999999 6778
Q ss_pred cEEEeccccceecCCCCC-cccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 784 MAHVSDFGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
.+||+|||+|+.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999999987643211 1223345689999999998874 5899999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=334.82 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=193.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc--------
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-------- 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 701 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999999988889999999643 345578899999999999999999999875421
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE 781 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 781 (953)
.......++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---------NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDE 151 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---------CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---------ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcC
Confidence 12346789999999999999999632 23578899999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCC------------cccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCC
Q 043900 782 EMMAHVSDFGLARFLPLSPA------------QTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 782 ~~~~kL~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf 848 (953)
++.+||+|||.++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986642210 1122344589999999998765 78999999999999999998 55
Q ss_pred CCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 043900 849 DSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928 (953)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 928 (953)
....... ......... ........ ....+..+.+++.+||+.||++|||++|
T Consensus 229 ~~~~~~~-~~~~~~~~~---------~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 229 STGMERV-NILKKLRSV---------SIEFPPDF------------------DDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp SSHHHHH-HHHHHHHST---------TCCCCTTC------------------CTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCchhHH-HHHHhcccc---------ccccCccc------------------cccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 4211110 000000000 00000000 0123456889999999999999999999
Q ss_pred HHH
Q 043900 929 VVR 931 (953)
Q Consensus 929 vl~ 931 (953)
+++
T Consensus 281 ll~ 283 (303)
T 1zy4_A 281 LLN 283 (303)
T ss_dssp HHH
T ss_pred HhC
Confidence 986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=337.30 Aligned_cols=258 Identities=18% Similarity=0.212 Sum_probs=175.4
Q ss_pred hhcCCcccC-cccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASAN-EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..++|.+.+ .||+|+||.||+|.+..+++.||||++.... .........++.++||||+++++++... ......
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCce
Confidence 456888855 6999999999999999888899999996432 1222223345667999999999997543 223456
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---CCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---EMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 784 (953)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--------DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCce
Confidence 899999999999999996432 23689999999999999999999999 9999999999999976 456
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 170 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~ 243 (336)
T 3fhr_A 170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKR 243 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHH
Confidence 999999999876422 22234589999999999888999999999999999999999999975322211000 000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......... ......++.++.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 244 RIRLGQYGFP-----------------------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------CCC-----------------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhccccccC-----------------------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000 0000123556889999999999999999999997
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=347.82 Aligned_cols=319 Identities=18% Similarity=0.157 Sum_probs=219.2
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
+.++.++++++. +|..+. .++++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 466777777775 554442 46777777777777666667777777777777777777666777777777777777777
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPL 190 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 190 (953)
++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++ ++.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~ 169 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPT 169 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS-CCH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc-cCh
Confidence 7775555566777777777777777776667777777777777777777776666677777777777777777774 343
Q ss_pred ccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccc
Q 043900 191 DFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSL 270 (953)
Q Consensus 191 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l 270 (953)
..+..+++|+.|++++|++++..+..|..+++|+.|++++|...+..+.
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~------------------------------- 218 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP------------------------------- 218 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT-------------------------------
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc-------------------------------
Confidence 3334778888888888888877777888888888888888766543221
Q ss_pred cccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCC
Q 043900 271 TNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLR 350 (953)
Q Consensus 271 ~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 350 (953)
..... .+|+.|++++|++++..+..|..+++|+.|+|++|.|++..+..|..+++|+
T Consensus 219 ----------------------~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (477)
T 2id5_A 219 ----------------------NCLYG-LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275 (477)
T ss_dssp ----------------------TTTTT-CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCC
T ss_pred ----------------------ccccC-ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCC
Confidence 11111 2566677777777654445667777777777777777766666777777777
Q ss_pred eEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccC
Q 043900 351 ELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT 407 (953)
Q Consensus 351 ~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 407 (953)
+|+|++|++++..|..|..+ .+++|+|++|.+++..+..|..+++|+.|+|++|.+.
T Consensus 276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 276 EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp EEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred EEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 77777777766555555554 3455555556565555666777777888888887776
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.89 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=195.0
Q ss_pred CcCHHHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcC--CCCeeEEEe
Q 043900 620 NISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIR--HRNLVKILT 695 (953)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~ 695 (953)
.+.++.+....++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|++++++++ ||||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 34444444556789999999999999999999876 568999999643 3445678899999999996 599999999
Q ss_pred eecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 043900 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPS 775 (953)
Q Consensus 696 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 775 (953)
++.. ....++||| +.+++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+
T Consensus 96 ~~~~-----~~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~ 156 (313)
T 3cek_A 96 YEIT-----DQYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 156 (313)
T ss_dssp EEEC-----SSEEEEEEC-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred Eeec-----CCEEEEEEe-cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcc
Confidence 9643 467899999 558899999953 23588999999999999999999999 9999999999
Q ss_pred CeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCC-----------CCCCcccchHHHHHHHHHHHhC
Q 043900 776 NVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-----------SEVSINGDVYSYGILLLELVTR 844 (953)
Q Consensus 776 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slG~vl~elltg 844 (953)
||++++ +.+||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++|
T Consensus 157 NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 235 (313)
T 3cek_A 157 NFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235 (313)
T ss_dssp GEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred cEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence 999964 8999999999987654333223334568999999999875 4788899999999999999999
Q ss_pred CCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 043900 845 KKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924 (953)
Q Consensus 845 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 924 (953)
+.||............ ..+........ ...+.++.+++.+||+.||++||
T Consensus 236 ~~pf~~~~~~~~~~~~------------~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rp 285 (313)
T 3cek_A 236 KTPFQQIINQISKLHA------------IIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRI 285 (313)
T ss_dssp SCTTTTCCSHHHHHHH------------HHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSC
T ss_pred CCchhhHHHHHHHHHH------------HHhcccccCCc------------------ccchHHHHHHHHHHccCCcccCc
Confidence 9999753221111111 11110000000 01134688999999999999999
Q ss_pred CHHHHHHH
Q 043900 925 NMTNVVRQ 932 (953)
Q Consensus 925 t~~evl~~ 932 (953)
|++|+++.
T Consensus 286 s~~ell~h 293 (313)
T 3cek_A 286 SIPELLAH 293 (313)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=342.79 Aligned_cols=203 Identities=26% Similarity=0.327 Sum_probs=170.4
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CC-----CeeEEEeeecccc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HR-----NLVKILTACSGVD 701 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~ 701 (953)
...++|++.+.||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.++ |+ +++++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 3467899999999999999999999999999999999743 234566778888888884 55 49999998643
Q ss_pred cCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-
Q 043900 702 YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD- 780 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~- 780 (953)
.+..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++
T Consensus 128 ---~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 128 ---RNHLCLVFEMLS-YNLYDLLRNTNF--------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN 194 (382)
T ss_dssp ---TTEEEEEEECCC-CBHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS
T ss_pred ---CCceEEEEecCC-CCHHHHHhhcCc--------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec
Confidence 378999999995 599999864322 2589999999999999999999952 23999999999999995
Q ss_pred -CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 781 -EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 781 -~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
.++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5778999999999876432 22356899999999999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=330.01 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=200.3
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CC
Confidence 34568999999999999999999999888899999996432 334678899999999999999999999964 34
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC---
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE--- 782 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 782 (953)
...++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred CeEEEEEEccCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCc
Confidence 788999999999999998852 23589999999999999999999999 99999999999999754
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~ 862 (953)
+.+||+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||......+ .....
T Consensus 161 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~ 234 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRV 234 (287)
T ss_dssp CCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH
T ss_pred ccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 479999999998664322 2223458999999999876 48999999999999999999999997532111 11100
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ..... ......++.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~-----------~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 235 ETG-----------KYAFD----------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHC-----------CCCCC----------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcC-----------CCCCC----------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00000 0000123456889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.20 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=197.0
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
....++|++.+.||+|+||.||+|++.+ .||+|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 100 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS----- 100 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----
Confidence 3345789999999999999999999865 39999986432 2334567789999999999999999999653
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++ ++.
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDA---------KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSS---------CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---C
T ss_pred CCceEEEeecccCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCC
Confidence 36789999999999999999632 23588999999999999999999999 999999999999998 679
Q ss_pred EEEeccccceecCCCC---CcccccccccccccccccccCC---------CCCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 785 AHVSDFGLARFLPLSP---AQTSSIDAKGSIGYIAPEYGLG---------SEVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
+||+|||+++...... .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987653211 1122233458999999999865 457899999999999999999999997532
Q ss_pred cCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... ......... .+.... ..++.++.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~--~~~~~~~~~--------~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 248 AEA--IIWQMGTGM--------KPNLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHH--HHHHHHTTC--------CCCCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHH--HHHHhccCC--------CCCCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 211 100000000 000000 0123458899999999999999999999999
Q ss_pred HHHHHHHhcc
Q 043900 933 LQSIKNILLG 942 (953)
Q Consensus 933 L~~i~~~~~~ 942 (953)
|+++.+....
T Consensus 297 l~~l~~~~~~ 306 (319)
T 2y4i_B 297 LEKLPKRNRR 306 (319)
T ss_dssp HTTC------
T ss_pred HHHHHHhhcc
Confidence 9998776543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=342.13 Aligned_cols=284 Identities=19% Similarity=0.267 Sum_probs=202.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-----------CCCeeEEEeeec
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-----------HRNLVKILTACS 698 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 698 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45799999999999999999999988999999999743 234567888999998886 899999999975
Q ss_pred ccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 699 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
.. .......++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+||+
T Consensus 97 ~~-~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIl 164 (373)
T 1q8y_A 97 HK-GPNGVHVVMVFEVL-GENLLALIKKYEH--------RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 164 (373)
T ss_dssp EE-ETTEEEEEEEECCC-CEEHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEE
T ss_pred cc-CCCCceEEEEEecC-CCCHHHHHHHhhc--------cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeE
Confidence 43 12334789999999 8999999964322 25899999999999999999999842 8999999999999
Q ss_pred ec------CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 779 LD------EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 779 l~------~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 4458999999999876432 223468999999999999999999999999999999999999997543
Q ss_pred cCC-----ccHHHHHHhh--CCchhh-------hhcccc-ccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhcccc
Q 043900 853 EGD-----MNLHNFARMA--LPDHVV-------DIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSM 917 (953)
Q Consensus 853 ~~~-----~~~~~~~~~~--~~~~~~-------~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 917 (953)
... .......... .+.... ...... ...........................+.++.+++.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 211 0111111110 011000 000000 0000000000000000111122234677889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 043900 918 ESPGDRMNMTNVVR 931 (953)
Q Consensus 918 ~dP~~RPt~~evl~ 931 (953)
.||++|||++|+++
T Consensus 320 ~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 320 LDPRKRADAGGLVN 333 (373)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred cCccccCCHHHHhh
Confidence 99999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=336.48 Aligned_cols=278 Identities=20% Similarity=0.269 Sum_probs=199.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC-eEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC------eeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK-TTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN------LVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 468999999999999999999997665 78999999743 234567888999999997665 888888854
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEe---
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLL--- 779 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--- 779 (953)
..+..++||||+ ++++.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~~--------~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKENN--------FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS 159 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred -eCCeEEEEEecc-CCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence 347899999999 667777664322 13589999999999999999999999 99999999999999
Q ss_pred ----------------cCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 043900 780 ----------------DEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843 (953)
Q Consensus 780 ----------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt 843 (953)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 56789999999999875322 223468999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCccHHHHHH--hhCCchhhhhccc---------cccCCchhh-hhcccchhhhhhhhhHHHHHHHHHHH
Q 043900 844 RKKPVDSMFEGDMNLHNFAR--MALPDHVVDIVDS---------TLLSDDEDL-AVHGNQRQRQARINSKIECLVAMVRI 911 (953)
Q Consensus 844 g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---------~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l 911 (953)
|+.||......+ ....... ...+......... .+....... ...................+.++.++
T Consensus 235 g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 313 (355)
T 2eu9_A 235 GFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313 (355)
T ss_dssp SSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence 999997532221 1111111 1111111100000 000000000 00000000000011122446689999
Q ss_pred hhccccCCCCCCCCHHHHHH
Q 043900 912 GVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 912 ~~~cl~~dP~~RPt~~evl~ 931 (953)
+.+||+.||++|||++|+++
T Consensus 314 i~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 314 MRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhcCChhhCcCHHHHhc
Confidence 99999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=334.10 Aligned_cols=246 Identities=21% Similarity=0.275 Sum_probs=190.7
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch------hhHHHHHHHHHHHhhc----CCCCeeEEE
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH------GAFKSFIAECNTLKNI----RHRNLVKIL 694 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~ 694 (953)
+.....++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 444556789999999999999999999988888999999964322 1223456789999888 899999999
Q ss_pred eeecccccCCCCceeEEEee-ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 043900 695 TACSGVDYQGNDFKALVFEF-MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLK 773 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 773 (953)
+++. ..+..++|||| +.+++|.+++.. ...+++..++.++.|++.||+|||+. +|+|||||
T Consensus 105 ~~~~-----~~~~~~~v~e~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 166 (312)
T 2iwi_A 105 DWFE-----TQEGFMLVLERPLPAQDLFDYITE----------KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIK 166 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCS
T ss_pred EEEe-----cCCeEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCC
Confidence 9953 34678999999 789999999953 23589999999999999999999999 99999999
Q ss_pred CCCeEec-CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCCc
Q 043900 774 PSNVLLD-EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVS-INGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 774 p~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
|+||+++ .++.+||+|||.++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||...
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999999 88999999999998764322 2344589999999998777664 5899999999999999999999642
Q ss_pred ccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 852 FEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. ....... .. ...++.++.+++.+||+.||++|||++|+++
T Consensus 243 ~-------~~~~~~~----------~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 243 Q-------EILEAEL----------HF----------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-------HHHHTCC----------CC----------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-------HHhhhcc----------CC----------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 0000000 00 0022456889999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=336.01 Aligned_cols=243 Identities=21% Similarity=0.244 Sum_probs=197.2
Q ss_pred HhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch------hhHHHHHHHHHHHhhcC--CCCeeEEEeeecc
Q 043900 628 NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH------GAFKSFIAECNTLKNIR--HRNLVKILTACSG 699 (953)
Q Consensus 628 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~ 699 (953)
...++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 345689999999999999999999999999999999964322 12245678999999995 599999999964
Q ss_pred cccCCCCceeEEEeeccC-CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeE
Q 043900 700 VDYQGNDFKALVFEFMQN-RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVL 778 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 778 (953)
..+..++||||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 181 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENIL 181 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEE
Confidence 34778999999976 899999853 23589999999999999999999999 9999999999999
Q ss_pred ec-CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCc
Q 043900 779 LD-EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDM 856 (953)
Q Consensus 779 l~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~ 856 (953)
++ +++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 99 7889999999999876432 2223458999999999877765 688999999999999999999996421
Q ss_pred cHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 857 NLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....... ... ..+++++.+++.+||+.||++|||++|+++
T Consensus 254 ---~~~~~~~----------~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ---EIIRGQV----------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHHCCC----------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhhcccc----------ccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000 012456889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=354.44 Aligned_cols=278 Identities=21% Similarity=0.245 Sum_probs=201.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|++++++++||||+++++++.... +..++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999988889999998643 4445678999999999999999999999975422 233677
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc---
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM--- 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 784 (953)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-------~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-------CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-------TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred EEEEEEeCCCCCHHHHHHhccc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence 8999999999999999964322 23588889999999999999999999 9999999999999997764
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||.++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...|...
T Consensus 163 vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~ 235 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK 235 (676)
T ss_dssp EEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred EEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence 9999999998764332 22345699999999999999999999999999999999999999975211 1111111
Q ss_pred hCCchhhh-hccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 865 ALPDHVVD-IVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 865 ~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
........ .......+... .....+.+ .......++.+.+++.+||++||++|||++|++
T Consensus 236 i~~~~~~~~~~~~~l~g~~~---~~~~lp~p---~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVK---FSSVLPTP---NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CC------CCSCCCCSSSCC---CCSSSCCS---CCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhcccchhhhhhhhhccccc---cccccCCc---hhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 10000000 00000000000 00000000 001123567899999999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=335.95 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=177.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHH-HHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECN-TLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ......+..|+. +++.++||||+++++++.. .+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence 367899999999999999999999888999999997543 333455666666 6777899999999999643 478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++ +|.+++..... .....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYS-----VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHH-----TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEEeecCC-ChHHHHHHHHh-----hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEE
Confidence 8999999975 88777742111 1134689999999999999999999984 28999999999999999999999
Q ss_pred eccccceecCCCCCccccccccccccccccccc----CCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYG----LGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
+|||+++...... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........ ...
T Consensus 168 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~ 240 (327)
T 3aln_A 168 CDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLT 240 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------C
T ss_pred ccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHH
Confidence 9999998664322 22233589999999998 566789999999999999999999999975321100 000
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....... ..+... ....+++++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~-----~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDP-----PQLSNS------------------EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCC-----CCCCCC------------------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCC-----CCCCCc------------------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000 000000 00123456899999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.65 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=177.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-h-hHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-G-AFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|++..+++.||||+++.... . ..+.+..+..+++.++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 4678999999999999999999998888999999975432 2 2334445555778889999999999964 3478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
.++||||+ ++.+..+.... ...+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+|
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~k 165 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRM---------QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIK 165 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEecc-CCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEE
Confidence 99999999 55555554311 2358999999999999999999998 6 899999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
|+|||.+....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.............
T Consensus 166 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 166 LCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred EEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 99999997654322 222345899999999984 5578899999999999999999999997532211111111
Q ss_pred HHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... +. .... ...++.++.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~-~~--------~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 243 LQEE-PP--------LLPG--------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSC-CC--------CCCS--------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hccC-CC--------CCCc--------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1100 00 0000 0023456889999999999999999999987
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=328.38 Aligned_cols=312 Identities=21% Similarity=0.214 Sum_probs=168.8
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.+.++++|++++|.++.+.+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 34555666666666665444445555666666666666654444455555555555555555554445555555555555
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|++|+++...+..|+++++|++|++++|++++..++.|..+++|++|++++|++++. .+.
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~---------------- 183 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLS---------------- 183 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGG----------------
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccc----------------
Confidence 5555555533333345555555555555555544444455555555555555544421 122
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCccc
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLN 265 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~ 265 (953)
.+++|+.|++++|.+++ +...++|+.|
T Consensus 184 ---------~l~~L~~L~l~~n~l~~-----~~~~~~L~~L--------------------------------------- 210 (390)
T 3o6n_A 184 ---------LIPSLFHANVSYNLLST-----LAIPIAVEEL--------------------------------------- 210 (390)
T ss_dssp ---------GCTTCSEEECCSSCCSE-----EECCSSCSEE---------------------------------------
T ss_pred ---------cccccceeecccccccc-----cCCCCcceEE---------------------------------------
Confidence 23344444444443331 1111233333
Q ss_pred ccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccC
Q 043900 266 FLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGE 345 (953)
Q Consensus 266 ~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 345 (953)
++++|.+..... ...++|+.|++++|.+++. ..+..
T Consensus 211 ---------------------------------------~l~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~ 246 (390)
T 3o6n_A 211 ---------------------------------------DASHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLLN 246 (390)
T ss_dssp ---------------------------------------ECCSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGG
T ss_pred ---------------------------------------ECCCCeeeeccc---cccccccEEECCCCCCccc--HHHcC
Confidence 333333332211 1124555556666655532 45566
Q ss_pred CCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeee
Q 043900 346 LQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLD 425 (953)
Q Consensus 346 l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ 425 (953)
+++|++|+|++|.+++ ..|..|..+++|+.|+|++|++++
T Consensus 247 l~~L~~L~Ls~n~l~~-----------------------~~~~~~~~l~~L~~L~L~~n~l~~----------------- 286 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEK-----------------------IMYHPFVKMQRLERLYISNNRLVA----------------- 286 (390)
T ss_dssp CTTCSEEECCSSCCCE-----------------------EESGGGTTCSSCCEEECCSSCCCE-----------------
T ss_pred CCCccEEECCCCcCCC-----------------------cChhHccccccCCEEECCCCcCcc-----------------
Confidence 6666666666665543 334555566666666666666651
Q ss_pred ccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccc
Q 043900 426 LSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505 (953)
Q Consensus 426 ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (953)
+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|+|++|++++
T Consensus 287 ---------~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 287 ---------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp ---------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred ---------cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 1122344566777777777776 5566667777777777777777743 3 6677788888888888875
Q ss_pred c
Q 043900 506 K 506 (953)
Q Consensus 506 ~ 506 (953)
.
T Consensus 354 ~ 354 (390)
T 3o6n_A 354 N 354 (390)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=340.77 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=182.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
+.|.+.+.||+|+||+||.+... +++.||||++... ..+.+.+|+++++++ +||||+++++++. .....+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEE
Confidence 34556788999999999876544 4569999998643 235678899999887 8999999999853 447899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC-------
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE------- 782 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------- 782 (953)
+||||++ |+|.+++....... ......++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCC
T ss_pred EEEecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccccc
Confidence 9999995 69999996443220 0011123445688999999999999999 99999999999999754
Q ss_pred ------CcEEEeccccceecCCCCCc--ccccccccccccccccccCC-------CCCCcccchHHHHHHHHHHHh-CCC
Q 043900 783 ------MMAHVSDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLG-------SEVSINGDVYSYGILLLELVT-RKK 846 (953)
Q Consensus 783 ------~~~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slG~vl~ellt-g~~ 846 (953)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999987543221 12234569999999999876 678999999999999999999 999
Q ss_pred CCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 043900 847 PVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNM 926 (953)
Q Consensus 847 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 926 (953)
||....... ............ . .......+++++.+++.+||+.||++|||+
T Consensus 239 Pf~~~~~~~---~~i~~~~~~~~~-------~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (434)
T 2rio_A 239 PFGDKYSRE---SNIIRGIFSLDE-------M------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTA 290 (434)
T ss_dssp TTCSTTTHH---HHHHHTCCCCCC-------C------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCchhhH---HHHhcCCCCccc-------c------------------cccccccchHHHHHHHHHHhhCChhhCCCH
Confidence 997532211 111111100000 0 000112456789999999999999999999
Q ss_pred HHHHH
Q 043900 927 TNVVR 931 (953)
Q Consensus 927 ~evl~ 931 (953)
.|+++
T Consensus 291 ~eil~ 295 (434)
T 2rio_A 291 MKVLR 295 (434)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 99985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.30 Aligned_cols=239 Identities=11% Similarity=0.071 Sum_probs=184.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. .+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CC
Confidence 367999999999999999999999888999999997432 3345788999999999999999999999643 47
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++++|.++++. .....++.+|+.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT------------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEE
T ss_pred cEEEEEEecCCCCHHHHHhc------------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEE
Confidence 79999999999999999842 135557889999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+++| |++ .++.++|||||||++|||+||+.||......+...
T Consensus 170 l~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------- 212 (286)
T 3uqc_A 170 LAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------- 212 (286)
T ss_dssp ECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------
T ss_pred EEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------
Confidence 98543 333 36889999999999999999999997633221000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHR 944 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 944 (953)
. .......... .. ......+++++.+++.+||+.||++| |++|+++.|+++........
T Consensus 213 -----~-~~~~~~~~~~---------~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~ 271 (286)
T 3uqc_A 213 -----P-AERDTAGQPI---------EP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTE 271 (286)
T ss_dssp -----E-CCBCTTSCBC---------CH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC------
T ss_pred -----H-HHHHhccCCC---------Ch---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccC
Confidence 0 0000000000 00 00011345678999999999999999 99999999999876655443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=345.11 Aligned_cols=343 Identities=20% Similarity=0.204 Sum_probs=190.2
Q ss_pred cccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEec
Q 043900 100 SKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDA 179 (953)
Q Consensus 100 ~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 179 (953)
.+++.|++++|.+....+..|+++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|.++++|+.|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 34444444444444333333444444444444444444444444444444444444444444444444444444444444
Q ss_pred CCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCC
Q 043900 180 GMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSR 259 (953)
Q Consensus 180 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~ 259 (953)
++|.++ .+|..++..+++|++|+|++|.+++..|..|+++++|+.|++++|.+++.+.
T Consensus 131 ~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------------------- 188 (597)
T 3oja_B 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--------------------- 188 (597)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG---------------------
T ss_pred eCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh---------------------
Confidence 444444 3333333355556666666666665666666666666666666666653210
Q ss_pred CCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccC
Q 043900 260 GHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTI 339 (953)
Q Consensus 260 ~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 339 (953)
..+ ++|+.|++++|.+++ +...++|+.|++++|.++...
T Consensus 189 -----------------------------------~~l-~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~ 227 (597)
T 3oja_B 189 -----------------------------------SLI-PSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVR 227 (597)
T ss_dssp -----------------------------------GGC-TTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEE
T ss_pred -----------------------------------hhh-hhhhhhhcccCcccc-----ccCCchhheeeccCCcccccc
Confidence 000 234444555444432 122234444555554444222
Q ss_pred CcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccc
Q 043900 340 PPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSW 419 (953)
Q Consensus 340 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~ 419 (953)
+..+ ++|+.|+|++|.+++ +..+..+++|+.|+|++|.+
T Consensus 228 ~~~~---~~L~~L~L~~n~l~~-------------------------~~~l~~l~~L~~L~Ls~N~l------------- 266 (597)
T 3oja_B 228 GPVN---VELTILKLQHNNLTD-------------------------TAWLLNYPGLVEVDLSYNEL------------- 266 (597)
T ss_dssp CSCC---SCCCEEECCSSCCCC-------------------------CGGGGGCTTCSEEECCSSCC-------------
T ss_pred cccC---CCCCEEECCCCCCCC-------------------------ChhhccCCCCCEEECCCCcc-------------
Confidence 1111 234444444443331 23344444444444444444
Q ss_pred cceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECC
Q 043900 420 LLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLS 499 (953)
Q Consensus 420 ~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 499 (953)
++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|+
T Consensus 267 ------------~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~ 332 (597)
T 3oja_B 267 ------------EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332 (597)
T ss_dssp ------------CEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred ------------CCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECC
Confidence 44456667777788888888888874 5666777888888888888887 567777888888888888
Q ss_pred CCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccccccCCcCCCCCCCCCCCCccc
Q 043900 500 QNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEFQLPTCI 564 (953)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~c~ 564 (953)
+|++++. | +..+++|+.|++++|++++..+ ...+.......+.++...|+.........|.
T Consensus 333 ~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~~~~~~~~~cc 393 (597)
T 3oja_B 333 HNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDYQLEHGLCC 393 (597)
T ss_dssp SSCCCCC-C--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCTTCEEETTEEE
T ss_pred CCCCCCc-C--hhhcCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCcchhccCCccc
Confidence 8888754 3 5567788888888888887542 2234455556678888999976654444453
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=354.10 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=196.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|++++++++||||++++++|..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999976 6789999998643 3345567899999999999999999999986543222223
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.|+||||+++++|.+++. ..+++.+++.|+.||+.||+|||+. +|+||||||+|||++.+ .+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence 699999999999998773 1589999999999999999999999 99999999999999885 8999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||........ +
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~ 285 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P 285 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c
Confidence 999999876432 3346999999999987654 8999999999999999999988764211100 0
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-NMTNVVRQLQSIKN 938 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~ 938 (953)
.. ......++.+.+++.+||+.||++|| +++++.+.|..+..
T Consensus 286 ------------~~-----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ------------ED-----------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ------------TT-----------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ------------cc-----------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00 00112345788999999999999999 56777777777643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.85 Aligned_cols=335 Identities=20% Similarity=0.203 Sum_probs=210.0
Q ss_pred ccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEe
Q 043900 99 LSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFD 178 (953)
Q Consensus 99 l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 178 (953)
++++++|++++|.++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 34555555555555533222345555555555555555544555555555555555555555544455555555556666
Q ss_pred cCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCC
Q 043900 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGS 258 (953)
Q Consensus 179 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~ 258 (953)
|++|+++ .+|..++..+++|++|++++|++++..+..+.++++|++|++++|++++...
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-------------------- 182 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL-------------------- 182 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCG--------------------
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccc--------------------
Confidence 6666555 3444443456666666666666666666667777777777777776653210
Q ss_pred CCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCccccc
Q 043900 259 RGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGT 338 (953)
Q Consensus 259 ~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~ 338 (953)
..+ ++|+.|++++|.+++ +...++|+.|++++|.++..
T Consensus 183 ------------------------------------~~l-~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~ 220 (390)
T 3o6n_A 183 ------------------------------------SLI-PSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV 220 (390)
T ss_dssp ------------------------------------GGC-TTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE
T ss_pred ------------------------------------ccc-cccceeecccccccc-----cCCCCcceEEECCCCeeeec
Confidence 001 345555555555542 12223455555555555432
Q ss_pred CCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCcc
Q 043900 339 IPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLS 418 (953)
Q Consensus 339 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 418 (953)
|..+ .++|+.|++++|++++ +..+..+++|++|+|+
T Consensus 221 -~~~~--~~~L~~L~l~~n~l~~-------------------------~~~l~~l~~L~~L~Ls---------------- 256 (390)
T 3o6n_A 221 -RGPV--NVELTILKLQHNNLTD-------------------------TAWLLNYPGLVEVDLS---------------- 256 (390)
T ss_dssp -ECCC--CSSCCEEECCSSCCCC-------------------------CGGGGGCTTCSEEECC----------------
T ss_pred -cccc--cccccEEECCCCCCcc-------------------------cHHHcCCCCccEEECC----------------
Confidence 2111 2344444444444331 1234444555555554
Q ss_pred ccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEEC
Q 043900 419 WLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDL 498 (953)
Q Consensus 419 ~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 498 (953)
+|.+++..|..|..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 257 ---------~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 257 ---------YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp ---------SSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred ---------CCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 45555556778889999999999999999 56777889999999999999999 57788999999999999
Q ss_pred CCCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccccccCCcCCCCCC
Q 043900 499 SQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGI 555 (953)
Q Consensus 499 s~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 555 (953)
++|+++.. | +..+++|+.|++++|++++... ...+.......+.+++..|+.+
T Consensus 326 ~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 326 DHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp CSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCTT
T ss_pred CCCcccee-C--chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceeccc
Confidence 99999854 4 6778999999999999987532 2234445555667777778753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.02 Aligned_cols=251 Identities=15% Similarity=0.124 Sum_probs=183.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCC-CCeeE--------------
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRH-RNLVK-------------- 692 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~-------------- 692 (953)
..|...+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+++.++| ++...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778889999999999999999888999999987322 2336789999999999977 22111
Q ss_pred -------EEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCC
Q 043900 693 -------ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQP 765 (953)
Q Consensus 693 -------~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 765 (953)
+..++...........+++|+++ +++|.+++...... ......+++..++.++.|++.||+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 11111100001123467777766 68999988422111 01234688999999999999999999999
Q ss_pred CeEeecCCCCCeEecCCCcEEEeccccceecCCCCCccccccccccccccccccc----------CCCCCCcccchHHHH
Q 043900 766 PITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYG----------LGSEVSINGDVYSYG 835 (953)
Q Consensus 766 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~slG 835 (953)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999999999865322 334457 999999998 666788999999999
Q ss_pred HHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhcc
Q 043900 836 ILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVAC 915 (953)
Q Consensus 836 ~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 915 (953)
|++|||++|+.||........ ....+. .. ..+++++.+++.+|
T Consensus 305 vil~elltg~~Pf~~~~~~~~-------------~~~~~~----~~--------------------~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGG-------------SEWIFR----SC--------------------KNIPQPVRALLEGF 347 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSC-------------SGGGGS----SC--------------------CCCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCcchhhh-------------HHHHHh----hc--------------------ccCCHHHHHHHHHH
Confidence 999999999999975322110 000000 00 02235689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 043900 916 SMESPGDRMNMTNVVR 931 (953)
Q Consensus 916 l~~dP~~RPt~~evl~ 931 (953)
|+.||++|||+.|+++
T Consensus 348 l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAME 363 (413)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred ccCChhhCcCHHHHHh
Confidence 9999999999988865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=333.06 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=179.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..+|.+.+.||+|+||+||..... +++.||||++..... ..+.+|+++++++ +||||+++++++. +....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES-SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe-CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEE
Confidence 346888899999999997644433 456899999864322 2356799999999 7999999999854 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-----CC
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-----EM 783 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~ 783 (953)
++||||++ |+|.+++..... ..++.+++.++.||+.||+|||+. +|+||||||+||+++. ..
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF---------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC---------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEECCC-CCHHHHHHhcCC---------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCce
Confidence 99999995 699999964332 233445678999999999999999 9999999999999953 23
Q ss_pred cEEEeccccceecCCCCC-cccccccccccccccccccC---CCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccH
Q 043900 784 MAHVSDFGLARFLPLSPA-QTSSIDAKGSIGYIAPEYGL---GSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNL 858 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~ 858 (953)
.+||+|||+|+....... ........||+.|+|||++. +..++.++||||+||++|||++ |..||...... .
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~ 237 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q 237 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H
Confidence 688999999987643321 12234456999999999987 4567889999999999999999 99998642111 0
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .......... .........+.+++.+||+.||++|||++||++
T Consensus 238 ~~~---~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 ANI---LLGACSLDCL------------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHH---HTTCCCCTTS------------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHH---HhccCCcccc------------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 0000000000 000123456789999999999999999999984
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.40 Aligned_cols=255 Identities=31% Similarity=0.498 Sum_probs=222.5
Q ss_pred cCcEEEcccCcccc--cCCccccCCCCCCEEEeec-CcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEE
Q 043900 300 TLEMLLLDNNKIFG--NIPAAIGKFVNLQRLEMWN-NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNL 375 (953)
Q Consensus 300 ~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L 375 (953)
+++.|+|++|++++ .+|..|.++++|++|++++ |.+.+.+|..|+.+++|++|+|++|++++.+|..++.+ .+++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 56777777777776 6777777777777777774 77777777777777777777777777777777777766 46777
Q ss_pred EccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcc
Q 043900 376 DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455 (953)
Q Consensus 376 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 455 (953)
+|++|.+++.+|..|..+++|++|+|++|++++.+|..+..+...++.|++++|++++.+|..|..++ |+.|++++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 77778887788999999999999999999999899999988886788999999999999999999998 99999999999
Q ss_pred cccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCC
Q 043900 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535 (953)
Q Consensus 456 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 535 (953)
++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..+
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 999999999999999999999999977665 8899999999999999999999999999999999999999999999988
Q ss_pred cccccccccccCCcCCCCCCC
Q 043900 536 VFKNATITSVLGNLKLCGGIP 556 (953)
Q Consensus 536 ~~~~~~~~~~~~n~~lcg~~~ 556 (953)
.++.+....+.+|+++||.++
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cccccChHHhcCCCCccCCCC
Confidence 889999999999999999765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=340.23 Aligned_cols=311 Identities=20% Similarity=0.199 Sum_probs=174.3
Q ss_pred CCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEe
Q 043900 51 LQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLF 130 (953)
Q Consensus 51 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 130 (953)
+.+++.|++++|.++...+..|.++++|+.|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34555566666655533333345556666666666666555555566666666666666666655555556666666666
Q ss_pred cccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCcccc
Q 043900 131 LTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210 (953)
Q Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 210 (953)
|++|.|++..+..|+.+++|++|+|++|.+++..|..+.++++|+.|+|++|.+++. +. ..+++|+.|++++|.++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~---~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DL---SLIPSLFHANVSYNLLS 205 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-CG---GGCTTCSEEECCSSCCS
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-Ch---hhhhhhhhhhcccCccc
Confidence 666666544444456666666666666666655555566666666666666665532 11 13444555555554444
Q ss_pred CCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccC
Q 043900 211 GAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLL 290 (953)
Q Consensus 211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~ 290 (953)
+ +....+|+.|++++|.+
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l--------------------------------------------------------- 223 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSI--------------------------------------------------------- 223 (597)
T ss_dssp E-----EECCTTCSEEECCSSCC---------------------------------------------------------
T ss_pred c-----ccCCchhheeeccCCcc---------------------------------------------------------
Confidence 1 11222334444443333
Q ss_pred ChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc
Q 043900 291 PACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL 370 (953)
Q Consensus 291 p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 370 (953)
....+.. .++|+.|+|++|.+++ +..+..+++|++|+|++|.+++
T Consensus 224 ---------------------~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~--------- 268 (597)
T 3oja_B 224 ---------------------NVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK--------- 268 (597)
T ss_dssp ---------------------CEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCE---------
T ss_pred ---------------------ccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCC---------
Confidence 3221111 1345555555555553 3455666666666666665543
Q ss_pred eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeee
Q 043900 371 KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDV 450 (953)
Q Consensus 371 ~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~L 450 (953)
..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 269 --------------~~~~~~~~l~~L~~L~Ls~N~l~~--------------------------l~~~~~~l~~L~~L~L 308 (597)
T 3oja_B 269 --------------IMYHPFVKMQRLERLYISNNRLVA--------------------------LNLYGQPIPTLKVLDL 308 (597)
T ss_dssp --------------EESGGGTTCSSCCEEECTTSCCCE--------------------------EECSSSCCTTCCEEEC
T ss_pred --------------CCHHHhcCccCCCEEECCCCCCCC--------------------------CCcccccCCCCcEEEC
Confidence 344555566666666666666552 1222334556666777
Q ss_pred cCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCccccc
Q 043900 451 FENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGK 506 (953)
Q Consensus 451 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 506 (953)
++|.++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|+|++|.+.+.
T Consensus 309 s~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 777666 5666666677777777777777643 2 56677888888888888764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.86 Aligned_cols=236 Identities=18% Similarity=0.251 Sum_probs=181.2
Q ss_pred hcCCccc-CcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHH-hhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASA-NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTL-KNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|++++ +..+||||+++++++... ......
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 4567777 789999999999999998889999999963 24567888887 555899999999997542 233567
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---CCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---EMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 784 (953)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT--------TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred EEEEEeecCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence 899999999999999996432 23689999999999999999999999 9999999999999997 789
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||++.... +..++.++||||+||++|||++|+.||........
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------- 206 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------- 206 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--------
Confidence 9999999997542 23467899999999999999999999975322110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......+....... .......+++++.+++.+||+.||++|||++|+++
T Consensus 207 --~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 --SPGMKTRIRMGQYEF---------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---CCSCCSSCTTCCSS---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --hHHHHHHHhhccccC---------------CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000000000 00011134567999999999999999999999987
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=306.14 Aligned_cols=308 Identities=23% Similarity=0.382 Sum_probs=219.1
Q ss_pred cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 23 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
.+..+++|++|++++|.++. +| .|..+++|++|+|++|+++ .++. +.++++|++|+|++|.+++ +| .|.++++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence 34577888888888888887 44 3888888888888888888 4444 8888888888888888874 43 68888888
Q ss_pred ceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCc
Q 043900 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 182 (953)
++|++++|++++ ++. +..+++|++|++++|..... +..+..+++|++|++++|++.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccC-chh-hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 888888888884 343 88888888888888865533 3448888888888888888874333 778888888888888
Q ss_pred ccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCC
Q 043900 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHS 262 (953)
Q Consensus 183 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~ 262 (953)
++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++.++ +..+++|+++++++|.+...
T Consensus 188 ~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--- 258 (347)
T 4fmz_A 188 QIEDISP---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--- 258 (347)
T ss_dssp CCCCCGG---GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC---
T ss_pred ccccccc---ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC---
Confidence 8885443 3478888888888888885444 7888888888888888887655 66667777777777766542
Q ss_pred cccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcC
Q 043900 263 NLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPA 342 (953)
Q Consensus 263 ~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 342 (953)
..+..+++|+.|++++|.+.+. ..+..+ ++|+.|++++|.+++..+..|..+++|+.|++++|.+++..|
T Consensus 259 -----~~~~~l~~L~~L~l~~n~l~~~--~~~~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-- 328 (347)
T 4fmz_A 259 -----NAVKDLTKLKMLNVGSNQISDI--SVLNNL-SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328 (347)
T ss_dssp -----GGGTTCTTCCEEECCSSCCCCC--GGGGGC-TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--
T ss_pred -----hhHhcCCCcCEEEccCCccCCC--hhhcCC-CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--
Confidence 2344555666666666666553 233333 456666666666665556666666666666666666664444
Q ss_pred ccCCCCCCeEEecccccc
Q 043900 343 IGELQNLRELRLQRNKFL 360 (953)
Q Consensus 343 ~~~l~~L~~L~L~~N~l~ 360 (953)
+..+++|++|++++|.|+
T Consensus 329 ~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 329 LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGCTTCSEESSSCC---
T ss_pred hhhhhccceeehhhhccc
Confidence 566666666666666654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=303.71 Aligned_cols=128 Identities=25% Similarity=0.346 Sum_probs=87.4
Q ss_pred ccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeec
Q 043900 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSV 107 (953)
Q Consensus 28 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (953)
.+++++++++|+++. +|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCccc-cCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 367777777777775 555543 57777777777777665667777777777777777777666777777777777777
Q ss_pred cccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 108 SVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 108 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
++|+++ .+|..+. ++|++|++++|+++...+..|..+++|++|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccc
Confidence 777776 4554444 56777777777776555555666666666666666654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=309.36 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=233.8
Q ss_pred CcEEEEEeCCCeeee--ecCccccCCccCceeecCC-CccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcE
Q 043900 4 QRVKILNLTSLKLAG--SISPHVGNLSFLKVLLLYN-NSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQ 80 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~ 80 (953)
++|+.|+|+++++.+ .+|+.++++++|++|+|++ |.+++.+|..|.++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 789999999999998 9999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EeccCccccccCCcccCCccccceeeccccccccccCCcccCCC-cccEEecccccccccCCccccccccccceeccccc
Q 043900 81 IRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLS-SINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENW 159 (953)
Q Consensus 81 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (953)
|+|++|.+++.+|..|+.+++|++|++++|++++.+|..++.++ +|++|+|++|++++..|..|..++ |++|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999999999999999999999999999999999999998 999999999999999999999998 9999999999
Q ss_pred ccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC
Q 043900 160 LSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239 (953)
Q Consensus 160 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (953)
+++..|..+..+++|+.|+|++|++++.+|. + ..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|.
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-V-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-C-CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-c-cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 9988999999999999999999999977776 3 4789999999999999999999999999999999999999988887
Q ss_pred CCCCCccceeeecccc
Q 043900 240 LEKPQRLSVFSITENS 255 (953)
Q Consensus 240 l~~~~~L~~l~l~~n~ 255 (953)
...+++|+.+++.+|.
T Consensus 287 ~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 287 GGNLQRFDVSAYANNK 302 (313)
T ss_dssp STTGGGSCGGGTCSSS
T ss_pred CccccccChHHhcCCC
Confidence 6666666666666664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.03 Aligned_cols=288 Identities=22% Similarity=0.270 Sum_probs=234.7
Q ss_pred cEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEecc
Q 043900 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~ 84 (953)
+++.++++++++. .+|..+. ++|++|+|++|+++++.|.+|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3677899999987 8898774 689999999999999888899999999999999999998889999999999999999
Q ss_pred CccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccccc--ccCCccccccccccceecccccccC
Q 043900 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLD--GGIPDTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (953)
+|.++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|.++ +..+..|..+ +|++|++++|+++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~- 185 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT- 185 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-
Confidence 99999 6777666 89999999999999776777999999999999999996 3778889888 9999999999998
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCC
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~ 242 (953)
.+|..+. ++|++|++++|++++..+..+. .+++|+.|++++|++++..+..+..+++|+.|++++|+++..+
T Consensus 186 ~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp----- 257 (332)
T 2ft3_A 186 GIPKDLP--ETLNELHLDHNKIQAIELEDLL-RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVP----- 257 (332)
T ss_dssp SCCSSSC--SSCSCCBCCSSCCCCCCTTSST-TCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCC-----
T ss_pred ccCcccc--CCCCEEECCCCcCCccCHHHhc-CCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecC-----
Confidence 5776655 6888888888888865555554 6788888888888888777777888888888888887776433
Q ss_pred CCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccC-
Q 043900 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGK- 321 (953)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~- 321 (953)
..+..+ ++|+.|++++|+|++..+..|..
T Consensus 258 -------------------------------------------------~~l~~l-~~L~~L~l~~N~l~~~~~~~~~~~ 287 (332)
T 2ft3_A 258 -------------------------------------------------AGLPDL-KLLQVVYLHTNNITKVGVNDFCPV 287 (332)
T ss_dssp -------------------------------------------------TTGGGC-TTCCEEECCSSCCCBCCTTSSSCS
T ss_pred -------------------------------------------------hhhhcC-ccCCEEECCCCCCCccChhHcccc
Confidence 233333 46777777777777666666654
Q ss_pred -----CCCCCEEEeecCccc--ccCCcCccCCCCCCeEEecccc
Q 043900 322 -----FVNLQRLEMWNNRLS--GTIPPAIGELQNLRELRLQRNK 358 (953)
Q Consensus 322 -----l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~ 358 (953)
...|+.|++++|.+. +..|.+|..+++|+.+++++|+
T Consensus 288 ~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 356888888888887 6677888888888888888875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-32 Score=297.68 Aligned_cols=297 Identities=21% Similarity=0.282 Sum_probs=181.0
Q ss_pred CccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceee
Q 043900 27 LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLS 106 (953)
Q Consensus 27 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (953)
..++++++++++.++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 3467777777777776 555443 5677777777777755555677777777777777777766677777777777777
Q ss_pred ccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC--CCCCcccccccceEEecCCccc
Q 043900 107 VSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG--TIPSSIFNISSITAFDAGMNQL 184 (953)
Q Consensus 107 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l 184 (953)
|++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|+++. ..+.
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------ 165 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG------------------ 165 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTT------------------
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChh------------------
Confidence 7777776 4555443 567777777777765555566666666666666666541 2222
Q ss_pred ccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcc
Q 043900 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNL 264 (953)
Q Consensus 185 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~ 264 (953)
.+.++++|+.|++++|.++..+..+
T Consensus 166 -------------------------------~~~~l~~L~~L~l~~n~l~~l~~~~------------------------ 190 (330)
T 1xku_A 166 -------------------------------AFQGMKKLSYIRIADTNITTIPQGL------------------------ 190 (330)
T ss_dssp -------------------------------GGGGCTTCCEEECCSSCCCSCCSSC------------------------
T ss_pred -------------------------------hccCCCCcCEEECCCCccccCCccc------------------------
Confidence 2333334444444444333211100
Q ss_pred cccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCcc
Q 043900 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIG 344 (953)
Q Consensus 265 ~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 344 (953)
.++|+.|++++|++++..+..|..+++|+.|+|++|.+++..+.+|.
T Consensus 191 ---------------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 191 ---------------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp ---------------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred ---------------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 02566677777777666677777777888888888888777777777
Q ss_pred CCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceee
Q 043900 345 ELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGL 424 (953)
Q Consensus 345 ~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L 424 (953)
.+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|....
T Consensus 238 ~l~~L~~L~L~~N~l~------------------------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------ 287 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV------------------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------ 287 (330)
T ss_dssp GSTTCCEEECCSSCCS------------------------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------
T ss_pred CCCCCCEEECCCCcCc------------------------cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------
Confidence 7888888888777776 3555666677777777777777633222222110
Q ss_pred eccCCcccCCCCccccCCCccceeeecCCcccc--cCCCCccCCccccEEEccCcc
Q 043900 425 DLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKG--EIPSTLGSCKKLEQLEMQGNF 478 (953)
Q Consensus 425 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~ 478 (953)
.......|+.|++++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 288 -------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 288 -------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp -------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred -------------cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 00112445555566665542 344556666666666666653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=317.66 Aligned_cols=247 Identities=16% Similarity=0.163 Sum_probs=184.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhhcC---------CCCeeE
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------HGAFKSFIAECNTLKNIR---------HRNLVK 692 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~ 692 (953)
.++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45789999999999999999998 45799999997442 223477889999988885 777777
Q ss_pred EEeeeccc-------------------------ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHH
Q 043900 693 ILTACSGV-------------------------DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747 (953)
Q Consensus 693 ~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~ 747 (953)
+.+++... ++.+....++||||+++|++.+.+.. ..+++.+++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~ 165 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKS 165 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHH
Confidence 77764211 01135789999999999977666631 3579999999
Q ss_pred HHHHHHHHHHHHh-hCCCCCeEeecCCCCCeEecCCC--------------------cEEEeccccceecCCCCCccccc
Q 043900 748 IGIDVACALSYLH-HDCQPPITHCDLKPSNVLLDEEM--------------------MAHVSDFGLARFLPLSPAQTSSI 806 (953)
Q Consensus 748 i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~~ 806 (953)
++.||+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 88 999999999999999887 8999999999876421
Q ss_pred ccccccccccccccCCCCCCcccchHHHHHH-HHHHHhCCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhh
Q 043900 807 DAKGSIGYIAPEYGLGSEVSINGDVYSYGIL-LLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDL 885 (953)
Q Consensus 807 ~~~gt~~y~aPE~~~~~~~~~~sDv~slG~v-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 885 (953)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||... .|.... ...+........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~----~~~~~~~~~~~~---- 298 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYL----TDKMLKQMTFKT---- 298 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHH----HHHHHHTCCCSS----
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHH----HHhhhhhhccCc----
Confidence 346999999999998776 899999998777 78888999998531 010000 000000000000
Q ss_pred hhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 043900 886 AVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930 (953)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 930 (953)
..........++++.+++.+||+.| |++|++
T Consensus 299 ---------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 299 ---------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ---------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ---------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 0001122357788999999999976 888887
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.17 Aligned_cols=289 Identities=20% Similarity=0.250 Sum_probs=235.3
Q ss_pred cEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEecc
Q 043900 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~ 84 (953)
+++.++++++++. .+|..+. +++++|+|++|+++++.+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4567899999887 7888764 689999999999999888899999999999999999998889999999999999999
Q ss_pred CccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccc--cCCccccccccccceecccccccC
Q 043900 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG--GIPDTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~ 162 (953)
+|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++. ..+..|.++++|++|++++|+++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~- 184 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence 99999 6777665 799999999999997777789999999999999999963 77889999999999999999998
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCC
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~ 242 (953)
.+|..+. ++|++|++++|++++..|..+. .+++|++|++++|++++..+..+..+++|+.|++++|+++..+..+..
T Consensus 185 ~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~ 261 (330)
T 1xku_A 185 TIPQGLP--PSLTELHLDGNKITKVDAASLK-GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 261 (330)
T ss_dssp SCCSSCC--TTCSEEECTTSCCCEECTGGGT-TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTT
T ss_pred cCCcccc--ccCCEEECCCCcCCccCHHHhc-CCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhcc
Confidence 6777665 7899999999999876666555 788899999999988877777888888888888888888754433322
Q ss_pred CCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccC-
Q 043900 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGK- 321 (953)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~- 321 (953)
+ ++|++|++++|+|++..+..|..
T Consensus 262 l-------------------------------------------------------~~L~~L~l~~N~i~~~~~~~f~~~ 286 (330)
T 1xku_A 262 H-------------------------------------------------------KYIQVVYLHNNNISAIGSNDFCPP 286 (330)
T ss_dssp C-------------------------------------------------------SSCCEEECCSSCCCCCCTTSSSCS
T ss_pred C-------------------------------------------------------CCcCEEECCCCcCCccChhhcCCc
Confidence 2 35666666666666555555543
Q ss_pred -----CCCCCEEEeecCcccc--cCCcCccCCCCCCeEEecccc
Q 043900 322 -----FVNLQRLEMWNNRLSG--TIPPAIGELQNLRELRLQRNK 358 (953)
Q Consensus 322 -----l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~ 358 (953)
...++.|++++|.+.. ..|..|..+.+++.++|++|+
T Consensus 287 ~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3567788888888753 556778888888888888775
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-32 Score=300.33 Aligned_cols=303 Identities=23% Similarity=0.367 Sum_probs=263.7
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+++.|+++++++. .++. +..+++|++|+|++|+++++ +. |..+++|++|+|++|.++ .+| .|.++++|++|++
T Consensus 44 ~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l 117 (347)
T 4fmz_A 44 ESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYL 117 (347)
T ss_dssp TTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred ccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEEC
Confidence 46889999999997 6654 89999999999999999984 44 999999999999999998 444 6999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCC
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGT 163 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 163 (953)
++|.+++ ++. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|++++
T Consensus 118 ~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~- 191 (347)
T 4fmz_A 118 NEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED- 191 (347)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-
T ss_pred cCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-
Confidence 9999984 444 9999999999999997664444 59999999999999999985444 9999999999999999984
Q ss_pred CCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCC
Q 043900 164 IPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKP 243 (953)
Q Consensus 164 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~ 243 (953)
++. +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.++.. +.+..+
T Consensus 192 ~~~-~~~l~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l 264 (347)
T 4fmz_A 192 ISP-LASLTSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-NAVKDL 264 (347)
T ss_dssp CGG-GGGCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTC
T ss_pred ccc-ccCCCccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-hhHhcC
Confidence 443 8899999999999999996555 3479999999999999996544 89999999999999999975 568889
Q ss_pred CccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCC
Q 043900 244 QRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFV 323 (953)
Q Consensus 244 ~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~ 323 (953)
++|+.+++++|.+... ..+..+++|+.|++++|.+.+..|..+..+ ++|+.|++++|.+++..| +..++
T Consensus 265 ~~L~~L~l~~n~l~~~--------~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~--~~~l~ 333 (347)
T 4fmz_A 265 TKLKMLNVGSNQISDI--------SVLNNLSQLNSLFLNNNQLGNEDMEVIGGL-TNLTTLFLSQNHITDIRP--LASLS 333 (347)
T ss_dssp TTCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCGGGHHHHHTC-TTCSEEECCSSSCCCCGG--GGGCT
T ss_pred CCcCEEEccCCccCCC--------hhhcCCCCCCEEECcCCcCCCcChhHhhcc-ccCCEEEccCCccccccC--hhhhh
Confidence 9999999999998764 346778999999999999999999988888 589999999999997666 88999
Q ss_pred CCCEEEeecCccc
Q 043900 324 NLQRLEMWNNRLS 336 (953)
Q Consensus 324 ~L~~L~L~~N~i~ 336 (953)
+|+.|++++|.|+
T Consensus 334 ~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 334 KMDSADFANQVIK 346 (347)
T ss_dssp TCSEESSSCC---
T ss_pred ccceeehhhhccc
Confidence 9999999999986
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-35 Score=338.32 Aligned_cols=390 Identities=18% Similarity=0.145 Sum_probs=198.5
Q ss_pred CCCcEEeCCCCccccccCcC-ccCCCCCcEEeccCccccc----cCCcccCCccccceeeccccccccccCCcc-cCCC-
Q 043900 52 QRLQVLALNNNSIGGEIPAN-ISSCSNLIQIRLFYNELVG----KIPSELGSLSKIEHLSVSVNNLTGSIPSSL-GNLS- 124 (953)
Q Consensus 52 ~~L~~L~L~~n~i~~~~p~~-~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~L~- 124 (953)
++|++|||++|+++...... +..+++|++|+|++|.++. .++..+..+++|++|+|++|++++..+..+ ..+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45667777777766433322 5566666666666666653 234445555666666666666654333222 2233
Q ss_pred ---cccEEecccccccc----cCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccc
Q 043900 125 ---SINTLFLTDNNLDG----GIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQ 197 (953)
Q Consensus 125 ---~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~ 197 (953)
+|++|+|++|+++. .++..|..+++|++|+|++|++++..+..+.. .+....+
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~--------------------~l~~~~~ 142 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE--------------------GLLDPQC 142 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH--------------------HHTSTTC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH--------------------HHhcCCC
Confidence 46666666666552 23444555555555555555544222221111 0111123
Q ss_pred cccEEEeeCccccCCC----CCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCccccccccccc
Q 043900 198 NLQFFSVFENQLTGAI----PPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNS 273 (953)
Q Consensus 198 ~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~ 273 (953)
+|++|++++|++++.. +..+..+++|++|++++|.++.....
T Consensus 143 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~---------------------------------- 188 (461)
T 1z7x_W 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR---------------------------------- 188 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH----------------------------------
T ss_pred cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH----------------------------------
Confidence 3444444444444321 23334445555555555554421100
Q ss_pred ccccEEeccCCcccccCChhhhhccccCcEEEcccCccccc----CCccccCCCCCCEEEeecCcccccC-----CcCcc
Q 043900 274 TRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGN----IPAAIGKFVNLQRLEMWNNRLSGTI-----PPAIG 344 (953)
Q Consensus 274 ~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~i~~~~-----~~~~~ 344 (953)
.+...+....++|++|++++|.+++. ++..+..+++|++|++++|.++... +..+.
T Consensus 189 ---------------~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~ 253 (461)
T 1z7x_W 189 ---------------VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH 253 (461)
T ss_dssp ---------------HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred ---------------HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhc
Confidence 00001111112455555555555432 2444455555666666666555322 22222
Q ss_pred CCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccC----cccc
Q 043900 345 ELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLG----LSWL 420 (953)
Q Consensus 345 ~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----~~~~ 420 (953)
.+++|++|++++|.++..... .++..+..+++|++|+|++|.+++..+..+.. ....
T Consensus 254 ~~~~L~~L~L~~n~l~~~~~~-------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~ 314 (461)
T 1z7x_W 254 PSSRLRTLWIWECGITAKGCG-------------------DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314 (461)
T ss_dssp TTCCCCEEECTTSCCCHHHHH-------------------HHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCC
T ss_pred CCCCceEEECcCCCCCHHHHH-------------------HHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCcc
Confidence 355555555555555421000 02334444555666666666554322211211 1123
Q ss_pred ceeeeccCCcccCC----CCccccCCCccceeeecCCcccccCCCCccC-----CccccEEEccCccccC----CCCccc
Q 043900 421 LIGLDLSRNQLTGS----IPSEVGNLKNLEVLDVFENKLKGEIPSTLGS-----CKKLEQLEMQGNFLQG----PIPSSL 487 (953)
Q Consensus 421 l~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~ 487 (953)
++.|++++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|+|++|++++ .+|..+
T Consensus 315 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l 394 (461)
T 1z7x_W 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred ceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHH
Confidence 44555555555543 4555667788888888888887554444432 5688888888888875 677777
Q ss_pred cCCCCCcEEECCCCcccccCCcccc-----ccccCceEeccCCcCcc
Q 043900 488 SSLKGLNVLDLSQNNLSGKIPEFLV-----GFQLLENLNLSNNNLEG 529 (953)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~l~l~~N~l~~ 529 (953)
..+++|++|||++|++++.-...+. ...+|+.|.+.+|.+..
T Consensus 395 ~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 395 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 7788888888888888753211111 12357777777766553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-35 Score=339.82 Aligned_cols=398 Identities=17% Similarity=0.129 Sum_probs=197.5
Q ss_pred CcEEEEEeCCCeeeeecCc-cccCCccCceeecCCCccCcC----CCccCCCCCCCcEEeCCCCccccccCcCcc-CCC-
Q 043900 4 QRVKILNLTSLKLAGSISP-HVGNLSFLKVLLLYNNSFNHG----IPSEFDRLQRLQVLALNNNSIGGEIPANIS-SCS- 76 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~-~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~- 76 (953)
.+++.|||+++++...... .+..+++|++|+|++|+++.. ++..+..+++|++|+|++|.+++..+..+. .+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 3566666666665432222 255566666666666666632 344555566666666666666543333322 233
Q ss_pred ---CCcEEeccCccccc----cCCcccCCccccceeeccccccccccCCccc-----CCCcccEEecccccccccCCccc
Q 043900 77 ---NLIQIRLFYNELVG----KIPSELGSLSKIEHLSVSVNNLTGSIPSSLG-----NLSSINTLFLTDNNLDGGIPDTF 144 (953)
Q Consensus 77 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~L~~L~~L~L~~N~l~~~~~~~~ 144 (953)
+|++|+|++|.++. .++..|..+++|++|+|++|++++..+..+. .+++|++|+|++|+++.....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 45566666655552 3345555555555555555555433222221 133455555555555432210
Q ss_pred cccccccceecccccccCCCCCcccccccceEEecCCccccccccccccc----ccccccEEEeeCccccCC----CCCC
Q 043900 145 GWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGF----TLQNLQFFSVFENQLTGA----IPPA 216 (953)
Q Consensus 145 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~----~l~~L~~L~L~~N~l~~~----~~~~ 216 (953)
.++..+..+++|++|++++|.+++..+..+.. .+++|++|++++|.++.. ++..
T Consensus 161 ------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 161 ------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp ------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 11233334445555555555554332222221 233566666666655532 2444
Q ss_pred CcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhh
Q 043900 217 ISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISN 296 (953)
Q Consensus 217 ~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~ 296 (953)
+..+++|++|++++|+++.... . .++..+..
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~-----------------------------~--------------------~l~~~~~~ 253 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGM-----------------------------A--------------------ELCPGLLH 253 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHH-----------------------------H--------------------HHHHHHTS
T ss_pred HHhCCCccEEeccCCcCChHHH-----------------------------H--------------------HHHHHHhc
Confidence 4555566666666555542100 0 00011111
Q ss_pred ccccCcEEEcccCccccc----CCccccCCCCCCEEEeecCcccccCCcCccC-----CCCCCeEEeccccccCCCCCCC
Q 043900 297 LSTTLEMLLLDNNKIFGN----IPAAIGKFVNLQRLEMWNNRLSGTIPPAIGE-----LQNLRELRLQRNKFLGNIPPSI 367 (953)
Q Consensus 297 ~~~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~p~~~ 367 (953)
..++|++|++++|+++.. ++..+..+++|++|++++|.+++..+..+.. .++|++|+|++|.+++...
T Consensus 254 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~--- 330 (461)
T 1z7x_W 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC--- 330 (461)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH---
T ss_pred CCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHH---
Confidence 113455555555555432 3344445555666666666555333333222 1455555555555442100
Q ss_pred CCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCcccc-CCCccc
Q 043900 368 GNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVG-NLKNLE 446 (953)
Q Consensus 368 ~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~-~l~~L~ 446 (953)
..++..+..+++|++|+|++|++++..+..+. ..+. ..++|+
T Consensus 331 ----------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~---------------------~~l~~~~~~L~ 373 (461)
T 1z7x_W 331 ----------------SHFSSVLAQNRFLLELQISNNRLEDAGVRELC---------------------QGLGQPGSVLR 373 (461)
T ss_dssp ----------------HHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH---------------------HHHTSTTCCCC
T ss_pred ----------------HHHHHHHhhCCCccEEEccCCccccccHHHHH---------------------HHHcCCCCceE
Confidence 01344555667777777777766532221111 1111 145777
Q ss_pred eeeecCCcccc----cCCCCccCCccccEEEccCccccCCCCcccc-----CCCCCcEEECCCCcccccCCcc
Q 043900 447 VLDVFENKLKG----EIPSTLGSCKKLEQLEMQGNFLQGPIPSSLS-----SLKGLNVLDLSQNNLSGKIPEF 510 (953)
Q Consensus 447 ~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~ 510 (953)
.|+|++|++++ .+|..+..+++|++|+|++|++++.....+. ...+|+.|++.+|.+....++.
T Consensus 374 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~ 446 (461)
T 1z7x_W 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 446 (461)
T ss_dssp EEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred EEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHH
Confidence 77777777775 5666777777788888888877643211111 2346777777777776544443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=286.56 Aligned_cols=279 Identities=20% Similarity=0.207 Sum_probs=150.6
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
.....++++|+++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 32 ~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 33445555555554 443333 355556666665554444455555566666666665555555555555566666666
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCC-ccccccccccceecccc-cccCCCCCcccccccceEEecCCccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIP-DTFGWLKNLATLAMAEN-WLSGTIPSSIFNISSITAFDAGMNQLQG 186 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 186 (953)
+|++++..+..|+++++|++|+|++|+++...+ ..|..+++|++|++++| .++...|..+.++++|++|++++|++++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence 665553333335555566666666665553322 35555566666666555 3443334555555566666666666555
Q ss_pred ccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccc
Q 043900 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNF 266 (953)
Q Consensus 187 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~ 266 (953)
..|..+. .+++|++|++++|+++......+..+++|+.|++++|++++.++.-
T Consensus 189 ~~~~~l~-~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-------------------------- 241 (353)
T 2z80_A 189 YEPKSLK-SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE-------------------------- 241 (353)
T ss_dssp ECTTTTT-TCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------
T ss_pred cCHHHHh-ccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc--------------------------
Confidence 4444443 4556666666666655322223344556666666666655432210
Q ss_pred cccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccc----cCCccccCCCCCCEEEeecCcccccCCcC
Q 043900 267 LCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFG----NIPAAIGKFVNLQRLEMWNNRLSGTIPPA 342 (953)
Q Consensus 267 l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 342 (953)
+...... ..++.++++++.+.+ .+|..+..+++|+.|++++|+|+...+..
T Consensus 242 l~~~~~~-------------------------~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~ 296 (353)
T 2z80_A 242 LSTGETN-------------------------SLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGI 296 (353)
T ss_dssp -----CC-------------------------CCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTT
T ss_pred ccccccc-------------------------chhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHH
Confidence 0000001 223444444444432 24556777777888888888887444444
Q ss_pred ccCCCCCCeEEeccccccCC
Q 043900 343 IGELQNLRELRLQRNKFLGN 362 (953)
Q Consensus 343 ~~~l~~L~~L~L~~N~l~~~ 362 (953)
|..+++|++|+|++|++.+.
T Consensus 297 ~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 297 FDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp TTTCTTCCEEECCSSCBCCC
T ss_pred HhcCCCCCEEEeeCCCccCc
Confidence 67778888888888877643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=273.70 Aligned_cols=226 Identities=18% Similarity=0.242 Sum_probs=192.7
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+|+.|+|+++++. .+|+.++++++|++|+|++|+++ .+|..|..+++|++|+|++|.++ .+|..|+++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 57888889888887 88888888888999999999888 58888888889999999999888 78888888889999999
Q ss_pred cCccccccCCcccCC---------ccccceeeccccccccccCCcccCCCcccEEecccccccccCCcccccccccccee
Q 043900 84 FYNELVGKIPSELGS---------LSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLA 154 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (953)
++|.+.+.+|..++. +++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..|..+++|++|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEE
Confidence 888887788877664 888888888888888 77888888888888888888888 4666788888888888
Q ss_pred cccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccccccc
Q 043900 155 MAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234 (953)
Q Consensus 155 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (953)
|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..+. .+++|++|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 888888888888888888888888888888888887765 7888888888888888888888888888888888877665
Q ss_pred C
Q 043900 235 G 235 (953)
Q Consensus 235 ~ 235 (953)
.
T Consensus 315 ~ 315 (328)
T 4fcg_A 315 Q 315 (328)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-29 Score=274.41 Aligned_cols=279 Identities=17% Similarity=0.211 Sum_probs=206.8
Q ss_pred CCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCccc
Q 043900 48 FDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127 (953)
Q Consensus 48 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 127 (953)
-..+......++++|.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|.+|+++++|+
T Consensus 27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (353)
T 2z80_A 27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103 (353)
T ss_dssp CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence 344556667899999999 8888765 4899999999999977677899999999999999999988888899999999
Q ss_pred EEecccccccccCCccccccccccceecccccccCCCCC--cccccccceEEecCCcc-cccccccccccccccccEEEe
Q 043900 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS--SIFNISSITAFDAGMNQ-LQGVIPLDFGFTLQNLQFFSV 204 (953)
Q Consensus 128 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L 204 (953)
+|+|++|++++..+..|+++++|++|+|++|+++ .+|. .+.++++|++|++++|. ++...+..+ ..+++|+.|++
T Consensus 104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~-~~l~~L~~L~l 181 (353)
T 2z80_A 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF-AGLTFLEELEI 181 (353)
T ss_dssp EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTT-TTCCEEEEEEE
T ss_pred EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHc-cCCCCCCEEEC
Confidence 9999999998666666899999999999999998 4554 67788888888888884 554334444 36788888888
Q ss_pred eCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCC
Q 043900 205 FENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINAN 284 (953)
Q Consensus 205 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n 284 (953)
++|++++..|..+..+++|++|++++|+++.
T Consensus 182 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~------------------------------------------------- 212 (353)
T 2z80_A 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHIL------------------------------------------------- 212 (353)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSCSTT-------------------------------------------------
T ss_pred CCCCcCccCHHHHhccccCCeecCCCCcccc-------------------------------------------------
Confidence 8888887777777777777777777777642
Q ss_pred cccccCChhhhhccccCcEEEcccCcccccCCcccc---CCCCCCEEEeecCcccc----cCCcCccCCCCCCeEEeccc
Q 043900 285 NFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIG---KFVNLQRLEMWNNRLSG----TIPPAIGELQNLRELRLQRN 357 (953)
Q Consensus 285 ~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~---~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N 357 (953)
+|..+....++|+.|++++|.+++..+..+. ....++.++++++.+++ .+|.++..+++|++|+|++|
T Consensus 213 -----~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 213 -----LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287 (353)
T ss_dssp -----HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSS
T ss_pred -----chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCC
Confidence 2233333235677777777777765544332 34567777777777764 25666777777777777777
Q ss_pred cccCCCCCCCCCceeeEEEccCCcCCCCCCcc-CCCCCCCcEEEcCCCccCCC
Q 043900 358 KFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSS-LGQYKTLTIIDLSDNNLTGT 409 (953)
Q Consensus 358 ~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~ 409 (953)
+++ .+|.. |..+++|++|+|++|.+++.
T Consensus 288 ~l~------------------------~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 288 QLK------------------------SVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp CCC------------------------CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCC------------------------ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 665 23333 46777788888888877744
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-29 Score=268.69 Aligned_cols=226 Identities=21% Similarity=0.255 Sum_probs=179.1
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccc--cCcCccCCCCCcEEeccC
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGE--IPANISSCSNLIQIRLFY 85 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~--~p~~~~~l~~L~~L~L~~ 85 (953)
.++.++.++. .+|..+. ++|++|+|++|+++.+.+..|.++++|++|+|++|.++.. .|..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 5677777776 7777554 6788888888888875556678888888888888888732 366777888888888888
Q ss_pred ccccccCCcccCCccccceeeccccccccccC-CcccCCCcccEEecccccccccCCccccccccccceecccccccC-C
Q 043900 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIP-SSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG-T 163 (953)
Q Consensus 86 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~ 163 (953)
|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..|..+++|++|+|++|++++ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 8888 567778888888888888888885544 578888888888888888887788888888888888888888875 4
Q ss_pred CCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC
Q 043900 164 IPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 164 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (953)
.|..+..+++|++|++++|++++..|..+. .+++|+.|++++|++++..+..+..+++|+.|++++|++++.++
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhc-CCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 778888888888888888888866565554 67888888888888887666677888888888888888876544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-29 Score=269.23 Aligned_cols=201 Identities=19% Similarity=0.232 Sum_probs=159.0
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcccccc--CCcccCCccccceeec
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGK--IPSELGSLSKIEHLSV 107 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L 107 (953)
-+.+++++++++. +|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++.. .|..+..+++|++|+|
T Consensus 9 ~~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CCEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 3678999999997 665553 6899999999999944445588999999999999998733 3667778899999999
Q ss_pred cccccccccCCcccCCCcccEEecccccccccCC-ccccccccccceecccccccCCCCCcccccccceEEecCCccccc
Q 043900 108 SVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186 (953)
Q Consensus 108 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 186 (953)
++|.++ .+|..+..+++|++|++++|++++..+ ..|..+++|++|++++|++++..|..+..+++|++|++++|++++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 999998 577778999999999999999986554 578889999999999999887778888888888888888888875
Q ss_pred -ccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccC
Q 043900 187 -VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235 (953)
Q Consensus 187 -~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (953)
..|..+. .+++|++|++++|++++..|..+..+++|+.|++++|++++
T Consensus 165 ~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 165 NFLPDIFT-ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp GEECSCCT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred ccchhHHh-hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 3454443 67777777777777776666666666666666666666654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=263.95 Aligned_cols=225 Identities=21% Similarity=0.246 Sum_probs=149.1
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
+.++.++.++. .+|..+ .++|++|+|++|+++++.+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666666665 566543 356777777777777766666777777777777777777666667777777777777777
Q ss_pred c-ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCC
Q 043900 87 E-LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 87 ~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
. ++...|..|.++++|++|++++|++++..|..|.++++|++|++++|++++..+..|+.+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 5 665556667777777777777777776666667777777777777777765555666777777777777777764444
Q ss_pred CcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccC
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (953)
..+..+++|+.|++++|++++..|..+. .+++|+.|++++|++++..+..+..+++|+.|++++|++..
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HHhcCccccCEEECCCCcccccCHhHcc-CcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 4566666677777777766655555544 56666666666666665555556666666666666666653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=274.55 Aligned_cols=245 Identities=20% Similarity=0.194 Sum_probs=208.8
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
..++.++.++. .+|..+. +++++|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 45677777776 7887664 68999999999999988899999999999999999999888889999999999999999
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccc-ccccccCCccccccccccceecccccccCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTD-NNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
.|++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++ |.++...+..|.++++|++|+|++|+++ .+|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc
Confidence 99977777799999999999999999977777899999999999998 5666555667999999999999999998 455
Q ss_pred CcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC-CCCCC
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-LEKPQ 244 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-l~~~~ 244 (953)
.+..+++|+.|+|++|++++..|..|. .+++|+.|+|++|++++..+..|.++++|+.|+|++|++++.++. +..++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFH-GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred -cccccccccEEECcCCcCcccCccccc-CccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 578899999999999999977676665 799999999999999988899999999999999999999987664 45566
Q ss_pred ccceeeecccccC
Q 043900 245 RLSVFSITENSLG 257 (953)
Q Consensus 245 ~L~~l~l~~n~l~ 257 (953)
+|+.+++++|.+.
T Consensus 291 ~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 291 YLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEccCCCcC
Confidence 6777777666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=273.75 Aligned_cols=245 Identities=21% Similarity=0.211 Sum_probs=198.8
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
..++.++.++. .+|..+. +++++|+|++|+|+.+.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 45667777775 7887664 67888999999999888888899999999999999998777788888999999999999
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccc-ccccccCCccccccccccceecccccccCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTD-NNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
+|++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++ |.++...+..|.++++|++|+|++|+++ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 98866666788899999999999998877777888899999999988 4566555667888999999999999888 566
Q ss_pred CcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC-CCCCC
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY-LEKPQ 244 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-l~~~~ 244 (953)
.+..+++|+.|+|++|++++..|..|. .+++|+.|+|++|+|++..+..|.++++|+.|+|++|+++..++. +..++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQ-GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTT-TCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhc-cCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 478888899999999998866666655 788899999999999888888888899999999999988877654 45556
Q ss_pred ccceeeecccccC
Q 043900 245 RLSVFSITENSLG 257 (953)
Q Consensus 245 ~L~~l~l~~n~l~ 257 (953)
+|+.+++++|.+.
T Consensus 280 ~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 280 HLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEcCCCCcc
Confidence 6666666666553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=270.31 Aligned_cols=230 Identities=22% Similarity=0.206 Sum_probs=192.7
Q ss_pred ccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEc
Q 043900 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDL 377 (953)
Q Consensus 299 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L 377 (953)
++++.|+|++|+|++..+..|.++++|+.|+|++|.|++..+.+|.++++|++|+|++|+|++..+..|..+ .+++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 468888888888888778888888888888888888887777888888888888888888886666677776 5788888
Q ss_pred cCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccc
Q 043900 378 SCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKG 457 (953)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 457 (953)
++|.++...+..|..+++|+.|+|++|...+.++...+.....++.|+|++|+++ .+| .+..+++|+.|+|++|+|++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCc
Confidence 8888887777788899999999999855444666655555566778888888888 455 47888999999999999998
Q ss_pred cCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCccc
Q 043900 458 EIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGM 530 (953)
Q Consensus 458 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 530 (953)
..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 8888999999999999999999988888899999999999999999987777888899999999999988754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-30 Score=312.13 Aligned_cols=432 Identities=12% Similarity=0.047 Sum_probs=208.3
Q ss_pred ccccCCccCceeecCCCccC---cCCCccCC------------CCCCCcEEeCCCCccccccCcCccCC--CCCcEEecc
Q 043900 22 PHVGNLSFLKVLLLYNNSFN---HGIPSEFD------------RLQRLQVLALNNNSIGGEIPANISSC--SNLIQIRLF 84 (953)
Q Consensus 22 ~~~~~l~~L~~L~L~~n~l~---~~~~~~~~------------~l~~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~ 84 (953)
..+..+++|++|+|++|... +..|..++ .+++|++|+|++|.+++..+..+..+ .+|++|+|+
T Consensus 67 ~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~ 146 (592)
T 3ogk_B 67 RLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD 146 (592)
T ss_dssp HHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEE
T ss_pred HHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECc
Confidence 34456667777777665321 22333333 45566666666665555444444442 236666665
Q ss_pred Ccc-ccc-cCCcccCCccccceeeccccccccc----cCCcccCCCcccEEecccccccc----cCCcccccccccccee
Q 043900 85 YNE-LVG-KIPSELGSLSKIEHLSVSVNNLTGS----IPSSLGNLSSINTLFLTDNNLDG----GIPDTFGWLKNLATLA 154 (953)
Q Consensus 85 ~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~ 154 (953)
+|. ++. .++..+.++++|++|+|++|.+++. ++..+.++++|++|++++|.+++ .++..+..+++|++|+
T Consensus 147 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~ 226 (592)
T 3ogk_B 147 KCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVK 226 (592)
T ss_dssp SCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEe
Confidence 554 110 1111123455556666665555433 22233445555555555555542 2223334455555555
Q ss_pred cccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccccccc
Q 043900 155 MAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234 (953)
Q Consensus 155 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (953)
|++|.+. .+|..+.++++|++|+++.+...... ...+..+..+++|+.|+++++...
T Consensus 227 L~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~----------------------~~~~~~l~~~~~L~~L~l~~~~~~ 283 (592)
T 3ogk_B 227 VGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGM----------------------PEKYMNLVFPRKLCRLGLSYMGPN 283 (592)
T ss_dssp CSSCBGG-GGHHHHHHCTTCCEEEECBCCCCTTC----------------------TTSSSCCCCCTTCCEEEETTCCTT
T ss_pred ccCccHH-HHHHHHhhhhHHHhhcccccccccch----------------------HHHHHHhhccccccccCccccchh
Confidence 5555554 24444555555555555432211000 122233444445555544443222
Q ss_pred CcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcc-------
Q 043900 235 GEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD------- 307 (953)
Q Consensus 235 ~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~------- 307 (953)
..+..+...++|++|++++|.+.... ....+..+++|+.|+++ +.+.......+....++|++|+++
T Consensus 284 ~l~~~~~~~~~L~~L~Ls~~~l~~~~-----~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~ 357 (592)
T 3ogk_B 284 EMPILFPFAAQIRKLDLLYALLETED-----HCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQG 357 (592)
T ss_dssp TGGGGGGGGGGCCEEEETTCCCCHHH-----HHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSST
T ss_pred HHHHHHhhcCCCcEEecCCCcCCHHH-----HHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccc
Confidence 22222222333333333333321110 00112344556666665 333222222222222457777776
Q ss_pred ----cCcccccCCc-cccCCCCCCEEEeecCcccccCCcCccC-CCCCCeEEeccccccCCCCCCCCCceeeEEEccCCc
Q 043900 308 ----NNKIFGNIPA-AIGKFVNLQRLEMWNNRLSGTIPPAIGE-LQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNF 381 (953)
Q Consensus 308 ----~N~i~~~~~~-~~~~l~~L~~L~L~~N~i~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~ 381 (953)
.|.+++.... .+..+++|++|+++.|.+++..+..+.. +++|+.|+++++. ..|.
T Consensus 358 ~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~-------------------~~n~ 418 (592)
T 3ogk_B 358 MEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD-------------------REER 418 (592)
T ss_dssp TSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECS-------------------CCSC
T ss_pred cccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecC-------------------CCcc
Confidence 2444432211 2334666777777666666555555544 6667777665221 1223
Q ss_pred CCCC-----CCccCCCCCCCcEEEcCCCc--cCCCCCccccCccccceeeeccCCcccC-CCCccccCCCccceeeecCC
Q 043900 382 LQGS-----IPSSLGQYKTLTIIDLSDNN--LTGTIPPQFLGLSWLLIGLDLSRNQLTG-SIPSEVGNLKNLEVLDVFEN 453 (953)
Q Consensus 382 l~~~-----~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~~~~~l~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N 453 (953)
+++. ++..+.++++|+.|+|++|. +++..+..+......++.|++++|++++ .++..+.++++|+.|++++|
T Consensus 419 l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n 498 (592)
T 3ogk_B 419 ITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498 (592)
T ss_dssp CSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred ccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence 3321 22335567778888886432 5544333333333445666777766654 23444566677777777777
Q ss_pred ccccc-CCCCccCCccccEEEccCccccCCCCccc-cCCCCCcEEECCCC
Q 043900 454 KLKGE-IPSTLGSCKKLEQLEMQGNFLQGPIPSSL-SSLKGLNVLDLSQN 501 (953)
Q Consensus 454 ~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N 501 (953)
.+++. ++..+..+++|+.|+|++|++++.-...+ ..++.+....+..+
T Consensus 499 ~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 499 CFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 76543 23334556777777777777765433333 24555555555443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=271.27 Aligned_cols=249 Identities=19% Similarity=0.192 Sum_probs=207.6
Q ss_pred cEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEecc
Q 043900 277 NRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQR 356 (953)
Q Consensus 277 ~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 356 (953)
..++.++..+.. +|..+ +++++.|+|++|+|++..+..|.++++|+.|+|++|.|++..+.+|.++++|++|+|++
T Consensus 57 ~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 57 SKVVCTRRGLSE-VPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp CEEECCSSCCSS-CCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cEEEECCCCcCc-cCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 345555555553 45433 36799999999999988888999999999999999999988889999999999999999
Q ss_pred ccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCC
Q 043900 357 NKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435 (953)
Q Consensus 357 N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~ 435 (953)
|+|++..+..|..+ .+++|+|++|.+++..+..|.++++|+.|+|++|...+.++...+.....++.|+|++|++++ +
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence 99997777778877 578999999999977778899999999999998544446776655555667789999999985 4
Q ss_pred CccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccc
Q 043900 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515 (953)
Q Consensus 436 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 515 (953)
| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 4 588889999999999999988888899999999999999999988888899999999999999999977777888889
Q ss_pred cCceEeccCCcCcccC
Q 043900 516 LLENLNLSNNNLEGMV 531 (953)
Q Consensus 516 ~L~~l~l~~N~l~~~~ 531 (953)
+|+.|+|++|++.+..
T Consensus 291 ~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 291 YLVELHLHHNPWNCDC 306 (452)
T ss_dssp TCCEEECCSSCEECST
T ss_pred CCCEEEccCCCcCCCC
Confidence 9999999999887643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-27 Score=274.79 Aligned_cols=108 Identities=29% Similarity=0.280 Sum_probs=65.7
Q ss_pred CCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEE
Q 043900 394 KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLE 473 (953)
Q Consensus 394 ~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 473 (953)
++|+.|++++|+++ .+|.. ...++.|++++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+
T Consensus 201 ~~L~~L~L~~N~l~-~l~~~----~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~ 267 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLS 267 (622)
T ss_dssp TTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEE
T ss_pred chhhEEECcCCccc-ccCCC----CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEe
Confidence 44555555555555 33322 1234455555555553 33 33466777777777776 4554 456677777
Q ss_pred ccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccc
Q 043900 474 MQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515 (953)
Q Consensus 474 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 515 (953)
|++|+|+ .+|..|..+++|+.|+|++|.+++.+|..+..++
T Consensus 268 Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 7777777 5666777777777777777777776666665554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=273.81 Aligned_cols=156 Identities=17% Similarity=0.227 Sum_probs=78.9
Q ss_pred cCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccc-cccCcCcc-------CCCCCcEEeccCccccccCCccc
Q 043900 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG-GEIPANIS-------SCSNLIQIRLFYNELVGKIPSEL 96 (953)
Q Consensus 25 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~p~~~~-------~l~~L~~L~L~~n~l~~~~~~~~ 96 (953)
+..++|++|++++|.+ .+|..+... |++|+|++|.++ ..+|..+. ++++|++|+|++|++++..|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3445566666666666 245444333 566666666663 23444333 45555555555555555555544
Q ss_pred --CCccccceeeccccccccccCCcccCC-----CcccEEecccccccccCCccccccccccceecccccccCC--CCCc
Q 043900 97 --GSLSKIEHLSVSVNNLTGSIPSSLGNL-----SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGT--IPSS 167 (953)
Q Consensus 97 --~~l~~L~~L~Ls~N~l~~~~p~~~~~L-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~ 167 (953)
+.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|+.|+.+++|++|+|++|++.+. .|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 4555555555555555533 4444444 5555555555555544445555555555555555554322 1222
Q ss_pred c--cccccceEEecCCcccc
Q 043900 168 I--FNISSITAFDAGMNQLQ 185 (953)
Q Consensus 168 l--~~l~~L~~L~L~~N~l~ 185 (953)
+ ..+++|++|+|++|+++
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCC
T ss_pred HHhccCCCCCEEECCCCcCc
Confidence 2 44444455555555444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=270.54 Aligned_cols=268 Identities=19% Similarity=0.164 Sum_probs=144.9
Q ss_pred EEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccC
Q 043900 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFY 85 (953)
Q Consensus 6 ~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~ 85 (953)
++.++++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ |..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4444444444432233333344455555555555555444455555555555555555553322 44555555555555
Q ss_pred ccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCC
Q 043900 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 86 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
|.+++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..|
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---------------------------~~~L~~L~l~~N~l~~~~~ 137 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---------------------------GQGKKNIYLANNKITMLRD 137 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---------------------------CSSCEEEECCSSCCCSGGG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---------------------------cCCCCEEECCCCCCCCccc
Confidence 5544211 1244444444444444332221 3344444444444443334
Q ss_pred CcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCc
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~ 245 (953)
..+..+++|+.|+|++|++++..+..+...+++|++|++++|+|++. + ....+++|++|++++|++++.+
T Consensus 138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~-------- 207 (317)
T 3o53_A 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMG-------- 207 (317)
T ss_dssp BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEEC--------
T ss_pred hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcch--------
Confidence 44444555555555555555444444433455555555555555532 1 1223556666666666555322
Q ss_pred cceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCC
Q 043900 246 LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNL 325 (953)
Q Consensus 246 L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L 325 (953)
..+..+ ++|+.|++++|+++ .+|..+..+++|
T Consensus 208 ----------------------------------------------~~~~~l-~~L~~L~L~~N~l~-~l~~~~~~l~~L 239 (317)
T 3o53_A 208 ----------------------------------------------PEFQSA-AGVTWISLRNNKLV-LIEKALRFSQNL 239 (317)
T ss_dssp ----------------------------------------------GGGGGG-TTCSEEECTTSCCC-EECTTCCCCTTC
T ss_pred ----------------------------------------------hhhccc-CcccEEECcCCccc-chhhHhhcCCCC
Confidence 223333 46888888888887 456678888888
Q ss_pred CEEEeecCccc-ccCCcCccCCCCCCeEEec-cccccCCCCC
Q 043900 326 QRLEMWNNRLS-GTIPPAIGELQNLRELRLQ-RNKFLGNIPP 365 (953)
Q Consensus 326 ~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~ 365 (953)
+.|++++|.+. +..|.++..+++|+.|+++ .+.+++..|.
T Consensus 240 ~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred CEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 99999999888 6778888888888888888 4445554443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=258.25 Aligned_cols=235 Identities=18% Similarity=0.280 Sum_probs=172.6
Q ss_pred ccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEE
Q 043900 274 TRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELR 353 (953)
Q Consensus 274 ~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 353 (953)
.+++.|++++|++. .+|..++.+ ++|++|+|++|.++ .+|..|+.+++|++|+|++|.++ .+|..|+.+++|++|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l-~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGG-TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCch-hcChhhhhC-CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 45555555555555 344445443 35555555555555 45555555555555555555555 4455555555555555
Q ss_pred eccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccC
Q 043900 354 LQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG 433 (953)
Q Consensus 354 L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~ 433 (953)
|++|++.+.+|..++.. ..+..|.++++|++|+|++|+++ .+|..+..+. .++.|++++|++++
T Consensus 157 L~~n~~~~~~p~~~~~~--------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~-~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAST--------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ-NLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEEE--------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCT-TCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhhc--------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCC-CCCEEEccCCCCCc
Confidence 55555555554443321 11223455899999999999998 8888766555 56689999999995
Q ss_pred CCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccc
Q 043900 434 SIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVG 513 (953)
Q Consensus 434 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 513 (953)
+|..|..+++|++|+|++|.+.+.+|..|+.+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|+.+.+
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 6678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCceEeccCCcCcc
Q 043900 514 FQLLENLNLSNNNLEG 529 (953)
Q Consensus 514 l~~L~~l~l~~N~l~~ 529 (953)
+++|+.+++..|.+..
T Consensus 300 L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 300 LPANCIILVPPHLQAQ 315 (328)
T ss_dssp SCTTCEEECCGGGSCC
T ss_pred ccCceEEeCCHHHHHH
Confidence 9999999999887654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-27 Score=273.17 Aligned_cols=134 Identities=24% Similarity=0.323 Sum_probs=86.9
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
++++|++++|+++. +|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 47788888888885 565554 67888888888887 5565 4677777777777777 4554 56777777777
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|+++ .+|. .+++|++|++++|+|+. +|.. +++|++|+|++|+++ .+|. .+.+|+.|++++|+|+
T Consensus 110 ~N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-~l~~---~~~~L~~L~L~~N~l~ 174 (622)
T 3g06_A 110 SNPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT 174 (622)
T ss_dssp SCCCC-CCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS
T ss_pred CCcCC-CCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC-CcCC---ccCCCCEEECCCCCCC
Confidence 77777 3443 45677777777777763 4432 356666666666665 3332 1234455555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-30 Score=309.89 Aligned_cols=380 Identities=15% Similarity=0.069 Sum_probs=194.1
Q ss_pred CccccceeeccccccccccCCcccCC--CcccEEeccccc-ccc-cCCccccccccccceecccccccCC----CCCccc
Q 043900 98 SLSKIEHLSVSVNNLTGSIPSSLGNL--SSINTLFLTDNN-LDG-GIPDTFGWLKNLATLAMAENWLSGT----IPSSIF 169 (953)
Q Consensus 98 ~l~~L~~L~Ls~N~l~~~~p~~~~~L--~~L~~L~L~~N~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~ 169 (953)
.+++|++|+|++|.+++..+..++.+ .+|++|+|++|. ++. .++..+..+++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 44555555555555554444444332 235555555554 110 1112223455666666666655433 222234
Q ss_pred ccccceEEecCCccccc----ccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCc
Q 043900 170 NISSITAFDAGMNQLQG----VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245 (953)
Q Consensus 170 ~l~~L~~L~L~~N~l~~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~ 245 (953)
.+++|++|++++|.+++ .++. +...+++|+.|++++|.+.+ ++..+..+++|+.|+++........+.
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~------ 261 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLET-IARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPE------ 261 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHH-HHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTT------
T ss_pred cCCCccEEEeeccCCCccCHHHHHH-HHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHH------
Confidence 55666666666666652 2222 22356777777777777774 556777788888888875322111000
Q ss_pred cceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCC-ccccCCCC
Q 043900 246 LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIP-AAIGKFVN 324 (953)
Q Consensus 246 L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~-~~~~~l~~ 324 (953)
....+..+++|+.|.++.+ ..+.+|..+..+ ++|++|++++|.+++... ..+..+++
T Consensus 262 --------------------~~~~l~~~~~L~~L~l~~~-~~~~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 262 --------------------KYMNLVFPRKLCRLGLSYM-GPNEMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp --------------------SSSCCCCCTTCCEEEETTC-CTTTGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred --------------------HHHHhhccccccccCcccc-chhHHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 0112233445555555543 223345544444 578888888888654333 33577888
Q ss_pred CCEEEeecCcccccCCcCccCCCCCCeEEecc-----------ccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCC
Q 043900 325 LQRLEMWNNRLSGTIPPAIGELQNLRELRLQR-----------NKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQY 393 (953)
Q Consensus 325 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-----------N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l 393 (953)
|+.|+++++-..+.++..+..+++|++|+|++ |.+++... +..+..+
T Consensus 320 L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~----------------------~~l~~~~ 377 (592)
T 3ogk_B 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL----------------------IALAQGC 377 (592)
T ss_dssp CCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH----------------------HHHHHHC
T ss_pred CCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH----------------------HHHHhhC
Confidence 88888883333333344446678888888883 44442111 1111223
Q ss_pred CCCcEEEcCCCccCCCCCccccCccccceeeecc----CCcccCC-----CCccccCCCccceeeecCC--cccccCCCC
Q 043900 394 KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLS----RNQLTGS-----IPSEVGNLKNLEVLDVFEN--KLKGEIPST 462 (953)
Q Consensus 394 ~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~p~~ 462 (953)
++|++|+++.|++++..+..+......++.|+++ .|.+++. ++..+.++++|+.|++++| .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 4444444444444433222222212233344443 3444432 2223445666666666532 244333333
Q ss_pred cc-CCccccEEEccCccccC-CCCccccCCCCCcEEECCCCccccc-CCccccccccCceEeccCCcCcc
Q 043900 463 LG-SCKKLEQLEMQGNFLQG-PIPSSLSSLKGLNVLDLSQNNLSGK-IPEFLVGFQLLENLNLSNNNLEG 529 (953)
Q Consensus 463 ~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~ 529 (953)
++ .+++|+.|+|++|++++ .++..+..+++|++|+|++|.+++. ++..+..+++|+.|++++|+++.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 33 25666666666666654 2333445566666666666666543 33334456666666666666554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=251.89 Aligned_cols=227 Identities=22% Similarity=0.217 Sum_probs=131.3
Q ss_pred cEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEecc
Q 043900 277 NRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQR 356 (953)
Q Consensus 277 ~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 356 (953)
+.++.+++.+.. +|.. .+++++.|++++|++++..+..|..+++|++|++++|.+++..|.+|..+++|++|+|++
T Consensus 14 ~~~~c~~~~l~~-ip~~---~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVG---IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSS-CCTT---CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCccc-CCcC---CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 456666666654 3432 235677777777777766666777777777777777777776677777777777777777
Q ss_pred cc-ccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCC
Q 043900 357 NK-FLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGS 434 (953)
Q Consensus 357 N~-l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~ 434 (953)
|+ +....|..+..+ .+++|++++|.+++..|..|.++++|++|+|++|+++ +.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~ 144 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-------------------------AL 144 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-------------------------cc
Confidence 76 554445555544 3455555555555555555555555555555555554 33
Q ss_pred CCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCcccccc
Q 043900 435 IPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGF 514 (953)
Q Consensus 435 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 514 (953)
.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+
T Consensus 145 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 33444555555555555555554334445555555555555555555445555555555555555555554444445555
Q ss_pred ccCceEeccCCcCcccCC
Q 043900 515 QLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 515 ~~L~~l~l~~N~l~~~~p 532 (953)
++|+.|++++|++.+..+
T Consensus 225 ~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp TTCCEEECCSSCEECSGG
T ss_pred cccCEEeccCCCccCCCC
Confidence 555555555555554433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=264.68 Aligned_cols=249 Identities=22% Similarity=0.231 Sum_probs=209.2
Q ss_pred cccccccEEeccCCcccccCChhhhhccccCcEEEcccCccc-ccCCcccc-------CCCCCCEEEeecCcccccCCcC
Q 043900 271 TNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIF-GNIPAAIG-------KFVNLQRLEMWNNRLSGTIPPA 342 (953)
Q Consensus 271 ~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~-~~~~~~~~-------~l~~L~~L~L~~N~i~~~~~~~ 342 (953)
...++|+.|++++|.+ .+|..+... ++.|++++|.+. ...|..+. ++++|++|+|++|.+++..|..
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 3456788889999999 778777654 889999999994 44565555 7899999999999999888887
Q ss_pred c--cCCCCCCeEEeccccccCCCCCCCCCc------eeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCC--CCc
Q 043900 343 I--GELQNLRELRLQRNKFLGNIPPSIGNL------KVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT--IPP 412 (953)
Q Consensus 343 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l------~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~ 412 (953)
+ ..+++|++|+|++|++++. |..++.+ .+++|+|++|.+++..|..|+.+++|++|+|++|++.+. +|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 8999999999999999977 7777654 579999999999998889999999999999999998764 233
Q ss_pred cc-cCccccceeeeccCCcccCC---CCccccCCCccceeeecCCcccccCC-CCccCCccccEEEccCccccCCCCccc
Q 043900 413 QF-LGLSWLLIGLDLSRNQLTGS---IPSEVGNLKNLEVLDVFENKLKGEIP-STLGSCKKLEQLEMQGNFLQGPIPSSL 487 (953)
Q Consensus 413 ~~-~~~~~~l~~L~ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~ 487 (953)
.+ +.....++.|+|++|+|++. ....+.++++|+.|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 24445677999999999832 22445688999999999999998775 56777899999999999999 788877
Q ss_pred cCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCccc
Q 043900 488 SSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGM 530 (953)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 530 (953)
. ++|++|||++|+|++. |. +..+++|+.|++++|++++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 7 8999999999999976 66 88999999999999999863
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=268.08 Aligned_cols=216 Identities=20% Similarity=0.214 Sum_probs=176.2
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+++.|||++|++.+..|..+.++++|++|+|++|++++..| |..+++|++|+|++|+|++ ++ ..++|++|++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l 106 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHA 106 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEEC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEEC
Confidence 468999999999987666799999999999999999998554 9999999999999999984 33 3489999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccc-cccccccceecccccccC
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTF-GWLKNLATLAMAENWLSG 162 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~ 162 (953)
++|.+++..+.. +++|++|++++|++++..+..|+.+++|++|+|++|++++..+..+ ..+++|++|+|++|+|++
T Consensus 107 ~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp CSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 999999665544 5789999999999998888899999999999999999998777776 478999999999999984
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccccccc
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (953)
+|.. ..+++|++|+|++|++++ +|..+. .+++|+.|++++|+|+ .+|..+..+++|+.|++++|+++
T Consensus 184 -~~~~-~~l~~L~~L~Ls~N~l~~-l~~~~~-~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~ 250 (317)
T 3o53_A 184 -VKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250 (317)
T ss_dssp -EECC-CCCTTCCEEECCSSCCCE-ECGGGG-GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCB
T ss_pred -cccc-cccccCCEEECCCCcCCc-chhhhc-ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCcc
Confidence 3433 347788888888888884 444443 6777777777777777 45666666666666666666665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-28 Score=284.63 Aligned_cols=186 Identities=18% Similarity=0.051 Sum_probs=128.9
Q ss_pred cccccceeeEEEEEEcCCCeEEEEEEeeccc----------hhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLH----------HGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 638 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
..+.|++|.+..++....++.||+|++.... ....+++.+|+++|+++ +|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 3566777777776666566789999996321 22346799999999999 799999999994 4568
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..||||||++|++|.+++... ..++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~----------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAG----------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTT----------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHhC----------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEE
Confidence 899999999999999999632 245543 5899999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~p 847 (953)
|+|||+|+...... ......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 380 L~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 99999998764322 23344679999999999876 467789999999998887766544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=242.85 Aligned_cols=227 Identities=20% Similarity=0.206 Sum_probs=198.9
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.++-++.++. .+|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 3556666665 7888664 579999999999999888899999999999999999997777899999999999999999
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccccccc-CCccccccccccceecccccccCCCCC
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGG-IPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
+++..+..|.++++|++|++++|++++..+..++++++|++|++++|++++. +|+.|..+++|++|+|++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 9988888999999999999999999977777899999999999999999864 589999999999999999999977777
Q ss_pred cccccccce----EEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC
Q 043900 167 SIFNISSIT----AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239 (953)
Q Consensus 167 ~l~~l~~L~----~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (953)
.+..+.+|+ .|++++|++++..+..+ ...+|+.|++++|++++..+..|..+++|+.|++++|++++..+.
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~--~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSS--CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred HhhhhhhccccceeeecCCCcccccCcccc--CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 888888777 89999999995544443 345899999999999987777889999999999999999876543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=266.75 Aligned_cols=215 Identities=23% Similarity=0.163 Sum_probs=141.5
Q ss_pred cCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccC
Q 043900 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSC 379 (953)
Q Consensus 300 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~ 379 (953)
+|+.|+|++|.+++..|..|..+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+. ..+++|++++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~~ 108 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHAAN 108 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEECCS
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEECcC
Confidence 56677777777766666666777777777777777765444 66667777777777766643322 3456677777
Q ss_pred CcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCcccc-CCCccceeeecCCccccc
Q 043900 380 NFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVG-NLKNLEVLDVFENKLKGE 458 (953)
Q Consensus 380 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~ 458 (953)
|.+++..+. .+++|+.|+|++|++++..|..+..+ ..++.|+|++|.+++..|..|. .+++|+.|+|++|.|++.
T Consensus 109 N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 109 NNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGG-SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCC-CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 777655443 24567777777777775545444433 3455777777777766666665 677777777777777754
Q ss_pred CCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCc
Q 043900 459 IPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528 (953)
Q Consensus 459 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 528 (953)
|. +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.
T Consensus 185 -~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 185 -KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp -EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred -cc-cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 22 33477777777777777753 3447777777777777777774 5666777777777777777776
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=261.53 Aligned_cols=217 Identities=18% Similarity=0.162 Sum_probs=182.8
Q ss_pred cCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccce
Q 043900 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEH 104 (953)
Q Consensus 25 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (953)
...++|++|+|++|++++..|..|..+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+ .++|++
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 344489999999999999888899999999999999999996665 9999999999999999985432 389999
Q ss_pred eeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCccc-ccccceEEecCCcc
Q 043900 105 LSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIF-NISSITAFDAGMNQ 183 (953)
Q Consensus 105 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~ 183 (953)
|++++|.|++..+. .+++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..+. .+++|+.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 99999999976664 457899999999999988899999999999999999999988888886 78999999999999
Q ss_pred cccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccc
Q 043900 184 LQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENS 255 (953)
Q Consensus 184 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~ 255 (953)
|++..+ .. .+++|+.|+|++|+|++. |..+..+++|+.|++++|.+++.++.+..+++|+.+++++|.
T Consensus 181 l~~~~~-~~--~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~ 248 (487)
T 3oja_A 181 IYDVKG-QV--VFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNG 248 (487)
T ss_dssp CCEEEC-CC--CCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCC
T ss_pred cccccc-cc--cCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCC
Confidence 996633 22 489999999999999964 445889999999999999999876655555555554444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=232.46 Aligned_cols=205 Identities=20% Similarity=0.194 Sum_probs=176.5
Q ss_pred cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 23 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
.+.++++++++++++|+++. +|..+. +++++|+|++|.|++..|..|.++++|++|+|++|.|++..+ . +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTC
T ss_pred cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcC
Confidence 36788899999999999997 665554 689999999999998888899999999999999999985433 2 789999
Q ss_pred ceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCc
Q 043900 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 182 (953)
++|+|++|+++ .+|..+.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 78888999999999999999999777888999999999999999999666677788999999999999
Q ss_pred ccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccC
Q 043900 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235 (953)
Q Consensus 183 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (953)
+|+ .+|...+..+++|+.|+|++|+|+ .+|..+..+.+|+.|++++|.+..
T Consensus 159 ~l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 159 NLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 998 566666657889999999999988 677777778888888888888864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=232.77 Aligned_cols=206 Identities=21% Similarity=0.196 Sum_probs=185.9
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
..++.|+|+++++.+..+..+.++++|++|+|++|+++++.+..|.++++|++|+|++|.+++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46899999999998666669999999999999999999988889999999999999999999888899999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccc-cCCcccCCCcccEEecccccccccCCcccccccccc----ceecccc
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGS-IPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA----TLAMAEN 158 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N 158 (953)
++|.+++..+..++++++|++|++++|++++. +|..|+++++|++|+|++|++++..+..|..+++|+ +|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999977777899999999999999999864 589999999999999999999988888999999888 8999999
Q ss_pred cccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccC
Q 043900 159 WLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG 211 (953)
Q Consensus 159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 211 (953)
+++ .+|.......+|+.|++++|+++ .+|...+..+++|+.|++++|.+.+
T Consensus 188 ~l~-~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 188 PMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCC-EECTTSSCSCCEEEEECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred ccc-ccCccccCCCcccEEECCCCcee-ecCHhHhcccccccEEEccCCcccc
Confidence 999 45555555669999999999999 4566665689999999999999985
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-24 Score=228.12 Aligned_cols=205 Identities=20% Similarity=0.167 Sum_probs=161.0
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
..+++++++++++. +|..+. .+|++|+|++|+|++..+..|.++++|++|+|++|.++...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 46788888888886 665554 578888888888886666678888888888888888885555567788888888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
+|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 88888666667788888888888888888777777888888888888888888555556778888888888888888544
Q ss_pred ccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcC
Q 043900 189 PLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV 237 (953)
Q Consensus 189 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (953)
+ ..+..+++|++|++++|++++..+..|..+++|+.|++++|.+....
T Consensus 174 ~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 174 E-GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp T-TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred h-hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 3 33347888888888888888777777888889999999998887543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=230.12 Aligned_cols=204 Identities=22% Similarity=0.240 Sum_probs=183.6
Q ss_pred cEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEecc
Q 043900 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF 84 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~ 84 (953)
.++.++++++++. .+|..+. +++++|+|++|+++.+.+.+|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 3567999999997 7888765 689999999999999888899999999999999999996656667999999999999
Q ss_pred CccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCC
Q 043900 85 YNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTI 164 (953)
Q Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 164 (953)
+|.+++..+..|.++++|++|++++|++++..+..|+++++|++|+|++|+|++..+..|..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 99999777778899999999999999999888888999999999999999999777778999999999999999999776
Q ss_pred CCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCC
Q 043900 165 PSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGA 212 (953)
Q Consensus 165 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 212 (953)
+..+.++++|+.|+|++|++++ +|...+..+++|+.|++++|.+...
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred hhHhccCCCcCEEECCCCcCCc-CCHHHhccccCCCEEEecCCCeeCC
Confidence 7779999999999999999995 5555555899999999999998743
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-28 Score=289.51 Aligned_cols=443 Identities=13% Similarity=0.105 Sum_probs=229.2
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCc---CCCcc------------CCCCCCCcEEeCCCCccccccCcCc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNH---GIPSE------------FDRLQRLQVLALNNNSIGGEIPANI 72 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~------------~~~l~~L~~L~L~~n~i~~~~p~~~ 72 (953)
.++++.+... .....+..+++|++|+|++|.... ..|.. +..+++|++|+|++|.+++..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4555555432 222345667888888888875321 12222 2356788888888888877666666
Q ss_pred c-CCCCCcEEeccCc-ccccc-CCcccCCccccceeeccccccccccCCcc----cCCCcccEEecccccccccCCcc--
Q 043900 73 S-SCSNLIQIRLFYN-ELVGK-IPSELGSLSKIEHLSVSVNNLTGSIPSSL----GNLSSINTLFLTDNNLDGGIPDT-- 143 (953)
Q Consensus 73 ~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~L~~L~~L~L~~N~l~~~~~~~-- 143 (953)
. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|++|++++|. .......
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~ 204 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALE 204 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHH
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHH
Confidence 5 6788888888887 45422 33344477888888888888765444333 356688888888876 2111222
Q ss_pred --ccccccccceecccc-cccCCCCCcccccccceEEecCCc-------ccccccccccccccccccEE-EeeCccccCC
Q 043900 144 --FGWLKNLATLAMAEN-WLSGTIPSSIFNISSITAFDAGMN-------QLQGVIPLDFGFTLQNLQFF-SVFENQLTGA 212 (953)
Q Consensus 144 --~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N-------~l~~~~~~~~~~~l~~L~~L-~L~~N~l~~~ 212 (953)
+..+++|++|+|++| .+. .+|..+..+++|++|+++.+ .+.+ ++..+ .++++|+.| .+.+... ..
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l-~~~~~L~~Ls~~~~~~~-~~ 280 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVAL-SGCKELRCLSGFWDAVP-AY 280 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHH-HTCTTCCEEECCBTCCG-GG
T ss_pred HHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHH-hcCCCcccccCCcccch-hh
Confidence 344578888888877 444 35666667777777774433 3332 22233 256666666 2322221 12
Q ss_pred CCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCCh
Q 043900 213 IPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPA 292 (953)
Q Consensus 213 ~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~ 292 (953)
++..+..+++|+.|++++|.++.... ...+..+++|++|++++| +......
T Consensus 281 l~~~~~~~~~L~~L~L~~~~l~~~~l----------------------------~~~~~~~~~L~~L~l~~~-~~~~~l~ 331 (594)
T 2p1m_B 281 LPAVYSVCSRLTTLNLSYATVQSYDL----------------------------VKLLCQCPKLQRLWVLDY-IEDAGLE 331 (594)
T ss_dssp GGGGHHHHTTCCEEECTTCCCCHHHH----------------------------HHHHTTCTTCCEEEEEGG-GHHHHHH
T ss_pred HHHHHHhhCCCCEEEccCCCCCHHHH----------------------------HHHHhcCCCcCEEeCcCc-cCHHHHH
Confidence 33333355666666666665442110 001223344555555544 2211112
Q ss_pred hhhhccccCcEEEcc---------cCcccccCCcccc-CCCCCCEEEeecCcccccCCcCcc-CCCCCCeEEeccccccC
Q 043900 293 CISNLSTTLEMLLLD---------NNKIFGNIPAAIG-KFVNLQRLEMWNNRLSGTIPPAIG-ELQNLRELRLQRNKFLG 361 (953)
Q Consensus 293 ~~~~~~~~L~~L~L~---------~N~i~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~ 361 (953)
.+....++|+.|++. .+.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+.|...
T Consensus 332 ~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~- 410 (594)
T 2p1m_B 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPK- 410 (594)
T ss_dssp HHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTT-
T ss_pred HHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCC-
Confidence 222222456666662 2333322222222 356666666666666654444443 3566666666622110
Q ss_pred CCCCCCCCceeeEEEccCCcCCC-----CCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCC
Q 043900 362 NIPPSIGNLKVFNLDLSCNFLQG-----SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIP 436 (953)
Q Consensus 362 ~~p~~~~~l~l~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~ 436 (953)
..|.++. .++..+..+++|+.|+|++ .+++..+..+..
T Consensus 411 ----------------~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~-------------------- 453 (594)
T 2p1m_B 411 ----------------APDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT-------------------- 453 (594)
T ss_dssp ----------------CCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH--------------------
T ss_pred ----------------CcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHH--------------------
Confidence 0011111 1111244566777777755 444221111111
Q ss_pred ccccCCCccceeeecCCcccccCCCCc-cCCccccEEEccCccccCCCCc-cccCCCCCcEEECCCCcccccCCccc-cc
Q 043900 437 SEVGNLKNLEVLDVFENKLKGEIPSTL-GSCKKLEQLEMQGNFLQGPIPS-SLSSLKGLNVLDLSQNNLSGKIPEFL-VG 513 (953)
Q Consensus 437 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~ 513 (953)
.+++|+.|+|++|.+++..+..+ .++++|+.|+|++|.+++..+. .+..+++|+.|+|++|+++..-...+ ..
T Consensus 454 ----~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~ 529 (594)
T 2p1m_B 454 ----YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQK 529 (594)
T ss_dssp ----HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHH
T ss_pred ----hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHh
Confidence 14556666666666554333333 4456666666666666433322 22335666666666666643322223 34
Q ss_pred cccCceEeccCCcC
Q 043900 514 FQLLENLNLSNNNL 527 (953)
Q Consensus 514 l~~L~~l~l~~N~l 527 (953)
+++|+...+..+.-
T Consensus 530 lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 530 MPKLNVEVIDERGA 543 (594)
T ss_dssp CTTEEEEEECSSSC
T ss_pred CCCCEEEEecCCCc
Confidence 55555555555543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=231.29 Aligned_cols=205 Identities=20% Similarity=0.253 Sum_probs=169.9
Q ss_pred cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 23 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
.+..+++|++|++++|.++. + ..+..+++|++|+|++|.+++ + ..+..+++|++|+|++|.+++..+..|+++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 35678888999999999886 3 358888999999999999874 3 478889999999999999987777778889999
Q ss_pred ceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCc
Q 043900 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 182 (953)
++|++++|++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 99999999998777777888999999999999998777777888999999999999998766667788899999999999
Q ss_pred ccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCC
Q 043900 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPY 239 (953)
Q Consensus 183 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (953)
++++..+..+ ..+++|++|++++|.+.+ .+++|+.|++..|.++|.+|.
T Consensus 192 ~l~~~~~~~~-~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 192 QLKSVPDGVF-DRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CCSCCCTTTT-TTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBC
T ss_pred cCCccCHHHH-hCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccC
Confidence 9986555444 478899999999998874 356788888999999887664
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-27 Score=284.47 Aligned_cols=214 Identities=16% Similarity=0.079 Sum_probs=131.5
Q ss_pred ccCcEEEcccCcccccCC-ccccCCCCCCEEEeecCccccc-CCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEE
Q 043900 299 TTLEMLLLDNNKIFGNIP-AAIGKFVNLQRLEMWNNRLSGT-IPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLD 376 (953)
Q Consensus 299 ~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~ 376 (953)
++|+.|++++|.+++... ..+..+++|+.|++++| +... .+.....+++|++|+|+++.-.| .
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g--------------~ 353 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV--------------M 353 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC--------------S
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc--------------c
Confidence 578888888887654322 22457788888888887 4422 22223357888888885432100 0
Q ss_pred ccCCcCCCCCCccC-CCCCCCcEEEcCCCccCCCCCccccCccccceeeecc--C----CcccCC-----CCccccCCCc
Q 043900 377 LSCNFLQGSIPSSL-GQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLS--R----NQLTGS-----IPSEVGNLKN 444 (953)
Q Consensus 377 L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls--~----N~l~~~-----~~~~~~~l~~ 444 (953)
.+.|.+++.....+ ..+++|+.|.++.|.+++..+..+....+.++.|+++ + |.++.. ++..+..+++
T Consensus 354 ~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~ 433 (594)
T 2p1m_B 354 EPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD 433 (594)
T ss_dssp SCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTT
T ss_pred ccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCC
Confidence 01111111111111 1245566666665655533333332222344556665 3 444421 1223567889
Q ss_pred cceeeecCCcccccCCCCccC-CccccEEEccCccccCCCCccc-cCCCCCcEEECCCCcccccCCc-cccccccCceEe
Q 043900 445 LEVLDVFENKLKGEIPSTLGS-CKKLEQLEMQGNFLQGPIPSSL-SSLKGLNVLDLSQNNLSGKIPE-FLVGFQLLENLN 521 (953)
Q Consensus 445 L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~l~ 521 (953)
|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. ....+++|+.|+
T Consensus 434 L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~ 512 (594)
T 2p1m_B 434 LRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLW 512 (594)
T ss_dssp CCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEE
T ss_pred ccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEe
Confidence 99999987 676555555555 8899999999999986655555 6689999999999999754443 445689999999
Q ss_pred ccCCcCc
Q 043900 522 LSNNNLE 528 (953)
Q Consensus 522 l~~N~l~ 528 (953)
+++|+++
T Consensus 513 l~~~~~~ 519 (594)
T 2p1m_B 513 MSSCSVS 519 (594)
T ss_dssp EESSCCB
T ss_pred eeCCCCC
Confidence 9999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-25 Score=232.28 Aligned_cols=204 Identities=22% Similarity=0.229 Sum_probs=177.1
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.+..+..++++++.+... ..+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..++.+++|++|
T Consensus 17 ~~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 90 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEE
T ss_pred hHHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEE
Confidence 455677889999988874 44678999999999999997 444 58999999999999999985 3 478999999999
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|++|++++..+..|+++++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..+..+++|+.|++++|+++
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 99999999887888999999999999999999888888999999999999999999776777889999999999999999
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCc
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGE 236 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (953)
+..+ ..+..+++|++|++++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 171 ~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 171 SLPE-GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CCCT-TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccCH-HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 5444 4444789999999999999988888889999999999999988754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=253.09 Aligned_cols=187 Identities=16% Similarity=0.121 Sum_probs=141.0
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
+...+.||+|+||.||+|.... +.+|+|+..... ....+++.+|++++++++||||+++..++..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----- 410 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYLD--FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----- 410 (540)
T ss_dssp ----------CCEEEEEEECSS--CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----
T ss_pred CCCCCEEeeCCCEEEEEEEECC--CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----
Confidence 3456789999999999995543 478888864211 1123568999999999999999944444321
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..++||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--S
T ss_pred CCccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--e
Confidence 2456999999999999999952 458999999999999999 9999999999999998 9
Q ss_pred EEEeccccceecCCCCCcc-----cccccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 043900 785 AHVSDFGLARFLPLSPAQT-----SSIDAKGSIGYIAPEYGLG--SEVSINGDVYSYGILLLELVTRKKPVD 849 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slG~vl~elltg~~pf~ 849 (953)
+||+|||+|+......... ......||+.|||||++.+ ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999999874322111 1134569999999999887 567888999999999999888877763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=222.76 Aligned_cols=204 Identities=18% Similarity=0.171 Sum_probs=182.4
Q ss_pred cCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcc
Q 043900 47 EFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126 (953)
Q Consensus 47 ~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L 126 (953)
.+.++++++++++++|+++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|+|++..+ . +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcC
Confidence 4778899999999999999 7887775 799999999999998888999999999999999999995443 3 899999
Q ss_pred cEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeC
Q 043900 127 NTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFE 206 (953)
Q Consensus 127 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 206 (953)
++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++ +|...+..+++|+.|+|++
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhhcccccCCCEEECCC
Confidence 99999999998 788899999999999999999997777889999999999999999994 5555555899999999999
Q ss_pred ccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccC
Q 043900 207 NQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLG 257 (953)
Q Consensus 207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~ 257 (953)
|+|+...+..|..+++|+.|++++|+++..++.+.....|+.+++.+|.+.
T Consensus 158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 158 NNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred CcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCcc
Confidence 999987778889999999999999999988888877778888888887764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=220.15 Aligned_cols=203 Identities=19% Similarity=0.176 Sum_probs=128.1
Q ss_pred ecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCc-cccccCcCccCCCCCcEEeccC-ccccccCCccc
Q 043900 19 SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS-IGGEIPANISSCSNLIQIRLFY-NELVGKIPSEL 96 (953)
Q Consensus 19 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~ 96 (953)
.+|. +. .+|++|+|++|+++++.+.+|.++++|++|+|++|. +++..+..|.++++|++|+|++ |.+++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 5555 32 267777777777777666667777777777777775 6655555677777777777776 77775555667
Q ss_pred CCccccceeeccccccccccCCcccCCCccc---EEecccc-cccccCCcccccccccc-ceecccccccCCCCCccccc
Q 043900 97 GSLSKIEHLSVSVNNLTGSIPSSLGNLSSIN---TLFLTDN-NLDGGIPDTFGWLKNLA-TLAMAENWLSGTIPSSIFNI 171 (953)
Q Consensus 97 ~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l 171 (953)
.++++|++|++++|++++ +|. |+.+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++ .+|...+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC
Confidence 777777777777777763 554 66666666 7777777 67655566677777777 7777777776 444444333
Q ss_pred ccceEEecCCcc-ccccccccccccc-ccccEEEeeCccccCCCCCCCcCCCCCcEEEcccc
Q 043900 172 SSITAFDAGMNQ-LQGVIPLDFGFTL-QNLQFFSVFENQLTGAIPPAISNASNLELFQADVN 231 (953)
Q Consensus 172 ~~L~~L~L~~N~-l~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 231 (953)
++|+.|++++|+ ++ .+|...+..+ ++|+.|++++|+++...+. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcc-cCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 666666666664 66 3333333355 6666666666666633222 3455555555543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=217.67 Aligned_cols=212 Identities=17% Similarity=0.156 Sum_probs=179.6
Q ss_pred eecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc-ccccCCcccCCccccceeeccc-c
Q 043900 33 LLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE-LVGKIPSELGSLSKIEHLSVSV-N 110 (953)
Q Consensus 33 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N 110 (953)
++++-++++. +|. +. .+|++|+|++|+|++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |
T Consensus 16 ~~v~c~~l~~-ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n 91 (239)
T 2xwt_C 16 FRVTCKDIQR-IPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91 (239)
T ss_dssp TEEEECSCSS-CCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEET
T ss_pred ceeEccCccc-cCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCC
Confidence 3333334776 665 44 389999999999997777799999999999999997 9877777899999999999999 9
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCcccccccccc---ceecccc-cccCCCCCcccccccce-EEecCCcccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLA---TLAMAEN-WLSGTIPSSIFNISSIT-AFDAGMNQLQ 185 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~L~~N~l~ 185 (953)
++++..+.+|.++++|++|++++|++++ +|+ |..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++
T Consensus 92 ~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 92 NLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp TCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 9997777899999999999999999995 666 89999998 9999999 99966667799999999 9999999999
Q ss_pred cccccccccccccccEEEeeCcc-ccCCCCCCCcCC-CCCcEEEcccccccCcCCCCCCCCccceeeeccc
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQ-LTGAIPPAISNA-SNLELFQADVNKLTGEVPYLEKPQRLSVFSITEN 254 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n 254 (953)
.+|...+.. ++|+.|++++|+ ++...+..|.++ ++|+.|++++|+++..++. .+.+|+.|.+.++
T Consensus 170 -~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 170 -SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp -EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred -ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 777766644 899999999995 997778899999 9999999999999977654 4555665555443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=232.59 Aligned_cols=200 Identities=16% Similarity=0.147 Sum_probs=87.8
Q ss_pred CCcEEeCCCCccccccCcCc--cCCCCCcEEeccCccccccCC----cccCCccccceeeccccccccccCCcccCCCcc
Q 043900 53 RLQVLALNNNSIGGEIPANI--SSCSNLIQIRLFYNELVGKIP----SELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126 (953)
Q Consensus 53 ~L~~L~L~~n~i~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L 126 (953)
+|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 34444444444444444444 444444444444444443222 222344444444444444444444444444444
Q ss_pred cEEeccccccccc---C-CccccccccccceecccccccCCCCC----cccccccceEEecCCcccccccccccccc--c
Q 043900 127 NTLFLTDNNLDGG---I-PDTFGWLKNLATLAMAENWLSGTIPS----SIFNISSITAFDAGMNQLQGVIPLDFGFT--L 196 (953)
Q Consensus 127 ~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~~~~~~~~--l 196 (953)
++|+|++|++.+. . +..++.+++|++|+|++|+++ .+|. .+.++++|++|||++|++++..|..+..- +
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 4444444444321 1 112234444444444444443 2222 12334444444555554444434333311 1
Q ss_pred ccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccC
Q 043900 197 QNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLG 257 (953)
Q Consensus 197 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~ 257 (953)
++|++|+|++|+|+ .+|..+. ++|+.|++++|++++. |.+..+++|+.+++++|.+.
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTS
T ss_pred CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCC
Confidence 34555555555554 3333332 4555555555555543 22344455555555555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.7e-25 Score=243.25 Aligned_cols=263 Identities=14% Similarity=0.088 Sum_probs=153.0
Q ss_pred eeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccC----cCccCCC-CCcEEeccCccccccCCcccCCc-----cc
Q 043900 32 VLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIP----ANISSCS-NLIQIRLFYNELVGKIPSELGSL-----SK 101 (953)
Q Consensus 32 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~ 101 (953)
++.|++|++++.+|..+...++|++|||++|.|++..+ ..|..++ +|++|+|++|.+++..+..|+.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35677777777666655666667777777777775444 5566666 67777777777765555555554 66
Q ss_pred cceeeccccccccccCCcc----cCC-CcccEEecccccccccCCccccc-----cccccceecccccccCCCCCccccc
Q 043900 102 IEHLSVSVNNLTGSIPSSL----GNL-SSINTLFLTDNNLDGGIPDTFGW-----LKNLATLAMAENWLSGTIPSSIFNI 171 (953)
Q Consensus 102 L~~L~Ls~N~l~~~~p~~~----~~L-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~p~~l~~l 171 (953)
|++|+|++|++++..+..+ ..+ ++|++|+|++|+|+...+..|.. .++|++|+|++|++++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--- 158 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL--- 158 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH---
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH---
Confidence 6666666666665444433 223 56666666666666444443332 1355555555555542221111
Q ss_pred ccceEEecCCcccccccccccccccc-cccEEEeeCccccCCCCCCC----cCC-CCCcEEEcccccccCcCCCCCCCCc
Q 043900 172 SSITAFDAGMNQLQGVIPLDFGFTLQ-NLQFFSVFENQLTGAIPPAI----SNA-SNLELFQADVNKLTGEVPYLEKPQR 245 (953)
Q Consensus 172 ~~L~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~----~~l-~~L~~L~L~~N~l~~~~~~l~~~~~ 245 (953)
+..+. .++ +|++|+|++|+|++..+..+ ..+ ++|++|++++|.++....
T Consensus 159 -----------------~~~l~-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~------- 213 (362)
T 3goz_A 159 -----------------IQILA-AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY------- 213 (362)
T ss_dssp -----------------HHHHH-TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH-------
T ss_pred -----------------HHHHh-cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH-------
Confidence 11111 122 44444444444443333222 223 356666666665542100
Q ss_pred cceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCC----ccccC
Q 043900 246 LSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIP----AAIGK 321 (953)
Q Consensus 246 L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~----~~~~~ 321 (953)
..++..+...+++|+.|+|++|.+++..+ ..+..
T Consensus 214 ------------------------------------------~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~ 251 (362)
T 3goz_A 214 ------------------------------------------AELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251 (362)
T ss_dssp ------------------------------------------HHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTT
T ss_pred ------------------------------------------HHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhc
Confidence 02344455544578888888888876544 33567
Q ss_pred CCCCCEEEeecCccccc-------CCcCccCCCCCCeEEeccccccCCCC
Q 043900 322 FVNLQRLEMWNNRLSGT-------IPPAIGELQNLRELRLQRNKFLGNIP 364 (953)
Q Consensus 322 l~~L~~L~L~~N~i~~~-------~~~~~~~l~~L~~L~L~~N~l~~~~p 364 (953)
+++|+.|+|++|.+.+. ++..+..+++|++|++++|++....+
T Consensus 252 l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp TTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred CCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 78899999999985432 34567788889999999999876533
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-25 Score=244.06 Aligned_cols=267 Identities=19% Similarity=0.129 Sum_probs=205.5
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCC----ccCCCCC-CCcEEeCCCCccccccCcCccCC-----CC
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIP----SEFDRLQ-RLQVLALNNNSIGGEIPANISSC-----SN 77 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l-----~~ 77 (953)
.++|+.+++.+.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999999888888889999999999999766 7888998 99999999999998878888775 99
Q ss_pred CcEEeccCccccccCCcccCCc-----cccceeeccccccccccCCcc----cC-CCcccEEecccccccccCC----cc
Q 043900 78 LIQIRLFYNELVGKIPSELGSL-----SKIEHLSVSVNNLTGSIPSSL----GN-LSSINTLFLTDNNLDGGIP----DT 143 (953)
Q Consensus 78 L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~----~~-L~~L~~L~L~~N~l~~~~~----~~ 143 (953)
|++|+|++|.+++..+..++.. ++|++|+|++|++++..+..+ .. .++|++|+|++|+++...+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997777655543 899999999999987665544 34 3699999999999985444 34
Q ss_pred ccccc-cccceecccccccCCCCCccc----cc-ccceEEecCCcccccc----cccccccccccccEEEeeCccccCCC
Q 043900 144 FGWLK-NLATLAMAENWLSGTIPSSIF----NI-SSITAFDAGMNQLQGV----IPLDFGFTLQNLQFFSVFENQLTGAI 213 (953)
Q Consensus 144 ~~~l~-~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~~~ 213 (953)
+..++ +|++|+|++|+|++..+..+. .+ ++|++|||++|+|++. ++..+....++|++|+|++|+|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45565 999999999999876665544 34 6999999999999863 44444433468999999999998655
Q ss_pred C----CCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCccccc
Q 043900 214 P----PAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL 289 (953)
Q Consensus 214 ~----~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~ 289 (953)
+ ..+..+++|+.|++++|.+....+.. .......+..+++|+.|++++|.+...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~----------------------~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQ----------------------CKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHH----------------------HHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHH----------------------HHHHHHHhccCCceEEEecCCCcCCCc
Confidence 4 45677889999999999865432210 000112344566677777777777666
Q ss_pred CChhhhh
Q 043900 290 LPACISN 296 (953)
Q Consensus 290 ~p~~~~~ 296 (953)
.+..+..
T Consensus 300 ~~~~~~~ 306 (362)
T 3goz_A 300 HSIPISN 306 (362)
T ss_dssp GCHHHHH
T ss_pred chHHHHH
Confidence 5555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-22 Score=212.28 Aligned_cols=177 Identities=22% Similarity=0.290 Sum_probs=84.6
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSV 109 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (953)
.+++++++++++. +|..+. .+|+.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 3444555555544 333332 3445555555555444444445555555555555555444444445555555555555
Q ss_pred cccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccc
Q 043900 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIP 189 (953)
Q Consensus 110 N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 189 (953)
|++++..+..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 55544444444555555555555555544444444555555555555555543333344455555555555555553222
Q ss_pred cccccccccccEEEeeCcccc
Q 043900 190 LDFGFTLQNLQFFSVFENQLT 210 (953)
Q Consensus 190 ~~~~~~l~~L~~L~L~~N~l~ 210 (953)
..+ ..+++|+.|++++|++.
T Consensus 173 ~~~-~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 173 GAF-DRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTT-TTCTTCCEEECCSCCBC
T ss_pred HHH-hCCCCCCEEEeeCCcee
Confidence 222 24555555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.1e-23 Score=222.21 Aligned_cols=201 Identities=22% Similarity=0.232 Sum_probs=142.7
Q ss_pred CCCCEEEeecCcccccCCcCc--cCCCCCCeEEeccccccCCCCC----CCCCc-eeeEEEccCCcCCCCCCccCCCCCC
Q 043900 323 VNLQRLEMWNNRLSGTIPPAI--GELQNLRELRLQRNKFLGNIPP----SIGNL-KVFNLDLSCNFLQGSIPSSLGQYKT 395 (953)
Q Consensus 323 ~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~----~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~ 395 (953)
++|++|++++|.+++..|..+ ..+++|++|+|++|++++..+. .+..+ .+++|+|++|.+.+..|..|+.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 345555555555555555555 5555566666666655543331 11222 4556666666666677778888888
Q ss_pred CcEEEcCCCccCCC--CC-ccccCccccceeeeccCCcccCCCCc----cccCCCccceeeecCCcccccCCCCccCC--
Q 043900 396 LTIIDLSDNNLTGT--IP-PQFLGLSWLLIGLDLSRNQLTGSIPS----EVGNLKNLEVLDVFENKLKGEIPSTLGSC-- 466 (953)
Q Consensus 396 L~~L~L~~N~l~~~--~p-~~~~~~~~~l~~L~ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-- 466 (953)
|++|+|++|++.+. ++ ..+.+....+++|+|++|+++. ++. .+..+++|++|+|++|+|++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 88888888887642 22 2222334466788888888873 333 35788999999999999998778888777
Q ss_pred -ccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcc
Q 043900 467 -KKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEG 529 (953)
Q Consensus 467 -~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 529 (953)
++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|+.|++++|+|+.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 6777775 7999999999999964 44 6788999999999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-23 Score=220.67 Aligned_cols=198 Identities=22% Similarity=0.345 Sum_probs=163.5
Q ss_pred ccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccc
Q 043900 24 VGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIE 103 (953)
Q Consensus 24 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (953)
+.++++|++|++++|+++. +| .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|.+++ ++ .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 4568889999999999987 44 68889999999999999984 444 8899999999999999984 33 688999999
Q ss_pred eeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcc
Q 043900 104 HLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQ 183 (953)
Q Consensus 104 ~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 183 (953)
+|++++|++++ ++ .+..+++|++|++++|++++..+ +..+++|++|+|++|++++ ++. +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCc
Confidence 99999999985 44 38899999999999999985443 8889999999999999984 443 8888999999999999
Q ss_pred cccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC
Q 043900 184 LQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 184 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (953)
+++..+ +..+++|++|++++|++++.. .+..+++|+.|++++|++++.+.
T Consensus 185 l~~~~~---l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 185 ISDISP---LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCCCGG---GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECCCE
T ss_pred cCcChh---hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecCCe
Confidence 986544 347889999999999998654 37888999999999999886543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-22 Score=209.99 Aligned_cols=178 Identities=19% Similarity=0.198 Sum_probs=126.1
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
+.+|++++++. .+|..+. +++++|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 93 (251)
T 3m19_A 17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN 93 (251)
T ss_dssp TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence 45677777765 6666554 46777777777777766667777777777777777777666666777777777777777
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
.+++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+.
T Consensus 94 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 77766566677777777777777777755555667777777777777777766666677777777777777777755555
Q ss_pred cccccccceEEecCCcccccc
Q 043900 167 SIFNISSITAFDAGMNQLQGV 187 (953)
Q Consensus 167 ~l~~l~~L~~L~L~~N~l~~~ 187 (953)
.+..+++|+.|+|++|.+...
T Consensus 174 ~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 174 AFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTCTTCCEEECCSCCBCTT
T ss_pred HHhCCCCCCEEEeeCCceeCC
Confidence 677777777777777777643
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=217.19 Aligned_cols=152 Identities=18% Similarity=0.103 Sum_probs=120.1
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch------------------hhHHHHHHHHHHHhhcC
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH------------------GAFKSFIAECNTLKNIR 686 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~ 686 (953)
.+......|.+.+.||+|+||.||+|++ .+++.||+|+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444556677889999999999999999 6677999999963221 13467889999999998
Q ss_pred CCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043900 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP 766 (953)
Q Consensus 687 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 766 (953)
|+++..+++. +..++||||+++|+|.+ +.. .+...++.|++.||+|||+. |
T Consensus 163 ~~~v~~~~~~---------~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~---g 213 (282)
T 1zar_A 163 GLAVPKVYAW---------EGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHR---G 213 (282)
T ss_dssp TSSSCCEEEE---------ETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCcCeEEec---------cceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHC---C
Confidence 5444443322 45699999999999998 521 12346999999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCC
Q 043900 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG 822 (953)
Q Consensus 767 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 822 (953)
|+||||||+|||++ ++.+||+|||+|+. +..|+|||++.+
T Consensus 214 iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 214 IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999999 99999999999973 345788998643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-22 Score=219.17 Aligned_cols=205 Identities=15% Similarity=0.095 Sum_probs=114.2
Q ss_pred EEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccC-cCccCCCCCcE-EeccCc
Q 043900 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIP-ANISSCSNLIQ-IRLFYN 86 (953)
Q Consensus 9 l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~-L~L~~n 86 (953)
++-+++++. +||..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.++++|++ +.++.|
T Consensus 14 v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N 90 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90 (350)
T ss_dssp EEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred EEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence 444555554 556544 2456666666666666545556666666666666666544443 34556665543 444556
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccc-ccccccCCccccccc-cccceecccccccCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTD-NNLDGGIPDTFGWLK-NLATLAMAENWLSGTI 164 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~ 164 (953)
+|+...|+.|.++++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ .+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i 169 (350)
T 4ay9_X 91 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EI 169 (350)
T ss_dssp TCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EE
T ss_pred cccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CC
Confidence 66655556666666666666666666644444555555566666643 445544445555553 4556666666665 44
Q ss_pred CCcccccccceEEecCC-cccccccccccccccccccEEEeeCccccCCCCCCCc
Q 043900 165 PSSIFNISSITAFDAGM-NQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAIS 218 (953)
Q Consensus 165 p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 218 (953)
|...+...+|++|++++ |.++ .+|.+.+.++++|++|+|++|+|+...+..|.
T Consensus 170 ~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~ 223 (350)
T 4ay9_X 170 HNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223 (350)
T ss_dssp CTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred ChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence 44444555566666653 3444 45554444566666666666666643333333
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.7e-24 Score=233.66 Aligned_cols=198 Identities=15% Similarity=0.132 Sum_probs=127.2
Q ss_pred CceeecCCCccCcCCCccCCCC--CCCcEEeCCCCccccccCcCccCCCCCcEEeccCcccccc-CCcccCCccccceee
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRL--QRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGK-IPSELGSLSKIEHLS 106 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ 106 (953)
++.|++++|.+. |..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 566666666655 3445555 6666667777666644333 44566677777777666544 556666667777777
Q ss_pred ccccccccccCCcccCCCcccEEecccc-cccc-cCCccccccccccceecccc-cccCC-CCCcccccc-cceEEecCC
Q 043900 107 VSVNNLTGSIPSSLGNLSSINTLFLTDN-NLDG-GIPDTFGWLKNLATLAMAEN-WLSGT-IPSSIFNIS-SITAFDAGM 181 (953)
Q Consensus 107 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N-~l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~L~~ 181 (953)
|++|++++..+..++.+++|++|+|++| .+++ .++..+..+++|++|+|++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 7777666666666666777777777776 4553 24555666777777777777 66532 455566666 777777777
Q ss_pred c--ccc-cccccccccccccccEEEeeCcc-ccCCCCCCCcCCCCCcEEEccccc
Q 043900 182 N--QLQ-GVIPLDFGFTLQNLQFFSVFENQ-LTGAIPPAISNASNLELFQADVNK 232 (953)
Q Consensus 182 N--~l~-~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~ 232 (953)
| .++ +.++..+ ..+++|+.|++++|. +++..+..+..+++|+.|++++|.
T Consensus 205 ~~~~~~~~~l~~~~-~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 205 YRKNLQKSDLSTLV-RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CGGGSCHHHHHHHH-HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CcccCCHHHHHHHH-hhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 7 343 2334333 357777777777777 665666677777888888887775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.7e-22 Score=215.11 Aligned_cols=191 Identities=21% Similarity=0.333 Sum_probs=168.4
Q ss_pred CcEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.+++.|++++|++. .++ .+..+++|++|+|++|++++..+ |..+++|++|+|++|.+++ ++ .+..+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 36889999999997 566 68999999999999999998444 9999999999999999984 44 6999999999999
Q ss_pred cCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCC
Q 043900 84 FYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGT 163 (953)
Q Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 163 (953)
++|.+++ ++ .+..+++|++|++++|++++..+ ++.+++|++|+|++|++++..+ +..+++|+.|+|++|++++.
T Consensus 115 ~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 115 TSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp TTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC
Confidence 9999985 44 39999999999999999995543 9999999999999999985443 99999999999999999854
Q ss_pred CCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccC
Q 043900 164 IPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG 211 (953)
Q Consensus 164 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 211 (953)
.+ +..+++|++|+|++|++++..+ + ..+++|+.|++++|++++
T Consensus 189 ~~--l~~l~~L~~L~L~~N~l~~~~~--l-~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 189 SP--LASLPNLIEVHLKNNQISDVSP--L-ANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GG--GGGCTTCCEEECTTSCCCBCGG--G-TTCTTCCEEEEEEEEEEC
T ss_pred hh--hcCCCCCCEEEccCCccCcccc--c-cCCCCCCEEEccCCeeec
Confidence 33 8899999999999999996654 3 479999999999999984
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-21 Score=215.89 Aligned_cols=203 Identities=15% Similarity=0.121 Sum_probs=161.2
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCC-cccCCccccce-eecc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIP-SELGSLSKIEH-LSVS 108 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~-L~Ls 108 (953)
++++.++++++. +|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 678999999997 67666 3689999999999995555679999999999999999865554 56889988775 6677
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccc-ccccCCCCCcccccc-cceEEecCCccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAE-NWLSGTIPSSIFNIS-SITAFDAGMNQLQG 186 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~ 186 (953)
+|+|+...|++|.++++|++|++++|+|+...+..+....++..|++.+ |++....+..+..+. .++.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 8999977788999999999999999999877777788888888898865 677744455666664 6888999999998
Q ss_pred ccccccccccccccEEEeeC-ccccCCCCCCCcCCCCCcEEEcccccccCcCC
Q 043900 187 VIPLDFGFTLQNLQFFSVFE-NQLTGAIPPAISNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 187 ~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (953)
.+|...+ ...+|+.|++.+ |.++...+++|.++++|++|++++|+|+..++
T Consensus 168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219 (350)
T ss_dssp EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence 5555555 456788888874 67775555678888888888888888876544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-23 Score=229.45 Aligned_cols=254 Identities=17% Similarity=0.206 Sum_probs=188.0
Q ss_pred CCcEEeCCCCccccccCcCccCC--CCCcEEeccCccccccCCcccCCccccceeeccccccccc-cCCcccCCCcccEE
Q 043900 53 RLQVLALNNNSIGGEIPANISSC--SNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGS-IPSSLGNLSSINTL 129 (953)
Q Consensus 53 ~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L 129 (953)
.++.||+++|.+. |..+..+ .+++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4789999999886 4567777 8999999999999866554 66899999999999998865 77788999999999
Q ss_pred ecccccccccCCccccccccccceecccc-cccCC-CCCcccccccceEEecCCc-ccccc-cccccccccc-cccEEEe
Q 043900 130 FLTDNNLDGGIPDTFGWLKNLATLAMAEN-WLSGT-IPSSIFNISSITAFDAGMN-QLQGV-IPLDFGFTLQ-NLQFFSV 204 (953)
Q Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~~~~~~~~l~-~L~~L~L 204 (953)
+|++|.+++..+..|+.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+ ..++ +|++|++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~-~~l~~~L~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV-AHVSETITQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH-HHSCTTCCEEEC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH-HhcccCCCEEEe
Confidence 99999998788888999999999999999 67642 5666788999999999999 88864 34333 4788 9999999
Q ss_pred eCcc--cc-CCCCCCCcCCCCCcEEEccccc-ccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEe
Q 043900 205 FENQ--LT-GAIPPAISNASNLELFQADVNK-LTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLL 280 (953)
Q Consensus 205 ~~N~--l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~ 280 (953)
++|. ++ +.++..+..+++|+.|++++|. +++..
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~------------------------------------------- 239 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC------------------------------------------- 239 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGG-------------------------------------------
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHH-------------------------------------------
Confidence 9994 54 3456677889999999999888 44221
Q ss_pred ccCCcccccCChhhhhccccCcEEEcccCc-ccccCCccccCCCCCCEEEeecCcccccCCcCccCC-CCCCeEEecccc
Q 043900 281 INANNFGGLLPACISNLSTTLEMLLLDNNK-IFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGEL-QNLRELRLQRNK 358 (953)
Q Consensus 281 l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~ 358 (953)
+..+..+ ++|+.|++++|. +.......+.++++|+.|++++| ++ ...+..+ .+|..|++++|+
T Consensus 240 ----------~~~l~~l-~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 240 ----------FQEFFQL-NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp ----------GGGGGGC-TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCC
T ss_pred ----------HHHHhCC-CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEeccc
Confidence 1122222 456666666663 22222224667778888888877 32 2334444 236677777788
Q ss_pred ccCCCCCCCCC
Q 043900 359 FLGNIPPSIGN 369 (953)
Q Consensus 359 l~~~~p~~~~~ 369 (953)
+++..|..+++
T Consensus 305 l~~~~~~~~~~ 315 (336)
T 2ast_B 305 FTTIARPTIGN 315 (336)
T ss_dssp SCCTTCSSCSS
T ss_pred CccccCCcccc
Confidence 77766666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-24 Score=241.92 Aligned_cols=263 Identities=17% Similarity=0.226 Sum_probs=181.4
Q ss_pred ecCccccCCccCceeecCCCccCcCCC----ccCCCCCCCcEEeCCCC---ccccccCcCc-------cCCCCCcEEecc
Q 043900 19 SISPHVGNLSFLKVLLLYNNSFNHGIP----SEFDRLQRLQVLALNNN---SIGGEIPANI-------SSCSNLIQIRLF 84 (953)
Q Consensus 19 ~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n---~i~~~~p~~~-------~~l~~L~~L~L~ 84 (953)
.++..+..+++|++|+|++|+|+...+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 567777788888888888888887533 44778888888888885 4444555544 678888888888
Q ss_pred Cccccc----cCCcccCCccccceeeccccccccccCCcc----cCC---------CcccEEeccccccc-ccCC---cc
Q 043900 85 YNELVG----KIPSELGSLSKIEHLSVSVNNLTGSIPSSL----GNL---------SSINTLFLTDNNLD-GGIP---DT 143 (953)
Q Consensus 85 ~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~L---------~~L~~L~L~~N~l~-~~~~---~~ 143 (953)
+|.+++ .+|..+..+++|++|+|++|.+++..+..+ ..+ ++|++|+|++|+++ ...+ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 888875 466777888888888888888865444333 333 78888888888886 3344 46
Q ss_pred ccccccccceecccccccC-----CCCCcccccccceEEecCCcccc----cccccccccccccccEEEeeCccccCC--
Q 043900 144 FGWLKNLATLAMAENWLSG-----TIPSSIFNISSITAFDAGMNQLQ----GVIPLDFGFTLQNLQFFSVFENQLTGA-- 212 (953)
Q Consensus 144 ~~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~----~~~~~~~~~~l~~L~~L~L~~N~l~~~-- 212 (953)
|..+++|++|+|++|+|+. ..|..+..+++|+.|+|++|+++ ..+|..+. .+++|++|+|++|+|++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~ 261 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-SWPNLRELGLNDCLLSARGA 261 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG-GCTTCCEEECTTCCCCHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc-cCCCcCEEECCCCCCchhhH
Confidence 7778888888888888862 34447778888888888888885 45565544 677888888888887754
Q ss_pred --CCCCC--cCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccc-cccccccEEeccCCccc
Q 043900 213 --IPPAI--SNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSL-TNSTRLNRLLINANNFG 287 (953)
Q Consensus 213 --~~~~~--~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l-~~~~~L~~L~l~~n~~~ 287 (953)
++..+ +.+++|+.|++++|.++.. +.. .....+ .++++|++|++++|.+.
T Consensus 262 ~~l~~~l~~~~~~~L~~L~L~~n~i~~~-----------------------g~~--~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 262 AAVVDAFSKLENIGLQTLRLQYNEIELD-----------------------AVR--TLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HHHHHHHHTCSSCCCCEEECCSSCCBHH-----------------------HHH--HHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHHHHhhccCCCeEEEECcCCcCCHH-----------------------HHH--HHHHHHHhcCCCceEEEccCCcCC
Confidence 34555 3377888888888877751 000 001112 34567778888888887
Q ss_pred ccCC--hhhhhccccCcEEEcc
Q 043900 288 GLLP--ACISNLSTTLEMLLLD 307 (953)
Q Consensus 288 ~~~p--~~~~~~~~~L~~L~L~ 307 (953)
+..+ ..+....+.++.+.+.
T Consensus 317 ~~~~~~~~l~~~l~~~~~~~l~ 338 (386)
T 2ca6_A 317 EEDDVVDEIREVFSTRGRGELD 338 (386)
T ss_dssp TTSHHHHHHHHHHHHHTCCEEC
T ss_pred cchhHHHHHHHHhhhcCcchhh
Confidence 7664 5555544555544443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-24 Score=237.94 Aligned_cols=235 Identities=15% Similarity=0.229 Sum_probs=195.3
Q ss_pred CcEEEEEeCCCeeeee----cCccccCCccCceeecCCCccC---cCCCccC-------CCCCCCcEEeCCCCcccc---
Q 043900 4 QRVKILNLTSLKLAGS----ISPHVGNLSFLKVLLLYNNSFN---HGIPSEF-------DRLQRLQVLALNNNSIGG--- 66 (953)
Q Consensus 4 ~~~~~l~l~~~~~~~~----~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~-------~~l~~L~~L~L~~n~i~~--- 66 (953)
..++.|+|++|++.+. ++..+..+++|++|+|++|.+. +.+|..+ ..+++|++|+|++|.|++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 5689999999999865 4556889999999999997544 4455544 789999999999999997
Q ss_pred -ccCcCccCCCCCcEEeccCccccccCCcccC----Cc---------cccceeeccccccc-cccC---CcccCCCcccE
Q 043900 67 -EIPANISSCSNLIQIRLFYNELVGKIPSELG----SL---------SKIEHLSVSVNNLT-GSIP---SSLGNLSSINT 128 (953)
Q Consensus 67 -~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~~~~~L~~L~~ 128 (953)
.+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ +.+| ..|..+++|++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 4788899999999999999999755444444 44 89999999999997 3445 46788999999
Q ss_pred Eecccccccc-----cCCccccccccccceeccccccc----CCCCCcccccccceEEecCCcccccc----cccccc-c
Q 043900 129 LFLTDNNLDG-----GIPDTFGWLKNLATLAMAENWLS----GTIPSSIFNISSITAFDAGMNQLQGV----IPLDFG-F 194 (953)
Q Consensus 129 L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~-~ 194 (953)
|+|++|+|+. ..+..+..+++|++|+|++|+++ ..+|..+..+++|+.|+|++|+|++. ++..+. .
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 271 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence 9999999972 34558899999999999999995 46788899999999999999999865 344442 1
Q ss_pred ccccccEEEeeCccccC----CCCCCC-cCCCCCcEEEcccccccCcCC
Q 043900 195 TLQNLQFFSVFENQLTG----AIPPAI-SNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 195 ~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~~~ 238 (953)
.+++|++|+|++|++++ .+|..+ .++++|+.|++++|++++..+
T Consensus 272 ~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred cCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 38999999999999997 477777 678999999999999997653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=196.74 Aligned_cols=181 Identities=18% Similarity=0.209 Sum_probs=118.8
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
+.+++++++++. +|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 456666666665 44333 346677777777776554555666777777777777776555555666777777777777
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPL 190 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 190 (953)
++++..+..|+++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 7765555556677777777777777765555566777777777777777765444456667777777777776653
Q ss_pred ccccccccccEEEeeCccccCCCCCCCcCCCC
Q 043900 191 DFGFTLQNLQFFSVFENQLTGAIPPAISNASN 222 (953)
Q Consensus 191 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 222 (953)
.+++|++|+++.|++++.+|..++.++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 4556777777777777777777665544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-21 Score=196.20 Aligned_cols=177 Identities=20% Similarity=0.203 Sum_probs=157.7
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
+.++.+++++. .+|..+ .++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 35677888776 777755 468999999999999977788999999999999999999666677899999999999999
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
.+++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 9997777778999999999999999997777779999999999999999997777789999999999999998874
Q ss_pred cccccccceEEecCCcccccccccccc
Q 043900 167 SIFNISSITAFDAGMNQLQGVIPLDFG 193 (953)
Q Consensus 167 ~l~~l~~L~~L~L~~N~l~~~~~~~~~ 193 (953)
.+++|+.|+++.|+++|.+|..+.
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCc
Confidence 456889999999999999998776
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.7e-21 Score=219.40 Aligned_cols=189 Identities=27% Similarity=0.332 Sum_probs=144.4
Q ss_pred cCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccC
Q 043900 300 TLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSC 379 (953)
Q Consensus 300 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~ 379 (953)
+++.|++++|++++ +|..+ +++|+.|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.+ .+++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~-~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA-SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT-TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc-CCCEEECCC
Confidence 68888888888886 55544 367888888888888 556 446888888888888886 666 555 778888888
Q ss_pred CcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccC
Q 043900 380 NFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEI 459 (953)
Q Consensus 380 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 459 (953)
|.|++ +|. .+++|+.|+|++|+|++ +|. ....++.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 88886 555 57888889999998884 665 33456688888888886 666 65 88888888888888 66
Q ss_pred CCCccCCccc-------cEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCcccccccc
Q 043900 460 PSTLGSCKKL-------EQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQL 516 (953)
Q Consensus 460 p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 516 (953)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 66 554 66 88888888888 57777777888888888888888888887776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-21 Score=221.46 Aligned_cols=181 Identities=24% Similarity=0.354 Sum_probs=147.7
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
+|++|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|++|+|++|.|++ +|. |++ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78999999999988 66655 378999999999998 777 457889999999999985 676 665 89999999
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
+|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999985 665 67889999999999985 555 57889999999999984 777 55 88999999999998 66
Q ss_pred ccccccccccc-------cEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC
Q 043900 189 PLDFGFTLQNL-------QFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 189 ~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (953)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|++++|++++..|
T Consensus 196 p~-~~~---~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 196 PA-VPV---RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp CC-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred hh-HHH---hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 66 442 66 99999999999 578888889999999999999987654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=190.31 Aligned_cols=158 Identities=18% Similarity=0.189 Sum_probs=125.2
Q ss_pred eEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecC
Q 043900 373 FNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFE 452 (953)
Q Consensus 373 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 452 (953)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..|..++.....++.|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35555666655 3455443 34567777777777554555444455566788888888777777889999999999999
Q ss_pred CcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCC
Q 043900 453 NKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 453 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99997777789999999999999999998888999999999999999999998888899999999999999999988765
Q ss_pred C
Q 043900 533 I 533 (953)
Q Consensus 533 ~ 533 (953)
.
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.2e-20 Score=187.71 Aligned_cols=153 Identities=21% Similarity=0.270 Sum_probs=119.2
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
+.+++++++++. +|..+. .+|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 567788888876 555443 67888888888888666667888888888888888888777788888888888888888
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 186 (953)
+|+...+..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 8885555567788888888888888887777888888888888888888886666677788888888888888764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8.3e-20 Score=186.77 Aligned_cols=151 Identities=22% Similarity=0.282 Sum_probs=110.9
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.++++++++. .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|.
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4667777765 6676554 567777777777777666677777777777777777776667777777777777777777
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
|+...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..++.|..+++|++|+|++|.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 77555555677777777777777777666777777777777777777777666667777777777777777775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=7e-20 Score=187.34 Aligned_cols=157 Identities=19% Similarity=0.200 Sum_probs=126.6
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccC-cCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIP-ANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
-+++++++|+++. +|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 3578888888887 565553 346788888888886544 457888888888888888887777788888888888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
+|++++..+..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+....
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 88888777777888888888888888888777888888888888888888888777888888888888888888887554
Q ss_pred c
Q 043900 189 P 189 (953)
Q Consensus 189 ~ 189 (953)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.8e-20 Score=204.24 Aligned_cols=175 Identities=19% Similarity=0.218 Sum_probs=123.7
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCcc-CCCCCcEEeccCccccccCCcccCCccccceeeccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANIS-SCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSV 109 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (953)
+.+++++++++. +|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 577777777776 555443 3477777777777766666666 777777777777777766666777777777777777
Q ss_pred cccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCc-c---cccccceEEecCCcccc
Q 043900 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSS-I---FNISSITAFDAGMNQLQ 185 (953)
Q Consensus 110 N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l---~~l~~L~~L~L~~N~l~ 185 (953)
|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+. +|.. + ..+++|+.|||++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCC
Confidence 77776666677777777777777777777777777777777777777777773 4443 3 45777888888888877
Q ss_pred ccccccccccccc--ccEEEeeCcccc
Q 043900 186 GVIPLDFGFTLQN--LQFFSVFENQLT 210 (953)
Q Consensus 186 ~~~~~~~~~~l~~--L~~L~L~~N~l~ 210 (953)
.+|...+..++. |+.|+|++|.+.
T Consensus 177 -~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 177 -KLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -CCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred -ccCHHHhhhccHhhcceEEecCCCcc
Confidence 344333335665 377888888776
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=198.16 Aligned_cols=148 Identities=21% Similarity=0.342 Sum_probs=69.1
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.+++|++|++++|.++.+ + .+..+++|++|+|++|++++. +. +.++++|++|+|++|.+++ +| .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 444455555555555542 2 244455555555555555422 22 4455555555555555542 22 24455555555
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
++++|++++ + ..+..+++|++|++++|++++. ..|..+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 118 ~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 555555542 2 2344455555555555555432 344444555555555554443222 444444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-20 Score=199.59 Aligned_cols=195 Identities=18% Similarity=0.267 Sum_probs=165.5
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.+..+..+.+..+.+++..+ +..+++|+.|++++|.++ .++ .+..+++|++|+|++|++++..+ +.++++|++|
T Consensus 22 ~l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L 95 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95 (291)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEE
Confidence 34556677888888887433 568999999999999998 555 48999999999999999995444 9999999999
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
++++|++++ +| .++.+++|++|+|++|++++. ..+..+++|++|+|++|++++. ..+..+++|+.|++++|+++
T Consensus 96 ~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 96 FLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp ECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence 999999984 44 599999999999999999853 5799999999999999999854 57889999999999999999
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcC
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV 237 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (953)
+..+ +..+++|+.|++++|+|++. + .+..+++|+.|++++|+++..+
T Consensus 170 ~~~~---l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 170 DIVP---LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp CCGG---GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCC
T ss_pred cchh---hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCc
Confidence 7655 34789999999999999853 3 4889999999999999988643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.5e-20 Score=202.25 Aligned_cols=175 Identities=18% Similarity=0.187 Sum_probs=106.9
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCC-CCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFD-RLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
.++++++++. .+|..+. ..+++|+|++|+|+++.+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566666664 5665443 2456666666666665555565 6666666666666666555556666666666666666
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccc---cccccccceecccccccCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTF---GWLKNLATLAMAENWLSGT 163 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~ 163 (953)
+|++..+..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|+|+...+..| ..+++|+.|+|++|+|+..
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 6665555566666666666666666665556666666666666666666664444444 4566666666666666633
Q ss_pred CCCccccccc--ceEEecCCcccc
Q 043900 164 IPSSIFNISS--ITAFDAGMNQLQ 185 (953)
Q Consensus 164 ~p~~l~~l~~--L~~L~L~~N~l~ 185 (953)
.+..+..+++ ++.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 3344555554 356666666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7.6e-20 Score=214.53 Aligned_cols=194 Identities=19% Similarity=0.282 Sum_probs=135.6
Q ss_pred CccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceee
Q 043900 27 LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLS 106 (953)
Q Consensus 27 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (953)
+..+..+.|+++.++...+ +..+.+|+.|+|++|.|+ .+| .|..+++|+.|+|++|.|++..| +..+++|++|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 4445666677777766433 456677777777777776 444 46777777777777777774433 77777777777
Q ss_pred ccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccc
Q 043900 107 VSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186 (953)
Q Consensus 107 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 186 (953)
|++|+|++ +| .|+.+++|+.|+|++|+|++ + ..|..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 77777763 33 67777777777777777764 2 3477777777777777777743 456777777777777777776
Q ss_pred ccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcC
Q 043900 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEV 237 (953)
Q Consensus 187 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (953)
..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+
T Consensus 168 ~~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 168 IVP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CGG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred chh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 555 33677888888888888753 35778888888888888887654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=183.18 Aligned_cols=156 Identities=22% Similarity=0.207 Sum_probs=118.4
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
.-+.+++++++++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus 20 s~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 35677888888776 554443 778888888888887777778888888888888888875555667788888888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
+|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+....
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 88888666666778888888888888887 66777788888888888888887555566777888888888888877543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.6e-19 Score=181.39 Aligned_cols=151 Identities=23% Similarity=0.275 Sum_probs=105.6
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.++.+++++. .+|..+. ++|++|+|++|+|+++.|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 4666666664 6666553 667777777777777667777777777777777777764444556777777777777777
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (953)
|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 77555556677777777777777777 666677777777777777777776555667777777777777777663
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=212.39 Aligned_cols=192 Identities=20% Similarity=0.338 Sum_probs=160.9
Q ss_pred eCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccc
Q 043900 11 LTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVG 90 (953)
Q Consensus 11 l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~ 90 (953)
+....+.+.+ .+..|.+|++|+|++|.|+. +| .|..+++|+.|+|++|+|++..| +..+++|+.|+|++|.|++
T Consensus 28 l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 101 (605)
T 1m9s_A 28 LKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD 101 (605)
T ss_dssp TTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC
Confidence 4444444222 35688999999999999997 44 59999999999999999995544 9999999999999999984
Q ss_pred cCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccc
Q 043900 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170 (953)
Q Consensus 91 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 170 (953)
+| .|..+++|++|+|++|+|++ + ..+..|++|+.|+|++|+|++. ..|..+++|+.|+|++|+|++..| +..
T Consensus 102 -l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~ 173 (605)
T 1m9s_A 102 -LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAG 173 (605)
T ss_dssp -CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTT
T ss_pred -Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hcc
Confidence 44 79999999999999999985 4 3699999999999999999855 679999999999999999996656 899
Q ss_pred cccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcC
Q 043900 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISN 219 (953)
Q Consensus 171 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 219 (953)
+++|+.|+|++|+|++. + .+ ..+++|+.|+|++|++.+.....+..
T Consensus 174 l~~L~~L~Ls~N~i~~l-~-~l-~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 174 LTKLQNLYLSKNHISDL-R-AL-AGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp CTTCCEEECCSSCCCBC-G-GG-TTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred CCCCCEEECcCCCCCCC-h-HH-ccCCCCCEEEccCCcCcCCccccccc
Confidence 99999999999999964 3 33 47999999999999998654444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=180.72 Aligned_cols=153 Identities=14% Similarity=0.250 Sum_probs=84.6
Q ss_pred CCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccE
Q 043900 49 DRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINT 128 (953)
Q Consensus 49 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~ 128 (953)
..+++|++|++++|.|+ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555555555555555 444 4555555555555555443 2234555566666666666665545555666666666
Q ss_pred EecccccccccCCccccccccccceeccccc-ccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCc
Q 043900 129 LFLTDNNLDGGIPDTFGWLKNLATLAMAENW-LSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFEN 207 (953)
Q Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N 207 (953)
|+|++|++++..+..|+.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+ ..+++|+.|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l-~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GI-EDFPKLNQLYAFSQ 191 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TG-GGCSSCCEEEECBC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-Hh-ccCCCCCEEEeeCc
Confidence 6666666655555556666666666666665 44 333 45556666666666666653 22 22 25666666666666
Q ss_pred ccc
Q 043900 208 QLT 210 (953)
Q Consensus 208 ~l~ 210 (953)
+|.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-21 Score=225.65 Aligned_cols=192 Identities=17% Similarity=0.148 Sum_probs=137.4
Q ss_pred cCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCc-------------cccccCcCccCCCCCcEEe-ccCccccc
Q 043900 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS-------------IGGEIPANISSCSNLIQIR-LFYNELVG 90 (953)
Q Consensus 25 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-------------i~~~~p~~~~~l~~L~~L~-L~~n~l~~ 90 (953)
..+++|+.|+|++|+++. +|..++.+++|+.|++++|. +.+..|..++.+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~~-Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHHH-HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHHh-hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 344555555555555553 55555555555555555543 2233334444444444444 333322
Q ss_pred cCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccc
Q 043900 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170 (953)
Q Consensus 91 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 170 (953)
.+|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..+.+
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 133344445555553222 258999999999985 676 999999999999999999 88999999
Q ss_pred cccceEEecCCcccccccccccccccccccEEEeeCccccCCC-CCCCcCCCCCcEEEcccccccCcCCCC
Q 043900 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAI-PPAISNASNLELFQADVNKLTGEVPYL 240 (953)
Q Consensus 171 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~l 240 (953)
+++|+.|+|++|+|++ +| .+. .+++|+.|+|++|+|++.. |..++.+++|+.|++++|++++.++..
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~-~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVA-NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGT-TCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCEEECCCCCCCC-Cc-ccC-CCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 9999999999999996 66 544 7999999999999999876 999999999999999999999887754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.8e-19 Score=184.71 Aligned_cols=137 Identities=22% Similarity=0.195 Sum_probs=105.8
Q ss_pred CcccCcccccceeeEEEEEEcCCCeE--EEEEEeeccchh------------------------hHHHHHHHHHHHhhcC
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTT--VAVKVFNLLHHG------------------------AFKSFIAECNTLKNIR 686 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 686 (953)
|++.+.||+|+||.||+|.+..+++. ||||+++..... ....+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999999656668 999997532111 1236789999999998
Q ss_pred CCCe--eEEEeeecccccCCCCceeEEEeeccC-C----chhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHH
Q 043900 687 HRNL--VKILTACSGVDYQGNDFKALVFEFMQN-R----SLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYL 759 (953)
Q Consensus 687 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L 759 (953)
|+++ ..++++ ...++||||+.+ | +|.++.. ..++.++..++.|++.||.||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~-------------~~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGR-------------ELKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGG-------------GGGGSCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhh-------------ccChHHHHHHHHHHHHHHHHH
Confidence 7753 444433 356899999942 4 5555432 122445778999999999999
Q ss_pred h-hCCCCCeEeecCCCCCeEecCCCcEEEeccccceec
Q 043900 760 H-HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796 (953)
Q Consensus 760 H-~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 796 (953)
| +. ||+||||||+|||++. .++|+|||+|...
T Consensus 187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 88 9999999999999998 8999999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=173.50 Aligned_cols=156 Identities=22% Similarity=0.285 Sum_probs=102.1
Q ss_pred cEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCc-cccCCCccceeeecCCcccccCCCCccCCccccEEEcc
Q 043900 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPS-EVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQ 475 (953)
Q Consensus 397 ~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 475 (953)
+.+++++|+++ .+|..+.. .++.|++++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 45566666664 55554432 345666666666654443 36777777777777777777667777777777777777
Q ss_pred CccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCCcccccccccccCCcCCCCCC
Q 043900 476 GNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGI 555 (953)
Q Consensus 476 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 555 (953)
+|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..+.......+....+.++...|+.+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 77777777777777777777777777777777777777777777777777777766543222222223344555556544
Q ss_pred C
Q 043900 556 P 556 (953)
Q Consensus 556 ~ 556 (953)
.
T Consensus 167 ~ 167 (192)
T 1w8a_A 167 S 167 (192)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-19 Score=187.04 Aligned_cols=170 Identities=23% Similarity=0.293 Sum_probs=122.4
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.+.++..+++++|.++++. .+..+++|++|++++|.|+ .+| .+..+++|++|+|++|+|++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 5677788888888888733 5788888888888888887 556 68888888888888888884433 8888888888
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|++|++++ +|. +.. ++|++|+|++|+|++. ..|..+++|++|+|++|+|++ +| .+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCc
Confidence 888888874 443 333 7888888888888743 357778888888888888873 33 5666777777777777776
Q ss_pred cccccccccccccccEEEeeCccccC
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTG 211 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~ 211 (953)
+. .. +..+++|+.|++++|++++
T Consensus 164 ~~--~~-l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 164 NT--GG-LTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp BC--TT-STTCCCCCEEEEEEEEEEC
T ss_pred ch--HH-hccCCCCCEEeCCCCcccC
Confidence 43 22 2255566666666666553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-19 Score=218.54 Aligned_cols=142 Identities=29% Similarity=0.297 Sum_probs=69.7
Q ss_pred CCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCC
Q 043900 44 IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNL 123 (953)
Q Consensus 44 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L 123 (953)
.|..|..+.+|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 3445555555555555555555 45544555555555555555555 45555555555555555555555 445555555
Q ss_pred CcccEEecccccccccCCccccccccccceecccccccCCCCCccccccc-ceEEecCCcccccccc
Q 043900 124 SSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISS-ITAFDAGMNQLQGVIP 189 (953)
Q Consensus 124 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~ 189 (953)
++|++|+|++|.|+ .+|..|+.|++|++|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 55555555555554 44444555555555555555555444444433321 1234455555554444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=174.43 Aligned_cols=156 Identities=19% Similarity=0.238 Sum_probs=137.0
Q ss_pred cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 23 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
....+++|++|++++|+++. +| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..|..|+.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 34778899999999999996 56 6999999999999999875 34589999999999999999998889999999999
Q ss_pred ceeeccccccccccCCcccCCCcccEEeccccc-ccccCCccccccccccceecccccccCCCCCcccccccceEEecCC
Q 043900 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN-LDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 181 (953)
++|++++|++++..|..|+.+++|++|++++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 999999999998788899999999999999998 76 555 69999999999999999984 55 788999999999999
Q ss_pred ccccc
Q 043900 182 NQLQG 186 (953)
Q Consensus 182 N~l~~ 186 (953)
|+|.+
T Consensus 191 N~i~~ 195 (197)
T 4ezg_A 191 QTIGG 195 (197)
T ss_dssp C----
T ss_pred cccCC
Confidence 99873
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-19 Score=185.80 Aligned_cols=171 Identities=18% Similarity=0.248 Sum_probs=145.7
Q ss_pred EEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccC
Q 043900 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFY 85 (953)
Q Consensus 6 ~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~ 85 (953)
++.++++.+.+. .++ .+..+++|++|++++|+|+. +| .+..+++|++|+|++|+|++ +|. +.++++|++|+|++
T Consensus 21 l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCC
Confidence 345667777776 444 68899999999999999997 55 79999999999999999995 444 99999999999999
Q ss_pred ccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCC
Q 043900 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 86 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
|++++ +|.. .. ++|++|+|++|++++ ++ .++++++|++|+|++|+|++. + .+..+++|++|+|++|++++.
T Consensus 95 N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-- 165 (263)
T 1xeu_A 95 NRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-- 165 (263)
T ss_dssp SCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred CccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence 99985 4443 33 999999999999995 44 699999999999999999854 4 799999999999999999955
Q ss_pred CcccccccceEEecCCccccccccccc
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDF 192 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~ 192 (953)
..+..+++|+.|++++|.+++. |..+
T Consensus 166 ~~l~~l~~L~~L~l~~N~~~~~-~~~~ 191 (263)
T 1xeu_A 166 GGLTRLKKVNWIDLTGQKCVNE-PVKY 191 (263)
T ss_dssp TTSTTCCCCCEEEEEEEEEECC-CEEC
T ss_pred HHhccCCCCCEEeCCCCcccCC-cccc
Confidence 7789999999999999999854 5443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=4.7e-20 Score=215.12 Aligned_cols=187 Identities=18% Similarity=0.201 Sum_probs=117.8
Q ss_pred CCccccceeeccccccccccCCcccCCCcccEEeccccc-------------ccccCCcccccccccccee-cccccccC
Q 043900 97 GSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN-------------LDGGIPDTFGWLKNLATLA-MAENWLSG 162 (953)
Q Consensus 97 ~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~ 162 (953)
..+++|+.|+|++|+++ .+|..+++|++|+.|++++|. +.+..|+.++.+++|+.|+ ++.|++.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45556666666666665 556666666666666665553 3446666777777777777 6666543
Q ss_pred CCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCC
Q 043900 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEK 242 (953)
Q Consensus 163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~ 242 (953)
+|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|.++.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~-------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~------- 477 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY-------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRA------- 477 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH-------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCC-------
T ss_pred ----------hhhhhhhhcccccccCc-------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccc-------
Confidence 44555666666663211 246667777777764 444 6666666666666666652
Q ss_pred CCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCC
Q 043900 243 PQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKF 322 (953)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l 322 (953)
+|..+..+ ++|+.|+|++|+|++ +| .|+.+
T Consensus 478 -----------------------------------------------lp~~~~~l-~~L~~L~Ls~N~l~~-lp-~l~~l 507 (567)
T 1dce_A 478 -----------------------------------------------LPPALAAL-RCLEVLQASDNALEN-VD-GVANL 507 (567)
T ss_dssp -----------------------------------------------CCGGGGGC-TTCCEEECCSSCCCC-CG-GGTTC
T ss_pred -----------------------------------------------cchhhhcC-CCCCEEECCCCCCCC-Cc-ccCCC
Confidence 33344444 467777777777765 44 67777
Q ss_pred CCCCEEEeecCcccccC-CcCccCCCCCCeEEeccccccC
Q 043900 323 VNLQRLEMWNNRLSGTI-PPAIGELQNLRELRLQRNKFLG 361 (953)
Q Consensus 323 ~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~ 361 (953)
++|+.|+|++|.|++.. |..|+.+++|+.|+|++|++++
T Consensus 508 ~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp SSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 77777777777777655 7777777777777777777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.9e-18 Score=185.62 Aligned_cols=305 Identities=9% Similarity=0.030 Sum_probs=177.5
Q ss_pred EEEEEeCCCeeeeecCccccC--CccCceeecCCCccCcCCCccCCC-CCCCcEEeCCCCccc--cccCcCccCCCCCcE
Q 043900 6 VKILNLTSLKLAGSISPHVGN--LSFLKVLLLYNNSFNHGIPSEFDR-LQRLQVLALNNNSIG--GEIPANISSCSNLIQ 80 (953)
Q Consensus 6 ~~~l~l~~~~~~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~i~--~~~p~~~~~l~~L~~ 80 (953)
++.+++.. .|+++..+.. +.+++.|.++++ +....-..+.. +++|++|||++|+|. ...+..+ +.++.
T Consensus 4 ~~~~~~~~---~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~ 76 (329)
T 3sb4_A 4 SKTYYVSK---PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKF 76 (329)
T ss_dssp EEEEEESS---TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCC
T ss_pred ceeEecCC---CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccc
Confidence 44455432 3445555554 677888888864 22111112223 677888888888887 2222222 22455
Q ss_pred EeccCccccccCCcccCC--------ccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccc
Q 043900 81 IRLFYNELVGKIPSELGS--------LSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLAT 152 (953)
Q Consensus 81 L~L~~n~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (953)
+.+..|.| .+..|.+ +++|+.|+|.+ +++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..
T Consensus 77 ~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~ 152 (329)
T 3sb4_A 77 YIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIF 152 (329)
T ss_dssp EEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEE
T ss_pred cccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEE
Confidence 55555533 3345556 77777777777 666555566777777777777777776666667777666666
Q ss_pred eecccccc----cCCCCCcccccccce-EEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEE
Q 043900 153 LAMAENWL----SGTIPSSIFNISSIT-AFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQ 227 (953)
Q Consensus 153 L~L~~N~l----~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 227 (953)
+.+..+.. ....+.+|.++.+|+ .+++.... .++..++. ......++..+.
T Consensus 153 l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~---------------------~~~~~~~~~~l~ 208 (329)
T 3sb4_A 153 IPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMK---------------------AGLQPRDINFLT 208 (329)
T ss_dssp ECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHH---------------------TTCCGGGCSEEE
T ss_pred ecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhh---------------------cccCccccceEE
Confidence 66555322 111223333444433 22221110 01110000 000111112222
Q ss_pred cccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcc
Q 043900 228 ADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307 (953)
Q Consensus 228 L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~ 307 (953)
+. ++ +.......+....++|+.++|+
T Consensus 209 ~~-----------------------------------------------------~~-l~~~~~~~l~~~~~~L~~l~L~ 234 (329)
T 3sb4_A 209 IE-----------------------------------------------------GK-LDNADFKLIRDYMPNLVSLDIS 234 (329)
T ss_dssp EE-----------------------------------------------------EC-CCHHHHHHHHHHCTTCCEEECT
T ss_pred Ee-----------------------------------------------------ee-ecHHHHHHHHHhcCCCeEEECC
Confidence 11 11 0000111122223578888888
Q ss_pred cCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCC-eEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCC
Q 043900 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLR-ELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGS 385 (953)
Q Consensus 308 ~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~ 385 (953)
+|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++ .++.+++++|.++.+
T Consensus 235 ~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I 312 (329)
T 3sb4_A 235 KTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL 312 (329)
T ss_dssp TBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred CCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence 88888788888999999999999888 7778888899999998 898887 6776666777776 467777777777777
Q ss_pred CCccCCCCCCCcEEEc
Q 043900 386 IPSSLGQYKTLTIIDL 401 (953)
Q Consensus 386 ~p~~~~~l~~L~~L~L 401 (953)
.+.+|.++++|+.++.
T Consensus 313 ~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 313 GDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTTTTCTTCCCCEEEC
T ss_pred chhhhcCCcchhhhcc
Confidence 7778888888887763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-18 Score=210.38 Aligned_cols=182 Identities=16% Similarity=0.163 Sum_probs=107.8
Q ss_pred ccCceeecCCCccCcCCCccCCCCCCCc-----EEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQ-----VLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 28 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~-----~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
+.++.|+|++|.+.. .+..+....+|. .++++.|.+. ..|+.|..+.+|+.|+|++|.+. .+|..++++++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 457778888888876 344333222222 2344445555 66778888888888888888888 777777788888
Q ss_pred ceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCc
Q 043900 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMN 182 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 182 (953)
++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+.|++|++|+|++|.|+ .+|..|.++++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 88888888888 78888888888888888888888 67888888888888888888887 77888888888888888888
Q ss_pred ccccccccccccccccccEEEeeCccccCCCCC
Q 043900 183 QLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPP 215 (953)
Q Consensus 183 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 215 (953)
.|++.+|..+......+..|+|++|.+++.+|.
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 888777766642112222345555655554443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.9e-17 Score=163.96 Aligned_cols=177 Identities=23% Similarity=0.262 Sum_probs=130.4
Q ss_pred eEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecC
Q 043900 373 FNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFE 452 (953)
Q Consensus 373 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 452 (953)
+++++++|.++ .+|..+.. +|+.|+|++|+|++..+..++.....++.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45566666664 45555443 7888888888887554444444555667888888888888899999999999999999
Q ss_pred CcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCC
Q 043900 453 NKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 453 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+-.. -...++...+..+...+..|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCC
Confidence 99998888889999999999999999999999999999999999999999997654321 11123333455555555555
Q ss_pred CCCcccccccccccCCcCCCCCC
Q 043900 533 IEGVFKNATITSVLGNLKLCGGI 555 (953)
Q Consensus 533 ~~~~~~~~~~~~~~~n~~lcg~~ 555 (953)
.. +.......+..+..-|.+.
T Consensus 167 ~~--l~~~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 167 SK--VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp TT--TTTSBGGGSCTTTCCCCCC
T ss_pred hH--HcCCChhhCcHhhcCcCCC
Confidence 43 4455555666665556543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.8e-17 Score=161.16 Aligned_cols=131 Identities=24% Similarity=0.315 Sum_probs=110.0
Q ss_pred cEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccC
Q 043900 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQG 476 (953)
Q Consensus 397 ~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 476 (953)
+.+++++|+++ .+|..+. ..++.|++++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 46777777777 6665543 35667888888887 6778889999999999999999987788899999999999999
Q ss_pred ccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCC
Q 043900 477 NFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 477 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99998888889999999999999999997666678889999999999999986543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.4e-17 Score=159.92 Aligned_cols=137 Identities=21% Similarity=0.208 Sum_probs=91.0
Q ss_pred CccCceeecCCCccC-cCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 27 LSFLKVLLLYNNSFN-HGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 27 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.++|++|+|++|+++ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|.+++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 456777777777776 34666677777777777777777643 666777777777777777765566666667777777
Q ss_pred ecccccccccc-CCcccCCCcccEEecccccccccCC---ccccccccccceecccccccCCCCC
Q 043900 106 SVSVNNLTGSI-PSSLGNLSSINTLFLTDNNLDGGIP---DTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 106 ~Ls~N~l~~~~-p~~~~~L~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
+|++|++++.. +..++.+++|++|++++|.+++..+ ..|..+++|++|++++|.+. .+|+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 77777776432 1566677777777777777764443 36666777777777777665 4443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-16 Score=158.65 Aligned_cols=127 Identities=23% Similarity=0.293 Sum_probs=87.5
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
+++++++|+++. +|..+. .+|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 567777777776 554442 46777777777777 66677777777777777777777666666777777777777777
Q ss_pred ccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 111 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
+|++..|.+|.++++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777666666777777777777777776555555666666666666666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.7e-17 Score=175.70 Aligned_cols=282 Identities=13% Similarity=0.037 Sum_probs=191.1
Q ss_pred cEEEEEeCCCeeeeecCccccC-CccCceeecCCCccC--cCCCccCCCCCCCcEEeCCCCccccccCcCccC-------
Q 043900 5 RVKILNLTSLKLAGSISPHVGN-LSFLKVLLLYNNSFN--HGIPSEFDRLQRLQVLALNNNSIGGEIPANISS------- 74 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~------- 74 (953)
+++.|++++. +...--..+.. +++|++|||++|+|+ ...+..+ ..+..+.+..|.| .+.+|.+
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTK 98 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEE
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccccc
Confidence 3556666542 11111123333 778999999999999 4333333 3356666666643 3566777
Q ss_pred -CCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccc----cccCCcccccccc
Q 043900 75 -CSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNL----DGGIPDTFGWLKN 149 (953)
Q Consensus 75 -l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l----~~~~~~~~~~l~~ 149 (953)
+++|+.|+|.+ .++.+.+.+|.+|++|+.|++++|.+....+.+|.++.++..+.+..+.. .......|.++.+
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 99999999999 88877788899999999999999999878888999988888888877432 3345566777887
Q ss_pred cc-ceecccccccCCCCCcc----cccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCc
Q 043900 150 LA-TLAMAENWLSGTIPSSI----FNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLE 224 (953)
Q Consensus 150 L~-~L~L~~N~l~~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 224 (953)
|+ .+.+.... .++..+ ....+++.+.+.++-.. .....+...+++|+.++|++|+++.+...+|.++.+|+
T Consensus 178 L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 178 LETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL 253 (329)
T ss_dssp CEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred cceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence 77 44443321 122221 13455666666554322 22222333477888888888888877777888888888
Q ss_pred EEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCc-E
Q 043900 225 LFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLE-M 303 (953)
Q Consensus 225 ~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~-~ 303 (953)
.+++..| ++.+.+ .+|..+ .+|+ .
T Consensus 254 ~l~l~~n-i~~I~~-----------------------------------------------------~aF~~~-~~L~~~ 278 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQ-----------------------------------------------------RVFSNC-GRLAGT 278 (329)
T ss_dssp EEECCTT-CCEECT-----------------------------------------------------TTTTTC-TTCCEE
T ss_pred EEECCcc-cceehH-----------------------------------------------------HHhhCC-hhccEE
Confidence 8888776 443221 223333 4577 7
Q ss_pred EEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEe
Q 043900 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRL 354 (953)
Q Consensus 304 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 354 (953)
+++.+ +++.+.+.+|.++++|+.|++++|.++.+.+.+|.++++|+.++.
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 77777 666677788888888888888888888777888888888888763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=6.5e-17 Score=157.87 Aligned_cols=137 Identities=24% Similarity=0.212 Sum_probs=122.7
Q ss_pred CcEEEEEeCCCeee-eecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEe
Q 043900 4 QRVKILNLTSLKLA-GSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIR 82 (953)
Q Consensus 4 ~~~~~l~l~~~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ 82 (953)
.+++.|+|++|++. +.+|..+..+++|++|+|++|.+++. ..|..+++|++|+|++|.+++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56899999999997 79999999999999999999999985 7899999999999999999977888888899999999
Q ss_pred ccCccccccC-CcccCCccccceeeccccccccccC---CcccCCCcccEEecccccccccCCcc
Q 043900 83 LFYNELVGKI-PSELGSLSKIEHLSVSVNNLTGSIP---SSLGNLSSINTLFLTDNNLDGGIPDT 143 (953)
Q Consensus 83 L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~L~~L~~L~L~~N~l~~~~~~~ 143 (953)
|++|.+++.. +..+..+++|++|++++|++++..+ ..|..+++|++|++++|.+. ..|++
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999998532 2789999999999999999995444 38999999999999999997 45543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=7.8e-17 Score=153.82 Aligned_cols=129 Identities=22% Similarity=0.223 Sum_probs=97.2
Q ss_pred CCccCceeecCCCccC-cCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccce
Q 043900 26 NLSFLKVLLLYNNSFN-HGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEH 104 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (953)
..++|++|++++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..++.+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3467888888888887 55777788888888888888888744 67778888888888888887667777777788888
Q ss_pred eeccccccccc-cCCcccCCCcccEEecccccccccCC---ccccccccccceecc
Q 043900 105 LSVSVNNLTGS-IPSSLGNLSSINTLFLTDNNLDGGIP---DTFGWLKNLATLAMA 156 (953)
Q Consensus 105 L~Ls~N~l~~~-~p~~~~~L~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~ 156 (953)
|++++|++++. .+..++++++|++|++++|.+++..+ ..|..+++|++|+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88888887753 23677778888888888888775544 467777777777765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.3e-16 Score=151.78 Aligned_cols=133 Identities=22% Similarity=0.225 Sum_probs=108.1
Q ss_pred CcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEcc
Q 043900 396 LTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQ 475 (953)
Q Consensus 396 L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 475 (953)
.+.+++++|+++ .+|..+. ..++.|++++|++++..+..|..+++|++|+|++|+|++..+..|+.+++|++|+|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 356677777776 5554433 345677888888876666778889999999999999987667778899999999999
Q ss_pred CccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCC
Q 043900 476 GNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 476 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
+|+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999998777778899999999999999997666667889999999999999988766
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.9e-15 Score=164.41 Aligned_cols=172 Identities=15% Similarity=0.080 Sum_probs=91.0
Q ss_pred ccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeec
Q 043900 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSV 107 (953)
Q Consensus 28 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (953)
..++.+.+-+ .++.+...+|.++ +|+.++|..| ++.+...+|.+. +|+.+.+.. .++.+.+.+|.++.+|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4455555543 3555555566553 5666666555 554444555553 466666654 444445555666666666666
Q ss_pred cccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccc
Q 043900 108 SVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187 (953)
Q Consensus 108 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 187 (953)
++|+++.....+|. .++|+.+.|.++ ++.+...+|.++++|+.+.|..| ++ .
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-------------------------~ 239 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-------------------------T 239 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-------------------------E
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-------------------------C
Confidence 66666544444444 356666666533 44455555666666665555543 33 2
Q ss_pred cccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccccccc
Q 043900 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLT 234 (953)
Q Consensus 188 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (953)
++...|.+ .+|+.+.+ .+.++.+...+|.++++|+.+.+..|.+.
T Consensus 240 I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 240 IGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp ECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred cccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 22222222 44555555 23344455566666666666666655543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.9e-16 Score=151.55 Aligned_cols=129 Identities=16% Similarity=0.184 Sum_probs=78.3
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSV 109 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (953)
.+.+++++|+++. +|..+ .++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|+++++|++|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4566677777665 44333 25666777777766644445556666666666666666654445556666666666666
Q ss_pred cccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 110 NNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 110 N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 6666555555566666666666666666444444555666666666666555
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-16 Score=152.43 Aligned_cols=129 Identities=20% Similarity=0.240 Sum_probs=116.9
Q ss_pred cCcEEEEEeCCCeee-eecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEE
Q 043900 3 HQRVKILNLTSLKLA-GSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQI 81 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L 81 (953)
..+++.|++++|++. +.+|..+..+++|++|+|++|++++. ..|..+++|++|+|++|.|++.+|..+.++++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356899999999998 79999999999999999999999985 789999999999999999997788888899999999
Q ss_pred eccCcccccc-CCcccCCccccceeeccccccccccC---CcccCCCcccEEeccc
Q 043900 82 RLFYNELVGK-IPSELGSLSKIEHLSVSVNNLTGSIP---SSLGNLSSINTLFLTD 133 (953)
Q Consensus 82 ~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~L~~L~~L~L~~ 133 (953)
++++|.+++. .+..++.+++|++|++++|++++..+ ..++.+++|++|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999853 34889999999999999999996554 4789999999999874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-14 Score=161.12 Aligned_cols=267 Identities=13% Similarity=0.108 Sum_probs=169.7
Q ss_pred cCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccc
Q 043900 73 SSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLAT 152 (953)
Q Consensus 73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (953)
..+..++.+.+.. .++.+...+|.++ +|+.+.+..| ++.+...+|.+ .+|+.+.+.+ .++.+.+.+|.++++|+.
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCe
Confidence 3456777777754 4554666777775 6888888766 66566677877 4788888875 666677788888888888
Q ss_pred eecccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccccc
Q 043900 153 LAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNK 232 (953)
Q Consensus 153 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 232 (953)
++|.+|+++ .+|...+.+.+|+.+.|..+ ++ .++...|.++++|+.+.+.+| ++.+...+|.+ .+|+.+.+. |.
T Consensus 185 l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~ 258 (401)
T 4fdw_A 185 ADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NG 258 (401)
T ss_dssp EECTTSCCS-EECTTTTTTCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TT
T ss_pred eecCCCcce-EechhhEeecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CC
Confidence 888888888 55555555788999998854 66 566666668999999999875 66577788887 788888884 33
Q ss_pred ccCcCCCCCCCCccceeeecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCccc
Q 043900 233 LTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIF 312 (953)
Q Consensus 233 l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~ 312 (953)
++.+.+. +|..+ ++|+.+.+.+|.+.
T Consensus 259 i~~I~~~-----------------------------------------------------aF~~c-~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 259 VTNIASR-----------------------------------------------------AFYYC-PELAEVTTYGSTFN 284 (401)
T ss_dssp CCEECTT-----------------------------------------------------TTTTC-TTCCEEEEESSCCC
T ss_pred ccEEChh-----------------------------------------------------HhhCC-CCCCEEEeCCcccc
Confidence 4332211 11122 24444444444432
Q ss_pred -----ccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCC
Q 043900 313 -----GNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIP 387 (953)
Q Consensus 313 -----~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p 387 (953)
.+.+.+|.++++|+.++|. +.++.+...+|.++++|+.+.|..| ++.+-+.+|.++.++.+++++|.+....+
T Consensus 285 ~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~~~l~~ 362 (401)
T 4fdw_A 285 DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTPPQVFE 362 (401)
T ss_dssp CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSCCBCCC
T ss_pred CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCCccccc
Confidence 3455666777777777776 3466566667777777777777443 44333344444444444444444444444
Q ss_pred ccCCCCC-CCcEEEcCCCcc
Q 043900 388 SSLGQYK-TLTIIDLSDNNL 406 (953)
Q Consensus 388 ~~~~~l~-~L~~L~L~~N~l 406 (953)
..|.+++ +++.|++..+.+
T Consensus 363 ~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 363 KVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp SSCCCSCTTCCEEEECGGGH
T ss_pred ccccCCCCCccEEEeCHHHH
Confidence 4455543 455555555443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-14 Score=159.41 Aligned_cols=137 Identities=6% Similarity=-0.019 Sum_probs=82.9
Q ss_pred ccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCC
Q 043900 39 SFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS 118 (953)
Q Consensus 39 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 118 (953)
.++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|..+ ++.+....|.++.+|+.+.+..+ +......
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 456666677888888888888644 66566677888888888888655 55455667777777777777654 3335556
Q ss_pred cccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCC
Q 043900 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGM 181 (953)
Q Consensus 119 ~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 181 (953)
+|.+...++....... ..+...+|.++++|+.+.+.++..+ .....|.++.+|+.+++..
T Consensus 135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~ 194 (394)
T 4fs7_A 135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPR 194 (394)
T ss_dssp TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCT
T ss_pred eeecccccccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCC
Confidence 6766654443333222 2234456666777776666544322 3334455555555554443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.60 E-value=7.1e-14 Score=156.65 Aligned_cols=331 Identities=10% Similarity=-0.007 Sum_probs=224.2
Q ss_pred ecCc-cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccC
Q 043900 19 SISP-HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELG 97 (953)
Q Consensus 19 ~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (953)
+|+. +|.++.+|+.+.|.. .++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ +......+|.
T Consensus 61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~ 137 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK 137 (394)
T ss_dssp EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence 5555 688999999999974 588888899999999999999866 66577788999999999988765 4446677788
Q ss_pred CccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEE
Q 043900 98 SLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAF 177 (953)
Q Consensus 98 ~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 177 (953)
++..++........ .....+|.++++|+.+.+.++..+ +....|.++.+|+.+.+..| ++.....++.++..|+.+
T Consensus 138 ~~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i 213 (394)
T 4fs7_A 138 GCDFKEITIPEGVT--VIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENM 213 (394)
T ss_dssp TCCCSEEECCTTCC--EECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBC
T ss_pred cccccccccCcccc--ccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhcccccccee
Confidence 87655554444333 245678999999999999876543 77788999999999999877 553556778899999999
Q ss_pred ecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccC
Q 043900 178 DAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLG 257 (953)
Q Consensus 178 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~ 257 (953)
.+..+... +...++ ...+|+.+.+.++ ++.....+|.++.+|+.+.+..+...-....+.....++.+....+.+.
T Consensus 214 ~~~~~~~~--i~~~~~-~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~ 289 (394)
T 4fs7_A 214 EFPNSLYY--LGDFAL-SKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP 289 (394)
T ss_dssp CCCTTCCE--ECTTTT-TTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC
T ss_pred ecCCCceE--eehhhc-ccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec
Confidence 88777544 233333 4578888888654 3435667888899999999887755433333444455554444333222
Q ss_pred CCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccc
Q 043900 258 SRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSG 337 (953)
Q Consensus 258 ~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~ 337 (953)
. .++... .+|+.+.+.++ ++.+...+|.++.+|+.+++.++ ++.
T Consensus 290 ~---------------------------------~~F~~~-~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~ 333 (394)
T 4fs7_A 290 E---------------------------------KTFYGC-SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEE 333 (394)
T ss_dssp T---------------------------------TTTTTC-TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCE
T ss_pred c---------------------------------cccccc-ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccE
Confidence 1 112222 45666666543 44455566666666666666533 554
Q ss_pred cCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEEEccCCcCCCCCCccCCCCCCCcEE
Q 043900 338 TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNLDLSCNFLQGSIPSSLGQYKTLTII 399 (953)
Q Consensus 338 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L~L~~N~l~~~~p~~~~~l~~L~~L 399 (953)
+...+|.++++|+.+.+..| ++..-..+|.++ .|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 334 I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 334 IGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp ECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 55666666666666666555 554445566654 4566666544 22 235678888887764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=8.8e-16 Score=150.98 Aligned_cols=131 Identities=15% Similarity=0.111 Sum_probs=66.7
Q ss_pred ccCCccCceeecCCCccCcCCCccCCCCC-CCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 24 VGNLSFLKVLLLYNNSFNHGIPSEFDRLQ-RLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 24 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
+.++.+|++|+|++|+++. +|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|.|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455556666666666664 332 33333 566666666666532 445555555555555555553333333555555
Q ss_pred ceeeccccccccccCC--cccCCCcccEEecccccccccCCcc----ccccccccceecccccc
Q 043900 103 EHLSVSVNNLTGSIPS--SLGNLSSINTLFLTDNNLDGGIPDT----FGWLKNLATLAMAENWL 160 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~--~~~~L~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l 160 (953)
++|+|++|+|+ .+|. .++++++|++|++++|.++ ..|.. +..+++|++|++++|.+
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 55555555554 3333 4555555555555555554 23332 44455555555554444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=162.09 Aligned_cols=141 Identities=14% Similarity=0.181 Sum_probs=101.8
Q ss_pred HHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch--------------hhHH--------HHHHHHHHHhh
Q 043900 627 YNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH--------------GAFK--------SFIAECNTLKN 684 (953)
Q Consensus 627 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~ 684 (953)
.....-|++.+.||+|++|.||+|.+.. ++.||||+++.... .... ...+|...+.+
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3333459999999999999999999876 45899999752110 0001 12346666666
Q ss_pred cCCCCe--eEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC
Q 043900 685 IRHRNL--VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD 762 (953)
Q Consensus 685 l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 762 (953)
+.+..+ ...+++ ...++||||++|++|.++.. . .....++.|++.+|.|||+.
T Consensus 170 L~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~--------------~--~~~~~l~~qll~~l~~lH~~ 224 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSS--------------V--PDPASLYADLIALILRLAKH 224 (397)
T ss_dssp HHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCC--------------C--SCHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCCCCCeeeec---------cCceEEEEecCCccHhhhcc--------------c--HHHHHHHHHHHHHHHHHHHC
Confidence 644332 222322 23479999999999877652 1 12356889999999999999
Q ss_pred CCCCeEeecCCCCCeEecCCC----------cEEEeccccceec
Q 043900 763 CQPPITHCDLKPSNVLLDEEM----------MAHVSDFGLARFL 796 (953)
Q Consensus 763 ~~~~ivH~Dlkp~NIll~~~~----------~~kL~DfG~a~~~ 796 (953)
|||||||||.|||+++++ .+.|+||+-+...
T Consensus 225 ---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 225 ---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred ---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999999998776 3899999988754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=150.41 Aligned_cols=134 Identities=20% Similarity=0.241 Sum_probs=100.0
Q ss_pred ccCCCCCCCcEEeCCCCccccccCcCccCCC-CCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCC
Q 043900 46 SEFDRLQRLQVLALNNNSIGGEIPANISSCS-NLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLS 124 (953)
Q Consensus 46 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~ 124 (953)
..|.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..|+.+++|++|+|++|+|++..+..|+.++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 35677888888888888888 5554 44444 888888888888854 5788888888888888888855445558888
Q ss_pred cccEEecccccccccCCc--cccccccccceecccccccCCCCCc----ccccccceEEecCCcccc
Q 043900 125 SINTLFLTDNNLDGGIPD--TFGWLKNLATLAMAENWLSGTIPSS----IFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 125 ~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~ 185 (953)
+|++|+|++|+|+ .+|. .|..+++|++|++++|.++ .+|.. +..+++|+.||++.|.+.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8888888888886 4554 6778888888888888887 55653 667777777777777665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-17 Score=167.40 Aligned_cols=133 Identities=23% Similarity=0.262 Sum_probs=64.7
Q ss_pred ccCCccCceeecCCCccCcCCCc------cCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccC
Q 043900 24 VGNLSFLKVLLLYNNSFNHGIPS------EFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELG 97 (953)
Q Consensus 24 ~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (953)
+.....++.++++.+.+++..|. .|..+++|++|+|++|.|++ +| .+.++++|++|+|++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34455666666666666665554 45555555555555555552 34 4444555555555555554 3444444
Q ss_pred CccccceeeccccccccccCCcccCCCcccEEecccccccccCC-ccccccccccceeccccccc
Q 043900 98 SLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 98 ~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 161 (953)
.+++|++|++++|++++ +| .++++++|++|++++|+++...+ +.+..+++|++|++++|.++
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 44445555555554442 23 34444444444444444442111 23444444444444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=8.7e-17 Score=161.59 Aligned_cols=137 Identities=17% Similarity=0.223 Sum_probs=96.2
Q ss_pred CCCCCCCcEEeCCCCccccccCc------CccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCccc
Q 043900 48 FDRLQRLQVLALNNNSIGGEIPA------NISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLG 121 (953)
Q Consensus 48 ~~~l~~L~~L~L~~n~i~~~~p~------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 121 (953)
+.....++.++++.|.+++..|. .|..+++|++|+|++|.+++ +| .+.++++|++|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44456777777777777777666 77777778888888777774 55 7777777777777777777 5666667
Q ss_pred CCCcccEEecccccccccCCccccccccccceecccccccCCCC-CcccccccceEEecCCcccccccc
Q 043900 122 NLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIP-SSIFNISSITAFDAGMNQLQGVIP 189 (953)
Q Consensus 122 ~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~ 189 (953)
.+++|++|+|++|++++ +| .|..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 77777777777777774 34 57777777777777777763221 356666677777777777665544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=4.6e-14 Score=137.46 Aligned_cols=107 Identities=21% Similarity=0.308 Sum_probs=60.2
Q ss_pred eeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCc
Q 043900 423 GLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNN 502 (953)
Q Consensus 423 ~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 502 (953)
.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3444444444 2333332 455556666666655555556666666666666666665555555566666666666666
Q ss_pred ccccCCccccccccCceEeccCCcCcccCC
Q 043900 503 LSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 503 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
|++..+..|..+++|+.|+|++|++++..+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 665444455566666666666666655443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=4.9e-14 Score=137.30 Aligned_cols=106 Identities=23% Similarity=0.270 Sum_probs=82.7
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
..++|++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 35778888888887 66555 3778888888888887767778888888888888888886666667788888888888
Q ss_pred ccccccccCCcccCCCcccEEeccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLD 137 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 137 (953)
+|+|++..+..|.++++|++|+|++|.+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 88888666667888888888888888876
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.1e-14 Score=137.60 Aligned_cols=105 Identities=24% Similarity=0.294 Sum_probs=78.2
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSV 109 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (953)
-+.+++++|+++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 3678888888876 565553 7788888888888866677777888888888888888755555567777888888888
Q ss_pred cccccccCCcccCCCcccEEeccccccc
Q 043900 110 NNLTGSIPSSLGNLSSINTLFLTDNNLD 137 (953)
Q Consensus 110 N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 137 (953)
|+|++..+..|..+++|++|+|++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 8877555555777778888888888776
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=9.1e-14 Score=135.81 Aligned_cols=106 Identities=21% Similarity=0.234 Sum_probs=57.8
Q ss_pred eeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCc
Q 043900 423 GLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNN 502 (953)
Q Consensus 423 ~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 502 (953)
.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 3444444444 3343332 455555555555555555555555666666666666655444445556666666666666
Q ss_pred ccccCCccccccccCceEeccCCcCcccC
Q 043900 503 LSGKIPEFLVGFQLLENLNLSNNNLEGMV 531 (953)
Q Consensus 503 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 531 (953)
|++..+..|..+++|+.|+|++|+|.+..
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccc
Confidence 65444444555666666666666655443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.47 E-value=5.1e-12 Score=141.50 Aligned_cols=144 Identities=11% Similarity=0.124 Sum_probs=93.1
Q ss_pred cEEEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCC-CCcEEeCCCCccccccCcCccCCCCCcEEec
Q 043900 5 RVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQ-RLQVLALNNNSIGGEIPANISSCSNLIQIRL 83 (953)
Q Consensus 5 ~~~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 83 (953)
.++.....+..-.-.||+.+..-. ....++.+...+|.+++ .|+.+.|..+ ++.+...+|.++.+|+.+.+
T Consensus 23 ~~~i~~y~g~~~~v~IP~~i~~~~-------~~~~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~ 94 (394)
T 4gt6_A 23 TATITKYTGNEHRITIPAQVTHGA-------YIYPVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTI 94 (394)
T ss_dssp CEEEEEECCCCSEEECCSEEEETT-------EEEEEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cEEEEEEeCCCceEEECCceeccc-------cceeeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEee
Confidence 344444444444446777653210 01235555667788774 5888888754 66577778888888888888
Q ss_pred cCcc---ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccc
Q 043900 84 FYNE---LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAEN 158 (953)
Q Consensus 84 ~~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (953)
..|. ++.+...+|.++.+|+.+.+..+ ++.....+|.++.+|+.+.+..+. ..+....|..+.+|+.+.+..+
T Consensus 95 ~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~ 170 (394)
T 4gt6_A 95 QDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS 170 (394)
T ss_dssp GGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT
T ss_pred cCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceecccccccccccce
Confidence 7764 55555667888888888777655 443556677778888888876543 3355666777777777766544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=9e-11 Score=131.30 Aligned_cols=334 Identities=13% Similarity=0.144 Sum_probs=201.0
Q ss_pred eecCc-cccCCc-cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCc---cccccCcCccCCCCCcEEeccCccccccC
Q 043900 18 GSISP-HVGNLS-FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS---IGGEIPANISSCSNLIQIRLFYNELVGKI 92 (953)
Q Consensus 18 ~~~~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~---i~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 92 (953)
..|++ +|.+.+ .|+.+.+-.+ ++.+...+|.++.+|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++.+.
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceeh
Confidence 36666 677774 5999999764 888889999999999999998874 77666788999999999998766 55466
Q ss_pred CcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccc
Q 043900 93 PSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNIS 172 (953)
Q Consensus 93 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 172 (953)
...|.++.+|+.+.+..+. ......+|.++.+|+.+.+.++ ++.+...+|.+ .+|+.+.+..+-.. ....++.++.
T Consensus 130 ~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~ 205 (394)
T 4gt6_A 130 SEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECF 205 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCT
T ss_pred hhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcc
Confidence 7789999999999998654 4366778999999999999876 44466667765 56888777655433 4445555555
Q ss_pred cceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeec
Q 043900 173 SITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSIT 252 (953)
Q Consensus 173 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~ 252 (953)
+++......+... .+...++. .......-..
T Consensus 206 ~l~~~~~~~~~~~-~~~~~~~~------------------------~~~~~~~~~~------------------------ 236 (394)
T 4gt6_A 206 ALSTITSDSESYP-AIDNVLYE------------------------KSANGDYALI------------------------ 236 (394)
T ss_dssp TCCEEEECCSSSC-BSSSCEEE------------------------ECTTSCEEEE------------------------
T ss_pred ccceecccccccc-cccceeec------------------------cccccccccc------------------------
Confidence 5555544333322 11100000 0000000000
Q ss_pred ccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeec
Q 043900 253 ENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWN 332 (953)
Q Consensus 253 ~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 332 (953)
..... ..+..+.+. +.++.+...+|.++..|+.+.+.+
T Consensus 237 ----------------~~~~~-------------------------~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~ 274 (394)
T 4gt6_A 237 ----------------RYPSQ-------------------------REDPAFKIP-NGVARIETHAFDSCAYLASVKMPD 274 (394)
T ss_dssp ----------------ECCTT-------------------------CCCSEEECC-TTEEEECTTTTTTCSSCCEEECCT
T ss_pred ----------------ccccc-------------------------cccceEEcC-CcceEcccceeeecccccEEeccc
Confidence 00000 011222221 122334455677777777777765
Q ss_pred CcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCc
Q 043900 333 NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPP 412 (953)
Q Consensus 333 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 412 (953)
+..+ +...+|.++++|+.+.+. +.++ .+...+|.++.+|+.++|.++ ++
T Consensus 275 ~~~~-I~~~aF~~c~~L~~i~l~-~~i~-----------------------~I~~~aF~~c~~L~~i~lp~~-v~----- 323 (394)
T 4gt6_A 275 SVVS-IGTGAFMNCPALQDIEFS-SRIT-----------------------ELPESVFAGCISLKSIDIPEG-IT----- 323 (394)
T ss_dssp TCCE-ECTTTTTTCTTCCEEECC-TTCC-----------------------EECTTTTTTCTTCCEEECCTT-CC-----
T ss_pred ccce-ecCcccccccccccccCC-Cccc-----------------------ccCceeecCCCCcCEEEeCCc-cc-----
Confidence 5543 566677777777777764 2222 133456666777777666543 22
Q ss_pred cccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCC
Q 043900 413 QFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKG 492 (953)
Q Consensus 413 ~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 492 (953)
.+-..+|.++.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... ..+....+
T Consensus 324 --------------------~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~ 379 (394)
T 4gt6_A 324 --------------------QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSG 379 (394)
T ss_dssp --------------------EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCC
T ss_pred --------------------EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCC
Confidence 123356667777777777544 554455667777777777777766542 35566667
Q ss_pred CcEEECCCCcc
Q 043900 493 LNVLDLSQNNL 503 (953)
Q Consensus 493 L~~L~Ls~N~l 503 (953)
|+.+.+..|.+
T Consensus 380 L~~i~i~~~~~ 390 (394)
T 4gt6_A 380 LQNLPVAPGSI 390 (394)
T ss_dssp C----------
T ss_pred CCEEEeCCCCE
Confidence 77777666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.2e-12 Score=140.66 Aligned_cols=104 Identities=16% Similarity=0.204 Sum_probs=87.3
Q ss_pred ceeecCCC-ccCcCCCccCCCCCCCcEEeCCC-CccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 31 KVLLLYNN-SFNHGIPSEFDRLQRLQVLALNN-NSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 31 ~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
..++++++ +++. +|. |..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.+|++|++|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45788888 8887 666 88888999999985 89987767888899999999999999988888888899999999999
Q ss_pred ccccccccCCcccCCCcccEEeccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLD 137 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 137 (953)
+|+|++..+..|..++ |++|+|.+|.+.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 9999866666666665 999999999887
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.5e-14 Score=157.75 Aligned_cols=163 Identities=15% Similarity=0.168 Sum_probs=83.9
Q ss_pred CCCcEEeCCCCccccccCcCccCC-----CCCcEEeccCccccccCCccc-CCccccceeeccccccccccCCcc-----
Q 043900 52 QRLQVLALNNNSIGGEIPANISSC-----SNLIQIRLFYNELVGKIPSEL-GSLSKIEHLSVSVNNLTGSIPSSL----- 120 (953)
Q Consensus 52 ~~L~~L~L~~n~i~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 120 (953)
++|++|+|++|.|+......+..+ .+|++|+|++|.++......+ ..+++|++|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 445566666665554333333222 456666666665543222222 234556666666666653332222
Q ss_pred cCCCcccEEeccccccccc----CCccccccccccceecccccccCC----CCCcccccccceEEecCCccccccccccc
Q 043900 121 GNLSSINTLFLTDNNLDGG----IPDTFGWLKNLATLAMAENWLSGT----IPSSIFNISSITAFDAGMNQLQGVIPLDF 192 (953)
Q Consensus 121 ~~L~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 192 (953)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|+|+.. +++.+...++|++|+|++|.|+......+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2345566666666666421 233345566666666666666532 23444555666666777666654322222
Q ss_pred cc---ccccccEEEeeCccccCCCC
Q 043900 193 GF---TLQNLQFFSVFENQLTGAIP 214 (953)
Q Consensus 193 ~~---~l~~L~~L~L~~N~l~~~~~ 214 (953)
.. ..++|++|+|++|.|+....
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~ 256 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGR 256 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHH
Confidence 11 34667777777777664333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2e-14 Score=158.61 Aligned_cols=160 Identities=18% Similarity=0.135 Sum_probs=101.0
Q ss_pred ccCceeecCCCccCcCCCccCCC-----CCCCcEEeCCCCccccccCcCcc-CCCCCcEEeccCccccccCCccc-----
Q 043900 28 SFLKVLLLYNNSFNHGIPSEFDR-----LQRLQVLALNNNSIGGEIPANIS-SCSNLIQIRLFYNELVGKIPSEL----- 96 (953)
Q Consensus 28 ~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~----- 96 (953)
++|++|+|++|.|+......|.. ..+|++|+|++|.|+......+. .+.+|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45777777777777543333322 25777777777777654433333 45677777777777764433333
Q ss_pred CCccccceeeccccccccc----cCCcccCCCcccEEeccccccccc----CCccccccccccceecccccccCC----C
Q 043900 97 GSLSKIEHLSVSVNNLTGS----IPSSLGNLSSINTLFLTDNNLDGG----IPDTFGWLKNLATLAMAENWLSGT----I 164 (953)
Q Consensus 97 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~ 164 (953)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+.. +++.+..+++|++|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2356677777777777542 334446677777777777777632 245566677777777777777632 2
Q ss_pred CCcccccccceEEecCCcccccc
Q 043900 165 PSSIFNISSITAFDAGMNQLQGV 187 (953)
Q Consensus 165 p~~l~~l~~L~~L~L~~N~l~~~ 187 (953)
+..+...++|++|||++|.|+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHH
Confidence 33344557777777777777643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=3.2e-12 Score=140.69 Aligned_cols=103 Identities=18% Similarity=0.194 Sum_probs=74.3
Q ss_pred EEeCCCC-ccccccCcCccCCCCCcEEeccC-ccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccc
Q 043900 56 VLALNNN-SIGGEIPANISSCSNLIQIRLFY-NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTD 133 (953)
Q Consensus 56 ~L~L~~n-~i~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~ 133 (953)
.++++++ +|+ .+|. |..+++|++|+|++ |.|++..+..|++|++|++|+|++|+|++..|.+|++|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 777 5777 77777777777775 777766666777777777777777777777777777777777777777
Q ss_pred ccccccCCccccccccccceeccccccc
Q 043900 134 NNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
|+|++..+..|..++ |++|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777755555565555 777777766665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-11 Score=127.23 Aligned_cols=148 Identities=15% Similarity=0.103 Sum_probs=112.8
Q ss_pred HHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCC
Q 043900 626 LYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQG 704 (953)
Q Consensus 626 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 704 (953)
+....++|++....+.|+.+.||++...+ ..+++|+...........+.+|+++++.+. +..+.++++++. .
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~--~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~ 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGEN--ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----H 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSS--CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----E
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCC--CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----c
Confidence 44556789888899999999999998653 479999986432223346888999999884 677788888753 2
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC---------------------
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC--------------------- 763 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------- 763 (953)
.+..++||||++|.++.+... +......++.+++++++.||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~---------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYE---------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCC---------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CCceEEEEEecCCeehhhccC---------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 367899999999999987642 01123478899999999999810
Q ss_pred -----------------------------------CCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 764 -----------------------------------QPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 764 -----------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13699999999999998766677999998863
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.4e-08 Score=112.97 Aligned_cols=77 Identities=13% Similarity=0.126 Sum_probs=45.9
Q ss_pred CccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCcccccc
Q 043900 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGF 514 (953)
Q Consensus 436 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 514 (953)
..+|.++.+|+.+.+.++.++.....+|.++.+|+.+.|..+ ++..-..+|.++.+|+.+.+..+ ++..-..+|.++
T Consensus 279 ~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 279 YLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 345666667777777666666555566667777777777544 55444556666677776666544 443334444444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.99 E-value=2e-08 Score=111.62 Aligned_cols=302 Identities=11% Similarity=-0.000 Sum_probs=187.3
Q ss_pred cccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccc
Q 043900 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102 (953)
Q Consensus 23 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (953)
++..-.+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|... +|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 455667889998864 588878889999999999999765 675667788877 6888888655 553555566654 79
Q ss_pred ceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccC------------CCCCcccc
Q 043900 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG------------TIPSSIFN 170 (953)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~p~~l~~ 170 (953)
+.+.+..+-.. ....+|.+. +|+.+.+-.+ ++.+....|..+.+++.+.+..+.... .....+..
T Consensus 116 ~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (379)
T 4h09_A 116 DDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA 192 (379)
T ss_dssp SEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred ccccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence 99999866433 555566654 6777766554 444667778888888887776543221 11222334
Q ss_pred cccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC-CCCCCCcccee
Q 043900 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-YLEKPQRLSVF 249 (953)
Q Consensus 171 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~l~~~~~L~~l 249 (953)
..++..+.+..+.- .+....+....+|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++.+.. .+.....|+.+
T Consensus 193 ~~~~~~~~~~~~~~--~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i 268 (379)
T 4h09_A 193 AKTGTEFTIPSTVK--TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTL 268 (379)
T ss_dssp TCCCSEEECCTTCC--EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccee--EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccc
Confidence 44555555443322 223333336778888877655 44466778888888988888655 332222 12222333333
Q ss_pred eecccccCCCCCCcccccccccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEE
Q 043900 250 SITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLE 329 (953)
Q Consensus 250 ~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 329 (953)
. +..+ +......+|..+ .+|+.+.+.++.++.+...+|.++.+|+.+.
T Consensus 269 ~------------------------------l~~~-i~~i~~~aF~~c-~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~ 316 (379)
T 4h09_A 269 N------------------------------FYAK-VKTVPYLLCSGC-SNLTKVVMDNSAIETLEPRVFMDCVKLSSVT 316 (379)
T ss_dssp E------------------------------ECCC-CSEECTTTTTTC-TTCCEEEECCTTCCEECTTTTTTCTTCCEEE
T ss_pred c------------------------------cccc-ceeccccccccc-cccccccccccccceehhhhhcCCCCCCEEE
Confidence 3 2211 221222233333 5677777777777766677787778888888
Q ss_pred eecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc
Q 043900 330 MWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL 370 (953)
Q Consensus 330 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 370 (953)
|..+ ++.+...+|.++++|+.+.+..+ ++.+-..+|.+.
T Consensus 317 lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 317 LPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 7654 65566777888888887777544 443334444433
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=8.6e-10 Score=115.84 Aligned_cols=139 Identities=17% Similarity=0.079 Sum_probs=96.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC--eeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~ 707 (953)
..+|.+....+.|..+.||++...+ ++.+++|+.... ....+.+|+++++.+.+.+ +.++++++. .++.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~-g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQG-RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTT-SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSC
T ss_pred cCCCceEecccCCCCceEEEEecCC-CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCC
Confidence 3445554444466679999997654 347999997643 2245778999998885444 455777643 2356
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC------------------------
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC------------------------ 763 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------ 763 (953)
.++||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEEEECCSSEETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred CEEEEEecCCcccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 89999999998884 210 11 1256777777888888641
Q ss_pred -------------------------------CCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 764 -------------------------------QPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 764 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877778999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=1e-10 Score=127.57 Aligned_cols=84 Identities=11% Similarity=0.110 Sum_probs=38.5
Q ss_pred cccccceecccccccCCCCCccc---ccccceEEecCCcccccccccccc---cccccccEEEeeCccccCCCCCCCcC-
Q 043900 147 LKNLATLAMAENWLSGTIPSSIF---NISSITAFDAGMNQLQGVIPLDFG---FTLQNLQFFSVFENQLTGAIPPAISN- 219 (953)
Q Consensus 147 l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~- 219 (953)
+++|++|+|.+|.+.+..+..+. .+++|++|||+.|.+++.-...+. ..+++|+.|+|++|.|+......+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 44555555555554422222221 245556666666655542211111 13556666666666655332222222
Q ss_pred CCCCcEEEccccc
Q 043900 220 ASNLELFQADVNK 232 (953)
Q Consensus 220 l~~L~~L~L~~N~ 232 (953)
+ ...++++.++
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 1 3446666665
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=6.1e-10 Score=119.68 Aligned_cols=190 Identities=16% Similarity=0.122 Sum_probs=122.2
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCC--eeEEEeeecccccCCCCceeEEE
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRN--LVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
.+.++.|.+..||++. ..+++|+.... .....+.+|+++++.+ .+.. +.+++.++... ......++||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence 4568999999999864 25889986432 3456788999999887 3322 34454442211 1112458899
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD------------------------------ 762 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------ 762 (953)
|+++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 9999988865331 2466777788888888888888861
Q ss_pred -------------------------CCCCeEeecCCCCCeEecC--CCcEEEeccccceecCCCCCccccccc---c---
Q 043900 763 -------------------------CQPPITHCDLKPSNVLLDE--EMMAHVSDFGLARFLPLSPAQTSSIDA---K--- 809 (953)
Q Consensus 763 -------------------------~~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~---~--- 809 (953)
..+.++|+|++|.||++++ +..+.++||+.+..-....+....... .
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 1246899999999999998 567889999998764321110000000 0
Q ss_pred ------ccccccc-ccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 043900 810 ------GSIGYIA-PEYGLGSEVSINGDVYSYGILLLELVTRKKPV 848 (953)
Q Consensus 810 ------gt~~y~a-PE~~~~~~~~~~sDv~slG~vl~elltg~~pf 848 (953)
..+++.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0111112 222111 122358999999999999998875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=5.1e-09 Score=115.45 Aligned_cols=145 Identities=14% Similarity=0.163 Sum_probs=106.3
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEee--ccc-hhhHHHHHHHHHHHhhcC--CCCeeEEEeeecccccCCCCcee
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLH-HGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
..+.++.|.++.||++...+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+.. ..+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 35678999999999998765 368888875 322 122356788999999986 456788888865331 124578
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC--------------------------
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC-------------------------- 763 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------- 763 (953)
+||||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp EEEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 999999998775422 124678888999999999999999731
Q ss_pred -----------------------------CCCeEeecCCCCCeEecCCCc--EEEecccccee
Q 043900 764 -----------------------------QPPITHCDLKPSNVLLDEEMM--AHVSDFGLARF 795 (953)
Q Consensus 764 -----------------------------~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~ 795 (953)
.+.++|||++|.||+++.++. +.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.80 E-value=4.4e-10 Score=122.62 Aligned_cols=64 Identities=16% Similarity=0.155 Sum_probs=35.7
Q ss_pred cccceEEecCCcccccccccccc--cccccccEEEeeCccccCC----CCCCCcCCCCCcEEEccccccc
Q 043900 171 ISSITAFDAGMNQLQGVIPLDFG--FTLQNLQFFSVFENQLTGA----IPPAISNASNLELFQADVNKLT 234 (953)
Q Consensus 171 l~~L~~L~L~~N~l~~~~~~~~~--~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 234 (953)
+++|+.|+|++|++.+..+..++ ..+++|++|+|+.|.|++. ++..+.++++|+.|++++|.++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 55666666666666543322222 1356666666666666642 2233344566666666666655
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=6.8e-09 Score=102.11 Aligned_cols=63 Identities=17% Similarity=0.198 Sum_probs=32.5
Q ss_pred ccccceeeccccccccc----cCCcccCCCcccEEec--cccccccc----CCccccccccccceeccccccc
Q 043900 99 LSKIEHLSVSVNNLTGS----IPSSLGNLSSINTLFL--TDNNLDGG----IPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 99 l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
.++|++|+|++|+|... +..++...++|++|+| ++|.|+.. +.+.+...++|++|+|++|.+.
T Consensus 92 n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 92 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 34455555555555432 2334455556666666 55665422 2233444566666666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.45 E-value=1.7e-08 Score=99.29 Aligned_cols=89 Identities=12% Similarity=0.175 Sum_probs=42.9
Q ss_pred CCccccceeeccccccccc----cCCcccCCCcccEEeccccccccc----CCccccccccccceec--ccccccCC---
Q 043900 97 GSLSKIEHLSVSVNNLTGS----IPSSLGNLSSINTLFLTDNNLDGG----IPDTFGWLKNLATLAM--AENWLSGT--- 163 (953)
Q Consensus 97 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~--- 163 (953)
...++|++|+|++|+|... +...+...++|++|+|++|.|+.. +.+.+...++|++|+| ++|.|...
T Consensus 62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~ 141 (185)
T 1io0_A 62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 141 (185)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH
Confidence 3334444444444444321 222333445566666666665422 2334455555666666 55655522
Q ss_pred -CCCcccccccceEEecCCcccc
Q 043900 164 -IPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 164 -~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+.+.+...++|++|+|++|.+.
T Consensus 142 ~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 142 EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeccCCCCC
Confidence 2223334455666666666554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.42 E-value=4.8e-08 Score=100.71 Aligned_cols=80 Identities=26% Similarity=0.362 Sum_probs=46.0
Q ss_pred cCCCccceeeecCCcccc--cCCCCccCCccccEEEccCccccCCCCccccCCC--CCcEEECCCCcccccCCc------
Q 043900 440 GNLKNLEVLDVFENKLKG--EIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLK--GLNVLDLSQNNLSGKIPE------ 509 (953)
Q Consensus 440 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------ 509 (953)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+.+.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 345666666666666665 3345555666666666666666643 2233333 666666666666655542
Q ss_pred -cccccccCceEe
Q 043900 510 -FLVGFQLLENLN 521 (953)
Q Consensus 510 -~~~~l~~L~~l~ 521 (953)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 244556665553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-08 Score=103.57 Aligned_cols=119 Identities=17% Similarity=0.194 Sum_probs=79.5
Q ss_pred eecCCCccCcCCC-ccCCCCCCCcE--EeCCCCccccccCc----CccCCCCCcEEeccCccccc--cCCcccCCccccc
Q 043900 33 LLLYNNSFNHGIP-SEFDRLQRLQV--LALNNNSIGGEIPA----NISSCSNLIQIRLFYNELVG--KIPSELGSLSKIE 103 (953)
Q Consensus 33 L~L~~n~l~~~~~-~~~~~l~~L~~--L~L~~n~i~~~~p~----~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~ 103 (953)
|....|.-+..+. ..|...+.|.. ++++.|... .++. ...++++|+.|+|++|+|++ .+|..+..+++|+
T Consensus 121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~ 199 (267)
T 3rw6_A 121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 199 (267)
T ss_dssp HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCC
T ss_pred HHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCC
Confidence 3444444443322 22555556665 777888544 3333 22467888888888888886 4456677888889
Q ss_pred eeeccccccccccCCcccCCC--cccEEecccccccccCCc-------ccccccccccee
Q 043900 104 HLSVSVNNLTGSIPSSLGNLS--SINTLFLTDNNLDGGIPD-------TFGWLKNLATLA 154 (953)
Q Consensus 104 ~L~Ls~N~l~~~~p~~~~~L~--~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~ 154 (953)
.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|+ .+..+++|+.|+
T Consensus 200 ~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 200 ILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 999999988854 2344444 899999999998866653 467888888775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.8e-06 Score=90.76 Aligned_cols=142 Identities=19% Similarity=0.121 Sum_probs=97.7
Q ss_pred cCCcccCccccccee-eEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFG-SVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..|+. +.+..|..| .||+.....++..+++|+... .....+.+|+..++.+. +--+.++++++.. ++..
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~ 95 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDA 95 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeE
Confidence 34443 345556655 699988877777899998753 23456788999988874 3336677777532 3678
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC--------------------------
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD-------------------------- 762 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------- 762 (953)
++|||+++|.++.+.... .......++.+++..++.||+.
T Consensus 96 ~lvme~l~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL 161 (272)
T ss_dssp EEEEECCCSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTC
T ss_pred EEEEEeeCCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhh
Confidence 999999999887765421 1112334566666666666631
Q ss_pred -----------------------------CCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 763 -----------------------------CQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 763 -----------------------------~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 162 VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012489999999999999887778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=4.1e-06 Score=89.51 Aligned_cols=137 Identities=15% Similarity=0.111 Sum_probs=92.6
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCC---CeeEEEeeecccccCCCCceeEEE
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHR---NLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
.+.++.|....||+. + ..+++|+.. .......+.+|+++++.+.+. .+.+++.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v---g--~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---N--GDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE---T--TTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE---C--CEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 456888999999998 2 358888853 233456788999999999642 3556666542 1235678999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD------------------------------ 762 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------ 762 (953)
||++|.++.+... ..++..+...++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 9999988876321 1233444445555555555555532
Q ss_pred ---------------------------CCCCeEeecCCCCCeEecC---CCc-EEEecccccee
Q 043900 763 ---------------------------CQPPITHCDLKPSNVLLDE---EMM-AHVSDFGLARF 795 (953)
Q Consensus 763 ---------------------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DfG~a~~ 795 (953)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 58999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.2e-05 Score=86.00 Aligned_cols=86 Identities=3% Similarity=-0.052 Sum_probs=55.9
Q ss_pred cCcc-cccceeeEEEEEEc---C---CCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcC-C--CCeeEEEeeeccccc
Q 043900 636 ANEI-GVGSFGSVYKGILD---Q---GKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIR-H--RNLVKILTACSGVDY 702 (953)
Q Consensus 636 ~~~i-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~ 702 (953)
.+.| +.|....+|+.... + +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999998764 1 13578899875322 101245677888888873 2 356777777533211
Q ss_pred CCCCceeEEEeeccCCchhhc
Q 043900 703 QGNDFKALVFEFMQNRSLEEW 723 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~ 723 (953)
.+..++||||++|..+.+.
T Consensus 105 --~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp --TSSCEEEEECCCCBCCCBT
T ss_pred --cCCceEEEEecCCCChhhc
Confidence 1356899999998877653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.90 E-value=2.3e-06 Score=81.49 Aligned_cols=92 Identities=15% Similarity=0.157 Sum_probs=53.8
Q ss_pred CCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc-ccccCCcccCCc----cccceeeccccc-cccccC
Q 043900 44 IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE-LVGKIPSELGSL----SKIEHLSVSVNN-LTGSIP 117 (953)
Q Consensus 44 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p 117 (953)
+|.....--+|++|||+++.|+...-..+.++++|++|+|++|. |+...-..++.+ ++|++|+|++|. |++.--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 34433333467777777777766555566667777777777764 543333334443 356777776664 554433
Q ss_pred CcccCCCcccEEeccccc
Q 043900 118 SSLGNLSSINTLFLTDNN 135 (953)
Q Consensus 118 ~~~~~L~~L~~L~L~~N~ 135 (953)
..+.++++|++|+|+++.
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 445566666666666654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=2.2e-05 Score=87.35 Aligned_cols=76 Identities=13% Similarity=0.122 Sum_probs=48.8
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccch-------hhHHHHHHHHHHHhhcCC--C-CeeEEEeeecccccCCC
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-------GAFKSFIAECNTLKNIRH--R-NLVKILTACSGVDYQGN 705 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 705 (953)
.+.+|.|..+.||+++...+++.|+||....... ....++..|.++++.+.. + .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 4679999999999998765556899998653211 123456778888887732 3 344555442 1
Q ss_pred CceeEEEeeccCC
Q 043900 706 DFKALVFEFMQNR 718 (953)
Q Consensus 706 ~~~~lv~e~~~~g 718 (953)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 3457999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.80 E-value=2.7e-06 Score=81.04 Aligned_cols=95 Identities=9% Similarity=0.039 Sum_probs=74.6
Q ss_pred ecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCc-cccccCcCccCC----CCCcEEeccCcc-ccccC
Q 043900 19 SISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS-IGGEIPANISSC----SNLIQIRLFYNE-LVGKI 92 (953)
Q Consensus 19 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~ 92 (953)
.+|.....-..|++|||++|.|+..--..+.++++|++|+|++|. |+...-..+..+ ++|++|+|++|. |+...
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 345533233469999999999998666778999999999999995 876666667765 479999999985 87554
Q ss_pred CcccCCccccceeeccccc-cc
Q 043900 93 PSELGSLSKIEHLSVSVNN-LT 113 (953)
Q Consensus 93 ~~~~~~l~~L~~L~Ls~N~-l~ 113 (953)
-..+.++++|++|+|+++. ++
T Consensus 132 l~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHHGGGCTTCCEEEEESCTTCC
T ss_pred HHHHhcCCCCCEEECCCCCCCC
Confidence 5567889999999999986 44
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=79.92 Aligned_cols=153 Identities=19% Similarity=0.149 Sum_probs=81.0
Q ss_pred CcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC--CCCeeEEEeeecccc-cCCCCceeEEEe
Q 043900 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVD-YQGNDFKALVFE 713 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~-~~~~~~~~lv~e 713 (953)
+.|+.|..+.||++...++ .+++|+.... ...+..|+.+++.+. .-.+.+++....+.. ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~--~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG--AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE--EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC--CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566678899999987543 5899998642 123344555555552 112333333211100 012356789999
Q ss_pred eccCCchhh--------------ccccCCcCCc-cc---CCccccCHHH-------------------------------
Q 043900 714 FMQNRSLEE--------------WLHPITREDK-TE---EAPRSLNLLQ------------------------------- 744 (953)
Q Consensus 714 ~~~~g~L~~--------------~l~~~~~~~~-~~---~~~~~l~~~~------------------------------- 744 (953)
|++|..+.. .+|....... .. .......|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999865531 1111110000 00 0000112211
Q ss_pred HHHHHHHHHHHHHHHhh----------CCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 745 RLNIGIDVACALSYLHH----------DCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 745 ~~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
...+..++..++++|++ .....++|||+++.||+++.++.+.++||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11122234456667763 1245899999999999998888999999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00019 Score=75.87 Aligned_cols=78 Identities=22% Similarity=0.176 Sum_probs=55.5
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-C--CCeeEEEeeecccccCCCCcee
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-H--RNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~~~~~ 709 (953)
....+.+|.|..+.||+.+..++ +.|++|+...........+..|+..|+.+. . --+.+++++ +..+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG-~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADG-TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDRT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTS-CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETTE
T ss_pred eEEEEecCCCCCeEEEEEEECCC-CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCce
Confidence 44567799999999999998776 489999875443333456788999888873 2 235556655 2347
Q ss_pred EEEeeccCCch
Q 043900 710 LVFEFMQNRSL 720 (953)
Q Consensus 710 lv~e~~~~g~L 720 (953)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.45 E-value=5.6e-05 Score=84.73 Aligned_cols=80 Identities=11% Similarity=0.141 Sum_probs=49.8
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCC---CCCcccchHHHHHHHHH
Q 043900 764 QPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLE 840 (953)
Q Consensus 764 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slG~vl~e 840 (953)
.+.++|||++|.||+++.++ ++++||+.+..-...-+..... ..-...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999998876 9999999997532110000000 0012346676654321 12233566688888888
Q ss_pred HHhCC
Q 043900 841 LVTRK 845 (953)
Q Consensus 841 lltg~ 845 (953)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=71.04 Aligned_cols=172 Identities=13% Similarity=0.083 Sum_probs=90.8
Q ss_pred CCcCHHHHHHhhcCCcc-----cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC--ee
Q 043900 619 PNISYQNLYNATDGFAS-----ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LV 691 (953)
Q Consensus 619 ~~~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv 691 (953)
..++.+++......|.. .+.|+.|....+|+....++ .+++|+.... .....+..|+.+++.+.... +.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 34566666666666654 24467788899999987654 5889988642 12234556777777763212 23
Q ss_pred EEEeeecccc-cCCCCceeEEEeeccCCchhhc--------------cccCCcCCcccCC---ccccCHHHHHH------
Q 043900 692 KILTACSGVD-YQGNDFKALVFEFMQNRSLEEW--------------LHPITREDKTEEA---PRSLNLLQRLN------ 747 (953)
Q Consensus 692 ~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~--------------l~~~~~~~~~~~~---~~~l~~~~~~~------ 747 (953)
+++....+.. ....+..+++|+|++|..+... ++..... ..... .....|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~-~~~~~~~~~~~~~w~~~~~~~~~~~ 159 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEG-FEIKRPNALSVDGWKVLWDKSEERA 159 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTT-CCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhcc-CCCcccCccChHHHHHHHHHHHHHH
Confidence 3332211100 0112456899999988654321 1111000 00000 00011221110
Q ss_pred ------HHHHHHHHHHHHhhC----CCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 748 ------IGIDVACALSYLHHD----CQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 748 ------i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
+...+...++++++. ...+++|+|+.+.||++++++.+.++||+.+..
T Consensus 160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011233445555432 234799999999999999876668999998863
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.26 E-value=4.2e-05 Score=74.28 Aligned_cols=115 Identities=14% Similarity=0.087 Sum_probs=52.0
Q ss_pred CCccCceeecCCC-ccCcC----CCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcc
Q 043900 26 NLSFLKVLLLYNN-SFNHG----IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLS 100 (953)
Q Consensus 26 ~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (953)
+-+.|++|+|++| +|... +.+++..-+.|++|+|++|+|....-..|. +.+..-+
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA--------------------~aL~~N~ 98 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLI--------------------ELIETSP 98 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHH--------------------HHHHHCS
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHH--------------------HHHhcCC
Confidence 3345566666553 44431 233344445555555555555432222221 1222334
Q ss_pred ccceeeccccccccc----cCCcccCCCcccEEeccccc---ccc----cCCccccccccccceecccccc
Q 043900 101 KIEHLSVSVNNLTGS----IPSSLGNLSSINTLFLTDNN---LDG----GIPDTFGWLKNLATLAMAENWL 160 (953)
Q Consensus 101 ~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~---l~~----~~~~~~~~l~~L~~L~L~~N~l 160 (953)
.|++|+|++|+|... +-+++..-+.|++|+|++|. +.. .+.+.+...+.|+.|+++.|.+
T Consensus 99 tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 99 SLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp SCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred ccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 455555555554431 22234444456666665442 221 1223444555666666665544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0015 Score=69.21 Aligned_cols=145 Identities=17% Similarity=0.148 Sum_probs=89.3
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC---CCCeeEEEeeecccccCCCCceeEEE
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR---HRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
.+.|+.|....+|+.... +..+++|+.... ....+..|++.++.+. ...+.++++++.. .+..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence 467899999999999864 347889987532 3466788988888883 3567778777532 35789999
Q ss_pred eeccCCchhh-----------ccccCCc-CCccc-----------CCccccCHHHHH---HHHH----------------
Q 043900 713 EFMQNRSLEE-----------WLHPITR-EDKTE-----------EAPRSLNLLQRL---NIGI---------------- 750 (953)
Q Consensus 713 e~~~~g~L~~-----------~l~~~~~-~~~~~-----------~~~~~l~~~~~~---~i~~---------------- 750 (953)
||+++..+.. .++.... ..... .....-+|.+.. ++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999876531 1222211 00000 001112444321 1111
Q ss_pred HHHHH-HHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 751 DVACA-LSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 751 ~i~~~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
+++.. ...|.. ..++.++|+|+.+.|++++.++ +.|.|++
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223321 2356899999999999999887 8899974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.24 E-value=4.2e-05 Score=74.24 Aligned_cols=114 Identities=11% Similarity=0.104 Sum_probs=79.1
Q ss_pred ccCCCCCcEEeccCc-cccc----cCCcccCCccccceeeccccccccccC----CcccCCCcccEEeccccccccc---
Q 043900 72 ISSCSNLIQIRLFYN-ELVG----KIPSELGSLSKIEHLSVSVNNLTGSIP----SSLGNLSSINTLFLTDNNLDGG--- 139 (953)
Q Consensus 72 ~~~l~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~L~~L~~L~L~~N~l~~~--- 139 (953)
+.+-+.|++|+|++| .|.. .+-+.+..-+.|+.|+|++|+|...-- +++..-+.|++|+|++|.|+..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 334556666666664 5542 234456667788888888888875433 3445668999999999999743
Q ss_pred -CCccccccccccceeccccc---ccC----CCCCcccccccceEEecCCcccc
Q 043900 140 -IPDTFGWLKNLATLAMAENW---LSG----TIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 140 -~~~~~~~l~~L~~L~L~~N~---l~~----~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+.+++...+.|++|+|++|. +.. .+.+.+..-++|+.|+++.|.+.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 33456677889999998764 332 13345667789999999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0017 Score=68.83 Aligned_cols=72 Identities=8% Similarity=0.104 Sum_probs=44.4
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCe-eEEEeeecccccCCCCceeEEEee
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .++++++ .+.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEEEC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEEee
Confidence 678999999999999 25889988643221 1123457777776632222 4555542 1234789999
Q ss_pred c-cCCchh
Q 043900 715 M-QNRSLE 721 (953)
Q Consensus 715 ~-~~g~L~ 721 (953)
+ ++.++.
T Consensus 89 i~~g~~l~ 96 (301)
T 3dxq_A 89 IAGAQTMS 96 (301)
T ss_dssp CTTCEECC
T ss_pred cCCCccCC
Confidence 9 665553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0024 Score=68.62 Aligned_cols=172 Identities=15% Similarity=0.147 Sum_probs=91.1
Q ss_pred CCCCcCHHHHHHhhcCCcc-----cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCC--C
Q 043900 617 SFPNISYQNLYNATDGFAS-----ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHR--N 689 (953)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--n 689 (953)
++...+.+.+....+.|.+ ...++ |....||++...++ +.+++|+..... .....+..|..+++.+... .
T Consensus 7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g-~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~ 83 (328)
T 1zyl_A 7 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVP 83 (328)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCC-CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCe
Confidence 3455666666655554432 23466 88889999877554 368999986321 1234566788887777422 2
Q ss_pred eeEEEeeecccc-cCCCCceeEEEeeccCCchhh-----------c---cccCCcCCcccCCccccCHHH----------
Q 043900 690 LVKILTACSGVD-YQGNDFKALVFEFMQNRSLEE-----------W---LHPITREDKTEEAPRSLNLLQ---------- 744 (953)
Q Consensus 690 iv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~-----------~---l~~~~~~~~~~~~~~~l~~~~---------- 744 (953)
+.+++.. .+.. ....+..++||||++|..+.. . ++...... ........++..
T Consensus 84 vp~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~-~~~~~~~~~~~~~~~~~~~~l~ 161 (328)
T 1zyl_A 84 VAAPVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQ-LFIHRPTIGLNEYLIEPRKLFE 161 (328)
T ss_dssp BCCCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSS-CCSSSCBCSHHHHTHHHHHHHH
T ss_pred ecceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccC-CCccCCCCCHHHHHhhHHHHHh
Confidence 3444433 1110 111345678999998865431 0 11100000 000001111111
Q ss_pred ------------HHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 745 ------------RLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 745 ------------~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
....+.+++..++.... .....++|||+++.||+++ + .+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 162 DATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11122222222222211 1234789999999999999 4 899999988864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0016 Score=71.03 Aligned_cols=148 Identities=11% Similarity=0.143 Sum_probs=84.1
Q ss_pred cCcccccceeeEEEEEEcC-------CCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCc
Q 043900 636 ANEIGVGSFGSVYKGILDQ-------GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+.+..|-...+|++...+ +++.|++|+..... .......+|..+++.+. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP-----E--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C---
Confidence 3567788889999998753 33579999874321 23455668999888873 333356666642 1
Q ss_pred eeEEEeeccCCchhhc-ccc-------------CCcCCcccCCcccc--CHHHHHHHHHHHHH-----------------
Q 043900 708 KALVFEFMQNRSLEEW-LHP-------------ITREDKTEEAPRSL--NLLQRLNIGIDVAC----------------- 754 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~-l~~-------------~~~~~~~~~~~~~l--~~~~~~~i~~~i~~----------------- 754 (953)
.+||||++|.++..- +.. ...... ...... -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~--~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM--PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC--SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC--CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 289999998666421 100 000000 011112 24455555544322
Q ss_pred --HHHHHhh----C-CCCCeEeecCCCCCeEecCC----CcEEEecccccee
Q 043900 755 --ALSYLHH----D-CQPPITHCDLKPSNVLLDEE----MMAHVSDFGLARF 795 (953)
Q Consensus 755 --~L~~LH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kL~DfG~a~~ 795 (953)
.++.|.+ . ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2233321 1 23479999999999999876 7899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0014 Score=59.41 Aligned_cols=56 Identities=21% Similarity=0.288 Sum_probs=30.1
Q ss_pred EEEccCcccc-CCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCc
Q 043900 471 QLEMQGNFLQ-GPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLE 528 (953)
Q Consensus 471 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 528 (953)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555554 23343322 24566666666666544555556666666666666654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0033 Score=70.46 Aligned_cols=76 Identities=14% Similarity=0.075 Sum_probs=48.8
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCe-eEEEeeecccccCCCCceeEEEee
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNL-VKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
.+.|+.|-...+|++...+++..|++|+........ -...+|..+++.+...++ .++++++. + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-------~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-------N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-------T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-------C--eEEEEe
Confidence 467888999999999987644678899875322211 112578888888854434 56666641 1 359999
Q ss_pred ccCCchh
Q 043900 715 MQNRSLE 721 (953)
Q Consensus 715 ~~~g~L~ 721 (953)
++|.++.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9886654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0025 Score=71.12 Aligned_cols=75 Identities=17% Similarity=0.186 Sum_probs=49.9
Q ss_pred cCcccccceeeEEEEEEcC-------CCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCc
Q 043900 636 ANEIGVGSFGSVYKGILDQ-------GKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+.|+.|....||++...+ .++.|++|+.... .....+.+|..+++.+. +.-..++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C---
Confidence 4568889999999998763 2357999998431 11145557888888884 322356666532 1
Q ss_pred eeEEEeeccCCchh
Q 043900 708 KALVFEFMQNRSLE 721 (953)
Q Consensus 708 ~~lv~e~~~~g~L~ 721 (953)
.+||||++|.++.
T Consensus 148 -g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 -GRLEEYIPSRPLS 160 (429)
T ss_dssp -EEEECCCCEEECC
T ss_pred -CEEEEEeCCcccC
Confidence 3899999875553
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0063 Score=65.47 Aligned_cols=32 Identities=28% Similarity=0.304 Sum_probs=28.0
Q ss_pred CCCeEeecCCCCCeEecCC----CcEEEecccccee
Q 043900 764 QPPITHCDLKPSNVLLDEE----MMAHVSDFGLARF 795 (953)
Q Consensus 764 ~~~ivH~Dlkp~NIll~~~----~~~kL~DfG~a~~ 795 (953)
...++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4589999999999999875 6899999998875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0026 Score=57.63 Aligned_cols=56 Identities=23% Similarity=0.337 Sum_probs=36.1
Q ss_pred eeeecCCccc-ccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCccc
Q 043900 447 VLDVFENKLK-GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS 504 (953)
Q Consensus 447 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (953)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555666654 23443332 35677777777777666666777777777888877765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0049 Score=67.47 Aligned_cols=75 Identities=15% Similarity=0.209 Sum_probs=44.5
Q ss_pred cCcccccceeeEEEEEEcCC--------CeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC-eeEEEeeecccccCCCC
Q 043900 636 ANEIGVGSFGSVYKGILDQG--------KTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN-LVKILTACSGVDYQGND 706 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~ 706 (953)
.+.++.|....+|++...++ ++.+++|+....... ......|.++++.+.... +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--------- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--------- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---------
Confidence 35678888899999987642 247889987543221 112356788887774223 44666542
Q ss_pred ceeEEEeeccCCch
Q 043900 707 FKALVFEFMQNRSL 720 (953)
Q Consensus 707 ~~~lv~e~~~~g~L 720 (953)
.-++||||++|..+
T Consensus 108 ~~~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 NGGRIEEWLYGDPL 121 (369)
T ss_dssp TTEEEEECCCSEEC
T ss_pred CCcEEEEEecCCcC
Confidence 12689999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.011 Score=63.65 Aligned_cols=32 Identities=22% Similarity=0.340 Sum_probs=28.5
Q ss_pred CCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 764 QPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 764 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
...++|+|+.+.||++++++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34799999999999999888899999988865
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0063 Score=59.15 Aligned_cols=103 Identities=16% Similarity=0.095 Sum_probs=65.7
Q ss_pred CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecC
Q 043900 718 RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797 (953)
Q Consensus 718 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 797 (953)
-+|.+.++. ...++++.++|.++.|.+.+|.-.-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~---------~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRL---------YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHHH---------cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---
Confidence 378888853 3457999999999999999987762110 101223456889999999888774 1111
Q ss_pred CCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 043900 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847 (953)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~p 847 (953)
.....+.|||... ...+.+.=|||+|+++|..+-=..|
T Consensus 98 -----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0223466888753 3556788999999999999974433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.72 E-value=0.039 Score=60.88 Aligned_cols=75 Identities=11% Similarity=0.148 Sum_probs=48.2
Q ss_pred cCcccccceeeEEEEEEcCC-------CeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCc
Q 043900 636 ANEIGVGSFGSVYKGILDQG-------KTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 707 (953)
.+.+..|-...+|+.....+ ++.|++|+....... .-...+|..+++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---------~ 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF---------P 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---------C
Confidence 45677888899999998631 357999987543221 122356788777773 33344555542 1
Q ss_pred eeEEEeeccCCch
Q 043900 708 KALVFEFMQNRSL 720 (953)
Q Consensus 708 ~~lv~e~~~~g~L 720 (953)
-+.||||++|.++
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.98 E-value=0.17 Score=55.62 Aligned_cols=30 Identities=27% Similarity=0.442 Sum_probs=25.3
Q ss_pred CeEeecCCCCCeEe------cCCCcEEEecccccee
Q 043900 766 PITHCDLKPSNVLL------DEEMMAHVSDFGLARF 795 (953)
Q Consensus 766 ~ivH~Dlkp~NIll------~~~~~~kL~DfG~a~~ 795 (953)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4566899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.75 E-value=0.05 Score=37.52 Aligned_cols=28 Identities=18% Similarity=0.179 Sum_probs=13.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhhccc
Q 043900 579 LALAIISGLTGLSLALSFLILCLVRKRKE 607 (953)
Q Consensus 579 ~~~~ii~~~~~~~~~~~~~~~~~~~~r~~ 607 (953)
++.++++|++++++++...+ +++|+|+.
T Consensus 13 IA~gVVgGv~~~~ii~~~~~-~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIG-LFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHH-HHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHH-HHhhhhHh
Confidence 44555666665554444433 44444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.56 E-value=0.11 Score=35.82 Aligned_cols=27 Identities=26% Similarity=0.287 Sum_probs=13.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhhc
Q 043900 579 LALAIISGLTGLSLALSFLILCLVRKR 605 (953)
Q Consensus 579 ~~~~ii~~~~~~~~~~~~~~~~~~~~r 605 (953)
++.++++|++++++++...+++++||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 555566666655555544444443333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.00 E-value=0.47 Score=32.56 Aligned_cols=17 Identities=18% Similarity=0.454 Sum_probs=7.1
Q ss_pred HHHHHHHHHhhhhhccc
Q 043900 591 SLALSFLILCLVRKRKE 607 (953)
Q Consensus 591 ~~~~~~~~~~~~~~r~~ 607 (953)
+++++++++++.|||+.
T Consensus 24 ~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 24 VVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhheehhhh
Confidence 33334444444444443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=83.15 E-value=1.5 Score=29.31 Aligned_cols=24 Identities=25% Similarity=0.213 Sum_probs=9.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhh
Q 043900 581 LAIISGLTGLSLALSFLILCLVRK 604 (953)
Q Consensus 581 ~~ii~~~~~~~~~~~~~~~~~~~~ 604 (953)
+++++|.++.+++++.+.++++||
T Consensus 14 AGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 14 VAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eeeehHHHHHHHHHHHHHHHHeec
Confidence 444444444333333333444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.54 E-value=2.1 Score=41.52 Aligned_cols=84 Identities=15% Similarity=0.198 Sum_probs=63.3
Q ss_pred ccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCccccccccccccccccc
Q 043900 739 SLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPE 818 (953)
Q Consensus 739 ~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE 818 (953)
..+...+++++.+|+....+++.. +|--+.|+||+++.++.+++.-.|.-..++ |.
T Consensus 77 ~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~ 132 (215)
T 4ann_A 77 SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVVD-------------------PL 132 (215)
T ss_dssp GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTBS-------------------CC
T ss_pred hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCCC-------------------CC
Confidence 578899999999999988777754 788999999999999999999887654332 11
Q ss_pred ccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 819 YGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 819 ~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
..+...=.-.+=|++..+++++..|+..
T Consensus 133 -----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 133 -----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp -----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred -----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 1122222345678889999999988653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 953 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-07 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 73/306 (23%), Positives = 121/306 (39%), Gaps = 53/306 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGA--FKSFIAECNTLKNIRHRNLVKIL 694
IG GSFG+VYKG VAVK+ N+ ++F E L+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ A+V ++ + SL LH +++ ++I A
Sbjct: 71 GYSTA------PQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQ 115
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+ YLH I H DLK +N+ L E++ + DFGLA GSI +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 815 IAPEYGLGSE---VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVV 871
+APE + S DVY++GI+L EL+T + P ++ + D ++
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQII 219
Query: 872 DIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931
+V LS D + C AM R+ C + +R ++
Sbjct: 220 FMVGRGYLSPDLS--------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
Query: 932 QLQSIK 937
++ +
Sbjct: 266 SIELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-48
Identities = 58/314 (18%), Positives = 114/314 (36%), Gaps = 39/314 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
IG G FG V++G VAVK+F+ ++ AE +RH N++ + A
Sbjct: 10 SIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ + LV ++ ++ SL ++L+ ++ + + + + A L+
Sbjct: 67 NKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLA 114
Query: 758 YLHHDC-----QPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP--LSPAQTSSIDAKG 810
+LH + +P I H DLK N+L+ + ++D GLA + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 811 SIGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
+ Y+APE S + D+Y+ G++ E+ R + + ++
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924
+ + + R E L M +I C + R+
Sbjct: 235 -----------DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 925 NMTNVVRQLQSIKN 938
+ + L +
Sbjct: 284 TALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-47
Identities = 56/275 (20%), Positives = 99/275 (36%), Gaps = 22/275 (8%)
Query: 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRH 687
D F +E+G G+ G V+K +A K+ +L + I E L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLN 747
+V A + ++ E M SL++ L R +
Sbjct: 64 PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGR----------IPEQILGK 108
Query: 748 IGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSID 807
+ I V L+YL I H D+KPSN+L++ + DFG++ L S A +
Sbjct: 109 VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--- 163
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867
G+ Y++PE G+ S+ D++S G+ L+E+ + P+ ++ L ++
Sbjct: 164 -VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 902
T + + I
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-47
Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 57/303 (18%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+G G FG V+ G + T VAVK + +F+AE N +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
+ + ++ E+M+N SL ++L + L + + L++ +A +
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
+++ H DL+ +N+L+ + + ++DFGLAR + + AK I + A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD---MNLHNFARMALPDHVVDI 873
PE +I DV+S+GILL E+VT + NL RM PD+ +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE- 237
Query: 874 VDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933
+ ++ C E P DR + L
Sbjct: 238 ---------------------------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 934 QSI 936
+
Sbjct: 265 EDF 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-46
Identities = 71/302 (23%), Positives = 110/302 (36%), Gaps = 55/302 (18%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
IG G FG V G VAVK + ++F+AE + + +RH NLV++L
Sbjct: 13 QTIGKGEFGDVMLGDYR--GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
+ +V E+M SL ++L L L +DV A+
Sbjct: 69 I----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 116
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YL H DL NVL+ E+ +A VSDFGL + ++ K + + A
Sbjct: 117 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTA 168
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876
PE + S DV+S+GILL E+ + + + L + + +D D
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPD- 223
Query: 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
C A+ + C R + + QL+ I
Sbjct: 224 --------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
Query: 937 KN 938
K
Sbjct: 258 KT 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 1e-46
Identities = 67/331 (20%), Positives = 126/331 (38%), Gaps = 64/331 (19%)
Query: 622 SYQNLYNATDGFASA---------NEIGVGSFGSVYKGIL---DQGKTTVAVKVFNL-LH 668
++++ A FA IG G FG V G L + + VA+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 669 HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPIT 728
+ F++E + + H N++ + + ++ EFM+N SL+ +L
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLR--- 119
Query: 729 REDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788
+ ++Q + + +A + YL H DL N+L++ ++ VS
Sbjct: 120 ------QNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170
Query: 789 DFGLARFLPLSPAQ---TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK 845
DFGL+RFL + TS++ K I + APE + + DV+SYGI++ E+++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 846 KPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECL 905
+ DM + D+ R+ ++C
Sbjct: 231 ERPYW----DMTNQDVINAIEQDY---------------------------RLPPPMDCP 259
Query: 906 VAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
A+ ++ + C + R +V L +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 57/258 (22%), Positives = 99/258 (38%), Gaps = 21/258 (8%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
IG GS+G K + K + + + ++E N L+ ++H N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ N +V E+ + L + T+E + L+ L + +
Sbjct: 70 DRIID---RTNTTLYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTL 120
Query: 755 ALSYLH--HDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
AL H D + H DLKP+NV LD + + DFGLAR L + + G+
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTP 178
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM--NLHNFARMALPDHV 870
Y++PE + D++S G LL EL P + + ++ + +P
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 871 ----VDIVDSTLLSDDED 884
+I+ L D
Sbjct: 239 SDELNEIITRMLNLKDYH 256
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 24/268 (8%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
EIG GSF +VYKG+ + VA L + F E LK ++H N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ +G LV E M + +L+ +L + + + + +
Sbjct: 75 DSWESTV-KGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILK 123
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMM-AHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
L +LH PPI H DLK N+ + + D GLA S A+ G+
Sbjct: 124 GLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 178
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873
++APE + + DVY++G+ +LE+ T + P + N R
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPAS 233
Query: 874 VDSTLLSDDEDLAVHGNQRQRQARINSK 901
D + + +++ ++ + R + K
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIK 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 67/320 (20%), Positives = 115/320 (35%), Gaps = 53/320 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTT---VAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVK 692
IG G FG VY G L AVK N + G F+ E +K+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+L C + +V +M++ L ++ + + + G+ V
Sbjct: 93 LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQV 139
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ--TSSIDAKG 810
A + H DL N +LDE+ V+DFGLAR + + AK
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870
+ ++A E + + DV+S+G+LL EL+TR P D+N +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY------ 246
Query: 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930
++ L E C + + + C R + + +V
Sbjct: 247 --LLQGRRLLQPEY-------------------CPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 931 RQLQSIKNILLGHRIVSNMQ 950
++ +I + +G V
Sbjct: 286 SRISAIFSTFIGEHYVHVNA 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 5e-45
Identities = 69/320 (21%), Positives = 122/320 (38%), Gaps = 59/320 (18%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNL 690
+IG G+FG V++ + T VAVK+ F E + + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH--------------PITREDKTEEA 736
VK+L C L+FE+M L E+L TR +
Sbjct: 79 VKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 737 PRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
P L+ ++L I VA ++YL H DL N L+ E M+ ++DFGL+R +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 797 PLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
+ + + I ++ PE + + DV++YG++L E+ +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--------- 241
Query: 857 NLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACS 916
+ MA + + + D +L+ E+ C + + + C
Sbjct: 242 ---PYYGMAHEEVIYYVRDGNILACPEN-------------------CPLELYNLMRLCW 279
Query: 917 MESPGDRMNMTNVVRQLQSI 936
+ P DR + ++ R LQ +
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 60/318 (18%), Positives = 114/318 (35%), Gaps = 54/318 (16%)
Query: 624 QNLYNATDGFASAN-EIGVGSFGSVYKGIL--DQGKTTVAVKVFNL-LHHGAFKSFIAEC 679
+ L+ D A+ E+G G+FGSV +G+ + + VA+KV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 680 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS 739
+ + + +V+++ C LV E L ++L
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV---------GKREE 105
Query: 740 LNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-PL 798
+ + + V+ + YL H DL NVLL A +SDFGL++ L
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 799 SPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858
T+ K + + APE + S DV+SYG+ + E ++ + ++
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGP 219
Query: 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSME 918
A + ++ R+ EC + + C +
Sbjct: 220 EVMAFI----------------------------EQGKRMECPPECPPELYALMSDCWIY 251
Query: 919 SPGDRMNMTNVVRQLQSI 936
DR + V +++++
Sbjct: 252 KWEDRPDFLTVEQRMRAC 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-44
Identities = 72/300 (24%), Positives = 109/300 (36%), Gaps = 51/300 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
EIG G FG V+ G VA+K + FI E + + H LV++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
C LVFEFM++ L ++L E L + +DV +
Sbjct: 69 C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGM 114
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
+ + + H DL N L+ E + VSDFG+ RF+ TSS K + + +
Sbjct: 115 ---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWAS 170
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876
PE S S DV+S+G+L+ E+ + K N N + +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------ENRSNSEVVEDISTGFRLYKP 224
Query: 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
L S + +I C E P DR + ++RQL I
Sbjct: 225 RLASTH-------------------------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
++G G FG V+ G + VA+K ++F+ E +K +RH LV++
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
S + +V E+M SL ++L T + Q +++ +A +
Sbjct: 81 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--------QLVDMAAQIASGM 126
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
+Y+ H DL+ +N+L+ E ++ V+DFGLAR + T+ AK I + A
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 182
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876
PE L +I DV+S+GILL EL T+ + M V+D V+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMV---------NREVLDQVER 229
Query: 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
R+ EC ++ + C + P +R + L+
Sbjct: 230 GY------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 64/308 (20%), Positives = 107/308 (34%), Gaps = 61/308 (19%)
Query: 637 NEIGVGSFGSVYKGILDQGKT--TVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVK 692
E+G G+FG+V KG K TVAVK+ +AE N ++ + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
++ C + LV E + L ++L R + + + V
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQV 116
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDAKGS 811
+ + YL H DL NVLL + A +SDFGL++ L + K
Sbjct: 117 SMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 812 IGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK-PVDSMFEGDM--NLHNFARMALPD 868
+ + APE + S DV+S+G+L+ E + + P M ++ L RM P
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTN 928
M + C +R
Sbjct: 234 GCPR----------------------------------EMYDLMNLCWTYDVENRPGFAA 259
Query: 929 VVRQLQSI 936
V +L++
Sbjct: 260 VELRLRNY 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 3e-43
Identities = 67/300 (22%), Positives = 123/300 (41%), Gaps = 49/300 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+++G G +G VY+G+ + TVAVK + F+ E +K I+H NLV++L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
C ++ EFM +L ++L R++ + L + ++ A+
Sbjct: 82 C-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--------VLLYMATQISSAM 128
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YL + H DL N L+ E + V+DFGL+R + T+ AK I + A
Sbjct: 129 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 184
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876
PE ++ SI DV+++G+LL E+ T ++L + D+ ++ +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYRMERPE- 239
Query: 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
C + + AC +P DR + + + +++
Sbjct: 240 --------------------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 64/318 (20%), Positives = 106/318 (33%), Gaps = 58/318 (18%)
Query: 638 EIGVGSFGSVYKGILDQGKTT-----VAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNL 690
+G G+FG V T VAVK+ ++ ++E + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH-------------PITREDKTEEAP 737
V +L AC + L+FE+ L +L + + EE
Sbjct: 104 VNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 738 RSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLP 797
L L VA + +L H DL NVL+ + + DFGLAR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 798 LSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMN 857
+A+ + ++APE +I DV+SYGILL E+ + + G
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPV 272
Query: 858 LHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSM 917
NF ++ Q +++ + I +C
Sbjct: 273 DANFYKLI---------------------------QNGFKMDQPFYATEEIYIIMQSCWA 305
Query: 918 ESPGDRMNMTNVVRQLQS 935
R + N+ L
Sbjct: 306 FDSRKRPSFPNLTSFLGC 323
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 61/306 (19%), Positives = 118/306 (38%), Gaps = 54/306 (17%)
Query: 637 NEIGVGSFGSVYKGILDQG----KTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLV 691
IG G FG VYKG+L + VA+K F+ E + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
++ ++ E+M+N +L+++L E ++LQ + +
Sbjct: 73 RLEGVI-----SKYKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRG 118
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQT-SSIDAKG 810
+A + + H DL N+L++ ++ VSDFGL+R L P T ++ K
Sbjct: 119 IAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870
I + APE + + DV+S+GI++ E++T + V
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHEV 222
Query: 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930
+ ++ R+ + ++C A+ ++ + C + R ++V
Sbjct: 223 MKAINDGF------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264
Query: 931 RQLQSI 936
L +
Sbjct: 265 SILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 27/237 (11%)
Query: 623 YQNLY---NATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAEC 679
Y+++ N D + E+G G+FG VYK + A KV + + ++ E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 680 NTLKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRS 739
+ L + H N+VK+L A + ++ EF +++ + E R
Sbjct: 61 DILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVML---------ELERP 106
Query: 740 LNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLS 799
L Q + AL+YLH I H DLK N+L + ++DFG++ +
Sbjct: 107 LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
Query: 800 PAQTSSIDAKGSIGYIAPEYGLGSEVSING-----DVYSYGILLLELVTRKKPVDSM 851
+ S G+ ++APE + DV+S GI L+E+ + P +
Sbjct: 164 IQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-42
Identities = 64/315 (20%), Positives = 105/315 (33%), Gaps = 53/315 (16%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLHH-GAFKSFIAECNTLKNI-RHRN 689
+G G+FG V + TVAVK+ H ++ ++E L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH--------PITREDKTEEAPRSLN 741
+V +L AC ++ E+ L +L T E+ +L+
Sbjct: 89 IVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 742 LLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
L L+ VA +++L H DL N+LL + + DFGLAR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
+A+ + ++APE + DV+SYGI L EL + D +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921
+ R+ S M I C P
Sbjct: 261 IKEGF------------------------------RMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 922 DRMNMTNVVRQLQSI 936
R +V+ ++
Sbjct: 291 KRPTFKQIVQLIEKQ 305
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-42
Identities = 61/329 (18%), Positives = 116/329 (35%), Gaps = 59/329 (17%)
Query: 618 FPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKS 674
+P + + + + IG G+FG V K + + + + + +
Sbjct: 4 YPVLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 675 FIAECNTLKNI-RHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH------PI 727
F E L + H N++ +L AC + + L E+ + +L ++L
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 728 TREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787
+L+ Q L+ DVA + + Q H DL N+L+ E +A +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP 847
+DFGL+R + +T + + ++A E S + N DV+SYG+LL E+V+
Sbjct: 169 ADFGLSRGQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 848 VDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVA 907
M + R+ + C
Sbjct: 226 ----PYCGMTCAELYEKLPQGY---------------------------RLEKPLNCDDE 254
Query: 908 MVRIGVACSMESPGDRMNMTNVVRQLQSI 936
+ + C E P +R + ++ L +
Sbjct: 255 VYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-42
Identities = 56/256 (21%), Positives = 97/256 (37%), Gaps = 30/256 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G FG+VY Q K +A+KV L G E ++RH N++++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
L+ E+ ++ L +++ + + ++A
Sbjct: 72 YGYF-----HDATRVYLILEYAPLGTVYRELQKLSK----------FDEQRTATYITELA 116
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
ALSY H + H D+KP N+LL ++DFG + P S T G++
Sbjct: 117 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLD 169
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM-NLHNFARMALPDHV-- 870
Y+ PE G D++S G+L E + K P ++ + + PD V
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229
Query: 871 --VDIVDSTLLSDDED 884
D++ L +
Sbjct: 230 GARDLISRLLKHNPSQ 245
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 63/300 (21%), Positives = 110/300 (36%), Gaps = 51/300 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
E+G G FG V G +G+ VA+K+ FI E + N+ H LV++
Sbjct: 10 KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
C ++ E+M N L +L Q L + DV A+
Sbjct: 68 C-----TKQRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAM 113
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
YL H DL N L++++ + VSDFGL+R++ TSS+ +K + +
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSP 169
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDS 876
PE + S+ S D++++G+L+ E+ + K +E + +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFT----------NSETAEHIAQ 216
Query: 877 TLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936
L L + I +C E +R ++ + +
Sbjct: 217 GLRLYRPHL------------------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-41
Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 20/246 (8%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G++G V + + VAVK+ ++ ++ E K + H N+VK
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 696 ACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACA 755
+ + + L E+ L + + P + +
Sbjct: 71 HR-----REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAG 115
Query: 756 LSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYI 815
+ YLH ITH D+KP N+LLDE +SDFGLA + + G++ Y+
Sbjct: 116 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 816 APEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIV 874
APE E + DV+S GI+L ++ + P D + ++ + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 875 DSTLLS 880
DS L+
Sbjct: 233 DSAPLA 238
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 2e-40
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 31/245 (12%)
Query: 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL---LHHGAFKSFIAECNTLKNIR 686
F+ EIG GSFG+VY + VA+K + + ++ I E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746
H N ++ LV E+ + + + L ++
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV----------HKKPLQEVEIA 118
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSI 806
+ L+YLH + H D+K N+LL E + + DFG A + +
Sbjct: 119 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169
Query: 807 DAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863
G+ ++APE L + DV+S GI +EL RK P+ +M L++ A+
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 228
Query: 864 MALPD 868
P
Sbjct: 229 NESPA 233
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 2e-40
Identities = 53/260 (20%), Positives = 100/260 (38%), Gaps = 37/260 (14%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTA 696
+IG G+ G+VY + VA++ NL + I E ++ ++ N+V L +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 697 CSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACAL 756
D +V E++ SL + + E Q + + AL
Sbjct: 86 Y-----LVGDELWVVMEYLAGGSLTDVVT---ETCMDEG--------QIAAVCRECLQAL 129
Query: 757 SYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA 816
+LH + H D+K N+LL + ++DFG + ++ S++ G+ ++A
Sbjct: 130 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMA 184
Query: 817 PEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA----------- 865
PE D++S GI+ +E++ + P + + L +A
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPE 240
Query: 866 -LPDHVVDIVDSTLLSDDED 884
L D ++ L D E
Sbjct: 241 KLSAIFRDFLNRCLDMDVEK 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 53/307 (17%), Positives = 111/307 (36%), Gaps = 45/307 (14%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNL 690
E+G GSFG VY+G+ D+ +T VA+K N F+ E + +K ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
V++L ++ E M L+ +L + +L + + +
Sbjct: 86 VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
++A ++YL+ H DL N ++ E+ + DFG+ R + +
Sbjct: 141 EIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870
+ +++PE + DV+S+G++L E+ T + ++ R + +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLRFVMEGGL 253
Query: 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930
+D D C + + C +P R + ++
Sbjct: 254 LDKPD---------------------------NCPDMLFELMRMCWQYNPKMRPSFLEII 286
Query: 931 RQLQSIK 937
++
Sbjct: 287 SSIKEEM 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (368), Expect = 9e-39
Identities = 55/258 (21%), Positives = 97/258 (37%), Gaps = 31/258 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
E+G G+FG V++ A K H ++ E T+ +RH LV + A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ ++ +++EFM L E + + ++ + + V L
Sbjct: 93 -----EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLC 138
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++H + H DLKP N++ + + DFGL L + S G+ +
Sbjct: 139 HMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFA 192
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM---------FEGDMNLHNFARMAL 866
APE G V D++S G+L L++ P D N+ + A +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 867 PDHVVDIVDSTLLSDDED 884
+ D + LL+D
Sbjct: 253 SEDGKDFIRKLLLADPNT 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 52/260 (20%), Positives = 94/260 (36%), Gaps = 34/260 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G GSF +V A+K+ ++ E + + + H VK+
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
Q ++ + +N L +++ I D+T A
Sbjct: 74 YFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------------TRFYTA 115
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+S L + I H DLKP N+LL+E+M ++DFG A+ L Q + G+
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA-------- 865
Y++PE + D+++ G ++ +LV P F F ++
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYDFPE 231
Query: 866 -LPDHVVDIVDSTLLSDDED 884
D+V+ L+ D
Sbjct: 232 KFFPKARDLVEKLLVLDATK 251
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 64/312 (20%), Positives = 107/312 (34%), Gaps = 48/312 (15%)
Query: 637 NEIGVGSFGSVYKGIL-----DQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNL 690
+G G+FG V + TVAVK+ H ++ ++E L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLH------PITREDKTEEAPRSLNLLQ 744
V L G + ++ EF + +L +L + + L L
Sbjct: 79 VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
+ VA + +L H DL N+LL E+ + + DFGLAR + P
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 805 SIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
DA+ + ++APE +I DV+S+G+LL E+ + + G F R
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRR 249
Query: 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM 924
+ D M + + C P R
Sbjct: 250 LKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRP 282
Query: 925 NMTNVVRQLQSI 936
+ +V L ++
Sbjct: 283 TFSELVEHLGNL 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 63/308 (20%), Positives = 98/308 (31%), Gaps = 55/308 (17%)
Query: 637 NEIGVGSFGSVYKGILDQGK---TTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNL 690
++G GSFG V +G D +VAVK L A FI E N + ++ HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
+++ +V E SL + L + L +
Sbjct: 74 IRLYGVVL------TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAV 118
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDAK 809
VA + YL H DL N+LL + + DFGL R LP + K
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869
+ APE S D + +G+ L E+ T + + G ++
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGE 232
Query: 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV 929
+ + +C + + V C P DR +
Sbjct: 233 RLPRPE---------------------------DCPQDIYNVMVQCWAHKPEDRPTFVAL 265
Query: 930 VRQLQSIK 937
L +
Sbjct: 266 RDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 62/331 (18%), Positives = 122/331 (36%), Gaps = 55/331 (16%)
Query: 628 NATDGFASANEIGVGSFGSVYKGIL----DQGKTTVAVKVFNLLHHG-AFKSFIAECNTL 682
T+ F +G G+FG+VYKG+ ++ K VA+K A K + E +
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 683 KNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNL 742
++ + ++ ++L C L+ + M L ++ +++ +
Sbjct: 66 ASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDY-VREHKDNIGSQ------- 111
Query: 743 LQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ 802
LN + +A ++YL + H DL NVL+ ++DFGLA+ L +
Sbjct: 112 -YLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 803 TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFA 862
+ K I ++A E L + DV+SYG+ + EL+T ++G
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPA----- 219
Query: 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD 922
+ I++ R+ C + + I V C M
Sbjct: 220 -----SEISSILEKGE------------------RLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 923 RMNMTNVVRQLQSIKNILLGHRIVSNMQRDN 953
R ++ + + + ++ +R +
Sbjct: 257 RPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 141 bits (355), Expect = 6e-38
Identities = 61/279 (21%), Positives = 106/279 (37%), Gaps = 23/279 (8%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+G G V+ + VAVKV + F E + H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
G +V E++ +L + +H + + + + D
Sbjct: 74 DTGEAETPAGPLP-YIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQ 122
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ-TSSIDAKGSIG 813
AL++ Q I H D+KP+N+++ V DFG+AR + S T + G+
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDI 873
Y++PE G V DVYS G +L E++T + P F GD + + D +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 235
Query: 874 VDSTLLSDD-EDLAVHGNQRQRQARINSKIECLVAMVRI 911
LS D + + + + + R + E +VR+
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 60/306 (19%)
Query: 638 EIGVGSFGSVYKGILDQGKTT---VAVKVFNLLHHGAFKS-FIAECNTLKNIRHRNLVKI 693
IG G FG V++GI + VA+K + + F+ E T++ H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
+ + + ++ E L +L SL+L + ++
Sbjct: 74 IGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLS 118
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
AL+YL H D+ NVL+ + DFGL+R++ S +S K I
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK 174
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKK-PVDSMFEGDM--NLHNFARMALPDHV 870
++APE + DV+ +G+ + E++ P + D+ + N R+ +P +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVV 930
+ + C P R T +
Sbjct: 235 PP----------------------------------TLYSLMTKCWAYDPSRRPRFTELK 260
Query: 931 RQLQSI 936
QL +I
Sbjct: 261 AQLSTI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 61/315 (19%), Positives = 108/315 (34%), Gaps = 54/315 (17%)
Query: 637 NEIGVGSFGSVYKGIL-------DQGKTTVAVKVFNL-LHHGAFKSFIAECNTLKNI-RH 687
+G G+FG V T VAVK+ I+E +K I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 688 RNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHP------ITREDKTEEAPRSLN 741
+N++ +L AC + ++ E+ +L E+L + + L+
Sbjct: 79 KNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 742 LLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
++ VA + YL H DL NVL+ E+ + ++DFGLAR +
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
+ + + + ++APE + DV+S+G+LL E+ T + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEEL 246
Query: 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPG 921
++ H +D C + + C P
Sbjct: 247 FKLLKEGHRMDKPS---------------------------NCTNELYMMMRDCWHAVPS 279
Query: 922 DRMNMTNVVRQLQSI 936
R +V L I
Sbjct: 280 QRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 1e-35
Identities = 45/255 (17%), Positives = 91/255 (35%), Gaps = 31/255 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
E+G G+FG V++ + K N + + E + + + H L+ + A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ L+ EF+ L + + ++ + +N L
Sbjct: 96 -----EDKYEMVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLK 141
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIGYI 815
++H + I H D+KP N++ + + + V DFGLA L + +
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFA 195
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKP---------VDSMFEGDMNLHNFARMAL 866
APE V D+++ G+L L++ P + ++ D A ++
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 867 PDHVVDIVDSTLLSD 881
D + + L +
Sbjct: 256 SPEAKDFIKNLLQKE 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (329), Expect = 5e-34
Identities = 49/257 (19%), Positives = 92/257 (35%), Gaps = 39/257 (15%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G GSFG V+ A+KV ++ + E L + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
Q ++ ++++ L L R A
Sbjct: 70 WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-------------AA 111
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
L + I + DLKP N+LLD+ ++DFG A+++P + G+
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPD 166
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA-------- 865
YIAPE + + D +S+GIL+ E++ P F + + ++
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAELRFPP 222
Query: 866 -LPDHVVDIVDSTLLSD 881
+ V D++ + D
Sbjct: 223 FFNEDVKDLLSRLITRD 239
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-34
Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 18/281 (6%)
Query: 625 NLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-GAFKSFIAECNTLK 683
+++ + + + IG G++G V + K VA+K + H + + E L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 684 NIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLL 743
RH N++ I + LV M L + L + L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-----------QHLSND 109
Query: 744 QRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL-PLSPAQ 802
+ L Y+H + H DLKPSN+LL+ + DFGLAR P
Sbjct: 110 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 803 TSSIDAKGSIGYIAPEYGLGSEVSIN-GDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861
+ + Y APE L S+ D++S G +L E+++ + D H
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
Query: 862 ARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKI 902
+ P L + + L++ + R+
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 6e-34
Identities = 52/258 (20%), Positives = 99/258 (38%), Gaps = 32/258 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
++G G FG V++ + K T K + E + L RHRN++ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ + ++FEF+ + E ++ + LN + ++ V AL
Sbjct: 71 -----ESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQ 116
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHV--SDFGLARFLPLSPAQTSSIDAKGSIGYI 815
+LH I H D++P N++ + + +FG AR L + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYY 170
Query: 816 APEYGLGSEVSINGDVYSYGILLLELVTRKKP---------VDSMFEGDMNLHNFARMAL 866
APE VS D++S G L+ L++ P ++++ + A +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 867 PDHVVDIVDSTLLSDDED 884
+D VD L+ + +
Sbjct: 231 SIEAMDFVDRLLVKERKS 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 5e-33
Identities = 47/272 (17%), Positives = 89/272 (32%), Gaps = 28/272 (10%)
Query: 623 YQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL-LHHGAFKSFIAECNT 681
++ + D + + +G G+F V + + VA+K G S E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 682 LKNIRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLN 741
L I+H N+V + + L+ + + L + +
Sbjct: 61 LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIV----------EKGFYT 105
Query: 742 LLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPA 801
+ V A+ YLH LDE+ +SDFGL++
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
Query: 802 QTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP---------VDSMF 852
+++ G+ GY+APE S D +S G++ L+ P + +
Sbjct: 166 LSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222
Query: 853 EGDMNLHNFARMALPDHVVDIVDSTLLSDDED 884
+ + + + D D + + D E
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 54/257 (21%), Positives = 100/257 (38%), Gaps = 29/257 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTL-KNIRHRNLVK 692
+G GSFG V+ + A+K +L + + E L H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 693 ILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDV 752
+ Q + V E++ L + + +L + ++
Sbjct: 68 MFCTF-----QTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEI 112
Query: 753 ACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSI 812
L +L I + DLK N+LLD++ ++DFG+ + L A+T++ G+
Sbjct: 113 ILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTP 167
Query: 813 GYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKP-----VDSMFEGDMNLHNFARMALP 867
YIAPE LG + + + D +S+G+LL E++ + P + +F + F L
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 868 DHVVDIVDSTLLSDDED 884
D++ + + E
Sbjct: 228 KEAKDLLVKLFVREPEK 244
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (318), Expect = 6e-33
Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 46/273 (16%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF---------KSFIAECNTLKNIR- 686
+G G V + I AVK+ ++ G+F ++ + E + L+ +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746
H N++++ + N F LVF+ M+ L ++L +L+ +
Sbjct: 69 HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETR 113
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSI 806
I + + LH + I H DLKP N+LLD++M ++DFG + L
Sbjct: 114 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 807 DAKGSIGYIAPEYGLGSEVSING------DVYSYGILLLELVTRKKP---------VDSM 851
G+ Y+APE S + D++S G+++ L+ P + +
Sbjct: 171 ---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 852 FEGDMNLHNFARMALPDHVVDIVDSTLLSDDED 884
G+ + D V D+V L+ +
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 65/312 (20%), Positives = 112/312 (35%), Gaps = 31/312 (9%)
Query: 637 NEIGVGSFGSVYKGI-LDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNL 690
EIG G++G V+K L G VA+K + + +A L+ H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 691 VKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGI 750
V++ C+ LVFE + + ++
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF 123
Query: 751 DVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+ L +LH + H DLKP N+L+ ++DFGLAR A TS +
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---V 177
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870
++ Y APE L S + D++S G + E+ RK F G ++ ++ +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILDVIGL 233
Query: 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKI-ECLVAMVRIGVACSMESPGDRMNMTNV 929
D A H Q + + I E ++ C +P R++ +
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSA 290
Query: 930 VRQ--LQSIKNI 939
+ Q ++
Sbjct: 291 LSHPYFQDLERC 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (314), Expect = 1e-31
Identities = 50/255 (19%), Positives = 86/255 (33%), Gaps = 29/255 (11%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH------HGAFKSFIAECNTLKN 684
+ F+ IG G FG VY A+K + + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 685 IRHRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQ 744
+V + A D + + + M L L + EA
Sbjct: 64 GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLS---QHGVFSEA-------D 108
Query: 745 RLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTS 804
++ L ++H + + DLKP+N+LLDE +SD GLA +
Sbjct: 109 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKK 161
Query: 805 SIDAKGSIGYIAPEYGL-GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863
+ G+ GY+APE G + D +S G +L +L+ P D + +
Sbjct: 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 864 MALPDHVVDIVDSTL 878
+ + + D L
Sbjct: 222 LTMAVELPDSFSPEL 236
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 30/234 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-----HGAFKSFIAECNTLKNIRHRNLV 691
+ +G G F +VYK VA+K L H G ++ + E L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+L A +LVF+FM+ L +
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDN----------SLVLTPSHIKAYMLM 108
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGS 811
L YLH I H DLKP+N+LLDE + ++DFGLA+ + +
Sbjct: 109 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVT 163
Query: 812 IGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
Y APE G+ + + D+++ G +L EL+ R GD +L R+
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRI 213
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-31
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 24/235 (10%)
Query: 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVK 692
+ IG GSFG VY+ L VA+K + E ++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 693 ILTAC-SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ S + + + LV +++ H + ++L ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-------QTLPVIYVKLYMYQ 130
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+ +L+Y+H I H D+KP N+LLD + + + DFG A+ L S I ++
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 186
Query: 811 SIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
Y APE G+ + + + DV+S G +L EL+ + F GD + +
Sbjct: 187 --YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-31
Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 25/236 (10%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+IG G+FG V+K + VA+K + G + + E L+ ++H N+V ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 695 TACSGVDYQGNDFKA---LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
C N K LVF+F ++ + + + +E I
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------------IKRV 122
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK-- 809
+ L+ L++ + I H D+K +NVL+ + + ++DFGLAR L+ +
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 810 GSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
++ Y PE LG + D++ G ++ E+ TR +G+ H A +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALI 234
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 49/237 (20%), Positives = 87/237 (36%), Gaps = 35/237 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLV 691
E+G G F V K A K + + E + LK I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 692 KILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGID 751
+ + L+ E + L ++L +E TEE
Sbjct: 77 TLHEVY-----ENKTDVILILELVAGGELFDFLA--EKESLTEEEATEF----------- 118
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA----HVSDFGLARFLPLSPAQTSSID 807
+ L+ +++ I H DLKP N++L + + + DFGLA + +
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKN 175
Query: 808 AKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
G+ ++APE + + D++S G++ L++ P F GD A +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANV 228
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 5e-30
Identities = 44/227 (19%), Positives = 78/227 (34%), Gaps = 27/227 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
+IG GSFG +Y G VA+K+ + E K ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
D+ +V E + + + R +L L + + +
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISRIE 117
Query: 758 YLHHDCQPPITHCDLKPSNVL---LDEEMMAHVSDFGLARFLPLSPAQT-----SSIDAK 809
Y+H H D+KP N L + + ++ DFGLA+ + + +
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 810 GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
G+ Y + LG E S D+ S G +L+ P +
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (295), Expect = 9e-30
Identities = 39/229 (17%), Positives = 74/229 (32%), Gaps = 29/229 (12%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
IG GSFG +++G VA+K E T K + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
Q LV + + + ED + R ++ + +
Sbjct: 70 ----GQEGLHNVLVIDLL----------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAH-----VSDFGLARFLPLSPAQTSSIDAK--- 809
+H + + + D+KP N L+ + V DFG+ +F + +
Sbjct: 116 SIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 810 --GSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856
G+ Y++ LG E S D+ + G + + + P +
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 116 bits (292), Expect = 2e-29
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 28/231 (12%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+IG G++G VYK + G+T A+K L G + I E + LK ++H N+VK+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
LVFE + + E E LLQ
Sbjct: 67 DVI-----HTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQ---------- 108
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
L+ + + + H DLKP N+L++ E ++DFGLAR + ++ Y
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWY 166
Query: 815 IAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
AP+ +GS+ S D++S G + E+V F G R+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRI 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 40/245 (16%), Positives = 88/245 (35%), Gaps = 18/245 (7%)
Query: 639 IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTAC 697
+G+G G V + + + A+K+ E + ++V+I+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 698 SGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALS 757
+ Y G +V E + L + + ++ + I + A+
Sbjct: 75 ENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQ 125
Query: 758 YLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAP 817
YLH I H D+KP N+L + + F + + S + Y+AP
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 818 EYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHVVDIVDST 877
E + + D++S G+++ L+ P S ++ R+ + + + +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 878 LLSDD 882
+S++
Sbjct: 243 EVSEE 247
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 52/230 (22%), Positives = 86/230 (37%), Gaps = 24/230 (10%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+IG G++G+V+K + VA+K L G S + E LK ++H+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ LVFEF D E +S +
Sbjct: 68 DVL-----HSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSF-----------LFQ 109
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
L L + H DLKP N+L++ +++FGLAR P + S +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYR 168
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
S + D++S G + EL +P +F G+ R+
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRI 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 26/237 (10%)
Query: 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHR 688
+ F +IG G++G VYK VA+K L G + I E + LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 689 NLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNI 748
N+VK+L + LVFEF+ ++ L++++ A + L +
Sbjct: 62 NIVKLLDVI-----HTENKLYLVFEFL-HQDLKKFMD--------ASALTGIPLPLIKSY 107
Query: 749 GIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDA 808
+ L++ H + H DLKP N+L++ E ++DFGLAR +
Sbjct: 108 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHE 162
Query: 809 KGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
++ Y APE LG + S D++S G + E+VTR+ F GD + R+
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRI 215
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-28
Identities = 51/260 (19%), Positives = 82/260 (31%), Gaps = 38/260 (14%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAF------KSFIAECNTLKNIR--HRN 689
+G G FGSVY GI VA+K + E LK +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
++++L + D L+ E + +L +
Sbjct: 71 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFF 116
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFLPLSPAQTSSIDA 808
V A+ + + H D+K N+L+D + DFG L +
Sbjct: 117 WQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---- 169
Query: 809 KGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGD---MNLHNFARM 864
G+ Y PE+ + V+S GILL ++V P FE D + F R
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQ 225
Query: 865 ALPDHVVDIVDSTLLSDDED 884
+ ++ L D
Sbjct: 226 RVSSECQHLIRWCLALRPSD 245
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 50/253 (19%), Positives = 91/253 (35%), Gaps = 28/253 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKI 693
+G G+FG V A+K+ ++ + E L+N RH L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 694 LTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVA 753
A Q +D V E+ L L TEE R A
Sbjct: 71 KYAF-----QTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFY-----------GA 112
Query: 754 CALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIG 813
+S L + + + D+K N++LD++ ++DFGL + A + G+
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPE 170
Query: 814 YIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDM-NLHNFARMALPDHV-- 870
Y+APE ++ D + G+++ E++ + P + + L + P +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230
Query: 871 --VDIVDSTLLSD 881
++ L D
Sbjct: 231 EAKSLLAGLLKKD 243
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 5e-27
Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 31/238 (13%)
Query: 637 NEIGVGSFGSVYKGILDQGKTT---VAVKVFNLLH----HGAFKSFIAECNTLKNIRHRN 689
+G G++G V+ G T A+KV + E L++IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 690 LVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIG 749
+ L +Q L+ +++ L L R +
Sbjct: 90 FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRER-------------FTEHEVQ 132
Query: 750 IDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAK 809
I V + L H + I + D+K N+LLD ++DFGL++ + + D
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFC 191
Query: 810 GSIGYIAPEYGLGSEVSING--DVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865
G+I Y+AP+ G + + D +S G+L+ EL+T P F D ++ A ++
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEIS 245
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-26
Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 26/230 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
IG G+ G V VA+K + + K E +K + H+N++ +L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 696 ACSGVD-YQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + LV E M + + E + + + C
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------------RMSYLLYQMLC 130
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
+ +LH H DLKPSN+++ + + DFGLAR S T + + Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 184
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
APE LG N D++S G ++ E+V K F G + + ++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKV 230
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 3e-26
Identities = 45/237 (18%), Positives = 84/237 (35%), Gaps = 27/237 (11%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN---LLHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+G GSFG V + A+K+ + ++ + + E L+ + LVK+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ V E++ + L I R + +
Sbjct: 108 FSFKDNSNLYM-----VMEYVAGGEMFSHLRRIGR----------FSEPHARFYAAQIVL 152
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
YLH + + DLKP N+L+D++ V+DFG A+ + + G+
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEA 204
Query: 815 IAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD-MNLHNFARMALPDHV 870
+APE L + D ++ G+L+ E+ P + ++ P H
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-26
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 26/231 (11%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKIL 694
+ +G G++GSV + VAVK + K E LK+++H N++ +L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + + L + + L + +
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILR 132
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
L Y+H H DLKPSN+ ++E+ + DFGLAR + Y
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWY 184
Query: 815 IAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864
APE L + D++S G ++ EL+T + F G ++ +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLI 231
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-26
Identities = 50/235 (21%), Positives = 84/235 (35%), Gaps = 24/235 (10%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFN--LLHHGAFKSFIAECNTLKNIRHRNLVKILT 695
+G G++G+V + + VA+K K E LK++RH N++ +L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 696 ACSGVDYQGNDFK-ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVAC 754
+ + + LV FM + H L + + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQFLVYQMLK 132
Query: 755 ALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGY 814
L Y+H H DLKP N+ ++E+ + DFGLAR + + Y
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWY 184
Query: 815 IAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868
APE L + D++S G ++ E++T K D P
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (269), Expect = 5e-26
Identities = 58/259 (22%), Positives = 98/259 (37%), Gaps = 31/259 (11%)
Query: 610 NPSSPINSFPNISYQNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH 669
N P + S+ + D + ++G G + V++ I V VK+ +
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73
Query: 670 GAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPIT 728
K E L+N+R N++ + + ALVFE + N ++ +T
Sbjct: 74 ---KKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQTLT 127
Query: 729 REDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHV 787
D ++ AL Y H I H D+KP NV++D E +
Sbjct: 128 DYD-------------IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL 171
Query: 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKK 846
D+GLA F + S + PE + + + D++S G +L ++ RK+
Sbjct: 172 IDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 847 PVDSMFEGDMNLHNFARMA 865
P F G N R+A
Sbjct: 229 P---FFHGHDNYDQLVRIA 244
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 8e-25
Identities = 44/225 (19%), Positives = 81/225 (36%), Gaps = 19/225 (8%)
Query: 638 EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTAC 697
++G G F +V+ T VA+K+ ++ E L+ + + K +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 698 SGVDYQGNDFKAL-VFEFMQNRSLEEWLHPITREDKT-----EEAPRSLNLLQRLNIGID 751
+ + K L F + + + + R + L+ I
Sbjct: 79 AN-----HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 752 VACALSYLHHDCQPPITHCDLKPSNVLLDEE-MMAHVSDFGLARFLPLSPAQTSSIDAKG 810
+ L Y+H C I H D+KP NVL++ ++ +A ++
Sbjct: 134 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 811 SIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGD 855
+ Y +PE LG+ D++S L+ EL+T FE D
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPD 232
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (250), Expect = 3e-23
Identities = 82/390 (21%), Positives = 152/390 (38%), Gaps = 38/390 (9%)
Query: 147 LKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFE 206
L + + ++ T+ + ++ +T A ++ + +++ L NL +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEY---LNNLTQINFSN 75
Query: 207 NQLTGAIPPAISNASNLELFQADVNKL----------TGEVPYLEKPQRLSVFSITENSL 256
NQLT P + N + L + N++ L Q + + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 257 GSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIP 316
+R + N + ++ + L L + ++NL+T + + N ++
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 317 AAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLK-VFNL 375
K NL+ L NN++S P I NL EL L N+ ++ +L + +L
Sbjct: 194 ---AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 376 DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435
DL+ N + P L LT + L N ++ P L+ L +L N+
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLED 299
Query: 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNV 495
S + NLKNL L ++ N + P + S KL++L N + SSL++L +N
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINW 355
Query: 496 LDLSQNNLSGKIPEFLVGFQLLENLNLSNN 525
L N +S P L + L L++
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 6e-22
Identities = 74/402 (18%), Positives = 136/402 (33%), Gaps = 40/402 (9%)
Query: 76 SNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNN 135
+ ++ L + + L ++ L + SI + L+++ + ++N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77
Query: 136 LDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFT 195
L P L L + M N
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQ-----------------IADITPLANLTNLTGLTLF 118
Query: 196 LQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENS 255
+ +N SN + + + L + + ++T
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178
Query: 256 LGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNI 315
+ ++ + L T L L+ N + P I T L+ L L+ N++
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD-- 233
Query: 316 PAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNL 375
+ NL L++ NN++S P + L L EL+L N+ I P G + NL
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNL 290
Query: 376 DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435
+L+ N L+ P S K LT + L NN++ P L L L + N+++
Sbjct: 291 ELNENQLEDISPIS--NLKNLTYLTLYFNNISDISPVSSLT---KLQRLFFANNKVSD-- 343
Query: 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGN 477
S + NL N+ L N++ P L + ++ QL +
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.3 bits (194), Expect = 3e-16
Identities = 70/403 (17%), Positives = 142/403 (35%), Gaps = 40/403 (9%)
Query: 51 LQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110
L L ++ + + + ++ + K + L+ + ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 111 NLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170
LT P L NL+ + + + +N + P TL + + N
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDPLKN 130
Query: 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADV 230
++++ + N + + L +LQ L F + + ++N + LE
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP------LANLTTLERLDISS 184
Query: 231 NKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLL 290
NK++ +T ++ ++ + L T L+ L +N N
Sbjct: 185 NKVSDISVL---------AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-- 233
Query: 291 PACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLR 350
+++L T L L L NN+I P + L L++ N++S P + L L
Sbjct: 234 IGTLASL-TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 288
Query: 351 ELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTI 410
L L N+ +I P + L L N + P + L + ++N ++
Sbjct: 289 NLELNENQL-EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 411 PPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFEN 453
L+ + L NQ++ P + NL + L + +
Sbjct: 344 VSSLANLTNINW-LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.1 bits (165), Expect = 1e-12
Identities = 72/369 (19%), Positives = 136/369 (36%), Gaps = 44/369 (11%)
Query: 4 QRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNS 63
+V L L + SI V L+ L + NN P L +L + +NNN
Sbjct: 44 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 64 IGGEIPANISSCSNLIQIRLFYNELVGKIP---------------SELGSLSKIEHLSVS 108
I P + + + + + S++ +LS + L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSI 168
+ L NL+++ L ++ N + L NL +L N +S P +
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--L 215
Query: 169 FNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQA 228
++++ NQL+ + L +L NL + NQ++ P +S + L +
Sbjct: 216 GILTNLDELSLNGNQLKDIGTL---ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 229 DVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGG 288
N+++ P +T + + L + ++N L L + NN
Sbjct: 271 GANQISNISPL---------AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD 321
Query: 289 LLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQN 348
+ P +S+L T L+ L NNK+ +++ N+ L +N++S P + L
Sbjct: 322 ISP--VSSL-TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTR 374
Query: 349 LRELRLQRN 357
+ +L L
Sbjct: 375 ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.3 bits (150), Expect = 1e-10
Identities = 46/189 (24%), Positives = 72/189 (38%), Gaps = 15/189 (7%)
Query: 373 FNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT 432
+L + N + P + L + L+ N L L+ L LDL+ NQ++
Sbjct: 200 ESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTD-LDLANNQIS 254
Query: 433 GSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKG 492
P + L L L + N++ P L L LE+ N L+ P S +LK
Sbjct: 255 NLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKN 308
Query: 493 LNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLC 552
L L L NN+S P + L+ L +NN + + + N S N ++
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLAN-LTNINWLSAGHN-QIS 364
Query: 553 GGIPEFQLP 561
P L
Sbjct: 365 DLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 2e-10
Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 30/176 (17%)
Query: 3 HQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN 62
+ L+L +L + +L+ L L L NN ++ P L +L L L N
Sbjct: 218 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 63 SIGGEIP--------------------ANISSCSNLIQIRLFYNELVGKIPSELGSLSKI 102
I P + IS+ NL + L++N + P + SL+K+
Sbjct: 274 QISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKL 331
Query: 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAEN 158
+ L + N ++ SSL NL++IN L N + P L + L + +
Sbjct: 332 QRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.6 bits (244), Expect = 5e-23
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 12/280 (4%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWN 332
L + N + NL L L+L NNKI P A V L+RL +
Sbjct: 30 PPDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88
Query: 333 NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQ 392
N+L LQ LR + K ++ + + V L + G +
Sbjct: 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148
Query: 393 YKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFE 452
K L+ I ++D N+T TIP GL L L L N++T + + L NL L +
Sbjct: 149 MKKLSYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 453 NKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG------K 506
N + +L + L +L + N L +P L+ K + V+ L NN+S
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 507 IPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVL 546
P + ++L +N ++ F+ + + +
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.3 bits (181), Expect = 6e-15
Identities = 51/275 (18%), Positives = 92/275 (33%), Gaps = 18/275 (6%)
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASN 222
+P + D N++ + DF L+NL + N+++ P A +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFK-NLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 223 LELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLIN 282
LE N+L + K + EN + S N L N + L N
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVH--ENEITKVRKSVFNGL----NQMIVVELGTN 134
Query: 283 ANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPA 342
G+ + + + D N IP + +L L + N+++ +
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTN--ITTIPQGL--PPSLTELHLDGNKITKVDAAS 190
Query: 343 IGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLS 402
+ L NL +L L N S+ N N +P L +K + ++ L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 403 DNNLTGTIPPQFLGLSWL-----LIGLDLSRNQLT 432
+NN++ F + G+ L N +
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.2 bits (173), Expect = 7e-14
Identities = 44/222 (19%), Positives = 69/222 (31%), Gaps = 8/222 (3%)
Query: 338 TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTL 396
+P + + L LQ NK NLK + L L N + P + L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 397 TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLK 456
+ LS N L +P + L + ++ S+ + + + +E L K
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSS 139
Query: 457 GEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQL 516
G KKL + + + SL L L N ++ L G
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNN 196
Query: 517 LENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLCGGIPEF 558
L L LS N++ + L N KL
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.1 bits (170), Expect = 2e-13
Identities = 50/283 (17%), Positives = 95/283 (33%), Gaps = 21/283 (7%)
Query: 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNL 150
K+P +L L + N +T NL +++TL L +N + P F L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 151 ATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210
L +++N L + + + + +++ + G + + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--NGLNQMIVVELGTNPLKSS 139
Query: 211 GAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSL 270
G A L + +T L P L+ + N + ++L L +L
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 271 TNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEM 330
L + N + + L L L+NNK+ +P + +Q + +
Sbjct: 198 -------AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 331 WNNRLSG------TIPPAIGELQNLRELRLQRNKF-LGNIPPS 366
NN +S P + + + L N I PS
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.3 bits (168), Expect = 3e-13
Identities = 39/273 (14%), Positives = 84/273 (30%), Gaps = 17/273 (6%)
Query: 44 IPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIE 103
+P + +L L NN I + + NL + L N++ P L K+E
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 104 HLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWL--S 161
L +S N L +P + ++ L + +N + F L + + + N L S
Sbjct: 83 RLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 162 GTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNAS 221
G + + ++ + + +L + N++T ++ +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQ----GLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 222 NLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLI 281
NL N ++ N + + L + + + +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNN------NKLVKVPGGLADHKYIQVVYL 249
Query: 282 NANNFGGLLPACISNLSTTLEMLLLDNNKIFGN 314
+ NN + + +F N
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.1 bits (165), Expect = 7e-13
Identities = 44/258 (17%), Positives = 83/258 (32%), Gaps = 34/258 (13%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIG 65
+L+L + K+ NL L L+L NN + P F L +L+ L L+ N +
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 66 GEIPANISSCSNLIQIRLFYNEL-----------------------VGKIPSELGSLSKI 102
+ L ++ G + K+
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
Query: 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162
++ ++ N+T +IP L S+ L L N + + L NLA L ++ N +S
Sbjct: 153 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG------AIPPA 216
S+ N + N+L + +Q + N ++ P
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLV--KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 217 ISNASNLELFQADVNKLT 234
+ ++ N +
Sbjct: 268 NTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.4 bits (145), Expect = 3e-10
Identities = 32/153 (20%), Positives = 53/153 (34%), Gaps = 4/153 (2%)
Query: 396 LTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455
L ++ SD L +P L LDL N++T + NLKNL L + NK+
Sbjct: 12 LRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQ 515
P KLE+L + N L+ +L+ L V + + + L
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 516 LLENLNLSNNNLEGMVPIEGVFKNATITSVLGN 548
++E + K + +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 4e-18
Identities = 53/258 (20%), Positives = 82/258 (31%), Gaps = 6/258 (2%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWN 332
R+ ++ N + A + L N + A G + Q N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 333 NRLSGTIPPAIGELQNLRELRLQRNKFLG-NIPPSIGNLKVFNLDLSCNFLQGSIPSSLG 391
+L P L L L L R G + L L N LQ +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 392 QYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVF 451
LT + L N ++ F GL L L +N++ P +L L L +F
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 452 ENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFL 511
N L L + L+ L + N + L S + + +P+ L
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268
Query: 512 VGFQLLENLNLSNNNLEG 529
G L L+ N+L+G
Sbjct: 269 AGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (180), Expect = 7e-15
Identities = 47/247 (19%), Positives = 77/247 (31%), Gaps = 5/247 (2%)
Query: 315 IPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN 374
+P I QR+ + NR+S + +NL L L N + L +
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 375 LDLSCN--FLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT 432
+ L+ P++ L + L + P L L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 433 GSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKG 492
+L NL L + N++ L++L + N + P + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 493 LNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEGVFKNATITSVLGNLKLC 552
L L L NNLS E L + L+ L L++N ++ + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 553 GGIPEFQ 559
Sbjct: 263 SLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 7e-14
Identities = 52/305 (17%), Positives = 96/305 (31%), Gaps = 36/305 (11%)
Query: 104 HLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGT 163
S L ++P + ++ +FL N + +F +NL L + N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 164 IPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNL 223
++ ++ + D N + L L + L P + L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 224 ELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINA 283
+ N L + + L L ++
Sbjct: 132 QYLYLQDNALQALPD-----------------------------DTFRDLGNLTHLFLHG 162
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI 343
N + L +L+ LLL N++ P A L L ++ N LS A+
Sbjct: 163 NRISSVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 344 GELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSD 403
L+ L+ LRL N ++ + + S + + S+P L + L+
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAA 278
Query: 404 NNLTG 408
N+L G
Sbjct: 279 NDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 7e-14
Identities = 44/255 (17%), Positives = 79/255 (30%), Gaps = 30/255 (11%)
Query: 6 VKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGI--------------------- 44
+ + L +++ + L +L L++N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 45 ----PSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLS 100
P+ F L RL L L+ + P + L + L N L L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 101 KIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWL 160
+ HL + N ++ + L S++ L L N + P F L L TL + N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 161 SGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNA 220
S ++ + ++ N LQ F +++ ++P ++
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 221 SNLELFQADVNKLTG 235
L N L G
Sbjct: 272 DLKRL---AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.4 bits (142), Expect = 5e-10
Identities = 42/177 (23%), Positives = 60/177 (33%), Gaps = 1/177 (0%)
Query: 356 RNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFL 415
+ L +P I + L N + +S + LTI+ L N L F
Sbjct: 19 PQQGLQAVPVGIPAA-SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 416 GLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQ 475
GL+ L QL P+ L L L + L+ P L+ L +Q
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 476 GNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532
N LQ + L L L L N +S G L+ L L N + + P
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 2e-17
Identities = 25/170 (14%), Positives = 45/170 (26%), Gaps = 33/170 (19%)
Query: 637 NEIGVGSFGSVYKGILDQGKTTVAVKVFNL----------LHHGAFKSFIAECNTLKNIR 686
+G G +V+ ++ VK + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRL 746
R L K+ Y A++ E + + L E
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE---------------- 107
Query: 747 NIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARFL 796
+ + ++ +H I H DL NVL+ E + DF + +
Sbjct: 108 -VLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.3 bits (199), Expect = 4e-17
Identities = 74/273 (27%), Positives = 108/273 (39%), Gaps = 10/273 (3%)
Query: 295 SNLSTTLEMLLLDNNKIFGN--IPAAIGKFVNLQRLEMWNN-RLSGTIPPAIGELQNLRE 351
+ + L L + IP+++ L L + L G IPPAI +L L
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 352 LRLQRNKFLGNIPPSIGNLKV-FNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTI 410
L + G IP + +K LD S N L G++P S+ L I N ++G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 411 PPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLE 470
P + S L + +SRN+LTG IP NL V +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 471 QLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGM 530
+ + LS N LDL N + G +P+ L + L +LN+S NNL G
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNL--NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 531 VPIEGVFKNATITSVLGNLKLCGGIPEFQLPTC 563
+P G + +++ N LCG LP C
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCG----SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.2 bits (196), Expect = 8e-17
Identities = 61/266 (22%), Positives = 101/266 (37%), Gaps = 6/266 (2%)
Query: 271 TNSTRLNRLLINANNFGGL--LPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRL 328
T + R+N L ++ N +P+ ++NL + + N + G IP AI K L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 329 EMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNL-DLSCNFLQGSIP 387
+ + +SG IP + +++ L L N G +PPSI +L N + G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 388 SSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEV 447
S G + L N P L + + ++
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 448 LDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKI 507
+ L L + N + G +P L+ LK L+ L++S NNL G+I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 508 PEFLVGFQLLENLNLSNNNLEGMVPI 533
P+ Q + +NN P+
Sbjct: 285 PQGG-NLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.5 bits (176), Expect = 3e-14
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 5/258 (1%)
Query: 2 RHQRVKILNLTSLKLAG--SISPHVGNLSFLKVLLLYNN-SFNHGIPSEFDRLQRLQVLA 58
+ RV L+L+ L L I + NL +L L + + IP +L +L L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 59 LNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS 118
+ + ++ G IP +S L+ + YN L G +P + SL + ++ N ++G+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFD 178
S G+ S + T N G NLA + ++ N L G + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 179 AGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238
N L + N N++ G +P ++ L N L GE+P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 239 YLEKPQRLSVFSITENSL 256
QR V + N
Sbjct: 286 QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.3 bits (160), Expect = 3e-12
Identities = 71/297 (23%), Positives = 107/297 (36%), Gaps = 36/297 (12%)
Query: 71 NISSCSNLIQIRLFYNELVGK--IPSELGSLSKIEHLSVSVN-NLTGSIPSSLGNLSSIN 127
+ + + L L IPS L +L + L + NL G IP ++ L+ ++
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 128 TLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187
L++T N+ G IPD +K L TL + N LSGT+P SI ++ ++ N++ G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLS 247
IP +G + ++ N+LTG IPP + L
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-------NLNLAFVDLSRNMLEGDASVLF 217
Query: 248 VFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLD 307
+ +S L + S LN L + N G LP ++ L
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK--------- 268
Query: 308 NNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP 364
L L + N L G IP G LQ NK L P
Sbjct: 269 ----------------FLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 42/141 (29%), Positives = 56/141 (39%), Gaps = 2/141 (1%)
Query: 388 SSLGQYKTLTIIDLSDNNLTG--TIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445
+ Q + +DLS NL IP L +L N L G IP + L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 446 EVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSG 505
L + + G IP L K L L+ N L G +P S+SSL L + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 506 KIPEFLVGFQLLENLNLSNNN 526
IP+ F L + N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 49/206 (23%), Positives = 77/206 (37%), Gaps = 25/206 (12%)
Query: 343 IGELQNLRELRLQRNKFLGNIPPSIG-NLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDL 401
+ ++ + E+ + L +PP + + + L LS N L ++L Y LT ++L
Sbjct: 6 VSKVASHLEVNCDKRN-LTALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 402 SDNNLTGTIPPQFLGLSWLLIGLDLSR--------------------NQLTGSIPSEVGN 441
LT L + L N+LT +
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 442 LKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQN 501
L L+ L + N+LK P L KLE+L + N L L+ L+ L+ L L +N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 502 NLSGKIPEFLVGFQLLENLNLSNNNL 527
+L IP+ G LL L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 3e-10
Identities = 51/214 (23%), Positives = 74/214 (34%), Gaps = 9/214 (4%)
Query: 291 PAC-ISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNL 349
P C +S +++ LE+ N +P + K + L + N L + L
Sbjct: 2 PICEVSKVASHLEVNCDKRN--LTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRL 57
Query: 350 RELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT 409
+L L R + G L V + S+P LT++D+S N LT
Sbjct: 58 TQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 410 IPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKL 469
GL L L L N+L P + LE L + N L L + L
Sbjct: 116 PLGALRGLGE-LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 470 EQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
+ L +Q N L IP L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 5e-04
Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 4/118 (3%)
Query: 60 NNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSS 119
N + P ++ L ++ L N L L L ++ L + N+L +IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 120 LGNLSSINTLFLTDNNL--DGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSIT 175
+ FL N + I WL++ A + + N++S+
Sbjct: 191 FFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVD-VKAMTSNVASVQ 247
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 5e-04
Identities = 39/198 (19%), Positives = 55/198 (27%), Gaps = 13/198 (6%)
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASN 222
+P + T N L L ++ +LT
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMP-YTRLTQLNLDRAELT--KLQVDGTLPV 78
Query: 223 LELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLIN 282
L N+L + L+V ++ N L S L L L
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL-------YL 131
Query: 283 ANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPA 342
N LP + + LE L L NN + + NL L + N L TIP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 343 IGELQNLRELRLQRNKFL 360
L L N +L
Sbjct: 191 FFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 36/211 (17%), Positives = 63/211 (29%), Gaps = 8/211 (3%)
Query: 23 HVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIR 82
V ++ + + +P + + +L L+ N + A + + L Q+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 83 LFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPD 142
L EL + +N S+P L ++ L ++ N L
Sbjct: 62 LDRAELTKLQVDG---TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 143 TFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFF 202
L L L + N L P + + N L + L+NL
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG-LENLDTL 177
Query: 203 SVFENQLTGAIPPAISNASNLELFQADVNKL 233
+ EN L IP + L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 36/244 (14%), Positives = 69/244 (28%), Gaps = 16/244 (6%)
Query: 276 LNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGN-IPAAIGKFVNLQRLEMWNNR 334
+ + L S ++ + L N+ I + + + + LQ L + R
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 335 LSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLD---------LSCNFLQGS 385
LS I + + NL L L LD + +Q +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 386 IPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445
+ L + N + L+ L E L L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 446 EVLDVFE-NKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLS 504
+ L + + E LG L+ L++ G G + +L L + + ++ +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFT 259
Query: 505 GKIP 508
Sbjct: 260 TIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 16/104 (15%), Positives = 38/104 (36%), Gaps = 1/104 (0%)
Query: 350 RELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGT 409
+ L L ++ + + V +F+ + ++ + +DLS++ + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 410 IPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFEN 453
L L L L +L+ I + + NL L++
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 30/255 (11%), Positives = 75/255 (29%), Gaps = 14/255 (5%)
Query: 289 LLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI-GELQ 347
L P L + + A +Q +++ N+ + + I +
Sbjct: 12 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 71
Query: 348 NLRELRLQRNKFLGNIPPSIG---NLKVFNLDLSCNFLQGSIPS------SLGQYKTLTI 398
L+ L L+ + I ++ NL NL F + ++ + L +
Sbjct: 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131
Query: 399 IDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGE 458
D ++ ++ + ++ L + Q + + + LK +
Sbjct: 132 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 191
Query: 459 IPSTLGSCKKLEQLEMQG-NFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLL 517
L+ L + + L + L L + G + + L
Sbjct: 192 CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK---EAL 248
Query: 518 ENLNLSNNNLEGMVP 532
+L ++ ++ +
Sbjct: 249 PHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 3/99 (3%)
Query: 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGE- 67
L+LT L ++ + + + + + + F R+Q + L+N+ I
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 68 IPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLS 106
+ +S CS L + L L I + L S + L+
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 7e-05
Identities = 18/96 (18%), Positives = 35/96 (36%), Gaps = 2/96 (2%)
Query: 326 QRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQG- 384
Q L++ L + + Q + R R+ + +V ++DLS + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWL 420
++ L Q L + L L+ I S L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 97
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 53.7 bits (127), Expect = 1e-08
Identities = 34/172 (19%), Positives = 73/172 (42%), Gaps = 7/172 (4%)
Query: 295 SNLSTTLEMLLLDNNKIFGNIPAAI-GKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELR 353
++ LLL++N++ + G+ +L +LE+ N+L+G P A +++EL+
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 354 LQRNKFLGNIPPSIGNLK-VFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPP 412
L NK L + L+L N + +P S +LT ++L+ N
Sbjct: 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144
Query: 413 QFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLG 464
+ L+ PS+ ++++++ D+ ++ K ++ G
Sbjct: 145 AWFAEWLRK--KSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 29/173 (16%), Positives = 53/173 (30%), Gaps = 8/173 (4%)
Query: 332 NNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSI-GNLKVFNLDLSCNFLQGSIPSSL 390
L IP I + EL L N+ + G L I +
Sbjct: 17 GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 391 GQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDV 450
+ + N I + L L+L NQ++ +P +L +L L++
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 451 FENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNL 503
N + L + + G + PS + + + + DL +
Sbjct: 134 ASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 33/168 (19%), Positives = 64/168 (38%), Gaps = 8/168 (4%)
Query: 44 IPSEFDRLQRLQVLALNNNSIGGEIPANI-SSCSNLIQIRLFYNELVGKIPSELGSLSKI 102
IP + L LN+N +G + +L+++ L N+L G P+ S I
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 103 EHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSG 162
+ L + N + L + TL L DN + +P +F L +L +L +A N +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 163 TIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210
+ F + + P ++++Q + ++
Sbjct: 141 NCHLAWF-AEWLRKKSLNGGAARCGAPSK----VRDVQIKDLPHSEFK 183
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 23/120 (19%), Positives = 46/120 (38%), Gaps = 5/120 (4%)
Query: 326 QRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGS 385
+ L + + L T+ + +L + L L N+ L +PP++ L+ + + + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNR-LRALPPALAALRCLEVLQASDNALEN 57
Query: 386 IPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNL 445
+ L + L +N L + Q L L+ L+L N L L +
Sbjct: 58 VDGV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 7e-08
Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 398 IIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKG 457
++ L+ +LT + L + LDLS N+L P+ + L+ LEVL +N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTH-LDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55
Query: 458 EIPSTLGSCKKLEQLEMQGNFLQG-PIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQL 516
E + + +L++L + N LQ L S L +L+L N+L + ++
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 517 LENLN 521
L +++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 7e-08
Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 6/113 (5%)
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
L L+ LT + + L + LD+ N+L+ P+ L + + LE +Q +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNALEN 57
Query: 484 PSSLSSLKGLNVLDLSQNNL-SGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535
+++L L L L N L + LV L LNL N+L I+
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 21/107 (19%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 105 LSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTI 164
L ++ +LT + L L + L L+ N L P L+ L L ++N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57
Query: 165 PSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTG 211
+ N+ + N+LQ + + L ++ N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 10/93 (10%)
Query: 377 LSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIP 436
N I S +L +++S+N L +P L L S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFNHLA-EVP 320
Query: 437 SEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKL 469
+NL+ L V N L+ E P S + L
Sbjct: 321 EL---PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 12/99 (12%)
Query: 426 LSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPS 485
N + I S +LE L+V NKL E+P+ LE+L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPE 321
Query: 486 SLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524
+LK L + N L + P+ + +E+L +++
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIP---ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 284 NNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAI 343
N + +L +LE L + NNK+ +PA L+RL N L+ +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLA-EVPE-- 321
Query: 344 GELQNLRELRLQRNKF--LGNIPPSIGNLKVFN 374
QNL++L ++ N +IP S+ +L++ +
Sbjct: 322 -LPQNLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 21/93 (22%), Positives = 32/93 (34%), Gaps = 8/93 (8%)
Query: 306 LDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPP 365
N I + +L+ L + NN+L +P L L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNH-LAEVPE 321
Query: 366 SIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTI 398
NLK L + N L+ P + L +
Sbjct: 322 LPQNLKQ--LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/92 (22%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 59 LNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS 118
N+ EI + +L ++ + N+L+ ++P+ L E L S N+L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPE 321
Query: 119 SLGNLSSINTLFLTDNNLDGGIPDTFGWLKNL 150
NL ++ + N L PD +++L
Sbjct: 322 LPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 23/83 (27%), Positives = 36/83 (43%), Gaps = 8/83 (9%)
Query: 451 FENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEF 510
+ N EI S LE+L + N L +P+ L+ L S N+L+ ++PE
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPEL 322
Query: 511 LVGFQLLENLNLSNNNLEGMVPI 533
Q L+ L++ N L I
Sbjct: 323 P---QNLKQLHVEYNPLREFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 16/61 (26%), Positives = 24/61 (39%), Gaps = 7/61 (11%)
Query: 348 NLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT 407
EL L L ++P +L+ L SCN L +P L + + +NNL
Sbjct: 39 QAHELELNNLG-LSSLPELPPHLES--LVASCNSLT-ELPELPQS---LKSLLVDNNNLK 91
Query: 408 G 408
Sbjct: 92 A 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 20/81 (24%), Positives = 33/81 (40%), Gaps = 9/81 (11%)
Query: 22 PHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQI 81
L+ L + NN +P+ RL+RL + N + E+P NL Q+
Sbjct: 278 SLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHL-AEVP---ELPQNLKQL 329
Query: 82 RLFYNELVGKIPSELGSLSKI 102
+ YN L + P S+ +
Sbjct: 330 HVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 20/96 (20%), Positives = 31/96 (32%), Gaps = 10/96 (10%)
Query: 130 FLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIP 189
N I +L L ++ N L +P+ + + A N L V
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAEVPE 321
Query: 190 LDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLEL 225
L QNL+ V N L P + +L +
Sbjct: 322 L-----PQNLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 16/68 (23%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 394 KTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFEN 453
+ ++L++ L+ ++P L L S N LT +P +LK+L V +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 454 KLKGEIPS 461
L P
Sbjct: 92 ALSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 16/71 (22%), Positives = 25/71 (35%), Gaps = 5/71 (7%)
Query: 324 NLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQ 383
LE+ N LS ++P +L L N L +P +LK +D +
Sbjct: 39 QAHELELNNLGLS-SLPELPP---HLESLVASCNS-LTELPELPQSLKSLLVDNNNLKAL 93
Query: 384 GSIPSSLGQYK 394
+P L
Sbjct: 94 SDLPPLLEYLG 104
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 4e-07
Identities = 22/151 (14%), Positives = 44/151 (29%), Gaps = 3/151 (1%)
Query: 74 SCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLT 132
+R + + L + L + + L L + L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 133 DNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDF 192
+ L PD F + L+ L ++ N L ++ S+ N L L +
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 193 GFTLQNLQFFSVFENQLTGAIPPAISNASNL 223
+ V E +L +++ N
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 23/151 (15%), Positives = 44/151 (29%), Gaps = 5/151 (3%)
Query: 268 CSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQR 327
C S+ L A + + E+ + + + + L+
Sbjct: 5 CCPHGSSGLRCTRDGALD----SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 328 LEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSI- 386
L + + L P A L L L N ++ L + L LS N L S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 387 PSSLGQYKTLTIIDLSDNNLTGTIPPQFLGL 417
L +++ + + + L +
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 14/92 (15%), Positives = 32/92 (34%), Gaps = 5/92 (5%)
Query: 444 NLEVLDVFENKLKGE-IPSTLGSCKKLEQLEMQGNFLQG----PIPSSLSSLKGLNVLDL 498
+++ LD+ +L L ++ + + + L I S+L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 499 SQNNLSGKIPEFLVGFQLLENLNLSNNNLEGM 530
N L ++ + + +L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 17/96 (17%), Positives = 30/96 (31%), Gaps = 15/96 (15%)
Query: 441 NLKNLEVLDVFENKLKGE----IPSTLGSCKKLEQLEMQGNFLQGPIPSSLSS-----LK 491
L VL + + + + +TL + L +L++ N L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 492 GLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNL 527
L L L S ++ L+ L +L
Sbjct: 427 LLEQLVLYDIYWSEEME------DRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 13/98 (13%), Positives = 25/98 (25%), Gaps = 5/98 (5%)
Query: 54 LQVLALNNNSIGGE-IPANISSCSNLIQIRLFYNEL----VGKIPSELGSLSKIEHLSVS 108
+Q L + + + +RL L I S L + L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGW 146
N L + + + +L G
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 14/84 (16%), Positives = 28/84 (33%), Gaps = 4/84 (4%)
Query: 396 LTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTG----SIPSEVGNLKNLEVLDVF 451
+ +D+ L+ + L L + L LT I S + L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 452 ENKLKGEIPSTLGSCKKLEQLEMQ 475
N+L + + ++Q
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 9e-05
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 369 NLKVFNLDLSCNFLQGS-IPSSLGQYKTLTIIDLSDNNLTGTIP---PQFLGLSWLLIGL 424
+L + +LD+ C L + L + ++ L D LT L ++ L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 425 DLSRNQLTGSIPSEVG-----NLKNLEVLD 449
+L N+L V ++ L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 19/111 (17%), Positives = 34/111 (30%), Gaps = 26/111 (23%)
Query: 323 VNLQRLEMWNNRLSGT-IPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNF 381
+++Q L++ LS + LQ + +RL
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC----------------- 44
Query: 382 LQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLT 432
I S+L L ++L N L G+ +L GL ++
Sbjct: 45 --KDISSALRVNPALAELNLRSNELGDV------GVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 8/84 (9%)
Query: 393 YKTLTIIDLSDNNLTGTIP---PQFLGLSWLLIGLDLSRNQLTGSIPSEVG-----NLKN 444
L ++ L+D +++ + L + L LDLS N L + ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 445 LEVLDVFENKLKGEIPSTLGSCKK 468
LE L +++ E+ L + +K
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/86 (20%), Positives = 33/86 (38%), Gaps = 12/86 (13%)
Query: 375 LDLSCNFLQG----SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGL----SWLLIGLDL 426
L L+ + S+ ++L +L +DLS+N L Q + LL L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 427 SRNQLTGSIPSEVGNLK----NLEVL 448
+ + + L+ +L V+
Sbjct: 434 YDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 17/77 (22%), Positives = 25/77 (32%), Gaps = 9/77 (11%)
Query: 465 SCKKLEQLEMQGNFLQG----PIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGF-----Q 515
L L + + + ++L + L LDLS N L LV
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 516 LLENLNLSNNNLEGMVP 532
LLE L L + +
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 14/101 (13%), Positives = 29/101 (28%), Gaps = 9/101 (8%)
Query: 36 YNNSFNHGIPSEFDRLQRLQVLALNNNSIGGE----IPANISSCSNLIQIRLFYNELVGK 91
+ L+VL L + + + A + + +L ++ L N L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 92 IPSELGS-----LSKIEHLSVSVNNLTGSIPSSLGNLSSIN 127
+L +E L + + + L L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 15/95 (15%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 293 CISNLSTTLEMLLLDNNKI----FGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGE--- 345
+ + L +L L + + ++ A + +L+ L++ NN L + E
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 346 --LQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLS 378
L +L L + + + L+ L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 16/92 (17%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 273 STRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKI----FGNIPAAIGKFVNLQRL 328
S + L I A + L +++ LD+ + +I +A+ L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 329 EMWNNRLSGTIPPAIGEL-----QNLRELRLQ 355
+ +N L + + +++L LQ
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 35/221 (15%), Positives = 64/221 (28%), Gaps = 18/221 (8%)
Query: 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNI 363
+ + + + A + L + ++ + L NL L L+ N+
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI--TD 77
Query: 364 PPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIG 423
+ NL ++ + G T+ S T L L
Sbjct: 78 LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL--- 134
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
I + + + + + L + KL L+ N +
Sbjct: 135 -----YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 484 PSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524
P L+SL L + L N +S P L L + L+N
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 31/219 (14%), Positives = 63/219 (28%), Gaps = 27/219 (12%)
Query: 272 NSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMW 331
++ +N + ++L + L + I + NL LE+
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGV-TTIEG-VQYLNNLIGLELK 71
Query: 332 NNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLG 391
+N++ T + L + EL L N + S + + L
Sbjct: 72 DNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 392 QYKTL----------------TIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSI 435
+ L T + L L L N+++
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 436 PSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEM 474
P + +L NL + + N++ P L + L + +
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 50/322 (15%), Positives = 99/322 (30%), Gaps = 25/322 (7%)
Query: 44 IPSEFDRLQRLQVLALNNNSIGGE----IPANISSCSNLIQIRLFYN---ELVGKIPSEL 96
+ + ++ + L+ N+IG E + NI+S +L + +IP L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 97 GSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMA 156
L + ++ + S + FL+ + + L A +A
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 157 ENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPA 216
+ N + + G N+L+ ++ T Q+ + + G P
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 217 ISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLTNSTRL 276
I + L K+ S + L
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLG------------SSALAIALKSWPNLRELGL 250
Query: 277 NRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAI-----GKFVNLQRLEMW 331
N L++A ++ A + L+ L L N+I + + K +L LE+
Sbjct: 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 310
Query: 332 NNRLSGTIPPAIGELQNLRELR 353
NR S + E++ + R
Sbjct: 311 GNRFSE-EDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 35/310 (11%), Positives = 73/310 (23%), Gaps = 25/310 (8%)
Query: 86 NELVGKIPSELGSLSKIEHLSVSVNNLTG----SIPSSLGNLSSINTLFLTDNNLDGGIP 141
E + + L ++ + +S N + + ++ + + +D
Sbjct: 17 TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKD 76
Query: 142 DTFGWLKNLATLAMAENWLS---------GTIPSSIFNISSITAFDAGMNQLQGVIPLDF 192
+ L+ L + L G L
Sbjct: 77 EIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 136
Query: 193 GFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSIT 252
+ N+ PP S + K + +
Sbjct: 137 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 196
Query: 253 ENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIF 312
H L L L+ + G A L L L++ +
Sbjct: 197 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 313 GNIPAAIG------KFVNLQRLEMWNNRLSGTIPPAIGE-----LQNLRELRLQRNKFLG 361
AA+ + + LQ L + N + + + +L L L N+F
Sbjct: 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-S 315
Query: 362 NIPPSIGNLK 371
+ ++
Sbjct: 316 EEDDVVDEIR 325
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 35/212 (16%), Positives = 70/212 (33%), Gaps = 17/212 (8%)
Query: 265 NFLCSLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVN 324
+ S + + + + + L +++ ++ +N+ I I N
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIKSVQG--IQYLPN 69
Query: 325 LQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQG 384
+ +L + N+L+ P L NL+ L S LS
Sbjct: 70 VTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 385 SIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKN 444
S + L L + L +N +T L L D + + + L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTK 179
Query: 445 LEVLDVFENKLKGEIPSTLGSCKKLEQLEMQG 476
L+ L + +N + ++ + L K L+ LE+
Sbjct: 180 LQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 37/196 (18%), Positives = 68/196 (34%), Gaps = 16/196 (8%)
Query: 304 LLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNI 363
L + + + ++ ++ N+ + I L N+ +L L NK
Sbjct: 29 DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 364 PPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIG 423
P + NLK +L + L +L GL L
Sbjct: 85 P--LANLKN------LGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 424 LDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPI 483
L + + + L L+ L + +N++ +P L KL+ L + N +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-- 192
Query: 484 PSSLSSLKGLNVLDLS 499
+L+ LK L+VL+L
Sbjct: 193 LRALAGLKNLDVLELF 208
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 29/140 (20%), Positives = 55/140 (39%), Gaps = 7/140 (5%)
Query: 1 RRHQRVKILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALN 60
R + L+L L+ P + + VL ++ + + + L L L+
Sbjct: 19 RYDGSQQALDLKGLR----SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLS 73
Query: 61 NNSIGG--EIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS 118
NN + ++ + + NL + L NEL + + K+E L + N+L+ +
Sbjct: 74 NNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
Query: 119 SLGNLSSINTLFLTDNNLDG 138
+S+I F LDG
Sbjct: 134 QSTYISAIRERFPKLLRLDG 153
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 35/225 (15%), Positives = 73/225 (32%), Gaps = 10/225 (4%)
Query: 315 IPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFN 374
IP+ + N L +L A +L ++ + +N L I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 375 LDLS----CNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQ 430
++ N L + + ++ + + L +L+ + + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 431 LTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSL 490
T S VG +L + +N ++ + E N L+
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 491 KGLNVLDLSQNNLSGKIPEFLVGFQLLENLN-LSNNNLEGMVPIE 534
G +LD+S+ + G + L+ L S NL+ + +E
Sbjct: 201 SGPVILDISRTRIHSLPSY---GLENLKKLRARSTYNLKKLPTLE 242
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 18/131 (13%), Positives = 40/131 (30%), Gaps = 5/131 (3%)
Query: 322 FVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNF 381
V + L++ ++ I L + N+ + + ++ L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE-IRKLDGFPLLRRLKTLLVNNNR 74
Query: 382 LQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLS---RNQLTGSIPSE 438
+ LT + L++N+L L L L +
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134
Query: 439 VGNLKNLEVLD 449
+ + + VLD
Sbjct: 135 IYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 19/137 (13%), Positives = 39/137 (28%), Gaps = 7/137 (5%)
Query: 21 SPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQ 80
+ N + L L I + L + + ++N I L
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 81 IRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTG-SIPSSLGNLSSINTLFLTDNN---L 136
+ + N + +L + L ++ N+L L +L S+ L + N
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 137 DGGIPDTFGWLKNLATL 153
+ + L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.9 bits (89), Expect = 0.001
Identities = 32/167 (19%), Positives = 61/167 (36%), Gaps = 20/167 (11%)
Query: 299 TTLEMLLLDNNKIFGNIP------AAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLREL 352
++ + ++ G IP A + + L + N + ++ ++NLR L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRIL 75
Query: 353 RLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPP 412
L RN ++ + +L ++ Q + S + + L ++ +S+N +T
Sbjct: 76 SLGRNLI--KKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEI 133
Query: 413 QFLGLSWLLIGLDLSRNQLTGSIPSE----------VGNLKNLEVLD 449
L L L L+ N L V L NL+ LD
Sbjct: 134 DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 953 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.64 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.94 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.38 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=431.33 Aligned_cols=264 Identities=28% Similarity=0.440 Sum_probs=206.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||+||+|++++ .||||+++.. .....+.+.+|++++++++||||+++++++.. +.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 4679999999999999999998753 5999999633 34556789999999999999999999998632 45
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.++++.. ...+++.++..|+.||++||+|||++ +||||||||+|||++.++.+||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII---------ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS---------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEecCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEE
Confidence 79999999999999999632 23589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS---EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||+|+...............||+.|||||++.+. .++.++|||||||++|||+||+.||.+..............
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence 999999877544444444556799999999998643 58999999999999999999999997643221111111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
..+..... ....+++++.+++.+||+.||++||||+||++.|+.+++..+
T Consensus 226 ~~~p~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 226 YLSPDLSK---------------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SCCCCGGG---------------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCcchh---------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11111000 011345679999999999999999999999999999988655
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=422.86 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=204.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|+++.+++.||||+++... .+..+.+.+|++++++++||||+++++++. +++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 357999999999999999999999988999999997433 234467899999999999999999999964 34789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 79 ~ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccCCCcHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEc
Confidence 999999999999999952 23689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+|+..............+||+.|||||++.+..+ +.++||||+||++|||+||+.||...................
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~ 225 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 225 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Confidence 9999998754443344455679999999999988876 578999999999999999999997643332222221111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ....+++++.+++.+||+.||++|||++|+++
T Consensus 226 ~~------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LN------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ST------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00123456789999999999999999999854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=419.80 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=206.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++||||+++++++. .++..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence 47999999999999999999999988999999998665556678999999999999999999999964 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++. ...+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 95 vmEy~~gg~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEECCTTCBHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccc
Confidence 999999999999874 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+|+.+.... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+. .........+.
T Consensus 161 G~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~-- 235 (293)
T d1yhwa1 161 GFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE-- 235 (293)
T ss_dssp TTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC--
T ss_pred hhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCC--
Confidence 9999774332 233455799999999999999999999999999999999999999975322111 11111100000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...+..+++++.+++.+||+.||++|||++|+++
T Consensus 236 ---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 ---------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001134567889999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-49 Score=421.64 Aligned_cols=270 Identities=24% Similarity=0.415 Sum_probs=202.3
Q ss_pred CcCHHHHHHhh---------cCCcccCcccccceeeEEEEEEcCCC---eEEEEEEeec-cchhhHHHHHHHHHHHhhcC
Q 043900 620 NISYQNLYNAT---------DGFASANEIGVGSFGSVYKGILDQGK---TTVAVKVFNL-LHHGAFKSFIAECNTLKNIR 686 (953)
Q Consensus 620 ~~~~~~~~~~~---------~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~ 686 (953)
.++|++...++ ++|++.+.||+|+||+||+|+++.++ ..||||++.. ......+.+.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34555555444 34667789999999999999987554 3589998864 34445678999999999999
Q ss_pred CCCeeEEEeeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043900 687 HRNLVKILTACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPP 766 (953)
Q Consensus 687 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 766 (953)
|||||+++|+|.. ++..++|||||++|+|.+++... ...+++.+++.++.||++||+|||++ +
T Consensus 86 HpnIv~l~g~~~~-----~~~~~iv~Ey~~~g~L~~~~~~~---------~~~l~~~~~~~i~~qia~gl~yLH~~---~ 148 (299)
T d1jpaa_ 86 HPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLADM---N 148 (299)
T ss_dssp CTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCCccEEEEEee-----CCEEEEEEEecCCCcceeeeccc---------cCCCCHHHHHHHHHHHHHHHHHHhhC---C
Confidence 9999999999643 47789999999999999988632 23589999999999999999999999 9
Q ss_pred eEeecCCCCCeEecCCCcEEEeccccceecCCCCCc---ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 043900 767 ITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQ---TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT 843 (953)
Q Consensus 767 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt 843 (953)
|+||||||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t 228 (299)
T d1jpaa_ 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228 (299)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence 999999999999999999999999999877543222 12223458999999999999999999999999999999998
Q ss_pred -CCCCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCC
Q 043900 844 -RKKPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGD 922 (953)
Q Consensus 844 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 922 (953)
|+.||.+.... .....+.... +.+.+.+++.++.+++.+||+.||++
T Consensus 229 ~g~~Pf~~~~~~--~~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 229 YGERPYWDMTNQ--DVINAIEQDY------------------------------RLPPPMDCPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp TSCCTTTTCCHH--HHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred CCCCCCCCCCHH--HHHHHHHcCC------------------------------CCCCCccchHHHHHHHHHHcCCCHhH
Confidence 89999753221 1111111000 00011134567899999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 043900 923 RMNMTNVVRQLQSIKN 938 (953)
Q Consensus 923 RPt~~evl~~L~~i~~ 938 (953)
||||+||++.|+++.+
T Consensus 277 RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 277 RPKFGQIVNTLDKMIR 292 (299)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHhc
Confidence 9999999999998865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=412.70 Aligned_cols=257 Identities=27% Similarity=0.378 Sum_probs=197.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||+||+|++.++ +.||||+++... ...+++.+|++++++++||||++++|+|.. ++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTT-EEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCC-CEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence 5788999999999999999999765 489999997533 345789999999999999999999999753 367899
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++... ...+++..++.|+.|||.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 78 v~E~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEECCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSC
T ss_pred EEEecCCCcHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEeccc
Confidence 99999999999998532 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR-KKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||... .. .............
T Consensus 146 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~-~~~~~~i~~~~~~- 221 (263)
T d1sm2a_ 146 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SN-SEVVEDISTGFRL- 221 (263)
T ss_dssp C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CH-HHHHHHHHHTCCC-
T ss_pred chheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CH-HHHHHHHHhcCCC-
Confidence 99987653322 223345689999999999999999999999999999999995 4444321 11 1111111110000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
..+..+++++.+++.+||+.||++||||+||++.|++++++
T Consensus 222 -----------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 -----------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 00012345789999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=415.57 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=195.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|++.+.||+|+||+||+|+++.+++.||||+++.. .+...+.+.+|++++++++||||+++++++.+ ..+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 36799999999999999999999999899999999643 34456778999999999999999999998743 23456
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeecCCCCCeEecCCCcE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDC--QPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTK------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 8999999999999999864322 1346999999999999999999999871 1249999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
||+|||+|+.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........
T Consensus 154 kl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~- 228 (269)
T d2java1 154 KLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIRE- 228 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-
T ss_pred EEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHc-
Confidence 999999998764322 2233467999999999999999999999999999999999999999753221 11111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
...... +..+++++.+++.+||+.||++|||++|+++
T Consensus 229 ----------~~~~~~-------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 ----------GKFRRI-------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----------TCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCCCC-------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000000 0123456889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=411.18 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=203.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++. +++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 5799999999999999999999999999999998632 2334577899999999999999999999964 4578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~----------~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEee
Confidence 9999999999999999952 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 148 ~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~ 218 (263)
T d2j4za1 148 ADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRISR 218 (263)
T ss_dssp CCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT
T ss_pred cccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----HHHHHHHc
Confidence 999999865432 223456999999999999999999999999999999999999999753211 11111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ... +..+++++.+++.+||+.||++|||++|+++
T Consensus 219 ~~------~~~----------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VE------FTF----------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TC------CCC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC------CCC----------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00 000 0123456889999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=419.42 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=210.7
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
..++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|++++++++|||||+++++|. +++..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCee
Confidence 3467899999999999999999999988899999997543 34578999999999999999999999964 34778
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+++|+|.+++.... ...+++..++.|+.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC--------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEeecccCcchHHHhhhcc--------ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEc
Confidence 99999999999999986432 23689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
|||+|+...... ........|++.|+|||++.+..++.++|||||||++|||++|..||....... ...+.....
T Consensus 158 DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~--- 232 (287)
T d1opja_ 158 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKD--- 232 (287)
T ss_dssp CCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTT---
T ss_pred cccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcC---
Confidence 999998764332 223334568999999999999999999999999999999999877764321111 111111110
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIK 937 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~ 937 (953)
... ..+..+++++.+++.+||+.||++||||+||++.|+.+.
T Consensus 233 ---------~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 ---------YRM------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---------CCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---------CCC------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 000 001134567899999999999999999999999988763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=408.57 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=198.3
Q ss_pred cccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 634 ASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 634 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
+..++||+|+||+||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++... ...+...++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 5667899999999999999998889999998643 344567789999999999999999999997543 3345678999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec-CCCcEEEecc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD-EEMMAHVSDF 790 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Df 790 (953)
|||+++|+|.+++.. ...+++.+++.++.||++||+|||++ .++|+||||||+|||++ +++.+||+||
T Consensus 91 mE~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCcHHHHHhc----------cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 999999999999952 23689999999999999999999998 12299999999999996 5789999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+|+.... .......||+.|||||++.+ .++.++|||||||++|||++|+.||....... ...........
T Consensus 160 Gla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~----~~~~~i~~~~~ 230 (270)
T d1t4ha_ 160 GLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRVTSGVK 230 (270)
T ss_dssp TGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHHTTTCC
T ss_pred CcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH----HHHHHHHcCCC
Confidence 99986432 22334579999999999875 59999999999999999999999997432211 11111100000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ......++++.+++.+||+.||++|||++|+++
T Consensus 231 ~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PA--------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CG--------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc--------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00 000122456889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=416.41 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=205.5
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++. +++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 46899999999999999999999999999999998766667788999999999999999999999964 3478999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 vmEy~~~g~L~~~~~~~---------~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL---------ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEec
Confidence 99999999999987532 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGL-----GSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|+.... .........||+.|+|||++. +..|+.++|||||||++|||+||+.||.+....+. +.......
T Consensus 155 G~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~ 231 (288)
T d2jfla1 155 GVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSE 231 (288)
T ss_dssp TTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSC
T ss_pred hhhhccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCC
Confidence 99986532 112233456999999999974 45689999999999999999999999975322211 11111100
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.+ ....+..+++++.+++.+||+.||++|||++|+++
T Consensus 232 ~~-----------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 PP-----------------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC-----------------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-----------------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00011134567899999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=409.71 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=208.6
Q ss_pred cCCcccCc-ccccceeeEEEEEEcC--CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANE-IGVGSFGSVYKGILDQ--GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~-ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. .....+++.+|++++++++|||||+++|+|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 45666664 9999999999998754 3457999999743 34456789999999999999999999999742 4
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeCCCCcHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence 579999999999999998532 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 787 VSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .....+..
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~ 227 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ 227 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHT
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHc
Confidence 9999999987544322 22234568999999999999999999999999999999998 99999753221 11111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhc
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILL 941 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 941 (953)
.. +...+..+++++.+++.+||+.||++||||.+|++.|+.+-....
T Consensus 228 ~~------------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 228 GK------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp TC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CC------------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 00 000111345678999999999999999999999999998765443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=409.88 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=206.0
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||+||+|+++++ +.||||+++... ...+.+.+|++++++++|||||+++++|.. +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCC-CEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence 35788999999999999999998754 589999997543 345679999999999999999999998642 4578
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|.+++.... ...+++.+++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~~~--------~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS--------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH--------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence 9999999999999885332 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||+|+...... ........||+.|+|||++.+..++.++|||||||++|||+||..|+....... ..........
T Consensus 153 FGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~~--- 227 (272)
T d1qpca_ 153 FGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY--- 227 (272)
T ss_dssp CTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTC---
T ss_pred ccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcC---
Confidence 99999875432 223344568999999999999999999999999999999999766654321111 1111111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
. ...+..+++++.+++.+||+.||++||||+||++.|+++-.
T Consensus 228 -----~----------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 -----R----------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----C----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----C----------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0 00011345678999999999999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=412.19 Aligned_cols=251 Identities=19% Similarity=0.267 Sum_probs=202.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++||||+++++++. +++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 5799999999999999999999988899999999632 2334577999999999999999999999954 4578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEccCCCCHHHhhhc----------cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEe
Confidence 9999999999999998852 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+.+.............||+.|+|||++.+..++.++||||+||++|||+||+.||...... ........
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~ 224 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKIIK 224 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHT
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-----HHHHHHHc
Confidence 9999999876544444445567999999999999999999999999999999999999999752111 11111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
... .. +..+++++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~------~~----------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 225 LEY------DF----------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TCC------CC----------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCC------CC----------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 000 00 00234568899999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=406.17 Aligned_cols=261 Identities=23% Similarity=0.390 Sum_probs=199.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCC----eEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGK----TTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
+.|+..++||+|+||+||+|.++.++ ..||||+++.. .......+.+|++++++++|||||+++|+|.. .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----C
Confidence 46888999999999999999987553 47999999643 33445678999999999999999999999643 3
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++||||+.+|++.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK---------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEEecccCcchhhhhcc---------cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeE
Confidence 7789999999999999887532 23689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+........ ....+..
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~ 228 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAIND 228 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHT
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhc
Confidence 99999999876543222 223345689999999999999999999999999999999997666543211111 1111110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
... .+.+..++.++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 229 ------------~~~------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 ------------GFR------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------------TCC------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------------cCC------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 000 001113456789999999999999999999999999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=418.16 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=176.5
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|+.++++++|||||+++++|. +++..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 56899999999999999999999999999999999743 3344578899999999999999999999964 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||
T Consensus 80 ~iVmEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEcCCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEE
Confidence 999999999999999952 2368999999999999999999996 6 8999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSM 851 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~ 851 (953)
+|||+|+.+... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 147 ~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 147 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred eeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999866322 223457999999999999999999999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=416.95 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=207.6
Q ss_pred cCCcccCcccccceeeEEEEEEcCCC-----eEEEEEEeec-cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGK-----TTVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 703 (953)
++|++.+.||+|+||+||+|++...+ ..||+|++.. ........+.+|+.++.++ +|||||+++++|.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----- 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----- 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-----
Confidence 57899999999999999999986543 3699999853 3344557889999999998 8999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCc-------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEee
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDK-------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHC 770 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 770 (953)
..+..++||||+++|+|.++++....... .......+++.+++.++.||++||+|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 34778999999999999999975432110 011234689999999999999999999999 99999
Q ss_pred cCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 043900 771 DLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVD 849 (953)
Q Consensus 771 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~ 849 (953)
||||+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765544444455668999999999999999999999999999999998 899997
Q ss_pred CcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 043900 850 SMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNV 929 (953)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 929 (953)
+..... .+......... .+.+..+++++.+++.+||+.||++||||+||
T Consensus 269 ~~~~~~-~~~~~~~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 269 GIPVDA-NFYKLIQNGFK------------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp TCCCSH-HHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCHHH-HHHHHHhcCCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 532221 12221111110 00111345679999999999999999999999
Q ss_pred HHHHH
Q 043900 930 VRQLQ 934 (953)
Q Consensus 930 l~~L~ 934 (953)
++.|.
T Consensus 318 ~~~L~ 322 (325)
T d1rjba_ 318 TSFLG 322 (325)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=404.06 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=198.8
Q ss_pred CcccccceeeEEEEEEcC--CCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEEE
Q 043900 637 NEIGVGSFGSVYKGILDQ--GKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALVF 712 (953)
Q Consensus 637 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 712 (953)
++||+|+||+||+|.++. .++.||||+++. ......+++.+|++++++++|||||+++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 469999999999998754 346899999963 233445789999999999999999999999742 4578999
Q ss_pred eeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecccc
Q 043900 713 EFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFGL 792 (953)
Q Consensus 713 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 792 (953)
||+++|+|.++++. ...+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EcCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence 99999999999852 23689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc-ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCchh
Q 043900 793 ARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDHV 870 (953)
Q Consensus 793 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 870 (953)
|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ..........
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~---- 227 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE---- 227 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC----
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCC----
Confidence 9977544332 22334568999999999999999999999999999999998 89999753221 1111111000
Q ss_pred hhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 871 VDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 871 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
+...+..+++++.+++.+||+.||++|||++||+++|+..
T Consensus 228 --------------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 --------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 0001113456789999999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=398.68 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=207.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|+..++||+|+||+||+|+++ +++.||||+++.... ..+++.+|++++++++||||++++|+|. ++...++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEE
Confidence 57999999999999999999996 456899999975433 4568999999999999999999999964 3477999
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|++.+++... ...+++..+++++.|+++||+|||+. ||+||||||+||++++++.+||+||
T Consensus 77 v~Ey~~~g~l~~~~~~~---------~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp EEECCTTEEHHHHHHSG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEccCCCcHHHhhhcc---------ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcc
Confidence 99999999999997532 33588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+.....
T Consensus 145 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~-- 219 (258)
T d1k2pa_ 145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLR-- 219 (258)
T ss_dssp SSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC--
T ss_pred hhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCC--
Confidence 99987654322 23344669999999999999999999999999999999998 899997643221 1111111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
...+..+++++.+++.+||+.||++|||++|+++.|.+
T Consensus 220 ----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 ----------------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----------------------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 00001234578999999999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=407.05 Aligned_cols=253 Identities=21% Similarity=0.236 Sum_probs=189.2
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
..+.|++.+.||+|+||+||+|+++.+++.||||++.... ......+.+|++++++++||||+++++++ .+++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3467999999999999999999999988999999996432 23345688999999999999999999995 34578
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---CCCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD---EEMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 784 (953)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||++. +++.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE----------KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEeccCCCcHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCce
Confidence 9999999999999999952 23699999999999999999999999 999999999999994 5789
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+|+...... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....+ ........
T Consensus 149 vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~ 224 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKA 224 (307)
T ss_dssp EEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTT
T ss_pred EEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhcc
Confidence 9999999998664322 2234569999999999999999999999999999999999999997532211 00111000
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .. ......+++++.+++.+||+.||++|||++|+++
T Consensus 225 ~~~------------~~----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 225 EYE------------FD----------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCC------------CC----------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC------------CC----------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 00 0000133567889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-46 Score=410.48 Aligned_cols=253 Identities=18% Similarity=0.237 Sum_probs=206.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.+.|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|++++++++||||+++++++. +++..+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 457999999999999999999999888999999998666666678899999999999999999999954 458899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec--CCCcEEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--EEMMAHV 787 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL 787 (953)
+||||+++|+|.+++... ...+++.+++.|+.||+.||+|||++ ||+||||||+|||++ .++.+||
T Consensus 103 ivmE~~~gg~L~~~~~~~---------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp EEEECCCCCBHHHHTTCT---------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCChHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEE
Confidence 999999999999887532 23589999999999999999999999 999999999999998 6789999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+.+.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ .+.........
T Consensus 171 ~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~ 246 (352)
T d1koba_ 171 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE 246 (352)
T ss_dssp CCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC
T ss_pred eecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 9999999875432 2334569999999999999999999999999999999999999997532211 01111110000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... .....+++++.+++.+||+.||++|||++|+++
T Consensus 247 ----------~~~------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 ----------FDE------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----------CCS------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----------CCc------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000123456889999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.1e-47 Score=410.90 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=207.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++|||||++++++. +++..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 468999999999999999999999999999999998766666788999999999999999999999964 347899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec--CCCcEEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD--EEMMAHV 787 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL 787 (953)
+|||||++|+|.+++... ...+++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||
T Consensus 100 ivmE~~~gg~L~~~l~~~---------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEECCCCSCBHHHHHTCT---------TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEcCCCCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence 999999999999998532 23599999999999999999999999 999999999999996 4678999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+.+.... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....+ .+.........
T Consensus 168 ~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~ 243 (350)
T d1koaa2 168 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN 243 (350)
T ss_dssp CCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred eecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 9999999875332 2234569999999999999999999999999999999999999997532111 11111110000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
. .. .....+++++.+++.+||+.||++|||++|+++
T Consensus 244 ~------------~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 M------------DD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp S------------CC----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred C------------Cc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 000123456889999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=405.27 Aligned_cols=272 Identities=24% Similarity=0.338 Sum_probs=205.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeec-cchhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNL-LHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|++.. +++.||||+++. ......+.+.+|...+.++ +|+||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~---- 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence 3679999999999999999999854 346899999964 3344556788888888887 6899999999864
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcc------cCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKT------EEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSN 776 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 776 (953)
..+...++|||||++|+|.++++........ ......+++.+++.++.||++||+|||++ +|+||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 3346789999999999999999654321100 11234689999999999999999999999 99999999999
Q ss_pred eEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCCcccCC
Q 043900 777 VLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK-KPVDSMFEGD 855 (953)
Q Consensus 777 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~-~pf~~~~~~~ 855 (953)
||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~- 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998776555544555667999999999999999999999999999999999975 567543222
Q ss_pred ccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 043900 856 MNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQS 935 (953)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 935 (953)
..+........... .+..+++++.+++.+||+.||++||||+||++.|++
T Consensus 244 ~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 244 EEFCRRLKEGTRMR------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCC------------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111111000 001234568999999999999999999999999999
Q ss_pred HHHH
Q 043900 936 IKNI 939 (953)
Q Consensus 936 i~~~ 939 (953)
+.++
T Consensus 294 ilq~ 297 (299)
T d1ywna1 294 LLQA 297 (299)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 8765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-47 Score=406.22 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=199.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
+.|+..+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++|||||++++++.+ ++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 35899999999999999999999999999999997432 3345678999999999999999999999643 478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++|||||++|++..++.. ...+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~----------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl 156 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVH----------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 156 (309)
T ss_dssp EEEEEECCSEEHHHHHHHH----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEEecCCCchHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEE
Confidence 9999999999999776631 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG---SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+|||+|+.... .....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+....+ .+......
T Consensus 157 ~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~ 229 (309)
T d1u5ra_ 157 GDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 229 (309)
T ss_dssp CCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS
T ss_pred eecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC
Confidence 99999986532 233569999999999864 468999999999999999999999997532111 01111110
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
..+. .. ...+++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~---------~~---------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESPA---------LQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCC---------CS---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---------CC---------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0000 00 0023456889999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-47 Score=407.19 Aligned_cols=273 Identities=25% Similarity=0.410 Sum_probs=211.8
Q ss_pred HHHHhhcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhhcCCCCeeEEEeeec
Q 043900 625 NLYNATDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLLH-HGAFKSFIAECNTLKNIRHRNLVKILTACS 698 (953)
Q Consensus 625 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 698 (953)
+++...++|++.+.||+|+||+||+|++++ +++.||||+++... ....+++.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 333445789999999999999999999863 45789999997433 334677999999999999999999999974
Q ss_pred ccccCCCCceeEEEeeccCCchhhccccCCcCCc--------------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 043900 699 GVDYQGNDFKALVFEFMQNRSLEEWLHPITREDK--------------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQ 764 (953)
Q Consensus 699 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 764 (953)
. ....++||||+++|+|.++++....... .......+++.+++.|+.|++.||+|||+.
T Consensus 87 ~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-- 159 (301)
T d1lufa_ 87 V-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159 (301)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred c-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence 3 4778999999999999999964332111 112234589999999999999999999999
Q ss_pred CCeEeecCCCCCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhC
Q 043900 765 PPITHCDLKPSNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTR 844 (953)
Q Consensus 765 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg 844 (953)
+||||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 9999999999999999999999999999876544444444456689999999999999999999999999999999998
Q ss_pred C-CCCCCcccCCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCC
Q 043900 845 K-KPVDSMFEGDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDR 923 (953)
Q Consensus 845 ~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 923 (953)
. +||......+ ....+... ... ..+..+++++.+++.+||+.||++|
T Consensus 239 ~~~p~~~~~~~e--~~~~v~~~-----------~~~-------------------~~p~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 239 GLQPYYGMAHEE--VIYYVRDG-----------NIL-------------------ACPENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp TCCTTTTSCHHH--HHHHHHTT-----------CCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCHHH--HHHHHHcC-----------CCC-------------------CCCccchHHHHHHHHHHcCCChhHC
Confidence 6 5665432111 11111100 000 0011345678999999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 043900 924 MNMTNVVRQLQSIK 937 (953)
Q Consensus 924 Pt~~evl~~L~~i~ 937 (953)
|||.||+++|+++.
T Consensus 287 Pt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 287 PSFCSIHRILQRMC 300 (301)
T ss_dssp CCHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHHhc
Confidence 99999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=406.17 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=203.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe----EEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT----TVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGN 705 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 705 (953)
++|++.++||+|+||+||+|++..+++ +||+|+++. ......+.+.+|++++++++|||||+++|+|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999976654 588888863 334456789999999999999999999999753
Q ss_pred CceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcE
Q 043900 706 DFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMA 785 (953)
Q Consensus 706 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 785 (953)
+..++++||+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHT---------SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred CCeeEEEEeccCCccccccccc---------ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence 3568899999999999988532 23689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHh
Q 043900 786 HVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 786 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~ 864 (953)
||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |..||+.....+ .......
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~ 228 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK 228 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHH
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999998765544444445568999999999999999999999999999999999 788887532221 1111111
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
... ...+..+++++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 229 ~~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GER------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TCC------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC------------------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 100 00111345678999999999999999999999999988754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=397.51 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=204.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc------hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH------HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 467999999999999999999999988999999996322 123578999999999999999999999954
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
+++..++|||||++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----------~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS
T ss_pred ECCEEEEEEEcCCCccccchhcc----------ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCC
Confidence 45789999999999999999952 23689999999999999999999999 999999999999998776
Q ss_pred ----cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHH
Q 043900 784 ----MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLH 859 (953)
Q Consensus 784 ----~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~ 859 (953)
.+|++|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+.
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~ 226 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 226 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH
T ss_pred CcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHH
Confidence 59999999998774332 2334568999999999999999999999999999999999999997532111 001
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
........ . .......+++++.+++.+||+.||++|||++|+++
T Consensus 227 ~i~~~~~~--------------~--------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 227 NVSAVNYE--------------F--------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHTTCCC--------------C--------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhcCCC--------------C--------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10000000 0 00011134567889999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=393.41 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=197.4
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeE
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKAL 710 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 710 (953)
++|++.+.||+|+||.||+|++++ +.||||+++.. ...+.+.+|++++++++||||++++|+|.+ ..+..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT--EEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEECC--eEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEE
Confidence 468889999999999999999953 57999999643 345789999999999999999999998742 3356799
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEecc
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDF 790 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 790 (953)
||||+++|+|.+++.... ...+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 79 v~ey~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EECCCTTEEHHHHHHHHH--------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEeccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccc
Confidence 999999999999996322 22589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhhCCch
Q 043900 791 GLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 791 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
|+++..... .....+|..|+|||++.+..++.++|||||||++|||+| |++||...... .....+.....
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~-- 218 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK-- 218 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC--
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence 999865322 223457899999999999999999999999999999998 67777643221 11111111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
.+.+..+++++.+++.+||+.||++||||.|++++|+.++.
T Consensus 219 ----------------------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 ----------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 00111234678999999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-46 Score=396.87 Aligned_cols=265 Identities=20% Similarity=0.305 Sum_probs=204.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++... .....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCc
Confidence 46799999999999999999999999999999999643 234456789999999999999999999997543 22234
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.++
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----------~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEE
T ss_pred eEEEEEECCCCCEehhhhcc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccce
Confidence 58999999999999998852 23689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCC-CcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSP-AQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
++|||.+....... .........||+.|+|||++.+..++.++||||+||++|||+||+.||......+. ........
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~ 230 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED 230 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcC
Confidence 99999998664332 22233455799999999999999999999999999999999999999975321111 00000000
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-NMTNVVRQLQSIK 937 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~ 937 (953)
. .. . ......+++++.+++.+||+.||++|| |++|+++.|.+++
T Consensus 231 ~-~~-~--------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 P-IP-P--------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp C-CC-G--------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-CC-C--------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 00 0 000012356789999999999999999 8999999988775
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=397.79 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=200.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||+||+|+++++. .||||+++.... ..+.+.+|+.++++++|||||+++++|.+ +..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTE-EEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCC-EEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence 357999999999999999999998775 799999975433 45789999999999999999999999632 4578
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||+++|+|..++.... ...++|.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~--------~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EEECCCTTCBHHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEecCCCchhhhhhhcc--------cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcc
Confidence 9999999999999986322 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||..||....... .....+.....
T Consensus 157 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~~~~~-- 232 (285)
T d1fmka3 157 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYR-- 232 (285)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC--
T ss_pred cchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCC--
Confidence 999987643322 23334568999999999999999999999999999999999766654322111 11111111000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
.+.+..+++++.+++.+||+.||++||||++|+++|++...
T Consensus 233 ----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 233 ----------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 00011345678999999999999999999999998887543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=396.12 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=197.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|++.+.||+|+||.||+|++..+ ...||||+++.. .....+.+.+|++++++++||||++++++|. .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence 5789999999999999999998654 346889988643 3445678999999999999999999999963 25
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|++.+++... ...+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~---------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~K 148 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK 148 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeccCCcHHhhhhcc---------CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEE
Confidence 689999999999999987532 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 865 (953)
|+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||......+ ........
T Consensus 149 l~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~ 225 (273)
T d1mp8a_ 149 LGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENG 225 (273)
T ss_dssp ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT
T ss_pred EccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC
Confidence 99999998764322 223334568999999999999999999999999999999998 899987543221 11111110
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
.. .+.+..+++++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 226 ~~------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 ER------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00 000113456799999999999999999999999999988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=400.12 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=204.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|+.++++++||||+++++++ .+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 35799999999999999999999999999999999642 233467789999999999999999999995 4558
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~----------~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ccccceeccCCCchhhhhhc----------ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence 89999999999999999853 34689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+|+..... .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... .......
T Consensus 146 l~DFG~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~~i~ 218 (337)
T d1o6la_ 146 ITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELIL 218 (337)
T ss_dssp ECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH
T ss_pred EeecccccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----HHHHHHh
Confidence 9999999865432 22334467999999999999999999999999999999999999999753211 1111000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
.. .. ..+..+++++.+++.+||++||++||+ ++|+++
T Consensus 219 ~~--------~~--------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 ME--------EI--------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HC--------CC--------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cC--------CC--------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 00 00 000123456889999999999999995 778776
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=393.72 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=208.2
Q ss_pred cCcccccceeeEEEEEEcCCC---eEEEEEEeec-cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCceeEE
Q 043900 636 ANEIGVGSFGSVYKGILDQGK---TTVAVKVFNL-LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKALV 711 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 711 (953)
.++||+|+||+||+|++..++ ..||||+++. ......+++.+|++++++++||||++++|+|.. .+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 468999999999999986543 3699999964 455566889999999999999999999999753 23578999
Q ss_pred EeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEeccc
Q 043900 712 FEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSDFG 791 (953)
Q Consensus 712 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 791 (953)
||||++|+|.+++... ....++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||
T Consensus 108 ~E~~~~g~l~~~~~~~---------~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EECCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEeecCchhhhhccc---------cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence 9999999999998632 23578889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc--ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCch
Q 043900 792 LARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPDH 869 (953)
Q Consensus 792 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 869 (953)
+++........ .......||+.|+|||++.+..++.++||||||+++|||+||..||....... ............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~- 253 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRL- 253 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC-
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCC-
Confidence 99876543322 23334568999999999999999999999999999999999888876432221 111111110000
Q ss_pred hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 043900 870 VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNILLGHRIV 946 (953)
Q Consensus 870 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~ 946 (953)
..+..+++++.+++.+||+.||++||||.||++.|+++.+......++
T Consensus 254 -----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~ 301 (311)
T d1r0pa_ 254 -----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301 (311)
T ss_dssp -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred -----------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhch
Confidence 000123457899999999999999999999999999998876665443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=395.00 Aligned_cols=282 Identities=21% Similarity=0.271 Sum_probs=202.9
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|...+.||+|+||+||+|++. ++.||||+++.... .......|+..+.+++||||++++++|... .......+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeC-CCcceEEE
Confidence 356788899999999999999974 46899999964332 122233455556678999999999998654 22234689
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeecCCCCCeEecCCCc
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD-----CQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
+|||||++|+|.++++. ..++|.++++++.|+|.||+|+|+. ..++|+||||||+|||++.++.
T Consensus 78 lv~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 99999999999999962 2589999999999999999999973 1349999999999999999999
Q ss_pred EEEeccccceecCCCCCc--ccccccccccccccccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCCcccCCc
Q 043900 785 AHVSDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGS------EVSINGDVYSYGILLLELVTRKKPVDSMFEGDM 856 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~ 856 (953)
+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999999887543322 223356799999999998765 367789999999999999999988764322211
Q ss_pred cHHHHHHhhCC-ch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 857 NLHNFARMALP-DH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 857 ~~~~~~~~~~~-~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
........... .. .....+....+.. .......+.+.++.+++.+||+.||++||||.||++.|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~-------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCC-------------CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCC-------------CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 11100000000 00 0001111111100 011112245677999999999999999999999999999
Q ss_pred HHHHH
Q 043900 935 SIKNI 939 (953)
Q Consensus 935 ~i~~~ 939 (953)
++.+.
T Consensus 294 ~i~~~ 298 (303)
T d1vjya_ 294 QLSQQ 298 (303)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=391.38 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=196.4
Q ss_pred cCCcccCcccccceeeEEEEEEcCC---CeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQG---KTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
++|++.+.||+|+||+||+|++... ...||||+++.. ..+..+++.+|++++++++||||++++|+|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5689999999999999999997533 246899998632 34456789999999999999999999999742
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
...++||||+++|++.+++... ...+++..++.++.||++||+|||++ +|+||||||+||+++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred -cchheeeeeecCcchhhhhhcc---------cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccc
Confidence 3568999999999999988532 23599999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcc-cccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcccCCccHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQT-SSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~~~~~~~~~~ 862 (953)
+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ..
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~ 224 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----IL 224 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----HH
Confidence 9999999999875543332 2334558889999999999999999999999999999998 899997532211 11
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
....... . +.+.+..++.++.+++.+||+.||++||||+||.+.|++.
T Consensus 225 ~~i~~~~--------~------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 HKIDKEG--------E------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHTSC--------C------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCC--------C------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1110000 0 0000113345789999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=394.82 Aligned_cols=271 Identities=23% Similarity=0.321 Sum_probs=213.8
Q ss_pred hcCCcccCcccccceeeEEEEEEc-----CCCeEEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILD-----QGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDY 702 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 702 (953)
.++|++.+.||+|+||.||+|++. ..++.||||+++.. .......+.+|+.+++++ +|||||+++++|..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 467899999999999999999873 45578999999753 334556789999999999 69999999999743
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCc--------ccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDK--------TEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
+...++||||+++|+|.++++....... .......+++..+..++.||++||+|||++ +++||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 3678999999999999999975442211 112334689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+..|+......
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999999876655555556678999999999999999999999999999999999955444332222
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQ 934 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 934 (953)
...+........... .+..+++++.+++.+||+.||++||||+||+++|+
T Consensus 254 ~~~~~~~i~~~~~~~------------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 254 DSKFYKMIKEGFRML------------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp SHHHHHHHHHTCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCC------------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 222222222111110 00123456899999999999999999999999998
Q ss_pred HHHH
Q 043900 935 SIKN 938 (953)
Q Consensus 935 ~i~~ 938 (953)
++..
T Consensus 304 ~~i~ 307 (311)
T d1t46a_ 304 KQIS 307 (311)
T ss_dssp HHHH
T ss_pred Hhhc
Confidence 7654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-45 Score=395.29 Aligned_cols=245 Identities=21% Similarity=0.257 Sum_probs=202.1
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+.++++++||||+++++++. +++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 5699999999999999999999998899999999632 2334578899999999999999999999954 4588
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||++||++..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred eeeEeeecCCccccccccc----------cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEE
Confidence 9999999999999998852 33578889999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... ......
T Consensus 146 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~i-- 213 (316)
T d1fota_ 146 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KTYEKI-- 213 (316)
T ss_dssp CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH--
T ss_pred ecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-----HHHHHH--
Confidence 999999976432 23456999999999999999999999999999999999999999753211 111100
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
..... ..+...++++.+++.+||+.||++|| |++|+++
T Consensus 214 ------~~~~~--------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 214 ------LNAEL--------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------HHCCC--------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HcCCC--------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00000 00012345688999999999999996 8999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=393.23 Aligned_cols=270 Identities=23% Similarity=0.367 Sum_probs=208.7
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCC-------eEEEEEEeeccc-hhhHHHHHHHHHHHhhc-CCCCeeEEEeeeccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGK-------TTVAVKVFNLLH-HGAFKSFIAECNTLKNI-RHRNLVKILTACSGV 700 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 700 (953)
.++|++.+.||+|+||.||+|+..... ..||||+++... .....++.+|+..+.++ +||||++++++|..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 357889999999999999999976543 479999997533 34457888999999888 79999999999753
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCC------cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITRED------KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
++..++||||+++|+|.+++....... ........+++.+++.++.||+.||+|||+. +||||||||
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 477899999999999999997544211 1112235689999999999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCccc
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVT-RKKPVDSMFE 853 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~ellt-g~~pf~~~~~ 853 (953)
+|||++.++.+||+|||.++...............||+.|+|||++.+..|+.++||||||||+|||++ |..||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999998765555555556679999999999999999999999999999999998 6888864322
Q ss_pred CCccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 043900 854 GDMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQL 933 (953)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 933 (953)
. .....+... ... ..+..+++++.+++.+||+.||++||||.||++.|
T Consensus 244 ~--~~~~~i~~~------------~~~------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 244 E--ELFKLLKEG------------HRM------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp H--HHHHHHHTT------------CCC------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H--HHHHHHHcC------------CCC------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 1 111111100 000 00012345689999999999999999999999999
Q ss_pred HHHHHH
Q 043900 934 QSIKNI 939 (953)
Q Consensus 934 ~~i~~~ 939 (953)
+++.+.
T Consensus 292 ~~i~a~ 297 (299)
T d1fgka_ 292 DRIVAL 297 (299)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.4e-45 Score=384.25 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=202.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch---------hhHHHHHHHHHHHhhcC-CCCeeEEEeeeccc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH---------GAFKSFIAECNTLKNIR-HRNLVKILTACSGV 700 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 700 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 579999999999999999999999999999999964321 12346889999999996 99999999995
Q ss_pred ccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 701 DYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 701 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
.+++..|+||||+++|+|.++++. ...+++.+++.++.||++||+|||++ +|+||||||+||+++
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD 144 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEc
Confidence 455889999999999999999952 23689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCCCCCcccC
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG------SEVSINGDVYSYGILLLELVTRKKPVDSMFEG 854 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slG~vl~elltg~~pf~~~~~~ 854 (953)
.++.+||+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp TTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 99999999999999875432 2344569999999998753 35788999999999999999999999753221
Q ss_pred CccHHHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 855 DMNLHNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
+ ............. ......+++++.+++.+||+.||++|||++||++
T Consensus 222 ~-~~~~i~~~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 L-MLRMIMSGNYQFG----------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H-HHHHHHHTCCCCC----------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-HHHHHHhCCCCCC----------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 0111111000000 0001134567899999999999999999999854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=394.93 Aligned_cols=257 Identities=19% Similarity=0.231 Sum_probs=201.1
Q ss_pred hcCCcccC-cccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCCc
Q 043900 630 TDGFASAN-EIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 630 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 707 (953)
.++|.+.. .||+|+||+||+|++..+++.||||+++. ...+.+|++++.++ +||||+++++++... +..+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46798875 69999999999999998889999999863 24567899987655 899999999987542 334567
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC---CCc
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE---EMM 784 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 784 (953)
.|+|||||+||+|.+++.... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++. ++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~--------~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS--------CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEECCCCCcHHHHHHhcC--------CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence 899999999999999996432 23699999999999999999999999 9999999999999985 557
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHh
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARM 864 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~ 864 (953)
+||+|||+|+...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+...... .... ..
T Consensus 153 ~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~-~~ 227 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGM-KT 227 (335)
T ss_dssp EEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHH-HH
Confidence 9999999998765432 23345699999999999999999999999999999999999999975322110 0000 00
Q ss_pred hCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 865 ALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 865 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ...... ........+++++.+++.+||+.||++|||+.|+++
T Consensus 228 ~i-----------~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RI-----------RMGQYE------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CC-----------CSCSSS------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH-----------hcCCCC------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 000000 000112245678999999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-45 Score=399.06 Aligned_cols=249 Identities=21% Similarity=0.233 Sum_probs=197.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc---hhhHH---HHHHHHHHHhhcCCCCeeEEEeeecccccCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH---HGAFK---SFIAECNTLKNIRHRNLVKILTACSGVDYQG 704 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 704 (953)
++|++.+.||+|+||.||+|++..+++.||||++.... ..... ...+|+++++.++||||+++++++. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence 57999999999999999999999999999999986321 11222 3344577788889999999999954 4
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
.+..|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGH 145 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSC
T ss_pred CCEEEEEEEecCCCcHHHHHHh----------cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCc
Confidence 4789999999999999999953 23578999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
+||+|||+|+.+.... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ......
T Consensus 146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~ 219 (364)
T d1omwa3 146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR 219 (364)
T ss_dssp EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHH
T ss_pred EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 9999999999775332 234569999999999865 568999999999999999999999997633222 111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMN-----MTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 931 (953)
....... . .+..+++++.+++.+||+.||++||| |+|+++
T Consensus 220 ~~~~~~~------~----------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTMAV------E----------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSCCC------C----------------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccCCC------C----------------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111000 0 00023456889999999999999999 677765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=391.35 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=203.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||+||+|.+..+++.||||+++.... ....+.+|++++++++||||+++++++. +++..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 4679999999999999999999999999999999975443 3456889999999999999999999954 447899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC--CcEEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE--MMAHV 787 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 787 (953)
+|||||++|+|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++.+ ..+||
T Consensus 78 lvmE~~~gg~L~~~i~~~---------~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS---------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTSS---------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEE
Confidence 999999999999999632 23589999999999999999999999 99999999999999854 48999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+++...... ......+|+.|+|||...+..++.++||||+||++|||++|+.||......+ .+.......
T Consensus 146 ~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~-- 219 (321)
T d1tkia_ 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAE-- 219 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC--
T ss_pred cccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC--
Confidence 9999998764322 2334568999999999999999999999999999999999999997532111 011111000
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... ......+++++.+++.+||+.||++|||++|+++
T Consensus 220 ----------~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 ----------YTFD----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----------CCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CCCC----------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0001123556889999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=396.42 Aligned_cols=269 Identities=20% Similarity=0.364 Sum_probs=212.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-----CCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-----GKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 703 (953)
.++|.+.+.||+|+||+||+|++.. .++.||||+++.. .......+.+|++++++++||||++++++|.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----- 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----
Confidence 3678899999999999999999853 2468999999743 3444567899999999999999999999964
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
..+..++||||+++|+|.+++...............+++..+.+++.|+++||.|||+. +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 34678999999999999999864432211222234579999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCCcccCCccHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRK-KPVDSMFEGDMNLHNFA 862 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~-~pf~~~~~~~~~~~~~~ 862 (953)
++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||..... .+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence 99999999998775544444455567999999999999999999999999999999999985 66654211 1111
Q ss_pred HhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 863 RMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 863 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
... .+..... .+..+++++.+++.+||+.||++||||+||+++|++..+
T Consensus 246 ~~i--------~~~~~~~-------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFV--------MEGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHH--------HTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH--------HhCCCCC-------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1100000 011345679999999999999999999999999987644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=392.69 Aligned_cols=266 Identities=24% Similarity=0.374 Sum_probs=204.9
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhhc-CCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKT--TVAVKVFNLL-HHGAFKSFIAECNTLKNI-RHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|++.+.||+|+||+||+|++++++. .||||+++.. .....+.+.+|+++++++ +||||++++++|.. .+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 568889999999999999999988765 4777877533 334556899999999999 79999999999753 37
Q ss_pred ceeEEEeeccCCchhhccccCCcCC------cccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 707 FKALVFEFMQNRSLEEWLHPITRED------KTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
..++||||+++|+|.++++...... ........+++.+++.++.||+.||.|+|+. +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 8999999999999999997542110 0112345799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCC-CCCCcccCCccHH
Q 043900 781 EEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKK-PVDSMFEGDMNLH 859 (953)
Q Consensus 781 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~-pf~~~~~~~~~~~ 859 (953)
.++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~ 233 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CA 233 (309)
T ss_dssp GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH
T ss_pred CCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HH
Confidence 99999999999998653222 2223458999999999999999999999999999999999765 565321 11
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKNI 939 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~ 939 (953)
+...... . .. +...+..+++++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 234 ~~~~~i~--------~-~~------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYEKLP--------Q-GY------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHGG--------G-TC------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHH--------h-cC------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111100 0 00 0001113456799999999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-45 Score=397.02 Aligned_cols=245 Identities=19% Similarity=0.224 Sum_probs=202.4
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 707 (953)
++|++++.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+++++.++||||+++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence 5799999999999999999999998899999999632 2334567899999999999999999999954 4478
Q ss_pred eeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEE
Q 043900 708 KALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHV 787 (953)
Q Consensus 708 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 787 (953)
.++||||+.+|+|.+++.. ...+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~----------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred cccccccccccchhhhHhh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEe
Confidence 8999999999999999852 23689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 788 SDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 788 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
+|||+|+.+... .....||+.|||||++.+..++.++||||+||++|||+||+.||.+.... ......
T Consensus 183 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~i-- 250 (350)
T d1rdqe_ 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-----QIYEKI-- 250 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH--
T ss_pred eeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-----HHHHHH--
Confidence 999999976422 23456999999999999999999999999999999999999999752111 111100
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
...... .+..+++++.+++.+||+.||.+|+ |++|+++
T Consensus 251 ------~~~~~~--------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 ------VSGKVR--------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------HHCCCC--------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------hcCCCC--------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 000000 0012345688999999999999994 8999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=393.52 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=200.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc---chhhHHHHHHHHHHHh-hcCCCCeeEEEeeecccccCCCC
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL---HHGAFKSFIAECNTLK-NIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
++|.+.+.||+|+||+||+|++..+++.||||+++.. .....+.+..|..++. .++||||+++++++. +++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence 5799999999999999999999999999999999642 2334556777777765 689999999999954 457
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----------~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEeecCCCcHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCcee
Confidence 89999999999999999953 23588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|+|||+|+..... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... .........
T Consensus 144 l~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~ 219 (320)
T d1xjda_ 144 IADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDN 219 (320)
T ss_dssp ECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCC
T ss_pred ccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHcCC
Confidence 9999999865432 223344579999999999999999999999999999999999999997532111 111010000
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMT-NVVR 931 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 931 (953)
... +..+++++.+++.+||+.||++|||+. |+++
T Consensus 220 ---------~~~----------------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ---------PFY----------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---------CCC----------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---------CCC----------------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 000 012345688999999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=386.46 Aligned_cols=272 Identities=23% Similarity=0.251 Sum_probs=195.3
Q ss_pred ccCcccccceeeEEEEEEcCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 635 SANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH-----GAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 635 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.+++||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++||||+++++++ ..++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 35789999999999999999889999999864322 1235688999999999999999999995 4457899
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEec
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVSD 789 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 789 (953)
+||||++++++..+... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 77 ivmE~~~~~~~~~~~~~----------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDN----------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EEEECCSEEHHHHHTTC----------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ehhhhhcchHHhhhhhc----------ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccccc
Confidence 99999998887776632 23588889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||.|+...... .......||+.|+|||++.+. .++.++||||+||++|||+||..||....+.+. +..........
T Consensus 144 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~ 220 (299)
T d1ua2a_ 144 FGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTP 220 (299)
T ss_dssp CGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCC
T ss_pred CccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCC
Confidence 99998664322 223345699999999988654 579999999999999999999999975332211 11111111111
Q ss_pred hhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 869 HVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 869 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
......+..-....... ......+. .......++++.+++.+||+.||++||||+|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTF--KSFPGIPL--HHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CTTTSSSTTSSTTCCCC--CCCCCCCH--HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred Chhhccchhccchhhhh--ccCCCCCh--HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000000000 00000000 0000123457899999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=385.10 Aligned_cols=277 Identities=25% Similarity=0.324 Sum_probs=200.0
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++. ++...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 58999999999999999999999888899999996432 234578899999999999999999999964 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++||||+.++ +.+++... ....+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 77 ~iv~e~~~~~-~~~~~~~~--------~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDAS--------ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEECCSEE-HHHHHHHT--------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEeecCCc-hhhhhhhh--------cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceec
Confidence 9999999654 44444221 123699999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.|+..... ........||+.|+|||++.... ++.++||||+||++|||++|+.||.+....+...........+
T Consensus 145 DFG~a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 145 DFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp STTHHHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cCCcceeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999876432 22334456999999999877765 5789999999999999999999997532221111111111111
Q ss_pred ch-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DH-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ....... ........ ...... .........++++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~-~~~~~~~~-~~~~~~---~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 223 DEVVWPGVTS-MPDYKPSF-PKWARQ---DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTTSTTGGG-STTCCTTS-CCCCCC---CHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhcccccc-cccccccc-cccccc---chhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11 1000000 00000000 000000 000011123467889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=387.56 Aligned_cols=281 Identities=22% Similarity=0.271 Sum_probs=202.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcC-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhhc---CCCCeeEEEeeecccccC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQ-GKTTVAVKVFNLLH--HGAFKSFIAECNTLKNI---RHRNLVKILTACSGVDYQ 703 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~ 703 (953)
.++|++.+.||+|+||+||+|++.. +++.||||+++... ......+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 4689999999999999999999964 46789999986432 22234566777777665 799999999998655455
Q ss_pred CCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC
Q 043900 704 GNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM 783 (953)
Q Consensus 704 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 783 (953)
.....+++|||++++++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred cCceEEEEEEeccCCchhhhhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 56788999999988877654432 234689999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHH
Q 043900 784 MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFAR 863 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~ 863 (953)
.+||+|||.++... .........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+.....
T Consensus 154 ~~kl~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~ 229 (305)
T d1blxa_ 154 QIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILD 229 (305)
T ss_dssp CEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred Ceeecchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence 99999999998643 2233445679999999999999999999999999999999999999997543221 1111111
Q ss_pred hhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 864 MALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 864 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.........+.. ........ .......+ ........++++.+++.+||++||++||||+|+++
T Consensus 230 ~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~--~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 230 VIGLPGEEDWPR-DVALPRQA--FHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHCCCCGGGSCT-TCSSCGGG--SCCCCCCC--GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhCCCchhcccc-cccchhhh--hccccccc--hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111110000000 00000000 00000000 00011123456889999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=379.03 Aligned_cols=241 Identities=22% Similarity=0.244 Sum_probs=194.2
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch------hhHHHHHHHHHHHhhcC--CCCeeEEEeeecccc
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH------GAFKSFIAECNTLKNIR--HRNLVKILTACSGVD 701 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 701 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ....++.+|+.++++++ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence 3579999999999999999999999889999999863221 12234678999999996 899999999954
Q ss_pred cCCCCceeEEEeeccC-CchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec
Q 043900 702 YQGNDFKALVFEFMQN-RSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD 780 (953)
Q Consensus 702 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 780 (953)
+++..++||||+.+ +++.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~~----------~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID 144 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred --eCCeEEEEEEeccCcchHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEe
Confidence 45789999999976 677777742 23689999999999999999999999 999999999999998
Q ss_pred C-CCcEEEeccccceecCCCCCcccccccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 781 E-EMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEV-SINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 781 ~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
. ++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------ 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred cCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence 5 479999999999875432 2334569999999999887765 577899999999999999999997421
Q ss_pred HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 859 HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....... ... ..+++++.+++.+||+.||++|||++|+++
T Consensus 215 -~i~~~~~----------~~~----------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 -EIIRGQV----------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -HHHHCCC----------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhhccc----------CCC----------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1110000 000 012456889999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=382.20 Aligned_cols=286 Identities=19% Similarity=0.217 Sum_probs=202.1
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc-chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999999988999999999743 34456788999999999999999999999866544444445
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
+++ +|+.+|+|.+++. ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 87 ~l~-~~~~~g~L~~~l~-----------~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLK-----------TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp EEE-EECCCEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEE-EeecCCchhhhhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEc
Confidence 555 5566999999995 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCc-ccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 789 DFGLARFLPLSPAQ-TSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 789 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
|||+|+........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...........
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 99999876433221 22345669999999999855 46789999999999999999999999754322211111111111
Q ss_pred CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 043900 867 PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ 932 (953)
Q Consensus 867 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 932 (953)
+.... ...............................+.++.+++.+|++.||++||||+|+++.
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 232 PSQED--LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHH--HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CChhh--hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11100 00000000000000000000000000011233568899999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-43 Score=373.17 Aligned_cols=276 Identities=22% Similarity=0.289 Sum_probs=198.7
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLH--HGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.++||+|+||+||+|+++.+ +.||||+++... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS-CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeCCC-CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 5799999999999999999999754 689999996432 334678999999999999999999999954 44789
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
+++|||+.++.+..+.+ ....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++
T Consensus 76 ~i~~e~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV----------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp EEEEECCSEEHHHHHHT----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeehhhhHHHHHh----------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEec
Confidence 99999998877777664 234699999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.|....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. +.........
T Consensus 143 DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~ 219 (286)
T d1ob3a_ 143 DFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219 (286)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCC
Confidence 999998764322 223344589999999998765 568999999999999999999999976433221 1111111111
Q ss_pred chhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.......+......... ....... ..........++++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDP-NFTVYEP--LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTTSTTGGGSTTCCT-TCCCCCC--CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhhhhccc-ccccccC--cchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10000000000000000 0000000 0000111123457889999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=374.77 Aligned_cols=285 Identities=22% Similarity=0.300 Sum_probs=200.8
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc---cCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD---YQG 704 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~ 704 (953)
.++|++.++||+|+||+||+|++..+++.||||++... ......++.+|++++++++|||++++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999988899999998532 3345677899999999999999999999975432 123
Q ss_pred CCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCc
Q 043900 705 NDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMM 784 (953)
Q Consensus 705 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 784 (953)
....++||||++++.+..+.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 155 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred CceEEEEEeccCCCccchhhh----------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCc
Confidence 457899999998877765553 233688899999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCc--ccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHH
Q 043900 785 AHVSDFGLARFLPLSPAQ--TSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNF 861 (953)
Q Consensus 785 ~kL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~ 861 (953)
+||+|||+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .....
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i 234 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 234 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHH
Confidence 999999999876543221 222335699999999998765 68999999999999999999999997532211 11111
Q ss_pred HHhh--CCchhhhhcc-ccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 862 ARMA--LPDHVVDIVD-STLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 862 ~~~~--~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.... .+.......+ ......... .....+..... .......+.+.+++.+||++||++||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLEL--VKGQKRKVKDR-LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------C--CSSCCBCHHHH-HHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCChhhccccchhhhhhhhcc--cccccccchhh-hccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111 1111111111 000000000 00000000000 011123456789999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-42 Score=370.73 Aligned_cols=263 Identities=19% Similarity=0.275 Sum_probs=201.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCcee
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
.++|++.+.||+|+||+||+|++..+++.||||++..... ..++.+|+++++.++|++++..+..|. ..++..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEE
Confidence 3579999999999999999999999889999999875332 245788999999998777666655542 3347789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEec---CCCcEE
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLD---EEMMAH 786 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k 786 (953)
+||||+ ++++.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|
T Consensus 80 ivme~~-~~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEc-CCchhhhhhhc---------cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceee
Confidence 999999 55666655321 23689999999999999999999999 999999999999986 345799
Q ss_pred EeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH--H
Q 043900 787 VSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL--H 859 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~--~ 859 (953)
|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 9999999987543322 22334569999999999999999999999999999999999999997643322111 1
Q ss_pred HHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHHHH
Q 043900 860 NFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSIKN 938 (953)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~ 938 (953)
........... ......+++++.+++..||+.||++||+++++.+.|+++..
T Consensus 227 ~~~~~~~~~~~---------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 227 RISEKKMSTPI---------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHSCH---------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhhcccCCCCh---------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11100000000 00011345679999999999999999999999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-42 Score=373.55 Aligned_cols=276 Identities=21% Similarity=0.261 Sum_probs=201.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCcee
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDFKA 709 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 709 (953)
++|++.++||+|+||+||+|++..+++.||||+++... .+++.+|++++++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 57999999999999999999999999999999997433 467889999999995 9999999998652 3446789
Q ss_pred EEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cEEEe
Q 043900 710 LVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHVS 788 (953)
Q Consensus 710 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 788 (953)
+||||+++++|..+.+ .+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+
T Consensus 109 ~v~e~~~~~~L~~~~~-------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEECCCSCBGGGTTT-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEeecCCCcHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence 9999999999987653 589999999999999999999999 999999999999998655 69999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||+|+...... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...................
T Consensus 173 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 173 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 999998775432 23345689999999998775 47999999999999999999999997533221111111111100
Q ss_pred chhhhhcccc---ccCCchhhhhcccc--hhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DHVVDIVDST---LLSDDEDLAVHGNQ--RQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~~~~~~~~~---l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
....+..... .............. .............++++.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000100000 00000000000000 0000011111234567899999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=378.89 Aligned_cols=283 Identities=20% Similarity=0.235 Sum_probs=200.3
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeec--cchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNL--LHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 706 (953)
.++|++++.||+|+||+||+|++..+++.||||+++. ......+.+.+|+++|++++|||||+++++|.... .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 5689999999999999999999999889999999964 23345678899999999999999999999986432 22345
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
+.++||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccc
Confidence 679999999 667877764 23699999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
++|||.|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+.......
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~ 235 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVT 235 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhcc
Confidence 9999999876432 2345699999999998764 56899999999999999999999997642221 111111111
Q ss_pred C--CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHH
Q 043900 866 L--PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSI 936 (953)
Q Consensus 866 ~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 936 (953)
. +........... .......................++++.+++.+||+.||++||||+|+++. ++++
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDE---AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCHHHHHTCSCHH---HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCcHHHHhhhcchh---hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1 111111000000 000000000000000000011234568899999999999999999999873 4444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=367.49 Aligned_cols=276 Identities=20% Similarity=0.254 Sum_probs=204.8
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCCce
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 708 (953)
++|++.+.||+|+||+||+|++..+++.||||+++.. ......++.+|+.++++++||||++++++|. +....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 5799999999999999999999999999999999643 3345678999999999999999999999964 44788
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEEEe
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAHVS 788 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 788 (953)
++|+|++.++++..++.. .+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 77 ~iv~~~~~~~~l~~~~~~----------~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSC----------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSEEHHHHHHHT----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred eEEeeecccccccccccc----------ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeee
Confidence 999999999999887752 23678999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCcccccccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCC
Q 043900 789 DFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSE-VSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALP 867 (953)
Q Consensus 789 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 867 (953)
|||.|+....... ......+++.|+|||++.+.. ++.++||||+||++|||++|+.||...................
T Consensus 144 DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 144 NFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 9999998754322 233345788999999987665 6899999999999999999999975432222222222111111
Q ss_pred ch--hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 868 DH--VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 868 ~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.. ......... ....... ...............+++.+++.+|++.||.+||||+|+++
T Consensus 222 ~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 222 PTEEQWPSMTKLP--DYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGST--TCCCCCC---CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhhhhhhhhcc--ccccccc---ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 000000000 0000000 00000011111233456889999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=373.54 Aligned_cols=282 Identities=20% Similarity=0.173 Sum_probs=198.4
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeeccccc-CCCC
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDY-QGND 706 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 706 (953)
.++|++.++||+|+||+||+|.+..+++.||||+++.. ......++.+|+.++++++||||+++++++..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999999998999999999743 34455678999999999999999999999754322 3557
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..|+||||+.++.+..+. ..+++.+++.++.||+.||+|||+. ||+||||||+|||++.++.+|
T Consensus 96 ~~~iv~Ey~~~~l~~~~~-------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp EEEEEEECCSEEHHHHHT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEeccchHHHHhhh-------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccccccee
Confidence 899999999765554442 2588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhC
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMAL 866 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~ 866 (953)
++|||.++..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+..... ..........
T Consensus 160 l~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~ 235 (355)
T d2b1pa1 160 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 235 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhcc
Confidence 9999999865432 23344569999999999999999999999999999999999999997532211 1111111111
Q ss_pred ----------CchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 867 ----------PDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 867 ----------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
.....+..+.............................++++.+++.+|++.||++||||+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01111111111100000000000000011112233456778999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9e-42 Score=363.70 Aligned_cols=264 Identities=16% Similarity=0.197 Sum_probs=206.6
Q ss_pred hcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCC-CCeeEEEeeecccccCCCCce
Q 043900 630 TDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDYQGNDFK 708 (953)
Q Consensus 630 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 708 (953)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+|++.++.++| +|++.+++++. .+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCcc
Confidence 3579999999999999999999999999999999864322 2456788899999864 89999998853 34788
Q ss_pred eEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecC-----CC
Q 043900 709 ALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDE-----EM 783 (953)
Q Consensus 709 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~ 783 (953)
++||||+ +++|.++++... ..+++.++..++.|++.||+|||+. ||+||||||+||+++. ++
T Consensus 77 ~~vme~~-~~~l~~~~~~~~---------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG---------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHhhc---------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence 9999999 789999885322 3589999999999999999999999 9999999999999974 56
Q ss_pred cEEEeccccceecCCCCCc-----ccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccH
Q 043900 784 MAHVSDFGLARFLPLSPAQ-----TSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNL 858 (953)
Q Consensus 784 ~~kL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~ 858 (953)
.+||+|||+|+.+...... .......||+.|||||++.+..++.++|||||||++|||+||+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 8999999999987543221 12334569999999999999999999999999999999999999997543321110
Q ss_pred --HHHHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHH
Q 043900 859 --HNFARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQLQSI 936 (953)
Q Consensus 859 --~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i 936 (953)
.............+ ....+++++.+++..|++.+|++||+++.+.+.|+++
T Consensus 224 ~~~~i~~~~~~~~~~~---------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 224 KYERIGEKKQSTPLRE---------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHHHHHSCHHH---------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhccCCCChHH---------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00000000000000 0013456799999999999999999999999999988
Q ss_pred HHHh
Q 043900 937 KNIL 940 (953)
Q Consensus 937 ~~~~ 940 (953)
.+..
T Consensus 277 ~~~~ 280 (293)
T d1csna_ 277 LERL 280 (293)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 6654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=376.15 Aligned_cols=281 Identities=20% Similarity=0.219 Sum_probs=198.6
Q ss_pred CCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCCeeEEEeeecccc-cCCCCceeE
Q 043900 632 GFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRNLVKILTACSGVD-YQGNDFKAL 710 (953)
Q Consensus 632 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 710 (953)
+|+..++||+|+||+||+|++..+++.||||+++.... ...+|++++++++||||++++++|.... ..+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58889999999999999999999999999999975432 2347999999999999999999975432 233456789
Q ss_pred EEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCC-cEEEec
Q 043900 711 VFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEM-MAHVSD 789 (953)
Q Consensus 711 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~D 789 (953)
||||++++.+..+.... .....+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus 97 v~Ey~~~~~~~~l~~~~-------~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp EEECCSEEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred EEeccCCccHHHHHhhh-------hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence 99999766444333211 1234689999999999999999999999 999999999999999775 899999
Q ss_pred cccceecCCCCCcccccccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhhCCc
Q 043900 790 FGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLG-SEVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMALPD 868 (953)
Q Consensus 790 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 868 (953)
||+|+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+..........
T Consensus 167 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 167 FGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTP 242 (350)
T ss_dssp CTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred ccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99998764332 2233569999999998765 578999999999999999999999997533221 111111111100
Q ss_pred --h-hhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHH
Q 043900 869 --H-VVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVRQ--LQSI 936 (953)
Q Consensus 869 --~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i 936 (953)
. .............. ........ .......++++.+++.+||+.||++||||+|+++. ++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFP-----QIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CHHHHHHHCC---CCCCC-----CCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hHHhhhhhccchhhcccc-----ccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 11110000000000 00000000 00011234568899999999999999999999862 4444
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=373.82 Aligned_cols=282 Identities=20% Similarity=0.209 Sum_probs=200.3
Q ss_pred hhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeecc--chhhHHHHHHHHHHHhhcCCCCeeEEEeeecccccCCCC
Q 043900 629 ATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL--HHGAFKSFIAECNTLKNIRHRNLVKILTACSGVDYQGND 706 (953)
Q Consensus 629 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 706 (953)
..++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||++++++++......+..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 467899999999999999999999999999999999643 334456788999999999999999999987544333344
Q ss_pred ceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCCCcEE
Q 043900 707 FKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEEMMAH 786 (953)
Q Consensus 707 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 786 (953)
..+++|+|+.+|+|.++++ ...+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+|
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-----------~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEeecCCchhhhcc-----------cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccc
Confidence 5566778888999999984 23589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcccccccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHHHHHhh
Q 043900 787 VSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS-EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHNFARMA 865 (953)
Q Consensus 787 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~~~~~~ 865 (953)
++|||.|.... .......||+.|+|||+..+. .++.++||||+||++|||++|+.||.+...... ........
T Consensus 162 l~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~ 235 (348)
T d2gfsa1 162 ILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLV 235 (348)
T ss_dssp ECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred ccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 99999997542 233445699999999987665 468999999999999999999999975322111 11111111
Q ss_pred CCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 043900 866 LPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRMNMTNVVR 931 (953)
Q Consensus 866 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 931 (953)
... ..+................................++++.+++.+|++.||++||||+|+++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 236 GTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCC-CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC-ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 100 00000000000000000000000000000001123456889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=364.80 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=197.9
Q ss_pred cCCcccCcccccceeeEEEEEE---cCCCeEEEEEEeecc----chhhHHHHHHHHHHHhhcCC-CCeeEEEeeeccccc
Q 043900 631 DGFASANEIGVGSFGSVYKGIL---DQGKTTVAVKVFNLL----HHGAFKSFIAECNTLKNIRH-RNLVKILTACSGVDY 702 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 702 (953)
++|++.+.||+|+||+||+|+. +.+++.||||+++.. .....+.+.+|++++++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 5699999999999999999987 345779999998532 22345678899999999966 89999999854
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeEecCC
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKPSNVLLDEE 782 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 782 (953)
+....++||||+.+|+|.+++.. ...+++..+..++.||+.||+|+|+. +|+||||||+||+++.+
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~----------~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN 165 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred -cCCceeeeeecccccHHHHHHHh----------cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC
Confidence 44789999999999999999853 23567889999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcccccccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcccCCccHHH
Q 043900 783 MMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGS--EVSINGDVYSYGILLLELVTRKKPVDSMFEGDMNLHN 860 (953)
Q Consensus 783 ~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slG~vl~elltg~~pf~~~~~~~~~~~~ 860 (953)
+.+||+|||+|+.+.... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. ...
T Consensus 166 ~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~ 243 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAE 243 (322)
T ss_dssp SCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHH
T ss_pred CCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 999999999998764332 2233445699999999998765 467899999999999999999999976433322 111
Q ss_pred HHHhhCCchhhhhccccccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 043900 861 FARMALPDHVVDIVDSTLLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSMESPGDRM-----NMTNVVR 931 (953)
Q Consensus 861 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 931 (953)
......... ...+..+++++.+++.+||++||++|| |++|+++
T Consensus 244 i~~~~~~~~----------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRILKSE----------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhcccCC----------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111110000 000113456789999999999999999 4788875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-36 Score=332.59 Aligned_cols=282 Identities=19% Similarity=0.215 Sum_probs=192.2
Q ss_pred cCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-----------CCCeeEEEeeecc
Q 043900 631 DGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-----------HRNLVKILTACSG 699 (953)
Q Consensus 631 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 699 (953)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999999999999999997543 23467788998888875 5789999988643
Q ss_pred cccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeE
Q 043900 700 VDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVL 778 (953)
Q Consensus 700 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIl 778 (953)
......+++|+++..+......... .....+++..+..++.||+.||+|||+ . ||+||||||+|||
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKK-------YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVL 158 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHH-------TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEE
T ss_pred ---ccccceeeeeeeccccccccccccc-------ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHee
Confidence 2234566677776554432222111 123468899999999999999999998 6 9999999999999
Q ss_pred ecCCC------cEEEeccccceecCCCCCcccccccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcc
Q 043900 779 LDEEM------MAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIAPEYGLGSEVSINGDVYSYGILLLELVTRKKPVDSMF 852 (953)
Q Consensus 779 l~~~~------~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG~vl~elltg~~pf~~~~ 852 (953)
++.++ .++++|||.|..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||....
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 98665 499999999986532 2234569999999999999999999999999999999999999997532
Q ss_pred cCCc-----cHHHHHHhh--CCchhh-------hhcccc-ccCCchhhhhcccchhhhhhhhhHHHHHHHHHHHhhcccc
Q 043900 853 EGDM-----NLHNFARMA--LPDHVV-------DIVDST-LLSDDEDLAVHGNQRQRQARINSKIECLVAMVRIGVACSM 917 (953)
Q Consensus 853 ~~~~-----~~~~~~~~~--~~~~~~-------~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 917 (953)
.... ......... .+.... ...+.. ...........................++++.+++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 2110 011111110 011100 000000 0000000000000011112222334667889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 043900 918 ESPGDRMNMTNVVR 931 (953)
Q Consensus 918 ~dP~~RPt~~evl~ 931 (953)
+||.+||||+|+++
T Consensus 314 ~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 314 LDPRKRADAGGLVN 327 (362)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=1.9e-32 Score=295.91 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=226.0
Q ss_pred cCcEEEcccCcccc--cCCccccCCCCCCEEEeec-CcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCc-eeeEE
Q 043900 300 TLEMLLLDNNKIFG--NIPAAIGKFVNLQRLEMWN-NRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNL-KVFNL 375 (953)
Q Consensus 300 ~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~l~~L 375 (953)
.++.|+|++|.+.+ .+|..++++++|++|+|++ |.++|.+|.+|+++++|++|+|++|++.+..+..+..+ .++.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46677777777765 3677788888888888875 77777778888888888888888888877777766665 46778
Q ss_pred EccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcc
Q 043900 376 DLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKL 455 (953)
Q Consensus 376 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 455 (953)
++++|.+.+.+|..+++++.|+.+++++|++++.+|..+..+..+++.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 8888888888999999999999999999999999999999888888899999999999999999887665 799999999
Q ss_pred cccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCCCCC
Q 043900 456 KGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVPIEG 535 (953)
Q Consensus 456 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 535 (953)
.+.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|+.+.++++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997655 68999999999999999999999999999999999999999999999888
Q ss_pred cccccccccccCCcCCCCCCCCCCCCccc
Q 043900 536 VFKNATITSVLGNLKLCGGIPEFQLPTCI 564 (953)
Q Consensus 536 ~~~~~~~~~~~~n~~lcg~~~~~~~~~c~ 564 (953)
.++.+....+.||+.+||.|+ |+|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl----p~c~ 313 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL----PACT 313 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS----SCCC
T ss_pred cCCCCCHHHhCCCccccCCCC----CCCC
Confidence 889999999999999999766 6773
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.6e-30 Score=280.57 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=228.0
Q ss_pred cCcEEEEEeCCCeeee--ecCccccCCccCceeecCC-CccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCc
Q 043900 3 HQRVKILNLTSLKLAG--SISPHVGNLSFLKVLLLYN-NSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLI 79 (953)
Q Consensus 3 ~~~~~~l~l~~~~~~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~ 79 (953)
..||+.|||+++++.| .||+++++|++|++|+|++ |++++.+|.+|+++++|++|+|++|+|.+..+..+..+.+|+
T Consensus 49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 3489999999999987 6899999999999999997 899988999999999999999999999999999999999999
Q ss_pred EEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcc-cEEecccccccccCCccccccccccceecccc
Q 043900 80 QIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI-NTLFLTDNNLDGGIPDTFGWLKNLATLAMAEN 158 (953)
Q Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (953)
.+++++|.+.+.+|..|+++++|+++++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 99999999999999999999999999999999999999999988886 899999999999999999888665 6999999
Q ss_pred cccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC
Q 043900 159 WLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP 238 (953)
Q Consensus 159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (953)
...+.+|..+..+.+++.+++++|.+.+.+| .+. .+++|+.|+|++|++++.+|..|+++++|++|+|++|+++|.+|
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~-~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred ccccccccccccccccccccccccccccccc-ccc-cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence 9999999999999999999999999997766 343 68999999999999999999999999999999999999999888
Q ss_pred CCCCCCccceeeecccc
Q 043900 239 YLEKPQRLSVFSITENS 255 (953)
Q Consensus 239 ~l~~~~~L~~l~l~~n~ 255 (953)
.+..+++|+.+++++|.
T Consensus 286 ~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 286 QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp CSTTGGGSCGGGTCSSS
T ss_pred CcccCCCCCHHHhCCCc
Confidence 76666666555555553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3e-28 Score=271.26 Aligned_cols=187 Identities=32% Similarity=0.478 Sum_probs=133.1
Q ss_pred ccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEcc
Q 043900 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLS 378 (953)
Q Consensus 299 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~ 378 (953)
+++..+++++|.+++..| +..+++|+.|++++|.++. ++.+..+++|+.|++++|++++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~----------------- 255 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN----------------- 255 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-----------------
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCC-----------------
Confidence 456667777777665433 3455667777777777663 2356666777777776666653
Q ss_pred CCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCccccc
Q 043900 379 CNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGE 458 (953)
Q Consensus 379 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 458 (953)
.. .+..+++|+.|++++|++++ +++ +.... .++.++++.|++++. ..+..+++++.|++++|++++.
T Consensus 256 ------~~--~~~~~~~L~~L~l~~~~l~~-~~~-~~~~~-~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l 322 (384)
T d2omza2 256 ------LA--PLSGLTKLTELKLGANQISN-ISP-LAGLT-ALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI 322 (384)
T ss_dssp ------CG--GGTTCTTCSEEECCSSCCCC-CGG-GTTCT-TCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC
T ss_pred ------CC--cccccccCCEeeccCcccCC-CCc-ccccc-ccccccccccccccc--cccchhcccCeEECCCCCCCCC
Confidence 22 25667778888888888773 332 22332 345778888888742 3577888899999999999854
Q ss_pred CCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCC
Q 043900 459 IPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNN 525 (953)
Q Consensus 459 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N 525 (953)
. .+..+++|++|++++|+|++ ++ .+..+++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 323 ~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 323 S--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred c--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 3 37888999999999999984 44 68889999999999999987654 788899999999887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5.6e-28 Score=269.10 Aligned_cols=358 Identities=23% Similarity=0.308 Sum_probs=223.5
Q ss_pred eeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccc
Q 043900 32 VLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNN 111 (953)
Q Consensus 32 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 111 (953)
...++.+.+++.+. ...+.+|++|++++|+|+ .+ +.+..+++|++|+|++|+|++ +| .|+++++|++|++++|+
T Consensus 26 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccc
Confidence 34566666666433 345667777777777776 33 356777777777777777773 33 37777777777777777
Q ss_pred cccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccccccc
Q 043900 112 LTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLD 191 (953)
Q Consensus 112 l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 191 (953)
+++. + .++++++|+.|++++|.+++.. .......+..+....|.+....+..................+..
T Consensus 100 i~~i-~-~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 170 (384)
T d2omza2 100 IADI-T-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP----- 170 (384)
T ss_dssp CCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGG-----
T ss_pred cccc-c-cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccchhhh-----
Confidence 7743 3 3677777777777777776332 23445566666666666653322222222222222222211110
Q ss_pred cccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCccccccccc
Q 043900 192 FGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLCSLT 271 (953)
Q Consensus 192 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~ 271 (953)
+ .............|... ....+..+++++.+++++|.++
T Consensus 171 ~-~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~------------------------------------- 210 (384)
T d2omza2 171 L-ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQIS------------------------------------- 210 (384)
T ss_dssp G-TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCC-------------------------------------
T ss_pred h-ccccccccccccccccc--cccccccccccceeeccCCccC-------------------------------------
Confidence 0 01222223333333322 2233444444444444444443
Q ss_pred ccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCe
Q 043900 272 NSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRE 351 (953)
Q Consensus 272 ~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 351 (953)
+..|. . ..++|+.|++++|+++. .+.+..+++|+.|++++|.+++.. .+..+++|++
T Consensus 211 ----------------~~~~~--~-~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~ 267 (384)
T d2omza2 211 ----------------DITPL--G-ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE 267 (384)
T ss_dssp ----------------CCGGG--G-GCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred ----------------CCCcc--c-ccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCC--cccccccCCE
Confidence 33221 1 12468888888888874 246778888999999999988543 3778888999
Q ss_pred EEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcc
Q 043900 352 LRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQL 431 (953)
Q Consensus 352 L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l 431 (953)
|++++|++++.. .+..++.++.+++++|++++ ++ .+ .....++.|++++|++
T Consensus 268 L~l~~~~l~~~~-------------------------~~~~~~~l~~l~~~~n~l~~-~~-~~-~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 268 LKLGANQISNIS-------------------------PLAGLTALTNLELNENQLED-IS-PI-SNLKNLTYLTLYFNNI 319 (384)
T ss_dssp EECCSSCCCCCG-------------------------GGTTCTTCSEEECCSSCCSC-CG-GG-GGCTTCSEEECCSSCC
T ss_pred eeccCcccCCCC-------------------------cccccccccccccccccccc-cc-cc-chhcccCeEECCCCCC
Confidence 999888876321 24455666666666666663 22 22 2223344677777777
Q ss_pred cCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCC
Q 043900 432 TGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQN 501 (953)
Q Consensus 432 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 501 (953)
++.. .+..+++|+.|++++|+|++ ++ .|+++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 320 ~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7543 37788999999999999984 44 58999999999999999997654 889999999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=241.53 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=160.7
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
..+.++.++++++. +|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCc-cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 56788888888887 565553 578888888888884444578888888888888888887777788888888888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGVI 188 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 188 (953)
+|+++ .+|..+. ..|+.|++++|.+....+..|.....+..++...|..... .
T Consensus 88 ~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~-----------------------~- 140 (305)
T d1xkua_ 88 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-----------------------G- 140 (305)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-----------------------G-
T ss_pred CCccC-cCccchh--hhhhhhhccccchhhhhhhhhhcccccccccccccccccc-----------------------C-
Confidence 88887 5554433 4677888888887755555555555555555555543200 0
Q ss_pred ccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeecccccCCCCCCcccccc
Q 043900 189 PLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSITENSLGSRGHSNLNFLC 268 (953)
Q Consensus 189 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~~n~l~~~~~~~~~~l~ 268 (953)
..+..+..+++|+.+++++|.++..+..
T Consensus 141 -----------------------~~~~~~~~l~~L~~l~l~~n~l~~l~~~----------------------------- 168 (305)
T d1xkua_ 141 -----------------------IENGAFQGMKKLSYIRIADTNITTIPQG----------------------------- 168 (305)
T ss_dssp -----------------------BCTTGGGGCTTCCEEECCSSCCCSCCSS-----------------------------
T ss_pred -----------------------CCccccccccccCccccccCCccccCcc-----------------------------
Confidence 1111223333344444444333321100
Q ss_pred cccccccccEEeccCCcccccCChhhhhccccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCC
Q 043900 269 SLTNSTRLNRLLINANNFGGLLPACISNLSTTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQN 348 (953)
Q Consensus 269 ~l~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 348 (953)
..++|+.|++++|.+.+..+..|.+++.++.|++++|.+++..+.+|.++++
T Consensus 169 ----------------------------~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 169 ----------------------------LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp ----------------------------CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred ----------------------------cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence 0135666666666666666667777777777777777777777777777777
Q ss_pred CCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEcCCCccC
Q 043900 349 LRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDLSDNNLT 407 (953)
Q Consensus 349 L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 407 (953)
|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+
T Consensus 221 L~~L~L~~N~L~------------------------~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 221 LRELHLNNNKLV------------------------KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CCEEECCSSCCS------------------------SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ceeeeccccccc------------------------ccccccccccCCCEEECCCCccC
Confidence 777777777665 34556666777777777777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.3e-25 Score=235.47 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=212.0
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
.+|=++.++. ++|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 14 ~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~ 90 (305)
T d1xkua_ 14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90 (305)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence 4566666776 8898774 689999999999999777789999999999999999997778899999999999999999
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccccc--ccCCccccccccccceecccccccCCCC
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLD--GGIPDTFGWLKNLATLAMAENWLSGTIP 165 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p 165 (953)
++ .+|..+. ..|+.|++++|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|.++ .+|
T Consensus 91 l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~ 166 (305)
T d1xkua_ 91 LK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 166 (305)
T ss_dssp CS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCC
T ss_pred cC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccC
Confidence 99 5665544 57899999999999766667888889999999988654 345678999999999999999998 666
Q ss_pred CcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCc
Q 043900 166 SSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQR 245 (953)
Q Consensus 166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~ 245 (953)
..+ +++|+.|++++|.++...+..+. .++.+++|++++|.+++..+.++.++++|++|+|++|+|+.+++.+..+++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~-~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~ 243 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLK-GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGT-TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSS
T ss_pred ccc--CCccCEEECCCCcCCCCChhHhh-ccccccccccccccccccccccccccccceeeecccccccccccccccccC
Confidence 654 57999999999999977776655 789999999999999988899999999999999999999988878888899
Q ss_pred cceeeecccccCCCCCC
Q 043900 246 LSVFSITENSLGSRGHS 262 (953)
Q Consensus 246 L~~l~l~~n~l~~~~~~ 262 (953)
|+++++++|+|...+..
T Consensus 244 L~~L~Ls~N~i~~i~~~ 260 (305)
T d1xkua_ 244 IQVVYLHNNNISAIGSN 260 (305)
T ss_dssp CCEEECCSSCCCCCCTT
T ss_pred CCEEECCCCccCccChh
Confidence 99999999888776543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.5e-25 Score=231.60 Aligned_cols=211 Identities=23% Similarity=0.206 Sum_probs=142.7
Q ss_pred ccCcEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEcc
Q 043900 299 TTLEMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLS 378 (953)
Q Consensus 299 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~ 378 (953)
+++++|+|++|+|+++.+.+|.++++|++|++++|.|..+.+..+..++.+..++.. .
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~----------------------~ 89 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS----------------------D 89 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----------------------S
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc----------------------c
Confidence 345555555555554444445555555555555555554445555555555544432 3
Q ss_pred CCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCccccc
Q 043900 379 CNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGE 458 (953)
Q Consensus 379 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 458 (953)
.|.++...|.+|+++++|++|++++|.+. .++...+.....++.+++++|+|+++.+..|..+++|+.|++++|+|++.
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l 168 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred ccccccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence 34455555667777777777777777776 44444444455556777777777766667777778888888888888777
Q ss_pred CCCCccCCccccEEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccCCcCcccCC
Q 043900 459 IPSTLGSCKKLEQLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSNNNLEGMVP 532 (953)
Q Consensus 459 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 532 (953)
.+.+|.++++|+.+++++|++++..|..|..+++|++||+++|++.+..|..|..+++|+.|++++|++.+..+
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 77777888888888888888887778888888888888888888887777777788888888888888876544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.2e-24 Score=230.43 Aligned_cols=225 Identities=21% Similarity=0.252 Sum_probs=195.6
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEecc-Cc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLF-YN 86 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~-~n 86 (953)
.++.+++++. ++|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|+|....+..+..+..++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3467777876 8888664 678999999999998777889999999999999999998888888899999998764 67
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
.++...|.+|+++++|++|++++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|+.|+|++|+++...+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 77767788899999999999999999877777888899999999999999977788899999999999999999877778
Q ss_pred cccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCc
Q 043900 167 SIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGE 236 (953)
Q Consensus 167 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (953)
.+.++++|+.+++++|++++..|..|. .+++|++|++++|++.+..+..|.++++|+.|++++|++...
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~-~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhccccccchhhhhhccccccChhHhh-hhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 888999999999999999977776665 789999999999999988888899999999999999988754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-23 Score=220.19 Aligned_cols=202 Identities=20% Similarity=0.182 Sum_probs=145.8
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
+...+.+.+.++++++. +|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 44555666777777776 565553 46777777777777555566777777777777777776 333 35677777778
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|++|+++ ..+..+.++++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++++.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 88777777 45667777777888888877777667777777777888888888777555566667777888888888877
Q ss_pred cccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccC
Q 043900 186 GVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTG 235 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (953)
+..+ ..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 162 ~~~~-~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 162 ELPA-GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCT-TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccCc-cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 4433 33346788888888888887 677777778888888888888764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.5e-23 Score=217.50 Aligned_cols=196 Identities=21% Similarity=0.206 Sum_probs=163.7
Q ss_pred EEEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCc
Q 043900 7 KILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 7 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n 86 (953)
..+|.++.++. +||+.+. +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccc
Confidence 44588888887 7887664 57888999999998877778888999999999999888 444 3577888999999999
Q ss_pred cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCC
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPS 166 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 166 (953)
+++ ..+..+.++++|++|++++|.+....+..+..+.+|++|++++|.++...+..|..+++|+.|++++|+|++..++
T Consensus 88 ~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~ 166 (266)
T d1p9ag_ 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (266)
T ss_dssp CCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred ccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence 888 5677888888999999999988877777888888999999999998877778888888999999999998877777
Q ss_pred cccccccceEEecCCcccccccccccccccccccEEEeeCcccc
Q 043900 167 SIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLT 210 (953)
Q Consensus 167 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 210 (953)
.+..+++|++|||++|+|+ .+|.+++ .+++|+.|+|++|.+.
T Consensus 167 ~~~~l~~L~~L~Ls~N~L~-~lp~~~~-~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 167 LLNGLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCBC
T ss_pred ccccccccceeecccCCCc-ccChhHC-CCCCCCEEEecCCCCC
Confidence 7888889999999999988 7887777 6888999999988876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=1.5e-20 Score=205.58 Aligned_cols=153 Identities=28% Similarity=0.376 Sum_probs=86.2
Q ss_pred ccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcE
Q 043900 319 IGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTI 398 (953)
Q Consensus 319 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~ 398 (953)
+..++.|+.+++++|... ..+.. ..++..+.+.+|.+.. .+. ....+..
T Consensus 200 ~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~------------------------~~~---~~~~l~~ 248 (353)
T d1jl5a_ 200 LQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTD------------------------LPE---LPQSLTF 248 (353)
T ss_dssp CTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSC------------------------CCC---CCTTCCE
T ss_pred cccccccccccccccccc-ccccc---cccccccccccccccc------------------------ccc---ccccccc
Confidence 455666667776666655 23322 2445555555555541 111 1234455
Q ss_pred EEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCCccceeeecCCcccccCCCCccCCccccEEEccCcc
Q 043900 399 IDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLKNLEVLDVFENKLKGEIPSTLGSCKKLEQLEMQGNF 478 (953)
Q Consensus 399 L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 478 (953)
.++..|.+.+ +..+.......++..|.+.+. ...+++|++|+|++|+|+ .+|.. +++|+.|+|++|+
T Consensus 249 ~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~ 315 (353)
T d1jl5a_ 249 LDVSENIFSG-----LSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNH 315 (353)
T ss_dssp EECCSSCCSE-----ESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSC
T ss_pred cccccccccc-----cccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCc
Confidence 5555554441 111222233455666655532 234567888888888887 56643 4677788888888
Q ss_pred ccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEecc
Q 043900 479 LQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLS 523 (953)
Q Consensus 479 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~ 523 (953)
|+ .+|.. +.+|+.|+|++|+|+ .+|+.. ..|+.|.+.
T Consensus 316 L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 316 LA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred CC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 87 45543 456888888888877 566543 245555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1e-22 Score=201.08 Aligned_cols=164 Identities=18% Similarity=0.132 Sum_probs=120.5
Q ss_pred CcccCcccccceeeEEEEEEcCCCeEEEEEEeeccch------------------hhHHHHHHHHHHHhhcCCCCeeEEE
Q 043900 633 FASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHH------------------GAFKSFIAECNTLKNIRHRNLVKIL 694 (953)
Q Consensus 633 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~ 694 (953)
+.+.++||+|+||+||+|++.+ ++.||||+++.... .......+|+..+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 4567899999999999999875 46899998752110 1123455788899999999999988
Q ss_pred eeecccccCCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 043900 695 TACSGVDYQGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHDCQPPITHCDLKP 774 (953)
Q Consensus 695 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 774 (953)
++ ...++||||++++.+.++ +......++.|++.|++|||+. ||+||||||
T Consensus 81 ~~---------~~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP 131 (191)
T d1zara2 81 AW---------EGNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 131 (191)
T ss_dssp EE---------ETTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred Ee---------cCCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCCh
Confidence 76 234799999987655432 2233567999999999999999 999999999
Q ss_pred CCeEecCCCcEEEeccccceecCCCCCccccccccccccccc------ccccCCCCCCcccchHHHHHHH
Q 043900 775 SNVLLDEEMMAHVSDFGLARFLPLSPAQTSSIDAKGSIGYIA------PEYGLGSEVSINGDVYSYGILL 838 (953)
Q Consensus 775 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDv~slG~vl 838 (953)
+|||+++++ ++|+|||.|+........ .|.. .| +....|+.++|+||..--+
T Consensus 132 ~NILv~~~~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 132 YNVLVSEEG-IWIIDFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSEEEETTE-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred hheeeeCCC-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 999999765 899999999865322111 1111 11 1235678899999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=1.1e-19 Score=198.49 Aligned_cols=137 Identities=28% Similarity=0.320 Sum_probs=96.2
Q ss_pred cCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 29 FLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 29 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
++++|||++|+++. +|+. .++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .+++ +. +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--ccccccccc
Confidence 58889999999886 6643 467888999999998 777653 57888888888887 3432 11 358888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
+|+++ .+| .++.+++|+.|++++|.+. ..+.. ...+..+.+..+... .+..+..++.++.|++++|.+.
T Consensus 107 ~n~l~-~lp-~~~~l~~L~~L~l~~~~~~-~~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCC-CCTTCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-ccc-chhhhccceeecccccccc-ccccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence 88887 566 3677888888888888886 33332 344555556555543 2344566667777777777665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=2.3e-19 Score=176.86 Aligned_cols=126 Identities=23% Similarity=0.327 Sum_probs=59.8
Q ss_pred EEeCCCeeeeecCccccCCccCceeecCCCccCc-CCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCcc
Q 043900 9 LNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNH-GIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNE 87 (953)
Q Consensus 9 l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 87 (953)
+|.++.++. +||..+. +++++|+|++|+|+. +.+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 444444444 4444332 344455555555543 223334445555555555555544444444445555555555555
Q ss_pred ccccCCcccCCccccceeeccccccccccCCcccCCCcccEEeccccccc
Q 043900 88 LVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLD 137 (953)
Q Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 137 (953)
|+...|++|.++++|++|+|++|+|++..|++|.++++|++|+|++|.+.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 54444444444555555555555554444444444455555555554443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=2.8e-19 Score=183.99 Aligned_cols=216 Identities=15% Similarity=0.141 Sum_probs=136.2
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCcccccc-CcCccCCCCCcEEecc-C
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI-PANISSCSNLIQIRLF-Y 85 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~L~L~-~ 85 (953)
.++.++.++. ++|+.+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+...+ +..|.++.+++++++. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4555555554 6666553 46777777777777755666777777777777777776443 3456777777777764 3
Q ss_pred ccccccCCcccCCccccceeeccccccccccCC-cccCCCcccEEecccccccccCCccccccc-cccceecccccccCC
Q 043900 86 NELVGKIPSELGSLSKIEHLSVSVNNLTGSIPS-SLGNLSSINTLFLTDNNLDGGIPDTFGWLK-NLATLAMAENWLSGT 163 (953)
Q Consensus 86 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~ 163 (953)
|.+....+..|.++++|++|++++|++....+. .+..+..|..+..+++.+....+..|.+++ .++.|++++|+++ .
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~ 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-E
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-c
Confidence 566656666677777777777777777633221 234556666666666677655566666654 6777777777776 4
Q ss_pred CCCcccccccceEE-ecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEc
Q 043900 164 IPSSIFNISSITAF-DAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQA 228 (953)
Q Consensus 164 ~p~~l~~l~~L~~L-~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 228 (953)
++...+...+++++ ++++|+++ .+|.+.+.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 44444445554444 45666666 455554456677777777777776555555666666665544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=1.6e-19 Score=177.88 Aligned_cols=129 Identities=23% Similarity=0.329 Sum_probs=107.1
Q ss_pred CceeecCCCccCcCCCccCCCCCCCcEEeCCCCcccccc-CcCccCCCCCcEEeccCccccccCCcccCCccccceeecc
Q 043900 30 LKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEI-PANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVS 108 (953)
Q Consensus 30 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (953)
.+++++++++++. +|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 4678999999997 666553 68889999999997544 5667888889999998888887888888888888888888
Q ss_pred ccccccccCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 109 VNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 109 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
+|+|+...|++|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+.
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 88888777788888888888888888888777888888888888888888876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.5e-18 Score=178.28 Aligned_cols=219 Identities=15% Similarity=0.130 Sum_probs=142.5
Q ss_pred cEEEcccCcccccCCccccCCCCCCEEEeecCcccccCCcCccCCCCCCeEEeccccccCCCC-CCCCCc-eeeEEEcc-
Q 043900 302 EMLLLDNNKIFGNIPAAIGKFVNLQRLEMWNNRLSGTIPPAIGELQNLRELRLQRNKFLGNIP-PSIGNL-KVFNLDLS- 378 (953)
Q Consensus 302 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l-~l~~L~L~- 378 (953)
+.++.++++++ .+|..+. +++++|+|++|.|+...+.+|.++++|++|+|++|.+...++ ..|.++ .+.++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34455555554 3333321 345566666666654444555566666666666665554332 234443 23444433
Q ss_pred CCcCCCCCCccCCCCCCCcEEEcCCCccCCCCCccccCccccceeeeccCCcccCCCCccccCCC-ccceeeecCCcccc
Q 043900 379 CNFLQGSIPSSLGQYKTLTIIDLSDNNLTGTIPPQFLGLSWLLIGLDLSRNQLTGSIPSEVGNLK-NLEVLDVFENKLKG 457 (953)
Q Consensus 379 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~ 457 (953)
.|.+....+..|.++++|+.|++++|++....+..+......+..+..+++.+....+..|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 35566567778888899999999999887443334444445555667778888866677777765 78889999999985
Q ss_pred cCCCCccCCcccc-EEEccCccccCCCCccccCCCCCcEEECCCCcccccCCccccccccCceEeccC
Q 043900 458 EIPSTLGSCKKLE-QLEMQGNFLQGPIPSSLSSLKGLNVLDLSQNNLSGKIPEFLVGFQLLENLNLSN 524 (953)
Q Consensus 458 ~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~ 524 (953)
..+..| ...+++ .+++++|+|+...+..|.++++|++|||++|+|+...+..|.++++|+.+++.+
T Consensus 168 i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 168 IHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp ECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 444444 445554 446788899866566789999999999999999965566678888887776644
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.1e-18 Score=177.13 Aligned_cols=188 Identities=22% Similarity=0.335 Sum_probs=98.0
Q ss_pred cCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccce
Q 043900 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEH 104 (953)
Q Consensus 25 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (953)
..|.+|++|++++|+|+. + ..+..+++|++|+|++|+|++..| +.++.+|+.+++++|.++ .++ .++++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccc
Confidence 455556666666666665 2 235566666666666666653222 555666666666666555 222 3555566666
Q ss_pred eeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccc
Q 043900 105 LSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184 (953)
Q Consensus 105 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 184 (953)
|++++|...+. ..+.....++.+.++++.+.. ...+.++++|++|++++|+++.. ..+.++++|++|+|++|++
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--chhccccchhhhhchhhhhch--hhhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 66666555422 124455556666665555542 22345555566666666655422 1245555555555555555
Q ss_pred ccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcc
Q 043900 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQAD 229 (953)
Q Consensus 185 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 229 (953)
++. +. +..+++|++|+|++|+|++.. .+.++++|+.|+++
T Consensus 186 ~~l-~~--l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 186 SDI-SP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp CCC-GG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred CCC-hh--hcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 532 21 224555555555555555322 24555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.1e-18 Score=177.38 Aligned_cols=210 Identities=20% Similarity=0.295 Sum_probs=169.7
Q ss_pred cCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccce
Q 043900 25 GNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEH 104 (953)
Q Consensus 25 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (953)
..|.++..++++.+++++.. .+..+.+|++|++++|.|+ .++ .+..+++|++|++++|.+++.. .+..+++|++
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~ 89 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITE 89 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCE
T ss_pred HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeeccc--cccccccccc
Confidence 34555667889999999744 4677899999999999998 554 5899999999999999998543 3899999999
Q ss_pred eeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccc
Q 043900 105 LSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQL 184 (953)
Q Consensus 105 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 184 (953)
|++++|.++ .++ .+.++++|+++++++|.... ...+...+.++.+.++.+.+... ..+.+..+|++|++++|.+
T Consensus 90 l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 90 LELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp EECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred ccccccccc-ccc-cccccccccccccccccccc--cchhccccchhhhhchhhhhchh--hhhcccccccccccccccc
Confidence 999999998 454 68899999999999998863 34478889999999999998743 3477888999999999998
Q ss_pred ccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCCCCCCCCccceeeec
Q 043900 185 QGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVPYLEKPQRLSVFSIT 252 (953)
Q Consensus 185 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~~~~L~~l~l~ 252 (953)
....+ + ..+++|+.|+|++|++++. ..++++++|++|++++|++++.++ +..+++|+.++++
T Consensus 164 ~~~~~--l-~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 164 SDLTP--L-ANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp CCCGG--G-TTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred ccchh--h-cccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence 75433 3 3789999999999999853 348899999999999999986543 5566666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.4e-18 Score=170.06 Aligned_cols=186 Identities=19% Similarity=0.302 Sum_probs=131.6
Q ss_pred ccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeec
Q 043900 28 SFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSV 107 (953)
Q Consensus 28 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (953)
..+...+++++.+++.++. ..+.+|++|++++|.++ .++ .+..+++|++|+|++|+|++ ++ .++.+++|++|++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l 97 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEEC
T ss_pred HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccc
Confidence 3444556777777764442 34667778888888876 333 36778888888888888774 33 3677788888888
Q ss_pred cccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccccc
Q 043900 108 SVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQGV 187 (953)
Q Consensus 108 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 187 (953)
++|+|+ .+| .+.++++|+.|++++|.+. . ...+.++++|+.+++++|.+++ +..+..+++|+.+++++|++++.
T Consensus 98 ~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~-~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 98 DENKVK-DLS-SLKDLKKLKSLSLEHNGIS-D-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp CSSCCC-CGG-GGTTCTTCCEEECTTSCCC-C-CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred cccccc-ccc-ccccccccccccccccccc-c-cccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence 888887 344 5777888888888888775 2 3357778888888888888763 33466777888888888888753
Q ss_pred cccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEccc
Q 043900 188 IPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADV 230 (953)
Q Consensus 188 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 230 (953)
.+ + ..+++|+.|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 172 ~~--l-~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 VP--L-AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GG--G-TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cc--c-cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 32 3 367888888888888874 33 588888888888763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=4.1e-21 Score=218.31 Aligned_cols=388 Identities=19% Similarity=0.148 Sum_probs=186.7
Q ss_pred cccceeecccccccccc-CCcccCCCcccEEecccccccc----cCCccccccccccceecccccccCC----CCCccc-
Q 043900 100 SKIEHLSVSVNNLTGSI-PSSLGNLSSINTLFLTDNNLDG----GIPDTFGWLKNLATLAMAENWLSGT----IPSSIF- 169 (953)
Q Consensus 100 ~~L~~L~Ls~N~l~~~~-p~~~~~L~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~- 169 (953)
.+|++||+++|++++.. .+.+..+++|++|+|++|.|+. .+...+..+++|++|+|++|+|+.. +.+.+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36788888888887531 3345667888888888888762 2234556777777777777777521 112222
Q ss_pred ccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccccccCcCC-----CCC-CC
Q 043900 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVNKLTGEVP-----YLE-KP 243 (953)
Q Consensus 170 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~l~-~~ 243 (953)
...+|++|+|++|++++..-.. ++..+..+++|++|++++|.++.... .+. ..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~---------------------l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~ 140 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGV---------------------LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 140 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHH---------------------HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred CCCCCCEEECCCCCcccccccc---------------------ccchhhccccccccccccccchhhhhhhhhhcccccc
Confidence 1235666666666665321111 12233444444555554444432100 000 00
Q ss_pred CccceeeecccccCCCCCCcccccccccccccccEEeccCCccccc----CChhhhhccccCcEEEcccCcccccC----
Q 043900 244 QRLSVFSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANNFGGL----LPACISNLSTTLEMLLLDNNKIFGNI---- 315 (953)
Q Consensus 244 ~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~~~~~----~p~~~~~~~~~L~~L~L~~N~i~~~~---- 315 (953)
............+...+ .......+.....++.+.++.+..... ....+.........+++..+.+....
T Consensus 141 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~ 218 (460)
T d1z7xw1 141 CRLEKLQLEYCSLSAAS--CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 218 (460)
T ss_dssp CCCCEEECTTSCCBGGG--HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred cccccccccccccchhh--hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcc
Confidence 01111111111111000 001111222334455555555544321 11111222223445555555543211
Q ss_pred CccccCCCCCCEEEeecCcccc-----cCCcCccCCCCCCeEEeccccccCCCCCCCCCceeeEEEccCCcCCCCCCccC
Q 043900 316 PAAIGKFVNLQRLEMWNNRLSG-----TIPPAIGELQNLRELRLQRNKFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSL 390 (953)
Q Consensus 316 ~~~~~~l~~L~~L~L~~N~i~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~ 390 (953)
...+...+.++.+++++|.+.. ..+..+.....++.+++++|.+...... .....+
T Consensus 219 ~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~-------------------~~~~~l 279 (460)
T d1z7xw1 219 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG-------------------DLCRVL 279 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH-------------------HHHHHH
T ss_pred cccccccccccccchhhccccccccchhhcccccccccccccccccccccccccc-------------------cccccc
Confidence 1123344556666666665531 1222333445566666666655421100 011223
Q ss_pred CCCCCCcEEEcCCCccCCCCCcc----ccCccccceeeeccCCcccCCCC----ccccCCCccceeeecCCccccc----
Q 043900 391 GQYKTLTIIDLSDNNLTGTIPPQ----FLGLSWLLIGLDLSRNQLTGSIP----SEVGNLKNLEVLDVFENKLKGE---- 458 (953)
Q Consensus 391 ~~l~~L~~L~L~~N~l~~~~p~~----~~~~~~~l~~L~ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~---- 458 (953)
...+.++.+++++|.++...... +......++.+++++|.++.... ..+...++|++|+|++|+|+..
T Consensus 280 ~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~ 359 (460)
T d1z7xw1 280 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 359 (460)
T ss_dssp HHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred cccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccch
Confidence 34455666666666554211111 11112234456666666553322 2233456788888888877642
Q ss_pred CCCCcc-CCccccEEEccCccccCC----CCccccCCCCCcEEECCCCcccccCCccc----c-ccccCceEeccCCcCc
Q 043900 459 IPSTLG-SCKKLEQLEMQGNFLQGP----IPSSLSSLKGLNVLDLSQNNLSGKIPEFL----V-GFQLLENLNLSNNNLE 528 (953)
Q Consensus 459 ~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~l~l~~N~l~ 528 (953)
++..+. ..+.|++|+|++|.|+.. ++..+..+++|++|||++|+|+......+ . +...|+.|++++|.+.
T Consensus 360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 222232 356688888888888642 34445566788888888888764322222 1 2336788888888775
Q ss_pred c
Q 043900 529 G 529 (953)
Q Consensus 529 ~ 529 (953)
.
T Consensus 440 ~ 440 (460)
T d1z7xw1 440 E 440 (460)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.1e-18 Score=172.37 Aligned_cols=166 Identities=22% Similarity=0.355 Sum_probs=117.8
Q ss_pred CCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 26 NLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 26 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
.|.+|++|++++|+++.. + .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+|+ .+| .++++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccc
Confidence 466778888888888763 2 36777888888888888774 33 3567788888888888877 344 47777888888
Q ss_pred eccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 185 (953)
++++|.+. .++ .+.++++|+.+++++|.++. +..+..+++|+++++++|++++ ++ .+.++++|++|+|++|+|+
T Consensus 118 ~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred cccccccc-ccc-cccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC
Confidence 88888776 333 57777788888888887762 3456777888888888888774 33 3677778888888888877
Q ss_pred cccccccccccccccEEEeeC
Q 043900 186 GVIPLDFGFTLQNLQFFSVFE 206 (953)
Q Consensus 186 ~~~~~~~~~~l~~L~~L~L~~ 206 (953)
. ++ .+ .++++|++|+|++
T Consensus 192 ~-l~-~l-~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-AL-AGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GG-TTCTTCSEEEEEE
T ss_pred C-Ch-hh-cCCCCCCEEEccC
Confidence 3 34 23 3677888887764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.8e-18 Score=169.99 Aligned_cols=183 Identities=23% Similarity=0.346 Sum_probs=120.7
Q ss_pred CccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceee
Q 043900 27 LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLS 106 (953)
Q Consensus 27 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (953)
+.++..+.++.+.+++..+ ...+.++++|++++|.|+ .++ .+..+++|++|+|++|++++.. .++++++|++|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCcc--cccCCccccccc
Confidence 4444556677777776333 345667777777777776 333 4677777777777777776432 277777777777
Q ss_pred ccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccccccceEEecCCccccc
Q 043900 107 VSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFNISSITAFDAGMNQLQG 186 (953)
Q Consensus 107 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 186 (953)
+++|.+. .++ .++++++|+.|++++|.+.. .+.+.++++|+.|++++|++. .++ .+..+++|+.|++++|++++
T Consensus 91 l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 91 MNNNQIA-DIT-PLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred ccccccc-ccc-cccccccccccccccccccc--ccccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC
Confidence 7777776 334 47777777777777777653 234677777777777777776 333 46677777777777777764
Q ss_pred ccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEE
Q 043900 187 VIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELF 226 (953)
Q Consensus 187 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 226 (953)
..+ + .++++|++|++++|++++ + +.++.+++|++|
T Consensus 165 l~~--l-~~l~~L~~L~ls~N~i~~-i-~~l~~L~~L~~L 199 (199)
T d2omxa2 165 LKP--L-ANLTTLERLDISSNKVSD-I-SVLAKLTNLESL 199 (199)
T ss_dssp CGG--G-TTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred Ccc--c-cCCCCCCEEECCCCCCCC-C-ccccCCCCCCcC
Confidence 322 2 367777777777777764 2 246677777664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.3e-21 Score=222.46 Aligned_cols=70 Identities=19% Similarity=0.094 Sum_probs=46.8
Q ss_pred CCCccceeeecCCccccc----CCCCccCCccccEEEccCccccCCCCcc----cc-CCCCCcEEECCCCcccccCCcc
Q 043900 441 NLKNLEVLDVFENKLKGE----IPSTLGSCKKLEQLEMQGNFLQGPIPSS----LS-SLKGLNVLDLSQNNLSGKIPEF 510 (953)
Q Consensus 441 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~-~l~~L~~L~Ls~N~l~~~~p~~ 510 (953)
..+.|++|+|++|.|+.. ++..+..+++|++|+|++|+|+...... +. ....|+.|++++|.+....+..
T Consensus 367 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~ 445 (460)
T d1z7xw1 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445 (460)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred ccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHH
Confidence 345688888888888642 3445566788888888888887432222 22 3346899999999888644443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2e-17 Score=163.72 Aligned_cols=175 Identities=21% Similarity=0.338 Sum_probs=143.3
Q ss_pred eCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccc
Q 043900 11 LTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVG 90 (953)
Q Consensus 11 l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~ 90 (953)
++.+++.+.++ ...+.++++|++++|+|+.+ ..+..+++|++|+|++|+|++. ++ ++++++|++|++++|.+.
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~- 97 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA- 97 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-
Confidence 44444443332 35688999999999999973 3588999999999999999854 43 999999999999999997
Q ss_pred cCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCccccccccccceecccccccCCCCCcccc
Q 043900 91 KIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170 (953)
Q Consensus 91 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 170 (953)
.++ .+.++++|+.|++++|.+... ..+.++++|+.|++++|++. .+ +.+..+++|++|++.+|++++ ++ .+.+
T Consensus 98 ~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~-~~l~~~~~L~~L~l~~n~l~~-l~-~l~~ 170 (199)
T d2omxa2 98 DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DI-SALSGLTSLQQLNFSSNQVTD-LK-PLAN 170 (199)
T ss_dssp CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CC-GGGTTCTTCSEEECCSSCCCC-CG-GGTT
T ss_pred ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-cc-ccccccccccccccccccccC-Cc-cccC
Confidence 444 489999999999999998743 35889999999999999997 33 468999999999999999984 33 4889
Q ss_pred cccceEEecCCcccccccccccccccccccEE
Q 043900 171 ISSITAFDAGMNQLQGVIPLDFGFTLQNLQFF 202 (953)
Q Consensus 171 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 202 (953)
+++|++|++++|++++ ++ .+ ..+++|+.|
T Consensus 171 l~~L~~L~ls~N~i~~-i~-~l-~~L~~L~~L 199 (199)
T d2omxa2 171 LTTLERLDISSNKVSD-IS-VL-AKLTNLESL 199 (199)
T ss_dssp CTTCCEEECCSSCCCC-CG-GG-GGCTTCSEE
T ss_pred CCCCCEEECCCCCCCC-Cc-cc-cCCCCCCcC
Confidence 9999999999999985 33 23 378888875
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=6.3e-16 Score=146.33 Aligned_cols=126 Identities=15% Similarity=0.130 Sum_probs=70.0
Q ss_pred ccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccc
Q 043900 24 VGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIE 103 (953)
Q Consensus 24 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (953)
+.+...+++|+|++|+|+. ++..+..+++|++|||++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 4455566666666666665 3445556666666666666666 332 355666666666666666533333344556666
Q ss_pred eeeccccccccccC--CcccCCCcccEEecccccccccCCc----ccccccccccee
Q 043900 104 HLSVSVNNLTGSIP--SSLGNLSSINTLFLTDNNLDGGIPD----TFGWLKNLATLA 154 (953)
Q Consensus 104 ~L~Ls~N~l~~~~p--~~~~~L~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ 154 (953)
+|++++|+|+. ++ ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 66666666552 22 24555566666666666554 2222 344455555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=1.5e-15 Score=136.33 Aligned_cols=102 Identities=21% Similarity=0.281 Sum_probs=70.2
Q ss_pred ceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeecccc
Q 043900 31 KVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVN 110 (953)
Q Consensus 31 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 110 (953)
|+|+|++|+|+. ++ .+..+++|++|||++|+|+ .+|+.|+.+++|+.|++++|.|+ .+| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 467777777775 33 3777777777777777777 66666777777777777777776 333 4677777777777777
Q ss_pred cccccc-CCcccCCCcccEEeccccccc
Q 043900 111 NLTGSI-PSSLGNLSSINTLFLTDNNLD 137 (953)
Q Consensus 111 ~l~~~~-p~~~~~L~~L~~L~L~~N~l~ 137 (953)
+|+... ...++.+++|++|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 776332 135666777777777777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.1e-15 Score=144.58 Aligned_cols=128 Identities=20% Similarity=0.216 Sum_probs=84.9
Q ss_pred cCCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcc
Q 043900 47 EFDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSI 126 (953)
Q Consensus 47 ~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L 126 (953)
.|.+..+|++|||++|+|+ .++..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4667777888888888887 556666677778888888887773 3 347777777777777777775444455667777
Q ss_pred cEEecccccccccCC-ccccccccccceecccccccCCCCC----cccccccceEEe
Q 043900 127 NTLFLTDNNLDGGIP-DTFGWLKNLATLAMAENWLSGTIPS----SIFNISSITAFD 178 (953)
Q Consensus 127 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~ 178 (953)
+.|++++|+|+.... ..+..+++|++|++++|.++ ..|. .+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 777777777763211 35666777777777777765 3332 244445555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=4e-15 Score=133.55 Aligned_cols=102 Identities=24% Similarity=0.314 Sum_probs=74.3
Q ss_pred cEEeCCCCccccccCcCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccc
Q 043900 55 QVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDN 134 (953)
Q Consensus 55 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N 134 (953)
|+|||++|+|+ .++ .+..+.+|++|++++|+|+ .+|..|+.+++|++|++++|+|+ .+| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 56888888887 555 3777888888888888887 56667777888888888888877 444 4777778888888888
Q ss_pred cccccC-Cccccccccccceeccccccc
Q 043900 135 NLDGGI-PDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 135 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 161 (953)
+|+... ...+..+++|++|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 776432 245677777777777777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.9e-15 Score=158.27 Aligned_cols=125 Identities=20% Similarity=0.170 Sum_probs=73.0
Q ss_pred EEEeCCCeeeeecCccccCCccCceeecCCCccCcCCCccCCCCCCCcEEeCCCCccccc-cCcCccCCCCCcEEeccCc
Q 043900 8 ILNLTSLKLAGSISPHVGNLSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNNSIGGE-IPANISSCSNLIQIRLFYN 86 (953)
Q Consensus 8 ~l~l~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~p~~~~~l~~L~~L~L~~n 86 (953)
.|||++..+.......+.. ..+..+.++++.+.. .........+|++|||++|.+++. ++..+..+++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5777777765333332221 234566666666664 223334555777888877777643 3344566777777777777
Q ss_pred cccccCCcccCCccccceeecccc-ccccc-cCCcccCCCcccEEecccc
Q 043900 87 ELVGKIPSELGSLSKIEHLSVSVN-NLTGS-IPSSLGNLSSINTLFLTDN 134 (953)
Q Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~L~~L~~L~L~~N 134 (953)
.+++..+..++.+++|++|++++| .+++. +...+.++++|++|+++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 766555666666777777777764 34421 1112345666777776664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=1.5e-15 Score=164.58 Aligned_cols=242 Identities=17% Similarity=0.193 Sum_probs=158.3
Q ss_pred ecCccccCCccCceeecCCCccCcC----CCccCCCCCCCcEEeCCCCccccc----------cCcCccCCCCCcEEecc
Q 043900 19 SISPHVGNLSFLKVLLLYNNSFNHG----IPSEFDRLQRLQVLALNNNSIGGE----------IPANISSCSNLIQIRLF 84 (953)
Q Consensus 19 ~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~----------~p~~~~~l~~L~~L~L~ 84 (953)
.+...+.+...|++|+|++|.|... +...+...++|+.|+++++.+... +...+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 4555667777888888888887542 334567778888888887754311 22335567788888888
Q ss_pred Ccccccc----CCcccCCccccceeeccccccccccCCc-------------ccCCCcccEEeccccccccc----CCcc
Q 043900 85 YNELVGK----IPSELGSLSKIEHLSVSVNNLTGSIPSS-------------LGNLSSINTLFLTDNNLDGG----IPDT 143 (953)
Q Consensus 85 ~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~L~~L~~L~L~~N~l~~~----~~~~ 143 (953)
+|.++.. +...+..+++|++|++++|.+....... ....+.|+.|++++|+++.. +...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 8887643 2333456678888888888764211111 13456788888888887632 2334
Q ss_pred ccccccccceecccccccCC-----CCCcccccccceEEecCCccccccccc---ccccccccccEEEeeCccccCCCCC
Q 043900 144 FGWLKNLATLAMAENWLSGT-----IPSSIFNISSITAFDAGMNQLQGVIPL---DFGFTLQNLQFFSVFENQLTGAIPP 215 (953)
Q Consensus 144 ~~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~ 215 (953)
+...+.|++|+|++|+|+.. +...+..+++|+.|+|++|.++..... .....+++|++|+|++|.|++....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence 56677888888888887632 344566778888888888887643211 1123577888888888888744222
Q ss_pred CC----c--CCCCCcEEEcccccccCc-----CCCC-CCCCccceeeecccccCCCC
Q 043900 216 AI----S--NASNLELFQADVNKLTGE-----VPYL-EKPQRLSVFSITENSLGSRG 260 (953)
Q Consensus 216 ~~----~--~l~~L~~L~L~~N~l~~~-----~~~l-~~~~~L~~l~l~~n~l~~~~ 260 (953)
.+ . ....|++|++++|+++.. ...+ .+.+.|+.+++++|.+....
T Consensus 262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 22 2 246788889998887642 1112 24567888888888886543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=1.2e-15 Score=149.83 Aligned_cols=110 Identities=19% Similarity=0.228 Sum_probs=46.0
Q ss_pred cCccCCCCCcEEeccCccccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCcccccccc
Q 043900 70 ANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKN 149 (953)
Q Consensus 70 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~ 149 (953)
.++..+++|++|+|++|+|+ .++ .|.++++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.. +.+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 33444444444444444443 222 2444444444444444444 3333333333444444444444421 22444444
Q ss_pred ccceecccccccCCCC--CcccccccceEEecCCcccc
Q 043900 150 LATLAMAENWLSGTIP--SSIFNISSITAFDAGMNQLQ 185 (953)
Q Consensus 150 L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~ 185 (953)
|++|+|++|+|+ .++ ..+..+++|+.|+|++|.+.
T Consensus 117 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 117 LRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 444444444444 222 23344444444444444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=2.8e-14 Score=149.13 Aligned_cols=184 Identities=17% Similarity=0.173 Sum_probs=106.0
Q ss_pred ccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCCCcCCCCCcEEEcccc-cccCcCCCCCCCCccce
Q 043900 170 NISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPAISNASNLELFQADVN-KLTGEVPYLEKPQRLSV 248 (953)
Q Consensus 170 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~l~~~~~L~~ 248 (953)
...+|++||+++|.++......++..+++|++|+|++|.+++..+..++.+++|+.|+++++ .++...
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~----------- 112 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA----------- 112 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-----------
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccc-----------
Confidence 44567777777776664444445556777777777777776656666677777777777763 343110
Q ss_pred eeecccccCCCCCCcccccccccccccccEEeccCCc-ccc-cCChhhhhccccCcEEEcccC--ccccc-CCccccCCC
Q 043900 249 FSITENSLGSRGHSNLNFLCSLTNSTRLNRLLINANN-FGG-LLPACISNLSTTLEMLLLDNN--KIFGN-IPAAIGKFV 323 (953)
Q Consensus 249 l~l~~n~l~~~~~~~~~~l~~l~~~~~L~~L~l~~n~-~~~-~~p~~~~~~~~~L~~L~L~~N--~i~~~-~~~~~~~l~ 323 (953)
...-..++++|++|+++++. ++. .+...+....++|+.|+++++ .++.. +...+.+++
T Consensus 113 -----------------l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~ 175 (284)
T d2astb2 113 -----------------LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175 (284)
T ss_dssp -----------------HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCT
T ss_pred -----------------cchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccc
Confidence 00001234455555555542 221 122334444456777777754 23221 122234567
Q ss_pred CCCEEEeecC-cccccCCcCccCCCCCCeEEeccc-cccCCCCCCCCCceeeEEEccCCcCCCCCCccCCCCCCCcEEEc
Q 043900 324 NLQRLEMWNN-RLSGTIPPAIGELQNLRELRLQRN-KFLGNIPPSIGNLKVFNLDLSCNFLQGSIPSSLGQYKTLTIIDL 401 (953)
Q Consensus 324 ~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~l~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (953)
+|++|++++| .+++.....+..+++|++|+|+++ .++. .....++++++|+.|++
T Consensus 176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~-----------------------~~l~~L~~~~~L~~L~l 232 (284)
T d2astb2 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP-----------------------ETLLELGEIPTLKTLQV 232 (284)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG-----------------------GGGGGGGGCTTCCEEEC
T ss_pred cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh-----------------------HHHHHHhcCCCCCEEee
Confidence 7778888775 466566666777777777777774 3432 22334566777888888
Q ss_pred CCC
Q 043900 402 SDN 404 (953)
Q Consensus 402 ~~N 404 (953)
+++
T Consensus 233 ~~~ 235 (284)
T d2astb2 233 FGI 235 (284)
T ss_dssp TTS
T ss_pred eCC
Confidence 776
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=3.4e-15 Score=146.46 Aligned_cols=145 Identities=20% Similarity=0.239 Sum_probs=107.7
Q ss_pred CCcEEeccCc--cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEecccccccccCCcccccccccccee
Q 043900 77 NLIQIRLFYN--ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLA 154 (953)
Q Consensus 77 ~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (953)
.++.+++.++ .+. .++..|..+++|++|+|++|+|+ .++ .|.+|++|++|+|++|+|+ .+|..+..+++|++|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence 3445555443 233 55677888999999999999998 555 5889999999999999998 5676677778899999
Q ss_pred cccccccCCCCCcccccccceEEecCCcccccccccccccccccccEEEeeCccccCCCCCC----------CcCCCCCc
Q 043900 155 MAENWLSGTIPSSIFNISSITAFDAGMNQLQGVIPLDFGFTLQNLQFFSVFENQLTGAIPPA----------ISNASNLE 224 (953)
Q Consensus 155 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L~ 224 (953)
+++|+|+. + ..+..+++|+.|++++|+|+.......+..+++|+.|++++|++....+.. +..+++|+
T Consensus 100 l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~ 177 (198)
T d1m9la_ 100 ISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177 (198)
T ss_dssp CSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred cccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence 99999983 3 347788889999999999884333233447888888888888886443332 45677777
Q ss_pred EEE
Q 043900 225 LFQ 227 (953)
Q Consensus 225 ~L~ 227 (953)
.||
T Consensus 178 ~LD 180 (198)
T d1m9la_ 178 KLD 180 (198)
T ss_dssp EES
T ss_pred EeC
Confidence 765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=2.4e-13 Score=127.39 Aligned_cols=84 Identities=15% Similarity=0.164 Sum_probs=40.3
Q ss_pred CCcEEeCCCCccccccCcCccCCCCCcEEeccCc-cccccCCcccCCccccceeeccccccccccCCcccCCCcccEEec
Q 043900 53 RLQVLALNNNSIGGEIPANISSCSNLIQIRLFYN-ELVGKIPSELGSLSKIEHLSVSVNNLTGSIPSSLGNLSSINTLFL 131 (953)
Q Consensus 53 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 131 (953)
..+.++.+++++. ..|..+.++++|++|++++| .|+...+++|.++++|+.|+|++|+|+.+.|.+|.++++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3444555555555 44444555555555555433 244333344444444444444444444444444444444444444
Q ss_pred cccccc
Q 043900 132 TDNNLD 137 (953)
Q Consensus 132 ~~N~l~ 137 (953)
++|+|+
T Consensus 88 s~N~l~ 93 (156)
T d2ifga3 88 SFNALE 93 (156)
T ss_dssp CSSCCS
T ss_pred cCCCCc
Confidence 444444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.40 E-value=4e-15 Score=161.08 Aligned_cols=192 Identities=16% Similarity=0.120 Sum_probs=142.1
Q ss_pred CCccCCCCCCCcEEeCCCCccccc----cCcCccCCCCCcEEeccCcccccc----------CCcccCCccccceeeccc
Q 043900 44 IPSEFDRLQRLQVLALNNNSIGGE----IPANISSCSNLIQIRLFYNELVGK----------IPSELGSLSKIEHLSVSV 109 (953)
Q Consensus 44 ~~~~~~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~Ls~ 109 (953)
+..++.....|+.|+|++|.|... +...+...++|+.|+++++..... +...+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 455677789999999999998643 344567889999999998765411 223356778999999999
Q ss_pred cccccc----cCCcccCCCcccEEecccccccccCCcc-------------ccccccccceecccccccCC----CCCcc
Q 043900 110 NNLTGS----IPSSLGNLSSINTLFLTDNNLDGGIPDT-------------FGWLKNLATLAMAENWLSGT----IPSSI 168 (953)
Q Consensus 110 N~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~l 168 (953)
|.+... +...+...++|+.|++++|.++...... ....+.|+.|.+++|+++.. +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 998753 3344567899999999999875221111 13467899999999998732 22335
Q ss_pred cccccceEEecCCccccccc----ccccccccccccEEEeeCccccCC----CCCCCcCCCCCcEEEcccccccC
Q 043900 169 FNISSITAFDAGMNQLQGVI----PLDFGFTLQNLQFFSVFENQLTGA----IPPAISNASNLELFQADVNKLTG 235 (953)
Q Consensus 169 ~~l~~L~~L~L~~N~l~~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~ 235 (953)
....+|++|+|++|+|+... .......+++|+.|+|++|.++.. +...+..+++|++|++++|.++.
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 56789999999999987421 122234688999999999998733 34567789999999999999874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.6e-12 Score=121.59 Aligned_cols=142 Identities=13% Similarity=0.042 Sum_probs=102.8
Q ss_pred CccCceeecCCCccCcCCCccCCCCCCCcEEeCCCC-ccccccCcCccCCCCCcEEeccCccccccCCcccCCcccccee
Q 043900 27 LSFLKVLLLYNNSFNHGIPSEFDRLQRLQVLALNNN-SIGGEIPANISSCSNLIQIRLFYNELVGKIPSELGSLSKIEHL 105 (953)
Q Consensus 27 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (953)
......+++++++++. .|..+..+++|++|+|++| .|+...+.+|.++++|+.|+|++|+|+.+.|.+|.++++|++|
T Consensus 7 c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 3445678889999887 7788889999999999766 5886666789999999999999999998878889999999999
Q ss_pred eccccccccccCCcccCCCcccEEecccccccc-cCCccccccccccceecccccccCCCCCcccc
Q 043900 106 SVSVNNLTGSIPSSLGNLSSINTLFLTDNNLDG-GIPDTFGWLKNLATLAMAENWLSGTIPSSIFN 170 (953)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 170 (953)
+|++|+|+...++.|.. .+|+.|+|++|.+.= -...+|..........+..++++...|..+.+
T Consensus 86 ~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~ 150 (156)
T d2ifga3 86 NLSFNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150 (156)
T ss_dssp ECCSSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSC
T ss_pred eccCCCCcccChhhhcc-ccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCc
Confidence 99999999554555555 479999999999851 11112222222333344445555445544443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=1.3e-09 Score=102.21 Aligned_cols=65 Identities=17% Similarity=0.099 Sum_probs=28.9
Q ss_pred CCCCCCCcEEeCCCCccccccCcCccCCCCCcEEeccCccccccC--CcccCCccccceeeccccccc
Q 043900 48 FDRLQRLQVLALNNNSIGGEIPANISSCSNLIQIRLFYNELVGKI--PSELGSLSKIEHLSVSVNNLT 113 (953)
Q Consensus 48 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~ 113 (953)
+..+..+..|++.++.+. .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 344444444444444433 33333344555555555555554221 122334444444455544444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=2.5e-09 Score=100.21 Aligned_cols=65 Identities=22% Similarity=0.136 Sum_probs=29.6
Q ss_pred CCccccceeeccccccccc--cCCcccCCCcccEEecccccccccCCccccccccccceeccccccc
Q 043900 97 GSLSKIEHLSVSVNNLTGS--IPSSLGNLSSINTLFLTDNNLDGGIPDTFGWLKNLATLAMAENWLS 161 (953)
Q Consensus 97 ~~l~~L~~L~Ls~N~l~~~--~p~~~~~L~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (953)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.++
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3445555555555555432 1223344555555555555554322222223334455555555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=6.4e-07 Score=91.17 Aligned_cols=150 Identities=15% Similarity=0.097 Sum_probs=99.5
Q ss_pred HHHHHhhcCCcccCcccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeeccccc
Q 043900 624 QNLYNATDGFASANEIGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDY 702 (953)
Q Consensus 624 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 702 (953)
.++....+.|+..+..+.++.+.||+....+ ..+++|+...........+.+|...+..+. +--+.++++++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~--~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~---- 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGEN--ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER---- 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSS--CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCC--CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe----
Confidence 3566667788877766656667999987543 357889886554444456678888877763 333556666532
Q ss_pred CCCCceeEEEeeccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhhC--------------------
Q 043900 703 QGNDFKALVFEFMQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHHD-------------------- 762 (953)
Q Consensus 703 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------- 762 (953)
.++..++||++++|.++.+..... ....+++.++++.++.||+.
T Consensus 81 -~~~~~~lv~~~l~G~~~~~~~~~~---------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 81 -HDGWSNLLMSEADGVLCSEEYEDE---------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp -ETTEEEEEEECCSSEEHHHHTTTC---------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred -cCCceEEEEEeccccccccccccc---------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 236779999999998886554210 01223445555555555531
Q ss_pred ------------------------------------CCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 763 ------------------------------------CQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 763 ------------------------------------~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
....++|+|+.|.||++++++.+-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012479999999999999877777999998863
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.66 E-value=4.3e-06 Score=77.96 Aligned_cols=17 Identities=12% Similarity=-0.115 Sum_probs=8.1
Q ss_pred ccCCCcccEEecccccc
Q 043900 120 LGNLSSINTLFLTDNNL 136 (953)
Q Consensus 120 ~~~L~~L~~L~L~~N~l 136 (953)
+...++|++|+|++|++
T Consensus 96 L~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp TTTTCCCSEEECCCCSS
T ss_pred HHhCCcCCEEECCCCcC
Confidence 33444455555555543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.64 E-value=0.0001 Score=73.83 Aligned_cols=131 Identities=15% Similarity=0.060 Sum_probs=81.5
Q ss_pred cccccce-eeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcC--CCCeeEEEeeecccccCCCCceeEEEee
Q 043900 638 EIGVGSF-GSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIR--HRNLVKILTACSGVDYQGNDFKALVFEF 714 (953)
Q Consensus 638 ~ig~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~ 714 (953)
.+..|.. +.||+....++. .+++|....... ..+..|+..++.+. .-.+.++++++. +++..++||+|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~-~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRP-VLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSC-CEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCCCC-EEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEe
Confidence 3455553 689999876654 688898754332 34566777777663 233556666532 33678999999
Q ss_pred ccCCchhhccccCCcCCcccCCccccCHHHHHHHHHHHHHHHHHHhh---------------------------------
Q 043900 715 MQNRSLEEWLHPITREDKTEEAPRSLNLLQRLNIGIDVACALSYLHH--------------------------------- 761 (953)
Q Consensus 715 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------------------------------- 761 (953)
++|.++.+... .. ...+.++++.++-||+
T Consensus 88 i~G~~~~~~~~---------------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (255)
T d1nd4a_ 88 VPGQDLLSSHL---------------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 149 (255)
T ss_dssp CSSEETTTSCC---------------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred eeccccccccc---------------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccc
Confidence 99877654221 00 1112223333333331
Q ss_pred ------------------C----CCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 762 ------------------D----CQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 762 ------------------~----~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
. ..+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 150 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 123489999999999999887778999998863
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=5.7e-06 Score=77.09 Aligned_cols=112 Identities=11% Similarity=0.043 Sum_probs=79.8
Q ss_pred cCCccCceeecCCC-ccCcC----CCccCCCCCCCcEEeCCCCccccccCc----CccCCCCCcEEeccCcccccc----
Q 043900 25 GNLSFLKVLLLYNN-SFNHG----IPSEFDRLQRLQVLALNNNSIGGEIPA----NISSCSNLIQIRLFYNELVGK---- 91 (953)
Q Consensus 25 ~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~p~----~~~~l~~L~~L~L~~n~l~~~---- 91 (953)
.+.++|++|+|+++ .++.. +..++...+.|++|+|++|.++..... .+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 35578999999874 46542 334567788899999999998754333 345678899999999998743
Q ss_pred CCcccCCccccceeeccccccccc-------cCCcccCCCcccEEecccccc
Q 043900 92 IPSELGSLSKIEHLSVSVNNLTGS-------IPSSLGNLSSINTLFLTDNNL 136 (953)
Q Consensus 92 ~~~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~L~~L~~L~L~~N~l 136 (953)
+-..+...++|++|++++|.+... +...+..-++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 233567778899999999875521 233455567788888876654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=8.1e-05 Score=79.63 Aligned_cols=77 Identities=14% Similarity=0.144 Sum_probs=49.3
Q ss_pred cCcccccceeeEEEEEEcCCCeEEEEEEeecc-------chhhHHHHHHHHHHHhhcC-C--CCeeEEEeeecccccCCC
Q 043900 636 ANEIGVGSFGSVYKGILDQGKTTVAVKVFNLL-------HHGAFKSFIAECNTLKNIR-H--RNLVKILTACSGVDYQGN 705 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 705 (953)
.+.||.|....||+++..++++.|+||..... .+....+...|++.++.+. + ..+.+++.+. .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 45689999999999998887778999976421 1112344566888887662 2 3456666552 2
Q ss_pred CceeEEEeeccCCc
Q 043900 706 DFKALVFEFMQNRS 719 (953)
Q Consensus 706 ~~~~lv~e~~~~g~ 719 (953)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 34579999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.02 E-value=3.7e-05 Score=71.34 Aligned_cols=65 Identities=9% Similarity=0.036 Sum_probs=33.2
Q ss_pred cCCccCceeecCC-CccCcC----CCccCCCCCCCcEEeCCCCccccccC----cCccCCCCCcEEeccCcccc
Q 043900 25 GNLSFLKVLLLYN-NSFNHG----IPSEFDRLQRLQVLALNNNSIGGEIP----ANISSCSNLIQIRLFYNELV 89 (953)
Q Consensus 25 ~~l~~L~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~p----~~~~~l~~L~~L~L~~n~l~ 89 (953)
.+.+.|++|+|++ +.++.. +..++...++|++|+|++|.++...- ..+...+.++.+++++|.++
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3456666677765 345432 22334456666666666666643222 22334455555555555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.94 E-value=0.00093 Score=69.12 Aligned_cols=147 Identities=16% Similarity=0.122 Sum_probs=77.6
Q ss_pred eeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC--eeEEEeeecccccCCCCceeEEEeeccCCchh
Q 043900 644 FGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVKILTACSGVDYQGNDFKALVFEFMQNRSLE 721 (953)
Q Consensus 644 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 721 (953)
--.||+++.+++. .|++|+.+.... ..+++..|...+..+.... ++..+....+......+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~-~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRR-RFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCC-CEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCC-EEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 3589999987664 789999875422 3456677888887773221 22222221111123346678899999875432
Q ss_pred hc--------------cccCCcCCcccCCccccCH-------------------H---HHHHHHHHHHHHHHHH-hhCCC
Q 043900 722 EW--------------LHPITREDKTEEAPRSLNL-------------------L---QRLNIGIDVACALSYL-HHDCQ 764 (953)
Q Consensus 722 ~~--------------l~~~~~~~~~~~~~~~l~~-------------------~---~~~~i~~~i~~~L~~L-H~~~~ 764 (953)
.. ++..... .........++ . .....+.++...+.-. .+...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~-~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRK-QLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTS-SCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCHHHHHHHHHHHHHHHhhccc-CCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 11 0000000 00000011111 1 1222233333332222 12224
Q ss_pred CCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 765 PPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 765 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
.+++|+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 579999999999999743 45899998874
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.88 E-value=4.7e-05 Score=70.65 Aligned_cols=86 Identities=13% Similarity=0.193 Sum_probs=36.3
Q ss_pred Cccccceeeccccccccc----cCCcccCCCcccEEeccccccccc----CCccccccccccceec--ccccccC----C
Q 043900 98 SLSKIEHLSVSVNNLTGS----IPSSLGNLSSINTLFLTDNNLDGG----IPDTFGWLKNLATLAM--AENWLSG----T 163 (953)
Q Consensus 98 ~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~----~ 163 (953)
..++|++|+|++|.+... +-..+...++|+.+++++|.++.. +.+.+...++|+.++| ++|.+.. .
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 444455555555544321 112234445555555555555321 1233444445544332 3344431 1
Q ss_pred CCCcccccccceEEecCCcc
Q 043900 164 IPSSIFNISSITAFDAGMNQ 183 (953)
Q Consensus 164 ~p~~l~~l~~L~~L~L~~N~ 183 (953)
+.+.+...++|+.|+++.+.
T Consensus 124 La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCCCcCEEeCcCCC
Confidence 22233344455555555443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.0074 Score=61.79 Aligned_cols=172 Identities=12% Similarity=0.002 Sum_probs=85.3
Q ss_pred CcCHHHHHHhhcCCcccCc-----ccccceeeEEEEEEcCCCeEEEEEEeeccchhhHHHHHHHHHHHhhcCCCC--eeE
Q 043900 620 NISYQNLYNATDGFASANE-----IGVGSFGSVYKGILDQGKTTVAVKVFNLLHHGAFKSFIAECNTLKNIRHRN--LVK 692 (953)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~-----ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~ 692 (953)
..+.+++......|.+.+. |..|.--+.|+.+..++ .+++|++.... ..+.+..|++++..+...+ +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g--~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC--cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 3466788888888877554 34566678999988765 48999986432 2234455666666663221 111
Q ss_pred EEeeeccc-ccCCCCceeEEEeeccCCchhhccc--------------cCCcCCc-ccCCcc----------------cc
Q 043900 693 ILTACSGV-DYQGNDFKALVFEFMQNRSLEEWLH--------------PITREDK-TEEAPR----------------SL 740 (953)
Q Consensus 693 ~~~~~~~~-~~~~~~~~~lv~e~~~~g~L~~~l~--------------~~~~~~~-~~~~~~----------------~l 740 (953)
.+....+. ...-......++.+..+......-. ....... ...... ..
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 11111000 0111234556666665533321110 0000000 000000 00
Q ss_pred CHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeEecCCCcEEEecccccee
Q 043900 741 NLLQRLNIGIDVACALSYLHH-DCQPPITHCDLKPSNVLLDEEMMAHVSDFGLARF 795 (953)
Q Consensus 741 ~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 795 (953)
........+..+...+...+. ..+.|+||+|+.++||+++.+...-+.||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 001111222222222222221 1345899999999999999988788999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.38 E-value=0.0041 Score=66.03 Aligned_cols=75 Identities=16% Similarity=0.146 Sum_probs=51.3
Q ss_pred cCcccccceeeEEEEEEcCC-------CeEEEEEEeeccchhhHHHHHHHHHHHhhcC-CCCeeEEEeeecccccCCCCc
Q 043900 636 ANEIGVGSFGSVYKGILDQG-------KTTVAVKVFNLLHHGAFKSFIAECNTLKNIR-HRNLVKILTACSGVDYQGNDF 707 (953)
Q Consensus 636 ~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 707 (953)
++.|+.|-.-.+|++...++ .+.|++++..... ......+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 46788899999999987543 3467788775322 2234567888888884 444457777753
Q ss_pred eeEEEeeccCCchh
Q 043900 708 KALVFEFMQNRSLE 721 (953)
Q Consensus 708 ~~lv~e~~~~g~L~ 721 (953)
-.+||||++|..+.
T Consensus 116 ~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 GGRLEEYIPSRPLS 129 (395)
T ss_dssp TEEEECCCCEEECC
T ss_pred CceEEEEeccccCC
Confidence 25899999876553
|